PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Koonce, NA; Levy, J; Hardee, ME; Jamshidi-Parsian, A; Vang, KB; Sharma, S; Raleigh, JA; Dings, RPM; Griffin, RJ				Koonce, Nathan A.; Levy, Joseph; Hardee, Matthew E.; Jamshidi-Parsian, Azemat; Vang, Kieng B.; Sharma, Sunil; Raleigh, James A.; Dings, Ruud P. M.; Griffin, Robert J.			Targeting Artificial Tumor Stromal Targets for Molecular Imaging of Tumor Vascular Hypoxia	PLOS ONE			English	Article							INTERSTITIAL FLUID PRESSURE; RADIATION-THERAPY; ENDOTHELIAL-CELLS; IN-VIVO; CANCER PATIENTS; WINDOW CHAMBER; STEM-CELLS; AGENTS; CLASSIFICATION; HIF-1-ALPHA	Developed and tested for many years, a variety of tumor hypoxia detection methods have been inconsistent in their ability to predict treatment outcomes or monitor treatment efficacy, limiting their present prognostic capability. These variable results might stem from the fact that these approaches are based on inherently wide-ranging global tumor oxygenation levels based on uncertain influences of necrotic regions present in most solid tumors. Here, we have developed a novel non-invasive and specific method for tumor vessel hypoxia detection, as hypoxemia (vascular hypoxia) has been implicated as a key driver of malignant progression, therapy resistance and metastasis. This method is based on high-frequency ultrasound imaging of a-pimonidazole targeted-microbubbles to the exogenously administered hypoxia marker pimonidazole. The degree of tumor vessel hypoxia was assessed in three mouse models of mammary gland carcinoma (4T1, SCK and MMTV-Wnt-1) and amassed up to 20% of the tumor vasculature. In the 4T1 mammary gland carcinoma model, the signal strength of a-pimonidazole targeted-microbubbles was on average 8-fold fold higher in tumors of pimonidazole-injected mice than in non-pimonidazole injected tumor bearing mice or non-targeted microbubbles in pimonidazole-injected tumor bearing mice. Overall, this provides proof of principle for generating and targeting artificial antigens able to be 'created' on-demand under tumor specific microenvironmental conditions, providing translational diagnostic, therapeutic and treatment planning potential in cancer and other hypoxia-associated diseases or conditions.	[Koonce, Nathan A.; Levy, Joseph; Hardee, Matthew E.; Jamshidi-Parsian, Azemat; Sharma, Sunil; Dings, Ruud P. M.; Griffin, Robert J.] Univ Arkansas Med Sci, Dept Radiat Oncol, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA; [Vang, Kieng B.] Univ Arkansas, Ctr Integrat Nanotechnol Sci, Little Rock, AR 72204 USA; [Raleigh, James A.] Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Griffin, RJ (corresponding author), Univ Arkansas Med Sci, Dept Radiat Oncol, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA.	RJGriffin@uams.edu	Dings, Ruud/R-3772-2019; Dings, Kieng Vang/AAW-3189-2021; Koonce, Nathan/AIA-0294-2022	Dings, Ruud/0000-0001-7686-1331; Vang Dings, Kieng/0000-0002-2892-1114; , Nathan/0000-0002-2361-2240; Griffin, Robert/0000-0002-3574-2958	Focused Ultrasound Surgery Foundation; NIH/NCI [CA44114]; Winthrop P. Rockefeller Cancer Institute; Brown Foundation, Houston, TX; Center for Microbial Pathogenesis and Host Inflammatory Responses grant through the NIH National Institute of General Medical Sciences Centers of Biomedical Research Excellence [P20GM103625]; NATIONAL CANCER INSTITUTE [R01CA044114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103625] Funding Source: NIH RePORTER	Focused Ultrasound Surgery Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Winthrop P. Rockefeller Cancer Institute; Brown Foundation, Houston, TX; Center for Microbial Pathogenesis and Host Inflammatory Responses grant through the NIH National Institute of General Medical Sciences Centers of Biomedical Research Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from Focused Ultrasound Surgery Foundation, NIH/NCI grant CA44114, Winthrop P. Rockefeller Cancer Institute and The Brown Foundation, Houston, TX. The study was also supported in part by the Center for Microbial Pathogenesis and Host Inflammatory Responses grant P20GM103625 through the NIH National Institute of General Medical Sciences Centers of Biomedical Research Excellence. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Barnes KD, 2013, INT J HYPERTHER, V29, P474, DOI 10.3109/02656736.2013.817615; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Branco-Price C, 2012, CANCER CELL, V21, P52, DOI 10.1016/j.ccr.2011.11.017; Chou SC, 2004, BRIT J CANCER, V90, P728, DOI 10.1038/sj.bjc.6601585; Chou SC, 1996, BRIT J CANCER, V74, pS213; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; DEWHIRST MW, 1992, RADIAT RES, V130, P171, DOI 10.2307/3578274; Dings RPM, 2005, INT J CANCER, V115, P312, DOI 10.1002/ijc.20850; Dings RPM, 2007, CLIN CANCER RES, V13, P3395, DOI 10.1158/1078-0432.CCR-06-2441; Durand RE, 1998, CANCER RES, V58, P3547; GRAY LH, 1953, BRIT J RADIOL, V26, P638, DOI 10.1259/0007-1285-26-312-638; Griffin RJ, 2012, RADIAT RES, V177, P804, DOI 10.1667/RR2784.1; GROSS MW, 1995, INT J CANCER, V61, P567, DOI 10.1002/ijc.2910610422; Hall EJ, 2012, RADIOBIOLOGY RADIOLO; Hardee ME, 2009, CURR MOL MED, V9, P435, DOI 10.2174/156652409788167122; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Ju M, 2014, CANCER BIOL THER, V15, P683, DOI 10.4161/cbt.28412; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Maftei CA, 2011, STRAHLENTHER ONKOL, V187, P260, DOI 10.1007/s00066-010-2216-0; MELIEF CJM, 1993, CURR OPIN IMMUNOL, V5, P709, DOI 10.1016/0952-7915(93)90125-C; Milosevic M, 2001, CANCER RES, V61, P6400; Milosevic MF, 2014, INT J CANCER, V135, P1692, DOI 10.1002/ijc.28403; Nedosekin DA, 2013, J BIOPHOTONICS, V6, P523, DOI 10.1002/jbio.201200242; Palmer GM, 2011, NAT PROTOC, V6, P1355, DOI 10.1038/nprot.2011.349; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Rofstad EK, 2009, NEOPLASIA, V11, P1243, DOI 10.1593/neo.91152; Ronald JA, 2015, P NATL ACAD SCI USA, V112, P3068, DOI 10.1073/pnas.1414156112; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Song CW, 2014, INT J RADIAT ONCOL, V89, P924, DOI 10.1016/j.ijrobp.2014.03.043; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; TEICHER BA, 1981, CANCER RES, V41, P73; TEICHER BA, 1990, CANCER RES, V50, P3339; Wachsberger P, 2003, CLIN CANCER RES, V9, P1957; Wankhede M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3316299	34	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135607	10.1371/journal.pone.0135607	http://dx.doi.org/10.1371/journal.pone.0135607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308944	gold, Green Submitted, Green Published			2022-12-27	WOS:000360069400067
J	Onwujekwe, O; Mangham-Jefferies, L; Cundill, B; Alexander, N; Langham, J; Ibe, O; Uzochukwu, B; Wiseman, V				Onwujekwe, Obinna; Mangham-Jefferies, Lindsay; Cundill, Bonnie; Alexander, Neal; Langham, Julia; Ibe, Ogochukwu; Uzochukwu, Benjamin; Wiseman, Virginia			Effectiveness of Provider and Community Interventions to Improve Treatment of Uncomplicated Malaria in Nigeria: A Cluster Randomized Controlled Trial	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; SOUTH-EAST NIGERIA; HEALTH FACILITIES; CASE-MANAGEMENT; SCHOOL; EDUCATION; ONCHOCERCIASIS; CHILDREN; PERCEPTIONS; IVERMECTIN	The World Health Organization recommends that malaria be confirmed by parasitological diagnosis before treatment using Artemisinin-based Combination Therapy (ACT). Despite this, many health workers in malaria endemic countries continue to diagnose malaria based on symptoms alone. This study evaluates interventions to help bridge this gap between guidelines and provider practice. A stratified cluster-randomized trial in 42 communities in Enugu state compared 3 scenarios: Rapid Diagnostic Tests (RDTs) with basic instruction (control); RDTs with provider training (provider arm); and RDTs with provider training plus a school-based community intervention (provider-school arm). The primary outcome was the proportion of patients treated according to guidelines, a composite indicator requiring patients to be tested for malaria and given treatment consistent with the test result. The primary outcome was evaluated among 4946 (93%) of the 5311 patients invited to participate. A total of 40 communities (12 in control, 14 per intervention arm) were included in the analysis. There was no evidence of differences between the three arms in terms of our composite indicator (p = 0.36): stratified risk difference was 14% (95% CI -8.3%, 35.8%; p = 0.26) in the provider arm and 1% (95% CI -21.1%, 22.9%; p = 0.19) in the provider-school arm, compared with control. The level of testing was low across all arms (34% in control; 48% provider arm; 37% provider-school arm; p = 0.47). Presumptive treatment of uncomplicated malaria remains an ingrained behaviour that is difficult to change. With or without extensive supporting interventions, levels of testing in this study remained critically low. Governments and researchers must continue to explore alternative ways of encouraging providers to deliver appropriate treatment and avoid the misuse of valuable medicines.	[Onwujekwe, Obinna; Ibe, Ogochukwu; Uzochukwu, Benjamin] Univ Nigeria, Coll Med, Dept Pharmacol & Therapeut, Hlth Policy Res Grp, Enugu, Nigeria; [Mangham-Jefferies, Lindsay; Wiseman, Virginia] Univ London London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Cundill, Bonnie; Alexander, Neal] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Cundill, Bonnie] Univ Leeds, Fac Med & Hlth, Leeds, W Yorkshire, England; [Langham, Julia] Univ London London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Wiseman, Virginia] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia	University of Nigeria; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Leeds; University of London; London School of Hygiene & Tropical Medicine; University of New South Wales Sydney	Wiseman, V (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Global Hlth & Dev, 15-17 Tavistock Pl, London, England.	Virginia.Wiseman@lshtm.ac.uk	Wiseman, Virginia/AAH-5011-2021; Onwujekwe, Obinna/O-6232-2014	Onwujekwe, Obinna/0000-0002-1214-4285; Cundill, Bonnie/0000-0002-3648-820X; Wiseman, Virginia/0000-0002-7911-0741; Mangham-Jefferies, Lindsay/0000-0002-7292-6342	Bill & Melinda Gates Foundation; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The ACT Consortium funded the study through a grant from the Bill & Melinda Gates Foundation to the London School of Hygiene & Tropical Medicine http://www.actconsortium.org/. ClinicalTrials.gov: NCT01350752. The Gates Foundation had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abba K, 2012, COCHRANE REV; Ansah EK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c930; Ayi I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-98; Bastiaens GJH, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001590; Bennett S, INT J EPIDOL, V31, P839; Chandler CIR, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-95; Cohen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048296; Ezeoke OP, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-368; Federal Ministry of Health Nigeria, 2005, FED REP NIG NAT ANT; Hamer DH, JAMA, V297, P2227; HEEREN T, 1987, STAT MED, V6, P79, DOI 10.1002/sim.4780060110; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Kyabayinze DJ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-200; Leslie T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3730; Mangham LJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-155; Mbacham WF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-34; Nonaka D, 2008, PARASITOL INT, V57, P76, DOI 10.1016/j.parint.2007.09.005; Okabayashi H, 2006, PARASITOL INT, V55, P121, DOI 10.1016/j.parint.2005.11.056; Onwujekwe O, 2010, HEALTH POLICY, V94, P144, DOI 10.1016/j.healthpol.2009.09.010; Onwujekwe O, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-246; Paul-Ebhohimhen VA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-4; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-275; Rutstein AS, 2004, DHS COMP REPORTS, V6; Shu EN, 1999, E AFR MED J, V76, P320; Shu EN, 1999, PUBLIC HEALTH, V113, P215, DOI 10.1016/S0033-3506(99)00162-6; Shu EN, 2000, TROP MED INT HEALTH, V5, P222, DOI 10.1046/j.1365-3156.2000.00531.x; Uzochukwu BSC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014627; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2010, GUID TREATM MAL, V2nd; Williams HA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-239; Wiseman V, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-81	31	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0133832	10.1371/journal.pone.0133832	http://dx.doi.org/10.1371/journal.pone.0133832			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309023	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000360069400016
J	Warner, FM; Cragg, JJ; Weisskopf, MG; Kramer, JK				Warner, Freda M.; Cragg, Jacquelyn J.; Weisskopf, Marc G.; Kramer, John K.			Spinal Cord Injury and Migraine Headache: A Population-Based Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; ENDOTHELIAL PROGENITOR CELLS; AUTONOMIC DYSREFLEXIA; RISK-FACTOR; HEALTH; IMPACT; PREVALENCE; COMORBIDITY; OUTCOMES; AURA	Migraine headaches are a common neurological condition, negatively impacting health and quality of life. Among potential risk factors for migraine headache, risk of migraine headaches was elevated in individuals with spinal cord injury (SCI). The association between migraines and SCI is intriguing to consider from the perspective that migraine headaches may be acquired in response to damage in the spinal cord. The primary objective of this study was to further examine the association between SCI and migraine headache, controlling for potential confounding variables. A secondary objective was to determine the impact of migraine headaches on self-perceived health. Data from a sample of 61,047 participants were obtained from the cross-sectional Canadian Community Health Survey. Multivariable logistic regression was used to explore the association between SCI and migraine headache using probability weights and adjusting for confounders. The multivariable age- and sex-adjusted model revealed a strong association between SCI and migraine headache, with an adjusted odds ratio for migraine of 4.82 (95% confidence interval [3.02, 7.67]) among those with SCI compared to those without SCI. Further, individuals who experienced both SCI and migraine tended to report poorer perceived general health compared with the other groups (i.e., SCI and no migraine). In conclusion, this study established a strong association between SCI and migraine headache. Further research is needed to explore the possible mechanisms underlying this relationship. Improvements in clinical practice to minimize this issue could result in significant improvements in quality of life.	[Warner, Freda M.; Kramer, John K.] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada; [Warner, Freda M.; Cragg, Jacquelyn J.; Kramer, John K.] Univ British Columbia, Int Collaborat Repair Discoveries ICORD, Vancouver, BC V5Z 1M9, Canada; [Cragg, Jacquelyn J.; Weisskopf, Marc G.] Harvard Univ, Sch Publ Hlth, Neuroepidemiol Res Grp, Boston, MA 02115 USA	University of British Columbia; University of British Columbia; Harvard University; Harvard T.H. Chan School of Public Health	Kramer, JK (corresponding author), Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada.	kramer@icord.org	Warner, Freda/AAJ-1821-2021					[Anonymous], 2013, EPIDEMIOLOGY; Artto V, 2010, CEREBROVASC DIS, V30, P36, DOI 10.1159/000313608; Beland Yves, 2002, Health Rep, V13, P9; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Carlozzi NE, 2013, ARCH PHYS MED REHAB, V94, P1721, DOI 10.1016/j.apmr.2013.02.024; Charlifue S, 2011, ARCH PHYS MED REHAB, V92, P457, DOI 10.1016/j.apmr.2010.07.237; Cragg JJ, 2013, NEUROLOGY, V81, P1864, DOI 10.1212/01.wnl.0000436074.98534.6e; Cragg JJ, 2013, NEUROLOGY, V81, P723, DOI 10.1212/WNL.0b013e3182a1aa68; Dodick D, 2006, HEADACHE, V46, pS182, DOI 10.1111/j.1526-4610.2006.00602.x; Dryden DM, 2004, SPINAL CORD, V42, P513, DOI 10.1038/sj.sc.3101629; Eising E, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-26; Erickson Jay C, 2010, Continuum (Minneap Minn), V16, P55, DOI 10.1212/01.CON.0000391453.37923.83; Fernandez-de-las-Penas C, 2010, J HEADACHE PAIN, V11, P97, DOI 10.1007/s10194-009-0176-5; Furlan JC, 2011, NEUROLOGY, V77, P792, DOI 10.1212/WNL.0b013e31822afff1; Giannini G, 2012, NEUROL SCI, V33, pS37, DOI 10.1007/s10072-012-1029-6; Hampton NZ, 2001, INT J REHABIL RES, V24, P69, DOI 10.1097/00004356-200103000-00010; Haran MJ, 2005, ARCH PHYS MED REHAB, V86, P2290, DOI 10.1016/j.apmr.2005.07.293; Iida H, 1999, J TRAUMA, V46, P450, DOI 10.1097/00005373-199903000-00018; Krassioukov A, 2009, ARCH PHYS MED REHAB, V90, P682, DOI 10.1016/j.apmr.2008.10.017; Lee ST, 2008, NEUROLOGY, V70, P1510, DOI 10.1212/01.wnl.0000294329.93565.94; Lipton RB, 2005, HEADACHE, V45, pS3, DOI 10.1111/j.1526-4610.2005.4501001.x; Manresa JAB, 2014, CLIN NEUROPHYSIOL, V125, P352, DOI 10.1016/j.clinph.2013.06.186; Martin S, 2001, CAN MED ASSOC J, V164, P1481; Meyers AR, 1999, ARCH PHYS MED REHAB, V80, P1450, DOI 10.1016/S0003-9993(99)90257-5; New PW, 2002, ARCH PHYS MED REHAB, V83, P996, DOI 10.1053/apmr.2002.33100; Noonan VK, 2012, NEUROEPIDEMIOLOGY, V38, P219, DOI 10.1159/000336014; Oksanen T, 2010, ANN EPIDEMIOL, V20, P547, DOI 10.1016/j.annepidem.2010.03.017; Peterlin BL, 2013, NEUROLOGY, V81, P1314, DOI 10.1212/WNL.0b013e3182a824f7; Rodriguez-Osorio X, 2012, NEUROLOGY, V79, P474, DOI 10.1212/WNL.0b013e31826170ce; RUSSELL MB, 1995, INT J EPIDEMIOL, V24, P612, DOI 10.1093/ije/24.3.612; Russell MB, 1996, CEPHALALGIA, V16, P239, DOI 10.1046/j.1468-2982.1996.1604239.x; Sabre L, 2015, CEPHALALGIA; Saunders K, 2008, NEUROLOGY, V70, P538, DOI 10.1212/01.wnl.0000297192.84581.21; SPIERINGS ELH, 1992, HEADACHE, V32, P45, DOI 10.1111/j.1526-4610.1992.hed3201045.x; Terwindt GM, 2000, NEUROLOGY, V55, P624, DOI 10.1212/WNL.55.5.624; Von Korff M, 2005, PAIN, V113, P331, DOI 10.1016/j.pain.2004.11.010; Wang JC, 2014, J SPINAL CORD MED; Wang Shuu-Jiun, 2010, Front Neurol, V1, P16, DOI 10.3389/fneur.2010.00016; Wong SL, 2014, HEALTH REP, V25, P10; Wu JC, 2012, NEUROLOGY, V78, P1051, DOI 10.1212/WNL.0b013e31824e8eaa	40	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135550	10.1371/journal.pone.0135550	http://dx.doi.org/10.1371/journal.pone.0135550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308549	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400063
J	Cai, LL; Yang, YL; Jiao, NZ; Zhang, R				Cai, Lanlan; Yang, Yunlan; Jiao, Nianzhi; Zhang, Rui			Evaluation of Tangential Flow Filtration for the Concentration and Separation of Bacteria and Viruses in Contrasting Marine Environments	PLOS ONE			English	Article							FRESH-WATER; AQUATIC ENVIRONMENTS; DRINKING-WATER; LARGE VOLUMES; ULTRAFILTRATION; SEA; ENUMERATION; ECOSYSTEMS; DIVERSITY; CYTOMETRY	Tangential flow filtration (TFF), which has been widely adopted to concentrate a diverse array of microbes from water, is a promising method of microbial separation or removal. However, it is essential to select an optimal membrane suitable for the specific filtration application. This study evaluated two different scales of TFF systems for concentrating and separating microbes (including bacteria and viruses) from contrasting marine waters. Among bacteria-size membranes, polyvinylidene difluoride (PVDF) membranes showed higher bacterial recovery, but lower viral permeation efficiencies than polyethersulfone (PES) membranes, regardless of environments and scales of TFF. Estuary samples showed significantly higher percentages of bacterial retention than nearshore and ocean samples. For virus-size membranes, a higher viral recovery and lower sorption was observed for regenerated cellulose membrane than PES membranes in the small-scale TFF. Similar viral recoveries were observed between PES membranes in the large-scale TFF, with higher viral concentrations being observed in estuary samples than in nearshore samples. Deep ocean samples showed the lowest recovery of viruses, which was consistent with observations of bacterial recovery. Synthetically, PVDF may be more suitable for the concentration of bacterial cells, while PES would be a better choice for the collection of viruses. When compared with the PES membrane, regenerated cellulose is better for viral concentration, while PES is recommended to obtain bacteria-and virus-free seawater.	[Cai, Lanlan; Yang, Yunlan; Jiao, Nianzhi; Zhang, Rui] Xiamen Univ Xiangan, Inst Marine Microbes & Ecospheres, State Key Lab Marine Environm Sci, Xiamen 361102, Fujian, Peoples R China		Jiao, NZ (corresponding author), Xiamen Univ Xiangan, Inst Marine Microbes & Ecospheres, State Key Lab Marine Environm Sci, Xiamen 361102, Fujian, Peoples R China.	jiao@xmu.edu.cn; ruizhang@xmu.edu.cn		Cai, Lanlan/0000-0002-1084-2848	973 project [2013CB955700]; SOA Project [GASI-03-01-02-05]; NSFC [41376132, 91428308]	973 project(National Basic Research Program of China); SOA Project; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by the 973 project (2013CB955700), the SOA Project (GASI-03-01-02-05), and the NSFC (41376132, 91428308).	Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; BARTHEL KG, 1989, J PLANKTON RES, V11, P1213, DOI 10.1093/plankt/11.6.1213; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Colombet J, 2007, J MICROBIOL METH, V71, P212, DOI 10.1016/j.mimet.2007.08.012; Danovaro R, 2008, NATURE, V454, P1084, DOI 10.1038/nature07268; Dell'Anno A, 2015, P NATL ACAD SCI USA, V112, pE2014, DOI 10.1073/pnas.1422234112; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Hill VR, 2007, APPL ENVIRON MICROB, V73, P4218, DOI 10.1128/AEM.02713-06; Hoffmann SR, 2000, ENVIRON SCI TECHNOL, V34, P3420, DOI 10.1021/es991004a; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; John SG, 2011, ENV MICROBIOL REP, V3, P195, DOI 10.1111/j.1758-2229.2010.00208.x; Lambertini E, 2008, APPL ENVIRON MICROB, V74, P2990, DOI 10.1128/AEM.02246-07; LOGAN KB, 1980, J VIROL METHODS, V1, P87, DOI 10.1016/0166-0934(80)90017-8; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; PAYMENT P, 1989, CAN J MICROBIOL, V35, P932, DOI 10.1139/m89-154; PETRUSEVSKI B, 1995, WATER RES, V29, P1419, DOI 10.1016/0043-1354(94)00269-D; Puro L, 2010, DESALINATION, V264, P249, DOI 10.1016/j.desal.2010.06.034; Sassoubre LM, 2012, J WATER HEALTH, V10, P419, DOI 10.2166/wh.2012.011; Short SM, 2008, AQUAT MICROB ECOL, V51, P13, DOI 10.3354/ame01183; SIM RB, 1985, BIOCHEM J, V232, P883, DOI 10.1042/bj2320883; WARREN RK, 1991, PROCESS BIOCHEM, V26, P337, DOI 10.1016/0032-9592(91)85023-H; WHITEHOUSE BG, 1990, LIMNOL OCEANOGR, V35, P1368, DOI 10.4319/lo.1990.35.6.1368; Williamson KE, 2005, APPL ENVIRON MICROB, V71, P3119, DOI 10.1128/AEM.71.6.3119-3125.2005; Williamson KE, 2003, APPL ENVIRON MICROB, V69, P6628, DOI 10.1128/AEM.69.11.6628-6633.2003; Winget DM, 2005, AQUAT MICROB ECOL, V41, P221, DOI 10.3354/ame041221; Zhang GJ, 2008, J MEMBRANE SCI, V309, P28, DOI 10.1016/j.memsci.2007.10.012	29	31	33	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136741	10.1371/journal.pone.0136741	http://dx.doi.org/10.1371/journal.pone.0136741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305356	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500112
J	Cho, WK; Lian, S; Kim, SM; Seo, BY; Jung, JK; Kim, KH				Cho, Won Kyong; Lian, Sen; Kim, Sang-Min; Seo, Bo Yoon; Jung, Jin Kyo; Kim, Kook-Hyung			Time-Course RNA-Seq Analysis Reveals Transcriptional Changes in Rice Plants Triggered by Rice stripe virus Infection	PLOS ONE			English	Article							GENE-EXPRESSION; DISEASE; STRESS; PHOTOSYNTHESIS; ELONGATION; PROTEIN	Rice stripe virus (RSV) has become a major pathogen of rice. To determine how the rice transcriptome is modified in response to RSV infection, we used RNA-Seq to perform a genome-wide gene expression analysis of a susceptible rice cultivar. The transcriptomes of RSV-infected samples were compared to those of mock-treated samples at 3, 7, and 15 days post-infection (dpi). From 8 to 11% of the genes were differentially expressed (>2-fold difference in expression) in RSV-infected vs. noninfected rice. Among them, 532 genes were differentially expressed at all three time points. Surprisingly, 37.6% of the 532 genes are related to transposons. Gene ontology enrichment analysis revealed that many chloroplast genes were down-regulated in infected plants at 3 and 15 dpi. Expression of genes associated with cell differentiation and flowering was significantly down-regulated in infected plants at 15 dpi. In contrast, most of the up-regulated genes in infected plants concern the cell wall, plasma membrane, and vacuole and are known to function in various metabolic pathways and stress responses. In addition, transcripts of diverse transcription factors gradually accumulated in infected plants with increasing infection time. We also confirmed that the expression of gene subsets (including NBS-LRR domain-containing genes, receptor-like kinase genes, and genes involving RNA silencing) was changed by RSV infection. Taken together, we demonstrated that down-regulation of genes related to photosynthesis and flowering was strongly associated with disease symptoms caused by RSV and that up-regulation of genes involved in metabolic pathways, stress responses, and transcription was related to host defense mechanisms.	[Cho, Won Kyong; Lian, Sen; Kim, Sang-Min; Kim, Kook-Hyung] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul 151921, South Korea; [Cho, Won Kyong; Lian, Sen; Kim, Sang-Min; Kim, Kook-Hyung] Seoul Natl Univ, Coll Agr & Life Sci, Plant Genom & Breeding Inst, Seoul 151921, South Korea; [Seo, Bo Yoon] RDA, Natl Acad Agr Sci, Crop Protect Div, Suwon 441707, South Korea; [Jung, Jin Kyo] RDA, Natl Inst Crop Sci, Crop Environm Res Div, Suwon 441857, South Korea; [Kim, Kook-Hyung] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea	Seoul National University (SNU); Seoul National University (SNU); Rural Development Administration (RDA), Republic of Korea; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; Seoul National University (SNU)	Kim, KH (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul 151921, South Korea.	kookkim@snu.ac.kr	Cho, Won Kyong/I-5098-2012	Cho, Won Kyong/0000-0002-8416-5173; Jung, Jin Kyo/0000-0003-3809-1836	Next-Generation BioGreen 21 Program, the Rural Development Administration [PJ01101301]; Vegetable Breeding Research Center through the Agriculture Research Center program from the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [710001-07-05]; Brain Korea 21 Plus Project	Next-Generation BioGreen 21 Program, the Rural Development Administration; Vegetable Breeding Research Center through the Agriculture Research Center program from the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; Brain Korea 21 Plus Project	This research was supported in part by grants from the Next-Generation BioGreen 21 Program (No. PJ01101301), the Rural Development Administration, and the Vegetable Breeding Research Center (No. 710001-07-05) through the Agriculture Research Center program from the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea. SL and WKC were supported by research fellowships from the Brain Korea 21 Plus Project.	Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Capy P, 2000, HEREDITY, V85, P101, DOI 10.1046/j.1365-2540.2000.00751.x; Choi H, 2013, PLANT PATHOLOGY J, V29, P99, DOI 10.5423/PPJ.NT.09.2012.0142; Cnops G, 2004, J EXP BOT, V55, P1529, DOI 10.1093/jxb/erh165; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dai MQ, 2007, PLANT PHYSIOL, V144, P380, DOI 10.1104/pp.107.095737; Ding WN, 2009, CELL RES, V19, P1309, DOI 10.1038/cr.2009.109; Favaro R, 2003, PLANT CELL, V15, P2603, DOI 10.1105/tpc.015123; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Guo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116175; Guo WX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046443; Hayano-Saito Y, 1998, THEOR APPL GENET, V96, P1044, DOI 10.1007/s001220050837; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Jiang SS, 2014, MOL PLANT PATHOL, V15, P907, DOI 10.1111/mpp.12153; Kong LF, 2014, MOL PLANT, V7, P691, DOI 10.1093/mp/sst158; Kusaba S, 1998, PLANT PHYSIOL, V116, P471, DOI 10.1104/pp.116.2.471; Kwon T, 2012, THEOR APPL GENET, V125, P1033, DOI 10.1007/s00122-012-1893-8; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; Lin Q. Y., 1990, Journal of Fujian Agricultural College, V19, P421; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nosaka M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002953; Otuka A, 2010, APPL ENTOMOL ZOOL, V45, P259, DOI 10.1303/aez.2010.259; Rahoutei J, 2000, PHYSIOL PLANTARUM, V110, P286, DOI 10.1034/j.1399-3054.2000.110220.x; Sasaya T, 2013, FRONTIERS MICROBIOLO, P4; Sato Y, 1999, EMBO J, V18, P992, DOI 10.1093/emboj/18.4.992; Satoh K, 2010, J GEN VIROL, V91, P294, DOI 10.1099/vir.0.015990-0; Shimizu T, 2007, MOL PLANT MICROBE IN, V20, P247, DOI 10.1094/MPMI-20-3-0247; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Wang HD, 2008, PLANT DIS, V92, P1190, DOI 10.1094/PDIS-92-8-1190; Wang Q, 2014, NATURE COMMUNICATION, P5; Wu XJ, 2011, THEOR APPL GENET, V122, P915, DOI 10.1007/s00122-010-1498-z; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591; Yu L., 2014, AGR SCI TECHNOLOGY, V15, P809; Zhang LY, 2009, PLANT CELL, V21, P3767, DOI 10.1105/tpc.109.070441; Zhao F, 2010, PLANT MOL BIOL REP, V28, P512, DOI 10.1007/s11105-009-0178-0; Zheng WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082126; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z	39	22	22	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136736	10.1371/journal.pone.0136736	http://dx.doi.org/10.1371/journal.pone.0136736			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305329	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500111
J	Murphy, RD; Scyphers, SB; Grabowski, JH				Murphy, Robert D., Jr.; Scyphers, Steven B.; Grabowski, Jonathan H.			Assessing Fishers' Support of Striped Bass Management Strategies	PLOS ONE			English	Article							MARINE; PARTICIPATION; STAKEHOLDERS; REGULATIONS; PERCEPTIONS; RESOURCES	Incorporating the perspectives and insights of stakeholders is an essential component of ecosystem-based fisheries management, such that policy strategies should account for the diverse interests of various groups of anglers to enhance their efficacy. Here we assessed fishing stakeholders' perceptions on the management of Atlantic striped bass (Morone saxatilis) and receptiveness to potential future regulations using an online survey of recreational and commercial fishers in Massachusetts and Connecticut (USA). Our results indicate that most fishers harbored adequate to positive perceptions of current striped bass management policies when asked to grade their state's management regime. Yet, subtle differences in perceptions existed between recreational and commercial fishers, as well as across individuals with differing levels of fishing experience, resource dependency, and tournament participation. Recreational fishers in both states were generally supportive or neutral towards potential management actions including slot limits (71%) and mandated circle hooks to reduce mortality of released fish (74%), but less supportive of reduced recreational bag limits (51%). Although commercial anglers were typically less supportive of management changes than their recreational counterparts, the majority were still supportive of slot limits (54%) and mandated use of circle hooks (56%). Our study suggests that both recreational and commercial fishers are generally supportive of additional management strategies aimed at sustaining healthy striped bass populations and agree on a variety of strategies. However, both stakeholder groups were less supportive of harvest reductions, which is the most direct measure of reducing mortality available to fisheries managers. By revealing factors that influence stakeholders' support or willingness to comply with management strategies, studies such as ours can help managers identify potential stakeholder support for or conflicts that may result from regulation changes.	[Murphy, Robert D., Jr.; Scyphers, Steven B.; Grabowski, Jonathan H.] Northeastern Univ, Ctr Marine Sci, Dept Marine & Environm Sci, Nahant, MA 01908 USA	Northeastern University	Murphy, RD (corresponding author), Northeastern Univ, Ctr Marine Sci, Dept Marine & Environm Sci, Nahant, MA 01908 USA.	murphy.rob@husky.neu.edu		Murphy, Robert/0000-0003-1701-2051; Grabowski, Jonathan/0000-0003-4711-5481	National Science Foundation SEES [OCE-1215828]; NOAA Saltonstall-Kennedy [NA14NMF4270030]	National Science Foundation SEES; NOAA Saltonstall-Kennedy	Funding was provided by the National Science Foundation SEES Fellowship (OCE-1215828) and NOAA Saltonstall-Kennedy (NA14NMF4270030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1997, STAT METHODS SOCIAL; [Anonymous], 2008, 46 NE REG STOCK ASS; Atlantic States Marine Fisheries Commission, 2003, AM 6 INT FISH MAN PL; Atlantic States Marine Fisheries Commission, 2014, ADD 4 AM 6 ATL STRIP; Atlantic States Marine Fisheries Commission, 2013, UPD STRIP BASS STOCK; Atlantic States Marine Fisheries Commission, 2012, REV ATL MAR FISH COM; CARUSO PG, 2000, F57R MASS DIV MAR FI; Cinner JE, 2006, ENVIRON CONSERV, V33, P73, DOI 10.1017/S0376892906002748; Close DA, 2002, FISHERIES, V27, P19, DOI 10.1577/1548-8446(2002)027<0019:TEACIO>2.0.CO;2; Coffey C, 2005, REV M T FIS, V4, P27; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Cooke SJ, 2004, AQUAT CONSERV, V14, P299, DOI 10.1002/aqc.614; Cooke SJ, 2006, BIOL CONSERV, V128, P93, DOI 10.1016/j.biocon.2005.09.019; Crosson S., 2009, SOCIAL EC ANAL COMME; Ferber R, 1952, J MARKETING, P171; Gelcich S, 2008, ENVIRON CONSERV, V35, P36, DOI 10.1017/S0376892908004475; Halpern BS, 2014, MARINE COMMUNITY ECOLOGY AND CONSERVATION, P477; Hatcher A, 2000, LAND ECON, V76, P448, DOI 10.2307/3147040; Hilborn R, 2007, FISH FISH, V8, P285, DOI 10.1111/j.1467-2979.2007.00263_2.x; JENTOFT S, 1995, MAR POLICY, V19, P227, DOI 10.1016/0308-597X(94)00010-P; Mackinson S, 2011, MAR POLICY, V35, P18, DOI 10.1016/j.marpol.2010.07.003; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; Mikalsen KH, 2001, MAR POLICY, V25, P281, DOI 10.1016/S0308-597X(01)00015-X; Muoneke Maurice I., 1994, Reviews in Fisheries Science, V2, P123; National Marine Fisheries Service, 2014, NMFSFSPO137 NOAA; Oh CO, 2006, LEISURE SCI, V28, P369, DOI 10.1080/01490400600745886; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Pierce Rodney B., 1998, North American Journal of Fisheries Management, V18, P720, DOI 10.1577/1548-8675(1998)018&lt;0720:ANWSLL&gt;2.0.CO;2; Quinn T.P., 2011, BEHAV ECOLOGY PACIFI; Richards R. Anne, 1999, North American Journal of Fisheries Management, V19, P356, DOI 10.1577/1548-8675(1999)019&lt;0356:ACHOEF&gt;2.0.CO;2; Scyphers SB, 2013, N AM J FISH MANAGE, V33, P1071, DOI 10.1080/02755947.2013.824932; Shrestha RK, 2002, ECOL ECON, V42, P289, DOI 10.1016/S0921-8009(02)00106-4; Storey David A., 1993, North American Journal of Fisheries Management, V13, P698, DOI 10.1577/1548-8675(1993)013&lt;0698:EIOMRF&gt;2.3.CO;2; United States Congress, 1994, ATL STRIP BASS CONS; Vaughan DS, 2002, N AM J FISH MANAGE, V22, P895, DOI 10.1577/1548-8675(2002)022<0895:EIISPR>2.0.CO;2	35	11	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136412	10.1371/journal.pone.0136412	http://dx.doi.org/10.1371/journal.pone.0136412			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305324	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500075
J	Oliver, RA; Lovric, V; Yu, Y; Christou, C; Aiken, SS; Cooper, JJ; Walsh, WR				Oliver, Rema A.; Lovric, Vedran; Yu, Yan; Christou, Chris; Aiken, Sean S.; Cooper, John J.; Walsh, William R.			Development of a Novel Model for the Assessment of Dead-Space Management in Soft Tissue	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; BIOABSORBABLE BONE SUBSTITUTE; LOCAL ANTIBIOTIC DELIVERY; IN-VITRO ELUTION; CALCIUM-SULFATE; EXPERIMENTAL OSTEOMYELITIS; GRAFT SUBSTITUTE; FLAP TRANSFER; GENTAMICIN; TOBRAMYCIN	Following extensive surgical debridement in the treatment of infection, a "dead space" can result following surgical closure that can fill with hematoma, an environment conducive to bacterial growth. The eradication of dead space is essential in order to prevent recurrent infection. This study describes a novel small animal model to investigate dead-space management in muscle tissue. Two absorbable test materials were implanted in each animal; beads of calcium sulfate alone, and beads loaded with vancomycin and tobramycin. In-life blood samples and radiographs were taken from each animal following implantation. Animals were sacrificed at 1, 7, 21, 42, and 63 days post-operatively (n = 4), and implant sites were analysed by micro-computed tomography, histology and immunohistochemistry. Complete resorption was confirmed radiographically at 3 weeks post-implantation. Histologically, the host tissue response to both materials was identical, and subsequent healing at the implant sites was observed with no dead space remaining. Vancomycin was not detected in blood serum. However, peak tobramycin levels were detected in all animals at 6 hours post-implantation with no detectable levels in any animals at 72 hours post implantation. Serological inflammatory cytokine expression for IL-6, TNF-alpha and IL-1 beta indicated no unusual inflammatory response to the implanted materials or surgical procedure. The model was found to be convenient and effective for the assessment of implant materials for management of dead space in muscle tissue. The two materials tested were effective in resolving the surgically created dead space, and did not elicit any unexpected adverse host response.	[Oliver, Rema A.; Lovric, Vedran; Yu, Yan; Christou, Chris; Walsh, William R.] Univ New S Wales, Surg & Orthopaed Res Labs, Sydney, NSW, Australia; [Oliver, Rema A.; Lovric, Vedran; Yu, Yan; Christou, Chris; Walsh, William R.] Prince Wales Hosp, Prince Wales Clin Sch, Randwick, NSW 2031, Australia; [Aiken, Sean S.; Cooper, John J.] Biocomposites Ltd, Keele Sci Pk, Staffs, England	University of New South Wales Sydney	Walsh, WR (corresponding author), Univ New S Wales, Surg & Orthopaed Res Labs, Sydney, NSW, Australia.	w.walsh@unsw.edu.au		Walsh, William/0000-0002-5023-6148; Christou, Chris/0000-0003-3231-0356	Biocomposites	Biocomposites	This study was funded by Biocomposites. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Anagnostakos K, 2006, ACTA ORTHOP, V77, P628, DOI 10.1080/17453670610012719; ANTHONY JP, 1991, PLAST RECONSTR SURG, V88, P311, DOI 10.1097/00006534-199108000-00023; Auregan JC, 2010, ORTHOP TRAUMATOL-SUR, V96, P180, DOI [10.1016/j.rcot.2010.02.013, 10.1016/j.otsr.2009.11.008]; Beardmore AA, 2005, J BONE JOINT SURG AM, V87A, P107, DOI 10.2106/JBJS.C.01670; BOWYER GW, 1994, J TRAUMA, V36, P331, DOI 10.1097/00005373-199403000-00008; Brown D. E., 2004, ORTHOPAEDIC SECRETS; Cohen J C, 1988, J Arthroplasty, V3, P369, DOI 10.1016/S0883-5403(88)80040-8; Della Valle AG, 2001, ACTA ORTHOP SCAND, V72, P237; Deresinski S, 2007, CLIN INFECT DIS, V44, P1543, DOI 10.1086/518452; Disch AC, 2007, ARCH ORTHOP TRAUM SU, V127, P691, DOI 10.1007/s00402-006-0263-x; ECKMAN JB, 1988, CLIN ORTHOP RELAT R, P213; Garazzino S, 2008, CLIN PHARMACOKINET, V47, P793, DOI 10.2165/0003088-200847120-00004; Gitelis Steven, 2002, J Orthop Surg (Hong Kong), V10, P53; Guelinckx PJ, 1995, MICROSURG, V16, P606, DOI 10.1002/micr.1920160906; HENRY SL, 1995, CLIN PHARMACOKINET, V29, P36, DOI 10.2165/00003088-199529010-00005; HENRY SL, 1993, CLIN ORTHOP RELAT R, P54; Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b; Howlin RP, 2014, ANTIMICROBIAL AGENTS; Kallala R, 2014, INT C JOINT REC PAN; Kanellakopoulou K, 2009, INT J ANTIMICROB AG, V33, P354, DOI 10.1016/j.ijantimicag.2008.09.008; Kim S, 2011, J MATER SCI-MATER M, V22, P2773, DOI 10.1007/s10856-011-4445-x; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Maale G. E., 2012, AM AC ORTH SURG ANN, P75; MACKEY D, 1982, CLIN ORTHOP RELAT R, P263; Manoso MW, 2006, ANN PLAS SURG, V56, P532, DOI 10.1097/01.sap.0000203990.08414.ad; MATZKE GR, 1986, CLIN PHARMACOKINET, V11, P257, DOI 10.2165/00003088-198611040-00001; McKee MD, 2002, J ORTHOP TRAUMA, V16, P622, DOI 10.1097/00005131-200210000-00002; Mckee MD, 2010, J ORTHOP TRAUMA, V24, P483, DOI 10.1097/BOT.0b013e3181df91d9; McPherson EJ, 2014, SPEC DAY SCI M KNEE, P76; McPherson EJ, 2013, RECONSTRUCT REV, V3, P32, DOI DOI 10.15438/RR.V3I1.27; Messina GA, 2008, ANAL BIOCHEM, V380, P262, DOI 10.1016/j.ab.2008.05.055; MIESCHER GC, 1989, IMMUNOL LETT, V23, P113, DOI 10.1016/0165-2478(89)90122-3; Nayar D, 2013, 32 ANN M EUR BON JOI; Nelson CL, 2002, J ORTHOP RES, V20, P643, DOI 10.1016/S0736-0266(01)00133-4; NELSON CL, 1992, CLIN ORTHOP RELAT R, P303; Neut D, 2001, J ANTIMICROB CHEMOTH, V47, P885, DOI 10.1093/jac/47.6.885; NORDEN CW, 1970, J INFECT DIS, V122, P410, DOI 10.1093/infdis/122.5.410; PRIGGE EK, 1946, J BONE JOINT SURG, V28, P576; Rodrigues LR, 2011, ADV EXP MED BIOL, V715, P351, DOI 10.1007/978-94-007-0940-9_22; Santschi EM, 2003, VET SURG, V32, P128, DOI 10.1053/jvet.2003.50010; Schlatterer D, 2014, 24 ANN SCI M LIMB LE; Skhirtladze K, 2006, ANTIMICROB AGENTS CH, V50, P1372, DOI 10.1128/AAC.50.4.1372-1375.2006; Stoodley P, 2008, J BONE JOINT SURG AM, V90A, P1751, DOI 10.2106/JBJS.G.00838; Swords K, 2013, J SEX MED, V10, P1162, DOI 10.1111/jsm.12060; Thomas DB, 2005, CLIN ORTHOP RELAT R, P366, DOI 10.1097/01.blo.0000181144.01306.b0; Turner TM, 2005, CLIN ORTHOP RELAT R, P97, DOI 10.1097/01.blo.0000175127.37343.0d; Turner TM, 2001, J BONE JOINT SURG AM, V83A, P8, DOI 10.2106/00004623-200100021-00003; Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]; WAHLIG H, 1978, J BONE JOINT SURG BR, V60, P270, DOI 10.1302/0301-620X.60B2.659478; WATANAKUNAKORN C, 1982, ANTIMICROB AGENTS CH, V22, P903, DOI 10.1128/AAC.22.5.903; Wenke JC, 2006, J BONE JOINT SURG BR, V88B, P1102, DOI 10.1302/0301-620X.88B8.17368; Whiteside LA, 2006, CLIN ORTHOP RELAT R, P203, DOI 10.1097/01.blo.0000246538.75123.db; Whiteside LA, 2013, CLIN ORTHOP RELAT R, V471, P221, DOI 10.1007/s11999-012-2532-z; Whitlark JD, 2013, 23 ANN OP SCI M MUSC; Winkler H, 2009, INT J MED SCI, V6, P247; Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031; Yao X, 2001, MODERN PATHOL, V14, P105, DOI 10.1038/modpathol.3880265; Younger AS, 2004, TECHNIQUES FOOT ANKL, V3, P177; Younger ASE, 1998, J BONE JOINT SURG AM, V80A, P60, DOI 10.2106/00004623-199801000-00011; Yu Y, 1998, Bull Hosp Jt Dis, V57, P23; Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020	62	79	79	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136514	10.1371/journal.pone.0136514	http://dx.doi.org/10.1371/journal.pone.0136514			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305692	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500088
J	Ozeki, M; Salah, A; Aini, W; Tamaki, K; Haga, H; Miyagawa-Hayashino, A				Ozeki, Munetaka; Salah, Adeeb; Aini, Wulamujiang; Tamaki, Keiji; Haga, Hironori; Miyagawa-Hayashino, Aya			Abnormal Localization of STK17A in Bile Canaliculi in Liver Allografts: An Early Sign of Chronic Rejection	PLOS ONE			English	Article							DUCT LOSS; ANTIVIRAL THERAPY; PROTEIN-KINASE; HLA ANTIBODIES; EXPRESSION; PREDICTION; EVOLUTION; GENE	The biological significance of STK17A, a serine/threonine kinase, in the liver is not known. We analyzed STK17A expression in HepG2 cells and human liver tissue. Accordingly, we investigated whether STK17A could help in identifying earlier changes during the evolution of chronic rejection (CR) after liver transplantation. RT-PCR and immunofluorescence were used to analyze STK17A expression in HepG2 cells. Antibody microarray was performed using human liver samples from CR and healthy donors. Immunohistochemistry was used to verify the clinical utility of STK17A on sequential biopsies for the subsequent development of CR. A novel short isoform of STK17A was found in HepG2 cells. STK17A was localized in the nuclei and bile canaliculi in HepG2 cells and human livers. Microarray of STK17A revealed its decrease in failed liver allografts by CR. During the evolution of CR, the staining pattern of bile canalicular STK17A gradually changed from diffuse linear to focal intermittent. The focal intermittent staining pattern was observed before the definite diagnosis of CR. In conclusion, the present study was the first to find localization of STK17A in normal bile canaliculi. Abnormal expression and localization of STK17A were associated with CR of liver allografts since the early stage of the rejection process.	[Ozeki, Munetaka; Tamaki, Keiji] Kyoto Univ, Grad Sch Med, Dept Forens Med, Kyoto, Japan; [Salah, Adeeb; Haga, Hironori] Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto 606, Japan; [Aini, Wulamujiang] Kocaeli Univ, Diabet & Res Lab, Expt & Clin Res Ctr, Izmit, Turkey; [Miyagawa-Hayashino, Aya] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan	Kyoto University; Kyoto University; Kocaeli University; Kyoto University	Miyagawa-Hayashino, A (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan.	ayam@kuhp.kyoto-u.ac.jp		Salah, Adeeb/0000-0002-3599-0521; Haga, Hironori/0000-0003-4322-9561	Japan Society for the Promotion of Science [26460450]; Fujiwara Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fujiwara Memorial Foundation	The Japan Society for the Promotion of Science (26460450, AM-H), Fujiwara Memorial Foundation (MO).	Bellizzi AM, 2011, AM J CLIN PATHOL, V135, P238, DOI 10.1309/AJCPNRXCAP92KNOJ; Blakolmer K, 2000, TRANSPLANTATION, V69, P2330, DOI 10.1097/00007890-200006150-00019; Blakolmer K, 1999, AM J SURG PATHOL, V23, P1328, DOI 10.1097/00000478-199911000-00003; Demetris A, 2000, HEPATOLOGY, V31, P792, DOI DOI 10.1002/HEP.510310337; Fernandez I, 2009, LIVER TRANSPLANT, V15, P948, DOI 10.1002/lt.21780; Fitzgerald J, 2004, TRENDS GENET, V20, P408, DOI 10.1016/j.tig.2004.07.002; Fu D, 2010, J CELL SCI, V123, P3294, DOI 10.1242/jcs.068098; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kojima H, 2001, J BIOL CHEM, V276, P19238, DOI 10.1074/jbc.M101023200; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lam P, 2010, SEMIN LIVER DIS, V30, P125, DOI 10.1055/s-0030-1253222; Lautenschlager I, 1997, HEPATOLOGY, V25, P190, DOI 10.1002/hep.510250135; Lunz JG, 2001, AM J PATHOL, V158, P1379, DOI 10.1016/S0002-9440(10)64089-8; Mao P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081803; Mao P, 2011, J BIOL CHEM, V286, P19381, DOI 10.1074/jbc.M111.218040; MATSUMOTO Y, 1993, TRANSPLANTATION, V56, P69, DOI 10.1097/00007890-199307000-00012; Miyagawa-Hayashino A, 2012, LIVER TRANSPLANT, V18, P1333, DOI 10.1002/lt.23534; Musat AI, 2011, AM J TRANSPLANT, V11, P500, DOI 10.1111/j.1600-6143.2010.03414.x; Neil DAH, 2002, HEPATOLOGY, V35, P639, DOI 10.1053/jhep.2002.31726; Neubueser D, 2010, MOL BIOL CELL, V21, P2869, DOI 10.1091/mbc.E10-04-0328; O'Leary JG, 2011, AM J TRANSPLANT, V11, P1868, DOI 10.1111/j.1600-6143.2011.03593.x; OGUMA S, 1989, HEPATOLOGY, V9, P204, DOI 10.1002/hep.1840090207; Park Y, 2015, ONCOGENE, V34, P5037, DOI 10.1038/onc.2014.423; Salah A, 2014, LIVER TRANSPLANT, V20, P200, DOI 10.1002/lt.23789; Sanjo H, 1998, J BIOL CHEM, V273, P29066, DOI 10.1074/jbc.273.44.29066; Taylor SS, 2012, PHILOS T R SOC B, V367, P2517, DOI 10.1098/rstb.2012.0054; Temmerman K, 2013, FEBS J, V280, P5533, DOI 10.1111/febs.12384; Treyer A, 2013, COMPR PHYSIOL, V3, P243, DOI 10.1002/cphy.c120009; Ueda Y, 2014, TRANSPLANTATION, V97, P344, DOI 10.1097/01.TP.0000435702.61642.0a; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang M, 2006, GENE, V366, P219, DOI 10.1016/j.gene.2005.07.015; Woods A, 2011, BIOCHEM J, V434, P49, DOI 10.1042/BJ20101721; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	34	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136381	10.1371/journal.pone.0136381	http://dx.doi.org/10.1371/journal.pone.0136381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305096	Green Submitted, Green Published, gold			2022-12-27	WOS:000359995500073
J	Shumbej, T; Belay, T; Mekonnen, Z; Tefera, T; Zemene, E				Shumbej, Teha; Belay, Tariku; Mekonnen, Zeleke; Tefera, Tamirat; Zemene, Endalew			Soil-Transmitted Helminths and Associated Factors among Pre-School Children in Butajira Town, South-Central Ethiopia: A Community-Based Cross-Sectional Study	PLOS ONE			English	Article							INTESTINAL PARASITIC INFECTIONS; PREVALENCE; IMPACT; EPIDEMIOLOGY	Background Soil-transmitted helminths (STH) remain a major public health problem, particularly in tropical and sub-tropical regions of the world. Though infections are prevalent among all age groups, the world health organization (WHO) considers Pre-school age children (PSAC), school-aged children, and pregnant women as segments of population at high risk of STH morbidities. Objective This study aimed at determining the prevalence and infection intensity of STH and associated factors among PSAC in Butajira Town, south-central Ethiopia. Methods A community-based cross-sectional study was conducted from May to June, 2014 in Butajira Town. The PSAC were selected by systematic sampling technique and invited to participate in the present study. McMaster technique was employed for parasitological analysis of stool samples. Pearson's Chi-square and Fisher's exact tests were performed where appropriate to identify any association between STH infection and independent factors. Multivariate logistic regression model was fitted to identify independent predictors of STH among the PSAC. P-value less than 0.05 was considered statistically significant. Results A total of 377 (with 96% compliance rate) PSAC were able to provide complete data (socio-demographic information and stool sample). The study showed that 23.3%(88/377) PSAC were infected with one or more species of STH. Ascaris lumbricoides was the most prevalent STH (14.9%) followed by Trichuris trichiura (6.4%). The overall infection intensity, expressed as geometric mean for A. lumbricoides, T. trichiura, and hookworms were 229, 178, and 154 eggs per gram of stool, respectively. The multivariate logistic regression model estimated that being in the age group of 36-47 months (AOR: 2.5, 95% CI: 1.2-5.3, P = 0.016), untrimmed finger nail (AOR: 3.2, 95% CI: 1.8-5.5, P < 0.001), and not washing hands before a meal (AOR: 3.0, 95% CI: 1.7-5.4, P < 0.001) were independent predictors of STH infections among the children. Conclusion The present study showed that STH was a public health problem among PSAC in the study area necessitating annual deworming to control morbidities associated with STH. Besides, the existing health education program should also be strengthened to prevent re-infection.	[Shumbej, Teha] Butajira Hosp, Dept Diagnost Lab, Butajira, Ethiopia; [Belay, Tariku; Mekonnen, Zeleke; Tefera, Tamirat; Zemene, Endalew] Jimma Univ, Coll Hlth Sci, Dept Med Lab Sci & Pathol, Jimma, Ethiopia	Jimma University	Tefera, T (corresponding author), Jimma Univ, Coll Hlth Sci, Dept Med Lab Sci & Pathol, Jimma, Ethiopia.	tamirat.tefera@ju.edu.et	Mekonnen, Zeleke/AAF-3877-2020; Zemene, Endalew/HHS-0999-2022	Mekonnen, Zeleke/0000-0003-3418-7291; Zemene, Endalew/0000-0001-6810-5800; Temesgen, Tamirat Tefera/0000-0002-6946-5055	Jimma University	Jimma University	TS received funding from Jimma University (www.ju.edu.et). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abera B, 2013, J INFECT DEV COUNTR, V7, P253, DOI 10.3855/jidc.2539; Abera Kumie, 2005, Ethiopian Journal of Health Development, V19, P89; Alfonso Rodriguez-Morales, 2012, CURRENT TOPICS IN TR; [Anonymous], 2012, WHO TECH REP SER, V972, P1; Belyhun Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-21; Brooker S, 2006, ADV PARASIT, V62, P221, DOI 10.1016/S0065-308X(05)62007-6; Crompton DWT, 2002, ANNU REV NUTR, V22, P35, DOI 10.1146/annurev.nutr.22.120501.134539; Dana D, 2015, T ROY SOC TROP MED H, V109, P225, DOI 10.1093/trstmh/tru178; de Silva NR, 2003, ACTA TROP, V86, P197, DOI 10.1016/S0001-706X(03)00035-4; EFMHACA, 2013, ETHIOPIAN MEDICINES; Haileamlak A., 2005, ETHIOP J HEALTH SCI, V15, P107; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Kirwan P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-20; Kounnavong S, 2011, T ROY SOC TROP MED H, V105, P160, DOI 10.1016/j.trstmh.2010.11.011; Levecke B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001201; Mokua D. O., 2014, Journal of Biology, Agriculture and Healthcare, V4, P36; Montresor A, 2012, HELMINTH CONTROL IN; Nasr NA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-27; Ngui R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001550; Nkengazong L., 2010, African Journal of Environmental Science and Technology, V4, P115; Nyantekyi LA, 2010, ETHIOP J HEALTH DEV, V24, P185; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Roy E, 2011, S AFR J CHILD HEALTH, V5, P78; Sah RB, 2013, INDAN J COMMUNITY HE, V25, P134; Sousa-Figueiredo JC, 2008, PARASITOLOGY, V135, P1; Sowemimo OA, 2011, J HELMINTHOL, V85, P234, DOI 10.1017/S0022149X10000489; Stephenson LS, 2000, PARASITOLOGY, V121, pS23, DOI 10.1017/S0031182000006491; Tadesse Z, 2008, T ROY SOC TROP MED H, V102, P213, DOI 10.1016/j.trstmh.2007.09.005; Unasho A, 2013, INT J CHILD HEALTH N, V2, P212, DOI 10.6000/1929-4247.2013.02.03.3; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Weldon A, NEW NTD DATA TO INFO; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; WHO, 2012, EL SOIL TRANSM HELM; *WHO, PREV CONTR SCHIST SO; who, PREVENTIVE CHEMOTHER; World Health Organization, 2002, WHO TRADITIONAL MED, P1; World Health Organization (WHO), SOIL TRANSM HELM	37	28	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136342	10.1371/journal.pone.0136342	http://dx.doi.org/10.1371/journal.pone.0136342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305361	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500067
J	Xu, MM; Che, L; Wang, DY; Yang, ZG; Zhang, P; Lin, Y; Fang, ZF; Che, LQ; Li, J; Chen, DW; Wu, D; Xu, SY				Xu, Mengmeng; Che, Long; Wang, Dingyue; Yang, Zhenguo; Zhang, Pan; Lin, Yan; Fang, Zhengfeng; Che, Lianqiang; Li, Jian; Chen, Daiwen; Wu, De; Xu, Shengyu			Proteomic Analysis of Fetal Ovary Reveals That Ovarian Developmental Potential Is Greater in Meishan Pigs than in Yorkshire Pigs	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; IN-VITRO; OOCYTE QUALITY; EXPRESSION; ALPHA; MATURATION; PROTEINS; MARKERS; IMMUNOLOCALIZATION; IMMATURE	Time-dependent expression of functional proteins in fetal ovaries is important to understand the developmental process of the ovary. This study was carried out to enhance our understanding of the developmental process of porcine fetal ovaries and to better address the differences in fetal ovary development of local and foreign pigs. The objective of the present study is to test the expression of key proteins that regulate the growth and development of fetal ovaries in Meishan and Yorkshire porcine breeds by using proteomics technology. Six Meishan and 6 Yorkshire pregnant gilts were used in this experiment. Fetal ovaries were obtained from Yorkshire and Meishan gilts on days 55 and 90 of the gestation period. Using 2D-DIGE (two dimensional-difference in gel electrophoresis) analysis, the results showed that there are about 1551 and 1400 proteins in gilt fetal ovaries on days 55 and 90, respectively of the gestation. Using MALDI TOF-TOF MS analysis, 27 differentially expressed proteins were identified in the fetal ovaries of the 2 breeds on day 55 of gestation, and a total of 18 proteins were identified on day 90 of gestation. These differentially expressed proteins were involved in the regulation of biological processes (cell death, stress response, cytoskeletal proteins) and molecular functions (enzyme regulator activity). We also found that alpha-1-antitrypsin, actin, vimentin, and PP2A proteins promote the formation of primordial follicles in the ovaries of Yorkshire pigs on day 55 of gestation while low expression heat shock proteins and high expression alpha-fetoproteins (AFP) may promote Meishan fetal ovarian follicular development on day 90 of gestation. These findings provide a deeper understanding of how reduced expression of heat shock proteins and increased expression of AFP can significantly reduce the risk of reproductive disease in obese Meishan sows. Our study also shows how these proteins can increase the ovulation rate and may be responsible for the low reproductive efficiency reported in other obese breeds. The ovarian developmental potential was found to be greater in Meishan pigs than in Yorkshire pigs.	[Xu, Mengmeng; Che, Long; Yang, Zhenguo; Zhang, Pan; Lin, Yan; Fang, Zhengfeng; Che, Lianqiang; Li, Jian; Chen, Daiwen; Wu, De; Xu, Shengyu] Sichuan Agr Univ, Inst Anim Nutr, Minist Educ China, Key Lab Anim Dis Resistance Nutr, Yaan 625014, Peoples R China; [Wang, Dingyue] Tequ Grp Sichuan Prov, Chengdu 610207, Peoples R China	Ministry of Education, China; Sichuan Agricultural University	Xu, SY (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Minist Educ China, Key Lab Anim Dis Resistance Nutr, Yaan 625014, Peoples R China.	shengyu_x@hotmail.com	Xu, Shengyu/AFN-8288-2022	Xu, Shengyu/0000-0002-4415-8542	Education Department in Sichuan Province [13ZA0259]; Sichuan Agricultural University; Program for Changjiang Scholars and Innovative Research Team in University [IRT13083]; Program form Feed Industry and Technology Research Institute of Sichuan Province [2013NZ0054]	Education Department in Sichuan Province; Sichuan Agricultural University; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program form Feed Industry and Technology Research Institute of Sichuan Province	These authors acknowledge funding from the Key Projects of Education Department in Sichuan Province (13ZA0259), Sichuan Agricultural University, the Program for Changjiang Scholars and Innovative Research Team in University (IRT13083), and the Program form Feed Industry and Technology Research Institute of Sichuan Province (2013NZ0054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTINI DF, 1987, DEV BIOL, V120, P121, DOI 10.1016/0012-1606(87)90110-2; Astiz S, 2013, REPROD DOMEST ANIM, V48, pe44, DOI 10.1111/rda.12148; Bianchi L, 2013, J PROTEOMICS, V90, P61, DOI 10.1016/j.jprot.2013.02.025; Bielanska-Osuchowska Zofia, 2006, Reprod Biol, V6, P161; Calvert Meredith E, 2003, Reprod Biol Endocrinol, V1, P27, DOI 10.1186/1477-7827-1-27; Chouchane L, 2001, INT J OBESITY, V25, P462, DOI 10.1038/sj.ijo.0801545; Ding W, 2010, J REPROD DEVELOP, V56, P162, DOI 10.1262/jrd.09-094H; Dix DJ, 1997, CELL STRESS CHAPERON, V2, P73, DOI 10.1379/1466-1268(1997)002<0073:HEAFDG>2.3.CO;2; Elliott TS, 2014, NAT BIOTECHNOL, V32, P465, DOI 10.1038/nbt.2860; Gao H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067727; Gilchrist RB, 2011, REPROD FERT DEVELOP, V23, P23, DOI 10.1071/RD10225; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Grive KJ, 2014, DEV BIOL, V392, P42, DOI 10.1016/j.ydbio.2014.05.001; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; HENDREY J, 1991, MOL REPROD DEV, V28, P1, DOI 10.1002/mrd.1080280102; Hu MW, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.120220; Hulas-Stasiak M, 2013, REPROD TOXICOL, V42, P125, DOI 10.1016/j.reprotox.2013.08.007; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Kanitz W, 2001, ARCH TIERZUCHT, V44, P9; Kim MR, 2004, BBA-MOL CELL RES, V1644, P205, DOI 10.1016/j.bbamcr.2003.10.012; Lanska V, 2006, ANIM REPROD SCI, V96, P154, DOI 10.1016/j.anireprosci.2005.12.005; LEDIVIDICH J, 1991, BIOL NEONATE, V59, P268, DOI 10.1159/000243360; Lee GJ, 1992, J REPROD FERTIL, V48, P247; Li R, 2013, NAT REV MOL CELL BIO, V14, P141, DOI 10.1038/nrm3531; Mora JM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096156; Mukherjee A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067068; Nakhjavani M, 2013, META GENE, V1, P1, DOI 10.1016/j.mgene.2013.09.002; Nebreda AR, 2000, CURR OPIN CELL BIOL, V12, P666, DOI 10.1016/S0955-0674(00)00150-2; Ohta T, 2007, BIOL REPROD, V77, P970, DOI 10.1095/biolreprod.107.062299; Park E, 2012, J OBSTET GYNAECOL RE, V38, P396, DOI 10.1111/j.1447-0756.2011.01705.x; Pelletier G, 2000, J ENDOCRINOL, V165, P359, DOI 10.1677/joe.0.1650359; PELLICER A, 1987, J IN VITRO FERTIL EM, V4, P205, DOI 10.1007/BF01533758; Picut CA, 2015, TOXICOL PATHOL, V43, P343, DOI 10.1177/0192623314544380; Revelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-40; Robin MA, 2005, HEPATOLOGY, V42, P1280, DOI 10.1002/hep.20949; Rojas C, 2004, CRYOBIOLOGY, V49, P211, DOI 10.1016/j.cryobiol.2004.07.002; Satoh M, 2009, J REPROD DEVELOP, V55, P316, DOI 10.1262/jrd.20217; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Seralini G, 1985, J INT SOC ONCODEV BI, V7, P1; Sirotkin AV, 2011, CELL STRESS CHAPERON, V16, P379, DOI 10.1007/s12192-010-0252-4; Sun XJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-111; Swatton JE, 2004, MOL PSYCHIATR, V9, P128, DOI 10.1038/sj.mp.4001475; Taskinen S, 2015, ACTA OBSTET GYN SCAN, V94, P425, DOI 10.1111/aogs.12598; van Wezel IL, 1999, REPROD FERT DEVELOP, V11, P37, DOI 10.1071/RD98069; VANBLERKOM J, 1991, P NATL ACAD SCI USA, V88, P5031, DOI 10.1073/pnas.88.11.5031; Wang NL, 2009, PROTEOMICS, V9, P3425, DOI 10.1002/pmic.200800822; Wang WH, 1999, BIOL REPROD, V60, P1020, DOI 10.1095/biolreprod60.4.1020; Wu YT, 2015, J ASSIST REPROD GEN, V32, P417, DOI 10.1007/s10815-014-0419-5; Xu P, 2014, WORLD J GASTROENTERO, V20, P11865, DOI 10.3748/wjg.v20.i33.11865	51	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135514	10.1371/journal.pone.0135514	http://dx.doi.org/10.1371/journal.pone.0135514			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305539	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500024
J	Elmasry, S; Asfour, S; Vaccari, JPD; Travascio, F				Elmasry, Shady; Asfour, Shihab; Vaccari, Juan Pablo de Rivero; Travascio, Francesco			Effects of Tobacco Smoking on the Degeneration of the Intervertebral Disc: A Finite Element Study	PLOS ONE			English	Article							NUCLEUS PULPOSUS CELLS; LOW-BACK-PAIN; GROWTH-FACTOR-I; IGF-I; CIGARETTE-SMOKING; ANNULUS FIBROSUS; COUPLED DIFFUSION; LACTIC-ACID; RISK-FACTOR; NICOTINE	Tobacco smoking is associated with numerous pathological conditions. Compelling experimental evidence associates smoking to the degeneration of the intervertebral disc (IVD). In particular, it has been shown that nicotine down-regulates both the proliferation rate and glycosaminoglycan (GAG) biosynthesis of disc cells. Moreover, tobacco smoking causes the constriction of the vascular network surrounding the IVD, thus reducing the exchange of nutrients and anabolic agents from the blood vessels to the disc. It has been hypothesized that both nicotine presence in the IVD and the reduced solute exchange are responsible for the degeneration of the disc due to tobacco smoking, but their effects on tissue homeostasis have never been quantified. In this study, a previously presented computational model describing the homeostasis of the IVD was deployed to investigate the effects of impaired solute supply and nicotine-mediated down-regulation of cell proliferation and biosynthetic activity on the health of the disc. We found that the nicotine-mediated down-regulation of cell anabolism mostly affected the GAG concentration at the cartilage endplate, reducing it up to 65% of the value attained in normal physiological conditions. In contrast, the reduction of solutes exchange between blood vessels and disc tissue mostly affected the nucleus pulposus, whose cell density and GAG levels were reduced up to 50% of their normal physiological levels. The effectiveness of quitting smoking on the regeneration of a degenerated IVD was also investigated, and showed to have limited benefit on the health of the disc. A cell-based therapy in conjunction with smoke cessation provided significant improvements in disc health, suggesting that, besides quitting smoking, additional treatments should be implemented in the attempt to recover the health of an IVD degenerated by tobacco smoking.	[Elmasry, Shady; Asfour, Shihab; Travascio, Francesco] Univ Miami, Dept Ind Engn, Biomech Res Lab, Coral Gables, FL 33124 USA; [Vaccari, Juan Pablo de Rivero] Univ Miami, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL USA	University of Miami; University of Miami	Travascio, F (corresponding author), Univ Miami, Dept Ind Engn, Biomech Res Lab, Coral Gables, FL 33124 USA.	f.travascio@miami.edu	Elmasry, Shady/AAP-4220-2020; de Rivero Vaccari, Juan Pablo/ABE-3248-2020; de Rivero Vaccari, Juan Pablo/H-5718-2019	Elmasry, Shady/0000-0003-0193-7711; de Rivero Vaccari, Juan Pablo/0000-0002-5460-8834; 				Akmal M, 2004, SPINE, V29, P568, DOI 10.1097/01.BRS.0000101422.36419.D8; Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y; AN HS, 1994, J SPINAL DISORD, V7, P369; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Asfour S, 2015, J BIOMECH, V48, P332, DOI 10.1016/j.jbiomech.2014.11.021; BATTIE MC, 1991, SPINE, V16, P1015, DOI 10.1097/00007632-199109000-00001; Behrend C, 2012, J BONE JOINT SURG AM, V94A, P2161, DOI 10.2106/JBJS.K.01598; Benowitz NL, 1996, ANNU REV PHARMACOL, V36, P597, DOI 10.1146/annurev.pa.36.040196.003121; Bibby SRS, 2005, SPINE, V30, P487, DOI 10.1097/01.brs.0000154619.38122.47; Bibby SRS, 2004, EUR SPINE J, V13, P695, DOI 10.1007/s00586-003-0616-x; Bibby SRS, 2002, SPINE, V27, P2220, DOI 10.1097/00007632-200210150-00007; Brand FJ, 2015, 61 ANN M ORTH RES SO; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; Chujo T, 2006, SPINE, V31, P2909, DOI 10.1097/01.brs.0000248428.22823.86; DEYO RA, 1989, SPINE, V14, P501, DOI 10.1097/00007632-198905000-00005; DORE S, 1994, ARTHRITIS RHEUM-US, V37, P253, DOI 10.1002/art.1780370215; Durai R, 2005, INT J COLORECTAL DIS, V20, P203, DOI 10.1007/s00384-004-0675-4; ERNST E, 1987, BRIT J HAEMATOL, V65, P485, DOI 10.1111/j.1365-2141.1987.tb04155.x; ERNST E, 1993, BRIT J RHEUMATOL, V32, P239; Eyre D. R., 1989, INTERVERTEBRAL DISK; Feldman DE, 1999, SPINE, V24, P2492, DOI 10.1097/00007632-199912010-00011; Ferguson SJ, 2004, J BIOMECH, V37, P213, DOI 10.1016/S0021-9290(03)00250-1; FEYERABEND C, 1985, BRIT J CLIN PHARMACO, V19, P239, DOI 10.1111/j.1365-2125.1985.tb02637.x; FRYMOYER JW, 1983, J BONE JOINT SURG AM, V65, P213, DOI 10.2106/00004623-198365020-00010; Gilbertson L, 2008, SPINE J, V8, P449, DOI 10.1016/j.spinee.2006.11.006; Gram IT, 2006, INT J OBESITY, V30, P1623, DOI 10.1038/sj.ijo.0803324; Gruber HE, 1997, EXP CELL RES, V235, P13, DOI 10.1006/excr.1997.3647; HOLM S, 1988, UPSALA J MED SCI, V93, P91, DOI 10.1517/03009734000000042; Holm S., 1982, CLIN ORTHOP RELAT R, V169, P234; Horner HA, 2001, SPINE, V26, P2543, DOI 10.1097/00007632-200112010-00006; Huang CY, 2012, J BIOMECH, V45, P1149, DOI 10.1016/j.jbiomech.2012.02.005; Huang CY, 2008, J BIOMECH, V41, P1184, DOI 10.1016/j.jbiomech.2008.02.002; Iatridis JC, 2006, J BONE JOINT SURG AM, V88A, P41, DOI 10.2106/JBJS.E.01407; Imai Y, 2007, SPINE, V32, P1303, DOI 10.1097/BRS.0b013e3180593238; Iwahashi M, 2002, SPINE, V27, P1396, DOI 10.1097/00007632-200207010-00005; Jackson AR, 2008, SPINE, V33, P1, DOI 10.1097/BRS.0b013e31815e4136; Jimbo K, 2005, J NEUROSURG-SPINE, V2, P589, DOI 10.3171/spi.2005.2.5.0589; Kelsey JL, 1992, EPIDEMIOLOGY LOW BAC, P537; King Brian, 2011, Morbidity and Mortality Weekly Report, V60, P1207; Lauffenburger D. A., 1993, RECEPTORS MODELS BIN; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Leboeuf YC, 1995, J MANIP PHYSIOL THER, V18, P237; Lin J., 2000, BIOTECHNOL BIOPROC E, V5, P382, DOI DOI 10.1007/BF02942217; Malandrino A, 2014, J BIOMECH, V47, P1520, DOI 10.1016/j.jbiomech.2014.02.004; Malandrino A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002112; MAROUDAS A, 1975, J ANAT, V120, P113; Masuda K., 2008, MOTION PRESERVATION; Masuda Koichi, 2004, Spine J, V4, p330S, DOI 10.1016/j.spinee.2004.07.028; Mikkonen P, 2008, SPINE, V33, P527, DOI 10.1097/BRS.0b013e3181657d3c; Miller VM, 2000, AM J PHYSIOL-HEART C, V279, pH1913, DOI 10.1152/ajpheart.2000.279.4.H1913; Musich S, 2003, AM J HEALTH PROMOT, V18, P133, DOI 10.4278/0890-1171-18.2.133; Mustard CA, 2005, AM J EPIDEMIOL, V162, P779, DOI 10.1093/aje/kwi271; NACHEMSON A, 1970, ACTA ORTHOP SCAND, V41, P589, DOI 10.3109/17453677008991550; Nadeau S, 2011, J NEUROSCI, V31, P12533, DOI 10.1523/JNEUROSCI.2840-11.2011; Vo N, 2011, J ORTHOP RES, V29, P1585, DOI 10.1002/jor.21417; Nemoto Y, 2006, J ORTHOP SCI, V11, P191, DOI 10.1007/s00776-005-0987-4; Oda H, 2004, J ORTHOP SCI, V9, P135, DOI 10.1007/s00776-003-0759-y; Osada R, 1996, J ORTHOP RES, V14, P690, DOI 10.1002/jor.1100140503; Pattappa G, 2012, J ANAT, V221, P480, DOI 10.1111/j.1469-7580.2012.01521.x; Paye JMD, 2006, ANN BIOMED ENG, V34, P618, DOI 10.1007/s10439-005-9064-6; POUNTAIN GD, 1987, SPINE, V12, P83, DOI 10.1097/00007632-198703000-00002; Pratsinis H, 2007, EUR SPINE J, V16, P1858, DOI 10.1007/s00586-007-0408-9; Schmidt H, 2013, J BIOMECH, V46, P2342, DOI 10.1016/j.jbiomech.2013.07.014; Scott SC, 1999, SPINE, V24, P1090, DOI 10.1097/00007632-199906010-00008; Selard E, 2003, SPINE, V28, P1945, DOI 10.1097/01.BRS.0000087210.93541.23; Services UDoHaH, 2010, TOB SMOK CAUS DIS BI; Shen B, 2003, EUR SPINE J, V12, P66, DOI 10.1007/s00586-002-0454-2; Shirazi-Adl A, 2010, J BIOMECH, V43, P1330, DOI 10.1016/j.jbiomech.2010.01.023; Shiri R, 2010, AM J EPIDEMIOL, V171, P135, DOI 10.1093/aje/kwp356; Siggins Robert W, 2014, Med Sci (Basel), V2, P37, DOI 10.3390/medsci2010037; Soukane DM, 2007, J BIOMECH, V40, P2645, DOI 10.1016/j.jbiomech.2007.01.003; Soukane DM, 2009, EUR SPINE J, V18, P254, DOI 10.1007/s00586-008-0822-7; Soukane DM, 2005, J BIOMECH ENG-T ASME, V127, P1121, DOI 10.1115/1.2073674; Theiss SM, 2000, SPINE, V25, P2588, DOI 10.1097/00007632-200010150-00008; THOMPSON JP, 1991, SPINE, V16, P253, DOI 10.1097/00007632-199103000-00001; Travascio F, 2010, TRANSPORT PHENOMENA; Travascio F, 2014, BIOMECH MODEL MECHAN, V13, P945, DOI 10.1007/s10237-013-0545-5; Travascio F, 2014, J BIOMECH, V47, P2269, DOI 10.1016/j.jbiomech.2014.04.046; Travascio F, 2009, J ORTHOP RES, V27, P1625, DOI 10.1002/jor.20927; Uematsu Y, 2001, J Orthop Sci, V6, P177, DOI 10.1007/s007760100067; Urban JPG, 2002, BIOCHEM SOC T, V30, P858, DOI 10.1042/bst0300858; URBAN JPG, 1985, BIORHEOLOGY, V22, P145; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Wang D, 2012, OSTEOARTHR CARTILAGE, V20, P896, DOI 10.1016/j.joca.2012.04.010; Wang Z, 2015, GENE, V564, P1, DOI 10.1016/j.gene.2015.03.022; Weber KT, 2015, CURR REV MUSCULOSKE, V8, P18, DOI 10.1007/s12178-014-9253-8; White AA, 1981, BIOMECHANICS LUMBAR; Zhang LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066870; Zhang LH, 2010, J THEOR BIOL, V263, P20, DOI 10.1016/j.jtbi.2009.11.023; Zhang LH, 2009, J ENG MECH, V135, P439, DOI 10.1061/(ASCE)0733-9399(2009)135:5(439); Zhu QQ, 2012, J BIOMECH, V45, P2769, DOI 10.1016/j.jbiomech.2012.08.044	91	41	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136137	10.1371/journal.pone.0136137	http://dx.doi.org/10.1371/journal.pone.0136137			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301590	Green Submitted, Green Published, gold			2022-12-27	WOS:000359951900042
J	Jarl, J; Cantor-Graae, E; Chak, T; Sunbaunat, K; Larsson, CA				Jarl, Johan; Cantor-Graae, Elizabeth; Chak, Thida; Sunbaunat, Ka; Larsson, Charlotte A.			Trauma and Poor Mental Health in Relation to Economic Status: The Case of Cambodia 35 Years Later	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DEPRESSION; SYMPTOMS; POVERTY	Background Cambodia is one of the poorest countries in south-east Asia and is still emerging from the events of the Khmer Rouge reign. It has been suggested that the atrocities experienced by the Cambodian population can explain why Cambodia continues to lag behind its neighbours in economic outcomes. The purpose of this study is to investigate whether there is an association between exposure to past trauma and/or current poor mental health and current economic status in Cambodia. Method A newly conducted survey performed in two regions (north-west and south-east Cambodia) collected information on trauma exposure, psychiatric symptoms, self-rated health outcomes and socio-economic information for 3200 persons aged 18-60. Economic outcomes were measured as household debt and poverty status and whether the respondent was economically inactive. All models were analysed using logistic regression. Results No association was found between high exposure to conflict-related or civilian trauma and any economic outcomes save for a negative association between civilian trauma and poverty in the south-east. Current post-traumatic stress was related solely to poverty status. All other measures of current mental health status, however, were found to be strongly negatively associated with all measures of economic status. Thus, mental health interventions could potentially be utilised in poverty reduction strategies, but greater efficacy is likely to be achieved by targeting current mental health status rather than previous trauma exposure.	[Jarl, Johan] Lund Univ, Dept Clin Sci, Hlth Econ Unit, Lund, Sweden; [Jarl, Johan] Lund Univ, Inst Econ Res, Hlth Econ & Management, Lund, Sweden; [Cantor-Graae, Elizabeth; Larsson, Charlotte A.] Lund Univ, Dept Clin Sci, Div Social Med & Global Hlth, Malmo, Sweden; [Chak, Thida; Sunbaunat, Ka] Univ Hlth Sci, Fac Med, Dept Psychiat, Phnom Penh, Cambodia	Lund University; Lund University; Lund University	Jarl, J (corresponding author), Lund Univ, Dept Clin Sci, Hlth Econ Unit, Lund, Sweden.	Johan.Jarl@med.lu.se		Jarl, Johan/0000-0002-9274-2479	Swedish Research Council; Swedish International Development Cooperation Agency (SIDA) [SWE2010-010]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency (SIDA)	This study was funded by the Swedish Research Council and the Swedish International Development Cooperation Agency (SIDA)-SWE2010-010. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, STAT; APA, 1994, DIAGN STAT MAN MENT; Besser A, 2013, PSYCHIATRY, V76, P381, DOI 10.1521/psyc.2013.76.4.381; Bolton P, 2002, J NERV MENT DIS, V190, P631, DOI 10.1097/00005053-200209000-00009; Cantor-Graae E, 2014, SOC SCI MED, V123, P133, DOI 10.1016/j.socscimed.2014.10.049; Chopra P, 2009, INT J MENTAL HLTH SY, V3; Das J, 2007, SOC SCI MED, V65, P467, DOI 10.1016/j.socscimed.2007.02.037; de Walque D, 2006, POP STUD-J DEMOG, V60, P223, DOI 10.1080/00324720600684767; DHS, 2006, CAMB DEM HLTH SURV 2; Engwall A, 2007, UNDERSTANDING RURAL; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Hill H, 2013, ASIAN ECON POLICY R, V8, P46, DOI 10.1111/aepr.12003; Johnson K., 2004, DHS WEALTH INDEX CAL; Long J.S., 2006, REGRESSION MODELS CA; Lund C, 2011, LANCET, V378, P1502, DOI 10.1016/S0140-6736(11)60754-X; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; Mollica RF, 1998, BRIT J PSYCHIAT, V173, P482, DOI 10.1192/bjp.173.6.482; Mollica RF, 2014, INT J SOC PSYCHIATR, V60, P6, DOI 10.1177/0020764012471597; Rieder H, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.21329; Sack WH, 1999, J AM ACAD CHILD PSY, V38, P1173, DOI 10.1097/00004583-199909000-00023; SACK WH, 1995, J AM ACAD CHILD PSY, V34, P1160, DOI 10.1097/00004583-199509000-00013; Sonis J, 2009, JAMA-J AM MED ASSOC, V302, P527, DOI 10.1001/jama.2009.1085; Stephens T, 2001, Chronic Dis Can, V22, P18; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; UBA L, 1991, J GEN PSYCHOL, V118, P215, DOI 10.1080/00221309.1991.9917782; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WHO, 2004, COMP INT DIAGN INT 3; Worldbank, 2006, CAMB HALV POV 2015 P; Worldbank, 2014, CLEAR SKIES CAMB EC; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5	30	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136410	10.1371/journal.pone.0136410	http://dx.doi.org/10.1371/journal.pone.0136410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5VA	26301591	Green Published, gold, Green Submitted			2022-12-27	WOS:000359951900068
J	Kyaw, NTT; Harries, AD; Chinnakali, P; Antierens, A; Soe, KP; Woodman, M; Das, M; Shetty, S; Zuu, MKL; Htwe, PS; Fernandez, M				Kyaw, Nang Thu Thu; Harries, Anthony D.; Chinnakali, Palanivel; Antierens, Annick; Soe, Kyi Pyar; Woodman, Mike; Das, Mrinalini; Shetty, Sharmila; Zuu, Moe Khine Lwin; Htwe, Pyae Sone; Fernandez, Marcelo			Low Incidence of Renal Dysfunction among HIV-Infected Patients on a Tenofovir-Based First Line Antiretroviral Treatment Regimen in Myanmar	PLOS ONE			English	Article							DISOPROXIL FUMARATE; METAANALYSIS; SAFETY; RISK	Background Since 2004, Medecins Sans Frontieres-Switzerland has provided treatment and care for people living with HIV in Dawei, Myanmar. Renal function is routinely monitored in patients on tenofovir (TDF)-based antiretroviral treatment (ART), and this provides an opportunity to measure incidence and risk factors for renal dysfunction. Methods We used routinely collected program data on all patients aged >= 15 years starting first-line TDF-based ART between January 2012 and December 2013. Creatinine clearance (CrCl) was assessed at base line and six-monthly, with renal dysfunction defined as CrCl < 50ml/min/1.73m(2). We calculated incidence of renal dysfunction and used Cox regression analysis to identify associated risk factors. Results There were 1391 patients, of whom 1372 had normal renal function at baseline. Of these, 86 (6.3%) developed renal dysfunction during a median time of follow-up 1.14 years with an incidence rate of 5.4 per 100 person-years: 78 had CrCl between 30-50ml/min/1.73m(2) and were maintained on TDF-based ART, but 5 were changed to another regimen: 4 because of CrCl <30ml/min/1.73m(2). Risk factors for renal dysfunction included age >= 45 years, diagnosed diabetes, underlying renal disease, underweight and CD4 count <200cells/mm(3). There were 19 patients with baseline renal dysfunction and all continued on TDF-based ART: CrCl stayed between 30-49 ml/qmin/q1.73m(2) in five patients while the remainder regained normal renal function. Conclusions In a resource-poor country like Myanmar, the low incidence of renal toxicity in our patient cohort suggests that routine assessment of CrCl may not be needed and could be targeted to high risk groups if resources permit.	[Kyaw, Nang Thu Thu; Soe, Kyi Pyar; Shetty, Sharmila; Zuu, Moe Khine Lwin; Htwe, Pyae Sone; Fernandez, Marcelo] Med Sans Frontieres Switzerland, Yangon, Myanmar; [Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, London WC1, England; [Chinnakali, Palanivel] JIPMER, Pondicherry, India; [Antierens, Annick] Med Sans Frontieres, Brussels, Belgium; [Woodman, Mike] Med Sans Frontieres, Geneva, Switzerland; [Das, Mrinalini] Med Sans Frontieres Doctors Borders, New Delhi, India	University of London; London School of Hygiene & Tropical Medicine; Jawaharlal Institute of Postgraduate Medical Education & Research; Doctors Without Borders; Doctors Without Borders	Kyaw, NTT (corresponding author), Med Sans Frontieres Switzerland, Yangon, Myanmar.	nangthu82@gmail.com	Chinnakali, Palanivel/AAV-7708-2020	Chinnakali, Palanivel/0000-0001-8320-1016	The Union, MSF, The Department for International Development (DFID), UK; World Health Organization	The Union, MSF, The Department for International Development (DFID), UK; World Health Organization(World Health Organization)	The programme was funded by The Union, MSF, The Department for International Development (DFID), UK and the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, GLOB UPD HLTH SECT R; Barraclough K, 2009, NEPHRON CLIN PRACT, V111, pC39, DOI 10.1159/000178978; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Bygrave H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017609; Chua AC, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-19; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Edginton M, 2012, PUBLIC HEALTH ACTION, V2, P21, DOI [10.5588/pha.12.0001, 10.5588/pha.12.0028]; EpiData, EPIDATA COMP PROGR; Gervasoni C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080242; Government of Myanmar, 2017, 2014 MYANM POP HOUS; Hall AM, 2013, PEDIATR NEPHROL, V28, P1011, DOI 10.1007/s00467-012-2269-7; Kalyesubula R, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/562790; McManus H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048839; Mizushima D, 2014, J INFECT CHEMOTHER, V20, P784, DOI 10.1016/j.jiac.2014.08.015; Mulenga L, 2014, CLIN INFECT DIS, V58, P1473, DOI 10.1093/cid/ciu117; National AIDS Programme, 2011, GUID CLIN MAN HIV IN; National AIDS Programme, 2014, GLOB AIDS RESP PROGR; National AIDS Programme, 2012, HIV SENT SER SURV SU; Nishijima T, 2014, AIDS, V28, P1903, DOI 10.1097/QAD.0000000000000347; Poizot-Martin I, 2013, JAIDS-J ACQ IMM DEF, V62, P375, DOI 10.1097/QAI.0b013e31827ce4ee; Pujari SN, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-173; Scherzer R, 2012, AIDS, V26, P867, DOI 10.1097/QAD.0b013e328351f68f; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Winston J, 2014, HIV CLIN TRIALS, V15, P231, DOI 10.1310/hct1506-231; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2010, ANT THER HIV INF AD	26	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135188	10.1371/journal.pone.0135188	http://dx.doi.org/10.1371/journal.pone.0135188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301416	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000359951900014
J	Samarasekera, N; Lerpiniere, C; Fonville, AF; Farrall, AJ; Wardlaw, JM; White, PM; Torgersen, A; Ironside, JW; Smith, C; Salman, RAS				Samarasekera, Neshika; Lerpiniere, Christine; Fonville, Arthur F.; Farrall, Andrew J.; Wardlaw, Joanna M.; White, Philip M.; Torgersen, Antonia; Ironside, James W.; Smith, Colin; Salman, Rustam Al-Shahi		LATCH Collaborators	Consent for Brain Tissue Donation after Intracerebral Haemorrhage: A Community-Based Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE RESEARCH; BANKING; AUTOPSY	Background Spontaneous intracerebral haemorrhage is a devastating form of stroke and its incidence increases with age. Obtaining brain tissue following intracerebral haemorrhage helps to understand its cause. Given declining autopsy rates worldwide, the feasibility of establishing an autopsy-based collection and its generalisability are uncertain. Methods We used multiple overlapping sources of case ascertainment to identify every adult diagnosed with intracerebral haemorrhage between 1st June 2010-31st May 2012, whilst resident in the Lothian region of Scotland. We sought consent from patients with intracerebral haemorrhage (or their nearest relative if the patient lacked mental capacity) to conduct a research autopsy. Results Of 295 adults with acute intracerebral haemorrhage, 110 (37%) could not be approached to consider donation. Of 185 adults/relatives approached, 91 (49%) consented to research autopsy. There were no differences in baseline demographic variables or markers of intracerebral haemorrhage severity between consenters and non-consenters. Adults who died and became donors (n = 46) differed from the rest of the cohort (n = 249) by being older (median age 80, IQR 76-86 vs. 75, IQR 65-83, p = 0.002) and having larger haemorrhages (median volume 23ml, IQR 13-50 vs. 13ml, IQR 4-40; p = 0.002). Conclusions Nearly half of those approached consent to brain tissue donation after acute intracerebral haemorrhage. The characteristics of adults who gave consent were comparable to those in an entire community, although those who donate early are older and have larger haemorrhage volumes.	[Samarasekera, Neshika; Lerpiniere, Christine; Fonville, Arthur F.; Farrall, Andrew J.; Wardlaw, Joanna M.; White, Philip M.; Torgersen, Antonia; Ironside, James W.; Smith, Colin; Salman, Rustam Al-Shahi] Univ Edinburgh, Ctr Clin Brain Sci, Div Clin Neurosci, Edinburgh, Midlothian, Scotland; [Farrall, Andrew J.; Wardlaw, Joanna M.] Univ Edinburgh, Brain Res Imaging Ctr, Edinburgh, Midlothian, Scotland; [Wardlaw, Joanna M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Salman, RAS (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Div Clin Neurosci, Edinburgh, Midlothian, Scotland.	Rustam.Al-Shahi@ed.ac.uk	Stone, Jon/C-3119-2014; Hernandez, María/GYU-3543-2022; Macleod, Malcolm Robert/B-2052-2010; McIntosh, Andrew M/B-9379-2008; Wardlaw, Joanna M/Y-3456-2019; Jones, Michael/M-5932-2013	Stone, Jon/0000-0001-9829-8092; Macleod, Malcolm Robert/0000-0001-9187-9839; McIntosh, Andrew M/0000-0002-0198-4588; Wardlaw, Joanna M/0000-0002-9812-6642; Ironside, James/0000-0001-5869-2108; foley, peter/0000-0001-7039-2976; Mackay, Graham/0000-0002-4316-2320; Duncan, Susan/0000-0003-0454-6564; Smith, Colin/0000-0002-4507-5132; Chandran, Siddharthan/0000-0001-6827-1593; White, Philip/0000-0001-6007-6013; Jaap, Alan/0000-0001-8289-704X; Reed, Matthew/0000-0003-1308-4824; Al-Shahi Salman, Rustam/0000-0002-2108-9222; Sudlow, Cathie/0000-0002-7725-7520; Jones, Michael/0000-0001-5002-0227; Samarasekera, Neshika/0000-0001-6840-0199; Whiteley, William/0000-0002-4816-8991	United Kingdom Medical Research Council/Stroke Association Clinical Research Training Fellowship [G0900428]; European Erasmus Program; Scottish Funding Council through the Scottish Imaging Network-A Platform for Scientific Excellence (SINAPSE) Collaboration; United Kingdom Medical Research Council [G1002605]; MRC [G0900428, G0901945, G0900580, G0600953, G1002605, G1100616, MR/L016400/1] Funding Source: UKRI; Medical Research Council [G0600953, G0901945, G1100616, G1002605, MR/L016400/1, G0900428, G0900580] Funding Source: researchfish	United Kingdom Medical Research Council/Stroke Association Clinical Research Training Fellowship; European Erasmus Program; Scottish Funding Council through the Scottish Imaging Network-A Platform for Scientific Excellence (SINAPSE) Collaboration; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a United Kingdom Medical Research Council/Stroke Association Clinical Research Training Fellowship (G0900428) to NS, a grant from the European Erasmus Program to AFF, support from the Scottish Funding Council through the Scottish Imaging Network-A Platform for Scientific Excellence (SINAPSE) Collaboration to JMW and a United Kingdom Medical Research Council Senior Clinical Fellowship ( ) to RA-SS.	Angelini P, 2011, J NEURO-ONCOL, V101, P75, DOI 10.1007/s11060-010-0224-7; [Anonymous], 2009, LANCET NEUROL, V8, P691, DOI 10.1016/S1474-4422(09)70185-1; Burton JL, 2007, LANCET, V369, P1471, DOI 10.1016/S0140-6736(07)60376-6; Cordonnier C, 2010, STROKE, V41, P685, DOI 10.1161/STROKEAHA.109.572495; Darnell KR, 2011, AM J ALZHEIMERS DIS, V26, P469, DOI 10.1177/1533317511423020; Di Carlo A, 2009, AGE AGEING, V38, P4, DOI 10.1093/ageing/afn282; Garrick T, 2009, CELL TISSUE BANK, V10, P309, DOI 10.1007/s10561-009-9136-1; Harris C, 2012, J ADV NURS, P1; Jefferson AL, 2011, ALZ DIS ASSOC DIS, V25, P11, DOI 10.1097/WAD.0b013e3181f3e059; KING EMFO, 1993, AGE AGEING, V22, P209, DOI 10.1093/ageing/22.3.209; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kretzschmar H, 2009, NAT REV NEUROSCI, V10, P70, DOI 10.1038/nrn2535; Kuhta T, 2011, PARKINSONISM RELAT D, V17, P204, DOI 10.1016/j.parkreldis.2010.12.009; Millar T, 2007, J PATHOL, V213, P369, DOI 10.1002/path.2247; Samarasekera N, 2015, STROKE, V46, P361, DOI 10.1161/STROKEAHA.114.007953; Samarasekera N, 2013, LANCET NEUROL, V12, P1096, DOI 10.1016/S1474-4422(13)70202-3; Sanner M. A., 2006, MORTALITY, V11, P133; Simpkin A, 2009, BJM, V339, pb991, DOI DOI 10.1136/BMJ.B991; Stevens M, 1998, AGE AGEING, V27, P623, DOI 10.1093/ageing/27.5.623; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0	20	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135043	10.1371/journal.pone.0135043	http://dx.doi.org/10.1371/journal.pone.0135043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302447	gold, Green Submitted, Green Published			2022-12-27	WOS:000359951900012
J	Curtis, SL; Mswia, RG; Weaver, EH				Curtis, Sian L.; Mswia, Robert G.; Weaver, Emily H.			Measuring Maternal Mortality: Three Case Studies Using Verbal Autopsy with Different Platforms	PLOS ONE			English	Article							HEALTH-STATISTICS; COUNTS; DEATH; PROGRESS	Background Accurate measurement of maternal mortality is needed to develop a greater understanding of the scale of the problem, to increase effectiveness of program planning and targeting, and to track progress. In the absence of good quality vital statistics, interim methods are used to measure maternal mortality. The purpose of this study is to document experience with three community-based interim methods that measure maternal mortality using verbal autopsy. Methods This study uses a post-census mortality survey, a sample vital registration with verbal autopsy, and a large-scale household survey to summarize the measures of maternal mortality obtained from these three platforms, compares and contrasts the different methodologies employed, and evaluates strengths and weaknesses of each approach. Included is also a discussion of issues related to death identification and classification, estimating maternal mortality ratios and rates, sample sizes and periodicity of estimates, data quality, and cost. Results The sample sizes vary considerably between the three data sources and the number of maternal deaths identified through each platform was small. The proportion of deaths to women of reproductive age that are maternal deaths ranged from 8.8% to 17.3%. The maternal mortality rate was estimable using two of the platforms while obtaining an estimate of the maternal mortality ratio was only possible using one of the platforms. The percentage of maternal deaths due to direct obstetric causes ranged from 45.2% to 80.4%. Conclusions This study documents experiences applying standard verbal autopsy methods to estimate maternal mortality and confirms that verbal autopsy is a feasible method for collecting maternal mortality data. None of these interim methods are likely to be suitable for detecting short term changes in mortality due to prohibitive sample size requirements, and thus, comprehensive and continuous civil registration systems to provide high quality vital statistics are essential in the long-term.	[Curtis, Sian L.] Univ N Carolina, Dept Maternal & Child Hlth, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA; [Curtis, Sian L.; Weaver, Emily H.] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Mswia, Robert G.] Palladium Grp, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Curtis, SL (corresponding author), Univ N Carolina, Dept Maternal & Child Hlth, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA.	sian_curtis@unc.edu			US Agency for International Development (USAID) [GHA-A-00-08-00003-00]; National Institute of Nursing Research [T32NR008856]; Carolina Population Center [R24HD050924]; Palladium Group; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [T32NR008856] Funding Source: NIH RePORTER	US Agency for International Development (USAID)(United States Agency for International Development (USAID)); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Carolina Population Center; Palladium Group; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Funding for this study was provided by the US Agency for International Development (USAID) under the terms of MEASURE Evaluation cooperative agreement GHA-A-00-08-00003-00. EHW's work on this study was supported by Award Number T32NR008856 from the National Institute of Nursing Research. The Carolina Population Center (R24HD050924) provided general support. A draft of the study manuscript was shared with USAID staff but no comments from the funders were incorporated and no individuals employed or contracted by the funding agencies other than the authors were involved in the study design, analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of United States Agency for International Development (www.usaid.gov), the National Institute of Nursing Research (http://www.ninr.nih.gov) or the National Institutes of Health (www.nih.gov). The Palladium Group provided support in the form of salaries for authors RGM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AbouZahr C, 2007, LANCET, V370, P1791, DOI 10.1016/S0140-6736(07)61310-5; Baiden F, 2007, B WORLD HEALTH ORGAN, V85, P570, DOI 10.2471/BLT.07.043745; Blanc AK, 2014, LANCET GLOB HEALTH, V2, pE201, DOI 10.1016/S2214-109X(14)70028-2; Blanc AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059864; Gaskell GD, 2000, PUBLIC OPIN QUART, V64, P77, DOI 10.1086/316761; Graham WJ, 2008, BEST PRACT RES CL OB, V22, P425, DOI 10.1016/j.bpobgyn.2007.12.001; Hakkert R, 2011, J POPUL RES, V28, P15, DOI 10.1007/s12546-011-9063-4; Hill K, 2007, LANCET, V370, P1726, DOI 10.1016/S0140-6736(07)61309-9; Leitao J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-22; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Mozambique National Institute of Statistics U. S. Census Bureau MEASURE Evaluation U. S. Centers for Disease Control and Prevention, 2012, MORT MOZ RES 2007 20; Mudenda SS, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-40; National Institute of Population Research and Training, 2012, BANGL MAT MORT HLTH; Nove A, 2014, LANCET GLOB HEALTH, V2, pE155, DOI 10.1016/S2214-109X(13)70179-7; Okonjo-Iweala N, 2007, LANCET, V370, P1527, DOI 10.1016/S0140-6736(07)61644-4; Say L, 2011, BJOG-INT J OBSTET GY, V118, P15, DOI 10.1111/j.1471-0528.2011.03105.x; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; Shibuya K, 2005, B WORLD HEALTH ORGAN, V83, P722; Singh K, 2015, GUIDE CONDUCTING POS; Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003; Stanton C, 2001, B WORLD HEALTH ORGAN, V79, P657; UNFPA UNICEF WHO World Bank, 2012, TRENDS MAT MORT 1990; United Nations, END POV 2015 GOAL 5; WHO, 2014, VERB AUT STAND ASC A; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; World Health Organization, 1992, STAT CLASS DIS REL P; World Health Organization, 2007, VERB AUT STAND ASC A	28	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135062	10.1371/journal.pone.0135062	http://dx.doi.org/10.1371/journal.pone.0135062			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295160	Green Submitted, Green Published, gold			2022-12-27	WOS:000359926900016
J	Jalili, M				Jalili, Mahdi			Resiliency of EEG-Based Brain Functional Networks	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; SCALE-FREE NETWORKS; COMPLEX NETWORKS; ATTACK TOLERANCE; CONNECTIVITY; ERROR; SYNCHRONIZABILITY; EFFICIENCY; CASCADE	Applying tools available in network science and graph theory to study brain networks has opened a new era in understanding brain mechanisms. Brain functional networks extracted from EEG time series have been frequently studied in health and diseases. In this manuscript, we studied failure resiliency of EEG-based brain functional networks. The network structures were extracted by analysing EEG time series obtained from 30 healthy subjects in resting state eyes-closed conditions. As the network structure was extracted, we measured a number of metrics related to their resiliency. In general, the brain networks showed worse resilient behaviour as compared to corresponding random networks with the same degree sequences. Brain networks had higher vulnerability than the random ones (P < 0.05), indicating that their global efficiency (i.e., communicability between the regions) is more affected by removing the important nodes. Furthermore, the breakdown happened as a result of cascaded failures in brain networks was severer (i.e., less nodes survived) as compared to randomized versions (P < 0.05). These results suggest that real EEG-based networks have not been evolved to possess optimal resiliency against failures.	RMIT Univ, Sch Elect & Comp Engn, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT)	Jalili, M (corresponding author), RMIT Univ, Sch Elect & Comp Engn, Melbourne, Vic, Australia.	Mahdi.Jalili@rmit.eud.au		Jalili, Mahdi/0000-0002-0517-9420	Australian Research Council [DE140100620]	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council project DE140100620. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Asztalos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084563; Baggio HC, 2014, HUM BRAIN MAPP, V35, P4620, DOI 10.1002/hbm.22499; Barabasi AL, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0375; Baronchelli A, 2013, TRENDS COGN SCI, V17, P348, DOI 10.1016/j.tics.2013.04.010; Barzegaran E, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00335; Basu P, 2013, IEEE J SEL AREA COMM, V31, P993, DOI 10.1109/JSAC.2013.130601; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Crucitti P, 2003, PHYSICA A, V320, P622, DOI 10.1016/S0378-4371(02)01545-5; Fornari E, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.014; Fornito A, 2015, EUR NEUROPSYCHOPHARM, V25, P733, DOI 10.1016/j.euroneuro.2014.02.011; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Jalili M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001059; Jalili M, 2011, COMPUT BIOL MED, V41, P1178, DOI 10.1016/j.compbiomed.2011.05.004; Jalili M, 2011, J INFORMETR, V5, P422, DOI 10.1016/j.joi.2011.03.002; Jalili M, 2011, PHYSICA A, V390, P4588, DOI 10.1016/j.physa.2011.06.053; Kayser J, 2006, CLIN NEUROPHYSIOL, V117, P348, DOI 10.1016/j.clinph.2005.08.034; Knyazeva MG, 2011, J NEUROL NEUROSUR PS, V82, P505, DOI 10.1136/jnnp.2010.224873; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Melian CJ, 2002, ECOL LETT, V5, P705, DOI 10.1046/j.1461-0248.2002.00386.x; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mirzasoleiman B, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046114; Motter AE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098701; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Pievani M, 2011, LANCET NEUROL, V10, P829, DOI 10.1016/S1474-4422(11)70158-2; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Srinivasan R, 2007, J NEUROSCI METH, V166, P41, DOI 10.1016/j.jneumeth.2007.06.026; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Sun S, 2007, PHYSICA A, V373, P851, DOI 10.1016/j.physa.2006.05.049; Tahaei MS, 2012, IEEE T NEUR SYS REH, V20, P636, DOI 10.1109/TNSRE.2012.2202127; Wang JJ, 2014, CLIN NEUROPHYSIOL, V125, P1744, DOI 10.1016/j.clinph.2013.12.120; Westdrop AF, 1993, BIOM ENG C NEW ORL L; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Xia YX, 2008, IEEE T CIRCUITS-II, V55, P65, DOI 10.1109/TCSII.2007.908954; Xia YX, 2010, PHYSICA A, V389, P1281, DOI 10.1016/j.physa.2009.11.037; Zalesky A, 2012, NEUROIMAGE, V60, P2096, DOI 10.1016/j.neuroimage.2012.02.001; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103	47	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135333	10.1371/journal.pone.0135333	http://dx.doi.org/10.1371/journal.pone.0135333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295341	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900026
J	Quave, CL; Lyles, JT; Kavanaugh, JS; Nelson, K; Parlet, CP; Crosby, HA; Heilmann, KP; Horswill, AR				Quave, Cassandra L.; Lyles, James T.; Kavanaugh, Jeffery S.; Nelson, Kate; Parlet, Corey P.; Crosby, Heidi A.; Heilmann, Kristopher P.; Horswill, Alexander R.			Castanea sativa (European Chestnut) Leaf Extracts Rich in Ursene and Oleanene Derivatives Block Staphylococcus aureus Virulence and Pathogenesis without Detectable Resistance	PLOS ONE			English	Article							QUORUM SENSING INHIBITORS; ACCESSORY GENE REGULATOR; SKIN; AGR; INFECTIONS; EPIDEMIOLOGY; DETERMINANTS; ANTIOXIDANT; EXPRESSION; HEMOLYSIN	The Mediterranean is home to a rich history of medical traditions that have developed under the influence of diverse cultures over millennia. Today, many such traditions are still alive in the folk medical practices of local people. Investigation of botanical folk medicines used in the treatment of skin and soft tissue infections led us to study Castanea sativa (European Chestnut) for its potential antibacterial activity. Here, we report the quorum sensing inhibitory activity of refined and chemically characterized European Chestnut leaf extracts, rich in oleanene and ursene derivatives (pentacyclic triterpenes), against all Staphylococcus aureus accessory gene regulator (agr) alleles. We present layers of evidence of agr blocking activity (IC50 1.56-25 mu gmL(-1)), as measured in toxin outputs, reporter assays hemolytic activity, cytotoxicity studies, and an in vivo abscess model. We demonstrate the extract's lack of cytotoxicity to human keratinocytes and murine skin, as well as lack of growth inhibitory activity against S. aureus and a panel of skin commensals. Lastly, we demonstrate that serial passaging of the extract does not result in acquisition of resistance to the quorum quenching composition. In conclusion, through disruption of quorum sensing in the absence of growth inhibition, this study provides insight into the role that non-biocide inhibitors of virulence may play in future antibiotic therapies.	[Quave, Cassandra L.; Lyles, James T.] Emory Univ, Ctr Study Human Hlth, Atlanta, GA 30322 USA; [Quave, Cassandra L.; Nelson, Kate] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA; [Kavanaugh, Jeffery S.; Parlet, Corey P.; Crosby, Heidi A.; Heilmann, Kristopher P.; Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	Emory University; Emory University; University of Iowa	Quave, CL (corresponding author), Emory Univ, Ctr Study Human Hlth, Atlanta, GA 30322 USA.	cquave@emory.edu	Quave, Cassandra/AAD-2066-2020	Quave, Cassandra/0000-0001-9615-7886; Crosby, Heidi/0000-0002-0360-0779	National Institutes of Health, National Center for Complementary and Alternative Medicine [R01 AT007052]; NIH T32 training grant [AI007511]; National Center for Complementary & Integrative Health [R01AT007052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007343] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Complementary & Alternative Medicine); NIH T32 training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health, National Center for Complementary and Alternative Medicine (R01 AT007052, PI: C.L.Q. and Co-I: A.R.H.). The content is solely the responsibility of the authors and does not necessarily reflect the official views of NCCAM or NIH. C.P.P. and H.A.C. were supported by NIH T32 training grant AI007511. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida IF, 2015, J PHOTOCH PHOTOBIO B, V144, P28, DOI 10.1016/j.jphotobiol.2015.01.010; Almeida IF, 2008, BASIC CLIN PHARMACOL, V103, P461, DOI 10.1111/j.1742-7843.2008.00301.x; Almeida IF, 2008, J PHOTOCH PHOTOBIO B, V91, P87, DOI 10.1016/j.jphotobiol.2008.02.001; Almeida IF, 2010, AAPS PHARMSCITECH, V11, P120, DOI 10.1208/s12249-009-9360-9; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; CDC U, 2013, ANTIBIOTIC RESISTANC; Clinical and Laboratory Standards Institute, 2013, M100S23 CLIN LAB STA; Clinical and Laboratory Standards Institute (CLSI), 2010, M45A2 CLSI; COX PA, 1994, SCI AM, V270, P82, DOI 10.1038/scientificamerican0694-82; Daly SM, 2015, ANTIMICROB AGENTS CH, V59, P2223, DOI 10.1128/AAC.04564-14; Daum RS, 2007, NEW ENGL J MED, V357, P380, DOI 10.1056/NEJMcp070747; Elfawal MA, 2015, P NATL ACAD SCI USA, V112, P821, DOI 10.1073/pnas.1413127112; Figueroa M, 2014, J NAT PROD, V77, P1351, DOI 10.1021/np5000704; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Geisinger E, 2008, J BIOL CHEM, V283, P8930, DOI 10.1074/jbc.M710227200; Geisinger E, 2009, P NATL ACAD SCI USA, V106, P1216, DOI 10.1073/pnas.0807760106; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; Gordon CP, 2013, J MED CHEM, V56, P1389, DOI 10.1021/jm3014635; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Henry F, COSMETIC COMPOSITION; Hersh AL, 2008, ARCH INTERN MED, V168, P1585, DOI 10.1001/archinte.168.14.1585; Heyer G, 2002, INFECT IMMUN, V70, P127, DOI 10.1128/IAI.70.1.127-133.2002; Ibberson CB, 2014, INFECT IMMUN, V82, P4253, DOI 10.1128/IAI.01710-14; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kirchdoerfer RN, 2011, J BIOL CHEM, V286, P17351, DOI 10.1074/jbc.M111.231258; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Malik A, 2002, CHEM NAT COMPD+, V38, P612, DOI 10.1023/A:1022667611501; Mayville P, 1999, P NATL ACAD SCI USA, V96, P1218, DOI 10.1073/pnas.96.4.1218; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Montgomery CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015177; Muszer M, 2015, ARCH IMMUNOL THER EX, V63, P287, DOI 10.1007/s00005-015-0332-3; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Nakayama J, 2009, ANTIMICROB AGENTS CH, V53, P580, DOI 10.1128/AAC.00995-08; Nielsen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084992; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Olson ME, 2013, INFECT IMMUN, V81, P1316, DOI 10.1128/IAI.01242-12; Otto M, 2000, BIOTECHNIQUES, V28, P1088, DOI 10.2144/00286bm07; Otto M, 2014, CURR OPIN MICROBIOL, V17, P32, DOI 10.1016/j.mib.2013.11.004; Park J, 2007, CHEM BIOL, V14, P1119, DOI 10.1016/j.chembiol.2007.08.013; Parker D, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00284-14; Pieroni A, 2004, J ETHNOPHARMACOL, V91, P331, DOI 10.1016/j.jep.2004.01.015; Pignatti S, 2002, FLORA DITALIA; Quave CL, 2008, J ETHNOPHARMACOL, V118, P418, DOI 10.1016/j.jep.2008.05.005; Quave CL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00706; Quave CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028737; Quave CL, 2011, PLANTA MED, V77, P188, DOI 10.1055/s-0030-1250145; Ross-Gillespie A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00054; Schmidt BM, 2007, NAT CHEM BIOL, V3, P360, DOI 10.1038/nchembio0707-360; Schwan WR, 2003, FEMS IMMUNOL MED MIC, V38, P23, DOI 10.1016/S0928-8244(03)00098-1; Somerville GA, 2003, J BACTERIOL, V185, P6686, DOI 10.1128/JB.185.22.6686-6694.2003; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Stryjewski ME, 2008, CLIN INFECT DIS, V46, pS368, DOI 10.1086/533593; Sully EK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004174; Talekar SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097314; Thoendel M, 2011, CHEM REV, V111, P117, DOI 10.1021/cr100370n; Tsai TH, 2010, FOOD CHEM, V119, P964, DOI 10.1016/j.foodchem.2009.07.062; Tsuji BT, 2007, DIAGN MICR INFEC DIS, V58, P41, DOI 10.1016/j.diagmicrobio.2006.10.021; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; WHO, 2003, GUID GOOD AGR COLL P; Wright JD, 2003, FEMS MICROBIOL LETT, V218, P377, DOI 10.1016/S0378-1097(02)01193-X; Wright JS, 2005, P NATL ACAD SCI USA, V102, P1691, DOI 10.1073/pnas.0407661102; Zhu J, 2013, CURR OPIN PHARMACOL, V13, P688, DOI 10.1016/j.coph.2013.07.003	68	71	74	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136486	10.1371/journal.pone.0136486	http://dx.doi.org/10.1371/journal.pone.0136486			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295163	Green Published, gold			2022-12-27	WOS:000359926900115
J	Rockett, IRH; Hobbs, GR; Wu, D; Jia, HM; Nolte, KB; Smith, GS; Putnam, SL; Caine, ED				Rockett, Ian R. H.; Hobbs, Gerald R.; Wu, Dan; Jia, Haomiao; Nolte, Kurt B.; Smith, Gordon S.; Putnam, Sandra L.; Caine, Eric D.			Variable Classification of Drug-Intoxication Suicides across US States: A Partial Artifact of Forensics?	PLOS ONE			English	Article							OF-DEATH ANALYSIS; UNITED-STATES; UNDETERMINED DEATHS; MEDICAL EXAMINERS; PUBLIC-HEALTH; MORTALITY; CORONERS; MISCLASSIFICATION; TRENDS; COMORBIDITY	Background The 21st-century epidemic of pharmaceutical and other drug-intoxication deaths in the United States (US) has likely precipitated an increase in misclassified, undercounted suicides. Drug-intoxication suicides are highly prone to be misclassified as accident or undetermined. Misclassification adversely impacts suicide and other injury mortality surveillance, etiologic understanding, prevention, and hence clinical and public health policy formation and practice. Objective To evaluate whether observed variation in the relative magnitude of drug-intoxication suicides across US states is a partial artifact of the scope and quality of toxicological testing and type of medicolegal death investigation system. Methods This was a national, state-based, ecological study of 111,583 drug-intoxication fatalities, whose manner of death was suicide, accident, or undetermined. The proportion of (nonhomicide) drug-intoxication deaths classified by medical examiners and coroners as suicide was analyzed relative to the proportion of death certificates citing one or more specific drugs and two types of state death investigation systems. Our model incorporated five sociodemographic covariates. Data covered the period 2008-2010, and derived from NCHS's Multiple Cause-of-Death public use files. Results Across states, the proportion of drug-intoxication suicides ranged from 0.058 in Louisiana to 0.286 in South Dakota and the rate from 1 per 100,000 population in North Dakota to 4 in New Mexico. There was a low correlation between combined accident and undetermined drug-intoxication death rates and corresponding suicide rates (Spearman's rho =0.38; p<0.01). Citation of 1 or more specific drugs on the death certificate was positively associated with the relative odds of a state classifying a nonhomicide drug-intoxication death as suicide rather than accident or undetermined, adjusting for region and type of state death investigation system (odds ratio, 1.062; 95% CI, 1.016-1.110). Region, too, was a significant predictor. Relative to the South, a 10% increase in drug citation was associated with 43% (95% CI, 11%-83%), 41% (95% CI, 7%-85%), and 33% (95% CI, 1%-76%) higher odds of a suicide classification in the West, Midwest, and Northeast, respectively. Conclusion Large interstate variation in the relative magnitude of nonhomicide drug-intoxication deaths classified as suicide by medical examiners and coroners in the US appears partially an artifact of geographic region and degree of toxicological assessment in the case ascertainment process. Etiologic understanding and prevention of drug-induced suicides and other drug-intoxication deaths first require rigorous standardization involving accurate concepts, definitions, and case ascertainment.	[Rockett, Ian R. H.] W Virginia Univ, Sch Publ Hlth, Injury Control Res Ctr, Morgantown, WV 26506 USA; [Rockett, Ian R. H.] W Virginia Univ, Sch Publ Hlth, Dept Epidemiol, Morgantown, WV 26506 USA; [Hobbs, Gerald R.] W Virginia Univ, Dept Stat, Morgantown, WV 26506 USA; [Wu, Dan] Guangdong Med Coll, Dept Psychol, Dongguan, Guandong, Peoples R China; [Wu, Dan] Zhejiang Univ, Sch Med, Dept Social Med, Hangzhou 310003, Zhejiang, Peoples R China; [Jia, Haomiao] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Jia, Haomiao] Columbia Univ, Sch Nursing, New York, NY USA; [Nolte, Kurt B.] Univ New Mexico, Sch Med, Dept Pathol, Off Med Investigator, Albuquerque, NM 87131 USA; [Smith, Gordon S.] Univ Maryland, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Putnam, Sandra L.] Social Solut Int Inc, Silver Spring, MD USA; [Caine, Eric D.] Univ Rochester, Med Ctr, Injury Control Res Ctr Suicide Prevent, Rochester, NY 14642 USA; [Caine, Eric D.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA	West Virginia University; West Virginia University; West Virginia University; Guangdong Medical University; Zhejiang University; Columbia University; Columbia University; University of New Mexico; University System of Maryland; University of Maryland Baltimore; University of Rochester; University of Rochester	Rockett, IRH (corresponding author), W Virginia Univ, Sch Publ Hlth, Injury Control Res Ctr, Morgantown, WV 26506 USA.	irockett@hsc.wvu.edu	Jia, Haomiao/AAU-8276-2021	Smith, Gordon/0000-0002-2911-3071	Centers for Disease Control and Prevention (CDC) [5R49CE002109, R49CE002093]; National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R01AA18707]; Social Solutions International, Inc.; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R49CE002093, R49CE002109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018707] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Social Solutions International, Inc.; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research received partial support from grants 5R49CE002109 and R49CE002093 from the Centers for Disease Control and Prevention (CDC), and grant R01AA18707 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA); http://www.cdc.gov/grants/; http://www.niaaa.nih.gov/grant-funding. The funders provided support in the form of salaries for three authors [I.R.H.R., E.D.C., G.S.S.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. At the time of the study, S.L.P. worked for a Small Disadvantaged Business (SDB), Social Solutions International, Inc., through a subcontract with the National Institute on Drug Abuse (NIDA); http://www.socialsolutions.biz/about-us/company-overview/. Her contributions to the research were made in her leisure time. Social Solutions International, Inc. provided support in the form of salary for author S.L.P. (although the salary was not related to this study) and Social Solutions International, Inc. did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bohnert ASB, 2013, INJURY PREV, V19, P326, DOI 10.1136/injuryprev-2012-040631; Breiding MJ, 2006, INJURY PREV, V12, P49, DOI 10.1136/ip.2006.012591; Cantor C, 2001, PSYCHOPATHOLOGY, V34, P140, DOI 10.1159/000049297; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Chen Li Hui, 2014, NCHS Data Brief, P1; Committee on Identifying the Needs of the Forensic Sciences Community: National Research Council, 2009, STRENGTH FOR SCI US; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; Davis GG, 2013, ACAD FORENSIC PATHOL, V3, P62; De Leo D, 2006, CRISIS, V27, P4, DOI 10.1027/0227-5910.27.1.4; Division of Violence Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention, 1994, MMWR, V46, P789; Gunnell D, 2013, PSYCHOL MED, V43, P1415, DOI 10.1017/S0033291712002401; Hanzlick R., 2007, DEATH INVESTIGATION; Hanzlick R, 2007, AM J FOREN MED PATH, V28, P279, DOI 10.1097/PAF.0b013e31815b4d5a; Hanzlick R, 2006, ARCH PATHOL LAB MED, V130, P1274; Huguet N, 2012, SUICIDE LIFE-THREAT, V42, P185, DOI 10.1111/j.1943-278X.2012.00081.x; JARVIS GK, 1991, SUICIDE LIFE-THREAT, V21, P115; Klugman J, 2013, SOC SCI QUART, V94, P462, DOI 10.1111/j.1540-6237.2012.00937.x; Linsley KR, 2001, BRIT J PSYCHIAT, V178, P465, DOI 10.1192/bjp.178.5.465; Mack KA, 2013, MMWR-MORBID MORTAL W, V62, P161; National Commission on Forensic Science, 2015, ACCR MED DEATH INV O; OCARROLL PW, 1989, SUICIDE LIFE-THREAT, V19, P1; Ohberg A, 1998, ACTA PSYCHIAT SCAND, V98, P214, DOI 10.1111/j.1600-0447.1998.tb10069.x; OVENSTONE IM, 1973, BRIT J PSYCHIAT, V123, P15, DOI 10.1192/bjp.123.1.15; PLATT S, 1988, SOC PSYCH PSYCH EPID, V23, P217, DOI 10.1007/BF01787820; Pritchard C, 2015, COMMUNITY MENT HLT J, V51, P365, DOI 10.1007/s10597-014-9810-z; Rockett IRH, 2007, INJURY PREV, V13, P311, DOI 10.1136/ip.2007.015230; Rockett IRH, 2014, AM J PUBLIC HEALTH, V104, pE49, DOI 10.2105/AJPH.2014.302244; Rockett IRH, 2014, JAMA PSYCHIAT, V71, P231, DOI 10.1001/jamapsychiatry.2013.3738; Rockett IRH, 2011, SUICIDOL ONLINE-SOL, V2, P48; Rockett IRH, 2010, CRISIS, V31, P227, DOI 10.1027/0227-5910/a000071; Rockett IRH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-705; Rockett IRH, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-35; Rockett IRH, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-10; Rockett IRH, 2012, AM J PUBLIC HEALTH, V102, pe84, DOI [10.2105/AJPH.2012.300960, DOI 10.2105/AJPH.2012.300960]; Rockett IRH, 2015, JAMA PSYCHI IN PRESS; ROSENBERG ML, 1988, J FORENSIC SCI, V33, P1445; Ruzicka LT, 2005, SOC SCI MED, V61, P333, DOI 10.1016/j.socscimed.2004.12.005; Salib E, 1996, MED SCI LAW, V36, P237, DOI 10.1177/002580249603600310; Stanistreet D, 2001, MED SCI LAW, V41, P111, DOI 10.1177/002580240104100205; US Public Health Service, 2001, NAT STRAT SUIC PREV; Varnik P, 2010, SCAND J PUBLIC HEALT, V38, P395, DOI 10.1177/1403494809354360; Vichi M, 2010, PSYCHIAT RES, V175, P89, DOI 10.1016/j.psychres.2008.12.008; Warner M, 2013, ACAD FORENSIC PATHOL, V3, P231, DOI [DOI 10.23907/2013.029, 10.23907/2013.029]; William III Massello, 1985, J FORENSIC SCI, V31, P1000; World Health Organization, INT CLASS DIS	45	44	44	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135296	10.1371/journal.pone.0135296	http://dx.doi.org/10.1371/journal.pone.0135296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26295155	Green Submitted, Green Published, gold			2022-12-27	WOS:000359926900025
J	Sun, PF; Lin, H; Wang, G; Zhang, XM; Zhang, QC; Zhao, YH				Sun, Pengfei; Lin, Hui; Wang, Guan; Zhang, Ximing; Zhang, Qichun; Zhao, Yuhua			Wheat Bran Enhances the Cytotoxicity of Immobilized Alcaligenes aquatilis F8 against Microcystis aeruginosa	PLOS ONE			English	Article							ACID-HYDROLYSIS; FRESH-WATER; DEGRADATION; STRAW; PRETREATMENT; STRATEGIES; ALGINATE; STARCH; BLOOMS	Algicidal bacteria offer a promising option for killing cyanobacteria. Therefore, a new Alcaligenes aquatilis strain F8 was isolated to control Microcystis aeruginosa in this study. The algicidal activity of strain F8 was dependent on the cell density of M. aeruginosa, and the maximal algicidal rate of the free bacterium reached 88.45% within 72 h. With a view to its application to the control of M. aeruginosa in the natural environment, strain F8 was immobilized in sodium alginate beads, but immobilization of the strain decreased its algicidal rate compared to that of the free bacterium. However, addition of wheat bran to the sodium alginate matrix used to immobilize strain F8 not only eliminated the adverse effects of immobilization on the bacteria but also resulted in an 8.83% higher algicidal rate of the immobilized than free bacteria. Exclusion and recovery methods were used to identify key ingredients of wheat bran and gain insight into the mechanism underlying the observed enhancement of algicidal activity. This analysis indicated that certain factors in wheat bran, including vitamins B-1, B-2, B-9, and E were responsible for promoting bacterial growth and thereby improving the algicidal rate of immobilized strain F8. Our findings indicate that wheat bran is able to improve the algicidal efficiency of A. aquatilis strain F8 for killing M. aeruginosa and is a good source of not only carbon and nitrogen but also vitamins for bacteria.	[Sun, Pengfei; Wang, Guan; Zhang, Ximing; Zhao, Yuhua] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Hui] Zhejiang Acad Agr Sci, Inst Environm Resource & Soil Fertilizer, Hangzhou, Zhejiang, Peoples R China; [Zhang, Qichun] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Academy of Agricultural Sciences; Zhejiang University	Zhang, QC (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China.	qczhang@zju.edu.cn; microbeapply@zju.edu.cn	Sun, Pengfei/GNM-5684-2022; Zhang, Qichun/AAN-6970-2020; LIN, HUI/AEA-6702-2022	Sun, Pengfei/0000-0002-2881-6461; LIN, HUI/0000-0002-5446-8069	Major State Basic Research Development Program of China (973 Program) [2015CB150502]; National Natural Science Foundation of China [41271335, 31470191]; Science and Technology Project of Zhejiang Province [2011C13016, 2014C33019]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Zhejiang Province	This study was supported by the Major State Basic Research Development Program of China (973 Program) (2015CB150502), the National Natural Science Foundation of China (41271335; 31470191), and the Science and Technology Project of Zhejiang Province (2011C13016; 2014C33019).	Aguilar R, 2002, J FOOD ENG, V55, P309, DOI 10.1016/S0260-8774(02)00106-1; Bjerre AB, 1996, BIOTECHNOL BIOENG, V49, P568, DOI 10.1002/(SICI)1097-0290(19960305)49:5<568::AID-BIT10>3.3.CO;2-4; Choi HJ, 2005, BIOL CONTROL, V33, P335, DOI 10.1016/j.biocontrol.2005.03.007; de Ory I, 2004, PROCESS BIOCHEM, V39, P547, DOI 10.1016/S0032-9592(03)00136-5; Huang C, 2009, BIORESOURCE TECHNOL, V100, P4535, DOI 10.1016/j.biortech.2009.04.022; Hui J., 2011, J ANHUI AGR SCI, V39, P834; Huisman J, 2005, SPRINGER AQUATIC E 3, VSpringer Aquatic Ecology, Ser. 3; Idris A, 2006, PROCESS BIOCHEM, V41, P1117, DOI 10.1016/j.procbio.2005.12.002; Iranmahboob J, 2002, BIOMASS BIOENERG, V22, P401, DOI 10.1016/S0961-9534(02)00016-8; Jung SW, 2008, J APPL MICROBIOL, V105, P186, DOI 10.1111/j.1365-2672.2008.03733.x; Kang YH, 2007, J APPL MICROBIOL, V103, P1983, DOI 10.1111/j.1365-2672.2007.03439.x; Kang YH, 2012, HYDROBIOLOGIA, V683, P151, DOI 10.1007/s10750-011-0951-6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIN H, 2013, MATH PROBL ENG, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0060516; Livingston L.R., 1968, YALE J BIOL MED, V40, P324; Manage PM, 2000, AQUAT MICROB ECOL, V22, P111, DOI 10.3354/ame022111; Manohar S, 2001, APPL MICROBIOL BIOT, V55, P311, DOI 10.1007/s002530000488; Mattila P, 2001, J AGR FOOD CHEM, V49, P2343, DOI 10.1021/jf001525d; MCGRATH R, 1972, ANAL BIOCHEM, V49, P95, DOI 10.1016/0003-2697(72)90245-X; Mu R, 2014, AFR J BIOTECHNOL, V11, P460; Mu RM, 2007, J ENVIRON SCI-CHINA, V19, P1336, DOI 10.1016/S1001-0742(07)60218-6; Pan G, 2006, ENVIRON POLLUT, V141, P195, DOI 10.1016/j.envpol.2005.08.041; Patil NK, 2006, INT BIODETER BIODEGR, V57, P82, DOI 10.1016/j.ibiod.2005.11.007; Powell LW, 1990, IMMOBILIZED BIOCATAL, P369; Pruckler M, 2014, LWT-FOOD SCI TECHNOL, V56, P211, DOI 10.1016/j.lwt.2013.12.004; Saha BC, 2010, NEW BIOTECHNOL, V27, P10, DOI 10.1016/j.nbt.2009.10.005; Smith VH, 1999, ENVIRON POLLUT, V100, P179, DOI 10.1016/S0269-7491(99)00091-3; Sun PF, 2015, J HAZARD MATER, V284, P215, DOI 10.1016/j.jhazmat.2014.11.025; Sun PengFei, 2013, Journal of Zhejiang University (Agriculture and Life Sciences), V39, P613; Surette MG, 1998, P NATL ACAD SCI USA, V95, P7046, DOI 10.1073/pnas.95.12.7046; TABATA S, 1971, STARKE, V23, P267, DOI 10.1002/star.19710230803; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tsuji K, 2006, CHEMOSPHERE, V65, P117, DOI 10.1016/j.chemosphere.2006.02.018; Wang YJ, 2003, CARBOHYD POLYM, V52, P327, DOI 10.1016/S0144-8617(02)00323-5; Weng Q, 1999, J GUIZHOU NORMAL U N, V18, P49; Wright JD, 1989, COMP TECHNICAL EVALU, P949; Zhang H, 2011, LIMNOLOGICA, V41, P70, DOI 10.1016/j.limno.2010.08.001; Zhang W.H, 2001, RES ENV SCI, V14, P57	38	14	14	6	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136429	10.1371/journal.pone.0136429	http://dx.doi.org/10.1371/journal.pone.0136429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295573	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900109
J	Wilson, AG; Chan, Y; Taylor, SS; Arcese, P				Wilson, Amy G.; Chan, Yvonne; Taylor, Sabrina S.; Arcese, Peter			Genetic Divergence of an Avian Endemic on the Californian Channel Islands	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; MELOSPIZA-MELODIA; LOGGERHEAD SHRIKES; SONG SPARROW; FREQUENCY; SOFTWARE; DIFFERENTIATION; CONSERVATION; PROGRAM; DIVERSITY	The Californian Channel Islands are near-shore islands with high levels of endemism, but extensive habitat loss has contributed to the decline or extinction of several endemic taxa. A key parameter for understanding patterns of endemism and demography in island populations is the magnitude of inter-island dispersal. This paper estimates the extent of migration and genetic differentiation in three extant and two extinct populations of Channel Island song sparrows (Melospiza melodia graminea). Inter-island differentiation was substantial (G''(ST):0.14-0.37), with San Miguel Island having the highest genetic divergence and lowest migration rates. Santa Rosa and Santa Cruz Island populations were less diverged with higher migration rates. Genetic signals of past population declines were detected in all of the extant populations. The Channel Island populations were significantly diverged from mainland populations of M. m. heermanni (G''(ST): 0.30-0.64). Ten mtDNA haplotypes were recovered across the extant and extinct Channel Island population samples. Two of the ten haplotypes were shared between the Northern and Southern Channel Islands, with one of these haplotypes being detected on the Californian mainland. Our results suggest that there is little contemporary migration between islands, consistent with early explanations of avian biogeography in the Channel Islands, and that song sparrow populations on the northern Channel Islands are demographically independent.	[Wilson, Amy G.; Arcese, Peter] Univ British Columbia, Dept Conservat & Forest Sci, Vancouver, BC V5Z 1M9, Canada; [Chan, Yvonne] Iolani Sch, Honolulu, HI USA; [Taylor, Sabrina S.] Louisiana State Univ, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA	University of British Columbia; Louisiana State University System; Louisiana State University	Wilson, AG (corresponding author), Univ British Columbia, Dept Conservat & Forest Sci, Vancouver, BC V5Z 1M9, Canada.	asg.wilson@gmail.com	Chan, Yvonne/A-3383-2009	Taylor, Sabrina/0000-0002-0118-9883	University of California Genetic Resources Conservation Program; Natural Sciences and Engineering Research Council of Canada	University of California Genetic Resources Conservation Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by AW-University of California Genetic Resources Conservation Program (http://grcp.ucdavis.edu/) and AW-Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich J.W., 1984, ORNITHOL MONOGR, V35; ARCESE P, 1989, ANIM BEHAV, V38, P96, DOI 10.1016/S0003-3472(89)80069-7; Arcese P, 2002, SONG SPARROW, DOI [10.2173/bna.704, DOI 10.2173/BNA.704]; Bloom A.L., 1983, LATE QUATERNARY ENV, P215; Caballero IC, 2011, CONSERV GENET, V12, P1485, DOI 10.1007/s10592-011-0247-4; Chan Y, 2003, J EVOLUTION BIOL, V16, P939, DOI 10.1046/j.1420-9101.2003.00601.x; Chan Y, 2002, AUK, V119, P641, DOI 10.1642/0004-8038(2002)119[0641:SDACOS]2.0.CO;2; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Collins PW., 2008, STUDIES W BIRDS, P425; Cornuet JM, 1996, GENETICS, V144, P2001; Delaney KS, 2005, CONSERV BIOL, V19, P523, DOI 10.1111/j.1523-1739.2005.00424.x; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eggert LS, 2004, MOL ECOL, V13, P2121, DOI 10.1111/j.1365-294X.2004.02218.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fair J., 2010, ORNITHOLOGICAL COUNC; Fry AJ, 1998, MOL ECOL, V7, P1303, DOI 10.1046/j.1365-294x.1998.00462.x; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Grant PR, 1998, EVOLUTION ISLANDS; Guthrie Daniel A., 1992, Natural History Museum of Los Angeles County Science Series, V36, P319; Hofman CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118240; HUDSON RR, 1992, GENETICS, V132, P583; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JOHNSON NK, 1972, CONDOR, V74, P295, DOI 10.2307/1366591; JOHNSTON RICHARD F., 1956, CONDOR, V58, P24, DOI 10.2307/1365044; Junak, 1995, FLORA SANTA CRUZ ISL; Kalinowski ST, 2006, CONSERV GENET, V7, P991, DOI 10.1007/s10592-006-9134-9; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kennett DJ, 2008, QUATERNARY SCI REV, V27, P2530, DOI 10.1016/j.quascirev.2008.09.006; Leigh JW, POPART POPULATION AN; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; LYNCH JF, 1974, CONDOR, V76, P370, DOI 10.2307/1365812; Mason NA, 2014, AUK, V131, P162, DOI 10.1642/AUK-13-181.1; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; MILLER ALDEN H., 1951, CONDOR, V53, P117, DOI 10.2307/1364626; Moody A, 2000, J BIOGEOGR, V27, P711, DOI 10.1046/j.1365-2699.2000.00435.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Patten MA, 2001, ROLES HABITAT SIGNAL; Patten MA, 2009, SYST BIODIVERS, V7, P33, DOI 10.1017/S1477200008002867; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pergams ORW, 2015, PEERJ, V3, DOI 10.7717/peerj.812; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Porcasi P., 1999, PACIFIC COAST ARCHAE, V35, P1; POWER DM, 1979, EVOLUTION, V33, P834, DOI 10.1111/j.1558-5646.1979.tb04738.x; Pritchard JK, 2000, GENETICS, V155, P945; Pruett CL, 2008, CONDOR, V110, P359, DOI 10.1525/cond.2008.8475; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Raven PH, 1965, FLORISTICS CALIFORNI; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rick TC, 2014, BIOSCIENCE, V64, P680, DOI 10.1093/biosci/biu094; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schoenherr AA., 2003, NATURAL HIST ISLANDS; Smith J.N.M., 2006, CONSERVATION BIOL SM; Stanley TR, 2012, WILDLIFE SOC B, V36, P61, DOI 10.1002/wsb.108; Van Vuren DH, 2013, WILSON J ORNITHOL, V125, P134, DOI 10.1676/12-102.1; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Wilson A, 2009, CONSERV GENET, V10, P419, DOI 10.1007/s10592-008-9612-3; Wilson AG, 2011, CONSERV GENET, V12, P213, DOI 10.1007/s10592-010-0134-4; Wilson GA, 2003, GENETICS, V163, P1177	65	6	6	3	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134471	10.1371/journal.pone.0134471	http://dx.doi.org/10.1371/journal.pone.0134471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308717	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400026
J	Yasui, M; Tamura, Y; Minami, M; Higuchi, S; Fujikawa, R; Ikedo, T; Nagata, M; Arai, H; Murayama, T; Yokode, M				Yasui, Mika; Tamura, Yukinori; Minami, Manabu; Higuchi, Sei; Fujikawa, Risako; Ikedo, Taichi; Nagata, Manabu; Arai, Hidenori; Murayama, Toshinori; Yokode, Masayuki			The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity	PLOS ONE			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; ISCHEMIA-REPERFUSION INJURY; ADIPOSE-TISSUE; ARACHIDONIC-ACID; LEPTIN RELEASE; METABOLIC DISEASE; RESISTANCE; ADIPONECTIN; E-2; MICE	With increasing body weight, macrophages accumulate in adipose tissue. There, activated macrophages secrete numerous proinflammatory cytokines and chemokines, giving rise to chronic inflammation and insulin resistance. Prostaglandin E-2 suppresses macrophage activation via EP4; however, the role of EP4 signaling in insulin resistance and type 2 diabetes mellitus remains unknown. In this study, we treated db/db mice with an EP4-selective agonist, ONO-AE1-329, for 4 weeks to explore the role of EP4 signaling in obesity-related inflammation in vivo. Administration of the EP4 agonist did not affect body weight gain or food intake; however, in the EP4 agonist-treated group, glucose tolerance and insulin resistance were significantly improved over that of the vehicle-treated group. Additionally, administration of the EP4 agonist inhibited the accumulation of F4/80-positive macrophages and the formation of crown-like structures in white adipose tissue, and the adipocytes were significantly smaller. The treatment of the EP4 agonist increased the number of anti-inflammatory M2 macrophages, and in the stromal vascular fraction of white adipose tissue, which includes macrophages, it markedly decreased the levels of proinflammatory cytokines and chemokines. Further, EP4 activation increased the expression of adiponectin and peroxidase proliferator-activated receptors in white adipose tissue. Next, we examined in vitro M1/M2 polarization assay to investigate the impact of EP4 signaling on determining the functional phenotypes of macrophages. Treatment with EP4 agonist enhanced M2 polarization in wild-type peritoneal macrophages, whereas EP4-deficient macrophages were less susceptible to M2 polarization. Notably, antagonizing peroxidase proliferator-activated receptor delta activity suppressed EP4 signaling-mediated shift toward M2 macrophage polarization. Thus, our results demonstrate that EP4 signaling plays a critical role in obesity-related adipose tissue inflammation and insulin resistance by regulating macrophage recruitment and polarization. The activation of EP4 signaling holds promise for treating obesity and type 2 diabetes mellitus.	[Yasui, Mika; Tamura, Yukinori; Minami, Manabu; Higuchi, Sei; Fujikawa, Risako; Ikedo, Taichi; Nagata, Manabu; Murayama, Toshinori; Yokode, Masayuki] Kyoto Univ, Grad Sch Med, Dept Clin Innovat Med, Kyoto, Kyoto, Japan; [Tamura, Yukinori] Kinki Univ, Fac Med, Dept Physiol & Regenerat Med, Osaka, Japan; [Ikedo, Taichi; Nagata, Manabu] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Kyoto, Japan; [Arai, Hidenori] Natl Ctr Geriatr & Gerontol, Obu, Aichi, Japan	Kyoto University; Kindai University (Kinki University); Kyoto University; National Center for Geriatrics & Gerontology	Minami, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Clin Innovat Med, Kyoto, Kyoto, Japan.	mminami@kuhp.kyoto-u.ac.jp	Arai, Hidenori/P-9816-2017	Arai, Hidenori/0000-0002-9000-6849; Fujikawa, Risako/0000-0003-4108-6202; Higuchi, Sei/0000-0002-5134-8619	Japan Society for the Promotion of Science (JSPS) KAKENHI [20890111, 23590361, 26460338, 15K08230]; Suzuken Memorial Foundation; Metabolic Syndrome Research Forum Fund; Takeda Science Foundation; SENSHIN Medical Research Foundation; Grants-in-Aid for Scientific Research [25500003] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Suzuken Memorial Foundation; Metabolic Syndrome Research Forum Fund; Takeda Science Foundation(Takeda Science Foundation (TSF)); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding for this work was provided by the the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 20890111, 23590361, and 26460338 (to MM), 15K08230 (to MY): https://www.jsps.go.jp/j-grantsinaid/index.html, the Suzuken Memorial Foundation (to MM): http://www.suzukenzaidan.or.jp, the Metabolic Syndrome Research Forum Fund (to MM), the Takeda Science Foundation (to MM): http://www.takeda-sci.or.jp, and the SENSHIN Medical Research Foundation (to MM): http://www.mt-pharma.co.jp/zaidan/.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Charo C, 2013, PANCREAS, V42, P467, DOI 10.1097/MPA.0b013e318264d0f8; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; COLEMAN RA, 1994, PHARMACOL REV, V46, P205; Fain JN, 2000, PROSTAG OTH LIPID M, V62, P343, DOI 10.1016/S0090-6980(00)00088-5; Fain JN, 2000, J LIPID RES, V41, P1689; Fain JN, 2001, METABOLISM, V50, P921, DOI 10.1053/meta.2001.24927; FAUST IM, 1978, AM J PHYSIOL, V235, pE279, DOI 10.1152/ajpendo.1978.235.3.E279; Fukushima J, 2009, HEPATOL RES, V39, P724, DOI 10.1111/j.1872-034X.2009.00509.x; Hill AA, 2014, IMMUNOL REV, V262, P134, DOI 10.1111/imr.12216; Hishikari K, 2009, CARDIOVASC RES, V81, P123, DOI 10.1093/cvr/cvn254; Hiuge A, 2007, ARTERIOSCL THROM VAS, V27, P635, DOI 10.1161/01.ATV.0000256469.06782.d5; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Largo R, 2004, ANN RHEUM DIS, V63, P1197, DOI 10.1136/ard.2003.011163; Liang XB, 2011, J CLIN INVEST, V121, P4362, DOI 10.1172/JCI46279; Lovren F, 2010, AM J PHYSIOL-HEART C, V299, pH656, DOI 10.1152/ajpheart.00115.2010; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Minami M, 2008, J BIOL CHEM, V283, P9692, DOI 10.1074/jbc.M709663200; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nakanishi Y, 2011, CARCINOGENESIS, V32, P1333, DOI 10.1093/carcin/bgr128; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; O'Leary VB, 2007, AM J PHYSIOL-ENDOC M, V293, pE421, DOI 10.1152/ajpendo.00123.2007; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ogawa M, 2009, TRANSPLANTATION, V87, P1645, DOI 10.1097/TP.0b013e3181a5c84c; Ohinata K, 2006, PROSTAG OTH LIPID M, V81, P31, DOI 10.1016/j.prostaglandins.2006.06.008; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Orr JS, 2014, DIABETES, V63, P421, DOI 10.2337/db13-0213; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Otani T, 2015, CELL SIGNAL; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Papadimitriou A, 2007, CELL PHYSIOL BIOCHEM, V20, P607, DOI 10.1159/000107544; Piya MK, 2013, J ENDOCRINOL, V216, pT1, DOI 10.1530/JOE-12-0498; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Sanchez-Alavez M, 2007, P NATL ACAD SCI USA, V104, P3009, DOI 10.1073/pnas.0611209104; Saraswathi V, 2013, METABOLISM, V62, P1673, DOI 10.1016/j.metabol.2013.07.007; Satoh T, 2013, NATURE, V495, P524, DOI 10.1038/nature11930; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; Shi J, 2010, J IMMUNOL, V184, P7207, DOI 10.4049/jimmunol.0903487; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Sugimoto Y, 2004, BIOCHEM BIOPH RES CO, V322, P911, DOI 10.1016/j.bbrc.2004.07.194; Suzawa T, 2000, ENDOCRINOLOGY, V141, P1554, DOI 10.1210/en.141.4.1554; Takayama K, 2006, CIRC RES, V98, P499, DOI 10.1161/01.RES.0000204451.88147.96; Tang EHC, 2011, CARDIOVASC RES, V89, P234, DOI 10.1093/cvr/cvq262; Tang EHC, 2011, ARTERIOSCL THROM VAS, V31, P261, DOI 10.1161/ATVBAHA.110.216580; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Varma V, 2009, AM J PHYSIOL-ENDOC M, V296, pE1300, DOI 10.1152/ajpendo.90885.2008; Vennemann A, 2012, DIABETES, V61, P1879, DOI 10.2337/db11-1396; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xiao CY, 2004, CIRCULATION, V109, P2462, DOI 10.1161/01.CIR.0000128046.54681.97; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yokota T, 2002, J CLIN INVEST, V109, P1303, DOI 10.1172/JCI200214506; Zahner G, 2009, BIOCHEM J, V422, P563, DOI 10.1042/BJ20090420	63	30	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136304	10.1371/journal.pone.0136304	http://dx.doi.org/10.1371/journal.pone.0136304			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308623	gold, Green Submitted, Green Published			2022-12-27	WOS:000360069400103
J	Zhang, GJ; Hu, HH; Zhang, CF; Tian, XJ; Peng, H; Gao, TG				Zhang, Guo-Jin; Hu, Hai-Hua; Zhang, Cai-Fei; Tian, Xiao-Juan; Peng, Hui; Gao, Tian-Gang			Inaccessible Biodiversity on Limestone Cliffs: Aster tianmenshanensis (Asteraceae), a New Critically Endangered Species from China	PLOS ONE			English	Article							EXTERNAL TRANSCRIBED SPACER; PHYLOGENETIC UTILITY; 18S-26S RDNA; ETS; AMPLIFICATION	Aster tianmenshanensis G. J. Zhang & T. G. Gao, a new species of Asteraceae from southern China is described and illustrated based on evidence from morphology, micromorphology and molecular phylogeny. The new species is superficially similar to Aster salwinensis Onno in having rosettes of spatulate leaves and a solitary, terminal capitulum, but it differs by its glabrous leaf margins, unequal disc floret lobes and 1-seriate pappus. The molecular phylogenetic analysis, based on nuclear sequences ITS, ETS and chloroplast sequence trnL-F, showed that the new species was nested within the genus Aster and formed a well supported clade with Aster verticillatus (Reinw.) Brouillet et al. The new species differs from the latter in having unbranched stems, much larger capitula, unequal disc floret lobes, beakless achenes and persistent pappus. In particular, A. tianmenshanensis has very short stigmatic lines, only ca. 0.18 mm long and less than 1/3 of the length of sterile style tip appendages, remarkably different from its congeners. This type of stigmatic line, as far as we know, has not been found in any other species of Aster. The very short stigmatic lines plus the unequal disc floret lobes imply that the new species may have a very specialized pollination system, which may be a consequence of habitat specialization. The new species grows only on the limestone cliffs of Mt. Tianmen, Hunan Province, at the elevation of 1400 m. It could only be accessed when a plank walkway was built across the cliffs for tourists. As it is known only from an area estimated at less than 10 km(2) and a walkway passes through this location, its habitat could be easily disturbed. This species should best be treated as Critically Endangered based on the International Union for Conservation of Nature Red List Categories and Criteria B2a.	[Zhang, Guo-Jin; Hu, Hai-Hua; Zhang, Cai-Fei; Gao, Tian-Gang] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Zhang, Guo-Jin; Hu, Hai-Hua; Zhang, Cai-Fei] Univ Chinese Acad Sci, Beijing 100039, Peoples R China; [Tian, Xiao-Juan; Peng, Hui] Tianmenshan Natl Forest Pk, Zhangjiajie 427300, Hunan, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, TG (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China.	Gaotg@ibcas.ac.cn			National Natural Science Foundation of China [31270237, 31110103911]; S T Basic Work [2013FY112100]; External Cooperation Program of BIC; Chinese Academy of Sciences [GJHZ 201321]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); S T Basic Work; External Cooperation Program of BIC; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work is supported by the National Natural Science Foundation of China (Grant No. 31270237, 31110103911) awarded to GTG and partially supported by S & T Basic Work (Grant No. 2013FY112100), the External Cooperation Program of BIC, the Chinese Academy of Sciences (Grant No. GJHZ 201321). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; ANDERSON L. E., 1954, BRYOLOGIST, V57, P242; [Anonymous], 2001, IUCN IUCN RED LIST C; Baldwin BG, 1998, MOL PHYLOGENET EVOL, V10, P449, DOI 10.1006/mpev.1998.0545; Brouillet L., 2009, SYSTEMATICS EVOLUTIO, P589; Chen Y. L., 2011, FLORA CHINA, V20-21, P574; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; ITO M, 1995, J PLANT RES, V108, P93, DOI 10.1007/BF02344311; Ito M., 1995, FLORA JAPAN ANGIOSPE, V3, P59; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Li JiaXiang, 2008, Journal of Tropical and Subtropical Botany, V16, P573; Li WP, 2012, ANN BOT-LONDON, V109, P1341, DOI 10.1093/aob/mcs054; Linder CR, 2000, MOL PHYLOGENET EVOL, V14, P285, DOI 10.1006/mpev.1999.0706; Ling R., 1985, FLORA REIPUBLICAE PO, V74, P70; LIPPERT W, 1973, Mitteilungen der Botanischen Staatssammlung Muenchen, V11, P153; Luo KW, 2009, HUNAN FORESTRY SCI T, V36, P37; Manning JC, 2012, STRELITZIA, V29, P792; Markos S, 2001, SYST BOT, V26, P168; Miller M.A., 2010, P GAT COMP ENV WORKS; NESOM G.L., 2000, SIDA BOT MISC, V20, P1; Nesom GL, 2007, FAMILIES GENERA VASC, V8, P317; Nesom Guy L., 1994, Phytologia, V77, P141; Noyes RD, 1999, AM J BOT, V86, P398, DOI 10.2307/2656761; Peng CL, 2007, ACTA PHYTOTAXON SIN, V45, P304, DOI 10.1360/aps06095; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanford AM, 2000, AM J BOT, V87, P872, DOI 10.2307/2656895; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	32	8	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134895	10.1371/journal.pone.0134895	http://dx.doi.org/10.1371/journal.pone.0134895			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308863	Green Submitted, gold, Green Published			2022-12-27	WOS:000360069400040
J	Lin, KY; Wang, CC; Lin, CH; Sheng, WH; Chang, SC				Lin, Kuan-Yin; Wang, Chi-Chuan; Lin, Chia-Hui; Sheng, Wang-Huei; Chang, Shan-Chwen			Fluoroquinolones versus beta-Lactam/beta-Lactamase Inhibitors in Outpatients with Chronic Obstructive Pulmonary Disease and Pneumonia: A Nationwide Population-Based Study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; ANTIBIOTIC-TREATMENT; ACUTE EXACERBATIONS; CHRONIC-BRONCHITIS; PSEUDOMONAS-AERUGINOSA; COPD; MANAGEMENT; MOXIFLOXACIN; OUTCOMES; CLARITHROMYCIN	Background Studies on the association between antibiotic treatment and outcomes in outpatients with chronic obstructive pulmonary disease (COPD) and pneumonia are scarce. This study aimed to evaluate the effectiveness of fluoroquinolones and beta-lactam/beta-lactamase inhibitors for pneumonia in COPD outpatients. Methods We conducted a retrospective cohort study and identified 4,851 episodes of pneumonia among COPD outpatients treated with fluoroquinolones or beta-lactam/beta-lactamase inhibitors from the Taiwan National Health Insurance Research Database during 2002-2011. Using the propensity score analysis, 1,296 pairs of episodes were matched for the demographic and clinical characteristics. The primary outcome was pneumonia/empyema-related hospitalization or emergency department (ED) visits, and the secondary outcomes were treatment failure, all-cause mortality and medical costs within 30 days. Results Compared with episodes treated with beta-lactam/beta-lactamase inhibitors, episodes treated with fluoroquinolones had similar clinical outcomes. The rates of pneumonia/empyema-related hospitalization or ED visits were 3.9% and 3.5% in the fluoroquinolone and beta-lactam/beta-lactamase inhibitor groups, respectively (adjusted hazard ratio [aHR], 1.11; 95% confidence interval [CI], 0.74-1.66). The percentage of treatment failure and all-cause mortality were 28.2% versus 31.3% (adjusted odds ratio, 0.86; 95% CI, 0.73-1.02) and 0.5% versus 0.4% (aHR, 1.40; 95% CI, 0.45-4.41) in the fluoroquinolone and beta-lactam/beta-lactamase inhibitor groups, respectively. The medical expenditures, including total medical costs (528 versus 455 US dollars) and pneumonia-related costs (202 vs. 155 USD) were also balanced between the two treatment groups (both P > 0.05). Conclusions For pneumonia in COPD outpatients, fluoroquinolones were associated with similar clinical outcomes and medical expenditures compared with beta-lactam/beta-lactamase inhibitors.	[Lin, Kuan-Yin] Ctr Drug Evaluat, Taipei, Taiwan; [Wang, Chi-Chuan] Natl Taiwan Univ, Sch Pharm, Taipei 10764, Taiwan; [Lin, Chia-Hui] Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan; [Sheng, Wang-Huei; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Sheng, Wang-Huei; Chang, Shan-Chwen] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Sheng, WH (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	whsheng@ntu.edu.tw		WANG, CHI-CHUAN/0000-0002-4597-4859; CHANG, SHAN-CHWEN/0000-0001-6505-4139; SHENG, WANG-HUEI/0000-0002-5605-7853; Lin, Kuan-Yin/0000-0001-6877-5345				Albertson TE, 2010, INT J CLIN PRACT, V64, P378, DOI 10.1111/j.1742-1241.2009.02239.x; [Anonymous], 2000, WORLD HLTH REP; Cilli A, 2015, CURR INFECT DIS REP, V17, DOI 10.1007/s11908-014-0444-7; Drummond MF, 2003, CHEST, V124, P526, DOI 10.1378/chest.124.2.526; [Food and Drug Administration U. S. Department of Health and Human Services Center for Drug Evaluation and Research], 2014, GUID IND COMM ACQ BA; Friedland IR, 2004, PULM PHARMACOL THER, V17, P199, DOI 10.1016/j.pupt.2004.03.002; Garcia-Vidal C, 2009, EUR RESPIR J, V34, P1072, DOI 10.1183/09031936.00003309; Global initiative for chronic obstructive lung disease, 2011, GLOB STRAT DIAGN MAN; Gomez-Junyent J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105854; Huerta A, 2013, CHEST, V144, P1134, DOI 10.1378/chest.13-0488; Kew KM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010115.pub2; Kuo SC, 2014, EMERG INFECT DIS, V20, P1386, DOI 10.3201/eid2008.140341; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Lin SH, 2007, RESPIROLOGY, V12, P81, DOI 10.1111/j.1440-1843.2006.00999.x; Loke YK, 2013, INT J CLIN PRACT, V67, P477, DOI 10.1111/ijcp.12120; Luo Zhehui, 2010, Med Care Res Rev, V67, P528, DOI 10.1177/1077558710361486; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; [Ministry of Health and Welfare Taiwan Centers for Disease Control], 2012, STATISTICS OF COMMUN; O'Donnell DE, 2008, CAN RESPIR J, V15, p1A, DOI 10.1155/2008/641965; Postma DF, 2015, NEW ENGL J MED, V372, P1312, DOI 10.1056/NEJMoa1406330; Rangelov K, 2014, CLIN CHEST MED, V35, P87, DOI 10.1016/j.ccm.2013.09.012; Shen GH, 2012, INT J ANTIMICROB AG, V39, P201, DOI 10.1016/j.ijantimicag.2011.11.014; Siempos II, 2007, EUR RESPIR J, V29, P1127, DOI 10.1183/09031936.00147806; Stefan MS, 2013, CHEST, V143, P82, DOI 10.1378/chest.12-0649; Tan WC, 2008, CHEST, V133, P517, DOI 10.1378/chest.07-1131; Wilson R, 2004, CHEST, V125, P953, DOI 10.1378/chest.125.3.953; Wilson R, 2002, CLIN THER, V24, P639, DOI 10.1016/S0149-2918(02)85139-6; Wilson R, 2013, J INFECTION, V67, P497, DOI 10.1016/j.jinf.2013.08.010; Wilson R, 2012, EUR RESPIR J, V40, P17, DOI 10.1183/09031936.00090311; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x	31	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136232	10.1371/journal.pone.0136232	http://dx.doi.org/10.1371/journal.pone.0136232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305908	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500054
J	Chen, SL; Lei, Y; Xu, X; Huang, JQ; Jiang, HF; Wang, J; Cheng, ZS; Zhang, JA; Song, YH; Liao, BS; Li, YR				Chen, Silong; Lei, Yong; Xu, Xian; Huang, Jiaquan; Jiang, Huifang; Wang, Jin; Cheng, Zengshu; Zhang, Jianan; Song, Yahui; Liao, Boshou; Li, Yurong			The Peanut (Arachis hypogaea L.) Gene AhLPAT2 Increases the Lipid Content of Transgenic Arabidopsis Seeds	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE; ACETYL-COA CARBOXYLASE; ACYL-CARRIER-PROTEIN; OIL CONTENT; FATTY-ACID; TRIACYLGLYCEROL BIOSYNTHESIS; ESCHERICHIA-COLI; DIACYLGLYCEROL ACYLTRANSFERASE; MOLECULAR CHARACTERIZATION; ERUCIC-ACID	Lysophosphatidic acid acyltransferase (LPAT), which converts lysophosphatidic acid (LPA) to phosphatidic acid (PA), catalyzes the addition of fatty acyl moieties to the sn-2 position of the LPA glycerol backbone in triacylglycerol (TAG) biosynthesis. We recently reported the cloning and temporal-spatial expression of a peanut (Arachis hypogaea) AhLPAT2gene, showing that an increase in AhLPAT2 transcript levels was closely correlated with an increase in seed oil levels. However, the function of the enzyme encoded by the AhLPAT2 gene remains unclear. Here, we report that AhLPAT2 transcript levels were consistently higher in the seeds of a high-oil cultivar than in those of a low-oil cultivar across different seed developmental stages. Seed-specific overexpression of AhLPAT2 in Arabidopsis results in a higher percentage of oil in the seeds and greater-than-average seed weight in the transgenic plants compared with the wild-type plants, leading to a significant increase in total oil yield per plant. The total fatty acid (FA) content and the proportion of unsaturated FAs also increased. In the developing siliques of AhLPAT2-overexpressing plants, the expression levels of genes encoding crucial enzymes involved in de novo FA synthesis, acetyl-CoA subunit (AtBCCP2) and acyl carrier protein 1 (AtACP1) were elevated. AhLPAT2 overexpression also promoted the expression of several key genes related to TAG assembly, sucrose metabolism, and glycolysis. These results demonstrate that the expression of AhLPAT2 plays an important role in glycerolipid production in peanuts.	[Chen, Silong; Xu, Xian; Wang, Jin; Cheng, Zengshu; Zhang, Jianan; Song, Yahui; Li, Yurong] Hebei Acad Agr & Forestry Sci, Cereal & Oil Crop Inst, Hebei Prov Lab Crop Genet & Breeding, Shijiazhuang, Peoples R China; [Lei, Yong; Huang, Jiaquan; Jiang, Huifang; Liao, Boshou] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan, Peoples R China	Hebei Academy of Agricultural & Forestry Sciences; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Liao, BS (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan, Peoples R China.	lboshou@hotmail.com; apeanutlab@gmail.com		Chen, Silong/0000-0001-9962-3686	National Natural Science Foundation of China [31201239, 31301354]; Key Basic Research Program of the Hebei Province Applied Basic Research Plan [14966317D]; Hebei Province Doctor Foundation [F14E055610]; China Agriculture Research System [CARS-14]; Science and Technology Research and Development Plans of Hebei Provice [14226313D]; Natural Science Fund of Hebei Province [C2010001594, C2013301044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Basic Research Program of the Hebei Province Applied Basic Research Plan; Hebei Province Doctor Foundation; China Agriculture Research System; Science and Technology Research and Development Plans of Hebei Provice; Natural Science Fund of Hebei Province	This work was supported by grants from the National Natural Science Foundation of China (31201239, 31301354), the Key Basic Research Program of the Hebei Province Applied Basic Research Plan (14966317D), the Hebei Province Doctor Foundation (F14E055610), the China Agriculture Research System (CARS-14), the Science and Technology Research and Development Plans of Hebei Provice (14226313D), and the Natural Science Fund of Hebei Province (C2010001594, C2013301044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski NM, 2009, P NATL ACAD SCI USA, V106, P20115, DOI 10.1073/pnas.0907024106; Ballicora MA, 2004, PHOTOSYNTH RES, V79, P1, DOI 10.1023/B:PRES.0000011916.67519.58; Banas W, 2013, PLANTA, V237, P1627, DOI 10.1007/s00425-013-1870-8; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; Bourgis F, 1999, PLANT PHYSIOL, V120, P913, DOI 10.1104/pp.120.3.913; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown AP, 2002, BIOCHEM J, V364, P795, DOI 10.1042/BJ20020071; Brown AP, 2002, PHYTOCHEMISTRY, V61, P493, DOI 10.1016/S0031-9422(02)00290-X; BROWN AP, 1994, PLANT MOL BIOL, V26, P211, DOI 10.1007/BF00039533; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Cagliari A, 2010, PLANT SCI, V179, P499, DOI 10.1016/j.plantsci.2010.07.015; Chapman KD, 2012, J BIOL CHEM, V287, P2288, DOI 10.1074/jbc.R111.290072; Chen SL, 2012, J BIOSCIENCES, V37, P1029, DOI 10.1007/s12038-012-9277-4; Chen SiLong, 2012, Acta Agronomica Sinica, V38, P245, DOI 10.1016/S1875-2780(11)60104-1; Chen SiLong, 2008, Acta Agronomica Sinica, V34, P142, DOI 10.3724/SP.J.1006.2008.00142; Chourey PS, 1998, MOL GEN GENET, V259, P88, DOI 10.1007/s004380050792; Chu Y, 2011, PLANT GENOME-US, V4, P110, DOI 10.3835/plantgenome2011.01.0001; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Craig J, 1999, PLANT J, V17, P353, DOI 10.1046/j.1365-313X.1999.00382.x; Cullinane M, 2005, MICROBIOL-SGM, V151, P3071, DOI 10.1099/mic.0.27958-0; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Eberhardt C, 1997, J BIOL CHEM, V272, P20299, DOI 10.1074/jbc.272.32.20299; FAO, 2014, AGRICULTURAL DATA; Focks N, 1998, PLANT PHYSIOL, V118, P91, DOI 10.1104/pp.118.1.91; Frentzen M, 1998, FETT-LIPID, V100, P161; Furumoto T, 2011, NATURE, V476, P472, DOI 10.1038/nature10250; Ghosh AK, 2009, PLANT PHYSIOL, V151, P869, DOI 10.1104/pp.109.144261; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Herbert D, 1997, PESTIC SCI, V50, P67, DOI 10.1002/(SICI)1096-9063(199705)50:1&lt;67::AID-PS552&gt;3.0.CO;2-#; Huang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050002; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; Jiang SL, 2012, J EXP BOT, V63, P2693, DOI 10.1093/jxb/err452; JOSEFSSON LG, 1987, J BIOL CHEM, V262, P12196; Katavic V, 2000, BIOCHEM SOC T, V28, P935, DOI 10.1042/BST0280935; Kim HU, 2005, PLANT CELL, V17, P1073, DOI 10.1105/tpc.104.030403; Kim HU, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1413-8; KNUTZON DS, 1995, PLANT PHYSIOL, V109, P999, DOI 10.1104/pp.109.3.999; Li RJ, 2006, PLANTA, V224, P952, DOI 10.1007/s00425-006-0266-4; Li YH, 2006, PHYTOCHEMISTRY, V67, P904, DOI 10.1016/j.phytochem.2006.02.015; Liu J, 2012, J EXP BOT, V63, P3727, DOI 10.1093/jxb/ers066; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CF, 2011, CURR OPIN BIOTECH, V22, P252, DOI 10.1016/j.copbio.2010.11.006; Luo M, 2005, PHYTOPATHOLOGY, V95, P381, DOI 10.1094/PHYTO-95-0381; Maisonneuve S, 2010, PLANT PHYSIOL, V152, P670, DOI 10.1104/pp.109.148247; Manas-Fernandez A, 2013, EUR J LIPID SCI TECH, V115, P1334, DOI 10.1002/ejlt.201300195; Arroyo-Caro JM, 2013, PLANT SCI, V199, P29, DOI 10.1016/j.plantsci.2012.09.015; Meyer K, 2012, PLANT PHYSIOL, V159, P1221, DOI 10.1104/pp.112.198309; Misra N, 2014, MOL BIOL REP, P1; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Ohlrogge JB, 1997, ANNU REV PLANT PHYS, V48, P109, DOI 10.1146/annurev.arplant.48.1.109; OO KC, 1989, PLANT PHYSIOL, V91, P1288, DOI 10.1104/pp.91.4.1288; Ozcan MM, 2010, J OLEO SCI, V59, P1, DOI 10.5650/jos.59.1; Pagac M, 2011, J BIOL CHEM, V286, P36438, DOI 10.1074/jbc.M111.256511; Penfield S, 2004, PLANT CELL, V16, P2705, DOI 10.1105/tpc.104.024711; Rao SS, 2009, LIPIDS, V44, P945, DOI 10.1007/s11745-009-3337-z; Roscoe TJ, 2005, EUR J LIPID SCI TECH, V107, P256, DOI 10.1002/ejlt.200590023; Sarvamangala C, 2011, FIELD CROP RES, V122, P49, DOI 10.1016/j.fcr.2011.02.010; Sasaki Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1175, DOI 10.1271/bbb.68.1175; Schwender J, 2008, CURR OPIN BIOTECH, V19, P131, DOI 10.1016/j.copbio.2008.02.006; Schwender J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00063; Scott A, 1999, BIOTECHNIQUES, V26, P1125, DOI 10.2144/99266st04; Shilman F, 2011, PLANT MOL BIOL REP, V29, P232, DOI 10.1007/s11105-010-0226-9; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Singsit C, 1997, TRANSGENIC RES, V6, P169, DOI 10.1023/A:1018481805928; Song QX, 2013, J EXP BOT, V64, P4329, DOI 10.1093/jxb/ert238; Sun MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047037; Tan HL, 2011, PLANT PHYSIOL, V156, P1577, DOI 10.1104/pp.111.175000; Taylor D. C., 2010, Open Plant Science Journal, V4, P7, DOI 10.2174/1874294701004010007; Taylor DC, 2002, MOL BREEDING, V8, P317, DOI 10.1023/A:1015234401080; Thelen JJ, 2000, BIOCHEM SOC T, V28, P595, DOI 10.1042/BST0280595; Tomosugi M, 2006, PLANTA, V223, P349, DOI 10.1007/s00425-005-0083-1; Upadhyay SK, 2009, J BIOL CHEM, V284, P22390, DOI 10.1074/jbc.M109.014829; van Erp H, 2014, PLANT PHYSIOL, V165, P30, DOI 10.1104/pp.114.236430; van Leeuwen W, 2001, J EXP BOT, V52, P949, DOI 10.1093/jexbot/52.358.949; Vassiliou EK, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-25; Vigeolas H, 2004, PLANT PHYSIOL, V136, P2676, DOI 10.1104/pp.104.046854; Wang ZJ, 2014, J CHEM-NY, V2014, DOI 10.1155/2014/475389; Xu K, 2010, AFR J BIOTECHNOL, V9, P3904; Yamashita A, 2007, BBA-MOL CELL BIOL L, V1771, P1202, DOI 10.1016/j.bbalip.2007.07.002; Yin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073767; Yu DQ, 1999, PLANT MOL BIOL, V39, P477, DOI 10.1023/A:1006180708533; Yu XH, 2014, PLANT PHYSIOL, V164, P455, DOI 10.1104/pp.113.230953; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zou JT, 1997, PLANT CELL, V9, P909, DOI 10.1105/tpc.9.6.909	84	6	15	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136170	10.1371/journal.pone.0136170	http://dx.doi.org/10.1371/journal.pone.0136170			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302041	Green Submitted, Green Published, gold			2022-12-27	WOS:000359951900047
J	Guizard, N; Fonov, VS; Garcia-Lorenzo, D; Nakamura, K; Aubert-Broche, B; Collins, DL				Guizard, Nicolas; Fonov, Vladimir S.; Garcia-Lorenzo, Daniel; Nakamura, Kunio; Aubert-Broche, Berengere; Collins, D. Louis			Spatio-Temporal Regularization for Longitudinal Registration to Subject-Specific 3d Template	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; ALZHEIMERS-DISEASE; ATLAS CONSTRUCTION; MRI; ATROPHY; SEGMENTATION; PROGRESSION; ACCURATE; ADNI; SETS	Neurodegenerative diseases such as Alzheimer's disease present subtle anatomical brain changes before the appearance of clinical symptoms. Manual structure segmentation is long and tedious and although automatic methods exist, they are often performed in a cross-sectional manner where each time-point is analyzed independently. With such analysis methods, bias, error and longitudinal noise may be introduced. Noise due to MR scanners and other physiological effects may also introduce variability in the measurement. We propose to use 4D non-linear registration with spatio-temporal regularization to correct for potential longitudinal inconsistencies in the context of structure segmentation. The major contribution of this article is the use of individual template creation with spatio-temporal regularization of the deformation fields for each subject. We validate our method with different sets of real MRI data, compare it to available longitudinal methods such as FreeSurfer, SPM12, QUARC, TBM, and KNBSI, and demonstrate that spatially local temporal regularization yields more consistent rates of change of global structures resulting in better statistical power to detect significant changes over time and between populations.	[Guizard, Nicolas; Fonov, Vladimir S.; Garcia-Lorenzo, Daniel; Nakamura, Kunio; Aubert-Broche, Berengere; Collins, D. Louis] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Garcia-Lorenzo, Daniel] CENIR ICM, Pitie Salpetriere, Paris, France	McGill University	Guizard, N (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	nicolas.guizard2@mail.mcgill.ca	Collins, D. Louis/ABD-7708-2021; Fonov, Vladimir/AAG-9572-2019	Collins, D. Louis/0000-0002-8432-7021; Fonov, Vladimir/0000-0003-3402-7749; Nakamura, Kunio/0000-0002-7833-8138	Canadian Institutes of Health Research [MOP-111169, 84360]; les Fonds de Recherche Sante Quebec; MS Society of Canada [691]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); les Fonds de Recherche Sante Quebec; MS Society of Canada	This study was funded by the Canadian Institutes of Health Research (MOP-111169 & 84360), les Fonds de Recherche Sante Quebec and the MS Society of Canada (BioMed PhD studentship, 691).	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 1998, HUM BRAIN MAPP, V6, P348, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<348::AID-HBM4>3.0.CO;2-P; Ashburner J, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00197; Aubert-Broche B, 2013, NEUROIMAGE, V82, P393, DOI 10.1016/j.neuroimage.2013.05.065; Avants BB, 2006, LECT NOTES COMPUT SC, V4057, P50; Balci S.K., 2007, MED IMAGE COMPUT COM, V10, P23, DOI DOI 10.1901/JABA.2007.10-23; Baron JC, 2001, NEUROIMAGE, V14, P298, DOI 10.1006/nimg.2001.0848; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Caramanos Z, 2010, NEUROIMAGE, V49, P1601, DOI 10.1016/j.neuroimage.2009.08.008; Chakravarty MM, 2006, NEUROIMAGE, V30, P359, DOI 10.1016/j.neuroimage.2005.09.041; Chard DT, 2003, J NEUROL NEUROSUR PS, V74, P1551, DOI 10.1136/jnnp.74.11.1551; Cheng J, 2010, STAT MED, V29, P504, DOI 10.1002/sim.3775; Chetelat G, 2005, NEUROIMAGE, V27, P934, DOI 10.1016/j.neuroimage.2005.05.015; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Collins DL, 1997, INT J PATTERN RECOGN, V11, P1271, DOI 10.1142/S0218001497000597; Coupe P, 2011, NEUROIMAGE, V54, P940, DOI 10.1016/j.neuroimage.2010.09.018; Coupe P, 2010, MED IMAGE ANAL, V14, P483, DOI 10.1016/j.media.2010.03.001; Cuingnet R, 2013, IEEE T PATTERN ANAL, V35, P682, DOI 10.1109/TPAMI.2012.142; Davis BC, 2010, INT J COMPUT VISION, V90, P255, DOI 10.1007/s11263-010-0367-1; Diggle Diggle P, 2013, ANAL LONGITUDINAL DA; Durrleman S, 2009, LECT NOTES COMPUT SC, V5761, P297, DOI 10.1007/978-3-642-04268-3_37; Eskildsen SF, 2012, NEUROIMAGE, V59, P2362, DOI 10.1016/j.neuroimage.2011.09.012; Fiot JB, 2014, NEUROIMAGE-CLIN, V4, P718, DOI 10.1016/j.nicl.2014.02.002; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fisher E, 2002, NEUROLOGY, V59, P1412, DOI 10.1212/01.WNL.0000036271.49066.06; Fonov V., 2009, NEUROIMAGE, V47, pS102, DOI [DOI 10.1016/S1053-8119(09)70884-5, 10.1016/s1053-8119(09)70884-5]; Fonov V.S., 2012, AUTOMATIC LATERAL VE; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Freeborough PA, 1997, IEEE T MED IMAGING, V16, P623, DOI 10.1109/42.640753; Frisoni GB, 2011, NAT REV NEUROL, V7, P429, DOI 10.1038/nrneurol.2011.99; Guimond A, 2001, IEEE T MED IMAGING, V20, P58, DOI 10.1109/42.906425; Guimond A, 1998, LECT NOTES COMPUT SC, V1496, P631, DOI 10.1007/BFb0056249; Hart G, 2010, SPATIO TEMPORAL IMAG; Holland D, 2012, HUM BRAIN MAPP, V33, P2586, DOI 10.1002/hbm.21386; Holland D, 2011, MED IMAGE ANAL, V15, P489, DOI 10.1016/j.media.2011.02.005; Hua X, 2013, NEUROIMAGE, V66, P648, DOI 10.1016/j.neuroimage.2012.10.086; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kraemer HC, 1987, MANY SUBJECTS STAT P; Leung KK, 2010, NEUROIMAGE, V51, P1345, DOI 10.1016/j.neuroimage.2010.03.018; Leung KK, 2010, NEUROIMAGE, V50, P516, DOI 10.1016/j.neuroimage.2009.12.059; Lewis EB, 2004, NEUROIMAGE, V23, P75, DOI 10.1016/j.neuroimage.2004.04.030; Liang ZP, 2000, PRINCIPLES MAGNETIC; Liao S, 2012, NEUROIMAGE, V59, P1275, DOI 10.1016/j.neuroimage.2011.07.095; Lorenzi M, 2010, SPATIO TEMPORAL IMAG; Marcus DS, 2010, J COGNITIVE NEUROSCI, V22, P2677, DOI 10.1162/jocn.2009.21407; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Ridha BH, 2006, LANCET NEUROL, V5, P828, DOI 10.1016/S1474-4422(06)70550-6; Sadeghi N, 2010, PROC SPIE, V7623, DOI 10.1117/12.844526; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Shen DG, 2004, NEUROIMAGE, V21, P1508, DOI 10.1016/j.neuroimage.2003.12.015; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Thompson P. M., 2002, Computing and Visualization in Science, V5, P13, DOI 10.1007/s00791-002-0084-6; Thompson WK, 2011, NEUROIMAGE, V57, P1, DOI 10.1016/j.neuroimage.2010.11.092; Verbeke G, 2000, LINEAR MIXED MODELS; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040; Wu GR, 2012, NEUROIMAGE, V59, P404, DOI 10.1016/j.neuroimage.2011.07.026; Wyman BT, 2013, ALZHEIMERS DEMENT, V9, P332, DOI 10.1016/j.jalz.2012.06.004; Yushkevich PA, 2010, NEUROIMAGE, V50, P434, DOI 10.1016/j.neuroimage.2009.12.007; Zijdenbos A, 1998, LECT NOTES COMPUT SC, V1496, P439, DOI 10.1007/BFb0056229	66	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0133352	10.1371/journal.pone.0133352	http://dx.doi.org/10.1371/journal.pone.0133352			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301716	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900004
J	Helmy, S; Bader, Y; Koch, M; Tiringer, D; Kollmann, C				Helmy, Samir; Bader, Yvonne; Koch, Marianne; Tiringer, Denise; Kollmann, Christian			Measurement of Thermal Effects of Doppler Ultrasound: An In Vitro Study	PLOS ONE			English	Article							DIAGNOSTIC ULTRASOUND; SAFETY; PREGNANCY; OBSTETRICS; BRAIN	Objective Ultrasound is considered a safe imaging modality and is routinely applied during early pregnancy. However, reservations are expressed concerning the application of Doppler ultrasound in early pregnancy due to energy emission of the ultrasound probe and its conversion to heat. The objective of this study was to evaluate the thermal effects of emitted Doppler ultrasound of different ultrasound machines and probes by means of temperature increase of in-vitro test-media. Methods We investigated the energy-output of 5 vaginal and abdominal probes of 3 ultrasound machines (GE Healthcare, Siemens, Aloka). Two in-vitro test objects were developed at the Center for Medical Physics and Biomedical Engineering, Medical University Vienna (water bath and hydrogel bath). Temperature increase during Doppler ultrasound emission was measured via thermal sensors, which were placed inside the test objects or on the probes' surface. Each probe was emitting for 5 minutes into the absorbing test object with 3 different TI/MI settings in Spectral Doppler mode. Results During water bath test, temperature increase varied between 0.1 and 1.0 degrees C, depending on probe, setting and focus, and was found highest for spectral Doppler mode alone. Maximum temperature increase was found during the surface heating test, where values up to 2.4 degrees C could be measured within 5 minutes of emission. Conclusions Activation of Doppler ultrasound in the waterbath model causes a significant increase of temperature within one minute. Thermally induced effects on the embryo cannot be excluded when using Doppler ultrasound in early pregnancy.	[Helmy, Samir; Koch, Marianne; Tiringer, Denise] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Bader, Yvonne] Univ Clin Saarland, Dept Gynecol Obstet & Reprod Med, Homburg, Germany; [Koch, Marianne] Karl Landsteiner Soc, Vienna, Austria; [Kollmann, Christian] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria	Medical University of Vienna; Universitatsklinikum des Saarlandes; Medical University of Vienna	Helmy, S (corresponding author), Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria.	Samir.helmy@meduniwien.ac.at	Kollmann, Christian/A-2475-2013	Kollmann, Christian/0000-0002-3047-5715; Koch, Marianne/0000-0003-4748-2994	Karl Landsteiner Society, Institute for General Gynecology and Gynecologic Oncology	Karl Landsteiner Society, Institute for General Gynecology and Gynecologic Oncology	The authors received no specific funding for this work. Material for conduction if this study was provided by the Center for Medical Physics & Biomedical Engineering UltraSound-Lab, Medical University of Vienna and the Department of Obstetrics and Gynecology, Medical University of Vienna. The authors acknowledge the financial support for open access publication provided by the Karl Landsteiner Society, Institute for General Gynecology and Gynecologic Oncology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowicz JS, 2008, J ULTRAS MED, V27, P541, DOI 10.7863/jum.2008.27.4.541; Abramowicz JS, 2013, SEMIN PERINATOL, V37, P295, DOI 10.1053/j.semperi.2013.06.004; Abramowicz JS, 2003, ULTRASOUND OBST GYN, V21, P100, DOI 10.1002/uog.36; [Anonymous], 1999, EUR J ULTRASOUND, V9, P281; Barnett S B, 2001, J Matern Fetal Med, V10, P75, DOI 10.1080/714904312; Bly S, 2005, J OBSTET GYNAECOL CA, V27, P572; Browne JE, 2003, ULTRASOUND MED BIOL, V29, P1053, DOI 10.1016/S0301-5629(03)00053-X; Church CC, 2007, PROG BIOPHYS MOL BIO, V93, P331, DOI 10.1016/j.pbiomolbio.2006.07.015; EDWARDS MJ, 1995, REPROD TOXICOL, V9, P411, DOI 10.1016/0890-6238(95)00043-A; Fowlkes JB, 2008, J ULTRAS MED, V27, P503; HENDERSON J, 1995, ULTRASOUND MED BIOL, V21, P699, DOI 10.1016/0301-5629(94)00158-A; Hershkovitz R, 2002, EUR J OBSTET GYN R B, V101, P15, DOI 10.1016/S0301-2115(01)00469-9; Horder MM, 1998, ULTRASOUND MED BIOL, V24, P1467, DOI 10.1016/S0301-5629(98)00111-2; Hoskins P.R., 2003, DIAGNOSTIC ULTRASOUN; Houston LE, 2009, PRENATAL DIAG, V29, P1204, DOI 10.1002/pd.2392; Jensh RP, 1999, TERATOLOGY, V59, P240, DOI 10.1002/(SICI)1096-9926(199904)59:4<240::AID-TERA10>3.0.CO;2-V; Kollmann C, 2013, ULTRASCHALL MED, V34, P422, DOI 10.1055/s-0033-1335843; Kollmann C, 2007, EUR J RADIOL, V64, P164, DOI 10.1016/j.ejrad.2007.07.024; McClintic AM, 2014, AUTISM RES, V7, P295, DOI 10.1002/aur.1349; Meizner I, 2012, HAREFUAH, V151, P252; Meizner Israel, 2012, Harefuah, V151, P234; MERRITT CRB, 1989, RADIOLOGY, V173, P304, DOI 10.1148/radiology.173.2.2678243; O'Brien WD, 2007, PROG BIOPHYS MOL BIO, V93, P212, DOI 10.1016/j.pbiomolbio.2006.07.010; Pfaffenberger S, 2013, ULTRASCHALL MED, V34, P51, DOI 10.1055/s-0032-1313083; Salvesen Kjell A, 2002, Eur J Ultrasound, V15, P165, DOI 10.1016/S0929-8266(02)00038-1; Sheiner E, 2012, CLIN OBSTET GYNECOL, V55, P188, DOI 10.1097/GRF.0b013e3182488386; Society SGotBMU, 2009, EUR J ULTRASOUND; Society) TBMUSSGotBMU, 2003, GUID SAF US DIAGN UL; ter Haar GR, 2013, ULTRASOUND MED BIOL, V39, P374, DOI 10.1016/j.ultrasmedbio.2012.11.024; Torloni MR, 2009, ULTRASOUND OBST GYN, V33, P599, DOI 10.1002/uog.6328; Vyskocil E, 2012, ULTRASCHALL MED; Wfumb/Isuog, 2013, ULTRASOUND MED BIOL, V39, P373, DOI [10.1016/j.ultrasmedbio.2012.11.025, DOI 10.1016/J.ULTRASMEDBIO.2012.11.025]	32	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135717	10.1371/journal.pone.0135717	http://dx.doi.org/10.1371/journal.pone.0135717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302465	Green Published, gold, Green Submitted			2022-12-27	WOS:000359951900026
J	Otti, A; Wohlschlaeger, AM; Noll-Hussong, M				Otti, Alexander; Wohlschlaeger, Afra M.; Noll-Hussong, Michael			Is the Medial Prefrontal Cortex Necessary for Theory of Mind?	PLOS ONE			English	Article							TEMPORO-PARIETAL JUNCTION; CHRONIC PAIN DISORDER; THEORY-OF-MIND; SOCIAL COGNITION; DEFAULT MODE; FRONTAL-LOBE; PERSPECTIVE-TAKING; NONVERBAL TASK; BRAIN-FUNCTION; FMRI	Background Successful social interaction relies on the ability to attribute mental states to other people. Previous functional neuroimaging studies have shown that this process, described as Theory of Mind (ToM) or mentalization, is reliably associated with activation of the medial prefrontal cortex (mPFC). However, this study presents a novel and surprising finding that provides new insight into the role of the mPFC in mentalization tasks. Methodology/Principal Findings Twenty healthy individuals were recruited from a wide range of ages and social backgrounds. Participants underwent functional magnetic resonance imaging (fMRI) while viewing a well-established ToM visual paradigm involving moving triangles. Functional MRI data were analyzed using a classical general linear model. No activation was detected in the medial prefrontal cortex (mPFC) during movement patterns that typically elicit ToM. However, increased activity was observed in the right middle occipital gyrus, right temporoparietal junction (TPJ), left middle occipital gyrus and right inferior frontal gyrus. No correlation was found between participants' age and BOLD response. Conclusions/Significance In contrast with previous neuroimaging research, our findings support the notion that mPFC function is not critical for reasoning about the mental states of others; furthermore, our data indicate that the right TPJ and right inferior frontal gyrus are able to perform mentalization without any contributions from the mPFC.	[Otti, Alexander] Tech Univ Munich, Klinikum Rechts Isar, Klin Psychosomat Med & Psychotherapie, D-80290 Munich, Germany; [Wohlschlaeger, Afra M.] Tech Univ Munich, Klinikum Rechts Isar, Abt Neuroradiol, D-80290 Munich, Germany; [Noll-Hussong, Michael] Univ Ulm Klinikum, Klin Psychosomat Med & Psychotherapie, Ulm, Germany	Technical University of Munich; Technical University of Munich; Ulm University	Otti, A (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Klin Psychosomat Med & Psychotherapie, D-80290 Munich, Germany.	alexander.otti@web.de	Noll-Hussong, Michael/K-3724-2012	Noll-Hussong, Michael/0000-0002-9734-0161				Abell F, 2000, COGNITIVE DEV, V15, P1, DOI 10.1016/S0885-2014(00)00014-9; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Baetens K, 2014, SOC COGN AFFECT NEUR, V9, P817, DOI 10.1093/scan/nst048; Bird CM, 2004, BRAIN, V127, P914, DOI 10.1093/brain/awh108; Boddaert N, 2004, NEUROIMAGE, V23, P364, DOI 10.1016/j.neuroimage.2004.06.016; Bonini L, 2013, CONSCIOUS COGN, V22, P1095, DOI 10.1016/j.concog.2013.03.001; Brunet E, NEUROIMAGE, V11, P157; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Castelli I, 2010, NEUROPSYCHOLOGIA, V48, P2586, DOI 10.1016/j.neuropsychologia.2010.05.005; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2012, J NEUROPHYSIOL, V108, P3068, DOI 10.1152/jn.00473.2012; Decety J, 2012, CEREB CORTEX, V22, P209, DOI 10.1093/cercor/bhr111; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Farrant A, 2005, EPILEPSY BEHAV, V7, P506, DOI 10.1016/j.yebeh.2005.07.018; Fossati P, 2012, EUR NEUROPSYCHOPHARM, V22, pS487, DOI 10.1016/j.euroneuro.2012.07.008; Frith C, 2005, CURR BIOL, V15, pR644, DOI 10.1016/j.cub.2005.08.041; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gobbini MI, 2007, J COGNITIVE NEUROSCI, V19, P1803, DOI 10.1162/jocn.2007.19.11.1803; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hartwright CE, 2014, J COGNITIVE NEUROSCI, V26, P683, DOI 10.1162/jocn_a_00520; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Hillebrandt H, 2013, NEUROIMAGE, V76, P116, DOI 10.1016/j.neuroimage.2013.02.072; Horn A, 2014, NEUROIMAGE, V102, P142, DOI 10.1016/j.neuroimage.2013.09.069; Hynes CA, 2006, NEUROPSYCHOLOGIA, V44, P374, DOI 10.1016/j.neuropsychologia.2005.06.011; Koelkebeck K, 2011, SOC NEUROSCI-UK, V6, P615, DOI 10.1080/17470919.2011.620763; Koster-Hale J, 2013, NEURON, V79, P836, DOI 10.1016/j.neuron.2013.08.020; Krause L, 2012, BEHAV BRAIN RES, V228, P87, DOI 10.1016/j.bbr.2011.11.037; Leslie AM, 2004, TRENDS COGN SCI, V8, P528, DOI 10.1016/j.tics.2004.10.001; Mahy CEV, 2014, DEV COGN NEUROS-NETH, V9, P68, DOI 10.1016/j.dcn.2014.01.002; Maroun M, 2013, NEUROSCIENTIST, V19, P370, DOI 10.1177/1073858412464527; Mitchell JP, 2008, CEREB CORTEX, V18, P262, DOI 10.1093/cercor/bhm051; Moran JM, 2012, J NEUROSCI, V32, P5553, DOI 10.1523/JNEUROSCI.5511-11.2012; Moriguchi Y, 2007, PSYCHIAT CLIN NEUROS, V61, P355, DOI 10.1111/j.1440-1819.2007.01687.x; Moriguchi Y, 2006, NEUROIMAGE, V32, P1472, DOI 10.1016/j.neuroimage.2006.04.186; Noll-Hussong M, 2013, PSYCHOSOM MED, V75, P124, DOI 10.1097/PSY.0b013e31827e60f3; Noll-Hussong M, 2010, J PSYCHOSOM RES, V68, P483, DOI 10.1016/j.jpsychores.2010.01.020; Otti A, 2010, NEUROSCIENCE, V169, P143, DOI 10.1016/j.neuroscience.2010.04.072; Otti A, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-84; Otti A, 2013, J PSYCHIATR NEUROSCI, V38, P57, DOI 10.1503/jpn.110187; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Price JL, 1999, ANN NY ACAD SCI, V877, P383, DOI 10.1111/j.1749-6632.1999.tb09278.x; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schneider D, 2014, COGNITION, V133, P43, DOI 10.1016/j.cognition.2014.05.016; Schneider F, 2008, NEUROSCIENCE, V157, P120, DOI 10.1016/j.neuroscience.2008.08.014; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Sebastian CL, 2012, SOC COGN AFFECT NEUR, V7, P53, DOI 10.1093/scan/nsr023; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Shamay-Tsoory SG, 2006, SOC NEUROSCI-UK, V1, P149, DOI 10.1080/17470910600985589; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Williams JHG, 2005, NEUROIMAGE, V25, P133, DOI 10.1016/j.neuroimage.2004.10.047; Young L, 2010, NEUROPSYCHOLOGIA, V48, P2658, DOI 10.1016/j.neuropsychologia.2010.05.012	62	9	9	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135912	10.1371/journal.pone.0135912	http://dx.doi.org/10.1371/journal.pone.0135912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301900	Green Submitted, Green Published, gold			2022-12-27	WOS:000359951900033
J	Zhao, BM; Keasey, SL; Tropea, JE; Lountos, GT; Dyas, BK; Cherry, S; Raran-Kurussi, S; Waugh, DS; Ulrich, RG				Zhao, Bryan M.; Keasey, Sarah L.; Tropea, Joseph E.; Lountos, George T.; Dyas, Beverly K.; Cherry, Scott; Raran-Kurussi, Sreejith; Waugh, David S.; Ulrich, Robert G.			Phosphotyrosine Substrate Sequence Motifs for Dual Specificity Phosphatases	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; CRYSTAL-STRUCTURE; KINASE PHOSPHATASE-1; CATALYTIC MECHANISM; ACTIVATION; INHIBITORS; CANCER; OVERPRODUCTION; OVEREXPRESSION; PURIFICATION	Protein tyrosine phosphatases dephosphorylate tyrosine residues of proteins, whereas, dual specificity phosphatases (DUSPs) are a subgroup of protein tyrosine phosphatases that dephosphorylate not only Tyr(P) residue, but also the Ser(P) and Thr(P) residues of proteins. The DUSPs are linked to the regulation of many cellular functions and signaling pathways. Though many cellular targets of DUSPs are known, the relationship between catalytic activity and substrate specificity is poorly defined. We investigated the interactions of peptide substrates with select DUSPs of four types: MAP kinases (DUSP1 and DUSP7), atypical (DUSP3, DUSP14, DUSP22 and DUSP27), viral (variola VH1), and Cdc25 (A-C). Phosphatase recognition sites were experimentally determined by measuring dephosphorylation of 6,218 microarrayed Tyr(P) peptides representing confirmed and theoretical phosphorylation motifs from the cellular proteome. A broad continuum of dephosphorylation was observed across the microarrayed peptide substrates for all phosphatases, suggesting a complex relationship between substrate sequence recognition and optimal activity. Further analysis of peptide dephosphorylation by hierarchical clustering indicated that DUSPs could be organized by substrate sequence motifs, and peptide-specificities by phylogenetic relationships among the catalytic domains. The most highly dephosphorylated peptides represented proteins from 29 cell-signaling pathways, greatly expanding the list of potential targets of DUSPs. These newly identified DUSP substrates will be important for examining structure-activity relationships with physiologically relevant targets.	[Zhao, Bryan M.; Keasey, Sarah L.; Dyas, Beverly K.; Ulrich, Robert G.] US Army Med Res Inst Infect Dis, Mol & Translat Sci Div, Frederick, MD 21702 USA; [Zhao, Bryan M.] Geneva Fdn, Tacoma, WA 98402 USA; [Tropea, Joseph E.; Lountos, George T.; Cherry, Scott; Raran-Kurussi, Sreejith; Waugh, David S.] NCI, Macromol Crystallog Lab, Ctr Canc Res, Frederick, MD 21702 USA; [Lountos, George T.] Leidos Biomed Res Inc, Basic Sci Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA	United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ulrich, RG (corresponding author), US Army Med Res Inst Infect Dis, Mol & Translat Sci Div, Frederick, MD 21702 USA.	rulrich@bhsai.org		RARAN-KURUSSI, SREEJITH/0000-0001-7738-9606	Geneva Foundation; Leidos Biomedical Research, Inc.; NATIONAL CANCER INSTITUTE [ZIABC011551] Funding Source: NIH RePORTER	Geneva Foundation; Leidos Biomedical Research, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Geneva Foundation and Leidos Biomedical Research, Inc. provided support in the form of salaries for authors BMZ and GTL, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chattopadhyay S, 2006, ONCOGENE, V25, P3335, DOI 10.1038/sj.onc.1209364; Chen AJ, 2002, J BIOL CHEM, V277, P36592, DOI 10.1074/jbc.M200453200; Csikesz CR, 2013, J INVEST DERMATOL, V133, P1680, DOI 10.1038/jid.2013.22; DENU JM, 1995, P NATL ACAD SCI USA, V92, P5910, DOI 10.1073/pnas.92.13.5910; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Doddareddy MR, 2012, CURR MED CHEM, V19, P163; Fauman EB, 1998, CELL, V93, P617, DOI 10.1016/S0092-8674(00)81190-3; Ferrari E, 2011, J BIOL CHEM, V286, P4173, DOI 10.1074/jbc.M110.157420; Friedberg I, 2007, FEBS LETT, V581, P2527, DOI 10.1016/j.febslet.2007.04.059; Gil-Araujo B, 2014, MOL ONCOL, V8, P27, DOI 10.1016/j.molonc.2013.08.012; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hardy S, 2012, ANTI-CANCER AGENT ME, V12, P4, DOI 10.2174/187152012798764741; Harrison SC, 2004, P NATL ACAD SCI USA, V101, P11178, DOI 10.1073/pnas.0403600101; Henkens R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-147; ISHIBASHI T, 1992, P NATL ACAD SCI USA, V89, P12170, DOI 10.1073/pnas.89.24.12170; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim SJ, 2012, BMB REP, V45, P693, DOI 10.5483/BMBRep.2012.45.12.240; Klinger S, 2008, DIABETES, V57, P584, DOI 10.2337/db07-1414; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavecchia A, 2012, MINI-REV MED CHEM, V12, P62, DOI 10.2174/138955712798868940; Lavecchia A, 2009, CURR MED CHEM, V16, P1831, DOI 10.2174/092986709788186084; Levy-Nissenbaum O, 2003, CANCER LETT, V199, P185, DOI 10.1016/S0304-3835(03)00352-5; Li JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4618; Li X, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003203; Lountos GT, 2011, ACTA CRYSTALLOGR D, V67, P471, DOI 10.1107/S090744491100970X; Lountos GT, 2009, ACTA CRYSTALLOGR D, V65, P1013, DOI 10.1107/S0907444909023762; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nunes-Xavier C, 2011, ANTI-CANCER AGENT ME, V11, P109, DOI 10.2174/187152011794941190; O'Shea JP, 2013, NAT METHODS, V10, P1211, DOI [10.1038/NMETH.2646, 10.1038/nmeth.2646]; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Perwitasari O, 2013, J VIROL, V87, P13775, DOI 10.1128/JVI.01509-13; Pulido R, 2008, FEBS J, V275, P848, DOI 10.1111/j.1742-4658.2008.06250.x; Rauhala HE, 2005, INT J CANCER, V117, P738, DOI 10.1002/ijc.21270; Reynolds RA, 1999, J MOL BIOL, V293, P559, DOI 10.1006/jmbi.1999.3168; Rudolph J, 2001, ANAL BIOCHEM, V289, P43, DOI 10.1006/abio.2000.4906; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schumacher MA, 2002, BIOCHEMISTRY-US, V41, P3009, DOI 10.1021/bi015799l; Sekine Y, 2007, ONCOGENE, V26, P6038, DOI 10.1038/sj.onc.1210426; Selner NG, 2014, BIOCHEMISTRY-US, V53, P397, DOI 10.1021/bi401223r; Shen Y, 2001, P NATL ACAD SCI USA, V98, P13613, DOI 10.1073/pnas.231499098; Sohn J, 2004, P NATL ACAD SCI USA, V101, P16437, DOI 10.1073/pnas.0407663101; Soulsby M, 2009, PHYSIOLOGY, V24, P281, DOI 10.1152/physiol.00017.2009; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tinti M, 2012, NEW BIOTECHNOL, V29, P571, DOI 10.1016/j.nbt.2011.12.001; Tropea Joseph E, 2007, Methods Mol Biol, V363, P1, DOI 10.1007/978-1-59745-209-0_1; Tropea JE, 2006, PROTEIN EXPRES PURIF, V50, P31, DOI 10.1016/j.pep.2006.05.007; Vicent S, 2004, CLIN CANCER RES, V10, P3639, DOI 10.1158/1078-0432.CCR-03-0771; Sanchez-Mut JV, 2014, HIPPOCAMPUS, V24, P363, DOI 10.1002/hipo.22245; Wang HY, 2003, CANCER LETT, V191, P229, DOI 10.1016/S0304-3835(02)00612-2; Yokota T, 2007, PROTEINS, V66, P272, DOI 10.1002/prot.21152; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; Zheng H, 2013, J BIOL CHEM, V288, P819, DOI 10.1074/jbc.M112.412643	61	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0134984	10.1371/journal.pone.0134984	http://dx.doi.org/10.1371/journal.pone.0134984			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302245	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900010
J	Zheng, SG; Zhao, SC; Li, Z; Wang, QG; Yao, FY; Yang, LQ; Pan, JW; Liu, W				Zheng, Shigang; Zhao, Shanchang; Li, Zhen; Wang, Qingguo; Yao, Fangyin; Yang, Lianqun; Pan, Jiaowen; Liu, Wei			Evaluating the Effect of Expressing a Peanut Resveratrol Synthase Gene in Rice	PLOS ONE			English	Article							VITIS-VINIFERA L.; STILBENE SYNTHASE; STRESS TOLERANCE; ACCUMULATION; GRAPEVINE; ANTIOXIDANT; TRANSFORMATION; RESISTANCE; FRUITS; BIOACTIVITY	Resveratrol (Res) is a type of natural plant stilbenes and phytoalexins that only exists in a few plant species. Studies have shown that the Res could be biosynthesized and accumulated within plants, once the complete metabolic pathway and related enzymes, such as the key enzyme resveratrol synthase (RS), existed. In this study, a RS gene named PNRS1 was cloned from the peanut, and the activity was confirmed in E. coli. Using transgenic approach, the PNRS1 transgenic rice was obtained. In T-3 generation, the Res production and accumulation were further detected by HPLC. Our data revealed that compared to the wild type rice which trans-resveratrol was undetectable, in transgenic rice, the trans-resveratrol could be synthesized and achieved up to 0.697 mu g/g FW in seedlings and 3.053 mu g/g DW in seeds. Furthermore, the concentration of trans-resveratrol in transgenic rice seedlings could be induced up to eight or four-fold higher by ultraviolet (UV-C) or dark, respectively. Simultaneously, the endogenous increased of Res also showed the advantages in protecting the host plant from UV-C caused damage or dark-induced senescence. Our data indicated that Res was involved in host-defense responses against environmental stresses in transgenic rice. Here the results describes the processes of a peanut resveratrol synthase gene transformed into rice, and the detection of trans-resveratrol in transgenic rice, and the role of trans-resveratrol as a phytoalexin in transgenic rice when treated by UV-C and dark. These findings present new outcomes of transgenic approaches for functional genes and their corresponding physiological functions, and shed some light on broadening available resources of Res, nutritional improvement of crops, and new variety cultivation by genetic engineering.	[Zheng, Shigang; Li, Zhen; Wang, Qingguo; Yao, Fangyin; Yang, Lianqun; Pan, Jiaowen; Liu, Wei] Shandong Acad Agr Sci, Dept Key Lab Genet Improvement Ecol & Physiol Cro, Dept Biotech Res Ctr, Jinan, Shandong, Peoples R China; [Zhao, Shanchang] Shandong Acad Agr Sci, Dept Agr Qual Stand & Testing Technol, Jinan, Shandong, Peoples R China; [Zheng, Shigang] Qingdao Agr Univ, Dept Life Sci, Qingdao, Shandong, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences; Qingdao Agricultural University	Liu, W (corresponding author), Shandong Acad Agr Sci, Dept Key Lab Genet Improvement Ecol & Physiol Cro, Dept Biotech Res Ctr, Jinan, Shandong, Peoples R China.	wheiliu@163.com		Zheng, Shigang/0000-0002-9904-5422	Shandong Academy of Agricultural Sciences Foundation [2014QNM37, 2014CXZ10-2]; major cuvltiation plan of scientific and technological achievements of Shandong Academy of Agricultural Sciences [2015CGPY10]; Shandong Provential Natural Science Foundtion [ZR2014CQ024]; National Science Foundation of China [31401310]; Foundation for Outstanding Young Scientist in Shandong Province [BS2014SW007]; Opening Project of State Key Laboratory of Crop Biology [2014KF13]	Shandong Academy of Agricultural Sciences Foundation; major cuvltiation plan of scientific and technological achievements of Shandong Academy of Agricultural Sciences; Shandong Provential Natural Science Foundtion; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Outstanding Young Scientist in Shandong Province; Opening Project of State Key Laboratory of Crop Biology	The fund of "Young Talents Training Program of Shandong Academy of Agricultural Sciences" had a role in study design; the fund of "Shandong Academy of Agricultural Sciences Foundation (2014QNM37, 2014CXZ10-2), the major cuvltiation plan of scientific and technological achievements of Shandong Academy of Agricultural Sciences (2015CGPY10) and Shandong Provential Natural Science Foundtion (ZR2014CQ024) had roles in data collection and analysis; the fund of "National Science Foundation of China (31401310)" http://www.nsfc.gov.cn/ and the Foundation for Outstanding Young Scientist in Shandong Province (BS2014SW007) had roles in data analysis, decision to publish, and preparation of the manuscript; the fund of "Shandong Agricultural of Seed Project" (2013-2015) and "Opening Project of State Key Laboratory of Crop Biology" (2014KF13) had roles in preparation of the manuscript.	Adrian M, 2012, FITOTERAPIA, V83, P1345, DOI 10.1016/j.fitote.2012.04.004; Amiri F, 2013, EUR J PHARMACOL, V718, P34, DOI 10.1016/j.ejphar.2013.09.020; Baek SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057930; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Beekwilder J, 2006, APPL ENVIRON MICROB, V72, P5670, DOI 10.1128/AEM.00609-06; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Cabello JV, 2014, CURR OPIN BIOTECH, V26, P62, DOI 10.1016/j.copbio.2013.09.011; Chang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026405; CORNEJO MJ, 1993, PLANT MOL BIOL, V23, P567, DOI 10.1007/BF00019304; D'Introno A, 2009, PLANT BIOTECHNOL J, V7, P422, DOI 10.1111/j.1467-7652.2009.00409.x; Delaunois B, 2009, PLANT BIOTECHNOL J, V7, P2, DOI 10.1111/j.1467-7652.2008.00377.x; Du HM, 2011, PLANT CELL PHYSIOL, V52, P306, DOI 10.1093/pcp/pcq186; Fan CH, 2008, PLANT CELL TISS ORG, V92, P197, DOI 10.1007/s11240-007-9324-2; Giorcelli A, 2004, TRANSGENIC RES, V13, P203, DOI 10.1023/B:TRAG.0000034658.64990.7f; Gui JS, 2011, PLANT PHYSIOL, V157, P574, DOI 10.1104/pp.111.178301; HAIN R, 1990, PLANT MOL BIOL, V15, P325, DOI 10.1007/BF00036918; HAIN R, 1993, NATURE, V361, P153, DOI 10.1038/361153a0; Halls C, 2008, TRENDS BIOTECHNOL, V26, P77, DOI 10.1016/j.tibtech.2007.11.002; Hanhineva K, 2009, J EXP BOT, V60, P2093, DOI 10.1093/jxb/erp085; Hare PD, 2002, NAT BIOTECHNOL, V20, P575, DOI 10.1038/nbt0602-575; Hipskind JD, 2000, MOL PLANT MICROBE IN, V13, P551, DOI 10.1094/MPMI.2000.13.5.551; Husken A, 2005, THEOR APPL GENET, V111, P1553, DOI 10.1007/s00122-005-0085-1; Jan A, 2013, PLANT PHYSIOL, V161, P1202, DOI 10.1104/pp.112.205385; King RE, 2006, COMPR REV FOOD SCI F, V5, P65, DOI 10.1111/j.1541-4337.2006.00001.x; Kobayashi S, 2000, PLANT CELL REP, V19, P904, DOI 10.1007/s002990000203; Kovacic P, 2010, OXID MED CELL LONGEV, V3, P86, DOI 10.4161/oxim.3.2.11147; [李海青 LI Haiqing], 2011, [华北农学报, Acta Agriculturae Boreali-Sinica], V26, P114; Lichtenthaler HK, 1983, BIOCHEM SOC T, V11, P691; Lim JD, 2005, MOL BREEDING, V16, P219, DOI 10.1007/s11032-005-8301-x; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Liu SJ, 2006, J AGR FOOD CHEM, V54, P8082, DOI 10.1021/jf061462k; Liu ZY, 2011, PLANT CELL REP, V30, P2027, DOI 10.1007/s00299-011-1110-2; Miura K, 2009, P NATL ACAD SCI USA, V106, P11218, DOI 10.1073/pnas.0901942106; Morelli R, 2006, MOL CELL BIOCHEM, V282, P65, DOI 10.1007/s11010-006-1260-7; Nicoletti I, 2007, J AGR FOOD CHEM, V55, P3304, DOI 10.1021/jf063175m; Pan LP, 2012, PLANT CELL REP, V31, P121, DOI 10.1007/s00299-011-1145-4; Parage C, 2012, PLANT PHYSIOL, V160, P1407, DOI 10.1104/pp.112.202705; Rascon B, 2012, AGING-US, V4, P499, DOI 10.18632/aging.100474; Richter A, 2006, PLANT CELL REP, V25, P1166, DOI 10.1007/s00299-006-0172-z; Sakihama Y, 2002, TOXICOLOGY, V177, P67, DOI 10.1016/S0300-483X(02)00196-8; Schwekendiek A, 2007, J AGR FOOD CHEM, V55, P7002, DOI 10.1021/jf070509e; StarkLorenzen P, 1997, PLANT CELL REP, V16, P668, DOI 10.1007/s002990050299; Szankowski I, 2003, PLANT CELL REP, V22, P141, DOI 10.1007/s00299-003-0668-8; Tang K, 2010, J PLANT PHYSIOL, V167, P95, DOI 10.1016/j.jplph.2009.07.011; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Tian WZ, 1998, ACTA BOT SIN, V40, P803; Urena AG, 2003, J AGR FOOD CHEM, V51, P82, DOI 10.1021/jf020663v; Wang W, 2010, PLANT PHYSIOL BIOCH, V48, P142, DOI 10.1016/j.plaphy.2009.12.002; Yu CKY, 2005, PLANT PHYSIOL, V138, P393, DOI 10.1104/pp.105.059337; Zheng SG, 2014, CHIN J BIOTECH, V30, P1	50	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136013	10.1371/journal.pone.0136013	http://dx.doi.org/10.1371/journal.pone.0136013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302213	Green Published, gold, Green Submitted			2022-12-27	WOS:000359951900036
J	Belcher, JM; Coca, SG; Parikh, CR				Belcher, Justin M.; Coca, Steven G.; Parikh, Chirag R.			Creatinine Change on Vasoconstrictors as Mortality Surrogate in Hepatorenal Syndrome: Systematic Review & Meta-Analysis	PLOS ONE			English	Review							ACUTE KIDNEY INJURY; TERLIPRESSIN PLUS ALBUMIN; IMPROVES RENAL-FUNCTION; CIRRHOTIC-PATIENTS; RANDOMIZED EXPERIMENTS; CONTROLLED-TRIAL; CLINICAL-TRIAL; SAFE THERAPY; DOUBLE-BLIND; END-POINTS	Background and Aims Hepatorenal syndrome is a severe complication of cirrhosis and associates with significant mortality. Vasoconstrictor medications improve renal function in patients with hepatorenal syndrome. However, it is unclear to what extent changes in serum creatinine during treatment may act as a surrogate for changes in mortality. We have performed a meta-analysis of randomized trials of vasoconstrictors assessing the association between changes in serum creatinine, taken as a continuous variable, and mortality, both while on treatment and during the follow-up period for survivors. Methods The electronic databases of PubMed, Web of Science and Embase were searched for randomized trials evaluating the efficacy of vasoconstrictor therapy for treatment of HRS type 1 or 2. The relative risk (RR) for mortality was calculated against delta creatinine. The proportion of treatment effect explained (PTE) was calculated for delta creatinine. Results Seven trials enrolling 345 patients were included. The correlation between delta creatinine and ln (RR) was moderately good (R-2 = 0.61). The intercept and parameter estimate indicated a fall in creatinine while on treatment of 1 mg/dL resulted in a 27% reduction in RR for mortality compared to the control arm. In patients surviving the treatment period, a fall in creatinine while on treatment of 1 mg/dL resulted in a 16% reduction in RR for post-treatment mortality during follow-up. The PTE of delta creatinine for overall mortality was 0.91 and 0.26 for post-treatment mortality. Conclusions Changes in serum creatinine in response to vasoconstrictor therapy appear to be a valid surrogate for mortality, even in the period following the completion of treatment.	[Belcher, Justin M.; Coca, Steven G.; Parikh, Chirag R.] Yale Univ, Sch Med, Program Appl Translat Res, New Haven, CT 06520 USA; [Belcher, Justin M.; Coca, Steven G.; Parikh, Chirag R.] Yale Univ, Sch Med, Nephrol Sect, New Haven, CT USA; [Belcher, Justin M.; Coca, Steven G.; Parikh, Chirag R.] VAMC, Clin Epidemiol Res Ctr, West Haven, CT USA	Yale University; Yale University	Parikh, CR (corresponding author), Yale Univ, Sch Med, Program Appl Translat Res, New Haven, CT 06520 USA.	chirag.parikh@yale.edu	Coca, Steven/L-7801-2019	Coca, Steven/0000-0002-0928-9168; Parikh, Chirag/0000-0001-9051-7385	National Institutes of Health (NIH) [K24-DK090203]; NIH; American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK090203] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project was supported by a grant from the National Institutes of Health (NIH) K24-DK090203 to Dr. Parikh. Dr. Belcher was supported on an institutional fellowship training grant from NIH and the Ben J. Lipps Research Fellowship grant from the American Society of Nephrology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandria C, 2002, EUR J GASTROEN HEPAT, V14, P1363, DOI 10.1097/00042737-200212000-00013; Alessandria C, 2007, J HEPATOL, V47, P499, DOI 10.1016/j.jhep.2007.04.010; Angeli P, 1999, HEPATOLOGY, V29, P1690, DOI 10.1002/hep.510290629; Angeli P, 2015, J HEPATOL, V62, P968, DOI 10.1016/j.jhep.2014.12.029; Belcher JM, 2013, CLIN GASTROENTEROL H, V11, P1550, DOI 10.1016/j.cgh.2013.03.018; Boyer TD, 2011, LIVER TRANSPLANT, V17, P1328, DOI 10.1002/lt.22395; Boyer TD, 2011, J HEPATOL, V55, P315, DOI 10.1016/j.jhep.2010.11.020; Buyse M, 2000, ONCOLOGY-NY, V14, P437; Buyse M, 1998, BIOMETRICS, V54, P1014, DOI 10.2307/2533853; Carvalho GC, 2010, ANN HEPATOL, V11, P90; Cheng JYW, 2007, PSYCHOPHARMACOLOGY, V194, P197, DOI 10.1007/s00213-007-0840-x; Colle I, 2002, J GASTROEN HEPATOL, V17, P882, DOI 10.1046/j.1440-1746.2002.02816.x; Danalioglu A, 2003, HEPATOGASTROENTER S2, V50, pccciii; Dobre M, 2011, INT UROL NEPHROL, V43, P175, DOI 10.1007/s11255-010-9725-8; du Cheyron D, 2005, INTENS CARE MED, V31, P1693, DOI 10.1007/s00134-005-2842-7; Duvoux C, 2002, HEPATOLOGY, V36, P374, DOI 10.1053/jhep.2002.34343; Esrailian E, 2007, DIGEST DIS SCI, V52, P742, DOI 10.1007/s10620-006-9312-0; Fabrizi F, 2009, INT J ARTIF ORGANS, V32, P133, DOI 10.1177/039139880903200303; Garcia-Tsao G, 2008, HEPATOLOGY, V48, P2064, DOI 10.1002/hep.22605; Garg AX, 2014, JAMA-J AM MED ASSOC, V311, P2191, DOI 10.1001/jama.2014.4952; Ghosh S, 2013, LIVER INT, V33, P1187, DOI 10.1111/liv.12179; Gluud LL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005162.pub3; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Guevara M, 1998, HEPATOLOGY, V27, P35, DOI 10.1002/hep.510270107; Hadengue A, 1998, J HEPATOL, V29, P565, DOI 10.1016/S0168-8278(98)80151-7; Halimi C, 2002, EUR J GASTROEN HEPAT, V14, P153, DOI 10.1097/00042737-200202000-00009; Institute of Medicine, 2010, EV BIOM SURR ENDP CH; Kiser TH, 2005, NEPHROL DIAL TRANSPL, V20, P1813, DOI 10.1093/ndt/gfh930; Maddukuri G, 2014, DIGEST DIS SCI, V59, P471, DOI 10.1007/s10620-013-2899-z; Martin-Llahi M, 2008, GASTROENTEROLOGY, V134, P1352, DOI 10.1053/j.gastro.2008.02.024; Martin-Llahi M, 2011, GASTROENTEROLOGY, V140, P488, DOI 10.1053/j.gastro.2010.07.043; Molenberghs G, 2001, STAT MED, V20, P3023, DOI 10.1002/sim.923; Moreau R, 2002, GASTROENTEROLOGY, V122, P923, DOI 10.1053/gast.2002.32364; Mulkay JP, 2001, ACTA GASTRO-ENT BELG, V64, P15; Nadim MK, 2012, LIVER TRANSPLANT, V18, P539, DOI 10.1002/lt.23384; Narahara Y, 2012, J GASTROENTEROL, V47, P313, DOI 10.1007/s00535-011-0485-8; Nazar A, 2010, HEPATOLOGY, V51, P219, DOI 10.1002/hep.23283; Neri S, 2008, DIGEST DIS SCI, V53, P830, DOI 10.1007/s10620-007-9919-9; Ortega R, 2002, HEPATOLOGY, V36, P941, DOI 10.1053/jhep.2002.35819; Pomier-Layrargues G, 2003, HEPATOLOGY, V38, P238, DOI 10.1053/jhep.2003.50276; Salerno F, 2011, J HEPATOL, V55, P1241, DOI 10.1016/j.jhep.2011.03.012; Salo J, 1996, J HEPATOL, V25, P916, DOI 10.1016/S0168-8278(96)80297-2; Saner FH, 2004, EUR J MED RES, V9, P78; Sanyal AJ, 2008, GASTROENTEROLOGY, V134, P1360, DOI 10.1053/j.gastro.2008.02.014; Sharma P, 2008, AM J GASTROENTEROL, V103, P1689, DOI 10.1111/j.1572-0241.2008.01828.x; Singh V, 2012, J HEPATOL, V56, P1293, DOI 10.1016/j.jhep.2012.01.012; Skagen C, 2009, J CLIN GASTROENTEROL, V43, P680, DOI 10.1097/MCG.0b013e318188947c; Solanki P, 2003, J GASTROEN HEPATOL, V18, P152, DOI 10.1046/j.1440-1746.2003.02934.x; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Uriz J, 2000, J HEPATOL, V33, P43, DOI 10.1016/S0168-8278(00)80158-0; von Kalckreuth V, 2009, Z GASTROENTEROL, V47, P21, DOI 10.1055/s-0028-1109084; Wong F, 2004, HEPATOLOGY, V40, P55, DOI 10.1002/hep.20262	52	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135625	10.1371/journal.pone.0135625	http://dx.doi.org/10.1371/journal.pone.0135625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295585	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900037
J	Kaneshiro, B; Guimaraes, MP; Kim, HS; Norcia, AM; Suppes, P				Kaneshiro, Blair; Guimaraes, Marcos Perreau; Kim, Hyung-Suk; Norcia, Anthony M.; Suppes, Patrick			A Representational Similarity Analysis of the Dynamics of Object Processing Using Single-Trial EEG Classification	PLOS ONE			English	Article							FUSIFORM FACE AREA; RESPONSE GENERALIZATION; NEURAL REPRESENTATION; DECISION-MAKING; ERP; N170; RECOGNITION; PERCEPTION; COMPONENTS; DISTANCE	The recognition of object categories is effortlessly accomplished in everyday life, yet its neural underpinnings remain not fully understood. In this electroencephalography (EEG) study, we used single-trial classification to perform a Representational Similarity Analysis (RSA) of categorical representation of objects in human visual cortex. Brain responses were recorded while participants viewed a set of 72 photographs of objects with a planned category structure. The Representational Dissimilarity Matrix (RDM) used for RSA was derived from confusions of a linear classifier operating on single EEG trials. In contrast to past studies, which used pairwise correlation or classification to derive the RDM, we used confusion matrices from multi-class classifications, which provided novel self-similarity measures that were used to derive the overall size of the representational space. We additionally performed classifications on subsets of the brain response in order to identify spatial and temporal EEG components that best discriminated object categories and exemplars. Results from category-level classifications revealed that brain responses to images of human faces formed the most distinct category, while responses to images from the two inanimate categories formed a single category cluster. Exemplar-level classifications produced a broadly similar category structure, as well as sub-clusters corresponding to natural language categories. Spatiotemporal components of the brain response that differentiated exemplars within a category were found to differ from those implicated in differentiating between categories. Our results show that a classification approach can be successfully applied to single- trial scalp-recorded EEG to recover fine-grained object category structure, as well as to identify interpretable spatiotemporal components underlying object processing. Finally, object category can be decoded from purely temporal information recorded at single electrodes.	[Kaneshiro, Blair; Guimaraes, Marcos Perreau; Suppes, Patrick] Stanford Univ, Ctr Study Language & Informat, Stanford, CA 94305 USA; [Kim, Hyung-Suk] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Norcia, Anthony M.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Kaneshiro, B (corresponding author), Stanford Univ, Ctr Study Language & Informat, Stanford, CA 94305 USA.	blairbo@ccrma.stanford.edu		Kaneshiro, Blair/0000-0003-0364-6985	National Institutes of Health [EY06579]; Patrick Suppes Gift Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Patrick Suppes Gift Fund	AMN received funding from National Institutes of Health, http://www.nih.gov/EY1 and EY06579. BK, MPG, PS received funding from the Patrick Suppes Gift Fund. Patrick Suppes (author PS) established the gift fund in his name in general support of his brain research group at Stanford University. PS was involved in study design, interpretation of data, and general organization of the manuscript. PS was not involved in data collection, data analysis, writing of the paper, or decision to submit the paper to PLOS ONE for publication.	Acunzo DJ, 2012, J NEUROSCI METH, V209, P212, DOI 10.1016/j.jneumeth.2012.06.011; Baldassi C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003167; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bieniek MM, 2012, J VISION, V12, DOI 10.1167/12.13.12; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Carlson T, 2013, J VISION, V13, DOI 10.1167/13.10.1; Carlson TA, 2011, J VISION, V11, DOI 10.1167/11.10.9; Cauchoix M, 2014, J NEUROSCI, V34, P846, DOI 10.1523/JNEUROSCI.3030-13.2014; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Cichy RM, 2014, NAT NEUROSCI, V17, P455, DOI 10.1038/nn.3635; Clarke A, 2015, CEREB CORTEX, V25, P3602, DOI 10.1093/cercor/bhu203; Connolly AC, 2012, J NEUROSCI, V32, P2608, DOI 10.1523/JNEUROSCI.5547-11.2012; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Das K, 2010, NEUROIMAGE, V51, P1425, DOI 10.1016/j.neuroimage.2010.03.030; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; DUBES R, 1980, ADV COMPUT, V19, P113; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Ganis G, 2012, NEUROIMAGE, V62, P1563, DOI 10.1016/j.neuroimage.2012.05.043; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Gerlach C, 2007, J COGNITIVE NEUROSCI, V19, P296, DOI 10.1162/jocn.2007.19.2.296; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Groen IIA, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00034; Guimaraes MP, 2007, IEEE T BIO-MED ENG, V54, P436, DOI 10.1109/TBME.2006.888824; Hanson SJ, 2004, NEUROIMAGE, V23, P156, DOI 10.1016/j.neuroimage.2004.05.020; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Haufe S, 2014, NEUROIMAGE, V87, P96, DOI 10.1016/j.neuroimage.2013.10.067; Haxby J.V., 2011, OXFORD HDB FACE PERC, P93, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0006; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Jacques C, 2007, NEUROIMAGE, V36, P863, DOI 10.1016/j.neuroimage.2007.04.016; JEFFREYS DA, 1989, EXP BRAIN RES, V78, P193; Jeffreys DA, 1996, VIS COGN, V3, P1, DOI 10.1080/713756729; Joyce C, 2005, CLIN NEUROPHYSIOL, V116, P2613, DOI 10.1016/j.clinph.2005.07.005; Jung TP, 1998, ADV NEUR IN, V10, P894; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2014, NEW VISUAL NEUROSCIENCES, P733; Kiani R, 2005, J NEUROPHYSIOL, V94, P1587, DOI 10.1152/jn.00540.2004; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2007, P NATL ACAD SCI USA, V104, P20600, DOI 10.1073/pnas.0705654104; Kriegeskorte Nikolaus, 2008, Front Syst Neurosci, V2, P4, DOI 10.3389/neuro.06.004.2008; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Lehmann E. L., 2006, NONPARAMETRICS STAT; Li Su, 2012, 2012 2nd International Workshop on Pattern Recognition in NeuroImaging (PRNI), P97, DOI 10.1109/PRNI.2012.26; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Malmivuo J, 2012, BRAIN TOPOGR, V25, P1, DOI 10.1007/s10548-011-0202-1; MARDIA KV, 1978, COMMUN STAT A-THEOR, V7, P1233, DOI 10.1080/03610927808827707; Murphy B, 2011, BRAIN LANG, V117, P12, DOI 10.1016/j.bandl.2010.09.013; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nestor A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003978; Op de Beeck HP, 2008, J NEUROSCI, V28, P10111, DOI 10.1523/JNEUROSCI.2511-08.2008; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Pegna AJ, 2002, NEUROREPORT, V13, P965, DOI 10.1097/00001756-200205240-00013; Philiastides MG, 2006, J NEUROSCI, V26, P8965, DOI 10.1523/JNEUROSCI.1655-06.2006; Philiastides MG, 2006, CEREB CORTEX, V16, P509, DOI 10.1093/cercor/bhi130; Reddy L, 2007, CURR BIOL, V17, P2067, DOI 10.1016/j.cub.2007.10.043; Rice GE, 2014, J NEUROSCI, V34, P8837, DOI 10.1523/JNEUROSCI.5265-13.2014; Rieger JW, 2008, NEUROIMAGE, V42, P1056, DOI 10.1016/j.neuroimage.2008.06.014; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion B, 2011, VISION RES, V51, P1297, DOI 10.1016/j.visres.2011.04.003; Rossion B, 2011, J VISION, V11, DOI 10.1167/11.2.16; Rousselet GA, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00131; SHAO J, 1993, J AM STAT ASSOC, V88, P486, DOI 10.2307/2290328; Shenoy P, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P845; SHEPARD RN, 1958, J EXP PSYCHOL, V55, P509, DOI 10.1037/h0042354; SHEPARD RN, 1958, PSYCHOL REV, V65, P242, DOI 10.1037/h0043083; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P219, DOI 10.1007/BF02289621; Simanova I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014465; Strang G., 2003, INTRODUCTION TO LINE; Suppes P, 2009, NEURAL COMPUT, V21, P3228, DOI 10.1162/neco.2009.04-08-764; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Torgerson WS, 1952, PSYCHOMETRIKA, V17, P401; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Tzovara A, 2012, PATTERN RECOGN, V45, P2109, DOI 10.1016/j.patcog.2011.04.007; van de Nieuwenhuijzen ME, 2013, NEUROIMAGE, V83, P1063, DOI 10.1016/j.neuroimage.2013.07.075; VanRullen R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00060; Wang CM, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/056013; Weiner KS, 2013, PSYCHOL RES-PSYCH FO, V77, P74, DOI 10.1007/s00426-011-0392-x; Widmann A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00233; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	90	78	78	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135697	10.1371/journal.pone.0135697	http://dx.doi.org/10.1371/journal.pone.0135697			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295970	Green Submitted, Green Published, gold			2022-12-27	WOS:000359926900040
J	Qian, C; Zhu, CY; Yu, WQ; Jiang, XQ; Zhang, FQ				Qian, Chao; Zhu, Chenyuan; Yu, Weiqiang; Jiang, Xinquan; Zhang, Fuqiang			High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes in Rats Impacts Osteogenesis and Wnt Signaling in Bone Marrow Stromal Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MELLITUS; CATENIN; PATHWAY; MODEL; REGENERATION; IMPLANT; TOPOGRAPHY; EXPRESSION; OSTEOPENIA	Bone regeneration disorders are a significant problem in patients with type 2 diabetes mellitus. Bone marrow stromal cells (BMSCs) are recognized as ideal seed cells for tissue engineering because they can stimulate osteogenesis during bone regeneration. Therefore, the aim of this study was to investigate the osteogenic potential of BMSCs derived from type 2 diabetic rats and the pathogenic characteristics of dysfunctional BMSCs that affect osteogenesis. BMSCs were isolated from normal and high-fat diet+streptozotocin-induced type 2 diabetic rats. Cell metabolic activity, alkaline phosphatase (ALP) activity, mineralization and osteogenic gene expression were reduced in the type 2 diabetic rat BMSCs. The expression levels of Wnt signaling genes, such as beta-catenin, cyclin D1 and c-myc, were also significantly decreased in the type 2 diabetic rat BMSCs, but the expression of GSK3 beta remained unchanged. The derived BMSCs were cultured on calcium phosphate cement (CPC) scaffolds and placed subcutaneously into nude mice for eight weeks; they were detected at a low level in newly formed bone. The osteogenic potential of the type 2 diabetic rat BMSCs was not impaired by the culture environment, but it was impaired by inhibition of the Wnt signaling pathway, likely due to an insufficient accumulation of beta-catenin rather than because of GSK3 beta stimulation. Using BMSCs derived from diabetic subjects could offer an alternative method of regenerating bone together with the use of supplementary growth factors to stimulate the Wnt signaling pathway.	[Qian, Chao; Zhu, Chenyuan; Yu, Weiqiang; Jiang, Xinquan; Zhang, Fuqiang] Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Peoples Hosp 9, Dept Prosthodont,Sch Stomatol,Sch Med, Shanghai 200011, Peoples R China	Shanghai Jiao Tong University	Jiang, XQ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Peoples Hosp 9, Dept Prosthodont,Sch Stomatol,Sch Med, Shanghai 200011, Peoples R China.	xinquanj@aliyun.com; fqzhang@vip.163.com			Shanghai Leading Academic Discipline Project [S30206, T0202]; Science and Technology committee of Shanghai [08DZ2271100, ZZjdyx13107]; National Natural Science Funds of China [81300912, 81201201]	Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Science and Technology committee of Shanghai(Shanghai Science & Technology Committee); National Natural Science Funds of China(National Natural Science Foundation of China (NSFC))	This work was supported by Shanghai Leading Academic Discipline Project (Project Number: S30206), Science and Technology committee of Shanghai (08DZ2271100 and ZZjdyx13107), Shanghai Leading Academic Discipline Project (T0202), and National Natural Science Funds of China (81300912 and 81201201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arioka M, 2013, BIOCHEM BIOPH RES CO, V440, P677, DOI 10.1016/j.bbrc.2013.09.126; Cao ZG, 2015, INT J BIOL SCI, V11, P335, DOI 10.7150/ijbs.10874; Chen Y, 2009, J CELL BIOCHEM, V106, P353, DOI 10.1002/jcb.22020; Chong ZZ, 2007, CURR NEUROVASC RES, V4, P194; Chung R, 2013, BONE, V52, P651, DOI 10.1016/j.bone.2012.10.035; del Pino-Montes J, 2004, CALCIFIED TISSUE INT, V75, P526, DOI 10.1007/s00223-004-0118-9; Dominguez L J, 2004, Reumatismo, V56, P235; Duarte VMG, 2005, J BONE MINER METAB, V23, P58, DOI 10.1007/s00774-004-0542-y; Erdal N, 2011, BIOL TRACE ELEM RES, V140, P342, DOI 10.1007/s12011-010-8703-4; Fajardo RJ, 2014, J BONE MINER RES, V29, P1025, DOI 10.1002/jbmr.2210; Galli C, 2012, EUR CELLS MATER, V24, P46, DOI 10.22203/eCM.v024a04; Hamann C, 2011, AM J PHYSIOL-ENDOC M, V301, pE1220, DOI 10.1152/ajpendo.00378.2011; Hie M, 2011, INT J MOL MED, V28, P455, DOI 10.3892/ijmm.2011.697; Hoeppner LH, 2009, EXPERT OPIN THER TAR, V13, P485, DOI [10.1517/14728220902841961, 10.1517/14728220902841961 ]; Hofmann A, 2009, ORTHOPADE, V38, P1009, DOI 10.1007/s00132-009-1488-5; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021; Jin P, 2010, TRANSPL P, V42, P2745, DOI 10.1016/j.transproceed.2010.05.145; Tolosa MJ, 2013, DIABETES RES CLIN PR, V101, P177, DOI 10.1016/j.diabres.2013.05.016; Khosla S, 2010, STEM CELLS, V28, P2124, DOI 10.1002/stem.546; Kim JH, 2014, J PERIODONTAL RES, V49, P792, DOI 10.1111/jre.12165; Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802; Korres N, 2013, WORLD J ORTHOP, V4, P124, DOI 10.5312/wjo.v4.i3.124; Kuo YR, 2011, PLAST RECONSTR SURG, V128, P872, DOI 10.1097/PRS.0b013e3182174329; Leng SH, 2010, J ENDOCRINOL, V206, P171, DOI 10.1677/JOE-09-0456; Leucht P, 2015, J AM ACAD ORTHOP SUR, V23, P67, DOI 10.5435/JAAOS-23-01-67; Lian ZZ, 2014, ANN DERMATOL, V26, P1, DOI 10.5021/ad.2014.26.1.1; Liu Z, 2013, J ETHNOPHARMACOL, V145, P233, DOI 10.1016/j.jep.2012.10.058; Lu KG, 2012, J BIOMAT SCI-POLYM E, V23, P509, DOI 10.1163/092050610X552861; Mauney JR, 2005, TISSUE ENG, V11, P787, DOI 10.1089/ten.2005.11.787; Milner PI, 2011, VET CLIN N AM-EQUINE, V27, P299, DOI 10.1016/j.cveq.2011.05.002; Minear S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000231; Musumeci G, 2011, ACTA HISTOCHEM, V113, P619, DOI 10.1016/j.acthis.2010.07.002; Pan XH, 2013, CELLS TISSUES ORGANS, V198, P414, DOI 10.1159/000358383; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P673, DOI 10.1111/j.1600-0501.2010.01923.x; Secreto Frank J, 2009, Curr Osteoporos Rep, V7, P64; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Sun TJ, 2014, EUR REV MED PHARMACO, V18, P2460; Tang Y, 2014, J DENT RES, V93, P175, DOI 10.1177/0022034513512507; Xia LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062645; Xu L, 2014, ORAL DIS, V20, P430, DOI 10.1111/odi.12148; Yang Y, 2013, CANCER LETT, V333, P9, DOI 10.1016/j.canlet.2012.11.056; Yaturu S, 2009, J DIABETES, V1, P246, DOI 10.1111/j.1753-0407.2009.00049.x; Yu M, 2011, BONE, V49, P387, DOI 10.1016/j.bone.2011.05.025; Zhang M, 2008, EXP DIABETES RES, DOI 10.1155/2008/704045; Zhang WJ, 2013, BIOMATERIALS, V34, P3184, DOI 10.1016/j.biomaterials.2013.01.008; Zhang WJ, 2013, INT J NANOMED, V8, P257, DOI 10.2147/IJN.S39357; Zhang WJ, 2012, INT J NANOMED, V7, P4459, DOI 10.2147/IJN.S33575; Zhang YL, 2011, J MATER SCI-MATER M, V22, P1933, DOI 10.1007/s10856-011-4375-7; Zhao YF, 2013, INT J MOL MED, V31, P614, DOI 10.3892/ijmm.2013.1227; Zheng T, 2015, BR J PHARM; Zhong QL, 2011, MOL MED REP, V4, P377, DOI 10.3892/mmr.2011.435	53	65	72	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136390	10.1371/journal.pone.0136390	http://dx.doi.org/10.1371/journal.pone.0136390			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296196	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900105
J	Datar, I; Feng, JW; Qiu, XL; Lewandowski, J; Yeung, M; Ren, G; Aras, S; Al-Mulla, F; Cui, HJ; Trumbly, R; Arudra, SKC; De las Casas, LE; de la Serna, I; Bitar, MS; Yeung, KC				Datar, Ila; Feng, Jingwei; Qiu, Xiaoliang; Lewandowski, John; Yeung, Miranda; Ren, Gang; Aras, Shweta; Al-Mulla, Fahd; Cui, Hongjuan; Trumbly, Robert; Arudra, Sri Krishna Chaitanya; De las Casas, Luis E.; de la Serna, Ivana; Bitar, Milad S.; Yeung, Kam C.			RKIP Inhibits Local Breast Cancer Invasion by Antagonizing the Transcriptional Activation of MMP13	PLOS ONE			English	Article							RAF KINASE INHIBITOR; MATRIX METALLOPROTEINASES; PROTEIN EXPRESSION; CELL-PROLIFERATION; TUMOR-METASTASIS; GENE-EXPRESSION; PROSTATE-CANCER; PROGRESSION; PATHWAY; DETERMINANTS	Raf Kinase Inhibitory Protein or RKIP was initially identified as a Raf-1 binding protein using the yeast 2-hybrid screen. RKIP inhibits the activation phosphorylation of MEK by Raf-1 by competitively inhibiting the binding of MEK to Raf-1 and thus exerting an inhibitory effect on the Raf-MEK-Erk pathway. RKIP has been identified as a metastasis suppressor gene. Expression of RKIP is low in cancer metastases. Although primary tumor growth remains unaffected, re-expression of RKIP inhibits cancer metastasis. Mechanistically, RKIP constrains metastasis by inhibiting angiogenesis, local invasion, intravasation, and colonization. The molecular mechanism of how RKIP inhibits these individual steps remains undefined. In our present study, using an unbiased PCR based screening and by analyzing DNA microarray expression datasets we observe that the expression of multiple metalloproteases (MMPs) including MMP1, MMP3, MMP10 and MMP13 are negatively correlated with RKIP expression in breast cancer cell lines and clinical samples. Since expression of MMPs by cancer cells is important for cancer metastasis, we hypothesize that RKIP may mediate suppression of breast cancer metastasis by inhibiting multiple MMPs. We show that the expression signature of RKIP and MMPs is better at predicting highmetastatic risk than the individual gene. Using a combination of loss-and gain-of-function approaches, we find that MMP13 is the cause of RKIP-mediated inhibition of local cancer invasion. Interestingly expression of MMP13 alone is not sufficient to reverse the inhibition of breast cancer cellmetastasis to the lung due to the expression of RKIP. We find that RKIP negatively regulates MMP13 through the Erk2 signaling pathway and the repression of MMP13 by RKIP is transcription factor AP-1 independent. Together, our findings indicate that RKIP inhibits cancer cell invasion, in part, via MMP13 inhibition. These data also implicate RKIP in the regulation of MMP transcription, suggesting a potential mechanism by which RKIP inhibits tumor progression and metastasis.	[Datar, Ila; Feng, Jingwei; Qiu, Xiaoliang; Lewandowski, John; Yeung, Miranda; Ren, Gang; Aras, Shweta; Trumbly, Robert; de la Serna, Ivana; Yeung, Kam C.] Univ Toledo, Coll Med, Dept Biochem & Canc Biol, Toledo, OH 43606 USA; [Al-Mulla, Fahd; Bitar, Milad S.] Kuwait Univ, Fac Med, Safat, Kuwait; [Cui, Hongjuan] State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Arudra, Sri Krishna Chaitanya; De las Casas, Luis E.] Univ Toledo, Dept Pathol, Coll Med, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; Kuwait University; University System of Ohio; University of Toledo	Bitar, MS (corresponding author), Kuwait Univ, Fac Med, POB 24923, Safat, Kuwait.	milad.bitar@gmail.com; kam.yeung@utoledo.edu	Qiu, Xiaoliang/C-5905-2016; Aras, Shweta/J-9866-2019; Qiu, Xiaoliang/O-6171-2019; Trumbly, Robert/AAF-6667-2020; Al-Mulla, Fahd/E-2068-2015	Aras, Shweta/0000-0003-2608-1366; Al-Mulla, Fahd/0000-0001-5409-3829; Trumbly, Robert/0000-0001-5618-146X	UT Foundation; NIH grant [RO1CA133479]; KFAS grant [2012-130-201]; NATIONAL CANCER INSTITUTE [R01CA133479] Funding Source: NIH RePORTER	UT Foundation; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KFAS grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the UT Foundation, a gift from Clement Lam to KCY, NIH grant (RO1CA133479) to KCY and KFAS grant no. 2012-130-201 to MSB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mulla F, 2006, J CLIN ONCOL, V24, P5672, DOI 10.1200/JCO.2006.07.5499; Al-Mulla F, 2014, J CELL BIOCHEM, V115, P488, DOI 10.1002/jcb.24682; Al-Mulla F, 2013, AM J CANCER RES, V3, P446; Al-Mulla F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029532; Al-Mulla F, 2011, CANCER RES, V71, P1334, DOI 10.1158/0008-5472.CAN-10-3102; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Beshir AB, 2010, CANCER LETT, V299, P137, DOI 10.1016/j.canlet.2010.08.012; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Chatterjee D, 2004, J BIOL CHEM, V279, P17515, DOI 10.1074/jbc.M313816200; Chatterjee D, 2008, CLIN CANCER RES, V14, P2994, DOI 10.1158/1078-0432.CCR-07-4496; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cui CJ, 2012, CELL SIGNAL, V24, P810, DOI 10.1016/j.cellsig.2011.11.019; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Delassus GS, 2008, J CELL PHYSIOL, V217, P739, DOI 10.1002/jcp.21548; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; Fu Z, 2006, PROSTATE, V66, P248, DOI 10.1002/pros.20319; Hegan S, 2005, CLIN CANC RES; Huntington JT, 2004, J BIOL CHEM, V279, P33168, DOI 10.1074/jbc.M405102200; Kang YB, 2009, METHODS MOL BIOL, V568, P7, DOI 10.1007/978-1-59745-280-9_2; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Lee HC, 2006, GASTROENTEROLOGY, V131, P1208, DOI 10.1053/j.gastro.2006.07.012; Li HZ, 2009, MOL CANCER RES, V7, P832, DOI 10.1158/1541-7786.MCR-08-0403; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Schuierer MM, 2006, ONCOL REP, V16, P451; Schuierer MM, 2004, CANCER RES, V64, P5186, DOI 10.1158/0008-5472.CAN-03-3861; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Yousuf S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092478; Yun JU, 2011, EMBO J, V30, P4500, DOI 10.1038/emboj.2011.312; Zhang B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-83; Zhang LZ, 2004, SURGERY, V136, P708, DOI 10.1016/j.surg.2003.12.013	41	15	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134494	10.1371/journal.pone.0134494	http://dx.doi.org/10.1371/journal.pone.0134494			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308852	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400027
J	Wutz, A; Shukla, A; Bapi, RS; Melcher, D				Wutz, Andreas; Shukla, Anuj; Bapi, Raju S.; Melcher, David			Expansion and Compression of Time Correlate with Information Processing in an Enumeration Task	PLOS ONE			English	Article							PSYCHOMETRIC FUNCTION; CONFIDENCE-INTERVALS; SUBJECTIVE TIME; INTERNAL CLOCK; CLICK TRAINS; PERCEPTION; DISCRIMINATION; ATTENTION; DURATION	Perception of temporal duration is subjective and is influenced by factors such as attention and context. For example, unexpected or emotional events are often experienced as if time subjectively expands, suggesting that the amount of information processed in a unit of time can be increased. Time dilation effects have been measured with an oddball paradigm in which an infrequent stimulus is perceived to last longer than standard stimuli in the rest of the sequence. Likewise, time compression for the oddball occurs when the duration of the standard items is relatively brief. Here, we investigated whether the amount of information processing changes when time is perceived as distorted. On each trial, an oddball stimulus of varying numerosity (1-14 items) and duration was presented along with standard items that were either short (70 ms) or long (1050 ms). Observers were instructed to count the number of dots within the oddball stimulus and to judge its relative duration with respect to the standards on that trial. Consistent with previous results, oddballs were reliably perceived as temporally distorted: expanded for longer standard stimuli blocks and compressed for shorter standards. The occurrence of these distortions of time perception correlated with perceptual processing; i.e. enumeration accuracy increased when time was perceived as expanded and decreased with temporal compression. These results suggest that subjective time distortions are not epiphenomenal, but reflect real changes in sensory processing. Such short-term plasticity in information processing rate could be evolutionarily advantageous in optimizing perception and action during critical moments.	[Wutz, Andreas; Melcher, David] Univ Trento, Ctr Mind & Brain Sci, Rovereto, Italy; [Shukla, Anuj; Bapi, Raju S.] Int Inst Informat Technol, Cognit Sci Lab, Hyderabad, Andhra Pradesh, India	University of Trento; International Institute of Information Technology Hyderabad	Wutz, A (corresponding author), Univ Trento, Ctr Mind & Brain Sci, Rovereto, Italy.	andreas.wutz-1@unitn.it	Wutz, Andreas/AAH-6931-2020; Melcher, David/D-1775-2010; Wutz, Andreas/E-9125-2019	Wutz, Andreas/0000-0003-2807-0863; Melcher, David/0000-0003-0926-585X; 	European Research Council Grant, "Construction of perceptual space-time" (CoPeST) [313658]; India-Trento Program for Advanced Research (ITPAR)	European Research Council Grant, "Construction of perceptual space-time" (CoPeST); India-Trento Program for Advanced Research (ITPAR)	The research was supported by a European Research Council Grant, "Construction of perceptual space-time" (CoPeST; agreement no. 313658) and the India-Trento Program for Advanced Research (ITPAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The India-Trento Program for Advanced Research (ITPAR) is a non-commercial funding source. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Agrillo C, 2010, COGN NEUROSCI-UK, V1, P96, DOI 10.1080/17588921003632537; Arstila V, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00196; Bates DM, 2013, PACKAGE LME4 LINEAR; Block RA, 1997, PSYCHON B REV, V4, P184, DOI 10.3758/BF03209393; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Campbell LA, 2007, BEHAV RES THER, V45, P1389, DOI 10.1016/j.brat.2006.05.011; Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Dormal V, 2006, ACTA PSYCHOL, V121, P109, DOI 10.1016/j.actpsy.2005.06.003; Droit-Volet S, 2003, J EXP CHILD PSYCHOL, V84, P63, DOI 10.1016/S0022-0965(02)00180-7; Esyenck MW, 1982, ATTENTION AROUSAL CO; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Gibbon J., 1984, TIMING TIME PERCEPTI; Harrell JFE, 2013, PACKAGE RMS REGRESSI; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jevons W.S., 1871, NATURE, V3, P281, DOI [10.1038/003281a0, DOI 10.1038/003281A0]; Jones LA, 2011, Q J EXP PSYCHOL, V64, P363, DOI 10.1080/17470218.2010.502580; KAUFMAN EL, 1949, AM J PSYCHOL, V62, P498, DOI 10.2307/1418556; Lambrechts A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082122; Maljkovic V, 2005, J VISION, V5, P215, DOI 10.1167/5.3.6; Marchetti G, 2009, COGN PROCESS, V10, P7, DOI 10.1007/s10339-008-0215-1; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PentonVoak IS, 1996, J EXP PSYCHOL ANIM B, V22, P307, DOI 10.1037/0097-7403.22.3.307; Seifried T, 2010, PSYCHOL RES-PSYCH FO, V74, P90, DOI 10.1007/s00426-008-0187-x; Stetson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001295; THOMAS EAC, 1975, PERCEPT PSYCHOPHYS, V17, P363, DOI 10.3758/BF03199347; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; TREISMAN M, 1990, PERCEPTION, V19, P705, DOI 10.1068/p190705; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; ULLMAN S, 1984, COGNITION, V18, P97, DOI 10.1016/0010-0277(84)90023-4; Ulrich R, 2006, PSYCHOL RES-PSYCH FO, V70, P77, DOI 10.1007/S00426-004-0195-4; van Wassenhove V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001437; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wearden JH, 2008, LANG LEARN, V58, P149, DOI 10.1111/j.1467-9922.2008.00468.x; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wittmann M, 2009, PHILOS T R SOC B, V364, P1955, DOI 10.1098/rstb.2009.0003; Wutz A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00952; Wutz A, 2014, J NEUROSCI, V34, P1554, DOI 10.1523/JNEUROSCI.3187-13.2014; Zakay D, 1997, CURR DIR PSYCHOL SCI, V6, P12, DOI 10.1111/1467-8721.ep11512604	46	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135794	10.1371/journal.pone.0135794	http://dx.doi.org/10.1371/journal.pone.0135794			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LO	26308546	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400076
J	Freestone, MC; Wilson, K; Jones, R; Mikton, C; Milsom, S; Sonigra, K; Taylor, C; Campbell, C				Freestone, Mark C.; Wilson, Kim; Jones, Rose; Mikton, Chris; Milsom, Sophia; Sonigra, Ketan; Taylor, Celia; Campbell, Colin			The Impact on Staff of Working with Personality Disordered Offenders: A Systematic Review	PLOS ONE			English	Review							MEDIUM SECURE UNIT; CARE; MANAGEMENT; DIAGNOSIS; ATTITUDES; SERVICES; PEOPLE; NEEDS	Background Personality disordered offenders (PDOs) are generally considered difficult to manage and to have a negative impact on staff working with them. Aims This study aimed to provide an overview of studies examining the impact on staff of working with PDOs, identify impact areas associated with working with PDOs, identify gaps in existing research, and direct future research efforts. Methods The authors conducted a systematic review of the English-language literature from 1964-2014 across 20 databases in the medical and social sciences. Results 27 papers were included in the review. Studies identified negative impacts upon staff including: negative attitudes, burnout, stress, negative counter-transferential experiences; two studies found positive impacts of job excitement and satisfaction, and the evidence related to perceived risk of violence from PDOs was equivocal. Studies demonstrated considerable heterogeneity and meta-analysis was not possible. The overall level of identified evidence was low: 23 studies (85%) were descriptive only, and only one adequately powered cohort study was found. Conclusions The review identified a significant amount of descriptive literature, but only one cohort study and no trials or previous systematic reviews of literatures. Clinicians and managers working with PDOs should be aware of the potential impacts identified, but there is an urgent need for further research focusing on the robust evaluation of interventions to minimise harm to staff working with offenders who suffer from personality disorder.	[Freestone, Mark C.; Wilson, Kim; Milsom, Sophia; Taylor, Celia] East London NHS Fdn Trust, London, England; [Freestone, Mark C.] Queen Mary Univ London, London, England; [Jones, Rose] Northumberland Tyne & Wear NHS Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Mikton, Chris] World Hlth Org, Geneva, Switzerland; [Sonigra, Ketan; Campbell, Colin] South London & Maudsley NHS Trust, London, England; [Campbell, Colin] Kings Coll London, London WC2R 2LS, England	University of London; Queen Mary University London; World Health Organization; South London & Maudsley NHS Trust; University of London; King's College London	Freestone, MC (corresponding author), East London NHS Fdn Trust, London, England.	m.c.freestone@qmul.ac.uk	Freestone, Mark/A-9086-2010	Freestone, Mark/0000-0002-0992-8468	East London NHS Foundation Trust, UK; South London and the Maudsley NHS Foundation Trust, UK; Northumberland, Tyne and Wear NHS Foundation Trust, UK	East London NHS Foundation Trust, UK; South London and the Maudsley NHS Foundation Trust, UK; Northumberland, Tyne and Wear NHS Foundation Trust, UK	Dr Freestone, Ms Wilson, Dr Milsom and Dr Taylor were funded by East London NHS Foundation Trust, UK. Dr Campbell and Mr Sonigra were funded by South London and the Maudsley NHS Foundation Trust, UK; and Ms Jones was funded by Northumberland, Tyne and Wear NHS Foundation Trust, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADSHEAD G, 2001, ADV PSYCHIAT TREAT, V7, P407, DOI DOI 10.1192/APT.7.6.407; Blom-Cooper L, 1999, MENTALLY DISORDERED; Bowers L., 2002, DANGEROUS SEVERE PER; Bowers L, 2006, PEER REV J, DOI DOI 10.1016/J.IJLP.2005.10.005.PEER; Bowers L., 2000, FACTORS UNDERLYING M; Bowers L, 2006, INT J LAW PSYCHIAT, V29, P333, DOI 10.1016/j.ijlp.2005.10.005; Bowers Len, 2005, Crim Behav Ment Health, V15, P171, DOI 10.1002/cbm.5; Boyle J, 2009, J SOC WORK PRACT, V23, P291, DOI 10.1080/02650530903102635; Crichton JH, 1998, CBMH, V8, P266, DOI DOI 10.1002/CBM.266; Crichton JH, 1999, PEER REV J; Crichton JHM, 2002, MED SCI LAW, V42, P30, DOI 10.1177/002580240204200106; Davies S, 2007, BRIT J PSYCHIAT, V191, P70, DOI 10.1192/bjp.bp.106.029215; Duggan C, 1998, REPORT NETWORK STAFF; Evans M, 2011, PSYCHOANAL PSYCHOTHE, V25, P143, DOI 10.1080/02668734.2011.576493; Fallon P, 1999, EXECUTIVE SUMMARY RE; Fortune Z, 2010, INT J SOC PSYCHIATR, V56, P186, DOI 10.1177/0020764009105281; Freestone M, 2006, THERAPEUTIC COMMUNIT, V27, P193; GRAHAM SA, 1980, J CONSULT CLIN PSYCH, V48, P796, DOI 10.1037/0022-006X.48.6.796; Greenhalgh T, 1997, READ PAPER ASSESSING; Grounds A, 2004, J FORENSIC PSYCHI PS, V15, P32, DOI 10.1080/14789940310001648212; Kosson DS, 2000, LEA SER PER CLIN PSY, P203; Kurtz A, 2005, J FORENSIC PSYCHI PS, V16, P399, DOI 10.1080/14789940500098475; Kurtz A, 2007, PSYCHOL PSYCHOTHER-T, V80, P421, DOI 10.1348/147608306X171510; Kurtz A, 2011, CRIM BEHAV MENT HEAL, V21, P245, DOI 10.1002/cbm.796; Lavender A, 2002, CRIMINAL BEHAV MEN S, V12; LEWIS G, 1988, BRIT J PSYCHIAT, V153, P44, DOI 10.1192/bjp.153.1.44; MacPhail S, 1999, MED SCI LAW, V39, P302, DOI 10.1177/002580249903900406; Mason T, 2010, J PSYCHIATR MENT HLT, V17, P131, DOI 10.1111/j.1365-2850.2009.01483.x; Mason T, 2009, J PSYCHIATR MENT HLT, V16, P158, DOI 10.1111/j.1365-2850.2008.01356.x; Mason T, 2010, PEER REVIEWED JOURNA, DOI DOI 10.3109/01612840903398727; Mason Tom, 2010, Issues Ment Health Nurs, V31, P336, DOI 10.3109/01612840903398727; McMillan I, 2007, MENTAL HLTH PRACTICE, P1465; Meloy J., 1998, PSYCHOL STALKING CLI; Ministry of Justice National Offender Management Service, 2011, WORK PERS DIS OFF PR; Morris M, 2003, ISSUES FORENSIC PSYC, V4, P65; Morris M, 2004, PEER REV J; Nathan R, 2007, J FORENSIC PSYCHI PS, V18, P342, DOI 10.1080/14789940701441136; National Institute for Mental Health, 2003, PERS DIS NO LONG DIA; Ndegwa D, 2006, BRIT J FORENSIC PRAC, V8, P29, DOI DOI 10.1108/14636646200600023; OECBM Levels of Evidence Working Group, 2011, OXF 2011 LEV EV; Petticrew M, 2006, SYSTEMATIC REVIEWS IN THE SOCIAL SCIENCES: A PRACTICAL GUIDE, P1, DOI 10.1002/9780470754887; Protter B, 1983, Bull Am Acad Psychiatry Law, V11, P223; Ruszczynski S, 2010, PEER REV J; Ruszczynski S, 2010, PSYCHOANAL PSYCHOTHE, V24, P224, DOI 10.1080/02668734.2010.501572; Tetley AC, 2011, J FORENSIC PSYCHI PS, V22, P321, DOI 10.1080/14789949.2010.528011; Trebilcock J. D., 2020, WILEY INT HDB PSYCHO, V2nd, DOI [10.1002/9781119159322.ch71, DOI 10.1002/9781119159322.CH71]; Turley C., 2013, MINISTRY JUSTICE ANA; Tyrer P, 2010, MED SCI LAW, V50, P95, DOI 10.1258/msl.2010.010001; VIUKARI M, 1979, ACTA PSYCHIAT SCAND, V59, P24, DOI 10.1111/j.1600-0447.1979.tb06943.x	49	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136378	10.1371/journal.pone.0136378	http://dx.doi.org/10.1371/journal.pone.0136378			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6KK	26305891	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500072
J	Hammer, N; Mobius, R; Schleifenbaum, S; Hammer, KH; Klima, S; Lange, JS; Soisson, O; Winkler, D; Milani, TL				Hammer, Niels; Moebius, Robert; Schleifenbaum, Stefan; Hammer, Karl-Heinz; Klima, Stefan; Lange, Justin S.; Soisson, Odette; Winkler, Dirk; Milani, Thomas L.			Pelvic Belt Effects on Health Outcomes and Functional Parameters of Patients with Sacroiliac Joint Pain	PLOS ONE			English	Article							RADIOFREQUENCY DENERVATION; PROVOCATION TESTS; COMPRESSION BELT; MANIPULATION; DIAGNOSIS; IMMEDIATE; PATTERNS; ANATOMY; IMPROVEMENTS; ARTHRODESIS	Introduction The sacroiliac joint (SIJ) is a common source of low back pain. However, clinical and functional signs and symptoms correlating with SIJ pain are widely unknown. Pelvic belts are routinely applied to treat SIJ pain but without sound evidence of their pain-relieving effects. This case-control study compares clinical and functional data of SIJ patients and healthy control subjects and evaluates belt effects on SIJ pain. Methods 17 SIJ patients and 17 healthy controls were included in this prospective study. The short-form 36 survey and the numerical rating scale were used to characterize health-related quality of life in patients in a six-week follow-up and the pain-reducing effects of pelvic belts. Electromyography data were obtained from the gluteus maximus, biceps femoris, rectus femoris and medial vastus. Alterations ofmuscle activity, variability and gait patterns were compared in patients and controls along with the belts' effects in a dynamic setting when walking. Results Significant improvements were observed in the short-form 36 survey of the SIJ patients, especially in the physical health subscores. Minor declines were also observed in the numerical rating scale on pain. Belt-related changes of muscle activity and variability were similar in patients and controls with one exception: the rectus femoris activity decreased significantly in patients with belt application when walking. Further belt effects include improved cadence and gait velocity in patients and controls. Conclusions Pelvic belts improve health-related quality of life and are potentially attributed to decreased SIJ-related pain. Belt effects include decreased rectus femoris activity in patients and improved postural steadiness during locomotion. Pelvic belts may therefore be considered as a cost-effective and low-risk treatment of SIJ pain.	[Hammer, Niels; Moebius, Robert] Univ Leipzig, Fac Med, Inst Anat, D-04109 Leipzig, Germany; [Schleifenbaum, Stefan; Klima, Stefan; Soisson, Odette] Univ Clin Leipzig, Dept Orthoped Trauma & Reconstruct Surg, Leipzig, Germany; [Hammer, Karl-Heinz; Milani, Thomas L.] Clin Orthoped Osteol & Pain Treatment, Kirchberg, Germany; [Lange, Justin S.; Soisson, Odette] Tech Univ Chemnitz, Inst Appl Kinesiol, Dept Human Locomot, Chemnitz, Germany; [Winkler, Dirk] Univ Clin Leipzig, Fac Med, Dept Neurosurg, Leipzig, Germany	Leipzig University; Leipzig University; Technische Universitat Chemnitz; Leipzig University	Hammer, N (corresponding author), Univ Leipzig, Fac Med, Inst Anat, D-04109 Leipzig, Germany.	nlshammer@googlemail.com	Klima, Stefan/K-3182-2019	Schleifenbaum, Stefan/0000-0002-9075-3756; Hammer, Niels/0000-0001-8230-9383	Bauerfeind AG	Bauerfeind AG	Bauerfeind AG provided financial and material support for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khayer A, 2008, J SPINAL DISORD TECH, V21, P359, DOI 10.1097/BSD.0b013e318145ab96; Arab AM, 2011, J MAN MANIP THER, V19, P5, DOI 10.1179/106698110X12804993426848; Armijo-Olivo S, 2011, MANUAL THER, V16, P563, DOI 10.1016/j.math.2011.05.006; Arumugam A, 2012, MANUAL THER, V17, P275, DOI 10.1016/j.math.2012.01.010; Ashman Bryan, 2010, Evid Based Spine Care J, V1, P35, DOI 10.1055/s-0030-1267066; Beales DJ, 2010, MANUAL THER, V15, P190, DOI 10.1016/j.math.2009.10.008; Bechtel R, 2001, Spine J, V1, P255, DOI 10.1016/S1529-9430(01)00081-X; BEECHER HK, 1955, JAMA-J AM MED ASSOC, V159, P1602, DOI 10.1001/jama.1955.02960340022006; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Buchowski Jacob M, 2005, Spine J, V5, P520, DOI 10.1016/j.spinee.2005.02.022; Bullinger M, 1996, Rehabilitation (Stuttg), V35, pXVII; Bullinger M, 1998, J CLIN EPIDEMIOL, V51, P913, DOI 10.1016/S0895-4356(98)00082-1; Bullinger M., 1996, DIE REHABILITATION, V35, pXXVII; Burnham RS, 2007, REGION ANESTH PAIN M, V32, P12, DOI 10.1016/j.rapm.2006.08.008; Childs JD, 2005, SPINE, V30, P1331, DOI 10.1097/01.brs.0000164099.92112.29; Childs JD, 2004, J MANIP PHYSIOL THER, V27, P306, DOI 10.1016/j.jmpt.2004.04.004; Chou LH, 2004, PAIN MED, V5, P26, DOI 10.1111/j.1526-4637.2004.04009.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen SP, 2005, ANESTH ANALG, V101, P1440, DOI 10.1213/01.ANE.0000180831.60169.EA; Cohen SP, 2008, ANESTHESIOLOGY, V109, P279, DOI 10.1097/ALN.0b013e31817f4c7c; Cohen SP, 2013, EXPERT REV NEUROTHER, V13, P99, DOI [10.1586/ERN.12.148, 10.1586/ern.12.148]; Cox RC, 2014, PAIN PHYSICIAN, V17, P459; Cusi MF, 2010, J BODYW MOV THER, V14, P152, DOI 10.1016/j.jbmt.2009.12.004; Daum W J, 1995, Am J Orthop (Belle Mead NJ), V24, P475; DePalma MJ, 2012, PAIN MED, V13, P498, DOI 10.1111/j.1526-4637.2012.01339.x; Dussault RG, 2000, RADIOLOGY, V214, P273, DOI 10.1148/radiology.214.1.r00ja28273; Farabeuf LH, 1894, ANN GYNEC OBSTET, V41, P407; Fick R, 1904, HDB ANATOMIE MECHANI; Forst Stacy L, 2006, Pain Physician, V9, P61; Fortin Joseph D, 2003, Pain Physician, V6, P269; Freburger JK, 2001, PHYS THER, V81, P1135, DOI 10.1093/ptj/81.5.1135; Fritz Jan, 2011, Top Magn Reson Imaging, V22, P143, DOI 10.1097/RMR.0b013e31827e5de1; Grassi DD, 2011, MANUAL THER, V16, P495, DOI 10.1016/j.math.2011.04.003; Guentchev M, 2015, NEUROMODULATION, V18, P392, DOI 10.1111/ner.12255; Hermens HJ, 2014, EUROPEAN APPLICATION; HERZOG W, 1994, J MANIP PHYSIOL THER, V17, P124; Ho KY, 2013, J PAIN RES, V6, P505, DOI 10.2147/JPR.S46827; Hrobjartsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003974.pub3; Hu H, 2010, J BIOMECH, V43, P532, DOI 10.1016/j.jbiomech.2009.09.035; Jung HS, 2013, MANUAL THER, V18, P143, DOI 10.1016/j.math.2012.09.003; Kamali F, 2012, J BODYW MOV THER, V16, P29, DOI 10.1016/j.jbmt.2011.02.002; Karaman H, 2011, ACTA NEUROCHIR, V153, P1461, DOI 10.1007/s00701-011-1003-8; Kim Jong T, 2013, Open Orthop J, V7, P51, DOI 10.2174/1874325001307010051; Kim YH, 2010, NEUROMODULATION, V13, P306, DOI 10.1111/j.1525-1403.2009.00270.x; Klein G., 1891, Z GEBURTSH GYNAKOL, V21, P74; Laplante BL, 2012, PAIN PHYSICIAN, V15, P171; Laslett M, 2005, MANUAL THER, V10, P207, DOI 10.1016/j.math.2005.01.003; Laslett M, 2008, J MAN MANIP THER, V16, P142, DOI 10.1179/jmt.2008.16.3.142; LeBlanche AF, 1996, SURG RADIOL ANAT, V18, P215; Maigne JY, 1996, SPINE, V21, P1889, DOI 10.1097/00007632-199608150-00012; Manchikanti L, 2013, PAIN PHYSICIAN, V16, pE635; Manchikanti L, 2013, PAIN PHYSICIAN, V16, pE379; Matsumoto Sonoko, 2012, Masui, V61, P993; McGuire R, 2002, EVID BASED SPINE J, V3, P21; Mendez-Sanchez R, 2014, J ALTERN COMPLEM MED, V20, P251, DOI 10.1089/acm.2013.0192; Merskey H, 1994, CLASSIFICATION CHRON, DOI DOI 10.1016/0304-3959(86)90113-2; Miller AN, 2012, J AM ACAD ORTHOP SUR, V20, P8, DOI 10.5435/JAAOS-20-01-008; Murakami E, 2008, J ORTHOP SCI, V13, P492, DOI 10.1007/s00776-008-1280-0; Orakifar N, 2012, ARCH PHYS MED REHAB, V93, P56, DOI 10.1016/j.apmr.2011.05.027; PANJABI MM, 1992, J SPINAL DISORD, V5, P390, DOI 10.1097/00002517-199212000-00002; Park KM, 2010, J ELECTROMYOGR KINES, V20, P1141, DOI 10.1016/j.jelekin.2010.05.009; Patil AA, 2014, NEUROMODULATION, V17, P98, DOI 10.1111/ner.12030; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Plastaras CT, 2012, PM&R, V4, P473, DOI 10.1016/j.pmrj.2012.02.001; Pool-Goudzwaard AL, 2001, J ANAT, V199, P457, DOI 10.1046/j.1469-7580.2001.19940457.x; Puhakka KB, 2004, SKELETAL RADIOL, V33, P15, DOI 10.1007/s00256-003-0691-4; Roberts SL, 2014, REGION ANESTH PAIN M, V39, P456, DOI 10.1097/AAP.0000000000000156; Rudolf Leonard, 2014, Open Orthop J, V8, P375, DOI 10.2174/1874325001408010375; Saint-Martin M., 1912, COMPTES RENDUS ASSOD, V14, P95; Salaffi F, 2004, EUR J PAIN, V8, P283, DOI 10.1016/j.ejpain.2003.09.004; SCHWARZER AC, 1995, SPINE, V20, P31, DOI 10.1097/00007632-199501000-00007; Shadmehr A, 2012, J BACK MUSCULOSKELET, V25, P27, DOI 10.3233/BMR-2012-0307; Soisson O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116739; Spiker William Ryan, 2012, Evid Based Spine Care J, V3, P41, DOI 10.1055/s-0032-1328142; Szadek KM, 2008, REGION ANESTH PAIN M, V33, P36, DOI 10.1016/j.rapm.2007.07.011; Szadek KM, 2009, J PAIN, V10, P354, DOI 10.1016/j.jpain.2008.09.014; Takasaki H, 2009, MANUAL THER, V14, P484, DOI 10.1016/j.math.2008.11.003; Terry RJ, 1926, JAMA-J AM MED ASSOC, V87, P307; Vleeming A, 2012, J ANAT, V221, P537, DOI 10.1111/j.1469-7580.2012.01564.x; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; WEISL H, 1954, ACTA ANAT, V20, P201; Wise CL, 2008, J SPINAL DISORD TECH, V21, P579, DOI 10.1097/BSD.0b013e31815ecc4b	82	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136375	10.1371/journal.pone.0136375	http://dx.doi.org/10.1371/journal.pone.0136375			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305790	Green Submitted, gold, Green Published			2022-12-27	WOS:000359995500071
J	Vijay, A; Inui, T; Dodds, M; Proctor, G; Carpenter, G				Vijay, Amrita; Inui, Taichi; Dodds, Michael; Proctor, Gordon; Carpenter, Guy			Factors That Influence the Extensional Rheological Property of Saliva	PLOS ONE			English	Article							HUMAN WHOLE SALIVA; GASTRIC MUCIN; MUCUS; BICARBONATE; PH; AGGREGATION; MICROSCOPY; INTERFACE; SECRETION; PROTEIN	The spinnbarkeit of saliva reflects the ability of saliva to adhere to surfaces within the mouth, thereby serving as a protective role and aiding in lubrication. Therefore, alterations in the extensional rheology of saliva may result in the loss in adhesiveness or the ability to bind onto surfaces. Mucin glycoproteins and their structures are known to be important factors for the extensional rheological properties of saliva. The conformation of mucin depends on factors such as pH and ionic strength. Chewing is one of the main stimuli for salivary secretion but creates significant sheer stress on the salivary film which could influence mouthfeel perceptions. The current study investigates the possible factors which affect the extensional rheological properties of saliva by comparing submandibular/sublingual saliva with different oral stimuli within the same group of subjects. Unstimulated and stimulated saliva (chew, smell and taste) salivas were collected primarily from submandibular/sublingual glands. The saliva samples were measured for Spinnbarkeit followed by the measuring mucin, total protein, total calcium and bicarbonate concentrations. The results indicated correlations between rheological properties and mucin/ion concentrations. However, chewing stimulated submandibular/sublingual saliva is shown to have significantly lower Spinnbarkeit, but factors such as mucin, protein and calcium concentrations did not account for this variation. Analysis of the concentration of bicarbonate and pH appears to suggest that it has a prominent effect on extensional rheology of saliva.	[Vijay, Amrita; Proctor, Gordon; Carpenter, Guy] Kings Coll London, Inst Dent, Salivary Res Unit, London WC2R 2LS, England; [Inui, Taichi; Dodds, Michael] Wm Wrigley Jr Co, Chicago, IL USA	University of London; King's College London; Mars	Vijay, A (corresponding author), Kings Coll London, Inst Dent, Salivary Res Unit, London WC2R 2LS, England.	amrita.vijay@kcl.ac.uk		Proctor, Gordon/0000-0002-5684-841X; Carpenter, Guy/0000-0003-3084-3415; Vijay, Amrita/0000-0002-9595-5680	Wrigley Jr. Co	Wrigley Jr. Co	Wrigley Jr. Co are the sponsors of this study. Wrigley had a role in study design, data analysis, decision to publish and helped editing the manuscript.	Acuie-Beghin V, 2008, J AGR FOOD CHEM, V56, P9600, DOI 10.1021/jf801672x; Bansil R, 2006, CURR OPIN COLLOID IN, V11, P164, DOI 10.1016/j.cocis.2005.11.001; Bardow A, 2000, Clin Oral Investig, V4, P245, DOI 10.1007/s007840000077; Bardow A, 2000, ARCH ORAL BIOL, V45, P1, DOI 10.1016/S0003-9969(99)00119-3; BEELEY JA, 1993, BIOCHEM SOC T, V21, P133, DOI 10.1042/bst0210133; Bhat PP, 2010, NAT PHYS, V6, P625, DOI 10.1038/NPHYS1682; Bongaerts JHH, 2007, TRIBOL LETT, V27, P277, DOI 10.1007/s11249-007-9232-y; Cao XX, 1999, BIOPHYS J, V76, P1250, DOI 10.1016/S0006-3495(99)77288-7; Chen EYT, 2010, AM J PHYSIOL-LUNG C, V299, pL542, DOI 10.1152/ajplung.00180.2010; Christersson CE, 2000, EUR J ORAL SCI, V108, P418, DOI 10.1034/j.1600-0722.2000.108005418.x; GLANTZ PO, 1989, ACTA ODONTOL SCAND, V47, P17, DOI 10.3109/00016358909004795; GLANTZ POJ, 1989, ACTA ODONTOL SCAND, V47, P111, DOI 10.3109/00016358909167311; Gohara K, 2004, J DENT, V32, P335, DOI 10.1016/j.jdent.2004.01.006; Haward SJ, 2011, RHEOL ACTA, V50, P869, DOI 10.1007/s00397-010-0494-1; Hong ZN, 2005, BIOMACROMOLECULES, V6, P3458, DOI 10.1021/bm0505843; Kesimer M, 2010, AM J PHYSIOL-LUNG C, V298, pL15, DOI 10.1152/ajplung.00194.2009; OConnor M, 1984, CIBA FDN S; Pramanik R, 2010, EUR J ORAL SCI, V118, P245, DOI 10.1111/j.1600-0722.2010.00728.x; Proctor GB, 2005, BIOCHEM J, V389, P111, DOI 10.1042/BJ20042012; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; Quinton PM, 2010, PEDIATR PULM, P215; Quinton PM, 2001, NAT MED, V7, P292, DOI 10.1038/85429; Raynal BDE, 2003, J BIOL CHEM, V278, P28703, DOI 10.1074/jbc.M304632200; Rossi S, 2010, EUR J PHARM BIOPHARM, V74, P248, DOI 10.1016/j.ejpb.2009.10.003; Rusanov AI, 2003, DOKL PHYS CHEM, V393, P350, DOI 10.1023/B:DOPC.0000010341.98197.11; Stokes JR, 2007, BIORHEOLOGY, V44, P141; Svensson O, 2010, CURR OPIN COLLOID IN, V15, P395, DOI 10.1016/j.cocis.2010.05.015; TABAK L A, 1990, Critical Reviews in Oral Biology and Medicine, V1, P229; TAM PY, 1981, NATURE, V292, P340, DOI 10.1038/292340a0; Teubl BJ, 2013, EUR J PHARM BIOPHARM, V84, P386, DOI 10.1016/j.ejpb.2012.10.021; Van Der Reijden W. A., 1993, Nederlands Tijdschrift voor Tandheelkunde, V100, P351; Veeregowda DH, 2012, PLOS ONE, V7; VEERMAN ECI, 1989, J BIOL BUCCALE, V17, P297; VERDUGO P, 1990, ANNU REV PHYSIOL, V52, P157, DOI 10.1146/annurev.ph.52.030190.001105	34	29	30	6	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135792	10.1371/journal.pone.0135792	http://dx.doi.org/10.1371/journal.pone.0135792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305698	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500034
J	Xu, ZX; Gan, L; Li, TY; Xu, C; Chen, K; Wang, XD; Qin, JG; Chen, LQ; Li, EC				Xu, Zhixin; Gan, Lei; Li, Tongyu; Xu, Chang; Chen, Ke; Wang, Xiaodan; Qin, Jian G.; Chen, Liqiao; Li, Erchao			Transcriptome Profiling and Molecular Pathway Analysis of Genes in Association with Salinity Adaptation in Nile Tilapia Oreochromis niloticus	PLOS ONE			English	Article							SHRIMP LITOPENAEUS-VANNAMEI; MESSENGER-RNA LEVELS; CHINESE MITTEN CRAB; CHOLESTEROL SULFATE; THYROID-HORMONE; ENERGY-METABOLISM; OXIDATIVE STRESS; ION REGULATION; EXPRESSION; FISH	Nile tilapia Oreochromis niloticus is a freshwater fish but can tolerate a wide range of salinities. The mechanism of salinity adaptation at the molecular level was studied using RNA-Seq to explore the molecular pathways in fish exposed to 0, 8, or 16 (practical salinity unit, psu). Based on the change of gene expressions, the differential genes unions from freshwater to saline water were classified into three categories. In the constant change category (1), steroid biosynthesis, steroid hormone biosynthesis, fat digestion and absorption, complement and coagulation cascades were significantly affected by salinity indicating the pivotal roles of sterol-related pathways in response to salinity stress. In the change-then-stable category (2), ribosomes, oxidative phosphorylation, signaling pathways for peroxisome proliferator activated receptors, and fat digestion and absorption changed significantly with increasing salinity, showing sensitivity to salinity variation in the environment and a responding threshold to salinity change. In the stable-then-change category (3), protein export, protein processing in endoplasmic reticulum, tight junction, thyroid hormone synthesis, antigen processing and presentation, glycolysis/gluconeogenesis and glycosaminoglycan biosynthesis-keratan sulfate were the significantly changed pathways, suggesting that these pathways were less sensitive to salinity variation. This study reveals fundamental mechanism of the molecular response to salinity adaptation in O. niloticus, and provides a general guidance to understand saline acclimation in O. niloticus.	[Xu, Zhixin; Gan, Lei; Li, Tongyu; Xu, Chang; Chen, Ke; Wang, Xiaodan; Chen, Liqiao; Li, Erchao] E China Normal Univ, Sch Life Sci, Lab Aquaculture Nutr & Environm Hlth, Shanghai 200241, Peoples R China; [Qin, Jian G.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia	East China Normal University; Flinders University South Australia	Chen, LQ (corresponding author), E China Normal Univ, Sch Life Sci, Lab Aquaculture Nutr & Environm Hlth, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	lqchen@bio.ecnu.edu.cn; ecli@bio.ecnu.edu.cn	Wang, Xiaodan/AAH-1305-2021; Li, Tongyu/GQA-7514-2022	Qin, Jianguang/0000-0003-2448-8058; LI, Erchao/0000-0001-8495-2241; Chen, Liqiao/0000-0003-0138-7828; Gan, Lei/0000-0002-7525-2574	National 'Twelfth Five-Year' Plan for Science & Technology Support [2012BAD25B03]; National Basic Research Program (973Program) [2014CB138803]	National 'Twelfth Five-Year' Plan for Science & Technology Support; National Basic Research Program (973Program)(National Basic Research Program of China)	This work was supported by the National 'Twelfth Five-Year' Plan for Science & Technology Support (2012BAD25B03) and the National Basic Research Program (973Program, No. 2014CB138803).	Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; ANDERSSON T, 1992, AQUAT TOXICOL, V24, P1, DOI 10.1016/0166-445X(92)90014-E; Armesto P, 2015, COMP BIOCHEM PHYS A, V184, P6, DOI 10.1016/j.cbpa.2015.01.021; ARMSTRONG JE, 1973, J CELL BIOL, V59, P444, DOI 10.1083/jcb.59.2.444; ARONICA SM, 1994, P NATL ACAD SCI USA, V91, P8517, DOI 10.1073/pnas.91.18.8517; Aruna A, 2015, GEN COMP ENDOCR, V211, P154, DOI 10.1016/j.ygcen.2014.12.005; Bai YC, 2015, AQUACULTURE, V437, P297, DOI 10.1016/j.aquaculture.2014.12.020; Barabasi AL, 2004, EUR PHYS J B, V38, P169, DOI 10.1140/epjb/e2004-00022-4; Barletta M, 2005, J FISH BIOL, V66, P45, DOI 10.1111/j.0022-1112.2005.00582.x; Barras C, 2015, NEW SCI, V225, P26, DOI 10.1016/S0262-4079(15)60121-X; Bayly I.A.E., 1972, Annual Rev Ecol Syst, V3, P233, DOI 10.1146/annurev.es.03.110172.001313; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLEAU G, 1974, BIOCHIM BIOPHYS ACTA, V352, P1, DOI 10.1016/0005-2736(74)90174-6; Bolivar RB, 2002, AQUACULTURE, V204, P371, DOI 10.1016/S0044-8486(01)00824-9; Breves JP, 2010, GEN COMP ENDOCR, V167, P135, DOI 10.1016/j.ygcen.2010.01.022; Chang JCH, 2007, J EXP BIOL, V210, P3494, DOI 10.1242/jeb.007146; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; CHEN K, 2014, AQUACULTURE, V33, P825, DOI DOI 10.2983/035.033.0317; Chong-Robles J, 2014, AQUACULTURE, V422, P261, DOI 10.1016/j.aquaculture.2013.11.034; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; DAHLBERG AE, 1989, CELL, V57, P525, DOI 10.1016/0092-8674(89)90122-0; DENNING MF, 1995, CELL GROWTH DIFFER, V6, P1619; Eales J. Geoffrey, 2006, P767; EDWARDS HA, 1982, J EXP BIOL, V101, P153; El-Zaeem SY, 2013, AFRICAN JOURNAL OF B, V10, P684; ElSayed AFM, 2006, TILAPIA CULTURE, P1, DOI 10.1079/9780851990149.0000; Fonseca-Madrigal J, 2012, FISH PHYSIOL BIOCHEM, V38, P1047, DOI 10.1007/s10695-011-9589-6; Franzellitti S, 2011, AQUAT TOXICOL, V101, P299, DOI 10.1016/j.aquatox.2010.11.001; Fridman S, 2012, AQUACULTURE, V334, P182, DOI 10.1016/j.aquaculture.2011.12.034; Fukuda R, 2002, JOURNAL OF BIOLOGICA; Gamage N, 2006, TOXICOL SCI, V90, P5, DOI 10.1093/toxsci/kfj061; GERARD J F, 1972, Journal of Experimental Marine Biology and Ecology, V10, P125, DOI 10.1016/0022-0981(72)90098-6; Goichberg P, 2006, BLOOD, V107, P870, DOI 10.1182/blood-2005-03-0941; Gonzalez RJ, 2012, J COMP PHYSIOL B, V182, P321, DOI 10.1007/s00360-011-0624-9; Gutierrez-Canovas C, 2013, GLOBAL ECOL BIOGEOGR, V22, P796, DOI 10.1111/geb.12060; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Hinton David E., 2001, P224; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Hwang PP, 2007, COMP BIOCHEM PHYS A, V148, P479, DOI 10.1016/j.cbpa.2007.06.416; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Javitt NB, 2001, ENDOCRINOLOGY, V142, P2978, DOI 10.1210/en.142.7.2978; JUGEAUBRY CE, 1995, J BIOL CHEM, V270, P18117, DOI 10.1074/jbc.270.30.18117; Kiiltz D, 2000, CE MO RE ST, V1, P157; Kimura A, 2009, FISH SHELLFISH IMMUN, V27, P768, DOI 10.1016/j.fsi.2009.08.008; Korhonen RK, 2010, J BIOMECH, V43, P783, DOI 10.1016/j.jbiomech.2009.10.022; LALUMIERE G, 1975, BIOCHIM BIOPHYS ACTA, V394, P120, DOI 10.1016/0005-2736(75)90210-2; Lapucki T, 2008, COMP BIOCHEM PHYS A, V149, P299, DOI 10.1016/j.cbpa.2008.01.009; Lee SH, 2010, J BIOL CHEM, V285, P41280, DOI 10.1074/jbc.M110.182188; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li EC, 2014, PHYSIOL GENOMICS, V46, P177, DOI 10.1152/physiolgenomics.00191.2013; Li JJ, 2014, BIOCHEM SYST ECOL, V56, P111, DOI 10.1016/j.bse.2014.05.006; Liu M, 2011, COMP BIOCHEM PHYS C, V154, P326, DOI 10.1016/j.cbpc.2011.06.018; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; Luvizotto-Santos R, 2003, J EXP ZOOL PART A, V295A, P200, DOI 10.1002/jez.a.10219; Luz RK, 2008, AQUACULTURE, V276, P171, DOI 10.1016/j.aquaculture.2008.01.042; MADARA JL, 1987, AM J PHYSIOL, V253, pC171, DOI 10.1152/ajpcell.1987.253.1.C171; Marra NJ, 2014, MOL ECOL, V23, P2699, DOI 10.1111/mec.12764; Meijerink J, 2015, BRIT J PHARMACOL, V172, P24, DOI 10.1111/bph.12747; Meng SL, 2014, ECOTOX ENVIRON SAFE, V101, P1, DOI 10.1016/j.ecoenv.2013.10.020; Merten M, 2001, CIRCULATION, V103, P2032; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; NESS GC, 1990, BIOCHEM BIOPH RES CO, V172, P1150, DOI 10.1016/0006-291X(90)91568-D; Ostrowski AD, 2011, AQUACULTURE, V314, P193, DOI 10.1016/j.aquaculture.2011.02.010; PARASASSI T, 1995, FREE RADICAL BIO MED, V19, P511, DOI 10.1016/0891-5849(95)00038-Y; Parvez S, 2003, BIOL TRACE ELEM RES, V93, P237, DOI 10.1385/BTER:93:1-3:237; Pennisi E, 2009, SCIENCE, V326, P1620, DOI 10.1126/science.326.5960.1620; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Raman R, 2014, TRENDS MICROBIOL, V22, P632, DOI 10.1016/j.tim.2014.07.002; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rhee JS, 2012, COMP BIOCHEM PHYS A, V161, P436, DOI 10.1016/j.cbpa.2012.01.004; Sacchi R, 2013, J EXP BIOL, V216, P4626, DOI 10.1242/jeb.093823; Sato J, 1998, J INVEST DERMATOL, V111, P189, DOI 10.1046/j.1523-1747.1998.00244.x; SCHIRF VR, 1987, COMP BIOCHEM PHYS A, V88, P383, DOI 10.1016/0300-9629(87)90050-8; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seale AP, 2012, GEN COMP ENDOCR, V178, P123, DOI 10.1016/j.ygcen.2012.04.020; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Storer NY, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001123; Sui L, 2007, AQUACULTURE, V273, P139, DOI 10.1016/j.aquaculture.2007.09.016; Takahashi M, 2002, AM J PHYSIOL-GASTR L, V282, pG338, DOI 10.1152/ajpgi.00376.2001; Tham DM, 2002, PHYSIOL GENOMICS, V11, P21, DOI 10.1152/physiolgenomics.00062.2002; Tseng YC, 2008, COMP BIOCHEM PHYS C, V148, P419, DOI 10.1016/j.cbpc.2008.04.009; Vargas-Chacoff L, 2014, POLAR BIOL, V37, P1235, DOI 10.1007/s00300-014-1515-9; Wang K, 2010, NUCLEIC ACIDS RES; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; WATANABE WO, 1985, AQUACULTURE, V48, P159, DOI 10.1016/0044-8486(85)90102-4; Watschinger K, 2013, BIOCHIMIE, V95, P59, DOI 10.1016/j.biochi.2012.06.027; WILSON RP, 1994, AQUACULTURE, V124, P67, DOI 10.1016/0044-8486(94)90363-8; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Yang CG, 2013, GENE, V527, P183, DOI 10.1016/j.gene.2013.06.013; Yasuda T, 2008, MOL CELL ENDOCRINOL, V294, P29, DOI 10.1016/j.mce.2008.06.014; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975; Zhang JD, 2009, BIOINFORMATICS, V25, P1470, DOI 10.1093/bioinformatics/btp167; Zhao Q, 2015, FISH SHELLFISH IMMUN, V42, P400, DOI 10.1016/j.fsi.2014.11.020	99	67	73	12	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136506	10.1371/journal.pone.0136506	http://dx.doi.org/10.1371/journal.pone.0136506			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305564	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500087
J	Grossman, Z; Avidor, B; Mor, Z; Chowers, M; Levy, I; Shahar, E; Riesenberg, K; Sthoeger, Z; Maayan, S; Shao, W; Lorber, M; Olstein-Pops, K; Elbirt, D; Elinav, H; Asher, I; Averbuch, D; Istomin, V; Gottesman, BS; Kedem, E; Girshengorn, S; Kra-Oz, Z; Avni, YS; Sade, SR; Turner, D; Maldarelli, F				Grossman, Zehava; Avidor, Boaz; Mor, Zohar; Chowers, Michal; Levy, Itzchak; Shahar, Eduardo; Riesenberg, Klaris; Sthoeger, Zev; Maayan, Shlomo; Shao, Wei; Lorber, Margalit; Olstein-Pops, Karen; Elbirt, Daniel; Elinav, Hila; Asher, Ilan; Averbuch, Diana; Istomin, Valery; Gottesman, Bat Sheva; Kedem, Eynat; Girshengorn, Shirley; Kra-Oz, Zipi; Avni, Yonat Shemer; Sade, Sara Radian; Turner, Dan; Maldarelli, Frank			A Population-Structured HIV Epidemic in Israel: Roles of Risk and Ethnicity	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE; PROTEASE; INFECTION; SUBTYPE; EUROPE; ADULT; MEN; SEX	Background HIV in Israel started with a subtype-B epidemic among men who have sex with men, followed in the 1980s and 1990s by introductions of subtype C from Ethiopia (predominantly acquired by heterosexual transmission) and subtype A from the former Soviet Union (FSU, most often acquired by intravenous drug use). The epidemic matured over the last 15 years without additional large influx of exogenous infections. Between 2005 and 2013 the number of infected men who have sex with men (MSM) increased 2.9-fold, compared to 1.6-fold and 1.3-fold for intravenous drug users (IVDU) and Ethiopian-origin residents. Understanding contemporary spread is essential for effective public health planning. Methods We analyzed demographic and virologic data from 1,427 HIV-infected individuals diagnosed with HIV-I during 1998-2012. HIV phylogenies were reconstructed with maximum-likelihood and Bayesian methods. Results Subtype-B viruses, but not A or C, demonstrated a striking number of large clusters with common ancestors having posterior probability >= 0.95, including some suggesting presence of transmission networks. Transmitted drug resistance was highest in subtype B (13%). MSM represented a frequent risk factor in cross-ethnic transmission, demonstrated by the presence of Israeli-born with non-B virus infections and FSU immigrants with non-A subtypes. Conclusions Reconstructed phylogenetic trees demonstrated substantial grouping in subtype B, but not in non-MSM subtype-A or in subtype-C, reflecting differences in transmission dynamics linked to HIV transmission categories. Cross-ethnic spread occurred through multiple independent introductions, with MSM playing a prevalent role in the transmission of the virus. Such data provide a baseline to track epidemic trends and will be useful in informing and quantifying efforts to reduce HIV transmission.	[Grossman, Zehava] Tel Aviv Univ, Sch Publ Hlth, IL-69978 Tel Aviv, Israel; [Grossman, Zehava; Maldarelli, Frank] NCI, Frederick, MD 21701 USA; [Avidor, Boaz; Girshengorn, Shirley; Turner, Dan] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Crusaid Kobler AIDS Ctr, IL-69978 Tel Aviv, Israel; [Avidor, Boaz; Girshengorn, Shirley] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Lab Viruses & Mol Biol, IL-69978 Tel Aviv, Israel; [Mor, Zohar] Minist Hlth, Ramla Dept Hlth, Ramla, Israel; [Chowers, Michal; Gottesman, Bat Sheva] Meir Med Ctr, Kefar Sava, Israel; [Levy, Itzchak] Chaim Sheba Med Ctr, Infect Dis Unit, Ramat Gan, Israel; [Shahar, Eduardo; Lorber, Margalit; Kedem, Eynat; Kra-Oz, Zipi] Rambam Med Ctr, Haifa, Israel; [Riesenberg, Klaris; Avni, Yonat Shemer] Soroka Med Ctr, IL-84101 Beer Sheva, Israel; [Sthoeger, Zev; Elbirt, Daniel; Asher, Ilan; Sade, Sara Radian] Kaplan Med Ctr, Rehovot, Israel; [Maayan, Shlomo; Olstein-Pops, Karen; Elinav, Hila; Averbuch, Diana] Hadassah Med Ctr, IL-91120 Jerusalem, Israel; [Shao, Wei] SAIC Frederick Inc, Adv Biomed Comp Ctr, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Istomin, Valery] Hillel Yaffe Med Ctr, Hadera, Israel	Tel Aviv University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology; Ben Gurion University; Soroka Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Grossman, Z (corresponding author), Tel Aviv Univ, Sch Publ Hlth, IL-69978 Tel Aviv, Israel.	Zehava.Grossman@gmail.com	AVNI, YONAT SHEMER/F-1772-2012; Averbuch, Dina/ABA-6433-2020; Maldarelli, Frank/O-2428-2016	Chowers, Michal/0000-0001-6148-254X	European Commission [LSHP-CT-2006-518211]; NIH; NATIONAL CANCER INSTITUTE [ZIABC010819] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a European Commission, Grant number LSHP-CT-2006-518211 (ZG) and by a NIH Bench to Bedside Grant (FM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidor B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057789; Bengtsson L, 2010, AIDS, V24, P2301, DOI 10.1097/QAD.0b013e32833d207d; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Chemtob D, 2004, INT J STD AIDS, V15, P691, DOI 10.1258/0956462041944321; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Frentz D, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-36; Gray RR, 2009, AIDS, V23, pF9, DOI 10.1097/QAD.0b013e32832faf61; Grossman Z, 2001, AIDS, V15, P1453, DOI 10.1097/00002030-200108170-00001; Grossman Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086239; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hue S, 2014, AIDS, V28, P1967, DOI 10.1097/QAD.0000000000000383; Israel Ministry of Health HIV/AIDS in Israel, EP PER REP 1998 2014; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; Katchman E, 2013, 14 EUR AIDS C OCT 16; Khanani MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022449; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Levy I, 2011, CLIN INFECT DIS, V52, P1363, DOI 10.1093/cid/cir244; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mor Z, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003078; Mor Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079691; Nei M., 2000, MOL EVOLUTION PHYLOG; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Pena ACP, 2010, INFECTIOUS GENETICS, V19, P337; Poon A., 2014, J INFECT DIS; Rambaut A, 2012, FIG TREE V1 4 0 TREE; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Salemi M, 2013, INFECT DIS REP, V5, P8, DOI 10.4081/idr.2013.s1.e3; SLATER PE, 1993, ISRAEL J MED SCI, V29, P2; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Theys K, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-81; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Worobey Michael, 2008, Proc Natl Acad Sci U S A, V105, pE16, DOI 10.1073/pnas.0712128105	37	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135061	10.1371/journal.pone.0135061	http://dx.doi.org/10.1371/journal.pone.0135061			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302493	Green Submitted, gold, Green Published			2022-12-27	WOS:000359951900013
J	Zieba, G; Fox, MG; Copp, GH				Zieba, Grzegorz; Fox, Michael G.; Copp, Gordon H.			How Will Climate Warming Affect Non-Native Pumpkinseed Lepomis gibbosus Populations in the UK?	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; PERCH PERCA-FLAVESCENS; PHENOTYPIC PLASTICITY; OVERWINTER MORTALITY; MORPHOLOGICAL CHANGE; PSEUDORASBORA-PARVA; TEMPORAL DIMENSION; LARGEMOUTH BASS; HATCH DATE; 1ST WINTER	Of the non-native fishes introduced to the U.K., the pumpkinseed is one of six species predicted to benefit from the forecasted climate warming conditions. To demonstrate the potential response of adults and their progeny to a water temperature increase, investigations of parental pumpkinseed acclimatization, reproduction and YOY over-wintering were carried out in outdoor experimental ponds under ambient and elevated water temperature regimes. No temperature effects were observed on either adult survivorship and growth, and none of the assessed reproductive activity variables (total spawning time, spawning season length, number of spawning bouts) appeared to be responsible for the large differences observed in progeny number and biomass. However, it was demonstrated in a previous study [Zieba G. et al., 2010] that adults in the heated ponds began spawning earlier than those of the ambient ponds. Ambient ponds produced 2.8x more progeny than the heated ponds, but these progeny were significantly smaller, probably due to their late hatching date, and subsequently suffered very high mortality over the first winter. Pumpkinseed in the U.K. will clearly benefit from climate warming through earlier seasonal reproduction, resulting in larger progeny going into winter, and as a result, higher over-winter survivorship would be expected relative to that which occurs under the present climatic regime.	[Zieba, Grzegorz; Copp, Gordon H.] Ctr Environm Fisheries & Aquaculture Sci, Salmon & Freshwater Team, Lowestoft, Suffolk, England; [Fox, Michael G.; Copp, Gordon H.] Trent Univ, Environm & Resource Studies Program, Peterborough, ON K9J 7B8, Canada; [Fox, Michael G.; Copp, Gordon H.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Copp, Gordon H.] Bournemouth Univ, Ctr Conservat Ecol & Environm Sci, Poole BH12 5BB, Dorset, England	Centre for Environment Fisheries & Aquaculture Science; Trent University; Trent University; Bournemouth University	Copp, GH (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Salmon & Freshwater Team, Lowestoft, Suffolk, England.	gordon.copp@cefas.co.uk		Zieba, Grzegorz/0000-0003-4443-6802	NATO Science Programme 'Collaborative Linkage Grant'; Marie Curie post-doctoral fellowship; National Science Centre, Poland [DEC-2011/01/D/NZ8/01807]; UK Department of Environment, Food & Rural Affairs (Defra); Defra; National Science and Engineering Research Council of Canada Discovery Grant	NATO Science Programme 'Collaborative Linkage Grant'; Marie Curie post-doctoral fellowship(European Commission); National Science Centre, Poland(National Science Centre, Poland); UK Department of Environment, Food & Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); National Science and Engineering Research Council of Canada Discovery Grant	This study, which is a product of an international network initiated under a NATO Science Programme 'Collaborative Linkage Grant' awarded to GHC, was funded jointly by a Marie Curie post-doctoral fellowship and National Science Centre, Poland, decision No DEC-2011/01/D/NZ8/01807 (to GZ) and the UK Department of Environment, Food & Rural Affairs (Defra). The participation of MGF was co-funded by Defra and a National Science and Engineering Research Council of Canada Discovery Grant.	Almeida D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088038; ANDERSON J T, 1988, Journal of Northwest Atlantic Fishery Science, V8, P55; Bashey F, 2006, EVOLUTION, V60, P348, DOI 10.1554/05-087.1; Bernard Gerry, 1997, North American Journal of Fisheries Management, V17, P581, DOI 10.1577/1548-8675(1997)017<0581:EOBSAP>2.3.CO;2; Britton JR, 2010, FRESHWATER BIOL, V55, P1130, DOI 10.1111/j.1365-2427.2010.02396.x; Britton JR, 2009, ECOL FRESHW FISH, V18, P8, DOI 10.1111/j.1600-0633.2008.00334.x; BROCKELMAN WY, 1975, AM NAT, V109, P677, DOI 10.1086/283037; Cargnelli LM, 1996, CAN J FISH AQUAT SCI, V53, P360, DOI 10.1139/cjfas-53-2-360; COPP GH, 1988, J FRESHWATER ECOL, V4, P419, DOI 10.1080/02705060.1988.9665193; Copp GH, 2002, ARCH HYDROBIOL, V155, P585; COPP GH, 1990, J FISH BIOL, V36, P803, DOI 10.1111/j.1095-8649.1990.tb05629.x; Copp GH, 2010, AM FISH S S, V73, P347; Copp Gordon H., 2007, V2, P289; Cucherousset J, 2009, BIOL INVASIONS, V11, P2171, DOI 10.1007/s10530-009-9493-5; DANYLCHUK AJ, 1994, ENVIRON BIOL FISH, V39, P119, DOI 10.1007/BF00004929; Dembski S, 2006, J FISH BIOL, V69, P331, DOI 10.1111/j.1095-8649.2006.01087.x; Dhillon RS, 2004, COPEIA, P37, DOI 10.1643/CI-02-098R1; Divino JN, 2007, ECOL FRESHW FISH, V16, P165, DOI 10.1111/j.1600-0633.2006.00208.x; EVANS DO, 1984, T AM FISH SOC, V113, P494, DOI 10.1577/1548-8659(1984)113&lt;494:TIOTAC&gt;2.0.CO;2; Fobert E, 2011, J FISH BIOL, V79, P1592, DOI 10.1111/j.1095-8649.2011.03083.x; Fobert E, 2013, ECOL FRESHW FISH, V22, P106, DOI 10.1111/eff.12008; Fox MG, 2007, J FISH BIOL, V71, P56, DOI 10.1111/j.1095-8649.2007.01683.x; Fox MG, 2001, ARCH HYDROBIOL, V150, P561; FOX MG, 1991, CAN J FISH AQUAT SCI, V48, P1792, DOI 10.1139/f91-211; Fox MG, 2014, OECOLOGIA, V174, P435, DOI 10.1007/s00442-013-2776-7; Garvey JE, 2002, ECOL APPL, V12, P194, DOI 10.1890/1051-0761(2002)012[0194:PRISTT]2.0.CO;2; Houde ED, 1997, J FISH BIOL, V51, P52, DOI 10.1111/j.1095-8649.1997.tb06093.x; Hulme M., 2002, CLIMATE CHANGE SCENA; Jenkins GJ, 2009, UK CLIMATE PROJECTIO; Jobling M, 1995, REPROD ENV FISH PHYS; Johnson TB, 1996, T AM FISH SOC, V125, P466, DOI 10.1577/1548-8659(1996)125<0466:NTCOOS>2.3.CO;2; Jorgensen C, 2011, AM NAT, V177, pE119, DOI 10.1086/659622; KEAST A, 1968, J FISH RES BOARD CAN, V25, P1199, DOI 10.1139/f68-105; Li YM, 2014, GLOBAL ECOL BIOGEOGR, V23, P1094, DOI 10.1111/geb.12191; LIBOSVARSKY J, 1990, FOLIA ZOOL, V39, P355; Ludsin SA, 1997, ECOL APPL, V7, P1024; Masson G, 2015, RIVER RES APPL, V31, P563, DOI 10.1002/rra.2761; MCGURK MD, 1986, MAR ECOL PROG SER, V34, P227, DOI 10.3354/meps034227; MILLER SJ, 1982, T AM FISH SOC, V111, P527, DOI 10.1577/1548-8659(1982)111<527:DGRIOO>2.0.CO;2; Moran R, 2010, FRESHWATER BIOL, V55, P315, DOI 10.1111/j.1365-2427.2009.02276.x; Murphy SC, 2012, J GREAT LAKES RES, V38, P404, DOI 10.1016/j.jglr.2012.06.004; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Persson L, 2004, ECOL MONOGR, V74, P135, DOI 10.1890/02-4092; PERSSON L, 1995, ECOLOGY, V76, P70, DOI 10.2307/1940632; POST JR, 1989, CAN J FISH AQUAT SCI, V46, P1958, DOI 10.1139/f89-246; POST JR, 1987, CAN J FISH AQUAT SCI, V44, P1840, DOI 10.1139/f87-228; Rogers MW, 2009, T AM FISH SOC, V138, P23, DOI 10.1577/T07-178.1; SARGENT RC, 1987, AM NAT, V129, P32, DOI 10.1086/284621; SHUTER BJ, 1980, T AM FISH SOC, V109, P1, DOI 10.1577/1548-8659(1980)109&lt;1:SSOTEO&gt;2.0.CO;2; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; SMITH RW, 1994, T AM FISH SOC, V123, P747, DOI 10.1577/1548-8659(1994)123<0747:SORTDT>2.3.CO;2; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stakenas S, 2009, ECOL FRESHW FISH, V18, P167, DOI 10.1111/j.1600-0633.2008.00339.x; Stakenas S, 2013, ECOL FRESHW FISH, V22, P202, DOI 10.1111/eff.12015; Tomecek Jozef, 2007, V2, P307; TONEYS ML, 1979, T AM FISH SOC, V108, P415, DOI 10.1577/1548-8659(1979)108<415:SFWMOF>2.0.CO;2; UNEP, 2004, ENV ALERT B, V2, P1, DOI DOI 10.1017/S0147547903000218; Vilizzi L, 2012, FISHERIES MANAG ECOL, V19, P93, DOI 10.1111/j.1365-2400.2011.00823.x; WARE DM, 1975, J FISH RES BOARD CAN, V32, P2503, DOI 10.1139/f75-288; Whitledge GW, 2002, J FRESHWATER ECOL, V17, P353, DOI 10.1080/02705060.2002.9663908; Williams P, 2004, BIOL CONSERV, V115, P329, DOI 10.1016/S0006-3207(03)00153-8; Yavno S, 2013, J EVOLUTION BIOL, V26, P2383, DOI 10.1111/jeb.12230; Yavno S, 2014, NATURWISSENSCHAFTEN, V101, P479, DOI 10.1007/s00114-014-1177-z; Yavno S, 2013, ENVIRON BIOL FISH, V96, P507, DOI 10.1007/s10641-012-0053-y; Zieba G, 2010, J FISH BIOL, V77, P1850, DOI 10.1111/j.1095-8649.2010.02778.x	65	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135482	10.1371/journal.pone.0135482	http://dx.doi.org/10.1371/journal.pone.0135482			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302021	Green Submitted, gold, Green Published			2022-12-27	WOS:000359951900021
J	Bellettiere, J; Carlson, JA; Rosenberg, D; Singhania, A; Natarajan, L; Berardi, V; LaCroix, AZ; Sears, DD; Moran, K; Crist, K; Kerr, J				Bellettiere, John; Carlson, Jordan A.; Rosenberg, Dori; Singhania, Anant; Natarajan, Loki; Berardi, Vincent; LaCroix, Andrea Z.; Sears, Dorothy D.; Moran, Kevin; Crist, Katie; Kerr, Jacqueline			Gender and Age Differences in Hourly and Daily Patterns of Sedentary Time in Older Adults Living in Retirement Communities	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; BEHAVIOR; ASSOCIATION; BREAKING; HEALTH	Background Total sedentary time varies across population groups with important health consequences. Patterns of sedentary time accumulation may vary and have differential health risks. The purpose of this study is to describe sedentary patterns of older adults living in retirement communities and illustrate gender and age differences in those patterns. Methods Baseline accelerometer data from 307 men and women (mean age = 84 +/- 6 years) who wore ActiGraph GT3X+ accelerometers for >= 4 days as part of a physical activity intervention were classified into bouts of sedentary time (<100 counts per minute). Linear mixed models were used to account for intra-person and site-level clustering. Daily and hourly summaries were examined in mutually non-exclusive bouts of sedentary time that were 1+, 5+, 10+, 20 +, 30+, 40+, 50+, 60+, 90+ and 120+ minutes in duration. Variations by time of day, age and gender were explored. Results Men accumulated more sedentary time than women in 1+, 5+, 10+, 20+, 30+, 40+, 50+ and 60+ minute bouts; the largest gender-differences were observed in 10+ and 20+ minute bouts. Age was positively associated with sedentary time, but only in bouts of 10+, 20+, 30 +, and 40+ minutes. Women had more daily 1+ minute sedentary bouts than men (71.8 vs. 65.2), indicating they break up sedentary time more often. For men and women, a greater proportion of time was spent being sedentary during later hours of the day than earlier. Gender differences in intra-day sedentary time were observed during morning hours with women accumulating less sedentary time overall and having more 1+ minute bouts. Conclusions Patterns identified using bouts of sedentary time revealed gender and age differences in the way in which sedentary time was accumulated by older adults in retirement communities. Awareness of these patterns can help interventionists better target sedentary time and may aid in the identification of health risks associated with sedentary behavior. Future studies should investigate the impact of patterns of sedentary time on healthy aging, disease, and mortality.	[Bellettiere, John] Univ Calif San Diego, San Diego Joint Doctoral Program Publ Hlth Epidem, San Diego State Univ, La Jolla, CA 92093 USA; [Bellettiere, John; Berardi, Vincent] San Diego State Univ, Grad Sch Publ Hlth, Ctr Behav Epidemiol & Community Hlth, San Diego, CA 92182 USA; [Carlson, Jordan A.] Childrens Mercy Hosp, Ctr Childrens Hlth Lifestyles & Nutr, Kansas City, MO 64108 USA; [Rosenberg, Dori] Univ Washington, Dept Hlth Serv, Sch Publ Hlth, Seattle, WA 98195 USA; [Singhania, Anant; Natarajan, Loki; LaCroix, Andrea Z.; Sears, Dorothy D.; Moran, Kevin; Crist, Katie; Kerr, Jacqueline] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Berardi, Vincent] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA	California State University System; San Diego State University; University of California System; University of California San Diego; California State University System; San Diego State University; Children's Mercy Hospital; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; California State University System; San Diego State University	Bellettiere, J (corresponding author), Univ Calif San Diego, San Diego Joint Doctoral Program Publ Hlth Epidem, San Diego State Univ, La Jolla, CA 92093 USA.	jbellettiere@ucsd.edu	Sears, Dorothy D/AHE-5524-2022; Bellettiere, John/AAC-6092-2020	Sears, Dorothy D/0000-0002-9260-3540; Bellettiere, John/0000-0002-7167-3048	National Heart, Lung, and Blood Institute [R01HL098425]; NIH grant [T32 HL79891]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098425, T32HL079891, K23HL119352] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the National Heart, Lung, and Blood Institute, R01HL098425. Funding was received by JK. Dr. Carlson was funded by NIH grant T32 HL79891. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Rheumatology, PRACT MAN; Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Chastin SFM, 2010, GAIT POSTURE, V31, P82, DOI 10.1016/j.gaitpost.2009.09.002; Chief Medical Officers of England, 2011, START ACTIVE STAY AC; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Davis MG, 2014, J AGING PHYS ACTIV, V22, P474, DOI [10.1123/japa.2013-0042, 10.1123/JAPA.2013-0042]; Duncan C, 1998, SOC SCI MED, V46, P97, DOI 10.1016/S0277-9536(97)00148-2; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Ellis K, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00036; Evenson KR, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110109; Ford ES, 2012, INT J EPIDEMIOL, V41, P1338, DOI 10.1093/ije/dys078; Gennuso KP, 2013, MED SCI SPORT EXER, V45, P1493, DOI 10.1249/MSS.0b013e318288a1e5; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hovell M, 2009, EMERGING THEORIES HL, P415; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; Jefferis Barbara J, 2015, Br J Sports Med, V49, P1591, DOI 10.1136/bjsports-2014-093514; Kang KH, 2004, J APPL GERONTOL, V23, P457, DOI 10.1177/0733464804271275; Kerr J, 2013, AM J PREV MED, V44, P290, DOI 10.1016/j.amepre.2012.11.004; Kerr J, 2012, CONTEMP CLIN TRIALS, V33, P1180, DOI 10.1016/j.cct.2012.08.005; Lee IM, 2014, BRIT J SPORT MED, V48, P197, DOI 10.1136/bjsports-2013-093154; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; Peddie MC, 2013, AM J CLIN NUTR, V98, P358, DOI 10.3945/ajcn.112.051763; Reid N, 2013, INT J ENV RES PUB HE, V10, P6783, DOI 10.3390/ijerph10126783; Rosenberg DE, 2015, MED SCI SPORT EXER, V47, P1311, DOI 10.1249/MSS.0000000000000520; Sardinha LB, 2015, J GERONTOL A-BIOL, V70, P119, DOI 10.1093/gerona/glu193; Shiroma EJ, 2013, JAMA-J AM MED ASSOC, V310, P2562, DOI 10.1001/jama.2013.278896; Stephens SK, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093524; Thorp A, 2009, STAND AUSTR SEDENTAR; U.S. Department of Labor Bureau of Labor, 2014, AM TIM US SURV 2013; Werner Carrie A., 2011, C2010BR09 US CENS BU; Wert DM, 2010, J GERIATR PHYS THER, V33, P41, DOI 10.1097/JPT.0b013e3181d07aee; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Zarem, 2010, TODAYS CONTINUING CA	36	52	51	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136161	10.1371/journal.pone.0136161	http://dx.doi.org/10.1371/journal.pone.0136161			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26296095	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900077
J	Brydegaard, M				Brydegaard, Mikkel			Towards Quantitative Optical Cross Sections in Entomological Laser Radar - Potential of Temporal and Spherical Parameterizations for Identifying Atmospheric Fauna	PLOS ONE			English	Article							IRIDESCENCE; FLIGHT; AGE	In recent years, the field of remote sensing of birds and insects in the atmosphere (the aerial fauna) has advanced considerably, and modern electro-optic methods now allow the assessment of the abundance and fluxes of pests and beneficials on a landscape scale. These techniques have the potential to significantly increase our understanding of, and ability to quantify and manage, the ecological environment. This paper presents a concept whereby laser radar observations of atmospheric fauna can be parameterized and table values for absolute cross sections can be catalogued to allow for the study of focal species such as disease vectors and pests. Wing-beat oscillations are parameterized with a discrete set of harmonics and the spherical scatter function is parameterized by a reduced set of symmetrical spherical harmonics. A first order spherical model for insect scatter is presented and supported experimentally, showing angular dependence of wing beat harmonic content. The presented method promises to give insights into the flight heading directions of species in the atmosphere and has the potential to shed light onto the km-range spread of pests and disease vectors.	[Brydegaard, Mikkel] Lund Univ, Dept Phys, Lund Laser Ctr, SE-22362 Lund, Sweden; [Brydegaard, Mikkel] Lund Univ, Dept Biol, Ctr Anim Movement Res, SE-22362 Lund, Sweden; [Brydegaard, Mikkel] Norsk Elektro Opt AS, Hyspex, N-2019 Skedsmokorset, Norway	Lund University; Lund University	Brydegaard, M (corresponding author), Lund Univ, Dept Phys, Lund Laser Ctr, Solvegatan 14, SE-22362 Lund, Sweden.	mikkel.brydegaard@fysik.lth.se			Swedish Research Council through Linnaeus grants; Lund Laser Centre	Swedish Research Council through Linnaeus grants; Lund Laser Centre	The continuous support from Ernst van Groningen, International Science Program, Uppsala, is greatly appreciated. Hyperspectral imaging was performed with Hyspex push broom cameras, kindly provided by Norsk Elektro Optikk A/S. This project also received funding from the Swedish Research Council through Linnaeus grants to the Centre for Animal Movement Research and the Lund Laser Centre. Mikkel Brydegaard is employed part time by Norsk Elektro Optikk AS and part time by Lund University. The specific roles of the author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ACM SIGKDD INT C KNO; Brydegaard M, 2012, THESIS TRYCKERIET E; Brydegaard M, 2015, ILRC NEW YORK US, V27; Brydegaard M, 2014, ADVANTAGES SHORTWAVE; Brydegaard M., 2015, APPL SPECTR IN PRESS; Brydegaard M., 2015, SPIE, DOI [10.1117/2.1201506.005977, DOI 10.1117/2.1201506.005977]; Brydegaard M, 2014, PROG ELECTROMAGN RES, V147, P141, DOI 10.2528/PIER14101001; Brydegaard M, 2013, APPL SPECTROSC, V67, P477, DOI 10.1366/12-06860; Chapman JW, 2012, P NATL ACAD SCI USA, V109, P14924, DOI 10.1073/pnas.1207255109; Combes SA, 2012, J EXP BIOL, V215, P903, DOI 10.1242/jeb.059394; Drake V. J, 2012, LIPOIC ACID; Eagles D, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-135; Fujii T., 2005, LASER REMOTE SENSING; Gauthreaux SA, 2003, AUK, V120, P266, DOI 10.1642/0004-8038(2003)120[0266:ROABC]2.0.CO;2; Gebru A, 2014, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083503; Grafarend E.W., 2012, APPL LINEAR NONLINEA, DOI 10.1080/14498596.2013.815147; Guan Z., 2010, APPL OPTICS, V49, P1; Hoffman DS, 2007, APPL OPTICS, V46, P3007, DOI 10.1364/AO.46.003007; Hooper W. P., 2010, J APPL REMOTE SENS, V4, P4; Kissling WD, 2014, BIOL REV, V89, P511, DOI 10.1111/brv.12065; Kjellman J, 2015, THESIS LUND U; Koul O, 2008, AREAWIDE PEST MANAGEMENT: THEORY AND IMPLEMENTATION, P560, DOI 10.1079/9781845933722.0560; Malmqvist E, 2015, INT LAS RAD C NYC US, V27; Mayagaya VS, 2009, AM J TROP MED HYG, V81, P622, DOI 10.4269/ajtmh.2009.09-0192; Moore A, 2002, ANN ENTOMOL SOC AM, V95, P1, DOI 10.1603/0013-8746(2002)095[0001:AIOOSA]2.0.CO;2; Muirhead-Thomson RC., 1991, TRAP RESPONSES FLYIN, V1st edn, DOI DOI 10.1007/s13355-015-0390-3; NATO, 2010, LAS BAS STAND OFF DE; Ovaskainen O, 2008, P NATL ACAD SCI USA, V105, P19090, DOI 10.1073/pnas.0802066105; Peiris K., 2014, AM J AGR SCI TECHNOL, V2, P49, DOI [10.7726/ajast.2014.1006, DOI 10.7726/AJAST.2014.1006]; Price P.W., 2011, INSECT ECOLOGY BEHAV; Reed SC, 1941, FREQUENCY WING BEAT; Reynolds DR, 1996, MED VET ENTOMOL, V10, P185, DOI 10.1111/j.1365-2915.1996.tb00727.x; Runemark A, 2012, IEEE J SEL TOP QUANT, V18, P1573, DOI 10.1109/JSTQE.2012.2184528; Sharma V, 2009, SCIENCE, V325, P449, DOI 10.1126/science.1172051; Shaw JA, 2005, OPT EXPRESS, V13, P5853, DOI 10.1364/OPEX.13.005853; Shevtsova E, 2011, P NATL ACAD SCI USA, V108, P668, DOI 10.1073/pnas.1017393108; Svensson EI, 2010, EVOLUTION, V64, P3101, DOI 10.1111/j.1558-5646.2010.01085.x; Torok S., 2013, THESIS LUND U	38	39	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135231	10.1371/journal.pone.0135231	http://dx.doi.org/10.1371/journal.pone.0135231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295706	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900020
J	Feber, RE; Johnson, PJ; Bell, JR; Chamberlain, DE; Firbank, LG; Fuller, RJ; Manley, W; Mathews, F; Norton, LR; Townsend, M; Macdonald, DW				Feber, Ruth E.; Johnson, Paul J.; Bell, James R.; Chamberlain, Dan E.; Firbank, Leslie G.; Fuller, Robert J.; Manley, Will; Mathews, Fiona; Norton, Lisa R.; Townsend, Martin; Macdonald, David W.			Organic Farming: Biodiversity Impacts Can Depend on Dispersal Characteristics and Landscape Context	PLOS ONE			English	Article							CARABID BEETLES COLEOPTERA; LAND-USE INTENSITY; AGRICULTURAL INTENSIFICATION; FARMLAND BIODIVERSITY; SPECIES RICHNESS; ARABLE FIELDS; SPIDERS; DIVERSITY; MANAGEMENT; ABUNDANCE	Organic farming, a low intensity system, may offer benefits for a range of taxa, but what affects the extent of those benefits is imperfectly understood. We explored the effects of organic farming and landscape on the activity density and species density of spiders and carabid beetles, using a large sample of paired organic and conventional farms in the UK. Spider activity density and species density were influenced by both farming system and surrounding landscape. Hunting spiders, which tend to have lower dispersal capabilities, had higher activity density, and more species were captured, on organic compared to conventional farms. There was also evidence for an interaction, as the farming system effect was particularly marked in the cropped area before harvest and was more pronounced in complex landscapes (those with little arable land). There was no evidence for any effect of farming system or landscape on web-building spiders (which include the linyphiids, many of which have high dispersal capabilities). For carabid beetles, the farming system effects were inconsistent. Before harvest, higher activity densities were observed in the crops on organic farms compared with conventional farms. After harvest, no difference was detected in the cropped area, but more carabids were captured on conventional compared to organic boundaries. Carabids were more species-dense in complex landscapes, and farming system did not affect this. There was little evidence that non-cropped habitat differences explained the farming system effects for either spiders or carabid beetles. For spiders, the farming system effects in the cropped area were probably largely attributable to differences in crop management; reduced inputs of pesticides (herbicides and insecticides) and fertilisers are possible influences, and there was some evidence for an effect of non-crop plant species richness on hunting spider activity density. The benefits of organic farming may be greatest for taxa with lower dispersal abilities generally. The evidence for interactions among landscape and farming system in their effects on spiders highlights the importance of developing strategies for managing farmland at the landscape-scale for most effective conservation of biodiversity.	[Feber, Ruth E.; Johnson, Paul J.; Bell, James R.; Townsend, Martin; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Tubney, England; [Chamberlain, Dan E.; Fuller, Robert J.] British Trust Ornithol, Thetford, Norfolk, England; [Firbank, Leslie G.; Norton, Lisa R.] Lancaster Environm Ctr, Ctr Ecol & Hydrol, Lancaster, Lancs, England; [Manley, Will] Royal Agr Univ, Cirencester, Glos, England	University of Oxford; British Trust for Ornithology; Lancaster University; UK Centre for Ecology & Hydrology (UKCEH)	Feber, RE (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Tubney, England.	ruth.feber@zoo.ox.ac.uk	Norton, Lisa/I-8778-2012; Bell, James/C-2247-2009; Chamberlain, Dan/K-1809-2015	Bell, James/0000-0003-1640-6120; Firbank, Leslie/0000-0003-1242-8293; Chamberlain, Dan/0000-0002-5381-2024	Department of Environment, Food and Rural Affairs (Defra), UK [OF0165]; BBSRC [BBS/E/C/00005195] Funding Source: UKRI; NERC [ceh020002, ceh020009] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005195] Funding Source: researchfish; Natural Environment Research Council [ceh020009, ceh020002] Funding Source: researchfish	Department of Environment, Food and Rural Affairs (Defra), UK(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The project was funded by the Department of Environment, Food and Rural Affairs (Defra), UK: Grant number OF0165. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D. R., 2008, MODEL BASED INFERENC; [Anonymous], 2013, FACTS FIGURES ORGANI; [Anonymous], 2014, R LANG ENV STAT COMP; Barton K., 2014, MUMIN MULTIMODEL INF; Batary P, 2008, BIOL CONSERV, V141, P2062, DOI 10.1016/j.biocon.2008.06.002; Batary P, 2012, AGR ECOSYST ENVIRON, V146, P130, DOI 10.1016/j.agee.2011.10.018; Bell JR, 2005, B ENTOMOL RES, V95, P69, DOI 10.1079/BER2004350; Bengtsson J, 2005, J APPL ECOL, V42, P261, DOI 10.1111/j.1365-2664.2005.01005.x; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Birkhofer K, 2014, BIOL CONSERV, V175, P25, DOI 10.1016/j.biocon.2014.04.014; Brooks DR, 2012, J APPL ECOL, V49, P1009, DOI 10.1111/j.1365-2664.2012.02194.x; Brooks DR, 2012, J ANIM ECOL, V81, P4, DOI 10.1111/j.1365-2656.2011.01897.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Carvalheiro LG, 2013, ECOL LETT, V16, P870, DOI 10.1111/ele.12121; Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x; Clothier L, 2008, AGR SPECIALISATION; Clough Y, 2007, J APPL ECOL, V44, P22, DOI 10.1111/j.1365-2664.2006.01239.x; Cole LJ, 2012, J APPL ECOL, V49, P1384, DOI 10.1111/j.1365-2664.2012.02200.x; Dauber J, 2005, GLOBAL ECOL BIOGEOGR, V14, P213, DOI 10.1111/j.1466-822x.2005.00150.x; Donald PF, 2006, AGR ECOSYST ENVIRON, V116, P189, DOI 10.1016/j.agee.2006.02.007; Drapela T, 2008, ECOGRAPHY, V31, P254, DOI 10.1111/j.0906-7590.2008.5250.x; European Environment Agency (EEA), 2013, 112013 EEA; Firbank LG, 2003, J ENVIRON MANAGE, V67, P207, DOI 10.1016/S0301-4797(02)00174-3; Fuller RJ, 2005, BIOL LETTERS, V1, P431, DOI 10.1098/rsbl.2005.0357; FULLER RM, 1987, BIOL CONSERV, V40, P281, DOI 10.1016/0006-3207(87)90121-2; Fuller RM, 2002, CARTOGR J, V39, P15; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Greig-Smith P. W., 1991, PESTICIDES CEREAL FA; Gutierrez D, 1997, J BIOGEOGR, V24, P903, DOI 10.1046/j.1365-2699.1997.00144.x; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Hodgson JA, 2010, ECOL LETT, V13, P1358, DOI 10.1111/j.1461-0248.2010.01528.x; Hole DG, 2005, BIOL CONSERV, V122, P113, DOI 10.1016/j.biocon.2004.07.018; Holland JM, 2005, J APPL ECOL, V42, P1140, DOI 10.1111/j.1365-2664.2005.01083.x; Howard DC, 1996, ENVIRON MONIT ASSESS, V39, P373, DOI 10.1007/BF00396156; Jonason D, 2013, LANDSCAPE ECOL, V28, P487, DOI 10.1007/s10980-013-9848-2; Kleijn D, 2009, P R SOC B, V276, P903, DOI 10.1098/rspb.2008.1509; Kohler HR, 2013, SCIENCE, V341, P759, DOI 10.1126/science.1237591; Lang A, 1999, AGR ECOSYST ENVIRON, V72, P189, DOI 10.1016/S0167-8809(98)00186-8; LINDROTH CH, 1974, HDB IDENTIFICATION 2, V4; LUCZAK J, 1979, Polish Ecological Studies, V5, P151; Norton L, 2009, AGR ECOSYST ENVIRON, V129, P221, DOI 10.1016/j.agee.2008.09.002; Oberg S, 2007, AGR ECOSYST ENVIRON, V122, P211, DOI 10.1016/j.agee.2006.12.034; Oberg S, 2009, BASIC APPL ECOL, V10, P614, DOI 10.1016/j.baae.2009.03.005; Oberg S, 2008, AGR ECOSYST ENVIRON, V123, P211, DOI 10.1016/j.agee.2007.06.005; Pe'er G, 2014, SCIENCE, V344, P1090, DOI 10.1126/science.1253425; Purtauf T, 2005, AGR ECOSYST ENVIRON, V108, P165, DOI 10.1016/j.agee.2005.01.005; Pywell RF, 2005, BIOL CONSERV, V123, P79, DOI 10.1016/j.biocon.2004.10.010; Roberts M.J., 1993, SPIDERS GREAT BRIT 1; Roschewitz I, 2005, J APPL ECOL, V42, P873, DOI 10.1111/j.1365-2664.2005.01072.x; Rundlof M, 2006, J APPL ECOL, V43, P1121, DOI 10.1111/j.1365-2664.2006.01233.x; Rusch A, 2013, AGR ECOSYST ENVIRON, V176, P63, DOI 10.1016/j.agee.2013.05.014; Samu F, 2002, J ARACHNOL, V30, P389, DOI 10.1636/0161-8202(2002)030[0389:OTNOAS]2.0.CO;2; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schmidt MH, 2008, J BIOGEOGR, V35, P157, DOI 10.1111/j.1365-2699.2007.01774.x; Schmidt MH, 2005, J APPL ECOL, V42, P281, DOI 10.1111/j.1365-2664.2005.01014.x; Schmidt MH, 2005, J BIOGEOGR, V32, P467, DOI 10.1111/j.1365-2699.2004.01244.x; Schnell M, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms5151, 10.1038/ncomms4499]; Schroter L, 2013, AGR ECOSYST ENVIRON, V164, P176, DOI 10.1016/j.agee.2012.09.018; Shah PA, 2003, AGR FOREST ENTOMOL, V5, P51, DOI 10.1046/j.1461-9563.2003.00162.x; Storkey J, 2012, P ROY SOC B-BIOL SCI, V279, P1421, DOI 10.1098/rspb.2011.1686; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; TOPPING CJ, 1992, J APPL ECOL, V29, P485, DOI 10.2307/2404516; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Tuck SL, 2014, J APPL ECOL, V51, P746, DOI 10.1111/1365-2664.12219; Uetz GW, 1999, J ARACHNOL, V27, P270; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; Weibull AC, 2003, BIODIVERS CONSERV, V12, P1335, DOI 10.1023/A:1023617117780; Winqvist C, 2011, J APPL ECOL, V48, P570, DOI 10.1111/j.1365-2664.2010.01950.x	70	21	21	6	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135921	10.1371/journal.pone.0135921	http://dx.doi.org/10.1371/journal.pone.0135921			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309040	Green Published, gold, Green Accepted			2022-12-27	WOS:000360069400081
J	Li, HB; Xu, DK; Li, YC; Feng, H; Liu, ZY; Li, XG; Gu, TY; Yang, K				Li, Huabing; Xu, Dake; Li, Yingchao; Feng, Hao; Liu, Zhiyong; Li, Xiaogang; Gu, Tingyue; Yang, Ke			Extracellular Electron Transfer Is a Bottleneck in the Microbiologically Influenced Corrosion of C1018 Carbon Steel by the Biofilm of Sulfate-Reducing Bacterium Desulfovibrio vulgaris	PLOS ONE			English	Article							BIOCIDE COCKTAIL; MITIGATION; BIOCORROSION; PIPELINE; EDDS	Carbon steels are widely used in the oil and gas industry from downhole tubing to transport trunk lines. Microbes form biofilms, some of which cause the so-called microbiologically influenced corrosion (MIC) of carbon steels. MIC by sulfate reducing bacteria (SRB) is often a leading cause in MIC failures. Electrogenic SRB sessile cells harvest extracellular electrons from elemental iron oxidation for energy production in their metabolism. A previous study suggested that electron mediators riboflavin and flavin adenine dinucleotide (FAD) both accelerated the MIC of 304 stainless steel by the Desulfovibrio vulgaris biofilm that is a corrosive SRB biofilm. Compared with stainless steels, carbon steels are usually far more prone to SRB attacks because SRB biofilms form much denser biofilms on carbon steel surfaces with a sessile cell density that is two orders of magnitude higher. In this work, C1018 carbon steel coupons were used in tests of MIC by D. vulgaris with and without an electron mediator. Experimental weight loss and pit depth data conclusively confirmed that both riboflavin and FAD were able to accelerate D. vulgaris attack against the carbon steel considerably. It has important implications in MIC failure analysis and MIC mitigation in the oil and gas industry.	[Li, Huabing; Feng, Hao] Northeast Univ, Sch Met & Mat, Shenyang, Liaoning, Peoples R China; [Xu, Dake; Yang, Ke] Chinese Acad Sci, Inst Met Res, Shenyang 110016, Liaoning, Peoples R China; [Li, Yingchao; Gu, Tingyue] Ohio Univ, Dept Chem & Biomol Engn, Inst Corros & Multiphase Technol, Athens, OH 45701 USA; [Liu, Zhiyong; Li, Xiaogang] Univ Sci & Technol Beijing, Ctr Corros & Protect, Beijing 100083, Peoples R China	Northeastern University - China; Chinese Academy of Sciences; Institute of Metal Research, CAS; University System of Ohio; Ohio University; University of Science & Technology Beijing	Xu, DK (corresponding author), Chinese Acad Sci, Inst Met Res, Shenyang 110016, Liaoning, Peoples R China.	xudake@imr.ac.cn; gu@ohio.edu		xu, dake/0000-0003-0931-7189; Li, Xiaogang/0000-0001-9255-7559	National Basic Research Program of China (973 Program) [2014CB643300]; National Environmental Corrosion Platform (NECP); "Young Merit Scholars" program by the Institute of Metal Research, Chinese Academy of Sciences	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Environmental Corrosion Platform (NECP); "Young Merit Scholars" program by the Institute of Metal Research, Chinese Academy of Sciences	This work was financially supported by the National Basic Research Program of China (973 Program project, No. 2014CB643300), the National Environmental Corrosion Platform (NECP) and the "Young Merit Scholars" program by the Institute of Metal Research, Chinese Academy of Sciences.	[Anonymous], 2012, J MICROBIAL BIOCH TE, DOI [10.4172/1948-5948.1000e107, DOI 10.4172/1948-5948.1000E107]; Bhat S, 2011, MATER PERFORMANCE, V50, P50; Du ZW, 2007, BIOTECHNOL ADV, V25, P464, DOI 10.1016/j.biotechadv.2007.05.004; Fu WJ, 2014, MATER PERFORMANCE, V53, P66; Gu T, CORROSION 2009; Gu T, 2013, NACE CORR ORL FL US; Hernandez ME, 2001, CELL MOL LIFE SCI, V58, P1562, DOI 10.1007/PL00000796; Jacobson GA, 2007, MATER PERFORMANCE, V46, P26; Martin-Gil J, 2004, ANTON LEEUW INT J G, V86, P283, DOI 10.1023/B:ANTO.0000047939.49597.eb; McLeod ES, 2002, WATER SA, V28, P123; Sherar BWA, 2011, CORROS SCI, V53, P955, DOI 10.1016/j.corsci.2010.11.027; Venzlaff H, 2013, CORROS SCI, V66, P88, DOI 10.1016/j.corsci.2012.09.006; Videla HA, 2002, INT BIODETER BIODEGR, V49, P259, DOI 10.1016/S0964-8305(02)00053-7; von Canstein H, 2008, APPL ENVIRON MICROB, V74, P615, DOI 10.1128/AEM.01387-07; Wang QZ, 2011, BIORESOURCE TECHNOL, V102, P8152, DOI 10.1016/j.biortech.2011.06.003; Xu D, 2014, MATER CORROS, V65, P837, DOI 10.1002/maco.201206894; Xu D, 2013, ENG FAIL ANAL, V28, P149, DOI 10.1016/j.engfailanal.2012.10.006; Xu D, 2012, CORROSION-US, V68, DOI 10.5006/0605; Xu D, 2012, WORLD J MICROB BIOT, V28, P3067, DOI 10.1007/s11274-012-1116-0; Xu D, 2012, WORLD J MICROB BIOT, V28, P1641, DOI 10.1007/s11274-011-0970-5; Xu D, 2014, INT BIODETER BIODEGR, V91, P74, DOI 10.1016/j.ibiod.2014.03.014; Xu DK, 2013, CORROS SCI, V77, P385, DOI 10.1016/j.corsci.2013.07.044; Zhang PY, 2015, BIOELECTROCHEMISTRY, V101, P14, DOI 10.1016/j.bioelechem.2014.06.010	23	37	40	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136183	10.1371/journal.pone.0136183	http://dx.doi.org/10.1371/journal.pone.0136183			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308855	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400092
J	Mu, WY; Wang, XF; Zhang, XL; Zhu, SD; Sun, DG; Ka, WB; Sung, LA; Yao, WJ				Mu, Weiyun; Wang, Xifu; Zhang, Xiaolan; Zhu, Sida; Sun, Dagong; Ka, Weibo; Sung, Lanping Amy; Yao, Weijuan			Fluid Shear Stress Upregulates E-Tmod41 via miR-23b-3p and Contributes to F-Actin Cytoskeleton Remodeling during Erythropoiesis	PLOS ONE			English	Article							TROPOMODULIN ISOFORMS; FLOW; EXPRESSION; MOUSE; MICRORNAS; DIFFERENTIATION; HEMATOPOIESIS; ACTIVATION; MEMBRANE; PROTEINS	The membrane skeleton of mature erythrocyte is formed during erythroid differentiation. Fluid shear stress is one of the main factors that promote embryonic hematopoiesis, however, its effects on erythroid differentiation and cytoskeleton remodeling are unclear. Erythrocyte tropomodulin of 41 kDa (E-Tmod41) caps the pointed end of actin filament (F-actin) and is critical for the formation of hexagonal topology of erythrocyte membrane skeleton. Our study focused on the regulation of E-Tmod41 and its role in F-actin cytoskeleton remodeling during erythroid differentiation induced by fluid shear stress. Mouse erythroleukemia (MEL) cells and embryonic erythroblasts were subjected to fluid shear stress (5 dyn/cm(2)) and erythroid differentiation was induced in both cells. F-actin content and E-Tmod41 expression were significantly increased in MEL cells after shearing. E-Tmod41 overexpression resulted in a significant increase in F-actin content, while the knockdown of E-Tmod41 generated the opposite result. An E-Tmod 3'UTR targeting miRNA, miR-23b-3p, was found suppressed by shear stress. When miR-23b-3p level was overexpressed / inhibited, both E-Tmod41 protein level and F-actin content were reduced / augmented. Furthermore, among the two alternative promoters of E-Tmod, P-E0 (upstream of exon 0), which mainly drives the expression of E-Tmod41, was found activated by shear stress. In conclusion, our results suggest that fluid shear stress could induce erythroid differentiation and F-actin cytoskeleton remodeling. It upregulates E-Tmod41 expression through miR-23b-3p suppression and P-E0 promoter activation, which, in turn, contributes to F-actin cytoskeleton remodeling.	[Mu, Weiyun; Zhu, Sida; Sun, Dagong; Ka, Weibo; Yao, Weijuan] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Hemorheol Ctr,Dept Physiol & Pathophysiol, Beijing 100191, Peoples R China; [Wang, Xifu] Capital Med Univ, Beijing Anzhen Hosp, Dept Emergency, Beijing 100029, Peoples R China; [Zhang, Xiaolan] Chinese Acad Sci, Inst Microbiol, Beijing 100101, Peoples R China; [Sung, Lanping Amy] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Peking University; Capital Medical University; Chinese Academy of Sciences; Institute of Microbiology, CAS; University of California System; University of California San Diego	Yao, WJ (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Hemorheol Ctr,Dept Physiol & Pathophysiol, Beijing 100191, Peoples R China.	weijuanyao@bjmu.edu.cn			National Natural Science Foundation of China [31170886]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China to W.Y. (No. 31170886). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Anguita E, 2004, EMBO J, V23, P2841, DOI 10.1038/sj.emboj.7600274; Blaybel R, 2008, CELL RES, V18, P834, DOI 10.1038/cr.2008.68; Breig O, 2013, CELL SIGNAL, V25, P2453, DOI 10.1016/j.cellsig.2013.08.011; Chu X, 2000, GENE, V256, P271, DOI 10.1016/S0378-1119(00)00327-9; Fischer RS, 2003, J CELL BIOL, V161, P371, DOI 10.1083/jcb.200209057; Fowler VM, 2013, CURR TOP MEMBR, V72, P39, DOI 10.1016/B978-0-12-417027-8.00002-7; FRASER PJ, 1987, GENE DEV, V1, P855, DOI 10.1101/gad.1.8.855; Gokhin DS, 2014, MOL BIOL CELL, V25, P852, DOI 10.1091/mbc.E13-10-0608; Gokhin DS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/103069; Green T, 2011, CELL MOL BIOENG, V4, P637, DOI 10.1007/s12195-011-0203-x; Komor M, 2005, STEM CELLS, V23, P1154, DOI 10.1634/stemcells.2004-0171; Kumar S, 2014, ARTERIOSCL THROM VAS, V34, P2206, DOI 10.1161/ATVBAHA.114.303425; Lim CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6951; Listowski MA, 2013, CELL MOL BIOL LETT, V18, P34, DOI 10.2478/s11658-012-0038-z; Moyer JD, 2010, BLOOD, V116, P2590, DOI 10.1182/blood-2010-02-268458; Neth P, 2013, CARDIOVASC RES, V99, P294, DOI 10.1093/cvr/cvt096; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Pellegrino Loredana, 2013, Bioarchitecture, V3, P119; Pellegrino L, 2013, NUCLEIC ACIDS RES, V41, P5400, DOI 10.1093/nar/gkt245; Phoon CKL, 2002, AM J PHYSIOL-HEART C, V283, pH908, DOI 10.1152/ajpheart.00869.2001; Pishesha N, 2014, P NATL ACAD SCI USA, V111, P4103, DOI 10.1073/pnas.1401598111; Rezvan A, 2011, ANTIOXID REDOX SIGN, V15, P1433, DOI 10.1089/ars.2010.3365; Sui ZH, 2014, BLOOD, V123, P758, DOI 10.1182/blood-2013-03-492710; SUNG LA, 1994, BIOCHEM BIOPH RES CO, V201, P627, DOI 10.1006/bbrc.1994.1747; SUNG LA, 1992, J BIOL CHEM, V267, P2616; Sung LPA, 1996, GENOMICS, V34, P92, DOI 10.1006/geno.1996.0245; Wang KC, 2010, P NATL ACAD SCI USA, V107, P3234, DOI 10.1073/pnas.0914825107; Wang L, 2011, BLOOD, V118, P4102, DOI 10.1182/blood-2011-05-353235; WICKREMA A, 1994, J CELL PHYSIOL, V160, P417, DOI 10.1002/jcp.1041600304; Yamashiro S, 2012, CYTOSKELETON, V69, P337, DOI 10.1002/cm.21031; Yao WJ, 2015, GENE EXPR PATTERNS, V17, P45, DOI 10.1016/j.gep.2015.02.001; Yao WJ, 2010, J BIOL CHEM, V285, P31408, DOI 10.1074/jbc.M110.130278	33	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136607	10.1371/journal.pone.0136607	http://dx.doi.org/10.1371/journal.pone.0136607			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308647	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400142
J	Nagaoka, M; Kobayashi, M; Kawai, C; Mallanna, SK; Duncan, SA				Nagaoka, Masato; Kobayashi, Motohiro; Kawai, Chie; Mallanna, Sunil K.; Duncan, Stephen A.			Design of a Vitronectin-Based Recombinant Protein as a Defined Substrate for Differentiation of Human Pluripotent Stem Cells into Hepatocyte-Like Cells	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; UNDIFFERENTIATED GROWTH; SUPPORT; CULTURE; LAMININ; INDUCTION; ACID	Maintenance and differentiation of human pluripotent stem cells (hPSCs) usually requires culture on a substrate for cell adhesion. A commonly used substratum is Matrigel purified from Engelbreth-Holm-Swarm sarcoma cells, and consists of a complex mixture of extracellular matrix proteins, proteoglycans, and growth factors. Several studies have successfully induced differentiation of hepatocyte-like cells from hPSCs. However, most of these studies have used Matrigel as a cell adhesion substrate, which is not a defined culture condition. In an attempt to generate a substratum that supports undifferentiated properties and differentiation into hepatic lineage cells, we designed novel substrates consisting of vitronectin fragments fused to the IgG Fc domain. hPSCs adhered to these substrates via interactions between integrins and the RGD (Arg-Gly-Asp) motif, and the cells maintained their undifferentiated phenotypes. Using a previously established differentiation protocol, hPSCs were efficiently differentiated into mesendodermal and hepatic lineage cells on a vitronectin fragment-containing substrate. We found that full-length vitronectin did not support stable cell adhesion during the specification stage. Furthermore, the vitronectin fragment with the minimal RGD-containing domain was sufficient for differentiation of human induced pluripotent stem cells into hepatic lineage cells under completely defined conditions that facilitate the clinical application of cells differentiated from hPSCs.	[Nagaoka, Masato; Kawai, Chie] Univ Fukui, Tenure Track Program Innovat Res, Fukui, Fukui, Japan; [Nagaoka, Masato; Mallanna, Sunil K.; Duncan, Stephen A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Kobayashi, Motohiro] Univ Fukui, Fac Med Sci, Dept Pathol Sci, Div Tumor Pathol, Fukui, Fukui, Japan	University of Fukui; Medical College of Wisconsin; University of Fukui	Nagaoka, M (corresponding author), Univ Fukui, Tenure Track Program Innovat Res, Fukui, Fukui, Japan.	mnagaoka@u-fukui.ac.jp	Nagaoka, Masato/J-1551-2014; Nagaoka, Masato/GRF-5030-2022	Duncan, Stephen/0000-0002-2507-7827	National Institutes of Health [DK55743, DK087377, DK102716, HG006398]; Japan Society for the Promotion of Science [26870230]; Grants-in-Aid for Scientific Research [26870230] Funding Source: KAKEN; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD082570] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK087377, R01DK055743, R01DK102716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SAD was supported by grants from the National Institutes of Health (Grant Number; DK55743, DK087377, DK102716 and HG006398), and MN was supported by Grant-in-Aid for Young Scientists (B) (Grant Number: 26870230) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; BISSELL DM, 1987, J CLIN INVEST, V79, P801, DOI 10.1172/JCI112887; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Brafman DA, 2013, CELL DEATH DIFFER, V20, P369, DOI 10.1038/cdd.2012.138; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Chen G, 2011, NAT METH; Chen HL, 1998, J BIOMED SCI, V5, P435, DOI 10.1007/BF02255932; CHERNY RC, 1993, J BIOL CHEM, V268, P9725; Chetty S, 2013, NAT METHODS, V10, P553, DOI [10.1038/NMETH.2442, 10.1038/nmeth.2442]; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547; Derda R, 2010, J AM CHEM SOC, V132, P1289, DOI 10.1021/ja906089g; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Goldman O, 2014, STEM CELL REP, V3, P556, DOI 10.1016/j.stemcr.2014.08.009; Haque A, 2011, BIOMATERIALS, V32, P2032, DOI 10.1016/j.biomaterials.2010.11.045; IMAI K, 1995, FEBS LETT, V369, P249, DOI 10.1016/0014-5793(95)00752-U; Ishii T, 2008, AM J PHYSIOL-GASTR L, V295, pG313, DOI 10.1152/ajpgi.00072.2008; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532; Liu YX, 2006, BIOCHEM BIOPH RES CO, V346, P131, DOI 10.1016/j.bbrc.2006.05.086; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Margagliotti S, 2008, DEV GROWTH DIFFER, V50, P331, DOI [10.1111/j.1440-169x.2008.01031.x, 10.1111/j.1440-169X.2008.01031.x]; Melkoumian Z, 2010, NAT BIOTECHNOL; Miyazaki T, 2008, BIOCHEM BIOPH RES CO, V375, P27, DOI 10.1016/j.bbrc.2008.07.111; Nagaoka M, 2003, PROTEIN ENG, V16, P243, DOI 10.1093/proeng/gzg037; Nagaoka M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000015; Nagaoka M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-60; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Okita K, 2011, NAT METH; Page JL, 2007, TOXICOL SCI, V97, P384, DOI 10.1093/toxsci/kfm034; Rodin S, 2010, NAT BIOTECHNOL; Si-Tayeb K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-81; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Sullivan GJ, 2010, HEPATOLOGY, V51, P329, DOI 10.1002/hep.23335; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Villa-Diaz LG, 2010, NAT BIOTECHNOL; VUKICEVIC S, 1992, EXP CELL RES, V202, P1, DOI 10.1016/0014-4827(92)90397-Q; Wong JCY, 2010, CELL ADHES MIGR, V4, P39, DOI 10.4161/cam.4.1.10627; Yamada T, 2002, STEM CELLS, V20, P146, DOI 10.1634/stemcells.20-2-146; Yamasaki C, 2006, J HEPATOL, V44, P749, DOI 10.1016/j.jhep.2005.10.028; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167	43	11	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136350	10.1371/journal.pone.0136350	http://dx.doi.org/10.1371/journal.pone.0136350			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308339	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400113
J	Shim, U; Kim, HN; Lee, H; Oh, JY; Sung, YA; Kim, HL				Shim, Unjin; Kim, Han-Na; Lee, Hyejin; Oh, Jee-Young; Sung, Yeon-Ah; Kim, Hyung-Lae			Pathway Analysis Based on a Genome-Wide Association Study of Polycystic Ovary Syndrome	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; INSULIN-RESISTANCE; PITUITARY GONADOTROPHS; GENETIC POLYMORPHISMS; LUTEINIZING-HORMONE; SUSCEPTIBILITY LOCI; CELL-LINE; WOMEN; EXPRESSION; PHENOTYPES	Background Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age, and it is affected by both environmental and genetic factors. Although the genetic component of PCOS is evident, studies aiming to identify susceptibility genes have shown controversial results. This study conducted a pathway-based analysis using a dataset obtained through a genome-wide association study (GWAS) to elucidate the biological pathways that contribute to PCOS susceptibility and the associated genes. Methods We used GWAS data on 636,797 autosomal single nucleotide polymorphisms (SNPs) from 1,221 individuals (432 PCOS patients and 789 controls) for analysis. A pathway analysis was conducted using meta-analysis gene-set enrichment of variant associations (MAGENTA). Top-ranking pathways or gene sets associated with PCOS were identified, and significant genes within the pathways were analyzed. Results The pathway analysis of the GWAS dataset identified significant pathways related to oocyte meiosis and the regulation of insulin secretion by acetylcholine and free fatty acids (all nominal gene-set enrichment analysis (GSEA) P-values < 0.05). In addition, INS, GNAQ, STXBP1, PLCB3, PLCB2, SMC3 and PLCZ1 were significant genes observed within the biological pathways (all gene P-values < 0.05). Conclusions By applying MAGENTA pathway analysis to PCOS GWAS data, we identified significant pathways and candidate genes involved in PCOS. Our findings may provide new leads for understanding the mechanisms underlying the development of PCOS.	[Shim, Unjin] Ewha Womans Univ, Med Ctr, Seoul Seonam Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Han-Na; Kim, Hyung-Lae] Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea; [Lee, Hyejin; Oh, Jee-Young; Sung, Yeon-Ah] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Sung, YA (corresponding author), Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea.	yasung@ewha.ac.kr; hyung@ewha.ac.kr						Amdani Siti Nornadhirah, 2013, Advances in Biological Regulation, V53, P292, DOI 10.1016/j.jbior.2013.07.005; Ansari M, 2014, J MED GENET, V51, P659, DOI 10.1136/jmedgenet-2014-102573; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Bassiouny YA, 2014, GYNECOL ENDOCRINOL, V30, P428, DOI 10.3109/09513590.2014.895982; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Carmody D, 2015, J MED GENET; Chen D, 2015, CANCER LETT, V362, P208, DOI 10.1016/j.canlet.2015.03.041; Chen Rui-min, 2012, Zhonghua Yixue Yichuanxue Zazhi, V29, P631, DOI 10.3760/cma.j.issn.1003-9406.2012.06.002; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Cheng Q, 2014, CLIN RESP J; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dumesic DA, 2008, SEMIN REPROD MED, V26, P53, DOI 10.1055/s-2007-992925; Ehrmann DA, 2005, J CLIN ENDOCR METAB, V90, P66, DOI 10.1210/jc.2004-0229; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Escobar-Morreale HF, 2012, HUM REPROD UPDATE, V18, P146, DOI 10.1093/humupd/dmr042; Ferk P, 2008, J INT MED RES, V36, P1180, DOI 10.1177/147323000803600603; Franks S, 2001, HUM REPROD UPDATE, V7, P405, DOI 10.1093/humupd/7.4.405; Gil-Rodriguez MC, 2015, HUM MUTAT, V36, P454, DOI 10.1002/humu.22761; Ha LX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126505; Haouzi D, 2012, HUM REPROD, V27, P3523, DOI 10.1093/humrep/des325; HATCH R, 1981, AM J OBSTET GYNECOL, V140, P815, DOI 10.1016/0002-9378(81)90746-8; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Klenke S, 2010, PHARMACOGENET GENOM, V20, P476, DOI 10.1097/FPC.0b013e32833b7497; Kon A, 2013, NAT GENET, V45, P1232, DOI 10.1038/ng.2731; Lam TKT, 2003, AM J PHYSIOL-ENDOC M, V284, pE281, DOI 10.1152/ajpendo.00332.2002; Lee H, 2015, HUM REPROD, V30, P723, DOI 10.1093/humrep/deu352; Legro RS, 1998, P NATL ACAD SCI USA, V95, P14956, DOI 10.1073/pnas.95.25.14956; Li Zhishuang, 2014, Zhonghua Bing Li Xue Za Zhi, V43, P455; Liu M, 2015, MOL ASPECTS MED, V42, P3, DOI 10.1016/j.mam.2014.12.001; Loveday C, 2015, HUM MOL GENET; Mohlig M, 2007, EUR J ENDOCRINOL, V157, P195, DOI 10.1530/EJE-07-0102; Moran L, 2009, HUM REPROD UPDATE, V15, P477, DOI 10.1093/humupd/dmp008; Nomikos M, 2012, BIOESSAYS, V34, P126, DOI 10.1002/bies.201100127; Ortmann O, 1998, CELL CALCIUM, V24, P223, DOI 10.1016/S0143-4160(98)90131-2; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramanan VK, 2012, TRENDS GENET, V28, P323, DOI 10.1016/j.tig.2012.03.004; San Millan JL, 2004, J CLIN ENDOCR METAB, V89, P2640, DOI 10.1210/jc.2003-031252; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Selway JL, 2012, ACTA DIABETOL, V49, P277, DOI 10.1007/s00592-011-0314-9; Shahbaba B, 2012, STAT MED, V31, P988, DOI 10.1002/sim.4477; Shi YY, 2012, NAT GENET, V44, P1020, DOI 10.1038/ng.2384; Simoni M, 2008, HUM REPROD UPDATE, V14, P459, DOI 10.1093/humupd/dmn024; Skrgatic L, 2013, COLLEGIUM ANTROPOL, V37, P141; Solomon DA, 2014, BMB REP, V47, P299, DOI 10.5483/BMBRep.2014.47.6.092; Sontag JM, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00016; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spurlin BA, 2004, DIABETES, V53, P2223, DOI 10.2337/diabetes.53.9.2223; Stringer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027964; Tse FW, 1997, NEURON, V18, P121, DOI 10.1016/S0896-6273(01)80051-9; Velusamy T, 2013, P NATL ACAD SCI USA, V110, P3035, DOI 10.1073/pnas.1214326110; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Vink JM, 2006, J CLIN ENDOCR METAB, V91, P2100, DOI 10.1210/jc.2005-1494; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Willis DS, 1998, J CLIN ENDOCR METAB, V83, P3984, DOI 10.1210/jc.83.11.3984; Wiltgen D, 2010, FERTIL STERIL, V94, P2493, DOI 10.1016/j.fertnstert.2010.02.015; Yu UY, 2014, KOREAN J PHYSIOL PHA, V18, P155, DOI 10.4196/kjpp.2014.18.2.155; Yun JH, 2012, GYNECOL ENDOCRINOL, V28, P525, DOI 10.3109/09513590.2011.650658; Zawadzki J, 1992, DIAGNOSTIC CRITERIA; Zawalich Walter S., 1997, Frontiers in Bioscience (online), V2, pD160; Zhang L, 2006, WORLD J GASTROENTERO, V12, P4056, DOI 10.3748/wjg.v12.i25.4056; Zhao Y, 2013, STEROIDS, V78, P755, DOI 10.1016/j.steroids.2013.04.006	62	25	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136609	10.1371/journal.pone.0136609	http://dx.doi.org/10.1371/journal.pone.0136609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308735	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400143
J	Strazhesko, I; Tkacheva, O; Boytsov, S; Akasheva, D; Dudinskaya, E; Vygodin, V; Skvortsov, D; Nilsson, P				Strazhesko, Irina; Tkacheva, Olga; Boytsov, Sergey; Akasheva, Dariga; Dudinskaya, Ekaterina; Vygodin, Vladimir; Skvortsov, Dmitry; Nilsson, Peter			Association of Insulin Resistance, Arterial Stiffness and Telomere Length in Adults Free of Cardiovascular Diseases	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; AORTIC STIFFNESS; METABOLIC SYNDROME; OXIDATIVE STRESS; RISK; GLUCOSE; MORTALITY; CELLS; MEN	Background Chronic inflammation and oxidative stress might be considered the key mechanisms of aging. Insulin resistance (IR) is a phenomenon related to inflammatory and oxidative stress. We tested the hypothesis that IR may be associated with cellular senescence, as measured by leukocyte telomere length (LTL), and arterial stiffness (core feature of arterial aging), as measured by carotid-femoral pulse wave velocity (c-f PWV). Methods The study group included 303 subjects, mean age 51.8 +/- 13.3 years, free of known cardiovascular diseases and regular drug consumption. For each patient, blood pressure was measured, blood samples were available for biochemical parameters, and LTL was analyzed by real time q PCR. C-f PWV was measured with the help of SphygmoCor. SAS 9.1 was used for statistical analysis. Results Through multiple linear regression analysis, c-f PWV is independently and positively associated with age (p = 0.0001) and the homeostasis model assessment of insulin resistance (HOMA-IR; p = 0.0001) and independently negatively associated with LTL (p = 0.0378). HOMA-IR seems to have a stronger influence than SBP on arterial stiffness. In all subjects, age, HOMA-IR, LTL, and SBP predicted 32% of the variance in c-f PWV. LTL was inversely associated with HOMA-IR (p = 0.0001) and age (p = 0.0001). In all subjects, HOMA-IR, age, sex, and SBP predicted 16% of the variance in LTL. Conclusions These data suggest that IR is associated with cell senescence and arterial aging and could, therefore, become the main target in preventing accelerated arterial aging, besides blood pressure control. Research in telomere biology may reveal new ways of estimating cardiovascular aging and risk.	[Strazhesko, Irina; Tkacheva, Olga; Akasheva, Dariga; Dudinskaya, Ekaterina] Natl Res Ctr Prevent Med, Dept Aging & Age Associated Dis Prevent, Moscow, Russia; [Boytsov, Sergey] Natl Res Ctr Prevent Med, Dept Clin Cardiol & Mol Genet, Moscow, Russia; [Vygodin, Vladimir] Natl Res Ctr Prevent Med, Dept Epidemiol Chron Noncommunicable Dis, Lab Biostat, Moscow, Russia; [Skvortsov, Dmitry] Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia; [Nilsson, Peter] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Malmo, Sweden	National Medical Research Center for Therapy & Preventive Medicine; National Medical Research Center for Therapy & Preventive Medicine; National Medical Research Center for Therapy & Preventive Medicine; Lomonosov Moscow State University; Lund University; Skane University Hospital	Strazhesko, I (corresponding author), Natl Res Ctr Prevent Med, Dept Aging & Age Associated Dis Prevent, Moscow, Russia.	istrazhesko@gmail.com	Boytsov, Sergey/AAK-5354-2021; Strazhesko, Irina/AAD-9390-2019; Boytsov, Sergey A/M-4486-2014; Skvortsov, Dmitry A/D-3738-2015; Dudinskaya, Ekaterina/H-3281-2013; Vygodin, Vladimir/AAB-9620-2020; Akasheva, Dariga U/K-2764-2017; Drapkina, Oksana/AAE-5376-2021	Boytsov, Sergey/0000-0001-6998-8406; Boytsov, Sergey A/0000-0001-6998-8406; Dudinskaya, Ekaterina/0000-0001-7891-6850; Akasheva, Dariga U/0000-0003-0694-7062; Drapkina, Oksana/0000-0002-4453-8430; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Skvortsov, Dmitry/0000-0001-8336-8596	Ministry of Health of Russian Federation	Ministry of Health of Russian Federation	Funding provided by State task of Ministry of Health of Russian Federation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviv A., 2004, SCI AGING KNOWLEDGE, V2004, pp, DOI [10.1126/sageke.2004.51.pe43, DOI 10.1126/SAGEKE.2004.51.PE43]; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Bjornholt JV, 1999, DIABETES CARE, V22, P45, DOI 10.2337/diacare.22.1.45; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cersosimo E, 2006, DIABETES-METAB RES, V22, P423, DOI 10.1002/dmrr.634; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Denil SLIJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115071; Diez J, 2007, ADV CARDIOL, V44, P76, DOI 10.1159/000096722; Fyhrquist F, 2013, NAT REV CARDIOL, V10, P274, DOI 10.1038/nrcardio.2013.30; Giltay EJ, 1999, DIABETOLOGIA, V42, P214, DOI 10.1007/s001250051141; Henry RMA, 2003, CIRCULATION, V107, P2089, DOI 10.1161/01.CIR.0000065222.34933.FC; Indolfi C, 2001, CIRCULATION, V103, P2980, DOI 10.1161/01.CIR.103.24.2980; Kaess BM, 2012, JAMA-J AM MED ASSOC, V308, P875, DOI 10.1001/2012.jama.10503; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Lukich E, 2010, DIABETES-METAB RES, V26, P365, DOI 10.1002/dmrr.1086; Meaume S, 2001, J HYPERTENS, V19, P871, DOI 10.1097/00004872-200105000-00006; Mitchell GF, 2007, CIRCULATION, V115, P2628, DOI 10.1161/CIRCULATIONAHA.106.667733; Moriyama M, 2006, CLIN CHEM, V52, P1423, DOI 10.1373/clinchem.2005.065995; Murillo-Ortiz B, 2012, AGING MALE, V15, P54, DOI 10.3109/13685538.2011.593658; Najjar SS, 2005, HYPERTENSION, V46, P454, DOI 10.1161/01.HYP.0000177474.06749.98; Negami Masako, 2012, Tokai J Exp Clin Med, V37, P102; Nilsson PM, 2013, TRANSL RES, V162, P371, DOI 10.1016/j.trsl.2013.05.004; Nilsson PM, 2013, J HYPERTENS, V31, P1517, DOI 10.1097/HJH.0b013e328361e4bd; Oeseburg H, 2007, J AM COLL CARDIOL, V50, P1911, DOI 10.1016/j.jacc.2007.07.055; Rajzer MW, 2008, J HYPERTENS, V26, P2001, DOI 10.1097/HJH.0b013e32830a4a25; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Scuteri A, 2004, J AM COLL CARDIOL, V43, P1388, DOI 10.1016/j.jacc.2003.10.061; Scuteri A, 2014, ATHEROSCLEROSIS, V233, P654, DOI 10.1016/j.atherosclerosis.2014.01.041; Sengstock DM, 2005, J CLIN ENDOCR METAB, V90, P2823, DOI 10.1210/jc.2004-1686; Serra V, 2003, J BIOL CHEM, V278, P6824, DOI 10.1074/jbc.M207939200; Shin JY, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-30; Strain WD, 2006, AM J HYPERTENS, V19, P889, DOI 10.1016/j.amjhyper.2006.01.009; Wang YY, 2011, AGING MALE, V14, P27, DOI 10.3109/13685538.2010.529196	36	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136676	10.1371/journal.pone.0136676	http://dx.doi.org/10.1371/journal.pone.0136676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308091	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400150
J	Bose, C; Megyesi, JK; Shah, SV; Hiatt, KM; Hall, KA; Karaduta, O; Swaminathan, S				Bose, Chhanda; Megyesi, Judit K.; Shah, Sudhir V.; Hiatt, Kim M.; Hall, Kimberly A.; Karaduta, Oleg; Swaminathan, Sundararaman			Evidence Suggesting a Role of Iron in a Mouse Model of Nephrogenic Systemic Fibrosis	PLOS ONE			English	Article							GADOLINIUM; MORTALITY; DISEASE; MICE	Nephrogenic systemic fibrosis is associated with gadolinium contrast exposure in patients with reduced kidney function and carries high morbidity and mortality. We have previously demonstrated that gadolinium contrast agents induce in vivo systemic iron mobilization and in vitro differentiation of peripheral blood mononuclear cells into ferroportin (iron exporter)-expressing fibrocytic cells. In the present study we examined the role of iron in a mouse model of nephrogenic systemic fibrosis. Chronic kidney disease was induced in 8-week-old male Balb/C mice with a two-step 5/6 nephrectomy surgery. Five groups of mice were studied: control (n = 5), sham surgery control (n = 5), chronic kidney disease control (n = 4), chronic kidney disease injected with 0.5 mmol/kg body weight of Omniscan 3 days per week, for a total of 10 injections (n = 8), and chronic kidney disease with Omniscan plus deferiprone, 125 mg/kg, in drinking water (n = 9). Deferiprone was continued for 16 weeks until the end of the experiment. Mice with chronic kidney disease injected with Omniscan developed skin changes characteristic of nephrogenic systemic fibrosis including hair loss, reddening, ulceration, and skin tightening by 10 to 16 weeks. Histopathological sections demonstrated dermal fibrosis with increased skin thickness (0.25 +/- 0.06 mm, sham; 0.34 +/- 0.3 mm, Omniscan-injected). Additionally, we observed an increase in tissue infiltration of ferroportin-expressing, fibrocyte-like cells accompanied by tissue iron accumulation in the skin of the Omniscan-treated mice. The deferiprone-treated group had significantly decreased skin thickness (p< 0.05) and significantly decreased dermal fibrosis compared to the Omniscan-only group. In addition, iron chelation prevented tissue infiltration of ferroportin-expressing, fibrocyte-like cells. Our in vitro experiments demonstrated that exposure to Omniscan resulted in the release of catalytic iron and this was prevented by the iron chelator deferiprone. Deferiprone inhibited the differentiation of human peripheral blood mononuclear cells into ferroportin-expressing cells by immunohistochemical staining and western blot analysis. Our studies support an important role of iron in the pathophysiology of gadolinium chelate toxicity and nephrogenic systemic fibrosis.	[Bose, Chhanda; Megyesi, Judit K.; Shah, Sudhir V.; Karaduta, Oleg; Swaminathan, Sundararaman] Cent Arkansas Vet Healthcare Syst, Renal Sect, Med Serv, Little Rock, AR 72205 USA; [Bose, Chhanda; Megyesi, Judit K.; Shah, Sudhir V.; Karaduta, Oleg; Swaminathan, Sundararaman] Univ Arkansas Med Sci, Dept Internal Med, Div Nephrol, Little Rock, AR 72205 USA; [Hiatt, Kim M.] Univ Arkansas Med Sci, Dept Dermatol, Little Rock, AR 72205 USA; [Hiatt, Kim M.; Hall, Kimberly A.] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Shah, SV (corresponding author), Cent Arkansas Vet Healthcare Syst, Renal Sect, Med Serv, Little Rock, AR 72205 USA.	shahsudhirv@uams.edu		KARADUTA, OLEG/0000-0003-3873-052X	University of Arkansas for Medical Sciences Translational Research Institute (TRI) through the NIH National Center for Research Resources [UL1TR000039, KL2TR000063]; National Center for Advancing Translational Sciences; VA Merit Review Grant, Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000063, UL1TR000039] Funding Source: NIH RePORTER	University of Arkansas for Medical Sciences Translational Research Institute (TRI) through the NIH National Center for Research Resources; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); VA Merit Review Grant, Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The project described was supported by the University of Arkansas for Medical Sciences Translational Research Institute (TRI), grants UL1TR000039 and KL2TR000063 through the NIH National Center for Research Resources, and the National Center for Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This material is based upon work supported in part by the VA Merit Review Grant (SVS), Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development.	BALIGA R, 1993, BIOCHEM J, V291, P901, DOI 10.1042/bj2910901; Cohen EP, 2009, RADIAT RES, V172, P260, DOI [10.1667/RR1739, 10.1667/RR1739.1]; Cowper SE, 2001, AM J DERMATOPATH, V23, P383, DOI 10.1097/00000372-200110000-00001; Cowper Shawn E, 2008, J Am Coll Radiol, V5, P23, DOI 10.1016/j.jacr.2007.08.013; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Ghio AJ, 2011, J BIOL INORG CHEM, V16, P567, DOI 10.1007/s00775-011-0757-z; HALLIWELL B, 1993, HAEMOSTASIS, V23, P118; Halliwell B, 2009, FREE RADICAL BIO MED, V46, P531, DOI 10.1016/j.freeradbiomed.2008.11.008; Hope TA, 2009, RADIOLOGY, V253, P390, DOI 10.1148/radiol.2532090580; Miyamoto J, 2011, AM J DERMATOPATH, V33, P271, DOI 10.1097/DAD.0b013e3181f63eb1; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Pagani A, 2011, BLOOD, V118, P736, DOI 10.1182/blood-2011-02-337212; PORTER JB, 1991, BLOOD, V78, P2727; Schroeder JA, 2008, CLIN J AM SOC NEPHRO, V3, P968, DOI 10.2215/CJN.00100108; Swaminathan S, 2008, KIDNEY INT, V73, P1413, DOI 10.1038/ki.2008.76; Swaminathan S, 2007, NEW ENGL J MED, V357, P720, DOI 10.1056/NEJMc070248; Swaminathan S, 2013, AM J PATHOL, V183, P796, DOI 10.1016/j.ajpath.2013.06.008; Telgmann L, 2012, ANAL BIOANAL CHEM, V404, P2133, DOI 10.1007/s00216-012-6404-x; Todd DJ, 2007, ARTHRITIS RHEUM, V56, P3433, DOI 10.1002/art.22925; WEDEKING P, 1992, MAGN RESON IMAGING, V10, P641, DOI 10.1016/0730-725X(92)90016-S	20	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136563	10.1371/journal.pone.0136563	http://dx.doi.org/10.1371/journal.pone.0136563			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305890	gold, Green Published, Green Submitted			2022-12-27	WOS:000359995500090
J	Jaafar, H; Rouis, M; Coudrat, L; Gelat, T; Noakes, TD; Driss, T				Jaafar, Hamdi; Rouis, Majdi; Coudrat, Laure; Gelat, Thierry; Noakes, Timothy David; Driss, Tarak			Influence of Affective Stimuli on Leg Power Output and Associated Neuromuscular Parameters during Repeated High Intensity Cycling Exercises	PLOS ONE			English	Article							REPEATED-SPRINT ABILITY; MUSCLE; PERFORMANCE; DURATION; FATIGUE; FORCE; TIME	The aim of this study was to examine the impact of emotional eliciting pictures on neuromuscular performance during repetitive supramaximal cycling exercises (RSE). In a randomized order, twelve male participants were asked to perform five 6-s cycle sprints (interspaced by 24 s of recovery) on a cycle ergometer in front of neutral, pleasant or unpleasant pictures. During each RSE, mean power output (MPO) and electromyographic activity [root mean square (RMS) and median frequency (MF)] of the vastus lateralis and vastus medialis muscles were analyzed. Neuromuscular efficiency (NME) was calculated as the ratio of MPO to RMS. Higher RMS (232.17 +/- 1.17 vs. 201.90 +/- 0.47 mu V) and MF (68.56 +/- 1.78 vs. 64.18 +/- 2.17 Hz) were obtained in pleasant compared to unpleasant conditions (p < 0.05). This emotional effect persisted from the first to the last sprint. Higher MPO was obtained in pleasant than in unpleasant conditions (690.65 +/- 38.23 vs. 656.73 +/- 35.95 W, p < 0.05). However, this emotional effect on MPO was observed only for the two first sprints. NME decreased from the third sprint (p < 0.05), which indicated the occurrence of peripheral fatigue after the two first sprints. These results suggested that, compared with unpleasant pictures, pleasant ones increased the neuromuscular performance during RSE. Moreover, the disappearance of the beneficial effect of pleasant emotion on mechanical output from the third sprint appears to be due to peripheral fatigue.	[Jaafar, Hamdi; Rouis, Majdi; Gelat, Thierry; Driss, Tarak] Univ Paris Ouest Nanterre La Def, UFR STAPS, Lab CeRSM, EA 2931, Nanterre, France; [Coudrat, Laure] Univ Lorraine, Dept STAPS Metz, UFR SciFA, LCOMS,EPSAP,Emot Act, Metz, France; [Noakes, Timothy David] Univ Cape Town, Dept Human Biol, ZA-7925 Cape Town, South Africa	Universite Paris Nanterre; Universite de Lorraine; University of Cape Town	Driss, T (corresponding author), Univ Paris Ouest Nanterre La Def, UFR STAPS, Lab CeRSM, EA 2931, Nanterre, France.	tarak.driss@u-paris10.fr	Noakes, Timothy D./E-7253-2011; DRISS, Tarak/AAR-2823-2020; Noakes, Tim/AAD-3162-2020	Noakes, Timothy D./0000-0001-7244-2375; DRISS, Tarak/0000-0001-6109-7393; Noakes, Tim/0000-0001-7244-2375; COUDRAT, LAURE/0000-0002-4206-5350				Baden DA, 2005, BRIT J SPORT MED, V39, P742, DOI 10.1136/bjsm.2004.016980; Baron B, 2011, BRIT J SPORT MED, V45, P511, DOI 10.1136/bjsm.2009.059964; Bercier S, 2009, J ELECTROMYOGR KINES, V19, P922, DOI 10.1016/j.jelekin.2008.03.012; Billaut F, 2006, INT J SPORTS MED, V27, P25, DOI 10.1055/s-2005-837488; Billaut F, 2005, NEUROSCI LETT, V380, P265, DOI 10.1016/j.neulet.2005.01.048; Billaut F, 2011, MED SCI SPORT EXER, V43, P665, DOI 10.1249/MSS.0b013e3181f6ee3b; Bishop D, 2001, J SCI MED SPORT, V4, P19, DOI 10.1016/S1440-2440(01)80004-9; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Chen M, 1999, PERS SOC PSYCHOL B, V25, P215, DOI 10.1177/0146167299025002007; Coombes SA, 2006, NEUROSCI LETT, V396, P192, DOI 10.1016/j.neulet.2005.11.048; Coudrat L, 2014, J SPORT SCI, V32, P892, DOI 10.1080/02640414.2013.865253; Dore E, 2000, MED SCI SPORT EXER, V32, P493; Duffy CR, 2012, J SPORT SCI, V30, P1311, DOI 10.1080/02640414.2012.710752; Gelat T, 2011, NEUROSCI LETT, V497, P64, DOI 10.1016/j.neulet.2011.04.030; Gibson ASC, 2006, SPORTS MED, V36, P705; Gibson AS, 2004, BRIT J SPORT MED, V38, P797, DOI 10.1136/bjsm.2003.009852; Girard O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061793; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; Hautier CA, 2000, MED SCI SPORT EXER, V32, P839, DOI 10.1097/00005768-200004000-00017; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Lang P. J., 2005, INT AFFECTIVE PICTUR; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; Laplaud D, 2006, J ELECTROMYOGR KINES, V16, P158, DOI 10.1016/j.jelekin.2005.04.002; Mendez-Villanueva A, 2008, EUR J APPL PHYSIOL, V103, P411, DOI 10.1007/s00421-008-0723-9; Pereira MG, 2006, EMOTION, V6, P622, DOI 10.1037/1528-3542.6.4.622; Racinais S, 2005, MED SCI SPORT EXER, V37, P256, DOI 10.1249/01.MSS.0000149885.82163.9F; Racinais S, 2007, MED SCI SPORT EXER, V39, P268, DOI 10.1249/01.mss.0000251775.46460.cb; Tenenbaum G. A., 2001, HDB SPORT PSYCHOL, V2, P810, DOI DOI 10.1080/026404199365425; Zarrouk N, 2012, INT J SPORTS MED, V33, P975, DOI 10.1055/s-0032-1312626	29	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136330	10.1371/journal.pone.0136330	http://dx.doi.org/10.1371/journal.pone.0136330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305334	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500066
J	Liu, WW; Yuan, SW; Wei, FQ; Yang, J; Zhang, Z; Zhu, CB; Ma, J				Liu, Wenwei; Yuan, Suwei; Wei, Fengqing; Yang, Jing; Zhang, Zhe; Zhu, Changbin; Ma, Jin			Reliability and Validity of the Chinese Version Appropriateness Evaluation Protocol	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY; LENGTH-OF-STAY; HEALTH-CARE; HOSPITAL STAY; ADMISSIONS; DESIGN; SYSTEM	Objective To adapt the Appropriateness Evaluation Protocol (AEP) to the specific settings of health care in China and to validate the Chinese version AEP (C-AEP). Methods Forward and backward translations were carried out to the original criteria. Twenty experts participated in the consultancy to form a preliminary version of the C-AEP. To ensure applicability, tests of reliability and validity were performed on 350 admissions and 3,226 hospital days of acute myocardial infraction patients and total hip replacement patients in two tertiary hospitals by two C-AEP reviewers and two physician reviewers. Overall agreement, specific agreement, and Cohen's Kappa were calculated to compare the concordance of decisions between pairs of reviewers to test inter-rater reliability and convergent validity. The use of "overrides" and opinions of experts were recorded as measurements of content validity. Face validity was tested through collecting perspectives of nonprofessionals. Sensitivity, specificity, and predictive values were also reported. Results There are 14 admission and 24 days of care criteria in the initial version of C-AEP. Kappa coefficients indicate substantial agreement between reviewers: with regard to inter-rater reliability, Kappa (.) coefficients are 0.746 (95% confidence interval [CI] 0.644-0.834) and 0.743 (95% CI 0.698-0.767) of admission and hospital days, respectively; for convergent validity, the. statistics are 0.678 (95% CI 0.567-0.778) and 0.691 (95% CI 0.644-0.717), respectively. Overrides account for less than 2% of all judgments. Content validity and face validity were confirmed by experts and nonprofessionals, respectively. According to the C-AEP reviewers, 18.3% of admissions and 28.5% of inpatient days were deemed inappropriate. Conclusions The C-AEP is a reliable and valid screening tool in China's tertiary hospitals. The prevalence of inappropriateness is substantial in our research. To reduce inappropriate utilization, further investigation is needed to elucidate the reasons and risk factors for this inappropriateness.	[Liu, Wenwei] Shanghai Jiao Tong Univ, Antai Coll Econ & Management, Shanghai 200030, Peoples R China; [Yuan, Suwei; Wei, Fengqing; Zhang, Zhe; Ma, Jin] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China; [Yang, Jing] Shanghai Rui Jin Hosp, Dept Med Adm, Shanghai, Peoples R China; [Zhu, Changbin] Erasmus MC, Dept Pathol, Rotterdam, Netherlands	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Erasmus University Rotterdam; Erasmus MC	Ma, J (corresponding author), 227 South Chong Qing Rd, Shanghai, Peoples R China.	majin@shsmu.edu.cn	Zhu, Changbin/AHA-8786-2022		National Natural Science Foundation of China [71273175]; Shanghai Municipal Education Commission [13YS022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This study is sponsored by National Natural Science Foundation of China [grant number 71273175], http://www.nsfc.gov.cn/publish/portal1/ and Shanghai Municipal Education Commission Innovative Project [grant number 13YS022], http://www.shmec.gov.cn/. The grants were received by JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], AVERAGE LENGTH STAY, DOI [10.1787/health_glance-2013-36-en, DOI 10.1787/HEALTH_GLANCE-2013-36-EN]; Apolone G, 1991, Qual Assur Health Care, V3, P1; ASH A, 1995, INT J QUAL HEALTH C, V7, P245, DOI 10.1093/intqhc/7.3.245; Barber SL, 2014, HEALTH POLICY PLANN, V29, P367, DOI 10.1093/heapol/czt023; BENTES M, 1995, INT J QUAL HEALTH C, V7, P201, DOI 10.1093/intqhc/7.3.201; Buetow SA, 1997, SOC SCI MED, V45, P261, DOI 10.1016/S0277-9536(96)00342-5; Cao JW, 2009, CHINESE HOSP MANAGEM, V29, P37; Davido A, 1991, Qual Assur Health Care, V3, P227; ERMANN D, 1988, J HEALTH POLIT POLIC, V13, P683, DOI 10.1215/03616878-13-4-683; Fontaine P, 2011, HEALTH POLICY, V99, P66, DOI 10.1016/j.healthpol.2010.06.011; GERTMAN PM, 1981, MED CARE, V19, P855, DOI 10.1097/00005650-198108000-00005; He MQ, 2008, CHINESE HOSP, V12, P31; Hwang JI, 2011, INT J QUAL HEALTH C, V23, P437, DOI 10.1093/intqhc/mzr028; Jimenez-Garcia R, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-43; Kalant N, 2000, CAN MED ASSOC J, V162, P1809; KREGER BE, 1989, PEDIATRICS, V84, P242; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LANG T, 1995, INT J QUAL HEALTH C, V7, P233, DOI 10.1093/intqhc/7.3.233; Lang T, 1999, INT J TECHNOL ASSESS, V15, P185, DOI 10.1017/S0266462399152784; Lavis JN, 1996, CAN MED ASSOC J, V154, P321; Leung L. P., 2008, Hong Kong Medical Journal, V14, P273; Liu K, 2014, CHINESE HOSP MANAGEM, V34, P58; Liu XZ, 1999, HEALTH POLICY PLANN, V14, P409, DOI 10.1093/heapol/14.4.409; Long Q, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-40; Lorenzo S, 1999, INT J QUAL HEALTH C, V11, P419, DOI 10.1093/intqhc/11.5.419; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Ministry of Health of the Peoples Republic of China, 2013, CHIN HLTH STAT YB 20; Panis LJGG, 2002, INT J QUAL HEALTH C, V14, P55, DOI 10.1093/intqhc/14.1.55; Qiu YZ, 2013, CHINESE HOSP MANAGEM, V33, P19; RESTUCCIA JD, 1995, INT J QUAL HEALTH C, V7, P253, DOI 10.1093/intqhc/7.3.253; RISHPON S, 1986, MED CARE, V24, P279, DOI 10.1097/00005650-198603000-00010; Sangha O, 2002, INT J QUAL HEALTH C, V14, P483, DOI 10.1093/intqhc/14.6.483; Shoukri MM, 2010, CH CRC BIOSTAT SER, P1, DOI 10.1201/b10433; Smeets PMJH, 2000, INT J QUAL HEALTH C, V12, P483, DOI 10.1093/intqhc/12.6.483; STRUMWASSER I, 1990, MED CARE, V28, P95, DOI 10.1097/00005650-199002000-00001; Tang SL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-S1-S8; [陶婧婧 Tao Jingjing], 2013, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University .Medical Science], V33, P1146; Vorhies JS, 2011, J ARTHROPLASTY, V26, P119, DOI 10.1016/j.arth.2011.04.036; [王欢 Wang Huan], 2002, [中华骨科杂志, Chinese Journal of Orthopedics], V22, P17; Wang X, 2001, J 4 MILITARY MED U, V22, P557; Zhang WT, 2014, CHINESE HOSP MANAGEM, V3, P38; Zhang Y, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0649-3; Zhou XY, 2013, CHINESE HLTH QUALITY, V20, P33	44	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136498	10.1371/journal.pone.0136498	http://dx.doi.org/10.1371/journal.pone.0136498			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6KK	26305363	Green Submitted, Green Published, gold			2022-12-27	WOS:000359995500085
J	Lunze, K; Lunze, FI; Raj, A; Samet, JH				Lunze, Karsten; Lunze, Fatima I.; Raj, Anita; Samet, Jeffrey H.			Stigma and Human Rights Abuses against People Who Inject Drugs in Russia-A Qualitative Investigation to Inform Policy and Public Health Strategies	PLOS ONE			English	Article							HARM REDUCTION; ST-PETERSBURG; HIV RISK; SYRINGE EXCHANGE; USERS; TRANSMISSION; PARTNERSHIPS; PREVENTION; BEHAVIORS; HIV/AIDS	Introduction Drug policing practices in the Russian Federation (Russia) are often punitive and have been shown to be associated with HIV risk behaviors among people who inject drugs (PWID). Less is known about strategies to address the problem in that setting, where substance use stigma is highly persistent. A better understanding of forms, causes and consequences of drug policing in Russia could inform drug policy in a context of substantial policy resistance. This qualitative study's goal is to characterize the phenomenon of police involvement with Russian PWID and to explore strategies for drug policing in the Russian country context. Methods Using a semi-structured interview guide, we collected data from a purposive sample of 23 key informants including PWID, police officers, and experts from civil society and international organizations in Russia. We used a thematic analysis approach to inductively generate new insight into the phenomenon of police involvement and potential strategies to address it. Results Policing practices involving PWID include unjustified arrests, planting of false evidence and extrajudicial syringe confiscations, and often constitute human rights violations. Russian PWID personally experienced police violence as ubiquitous, taking on various forms such as beating, unjustified arrests, verbal harassment, and coercion. The persistent societal stigma dehumanizes PWID, and such stigmatization facilitates police abuse. To address stigma and overcome the PWID-police adversity, study participants suggested fostering a mutual understanding between the police and public health sectors. Conclusions Participants describe substantial human rights violations as part of policing illicit drug use in Russia. Police should include principles of effective prevention of substance use and HIV risk reduction in their trainings. Alignment of public safety and public health goals could address drug use-related risks and HIV prevention among key populations in Russia.	[Lunze, Karsten; Samet, Jeffrey H.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Lunze, Fatima I.] Harvard Univ, Sch Med, Boston Childrens Hosp, Boston, MA USA; [Raj, Anita] Univ Calif San Diego, Sch Med, Dept Med, Div Global Publ Hlth, San Diego, CA 92103 USA	Boston University; Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California San Diego	Lunze, K (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.	Karsten.lunze@post.harvard.edu	Lunze, Karsten/AAL-7240-2021	Lunze, Karsten/0000-0001-8495-0350; Samet, Jeffrey/0000-0002-0897-3400	 [U24AA020778]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA020778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA013582] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors received no specific funding for this work. The publication fee was supported by grant U24AA020778.	Aitken C, 2002, INT J DRUG POLICY, V13, P10; Amirkhanian YA, 2003, AIDS, V17, P2367, DOI 10.1097/00002030-200311070-00012; Amirkhanian YA, 2011, AIDS BEHAV; Balabanova Y, 2006, AIDS CARE, V18, P846, DOI 10.1080/09540120600643641; Beletsky L, 2005, INT J DRUG POLICY, V16, P267, DOI 10.1016/j.drugpo.2005.01.009; Beletsky L, 2011, DRUG ALCOHOL DEPEN, V119, P145, DOI 10.1016/j.drugalcdep.2011.05.034; Beletsky L, 2011, AM J PUBLIC HEALTH, V101, P2012, DOI 10.2105/AJPH.2011.300254; Beyrer C, 2012, HARM REDUCT J, V9, DOI 10.1186/1477-7517-9-32; Blankenship KM, 2002, J LAW MED ETHICS, V30, P548, DOI 10.1111/j.1748-720X.2002.tb00425.x; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burchell AN, 2008, SEX TRANSM DIS, V35, P807, DOI 10.1097/OLQ.0b013e3181728a9e; Burris S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001571; Burris S, 2009, INT J DRUG POLICY, V20, P293, DOI 10.1016/j.drugpo.2009.04.001; Cepeda JA, 2011, AIDS BEHAV; Chakrapani V, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-9; Clark J, 2003, QUALITATIVE RES REV; Cooper H, 2005, SOC SCI MED, V61, P673, DOI 10.1016/j.socscimed.2004.12.030; Corbin Juliet M., 2007, BASICS QUALITATIVE R; Davis CS, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-16; Davis CS, 2005, AM J PUBLIC HEALTH, V95, P233, DOI 10.2105/AJPH.2003.031310; DeBeck K, 2008, SUBST ABUSE TREAT PR, V3, DOI 10.1186/1747-597X-3-11; Des Jarlais DC, 2000, AIDS, V14, pS41, DOI 10.1097/00002030-200006001-00006; Fairbairn N, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-24; Federal Scientific and Methodological Center for Prevention and Control of AIDS, 2010, DISTR RISK FACT HIV; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Goliusov AT, 2010, COUNTRY PROGRESS REP; Hayashi K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001570; Heimer R, 2010, DRUG ALCOHOL DEPEN, V109, P79, DOI 10.1016/j.drugalcdep.2009.12.010; Izenberg JM, 2013, DRUG ALCOHOL DEPEN, V133, P154, DOI 10.1016/j.drugalcdep.2013.05.018; Jurgens R, 2010, LANCET, V376, P475, DOI 10.1016/S0140-6736(10)60830-6; Lunze K, 2013, INT SOC ADD MED ISAM; Lunze K, 2013, INT C GLOB HLTH PREV; Lunze K, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19043; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Miller CL, 2008, INT J DRUG POLICY, V19, P324, DOI 10.1016/j.drugpo.2007.06.002; Mimiaga MJ, 2010, AIDS CARE, V22, P1305, DOI 10.1080/09540121003758515; Nebrenchina L, 2009, DRUG POLICY RUSSIA; Ottersen OP, 2014, LANCET, V383, P630, DOI 10.1016/S0140-6736(13)62407-1; Pollini RA, 2008, ADDICTION, V103, P101, DOI 10.1111/j.1360-0443.2007.02051.x; QSR International, 2015, NVIVO 10 RES SOFTW A; Rahman F, 2012, 6 ANN C INT SOC STUD; Rhodes T, 1999, AIDS, V13, pS259; Rhodes T, 2005, SOC SCI MED, V61, P1026, DOI 10.1016/j.socscimed.2004.12.024; Rhodes T, 2003, SOC SCI MED, V57, P39, DOI 10.1016/S0277-9536(02)00521-X; Rhodes T, 2002, INT J DRUG POLICY, V13, P10; Rhodes T, 2006, J URBAN HEALTH, V83, P911, DOI 10.1007/s11524-006-9085-y; Rhodes T, 2012, RETHINKING SOCIAL EPIDEMIOLOGY: TOWARDS A SCIENCE OF CHANGE, P205, DOI 10.1007/978-94-007-2138-8_10; Rhodes T, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3439; Saldana J, 2012, CODING MANUAL QUALIT, VKindle Edition; Sarang A, 2010, SUBST USE MISUSE, V45, P813, DOI 10.3109/10826081003590938; Saranga A, 2008, INT J DRUG POLICY, V19, pS25, DOI 10.1016/j.drugpo.2007.11.008; Sarin E, 2011, INT J DRUG POLICY, V22, P161, DOI 10.1016/j.drugpo.2010.09.011; Silverman B, 2012, HARM REDUCT J, V9, DOI 10.1186/1477-7517-9-17; Small W, 2005, INT J DRUG POLICY, V17, P11; Somlai AM, 2002, AIDS EDUC PREV, V14, P295, DOI 10.1521/aeap.14.5.295.23873; Spicer N, 2011, SOC SCI MED, V73, P1748, DOI 10.1016/j.socscimed.2011.08.024; Strathdee SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019048; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNAIDS, 2012, UNAIDS RUSS HIV AIDS; UNAIDS, 2013, RUSS FED COUNTR PROF; UNDP (United National Development Programme), 2008, LIV HIV E EUR CIS HU; Volkmann T, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-7; Werb D, 2008, INT J DRUG POLICY, V19, P332, DOI 10.1016/j.drugpo.2007.08.004; Wodak A, 2008, AIDS, V22, pS81, DOI 10.1097/01.aids.0000327439.20914.33; World health organization (WHO), POL BRIEF RED HIV TR	65	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136030	10.1371/journal.pone.0136030	http://dx.doi.org/10.1371/journal.pone.0136030			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6KK	26305697	gold, Green Published, Green Submitted			2022-12-27	WOS:000359995500043
J	Peter, AP; Lakshmanan, K; Mohandass, S; Varadharaj, S; Thilagar, S; Kareem, KAA; Dharmar, P; Gopalakrishnan, S; Lakshmanan, U				Peter, Arul Prakasam; Lakshmanan, Karthick; Mohandass, Shylajanaciyar; Varadharaj, Sangeetha; Thilagar, Sivasudha; Kareem, Kaleel Ahamed Abdul; Dharmar, Prabaharan; Gopalakrishnan, Subramanian; Lakshmanan, Uma			Cyanobacterial KnowledgeBase (CKB), a Compendium of Cyanobacterial Genomes and Proteomes	PLOS ONE			English	Article							MARINE CYANOBACTERIA; PROTEIN-INTERACTION; DATABASE	Cyanobacterial KnowledgeBase (CKB) is a free access database that contains the genomic and proteomic information of 74 fully sequenced cyanobacterial genomes belonging to seven orders. The database also contains tools for sequence analysis. The Species report and the gene report provide details about each species and gene (including sequence features and gene ontology annotations) respectively. The database also includes cyanoBLAST, an advanced tool that facilitates comparative analysis, among cyanobacterial genomes and genomes of E. coli (prokaryote) and Arabidopsis (eukaryote). The database is developed and maintained by the Sub-Distributed Informatics Centre (sponsored by the Department of Biotechnology, Govt. of India) of the National Facility for Marine Cyanobacteria, a facility dedicated to marine cyanobacterial research. CKB is freely available at http://nfmc.res.in/ckb/index.html.	[Peter, Arul Prakasam; Lakshmanan, Karthick; Mohandass, Shylajanaciyar; Varadharaj, Sangeetha; Dharmar, Prabaharan; Gopalakrishnan, Subramanian; Lakshmanan, Uma] Bharathidasan Univ, Natl Facil Marine Cyanobacteria Sub Distributed B, Dept Marine Biotechnol, Sch Marine Sci, Tiruchirappalli, Tamil Nadu, India; [Thilagar, Sivasudha] Bharathidasan Univ, Dept Environm Biotechnol, Tiruchirappalli, Tamil Nadu, India; [Kareem, Kaleel Ahamed Abdul] Jamal Mohammed Coll, Dept Bot, Tiruchirappalli, Tamil Nadu, India	Bharathidasan University; Bharathidasan University; Jamal Mohamed College	Lakshmanan, U (corresponding author), Bharathidasan Univ, Natl Facil Marine Cyanobacteria Sub Distributed B, Dept Marine Biotechnol, Sch Marine Sci, Tiruchirappalli, Tamil Nadu, India.	lumaprabakar@yahoo.com	Peter, Arul Prakasam/AAO-8157-2020; Thilagar, Sivasudha/AAZ-7386-2020	Thilagar, Sivasudha/0000-0001-6460-1612; Peter, Arul Prakasam/0000-0002-4706-5165	Sub-DIC [(BT/BI/)4/038/02];  [BT/03/040/89]	Sub-DIC; 	The authors thank the facility BT/03/040/89 and the Sub-DIC (BT/BI/)4/038/02 for their fiscal support.	Arun PVPS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049425; Blaha Ludek, 2009, Interdiscip Toxicol, V2, P36, DOI 10.2478/v10102-009-0006-2; Bretaudeau A, 2013, NUCLEIC ACIDS RES, V41, pD396, DOI 10.1093/nar/gks1091; Bryant DA, 1994, MOL BIOL CYANOBACTER, P613, DOI [10.1007/978-94-011-0227-8, DOI 10.1007/978-94-011-0227-8]; Burja AM, 2001, TETRAHEDRON, V57, P9347, DOI 10.1016/S0040-4020(01)00931-0; Elhai J, 2009, NUCLEIC ACIDS RES, V37, pW28, DOI 10.1093/nar/gkp354; Fujisawa T, 2014, NUCLEIC ACIDS RES, V42, pD666, DOI 10.1093/nar/gkt1145; Furumichi M., 2002, GENOME INF, V13, P402; Hernandez-Prieto MA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00191; Hernandez-Prieto MA, 2012, BIOINFORMATION, V8, P634, DOI 10.6026/97320630008634; Kehr JC, 2011, BEILSTEIN J ORG CHEM, V7, P1622, DOI 10.3762/bjoc.7.191; Kelly L, 2012, NUCLEIC ACIDS RES, V40, pD632, DOI 10.1093/nar/gkr1022; Kim WY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S20; Miller CA, 2013, BIOINFORMATICS, V29, P381, DOI 10.1093/bioinformatics/bts677; NCBI standalone blast, NCBI STAND BLAST; Sasaki NV, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap025; Tan LT, 2007, PHYTOCHEMISTRY, V68, P954, DOI 10.1016/j.phytochem.2007.01.012; Whitton B., 2002, ECOLOGY CYANOBACTERI, DOI [10.1007/0-306-46855-7, DOI 10.1007/0-306-46855-7]; Wu JY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-104	19	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136262	10.1371/journal.pone.0136262	http://dx.doi.org/10.1371/journal.pone.0136262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305368	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500058
J	Torres, LH; Garcia, RCT; Blois, AMM; Dati, LMM; Durao, AC; Alves, AS; Pacheco-Neto, M; Mauad, T; Britto, LRG; Xavier, GF; Camarini, R; Marcourakis, T				Torres, Larissa Helena; Garcia, Raphael C. T.; Blois, Anne M. M.; Dati, Livia M. M.; Durao, Ana Carolina; Alves, Adilson Silva; Pacheco-Neto, Maurilio; Mauad, Thais; Britto, Luiz R. G.; Xavier, Gilberto Fernando; Camarini, Rosana; Marcourakis, Tania			Exposure of Neonatal Mice to Tobacco Smoke Disturbs Synaptic Proteins and Spatial Learning and Memory from Late Infancy to Early Adulthood	PLOS ONE			English	Article							SYNAPSIN-I; HIPPOCAMPAL NEUROGENESIS; BRAIN-DEVELOPMENT; CIGARETTE-SMOKE; DENTATE GYRUS; MOUSE-BRAIN; SHORT-TERM; RAT-BRAIN; EXPRESSION; BDNF	Exposure to environmental tobacco smoke (ETS) in the early postnatal period has been associated with several diseases; however, little is known about the brain effects of ETS exposure during this critical developmental period or the long-term consequences of this exposure. This study investigated the effects of the early postnatal ETS exposure on both reference and working memory, synaptic proteins and BDNF fromlate infancy to early adulthood (P3-P73). BALB/c mice were exposed to ETS generated from 3R4F reference research cigarettes (0.73 mg of nicotine/cigarette) from P3 to P14. Spatial reference and workingmemory were evaluated in the Morris water maze during infancy (P20-P29), adolescence (P37-P42) and adulthood (P67-P72). Synapsin, synaptophysin, PSD95 and brain-derived neurotrophic factor (BDNF) were assessed at P15, P35 and P65 by immunohistochemistry and immunoblotting. Mice that were exposed to ETS during the early postnatal period showed poorer performance in the spatial referencememory task. Specifically, the ETS-exposed mice exhibited a significantly reduced time and distance traveled in the target quadrant and in the platformlocation area than the controls at all ages evaluated. In the spatial working memory task, ETS disrupted the maintenance but not the acquisition of the critical spatial information in both infancy and adolescence. ETS also induced changes in synaptic components, including decreases in synapsin, synaptophysin, PSD95 and BDNF levels in the hippocampus. Exposure to ETS in the early postnatal period disrupts both spatial reference and working memory; these results may be related to changes in synaptogenesis in the hippocampus. Importantly, most of these effects were not reversed even after a long exposure-free period.	[Torres, Larissa Helena; Garcia, Raphael C. T.; Blois, Anne M. M.; Dati, Livia M. M.; Durao, Ana Carolina; Marcourakis, Tania] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508000 Sao Paulo, SP, Brazil; [Alves, Adilson Silva; Britto, Luiz R. G.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, BR-05508000 Sao Paulo, SP, Brazil; [Pacheco-Neto, Maurilio] Univ Sao Paulo, Sch Med, Dept Clin Pathol, BR-05403010 Sao Paulo, SP, Brazil; [Mauad, Thais] Univ Sao Paulo, Sch Med, Dept Pathol, BR-01246903 Sao Paulo, SP, Brazil; [Xavier, Gilberto Fernando] Univ Sao Paulo, Inst Biosci, Dept Physiol, BR-05508900 Sao Paulo, SP, Brazil; [Camarini, Rosana] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, BR-05508900 Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Marcourakis, T (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508000 Sao Paulo, SP, Brazil.	tmarcour@usp.br	Torres, Larissa Helena/X-1496-2019; Marcourakis, Tânia/D-6667-2012; Camarini, Rosana/D-2251-2012; Xavier, Gilberto F/B-9464-2013	Torres, Larissa Helena/0000-0002-7065-7484; Marcourakis, Tânia/0000-0002-0076-5017; Camarini, Rosana/0000-0002-8131-6108; Xavier, Gilberto F/0000-0002-8567-7031; Tamborelli Garcia, Raphael Caio/0000-0002-7080-3955	Sao Paulo Research Foundation (FAPESP) [2009/14621-1]; Coordination for the Improvement of Higher Education Personnel (CAPES); National Counsel of Technological and Scientific Development (CNPq)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Sao Paulo Research Foundation (FAPESP; 2009/14621-1), Coordination for the Improvement of Higher Education Personnel (CAPES) and National Counsel of Technological and Scientific Development (CNPq). Th.M., L.R.G.B., G.F.X., R.C. and T.M. are research fellows of CNPq.	Alves NC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009261; Amos-Kroohs RM, 2013, NEUROTOXICOL TERATOL, V35, P34, DOI 10.1016/j.ntt.2013.01.001; Anbarasi K, 2006, NEUROSCIENCE, V138, P1127, DOI 10.1016/j.neuroscience.2005.11.029; BADDELEY A, 1992, J COGNITIVE NEUROSCI, V4, P281, DOI 10.1162/jocn.1992.4.3.281; Bandiera FC, 2011, ARCH PEDIAT ADOL MED, V165, P332, DOI 10.1001/archpediatrics.2011.30; Bogen IL, 2009, NEUROSCIENCE, V158, P231, DOI 10.1016/j.neuroscience.2008.05.055; Cho SC, 2013, PSYCHOL MED, V43, P209, DOI 10.1017/S0033291712001109; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Dribben WH, 2011, NEUROTOXICOL TERATOL, V33, P473, DOI 10.1016/j.ntt.2011.05.006; Dumas TC, 2005, HIPPOCAMPUS, V15, P562, DOI 10.1002/hipo.20077; Dwyer JB, 2009, PHARMACOL THERAPEUT, V122, P125, DOI 10.1016/j.pharmthera.2009.02.003; El-Hussein AE, 2000, SCIENCE, V290, P1364; Ferreira AFB, 2011, BRAIN RES, V1425, P111, DOI 10.1016/j.brainres.2011.10.004; Frick KM, 2003, NEUROBIOL AGING, V24, P615, DOI 10.1016/S0197-4580(02)00138-0; Fried PA, 2001, NEUROTOXICOL TERATOL, V23, P421, DOI 10.1016/S0892-0362(01)00160-X; Fuller BF, 2010, J MOL NEUROSCI, V41, P165, DOI 10.1007/s12031-009-9316-2; Gomez-Pinilla F, 2001, BRAIN RES, V904, P13, DOI 10.1016/S0006-8993(01)02394-0; Gospe SM, 1996, PEDIATR RES, V39, P494, DOI 10.1203/00006450-199603000-00018; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Heath CJ, 2009, NEUROPHARMACOLOGY, V56, P254, DOI 10.1016/j.neuropharm.2008.07.020; Jacobsen LK, 2007, NEUROPSYCHOPHARMACOL, V32, P2453, DOI 10.1038/sj.npp.1301398; John JPP, 2009, HIPPOCAMPUS, V19, P731, DOI 10.1002/hipo.20553; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Julvez J, 2007, INT J EPIDEMIOL, V36, P825, DOI 10.1093/ije/dym107; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Torres LHL, 2012, J TOXICOL ENV HEAL A, V75, P971, DOI 10.1080/15287394.2012.695985; Lotufo JPB, 2005, PASSIVE SMOKERS URIN, V27, P19; Mullany PM, 1998, NEUROREPORT, V9, P2489, DOI 10.1097/00001756-199808030-00012; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Obot CJ, 2004, INHAL TOXICOL, V16, P701, DOI 10.1080/08958370490476604; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Schmitt U, 2009, NEUROSCIENCE, V162, P234, DOI 10.1016/j.neuroscience.2009.04.046; Slotkin TA, 2004, TOXICOL APPL PHARM, V198, P132, DOI 10.1016/j.taap.2003.06.001; Slotkin TA, 2002, DEV BRAIN RES, V133, P175; Slotkin TA, 2006, BRAIN RES, V1111, P30, DOI 10.1016/j.brainres.2006.06.094; Slotkin TA, 2015, BRAIN RES BULL, V111, P84, DOI 10.1016/j.brainresbull.2015.01.003; Slotkin TA, 2014, BRAIN RES BULL, V102, P1, DOI 10.1016/j.brainresbull.2014.01.004; Stangherlin EC, 2009, INHAL TOXICOL, V21, P868, DOI 10.1080/08958370802526881; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Substance Abuse and Mental Health Services Administration (SA1VIHSA), 2012, NSDUH SER H, VH-44; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Torres LH, 2014, ARCH TOXICOL; Troe EJWM, 2008, NICOTINE TOB RES, V10, P1373, DOI 10.1080/14622200802238944; Tsai YW, 2013, J CEREBR BLOOD F MET, V33, P764, DOI 10.1038/jcbfm.2013.15; WATSON ES, 1987, J ANAL TOXICOL, V11, P19, DOI 10.1093/jat/11.1.19; Xavier GF, 1999, HIPPOCAMPUS, V9, P668, DOI 10.1002/(SICI)1098-1063(1999)9:6<668::AID-HIPO8>3.0.CO;2-9; Zhao WQ, 2000, P NATL ACAD SCI USA, V97, P8098, DOI 10.1073/pnas.97.14.8098	50	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136399	10.1371/journal.pone.0136399	http://dx.doi.org/10.1371/journal.pone.0136399			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305213	Green Submitted, Green Published, gold			2022-12-27	WOS:000359995500074
J	Zhang, C; Belanger, S; Pouliot, P; Lesage, F				Zhang, Cong; Belanger, Samuel; Pouliot, Philippe; Lesage, Frederic			Measurement of Local Partial Pressure of Oxygen in the Brain Tissue under Normoxia and Epilepsy with Phosphorescence Lifetime Microscopy	PLOS ONE			English	Article							BLOOD-FLOW; PO-2; MICROCIRCULATION; STIMULATION; TRANSPORT; NETWORKS; DYNAMICS; DELIVERY; OXIMETRY; SPIKES	In this work a method for measuring brain oxygen partial pressure with confocal phosphorescence lifetime microscopy system is reported. When used in conjunction with a dendritic phosphorescent probe, Oxyphor G4, this system enabled minimally invasive measurements of oxygen partial pressure (pO2) in cerebral tissue with high spatial and temporal resolution during 4-AP induced epileptic seizures. Investigating epileptic events, we characterized the spatio-temporal distribution of the "initial dip" in pO2 near the probe injection site and along nearby arterioles. Our results reveal a correlation between the percent change in the pO2 signal during the "initial dip" and the duration of seizure-like activity, which can help localize the epileptic focus and predict the length of seizure.	[Zhang, Cong; Belanger, Samuel; Pouliot, Philippe; Lesage, Frederic] Ecole Polytech, Dept Elect Engn, Montreal, PQ H3C 3A7, Canada; [Pouliot, Philippe; Lesage, Frederic] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada	Universite de Montreal; Polytechnique Montreal; Universite de Montreal	Lesage, F (corresponding author), Ecole Polytech, Dept Elect Engn, CP 6079 Succ Ctr Ville, Montreal, PQ H3C 3A7, Canada.	frederic.lesage@polymtl.ca			Canadian Institutes of Health Research [RN299166]; Reseau de Bioimagerie du Quebec (RBIQ); Chinese Science Foundation (CSC) scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Reseau de Bioimagerie du Quebec (RBIQ); Chinese Science Foundation (CSC) scholarship	This work was supported by funding from the Canadian Institutes of Health Research (RN299166) and the Reseau de Bioimagerie du Quebec (RBIQ) to F. Lesage. Cong Zhang was supported by a Chinese Science Foundation (CSC) scholarship.	Ances BM, 2001, NEUROSCI LETT, V306, P106, DOI 10.1016/S0304-3940(01)01868-7; Arthurs OJ, 2000, NEUROSCIENCE, V101, P803, DOI 10.1016/S0306-4522(00)00511-X; Bahar S, 2006, NEUROREPORT, V17, P499, DOI 10.1097/01.wnr.0000209010.78599.f5; Cheng MY, 2014, P NATL ACAD SCI USA, V111, P12913, DOI 10.1073/pnas.1404109111; Nguyen DK, 2013, EPILEPSIA, V54, P331, DOI 10.1111/epi.12011; Dunphy I, 2002, ANAL BIOCHEM, V310, P191, DOI 10.1016/S0003-2697(02)00384-6; Esipova TV, 2011, ANAL CHEM, V83, P8756, DOI 10.1021/ac2022234; Estrada AD, 2008, OPT LETT, V33, P1038, DOI 10.1364/OL.33.001038; Ferris CF, 2013, BRAIN BEHAV, V3, P351, DOI 10.1002/brb3.138; Finikova OS, 2008, CHEMPHYSCHEM, V9, P1673, DOI 10.1002/cphc.200800296; Golub AS, 2008, AM J PHYSIOL-HEART C, V294, pH2905, DOI 10.1152/ajpheart.01347.2007; Guevara E, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.7.076021; Hogan MC, 1999, J APPL PHYSIOL, V86, P720, DOI 10.1152/jappl.1999.86.2.720; Hyder F, 2002, P NATL ACAD SCI USA, V99, P10771, DOI 10.1073/pnas.132272299; IVANOV KP, 1979, MICROVASC RES, V18, P434, DOI 10.1016/0026-2862(79)90049-9; Kasischke KA, 2011, J CEREBR BLOOD F MET, V31, P68, DOI 10.1038/jcbfm.2010.158; Lauritzen M, 2001, J CEREBR BLOOD F MET, V21, P1367, DOI 10.1097/00004647-200112000-00001; Lebedev AY, 2009, ACS APPL MATER INTER, V1, P1292, DOI 10.1021/am9001698; Masamoto K, 2003, J CEREBR BLOOD F MET, V23, P1075, DOI 10.1097/01.WCB.0000084248.20114.B3; Mintun MA, 2001, P NATL ACAD SCI USA, V98, P6859, DOI 10.1073/pnas.111164398; Nagata K, 2002, ANN NY ACAD SCI, V977, P391, DOI 10.1111/j.1749-6632.2002.tb04843.x; Nielsen AN, 2001, J PHYSIOL-LONDON, V533, P773, DOI 10.1111/j.1469-7793.2001.00773.x; Osharina V, 2010, NEUROIMAGE, V50, P600, DOI 10.1016/j.neuroimage.2010.01.009; Papkovsky DB, 2013, CHEM SOC REV, V42, P8700, DOI 10.1039/c3cs60131e; PLANT RL, 1993, APPL SPECTROSC, V47, P1594, DOI 10.1366/0003702934334868; Pouliot P, 2012, J NEUROSCI METH, V204, P326, DOI 10.1016/j.jneumeth.2011.11.016; Puntoriero, 2011, DESIGNING DENDRIMERS, P463, DOI [DOI 10.1039/C39930001260, 10.1039/C39930001260]; Quaranta Michela, 2012, Bioanal Rev, V4, P115; RUMSEY WL, 1988, SCIENCE, V241, P1649, DOI 10.1126/science.3420417; Sakadzic S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6734; Sakadzic S, 2010, NAT METHODS, V7, P755, DOI 10.1038/nmeth.1490; Secomb TW, 2000, MICROCIRCULATION, V7, P237, DOI 10.1038/sj.mn.7300114; Sharan M, 2008, J CEREBR BLOOD F MET, V28, P1597, DOI 10.1038/jcbfm.2008.51; Shonat RD, 1997, BIOPHYS J, V73, P1223, DOI 10.1016/S0006-3495(97)78155-4; Shonat RD, 2003, ANN BIOMED ENG, V31, P1084, DOI 10.1114/1.1603256; Smith LM, 2002, MICROCIRCULATION, V9, P389, DOI 10.1038/sj.mn.7800147; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; TORRES IP, 1994, P NATL ACAD SCI USA, V91, P2081, DOI 10.1073/pnas.91.6.2081; VANDERKOOI JM, 1987, J BIOL CHEM, V262, P5476; Wilson DF, 2005, APPL OPTICS, V44, P5239, DOI 10.1364/AO.44.005239; Zhao MR, 2011, J NEUROSCI, V31, P13292, DOI 10.1523/JNEUROSCI.2597-11.2011; Zhao MR, 2009, J NEUROSCI, V29, P2814, DOI 10.1523/JNEUROSCI.4667-08.2009	42	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135536	10.1371/journal.pone.0135536	http://dx.doi.org/10.1371/journal.pone.0135536			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305777	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000359995500026
J	Briber, BM; Hutyra, LR; Reinmann, AB; Raciti, SM; Dearborn, VK; Holden, CE; Dunn, AL				Briber, Brittain M.; Hutyra, Lucy R.; Reinmann, Andrew B.; Raciti, Steve M.; Dearborn, Victoria K.; Holden, Christopher E.; Dunn, Allison L.			Tree Productivity Enhanced with Conversion from Forest to Urban Land Covers	PLOS ONE			English	Article							CARBON STORAGE; RED OAK; GROWTH; URBANIZATION; NITROGEN; BOSTON; CONSEQUENCES; GRADIENT; IMPACTS; BIOMASS	Urban areas are expanding, changing the structure and productivity of landscapes. While some urban areas have been shown to hold substantial biomass, the productivity of these systems is largely unknown. We assessed how conversion from forest to urban land uses affected both biomass structure and productivity across eastern Massachusetts. We found that urban land uses held less than half the biomass of adjacent forest expanses with a plot level mean biomass density of 33.5 +/- 8.0 Mg C ha(-1). As the intensity of urban development increased, the canopy cover, stem density, and biomass decreased. Analysis of Quercus rubra tree cores showed that tree-level basal area increment nearly doubled following development, increasing from 17.1 +/- 3.0 to 35.8 +/- 4.7 cm(2) yr(-1). Scaling the observed stem densities and growth rates within developed areas suggests an aboveground biomass growth rate of 1.8 +/- 0.4 Mg C ha(-1) yr(-1), a growth rate comparable to nearby, intact forests. The contrasting high growth rates and lower biomass pools within urban areas suggest a highly dynamic ecosystem with rapid turnover. As global urban extent continues to grow, cities consider climate mitigation options, and as the verification of net greenhouse gas emissions emerges as critical for policy, quantifying the role of urban vegetation in regional-to-global carbon budgets will become ever more important.	[Briber, Brittain M.; Hutyra, Lucy R.; Reinmann, Andrew B.; Raciti, Steve M.; Dearborn, Victoria K.; Holden, Christopher E.] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Raciti, Steve M.] Hofstra Univ, Dept Biol, Hempstead, NY 11550 USA; [Dunn, Allison L.] Worcester State Univ, Dept Earth Environm & Phys, Worcester, MA USA	Boston University; Hofstra University; Massachusetts System of Public Higher Education; Worcester State University	Hutyra, LR (corresponding author), Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA.	lrhutyra@bu.edu			National Science Foundation NSF CAREER award [DEB-1149471]; NASA Interdisciplinary Science grant [NNX12AM82G]	National Science Foundation NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NASA Interdisciplinary Science grant	For this study, Lucy Hutyra received funding from the National Science Foundation NSF CAREER award (DEB-1149471, http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503214) and a NASA Interdisciplinary Science grant (NNX12AM82G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, FOR INV AN TREE COUN; [Anonymous], 2004, GEOPHYS RES LETT; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Bettez ND, 2013, BIOGEOCHEMISTRY, V114, P149, DOI 10.1007/s10533-013-9847-z; Bonan GB, 2008, ECOLOGICAL CLIMATOLO, Vxvi; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; Briber BM, 2013, LAND-BASEL, V2, P304, DOI 10.3390/land2030304; Christen A, 2014, URBAN CLIMA IN PRESS; Churkina G, 2008, ECOL MODEL, V216, P107, DOI 10.1016/j.ecolmodel.2008.03.006; Coutts AM, 2007, ATMOS ENVIRON, V41, P51, DOI 10.1016/j.atmosenv.2006.08.030; Davies ZG, 2011, J APPL ECOL, V48, P1125, DOI 10.1111/j.1365-2664.2011.02021.x; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Efron B., 1994, INTRO BOOTSTRAP; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Food Agriculture Organization, 2001, STAT WORLDS FOR 2001; Foster CHW, 2005, J INTERDISCIPL HIST, V36, P270, DOI 10.1162/0022195054741442; Foster D.R., 2004, FORESTS TIME ENV CON; Fulton W., 2001, WHO SPRAWLS MOST GRO; George K, 2007, ATMOS ENVIRON, V41, P7654, DOI 10.1016/j.atmosenv.2007.08.018; Golubiewski NE, 2006, ECOL APPL, V16, P555, DOI 10.1890/1051-0761(2006)016[0555:UIGCPE]2.0.CO;2; Google, 2020, GOOGL EARTH; Gregg JW, 2003, NATURE, V424, P183, DOI 10.1038/nature01728; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Grissino-Mayer H.D, 2001, EVALUATING CROSSDATI; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Hope D, 2003, P NATL ACAD SCI USA, V100, P8788, DOI 10.1073/pnas.1537557100; Hutyra LR., 2014, EARTHS FUTURE; Hutyra LR, 2011, LANDSCAPE URBAN PLAN, V103, P83, DOI 10.1016/j.landurbplan.2011.06.004; Hutyra LR, 2011, GLOBAL CHANGE BIOL, V17, P783, DOI 10.1111/j.1365-2486.2010.02238.x; Iakovoglou Valasia, 2001, Urban Ecosystems, V5, P71, DOI 10.1023/A:1021829702654; International Energy Agency, 2008, WORLD EN OUTL 2008; Jacovides CP, 1997, AGR FOREST METEOROL, V87, P91, DOI 10.1016/S0168-1923(97)00031-2; Jenerette GD, 2001, LANDSCAPE ECOL, V16, P611, DOI 10.1023/A:1013170528551; Jin SM, 2013, REMOTE SENS ENVIRON, V132, P159, DOI 10.1016/j.rse.2013.01.012; Kaye JP, 2006, TRENDS ECOL EVOL, V21, P192, DOI 10.1016/j.tree.2005.12.006; Lorenz K, 2009, ENVIRON INT, V35, P1, DOI 10.1016/j.envint.2008.05.006; McDonald RI, 2004, ECOLOGY, V85, P2258, DOI 10.1890/03-0313; McDonnell Mark J., 1997, Urban Ecosystems, V1, P21, DOI 10.1023/A:1014359024275; Munger W, 1999, EMS BIOMASS INVENTOR; Naidoo R, 2001, FOREST SCI, V47, P338; NASA Carbon Monitoring System, 2014, CMS BIOM PIL; Novak K, 2003, ENVIRON POLLUT, V125, P41, DOI 10.1016/S0269-7491(03)00085-X; Nowak D. J., 1990, Journal of Arboriculture, V16, P124; Nowak David J., 2004, Urban Forestry & Urban Greening, V2, P139, DOI 10.1078/1618-8667-00030; OKE TR, 1982, Q J ROY METEOR SOC, V108, P1, DOI 10.1002/qj.49710845502; Pataki DE, 2011, FRONT ECOL ENVIRON, V9, P27, DOI 10.1890/090220; Pickett STA, 2011, J ENVIRON MANAGE, V92, P331, DOI 10.1016/j.jenvman.2010.08.022; Pongratz J, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003488; R Core Team, 2012, R LANG ENV STAT COMP; Raciti SM, 2014, SCI TOTAL ENVIRON, V500, P72, DOI 10.1016/j.scitotenv.2014.08.070; Raciti SM, 2012, ECOL APPL, V22, P1015, DOI 10.1890/11-1250.1; Raciti SM, 2012, BIOSCIENCE, V62, P23, DOI 10.1525/bio.2012.62.1.7; Raciti SM, 2011, ECOSYSTEMS, V14, P287, DOI 10.1007/s10021-010-9409-3; Rao P, 2013, URBAN ECOSYST, V16, P593, DOI 10.1007/s11252-013-0291-6; Roman LA, 2014, URBAN ECOSYST, V17, P387, DOI 10.1007/s11252-013-0320-5; Romero-Lankao P, 2014, EARTHS FUTURE; Schneider A, 2009, ENVIRON RES LETT, V4, P168; Searle SY, 2012, TREE PHYSIOL, V32, P389, DOI 10.1093/treephys/tps027; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Seto KC, 2012, P NATL ACAD SCI USA, V109, P7687, DOI 10.1073/pnas.1117622109; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Stocker T.F., 2013, CONTRIBUTION WORKING; Strong C, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015693; Takagi Masahiro, 2004, Urban Forestry & Urban Greening, V2, P167, DOI 10.1078/1618-8667-00033; TerMikaelian MT, 1997, FOREST ECOL MANAG, V97, P1, DOI 10.1016/S0378-1127(97)00019-4; Troxel B, 2013, URBAN FOR URBAN GREE, V12, P144, DOI 10.1016/j.ufug.2013.02.006; U.S. Census 2012, 2012, US CENS BUR 2012 CEN; UNDESA, 2012, WORLD URB PROSP 2011; United States Census, 2010, US CENS BUR 2010 CEN; Urbanski S, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000293; USDA NRCS, 2009, SOIL SURV MIDDL COUN; Ward JS, 2008, CROP TREE RELEASE IN, P457; WARD JS, 2011, US FOR SERV GEN TECH, V78, P502; Wu CY, 2012, GLOBAL PLANET CHANGE, V92-93, P179, DOI 10.1016/j.gloplacha.2012.05.021; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9; Zhao TT, 2012, LANDSCAPE ECOL, V27, P1149, DOI 10.1007/s10980-012-9766-8; Zhu Z, 2014, REMOTE SENS ENVIRON, V144, P152, DOI 10.1016/j.rse.2014.01.011	77	35	37	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136237	10.1371/journal.pone.0136237	http://dx.doi.org/10.1371/journal.pone.0136237			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302444	Green Submitted, Green Published, gold			2022-12-27	WOS:000359951900051
J	Mombo, IM; Berthet, N; Lukashev, AN; Bleicker, T; Brunink, S; Leger, L; Atencia, R; Cox, D; Bouchier, C; Durand, P; Arnathau, C; Brazier, L; Fair, JN; Schneider, BS; Drexler, JF; Prugnolle, F; Drosten, C; Renaud, F; Leroy, EM; Rougeron, V				Mombo, Illich Manfred; Berthet, Nicolas; Lukashev, Alexander N.; Bleicker, Tobias; Bruenink, Sebastian; Leger, Lucas; Atencia, Rebeca; Cox, Debby; Bouchier, Christiane; Durand, Patrick; Arnathau, Celine; Brazier, Lionel; Fair, Joseph N.; Schneider, Bradley S.; Drexler, Jan Felix; Prugnolle, Franck; Drosten, Christian; Renaud, Francois; Leroy, Eric M.; Rougeron, Virginie			First Detection of an Enterovirus C99 in a Captive Chimpanzee with Acute Flaccid Paralysis, from the Tchimpounga Chimpanzee Rehabilitation Center, Republic of Congo	PLOS ONE			English	Article							NATIONAL-PARK; VIRUS TYPE-1; EBOLA-VIRUS; GREAT APES; SEQUENCE; RNA; IDENTIFICATION; DIVERSITY; EVOLUTION; PRIMATES	Enteroviruses, members of the Picornaviridae family, are ubiquitous viruses responsible for mild to severe infections in human populations around the world. In 2010 Pointe-Noire, Republic of Congo recorded an outbreak of acute flaccid paralysis (AFP) in the humans, caused by wild poliovirus type 1 (WPV1). One month later, in the Tchimpounga sanctuary near Pointe-Noire, a chimpanzee developed signs similar to AFP, with paralysis of the lower limbs. In the present work, we sought to identify the pathogen, including viral and bacterial agents, responsible for this illness. In order to identify the causative agent, we evaluated a fecal specimen by PCR and sequencing. A Human enterovirus C, specifically of the EV-C99 type was potentially responsible for the illness in this chimpanzee. To rule out other possible causative agents, we also investigated the bacteriome and the virome using next generation sequencing. The majority of bacterial reads obtained belonged to commensal bacteria (95%), and the mammalian virus reads matched mainly with viruses of the Picornaviridae family (99%), in which enteroviruses were the most abundant (99.6%). This study thus reports the first identification of a chimpanzee presenting AFP most likely caused by an enterovirus and demonstrates once again the cross-species transmission of a human pathogen to an ape.	[Mombo, Illich Manfred; Berthet, Nicolas; Prugnolle, Franck; Leroy, Eric M.; Rougeron, Virginie] Ctr Int Rech Med Franceville, Franceville, Gabon; [Mombo, Illich Manfred; Leger, Lucas; Durand, Patrick; Arnathau, Celine; Brazier, Lionel; Prugnolle, Franck; Renaud, Francois; Leroy, Eric M.; Rougeron, Virginie] IRD, Lab MIVEGEC, CNRS, UMR 224 5290,UM1,UM2, Montpellier, France; [Berthet, Nicolas] Ctr Natl Rech Sci, UMR3569, F-75724 Paris, France; [Lukashev, Alexander N.] Chumakov Inst Poliomyelitis & Viral Encephal, Moscow, Russia; [Bleicker, Tobias; Bruenink, Sebastian; Drexler, Jan Felix; Drosten, Christian] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany; [Atencia, Rebeca; Cox, Debby] Jane Goodall Inst, Vienna, VA 22182 USA; [Bouchier, Christiane] Inst Pasteur, Genom Platform, F-75724 Paris, France; [Fair, Joseph N.; Schneider, Bradley S.] Metabiota Inc, San Francisco, CA 91404 USA; [Renaud, Francois] CHRU Montpellier, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Chumakov Federal Scientific Center for Research & Development of Immune & Biological Products of Russian Academy of Sciences; University of Bonn; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite de Montpellier; CHU de Montpellier	Mombo, IM (corresponding author), Ctr Int Rech Med Franceville, BP769, Franceville, Gabon.	mombo.illich@gmail.com	Lukashev, Alexander/G-2777-2013; Berthet, Nicolas/J-9373-2012; Rougeron, Virginie/AAH-7447-2020; Drexler, Jan Felix/GMW-5098-2022; LEROY, Eric M/I-4347-2016	Lukashev, Alexander/0000-0001-7365-0352; LEROY, Eric M/0000-0003-0022-0890; Rougeron, Virginie/0000-0001-5873-5681; MOMBO, Illich Manfred/0000-0001-9292-7943; Schneider, Bradley S/0000-0001-7642-0018; Prugnolle, Franck/0000-0001-8519-1253; Drexler, Jan Felix/0000-0002-3509-0232	Gabonese Government; Total Gabon; 'Institut National d'Ecologie et d'Evolution' of CNRS (France); Institut de Recherche pour le Developpement (IRD), France; United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT; Metabiota, Inc.	Gabonese Government; Total Gabon(Total SA); 'Institut National d'Ecologie et d'Evolution' of CNRS (France); Institut de Recherche pour le Developpement (IRD), France; United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT(United States Agency for International Development (USAID)); Metabiota, Inc.	This work was supported by the Gabonese Government, Total Gabon and the 'Institut National d'Ecologie et d'Evolution' of CNRS (France). The work was also supported by a fellowship BSTD of the Institut de Recherche pour le Developpement (IRD), France, as well as the generous support of the American people through the United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. Metabiota, Inc. provided support in the form of salaries for authors BSS and JNF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALLMOND BW, 1967, AM J EPIDEMIOL, V85, P229, DOI 10.1093/oxfordjournals.aje.a120686; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Berthet N, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-77; Bessaud M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024823; Blinkova O, 2009, J VIROL, V83, P4631, DOI 10.1128/JVI.02085-08; Brown BA, 2009, J GEN VIROL, V90, P1713, DOI 10.1099/vir.0.008540-0; Dierssen U, 2008, J CLIN VIROL, V42, P58, DOI 10.1016/j.jcv.2007.11.016; Dowdle WR, 1997, J INFECT DIS, V175, pS286, DOI 10.1093/infdis/175.Supplement_1.S286; Formenty P, 1999, J INFECT DIS, V179, pS48, DOI 10.1086/514285; Gilardi KVK, 2014, EMERG INFECT DIS, V20, P1883, DOI 10.3201/eid2011.140075; Gillespie TR, 2008, YEARB PHYS ANTHROPOL, V51, P53, DOI 10.1002/ajpa.20949; Grard G, 2010, EUROSURVEILLANCE B E, V15; Hansman GS, 2007, J CLIN MICROBIOL, V45, P1347, DOI 10.1128/JCM.01854-06; Harvala H, 2014, J GEN VIROL, V95, P403, DOI 10.1099/vir.0.059048-0; Harvala H, 2011, J VIROL, V85, P4480, DOI 10.1128/JVI.02285-10; HOFFERT WR, 1958, AM J HYG, V68, P15, DOI 10.1093/oxfordjournals.aje.a119946; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; KALTER S S, 1960, Bull World Health Organ, V22, P319; Kaur T, 2008, AM J PRIMATOL, V70, P755, DOI 10.1002/ajp.20565; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Kelly H, 2006, J PAEDIATR CHILD H, V42, P370, DOI 10.1111/j.1440-1754.2006.00875.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Kondgen S, 2010, ECOHEALTH, V7, P332, DOI 10.1007/s10393-010-0340-z; Leendertz FH, 2006, BIOL CONSERV, V131, P325, DOI 10.1016/j.biocon.2006.05.002; Leendertz FH, 2006, AM J PRIMATOL, V68, P928, DOI 10.1002/ajp.20298; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Logan G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-828; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lukashev AN, 2012, J GEN VIROL, V93, P2357, DOI 10.1099/vir.0.043216-0; Moeller AH, 2013, CELL HOST MICROBE, V14, P340, DOI 10.1016/j.chom.2013.08.005; Mombo IM, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00680-14; Nix WA, 2008, J CLIN MICROBIOL, V46, P2874, DOI 10.1128/JCM.00074-08; Oberste MS, 2013, J VIROL, V87, P558, DOI 10.1128/JVI.00837-12; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Prugnolle F, 2013, P NATL ACAD SCI USA, V110, P8123, DOI 10.1073/pnas.1306004110; Pusey AE, 2007, CONSERV BIOL, V21, P623, DOI 10.1111/j.1523-1739.2007.00704.x; Sadeuh-Mba SA, 2013, J CLIN MICROBIOL, V51, P759, DOI 10.1128/JCM.02119-12; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scheuer KA, 2013, J CLIN MICROBIOL, V51, P2344, DOI 10.1128/JCM.00865-13; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; SIMPSON LL, 1986, ANNU REV PHARMACOL, V26, P427, DOI 10.1146/annurev.pa.26.040186.002235; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Team RC, 2012, R LANG ENV STAT COMP; Tse H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034987; Woodford MH, 2002, ORYX, V36, P153, DOI 10.1017/S0030605302000224	48	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136700	10.1371/journal.pone.0136700	http://dx.doi.org/10.1371/journal.pone.0136700			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301510	Green Published, gold, Green Submitted			2022-12-27	WOS:000359951900080
J	de Wouters, T; Jans, C; Niederberger, T; Fischer, P; Ruhs, PA				de Wouters, Tomas; Jans, Christoph; Niederberger, Tobias; Fischer, Peter; Ruehs, Patrick Alberto			Adhesion Potential of Intestinal Microbes Predicted by Physico-Chemical Characterization Methods	PLOS ONE			English	Article							SURFACE FREE-ENERGY; BIOFILM FORMATION; LISTERIA-MONOCYTOGENES; ENTEROCOCCUS-FAECALIS; INTERFACIAL RHEOLOGY; ESCHERICHIA-COLI; HOST METABOLISM; CELL; HYDROPHOBICITY; BACTERIA	Bacterial adhesion to epithelial surfaces affects retention time in the human gastro-intestinal tract and therefore significantly contributes to interactions between bacteria and their hosts. Bacterial adhesion among other factors is strongly influenced by physico-chemical factors. The accurate quantification of these physico-chemical factors in adhesion is however limited by the available measuring techniques. We evaluated surface charge, interfacial rheology and tensiometry (interfacial tension) as novel approaches to quantify these interactions and evaluated their biological significance via an adhesion assay using intestinal epithelial surface molecules (IESM) for a set of model organisms present in the human gastrointestinal tract. Strain pairs of Lactobacillus plantarum WCFS1 with its sortase knockout mutant Lb. plantarum NZ7114 and Lb. rhamnosus GG with Lb. rhamnosus DSM 20021(T) were used with Enterococcus faecalis JH2-2 as control organism. Intra-species comparison revealed significantly higher abilities for Lb. plantarum WCSF1 and Lb. rhamnosus GG vs. Lb. plantarum NZ7114 and Lb. rhamnosus DSM 20021(T) to dynamically increase interfacial elasticity (10(-2) vs. 10(-3) Pa*m) and reduce interfacial tension (32 vs. 38 mN/m). This further correlated for Lb. plantarum WCSF1 and Lb. rhamnosus GG vs. Lb. plantarum NZ7114 and Lb. rhamnosus DSM 20021(T) with the decrease of relative hydrophobicity (80-85% vs. 57-63%), Zeta potential (-2.9 to -4.5 mV vs. -8.0 to -13.8 mV) and higher relative adhesion capacity to IESM (3.0-5.0 vs 1.5-2.2). Highest adhesion to the IESM collagen I and fibronectin was found for Lb. plantarum WCFS1 (5.0) and E. faecalis JH2-2 (4.2) whereas Lb. rhamnosus GG showed highest adhesion to type II mucus (3.8). Significantly reduced adhesion (2 fold) to the tested IESM was observed for Lb. plantarum NZ7114 and Lb. rhamnosus DSM 20021(T) corresponding with lower relative hydrophobicity, Zeta potential and abilities to modify interfacial elasticity and tension. Conclusively, the use of Zeta potential, interfacial elasticity and interfacial tension are proposed as suitable novel descriptive and predictive parameters to study the interactions of intestinal microbes with their hosts.	[de Wouters, Tomas; Jans, Christoph; Niederberger, Tobias] ETH, Inst Food Nutr & Hlth, Lab Food Biotechnol, CH-8092 Zurich, Switzerland; [Fischer, Peter; Ruehs, Patrick Alberto] ETH, Inst Food Nutr & Hlth, Lab Food Proc Engn, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	de Wouters, T (corresponding author), ETH, Inst Food Nutr & Hlth, Lab Food Biotechnol, Schmelzbergstr 9, CH-8092 Zurich, Switzerland.	tomas.dewouters@hest.ethz.ch; peter.fischer@hest.ethz.ch	Fischer, Peter/A-8740-2011	Fischer, Peter/0000-0002-2992-5037; Jans, Christoph/0000-0003-0387-606X	ETH Zurich [ETHIIRA TH32-1]	ETH Zurich(ETH Zurich)	P.R. acknowledges financial support by ETH Zurich (Project ETHIIRA TH32-1, https://www.ethz.ch/intranet/en/research-and-technology-transfer/research-promotion/eth-internal-programmes/eth-grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belzer C, 2012, ISME J, V6, P1449, DOI 10.1038/ismej.2012.6; Boekhorst J, 2006, MICROBIOL-SGM, V152, P3175, DOI 10.1099/mic.0.29217-0; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Bron PA, 2013, CURR OPIN MICROBIOL, V16, P262, DOI 10.1016/j.mib.2013.06.001; BUSSCHER HJ, 1984, COLLOID SURFACE, V9, P319, DOI 10.1016/0166-6622(84)80175-4; BUSSCHER HJ, 1995, COLLOID SURFACE B, V5, P111, DOI 10.1016/0927-7765(95)01224-7; BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980, DOI 10.1128/AEM.48.5.980-983.1984; BUSSCHER HJ, 1983, J COLLOID INTERF SCI, V95, P23, DOI 10.1016/0021-9797(83)90067-X; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; Erni P, 2003, REV SCI INSTRUM, V74, P4916, DOI 10.1063/1.1614433; Erni P, 2011, SOFT MATTER, V7, P7586, DOI 10.1039/c1sm05263b; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fontana L, 2013, BRIT J NUTR, V109, pS35, DOI 10.1017/S0007114512004011; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Hollenbeck EC, 2014, BIOPHYS J, V107, P2245, DOI 10.1016/j.bpj.2014.10.015; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; JACOB AE, 1974, J BACTERIOL, V117, P360, DOI 10.1128/JB.117.2.360-372.1974; JACOB AE, 1975, J BACTERIOL, V121, P863, DOI 10.1128/JB.121.3.863-872.1975; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kline KA, 2009, J BACTERIOL, V191, P3237, DOI 10.1128/JB.01837-08; Kragel J, 2010, CURR OPIN COLLOID IN, V15, P246, DOI 10.1016/j.cocis.2010.02.001; Lakhdari O, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/282356; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; LICHTENBERGER LM, 1995, ANNU REV PHYSIOL, V57, P565, DOI 10.1146/annurev.ph.57.030195.003025; Marteyn B, 2010, NATURE, V465, P355, DOI 10.1038/nature08970; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Miller R, 2010, COLLOID POLYM SCI, V288, P937, DOI 10.1007/s00396-010-2227-5; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Nallapareddy SR, 2000, INFECT IMMUN, V68, P5218, DOI 10.1128/IAI.68.9.5218-5224.2000; Pamp SJ, 2012, GENOME RES, V22, P1107, DOI 10.1101/gr.131482.111; Pan Y, 2006, APPL ENVIRON MICROB, V72, P7711, DOI 10.1128/AEM.01065-06; Poortinga AT, 2002, SURF SCI REP, V47, P3, DOI 10.1016/S0167-5729(02)00032-8; Ravera F, 2010, CURR OPIN COLLOID IN, V15, P217, DOI 10.1016/j.cocis.2010.04.001; Remus DM, 2013, J BACTERIOL, V195, P502, DOI 10.1128/JB.01321-12; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Ruhs PA, 2014, COLLOID SURFACE B, V117, P174, DOI 10.1016/j.colsurfb.2014.02.023; Ruhs PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078524; Ruhs PA, 2012, LANGMUIR, V28, P12536, DOI 10.1021/la3026705; Sagis LMC, 2014, CURR OPIN COLLOID IN, V19, P520, DOI 10.1016/j.cocis.2014.09.003; Sagis LMC, 2011, REV MOD PHYS, V83, P1367, DOI 10.1103/RevModPhys.83.1367; Servin AL, 2003, BEST PRACT RES CL GA, V17, P741, DOI 10.1016/S1521-6918(03)00052-0; Stepanovic S, 2004, LETT APPL MICROBIOL, V38, P428, DOI 10.1111/j.1472-765X.2004.01513.x; Valladares R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010507; VANDERMEI HC, 1987, J MICROBIOL METH, V6, P277, DOI 10.1016/0167-7012(87)90065-0; VANDERMEI HC, 1995, COLLOID SURFACE B, V5, P117, DOI 10.1016/0927-7765(95)01225-8; VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893, DOI 10.1128/AEM.53.8.1893-1897.1987; VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1898, DOI 10.1128/AEM.53.8.1898-1901.1987; Velraeds MMC, 1997, UROLOGY, V49, P790, DOI 10.1016/S0090-4295(97)00065-4; Wu C, 2013, LANGMUIR, V29, P920, DOI 10.1021/la304710k; Wu C, 2012, BIOPHYS J, V103, P464, DOI 10.1016/j.bpj.2012.06.049; Xu H, 2009, LETT APPL MICROBIOL, V49, P434, DOI 10.1111/j.1472-765X.2009.02684.x	54	23	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136437	10.1371/journal.pone.0136437	http://dx.doi.org/10.1371/journal.pone.0136437			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295945	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900112
J	Herbas, MS; Shichiri, M; Ishida, N; Kume, A; Hagihara, Y; Yoshida, Y; Suzuki, H				Herbas, Maria Shirely; Shichiri, Mototada; Ishida, Noriko; Kume, Aiko; Hagihara, Yoshihisa; Yoshida, Yasukazu; Suzuki, Hiroshi			Probucol-Induced alpha-Tocopherol Deficiency Protects Mice against Malaria Infection	PLOS ONE			English	Article							PARASITE PLASMODIUM-FALCIPARUM; RED-BLOOD-CELLS; OXIDATIVE STRESS; VITAMIN-E; IN-VIVO; ARTEMISININ RESISTANCE; LIPID-PEROXIDATION; CEREBRAL MALARIA; MURINE MALARIA; MEMBRANE	The emergence of malaria pathogens having resistance against antimalarials implies the necessity for the development of new drugs. Recently, we have demonstrated a resistance against malaria infection of alpha-tocopherol transfer protein knockout mice showing undetectable plasma levels of alpha-tocopherol, a lipid-soluble antioxidant. However, dietary restriction induced alpha-tocopherol deficiency is difficult to be applied as a clinical antimalarial therapy. Here, we report on a new strategy to potentially treat malaria by using probucol, a drug that can reduce the plasma alpha-tocopherol concentration. Probucol pre-treatment for 2 weeks and treatment throughout the infection rescued from death of mice infected with Plasmodium yoelii XL-17 or P. berghei ANKA. In addition, survival was extended when the treatment started immediately after parasite inoculation. The ratio of lipid peroxidation products to parent lipids increased in plasma after 2 weeks treatment of probucol. This indicates that the protective effect of probucol might be mediated by the oxidative stressful environment induced by alpha-tocopherol deficiency. Probucol in combination with dihydroartemisin suppressed the proliferation of P. yoelii XL-17. These results indicated that probucolmight be a candidate for a drug against malaria infection by inducing alpha-tocopherol deficiency without dietary alpha-tocopherol restriction.	[Herbas, Maria Shirely; Kume, Aiko; Suzuki, Hiroshi] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Res Unit Funct Genom, Sapporo, Hokkaido, Japan; [Shichiri, Mototada; Ishida, Noriko; Hagihara, Yoshihisa; Yoshida, Yasukazu] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Osaka, Japan; [Kume, Aiko; Suzuki, Hiroshi] Gifu Univ, United Grad Sch Vet Sci, Dept Vet Basic Sci, Gifu, Japan	Obihiro University of Agriculture & Veterinary Medicine; National Institute of Advanced Industrial Science & Technology (AIST); Gifu University	Suzuki, H (corresponding author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Res Unit Funct Genom, Sapporo, Hokkaido, Japan.	hisuzuki@obihiro.ac.jp	HAGIHARA, Yoshihisa/K-4996-2016; YOSHIDA, YASUKAZU/H-8510-2016; Shichiri, Mototada/L-9276-2018	HAGIHARA, Yoshihisa/0000-0002-5980-1764; YOSHIDA, YASUKAZU/0000-0001-6034-2502; Shichiri, Mototada/0000-0003-1108-7597	National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine [25-joint-6, 26-joint-6]	National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine	This work was supported by the Joint Research Grant (25-joint-6 and 26-joint-6) of the National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine (to MS) (http://www.obihiro.ac.jp/similar to protozoa/koubo.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATAMNA H, 1993, MOL BIOCHEM PARASIT, V61, P231, DOI 10.1016/0166-6851(93)90069-A; Attaran A, 2004, LANCET, V363, P237, DOI 10.1016/S0140-6736(03)15330-5; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Bell SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020047; Carvalho LJM, 2000, EXP PARASITOL, V95, P1, DOI 10.1006/expr.2000.4508; CLARK IA, 1983, INFECT IMMUN, V39, P1; Coppens I, 2013, NAT REV MICROBIOL, V11, P823, DOI 10.1038/nrmicro3139; Deitsch KW, 1996, MOL BIOCHEM PARASIT, V76, P1, DOI 10.1016/0166-6851(95)02575-8; ELINDER LS, 1995, ARTERIOSCL THROM VAS, V15, P1057, DOI 10.1161/01.ATV.15.8.1057; Favari E, 2004, ARTERIOSCL THROM VAS, V24, P2345, DOI 10.1161/01.ATV.0000148706.15947.8a; Gharbi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077775; Gibbons PL, 2007, INT J PARASITOL, V37, P1569, DOI 10.1016/j.ijpara.2007.05.001; Greene LS, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P185; GRELLIER P, 1991, J CELL BIOL, V112, P267, DOI 10.1083/jcb.112.2.267; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Hakimi H, 2012, PARASITOL RES, V111, P525, DOI 10.1007/s00436-012-2864-3; Herbas MS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-101; Herbas MS, 2010, AM J CLIN NUTR, V91, P200, DOI 10.3945/ajcn.2009.28260; Hodel EM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-138; JACOB HS, 1968, BLOOD, V32, P549, DOI 10.1182/blood.V32.4.549.549; Jortzik E, 2012, INT J MED MICROBIOL, V302, P187, DOI 10.1016/j.ijmm.2012.07.007; Kawazu S, 2003, INT J PARASITOL, V33, P1455, DOI 10.1016/S0020-7519(03)00184-X; Kawazu SI, 2008, PARASITOL INT, V57, P1, DOI 10.1016/j.parint.2007.08.001; Kehr S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001242; Kim JH, 2011, J PHARMACOL EXP THER, V338, P451, DOI 10.1124/jpet.111.181180; Koncarevic S, 2009, P NATL ACAD SCI USA, V106, P13323, DOI 10.1073/pnas.0905387106; KUMARATILAKE LM, 1992, J CLIN INVEST, V89, P961, DOI 10.1172/JCI115678; Lauer SA, 1997, SCIENCE, V276, P1122, DOI 10.1126/science.276.5315.1122; LEBEAU JE, 1980, NOUV PRESSE MED, V9, P3001; LEVANDER OA, 1995, J PARASITOL, V81, P99, DOI 10.2307/3284013; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-328; Muller S, 2004, MOL MICROBIOL, V53, P1291, DOI 10.1111/j.1365-2958.2004.04257.x; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Nogawa H, 2013, EUR J PHARMACOL, V720, P29, DOI 10.1016/j.ejphar.2013.10.056; Patel K, 2014, J ANTIMICROB CHEMOTH, V69, P2155, DOI 10.1093/jac/dku120; Pekmezci D, 2011, VITAM HORM, V86, P179, DOI 10.1016/B978-0-12-386960-9.00008-3; Shaik N, 2013, J CARDIOVASC PHARM, V61, P120, DOI 10.1097/FJC.0b013e3182798abc; Shankar AH, 2000, J INFECT DIS, V182, pS37, DOI 10.1086/315906; Shichiri M, 2011, FREE RADICAL BIO MED, V50, P1801, DOI 10.1016/j.freeradbiomed.2011.03.023; Shichiri M, 2010, J NUTR BIOCHEM, V21, P451, DOI 10.1016/j.jnutbio.2009.02.002; Sutherland CJ, 2007, J ANTIMICROB CHEMOTH, V59, P1197, DOI 10.1093/jac/dkm104; Talisuna A, 2012, LANCET INFECT DIS, V12, P888, DOI 10.1016/S1473-3099(12)70241-4; Tamez PA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000118; Taylor SM, 2015, J INFECT DIS, V211, P680, DOI 10.1093/infdis/jiu467; Traber MG, 2012, ADV NUTR, V3, P330, DOI 10.3945/an.112.002139; Umeno A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063542; Wellems TE, 2002, SCIENCE, V298, P124, DOI 10.1126/science.1078167; WHO, 2014, WORLD MALARIA REPORT, px; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Wu CA, 2004, J BIOL CHEM, V279, P30168, DOI 10.1074/jbc.M403765200; Yamashita S, 2009, ATHEROSCLEROSIS, V207, P16, DOI 10.1016/j.atherosclerosis.2009.04.002; Yokota T, 2001, P NATL ACAD SCI USA, V98, P15185, DOI 10.1073/pnas.261456098; Yoshida Y, 2013, J CLIN BIOCHEM NUTR, V52, P9, DOI 10.3164/jcbn.12-112	53	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136014	10.1371/journal.pone.0136014	http://dx.doi.org/10.1371/journal.pone.0136014			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296197	gold, Green Published, Green Submitted			2022-12-27	WOS:000359926900060
J	McFarland, KN; Liu, JL; Landrian, I; Godiska, R; Shanker, S; Yu, FH; Farmerie, WG; Ashizawa, T				McFarland, Karen N.; Liu, Jilin; Landrian, Ivette; Godiska, Ronald; Shanker, Savita; Yu, Fahong; Farmerie, William G.; Ashizawa, Tetsuo			SMRT Sequencing of Long Tandem Nucleotide Repeats in SCA10 Reveals Unique Insight of Repeat Expansion Structure	PLOS ONE			English	Article							ATAXIA TYPE 10; INTERRUPTIONS; EFFICIENT	A large, non-coding ATTCT repeat expansion causes the neurodegenerative disorder, spinocerebellar ataxia type 10 (SCA10). In a subset of SCA10 patients, interruption motifs are present at the 5' end of the expansion and strongly correlate with epileptic seizures. Thus, interruption motifs are a predictor of the epileptic phenotype and are hypothesized to act as a phenotypic modifier in SCA10. Yet, the exact internal sequence structure of SCA10 expansions remains unknown due to limitations in current technologies for sequencing across long extended tracts of tandem nucleotide repeats. We used the third generation sequencing technology, Single Molecule Real Time (SMRT) sequencing, to obtain full-length contiguous expansion sequences, ranging from 2.5 to 4.4 kb in length, from three SCA10 patients with different clinical presentations. We obtained sequence spanning the entire length of the expansion and identified the structure of known and novel interruption motifs within the SCA10 expansion. The exact interruption patterns in expanded SCA10 alleles will allow us to further investigate the potential contributions of these interrupting sequences to the pathogenic modification leading to the epilepsy phenotype in SCA10. Our results also demonstrate that SMRT sequencing is useful for deciphering long tandem repeats that pose as "gaps" in the human genome sequence.	[McFarland, Karen N.; Liu, Jilin; Landrian, Ivette; Ashizawa, Tetsuo] Univ Florida, Dept Neurol, Gainesville, FL 32610 USA; [McFarland, Karen N.; Liu, Jilin; Landrian, Ivette; Ashizawa, Tetsuo] Univ Florida, McKnight Brain Inst, Gainesville, FL 32610 USA; [Godiska, Ronald] Lucigen Corp, Middleton, WI 53562 USA; [Shanker, Savita; Yu, Fahong; Farmerie, William G.] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ashizawa, T (corresponding author), Univ Florida, Dept Neurol, Gainesville, FL 32610 USA.	tetsuo.ashizawa@neurology.ufl.edu	Godiska, Ronald/V-7489-2017	Godiska, Ronald/0000-0003-0101-6365	National Institutes Health grant [NS041547, NS083564]; University of Florida Opportunity grant; Lucigen Corporation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R43HG006084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083564, R01NS041547] Funding Source: NIH RePORTER	National Institutes Health grant; University of Florida Opportunity grant; Lucigen Corporation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by an National Institutes Health grant (NS041547 and NS083564) and University of Florida Opportunity grant to TA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Lucigen Corporation provided support in the form of salaries for authors RG and limited research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. RG did edit the manuscript for clarity. The specific roles of these authors are articulated in the 'author contributions' section.	Bushara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081342; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Doi K, 2014, BIOINFORMATICS, V30, P815, DOI 10.1093/bioinformatics/btt647; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Godiska R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1181; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Illumina, LONG READ SEQ TECHN; Jain M, 2015, NAT METHODS, V12, P351, DOI [10.1038/NMETH.3290, 10.1038/nmeth.3290]; Liu JL, 2014, NEUROL CLIN NEUROSCI, V2, P38, DOI 10.1111/ncn3.78; Loomis EW, 2013, GENOME RES, V23, P121, DOI 10.1101/gr.141705.112; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; Matsuura T, 2006, AM J HUM GENET, V78, P125, DOI 10.1086/498654; McCoy RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106689; McFarland KN, 2014, NEUROGENETICS, V15, P59, DOI 10.1007/s10048-013-0385-6; McFarland KN, 2013, EUR J HUM GENET, V21, P1272, DOI 10.1038/ejhg.2013.32; Mikheyev AS, 2014, MOL ECOL RESOUR, V14, P1097, DOI 10.1111/1755-0998.12324; Ravin NV, 2003, NUCLEIC ACIDS RES, V31, P6552, DOI 10.1093/nar/gkg856; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543; Wakamiya M, 2006, NEUROLOGY, V67, P607, DOI 10.1212/01.wnl.0000231140.26253.eb; White M, 2012, J NEUROSCI RES, V90, P706, DOI 10.1002/jnr.22786; White MC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000984; Xia GB, 2013, J NEUROL NEUROSUR PS, V84, P1409, DOI 10.1136/jnnp-2013-305080	24	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135906	10.1371/journal.pone.0135906	http://dx.doi.org/10.1371/journal.pone.0135906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295943	Green Submitted, gold, Green Published			2022-12-27	WOS:000359926900049
J	Naftulin, JS; Kimchi, EY; Cash, SS				Naftulin, Jason S.; Kimchi, Eyal Y.; Cash, Sydney S.			Streamlined, Inexpensive 3D Printing of the Brain and Skull	PLOS ONE			English	Article							MODEL; FABRICATION; SCAFFOLDS; ACCURACY; HAND	Neuroimaging technologies such as Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) collect three-dimensional data (3D) that is typically viewed on two-dimensional (2D) screens. Actual 3D models, however, allow interaction with real objects such as implantable electrode grids, potentially improving patient specific neurosurgical planning and personalized clinical education. Desktop 3D printers can now produce relatively inexpensive, good quality prints. We describe our process for reliably generating life-sized 3D brain prints from MRIs and 3D skull prints from CTs. We have integrated a standardized, primarily open-source process for 3D printing brains and skulls. We describe how to convert clinical neuroimaging Digital Imaging and Communications in Medicine (DICOM) images to stereolithography (STL) files, a common 3D object file format that can be sent to 3D printing services. We additionally share how to convert these STL files to machine instruction gcode files, for reliable in-house printing on desktop, open-source 3D printers. We have successfully printed over 19 patient brain hemispheres from 7 patients on two different open-source desktop 3D printers. Each brain hemisphere costs approximately $3-4 in consumable plastic filament as described, and the total process takes 14-17 hours, almost all of which is unsupervised (preprocessing = 4-6 hr; printing = 9-11 hr, post-processing = < 30 min). Printing a matching portion of a skull costs $1-5 in consumable plastic filament and takes less than 14 hr, in total. We have developed a streamlined, cost-effective process for 3D printing brain and skull models. We surveyed healthcare providers and patients who confirmed that rapid-prototype patient specific 3D models may help interdisciplinary surgical planning and patient education. The methods we describe can be applied for other clinical, research, and educational purposes.	[Naftulin, Jason S.; Kimchi, Eyal Y.; Cash, Sydney S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Kimchi, Eyal Y.; Cash, Sydney S.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kimchi, EY (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.	ekimchi@partners.org	Chan, Simmy/AAD-9046-2021		National Institute of Neurological Disorders and Stroke [T32-NS048005, R01-NS062092]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062092, T32NS048005] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by grants from the National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov/) (T32-NS048005 EYK, R01-NS062092 SSC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 2015, BRIT J OPHTHALMOL, V99, P1162, DOI 10.1136/bjophthalmol-2014-306189; Chung KJ, 2015, FOOT ANKLE INT, V36, P1504, DOI 10.1177/1071100715595695; Cohen J, 2015, AM J OTOLARYNG, V36, P619, DOI 10.1016/j.amjoto.2015.02.012; Davison AP, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00022; Delgado J, 2014, NEUROINFORMATICS, V12, P413, DOI 10.1007/s12021-013-9214-1; Fasel JHD, 2013, ANN ROY COLL SURG, V95, P401, DOI 10.1308/003588413X13629960046994; Gaetani R, 2015, BIOMATERIALS, V61, P339, DOI 10.1016/j.biomaterials.2015.05.005; Gerstle TL, 2014, PLAST RECONSTR SURG, V133, P446, DOI 10.1097/01.prs.0000436844.92623.d3; He Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06973; Jung J, 2015, INT J RADIAT ONCOL, V92, P745, DOI 10.1016/j.ijrobp.2015.02.055; McMenamin PG, 2014, ANAT SCI EDUC, V7, P479, DOI 10.1002/ase.1475; Michalski MH, 2014, JAMA-J AM MED ASSOC, V312, P2213, DOI 10.1001/jama.2014.9542; Mohanty S, 2015, MAT SCI ENG C-MATER, V55, P569, DOI 10.1016/j.msec.2015.06.002; Owusu JA, 2015, CURR OPIN OTOLARYNGO, V23, P261, DOI 10.1097/MOO.0000000000000175; Park JH, 2015, BIOMATERIALS, V62, P106, DOI 10.1016/j.biomaterials.2015.05.008; Park SW, 2015, J ORAL MAXIL SURG, V73, P1540, DOI 10.1016/j.joms.2015.03.025; Pati F, 2015, BIOMATERIALS, V62, P164, DOI 10.1016/j.biomaterials.2015.05.043; Pietrabissa A, 2016, SURG ENDOSC, V30, P366, DOI 10.1007/s00464-015-4185-y; Preece D, 2013, ANAT SCI EDUC, V6, P216, DOI 10.1002/ase.1345; Rengier F, 2010, INT J COMPUT ASS RAD, V5, P335, DOI 10.1007/s11548-010-0476-x; Rosenzweig DH, 2015, INT J MOL SCI, V16, P15118, DOI 10.3390/ijms160715118; Salmi M, 2013, J CRANIO MAXILL SURG, V41, P603, DOI 10.1016/j.jcms.2012.11.041; Samuel BP, 2015, J DIGIT IMAGING, V28, P459, DOI 10.1007/s10278-014-9761-5; Schubert C, 2014, BRIT J OPHTHALMOL, V98, P159, DOI 10.1136/bjophthalmol-2013-304446; Tan HT, 2015, J RECONSTR MICROSURG, V31, P369, DOI 10.1055/s-0035-1546419; Tumbleston JR, 2015, SCIENCE, V347, P1349, DOI 10.1126/science.aaa2397; Waran V, 2015, SIMUL HEALTHC, V10, P43, DOI 10.1097/SIH.0000000000000060; Waran V, 2014, J SURG EDUC, V71, P193, DOI 10.1016/j.jsurg.2013.08.010; West SJ, 2014, REGION ANESTH PAIN M, V39, P429, DOI 10.1097/AAP.0000000000000136; Xu WH, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.08.02; Zuniga Jorge, 2015, BMC Res Notes, V8, P10, DOI 10.1186/s13104-015-0971-9	31	75	77	2	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136198	10.1371/journal.pone.0136198	http://dx.doi.org/10.1371/journal.pone.0136198			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295459	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900081
J	Bookstein, FL; Domjanic, J				Bookstein, Fred L.; Domjanic, Jacqueline			The Principal Components of Adult Female Insole Shape Align Closely with Two of Its Classic Indicators	PLOS ONE			English	Article							FOOT TYPE CLASSIFICATION; FOOTPRINT PARAMETERS; LONGITUDINAL ARCH; HEIGHT; CHILDREN	The plantar surface of the human foot transmits the weight and dynamic force of the owner's lower limbs to the ground and the reaction forces back to the musculoskeletal system. Its anatomical variation is intensely studied in such fields as sports medicine and orthopedic dysmorphology. Yet, strangely, the shape of the insole that accommodates this surface and elastically buffers these forces is neither an aspect of the conventional anthropometrics of feet nor an informative label on the packet that markets supplementary insoles. In this paper we pursue an earlier suggestion that insole form in vertical view be quantified in terms of the shape of the foot not at the plane of support (the "footprint") but some two millimeters above that level. Using such sections extracted from laser scans of 158 feet of adult women from the University of Zagreb, in conjunction with an appropriate modification of today's standard geometric morphometrics (GMM), we find that the sectioned form can be described by its size together with two meaningful relative warps of shape. The pattern of this shape variation is not novel. It is closely aligned with two of the standard footprint measurements, the Chippaux-Smirak arch index and the Clarke arch angle, whose geometrical foci (the former in the ball of the foot, the latter in the arch) it apparently combines. Thus a strong contemporary analysis complements but does not supplant the simpler anthropometric analyses of half a century ago, with implications for applied anthropology.	[Bookstein, Fred L.] Univ Vienna, Dept Anthropol, Vienna, Austria; [Domjanic, Jacqueline] Univ Zagreb, Dept Clothing Technol, Zagreb 41000, Croatia	University of Vienna; University of Zagreb	Bookstein, FL (corresponding author), Univ Vienna, Dept Anthropol, Vienna, Austria.	fred.bookstein@univie.ac.at						Allen B, 2003, ACM T GRAPHIC, V22, P587, DOI 10.1145/882262.882311; Bookstein FL, 2014, MEASURING AND REASONING: NUMERICAL INFERENCE IN THE SCIENCES, P1, DOI 10.1017/CBO9781139161923; Bookstein F L, 1997, Med Image Anal, V1, P225; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bookstein Fred L, 2014, Coll Antropol, V38, P855; Bousie JA, 2013, J SCI MED SPORT, V16, P60, DOI 10.1016/j.jsams.2012.04.006; Chang Chia-Hsieh, 2014, PLoS One, V9, pe115808, DOI 10.1371/journal.pone.0115808; Chen KC, 2010, J PEDIAT, V169, P1; Chippaux C, 1947, ELEMENTS ANTHR ECOLE; Clarke HH, 1933, RES QUART, V4, P99; Coblentz AM, 1978, P SPIE, V166; Crabtree P, 2009, ROBOT CIM-INT MANUF, V25, P972, DOI 10.1016/j.rcim.2009.04.016; de Castro MP, 2014, APPL ERGON, V45, P1028, DOI 10.1016/j.apergo.2014.01.005; Domjanic J, 2013, J FOOT ANKLE RES, V6, DOI 10.1186/1757-1146-6-27; Harrison C. R., 2002, CAESAR SUMMARY STAT; HAWES MR, 1992, FOOT ANKLE, V13, P22, DOI 10.1177/107110079201300104; Ibrahim M, 2013, CLIN BIOMECH, V28, P68, DOI 10.1016/j.clinbiomech.2012.09.003; Kim S, 2007, INT J CLOTH SCI TECH, V19, P7, DOI 10.1108/09556220710717017; Mathieson I., 1999, FOOT, V9, P145, DOI [10.1054/foot.1999.0544, DOI 10.1054/FOOT.1999.0544]; Mauch M, 2008, INT J OBESITY, V32, P1068, DOI 10.1038/ijo.2008.52; Mauch M, 2009, ERGONOMICS, V52, P999, DOI 10.1080/00140130902803549; Mitteroecker P, 2007, SYST BIOL, V56, P818, DOI 10.1080/10635150701648029; Morton DJ, 1924, J BONE JOINT SURG, V6, P56; Sacco IDN, 2009, ACTA ORTOP BRAS, V17, P13, DOI 10.1590/S1413-78522009000100002; Onodera Andrea Naomi, 2008, Foot (Edinb), V18, P142, DOI 10.1016/j.foot.2008.03.003; Owings TM, 2013, SCI FOOTWEAR; Ozer MC., 2012, INT SPORTMED J, V13, P8; Razeghi M, 2002, GAIT POSTURE, V15, P282, DOI 10.1016/S0966-6362(01)00151-5; Riddiford-Harland DL, 2000, INT J OBESITY, V24, P541, DOI 10.1038/sj.ijo.0801192; Rogers FR, 1932, FUNDAMENTAL ADM MEAS; Schwartz L, 1928, US PUBLIC HLTH B, V179; Shiang TY, 1998, IEEE ENG MED BIOL, V17, P62; SMAHEL Z, 1977, Zeitschrift fuer Morphologie und Anthropologie, V68, P201; Smirak J, 1960, PRISPEVEK K PROBLEMA; Smirnova LM, 2010, BIOMEDICAL ENG, V44, P41, DOI [10.1007/s10527-010-9152-2, DOI 10.1007/S10527-010-9152-2]; Stafford GT, 1928, PREVENTIVE CORRECTIV; Stavlas Panagiotis, 2005, J Foot Ankle Surg, V44, P424, DOI 10.1053/j.jfas.2005.07.023; Waerlop I, 2006, PEDOGRAPHS GAIT ANAL; Weber GW, 2011, VIRTUAL ANTHROPOLOGY: GUIDE TO A NEW INTERDISCIPLINARY FIELD, P1, DOI 10.1007/978-3-211-49347-2; Yick KL, 2013, HDB FOOTWEAR DESIGN	40	3	5	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0133303	10.1371/journal.pone.0133303	http://dx.doi.org/10.1371/journal.pone.0133303			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308442	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400010
J	Leijs, R; Bradford, T; Mitchell, JG; Humphreys, WF; Cooper, SJB; Goonan, P; King, RA				Leijs, Remko; Bradford, Tessa; Mitchell, James G.; Humphreys, William F.; Cooper, Steven J. B.; Goonan, Peter; King, Rachael A.			The Evolution of Epigean and Stygobitic Species of Koonunga Sayce, 1907 (Syncarida: Anaspidacea) in Southern Australia, with the Description of Three New Species	PLOS ONE			English	Article							CRUSTACEAN; PATTERNS; MODEL; CAVE; EYE	Three new species of Koonunga were discovered in surface and subterranean waters in southern Australia, and were defined using mtDNA analyses and morphology. The new species are: Koonunga hornei Leijs & King; K. tatiaraensis Leijs & King and K. allambiensis Leijs & King. Molecular clock analyses indicate that the divergence times of the species are older than the landscape that they currently inhabit. Different scenarios explaining this apparent discrepancy are discussed in the context of the palaeography of the area. A freshwater epigean origin for Koonunga is considered the most likely hypothesis, whereby some lineages made the transition to the subterranean environment within the last few million years influenced by significant climatic cooling/drying. We discuss the possibility that one stygobitic lineage secondarily regained some of its body pigmentation as adaptation to increased photic conditions after cave collapse and forming of cenotes during the last glacial maximum.	[Leijs, Remko; Bradford, Tessa; Mitchell, James G.] Flinders Univ S Australia, Sch Biol Sci, Bedford Pk, SA, Australia; [Leijs, Remko; Cooper, Steven J. B.; King, Rachael A.] S Australian Museum, Adelaide, SA 5000, Australia; [Leijs, Remko; Humphreys, William F.; Cooper, Steven J. B.; King, Rachael A.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Leijs, Remko; Humphreys, William F.; Cooper, Steven J. B.; King, Rachael A.] Univ Adelaide, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia; [Humphreys, William F.] Western Australian Museum, Welshpool, Australia; [Humphreys, William F.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Goonan, Peter] South Australian Environm Protect Author, Adelaide, SA, Australia	Flinders University South Australia; University of Adelaide; University of Adelaide; Western Australian Museum; University of Western Australia	Leijs, R (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Bedford Pk, SA, Australia.	Remko.Leijs@samuseum.sa.gov.au	Cooper, Steven JB/I-6291-2012	Bradford, Tessa/0000-0003-0607-1398; , Tessa/0000-0003-1442-8449; Mitchell, Jim/0000-0002-8445-0935; King, Rachael/0000-0001-8089-7599; Leijs, Remko/0000-0001-6909-5659; Humphreys, William/0000-0002-8998-9323	Australian Research Council grant [LP-00776478]; ABRS Bush Blitz Tactical Taxonomy Grant [TTC211-07]	Australian Research Council grant(Australian Research Council); ABRS Bush Blitz Tactical Taxonomy Grant	This research was supported by Australian Research Council grant, www.arc.gov.au, LP-00776478 to JGM and an ABRS Bush Blitz Tactical Taxonomy Grant, www.environment.gov.au/science/abrs/grants, TTC211-07 to RL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; BOU C, 1967, CR ACAD SCI D NAT, V265, P369; Boutin C., 1991, Revue de Micropaleontologie, V33, P303; BROOKS H. K., 1962, CRUSTACEANA, V4, P229, DOI 10.1163/156854062X00364; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Calman W. T., 1904, Annals of Natural History, V(7), P144; Camacho AI, 2008, HYDROBIOLOGIA, V595, P257, DOI 10.1007/s10750-007-9021-5; Carlini DB, 2009, MOL ECOL, V18, P1932, DOI 10.1111/j.1365-294X.2009.04161.x; Chilton C., 1929, Journal of the Royal Society of New South Wales, V62, P366; Chomczynski P, 1997, BIOTECHNIQUES, V22, P550, DOI 10.2144/97223pf01; COINEAU (N.), 1992, MONOGRAFIAS MUS NAC, V7, P423; de Deckker P., 1980, Transactions of the Royal Society of South Australia, V104, P21; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; DRUMMOND F. H., 1959, AUSTRALIAN MUS MAG, V13, P63; Finston TL, 2007, MOL ECOL, V16, P355, DOI 10.1111/j.1365-294X.2006.03123.x; Fiser C, 2012, BIOL LETTERS, V8, P578, DOI 10.1098/rsbl.2012.0125; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Garm A, 2004, ZOOL J LINN SOC-LOND, V142, P233, DOI 10.1111/j.1096-3642.2004.00132.x; IMBRIE J, 1984, MILANKOVITCH CLIMA 1, P269; Jarman SN, 2002, J EVOLUTIONARY BIOL, V13, P624; Leys R, 2005, BIOL LETTERS, V1, P496, DOI 10.1098/rsbl.2005.0358; Linnaeus C, SYSTEMA NATURAE, V1758; McLaren S, 2011, QUATERNARY SCI REV, V30, P1086, DOI 10.1016/j.quascirev.2010.12.016; Murray-Wallace CV, 2001, J GEOL SOC LONDON, V158, P111, DOI 10.1144/jgs.158.1.111; Mustafa S, 2002, REV TERTIARY GAMBIER; NICHOLLS GEORGE E., 1931, JOUR LINNEAN SOC [LONDON] ZOOL, V37, P473; Noodt D. W., 1963, Investigaciones Zoologicas Chilenas, V10, P151; NOTENBOOM J, 1991, J BIOGEOGR, V18, P437, DOI 10.2307/2845485; PACKARD A. S., 1885, AM NAT, V19; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Peltier WR, 2006, QUATERNARY SCI REV, V25, P3322, DOI 10.1016/j.quascirev.2006.04.010; Poore G. C. B., 2002, ZOOLOGICAL CATALOG A; Protas ME, 2011, P NATL ACAD SCI USA, V108, P5702, DOI 10.1073/pnas.1013850108; Rambaut A, 2007, DRUMMOND A J TRACER; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Sandiford M, 2009, AUST J EARTH SCI, V56, P5, DOI 10.1080/08120090902870764; Say T., 1817, J ACAD NATURAL SCI P, V1, P57; Sayce OA, 1907, ANN MAGAZINE NATURAL, V8, P350; SCHMINKE HK, 1974, ZOOL SCR, V3, P177, DOI 10.1111/j.1463-6409.1974.tb00814.x; SCHRAM F R, 1984, Transactions of the San Diego Society of Natural History, V20, P189; STEPHENSON AE, 1986, PALAEOGEOGR PALAEOCL, V57, P137, DOI 10.1016/0031-0182(86)90011-8; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomson G.M., 1894, T LINN SOC LOND, V6, P285, DOI DOI 10.1111/J.1096-3642.1894.TB00482.X; Thomson G. M., 1893, PAPERS P ROYAL SOC T, V1892, P45; Webb JA, 2010, GEOMORPHOLOGY, V119, P23, DOI 10.1016/j.geomorph.2010.02.015; WILLIAMS WD, 1974, BIOGEOGRAPHY ECOLOGY, P63; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; ZEIDLER W, 1985, Transactions of the Royal Society of South Australia, V109, P63	50	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134673	10.1371/journal.pone.0134673	http://dx.doi.org/10.1371/journal.pone.0134673			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309115	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400030
J	Winterbach, CW; Whitesell, C; Somers, MJ				Winterbach, Christiaan W.; Whitesell, Carolyn; Somers, Michael J.			Wildlife Abundance and Diversity as Indicators of Tourism Potential in Northern Botswana	PLOS ONE			English	Article							CONSERVATION; BIODIVERSITY; COSTS	Wildlife tourism can provide economic incentives for conservation. Due to the abundance of wildlife and the presence of charismatic species some areas are better suited to wildlife tourism. Our first objective was to develop criteria based on wildlife abundance and diversity to evaluate tourism potential in the Northern Conservation Zone of Botswana. Secondly we wanted to quantify and compare tourism experiences in areas with high and low tourism potential. We used aerial survey data to estimate wildlife biomass and diversity to determine tourism potential, while data from ground surveys quantified the tourist experience. Areas used for High Paying Low Volume tourism had significantly higher mean wildlife biomass and wildlife diversity than the areas avoided for this type of tourism. Only 22% of the Northern Conservation Zone has intermediate to high tourism potential. The areas with high tourism potential, as determined from the aerial survey data, provided tourists with significantly better wildlife sightings (ground surveys) than the low tourism potential areas. Even Low Paying tourism may not be economically viable in concessions that lack areas with intermediate to high tourism potential. The largest part of the Northern Conservation Zone has low tourism potential, but low tourism potential is not equal to low conservation value. Alternative conservation strategies should be developed to complement the economic incentive provided by wildlife-based tourism in Botswana.	[Winterbach, Christiaan W.; Somers, Michael J.] Univ Pretoria, Ctr Wildlife Management, ZA-0028 Pretoria, South Africa; [Winterbach, Christiaan W.; Whitesell, Carolyn] Tau Consultants Pty Ltd, Maun, Botswana; [Somers, Michael J.] Univ Pretoria, Ctr Invas Biol, ZA-0028 Pretoria, South Africa	University of Pretoria; University of Pretoria	Winterbach, CW (corresponding author), Univ Pretoria, Ctr Wildlife Management, Private Bag X20 Hatfield, ZA-0028 Pretoria, South Africa.	tauconsultants@gmail.com	/A-1523-2008	/0000-0002-5836-8823	Tau Consultants (Pty) Ltd	Tau Consultants (Pty) Ltd	Tau Consultants (Pty) Ltd provided support in the form of salaries for authors CWW and CW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	[Anonymous], 2012, MAN PLAN CONTR HUNT; [Anonymous], 2000, BOTSWANA AERIAL SURV; [Anonymous], 2000, BOTSWANA TOURISM MAS; Balmford A, 2003, ORYX, V37, P238, DOI 10.1017/S0030605303000413; Bartlam-Brooks HLA, 2011, ORYX, V45, P210, DOI 10.1017/S0030605310000414; Bookbinder MP, 1998, CONSERV BIOL, V12, P1399, DOI 10.1046/j.1523-1739.1998.97229.x; Chase M., 2011, DRY SEASON FIXED WIN; Department of Surveys and Mapping, 2001, BOTSW NAT ATL; Di Minin E, 2013, ANIM CONSERV, V16, P263, DOI 10.1111/acv.12060; Findley, 2010, IUCN RED LIST THREAT; Frazee SR, 2003, BIOL CONSERV, V112, P275, DOI 10.1016/S0006-3207(02)00400-7; Goodwin Harold J., 2000, Conservation Biology Series (Cambridge), V3, P257; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Hutton JM, 2003, ORYX, V37, P215, DOI 10.1017/S0030605303000395; IUCN/SSC, 2006, REG CONS STRAT LION; Kerley GIH, 2003, S AFR J WILDL RES, V33, P13; Klein Rebecca, 2007, Cat News, P14; Lindsey Peter A., 2007, Journal of Ecotourism, V6, P19, DOI 10.2167/joe133.0; Maciejewski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088192; Mbaiwa JE, 2009, TRANSBOUNDARY DIAGNO; Mills M.G.L., 1998, STATUS SURVEY CONSER; Mills MGL, 1997, CONSERV BIOL, V11, P1397, DOI 10.1046/j.1523-1739.1997.96252.x; Mladenov N., 2007, Development Southern Africa, V24, P409, DOI 10.1080/03768350701445525; Office of the President, 2012, STAT NAT 2012; Quinn GP, 2003, EXPT DESIGN DATA ANA; Thomas DSG., 1991, KALAHARI ENV; Wint W, 2000, 7ACPBT022 DEP WILDL; Winterbach CW, 2003, PREDATOR MA IN PRESS; Winterbach HEK, 2013, MAMMAL REV, V43, P89, DOI 10.1111/j.1365-2907.2011.00209.x; Winterbach HEK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100202; WTTC, 2008, BOTSW IMP TRAV TOUR	31	17	17	7	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135595	10.1371/journal.pone.0135595	http://dx.doi.org/10.1371/journal.pone.0135595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308859	Green Submitted, Green Published, gold			2022-12-27	WOS:000360069400066
J	Chen, JY; Wang, LK; Feng, PH; Chu, CC; Cheng, TJ; Weng, SF; Wu, SZ; Lu, TH; Chang, CY				Chen, Jen-Yin; Wang, Li-Kai; Feng, Ping-Hsun; Chu, Chin-Chen; Cheng, Tain-Junn; Weng, Shih-Feng; Wu, Su-Zhen; Lu, Tsung-Hsueh; Chang, Chia-Yu			Risk of Shingles in Adults with Primary Sjogren's Syndrome and Treatments: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							HERPES-ZOSTER; POSTHERPETIC NEURALGIA; RHEUMATOID-ARTHRITIS; CLASSIFICATION CRITERIA; NUTRITIONAL FACTORS; COMPLICATION RATES; PEPTIC-ULCER; VITAMIN-C; DEFICIENCIES; VACCINATION	Background Primary Sjogren's syndrome (pSS) is associated with immunological dysfunctions-a well-known risk factor of shingles. This study aimed to examine the incidence and risk of shingles in adults with pSS and pharmacological treatments. Methods This retrospective population-based cohort study was conducted using National Health Insurance claims data. Using propensity scores, 4,287 pSS adult patients and 25,722-matched cohorts by age, gender, selected comorbidities and Charlson comorbidity index scores were identified. Kaplan-Meier analysis and Cox regression were conducted to compare the differences in developing shingles. In pSS, oral and eye dryness are treated with substitute agents. Extraglandular features are often treated with pharmacological drugs including steroids and immunosuppressants. pSS patients were grouped as follows: no pharmacological drugs, steroids alone; immunosuppressants alone; combined therapies. Results During the follow-up, 463 adults with pSS (10.80%) and 1,345 control cohorts (5.23%) developed shingles. The cumulative incidence of shingles in pSS patients (18.74/1,000 patient-years) was significantly higher than controls (8.55/1,000 patient-years). The adjusted hazard ratio (HR) of shingles was 1.69 (95% confidence interval (CI) 1.50-1.90). In age-subgroup analyses, incidences of shingles in pSS increased with age and peaked in pSS patients aged. 60; however, adjusted HRs decreased with age. Compared to control cohorts with no drugs, adjusted HRs for shingles in pSS patients were ranked from high to low as: combined therapies (4.14; 95% CI 3.14-5.45) > immunosuppressants alone (3.24; 95% CI 2.36-4.45) > steroids alone (2.54; 95% CI 2.16-2.97) > no pharmacological drugs (2.06; 95% CI 1.76-2.41). Rates of shingles-associated hospitalization and postherpetic neuralgia were 5.62% and 24.41%, both of which were significantly higher than those (2.60%; 13.01%) in the control cohorts. Conclusions Adults with pSS were at greater risk for shingles than control cohorts. Drug exposures significantly increased the risk of shingles in pSS.	[Chen, Jen-Yin; Wang, Li-Kai; Feng, Ping-Hsun; Chu, Chin-Chen; Wu, Su-Zhen] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan; [Chen, Jen-Yin] Chia Nan Univ Pharm & Sci, Dept Senior Citizen Serv Management, Tainan, Taiwan; [Cheng, Tain-Junn; Chang, Chia-Yu] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Weng, Shih-Feng] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Lu, Tsung-Hsueh] Natl Cheng Kung Univ, Coll Med, Inst Publ Hlth, Tainan 70101, Taiwan; [Chang, Chia-Yu] Natl Chung Hsing Univ, Dept Food Sci & Appl Biotechnol, Taichung 40227, Taiwan; [Chang, Chia-Yu] Southern Taiwan Univ Sci & Technol, Ctr Gen Educ, Tainan, Taiwan	Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chi Mei Hospital; National Cheng Kung University; National Chung Hsing University; Southern Taiwan University of Science & Technology	Chang, CY (corresponding author), Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan.	chiayu.chang7@msa.hinet.net		chang, chia-yu/0000-0002-3403-7165; Chu, Chin-Chen/0000-0001-8745-239X; Weng, Shih-Feng/0000-0001-8684-3487	Chi Mei Medical Center, Tainan, Taiwan [CMFHR10403, CMFHR10080]	Chi Mei Medical Center, Tainan, Taiwan	This work was supported by the Chi Mei Medical Center, Tainan, Taiwan (CMFHR10403) and (CMFHR10080) to J-YC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldini C, 2012, J AUTOIMMUN, V39, P9, DOI 10.1016/j.jaut.2011.12.006; Bowman SJ, 2010, J RHEUMATOL, V37, P1010, DOI 10.3899/jrheum.090734; Callaghan R, 2007, RHEUMATOLOGY, V46, P105, DOI 10.1093/rheumatology/kel155; Cermak JM, 2003, EUR J CLIN NUTR, V57, P328, DOI 10.1038/sj.ejcn.1601543; Chang YS, 2014, CLIN RHEUMATOL, V33, P377, DOI 10.1007/s10067-013-2408-y; Chen HH, 2011, CLINICS, V66, P1177, DOI 10.1590/S1807-59322011000700009; Chen JY, 2015, J MED VIROL, V87, P222, DOI 10.1002/jmv.24051; Chen JY, 2013, INT J EPIDEMIOL, V42, P1873, DOI 10.1093/ije/dyt213; Chen JY, 2012, POPUL HEALTH MANAG, V15, P391, DOI 10.1089/pop.2012.1563; Chen JY, 2011, BRIT J NUTR, V106, P700, DOI 10.1017/S0007114511000481; Chen JY, 2009, CLIN J PAIN, V25, P562, DOI 10.1097/AJP.0b013e318193cf32; Choo PW, 1997, ARCH INTERN MED, V157, P1217, DOI 10.1001/archinte.157.11.1217; Chu CC, 2015, ANESTHESIOLOGY; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Guthridge JM, 2013, J RHEUMATOL, V40, P1875, DOI 10.3899/jrheum.130170; Hata A, 2011, INFECTION, V39, P537, DOI 10.1007/s15010-011-0162-0; Jih JS, 2009, ACTA DERM-VENEREOL, V89, P612, DOI 10.2340/00015555-0729; Joesoef RM, 2012, MAYO CLIN PROC, V87, P961, DOI 10.1016/j.mayocp.2012.05.021; Lesourd B, 2006, P NUTR SOC, V65, P319, DOI 10.1079/PNS2006507; Lin YH, 2010, VACCINE, V28, P1217, DOI 10.1016/j.vaccine.2009.11.029; Lundstrom IMC, 2001, ORAL DIS, V7, P144, DOI 10.1034/j.1601-0825.2001.0070302.x; McDonald JR, 2009, CLIN INFECT DIS, V48, P1364, DOI 10.1086/598331; Ng WF, 2011, RHEUMATOLOGY, V50, P32, DOI 10.1093/rheumatology/keq240; Ng WF, 2010, RHEUMATOLOGY, V49, P844, DOI 10.1093/rheumatology/keq009; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Pillemer SR, 2001, MAYO CLIN PROC, V76, P593; Ramos-Casals M, 2010, JAMA-J AM MED ASSOC, V304, P452, DOI 10.1001/jama.2010.1014; Sardu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032487; Schencking M, 2012, MED SCI MONITOR, V18, pCR215, DOI 10.12659/MSM.882621; SCHMADER K, 1995, J INFECT DIS, V171, P701, DOI 10.1093/infdis/171.3.701; Smitten AL, 2007, ARTHRIT RHEUM-ARTHR, V57, P1431, DOI 10.1002/art.23112; Thomas SL, 2006, INT J EPIDEMIOL, V35, P307, DOI 10.1093/ije/dyi270; Toyama N, 2009, J MED VIROL, V81, P2053, DOI 10.1002/jmv.21599; Tzioufas AG, 2012, J AUTOIMMUN, V39, P4, DOI 10.1016/j.jaut.2012.01.002; van Dartel SAA, 2013, ANN RHEUM DIS, V72, P895, DOI 10.1136/annrheumdis-2012-201338; Veetil BMA, 2013, ARTHRIT CARE RES, V65, P854, DOI 10.1002/acr.21928; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Weng MY, 2012, ANN RHEUM DIS, V71, P524, DOI 10.1136/annrheumdis-2011-200402; Weng MY, 2011, J RHEUMATOL, V38, P706, DOI 10.3899/jrheum.100883; Yang YW, 2011, CAN MED ASSOC J, V183, pE275, DOI 10.1503/cmaj.101137; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341; Yawn BP, 2011, AM J EPIDEMIOL, V174, P1054, DOI 10.1093/aje/kwr206; Yawn BP, 2009, MAYO CLIN PROC, V84, P787, DOI [10.4065/84.9.787, 10.1016/S0025-6196(11)60488-6]; Zhang J, 2012, JAMA-J AM MED ASSOC, V308, P43, DOI 10.1001/jama.2012.7304; Zhang J, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3497; Zisman D, 2014, ANN RHEUM DIS	46	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0134930	10.1371/journal.pone.0134930	http://dx.doi.org/10.1371/journal.pone.0134930			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305359	Green Submitted, gold, Green Published			2022-12-27	WOS:000359995500013
J	De Cecco, L; Capaia, M; Zupo, S; Cutrona, G; Matis, S; Brizzolara, A; Orengo, AM; Croce, M; Marchesi, E; Ferrarini, M; Canevari, S; Ferrini, S				De Cecco, Loris; Capaia, Matteo; Zupo, Simona; Cutrona, Giovanna; Matis, Serena; Brizzolara, Antonella; Orengo, Anna Maria; Croce, Michela; Marchesi, Edoardo; Ferrarini, Manlio; Canevari, Silvana; Ferrini, Silvano			Interleukin 21 Controls mRNA and MicroRNA Expression in CD40-Activated Chronic Lymphocytic Leukemia Cells	PLOS ONE			English	Article							B-CELLS; LYMPHOPROLIFERATIVE DISORDERS; DOWN-REGULATION; UP-REGULATION; T-CELLS; C-MYC; IL-21; APOPTOSIS; PROLIFERATION; CHEMOKINES	Several factors support CLL cell survival in the microenvironment. Under different experimental conditions, IL21 can either induce apoptosis or promote CLL cell survival. To investigate mechanisms involved in the effects of IL21, we studied the ability of IL21 to modulate gene and miRNA expressions in CD40-activated CLL cells. IL21 was a major regulator of chemokine production in CLL cells and it modulated the expression of genes involved in cell movement, metabolism, survival and apoptosis. In particular, IL21 down-regulated the expression of the chemokine genes CCL4, CCL3, CCL3L1, CCL17, and CCL2, while it upregulated the Th1-related CXCL9 and CXCL10. In addition, IL21 down-regulated the expression of genes encoding signaling molecules, such as CD40, DDR1 and PIK3CD. IL21 modulated a similar set of genes in CLL and normal B-cells (e.g. chemokine genes), whereas other genes, including MYC, TNF, E2F1, EGR2 and GAS-6, were regulated only in CLL cells. An integrated analysis of the miRNome and gene expression indicated that several miRNAs were under IL21 control and these could, in turn, influence the expression of potential target genes. We focused on hsa-miR-663b predicted to down-regulate several relevant genes. Transfection of hsa-miR-663b or its specific antagonist showed that this miRNA regulated CCL17, DDR1, PIK3CD and CD40 gene expression. Our data indicated that IL21 modulates the expression of genes mediating the crosstalk between CLL cells and their microenvironment and miRNAs may take part in this process.	[De Cecco, Loris; Marchesi, Edoardo; Canevari, Silvana] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Funct Genom & Bioinformat, Milan, Italy; [Capaia, Matteo; Brizzolara, Antonella; Orengo, Anna Maria; Croce, Michela; Ferrini, Silvano] Ist Nazl Ric Canc, IRCCS AOU San Martino IST, Lab Biotherapy, I-16132 Genoa, Italy; [Zupo, Simona; Cutrona, Giovanna] Ist Nazl Ric Canc, IRCCS AOU San Martino IST, Lab Mol Diagnost, I-16132 Genoa, Italy; [Matis, Serena; Ferrarini, Manlio] Ist Nazl Ric Canc, IRCCS AOU San Martino IST, Sci Direct, I-16132 Genoa, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST	Canevari, S (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Funct Genom & Bioinformat, Milan, Italy.	silvana.canevari@istitutotumori.mi.it; silvanodomenico.ferrini@hsanmartino.it	Orengo, Anna Maria/AAC-2108-2020; De Cecco, Loris/K-7036-2016; Cutrona, Giovanna/I-7868-2018; Croce, Michela/AAA-8966-2020; Matis, Serena/AAB-2832-2020; Zupo, Simona/AAC-2757-2020	Orengo, Anna Maria/0000-0003-2959-6859; De Cecco, Loris/0000-0002-7066-473X; Cutrona, Giovanna/0000-0002-3335-1101; Croce, Michela/0000-0003-4683-4951; Matis, Serena/0000-0003-3023-0213; Zupo, Simona/0000-0001-6837-5763; Ferrarini, Manlio/0000-0002-6154-2570; Ferrini, Silvano/0000-0001-7254-2616	AIRC [IG10492, IG13518]; Special Program Molecular Clinical Oncology-"5 per mille" [9980]; "Innovative tools for cancer risk assessment and early diagnosis-5 per mille" [12162]; Italian Ministry of Health; Fondazione Compagnia di San Paolo	AIRC(Fondazione AIRC per la ricerca sul cancro); Special Program Molecular Clinical Oncology-"5 per mille"(Fondazione AIRC per la ricerca sul cancro); "Innovative tools for cancer risk assessment and early diagnosis-5 per mille"; Italian Ministry of Health(Ministry of Health, Italy); Fondazione Compagnia di San Paolo(Compagnia di San Paolo)	This work was funded by: AIRC (IG10492 to MF, IG13518 to SF); Special Program Molecular Clinical Oncology-"5 per mille", grant 9980, 2010-15 to MF; "Innovative tools for cancer risk assessment and early diagnosis-5 per mille", grant 12162 to SC; and Italian Ministry of Health and Fondazione Compagnia di San Paolo to SF.	ADERKA D, 1993, BLOOD, V81, P2076; Ahearne MJ, 2013, BRIT J HAEMATOL, V162, P360, DOI 10.1111/bjh.12401; Bagnoli M, 2011, ONCOTARGET, V2, P1265, DOI 10.18632/oncotarget.401; Burger JA, 2000, BLOOD, V96, P2655; Burger JA, 2013, BLOOD, V121, P1501, DOI 10.1182/blood-2012-08-452607; Burger JA, 2010, SEMIN CANCER BIOL, V20, P424, DOI 10.1016/j.semcancer.2010.09.005; Burger JA, 2009, BLOOD, V113, P3050, DOI 10.1182/blood-2008-07-170415; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Callari M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045105; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Chiorazzi N, 2011, BLOOD, V117, P1781, DOI 10.1182/blood-2010-07-155663; Cols M, 2012, J IMMUNOL, V188, P6071, DOI 10.4049/jimmunol.1102066; Damm F, 2014, CANCER DISCOV, V4, P1088, DOI 10.1158/2159-8290.CD-14-0104; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; de Totero D, 2006, BLOOD, V107, P3708, DOI 10.1182/blood-2005-09-3535; de Totero D, 2008, BLOOD, V111, P517, DOI 10.1182/blood-2007-04-087882; de Totero D, 2010, EXP HEMATOL, V38, P373, DOI 10.1016/j.exphem.2010.02.008; Di Carlo E, 2004, J IMMUNOL, V172, P1540, DOI 10.4049/jimmunol.172.3.1540; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Duckworth A, 2014, BLOOD, V123, P3277, DOI 10.1182/blood-2013-11-539049; Fecteau Jessi-F, 2012, Front Biosci (Schol Ed), V4, P61; Furman RR, 2000, J IMMUNOL, V164, P2200, DOI 10.4049/jimmunol.164.4.2200; Gelebart P, 2009, LEUKEMIA, V23, P1836, DOI 10.1038/leu.2009.100; Ghalamfarsa G, 2013, CYTOKINE, V62, P439, DOI 10.1016/j.cyto.2013.03.023; Ghia P, 2002, EUR J IMMUNOL, V32, P1403, DOI 10.1002/1521-4141(200205)32:5<1403::AID-IMMU1403>3.0.CO;2-Y; Giannoni P, 2011, HAEMATOL-HEMATOL J, V96, P1015, DOI 10.3324/haematol.2010.029736; Gowda A, 2008, BLOOD, V111, P4723, DOI 10.1182/blood-2007-07-099531; Granziero L, 2001, BLOOD, V97, P2777, DOI 10.1182/blood.V97.9.2777; Hoshida Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001195; Jahrsdorfer B, 2006, BLOOD, V108, P2712, DOI 10.1182/blood-2006-03-014001; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Konforte D, 2009, J IMMUNOL, V182, P1781, DOI 10.4049/jimmunol.0803009; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Marcatili P, 2013, J IMMUNOL, V190, P5771, DOI 10.4049/jimmunol.1300321; Marzec M, 2008, CANCER RES, V68, P1083, DOI 10.1158/0008-5472.CAN-07-2403; Merlo A, 2005, CLIN DIAGN LAB IMMUN, V12, P705, DOI 10.1128/CDLI.12.6.705-712.2005; Messmer BT, 2005, J CLIN INVEST, V115, P755, DOI 10.1172/JCI200523409; Nishio M, 2005, BLOOD, V106, P1012, DOI 10.1182/blood-2004-03-0889; Ohno M, 2009, MOL CANCER RES, V7, P2022, DOI 10.1158/1541-7786.MCR-09-0319; Pascutti MF, 2013, BLOOD, V122, P3010, DOI 10.1182/blood-2012-11-467670; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Sarosiek KA, 2010, BLOOD, V115, P570, DOI 10.1182/blood-2009-08-239996; Seifert M, 2012, J EXP MED, V209, P2183, DOI 10.1084/jem.20120833; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Timmerman JM, 2012, CLIN CANCER RES, V18, P5752, DOI 10.1158/1078-0432.CCR-12-0456; Trentin L, 1996, BLOOD, V87, P3327, DOI 10.1182/blood.V87.8.3327.bloodjournal8783327; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zhang SP, 2014, ANNU REV PATHOL-MECH, V9, P103, DOI 10.1146/annurev-pathol-020712-163955; Zucchetto A, 2009, CANCER RES, V69, P4001, DOI 10.1158/0008-5472.CAN-08-4173	52	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0134706	10.1371/journal.pone.0134706	http://dx.doi.org/10.1371/journal.pone.0134706			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305332	Green Submitted, gold, Green Published			2022-12-27	WOS:000359995500012
J	Kilarski, LL; Rutten-Jacobs, LCA; Bevan, S; Baker, R; Hassan, A; Hughes, DA; Markus, HS				Kilarski, Laura L.; Rutten-Jacobs, Loes C. A.; Bevan, Steve; Baker, Rob; Hassan, Ahamad; Hughes, Derralynn A.; Markus, Hugh S.		UK Young Lacunar Stroke DNA Study	Prevalence of CADASIL and Fabry Disease in a Cohort of MRI Defined Younger Onset Lacunar Stroke	PLOS ONE			English	Article							CRYPTOGENIC ISCHEMIC-STROKE; NOTCH3 GENE; CEREBROVASCULAR-DISEASE; SIGNAL HYPERINTENSITIES; KOREAN PATIENTS; FAMILY-HISTORY; MUTATIONS; SUBTYPES; TIA	Background and Purpose Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), caused by mutations in the NOTCH3 gene, is the most common monogenic disorder causing lacunar stroke and cerebral small vessel disease (SVD). Fabry disease (FD) due to mutations in the GLA gene has been suggested as an underdiagnosed cause of stroke, and one feature is SVD. Previous studies reported varying prevalence of CADASIL and FD in stroke, likely due to varying subtypes studied; no studies have looked at a large cohort of younger onset SVD. We determined the prevalence in a well- defined, MRI- verified cohort of apparently sporadic patients with lacunar infarct. Methods Caucasian patients with lacunar infarction, aged <= 70 years (mean age 56.7 (SD8.6)), were recruited from 72 specialist stroke centres throughout the UK as part of the Young Lacunar Stroke DNA Resource. Patients with a previously confirmed monogenic cause of stroke were excluded. All MRI's and clinical histories were reviewed centrally. Screening was performed for NOTCH3 and GLA mutations. Results Of 994 subjects five had pathogenic NOTCH3 mutations (R169C, R207C, R587C, C1222G and C323S) all resulting in loss or gain of a cysteine in the NOTCH3 protein. All five patients had confluent leukoaraiosis (Fazekas grade >= 2). CADASIL prevalence overall was 0.5% (95% CI 0.2%- 1.1%) and among cases with confluent leukoaraiosis 1.5% (95% CI 0.6%- 3.3%). No classic pathogenic FD mutations were found; one patient had a missensemutation (R118C), associated with late-onset FD. Conclusion CADASIL cases are rare and only detected in SVD patients with confluent leukoaraiosis. No definite FD cases were detected.	[Kilarski, Laura L.] St Georges Univ London, Stroke & Dementia Res Ctr, London, England; [Rutten-Jacobs, Loes C. A.; Bevan, Steve; Markus, Hugh S.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Baker, Rob; Hughes, Derralynn A.] Royal Free Hosp, Dept Haematol, Lysosomal Storage Disorders Unit, London NW3 2QG, England; [Baker, Rob; Hughes, Derralynn A.] UCL, Sch Med, London W1N 8AA, England; [Hassan, Ahamad] Leeds Gen Infirm, Dept Neurol, Leeds, W Yorkshire, England	St Georges University London; University of Cambridge; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; UCL Medical School; Leeds General Infirmary; University of Leeds	Rutten-Jacobs, LCA (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.	LR406@medschl.cam.ac.uk	Rutten-Jacobs, Loes/C-7746-2013; Muir, Keith W/A-7670-2011; Bath, Philip/F-9020-2011; hughes, derralynn/J-8012-2013	Rutten-Jacobs, Loes/0000-0003-3223-885X; Muir, Keith W/0000-0001-9535-022X; James, Martin/0000-0001-6065-6018; Price, Christopher/0000-0003-3566-3157; Bevan, Steve/0000-0003-0490-6830; Macleod, Mary Joan/0000-0003-2115-8184; Ford, Gary A/0000-0001-8719-4968; Sudlow, Cathie/0000-0002-7725-7520; Brown, Martin M/0000-0002-3273-1356; baron, jean-claude/0000-0002-5264-2588; Bath, Philip/0000-0003-2734-5132; hughes, derralynn/0000-0003-4531-9173; Kilarski, Laura/0000-0003-0645-3134; Chatterjee, Kausik/0000-0002-3093-1469	Wellcome Trust [WT072952]; Stroke Association [TSA 2010/01, TSA 2013/02]; Shire Human Genetic Therapies; Stroke Association/British Heart Foundation [TSA/BHF 2010/01]; National Institute for Health Research; Cambridge University Trust National Institute for Health Research Comprehensive Research Centre; National Institute for Health Research [NF-SI-0512-10019] Funding Source: researchfish; Stroke Association [TSA2010/01, TSA2013/02] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Stroke Association; Shire Human Genetic Therapies; Stroke Association/British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR)); Cambridge University Trust National Institute for Health Research Comprehensive Research Centre; National Institute for Health Research(National Institute for Health Research (NIHR)); Stroke Association	The UK Young Lacunar Stroke DNA Study was funded by grants from the Wellcome Trust (WT072952, www.wellcome.ac.uk) and the Stroke Association (TSA 2010/01& TSA 2013/02, www.stroke.org.uk). Fabry disease screening was supported by an unrestricted scientific grant from Shire Human Genetic Therapies (www.shire.com). The sponsors of the study had no role in the study design, data collection, data analysis, interpretation, writing of the manuscript, or the decision to submit the manuscript for publication. L R-J's salary is funded by a Stroke Association/British Heart Foundation grant (TSA/BHF 2010/01). HM is supported by an National Institute for Health Research Senior Investigator award (www.nihr.ac.uk). HM and SB are supported by the Cambridge University Trust National Institute for Health Research Comprehensive Research Centre (www.cambridge-brc.org.uk).	Adams Jr HP, 1993, ARTERIOSCLER THROMB, V24, P35, DOI DOI 10.1161/01.STR.24.1.35; Adib-Samii P, 2010, STROKE, V41, P630, DOI 10.1161/STROKEAHA.109.568402; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Baptista MV, 2010, STROKE, V41, P431, DOI 10.1161/STROKEAHA.109.570499; Bersano A, 2012, FUNCT NEUROL, V27, P247; Brouns R, 2007, CLIN NEUROL NEUROSUR, V109, P479, DOI 10.1016/j.clineuro.2007.03.008; Brouns R, 2010, STROKE, V41, P863, DOI 10.1161/STROKEAHA.110.579409; CHABRIAT H, 1995, LANCET, V346, P934, DOI 10.1016/S0140-6736(95)91557-5; Choi JC, 2013, J STROKE CEREBROVASC, V22, P608, DOI 10.1016/j.jstrokecerebrovasdis.2011.10.013; Clarke JTR, 2007, ANN INTERN MED, V146, P425, DOI 10.7326/0003-4819-146-6-200703200-00007; Dong YB, 2003, STROKE, V34, P203, DOI 10.1161/01.STR.0000048162.16852.88; Dubuc V, 2013, J STROKE CEREBROVASC, V22, P1288, DOI 10.1016/j.jstrokecerebrovasdis.2012.10.005; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Fouillade C, 2008, HUM MUTAT, V29, P452, DOI 10.1002/humu.9527; Ginsberg L, 2006, ACTA PAEDIATR, V95, P57, DOI 10.1080/08035320600618908; Herve D, 2010, J GERIATR PSYCH NEUR, V23, P269, DOI 10.1177/0891988710383570; Jerrard-Dunne P, 2003, STROKE, V34, P1364, DOI 10.1161/01.STR.0000069723.17984.FD; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; Kim Y, 2006, MUTAT RES-FUND MOL M, V593, P116, DOI 10.1016/j.mrfmmm.2005.06.031; Knottnerus ILH, 2011, STROKE, V42, P1196, DOI 10.1161/STROKEAHA.110.602383; Markus HS, 2002, NEUROLOGY, V59, P1134, DOI 10.1212/WNL.59.8.1134; Marquardt L, 2012, EUR J NEUROL, V19, P1427, DOI 10.1111/j.1468-1331.2012.03739.x; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Niemann M, 2014, CIRC-CARDIOVASC GENE, V7, P8, DOI 10.1161/CIRCGENETICS.113.000249; Oberstein SAJL, 1999, NEUROLOGY, V52, P1913, DOI 10.1212/WNL.52.9.1913; Rolfs A, 2005, LANCET, V366, P1794, DOI 10.1016/S0140-6736(05)67635-0; Rolfs A, 2013, STROKE, V44, P340, DOI 10.1161/STROKEAHA.112.663708; Sarikaya H, 2012, EUR J NEUROL, V19, P1421, DOI 10.1111/j.1468-1331.2012.03737.x; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shi QY, 2014, J STROKE CEREBROVASC, V23, P985, DOI 10.1016/j.jstrokecerebrovasdis.2013.08.010; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Tai CL, 2012, CLIN CHIM ACTA, V413, P422, DOI 10.1016/j.cca.2011.10.023; Wang T, 2000, J NEUROL NEUROSUR PS, V69, P652, DOI 10.1136/jnnp.69.5.652; Wollenweber FA, 2015, STROKE, V46, P786, DOI 10.1161/STROKEAHA.114.007472; Wozniak MA, 2010, STROKE, V41, P78, DOI 10.1161/STROKEAHA.109.558320	37	26	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136352	10.1371/journal.pone.0136352	http://dx.doi.org/10.1371/journal.pone.0136352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305465	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000359995500068
J	Yazdi, PG; Pedersen, BA; Taylor, JF; Khattab, OS; Chen, YH; Chen, YM; Jacobsen, SE; Wang, PH				Yazdi, Puya G.; Pedersen, Brian A.; Taylor, Jared F.; Khattab, Omar S.; Chen, Yu-Han; Chen, Yumay; Jacobsen, Steven E.; Wang, Ping H.			Nucleosome Organization in Human Embryonic Stem Cells	PLOS ONE			English	Article							HISTONE-DNA INTERACTIONS; HUMAN GENOME; REGULATORY ELEMENTS; CHROMATIN-STRUCTURE; EUKARYOTIC GENOME; IN-VIVO; PLURIPOTENT; RESOLUTION; METHYLATION; YEAST	The fundamental repeating unit of eukaryotic chromatin is the nucleosome. Besides being involved in packaging DNA, nucleosome organization plays an important role in transcriptional regulation and cellular identity. Currently, there is much debate about the major determinants of the nucleosome architecture of a genome and its significance with little being known about its role in stem cells. To address these questions, we performed ultra-deep sequencing of nucleosomal DNA in two human embryonic stem cell lines and integrated our data with numerous epigenomic maps. Our analyses have revealed that the genome is a determinant of nucleosome organization with transcriptionally inactive regions characterized by a "ground state" of nucleosome profiles driven by underlying DNA sequences. DNA sequence preferences are associated with heterogeneous chromatin organization around transcription start sites. Transcription, histone modifications, and DNA methylation alter this "ground state" by having distinct effects on both nucleosome positioning and occupancy. As the transcriptional rate increases, nucleosomes become better positioned. Exons transcribed and included in the final spliced mRNA have distinct nucleosome profiles in comparison to exons not included at exon-exon junctions. Genes marked by the active modification H3K4m3 are characterized by lower nucleosome occupancy before the transcription start site compared to genes marked by the inactive modification H3K27m3, while bivalent domains, genes associated with both marks, lie exactly in the middle. Combinatorial patterns of epigenetic marks (chromatin states) are associated with unique nucleosome profiles. Nucleosome organization varies around transcription factor binding in enhancers versus promoters. DNA methylation is associated with increasing nucleosome occupancy and different types of methylations have distinct location preferences within the nucleosome core particle. Finally, computational analysis of nucleosome organization alone is sufficient to elucidate much of the circuitry of pluripotency. Our results, suggest that nucleosome organization is associated with numerous genomic and epigenomic processes and can be used to elucidate cellular identity.	[Yazdi, Puya G.; Pedersen, Brian A.; Taylor, Jared F.; Khattab, Omar S.; Chen, Yu-Han; Chen, Yumay; Wang, Ping H.] Univ Calif Irvine, Ctr Diabet, Irvine, CA 92697 USA; [Yazdi, Puya G.; Pedersen, Brian A.; Taylor, Jared F.; Khattab, Omar S.; Chen, Yu-Han; Chen, Yumay; Wang, Ping H.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA USA; [Yazdi, Puya G.; Pedersen, Brian A.; Taylor, Jared F.; Chen, Yu-Han; Chen, Yumay; Wang, Ping H.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Wang, Ping H.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Wang, Ping H.] Univ Calif Irvine, Dept Physiol Biophys, Irvine, CA USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Wang, PH (corresponding author), Univ Calif Irvine, Ctr Diabet, Irvine, CA 92697 USA.	phwang@uci.edu	; Imhof, Axel/O-8905-2018	Yazdi, Puya/0000-0003-3456-8043; Imhof, Axel/0000-0003-2993-8249	Ko Family Foundation; Oxnard Foundation; California Institute of Regenerative Medicine [CIRM TG2-01152]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER	Ko Family Foundation; Oxnard Foundation; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Ko Family Foundation and Oxnard Foundation (to P.H.W.). S.E.J is an investigator of the Howard Hughes Medical Institute. P.G.Y. and B.A.P. are recipients of fellowship awards from the California Institute of Regenerative Medicine (CIRM TG2-01152).	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Allan J, 2012, J MOL BIOL, V417, P152, DOI 10.1016/j.jmb.2012.01.043; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112; Chen KF, 2013, GENOME RES, V23, P312, DOI 10.1101/gr.141952.112; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Enroth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029911; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gaffney DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003036; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Gkikopoulos T, 2011, SCIENCE, V333, P1758, DOI 10.1126/science.1206097; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ioshikhes I, 2011, GENOME RES, V21, P1863, DOI 10.1101/gr.116228.110; Kaplan N, 2010, NAT STRUCT MOL BIOL, V17, P918, DOI 10.1038/nsmb0810-918; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Kundaje A, 2012, GENOME RES, V22, P1735, DOI 10.1101/gr.136366.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lantermann AB, 2010, NAT STRUCT MOL BIOL, V17, P251, DOI 10.1038/nsmb.1741; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li ZY, 2011, NAT STRUCT MOL BIOL, V18, P742, DOI 10.1038/nsmb.2060; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Soukas A, 2000, GENE DEV, V14, P963; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teif VB, 2012, NAT STRUCT MOL BIOL, V19, P1185, DOI 10.1038/nsmb.2419; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Tolstorukov MY, 2011, NAT STRUCT MOL BIOL, V18, P510, DOI 10.1038/nsmb.2012; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yen KY, 2012, CELL, V149, P1461, DOI 10.1016/j.cell.2012.04.036; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zhang Y, 2010, NAT STRUCT MOL BIOL, V17, P920, DOI 10.1038/nsmb0810-920; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508	63	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136314	10.1371/journal.pone.0136314	http://dx.doi.org/10.1371/journal.pone.0136314			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305225	Green Published, gold			2022-12-27	WOS:000359995500065
J	Sasaki-Haraguchi, N; Ikuyama, T; Yoshii, S; Takeuchi-Andoh, T; Frendewey, D; Tani, T				Sasaki-Haraguchi, Noriko; Ikuyama, Takeshi; Yoshii, Shogo; Takeuchi-Andoh, Tomoko; Frendewey, David; Tani, Tokio			Cwf16p Associating with the Nineteen Complex Ensures Ordered Exon Joining in Constitutive Pre-mRNA Splicing in Fission Yeast	PLOS ONE			English	Article							INITIATION-FACTOR 2-GAMMA; SCHIZOSACCHAROMYCES-POMBE; TRANSLATION INITIATION; SACCHAROMYCES-CEREVISIAE; TERMINAL DOMAIN; POLYMERASE-II; START CODON; SPLICEOSOME; FIDELITY; ACTIVATION	Exons are ligated in an ordered manner without the skipping of exons in the constitutive splicing of pre-mRNAs with multiple introns. To identify factors ensuring ordered exon joining in constitutive pre-mRNA splicing, we previously screened for exon skipping mutants in Schizosaccharomyces pombe using a reporter plasmid, and characterized three exon skipping mutants named ods1 (ordered splicing 1), ods2, and ods3, the responsible genes of which encode Prp2/U2AF(59), U2AF(23), and SF1, respectively. They form an SF1-U2AF(59)-U2AF(23) complex involved in recognition of the branch and 30 splice sites in pre-mRNA. In the present study, we identified a fourth ods mutant, ods4, which was isolated in an exon-skipping screen. The ods4(+) gene encodes Cwf16p, which interacts with the NineTeen Complex (NTC), a complex thought to be involved in the first catalytic step of the splicing reaction. We isolated two multi-copy suppressors for the ods4-1 mutation, Srp2p, an SR protein essential for pre-mRNA splicing, and Tif213p, a translation initiation factor, in S. pombe. The overexpression of Srp2p suppressed the exon-skipping phenotype of all ods mutants, whereas Tif213p suppressed only ods4-1, which has a mutation in the translational start codon of the cwf16 gene. We also showed that the decrease in the transcriptional elongation rate induced by drug treatment suppressed exon skipping in ods4-1. We propose that Cwf16p/NTC participates in the early recognition of the branch and 30 splice sites and cooperates with the SF1-U2AF(59)-U2AF(23) complex to maintain ordered exon joining.	[Sasaki-Haraguchi, Noriko; Ikuyama, Takeshi; Yoshii, Shogo; Takeuchi-Andoh, Tomoko; Tani, Tokio] Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, Kumamoto, Japan; [Frendewey, David] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA	Kumamoto University; Regeneron	Tani, T (corresponding author), Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, Kumamoto, Japan.	ttani@sci.kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23112716]; Japan Science and Technology Agency (CREST); Regeneron	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Regeneron(Regeneron)	This research was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant Number 23112716 and a grant from the Japan Science and Technology Agency (CREST). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Regeneron provided support in the form of a salary for the author DF, but did not fund nor in any way direct the research described in this publication. The specific roles of DF are articulated in the 'author contributions'.	Abovich N, 1997, CELL, V89, P403, DOI 10.1016/S0092-8674(00)80221-4; AEBI M, 1987, TRENDS GENET, V3, P102, DOI 10.1016/0168-9525(87)90193-4; Alfa C., 1993, EXPT FISSION YEAST; Alone PV, 2008, MOL CELL BIOL, V28, P6877, DOI 10.1128/MCB.01147-08; Awan AR, 2013, P NATL ACAD SCI USA, V110, P12762, DOI 10.1073/pnas.1218353110; Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Bitton DA, 2011, GENETICS, V187, P1207, DOI 10.1534/genetics.110.123497; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; BURKE JD, 1994, MOL GEN GENET, V242, P169, DOI 10.1007/BF00391010; CACERES JF, 1997, EUKARYOTIC MRNA PROC, P174; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; COTTAREL G, 1993, CURR GENET, V23, P547, DOI 10.1007/BF00312650; David CJ, 2011, GENE DEV, V25, P972, DOI 10.1101/gad.2038011; de la Mata M, 2010, RNA, V16, P904, DOI 10.1261/rna.1993510; Erickson FL, 1997, MOL GEN GENET, V253, P711; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Gutz H, 1974, HDB GENETICS, P395, DOI 10.1007/978-1-4899-1710-2_25; Haraguchi N, 2007, J BIOL CHEM, V282, P2221, DOI 10.1074/jbc.M609430200; Hogg R, 2010, BIOCHEM SOC T, V38, P1110, DOI 10.1042/BST0381110; Howe KJ, 2003, RNA, V9, P993, DOI 10.1261/rna.5390803; Huang HK, 1997, GENE DEV, V11, P2396, DOI 10.1101/gad.11.18.2396; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Liu YC, 2007, MOL CELL BIOL, V27, P5403, DOI 10.1128/MCB.00346-07; Livesay SB, 2013, EUKARYOT CELL, V12, P1472, DOI 10.1128/EC.00140-13; Lutzelberger M, 1999, NUCLEIC ACIDS RES, V27, P2618, DOI 10.1093/nar/27.13.2618; Makarova OV, 2001, EMBO J, V20, P2553, DOI 10.1093/emboj/20.10.2553; McDonald WH, 1999, MOL CELL BIOL, V19, P5352; Morris DP, 2000, J BIOL CHEM, V275, P39935, DOI 10.1074/jbc.M004118200; NAKASEKO Y, 1986, EMBO J, V5, P1011, DOI 10.1002/j.1460-2075.1986.tb04316.x; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Reed R, 2000, CURR OPIN CELL BIOL, V12, P340, DOI 10.1016/S0955-0674(00)00097-1; Roll-Mecak A, 2004, J BIOL CHEM, V279, P10634, DOI 10.1074/jbc.M310418200; Sherman F, 1986, METHODS YEAST GENETI, P61; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Urushiyama S, 1997, GENETICS, V147, P101; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Webb CJ, 2005, GENE DEV, V19, P242, DOI 10.1101/gad.1265905; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z	43	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136336	10.1371/journal.pone.0136336	http://dx.doi.org/10.1371/journal.pone.0136336			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302002	Green Submitted, Green Published, gold			2022-12-27	WOS:000359951900060
J	Bianco, A; Chiefari, E; Nobile, CGA; Foti, D; Pavia, M; Brunetti, A				Bianco, Aida; Chiefari, Eusebio; Nobile, Carmelo G. A.; Foti, Daniela; Pavia, Maria; Brunetti, Antonio			The Association between HMGA1 rs146052672 Variant and Type 2 Diabetes: A Transethnic Meta-Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INSULIN-RECEPTOR GENE; SYSTEMATIC REVIEWS; INCREASED RISK; BETA; HETEROGENEITY; PATHOGENESIS; PUBLICATION; SELECTION; PROTEINS	The high-mobility group A1 (HMGA1) gene has been previously identified as a potential novel candidate gene for susceptibility to insulin resistance and type 2 diabetes (T2D) mellitus. For this reason, several studies have been conducted in recent years examining the association of the HMGA1 gene variant rs146052672 (also designated IVS5-13insC) with T2D. Because of non-univocal data and non-overlapping results among laboratories, we conducted the current meta-analysis with the aim to yield a more precise and reliable conclusion for this association. Using predetermined inclusion criteria, MEDLINE, PubMed, Web of Science, Scopus, Google Scholar and Embase were searched for all relevant available literature published until November 2014. Two of the authors independently evaluated the quality of the included studies and extracted the data. Values from the single studies were combined to determine the meta-analysis pooled estimates. Heterogeneity and publication bias were also examined. Among the articles reviewed, five studies (for a total of 13,789 cases and 13,460 controls) met the predetermined criteria for inclusion in this meta-analysis. The combined adjusted odds ratio estimates revealed that the rs146052672 variant genotype had an overall statistically significant effect on increasing the risk of development of T2D. As most of the study subjects were Caucasian, further studies are needed to establish whether the association of this variant with an increased risk of T2D is generalizable to other populations. Also, in the light of this result, it would appear to be highly desirable that further in-depth investigations should be undertaken to elucidate the biological significance of the HMGA1 rs146052672 variant.	[Bianco, Aida; Chiefari, Eusebio; Nobile, Carmelo G. A.; Foti, Daniela; Pavia, Maria; Brunetti, Antonio] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy	Magna Graecia University of Catanzaro	Pavia, M (corresponding author), Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy.	pavia@unicz.it; brunetti@unicz.it	Chiefari, Eusebio/Y-2558-2019; Bianco, Aida/R-6612-2016; Odeku, Oluwatoyin A./D-3462-2011; Brunetti, Antonio/K-7756-2016; Foti, Daniela P/K-8038-2016	Chiefari, Eusebio/0000-0001-5329-3124; Odeku, Oluwatoyin A./0000-0002-0732-1304; BIANCO, Aida/0000-0003-4674-0306; Foti, Daniela/0000-0002-9536-5736; PAVIA, Maria/0000-0003-3879-1322; NOBILE, Carmelo Giuseppe Angelo/0000-0002-0762-513X; Brunetti, Antonio/0000-0003-1533-8779				American Diabetes Association, 2014, DIABETES CARE S1, V37; Arcidiacono B, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00237; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Brunetti A, 2001, FASEB J, V15, P492, DOI 10.1096/fj.00-0190com; Brunetti A, 2012, DIABETES, V61, P524; Brunetti A, 2014, WORLD J DIABETES, V5, P128, DOI 10.4239/wjd.v5.i2.128; Chen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076653; Chiefari E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01491; Chiefari E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00251; Chiefari E, 2011, JAMA-J AM MED ASSOC, V305, P903, DOI 10.1001/jama.2011.207; Chiefari E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1040; Chiefari E, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-24; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Expert Committee, 2003, DIABETES CARE S1, V26, pS5, DOI DOI 10.2337/DIACARE.26.2007.S5; Foti D, 2005, NAT MED, V11, P765, DOI 10.1038/nm1254; Foti D, 2003, MOL CELL BIOL, V23, P2720, DOI 10.1128/MCB.23.8.2720-2732.2003; Fradin DD, 2009, BMC PROC SUPPLEMENT, V3; Froguel Philippe, 2012, Diabetes, V61, pe15, DOI 10.2337/db12-0800; Genuth S, 2003, DIABETES CARE, V26, P3160; HANIS CL, 1991, DIABETES CARE, V14, P618, DOI 10.2337/diacare.14.7.618; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hunter LH, 2014, J DIABETES METAB DIS, V1; Iiritano S, 2012, MOL ENDOCRINOL, V26, P1578, DOI 10.1210/me.2011-1379; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Karnes JH, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-12; Liu L, 2012, DIABETOLOGIA, V55, P1685, DOI 10.1007/s00125-012-2518-0; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marquez M, 2012, DIABETES, V61, P524, DOI 10.2337/db11-0728; McCarthy MI, 2009, CURR DIABETES REP, V9, P164, DOI 10.1007/s11892-009-0027-4; Melillo RM, 2001, MOL CELL BIOL, V21, P2485, DOI 10.1128/MCB.21.7.2485-2495.2001; MIETTINEN OS, 1985, J CHRON DIS, V38, P543, DOI 10.1016/0021-9681(85)90039-6; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Nakaoka H, 2009, J HUM GENET, V54, P615, DOI 10.1038/jhg.2009.95; NEEL JV, 1962, AM J HUM GENET, V14, P353; Pullinger CR, 2014, METAB SYNDR RELAT D, V12, P25, DOI 10.1089/met.2013.0086; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Schneiderman N, 2014, DIABETES CARE, V37, P2233, DOI 10.2337/dc13-2939; Semple Robert K., 2009, Journal of Biology (London), V8, P64, DOI 10.1186/jbiol164; Smith S, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-124; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Stumvoll M, 2008, LANCET, V371, P2153, DOI 10.1016/S0140-6736(08)60932-0; Taylor LE, 2014, VACCINE, V32, P3623, DOI 10.1016/j.vaccine.2014.04.085; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Unger RH, 2008, JAMA-J AM MED ASSOC, V299, P1185, DOI 10.1001/jama.299.10.1185; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397; Wei CD, 2013, INT J MED SCI, V10, P457, DOI 10.7150/ijms.5234; Wells G., 2013, OTTAWA HOSP RES I; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wray NR, 2012, EUR J HUM GENET, V20, P668, DOI 10.1038/ejhg.2011.257; Wu WX, 2015, SCI REP-UK, V5, DOI 10.1038/srep11350; Ye XH, 2014, MOL BIOL REP, V41, P373, DOI 10.1007/s11033-013-2871-1; Zhang XP, 2010, DIABETES CARE, V33, P1665, DOI 10.2337/dc09-1939; Zheng G, 2005, STAT MED, V24, P869, DOI 10.1002/sim.1976	60	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136077	10.1371/journal.pone.0136077	http://dx.doi.org/10.1371/journal.pone.0136077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296198	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900069
J	Jeong, MH; Kim, SJ; Kang, H; Park, KW; Park, WJ; Yang, SY; Yang, DK				Jeong, Moon Hee; Kim, Shang-Jin; Kang, Hara; Park, Kye Won; Park, Woo Jin; Yang, Seung Yul; Yang, Dong Kwon			Cucurbitacin I Attenuates Cardiomyocyte Hypertrophy via Inhibition of Connective Tissue Growth Factor (CCN2) and TGF-beta/Smads Signalings	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; MITOCHONDRIAL-FUNCTION; WILBRANDIA-EBRACTEATA; BIOLOGICAL-ACTIVITIES; RESVERATROL; MICE; FIBROSIS; CANCER; CELLS; OVERLOAD	Cucurbitacin I is a naturally occurring triterpenoid derived from Cucurbitaceae family plants that exhibits a number of potentially useful pharmacological and biological activities. However, the therapeutic impact of cucurbitacin I on the heart has not heretofore been reported. To evaluate the functional role of cucurbitacin I in an in vitro model of cardiac hypertrophy, phenylephrine (PE)-stimulated cardiomyocytes were treated with a sub-cytotoxic concentration of the compound, and the effects on cell size and mRNA expression levels of ANF and beta-MHC were investigated. Consequently, PE-induced cell enlargement and upregulation of ANF and beta-MHC were significantly suppressed by pretreatment of the cardiomyocytes with cucurbitacin I. Notably, cucurbitacin I also impaired connective tissue growth factor (CTGF) and MAPK signaling, pro-hypertrophic factors, as well as TGF-beta/Smad signaling, the important contributing factors to fibrosis. The protective impact of cucurbitacin I was significantly blunted in CTGF-silenced or TGF-beta 1-silenced hypertrophic cardiomyocytes, indicating that the compound exerts its beneficial actions through CTGF. Taken together, these findings signify that cucurbitacin I protects the heart against cardiac hypertrophy via inhibition of CTGF/MAPK, and TGF-beta/Smad-facilitated events. Accordingly, the present study provides new insights into the defensive capacity of cucurbitacin I against cardiac hypertrophy, and further suggesting cucurbitacin I's utility as a novel therapeutic agent for the management of heart diseases.	[Jeong, Moon Hee; Park, Woo Jin; Yang, Dong Kwon] Gwangju Inst Sci & Technol, Coll Life Sci, Gwangju, South Korea; [Kim, Shang-Jin] Chonbuk Natl Univ, Coll Vet Med, Dept Vet Pharmacol & Toxicol, Jeonju, Jeonbuk, South Korea; [Kang, Hara] Incheon Natl Univ, Div Life Sci, Coll Life Sci & Bioengn, Inchon, South Korea; [Park, Kye Won] Sungkyunkwan Univ, Dept Food Sci & Biotechnol, Coll Biotechnol & Bioengn, Suwon, South Korea; [Yang, Seung Yul] Sunchon Natl Univ, Dept Hort, Sunchon, Jeonnam, South Korea	Gwangju Institute of Science & Technology (GIST); Jeonbuk National University; Incheon National University; Sungkyunkwan University (SKKU); Sunchon National University	Yang, DK (corresponding author), Gwangju Inst Sci & Technol, Coll Life Sci, Gwangju, South Korea.	dkyang0502@gmail.com		Park, Kye Won/0000-0003-2771-249X	Rural development Administration [PJ008777]; Jeonnam Agricultural Research & Extension Services, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2013R1A1A2060447]	Rural development Administration(Rural Development Administration (RDA), Republic of Korea); Jeonnam Agricultural Research & Extension Services, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea)	S.Y.Y. and D.K.Y. were supported by a grant (No. PJ008777) from the Rural development Administration and Jeonnam Agricultural Research & Extension Services, Republic of Korea. K.W.P. was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A2060447).	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Butler MS, 2014, NAT PROD REP, V31, P1612, DOI 10.1039/c4np00064a; Chen JC, 2005, NAT PROD REP, V22, P386, DOI 10.1039/b418841c; Chen XP, 2012, ANTI-CANCER DRUG, V23, P777, DOI 10.1097/CAD.0b013e3283541384; Debnath B, 2012, J MED CHEM, V55, P6645, DOI 10.1021/jm300207s; DIRR HW, 1986, BIOCHEM J, V233, P649, DOI 10.1042/bj2330649; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Dolinsky VW, 2011, BBA-MOL BASIS DIS, V1812, P1477, DOI 10.1016/j.bbadis.2011.06.010; Escandell JM, 2007, J PHARMACOL EXP THER, V320, P581, DOI 10.1124/jpet.106.107003; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Hardt SE, 2004, CARDIOVASC RES, V63, P500, DOI 10.1016/j.cardiores.2004.03.015; Hayata N, 2008, BIOCHEM BIOPH RES CO, V370, P274, DOI 10.1016/j.bbrc.2008.03.100; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hsu HS, 2011, CANCER-AM CANCER SOC, V117, P2970, DOI 10.1002/cncr.25869; Javadov S, 2014, PHARMACOL THERAPEUT, V144, P202, DOI 10.1016/j.pharmthera.2014.05.013; Jayaprakasam B, 2003, CANCER LETT, V189, P11, DOI 10.1016/S0304-3835(02)00497-4; Jeong MH, 2012, BIOCHEM BIOPH RES CO, V428, P191, DOI 10.1016/j.bbrc.2012.10.040; KATZ AM, 1990, NEW ENGL J MED, V322, P100; Koitabashi N, 2011, J CLIN INVEST, V121, P2301, DOI 10.1172/JCI44824; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee DH, 2010, THESCIENTIFICWORLDJO, V10, P413, DOI 10.1100/tsw.2010.44; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lui VWY, 2009, CARCINOGENESIS, V30, P2085, DOI 10.1093/carcin/bgp253; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Matsui Y, 2004, J MOL CELL CARDIOL, V37, P477, DOI 10.1016/j.yjmcc.2004.05.012; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Newman DJ, 2012, J NAT PRODUCTS, V75, P311, DOI DOI 10.1021/NP200906S; Peters RR, 1999, LIFE SCI, V64, P2429, DOI 10.1016/S0024-3205(99)00200-3; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rosenkranz S, 2002, AM J PHYSIOL-HEART C, V283, pH1253, DOI 10.1152/ajpheart.00578.2001; Seo CR, 2014, FOOD CHEM TOXICOL, V64, P217, DOI 10.1016/j.fct.2013.11.040; Shimo T, 1999, J BIOCHEM-TOKYO, V126, P137, DOI 10.1093/oxfordjournals.jbchem.a022414; Siqueira JM, 2007, LIFE SCI, V80, P1382, DOI 10.1016/j.lfs.2006.12.021; Wang QJ, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-4	39	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136236	10.1371/journal.pone.0136236	http://dx.doi.org/10.1371/journal.pone.0136236			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296085	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900086
J	Ma, LN; Zhao, XL; Tang, Z; Li, Y; Sun, F; Diao, LJ; Ge, GZ; Feng, M; Wang, JY				Ma, Lina; Zhao, Xiaoling; Tang, Zhe; Li, Yun; Sun, Fei; Diao, Lijun; Ge, Gaizhen; Feng, Ming; Wang, Jieyu			Epidemiological Characteristics of Hypertension in the Elderly in Beijing, China	PLOS ONE			English	Article							BLOOD-PRESSURE; PREVALENCE; HEALTH; AWARENESS; ADULTS; TRENDS; RISK; POPULATION; NUTRITION	Background/Objectives The prevalence rate of hypertension increases significantly with the aging society, and hypertension is obviously becoming a major health care concern in China. The aim of the study was to explore the epidemiological characteristics of hypertension in the elderly and to provide a basis for the prevention of hypertension. Design 3-cross sectional studies in 2000, 2004, and 2007, respectively. Setting Beijing, China. Participants A group of 2,832, 1,828, and 2,277 elderly residents aged >= 60 years were included this study in 2000, 2004, and 2007, respectively. Intervention None. Measurements Statistical sampling techniques included cluster, stratification, and random selection. Trained staff used a comprehensive geriatric assessment questionnaire and a standard survey instrument to complete the assessments. During the person-to-person interviews, the participants' demographic characteristics, living conditions, and health status were collected, and their blood pressure was measured. Results The prevalence rates (69.2%, 61.9%, and 56.0%) of hypertension and the control rates (22.6%, 16.7%, and 21.5%) lowered annually, while the awareness rates (43.7%, 55.8%, and 57.6%) of the treatment elevated annually in 2000, 2004, and 2007, respectively. There was no increase in the control rates for males (26.2%, 16.7%, and 20.8%), younger participants (28.0%, 18.4%, and 21.0%), and rural residents (19.5%, 9.6%, and 13.4%) in 2000, 2004, and 2007, respectively. Conclusions Our study findings indicated that the prevalence of hypertension is high in rural elderly participants, while the rates of awareness, treatment, and control were low. This suggests that effective public measures need to be developed to improve the prevention and control of hypertension.	[Ma, Lina; Li, Yun; Feng, Ming; Wang, Jieyu] Capital Med Univ, Xuan Wu Hosp, Dept Geriatr, Beijing, Peoples R China; [Ma, Lina; Zhao, Xiaoling; Tang, Zhe; Sun, Fei; Diao, Lijun; Ge, Gaizhen] Capital Med Univ, Key Lab Neurodegenerat Dis, Ctr Alzheimers Dis,Beijing Inst Brain Disorders, Dept Epidemiol & Social Med,Xuan Wu Hosp,Minist E, Beijing, Peoples R China; [Zhao, Xiaoling] Three Gorges Univ, Peoples Hosp, Peoples Hosp Yichang 1, Dept Emergency, Yichang, Peoples R China	Capital Medical University; Capital Medical University; China Three Gorges University	Tang, Z (corresponding author), Capital Med Univ, Key Lab Neurodegenerat Dis, Ctr Alzheimers Dis,Beijing Inst Brain Disorders, Dept Epidemiol & Social Med,Xuan Wu Hosp,Minist E, Beijing, Peoples R China.	tangzhe@medmail.com.cn	wang, jie/GRS-0942-2022					Chen X, 2014, AM J HYPERTENS, V27, P1503, DOI 10.1093/ajh/hpu026; Cheng HM, 2015, AM J HYPERTENS, V28, P604, DOI 10.1093/ajh/hpu214; Fan L, 2014, AUST J RURAL HEALTH, V22, P264, DOI 10.1111/ajr.12116; Guilbert J J, 2003, Educ Health (Abingdon), V16, P230; Huang YL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006551; Joshi Shashank R, 2003, J Assoc Physicians India, V51, P151; Kaplan NM, 2006, LANCET, V367, P168, DOI 10.1016/S0140-6736(06)67965-8; Kim JS, 2014, INT J STROKE, V9, P856, DOI 10.1111/ijs.12317; Li X, 2006, CHIN CHRONIC PREVENT, V14, P94; Liang XY, 2006, J HUM HYPERTENS, V20, P227, DOI 10.1038/sj.jhh.1001967; Liang YJ, 2014, INT J CARDIOL, V175, P96, DOI 10.1016/j.ijcard.2014.04.258; Ling RE, 2011, PUBLIC HEALTH, V125, P9, DOI 10.1016/j.puhe.2010.10.009; Lu JP, 2012, MOL BIOL REP, V39, P8937, DOI 10.1007/s11033-012-1762-1; Mancia G, 2015, J HYPERTENS, V33, P33, DOI 10.1097/HJH.0000000000000424; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Parati G, 1998, HYPERTENSION, V31, P1185, DOI 10.1161/01.HYP.31.5.1185; Peng XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012129; Primatesta P, 2004, J HYPERTENS, V22, P1093, DOI 10.1097/00004872-200406000-00008; Shao S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082446; Su DT, 2014, INT J EPIDEMIOL, V43, P1835, DOI 10.1093/ije/dyu158; Supiyev A, 2015, PUBLIC HEALTH, V129, P948, DOI 10.1016/j.puhe.2015.02.020; Wang CX, 2014, J AM GERIATR SOC, V62, P821, DOI 10.1111/jgs.12792; Weinehall L, 2002, J HYPERTENS, V20, P2081, DOI 10.1097/00004872-200210000-00029; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Yan YX, 2013, J EPIDEMIOL, V23, P389, DOI 10.2188/jea.JE20130035; Yang L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-903; Zimmer Z, 2014, J AGING HEALTH, V26, P207, DOI 10.1177/0898264313513609	27	2	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135480	10.1371/journal.pone.0135480	http://dx.doi.org/10.1371/journal.pone.0135480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26295836	gold, Green Published, Green Submitted			2022-12-27	WOS:000359926900030
J	Mrug, M; Zhou, JL; Yang, CZ; Aronow, BJ; Cui, XQ; Schoeb, TR; Siegal, GP; Yoder, BK; Guay-Woodford, LM				Mrug, Michal; Zhou, Juling; Yang, Chaozhe; Aronow, Bruce J.; Cui, Xiangqin; Schoeb, Trenton R.; Siegal, Gene P.; Yoder, Bradley K.; Guay-Woodford, Lisa M.			Genetic and Informatic Analyses Implicate Kif12 as a Candidate Gene within the Mpkd2 Locus That Modulates Renal Cystic Disease Severity in the Cys1(cpk) Mouse	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; AUTOSOMAL-DOMINANT; PROTEIN; MACROPHAGES; MODIFIER; ENCODES; MODEL; PKHD1; IDENTIFICATION; TRANSCRIPTION	We have previously mapped the interval on Chromosome 4 for a major polycystic kidney disease modifier (Mpkd) of the B6(Cg)-Cys1(cpk)/J mouse model of recessive polycystic kidney disease (PKD). Informatic analyses predicted that this interval contains at least three individual renal cystic disease severity-modulating loci (Mpkd1-3). In the current study, we provide further validation of these predicted effects using a congenic mouse line carrying the entire CAST/EiJ (CAST)-derived Mpkd1-3 interval on the C57BL/6J background. We have also generated a derivative congenic line with a refined CAST-derived Mpkd1-2 interval and demonstrated its dominantly-acting disease-modulating effects (e.g., 4.2-fold increase in total cyst area; p<0.001). The relative strength of these effects allowed the use of recombinants from these crosses to fine map the Mpkd2 effects to a <14 Mbp interval that contains 92 RefSeq sequences. One of them corresponds to the previously described positional Mpkd2 candidate gene, Kif12. Among the positional Mpkd2 candidates, only expression of Kif12 correlates strongly with the expression pattern of Cys1 across multiple anatomical nephron structures and developmental time points. Also, we demonstrate that Kif12 encodes a primary cilium-associated protein. Together, these data provide genetic and informatic validation of the predicted renal cystic disease-modulating effects of Mpkd-13 loci and implicate Kif12 as the candidate locus for Mpkd2.	[Mrug, Michal; Zhou, Juling] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Yang, Chaozhe; Schoeb, Trenton R.; Guay-Woodford, Lisa M.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Cui, Xiangqin] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Siegal, Gene P.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Yoder, Bradley K.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Aronow, Bruce J.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Mrug, Michal] Dept Vet Affairs Med Ctr, Birmingham, AL 35233 USA; [Yang, Chaozhe; Guay-Woodford, Lisa M.] Childrens Natl Hlth Syst, Ctr Translat Sci, Washington, DC 20010 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Cincinnati Children's Hospital Medical Center; Children's National Health System	Mrug, M (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	mmrug@uab.edu; LGuaywoo@childrensnational.org		Cui, Xiangqin/0000-0003-0621-9313	American Heart Association National Scientist Development Award [0535335N]; Burroughs Wellcome Fund Clinical Scientific Award in Translational Research; Office of Research and Development, Medical Research Service, Department of Veterans Affairs [DK097423, BX002985]; Detraz Endowed Research Fund in Polycystic Kidney Disease; National Institutes of Health [P30-DK-074038, P30 DK064400, 1P30 DK079337]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097423, P30DK074038, R24DK064400, P30DK079337] Funding Source: NIH RePORTER	American Heart Association National Scientist Development Award(American Heart Association); Burroughs Wellcome Fund Clinical Scientific Award in Translational Research; Office of Research and Development, Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); Detraz Endowed Research Fund in Polycystic Kidney Disease; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Heart Association National Scientist Development Award 0535335N (M.M.) and by the Burroughs Wellcome Fund Clinical Scientific Award in Translational Research (L.G-W). In addition, X.C. was in part supported by the National Institutes of Health funded UAB-UCSD O'Brien Center 1P30 DK079337 and M.M. by DK097423, by BX002985 from the Office of Research and Development, Medical Research Service, Department of Veterans Affairs, and by the Detraz Endowed Research Fund in Polycystic Kidney Disease. The presented study also utilized services provided by Core A and Core D of the National Institutes of Health funded UAB Hepatorenal Fibrocystic Disease Core Center P30-DK-074038. Finally, a subset of experimental crosses was generated by Core 3 (Gnotobiotic and Genetically-Engineered Mouse Core) of the National Institutes of Health funded Mucosal HIV and Immunobiology Center P30 DK064400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bergmann C, 2005, KIDNEY INT, V67, P829, DOI 10.1111/j.1523-1755.2005.00148.x; BURN TC, 1995, HUM MOL GENET, V4, P575, DOI 10.1093/hmg/4.4.575; Cui XQ, 2009, AM J NEPHROL, V30, P413, DOI 10.1159/000235993; Dafinger C, 2011, J CLIN INVEST, V121, P2662, DOI 10.1172/JCI43639; Davis RC, 2007, GENOMICS, V90, P306, DOI 10.1016/j.ygeno.2007.05.009; DEGET F, 1995, CLIN GENET, V47, P248, DOI 10.1111/j.1399-0004.1995.tb04305.x; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Fedeles SV, 2011, NAT GENET, V43, P639, DOI 10.1038/ng.860; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Garcia Nilda M, 2006, J Pediatr Urol, V2, P233, DOI 10.1016/j.jpurol.2006.03.006; Garcia-Gonzalez MA, 2007, HUM MOL GENET, V16, P1940, DOI 10.1093/hmg/ddm141; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Gong YM, 2009, J AM SOC NEPHROL, V20, P41, DOI 10.1681/ASN.2008020238; Guay-Woodford LM, 2000, J AM SOC NEPHROL, V11, P1253, DOI 10.1681/ASN.V1171253; Hogan MC, 2009, J AM SOC NEPHROL, V20, P278, DOI 10.1681/ASN.2008060564; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Igarashi P, 2005, KIDNEY INT, V68, P1944, DOI 10.1111/j.1523-1755.2005.00625.x; Karihaloo A, 2011, J AM SOC NEPHROL, V22, P1809, DOI 10.1681/ASN.2011010084; KIZER NL, 1995, AM J PHYSIOL-RENAL, V268, pF347, DOI 10.1152/ajprenal.1995.268.2.F347; Kobayashi T, 2011, CELL, V145, P914, DOI 10.1016/j.cell.2011.04.028; Kuida S, 2000, GENOME RES, V10, P49; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lambie L, 2015, PEDIATR NEPHROL, V30, P273, DOI 10.1007/s00467-014-2917-1; Ma M, 2013, NAT GENET, V45, P1004, DOI 10.1038/ng.2715; Maouche S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-302; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; McMahon AP, 2008, J AM SOC NEPHROL, V19, P667, DOI 10.1681/ASN.2007101078; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Mrug M, 2008, KIDNEY INT, V73, P63, DOI 10.1038/sj.ki.5002627; Mrug M, 2005, J AM SOC NEPHROL, V16, P905, DOI 10.1681/ASN.2004121083; Mrug M, 2013, NEPHROLOGY, V18, P746, DOI 10.1111/nep.12153; O'Connor Amber K, 2013, Cilia, V2, P8, DOI 10.1186/2046-2530-2-8; Onuchic LF, 2002, AM J HUM GENET, V70, P1305, DOI 10.1086/340448; Raynaud P, 2011, HEPATOLOGY, V53, P1959, DOI 10.1002/hep.24292; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schuffenhauer S, 1998, EUR J HUM GENET, V6, P213, DOI 10.1038/sj.ejhg.5200183; Swenson-Fields KI, 2013, KIDNEY INT, V83, P855, DOI 10.1038/ki.2012.446; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; WARD CJ, 1994, CELL, V77, P881; Wickstead B, 2006, MOL BIOL CELL, V17, P1734, DOI 10.1091/mbc.E05-11-1090; Woo D, 1995, J AM SOC NEPHROL, V6, p731A; Woo DDL, 1997, J CLIN INVEST, V100, P1934, DOI 10.1172/JCI119724; Zhou JL, 2012, J AM SOC NEPHROL, V23, P1161, DOI 10.1681/ASN.2011050442; Zhou JL, 2010, KIDNEY INT, V78, P550, DOI 10.1038/ki.2010.175; Zvereff V, 2010, GENET TEST MOL BIOMA, V14, P505, DOI 10.1089/gtmb.2009.0188	46	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e01356780	10.1371/journal.pone.0135678	http://dx.doi.org/10.1371/journal.pone.0135678			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295839	Green Submitted, Green Published, gold			2022-12-27	WOS:000359926900039
J	Ruiz-Raya, F; Soler, M; Sanchez-Perez, LLI; Ibanez-Alamo, JD				Ruiz-Raya, Francisco; Soler, Manuel; Sanchez-Perez, Lucia L. I.; Ibanez-Alamo, Juan Diego			Could a Factor That Does Not Affect Egg Recognition Influence the Decision of Rejection?	PLOS ONE			English	Article							CUCKOO CUCULUS-CANORUS; REED WARBLERS; BROOD PARASITISM; MODEL SYSTEM; HOST; DISCRIMINATION; SIZE; COEVOLUTION; ADAPTATIONS; EJECTION	Rejection of the parasitic egg is the most important defence of hosts against brood parasites. However, this response is variable among and within species, and egg discrimination is not always followed by egg rejection. Low risk of parasitism and high risk of rejection costs may lead to the acceptance of the parasitic egg even if it has been previously recognized. The main aim of this paper is to answer a relevant question: can a single egg trait provoke the acceptance of an experimental egg previously recognized as foreign? Increased egg mass should hamper the ejection of an egg that has been discriminated because ejection of a heavy egg may imply higher rejection costs for hosts. We have tested this prediction by experimentally parasitizing natural nests of Common Blackbirds (Turdus merula) with non-mimetic model eggs of different mass (heavy, normal-weight, and light) while controlling for potential confounding factors such as egg size and colour. Our results showed that blackbirds more frequently accepted heavy eggs, even when previously recognized. This differential acceptance may be related to insufficient motivation to assume the higher costs that the ejection of a heavy egg could impose.	[Ruiz-Raya, Francisco; Soler, Manuel; Sanchez-Perez, Lucia L. I.; Ibanez-Alamo, Juan Diego] Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain; [Soler, Manuel] Univ Granada, Unidad Asociada CSIC, Grp Coevoluc, Granada, Spain; [Ibanez-Alamo, Juan Diego] Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands; [Ibanez-Alamo, Juan Diego] CSIC, Estn Biol Donana, Dept Wetland Ecol, E-41080 Seville, Spain	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); University of Granada; University of Groningen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Ruiz-Raya, F (corresponding author), Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain.	fraruiz@correo.ugr.es	Ruiz-Raya, Francisco/L-8639-2019; Ibáñez-Álamo, Juan Diego/H-7624-2019	Ruiz-Raya, Francisco/0000-0002-4646-1975; Ibanez Alamo, Juan Diego/0000-0002-2136-1767	Consejeria Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia [CVI-6653]	Consejeria Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia(Junta de Andalucia)	Financial support has been provided by the Consejeria Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (research project CVI-6653). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez F, 1996, IBIS, V138, P340, DOI 10.1111/j.1474-919X.1996.tb04349.x; Alvarez F, 2003, ARDEA, V91, P127; Antonov A, 2008, BEHAV ECOL, V19, P100, DOI 10.1093/beheco/arm102; Antonov A, 2009, BIOL LETTERS, V5, P169, DOI 10.1098/rsbl.2008.0645; Aviles JM, 2011, J EVOLUTION BIOL, V24, P314, DOI 10.1111/j.1420-9101.2010.02168.x; Aviles JM, 2004, ANIM BEHAV, V67, P951, DOI 10.1016/j.anbehav.2003.08.022; Brooke MD, 1998, P ROY SOC B-BIOL SCI, V265, P1277, DOI 10.1098/rspb.1998.0430; BROOKE MD, 1988, NATURE, V335, P630; Cherry MI, 2001, P ROY SOC B-BIOL SCI, V268, P565, DOI 10.1098/rspb.2000.1414; Christians JK, 2002, BIOL REV, V77, P1, DOI 10.1017/S1464793101005784; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Davies NB, 1996, P ROY SOC B-BIOL SCI, V263, P925, DOI 10.1098/rspb.1996.0137; DAVIES NB, 1988, ANIM BEHAV, V36, P262, DOI 10.1016/S0003-3472(88)80269-0; DAVIES NB, 1989, J ANIM ECOL, V58, P207, DOI 10.2307/4995; DEEMING DC, 1989, J MORPHOL, V201, P179, DOI 10.1002/jmor.1052010207; Ibanez-Alamo JD, 2010, BIOL J LINN SOC, V101, P759, DOI 10.1111/j.1095-8312.2010.01543.x; Finger J., 1992, GUIDE THEORY PRACTIC; Grim T, 2011, J ANIM ECOL, V80, P508, DOI 10.1111/j.1365-2656.2010.01798.x; Hauber ME, 2006, BIOL LETTERS, V2, P177, DOI 10.1098/rsbl.2005.0438; Honza M, 2005, J AVIAN BIOL, V36, P517, DOI 10.1111/j.0908-8857.2005.03358.x; Honza M, 2007, BIOL J LINN SOC, V92, P269, DOI 10.1111/j.1095-8312.2007.00848.x; Ibanez-Alamo JD, 2012, BEHAV ECOL SOCIOBIOL, V66, P1067, DOI 10.1007/s00265-012-1357-9; Lahti DC, 2002, ANIM BEHAV, V63, P1135, DOI 10.1006/anbe.2002.3009; Langmore NE, 2005, BEHAV ECOL, V16, P686, DOI 10.1093/beheco/ari041; Lindholm AK, 2000, BEHAVIOUR, V137, P25, DOI 10.1163/156853900501854; Lyon BE, 2003, NATURE, V422, P495, DOI 10.1038/nature01505; Lyon B, 2007, BEHAV ECOL SOCIOBIOL, V61, P455, DOI 10.1007/s00265-006-0273-2; MAGRATH RD, 1992, AUK, V109, P474; Martin-Galvez D, 2006, J EVOLUTION BIOL, V19, P543, DOI 10.1111/j.1420-9101.2005.01002.x; Martin-Vivaldi M, 2013, IBIS, V155, P140, DOI 10.1111/ibi.12000; MOKSNES A, 1991, BEHAVIOUR, V116, P64, DOI 10.1163/156853990X00365; MOKSNES A, 1989, BEHAV ECOL SOCIOBIOL, V24, P25, DOI 10.1007/BF00300114; Moskat C, 2007, ANIM COGN, V10, P377, DOI 10.1007/s10071-007-0071-x; NEW DAT, 1957, J EMBRYOL EXP MORPH, V5, P293; PAYNE RB, 1977, ECOLOGY, V58, P500, DOI 10.2307/1939000; Polacikova L, 2010, J AVIAN BIOL, V41, P111, DOI 10.1111/j.1600-048X.2010.04983.x; ROTHSTEIN SI, 1990, ANNU REV ECOL SYST, V21, P481, DOI 10.1146/annurev.es.21.110190.002405; Samas P, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-34; Samas P, 2011, ETHOLOGY, V117, P606, DOI 10.1111/j.1439-0310.2011.01917.x; Soler JJ, 1999, EVOLUTION, V53, P947, DOI 10.1111/j.1558-5646.1999.tb05388.x; Soler JJ, 2000, OECOLOGIA, V125, P309, DOI 10.1007/s004420000487; Soler M, 2002, ETHOLOGY, V108, P1093, DOI 10.1046/j.1439-0310.2002.00841.x; SOLER M, 1990, NATURE, V343, P748, DOI 10.1038/343748a0; Soler M, 2015, J AVIAN BIOL, V46, P1; Soler M, 2014, BIOL REV, V89, P688, DOI 10.1111/brv.12075; Soler M, 2012, ETHOLOGY, V118, P662, DOI 10.1111/j.1439-0310.2012.02058.x; Soler M, 2011, BEHAV ECOL SOCIOBIOL, V65, P1997, DOI 10.1007/s00265-011-1209-z; Spottiswoode CN, 2011, P ROY SOC B-BIOL SCI, V278, P3566, DOI 10.1098/rspb.2011.0401; Spottiswoode CN, 2010, P NATL ACAD SCI USA, V107, P8672, DOI 10.1073/pnas.0910486107; Stoddard MC, 2011, EVOLUTION, V65, P2004, DOI 10.1111/j.1558-5646.2011.01262.x; Stokke BG, 2008, BEHAV ECOL, V19, P612, DOI 10.1093/beheco/arn007; Stokke BG, 1999, P ROY SOC B-BIOL SCI, V266, P1483, DOI 10.1098/rspb.1999.0804; Svennungsen TO, 2010, EVOLUTION, V64, P1459, DOI 10.1111/j.1558-5646.2009.00919.x; Underwood TJ, 2006, ANIM BEHAV, V71, P409, DOI 10.1016/j.anbehav.2005.06.004	54	29	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135624	10.1371/journal.pone.0135624	http://dx.doi.org/10.1371/journal.pone.0135624			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295481	gold, Green Published			2022-12-27	WOS:000359926900036
J	Strom, CM; Rivera, S; Elzinga, C; Angeloni, T; Rosenthal, SH; Goos-Root, D; Siaw, M; Platt, J; Braastadt, C; Cheng, L; Ross, D; Sun, WM				Strom, Charles M.; Rivera, Steven; Elzinga, Christopher; Angeloni, Taraneh; Rosenthal, Sun Hee; Goos-Root, Dana; Siaw, Martin; Platt, Jamie; Braastadt, Cory; Cheng, Linda; Ross, David; Sun, Weimin			Development and Validation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Variants for the Clinical Laboratory	PLOS ONE			English	Article							OVARIAN-CANCER; BREAST-CANCER; MUTATION CARRIERS; FAMILY-HISTORY; POPULATION; PREVALENCE; RISKS	The objective of this study was to design and validate a next-generation sequencing assay (NGS) to detect BRCA1 and BRCA2 mutations. We developed an assay using random shearing of genomic DNA followed by RNA bait tile hybridization and NGS sequencing on both the Illumina MiSeq and Ion Personal Gene Machine (PGM). We determined that the MiSeq Reporter software supplied with the instrument could not detect deletions greater than 9 base pairs. Therefore, we developed an alternative alignment and variant calling software, Quest Sequencing Analysis Pipeline (QSAP), that was capable of detecting large deletions and insertions. In validation studies, we used DNA from 27 stem cell lines, all with known deleterious BRCA1 or BRCA2 mutations, and DNA from 67 consented control individuals who had a total of 352 benign variants. Both the MiSeq/QSAP combination and PGM/Torrent Suite combination had 100% sensitivity for the 379 known variants in the validation series. However, the PGM/Torrent Suite combination had a lower intra-and inter-assay precision of 96.2% and 96.7%, respectively when compared to the MiSeq/QSAP combination of 100% and 99.4%, respectively. All PGM/Torrent Suite inconsistencies were false-positive variant assignments. We began commercial testing using both platforms and in the first 521 clinical samples MiSeq/QSAP had 100% sensitivity for BRCA1/2 variants, including a 64-bp deletion and a 10-bp insertion not identified by PGM/Torrent Suite, which also suffered from a high false-positive rate. Neither the MiSeq nor PGM platform with their supplied alignment and variant calling software are appropriate for a clinical laboratory BRCA sequencing test. We have developed an NGS BRCA1/2 sequencing assay, MiSeq/QSAP, with 100% analytic sensitivity and specificity in the validation set consisting of 379 variants. The MiSeq/QSAP combination has sufficient performance for use in a clinical laboratory.	[Strom, Charles M.; Rivera, Steven; Angeloni, Taraneh; Rosenthal, Sun Hee; Goos-Root, Dana; Siaw, Martin; Platt, Jamie; Cheng, Linda; Sun, Weimin] Quest Diagnost Nichols Inst, Dept Genet, San Juan Capistrano, CA 92675 USA; [Elzinga, Christopher; Braastadt, Cory] Athena Quest Diagnost, Marlborough, MA USA; [Ross, David] Celera Quest Diagnost, Alameda, CA USA	Nichols Institute	Strom, CM (corresponding author), Quest Diagnost Nichols Inst, Dept Genet, San Juan Capistrano, CA 92675 USA.	charles.m.strom@questdiagnostics.com			Quest Diagnostics	Quest Diagnostics	This research was supported by Quest Diagnostics. The specific roles of these authors are articulated in the 'author contributions' section. The authors received no specific funding for this work. Quest Diagnostics provided support in the form of salaries for all authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, CANC FACTS FIG 2013; American Society of Breast Surgeons, POS STAT BRCA GEN TE; [Anonymous], 2009, Obstet Gynecol, V113, P957, DOI 10.1097/AOG.0b013e3181a106d4; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Hartman AR, 2012, CANCER-AM CANCER SOC, V118, P2787, DOI 10.1002/cncr.26576; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; Metcalfe K, 2004, J CLIN ONCOL, V22, P2328, DOI 10.1200/JCO.2004.04.033; National Comprehensive Cancer Network, 2014, NCCN CLIN PRACT GUID; Petrucelli N, 1993, GENE REV; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Robson M, 2001, CURR PROB SURG, V38, P381; Rubin SC, 1998, AM J OBSTET GYNECOL, V178, P670, DOI 10.1016/S0002-9378(98)70476-4; Whittemore AS, 1997, AM J HUM GENET, V60, P496	14	33	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136419	10.1371/journal.pone.0136419	http://dx.doi.org/10.1371/journal.pone.0136419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295337	Green Submitted, Green Published, gold			2022-12-27	WOS:000359926900107
J	Utsumi, A				Utsumi, Akira			A Complex Network Approach to Distributional Semantic Models	PLOS ONE			English	Article							WORD COOCCURRENCE STATISTICS; ASSOCIATION; LANGUAGE; REPRESENTATIONS; RETRIEVAL	A number of studies on network analysis have focused on language networks based on free word association, which reflects human lexical knowledge, and have demonstrated the small-world and scale-free properties in the word association network. Nevertheless, there have been very few attempts at applying network analysis to distributional semantic models, despite the fact that these models have been studied extensively as computational or cognitive models of human lexical knowledge. In this paper, we analyze three network properties, namely, small-world, scale-free, and hierarchical properties, of semantic networks created by distributional semantic models. We demonstrate that the created networks generally exhibit the same properties as word association networks. In particular, we show that the distribution of the number of connections in these networks follows the truncated power law, which is also observed in an association network. This indicates that distributional semantic models can provide a plausible model of lexical knowledge. Additionally, the observed differences in the network properties of various implementations of distributional semantic models are consistently explained or predicted by considering the intrinsic semantic features of a word-context matrix and the functions of matrix weighting and smoothing. Furthermore, to simulate a semantic network with the observed network properties, we propose a new growing network model based on the model of Steyvers and Tenenbaum. The idea underlying the proposed model is that both preferential and random attachments are required to reflect different types of semantic relations in network growth process. We demonstrate that this model provides a better explanation of network behaviors generated by distributional semantic models.	Univ Electrocommun, Dept Informat, Tokyo, Japan	University of Electro-Communications - Japan	Utsumi, A (corresponding author), Univ Electrocommun, Dept Informat, Tokyo, Japan.	utsumi@uec.ac.jp		Utsumi, Akira/0000-0002-7328-4417	Japan Society for the Promotion of Science KAKENHI [23300098, 15H02713]; UEC Research Support Program from the University of Electro-Communications	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); UEC Research Support Program from the University of Electro-Communications	Financial support for this study was provided by Japan Society for the Promotion of Science KAKENHI Grant Numbers 23300098 and 15H02713, and by UEC Research Support Program from the University of Electro-Communications.	Aitchison J, 2003, WORDS IN THE MIND AN; Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Andrews M, 2009, PSYCHOL REV, V116, P463, DOI 10.1037/a0016261; Arias-Trejo N, 2013, COGNITION, V128, P214, DOI 10.1016/j.cognition.2013.03.008; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baronchelli A, 2013, TRENDS COGN SCI, V17, P348, DOI 10.1016/j.tics.2013.04.010; Borge-Holthoefer J, 2010, ENTROPY-SWITZ, V12, P1264, DOI 10.3390/e12051264; Bullinaria JA, 2007, BEHAV RES METHODS, V39, P510, DOI 10.3758/BF03193020; Bullinaria JA, 2012, BEHAV RES METHODS, V44, P890, DOI 10.3758/s13428-011-0183-8; Cancho RFI, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051915; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; Choudhury M., 2010, P 23 INT C COMP LING, P162; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; COLLINS AM, 1969, J VERB LEARN VERB BE, V8, P240, DOI 10.1016/S0022-5371(69)80069-1; Cong J, 2014, PHYS LIFE REV, V11, P598, DOI 10.1016/j.plrev.2014.04.004; Cruse A., 2004, MEANING IN LANGUAGE; De Deyne S, 2008, BEHAV RES METHODS, V40, P198, DOI 10.3758/BRM.40.1.198; De Deyne S, 2008, BEHAV RES METHODS, V40, P213, DOI 10.3758/BRM.40.1.213; De Deyne S, 2013, BEHAV RES METHODS, V45, P480, DOI 10.3758/s13428-012-0260-7; Dorogovtsev SN, 2001, P ROY SOC B-BIOL SCI, V268, P2603, DOI 10.1098/rspb.2001.1824; Erk K, 2012, LANG LINGUIST COMPAS, V6, P635, DOI 10.1002/Inc3.362; Ferrand L, 2003, MENTAL LEXICON: SOME WORDS TO TALK ABOUT WORDS, P25; Gao YY, 2014, PHYSICA A, V393, P579, DOI 10.1016/j.physa.2013.08.075; Goemann B, 2011, NETWORK BIOL, V1, P134; Grady JE, 1997, COGN LINGUIST, V8, P267, DOI 10.1515/cogl.1997.8.4.267; Gravino P, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500543; Griffiths TL, 2007, PSYCHOL REV, V114, P211, DOI 10.1037/0033-295X.114.2.211; Harley TA, 2014, THE PSYCHOLOGY OF LA; Holanda AD, 2004, PHYSICA A, V344, P530, DOI 10.1016/j.physa.2004.06.025; Huettig F, 2006, ACTA PSYCHOL, V121, P65, DOI 10.1016/j.actpsy.2005.06.002; Hutchison KA, 2003, PSYCHON B REV, V10, P785, DOI 10.3758/BF03196544; Jones MN, 2006, J MEM LANG, V55, P534, DOI 10.1016/j.jml.2006.07.003; Kenett YN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023912; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Landauer TK, 2007, HANDBOOK OF LATENT S; Lerner AJ, 2009, COGN BEHAV NEUROL, V22, P45, DOI 10.1097/WNN.0b013e318192ccaf; Liu ZH, 2002, PHYS LETT A, V303, P337, DOI 10.1016/S0375-9601(02)01317-8; Louwerse MM, 2011, TOP COGN SCI, V3, P273, DOI 10.1111/j.1756-8765.2010.01106.x; Lucas M, 2000, PSYCHON B REV, V7, P618, DOI 10.3758/BF03212999; Lund K, 1996, BEHAV RES METH INSTR, V28, P203, DOI 10.3758/BF03204766; Markosova M, 2008, PHYSICA A, V387, P661, DOI 10.1016/j.physa.2007.09.027; Michelbacher L, 2011, CORPUS LINGUIST LING, V7, P245, DOI 10.1515/CLLT.2011.012; Miller George, 1998, WORDNET ELECT LEXICA; Morais AS, 2013, COGNITIVE SCI, V37, P125, DOI 10.1111/cogs.12013; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Nelson DL, 2004, BEHAV RES METH INS C, V36, P402, DOI 10.3758/BF03195588; Quesada J., 2007, HDB LATENT SEMANTIC, P71, DOI DOI 10.4324/9780203936399.CH4; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Recchia G, 2009, BEHAV RES METHODS, V41, P647, DOI 10.3758/BRM.41.3.647; Riordan B, 2011, TOP COGN SCI, V3, P303, DOI 10.1111/j.1756-8765.2010.01111.x; Rogers TT, 2004, SEMANTIC COGNITION A; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P573, DOI 10.1016/0010-0285(75)90024-9; Rosch E., 1978, COGNITION CATEGORIZA, P27, DOI DOI 10.1037/0012-1649.16.5.391; Sahlgren M, 2008, ITAL J LINGUIST, V20, P33; SMITH EE, 1988, COGNITIVE SCI, V12, P485, DOI 10.1207/s15516709cog1204_1; SMITH EE, 1974, PSYCHOL REV, V81, P214, DOI 10.1037/h0036351; Steyvers M, 2005, COGNITIVE SCI, V29, P41, DOI 10.1207/s15516709cog2901_3; Turney PD, 2010, J ARTIF INTELL RES, V37, P141, DOI 10.1613/jair.2934; Ullman M. T., 2007, OXFORD HDB PSYCHOLIN, P267, DOI DOI 10.1093/OXFORDHB/9780198568971.013.0016; Utsumi A, 2010, P 7 INT JOINT C LANG, P257; Utsumi A, 2011, COGNITIVE SCI, V35, P251, DOI 10.1111/j.1551-6709.2010.01144.x; Vazquez A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056104; Vigliocco G., 2007, OXFORD HDB PSYCHOLIN, P217; Vitevitch MS, 2014, COGNITIVE PSYCHOL, V68, P1, DOI 10.1016/j.cogpsych.2013.10.002; Vitevitch MS, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00369; Voss A, 2013, J EXP PSYCHOL GEN, V142, P536, DOI 10.1037/a0029459; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	70	10	10	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136277	10.1371/journal.pone.0136277	http://dx.doi.org/10.1371/journal.pone.0136277			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26295940	gold, Green Submitted, Green Published			2022-12-27	WOS:000359926900094
J	Lee, KM; Barrett, KC; Kim, Y; Lim, Y; Lee, K				Lee, Kyung Myun; Barrett, Karen Chan; Kim, Yeonhwa; Lim, Yeoeun; Lee, Kyogu			Dance and Music in "Gangnam Style": How Dance Observation Affects Meter Perception	PLOS ONE			English	Article							CROSS-MODAL INTERACTIONS; VISUAL RHYTHMS; BEAT PERCEPTION; SYNCHRONIZATION; HEARING; VISION; REPRESENTATION; ATTENTION; MOVEMENT	Dance and music often co-occur as evidenced when viewing choreographed dances or singers moving while performing. This study investigated how the viewing of dance motions shapes sound perception. Previous research has shown that dance reflects the temporal structure of its accompanying music, communicating musical meter (i.e. a hierarchical organization of beats) via coordinated movement patterns that indicate where strong and weak beats occur. Experiments here investigated the effects of dance cues on meter perception, hypothesizing that dance could embody the musical meter, thereby shaping participant reaction times (RTs) to sound targets occurring at different metrical positions. In experiment 1, participants viewed a video with dance choreography indicating 4/4 meter (dance condition) or a series of color changes repeated in sequences of four to indicate 4/4 meter (picture condition). A sound track accompanied these videos and participants reacted to timbre targets at different metrical positions. Participants had the slowest RT's at the strongest beats in the dance condition only. In experiment 2, participants viewed the choreography of the horse-riding dance from Psy's "Gangnam Style" in order to examine how a familiar dance might affect meter perception. Moreover, participants in this experiment were divided into a group with experience dancing this choreography and a group without experience. Results again showed slower RTs to stronger metrical positions and the group with experience demonstrated a more refined perception of metrical hierarchy. Results likely stem from the temporally selective division of attention between auditory and visual domains. This study has implications for understanding: 1) the impact of splitting attention among different sensory modalities, and 2) the impact of embodiment, on perception of musical meter. Viewing dance may interfere with sound processing, particularly at critical metrical positions, but embodied familiarity with dance choreography may facilitate meter awareness. Results shed light on the processing of multimedia environments.	[Lee, Kyung Myun; Lee, Kyogu] Seoul Natl Univ, Smart Humanity Convergence Ctr, Grad Sch Convergence Sci & Technol, Seoul, South Korea; [Barrett, Karen Chan] Johns Hopkins Univ, Peabody Inst Mus, Baltimore, MD USA; [Kim, Yeonhwa; Lee, Kyogu] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Seoul, South Korea; [Lim, Yeoeun] Seoul Natl Univ, Coll Mus, Seoul, South Korea	Seoul National University (SNU); Johns Hopkins University; Seoul National University (SNU); Seoul National University (SNU)	Lee, KM (corresponding author), Seoul Natl Univ, Smart Humanity Convergence Ctr, Grad Sch Convergence Sci & Technol, Seoul, South Korea.	kmlee2@snu.ac.kr	Barrett, Karen Chan/AAO-7398-2021; Lee, Kyung Myun/G-3057-2016	Barrett, Karen Chan/0000-0002-8991-4778; Lim, Yeoeun/0000-0003-1991-2336	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2014R1A1A3050648]; National Research Foundation of Korea (NRF) - Korea government (MSIP) [2014R1A2A2A04002619]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; National Research Foundation of Korea (NRF) - Korea government (MSIP)	KML was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No. 2014R1A1A3050648). KL was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2014R1A2A2A04002619). URL: https://www.nrf.re.kr/nrf_eng_cms/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2006, P R SOC B, V273, P1339, DOI 10.1098/rspb.2005.3420; Barrett KC., 2015, THESIS; Bella SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071945; Bolger D, 2014, J COGNITIVE NEUROSCI, V26, P593, DOI 10.1162/jocn_a_00511; Bolger D, 2013, ACTA PSYCHOL, V142, P238, DOI 10.1016/j.actpsy.2012.11.012; Brochard R, 2013, COGNITION, V127, P214, DOI 10.1016/j.cognition.2013.01.007; Burger B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00903; Chemin B, 2014, PSYCHOL SCI, V25, P2147, DOI 10.1177/0956797614551161; Chen LH, 2013, ATTEN PERCEPT PSYCHO, V75, P244, DOI [10.3758/s13414-012-0395-8, 10.3758/s13414-013-0475-4]; Chen YQ, 2002, HUM MOVEMENT SCI, V21, P515, DOI 10.1016/S0167-9457(02)00138-0; Clarke Eric F., 1999, PSYCHOL MUSIC, P473, DOI DOI 10.1016/B978-012213564-4/50014-7; Dahl S, 2007, MUSIC PERCEPT, V24, P433, DOI 10.1525/MP.2007.24.5.433; Escoffier N, 2010, ACTA PSYCHOL, V135, P12, DOI 10.1016/j.actpsy.2010.04.005; Fritz JB, 2007, CURR OPIN NEUROBIOL, V17, P437, DOI 10.1016/j.conb.2007.07.011; Gillespie R, 1997, J RES MUSIC EDUC, V45, P212, DOI 10.2307/3345581; Grahn JA, 2012, TOP COGN SCI, V4, P585, DOI 10.1111/j.1756-8765.2012.01213.x; Grahn JA, 2012, EXP BRAIN RES, V220, P51, DOI 10.1007/s00221-012-3114-8; Grahn JA, 2011, NEUROIMAGE, V54, P1231, DOI 10.1016/j.neuroimage.2010.09.033; Grondin S, 2009, PERCEPTION, V38, P1542, DOI 10.1068/p6359; Hove MJ, 2013, PSYCHOL RES-PSYCH FO, V77, P388, DOI 10.1007/s00426-012-0441-0; Hove MJ, 2013, NEUROIMAGE, V67, P313, DOI 10.1016/j.neuroimage.2012.11.032; Hove MJ, 2010, J EXP PSYCHOL HUMAN, V36, P1525, DOI 10.1037/a0019059; Iversen JR, 2015, COGNITION, V134, P232, DOI 10.1016/j.cognition.2014.10.018; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; Jones MR, 1997, J EXP PSYCHOL HUMAN, V23, P693, DOI 10.1037/0096-1523.23.3.693; Klein JM, 1996, PERCEPT PSYCHOPHYS, V58, P34, DOI 10.3758/BF03205473; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Lerdahl F., 1985, GENERATIVE THEORY TO; Loras H, 2012, EXP BRAIN RES, V220, P335, DOI 10.1007/s00221-012-3142-4; McAuley JD, 2010, ATTEN PERCEPT PSYCHO, V72, P1377, DOI 10.3758/APP.72.5.1377; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Patel AD, 2005, EXP BRAIN RES, V163, P226, DOI 10.1007/s00221-004-2159-8; Phillips-Silver J, 2007, COGNITION, V105, P533, DOI 10.1016/j.cognition.2006.11.006; Repp BH, 2004, PSYCHOL RES-PSYCH FO, V68, P252, DOI 10.1007/s00426-003-0143-8; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P1085, DOI 10.1037//0096-1523.28.5.1085; Santamaria M., 2012, P IEEE 7 COL COMP C, P1, DOI DOI 10.1109/COLOMBIANCC.2012.6398002; Schutz M, 2007, PERCEPTION, V36, P888, DOI 10.1068/p5635; Spence C, 2010, AUDITORY PERCEPTION; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Su YH, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00092; Thompson WF, 2010, PSYCHON B REV, V17, P317, DOI 10.3758/PBR.17.3.317; Toiviainen P, 2010, MUSIC PERCEPT, V28, P59, DOI 10.1525/MP.2010.28.1.59; Tsay CJ, 2014, ORGAN BEHAV HUM DEC, V124, P24, DOI 10.1016/j.obhdp.2013.10.003; Tsay CJ, 2013, P NATL ACAD SCI USA, V110, P14580, DOI 10.1073/pnas.1221454110; van Wassenhove V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001437; Vines BW, 2006, COGNITION, V101, P80, DOI 10.1016/j.cognition.2005.09.003; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; Woods JW., 2011, MULTIDIMENSIONAL SIG; Woolhouse M, 2010, PROCEEDINGS OF THE 1; Woolhouse MH, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00965	53	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134725	10.1371/journal.pone.0134725	http://dx.doi.org/10.1371/journal.pone.0134725			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CP7LO	26308092	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400033
J	McElreath, R; Smaldino, PE				McElreath, Richard; Smaldino, Paul E.			Replication, Communication, and the Population Dynamics of Scientific Discovery	PLOS ONE			English	Article							SOCIAL-SCIENCES; FILE DRAWER; POWER; FALSE; SIZE	Many published research results are false (Ioannidis, 2005), and controversy continues over the roles of replication and publication policy in improving the reliability of research. Addressing these problems is frustrated by the lack of a formal framework that jointly represents hypothesis formation, replication, publication bias, and variation in research quality. We develop a mathematical model of scientific discovery that combines all of these elements. This model provides both a dynamic model of research as well as a formal framework for reasoning about the normative structure of science. We show that replication may serve as a ratchet that gradually separates true hypotheses from false, but the same factors that make initial findings unreliable also make replications unreliable. The most important factors in improving the reliability of research are the rate of false positives and the base rate of true hypotheses, and we offer suggestions for addressing each. Our results also bring clarity to verbal debates about the communication of research. Surprisingly, publication bias is not always an obstacle, but instead may have positive impacts-suppression of negative novel findings is often beneficial. We also find that communication of negative replications may aid true discovery even when attempts to replicate have diminished power. The model speaks constructively to ongoing debates about the design and conduct of science, focusing analysis and discussion on precise, internally consistent models, as well as highlighting the importance of population dynamics.	[McElreath, Richard; Smaldino, Paul E.] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [McElreath, Richard] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	McElreath, R (corresponding author), Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.	mcelreath@ucdavis.edu		Smaldino, Paul/0000-0002-7133-5620; McElreath, Richard/0000-0002-0387-5377	Division of Social Sciences Dean's Office at the University of California Davis	Division of Social Sciences Dean's Office at the University of California Davis	The Division of Social Sciences Dean's Office at the University of California Davis provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Political Science Association Task Force on Public Engagement, 2014, INCR CRED POL SCI RE; [Anonymous], 2014, CHANCE, DOI [DOI 10.1080/09332480.2014.890872, 10.1080/09332480.2014.890872]; [Anonymous], 2013, THESIS COLUMBIA U NE; Bakker M, 2014, PSYCHOL METHODS, V19, P409, DOI 10.1037/met0000014; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Bissell M, 2013, NATURE, V503, P333, DOI 10.1038/503333a; Bohannon J, 2014, SCIENCE, V344, P788, DOI 10.1126/science.344.6186.788; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Campbell DT, 1985, SCI TECHNOL HUM VALU, V10, P38; COX RT, 1946, AM J PHYS, V14, P1, DOI 10.1119/1.1990764; Fontani M., 2014, LOST ELEMENTS PERIOD; Franco A, 2014, SCIENCE, V345, P1502, DOI 10.1126/science.1255484; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Hull, 2010, SCI PROCESS EVOLUTIO; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kahneman D, 2014, SOC PSYCHOL-GERMANY, V45, P310; Kitcher P, 2000, PHILOS SCI, V67, pS33, DOI 10.1086/392807; Levins R, 1966, AM SCI, V54; Makel MC, 2012, PERSPECT PSYCHOL SCI, V7, P537, DOI 10.1177/1745691612460688; Mitchell J., 2014, EMPTINESS FAILED REP; OROURKE K, 1989, J CLIN EPIDEMIOL, V42, P1021, DOI 10.1016/0895-4356(89)90168-6; POPPER K, 1996, MYTH FRAMEWORK DEFEN; Popper K. R., 1963, CONJECTURES REFUTAT; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Schmidt S, 2009, REV GEN PSYCHOL, V13, P90, DOI 10.1037/a0015108; Schnall S, 2014, SOC PSYCHOL-GERMANY, V45, P315, DOI 10.1027/1864-9335/a000204; Scott IM, 2014, P NATL ACAD SCI USA, V111, P14388, DOI 10.1073/pnas.1409643111; SEDLMEIER P, 1989, PSYCHOL BULL, V105, P309, DOI 10.1037/0033-2909.105.2.309; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Smaldino PE, 2015, ORG PSYCHOL IN PRESS; Sullivan PF, 2007, BIOL PSYCHIAT, V61, P1121, DOI 10.1016/j.biopsych.2006.11.010; WIMSATT W C, 1987, P23	33	55	55	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136088	10.1371/journal.pone.0136088	http://dx.doi.org/10.1371/journal.pone.0136088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LO	26308448	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400088
J	Muroya, S; Ogasawara, H; Hojito, M				Muroya, Susumu; Ogasawara, Hideki; Hojito, Masayuki			Grazing Affects Exosomal Circulating MicroRNAs in Cattle	PLOS ONE			English	Article							POTENTIAL-DIAGNOSTIC-MARKER; ACUTE ENDURANCE EXERCISE; MUSCLE-SPECIFIC MICRORNA; HUMAN SKELETAL-MUSCLE; LARGE GENE LISTS; AEROBIC EXERCISE; HEPATOCELLULAR-CARCINOMA; BIOINFORMATICS ANALYSIS; CHAROLAIS STEERS; EXPRESSION	Circulating microRNAs (c-miRNAs) are associated with physiological adaptation to acute and chronic aerobic exercise in humans. To investigate the potential effect of grazing movement on miRNA circulation in cattle, here we profiled miRNA expression in centrifugally prepared exosomes from the plasma of both grazing and housed Japanese Shorthorn cattle. Microarray analysis of the c-miRNAs resulted in detection of a total of 231 bovine exosomal miRNAs in the plasma, with a constant expression level of let-7g across the duration and cattle groups. Expression of muscle-specific miRNAs such as miR-1, miR-133a, miR-206, miR-208a/b, and miR-499 were undetectable, suggesting the mildness of grazing movement as exercise. According to validation by quantitative RT-PCR, the circulating miR-150 level in the grazing cattle normalized by the endogenous let-7g level was down-regulated after 2 and 4 months of grazing (P < 0.05), and then its levels in housed and grazing cattle equalized when the grazing cattle were returned to a housed situation. Likewise, the levels of miR-19b, miR-148a, miR-221, miR-223, miR-320a, miR-361, and miR-486 were temporarily lowered in the cattle at 1 and/or 2 month of grazing compared to those of the housed cattle (P < 0.05). In contrast, the miR-451 level was up-regulated in the grazing cattle at 2 months of grazing (P = 0.044). The elevation of miR-451 level in the plasma was coincident with that in the biceps femoris muscle of the grazing cattle (P = 0.008), which suggests the secretion or intake of miR-451 between skeletal muscle cells and circulation during grazing. These results revealed that exosomal c-miRNAs in cattle were affected by grazing, suggesting their usefulness as molecular grazing markers and functions in physiological adaptation of grazing cattle associated with endocytosis, focal adhesion, axon guidance, and a variety of intracellular signaling, as predicted by bioinformatic analysis.	[Muroya, Susumu] Natl Inst Livestock & Grassland Sci, Anim Prod Res Div, Tsukuba, Ibaraki, Japan; [Ogasawara, Hideki; Hojito, Masayuki] Kitasato Univ, Sch Vet Med, Field Sci Ctr, Yakumo, Hokkaido, Japan	National Agriculture & Food Research Organization - Japan	Muroya, S (corresponding author), Natl Inst Livestock & Grassland Sci, Anim Prod Res Div, Tsukuba, Ibaraki, Japan.	muros@affrc.go.jp	MUROYA, Susumu/H-9604-2019	MUROYA, Susumu/0000-0002-2376-9352	Japan Society for the Promotion of Science [JSPS KAKENHI 15K07775]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by the Japan Society for the Promotion of Science (JSPS KAKENHI 15K07775 to SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi W, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00039; Aoi W, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00080; Aoi W, 2010, AM J PHYSIOL-ENDOC M, V298, pE799, DOI 10.1152/ajpendo.00448.2009; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Baggish AL, 2014, J APPL PHYSIOL, V116, P522, DOI 10.1152/japplphysiol.01141.2013; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Banzet S, 2013, J APPL PHYSIOL, V115, P1237, DOI 10.1152/japplphysiol.00075.2013; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; Cassar-Malek I, 2009, J PHYSIOL PHARMACOL, V60, P83; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen Y, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-43; Coutinho LL, 2007, PHYSIOL GENOMICS, V29, P35, DOI 10.1152/physiolgenomics.00081.2006; Davidsen PK, 2011, J APPL PHYSIOL, V110, P309, DOI 10.1152/japplphysiol.00901.2010; de Gonzalo-Calvo D, 2015, J APPL PHYSIOL, V119, P124, DOI 10.1152/japplphysiol.00077.2015; Deng ZL, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-115; Dmitriev P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-265; Drummond MJ, 2009, J NUTR, V139, P2279, DOI 10.3945/jn.109.112797; Edelstein LC, 2011, BLOOD, V117, P5289, DOI 10.1182/blood-2011-01-292011; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Goto Takafumi, 1995, Animal Science and Technology, V66, P62; Haneklaus M, 2013, J INTERN MED, V274, P215, DOI 10.1111/joim.12099; Horikawa A, 2015, ANIM SCI J IN PRESS; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jin WW, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-90; Jurie C, 2006, LIVEST SCI, V104, P182, DOI 10.1016/j.livsci.2006.04.016; Kanaan Z, 2012, ANN SURG, V256, P544, DOI 10.1097/SLA.0b013e318265bd6f; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Keller P, 2011, J APPL PHYSIOL, V110, P46, DOI 10.1152/japplphysiol.00634.2010; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kiyoshi Kentaro, 2010, Research Bulletin of the Aichi-ken Agricultural Research Center, P65; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Kroesen BJ, 2015, IMMUNOLOGY, V144, P1, DOI 10.1111/imm.12367; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li ZY, 2011, MOL BIOSYST, V7, P871, DOI 10.1039/c0mb00230e; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; McCarthy JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC451, DOI 10.1152/ajpcell.00077.2007; Mercken EM, 2013, AGING-US, V5, P692, DOI 10.18632/aging.100598; Miyachi M, 2010, BIOCHEM BIOPH RES CO, V400, P89, DOI 10.1016/j.bbrc.2010.08.015; Mizuno H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018388; Mooren FC, 2014, AM J PHYSIOL-HEART C, V306, pH557, DOI 10.1152/ajpheart.00711.2013; Muroya S, 2013, J ANIM SCI, V91, P90, DOI 10.2527/jas.2012-5371; Nielsen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087308; Nielsen S, 2010, J PHYSIOL-LONDON, V588, P4029, DOI 10.1113/jphysiol.2010.189860; Pan X, 2013, MOL CANCER THER, V12, P1153, DOI 10.1158/1535-7163.MCT-12-0802; Rani S, 2011, METHODS MOL BIOL, V784, P181, DOI 10.1007/978-1-61779-289-2_13; Romao JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-137; Russell AP, 2013, J PHYSIOL-LONDON, V591, P4637, DOI 10.1113/jphysiol.2013.255695; Safdar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005610; Shibata M, 2009, J ANIM SCI, V87, P2700, DOI 10.2527/jas.2008-1486; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sun JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102142; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang HB, 2012, FASEB J, V26, P4710, DOI 10.1096/fj.11-197467; Tome-Carneiro J, 2013, PHARMACOL RES, V72, P69, DOI 10.1016/j.phrs.2013.03.011; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Vestergaard M, 2000, MEAT SCI, V54, P187, DOI 10.1016/S0309-1740(99)00098-4; Vignier N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055281; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Zhang J, 2012, J BIOL CHEM, V287, P21093, DOI 10.1074/jbc.M111.330381; Zheng Y, 2014, CELL STRESS CHAPERON, V19, P973, DOI 10.1007/s12192-014-0521-8; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697	63	24	26	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136475	10.1371/journal.pone.0136475	http://dx.doi.org/10.1371/journal.pone.0136475			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308447	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400127
J	Polanski, J; Bartczak, P; Ambrozkiewicz, W; Sitko, R; Siudyga, T; Mianowski, A; Szade, J; Balin, K; Lelatko, J				Polanski, Jaroslaw; Bartczak, Piotr; Ambrozkiewicz, Weronika; Sitko, Rafal; Siudyga, Tomasz; Mianowski, Andrzej; Szade, Jacek; Balin, Katarzyna; Lelatko, Jozef			Ni-Supported Pd Nanoparticles with Ca Promoter: A New Catalyst for Low-Temperature Ammonia Cracking	PLOS ONE			English	Article							COX-FREE HYDROGEN; NH3 DECOMPOSITION; OXIDATION; ALLOYS; RH; RU	In this paper we report a new nanometallic, self-activating catalyst, namely, Ni-supported Pd nanoparticles (Pd-NPs/Ni) for low temperature ammonia cracking, which was prepared using a novel approach involving the transfer of nanoparticles from the intermediate carrier, i.e. nano-spherical SiO2, to the target carrier technical grade Ni (t-Ni) or high purity Ni (p-Ni) grains. The method that was developed allows a uniform nanoparticle size distribution (4,4 +/- 0.8 nm) to be obtained. Unexpectedly, the t-Ni-supported Pd NPs, which seemed to have a surface Ca impurity, appeared to be more active than the Ca-free (p-Ni) system. A comparison of the novel Pd-NPs/Ni catalyst with these reported in the literature clearly indicates the much better hydrogen productivity of the new system, which seems to be a highly efficient, flexible and durable catalyst for gas-phase heterogeneous ammonia cracking in which the TOF reaches a value of 2615 mmol(H2)/g(Pd) min (10,570 mol(NH3)/mol(Pd(NP))(h)) at 600 degrees C under a flow of 12 dm(3)/h (t-Ni).	[Polanski, Jaroslaw; Bartczak, Piotr; Ambrozkiewicz, Weronika; Sitko, Rafal] Univ Silesia, Inst Chem, PL-40006 Katowice, Poland; [Szade, Jacek; Balin, Katarzyna] Silesian Tech Univ, Dept Chem, PL-44100 Gliwice, Poland; [Siudyga, Tomasz; Mianowski, Andrzej] Univ Silesia, Silesian Ctr Educ & Interdisciplinary Res, A Chelkowski Inst Phys, PL-41500 Chorzow, Poland; [Lelatko, Jozef] Univ Silesia, Inst Mat Sci, PL-41500 Chorzow, Poland	University of Silesia in Katowice; Silesian University of Technology; University of Silesia in Katowice; University of Silesia in Katowice	Polanski, J (corresponding author), Univ Silesia, Inst Chem, Szkolna 9, PL-40006 Katowice, Poland.	polanski@us.edu.pl	Bartczak, Piotr/V-9520-2018; Balin, Katarzyna/D-6225-2017; Ambrożkiewicz-Mosler, Weronika/ABC-7354-2020; Szade, Jacek/W-6169-2018	Bartczak, Piotr/0000-0002-2035-8654; Balin, Katarzyna/0000-0002-1811-3033; Ambrożkiewicz-Mosler, Weronika/0000-0001-8119-1491; Polanski, Jaroslaw/0000-0001-7361-2671; Lelatko, Jozef/0000-0003-1868-5426; Sitko, Rafal/0000-0002-0469-5159; Szade, Jacek/0000-0003-2083-4275	National Research and Development Center (NCBiR) [PBS2/A5/40/2014]	National Research and Development Center (NCBiR)	The research was financed by the National Research and Development Center (NCBiR) under Grant ORGANOMET No: PBS2/A5/40/2014.	Boisen A, 2005, J CATAL, V230, P309, DOI 10.1016/j.jcat.2004.12.013; Cheddie D, 2012, HYDROGEN ENERGY CHAL; Choudhary TV, 2001, CATAL LETT, V72, P197, DOI 10.1023/A:1009023825549; Duan XZ, 2013, SPR-CATAL, V25, P118, DOI 10.1039/9781849737203-00118; Dye JL, 2005, J AM CHEM SOC, V127, P9338, DOI 10.1021/ja051786+; Edwards JK, 2014, ANGEW CHEM INT EDIT, V53, P2381, DOI 10.1002/anie.201308067; Ganley JC, 2004, CATAL LETT, V96, P117, DOI 10.1023/B:CATL.0000030108.50691.d4; Hacker V, 2003, HDB FUEL CELLS FUNDA, P121; Hansgen DA, 2011, SURF SCI, V605, P2055, DOI 10.1016/j.susc.2011.08.004; Hansgen DA, 2010, NAT CHEM, V2, P484, DOI [10.1038/nchem.626, 10.1038/NCHEM.626]; HILLEBRECHT FU, 1982, PHYS REV B, V25, P3550, DOI 10.1103/PhysRevB.25.3550; Jacobsen CJH, 2001, J AM CHEM SOC, V123, P8404, DOI 10.1021/ja010963d; Kao J, 2013, CHEM SOC REV, V42, P2654, DOI 10.1039/c2cs35375j; Kapkowski M, 2014, J CATAL, V319, P110, DOI 10.1016/j.jcat.2014.08.003; Klerke A, 2008, J MATER CHEM, V18, P2304, DOI 10.1039/b720020j; Korzec M, 2014, J CATAL, V313, P1, DOI 10.1016/j.jcat.2014.02.008; Li DL, 2007, APPL CATAL A-GEN, V332, P98, DOI 10.1016/j.apcata.2007.08.008; Papapolymerou G, 1997, J MOL CATAL A-CHEM, V120, P165, DOI 10.1016/S1381-1169(96)00428-1; Rao KS, 2005, J COLLOID INTERF SCI, V289, P125, DOI 10.1016/j.jcis.2005.02.019; Rotello V., 2004, NANOPARTICLES BUILDI, P32; Schuth F, 2012, ENERG ENVIRON SCI, V5, P6278, DOI 10.1039/c2ee02865d; Shan SY, 2014, J AM CHEM SOC, V136, P7140, DOI 10.1021/ja5026744; Shang L, 2014, ANGEW CHEM INT EDIT, V53, P250, DOI 10.1002/anie.201306863; TAKAGI Y, 1981, T JPN I MET, V22, P677, DOI 10.2320/matertrans1960.22.677; UTSUMI K, 1980, T JPN I MET, V21, P269, DOI 10.2320/matertrans1960.21.269; Yao LH, 2011, CATAL TODAY, V164, P112, DOI 10.1016/j.cattod.2010.10.056; Yin SF, 2004, CATAL TODAY, V93-5, P27, DOI 10.1016/j.cattod.2004.05.011; Zhang J, 2005, APPL CATAL A-GEN, V296, P257, DOI 10.1016/j.apcata.2005.08.046; Zhang J, 2005, APPL CATAL A-GEN, V290, P87, DOI 10.1016/j.apcata.2005.05.020	29	14	15	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136805	10.1371/journal.pone.0136805	http://dx.doi.org/10.1371/journal.pone.0136805			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308929	Green Submitted, Green Published, gold			2022-12-27	WOS:000360069400158
J	Teedon, P; Galea, KS; MacCalman, L; Jones, K; Cocker, J; Cherrie, JW; van Tongeren, M				Teedon, Paul; Galea, Karen S.; MacCalman, Laura; Jones, Kate; Cocker, John; Cherrie, John W.; van Tongeren, Martie			Engaging with Community Researchers for Exposure Science: Lessons Learned from a Pesticide Biomonitoring Study	PLOS ONE			English	Article							PARTICIPATORY RESEARCH; HEALTH SURVEY; STRATEGIES; RETENTION; RECRUITMENT; ENVIRONMENT; TRIAL	A major challenge in biomonitoring studies with members of the general public is ensuring their continued involvement throughout the necessary length of the research. The paper presents evidence on the use of community researchers, recruited from local study areas, as a mechanism for ensuring effective recruitment and retention of farmer and resident participants for a pesticides biomonitoring study. The evidence presented suggests that community researchers' abilities to build and sustain trusting relationships with participants enhanced the rigour of the study as a result of their on-the-ground responsiveness and flexibility resulting in data collection beyond targets expected.	[Teedon, Paul] Glasgow Caledonian Univ, Sch Engn & Built Environm, Glasgow G4 0BA, Lanark, Scotland; [Galea, Karen S.; MacCalman, Laura; Cherrie, John W.; van Tongeren, Martie] Inst Occupat Med, Ctr Human Exposure Sci, Edinburgh EH8 9SV, Midlothian, Scotland; [Jones, Kate; Cocker, John] HSL, Buxton, England; [Cherrie, John W.] Heriot Watt Univ, Sch Life Sci, Edinburgh, Midlothian, Scotland	Glasgow Caledonian University; Heriot Watt University	Galea, KS (corresponding author), Inst Occupat Med, Ctr Human Exposure Sci, Edinburgh EH8 9SV, Midlothian, Scotland.	karen.galea@iom-world.org	Cherrie, John/K-5530-2019; Jones, Kate/C-8983-2009	Cherrie, John/0000-0001-8901-6890; Jones, Kate/0000-0001-8923-2999; van Tongeren, Martie/0000-0002-1205-1898	UK Government Department for Environment Food and Rural Affairs (DEFRA) [PS2620]	UK Government Department for Environment Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by the UK Government Department for Environment Food and Rural Affairs (DEFRA), project code PS2620. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta MSV, 2005, AM J IND MED, V47, P237, DOI 10.1002/ajim.20136; *ADV COMM PEST, 2005, CROP SPRAYING HLTH R; Ballard HL, 2010, ENVIRON EDUC RES, V16, P611, DOI 10.1080/13504622.2010.505440; Bell M, 2004, TECHNICAL REPORT; Booker CL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-249; Borda O.F., 2006, HDB ACTION RES PARTI, P27; Burns S, 2009, FIELD METHOD, V21, P309, DOI 10.1177/1525822X09333514; Cassidy EL, 2001, AM J GERIAT PSYCHIAT, V9, P136, DOI 10.1176/appi.ajgp.9.2.136; CHISHOLM RF, 1993, HUM RELAT, V46, P275, DOI 10.1177/001872679304600207; Cohen A, 2012, HEALTH EDUC BEHAV, V39, P198, DOI 10.1177/1090198111412591; Collins BN, 2011, TRANSL BEHAV MED, V1, P394, DOI 10.1007/s13142-011-0059-6; Corburn J., 2005, STREET SCI COMMUNITY; Crane M, 2006, PEST MANAG SCI, V62, P5, DOI 10.1002/ps.1134; *DEP ENV FOOD RUR, 2006, PEST COD PRACT US PL; Department for Environment Food & Rural Affairs, 2006, ROYAL COMM ENV POLL; Drews KL, 2009, INT J OBESITY, V33, pS21, DOI 10.1038/ijo.2009.113; Farquhar S, 2014, J IMMIGR MINOR HEALT, V16, P1011, DOI 10.1007/s10903-013-9849-x; Galea KS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-856; Garnett ST, 2009, BIOTROPICA, V41, P571, DOI 10.1111/j.1744-7429.2009.00558.x; Govindasamy R, 2001, ECON REV, V30, P151; Henderson M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-9; Horsburgh S, 2011, J OCCUP MED TOXICOL, V6, DOI 10.1186/1745-6673-6-16; Ingoldsby EM, 2010, J CHILD FAM STUD, V19, P629, DOI 10.1007/s10826-009-9350-2; Letcher AS, 2009, AM J PREV MED, V37, pS292, DOI 10.1016/j.amepre.2009.08.008; Levy LS, 2007, INT J HYG ENVIR HEAL, V210, P387, DOI 10.1016/j.ijheh.2007.01.032; McQuiston C, 2005, J PROF NURS, V21, P210, DOI 10.1016/j.profnurs.2005.05.003; Meneses KM, 2013, APPL NURS RES, V26, P257, DOI 10.1016/j.apnr.2013.08.001; Meyers K, 2003, DRUG ALCOHOL DEPEN, V69, P73, DOI 10.1016/S0376-8716(02)00252-1; Minkler M, 2004, HEALTH EDUC BEHAV, V31, P684, DOI 10.1177/1090198104269566; Minkler M, 2008, COMMUNITY BASED PART; Minkler M, 2010, AM J PUBLIC HEALTH, V100, pS81, DOI 10.2105/AJPH.2009.165720; Morello--Frosch R., 2006, NEW POLITICAL SOCIOL, P244; Ribisl KM, 1996, EVAL PROGRAM PLANN, V19, P1, DOI 10.1016/0149-7189(95)00037-2; Robinson KA, 2007, J CLIN EPIDEMIOL, V60, P757, DOI 10.1016/j.jclinepi.2006.11.023; Schinke RJ, 2010, CANADA J ACAD ETHICS, V8, P233; Shepard PM, 2002, ENV HLTH PERSP S2, V110; Shirk JL, 2012, ECOL SOC, V17, DOI 10.5751/ES-04705-170229; The Royal Commission on Environmental Pollution, 2005, CROP SPRAYING HLTH R; Warren C., 2002, HDB INTERVIEW RES CO	39	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136347	10.1371/journal.pone.0136347	http://dx.doi.org/10.1371/journal.pone.0136347			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LO	26308094	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400111
J	Zoghi, M; Vaseghi, B; Bastani, A; Jaberzadeh, S; Galea, MP				Zoghi, Maryam; Vaseghi, Bita; Bastani, Andisheh; Jaberzadeh, Shapour; Galea, Mary P.			The Effects of Sex Hormonal Fluctuations during Menstrual Cycle on Cortical Excitability and Manual Dexterity (a Pilot Study)	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; INTRACORTICAL INHIBITION; NEUROACTIVE STEROIDS; CORTICOCORTICAL INHIBITION; HIPPOCAMPAL-NEURONS; SALIVARY ESTRADIOL; OVARIAN HORMONES; PREMOTOR CORTEX; PRIMATE MOTOR	Aim To investigate whether hormonal fluctuations during the menstrual cycle affect corticospinal excitability, intracortical inhibition (ICI) or facilitation (ICF) in primary motor cortex, and also whether the hormonal fluctuations have any effect on manual dexterity in neurologically intact women. Materials and Methods Twenty volunteers (10 Female, 10 Male) were included in this study. The levels of progesterone and estradiol were measured from saliva during the women's menstrual follicular, ovulation and mid-luteal phases. Motor evoked potentials were recorded from the right first dorsal interosseous muscle. Single and paired-pulse Transcranial Magnetic Stimulation (TMS) were delivered in a block of 20 stimuli. With paired-pulse technique, 3ms and 10ms inter-stimulus intervals were used to assess ICI and ICF, respectively. The Grooved Pegboard Test (GPT) was completed in each session before the TMS assessments. Male participants were tested at similar time intervals as female participants. Results Mixed design ANOVA revealed that GPT score in female participants was significantly lower at the mid-luteal phase compared to the ovulation phase (p = 0.017). However, it was not correlated with progesterone or estrogen fluctuations during the menstrual cycle. The results also showed that the effect of phase, sex and the interaction of phase by sex for resting motor threshold, ICI or ICF were not significant (p > 0.05). Conclusion Manual dexterity performance fluctuates during the menstrual cycle in neurologically intact women, which might be due to the balance of the neuromodulatory effects of P4 and E2 in the motor cortex during different phases.	[Zoghi, Maryam; Bastani, Andisheh; Galea, Mary P.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia; [Vaseghi, Bita; Jaberzadeh, Shapour] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Primary Hlth Care, Melbourne, Vic 3004, Australia	Royal Melbourne Hospital; University of Melbourne; Monash University	Zoghi, M (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia.	mzoghi@unimelb.edu.au	, Zoghi/AAF-9536-2019; Galea, Mary/F-4242-2010	, Zoghi/0000-0002-1819-6895; Galea, Mary/0000-0003-0045-7978; jaberzadeh, shapour/0000-0003-2957-4510				Aardal-Eriksson E, 1998, CLIN CHEM LAB MED, V36, P215, DOI 10.1515/CCLM.1998.037; Alexander GM, 2002, NEUROPSYCHOLOGIA, V40, P1293, DOI 10.1016/S0028-3932(01)00220-2; Andreescu CE, 2007, J NEUROSCI, V27, P10832, DOI 10.1523/JNEUROSCI.2588-07.2007; Backstrom T, 2014, PROG NEUROBIOL, V113, P88, DOI 10.1016/j.pneurobio.2013.07.005; Backstrom T, 2011, NEUROSCIENCE, V191, P46, DOI 10.1016/j.neuroscience.2011.03.061; BACKSTROM T, 1976, ACTA NEUROL SCAND, V54, P321; Bauer J, 2001, EPILEPSIA, V42, P20, DOI 10.1046/j.1528-1157.2001.042suppl.3020.x; BELKIEN LD, 1985, FERTIL STERIL, V44, P322; Beyenburg S, 2001, EPILEPSY RES, V44, P141, DOI 10.1016/S0920-1211(01)00194-2; Bolaji II, 1994, INT J GYNAECOL OBSTE, V45, P125; Butefisch C, 2000, TASK DEPENDENT IN S3, V15, P153; Comasco E, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00388; DEBOEVER J, 1986, CLIN CHEM, V32, P763; Deligiannidis KM, 2013, J PSYCHIATR RES, V47, P816, DOI 10.1016/j.jpsychires.2013.02.010; Devanne H, 2006, EUR J NEUROSCI, V23, P2467, DOI 10.1111/j.1460-9568.2006.04760.x; Di Lazzaro V, 2000, CLIN NEUROPHYSIOL, V111, P794, DOI 10.1016/S1388-2457(99)00314-4; Epting LK, 1998, BEHAV NEUROSCI, V112, P1304, DOI 10.1037/0735-7044.112.6.1304; Fernandez G, 2003, J NEUROSCI, V23, P3790; Finocchi C, 2011, NEUROL SCI, V32, pS31, DOI 10.1007/s10072-011-0532-5; HAMPSON E, 1990, PSYCHONEUROENDOCRINO, V15, P97, DOI 10.1016/0306-4530(90)90018-5; HAMPSON E, 1990, BRAIN COGNITION, V14, P26, DOI 10.1016/0278-2626(90)90058-V; Hanajima R, 1998, J PHYSIOL-LONDON, V509, P607, DOI 10.1111/j.1469-7793.1998.607bn.x; Hanajima R, 2003, EXP BRAIN RES, V151, P427, DOI 10.1007/s00221-003-1455-z; Hattemer K, 2007, CLIN ENDOCRINOL, V66, P387, DOI 10.1111/j.1365-2265.2007.02744.x; Hausmann M, 2002, NEUROPSYCHOLOGIA, V40, P808, DOI 10.1016/S0028-3932(01)00179-8; HENDRY SHC, 1987, J NEUROSCI, V7, P1503; Herzog AG, 2001, EPILEPSY BEHAV, V2, P367, DOI 10.1006/ebeh.2001.0232; Inghilleri M, 2004, CLIN NEUROPHYSIOL, V115, P1063, DOI 10.1016/j.clinph.2003.12.003; Joels M, 1997, FRONT NEUROENDOCRIN, V18, P2, DOI 10.1006/frne.1996.0144; JONES EG, 1993, CEREB CORTEX, V3, P361, DOI 10.1093/cercor/3.5.361-a; Jones EG, 1981, ANATOMY CEREBRAL COR; KEENAN PA, 1992, PSYCHONEUROENDOCRINO, V17, P179, DOI 10.1016/0306-4530(92)90056-D; KEENAN PA, 1995, BIOL PSYCHIAT, V38, P369, DOI 10.1016/0006-3223(94)00303-K; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lang N, 2011, CEREB CORTEX, V21, P2299, DOI 10.1093/cercor/bhr003; Lemon R, 1995, ELECTROENCEPHALOGRAP, V97, pS6; Lemon RN, 1999, EXP BRAIN RES, V128, P6, DOI 10.1007/s002210050811; Liepert J, 1997, J NEURAL TRANSM, V104, P1207, DOI 10.1007/BF01294721; Lissek S, 2007, NEUROIMAGE, V37, P912, DOI 10.1016/j.neuroimage.2007.05.037; Lu YC, 1997, J IMMUNOASSAY, V18, P149, DOI 10.1080/01971529708005810; Lu YC, 1999, FERTIL STERIL, V71, P863, DOI 10.1016/S0015-0282(99)00093-X; Maki PM, 2002, NEUROPSYCHOLOGIA, V40, P518, DOI 10.1016/S0028-3932(01)00126-9; MATSUMURA M, 1991, J NEUROPHYSIOL, V65, P1542, DOI 10.1152/jn.1991.65.6.1542; MATSUMURA M, 1992, J NEUROPHYSIOL, V68, P692, DOI 10.1152/jn.1992.68.3.692; Morrell MJ, 1999, NEUROLOGY, V53, pS42; Murphy DD, 1998, J NEUROSCI, V18, P2550; Murphy DD, 2000, NEUROENDOCRINOLOGY, V72, P133, DOI 10.1159/000054580; Nakajima K, 2000, J NEUROPHYSIOL, V84, P698, DOI 10.1152/jn.2000.84.2.698; Nakamura H, 1997, J PHYSIOL-LONDON, V498, P817, DOI 10.1113/jphysiol.1997.sp021905; Oh S.J., 2003, CLIN ELECTROMYOGRAPH, DOI [10.1046/j.1468-1331.2003.00654.x, DOI 10.1046/J.1468-1331.2003.00654.X]; Perotto A., 2005, ANATOMICAL GUIDE ELE; Porter R, 1993, CORTICOSPINAL FUNCTI; Rupprecht R, 2001, BRAIN RES REV, V37, P59, DOI 10.1016/S0165-0173(01)00123-0; Schieber MH, 1998, J NEUROSCI, V18, P9038; Simic N, 2010, ARH HIG RADA TOKSIKO, V61, P407, DOI 10.2478/10004-1254-61-2010-2055; Smith MD, 2002, NEUROSCIENCE, V109, P517, DOI 10.1016/S0306-4522(01)00490-0; Smith MJ, 1999, NEUROLOGY, V53, P2069, DOI 10.1212/WNL.53.9.2069; Smith MJ, 2002, ANN NEUROL, V51, P599, DOI 10.1002/ana.10180; SMITH SS, 1987, BRAIN RES, V400, P353, DOI 10.1016/0006-8993(87)90634-2; Solis-Ortiz S, 2008, PSYCHONEUROENDOCRINO, V33, P989, DOI 10.1016/j.psyneuen.2008.04.003; Stahl S. M., 2008, DEPRESSION BIPOLAR D; Stinear CM, 2003, J NEUROPHYSIOL, V89, P2014, DOI 10.1152/jn.00925.2002; Toffoletto S, 2014, PSYCHONEUROENDOCRINO, V50, P28, DOI 10.1016/j.psyneuen.2014.07.025; van Broekhoven F, 2006, PSYCHONEUROENDOCRINO, V31, P1190, DOI 10.1016/j.psyneuen.2006.08.007; WANG DY, 1986, EUR J CANCER CLIN ON, V22, P487, DOI 10.1016/0277-5379(86)90116-1; Wang Mingde, 2011, Front Endocrinol (Lausanne), V2, P44, DOI 10.3389/fendo.2011.00044; Wang YC, 2011, J HAND THER, V24, P313, DOI 10.1016/j.jht.2011.05.001; Wood P, 2009, ANN CLIN BIOCHEM, V46, P183, DOI 10.1258/acb.2008.008208; WORTHMAN CM, 1990, CLIN CHEM, V36, P1769; Yancosek KE, 2009, J HAND THER, V22, P258, DOI 10.1016/j.jht.2008.11.004; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306; Ziemann U, 1996, NEUROSCI LETT, V208, P187, DOI 10.1016/0304-3940(96)12575-1; Ziemann U, 1996, EXP BRAIN RES, V109, P127; Ziemann U, 1995, BRAIN, V118, P1437, DOI 10.1093/brain/118.6.1437; Ziemann U, 2015, CLIN NEUROPHYSIOL, V126, P1847, DOI 10.1016/j.clinph.2014.08.028; Zoghi M, 2003, J PHYSIOL-LONDON, V550, P933, DOI 10.1113/jphysiol.2003.042606	78	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136081	10.1371/journal.pone.0136081	http://dx.doi.org/10.1371/journal.pone.0136081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308341	gold, Green Published			2022-12-27	WOS:000360069400087
J	Dadi, H; Le, M; Dinka, H; Nguyen, D; Choi, H; Cho, H; Choi, M; Kim, JH; Park, JK; Soundrarajan, N; Park, C				Dadi, Hailu; MinhThong Le; Dinka, Hunduma; DinhTruong Nguyen; Choi, Hojun; Cho, Hyesun; Choi, Minkyeung; Kim, Jin-Hoi; Park, Jin-Ki; Soundrarajan, Nagasundarapandian; Park, Chankyu			Genetic Diversity and mRNA Expression of Porcine MHC Class I Chain-Related 2 (SLA-MIC2) Gene and Development of a High-Resolution Typing Method	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; T-CELLS; SURFACE EXPRESSION; ENDOTHELIAL-CELLS; MIC GENES; SEQUENCE; DISEASE; NKG2D; HLA; IDENTIFICATION	The genetic structure and function of MHC class I chain-related (MIC) genes in the pig genome have not been well characterized, and show discordance in available data. Therefore, we have experimentally characterized the exon-intronstructure and functional copy expression pattern of the pig MIC gene, SLA-MIC2. We have also studied the genetic diversity of SLA-MIC2 from seven different breeds using a high-resolution genomic sequence-based typing (GSBT) method. Our results showed that the SLA-MIC2 gene has a similar molecular organization as the human and cattle orthologs, and is expressed in only a few tissues including the small intestine, lung, and heart. A total of fifteen SLA-MIC2 alleles were identified from typing 145 animals, ten of which were previously unreported. Our analysis showed that the previously reported and tentatively named SLA-MIC2*05, 07, and 01 alleles occurred most frequently. The observed heterozygosity varied from 0.26 to 0.73 among breeds. The number of alleles of the SLA-MIC2 gene in pigs is somewhat lower compared to the number of alleles of the porcine MHC class I and II genes; however, the level of heterozygosity was similar. Our results indicate the comprehensiveness of using genomic DNA-based typing for the systemic study of the SLA-MIC2 gene. The method developed for this study, as well as the detailed information that was obtained, could serve as fundamental tools for understanding the influence of the SLA-MIC2 gene on porcine immune responses.	[Dadi, Hailu; MinhThong Le; Dinka, Hunduma; DinhTruong Nguyen; Choi, Hojun; Cho, Hyesun; Choi, Minkyeung; Kim, Jin-Hoi; Soundrarajan, Nagasundarapandian; Park, Chankyu] Konkuk Univ, Dept Anim Biotechnol, Seoul 143701, South Korea; [Park, Jin-Ki] Natl Inst Anim Sci, Anim Biotechnol Div, Suwon 441350, South Korea	Konkuk University; National Institute of Animal Science, Republic of Korea	Park, C (corresponding author), Konkuk Univ, Dept Anim Biotechnol, Seoul 143701, South Korea.	chankyu@konkuk.ac.kr	Dinka, Hunduma/AAQ-3363-2021; Nguyen, Dinh-Truong/AAI-5062-2021; Park, Chankyu/D-8775-2011; Dinka, Hunduma/AAY-7307-2021	Dinka, Hunduma/0000-0002-3498-7689; Nguyen, Dinh-Truong/0000-0002-6452-5573; Dinka, Hunduma/0000-0002-3498-7689; kim, jin-hoi/0000-0003-1232-5307; Park, Chankyu/0000-0003-4855-2210; Le, Minh Thong/0000-0002-9527-0796	Next-Generation BioGreen 21 Program [PJ011130]; Cooperative Research Program for Agriculture Science & Technology Development of the Rural Development Administration, Republic of Korea [PJ009103]; Konkuk University	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Cooperative Research Program for Agriculture Science & Technology Development of the Rural Development Administration, Republic of Korea; Konkuk University	This work was supported by grants from the Next-Generation BioGreen 21 Program (No. PJ011130) and the "Cooperative Research Program for Agriculture Science & Technology Development (PJ009103)" of the Rural Development Administration, Republic of Korea. Soundrarajan was supported by the 2013 KU Brain Pool of Konkuk University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahram S, 1996, IMMUNOGENETICS, V43, P230, DOI 10.1007/BF00587305; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bahram S, 2000, Adv Immunol, V76, P1; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Birch J, 2008, IMMUNOGENETICS, V60, P477, DOI 10.1007/s00251-008-0306-2; Bravo MJ, 2007, TISSUE ANTIGENS, V69, P358, DOI 10.1111/j.1399-0039.2007.00823.x; Bush EJ, 2002, SWINE 2000 PART II R; Chardon P, 2001, TISSUE ANTIGENS, V57, P55, DOI 10.1034/j.1399-0039.2001.057001055.x; Chardon P, 1999, IMMUNOL REV, V167, P179, DOI 10.1111/j.1600-065X.1999.tb01391.x; Cohen R, 2002, ANN RHEUM DIS, V61, P157, DOI 10.1136/ard.61.2.157; Collins RWM, 2004, EUR J IMMUNOGENET, V31, P105, DOI 10.1111/j.1365-2370.2004.00457.x; Culyba EK, 2011, SCIENCE, V331, P571, DOI 10.1126/science.1198461; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hankey KG, 2002, TRANSPLANTATION, V73, P304, DOI 10.1097/00007890-200201270-00029; Hanson SR, 2009, P NATL ACAD SCI USA, V106, P3131, DOI 10.1073/pnas.0810318105; HARVEY R. B., 2005, J ANIM SCI, V83, pE44; HEDRICK PW, 1994, AM NAT, V143, P945, DOI 10.1086/285643; HUGHES AL, 1995, IMMUNOGENETICS, V42, P233, DOI 10.1007/BF00176440; Jinushi M, 2008, P NATL ACAD SCI USA, V105, P1285, DOI 10.1073/pnas.0711293105; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lopez-Vazquez A, 2004, J INFECT DIS, V189, P957, DOI 10.1086/382189; Luetkemeier ES, 2009, IMMUNOGENETICS, V61, P119, DOI 10.1007/s00251-008-0348-5; Miseta A, 2000, MOL BIOL EVOL, V17, P1232, DOI 10.1093/oxfordjournals.molbev.a026406; Molinero LL, 2002, J LEUKOCYTE BIOL, V71, P791; Park K, 2010, TISSUE ANTIGENS, V76, P301, DOI 10.1111/j.1399-0039.2010.01522.x; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Renard C, 2006, GENOMICS, V88, P96, DOI 10.1016/j.ygeno.2006.01.004; Renard C, 2003, J MOL EVOL, V57, P420, DOI 10.1007/s00239-003-2491-9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2001, MOL CLONING LAB MANU; Schrambach S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000518; Suarez-Alvarez B, 2009, TRANSPLANTATION, V88, pS68, DOI 10.1097/TP.0b013e3181afeb7a; SVEJGAARD A, 1994, TISSUE ANTIGENS, V43, P18, DOI 10.1111/j.1399-0039.1994.tb02291.x; Tamura K, 2013, MOLECULAR BIOLOGY AN; Tennant LM, 2007, IMMUNOGENETICS, V59, P377, DOI 10.1007/s00251-007-0206-x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thong LM, 2011, TISSUE ANTIGENS, V77, P572, DOI 10.1111/j.1399-0039.2011.01662.x; Tieng V, 2002, P NATL ACAD SCI USA, V99, P2977, DOI 10.1073/pnas.032668099; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Velten FW, 1999, IMMUNOGENETICS, V49, P919, DOI 10.1007/s002510050575; Wallace GR, 1999, IMMUNOGENETICS, V49, P613, DOI 10.1007/s002510050656; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Yeh F.C., TJBB POPULATION GENE, V129, P157; Zwirner NW, 1999, HUM IMMUNOL, V60, P323, DOI 10.1016/S0198-8859(98)00128-1; Zwirner NW, 1998, IMMUNOGENETICS, V47, P139	49	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135922	10.1371/journal.pone.0135922	http://dx.doi.org/10.1371/journal.pone.0135922			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305091	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500037
J	Foster, LJR; Ho, S; Hook, J; Basuki, M; Marcal, H				Foster, Leslie John Ray; Ho, Sonia; Hook, James; Basuki, Monica; Marcal, Helder			Chitosan as a Biomaterial: Influence of Degree of Deacetylation on Its Physiochemical, Material and Biological Properties	PLOS ONE			English	Article							OLFACTORY ENSHEATHING CELLS; IN-VITRO; FILMS; TRANSPLANTATION; ACETYLATION; DEGRADATION; CHITINS; INJURY; VIVO	Chitosan is a biomaterial with a range of current and potential biomedical applications. Manipulation of chitosan degree of deacetylation (DDA) to achieve specific properties appears feasible, but studies investigating its influence on properties are often contradictory. With a view to the potential of chitosan in the regeneration of nerve tissue, the influence of DDA on the growth and health of olfactory ensheathing cells (OECs) was investigated. There was a linear increase in OEC proliferation as the DDA increased from 72 to 85%. This correlated with linear increases in average surface roughness (0.62 to 0.78 mu m) and crystallinity (4.3 to 10.1%) of the chitosan films. Mitochondrial activity and membrane integrity of OECs was significantly different for OECs cultivated on chitosan with DDAs below 75%, while those on films with DDAs up to 85% were similar to cells in asynchronous growth. Apoptotic indices and cell cycle analysis also suggested that chitosan films with DDAs below 75% were cytocompatible but induced cellular stress, while OECs grown on films fabricated from chitosan with DDAs above 75% showed no significant differences compared to those in asynchronous growth. Tensile strength and elongation to break varied with DDA from 32.3 to 45.3 MPa and 3.6 to 7.1% respectively. DDA had no significant influence on abiotic and biotic degradation profiles of the chitosan films which showed approximately 8 and 20% weight loss respectively. Finally, perceived patterns in property changes are subject to change based on potential variations in DDA analysis. NMR examination of the chitosan samples here revealed significant differences depending upon which peaks were selected for integration; 6 to 13% in DDA values within individual samples. Furthermore, differences between DDA values determined here and those reported by the commercial suppliers were significant and this may also be a source of concern when selecting commercial chitosans for biomaterial research.	[Foster, Leslie John Ray; Ho, Sonia; Basuki, Monica; Marcal, Helder] Univ New S Wales, Sch Biotechnol & Biomol Sci, Bio Polymer Res Grp, Sydney, NSW, Australia; [Hook, James] Univ New S Wales, Mark Wainwright Analyt Ctr, NMR Facil, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Foster, LJR (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Bio Polymer Res Grp, Sydney, NSW, Australia.	J.Foster@unsw.edu.au	Hook, James M/D-6805-2011; Marcal, Helder/A-7690-2008	Hook, James M/0000-0002-1185-7320; Marcal, Helder/0000-0002-5111-2761; Foster, Leslie John Ray/0000-0001-5728-4479	National Health and Medical Research Council of Australia [63510]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia, http://www.nhmrc.gov.au, (63510 to JF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 2010, BIOMACROMOLECULES, V11, P2707, DOI 10.1021/bm1007579; Au E, 2003, GLIA, V41, P224, DOI 10.1002/glia.10160; Azad AK, 2004, J BIOMED MATER RES B, V69B, P216, DOI 10.1002/jbm.b.30000; Barnett SC, 2004, J ANAT, V204, P57, DOI 10.1111/j.1469-7580.2004.00257.x; Baxter S, 2005, FOOD HYDROCOLLOID, V19, P821, DOI 10.1016/j.foodhyd.2004.11.002; BROUWER J, 1984, CLIN CHIM ACTA, V142, P21, DOI 10.1016/0009-8981(84)90097-4; Cao WL, 2005, J BIOMATER APPL, V20, P157, DOI 10.1177/0885328205049897; Chan RTH, 2013, POLYM INT, V62, P884, DOI 10.1002/pi.4451; Chan RTH, 2011, INT J POLYM SCI, V2011, DOI [10.1155/2011/473045, 10.1155/2011/651549]; Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6; Chenite A, 2001, CARBOHYD POLYM, V46, P39, DOI 10.1016/S0144-8617(00)00281-2; Chung TW, 2003, BIOMATERIALS, V24, P4655, DOI 10.1016/S0142-9612(03)00361-2; Clasen C, 2006, BIOMACROMOLECULES, V7, P3210, DOI 10.1021/bm060486x; Daranarong D, 2014, POLYM INT, V63, P1254, DOI 10.1002/pi.4631; Daranarong D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/741408; Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5; Dodane V, 1999, INT J PHARM, V182, P21, DOI 10.1016/S0378-5173(99)00030-7; Foster J, 2010, BIOPOLYMERS, P243; Foster LJR, 2012, JOVE-J VIS EXP, DOI 10.3791/3527; Foster LJR, 2010, BIOMACROMOLECULES, V11, P3563, DOI 10.1021/bm101028g; Foster LJR, 2014, BIOADHESION BIOMIMET, P195; Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Hoekstra A, 1998, BIOMATERIALS, V19, P1467, DOI 10.1016/S0142-9612(98)00060-X; Kim BS, 2004, J BIOMED MATER RES A, V68A, P201, DOI 10.1002/jbm.a.10045; Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1; Lakatos A, 2000, GLIA, V32, P214, DOI 10.1002/1098-1136(200012)32:3<214::AID-GLIA20>3.0.CO;2-7; Lakatos A, 2003, EXP NEUROL, V184, P237, DOI 10.1016/S0014-4886(03)00270-X; Lavertu M, 2003, J PHARMACEUT BIOMED, V32, P1149, DOI 10.1016/S0731-7085(03)00155-9; MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2; Muzzarelli RAA, 1999, EXS, V87, P251; Nectow AR, 2012, TISSUE ENG PART B-RE, V18, P40, DOI [10.1089/ten.teb.2011.0240, 10.1089/ten.TEB.2011.0240]; Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100; PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0; Revi D, 2014, J BIOMED MATER RES A, V102, P3273, DOI 10.1002/jbm.a.35003; Richter MW, 2008, EXP NEUROL, V209, P353, DOI 10.1016/j.expneurol.2007.06.011; Ruitenberg MJ, 2006, J NEUROTRAUM, V23, P468, DOI 10.1089/neu.2006.23.468; SAMUELS RJ, 1981, J POLYM SCI POL PHYS, V19, P1081, DOI 10.1002/pol.1981.180190706; Sanguanchaipaiwong V, 2004, BIOMACROMOLECULES, V5, P643, DOI 10.1021/bm0344708; Shahbazi J, 2011, LASER SURG MED, V43, P490, DOI 10.1002/lsm.21076; Su ZD, 2010, PROG NEUROBIOL, V92, P517, DOI 10.1016/j.pneurobio.2010.08.008; Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6; Venault A, 2012, AICHE J, V58, P2226, DOI 10.1002/aic.12737; Wan Y, 2003, POLYMER, V44, P1057, DOI 10.1016/S0032-3861(02)00881-9; Woolnough CA, 2008, POLYM INT, V57, P1042, DOI 10.1002/pi.2444	45	98	102	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135153	10.1371/journal.pone.0135153	http://dx.doi.org/10.1371/journal.pone.0135153			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305690	gold, Green Published, Green Submitted			2022-12-27	WOS:000359995500016
J	Gong, DZ; Hao, WP; Mei, XR; Gao, X; Liu, Q; Caylor, K				Gong, Daozhi; Hao, Weiping; Mei, Xurong; Gao, Xiang; Liu, Qi; Caylor, Kelly			Warmer and Wetter Soil Stimulates Assimilation More than Respiration in Rainfed Agricultural Ecosystem on the China Loess Plateau: The Role of Partial Plastic Film Mulching Tillage	PLOS ONE			English	Article							CARBON-DIOXIDE EXCHANGE; RIDGE-FURROW; EDDY COVARIANCE; HARVESTING SYSTEM; CROPPING SYSTEM; MAIZE; STRATEGIES; BALANCE; YIELD; WATER	Effects of agricultural practices on ecosystem carbon storage have acquired widespread concern due to its alleviation of rising atmospheric CO2 concentrations. Recently, combining of furrow-ridge with plastic film mulching in spring maize ecosystem was widely applied to boost crop water productivity in the semiarid regions of China. However, there is still limited information about the potentials for increased ecosystem carbon storage of this tillage method. The objective of this study was to quantify and contrast net carbon dioxide exchange, biomass accumulation and carbon budgets of maize (Zea maize L.) fields under the traditional non-mulching with flat tillage (CK) and partial plastic film mulching with furrow-ridge tillage (MFR) on the China Loess Plateau. Half-hourly net ecosystem CO2 exchange (NEE) of both treatments were synchronously measured with two eddy covariance systems during the growing seasons of 2011 through 2013. At same time green leaf area index (GLAI) and biomass were also measured biweekly. Compared with CK, the warmer and wetter (+1.3 degrees C and +4.3%) top soil at MFR accelerated the rates of biomass accumulation, promoted greater green leaf area and thus shortened the growing seasons by an average value of 10.4 days for three years. MFR stimulated assimilation more than respiration during whole growing season, resulting in a higher carbon sequestration in terms of NEE of -79 gC/m(2) than CK. However, after considering carbon in harvested grain (or aboveground biomass), there is a slight higher carbon sink (or a stronger carbon source) in MFR due to its greater difference of aboveground biomass than that of grain between both treatments. These results demonstrate that partial plastic film mulched furrow-ridge tillage with aboveground biomass exclusive of grain returned to the soil is an effective way to enhance simultaneously carbon sequestration and grain yield of maize in the semiarid regions.	[Gong, Daozhi; Hao, Weiping; Mei, Xurong; Gao, Xiang; Liu, Qi] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, MOA Key Lab Dryland Agr, State Engn Lab Efficient Water Use Crops & Disast, Beijing 100081, Peoples R China; [Caylor, Kelly] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Princeton University	Mei, XR (corresponding author), Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, MOA Key Lab Dryland Agr, State Engn Lab Efficient Water Use Crops & Disast, Beijing 100081, Peoples R China.	meixurong@caas.cn; kcaylor@princeton.edu	Caylor, Kelly/ABF-2818-2020	Caylor, Kelly/0000-0002-6466-6448; gong, daozhi/0000-0002-3198-9929; hao, weiping/0000-0003-1102-9119	National Natural Science Foundation of China [51179194]; National High-Tech R&D Program of China [2011AA100501, 2011AA100503]; National Key Technologies R&D Program of China [2012BAD09B01]; Princeton Global Collaborative Networks Fund (Coupling Hydrological Forecasts and Food Security in Sub-Saharan Africa and China)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech R&D Program of China(National High Technology Research and Development Program of China); National Key Technologies R&D Program of China(National Key Technology R&D Program); Princeton Global Collaborative Networks Fund (Coupling Hydrological Forecasts and Food Security in Sub-Saharan Africa and China)	Funded by National Natural Science Foundation of China (No. 51179194) (DG), National High-Tech R&D Program of China (No. 2011AA100501, No. 2011AA100503) (DG, WH), National Key Technologies R&D Program of China (No. 2012BAD09B01) founded by MOST of China (XM, WH, DG), and Princeton Global Collaborative Networks Fund (Coupling Hydrological Forecasts and Food Security in Sub-Saharan Africa and China) (KC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulakh MS, 2001, BIOL FERT SOILS, V34, P375, DOI 10.1007/s003740100420; Baker JM, 2005, AGR FOREST METEOROL, V128, P163, DOI 10.1016/j.agrformet.2004.11.005; Barford CC, 2001, SCIENCE, V294, P1688, DOI 10.1126/science.1062962; Beziat P, 2009, AGR FOREST METEOROL, V149, P1628, DOI 10.1016/j.agrformet.2009.05.004; Desjardins RL, 2005, CLIMATIC CHANGE, V70, P283, DOI 10.1007/s10584-005-5951-y; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Gan YT, 2013, ADV AGRON, V118, P429, DOI 10.1016/B978-0-12-405942-9.00007-4; Glenn AJ, 2010, AGR FOREST METEOROL, V150, P908, DOI 10.1016/j.agrformet.2010.02.010; Ham JM, 2003, AGRON J, V95, P1393, DOI 10.2134/agronj2003.1393; Hollinger SE, 2005, AGR FOREST METEOROL, V130, P59, DOI 10.1016/j.agrformet.2005.01.005; Johnson JMF, 2007, ENVIRON POLLUT, V150, P107, DOI 10.1016/j.envpol.2007.06.030; Li C, 2012, ANN SURG ONCOL, V7, P7, DOI DOI 10.1504/IJHPCN.2012.046371; Li R, 2013, AGR WATER MANAGE, V116, P101, DOI 10.1016/j.agwat.2012.10.001; Li S, 2008, AGR WATER MANAGE, V95, P1214, DOI 10.1016/j.agwat.2008.04.014; Li XY, 2008, AGR WATER MANAGE, V95, P539, DOI 10.1016/j.agwat.2007.12.005; Li XL, 2007, SOIL TILL RES, V93, P117, DOI 10.1016/j.still.2006.03.022; Li XY, 2002, AGR WATER MANAGE, V54, P243, DOI 10.1016/S0378-3774(01)00172-X; Li XY, 2001, AGR WATER MANAGE, V50, P173, DOI 10.1016/S0378-3774(01)00105-6; Li ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050760; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Moffat AM, 2007, AGR FOREST METEOROL, V147, P209, DOI 10.1016/j.agrformet.2007.08.011; Paustian K, 2000, BIOGEOCHEMISTRY, V48, P147, DOI 10.1023/A:1006271331703; Paw KT, 2000, BOUND-LAY METEOROL, V97, P487, DOI 10.1023/A:1002786702909; Shen YJ, 2013, AGR FOREST METEOROL, V181, P133, DOI 10.1016/j.agrformet.2013.07.013; Suyker AE, 2004, AGR FOREST METEOROL, V124, P1, DOI 10.1016/j.agrformet.2004.01.011; Tian Y, 2003, FIELD CROP RES, V84, P385, DOI 10.1016/S0378-4290(03)00118-7; Verma SB, 2005, AGR FOREST METEOROL, V131, P77, DOI 10.1016/j.agrformet.2005.05.003; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; Wang YJ, 2011, AGR WATER MANAGE, V101, P88, DOI 10.1016/j.agwat.2011.09.006; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Xu LK, 2004, AGR FOREST METEOROL, V123, P79, DOI 10.1016/j.agrformet.2003.10.004; Yu J, 2005, FIELD CROPS RES, V97, P167; Zhou LM, 2012, FIELD CROP RES, V126, P181, DOI 10.1016/j.fcr.2011.10.010; Zhou LM, 2009, FIELD CROP RES, V113, P41, DOI 10.1016/j.fcr.2009.04.005	34	42	51	3	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136578	10.1371/journal.pone.0136578	http://dx.doi.org/10.1371/journal.pone.0136578			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305354	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500094
J	Qin, SB; Mo, YM; Jiang, K; Cai, B; Xie, F; Jiang, JP; Murphy, RW; Li, JT; Wang, YZ				Qin, Shaobo; Mo, Yunming; Jiang, Ke; Cai, Bo; Xie, Feng; Jiang, Jianping; Murphy, Robert W.; Li, Jia-Tang; Wang, Yuezhao			Two New Species of Liuixalus (Rhacophoridae, Anura): Evidence from Morphological and Molecular Analyses	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CLUSTAL-X; PHYLOGENY; EVOLUTION; VIETNAM; GENERA; FROGS	Due to small body sizes, superficial similarities in morphologies, and obscure activity behaviors, the phylogeny and taxonomy of species in the genus Liuixalus were very troublesome. Some species might comprise a complex of cryptic species. To investigate the species of group, we constructed the matrilineal genealogy of the genus using 16s rRNA mitochondrial DNA sequences. Analyses recovered six well supported matrilines that involved L. romeri, L. ocellatus, L. hainanus, L. calcarius, Liuixalus shiwandashan sp. nov. and Liuixalus jinxiuensis sp. nov., though the historical relationships among them remained unresolved. Currently, Liuixalus included 4 species, distributed eastwards from northern Vietnam to Hong Kong, China. Based on genealogical and morphological distinctiveness, we described Liuixalus jinxiuensis sp. nov. from the type locality Mt. Dayao, Jinxiu, China and Liuixalus shiwandashan sp. nov. from the type locality Mt. Shiwanda, China. A combination of morphological measurements, genetic, bioacoustic and osteological analysis was served to diagnose the new taxa.	[Qin, Shaobo; Jiang, Ke; Cai, Bo; Xie, Feng; Jiang, Jianping; Li, Jia-Tang; Wang, Yuezhao] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Mo, Yunming] Nat Hist Museum Guangxi, Nanning, Guangxi, Peoples R China; [Murphy, Robert W.] Royal Ontario Museum, Ctr Biodivers & Conservat Biol, Toronto, ON M5S 2C6, Canada; [Qin, Shaobo] Sichuan Univ, Coll Life Sci, Chengdu 610064, Sichuan, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Royal Ontario Museum; Sichuan University	Li, JT (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China.	lijt@cib.ac.cn; arcib@cib.ac.cn	Li, Jia-Tang/AAC-7626-2020		National Natural Science Foundation of China [31372173, 31411130190, 31101618, 31471964, 31372174]; Youth Innovation Promotion Association CAS; Ministry of Science and Technology of China (MOST) [2011FY120200, 2005DKA21402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association CAS; Ministry of Science and Technology of China (MOST)(Ministry of Science and Technology, China)	This study was supported by the National Natural Science Foundation of China (31372173, 31411130190, 31101618, 31471964, 31372174), Youth Innovation Promotion Association CAS, and grants from the Ministry of Science and Technology of China (MOST Grant 2011FY120200, Grant 2005DKA21402).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bossuyt F., 2001, ZEYLANICA, V6, P1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Deng DJ, 2007, GUANGXI FOR SCI, V3, P010; DONOGHUE MJ, 1985, BRYOLOGIST, V88, P172, DOI 10.2307/3243026; Drewes RC, 2000, CONT HERPETOL, V2000, P2; Fei L., 2009, FAUNA SIN; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Heyer W.R., 1975, Smithsonian Contributions to Zoology, VNo. 199, P1; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li JT, 2008, MOL PHYLOGENET EVOL, V48, P302, DOI 10.1016/j.ympev.2008.03.023; Li JT, 2009, MOL PHYLOGENET EVOL, V53, P509, DOI 10.1016/j.ympev.2009.06.023; Liu Cheng-chao. Hu Shu-chin, 1973, Acta Zoologica Sinica, V19, P385; Liu Shao-long, 2004, Sichuan Journal of Zoology, V23, P202; Lynch J. D., 1971, Misc Publs Mus nat Hist Univ Kansas, VNo. 53, P1; Menzies M.A., 1993, GEOL SOC SPEC PUBL, V76, P71, DOI 10.1144/GSL.SP.1993.076.01.04; Metcalfe I, 1996, AUST J EARTH SCI, V43, P605, DOI 10.1080/08120099608728282; Milto KD, 2013, RUSS J HERPETOL, V20, P287; Ponssa ML, 2007, ZOOTAXA, P37; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SMITH MALCOLM, 1953, ANN AND MAG NAT HIST, V6, P477; SOKAL RR, 1970, AM NAT, V104, P127, DOI 10.1086/282646; Tao Tiben Nguyen, 2014, Current Herpetology, V33, P29, DOI 10.5358/hsj.33.29; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trueb L., 1973, P65; Trueb L, 2000, J MORPHOL, V243, P75, DOI 10.1002/(SICI)1097-4687(200001)243:1<75::AID-JMOR4>3.0.CO;2-L; Trueb Linda, 1993, P255; WASSERSUG RJ, 1976, STAIN TECHNOL, V51, P131, DOI 10.3109/10520297609116684; Wilkinson JA, 2002, MOL PHYLOGENET EVOL, V24, P265, DOI 10.1016/S1055-7903(02)00212-9; Yu GH, 2010, BIOCHEM SYST ECOL, V38, P402, DOI 10.1016/j.bse.2010.03.011	32	0	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136134	10.1371/journal.pone.0136134	http://dx.doi.org/10.1371/journal.pone.0136134			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305377	gold, Green Submitted, Green Published			2022-12-27	WOS:000359995500049
J	Roswall, N; Eriksen, KT; Hjortebjerg, D; Jensen, SS; Overvad, K; Tjonneland, A; Raaschou-Nielsen, O; Sorensen, M				Roswall, Nina; Eriksen, Kirsten T.; Hjortebjerg, Dorrit; Jensen, Steen S.; Overvad, Kim; Tjonneland, Anne; Raaschou-Nielsen, Ole; Sorensen, Mette			Residential Exposure to Road and Railway Noise and Risk of Prostate Cancer: A Prospective Cohort Study	PLOS ONE			English	Article							SLEEP DURATION; SHIFT WORK; MELATONIN; METAANALYSIS; DISRUPTION; MORTALITY; POLLUTION; STREET; NIGHT; MEN	Background Few modifiable risk factors for prostate cancer are known. Recently, disruption of the circadian system has been proposed to affect risk, as it entails an inhibited melatonin production, and melatonin has demonstrated beneficial effects on cancer inhibition. This suggests a potential role of traffic noise in prostate cancer. Methods Road traffic and railway noise was calculated for all present and historical addresses from 1987-2010 for a cohort of 24,473 middle-aged, Danish men. During follow-up, 1,457 prostate cancer cases were identified. We used Cox Proportional Hazards Models to calculate the association between noise exposure and incident prostate cancer. Incidence Rate Ratios (IRR) were calculated as crude and adjusted for smoking status, education, socioeconomic position, BMI, waist circumference, physical activity, calendar year, and traffic noise from other sources than the one investigated. Results There was no association between residential road traffic noise and risk of prostate cancer for any of the three exposure windows: 1, 5 or 10-year mean noise exposure before prostate cancer diagnosis. This result persisted when stratifying cases by aggressiveness. For railway noise, there was no association with overall prostate cancer. There was no statistically significant effect modification by age, education, smoking status, waist circumference or railway noise, on the association between road traffic noise and prostate cancer, although there seemed to be a suggestion of an association among never smokers (IRR: 1.16; 95% CI: 1.00-1.36). Conclusion The present study does not support an overall association between either railway or road traffic noise and overall prostate cancer.	[Roswall, Nina; Eriksen, Kirsten T.; Hjortebjerg, Dorrit; Tjonneland, Anne; Raaschou-Nielsen, Ole; Sorensen, Mette] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Jensen, Steen S.; Raaschou-Nielsen, Ole] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark	Danish Cancer Society; Aarhus University; Aarhus University	Sorensen, M (corresponding author), Danish Canc Soc, Res Ctr, Copenhagen, Denmark.	mettes@cancer.dk	Jensen, Steen Solvang/AAM-2945-2021; Roswall, Nina/AAJ-6700-2020; Raaschou-Nielsen, Ole/GOK-0338-2022	Roswall, Nina/0000-0003-3071-1658; Raaschou-Nielsen, Ole/0000-0002-1223-0909; Overvad, Kim/0000-0001-6429-7921; Sorensen, Mette/0000-0002-7302-4789; Jensen, Steen Solvang/0000-0001-5923-8441	European Research Council, EU 7th Research Framework Programme [281760]	European Research Council, EU 7th Research Framework Programme(European Research Council (ERC))	The research presented in this paper was funded by the European Research Council, EU 7th Research Framework Programme (http://ec.europa.eu/research/fp7/index_en.cfm); Grant number 281760. The funders had no role in the study design, data collection, analyses, decision to publish, or preparation of the manuscript.	BARTSCH C, 1992, CLIN CHIM ACTA, V209, P153, DOI 10.1016/0009-8981(92)90164-L; Bartsch C, 1999, ADV EXP MED BIOL, V467, P247; Bendtsen H, 1999, SCI TOTAL ENVIRON, V235, P331, DOI 10.1016/S0048-9697(99)00216-8; Berkowicz R, 2008, ENVIRON MODELL SOFTW, V23, P296, DOI 10.1016/j.envsoft.2007.04.007; Blask DE, 2005, ENDOCRINE, V27, P179, DOI 10.1385/ENDO:27:2:179; Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Conlon M, 2007, EPIDEMIOLOGY, V18, P182, DOI 10.1097/01.ede.0000249519.33978.31; Costa G, 2010, SCAND J WORK ENV HEA, V36, P163, DOI 10.5271/sjweh.2899; Cuzick J, 2014, LANCET ONCOL, V15, pE484, DOI 10.1016/S1470-2045(14)70211-6; Erren TC, 2015, EUR UROL, V67, P195, DOI 10.1016/j.eururo.2014.09.033; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gapstur SM, 2014, AM J PREV MED, V46, pS26, DOI 10.1016/j.amepre.2013.10.033; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Graham J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7524; Huncharek M, 2010, AM J PUBLIC HEALTH, V100, P693, DOI 10.2105/AJPH.2008.150508; Islami F, 2014, EUR UROL, V66, P1054, DOI 10.1016/j.eururo.2014.08.059; Jensen SS, 2009, 678 NERI AARH U; Jung-Hynes B, 2011, J PINEAL RES, V50, P140, DOI 10.1111/j.1600-079X.2010.00823.x; Kakizaki M, 2008, BRIT J CANCER, V99, P176, DOI 10.1038/sj.bjc.6604425; Ketzel M, 2003, ATMOS ENVIRON, V37, P2735, DOI 10.1016/S1352-2310(03)00245-0; Ketzel M, 2011, INT J ENVIRON POLLUT, V47, P226, DOI 10.1504/IJEP.2011.047337; Kubo T, 2006, AM J EPIDEMIOL, V164, P549, DOI 10.1093/aje/kwj232; Miedema Henk M E, 2007, Behav Sleep Med, V5, P1, DOI 10.1207/s15402010bsm0501_1; Moretti RM, 2000, ONCOL REP, V7, P347; Muzet A, 2007, SLEEP MED REV, V11, P135, DOI 10.1016/j.smrv.2006.09.001; Parent ME, 2012, AM J EPIDEMIOL, V176, P751, DOI 10.1093/aje/kws318; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pirrera S, 2010, ENVIRON INT, V36, P492, DOI 10.1016/j.envint.2010.03.007; Reiter RJ, 2009, INTEGR CANCER THER, V8, P354, DOI 10.1177/1534735409352026; Savvidis C, 2012, MOL MED, V18, P1249, DOI 10.2119/molmed.2012.00077; Selander J, 2009, EPIDEMIOLOGY, V20, P272, DOI 10.1097/EDE.0b013e31819463bd; Sigurdardottir LG, 2015, EUR UROL, V67, P191, DOI 10.1016/j.eururo.2014.07.008; Siu SWF, 2002, PROSTATE, V52, P106, DOI 10.1002/pros.10098; Sorensen M, 2014, INT J CANCER, V134, P2691, DOI 10.1002/ijc.28592; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; WHO (WorldHealthOrganization), 2009, NIGHT NOIS GUID EUR; World Cancer Research Fund International/American Institute for Cancer Research Continuous Update Project Report, 2014, DIET NUTR PHYS ACT P; Zhu Y, 2006, CANCER EPIDEM BIOMAR, V15, P3, DOI 10.1158/1055-9965.EPI-05-0631	39	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135407	10.1371/journal.pone.0135407	http://dx.doi.org/10.1371/journal.pone.0135407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305219	gold, Green Submitted, Green Published			2022-12-27	WOS:000359995500020
J	Zhou, AF; Xiong, C; Hu, RH; Zhang, YM; Bassig, BA; Triche, E; Yang, SP; Qiu, L; Zhang, YQ; Yao, C; Xu, SQ; Wang, YJ; Xia, W; Qian, ZM; Zheng, TZ; Zhang, B				Zhou, Aifen; Xiong, Chao; Hu, Ronghua; Zhang, Yiming; Bassig, Bryan A.; Triche, Elizabeth; Yang, Shaoping; Qiu, Lin; Zhang, Yaqi; Yao, Cong; Xu, Shunqing; Wang, Youjie; Xia, Wei; Qian, Zhengmin; Zheng, Tongzhang; Zhang, Bin			Pre-Pregnancy BMI, Gestational Weight Gain, and the Risk of Hypertensive Disorders of Pregnancy: A Cohort Study in Wuhan, China	PLOS ONE			English	Article							BODY-MASS INDEX; PREECLAMPSIA; ASSOCIATIONS; OUTCOMES; HEIGHT; WOMEN	Background Hypertensive disorders of pregnancy (HDP) are major causes of maternal death worldwide and the risk factors are not fully understood. Few studies have investigated the risk factors for HDP among Chinese women. A cohort study involving 84,656 women was conducted to investigate pre-pregnancy BMI, total gestational weight gain (GWG), and GWG during early pregnancy as risk factors for HDP among Chinese women. Methods The study was conducted between 2011-2013 in Wuhan, China, utilizing data from the Maternal and Children Healthcare Information Tracking System of Wuhan. A total of 84,656 women with a live singleton pregnancy were included. Multiple unconditional logistic regression was conducted to evaluate associations between putative risk factors and HDP. Results Women who were overweight or obese before pregnancy had an elevated risk of developing HDP (overweight: OR = 2.66, 95% CI = 2.32-3.05; obese: OR = 5.53, 95% CI = 4.28-7.13) compared to their normal weight counterparts. Women with total GWG above the Institute of Medicine (IOM) recommendation had an adjusted OR of 1.72 (95% CI = 1.54-1.93) for HDP compared to women who had GWG within the IOM recommendation. Women with gestational BMI gain >10 kg/m(2) during pregnancy had an adjusted OR of 3.35 (95% CI = 2.89-3.89) for HDP, compared to women with a gestational BMI gain <5 kg/m(2). The increased risk of HDP was also observed among women with higher early pregnancy (up to 18 weeks of pregnancy) GWG (> 600g/ wk: adjusted OR = 1.48, 95% CI = 1.19- 1.84). Conclusion The results from this study show that maternal pre-pregnancy BMI, early GWG, and total GWG are positively associated with the risk of HDP. Weight control efforts before and during pregnancy may help to reduce the risk of HDP.	[Zhou, Aifen; Xiong, Chao; Hu, Ronghua; Zhang, Yiming; Yang, Shaoping; Qiu, Lin; Zhang, Yaqi; Yao, Cong; Zhang, Bin] Wuhan Women & Children Hlth Care Ctr, Wuhan, Hubei, Peoples R China; [Bassig, Bryan A.; Zheng, Tongzhang] Yale Univ, Dept Environm Hlth Sci, Sch Publ Hlth, New Haven, CT 06520 USA; [Triche, Elizabeth] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA; [Xiong, Chao; Xu, Shunqing; Wang, Youjie; Xia, Wei] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm & Hlth, Wuhan 430074, Hubei, Peoples R China; [Qian, Zhengmin] St Louis Univ, Dept Epidemiol, Coll Publ Hlth & Social Justice, St Louis, MO 63103 USA	Yale University; Brown University; Huazhong University of Science & Technology; Saint Louis University	Zheng, TZ (corresponding author), Yale Univ, Dept Environm Hlth Sci, Sch Publ Hlth, New Haven, CT 06520 USA.	tongzhang.zheng@yale.edu; mchwhzb@163.com	Zhang, Yiming/HGB-7344-2022		US National Institutes of Health [D43TW 008323, D43TW 007864-01]; FOGARTY INTERNATIONAL CENTER [D43TW008323, D43TW007864] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Fogarty training grants D43TW 008323 and D43TW 00786401 from the US National Institutes of Health (http://www.nih.gov/), and Dr. Tongzhang Zheng received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Cedergren M, 2006, INT J GYNECOL OBSTET, V93, P269, DOI 10.1016/j.ijgo.2006.03.002; de la Torre L, 2011, AM J PERINAT, V28, P285, DOI 10.1055/s-0030-1271211; Dekker G, 2003, J REPROD IMMUNOL, V59, P245, DOI 10.1016/S0165-0378(03)00051-2; Ehrenthal DB, 2011, J WOMENS HEALTH, V20, P67, DOI 10.1089/jwh.2010.1970; Haugen M, 2014, BMC PREGNANCY CHILDB, V14, P201, DOI DOI 10.1186/1471-2393-14-201; Heude B, 2012, MATERN CHILD HLTH J, V16, P355, DOI 10.1007/s10995-011-0741-9; Hogberg U, 2005, SCAND J PUBLIC HEALT, V33, P409, DOI 10.1080/14034940500217037; Huber LRB, 2007, MATERN CHILD HLTH J, V11, P137, DOI 10.1007/s10995-006-0157-0; Johnson J, 2013, OBSTET GYNECOL, V121, P969, DOI 10.1097/AOG.0b013e31828aea03; Li Q, 2011, NEW ENGL J MED, V364, P2469, DOI 10.1056/NEJMc1102459; Lijnen HR, 2008, CARDIOVASC RES, V78, P286, DOI 10.1093/cvr/cvm007; Liu JH, 2014, ANN EPIDEMIOL, V24, P441, DOI 10.1016/j.annepidem.2014.02.009; Macdonald-Wallis C, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.042; Morikawa M, 2013, HYPERTENS RES PREGNA, V1, P75, DOI 10.14390/jsshp.1.75; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Reyes LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041622; Rosser ML, 2013, ADV CHRONIC KIDNEY D, V20, P287, DOI 10.1053/j.ackd.2013.02.005; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sibai BM, 1997, AM J OBSTET GYNECOL, V177, P1003, DOI 10.1016/S0002-9378(97)70004-8; SIBAI BM, 1995, AM J OBSTET GYNECOL, V172, P642, DOI 10.1016/0002-9378(95)90586-3; Siega-Riz AM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.002; Sohlberg S, 2012, AM J HYPERTENS, V25, P120, DOI 10.1038/ajh.2011.175; Swank ML, 2014, J PERINATOL, V34, P181, DOI 10.1038/jp.2013.168; Tanaka T, 2014, J OBSTET GYNAECOL RE, V40, P1296, DOI 10.1111/jog.12353; Thomson A M, 1967, J Obstet Gynaecol Br Commonw, V74, P1; Wang JX, 2002, LANCET, V359, P673, DOI 10.1016/S0140-6736(02)07804-2; Yaktine AL, 2009, WEIGHT GAIN PREGNANC; Yazdani Shahla, 2012, BMC Res Notes, V5, P34, DOI 10.1186/1756-0500-5-34; Yu CKH, 2006, BJOG-INT J OBSTET GY, V113, P1117, DOI 10.1111/j.1471-0528.2006.00991.x	31	35	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136291	10.1371/journal.pone.0136291	http://dx.doi.org/10.1371/journal.pone.0136291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305565	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500060
J	Li, WB; Liu, YF; Zeng, SH; Xiao, G; Wang, G; Wang, Y; Peng, M; Huang, HW				Li, Wenbin; Liu, Yifei; Zeng, Shaohua; Xiao, Gong; Wang, Gan; Wang, Ying; Peng, Ming; Huang, Hongwen			Gene Expression Profiling of Development and Anthocyanin Accumulation in Kiwifruit (Actinidia chinensis) Based on Transcriptome Sequencing	PLOS ONE			English	Article							PROANTHOCYANIDIN BIOSYNTHESIS; GRAPE BERRY; VITAMIN-C; ARABIDOPSIS; FRUIT; IDENTIFICATION; TOOL	Red-fleshed kiwifruit (Actinidia chinensis Planch. 'Hongyang') is a promising commercial cultivar due to its nutritious value and unique flesh color, derived from vitamin C and anthocyanins. In this study, we obtained transcriptome data of 'Hongyang' from seven developmental stages using Illumina sequencing. We mapped 39-54 million reads to the recently sequenced kiwifruit genome and other databases to define gene structure, to analyze alternative splicing, and to quantify gene transcript abundance at different developmental stages. The transcript profiles throughout red kiwifruit development were constructed and analyzed, with a focus on the biosynthesis and metabolism of compounds such as phytohormones, sugars, starch and L-ascorbic acid, which are indispensable for the development and formation of quality fruit. Candidate genes for these pathways were identified through MapMan and phylogenetic analysis. The transcript levels of genes involved in sucrose and starch metabolism were consistent with the change in soluble sugar and starch content throughout kiwifruit development. The metabolism of L-ascorbic acid was very active, primarily through the L-galactose pathway. The genes responsible for the accumulation of anthocyanin in red kiwifruit were identified, and their expression levels were investigated during kiwifruit development. This survey of gene expression during kiwifruit development paves the way for further investigation of the development of this uniquely colored and nutritious fruit and reveals which factors are needed for high quality fruit formation. This transcriptome data and its analysis will be useful for improving kiwifruit genome annotation, for basic fruit molecular biology research, and for kiwifruit breeding and improvement.	[Li, Wenbin; Xiao, Gong; Wang, Ying; Huang, Hongwen] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Hubei, Peoples R China; [Li, Wenbin; Wang, Gan; Peng, Ming] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Hainan, Peoples R China; [Liu, Yifei; Zeng, Shaohua; Huang, Hongwen] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Li, Wenbin; Wang, Gan] Minist Agr, Key Lab Biol & Genet Resources Trop Crops, Haikou, Peoples R China; [Li, Wenbin] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Sciences; South China Botanical Garden, CAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, Y (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Hubei, Peoples R China.	yingwang@wbgcas.cn; mmpeng_2000@yahoo.com; huanghw@scbg.ac.cn			National Natural Science Foundation of China [30900119]; Key Laboratory of Plant Conservation and Sustainable Utilization of SCBG-CAS [211006]; major technology project of Hainan [ZDZX2013023-1]; National Natural Science Foundation [31471847]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Plant Conservation and Sustainable Utilization of SCBG-CAS; major technology project of Hainan; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	RNA sequencing and analysis was supported by the National Natural Science Foundation of China (30900119) and the key grant from the Key Laboratory of Plant Conservation and Sustainable Utilization of SCBG-CAS (211006). Gene cloning and verification were supported by the major technology project of Hainan (ZDZX2013023-1). The authors add another National Natural Science Foundation (31471847).	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Azuma A, 2008, THEOR APPL GENET, V117, P1009, DOI 10.1007/s00122-008-0840-1; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Boldingh H, 2000, ANN BOT-LONDON, V85, P469, DOI 10.1006/anbo.1999.1094; Bulley SM, 2009, J EXP BOT, V60, P765, DOI 10.1093/jxb/ern327; Cui Z. X., 1993, ACTINIDIA IN CHINA; Das PK, 2012, MOL CELLS, V34, P501, DOI 10.1007/s10059-012-0151-x; Das PK, 2011, PLANT SIGNAL BEHAV, V6, P23, DOI 10.4161/psb.6.1.14082; Dawes HM, 1999, J AGR FOOD CHEM, V47, P2398, DOI 10.1021/jf9810261; [丁捷 Ding Jie], 2010, [食品科学, Food Science], V31, P473; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Falginella L, 2012, PLANTA, V236, P1037, DOI 10.1007/s00425-012-1658-2; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Feng FJ, 2013, PLANT PHYSIOL BIOCH, V69, P54, DOI 10.1016/j.plaphy.2013.04.020; Feng SQ, 2010, PLANTA, V232, P245, DOI 10.1007/s00425-010-1170-5; Ferguson A. R., 2008, P235, DOI 10.1007/978-1-4020-6907-9_8; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Fraser LG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-28; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754; Huang H. W., 2013, ACTINIDIA JAXONOMY G; Huang SX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3640; Jin Gook Kim, 2009, Scientia Horticulturae, V120, P551, DOI 10.1016/j.scienta.2008.11.032; Kanter U, 2005, PLANTA, V221, P243, DOI 10.1007/s00425-004-1441-0; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lastdrager J, 2014, J EXP BOT, V65, P799, DOI 10.1093/jxb/ert474; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046070; Li MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033055; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Lu QM, 2008, RAPID COMMUN MASS SP, V22, P2565, DOI 10.1002/rcm.3642; Lu XD, 2013, PLANT PHYSIOL, V162, P440, DOI 10.1104/pp.113.214874; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; Montefiori M, 2005, J AGR FOOD CHEM, V53, P9526, DOI 10.1021/jf051629u; Montefiori M, 2011, PLANT J, V65, P106, DOI 10.1111/j.1365-313X.2010.04409.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mu Li-qiang, 2010, Journal of Forestry Research (Harbin), V21, P77, DOI 10.1007/s11676-010-0013-3; Nagalakshmi Ugrappa, 2010, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0411s89; Nardozza S, 2013, J EXP BOT, V64, P5049, DOI 10.1093/jxb/ert293; Ong WD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046937; Ostrowski M., 2014, MED J CELL BIOL, V4, P43, DOI DOI 10.2478/acb-2014-0003; Page M, 2012, PLANT CELL ENVIRON, V35, P388, DOI 10.1111/j.1365-3040.2011.02369.x; Rahim MA, 2014, PLANTA, V240, P913, DOI 10.1007/s00425-014-2078-2; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; [阮孟斌 Ruan Mengbin], 2011, [热带作物学报, Chinese Journal of Tropical Crops], V32, P1704; Rudenko AO, 2010, J ANAL CHEM+, V65, P71, DOI 10.1134/S1061934810010132; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shin DH, 2013, FEBS LETT, V587, P1543, DOI 10.1016/j.febslet.2013.03.037; Sivitz AB, 2008, PLANT PHYSIOL, V147, P92, DOI 10.1104/pp.108.118992; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Su FY, 2012, SCI HORTIC-AMSTERDAM, V136, P115, DOI 10.1016/j.scienta.2012.01.013; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang J, 2011, PLANT CELL PHYSIOL, V52, P2200, DOI 10.1093/pcp/pcr152; Wang M, 2003, ACTA HORTIC, P115, DOI 10.17660/ActaHortic.2003.610.13; Wang ZG, 2013, PLANT PHYSIOL, V162, P885, DOI 10.1104/pp.113.214700; Wei YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019455; Xie XB, 2012, PLANT CELL ENVIRON, V35, P1884, DOI 10.1111/j.1365-3040.2012.02523.x; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhou LL, 2012, PLANTA, V236, P825, DOI 10.1007/s00425-012-1674-2; Zhou Y, 2013, TREE GENET GENOMES, V9, P265, DOI 10.1007/s11295-012-0552-1	63	57	67	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136439	10.1371/journal.pone.0136439	http://dx.doi.org/10.1371/journal.pone.0136439			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301713	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900069
J	McCoy, TH; Castro, VM; Cagan, A; Roberson, AM; Kohane, IS; Perlis, RH				McCoy, Thomas H.; Castro, Victor M.; Cagan, Andrew; Roberson, Ashlee M.; Kohane, Isaac S.; Perlis, Roy H.			Sentiment Measured in Hospital Discharge Notes Is Associated with Readmission and Mortality Risk: An Electronic Health Record Study	PLOS ONE			English	Article							ENTERPRISE; DISORDERS; TWITTER	Natural language processing tools allow the characterization of sentiment-that is, terms expressing positive and negative emotion-in text. Applying such tools to electronic health records may provide insight into meaningful patient or clinician features not captured in coded data alone. We performed sentiment analysis on 2,484 hospital discharge notes for 2,010 individuals from a psychiatric inpatient unit, as well as 20,859 hospital discharges for 15,011 individuals from general medical units, in a large New England health system between January 2011 and 2014. The primary measures of sentiment captured intensity of subjective positive or negative sentiment expressed in the discharge notes. Mean scores were contrasted between sociodemographic and clinical groups in mixed effects regression models. Discharge note sentiment was then examined for association with risk for readmission in Cox regression models. Discharge notes for individuals with greater medical comorbidity were modestly but significantly lower in positive sentiment among both psychiatric and general medical cohorts (p<0.001 in each). Greater positive sentiment at discharge was associated with significantly decreased risk of hospital readmission in each cohort (similar to 12% decrease per standard deviation above the mean). Automated characterization of discharge notes in terms of sentiment identifies differences between sociodemographic groups, as well as in clinical outcomes, and is not explained by differences in diagnosis. Clinician sentiment merits investigation to understand why and how it reflects or impacts outcomes.	[McCoy, Thomas H.; Castro, Victor M.; Cagan, Andrew; Roberson, Ashlee M.; Perlis, Roy H.] Massachusetts Gen Hosp, Dept Psychiat, Ctr Expt Drugs & Diagnost, Boston, MA 02114 USA; [McCoy, Thomas H.; Castro, Victor M.; Cagan, Andrew; Roberson, Ashlee M.; Perlis, Roy H.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Castro, Victor M.; Cagan, Andrew] Partners HealthCare Syst, Partners Res Comp, Constitut Ctr 1, Boston, MA 02129 USA; [Kohane, Isaac S.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Partners Healthcare System; Harvard University; Brigham & Women's Hospital	Perlis, RH (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Ctr Expt Drugs & Diagnost, 185 Cambridge St,6th Floor, Boston, MA 02114 USA.	rperlis@partners.org	Castro, Victor M/CAF-9395-2022; Castro, Victor M/CAH-3428-2022	Castro, Victor M/0000-0001-7390-6354; Castro, Victor M/0000-0001-7390-6354; McCoy, Thomas/0000-0002-5624-0439	National Institute of Mental Health [1P50MH106933]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH094612, P50MH106933] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported through funding from the National Institute of Mental Health (1P50MH106933).	Baccianella S, 2010, LREC, V10; Bo Pang, 2008, Foundations and Trends in Information Retrieval, V2, P1, DOI 10.1561/1500000001; Castro VM, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5863; Dahabreh IJ, 2014, JAMA-J AM MED ASSOC, V312, P129, DOI 10.1001/jama.2014.4364; De Smedt T, 2012, LREC; De Smedt T, SENTIMENT ANAL UPDAT; De Smedt T, MULTILINGUAL WORD FR; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Earl TR, 2015, ETHNIC HEALTH, V20, P273, DOI 10.1080/13557858.2014.921888; Greaves F, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2721; Green JG, 2012, INT J METH PSYCH RES, V21, P311, DOI 10.1002/mpr.1371; Hermann KM, 2013, ROLE SYNTAX VECTOR S, P894; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; King D, 2013, HEALTH POLICY, V110, P291, DOI 10.1016/j.healthpol.2013.02.005; McCoy TH, 2014, AM J PSYCHIAT; Mitchell L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064417; Murphy S, 2009, GENOME RES, V19, P1675, DOI 10.1101/gr.094615.109; Murphy Shawn N, 2007, AMIA Annu Symp Proc, P548; Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893; Myslin M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2534; Pang B, 2002, PROCEEDINGS OF THE 2002 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING, P79, DOI 10.3115/1118693.1118704; Portier Kenneth, 2013, Journal of the National Cancer Institute Monographs, P195, DOI 10.1093/jncimonographs/lgt025; Schrauwen Sarah, 2010, MACHINE LEARNING APP; Turney P., 2002, UNSUPERVISED LEARNIN	25	39	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136341	10.1371/journal.pone.0136341	http://dx.doi.org/10.1371/journal.pone.0136341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302085	gold, Green Published, Green Submitted			2022-12-27	WOS:000359951900061
J	Reis, FCG; Haro, AS; Bacurau, AVN; Hirabara, SM; Wasinski, F; Ormanji, MS; Moreira, JBN; Kiyomoto, BH; Bertoncini, CRA; Brum, PC; Curi, R; Bader, M; Bacurau, RFP; Pesquero, JB; Araujo, RC				Reis, Felipe C. G.; Haro, Anderson S.; Bacurau, Aline V. N.; Hirabara, Sandro M.; Wasinski, Frederick; Ormanji, Milene S.; Moreira, Jose B. N.; Kiyomoto, Beatriz H.; Bertoncini, Clelia R. A.; Brum, Patricia C.; Curi, Rui; Bader, Michael; Bacurau, Reury F. P.; Pesquero, Joao B.; Araujo, Ronaldo C.			Deletion of Kinin B2 Receptor Alters Muscle Metabolism and Exercise Performance	PLOS ONE			English	Article							SKELETAL-MUSCLE; B-2 RECEPTOR; MITOCHONDRIAL BIOGENESIS; INSULIN-RESISTANCE; DEFICIENCY LEADS; POTENTIAL ROLE; GLUCOSE-UPTAKE; BRADYKININ; GENE; HYPERTROPHY	Metabolic syndrome is a cluster of metabolic risk factors such as obesity, diabetes and cardiovascular diseases. Mitochondria is the main site of ATP production and its dysfunction leads to decreased oxidative phosphorylation, resulting in lipid accumulation and insulin resistance. Our group has demonstrated that kinins can modulate glucose and lipid metabolism as well as skeletal muscle mass. By using B2 receptor knockout mice (B2R(-/-)) we investigated whether kinin action affects weight gain and physical performance of the animals. Our results show that B2R(-/-) mice are resistant to high fat diet-induced obesity, have higher glucose tolerance as well as increased mitochondrial mass. These features are accompanied by higher energy expenditure and a lower feed efficiency associated with an increase in the proportion of type I fibers and intermediary fibers characterized by higher mitochondrial content and increased expression of genes related to oxidative metabolism. Additionally, the increased percentage of oxidative skeletal muscle fibers and mitochondrial apparatus in B2R(-/-) mice is coupled with a higher aerobic exercise performance. Taken together, our data give support to the involvement of kinins in skeletal muscle fiber type distribution and muscle metabolism, which ultimately protects against fat-induced obesity and improves aerobic exercise performance.	[Reis, Felipe C. G.; Haro, Anderson S.; Wasinski, Frederick; Pesquero, Joao B.; Araujo, Ronaldo C.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Bacurau, Aline V. N.; Brum, Patricia C.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Hirabara, Sandro M.; Curi, Rui] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Ormanji, Milene S.; Bertoncini, Clelia R. A.] Univ Fed Sao Paulo, CEDEME, Sao Paulo, Brazil; [Moreira, Jose B. N.] Norwegian Univ Sci & Technol NTNU, KG Jebsen Ctr Exercise Med, Trondheim, Norway; [Kiyomoto, Beatriz H.] Univ Fed Sao Paulo, Dept Neurol & Neurosurg, Sao Paulo, Brazil; [Bader, Michael] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Bacurau, Reury F. P.] Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Norwegian University of Science & Technology (NTNU); Universidade Federal de Sao Paulo (UNIFESP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Universidade de Sao Paulo	Pesquero, JB (corresponding author), Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil.	jbpesquero@unifesp.br; araujo.ronaldo@unifesp.br	Bertoncini, Clelia/AAW-3148-2021; Bacurau, Aline Villa Nova/AAK-7446-2021; dos Reis, Felipe C Gomes/J-9867-2012; Araujo, Ronaldo Carvalho/O-7569-2019; Bertoncini, Clelia Rejane Antonio/AAE-1344-2019; Ormanji, Milene Subtil/M-3917-2017; Bertoncini, Clelia R A/B-5942-2014; Hirabara, Sandro Massao/C-4014-2012; Curi, Rui/AAT-7970-2021; Brum, Patricia C/E-6605-2011; Bader, Michael/K-2124-2013	Bertoncini, Clelia/0000-0001-9025-5370; Bacurau, Aline Villa Nova/0000-0002-5129-5115; dos Reis, Felipe C Gomes/0000-0001-8357-5261; Araujo, Ronaldo Carvalho/0000-0003-0095-4608; Bertoncini, Clelia Rejane Antonio/0000-0001-9025-5370; Ormanji, Milene Subtil/0000-0003-1324-5800; Bertoncini, Clelia R A/0000-0001-9025-5370; Hirabara, Sandro Massao/0000-0002-7392-0444; Curi, Rui/0000-0001-5095-9154; Brum, Patricia C/0000-0002-4750-6506; Bader, Michael/0000-0003-4780-4164	Sao Paulo Research Foundation FAPESP [2007/56227-2, 2008/06676-8, 2013/04757-9]	Sao Paulo Research Foundation FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Sao Paulo Research Foundation FAPESP (2007/56227-2; 2008/06676-8; 2013/04757-9).	Araujo RC, 2006, BIOL CHEM, V387, P431, DOI 10.1515/BC.2006.057; Barros CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040573; Barros CC, 2012, LAB INVEST, V92, P1419, DOI 10.1038/labinvest.2012.105; Batista EC, 2008, INT IMMUNOPHARMACOL, V8, P271, DOI 10.1016/j.intimp.2007.08.029; Braun A, 1996, IMMUNOPHARMACOLOGY, V33, P32, DOI 10.1016/0162-3109(96)00079-3; Calio ML, 2014, FREE RADICAL BIO MED, V70, P141, DOI 10.1016/j.freeradbiomed.2014.01.024; Dietze GJ, 1996, DIABETES, V45, pS110, DOI 10.2337/diab.45.1.S110; Duka I, 2001, HYPERTENSION, V38, P1355, DOI 10.1161/hy1201.096574; Fischer M, 2004, CLIN SCI, V107, P505, DOI 10.1042/CS20040129; Fonseca RG, 2013, J MOL MED, V91, P851, DOI 10.1007/s00109-013-1004-6; Gacesa JZP, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-217; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; GOLLNICK PD, 1984, AM J SPORT MED, V12, P212, DOI 10.1177/036354658401200309; Guderley H, 2004, COMP BIOCHEM PHYS B, V139, P371, DOI 10.1016/j.cbpc.2004.04.001; Hirabara SM, 2013, J NUTR BIOCHEM, V24, P1136, DOI 10.1016/j.jnutbio.2012.08.014; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Kishi K, 1998, DIABETES, V47, P550, DOI 10.2337/diabetes.47.4.550; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Contarteze RVL, 2008, COMP BIOCHEM PHYS A, V151, P415, DOI 10.1016/j.cbpa.2007.03.005; Lee B, 2014, REV ENDOCR METAB DIS, V15, P149, DOI 10.1007/s11154-013-9283-3; LEIGHTON B, 1988, NATURE, V335, P632, DOI 10.1038/335632a0; Miyata T, 1998, EUR J ENDOCRINOL, V138, P344, DOI 10.1530/eje.0.1380344; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mori MA, 2008, DIABETES, V57, P1491, DOI 10.2337/db07-1508; Ojuka EO, 2004, P NUTR SOC, V63, P275, DOI 10.1079/PNS2004339; Parreiras-e-Silva LT, 2014, CLIN SCI, V127, P185, DOI 10.1042/CS20130358; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Schweitzer GG, 2011, PHYSIOL RES, V60, P511, DOI 10.33549/physiolres.932085; Souza KD, 2010, NEUROPEPTIDES, V44, P209, DOI 10.1016/j.npep.2009.12.001; Stuart CA, 2013, J CLIN ENDOCR METAB, V98, P2027, DOI 10.1210/jc.2012-3876; Wasinski F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/395672; Williams AG, 2000, NATURE, V403, P614, DOI 10.1038/35001141; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	35	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0134844	10.1371/journal.pone.0134844	http://dx.doi.org/10.1371/journal.pone.0134844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302153	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000359951900009
J	Feng, DM; Chen, Z; Wang, ZW; Zhang, CL; He, KL; Guo, SY				Feng, Dongmei; Chen, Zhen; Wang, Zhiwen; Zhang, Chunlu; He, Kanglai; Guo, Shuyuan			Domain III of Bacillus thuringiensis Cry1Ie Toxin Plays an Important Role in Binding to Peritrophic Membrane of Asian Corn Borer	PLOS ONE			English	Article							PLANT-INSECT INTERACTIONS; BRUSH-BORDER MEMBRANE; CRYSTAL PROTEINS; HELIOTHIS-VIRESCENS; PLUTELLA-XYLOSTELLA; CYSTEINE PROTEASE; TOBACCO HORNWORM; AMINOPEPTIDASE-N; MANDUCA-SEXTA; RESISTANCE	The insecticidal IE648 toxin is a truncated Cry1Ie protein with increased toxicity against Asian corn borer (ACB). Cry toxins are pore-forming toxins that disrupt insect midgut cells to kill the larvae. However, the peritrophic membrane (PM) is an important barrier that Cry toxins must cross before binding to midgut cells. Previously, it was shown that Cry toxins are able to bind and accumulate in the PM of several lepidopteran insects. Binding of IE648 toxin to PM of ACB was previously reported and the goal of the current work was the identification of the binding region between Cry1Ie and the PM of ACB. Homologous competition binding assays showed that this interaction was specific. Heterologous competition binding assays performed with different fragments corresponding to domain I, domain II and domain III allowed us to identify that domain III participates in the interaction of IE648 with the PM. Specifically, peptide D3-L8 (corresponding to Cry1Ie toxin residues 607 to 616), located in an exposed loop region of domain III is probably involved in this interaction. Ligand blot assays show that IE648 interact with chitin and PM proteins with sizes of 30, 32 and 80 kDa. The fact that domain III interacts with proteins of similar molecular masses supports that this region of the toxin might be involved in PM interaction. These data provide for the first time the identification of domain III as a putative binding region between PM and 3D-Cry toxin.	[Feng, Dongmei; Chen, Zhen; Wang, Zhiwen; Zhang, Chunlu; Guo, Shuyuan] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China; [He, Kanglai] Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100193, Peoples R China	Beijing Institute of Technology; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Guo, SY (corresponding author), Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China.	guosy@bit.edu.cn			Natural Science Foundation of China [31171911]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (no. 31171911 http://www.nsfc.gov.cn/). SG received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADANG MJ, 1981, CELL TISSUE RES, V218, P141; Aranda E, 1996, J INVERTEBR PATHOL, V68, P203, DOI 10.1006/jipa.1996.0087; Bolognesi R, 2008, J INSECT PHYSIOL, V54, P1413, DOI 10.1016/j.jinsphys.2008.08.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAVO A, 1992, J INVERTEBR PATHOL, V60, P237, DOI 10.1016/0022-2011(92)90004-N; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Burton SL, 1999, J MOL BIOL, V287, P1011, DOI 10.1006/jmbi.1999.2649; Chen J, 2005, CELL TISSUE RES, V321, P123, DOI 10.1007/s00441-005-1124-6; Crickmore N, 1998, MICROBIOL MOL BIOL R, V62, P807, DOI 10.1128/MMBR.62.3.807-813.1998; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; DENOLF P, 1993, APPL ENVIRON MICROB, V59, P1828, DOI 10.1128/AEM.59.6.1828-1837.1993; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Ferry N, 2004, CURR OPIN BIOTECH, V15, P155, DOI 10.1016/j.copbio.2004.01.008; GLEAVE AP, 1993, APPL ENVIRON MICROB, V59, P1683, DOI 10.1128/AEM.59.5.1683-1687.1993; Gomez I, 2006, J BIOL CHEM, V281, P34032, DOI 10.1074/jbc.M604721200; Guo SY, 2014, J INTEGR AGR, V13, P1043, DOI 10.1016/S2095-3119(13)60589-4; Guo SY, 2011, PROTEIN EXPRES PURIF, V78, P204, DOI 10.1016/j.pep.2011.03.006; Hayakawa T, 2004, FEBS LETT, V576, P331, DOI 10.1016/j.febslet.2004.09.029; HORST MN, 1983, ARCH BIOCHEM BIOPHYS, V223, P254, DOI 10.1016/0003-9861(83)90590-8; Jurat-Fuentes JL, 2003, APPL ENVIRON MICROB, V69, P5898, DOI 10.1128/AEM.69.10.5898-5906.2003; Liu XY, 2011, ARCH VIROL, V156, P1707, DOI 10.1007/s00705-011-1039-3; Liu YJ, 2004, ACTA BIOCH BIOPH SIN, V36, P309, DOI 10.1093/abbs/36.4.309; MACINTOSH SC, 1991, P NATL ACAD SCI USA, V88, P8930, DOI 10.1073/pnas.88.20.8930; Michiels K, 2010, ARCH INSECT BIOCHEM, V73, P193, DOI 10.1002/arch.20351; Mohan S, 2006, J INSECT PHYSIOL, V52, P21, DOI 10.1016/j.jinsphys.2005.08.011; Mohan S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001786; Padilla C, 2006, APPL ENVIRON MICROB, V72, P901, DOI 10.1128/AEM.72.1.901-907.2006; Rees JS, 2009, J INVERTEBR PATHOL, V100, P139, DOI 10.1016/j.jip.2009.01.002; Sayyed AH, 2005, APPL ENVIRON MICROB, V71, P6863, DOI 10.1128/AEM.71.11.6863-6869.2005; Sekar V, 1997, APPL ENVIRON MICROB, V63, P2798, DOI 10.1128/AEM.63.7.2798-2801.1997; Song FP, 2003, APPL ENVIRON MICROB, V69, P5207, DOI 10.1128/AEM.69.9.5207-5211.2003; TABASHNIK BE, 1994, P NATL ACAD SCI USA, V91, P4120, DOI 10.1073/pnas.91.10.4120; TAILOR R, 1992, MOL MICROBIOL, V6, P1211, DOI 10.1111/j.1365-2958.1992.tb01560.x; Tellam RL, 1999, INSECT BIOCHEM MOLEC, V29, P87, DOI 10.1016/S0965-1748(98)00123-4; Valaitis AP, 2013, J INVERTEBR PATHOL, V112, P1, DOI 10.1016/j.jip.2012.10.002; Wang P, 2001, ARCH INSECT BIOCHEM, V47, P110, DOI 10.1002/arch.1041; Wu YuE, 2003, Plant Protection, V29, P15; Zimoch L, 2002, CELL TISSUE RES, V308, P287, DOI 10.1007/s00441-002-0546-7	38	10	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136430	10.1371/journal.pone.0136430	http://dx.doi.org/10.1371/journal.pone.0136430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295704	gold, Green Published, Green Submitted			2022-12-27	WOS:000359926900110
J	Scheuing, N; Wiegand, S; Bachle, C; Frohlich-Reiterer, E; Hahn, E; Icks, A; Ludwig, KH; Monkemller, K; Razum, O; Rosenbauer, J; Holl, RW				Scheuing, Nicole; Wiegand, Susanna; Baechle, Christina; Froehlich-Reiterer, Elke; Hahn, Eva; Icks, Andrea; Ludwig, Karl-Heinz; Moenkemller, Kirsten; Razum, Oliver; Rosenbauer, Joachim; Holl, Reinhard W.		DPV Initiative	Impact of Maternal Country of Birth on Type-1-Diabetes Therapy and Outcome in 27,643 Children and Adolescents from the DPV Registry	PLOS ONE			English	Article							HVIDOERE STUDY-GROUP; METABOLIC-CONTROL; HEALTH LITERACY; TYPE-1; INSULIN; TURKISH; RISK; ASSOCIATION; EXPERIENCE; STATEMENT	Objective To study the impact of maternal country of birth on type-1-diabetes (T1D) therapy and outcome. Study Design and Methods 27,643 T1D patients aged <= 20 years with documented maternal country of birth from the multicenter German/Austrian diabetes patient registry (DPV) were analyzed. Patients were categorized based on their mother's origin: Germany/Austria (reference), Turkey, Southern Europe, and Eastern Europe. To compare BMI standard deviation score (BMI-SDS), diabetes therapy and outcome between groups, multivariable regression was applied with adjustments for age, sex and duration of diabetes. Based on observed marginal frequencies, adjusted estimates were calculated. Linear regression was used for continuous data, logistic regression for binary data and Poisson regression for count data. All statistical analyses were performed using SAS 9.4. Significance was set at a two-tailed p<0.05. Results 83.3% of patients were offspring of native mothers. A Turkish, Southern or Eastern European background was documented in 2.4%, 1.7% and 4.3% of individuals. After demographic adjustment, patients with migration background had a higher mean BMI-SDS (Turkey, Southern Europe or Eastern Europe vs. Germany/Austria: 0.58 +/- 0.03, 0.40 +/- 0.04, or 0.37 +/- 0.02 vs. 0.31 +/- 0.01; +/- SE) and a lower use of insulin pumps (26.8%, 27.9%, or 32.6% vs. 37.9%) compared to offspring of native mothers. Mean HbA1c was worst in individuals of Turkish mothers (Turkey vs. Germany/Austria: 69.7 +/- 0.7 vs. 66.6 +/- 0.1 mmol/mol; +/- SE). Patients of Eastern European descent had an increased rate of severe hypoglycemia (22.0 +/- 0.13 vs. 16.13 +/- 0.02 events per 100 patient-years) and ketoacidosis was more prevalent in offspring of Turkish or Southern European mothers (7.50 +/- 0.10, or 7.13 +/- 0.11 vs. 6.54 +/- 0.02 events per 100 patient-years). Patients of Turkish descent were more often hospitalized (57.2 +/- 2.7 vs. 48.5 +/- 0.4 per 100 patient-years). All differences were significant. Conclusion The differences in diabetes therapy and outcome among patients with distinct migration background suggest that specific challenges have to be considered in clinical care.	[Scheuing, Nicole; Holl, Reinhard W.] Univ Ulm, German Ctr Diabet Res DZD, Cent Inst Biomed Technol, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Wiegand, Susanna] Charite, Dept Pediat Endocrinol & Diabetol, D-13353 Berlin, Germany; [Baechle, Christina; Hahn, Eva; Rosenbauer, Joachim] German Ctr Diabet Res DZD, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Froehlich-Reiterer, Elke] Med Univ Graz, Dept Pediat, Graz, Austria; [Hahn, Eva] Protestant Hosp Oberhausen, Dept Pediat & Adolescent Med, Oberhausen, Germany; [Icks, Andrea] Univ Dusseldorf, Dept Publ Hlth, Dusseldorf, Germany; [Ludwig, Karl-Heinz] Mutterhaus Borromaerinnen, Clin Children & Adolescent Med, Trier, Germany; [Moenkemller, Kirsten] Hosp City Cologne, Childrens Hosp, Cologne, Germany; [Razum, Oliver] Univ Bielefeld, Sch Publ Hlth, Dept Epidemiol & Int Publ Hlth, D-33615 Bielefeld, Germany	Ulm University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Diabetes-Zentrum (DDZ); Medical University of Graz; Heinrich Heine University Dusseldorf; University of Bielefeld	Scheuing, N (corresponding author), Univ Ulm, German Ctr Diabet Res DZD, Cent Inst Biomed Technol, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany.	nicole.scheuing@uni-ulm.de		Wiegand, Susanna/0000-0001-8341-9533; Holl, Reinhard/0000-0003-1395-4842; Razum, Oliver/0000-0002-1244-7649	Federal Ministry of Education and Research within the German Competence Network for Diabetes mellitus [01GI1106]; German Diabetes Association; European Foundation for the Study of Diabetes (EFSD) [115317]; Diabetes Research for Patient Stratification consortium (DIRECT); European Foundation for the Study of Diabetes [AZ Macrov 2014_2] Funding Source: researchfish	Federal Ministry of Education and Research within the German Competence Network for Diabetes mellitus; German Diabetes Association; European Foundation for the Study of Diabetes (EFSD); Diabetes Research for Patient Stratification consortium (DIRECT); European Foundation for the Study of Diabetes	This work was supported by the Federal Ministry of Education and Research within the German Competence Network for Diabetes mellitus (grant number 01GI1106; www.kompetenznetz-diabetes-mellitus.net) which is integrated in the German Center for Diabetes Research (DZD; www.dzd-ev.de) as of January 2015. Further financial support was provided by the German Diabetes Association (www.deutsche-diabetes-gesellschaft.de), the European Foundation for the Study of Diabetes (EFSD, grant number 115317; www.europeandiabetesfoundation.org) and the Diabetes Research for Patient Stratification consortium (DIRECT; www.direct-diabetes.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borchers AT, 2010, AUTOIMMUN REV, V9, pA355, DOI 10.1016/j.autrev.2009.12.003; Cadario F, 2014, ACTA DIABETOL, V51, P263, DOI 10.1007/s00592-013-0514-6; Chang YC, 2015, WORLD J DIABETES, V6, P715, DOI 10.4239/wjd.v6.i5.715; Danne T, 2014, GERMAN HLTH REPORT D, P118; de Beaufort CE, 2007, DIABETES CARE, V30, P2245, DOI 10.2337/dc07-0475; Donaghue KC, 2014, PEDIATR DIABETES, V15, P257, DOI 10.1111/pedi.12180; Fredheim S, 2014, PEDIATR DIABETES, V15, P519, DOI 10.1111/pedi.12157; Fritsch M, 2011, PEDIATR DIABETES, V12, P307, DOI 10.1111/j.1399-5448.2010.00728.x; Galler A, 2012, EUR J ENDOCRINOL, V166, P493, DOI 10.1530/EJE-11-0695; Grunberger G, 2014, ENDOCR PRACT, V20, P463, DOI 10.4158/EP14145.PS; Gualdi-Russo E, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-85; Hayman LL, 2007, CIRCULATION, V116, P344, DOI 10.1161/CIRCULATIONAHA.107.184595; Hergenc G, 1999, ATHEROSCLEROSIS, V145, P147, DOI 10.1016/S0021-9150(99)00027-1; Hermann Julia M, 2014, PLoS One, V9, pe91137, DOI 10.1371/journal.pone.0091137; Hoey H, 2009, PEDIATR DIABETES, V10, P9, DOI 10.1111/j.1399-5448.2009.00609.x; Hsu WC, 2015, DIABETES CARE, V38, P150, DOI 10.2337/dc14-2391; Icks A, 2007, DIABETIC MED, V24, P440, DOI 10.1111/j.1464-5491.2007.02105.x; Icks A, 2012, DIABETES TECHNOL THE, V14, P1105, DOI 10.1089/dia.2012.0138; Kamps JL, 2010, DIABETES CARE, V33, P1025, DOI 10.2337/dc09-1440; Karges B, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001742; Keenan HT, 2002, PEDIATRICS, V109, P40, DOI 10.1542/peds.109.1.40; Kleiser C, 2010, PUBLIC HEALTH NUTR, V13, P324, DOI 10.1017/S1368980009991030; MARMOT MG, 1976, AM J EPIDEMIOL, V104, P225, DOI 10.1093/oxfordjournals.aje.a112296; Martin L, 2015, INT J OBESITY, V39, P45, DOI 10.1038/ijo.2014.167; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Neuhauser HK, 2011, PEDIATRICS, V127, pE978, DOI 10.1542/peds.2010-1290; Okrainec K, 2015, DIABETES CARE, V38, P189, DOI 10.2337/dc14-0801; Povlsen L, 2005, PATIENT EDUC COUNS, V59, P164, DOI 10.1016/j.pec.2004.10.014; Razum O., 2008, MIGRATION HLTH FOCUS; Robert Koch-Institut, 2008, GERM HLTH INT EX SUR; Rosario AS, 2010, EUR J CLIN NUTR, V64, P341, DOI 10.1038/ejcn.2010.8; Rosenbauer J, 2012, DIABETES CARE, V35, P80, DOI 10.2337/dc11-0993; Sander M., 2008, SOEP PAPERS MULTIDIS, V122; Schwenk RW, 2013, MOL METAB, V2, P337, DOI 10.1016/j.molmet.2013.09.002; Shield KD, 2012, ALCOHOL EUROPEAN UNI, P10; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; United Nations Department of Economic and Social Affairs, 2013, CLASS COUNTR MAJ AR; Urquia ML, 2011, J EPIDEMIOL COMMUN H, V65, P467, DOI 10.1136/jech.2010.109405; Wangdahl J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1030; Wengler A, 2011, INT J PUBLIC HEALTH, V56, P493, DOI 10.1007/s00038-011-0254-8; Whittemore R, 2012, DIABETES EDUCATOR, V38, P562, DOI 10.1177/0145721712445216	41	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135178	10.1371/journal.pone.0135178	http://dx.doi.org/10.1371/journal.pone.0135178			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295472	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900018
J	Watanabe, B; Minami, S; Ishida, H; Yoshioka, R; Nakagawa, Y; Morita, T; Hayashi, K				Watanabe, Bunta; Minami, Saki; Ishida, Hideaki; Yoshioka, Ryuzo; Nakagawa, Yoshiaki; Morita, Tsuyoshi; Hayashi, Ken'ichiro			Stereospecific Inhibitory Effects of CCG-1423 on the Cellular Events Mediated by Myocardin-Related Transcription Factor A	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CONFORMER GENERATION; NUCLEAR IMPORT; MRTF-A; EXPRESSION; MECHANISM; DYNAMICS; FIBROSIS	CCG-1423 suppresses several pathological processes including cancer cell migration, tissue fibrosis, and the development of atherosclerotic lesions. These suppressions are caused by inhibition of myocardin-related transcription factor A (MRTF-A), which is a critical factor for epithelial-mesenchymal transition (EMT). CCG-1423 can therefore be a potent inhibitor for EMT. CCG-1423 and related compounds, CCG-100602 and CCG-203971 possess similar biological activities. Although these compounds are comprised of two stereoisomers, the differences in their biological activities remain to be assessed. To address this issue, we stereoselectively synthesized optically pure isomers of these compounds and validated their biological activities. The S-isomer of CCG-1423 rather than the R-isomer exhibited modestly but significantly higher inhibitory effects on the cellular events triggered by MRTF-A activation including serum response factor-mediated gene expression and cell migration of fibroblasts and B16F10 melanoma cells. Accordingly, the S-isomer of CCG-1423 more potently blocked the serum-induced nuclear import of MRTF-A than the R-isomer. No such difference was observed in cells treated with each of two stereoisomers of CCG-100602 or CCG-203971. We previously reported that the N-terminal basic domain (NB), which functions as a nuclear localization signal of MRTF-A, is a binding site for CCG-1423. Consistent with the biological activities of two stereoisomers of CCG-1423, docking simulation demonstrated that the S-isomer of CCG-1423 was more likely to bind to NB than the R-isomer. This is a first report demonstrating the stereospecific biological activities of CCG-1423.	[Watanabe, Bunta] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Minami, Saki; Nakagawa, Yoshiaki] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068502, Japan; [Ishida, Hideaki] Toabo Corp Co Ltd, Chuo Ku, Osaka 5406018, Japan; [Yoshioka, Ryuzo] NAHLS Co Ltd, Nishikyo Ku, Kyoto 6158245, Japan; [Morita, Tsuyoshi; Hayashi, Ken'ichiro] Osaka Univ, Grad Sch Med, Dept RNA Biol & Neurosci, Suita, Osaka 5650871, Japan	Kyoto University; Kyoto University; Osaka University	Hayashi, K (corresponding author), Osaka Univ, Grad Sch Med, Dept RNA Biol & Neurosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	khayashi@nbiochem.med.osaka-u.ac.jp		Watanabe, Bunta/0000-0003-3645-5712	Ministry of Education, Science, Sports and Culture of Japan [23590332]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (23590332 to K. H.).	Bell JL, 2013, BEILSTEIN J ORG CHEM, V9, P966, DOI 10.3762/bjoc.9.111; Bell JL, 2013, BIOORG MED CHEM LETT, V23, P3826, DOI 10.1016/j.bmcl.2013.04.080; Elberg G, 2008, AM J PHYSIOL-RENAL, V294, pF1116, DOI 10.1152/ajprenal.00142.2007; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Evelyn CR, 2010, BIOORG MED CHEM LETT, V20, P665, DOI 10.1016/j.bmcl.2009.11.056; Hawkins PCD, 2012, J CHEM INF MODEL, V52, P2919, DOI 10.1021/ci300314k; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Hayashi K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10627; Hayashi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089016; Hayashi K, 2013, J BIOL CHEM, V288, P5743, DOI 10.1074/jbc.M112.408120; Hirano H, 2011, BIOCHEM BIOPH RES CO, V414, P373, DOI 10.1016/j.bbrc.2011.09.079; Iwasaki K, 2008, J BIOL CHEM, V283, P21230, DOI 10.1074/jbc.M710525200; Jin WZ, 2011, J CLIN INVEST, V121, P918, DOI 10.1172/JCI41940; Johnson LA, 2014, INFLAMM BOWEL DIS, V20, P154, DOI 10.1097/01.MIB.0000437615.98881.31; Kim YJ, 2014, TOXICOLOGY, V322, P23, DOI 10.1016/j.tox.2014.04.002; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Lundquist MR, 2014, CELL, V156, P563, DOI 10.1016/j.cell.2013.12.035; McGann M, 2011, J CHEM INF MODEL, V51, P578, DOI 10.1021/ci100436p; McGann MR, 2003, BIOPOLYMERS, V68, P76, DOI 10.1002/bip.10207; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Minami T, 2012, EMBO J, V31, P4428, DOI 10.1038/emboj.2012.296; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Nakamura S, 2010, J BIOL CHEM, V285, P37314, DOI 10.1074/jbc.M110.180786; Pawlowski R, 2010, EMBO J, V29, P3448, DOI 10.1038/emboj.2010.216; Scharenberg M. A., 2010, INT J BIOCHEM CELL B, V53, P8627; Scharenberg MA, 2010, INT J BIOCHEM CELL B, V42, P1911, DOI 10.1016/j.biocel.2010.08.014; Shin I, 2000, J ORG CHEM, V65, P7667, DOI 10.1021/jo0006573; Sisson TH, 2015, AM J PATHOL, V185, P969, DOI 10.1016/j.ajpath.2014.12.005; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Sun Y, 2006, MOL CELL BIOL, V26, P5809, DOI 10.1128/MCB.00024-06; Weng SS, 2011, TETRAHEDRON, V67, P1640, DOI 10.1016/j.tet.2011.01.009	31	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136242	10.1371/journal.pone.0136242	http://dx.doi.org/10.1371/journal.pone.0136242			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295164	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900088
J	Duan, JX; Rapti, M; Tsigkou, A; Lee, MH				Duan, Jing Xian; Rapti, Magdalini; Tsigkou, Anastasia; Lee, Meng Huee			Expanding the Activity of Tissue Inhibitors of Metalloproteinase (TIMP)-1 against Surface-Anchored Metalloproteinases by the Replacement of Its C-Terminal Domain: Implications for Anti-Cancer Effects	PLOS ONE			English	Article							ALPHA-CONVERTING-ENZYME; TUMOR-GROWTH; STEM-CELLS; IN-VITRO; TIMP-1; BINDING; CANCER; IDENTIFICATION; ANGIOGENESIS; MT1-MMP	Tissue inhibitors of metalloproteinases (TIMPs) are the endogenous inhibitors of the matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinases (ADAMs). TIMP molecules are made up of two domains: an N-terminal domain that associates with the catalytic cleft of the metalloproteinases (MP) and a smaller C-terminal domain whose role in MP association is still poorly understood. This work is aimed at investigating the role of the C-terminal domain in MP selectivity. In this study, we replaced the C-terminal domain of TIMP-1 with those of TIMP-2, -3 and -4 to create a series of "T1:TX" chimeras. The affinity of the chimeras against ADAM10, ADAM17, MMP14 and MMP19 was investigated. We can show that replacement of the C-terminal domain by those of other TIMPs dramatically increased the affinity of TIMP-1 for some MPs. Furthermore, the chimeras were able to suppress TNF-alpha and HB-EGF shedding in cell-based setting. Unlike TIMP-1, T1:TX chimeras had no growth-promoting activity. Instead, the chimeras were able to inhibit cell migration and development in several cancer cell lines. Our findings have broadened the prospect of TIMPs as cancer therapeutics. The approach could form the basis of a new strategy for future TIMP engineering.	[Duan, Jing Xian; Tsigkou, Anastasia; Lee, Meng Huee] Xian Jiaotong Liverpool Univ, Dept Biol Sci, Suzhou, Peoples R China; [Rapti, Magdalini] Univ Cambridge, Dept Oncol, Canc Res Inst, Cambridge, England	Xi'an Jiaotong-Liverpool University; University of Cambridge	Lee, MH (corresponding author), Xian Jiaotong Liverpool Univ, Dept Biol Sci, 111 Ren Ai Rd, Suzhou, Peoples R China.	Meng.lee@xjtlu.edu.cn	Duan, Jingxian/AAL-2193-2021	Duan, Jingxian/0000-0002-9453-2651	National Natural Science Foundation of China [31270850]; Research Development Fund, XJTLU	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Development Fund, XJTLU	The authors thank the National Natural Science Foundation of China (grant 31270850) and the Research Development Fund, XJTLU for their generous funding of this project.	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Batra J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075836; Batra J, 2012, J BIOL CHEM, V287, P15935, DOI 10.1074/jbc.M112.341156; Chen WT, 1999, ANN NY ACAD SCI, V878, P361, DOI 10.1111/j.1749-6632.1999.tb07695.x; Egea V, 2012, P NATL ACAD SCI USA, V109, pE309, DOI 10.1073/pnas.1115083109; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Ikenaka Y, 2003, INT J CANCER, V105, P340, DOI 10.1002/ijc.11094; Jia AY, 2014, BRIT J CANCER, V110, P2945, DOI 10.1038/bjc.2014.245; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Koziol A, 2012, FASEB J, V26, P4481, DOI 10.1096/fj.12-205906; Lee MH, 2007, J BIOL CHEM, V282, P6887, DOI 10.1074/jbc.M610490200; Lee MH, 2003, J BIOL CHEM, V278, P40224, DOI 10.1074/jbc.M305678200; Lee MH, 2002, BIOCHEM J, V364, P227, DOI 10.1042/bj3640227; Lee MH, 2001, BIOCHEM BIOPH RES CO, V280, P945, DOI 10.1006/bbrc.2000.4192; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Maskos K, 2007, J MOL BIOL, V366, P1222, DOI 10.1016/j.jmb.2006.11.072; Milla ME, 1999, J BIOL CHEM, V274, P30563, DOI 10.1074/jbc.274.43.30563; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Ries C, 2014, CELL MOL LIFE SCI, V71, P659, DOI 10.1007/s00018-013-1457-3; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Rizvi NA, 2004, CLIN CANCER RES, V10, P1963, DOI 10.1158/1078-0432.CCR-1183-02; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Schlage P, 2015, MATRIX BIOL; Stanger KJ, 2006, COMB CHEM HIGH T SCR, V9, P651, DOI 10.2174/138620706778700161; Stegemann C, 2013, CIRC-CARDIOVASC GENE, V6, P106, DOI 10.1161/CIRCGENETICS.112.964452; Stracke JO, 2000, J BIOL CHEM, V275, P14809, DOI 10.1074/jbc.275.20.14809; Su YS, 2014, FEBS LETT, V588, P1983, DOI 10.1016/j.febslet.2014.04.022; Watanabe A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003086; Wu B, 2000, J MOL BIOL, V295, P257, DOI 10.1006/jmbi.1999.3362; Xia Dong, 2006, Hepatobiliary Pancreat Dis Int, V5, P409; Yan YB, 2002, J CELL BIOL, V158, P221, DOI 10.1083/jcb.200112026; Zacchigna S, 2004, CANCER GENE THER, V11, P73, DOI 10.1038/sj.cgt.7700657; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200	39	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136384	10.1371/journal.pone.0136384	http://dx.doi.org/10.1371/journal.pone.0136384			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308720	gold, Green Submitted, Green Published			2022-12-27	WOS:000360069400117
J	Mari-Dell'Olmo, M; Martiinez-Beneito, MA				Mari-Dell'Olmo, Marc; Angel Martinez-Beneito, Miguel			A Multilevel Regression Model for Geographical Studies in Sets of Non-Adjacent Cities	PLOS ONE			English	Article							SOCIOECONOMIC INEQUALITIES; SMALL AREAS; MORTALITY; WINBUGS	In recent years, small-area-based ecological regression analyses have been published that study the association between a health outcome and a covariate in several cities. These analyses have usually been performed independently for each city and have therefore yielded unrelated estimates for the cities considered, even though the same process has been studied in all of them. In this study, we propose a joint ecological regression model for multiple cities that accounts for spatial structure both within and between cities and explore the advantages of this model. The proposed model merges both disease mapping and geostatistical ideas. Our proposal is compared with two alternatives, one that models the association for each city as fixed effects and another that treats them as independent and identically distributed random effects. The proposed model allows us to estimate the association (and assess its significance) at locations with no available data. Our proposal is illustrated by an example of the association between unemployment (as a deprivation surrogate) and lung cancer mortality among men in 31 Spanish cities. In this example, the associations found were far more accurate for the proposed model than those from the fixed effects model. Our main conclusion is that ecological regression analyses can be markedly improved by performing joint analyses at several locations that share information among them. This finding should be taken into consideration in the design of future epidemiological studies.	[Mari-Dell'Olmo, Marc; Angel Martinez-Beneito, Miguel] CIBERESP, Madrid, Spain; [Mari-Dell'Olmo, Marc] Agencia Salut Publ Barcelona, Barcelona, Spain; [Mari-Dell'Olmo, Marc] Inst Invest Biomed IIB St Pau, Barcelona, Spain; [Angel Martinez-Beneito, Miguel] Fdn El Fomento Invest Sanitaria Biomed Comunidad, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Public Health Agency of Barcelona	Mari-Dell'Olmo, M (corresponding author), CIBERESP, Madrid, Spain.	mmari@aspb.cat	Beneito, Miguel Ángel Martínez/M-8616-2014	Beneito, Miguel Ángel Martínez/0000-0001-8406-8050	Spanish Ministry of Economy and Competitiveness [MTM2013-4323-P]; Plan Nacional de I+D+I [PI081488, PI080330]; ISCIII -Subdireccion General de Evaluacion y Fomento de la Investigacion	Spanish Ministry of Economy and Competitiveness(Spanish Government); Plan Nacional de I+D+I; ISCIII -Subdireccion General de Evaluacion y Fomento de la Investigacion	This work was supported by research grant MTM2013-4323-P from the Spanish Ministry of Economy and Competitiveness and grants PI081488 and PI080330 from the "Plan Nacional de I+D+I 2008-2011" and the "ISCIII -Subdireccion General de Evaluacion y Fomento de la Investigacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Barcelo MA, 2008, GAC SANIT, V22, P596, DOI 10.1016/S0213-9111(08)75362-7; Banerjee S., 2003, HIERARCHICAL MODELIN, P472; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Borrell C, 2014, SCAND J PUBLIC HEALT, V42, P245, DOI 10.1177/1403494814522556; Borrell C, 2010, HEALTH PLACE, V16, P703, DOI 10.1016/j.healthplace.2010.03.002; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Gelman A, 2004, TEXTS STAT SCI, P668; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gotsens M, 2013, HEALTH PLACE, V24, P165, DOI 10.1016/j.healthplace.2013.09.003; Gotsens M, 2011, ACCIDENT ANAL PREV, V43, P1802, DOI 10.1016/j.aap.2011.04.013; Hoffmann R, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-8; Howes RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001339; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mari-Dell'Olmo M, 2015, J EPIDEMIOL COMMUN H, V69, P432, DOI 10.1136/jech-2014-204312; Martinez-Beneito MA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-480; Puigpinos-Riera R, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-6; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Wang FJ, 2003, BIOSTATISTICS, V4, P569, DOI 10.1093/biostatistics/4.4.569	20	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0133649	10.1371/journal.pone.0133649	http://dx.doi.org/10.1371/journal.pone.0133649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308613	gold, Green Submitted, Green Published			2022-12-27	WOS:000360069400012
J	Wang, XX; Liu, SL; Mao, HY; Yu, Z; Chen, EF; Chai, CL				Wang, Xiaoxiao; Liu, Shelan; Mao, Haiyan; Yu, Zhao; Chen, Enfu; Chai, Chengliang			Surveillance of Avian H7N9 Virus in Various Environments of Zhejiang Province, China before and after Live Poultry Markets Were Closed in 2013-2014	PLOS ONE			English	Article							INFLUENZA-A H5N1; BIRD MARKETS; TRANSMISSION; A(H7N9); RISK; INFECTION; HUMIDITY; CAMBODIA; CLOSURE	Background To date, there have been a total of 637 laboratory-confirmed cases of human infection with avian influenza A (H7N9) virus across mainland China, with 28% (179/637) of these reported in Zhejiang Province. Surveillance of avian H7N9 virus was conducted to investigate environmental contamination during H7N9 outbreaks. We sought to evaluate the prevalence of H7N9 in the environment, and the effects of poultry market closures on the incidence of human H7N9 cases. Methods We collected 6740 environmental samples from 751 sampling sites across 11 cities of Zhejiang Province (China) between January 2013 and March 2014. The presence of H7N9 was determined by reverse transcription polymerase chain reaction, with prevalence compared between sites and over time. The relationship between environmental contamination and human cases of H7N9 infection were analyzed using Spearman's ranked correlation coefficient. Results Of the 6740 samples, 10.09% (680/6740) were H7N9-positive. The virus was found to circulate seasonally, and peaked during the spring and winter of 2013-2014. The prevalence of the virus decreased from the north to the southeast of the province, coinciding with the geographical distribution of human H7N9 cases. Compared with other sampling sites, live poultry markets (LPMs) had the highest prevalence of H7N9 virus at 13.94% (667/4784). Of the various sample types analyzed, virus prevalence was highest for chopping board swabs at 15.49% (110/710). The prevalence of the virus in the environment positively correlated with the incidence of human H7N9 cases (r(2) = 0.498; P < 0.01). Cities with a higher incidence of human H7N9 cases also had a higher prevalence of H7N9 among samples and at sampling sites. Following the closure of LPMs at the end of January 2014, the prevalence of H7N9 decreased from 19.18% (487/2539) to 6.92% (79/1141). This corresponded with a decrease in the number of human H7N9 cases reported. Conclusions The prevalence of H7N9 virus in environmental samples oscillated seasonally, regardless of whether LPMs were open. The presence of H7N9 in environmental samples positively correlated with the number of human H7N9 cases, indicating that eradication of the virus from the environment is essential in reducing the numbers of H7N9 cases and halting the spread of the virus.	[Wang, Xiaoxiao; Liu, Shelan; Mao, Haiyan; Yu, Zhao; Chen, Enfu; Chai, Chengliang] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Wang, Xiaoxiao] Field Epidemiol Training Program Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Chai, CL (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	chlchai@cdc.zj.cn			Medical Research Program of Zhejiang province [2014KYA034]; Zhejiang Province Major Science and Technology Program [2014C03039]	Medical Research Program of Zhejiang province; Zhejiang Province Major Science and Technology Program	This work was financially supported by grants from the Medical Research Program of Zhejiang province (No. 2014KYA034) and Zhejiang Province Major Science and Technology Program (No. 2014C03039). None of the funders had any role in the study design and the collection, analysis, and interpretation of data, or in the writing of the article and the decision to submit it for publication. The researchers confirm their independence from funders and sponsors.	Bulaga LL, 2003, AVIAN DIS, V47, P996, DOI 10.1637/0005-2086-47.s3.996; Chen E, 2013, EURO SURVEILLANCE, V18; Chen EF, 2013, FRONT MED-PRC, V7, P333, DOI 10.1007/s11684-013-0275-1; Chen ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107266; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Gong ZY, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-244; Han J, 2013, EUROSURVEILLANCE, V2013, P18; He F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095015; He Y, 2014, EMERG INFECT DIS, V20, P1565, DOI 10.3201/eid2009.131243; Horm SV, 2013, EMERG INFECT DIS, V19, P305, DOI 10.3201/eid1902.121201; Indriani R, 2010, EMERG INFECT DIS, V16, P1889, DOI 10.3201/eid1612.100402; Khalenkov A, 2008, J VIROL METHODS, V149, P180, DOI 10.1016/j.jviromet.2008.01.001; Kung NY, 2007, EMERG INFECT DIS, V13, P412, DOI 10.3201/eid1303.060365; Leung YHC, 2012, EMERG INFECT DIS, V18, P1339, DOI 10.3201/eid1808.111879; Li LH, 2013, J THORAC DIS, V5, P790, DOI 10.3978/j.issn.2072-1439.2013.12.45; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liu B, 2014, CLIN INFECT DIS, V59, P787, DOI 10.1093/cid/ciu423; Liu SL, 2013, J INFECTION, V67, P595, DOI 10.1016/j.jinf.2013.08.007; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Martin V, 2011, PREV VET MED, V102, P196, DOI 10.1016/j.prevetmed.2011.07.007; Murray EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024042; Samaan G, 2011, PREV VET MED, V100, P71, DOI 10.1016/j.prevetmed.2011.03.003; Santhia K, 2009, INFLUENZA OTHER RESP, V3, P81, DOI 10.1111/j.1750-2659.2009.00069.x; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; Sun JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093775; Vong S, 2008, EMERG INFECT DIS, V14, P1303, DOI 10.3201/eid1408.070912; Wang CM, 2014, J INFECT DIS, V209, P34, DOI 10.1093/infdis/jit478; Wang XY, 2015, EPIDEMIOL INFECT, V143, P1839, DOI 10.1017/S095026881400257X; Xiao YY, 2015, EPIDEMIOL INFECT, V143, P1833, DOI 10.1017/S0950268814002866; Xie L, 2013, EUR J CLIN MICROBIOL, V32, P1617, DOI 10.1007/s10096-013-1922-9; Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2	32	20	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135718	10.1371/journal.pone.0135718	http://dx.doi.org/10.1371/journal.pone.0135718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308215	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400073
J	Bhuiyan, T; Waridel, P; Kapuria, V; Zoete, V; Herr, W				Bhuiyan, Tanja; Waridel, Patrice; Kapuria, Vaibhav; Zoete, Vincent; Herr, Winship			Distinct OGT-Binding Sites Promote HCF-1 Cleavage	PLOS ONE			English	Article							O-GLCNAC TRANSFERASE; FREE-ENERGY DECOMPOSITION; POLYACRYLAMIDE-GELS; LINKED GLCNAC; ACTIVE-SITE; MLL FAMILY; CROSS-TALK; GLCNACYLATION; PROTEIN; PHOSPHORYLATION	Human HCF-1 (also referred to as HCFC-1) is a transcriptional co-regulator that undergoes a complex maturation process involving extensive O-GlcNAcylation and site-specific proteolysis. HCF-1 proteolysis results in two active, noncovalently associated HCF-1(N) and HCF-1(C) subunits that regulate distinct phases of the cell-division cycle. HCF-1 O-GlcNAcylation and site-specific proteolysis are both catalyzed by O-GlcNAc transferase (OGT), which thus displays an unusual dual enzymatic activity. OGT cleaves HCF-1 at six highly conserved 26 amino acid repeat sequences called HCF-1(PRO) repeats. Here we characterize the substrate requirements for OGT cleavage of HCF-1. We show that the HCF-1(PRO)-repeat cleavage signal possesses particular OGT-binding properties. The glutamate residue at the cleavage site that is intimately involved in the cleavage reaction specifically inhibits association with OGT and its bound cofactor UDP-GlcNAc. Further, we identify a novel OGT-binding sequence nearby the first HCF-1(PRO)-repeat cleavage signal that enhances cleavage. These results demonstrate that distinct OGT-binding sites in HCF-1 promote proteolysis, and provide novel insights into the mechanism of this unusual protease activity.	[Bhuiyan, Tanja; Kapuria, Vaibhav; Herr, Winship] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Waridel, Patrice] Univ Lausanne, Ctr Integrat Genom, Fac Biol & Med, Prot Anal Facil, Lausanne, Switzerland; [Zoete, Vincent] Swiss Inst Bioinformat, Mol Modeling Grp, Lausanne, Switzerland	University of Lausanne; University of Lausanne; Swiss Institute of Bioinformatics	Herr, W (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	winship.herr@unil.ch	Herr, Winship/E-6491-2012	Herr, Winship/0000-0002-3606-4546; Kapuria, Vaibhav/0000-0003-1514-419X	Swiss National Science Foundation (SNSF) [31003A_130829]; University of Lausanne; Div Of Electrical, Commun & Cyber Sys [1542152] Funding Source: National Science Foundation	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); University of Lausanne; Div Of Electrical, Commun & Cyber Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the Swiss National Science Foundation (SNSF) grant 31003A_130829 (URL: http://www.snf.ch/en/Pages/default.aspx) and the University of Lausanne to WH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKS CL, 1989, J MOL BIOL, V208, P159, DOI 10.1016/0022-2836(89)90093-4; BROOKS CL, 1983, J CHEM PHYS, V79, P6312, DOI 10.1063/1.445724; Brooks CL, 1988, PROTEINS A THEORETIC, Vxiii; Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Daou S, 2011, P NATL ACAD SCI USA, V108, P2747, DOI 10.1073/pnas.1013822108; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; FRASER D, 1950, J BIOL CHEM, V187, P803; Gambetta MC, 2014, DEV CELL, V31, P629, DOI 10.1016/j.devcel.2014.10.020; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; KRISTIE TM, 1995, J BIOL CHEM, V270, P4387, DOI 10.1074/jbc.270.9.4387; Lazarus MB, 2013, SCIENCE, V342, P1235, DOI 10.1126/science.1243990; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lee J, 2004, BIOTECHNIQUES, V36, P398, DOI 10.2144/04363BM04; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; Lee MS, 2002, J CHEM PHYS, V116, P10606, DOI 10.1063/1.1480013; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Myers SA, 2013, PROTEOMICS, V13, P982, DOI 10.1002/pmic.201200332; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Park J, 2012, P NATL ACAD SCI USA, V109, P17430, DOI 10.1073/pnas.1208378109; Parker JB, 2012, MOL CELL BIOL, V32, P1654, DOI 10.1128/MCB.06033-11; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips RS, 2014, BIOORG CHEM, V57, P198, DOI 10.1016/j.bioorg.2014.06.002; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; Ruan HB, 2013, MOL CELL PROTEOMICS, V12, P3489, DOI 10.1074/mcp.R113.029751; Schregel V, 2009, P NATL ACAD SCI USA, V106, P5342, DOI 10.1073/pnas.0810950106; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Slawson C, 2003, CURR OPIN STRUC BIOL, V13, P631, DOI 10.1016/j.sbi.2003.08.003; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Tyagi S, 2009, EMBO J, V28, P3185, DOI 10.1038/emboj.2009.258; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wells L, 2003, FEBS LETT, V546, P154, DOI 10.1016/S0014-5793(03)00641-0; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; WILSON AC, 1995, GENE DEV, V9, P2445, DOI 10.1101/gad.9.20.2445; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2001, BIOCHEMISTRY-US, V40, P5786, DOI 10.1021/bi010086o; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zhu YP, 2015, NAT CHEM BIOL, V11, P319, DOI [10.1038/NCHEMBIO.1774, 10.1038/nchembio.1774]; Zoete V, 2005, PROTEINS, V61, P79, DOI 10.1002/prot.20528; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395	55	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136636	10.1371/journal.pone.0136636	http://dx.doi.org/10.1371/journal.pone.0136636			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305326	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500102
J	da Silva, JM; Giachetto, PF; da Silva, LOC; Cintra, LC; Paiva, SR; Caetano, AR; Yamagishi, MEB				da Silva, Joaquim Manoel; Giachetto, Poliana Fernanda; Campos da Silva, Luiz Otavio; Cintra, Leandro Carrijo; Paiva, Samuel Rezende; Caetano, Alexandre Rodrigues; Beleza Yamagishi, Michel Eduardo			Genomic Variants Revealed by Invariably Missing Genotypes in Nelore Cattle	PLOS ONE			English	Article							BOS-INDICUS CATTLE; COPY NUMBER; MUTATIONS; TAURUS; ADIPOGENESIS; EXPRESSION; DISCOVERY; RESPONSES; COMMON	High density genotyping panels have been used in a wide range of applications. From population genetics to genome-wide association studies, this technology still offers the lowest cost and the most consistent solution for generating SNP data. However, in spite of the application, part of the generated data is always discarded from final datasets based on quality control criteria used to remove unreliable markers. Some discarded data consists of markers that failed to generate genotypes, labeled as missing genotypes. A subset of missing genotypes that occur in the whole population under study may be caused by technical issues but can also be explained by the presence of genomic variations that are in the vicinity of the assayed SNP and that prevent genotyping probes from annealing. The latter case may contain relevant information because these missing genotypes might be used to identify population-specific genomic variants. In order to assess which case is more prevalent, we used Illumina HD Bovine chip genotypes from 1,709 Nelore (Bos indicus) samples. We found 3,200 missing genotypes among the whole population. NGS re-sequencing data from 8 sires were used to verify the presence of genomic variations within their flanking regions in 81.56% of these missing genotypes. Furthermore, we discovered 3,300 novel SNPs/Indels, 31% of which are located in genes that may affect traits of importance for the genetic improvement of cattle production.	[da Silva, Joaquim Manoel] Univ Estado Mato Grosso UNEMAT, Fac Ciencias Agr Biol & Sociais Aplicadas, Nova Xavantina, Mato Grosso, Brazil; [da Silva, Joaquim Manoel] Univ Estadual Campinas UNICAMP, Inst Biol, Programa Posgrad Genet & Biol Mol, Sao Paulo, Brazil; [Giachetto, Poliana Fernanda; Cintra, Leandro Carrijo; Beleza Yamagishi, Michel Eduardo] Embrapa Informat Agr, LMB, Sao Paulo, Brazil; [Campos da Silva, Luiz Otavio] Embrapa Gado Corte, Campo Grande, MS, Brazil; [Paiva, Samuel Rezende] Embrapa Secretaria Relacoes Int, Brasilia, DF, Brazil; [Caetano, Alexandre Rodrigues] Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil	Universidade do Estado de Mato Grosso; Universidade de Sao Paulo; Universidade Estadual de Campinas; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	da Silva, JM (corresponding author), Univ Estado Mato Grosso UNEMAT, Fac Ciencias Agr Biol & Sociais Aplicadas, Nova Xavantina, Mato Grosso, Brazil.	joaquimmanoel@unemat.br	Caetano, Alexandre Rodrigues/B-5227-2017; da Silva, Joaquim Manoel/C-1447-2012; Paiva, Samuel R/G-6404-2012; Giachetto, Poliana/ABV-6736-2022; Yamagishi, Michel Eduardo Beleza/B-7902-2012	Caetano, Alexandre Rodrigues/0000-0002-3419-7337; da Silva, Joaquim Manoel/0000-0002-4046-1405; Paiva, Samuel R/0000-0001-6687-2491; Yamagishi, Michel Eduardo Beleza/0000-0001-7109-3038	FAPESP [2012/05002-9]; EMBRAPA [02.10.06.009.00]; CNPq [578592/2008-8]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); EMBRAPA(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants provided by FAPESP (grant # 2012/05002-9), EMBRAPA (grant # 02.10.06.009.00) and CNPq (grant # 578592/2008-8).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Beatty DT, 2006, J ANIM SCI, V84, P972, DOI 10.2527/2006.844972x; Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Bolormaa S, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-43; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Brunelle BW, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-36; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Burt David W., 2009, Journal of Biology (London), V8, P36, DOI 10.1186/jbiol137; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Crooks L, 2013, G3-GENES GENOM GENET, V3, P1253, DOI 10.1534/g3.113.006643; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diwan D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-142; Duarte MS, 2013, J ANIM SCI, V91, P2938, DOI 10.2527/jas.2012-5892; Duesberg P, 2007, SCI AM, V296, P52, DOI 10.1038/scientificamerican0507-52; Ellis SA, 2014, ANNU REV ANIM BIOSCI, V2, P285, DOI 10.1146/annurev-animal-022513-114234; Fleischer J, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.009.2009; Fortes MRS, 2010, P NATL ACAD SCI USA, V107, P13642, DOI 10.1073/pnas.1002044107; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Graffelman J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083316, DOI 10.1371/J0URNAL.P0NE.0083316]; Graugnard DE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-142; Griggs RC, 2009, MOL GENET METAB, V96, P20, DOI 10.1016/j.ymgme.2008.10.003; Hassan NJ, 2006, MOL CELL BIOL, V26, P6727, DOI 10.1128/MCB.00688-06; Herzig CTA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-100; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hou YL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-376; Huang Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047496, DOI 10.1371/J0URNAL.P0NE.0047496]; Iskow RC, 2012, TRENDS GENET, V28, P245, DOI 10.1016/j.tig.2012.03.002; Jiang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048732, DOI 10.1371/J0URNAL.P0NE.0048732]; Jiang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-131; Johnston SE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-439; Lam CW, 2013, CLIN CHIM ACTA, V421, P208, DOI 10.1016/j.cca.2013.03.014; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee Hahn-Ey, 2013, J Biomark, V2013, P413853, DOI 10.1155/2013/413853; Lee K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-596; Li C., 2013, CURR GENET MED REP, V1, P212; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Lupski JR, 2013, SCIENCE, V341, P358, DOI 10.1126/science.1239503; Macaulay IC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004126; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Moisa SJ, 2014, GENE REGUL SYST BIO, V8, P17, DOI 10.4137/GRSB.S11782; Muroya S, 2012, ANIM SCI J, V83, P252, DOI 10.1111/j.1740-0929.2011.00954.x; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Nattrass GS, 2014, J ANIM SCI, V92, P443, DOI 10.2527/jas.2013-6978; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; O'Brien AMP, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-19; O'Huallachain M, 2013, CELL CYCLE, V12, P5, DOI 10.4161/cc.23069; Okubo T, 2011, DEVELOPMENT, V138, P339, DOI 10.1242/dev.054056; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Ouyang LM, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-2; Parida SK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-426; Piper EK, 2009, CLIN VACCINE IMMUNOL, V16, P1074, DOI 10.1128/CVI.00157-09; Porto-Neto LR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-876; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Romao JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-137; Seroussi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-673; Shin DH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-240; Silva-Santos KC, 2014, REPROD DOMEST ANIM, V49, P48, DOI 10.1111/rda.12222; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Timmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015661; van Poecke RMP, 2013, PLANT BIOTECHNOL J, V11, P809, DOI 10.1111/pbi.12072; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	71	2	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136035	10.1371/journal.pone.0136035	http://dx.doi.org/10.1371/journal.pone.0136035			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305794	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500044
J	Shankar, P; Nishikawa, M; Shibata, T				Shankar, Prabhat; Nishikawa, Masatoshi; Shibata, Tatsuo			Adaptive Responses Limited by Intrinsic Noise	PLOS ONE			English	Article							TIME-VARYING STIMULI; BACTERIAL CHEMOTAXIS; ESCHERICHIA-COLI; PERFECT ADAPTATION; BEHAVIORAL VARIABILITY; EUKARYOTIC CHEMOTAXIS; SIGNAL AMPLIFICATION; SYSTEMS; NETWORK; RANGE	Sensory systems have mechanisms to respond to the external environment and adapt to them. Such adaptive responses are effective for a wide dynamic range of sensing and perception of temporal change in stimulus. However, noise generated by the adaptation system itself as well as extrinsic noise in sensory inputs may impose a limit on the ability of adaptation systems. The relation between response and noise is well understood for equilibrium systems in the form of fluctuation response relation. However, the relation for non-equilibrium systems, including adaptive systems, are poorly understood. Here, we systematically explore such a relation between response and fluctuation in adaptation systems. We study the two network motifs, incoherent feedforward loops (iFFL) and negative feedback loops (nFBL), that can achieve perfect adaptation. We find that the response magnitude in adaption systems is limited by its intrinsic noise, implying that higher response would have higher noise component as well. Comparing the relation of response and noise in iFFL and nFBL, we show that whereas iFFL exhibits adaptation over a wider parameter range, nFBL offers higher response to noise ratio than iFFL. We also identify the condition that yields the upper limit of response for both network motifs. These results may explain the reason of why nFBL seems to be more abundant in nature for the implementation of adaption systems.	[Shankar, Prabhat; Shibata, Tatsuo] Hiroshima Univ, Dept Math & Life Sci, Higashihiroshima, Japan; [Shankar, Prabhat; Shibata, Tatsuo] RIKEN, Quantitat Biol Ctr, Phys Biol Lab, Kobe, Hyogo, Japan; [Nishikawa, Masatoshi; Shibata, Tatsuo] RIKEN, Ctr Dev Biol, Kobe, Hyogo, Japan	Hiroshima University; RIKEN; RIKEN	Shibata, T (corresponding author), Hiroshima Univ, Dept Math & Life Sci, Higashihiroshima, Japan.	tatsuoshibata@cdb.riken.jp	Shibata, Tatsuo/A-8119-2012; shankar, prabhat/D-6779-2017	Shibata, Tatsuo/0000-0002-9294-9998; shankar, prabhat/0000-0003-3548-5223	KAKENHI [26115722]; Grants-in-Aid for Scientific Research [26115722] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work is supported by KAKENHI (grant number: 26115722) http://www.mext.go.jp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews BW, 2006, PLOS COMPUT BIOL, V2, P1407, DOI 10.1371/journal.pcbi.0020154; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; Celani A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.258102; El-Samad H, 2002, J THEOR BIOL, V214, P17, DOI 10.1006/jtbi.2001.2422; Emonet T, 2008, P NATL ACAD SCI USA, V105, P3304, DOI 10.1073/pnas.0705463105; Francois P, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026009; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GOLDBETER A, 1984, J BIOL CHEM, V259, P14441; Iglesias PA, 2014, IET SYST BIOL, V8, P268, DOI 10.1049/iet-syb.2014.0026; Lan GH, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0489; Lan G, 2012, NAT PHYS, V8, P422, DOI 10.1038/NPHYS2276; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; Mello BA, 2003, BIOPHYS J, V84, P2943, DOI 10.1016/S0006-3495(03)70021-6; Mello BA, 2007, BIOPHYS J, V92, P2329, DOI 10.1529/biophysj.106.097808; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Nakajima A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6367; Nishikawa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011224; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Park H, 2010, NATURE, V468, P819, DOI 10.1038/nature09551; Rao CV, 2004, PLOS BIOL, V2, P239, DOI 10.1371/journal.pbio.0020049; Ratushny AV, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002091; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; Risken H., 1996, FOKKER PLANCK EQUATI; Sartori P, 2011, J STAT PHYS, V142, P1206, DOI 10.1007/s10955-011-0169-z; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; Seifert U, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/12/126001; Shibata T, 2005, P NATL ACAD SCI USA, V102, P331, DOI 10.1073/pnas.0403350102; Shimizu TS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.37; Skoge M, 2014, P NATL ACAD SCI USA, V111, P14448, DOI 10.1073/pnas.1412197111; STADTMAN ER, 1977, P NATL ACAD SCI USA, V74, P2761, DOI 10.1073/pnas.74.7.2761; Takeda K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002413; Tu YH, 2013, ANNU REV BIOPHYS, V42, P337, DOI 10.1146/annurev-biophys-083012-130358; Tu YH, 2008, P NATL ACAD SCI USA, V105, P14855, DOI 10.1073/pnas.0807569105; VanKampen N. G., 1992, STOCHASTIC PROCESSES, V1; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649; Zhang JJ, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046009	41	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136095	10.1371/journal.pone.0136095	http://dx.doi.org/10.1371/journal.pone.0136095			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305221	Green Submitted, gold, Green Published			2022-12-27	WOS:000359995500047
J	Ohta, S; Kawada, K; Swangsri, J; Fujiwara, N; Saito, K; Fujiwara, H; Ryotokuji, T; Okada, T; Miyawaki, Y; Tohkairin, Y; Nakajima, Y; Kumagai, Y; Nagai, K; Ito, T; Eishi, Y; Kawano, T				Ohta, Shunsuke; Kawada, Kenro; Swangsri, Jirawat; Fujiwara, Naoto; Saito, Katsumasa; Fujiwara, Hisashi; Ryotokuji, Tairo; Okada, Takuya; Miyawaki, Yutaka; Tohkairin, Yutaka; Nakajima, Yasuaki; Kumagai, Youichi; Nagai, Kagami; Ito, Takashi; Eishi, Yoshinobu; Kawano, Tatsuyuki			Relationships between Micro-Vascular and Iodine-Staining Patterns in the Vicinity of the Tumor Front of Superficial Esophageal Squamous Carcinoma	PLOS ONE			English	Article							CELL CARCINOMA; CANCER; ANGIOGENESIS; LESIONS	Objective The aim of the present study was to clarify differences between micro-vascular and iodine-staining patterns in the vicinity of the tumor fronts of superficial esophageal squamous cell carcinomas (ESCCs). Methods Ten consecutive patients with ESCCs who were treated by endoscopic submucosal dissection (ESD) were enrolled. At the edge of the iodine-unstained area, we observed 183 sites in total using image-enhanced magnifying endoscopy. We classified the micro-vascular and iodine-staining patterns into three types: Type A, in which the line of vascular change matched the border of the iodine-unstained area; Type B, in which the border of the iodine-unstained area extended beyond the line of vascular change; Type C, in which the line of vascular change extended beyond the border of the iodine-unstained area. Then, by examining histopathological sections, we compared the diameter of intra-papillary capillary loops (IPCLs) in cancerous areas and normal squamous epithelium. Results We investigated 160 sites that the adequate quality of pictures were obtained. There was no case in which the line of vascular change completely matched the whole circumference of the border of an iodine-unstained area. Among the 160 sites, type A was recognized at 76 sites (47.5%), type B at 79 sites (49.4%), and type C at 5 sites (3.1%). Histological examination showed that the mean diameter of the IPCLs in normal squamous epithelium was 16.2 +/- 3.7 mu m, whereas that of IPCLs in cancerous lesions was 21.0 +/- 4.4 mu m. Conclusions The development of iodine-unstained areas tends to precede any changes in the vascularity of the esophageal surface epithelium.	[Ohta, Shunsuke; Kawada, Kenro; Swangsri, Jirawat; Fujiwara, Naoto; Saito, Katsumasa; Fujiwara, Hisashi; Ryotokuji, Tairo; Okada, Takuya; Miyawaki, Yutaka; Tohkairin, Yutaka; Nakajima, Yasuaki; Kumagai, Youichi; Nagai, Kagami; Kawano, Tatsuyuki] Tokyo Med & Dent Univ, Dept Esophageal & Gen Surg, Bunkyo Ku, Tokyo 1138519, Japan; [Ito, Takashi; Eishi, Yoshinobu] Tokyo Med & Dent Univ, Dept Human Pathol, Bunkyo Ku, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Kawano, T (corresponding author), Tokyo Med & Dent Univ, Dept Esophageal & Gen Surg, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138519, Japan.	kawano.srg1@tmd.ac.jp	Eishi, Yoshinobu/N-3602-2017; Miyawaki, Yutaka/AAV-7999-2020	Eishi, Yoshinobu/0000-0002-0521-1670; Miyawaki, Yutaka/0000-0001-7141-2473; Okada, Takuya/0000-0002-9770-2871				Chen Wei-feng, 2013, Zhonghua Wei Chang Wai Ke Za Zhi, V16, P1138; Endo M, 1997, Dis Esophagus, V10, P155; Huang LY, 2009, CHINESE MED J-PEKING, V122, P776, DOI 10.3760/cma.j.issn.0366-6999.2009.07.003; Inoue H, 1997, DIGEST ENDOSC, V9, P16, DOI DOI 10.1111/j.1443-1661.1997.tb00453.x; Jang JY, 2012, CLIN ENDOSC, V45, P379, DOI 10.5946/ce.2012.45.4.379; Kawamura Tohru, 1994, Stomach and Intestine, V29, P875; Kondo H, 2001, GASTROINTEST ENDOSC, V53, P199, DOI 10.1067/mge.2001.110730; Kubo K, 1997, Gastrointest Endosc, V46, P96; Kubota Y, 2009, FRONT BIOSCI-LANDMRK, V14, P3872, DOI [10.2735/3495, 10.2741/3495]; Kumagai Y, 2002, LANCET ONCOL, V3, P604, DOI 10.1016/S1470-2045(02)00874-4; Kumagai Y, 2002, ENDOSCOPY, V34, P369, DOI 10.1055/s-2002-25285; Kumagai Y, 2014, JPN J CLIN ONCOL, V44, P526, DOI 10.1093/jjco/hyu039; Kumagai Y, 2010, DIGEST ENDOSC, V22, P259, DOI 10.1111/j.1443-1661.2010.01010.x; Li SL, 2007, WORLD J GASTROENTERO, V13, P6076, DOI 10.3748/wjg.13.6076; MORI M, 1993, AM J GASTROENTEROL, V88, P701; Muto M, 2010, J CLIN ONCOL, V28, P1566, DOI 10.1200/JCO.2009.25.4680; Park JM, 2007, SCAND J GASTROENTERO, V42, P135, DOI 10.1080/00365520600825141; Ponchon T, 2004, ENDOSCOPY, V36, P811, DOI 10.1055/s-2004-825846; Shimizu Y, 2001, GASTROINTEST ENDOSC, V53, P1, DOI 10.1067/mge.2001.111387; Swangsri J, 2013, J MED DENT SCI, V60, P83; Takubo K, 2007, HISTOPATHOLOGY, V51, P733, DOI 10.1111/j.1365-2559.2007.02766.x	21	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0126533	10.1371/journal.pone.0126533	http://dx.doi.org/10.1371/journal.pone.0126533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301414	Green Submitted, Green Published, gold			2022-12-27	WOS:000359951900001
J	Wang, XY; Chen, ML; Xiao, JF; Hao, LR; Crowley, DE; Zhang, ZW; Yu, J; Huang, N; Huo, MX; Wu, JY				Wang, Xiaoyu; Chen, Meili; Xiao, Jingfa; Hao, Lirui; Crowley, David E.; Zhang, Zhewen; Yu, Jun; Huang, Ning; Huo, Mingxin; Wu, Jiayan			Genome Sequence Analysis of the Naphthenic Acid Degrading and Metal Resistant Bacterium Cupriavidus gilardii CR3	PLOS ONE			English	Article							ALCALIGENES-EUTROPHUS CH34; CYCLOHEXANECARBOXYLIC ACID; RALSTONIA-METALLIDURANS; MICROBIAL-DEGRADATION; CHROMATE RESISTANCE; SILVER RESISTANCE; PATHWAY; GENES; BIODEGRADATION; RECONSTRUCTION	Cupriavidus sp. are generally heavy metal tolerant bacteria with the ability to degrade a variety of aromatic hydrocarbon compounds, although the degradation pathways and substrate versatilities remain largely unknown. Here we studied the bacterium Cupriavidus gilardii strain CR3, which was isolated from a natural asphalt deposit, and which was shown to utilize naphthenic acids as a sole carbon source. Genome sequencing of C. gilardii CR3 was carried out to elucidate possible mechanisms for the naphthenic acid biodegradation. The genome of C. gilardii CR3 was composed of two circular chromosomes chr1 and chr2 of respectively 3,539,530 bp and 2,039,213 bp in size. The genome for strain CR3 encoded 4,502 putative protein-coding genes, 59 tRNA genes, and many other non-coding genes. Many genes were associated with xenobiotic biodegradation and metal resistance functions. Pathway prediction for degradation of cyclohexanecarboxylic acid, a representative naphthenic acid, suggested that naphthenic acid undergoes initial ring-cleavage, after which the ring fission products can be degraded via several plausible degradation pathways including a mechanism similar to that used for fatty acid oxidation. The final metabolic products of these pathways are unstable or volatile compounds that were not toxic to CR3. Strain CR3 was also shown to have tolerance to at least 10 heavy metals, which was mainly achieved by self-detoxification through ion efflux, metal-complexation and metal-reduction, and a powerful DNA self-repair mechanism. Our genomic analysis suggests that CR3 is well adapted to survive the harsh environment in natural asphalts containing naphthenic acids and high concentrations of heavy metals.	[Wang, Xiaoyu; Hao, Lirui; Huang, Ning; Huo, Mingxin] NE Normal Univ, Sch Environm Sci, Key Lab Wetland Ecol & Vegetat Restorat Natl Envi, Changchun, Peoples R China; [Chen, Meili; Xiao, Jingfa; Zhang, Zhewen; Yu, Jun; Wu, Jiayan] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Crowley, David E.] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA	Northeast Normal University - China; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of California System; University of California Riverside	Wang, XY (corresponding author), NE Normal Univ, Sch Environm Sci, Key Lab Wetland Ecol & Vegetat Restorat Natl Envi, Changchun, Peoples R China.	xywang@nenu.edu.cn; wujy@big.ac.cn	Crowley, David/C-1216-2014	Crowley, David/0000-0002-1805-8599; wu, jia yan/0000-0001-6048-405X	National Natural Science Foundation of China [31170476, 51238001]; Jilin Provincial Science and Technology Department Project [20110745, 20150414046GH]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Provincial Science and Technology Department Project	XW received support from National Natural Science Foundation of China (No. 31170476), http://www.nsfc.gov.cn/. XW received support from Jilin Provincial Science and Technology Department Project (No. 20110745 and No. 20150414046GH), http://kjt.jl.gov.cn/kjt/4/tindex.shtml. MH received support from National Natural Science Foundation of China, No. 51238001.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amadou C, 2008, GENOME RES, V18, P1472, DOI 10.1101/gr.076448.108; Bersch B, 2011, BIOCHEMISTRY-US, V50, P2194, DOI 10.1021/bi200005k; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; BLAKLEY ER, 1974, CAN J MICROBIOL, V20, P1297, DOI 10.1139/m74-202; BLAKLEY ER, 1978, CAN J MICROBIOL, V24, P847, DOI 10.1139/m78-141; BLAKLEY ER, 1982, CAN J MICROBIOL, V28, P1324, DOI 10.1139/m82-198; Borremans B, 2001, J BACTERIOL, V183, P5651, DOI 10.1128/JB.183.19.5651-5658.2001; Branco R, 2008, J BACTERIOL, V190, P6996, DOI 10.1128/JB.00289-08; Brient J. A., 1995, KIRK OTHMERS ENCY CH, P1017, DOI DOI 10.1002/JCTB.280620118; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Coenye T, 2003, INT J SYST EVOL MICR, V53, P1075, DOI 10.1099/ijs.0.02555-0; Cserhati M, 2012, J BACTERIOL, V194, P2109, DOI 10.1128/JB.06752-11; Cuadrado V, 2010, INT J SYST EVOL MICR, V60, P2606, DOI 10.1099/ijs.0.018341-0; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; DIELS L, 1995, J IND MICROBIOL, V14, P142, DOI 10.1007/BF01569896; Dokholyan B, 1983, J ICHTHYOL, V23, P125; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Grass G, 2001, J BACTERIOL, V183, P2803, DOI 10.1128/JB.183.9.2803-2807.2001; Gupta A, 2001, MICROBIOL-SGM, V147, P3393, DOI 10.1099/00221287-147-12-3393; Gupta A, 1999, NAT MED, V5, P183, DOI 10.1038/5545; Headley JV, 2004, J ENVIRON SCI HEAL A, V39, P1989, DOI 10.1081/ESE-120039370; Hong KW, 2012, J BACTERIOL, V194, P6324, DOI 10.1128/JB.01608-12; Huang J, 2012, J HAZARD MATER, V201, P132, DOI 10.1016/j.jhazmat.2011.11.052; Hynninen A, 2009, MOL MICROBIOL, V74, P384, DOI 10.1111/j.1365-2958.2009.06868.x; Iwaki H, 2008, CURR MICROBIOL, V57, P107, DOI 10.1007/s00284-008-9158-0; Janssen PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010433; Johnson RJ, 2011, ISME J, V5, P486, DOI 10.1038/ismej.2010.146; Juhnke S, 2002, ARCH MICROBIOL, V179, P15, DOI 10.1007/s00203-002-0492-5; Kim JS, 2007, APPL ENVIRON MICROB, V73, P4579, DOI 10.1128/AEM.01372-06; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Lykidis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009729; Mergeay M, 2003, FEMS MICROBIOL REV, V27, P385, DOI 10.1016/S0168-6445(03)00045-7; MERGEAY M, 1985, J BACTERIOL, V162, P328, DOI 10.1128/JB.162.1.328-334.1985; Monchy S, 2007, J BACTERIOL, V189, P7417, DOI 10.1128/JB.00375-07; Monsieurs P, 2011, BIOMETALS, V24, P1133, DOI 10.1007/s10534-011-9473-y; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Moriya Y, 2010, NUCLEIC ACIDS RES, V38, pW138, DOI 10.1093/nar/gkq318; Ngendahimana VM, 2012, IDENTIFICATION PUTAT; NIES A, 1990, J BIOL CHEM, V265, P5648; Page RDM, 2002, VISUALIZING PHYLOGEN; Paslawski JC, 2009, BIODEGRADATION, V20, P125, DOI 10.1007/s10532-008-9206-2; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; Poehlein A, 2011, J BACTERIOL, V193, P5017, DOI 10.1128/JB.05660-11; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; Rebello RCDL, 2013, INT J BIODIVERSITY; RHO EM, 1975, BIOCHEM J, V148, P11, DOI 10.1042/bj1480011; Scarlett AG, 2012, SCI TOTAL ENVIRON, V425, P119, DOI 10.1016/j.scitotenv.2012.02.064; Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0; Sone Y, 2013, BIOL PHARM BULL, V36, P1835; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; TOKUYAMA T, 1973, CAN J MICROBIOL, V19, P937, DOI 10.1139/m73-150; Trefault N, 2004, ENVIRON MICROBIOL, V6, P655, DOI 10.1111/j.1462-2920.2004.00596.x; Vandamme P, 2004, INT J SYST EVOL MICR, V54, P2285, DOI 10.1099/ijs.0.63247-0; Wei YH, 2011, INT J MOL SCI, V12, P252, DOI 10.3390/ijms12010252; Whitby C, 2010, ADV APPL MICROBIOL, V70, P93, DOI 10.1016/S0065-2164(10)70003-4; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhao YB, 2012, BIOINFORMATICS, V28, P416, DOI 10.1093/bioinformatics/btr655	65	21	24	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0132881	10.1371/journal.pone.0132881	http://dx.doi.org/10.1371/journal.pone.0132881			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301592	Green Submitted, Green Published, gold			2022-12-27	WOS:000359951900003
J	Chang, CH; Chen, SJ; Liu, CY				Chang, Chun-Hung; Chen, Shaw-Ji; Liu, Chieh-Yu			Risk of Developing Depressive Disorders following Hepatocellular Carcinoma: A Nationwide Population-Based Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; CANCER-PATIENTS; EPIDEMIOLOGY; ANXIETY; LIVER; PREVALENCE; DIAGNOSIS; RESECTION; SYMPTOMS; HRQOL	Background & Aims To evaluate the risk of depressive disorders among patients with Hepatocellular Carcinoma (HCC) using the National Health Insurance Research Database (NHIRD) in Taiwan. Methods We conducted a retrospective study of a newly diagnosed HCC cohort of 55,973 participants who were selected from the NHIRD. Patients were observed for a maximum of 6 years to determine the rates of newly onset depressive disorders, and Cox regression was used to identify the risk factors associated with depressive disorders in HCC patients. Results Of the total 55,973 HCC patients, 1,041 patients (1.86%) were diagnosed with depressive disorders during a mean (SD) follow-up period of 1.1 (1.2) years. The Cox multivariate proportional hazards analysis showed that age of 40-59 (HR 1.376, 95% CI 1.049-1.805, p = 0.021), age of 60-79 (HR 1.341, 95% CI 1.025-1.753, p = 0.032), women (HR 1.474 95% CI 1.301-1.669, p < 0.001), metastasis (HR 1.916, 95% CI 1.243-2.953, p = 0.003), and HCV (HR 1.445, 95% CI 1.231-1.697, p < 0.001) were independent risk factors for developing depressive disorders. Conclusions Our study indicated a subsequent risk of depressive disorders in patients with HCC, and the risk increased for those with female gender, aged 40 to 59, aged 60 to 79, with metastasis, or with HCV. Psychological evaluation and support are two critical issues in these HCC patients with the risk factors.	[Chang, Chun-Hung] China Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Chang, Chun-Hung] China Med Univ, Inst Clin Med, Taichung, Taiwan; [Chen, Shaw-Ji] Mackay Mem Hosp, Dept Psychiat, Taitung Branch, Taitung, Taiwan; [Chen, Shaw-Ji] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Chen, Shaw-Ji] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Liu, Chieh-Yu] Natl Taipei Univ Nursing & Hlth Sci, Inst Nursing Midwifery, Taipei, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Tzu Chi University; National Taipei University of Nursing & Health Science (NTUNHS)	Liu, CY (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Inst Nursing Midwifery, Taipei, Taiwan.	b89401068@ntu.edu.tw	Liu, Chieh-Yu/AAR-9654-2021; Chang, Chun-Hung/AAT-1641-2021; Liu, Chieh-Yu/J-3789-2019	Liu, Chieh-Yu/0000-0003-3283-028X; 				Bianchi G, 2005, DIGEST LIVER DIS, V37, P593, DOI 10.1016/j.dld.2005.01.020; Boscarino JA, 2015, HEPATOLOGY, V61, P802, DOI 10.1002/hep.27422; Brintzenhofe-Szoc KM, 2009, PSYCHOSOMATICS, V50, P383, DOI 10.1176/appi.psy.50.4.383; Bromet Evelyn, 2011, BMC Med, V9, P90, DOI 10.1186/1741-7015-9-90; Cahill Bridget A, 2004, Clin J Oncol Nurs, V8, P393, DOI 10.1188/04.CJON.393-399; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chien IC, 2007, CAN J PSYCHIAT, V52, P28, DOI 10.1177/070674370705200106; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Fan SY, 2010, CLIN GASTROENTEROL H, V8, P559, DOI 10.1016/j.cgh.2010.03.008; Huet PM, 2000, AM J GASTROENTEROL, V95, P760; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaplan BJKV, 2007, KAPLAN SADOCKS SYNOP, P529; Khan NF, 2010, EUR J CANCER, V46, P3339, DOI 10.1016/j.ejca.2010.07.035; Lai SY, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/838302; Lau WY, 2008, HEPATOB PANCREAT DIS, V7, P237; Mikoshiba N, 2013, PSYCHO-ONCOLOGY, V22, P2347, DOI 10.1002/pon.3300; Miovic M, 2007, CANCER-AM CANCER SOC, V110, P1665, DOI 10.1002/cncr.22980; Nardelli S, 2013, METAB BRAIN DIS, V28, P239, DOI 10.1007/s11011-012-9364-0; Palmieri VO, 2015, CLIN EXP MED, V15, P65, DOI 10.1007/s10238-013-0267-0; Pasquini M, 2006, DEPRESS ANXIETY, V23, P441, DOI 10.1002/da.20198; Perng CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088721; Poon RTP, 2001, ARCH SURG-CHICAGO, V136, P693, DOI 10.1001/archsurg.136.6.693; Raison CL, 2003, BIOL PSYCHIAT, V54, P283, DOI 10.1016/S0006-3223(03)00413-X; Satin JR, 2009, CANCER-AM CANCER SOC, V115, P5349, DOI 10.1002/cncr.24561; Shun SC, 2008, SUPPORT CARE CANCER, V16, P1059, DOI 10.1007/s00520-007-0384-y; Spiegel D, 2003, BIOL PSYCHIAT, V54, P269, DOI 10.1016/S0006-3223(03)00566-3; Tanabe G, 2001, HEPATO-GASTROENTEROL, V48, P506; Udina M, 2012, J CLIN PSYCHIAT, V73, P1128, DOI 10.4088/JCP.12r07694; WEISSMAN MM, 1977, ARCH GEN PSYCHIAT, V34, P98; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Wong WS, 2008, ACTA ONCOL, V47, P71, DOI 10.1080/02841860701441814	34	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135417	10.1371/journal.pone.0135417	http://dx.doi.org/10.1371/journal.pone.0135417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295711	Green Submitted, Green Published, gold			2022-12-27	WOS:000359926900029
J	Jia, XX; Xie, BN; Shao, M; Zhao, CL				Jia, Xiaoxu; Xie, Baoni; Shao, Ming'an; Zhao, Chunlei			Primary Productivity and Precipitation-Use Efficiency in Temperate Grassland in the Loess Plateau of China	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; WATER-USE EFFICIENCY; RAIN USE EFFICIENCY; DRIED SOIL LAYERS; INNER-MONGOLIA; ECOSYSTEM; VARIABILITY; CLIMATE; GRADIENT; BIOMASS	Clarifying spatial variations in aboveground net primary productivity (ANPP) and precipitation-use efficiency (PUE) of grasslands is critical for effective prediction of the response of terrestrial ecosystem carbon and water cycle to future climate change. Though the combination use of remote sensing products and in situ ANPP measurements, we quantified the effects of climatic [mean annual precipitation (MAP) and precipitation seasonal distribution (PSD)], biotic [leaf area index (LAI)] and abiotic [slope gradient, aspect, soil water storage (SWS) and other soil physical properties] factors on the spatial variations in ANPP and PUE across different grassland types (i.e., meadow steppe, typical steppe and desert steppe) in the Loess Plateau. Based on the study, ANPP increased exponentially with MAP for the entire temperate grassland; suggesting that PUE increased with increasing MAP. Also PSD had a significant effect on ANPP and PUE; where more even PSD favored higher ANPP and PUE. Then MAP, more than PSD, explained spatial variations in typical steppe and desert steppe. However, PSD was the dominant driving factor of spatial variations in ANPP of meadow steppe. This suggested that in terms of spatial variations in ANPP of meadow steppe, change in PSD due to climate change was more important than that in total annual precipitation. LAI explained 78% of spatial PUE in the entire Loess Plateau temperate grassland. As such, LAI was the primary driving factor of spatial variations in PUE. Although the effect of SWS on ANPP and PUE was significant, it was nonetheless less than that of precipitation and vegetation. We therefore concluded that changes in vegetation structure and consequently in LAI and/or altered pattern of seasonal distribution of rainfall due to global climate change could significantly influence ecosystem carbon and water cycle in temperate grasslands.	[Jia, Xiaoxu; Shao, Ming'an] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing 100101, Peoples R China; [Xie, Baoni; Zhao, Chunlei] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling 712100, Peoples R China; [Shao, Ming'an; Zhao, Chunlei] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Northwest A&F University - China; Northwest A&F University - China	Shao, M (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing 100101, Peoples R China.	shaoma@igsnrr.ac.cn			National Natural Science Foundation of China [41390461, 51179180]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 41390461 and No. 51179180). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; BRIGGS JM, 1995, AM J BOT, V82, P1024, DOI 10.2307/2446232; Brummer C, 2012, AGR FOREST METEOROL, V153, P14, DOI 10.1016/j.agrformet.2011.04.008; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Guo Q, 2012, GLOBAL CHANGE BIOL, V18, P3624, DOI 10.1111/gcb.12010; Guo R, 2006, J ENVIRON SCI, V18, P1024, DOI 10.1016/S1001-0742(06)60033-8; Heisler-White JL, 2008, OECOLOGIA, V158, P129, DOI 10.1007/s00442-008-1116-9; Heisler-White JL, 2009, GLOBAL CHANGE BIOL, V15, P2894, DOI 10.1111/j.1365-2486.2009.01961.x; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Hu ZM, 2008, GLOBAL CHANGE BIOL, V14, P1609, DOI 10.1111/j.1365-2486.2008.01582.x; Hu ZM, 2010, GLOBAL ECOL BIOGEOGR, V19, P842, DOI 10.1111/j.1466-8238.2010.00564.x; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Jia XX, 2011, BIODIVERS CONSERV, V20, P3435, DOI 10.1007/s10531-011-0130-0; Jia XX, 2011, GEODERMA, V160, P281, DOI 10.1016/j.geoderma.2010.09.016; Jongen M, 2013, AGR FOREST METEOROL, V171, P163, DOI 10.1016/j.agrformet.2012.11.020; Kato T, 2004, AGR WATER MANAGE, V65, P173, DOI 10.1016/j.agwat.2003.10.001; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Lauenroth WK, 2006, ECOSYSTEMS, V9, P756, DOI 10.1007/s10021-006-0063-8; Lauenroth WK, 2000, ECOSYSTEMS, V3, P344, DOI 10.1007/s100210000031; LAUENROTH WK, 1992, ECOL APPL, V2, P397, DOI 10.2307/1941874; LEHOUEROU HN, 1988, J ARID ENVIRON, V15, P1, DOI 10.1016/S0140-1963(18)31001-2; LEHOUEROU HN, 1984, J ARID ENVIRON, V7, P213; Li W., 2009, REMOTE SENS TECHNOL, V24, P660; Ma WH, 2008, SCI CHINA SER C, V51, P263, DOI 10.1007/s11427-008-0029-5; Ma WH, 2010, SCI CHINA LIFE SCI, V53, P841, DOI 10.1007/s11427-010-4020-6; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; O'Connor TG, 2001, J ECOL, V89, P850, DOI 10.1046/j.0022-0477.2001.00605.x; Paruelo JM, 1999, ECOSYSTEMS, V2, P64, DOI 10.1007/s100219900058; Peng SS, 2013, AGR FOREST METEOROL, V178, P46, DOI 10.1016/j.agrformet.2013.02.002; Potts DL, 2006, NEW PHYTOL, V170, P849, DOI 10.1111/j.1469-8137.2006.01732.x; Prince SD, 1998, GLOBAL CHANGE BIOL, V4, P359, DOI 10.1046/j.1365-2486.1998.00158.x; SALA OE, 1988, ECOLOGY, V69, P40, DOI 10.2307/1943158; Scanlon TM, 2004, GLOBAL CHANGE BIOL, V10, P329, DOI 10.1046/j.1365-2486.2003.00700.x; Scurlock JMO, 2002, GLOBAL CHANGE BIOL, V8, P736, DOI 10.1046/j.1365-2486.2002.00512.x; Thomey ML, 2011, GLOBAL CHANGE BIOL, V17, P1505, DOI 10.1111/j.1365-2486.2010.02363.x; Tsunekawa A., 2014, RESTORATION DEV DEGR; Wang YQ, 2010, GEODERMA, V159, P99, DOI 10.1016/j.geoderma.2010.07.001; Wang YQ, 2010, J HYDROL, V381, P9, DOI 10.1016/j.jhydrol.2009.09.042; WEI S, 2006, CHINESE AGR SCI B, V22, P448; Yang WZ., 2001, J NATURAL RESOURCES, V16, P433, DOI DOI 10.11849/ZRZYXB.2001.05.006; Yu H., 1992, ARID LAND GEOGR, V15, P59	45	27	27	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135490	10.1371/journal.pone.0135490	http://dx.doi.org/10.1371/journal.pone.0135490			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295954	Green Submitted, Green Published, gold			2022-12-27	WOS:000359926900031
J	Li, J; Ding, J; Zhai, K				Li, Jie; Ding, Jie; Zhai, Kan			Detection of Human Papillomavirus DNA in Patients with Breast Tumor in China	PLOS ONE			English	Article							NO EVIDENCE; HPV INFECTION; CANCER; ASSOCIATION; CARCINOMA; VIRUS; PREVALENCE; ETIOLOGY; ABSENCE; SEQUENCES	The presence of HPV in breast tissue and the potential causal association between human papillomavirus (HPV) and breast cancer (BC) remains controversial. The aim of the present study was to compare the HPV prevalence in BC tissues, adjacent normal breast tissues and breast benign disease tissues and to investigate the possible association between HPV and breast tumor development in Chinese women. Paraffin-embedded specimens from 187 pairs of BCs including tumor and normal breast tissue adjacent to tumors and 92 breast benign lesions between June 2009 and July 2014 were investigated by nested polymerase chain reaction (PCR) and type-specific PCR, respectively. With strictly quality control, HPV positive infection was detected in three BC tissues. No HPV positive infection was detected in all normal breast tissue adjacent to tumors and benign breast tissues. Through our detailed analysis, rare HPV infection in this study suggests that HPV might not be associated with BC progression.	[Li, Jie] Capital Med Univ, Beijing Chao Yang Hosp, Dept Gen Surg, Beijing, Peoples R China; [Ding, Jie; Zhai, Kan] Capital Med Univ, Beijing Chao Yang Hosp, Med Res Ctr, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Zhai, K (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Med Res Ctr, Beijing, Peoples R China.	kan_zhai@sina.com		Zhai, Kan/0000-0002-6495-3690				Ahangar-Oskouee M, 2014, ASIAN PAC J CANCER P, V15, P4061, DOI 10.7314/APJCP.2014.15.9.4061; Ali SHM, 2014, E MEDITERR HEALTH J, V20, P372, DOI 10.26719/2014.20.6.372; BAND V, 1990, P NATL ACAD SCI USA, V87, P463, DOI 10.1073/pnas.87.1.463; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; BRATTHAUER GL, 1992, PATHOL RES PRACT, V188, P384, DOI 10.1016/S0344-0338(11)81229-X; de Leon DC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-26; Chaiwongkot A, 2007, ASIAN PAC J CANCER P, V8, P279; Chang P, 2012, MED ONCOL, V29, P521, DOI 10.1007/s12032-011-9945-5; Choi YL, 2007, TUMOR BIOL, V28, P327, DOI 10.1159/000124238; Czerwenka K, 1996, BREAST CANCER RES TR, V41, P51, DOI 10.1007/BF01807036; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; Damin APS, 2004, BREAST CANCER RES TR, V84, P131, DOI 10.1023/B:BREA.0000018411.89667.0d; de Cremoux P, 2008, BREAST CANCER RES TR, V109, P55, DOI 10.1007/s10549-007-9626-4; de Villiers EM, 2005, BREAST CANCER RES, V7, pR1, DOI 10.1186/bcr940; DILONARDO A, 1992, BREAST CANCER RES TR, V21, P95, DOI 10.1007/BF01836955; Doorbar J, 2007, DIS MARKERS, V23, P297, DOI 10.1155/2007/613150; Frega A, 2012, EUR J GYNAECOL ONCOL, V33, P164; Fu L, 2015, J MED VIROL, V87, P1034, DOI 10.1002/jmv.24142; Glenn WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048788; Gopalkrishna V, 1996, BREAST CANCER RES TR, V39, P197, DOI 10.1007/BF01806186; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Hachana M, 2010, BREAST, V19, P541, DOI 10.1016/j.breast.2010.05.007; He Q, 2009, MOL BIOL REP, V36, P807, DOI 10.1007/s11033-008-9249-9; Hedau S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-27; Heideman DAM, 2007, J CLIN ONCOL, V25, P4550, DOI 10.1200/JCO.2007.12.3182; Heng B, 2009, BRIT J CANCER, V101, P1345, DOI 10.1038/sj.bjc.6605282; Hobbs CGL, 2006, CLIN OTOLARYNGOL, V31, P259, DOI 10.1111/j.1749-4486.2006.01246.x; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Khan NA, 2008, BRIT J CANCER, V99, P408, DOI 10.1038/sj.bjc.6604502; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Lawson JS, 2009, BRIT J CANCER, V101, P1351, DOI 10.1038/sj.bjc.6605328; Li N, 2011, BREAST CANCER RES TR, V126, P515, DOI 10.1007/s10549-010-1128-0; Liang WL, 2013, J MED VIROL, V85, P2087, DOI 10.1002/jmv.23703; Lindel K, 2007, BREAST, V16, P172, DOI 10.1016/j.breast.2006.09.001; Manzouri Leila, 2014, Adv Biomed Res, V3, P75, DOI 10.4103/2277-9175.125873; Mendizabal-Ruiz AP, 2009, BREAST CANCER RES TR, V114, P189, DOI 10.1007/s10549-008-9989-1; Mou X, 2011, J INT MED RES, V39, P1636, DOI 10.1177/147323001103900506; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; Peng JP, 2014, J CLIN VIROL, V61, P255, DOI 10.1016/j.jcv.2014.07.010; Piana AF, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0190-3; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sigaroodi A, 2012, SCI WORLD J, P1, DOI 10.1100/2012/837191; Silva RG, 2011, BREAST CANCER RES TR, V125, P261, DOI 10.1007/s10549-010-1129-z; Simoes PW, 2012, INT J GYNECOL CANCER, V22, P343, DOI 10.1097/IGC.0b013e31823c712e; Stanley MA, 2007, BIOCHEM SOC T, V35, P1456, DOI 10.1042/BST0351456; Syrjanen S, 2011, ORAL DIS, V17, P58, DOI 10.1111/j.1601-0825.2011.01792.x; Tjalma WAA, 2013, EUR J OBSTET GYN R B, V170, P45, DOI 10.1016/j.ejogrb.2013.06.027; Tsai JH, 2005, J MED VIROL, V75, P276, DOI 10.1002/jmv.20267; Vernet-Tomas M, 2015, ANTICANCER RES, V35, P851; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang YP, 2008, ONCOL REP, V20, P333, DOI 10.3892/or_00000011; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; Widschwendter A, 2004, J CLIN VIROL, V31, P292, DOI 10.1016/j.jcv.2004.06.009; WREDE D, 1992, BRIT J CANCER, V65, P891, DOI 10.1038/bjc.1992.186; Yu YY, 1999, ANTICANCER RES, V19, P5057; Zhai K, 2015, J CLIN VIROL, V63, P84, DOI 10.1016/j.jcv.2014.09.014	56	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136050	10.1371/journal.pone.0136050	http://dx.doi.org/10.1371/journal.pone.0136050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295705	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900065
J	Vidyasekar, P; Shyamsunder, P; Arun, R; Santhakumar, R; Kapadia, NK; Kumar, R; Verma, RS				Vidyasekar, Prasanna; Shyamsunder, Pavithra; Arun, Rajpranap; Santhakumar, Rajalakshmi; Kapadia, Nand Kishore; Kumar, Ravi; Verma, Rama Shanker			Genome Wide Expression Profiling of Cancer Cell Lines Cultured in Microgravity Reveals Significant Dysregulation of Cell Cycle and MicroRNA Gene Networks	PLOS ONE			English	Article							APOPTOSIS; PROGRESSION; MIR-21; GROWTH; OVEREXPRESSION; PROLIFERATION; CYTOSKELETON; METASTASIS; PROTEINS; PROTECTS	Zero gravity causes several changes in metabolic and functional aspects of the human body and experiments in space flight have demonstrated alterations in cancer growth and progression. This study reports the genome wide expression profiling of a colorectal cancer cell line-DLD-1, and a lymphoblast leukemic cell line-MOLT-4, under simulated microgravity in an effort to understand central processes and cellular functions that are dysregulated among both cell lines. Altered cell morphology, reduced cell viability and an aberrant cell cycle profile in comparison to their static controls were observed in both cell lines under microgravity. The process of cell cycle in DLD-1 cells was markedly affected with reduced viability, reduced colony forming ability, an apoptotic population and dysregulation of cell cycle genes, oncogenes, and cancer progression and prognostic markers. DNA microarray analysis revealed 1801 (upregulated) and 2542 (downregulated) genes (>2 fold) in DLD-1 cultures under microgravity while MOLT-4 cultures differentially expressed 349 (upregulated) and 444 (downregulated) genes (>2 fold) under microgravity. The loss in cell proliferative capacity was corroborated with the downregulation of the cell cycle process as demonstrated by functional clustering of DNA microarray data using gene ontology terms. The genome wide expression profile also showed significant dysregulation of post transcriptional gene silencing machinery and multiple microRNA host genes that are potential tumor suppressors and proto-oncogenes including MIR22HG, MIR17HG and MIR21HG. The MIR22HG, a tumor-suppressor gene was one of the highest upregulated genes in the microarray data showing a 4.4 log fold upregulation under microgravity. Real time PCR validated the dysregulation in the host gene by demonstrating a 4.18 log fold upregulation of the miR-22 microRNA. Microarray data also showed dysregulation of direct targets of miR-22, SP1, CDK6 and CCNA2.	[Vidyasekar, Prasanna; Shyamsunder, Pavithra; Arun, Rajpranap; Santhakumar, Rajalakshmi; Verma, Rama Shanker] Indian Inst Technol Madras, Dept Biotechnol, Stem Cell & Mol Biol Lab, Madras, Tamil Nadu, India; [Kapadia, Nand Kishore] Global Hosp, Dept Cardiothorac Surg, Madras, Tamil Nadu, India; [Kumar, Ravi] Fortis Malar Hosp, Dept Cardiol, Madras, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Verma, RS (corresponding author), Indian Inst Technol Madras, Dept Biotechnol, Stem Cell & Mol Biol Lab, Madras, Tamil Nadu, India.	vermars@iitm.ac.in		Verma, Rama/0000-0001-7287-7803; Arun, Raj Pranap/0000-0001-5746-4728	Defense Research Development Organization [DLS/81/48222/LSRB-189/ID/2009, DLS/81/48222/LSRB-273/SHDD/2013]	Defense Research Development Organization(Defence Research & Development Organisation (DRDO))	This work was supported by Defense Research Development Organization (DLS/81/48222/LSRB-189/ID/2009 and DLS/81/48222/LSRB-273/SH&DD/2013) to RSV. url: http://www.drdo.gov.in/drdo/boards/lsrb/fplsrb.htm	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Augenlicht LH, 1997, CANCER RES, V57, P1769; Becker JL, 2013, NAT REV CANCER, V13, P315, DOI 10.1038/nrc3507; Behboudi A, 2006, GENE CHROMOSOME CANC, V45, P470, DOI 10.1002/gcc.20306; Belandia B, 2005, MOL CELL BIOL, V25, P1425, DOI 10.1128/MCB.25.4.1425-1436.2005; Bellone G, 2001, CANCER RES, V61, P2200; Blair A, 1997, BLOOD, V89, P3104, DOI 10.1182/blood.V89.9.3104; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Calabro L, 2003, J CELL PHYSIOL, V194, P171, DOI 10.1002/jcp.10200; Carlsson SIM, 2003, BBA-MOL CELL RES, V1642, P173, DOI 10.1016/j.bbamcr.2003.08.003; Castedo M, 2002, CELL DEATH DIFFER, V9, P1287, DOI 10.1038/sj.cdd.4401130; Chung JS, 2009, FREE RADICAL RES, V43, P729, DOI 10.1080/10715760903038432; CogoliGreuter M, 1997, ESA SP PUBL, V397, P73; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Del Poeta G, 2010, LEUKEMIA LYMPHOMA, V51, P95, DOI 10.3109/10428190903350421; Ferrarini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071613; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Habashy HO, 2010, BREAST CANCER RES TR, V119, P283, DOI 10.1007/s10549-009-0345-x; Houde C, 2004, BLOOD, V104, P3697, DOI 10.1182/blood-2003-12-4114; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; IWAKI K, 1990, J BIOL CHEM, V265, P13809; Jhala DV, 2014, CURR CANCER DRUG TAR, V14, P394, DOI 10.2174/1568009614666140407113633; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Lee SB, 2010, APOPTOSIS, V15, P204, DOI 10.1007/s10495-009-0411-1; Li MF, 2010, AAPS J, V12, P309, DOI 10.1208/s12248-010-9194-0; Liu LH, 2010, TOXICOL IN VITRO, V24, P1168, DOI 10.1016/j.tiv.2010.02.016; Liu XY, 2013, CLIN SCI, V124, P567, DOI 10.1042/CS20120240; Lu AG, 2012, WORLD J GASTROENTERO, V18, P4704, DOI 10.3748/wjg.v18.i34.4704; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Masiello MG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/652434; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Morabito C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/754283; Naor D, 2008, SEMIN CANCER BIOL, V18; NELSON RL, 1994, JNCI-J NATL CANCER I, V86, P455, DOI 10.1093/jnci/86.6.455; Patel JB, 2011, ONCOGENE, V30, P1290, DOI 10.1038/onc.2010.510; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Piazzi G, 2011, ONCOTARGET, V2, P1291; Pisanu ME, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/470253; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Schatten H, 2001, ACTA ASTRONAUT, V49, P399, DOI 10.1016/S0094-5765(01)00116-3; Schwarzenberg M, 1999, ADV SPACE RES, V24, P793, DOI 10.1016/S0273-1177(99)00075-7; Thangaraju M, 2009, BIOCHEM J, V417, P379, DOI 10.1042/BJ20081132; Toussaint O, 2002, BIOCHEM PHARMACOL, V64; Tremblay CS, 2008, BLOOD, V112, P2062, DOI 10.1182/blood-2008-04-152710; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Viallard J F, 2001, Cancer Radiother, V5, P109, DOI 10.1016/S1278-3218(01)00087-7; Wang AJ, 1997, J CANCER RES CLIN, V123, P124, DOI 10.1007/BF01269891; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100; Yang F, 2015, J BIOL CHEM; Yu YJ, 2013, TRANSL ONCOL, V6, P180, DOI 10.1593/tlo.12397; Zhang J, 2012, BRIT J CANCER, V107, P352, DOI 10.1038/bjc.2012.251	53	30	30	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135958	10.1371/journal.pone.0135958	http://dx.doi.org/10.1371/journal.pone.0135958			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295583	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900055
J	Brown, AC; Kokoczka, R; Parish, T				Brown, Amanda Claire; Kokoczka, Rachel; Parish, Tanya			LytB1 and LytB2 of Mycobacterium tuberculosis Are Not Genetically Redundant	PLOS ONE			English	Article							(E)-4-HYDROXY-3-METHYLBUT-2-ENYL DIPHOSPHATE REDUCTASE; DEOXYXYLULOSE PHOSPHATE-PATHWAY; ESCHERICHIA-COLI; ISOPRENOID BIOSYNTHESIS; ISPH PROTEIN; INHIBITION; MECHANISM; CATALYSIS; MUTANT; GENE	Mycobacterium tuberculosis synthesises isoprenoid precursors via the MEP/DOXP pathway and at least five enzymes in the pathway (Dxs1, Dxr/IspC, IspD, IspF, and GcpE/IspG) are required for growth in vitro. We investigated the role of LytB (IspH) in M. tuberculosis; M. tuberculosis is unusual in that it has two homologs-LytB1 and LytB2. We were unable to delete the lytB2 gene unless we provided an additional copy elsewhere, demonstrating that this is the essential homolog. We expressed lytB1 from the lytB2 promoter and confirmed that this could not complement for loss of function of lytB2, despite LytB1 possessing all the previously described conserved critical residues. Interestingly the sole LytB homolog of Mycobacterium smegmatis was able to compensate for loss of LytB2 in M. tuberculosis. We tested translational fusions of LytB1 and LytB2 for functionality in M. tuberculosis, but only a fusion with 90% N-terminal LytB2 and 10% C-terminal LytB1 was functional. In order to identify the key difference between the two proteins, site directed mutagenesis was used to change LytB2 residues into their counterparts in LytB1. None of these amino acid substitutions was essential for function and all lytB2 mutant alleles were functional. In contrast, mutation of the key residues for [Fe4S4] cluster formation, as well as a catalytic residue in LytB1 did not result in functional complementation. Thus, although LytB1 and LytB2 are not genetically redundant, this is not dependent on small amino acid changes, but is likely to be a result of major overall structural differences.	[Brown, Amanda Claire; Parish, Tanya] Queen Mary Univ London, London E1 2AD, England; [Brown, Amanda Claire; Parish, Tanya] Barts & London Queen Marys Sch Med & Dent, London E1 2AD, England; [Kokoczka, Rachel; Parish, Tanya] TB Discovery Res, Infect Dis Res Inst, Seattle, WA 98102 USA	University of London; Queen Mary University London; University of London; Queen Mary University London	Parish, T (corresponding author), Queen Mary Univ London, London E1 2AD, England.	tanya.parish@idri.org			EU [QLRT-2001-00887]; BBSRC [BB/D000181/1]; NIAID of the National Institutes of Health [R01AI0976550]; Biotechnology and Biological Sciences Research Council [BB/D000181/1] Funding Source: researchfish	EU(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIAID of the National Institutes of Health; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the EU Quality of Life and Management of Living Resources project QLRT-2001-00887, BBSRC Project number BB/D000181/1. Research reported in this publication was, in part, supported by NIAID of the National Institutes of Health under award number R01AI0976550. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey AM, 2002, GLYCOBIOLOGY, V12, P813, DOI 10.1093/glycob/cwf100; Brown AC, 2010, J BACTERIOL, V192, P2424, DOI 10.1128/JB.01402-09; Brown AC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-78; Brown Amanda Claire, 2008, V465, P337, DOI 10.1007/978-1-59745-207-6_23; Buetow L, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-68; Carroll Paul, 2008, V465, P265, DOI 10.1007/978-1-59745-207-6_18; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Davey MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002040; Dhiman RK, 2005, J BACTERIOL, V187, P8395, DOI 10.1128/JB.187.24.8395-8402.2005; Eberl M, 2002, IMMUNOLOGY, V106, P200, DOI 10.1046/j.1365-2567.2002.01414.x; Eisenreich W, 2001, TRENDS PLANT SCI, V6, P78, DOI 10.1016/S1360-1385(00)01812-4; Eoh H, 2007, J BACTERIOL, V189, P8922, DOI 10.1128/JB.00925-07; Grawert T, 2010, P NATL ACAD SCI USA, V107, P1077, DOI 10.1073/pnas.0913045107; Grawert T, 2009, ANGEW CHEM INT EDIT, V48, P5756, DOI 10.1002/anie.200900548; Grawert T, 2004, J AM CHEM SOC, V126, P12847, DOI 10.1021/ja0471727; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Henriksson LM, 2007, J BIOL CHEM, V282, P19905, DOI 10.1074/jbc.M701935200; Hsieh WY, 2014, PLANT PHYSIOL, V166, P57, DOI 10.1104/pp.114.243642; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Mann FM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00368; Matsoso LG, 2005, J BACTERIOL, V187, P6300, DOI 10.1128/JB.187.18.6300-6308.2005; Merkel JS., 2001, KEYST S MOL CELL ASP, P61; MIKUSOVA K, 1995, ANTIMICROB AGENTS CH, V39, P2484, DOI 10.1128/AAC.39.11.2484; Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Parish T, 2007, J BACTERIOL, V189, P3721, DOI 10.1128/JB.01740-06; Pashley CA, 2003, FEMS MICROBIOL LETT, V229, P211, DOI 10.1016/S0378-1097(03)00823-1; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Rekittke I, 2013, FEBS LETT, V587, P3968, DOI 10.1016/j.febslet.2013.10.029; Rekittke I, 2008, J AM CHEM SOC, V130, P17206, DOI 10.1021/ja806668q; Reyrat JM, 2001, TRENDS MICROBIOL, V9, P472, DOI 10.1016/S0966-842X(01)02168-0; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Seemann M, 2009, J AM CHEM SOC, V131, P13184, DOI 10.1021/ja9012408; Shin SJ, 2006, INFECT IMMUN, V74, P3825, DOI 10.1128/IAI.01742-05; Span I, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2052; Span I, 2012, J MOL BIOL, V416, P1, DOI 10.1016/j.jmb.2011.11.033; Timmins GS, 2006, MOL MICROBIOL, V62, P1220, DOI 10.1111/j.1365-2958.2006.05467.x; Wang K, 2010, J AM CHEM SOC, V132, P6719, DOI 10.1021/ja909664j; Wang WX, 2014, ANGEW CHEM INT EDIT, V53, P4294, DOI 10.1002/anie.201306712; Wang WX, 2010, P NATL ACAD SCI USA, V107, P11189, DOI 10.1073/pnas.1000264107; Wang WX, 2010, P NATL ACAD SCI USA, V107, P4522, DOI 10.1073/pnas.0911087107; WHO, TUBERCULOSIS; Wolff M, 2003, FEBS LETT, V541, P115, DOI 10.1016/S0014-5793(03)00317-X; Wu CW, 2007, INFECT IMMUN, V75, P2110, DOI 10.1128/IAI.01739-06; Xiao YL, 2009, J AM CHEM SOC, V131, P9931, DOI 10.1021/ja903778d; Xu WY, 2012, BIOCHEMISTRY-US, V51, P4835, DOI 10.1021/bi3001215	48	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135638	10.1371/journal.pone.0135638	http://dx.doi.org/10.1371/journal.pone.0135638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309039	Green Submitted, gold, Green Published			2022-12-27	WOS:000360069400068
J	Davarniya, B; Hu, H; Kahrizi, K; Musante, L; Fattahi, Z; Hosseini, M; Maqsoud, F; Farajollahi, R; Wienker, TF; Ropers, HH; Najmabadi, H				Davarniya, Behzad; Hu, Hao; Kahrizi, Kimia; Musante, Luciana; Fattahi, Zohreh; Hosseini, Masoumeh; Maqsoud, Fariba; Farajollahi, Reza; Wienker, Thomas F.; Ropers, H. Hilger; Najmabadi, Hossein			The Role of a Novel TRMT1 Gene Mutation and Rare GRM1 Gene Defect in Intellectual Disability in Two Azeri Families	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; MENTAL-RETARDATION; PHARMACOLOGY; PREVALENCE; MECHANISMS; EXPRESSION	Cognitive impairment or intellectual disability (ID) is a widespread neurodevelopmental disorder characterized by low IQ (below 70). ID is genetically heterogeneous and is estimated to affect 1-3% of the world's population. In affected children from consanguineous families, autosomal recessive inheritance is common, and identifying the underlying genetic cause is an important issue in clinical genetics. In the framework of a larger project, aimed at identifying candidate genes for autosomal recessive intellectual disorder (ARID), we recently carried out single nucleotide polymorphism-based genome-wide linkage analysis in several families from Ardabil province in Iran. The identification of homozygosity-by-descent loci in these families, in combination with whole exome sequencing, led us to identify possible causative homozygous changes in two families. In the first family, a missense variant was found in GRM1 gene, while in the second family, a frameshift alteration was identified in TRMT1, both of which were found to co-segregate with the disease. GRM1, a known causal gene for autosomal recessive spinocerebellar ataxia (SCAR13, MIM#614831), encodes the metabotropic glutamate receptor1 (mGluR1). This gene plays an important role in synaptic plasticity and cerebellar development. Conversely, the TRMT1 gene encodes a tRNA methyltransferase that dimethylates a single guanine residue at position 26 of most tRNAs using S-adenosyl methionine as the methyl group donor. We recently presented TRMT1 as a candidate gene for ARID in a consanguineous Iranian family (Najmabadi et al., 2011). We believe that this second Iranian family with a biallelic loss-of-function mutation in TRMT1 gene supports the idea that this gene likely has function in development of the disorder.	[Davarniya, Behzad; Kahrizi, Kimia; Fattahi, Zohreh; Hosseini, Masoumeh; Najmabadi, Hossein] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran, Iran; [Hu, Hao; Musante, Luciana; Wienker, Thomas F.; Ropers, H. Hilger] Max Plank Inst Mol Genet, Dept Human Mol Genet, Berlin, Germany; [Maqsoud, Fariba; Farajollahi, Reza] Welf Org Ardabil Prov, Ardebil, Iran	Max Planck Society	Najmabadi, H (corresponding author), Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran, Iran.	hnajm12@yahoo.com	Kahrizi, Kimia/D-7989-2017; Musante, Luciana/AAA-5726-2021; Najmabadi, Hossein/P-8182-2017; Fattahi, Zohreh/Z-5165-2019	Musante, Luciana/0000-0002-2742-1484; Najmabadi, Hossein/0000-0002-6084-7778; davarnia, behzad/0000-0002-3026-7326	Max-Planck Society; EU FP 7 Project GENCODYS; University of Social Welfare and Rehabilitation Sciences [92/801/T/1/7829];  [241995]	Max-Planck Society(Max Planck SocietyFoundation CELLEX); EU FP 7 Project GENCODYS; University of Social Welfare and Rehabilitation Sciences; 	This work was supported by a grant (number 241995 - 1/3/2010), the Max-Planck Society, the EU FP 7 Project GENCODYS and also by the University of Social Welfare and Rehabilitation Sciences (92/801/T/1/7829 - May 2013).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Basel-Vanagaite L, 2003, J MED GENET, V40, P729, DOI 10.1136/jmg.40.10.729; Bellone C, 2008, CELL MOL LIFE SCI, V65, P2913, DOI 10.1007/s00018-008-8263-3; Berg JS, 2011, GENET MED, V13, P499, DOI 10.1097/GIM.0b013e318220aaba; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Coutinho V, 2002, NEUROSCIENTIST, V8, P551, DOI 10.1177/1073858402238514; DESAI MA, 1995, MOL PHARMACOL, V48, P648; Freude K, 2004, AM J HUM GENET, V75, P305, DOI 10.1086/422507; Gil-Sanz C, 2008, CEREB CORTEX, V18, P1653, DOI 10.1093/cercor/bhm193; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Hoodfar E, 1996, J MED GENET, V33, P212, DOI 10.1136/jmg.33.3.212; Khan MA, 2012, AM J HUM GENET, V90, P856, DOI 10.1016/j.ajhg.2012.03.023; Kleefstra T, 2012, AM J HUM GENET, V91, P73, DOI 10.1016/j.ajhg.2012.05.003; Kullmann DM, 2008, J PHYSIOL-LONDON, V586, P1481, DOI 10.1113/jphysiol.2007.148064; Kuss AW, 2011, HUM GENET, V129, P141, DOI 10.1007/s00439-010-0907-3; Laumonnier F, 2007, AM J HUM GENET, V80, P205, DOI 10.1086/511441; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Liu JM, 2000, NUCLEIC ACIDS RES, V28, P3445, DOI 10.1093/nar/28.18.3445; Mannaioni G, 2001, J NEUROSCI, V21, P5925, DOI 10.1523/JNEUROSCI.21-16-05925.2001; MCLAREN J, 1987, AM J MENT RETARD, V92, P243; Musante L, 2014, TRENDS GENET, V30, P32, DOI 10.1016/j.tig.2013.09.008; Najmabadi H, 2007, HUM GENET, V121, P43, DOI 10.1007/s00439-006-0292-0; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Rauch A, 2006, AM J MED GENET A, V140A, P2063, DOI 10.1002/ajmg.a.31416; Roeleveld N, 1997, DEV MED CHILD NEUROL, V39, P125, DOI 10.1111/j.1469-8749.1997.tb07395.x; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Sachs AJ, 2007, MAMM GENOME, V18, P749, DOI 10.1007/s00335-007-9064-y; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Valenti O, 2002, J CELL PHYSIOL, V191, P125, DOI 10.1002/jcp.10081; Van Bokhoven H, 2001, ANNU REV GENET, V45, P81; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548	42	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0129631	10.1371/journal.pone.0129631	http://dx.doi.org/10.1371/journal.pone.0129631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308914	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400002
J	Rigaill, L; MacIntosh, AJJ; Higham, JP; Winters, S; Shimizu, K; Mouri, K; Furuichi, T; Garcia, C				Rigaill, Lucie; MacIntosh, Andrew J. J.; Higham, James P.; Winters, Sandra; Shimizu, Keiko; Mouri, Keiko; Furuichi, Takeshi; Garcia, Cecile			Multimodal Advertisement of Pregnancy in Free-Ranging Female Japanese Macaques (Macaca fuscata)	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; COPULATION CALLS; FERTILE PHASE; REPRODUCTIVE SUCCESS; SOCIOSEXUAL BEHAVIOR; INFORMATION-CONTENT; MATING-BEHAVIOR; OVARIAN CYCLES; CONCEPTION; SIGNAL	The role of multiple sexual signals in indicating the timing of female ovulation, and discrimination of this timing by males, has been particularly well studied among primates. However the exhibition of pregnancy signals, and how such signals might modulate male post-conception mating decisions, is still poorly understood. Here we aimed to determine if Japanese macaque males use changes in female sexual signals (behavioral, visual and auditory) to discriminate pregnancy and adjust their socio-sexual behaviors. We combined behavioral observations, digital photography and endocrinological (progestogen and estrogen) data, collected systematically during three one-month periods: the pre-conceptive period, the 1st month of pregnancy and the 2nd month of pregnancy. We analyzed variation in the probability of detecting male and female socio-sexual behaviors and estrus calls, as well as changes in female face color parameters, in relation to female reproductive state. Based on our focal observations, we found that males did not copulate during the pregnancy period, and that female socio-sexual behaviors generally decreased from the pre-conceptive to post-conceptive periods. Female face luminance decreased from the pre-conceptive month to the pregnancy period whereas face color only varied between the 1st and 2nd month of gestation. Our results suggest that Japanese macaque females display sexual cues of pregnancy that males might use to reduce energy wasted on non-reproductive copulations with pregnant females. We hypothesize that females advertize their pregnancy through changes in behavioral, visual and potential auditory signals that males can use to adjust their mating behaviors. We finish by discussing implications for male and female post-conception strategies.	[Rigaill, Lucie; MacIntosh, Andrew J. J.; Mouri, Keiko; Furuichi, Takeshi] Kyoto Univ, Primate Res Inst, Social Syst Evolut Sect, Dept Ecol & Social Behav, Inuyama, Aichi 484, Japan; [MacIntosh, Andrew J. J.] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan; [Higham, James P.; Winters, Sandra] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA; [Shimizu, Keiko] Okayama Univ Sci, Fac Sci, Dept Zool, Okayama, Okayama, Japan; [Garcia, Cecile] CNRS, Lab Dynam Evolut Humaine, UPR 2147, Paris, France	Kyoto University; Kyoto University; New York University; Okayama University of Science; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Rigaill, L (corresponding author), Kyoto Univ, Primate Res Inst, Social Syst Evolut Sect, Dept Ecol & Social Behav, Inuyama, Aichi 484, Japan.	lucie.rigaill.75w@st.kyoto-u.ac.jp	Rigaill, Lucie/AAG-6631-2019; Winters, Sandra/L-7513-2013; MacIntosh, Andrew/B-2242-2013	Rigaill, Lucie/0000-0001-7040-3188; Winters, Sandra/0000-0002-9561-5950; MacIntosh, Andrew/0000-0002-9136-7099	Centre National de la Recherche Scientifique [06274]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Centre National de la Recherche Scientifique, Projet Internationauw de Collaboration Scientifique no 06274 to CG (http://www.cnrs.fr/derci/spip.php?article198).	Bercovitch FB, 1998, ENCYCLOPEDIA OF REPR, V4; Bergman TJ, 2008, BIOL J LINN SOC, V94, P231, DOI 10.1111/j.1095-8312.2008.00981.x; BIELERT C, 1976, J REPROD FERTIL, V46, P179; Borries C, 2001, BEHAV ECOL SOCIOBIOL, V50, P391, DOI 10.1007/s002650100391; Bradley BJ, 2008, EVOL ANTHROPOL, V17, P97, DOI 10.1002/evan.20164; Brauch K, 2007, HORM BEHAV, V52, P375, DOI 10.1016/j.yhbeh.2007.06.001; Clarke PMR, 2009, AM J PRIMATOL, V71, P493, DOI 10.1002/ajp.20678; Crawford JC, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0831; De Vries H, 2006, ANIM BEHAV, V71, P585, DOI 10.1016/j.anbehav.2005.05.015; Dixson A.F., 1998, PRIMATE SEXUALITY CO; Dubuc C, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1602; Dubuc C, 2009, INT J PRIMATOL, V30, P777, DOI 10.1007/s10764-009-9369-7; Engelhardt A, 2004, ANIM BEHAV, V67, P915, DOI 10.1016/j.anbehav.2003.09.006; Engelhardt A, 2007, HORM BEHAV, V51, P3, DOI 10.1016/j.yhbeh.2006.06.009; Engelhardt A, 2012, BEHAV ECOL SOCIOBIOL, V66, P121, DOI 10.1007/s00265-011-1260-9; Fooden J, 2003, PRIMATES, V44, P109, DOI 10.1007/s10329-002-0011-y; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Furtbauer I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023105; Fujita S, 2004, AM J PRIMATOL, V64, P367, DOI 10.1002/ajp.20086; Fujita S, 2001, AM J PRIMATOL, V53, P167, DOI 10.1002/ajp.3; Fujita S, 2010, JAPANESE MACAQUES, P221, DOI 10.1007/978-4-431-53886-8_10; FURUICHI T, 1987, PRIMATES, V28, P309, DOI 10.1007/BF02381014; Furuichi T, 2014, PRIMATES AND CETACEA; Furuichi T, 2011, EVOL ANTHROPOL, V20, P131, DOI 10.1002/evan.20308; Garcia C, 2011, AM J PHYS ANTHROPOL, V146, P161, DOI 10.1002/ajpa.21553; Garcia C, 2009, AM J PRIMATOL, V71, P868, DOI 10.1002/ajp.20717; Gerald MS, 2009, BEHAV PROCESS, V80, P7, DOI 10.1016/j.beproc.2008.08.001; Go M, 2010, PRIMATES, V51, P149, DOI 10.1007/s10329-009-0179-5; GORDON TP, 1991, INT J PRIMATOL, V12, P585, DOI 10.1007/BF02547671; GUST DA, 1994, INT J PRIMATOL, V15, P289, DOI 10.1007/BF02735278; HADIDIAN J, 1979, Primates, V20, P429, DOI 10.1007/BF02373394; HANBY JP, 1971, FOLIA PRIMATOL, V16, P123, DOI 10.1159/000155394; Haselton MG, 2007, HORM BEHAV, V51, P40, DOI 10.1016/j.yhbeh.2006.07.007; Havlicek J, 2006, ETHOLOGY, V112, P81, DOI 10.1111/j.1439-0310.2006.01125.x; Higham JP, 2008, HORM BEHAV, V53, P452, DOI 10.1016/j.yhbeh.2007.11.019; Higham JP, 2014, INT J PRIMATOL, V35, P661, DOI 10.1007/s10764-014-9789-x; Higham JP, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-89; Higham JP, 2010, BEHAV ECOL, V21, P739, DOI 10.1093/beheco/arq047; Hill DA, 1997, AM J PRIMATOL, V43, P305; HUFFMAN MA, 1992, FOLIA PRIMATOL, V59, P77, DOI 10.1159/000156645; INOUE M, 1993, PRIMATES, V34, P503, DOI 10.1007/BF02382661; IWAMOTO T, 1982, Primates, V23, P153, DOI 10.1007/BF02381158; Keverne EB, 2004, PHYSIOL BEHAV, V83, P177, DOI 10.1016/j.physbeh.2004.08.013; KUSTER J, 1984, FOLIA PRIMATOL, V43, P69, DOI 10.1159/000156173; Cerda-Molina AL, 2006, INT J PRIMATOL, V27, P791, DOI 10.1007/s10764-006-9045-0; Lu A, 2012, AM J PRIMATOL, V74, P471, DOI 10.1002/ajp.22004; Maestripieri D, 2005, INT J PRIMATOL, V26, P737, DOI 10.1007/s10764-005-5306-6; Manson JH, 1997, INT J PRIMATOL, V18, P767, DOI 10.1023/A:1026395829818; Martin P., 2007, MEASURING BEHAVIOUR; Miller G, 2007, EVOL HUM BEHAV, V28, P375, DOI 10.1016/j.evolhumbehav.2007.06.002; NAKAGAWA N, 1989, PRIMATES, V30, P441, DOI 10.1007/BF02380873; Neumann C, 2011, ANIM BEHAV, V82, P911, DOI 10.1016/j.anbehav.2011.07.016; NIEUWENHUIJSEN K, 1986, HUM REPROD, V1, P159, DOI 10.1093/oxfordjournals.humrep.a136373; NIGI H, 1976, Primates, V17, P81, DOI 10.1007/BF02381568; NIGI H, 1990, PRIMATES, V31, P243, DOI 10.1007/BF02380945; Nunn CL, 1999, ANIM BEHAV, V58, P229, DOI 10.1006/anbe.1999.1159; O'Neill AC, 2004, AM J PHYS ANTHROPOL, V125, P352, DOI 10.1002/ajpa.20024; Ostner J, 2006, AM J PRIMATOL, V68, P701, DOI 10.1002/ajp.20260; Palagi E, 2003, INT J PRIMATOL, V24, P335, DOI 10.1023/A:1023001316988; Pfefferle D, 2008, P R SOC B, V275, P571, DOI 10.1098/rspb.2007.1499; Pfefferle D, 2011, INT J PRIMATOL, V32, P992, DOI 10.1007/s10764-011-9517-8; Pfluger LS, 2014, ANIM BEHAV, V94, P61, DOI 10.1016/j.anbehav.2014.05.022; Pinheiro J., 2014, NLME LINEAR AND NONL; Pipitone RN, 2008, EVOL HUM BEHAV, V29, P268, DOI 10.1016/j.evolhumbehav.2008.02.001; Pradhan GR, 2006, BEHAV ECOL SOCIOBIOL, V59, P333, DOI 10.1007/s00265-005-0075-y; Rhodes L, 1997, J REPROD FERTIL, V111, P51; Rigaill L, 2013, AM J PRIMATOL, V75, P774, DOI 10.1002/ajp.22154; Setchell JM, 2006, P ROY SOC B-BIOL SCI, V273, P2395, DOI 10.1098/rspb.2006.3573; Shimizu K, 2003, PRIMATES, V44, P183, DOI 10.1007/s10329-002-0021-9; Skaug H., 2014, GENERALIZED LINEAR M; Smith T, 2006, AM J PRIMATOL, V68, P585, DOI 10.1002/ajp.20254; Soltis J, 2000, BEHAV ECOL SOCIOBIOL, V48, P195, DOI 10.1007/s002650000224; SOMMER V, 1992, AM J PRIMATOL, V28, P1, DOI 10.1002/ajp.1350280102; Stevens M, 2009, INT J PRIMATOL, V30, P893, DOI 10.1007/s10764-009-9356-z; TAKAHATA Y, 1980, Primates, V21, P303, DOI 10.1007/BF02390462; Van Belle S, 2009, AM J PRIMATOL, V71, P153, DOI 10.1002/ajp.20635; WALLIS J, 1982, AM J PRIMATOL, V3, P77, DOI 10.1002/ajp.1350030107; WILCOX AJ, 1995, NEW ENGL J MED, V333, P1517, DOI 10.1056/NEJM199512073332301; Young C, 2013, HORM BEHAV, V63, P32, DOI 10.1016/j.yhbeh.2012.11.004; Zuur Alain F., 2009, P1	80	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135127	10.1371/journal.pone.0135127	http://dx.doi.org/10.1371/journal.pone.0135127			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308441	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400049
J	Shen, H; Wu, XH; Tang, ZH; Zhou, XY; Sun, N; Li, XQ				Shen, Hui; Wu, Xinhua; Tang, Zihua; Zhou, Xinying; Sun, Nan; Li, Xiaoqiang			Wood Usage and Fire Veneration in the Pamir, Xinjiang, 2500 yr BP	PLOS ONE			English	Article							FOSSIL CHARCOAL; SELECTION	Located on the Pamir Plateau in Xinjiang Province, China, the Ji'erzankale Necropolis dates back to 2500 yr BP. Many materials that have been unearthed in this cemetery, including shoo konghou (musical instrument), bronze mirrors and glass beads, suggest cultural transference between East and West. Furthermore, small-sized and rounded fire altars made from sweet-scented Sabina were found for the first time and regarded as implements for fire veneration. We identified 70 wooden objects from 25 tombs within the Necropolis, and found that each object had been made from one of seven tree species. Analysis revealed that the inhabitants of the region mainly used the most widely available types of wood, namely Betula and Populus. People also specifically chose inflammable Populus wood to make hearth boards and hand drills (both are used for making fire by drilling), rigid Betula wood to craft wooden plates. Salix was used for fashioning wooden sticks, while sweet-scented Sabina was the preferred choice for making fire altars. Lonicera was selected for arrow shaft manufacture and Fraxinus syriaca, which has a beautiful grain, was chosen for making musical instruments. Conscious selection of different types of wood indicates that people of the Pamir Plateau were aware of the properties of various types of timbers, and were able to exploit these properties to the full. In turn, this demonstrates their wisdom and their ability to survive in, and adapt to, their local environment.	[Shen, Hui; Zhou, Xinying; Li, Xiaoqiang] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing, Peoples R China; [Shen, Hui] Univ Chinese Acad Sci, Dept Earth Sci, Beijing, Peoples R China; [Wu, Xinhua] Chinese Acad Social Sci, Inst Archaeol, Beijing, Peoples R China; [Tang, Zihua] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China; [Sun, Nan] Changan Univ, Dept Earth Sci & Resources, Xian, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Social Sciences; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Chang'an University	Li, XQ (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing, Peoples R China.	lixiaoqiang@ivpp.ac.cn		Tang, Zihua/0000-0003-1772-7145	National Natural Science Foundation of China [41172161, 41371003]; National Basic Research Program of China [2015CB953803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (grant nos. 41172161, XL and 41371003, XZ [http://www.973.gov.cn/]) and the National Basic Research Program of China (grant no. 2015CB953803, XL [http://www.nsfc.gov.cn/]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barua D.K., 2003, J INDIAN BUDDH STUD, V51, P1017; BORTENSCHLAGER S, 2000, ICEMAN HIS NATURAL E; BOYCE M, 1975, J AM ORIENTAL SOC, V95, P454, DOI 10.2307/599356; Cao SQ, 2006, TECHNOLOGY, P26; Carcaillet C., 2007, ENCY QUATERNARY SCI, P1582; Cheng JQ., 1992, ATLAS WOOD CHINA; COPE MJ, 1980, NATURE, V283, P647, DOI 10.1038/283647a0; Deforce K, 2014, QUATERN INT, P1, DOI 10.1016/j.quaint.2014.05.056; Deforce K, 2012, J ARCHAEOL SCI, V39, P1338, DOI 10.1016/j.jas.2011.12.024; *ED BOARD FLOR CHI, 2004, FLORA CHINA; Fahn A., 1986, Wood anatomy and identification of trees and shrubs from Israel and adjacent regions., pplates; Figueiral I, 2005, QUATERNARY SCI REV, V24, P2466, DOI 10.1016/j.quascirev.2005.02.004; [郭柯 Guo Ke], 2002, [植物生态学报, Acta Phytoecologica Sinica], V26, P17; Han X, 2006, J SHANGHAI NORMAL U, V35, P57; He ZL, 2006, MUSICOLOGY CHINA, V1, P43; Herodotus, 1985, HISTORY; Hollman JR, 1971, THESIS U OKLAHOMA NO; LAWSON DI, 1952, BRIT J APPL PHYS, V3, P288, DOI 10.1088/0508-3443/3/9/305; Li JX., 2009, RELIG RES SILK ROAD; Li JX., 2007, W REGIONS STUDIES, V1, P81; Li XQ, 2012, J ARCHAEOL SCI, V39, P3141, DOI 10.1016/j.jas.2012.04.052; Li XQ, 2013, VEG HIST ARCHAEOBOT, V22, P61, DOI 10.1007/s00334-011-0344-9; Lin MC., 1996, W REGIONS STUDIES, V4, P54; Lin MC, 2006, 15 LECT ARCHAEOLOGY; Liu X.T., 2012, J XINJIANG NORMAL U, V33, P47; Malanggan KS, 2002, MEMORY SACRIFICE; Mary B., 2013, ORTHODOXY SASANIAN Z; Mary B., 1979, ZOROASTRIANS THEIR R; Moskal-del Hoyo M, 2012, J ARCHAEOL SCI, V39, P3386, DOI 10.1016/j.jas.2012.05.011; Pessenda LCR, 2004, QUATERN INT, V114, P35, DOI 10.1016/S1040-6182(03)00040-5; PRIOR J, 1985, J ARCHAEOL SCI, V12, P457, DOI 10.1016/0305-4403(85)90005-6; Scott AC, 2010, PALAEOGEOGR PALAEOCL, V291, P11, DOI 10.1016/j.palaeo.2009.12.012; Scott AC, 2010, PALAEOGEOGR PALAEOCL, V291, P1, DOI 10.1016/j.palaeo.2010.03.044; SHACKLETON CM, 1992, J ARCHAEOL SCI, V19, P631, DOI 10.1016/0305-4403(92)90033-Y; [杨淑萍 Shuping Yang], 2007, [植物学通报, Chinese Bulletin of Botany], V24, P597; Stausberg M, 2008, NUMEN-INT REV HIST R, V55, P561, DOI 10.1163/156852708X310536; Sun N, 2013, QUATERN INT, V308, P27, DOI 10.1016/j.quaint.2013.05.014; Szopa P. S., 1974, USE SCANNING ELECT M; Turfanica Academia, 2011, ACTA ARCHAEOLOGICA S, V1, P99; Upadhyaya K. D., 1964, ASIAN FOLKLORE STUD, V23, P15, DOI DOI 10.2307/1177747; Wang BH., 1981, CULTURAL RELICS, V1, P18; Wang SZ., 2011, SO HERITAGE, V1, P156; Wang ZL., 2007, GEN HIST CENTRAL ASI; Williams H, 2004, J MAT CULT, V9, P263, DOI 10.1177/1359183504046894; Wu X.H., 2014, XINJIANG 2013 W REGI, V4, P36; Wu Y., 2012, W REG STUD, V4, P36, DOI [10.16363/j.cnki.xyyj.2012.04.013, DOI 10.16363/J.CNKI.XYYJ.2012.04.013]; Wu YuZhang, 2004, Scientia Silvae Sinicae, V40, P131; Xinjiang integrated Expedition Team and Institute of Botany CASS, 1978, VEG ITS UT XINJ; Xu F, 2008, ANATOMICAL FIGURES W; Yang JX., 1988, SILK ROAD; Zhang XS, 2007, CHINAS VEGETATION IT; Zhou JB., 1991, N W ETHNONATIONAL ST, V1, P115; Zhou Q, 1994, WOOD ANATOMY ULTRAST; 侯亚梅, 2005, [第四纪研究, Quaternary Sciences], V25, P750	54	6	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134847	10.1371/journal.pone.0134847	http://dx.doi.org/10.1371/journal.pone.0134847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CP7LO	26308646	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400038
J	Simas, T; Chattopadhyay, S; Hagan, C; Kundu, P; Patel, A; Holt, R; Floris, D; Graham, J; Ooi, C; Tait, R; Spencer, M; Baron-Cohen, S; Sahakian, B; Bullmore, E; Goodyer, I; Suckling, J				Simas, Tiago; Chattopadhyay, Shayanti; Hagan, Cindy; Kundu, Prantik; Patel, Ameera; Holt, Rosemary; Floris, Dorothea; Graham, Julia; Ooi, Cinly; Tait, Roger; Spencer, Michael; Baron-Cohen, Simon; Sahakian, Barbara; Bullmore, Ed; Goodyer, Ian; Suckling, John			Semi-Metric Topology of the Human Connectome: Sensitivity and Specificity to Autism and Major Depressive Disorder	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY MRI; BRAIN NETWORKS; NEURON NUMBER; CHILDREN; CORTEX; ADOLESCENTS; SEROTONIN; FREQUENCY; LANGUAGE; NEGLECT	Introduction The human functional connectome is a graphical representation, consisting of nodes connected by edges, of the inter-relationships of blood oxygenation-level dependent (BOLD) time-series measured by MRI from regions encompassing the cerebral cortices and, often, the cerebellum. Semi-metric analysis of the weighted, undirected connectome distinguishes an edge as either direct (metric), such that there is no alternative path that is accumulatively stronger, or indirect (semi-metric), where one or more alternative paths exist that have greater strength than the direct edge. The sensitivity and specificity of this method of analysis is illustrated by two case-control analyses with independent, matched groups of adolescents with autism spectrum conditions (ASC) and major depressive disorder (MDD). Results Significance differences in the global percentage of semi-metric edges was observed in both groups, with increases in ASC and decreases in MDD relative to controls. Furthermore, MDD was associated with regional differences in left frontal and temporal lobes, the right limbic system and cerebellum. In contrast, ASC had a broadly increased percentage of semi-metric edges with a more generalised distribution of effects and some areas of reduction. In summary, MDD was characterised by localised, large reductions in the percentage of semi-metric edges, whilst ASC is characterised by more generalised, subtle increases. These differences were corroborated in greater detail by inspection of the semi-metric backbone for each group; that is, the sub-graph of semi-metric edges present in > 90% of participants, and by nodal degree differences in the semi-metric connectome. Conclusion These encouraging results, in what we believe is the first application of semi-metric analysis to neuroimaging data, raise confidence in the methodology as potentially capable of detection and characterisation of a range of neurodevelopmental and psychiatric disorders.	[Simas, Tiago; Chattopadhyay, Shayanti; Hagan, Cindy; Kundu, Prantik; Patel, Ameera; Holt, Rosemary; Floris, Dorothea; Graham, Julia; Ooi, Cinly; Spencer, Michael; Baron-Cohen, Simon; Sahakian, Barbara; Bullmore, Ed; Goodyer, Ian; Suckling, John] Univ Cambridge, Dept Psychiat, Cambridge, England; [Bullmore, Ed; Goodyer, Ian; Suckling, John] Cambridge & Peterborough Fdn NHS Trust, Cambridge, England; [Tait, Roger; Baron-Cohen, Simon; Sahakian, Barbara; Bullmore, Ed; Goodyer, Ian; Suckling, John] Univ Cambridge, MRC, Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England; [Kundu, Prantik] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA; [Hagan, Cindy] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Graham, Julia] Univ Oxford, Dept Psychiat, Div Med Sci, Oxford, England	University of Cambridge; University of Cambridge; Icahn School of Medicine at Mount Sinai; Columbia University; University of Oxford	Suckling, J (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge, England.	js369@cam.ac.uk	Bullmore, Ed/C-1706-2012; Suckling, John/ABD-7246-2021; Sahakian, Barbara/AAW-1198-2020	Bullmore, Ed/0000-0002-8955-8283; Suckling, John/0000-0002-5098-1527; Sahakian, Barbara/0000-0001-7352-1745; Floris, Dorothea/0000-0001-5838-6821; Baron-Cohen, Simon/0000-0001-9217-2544; Patel, Ameera/0000-0002-4157-2705; Simas, Tiago/0000-0002-3133-1537; Hagan, Cindy/0000-0002-4576-7120; Spencer, Michael/0000-0002-1646-5254; Kundu, Prantik/0000-0001-9367-3068	UK Medical Research Council [G0802226, G0701919]; National Institute for Health Research (NIHR) [06/05/01]; Behavioural and Clinical Neuroscience Institute (BCNI), University of Cambridge; Medical Research Council; Wellcome Trust; NIHR Cambridge Biomedical Research Centre; Parke Davis Fellowship from the University of Cambridge; Medical Research Council [G0001354, G1000183B, G0001354B, G0701919, G0802226, G1000183] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10051, 97/29/01, 06/05/01] Funding Source: researchfish; MRC [G0802226, G1000183, G0701919] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Behavioural and Clinical Neuroscience Institute (BCNI), University of Cambridge; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Parke Davis Fellowship from the University of Cambridge; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the UK Medical Research Council (grants: G0802226 and G0701919), the National Institute for Health Research (NIHR) (grant: 06/05/01) and the Behavioural and Clinical Neuroscience Institute (BCNI), University of Cambridge. The BCNI is jointly funded by the Medical Research Council and the Wellcome Trust. Additional support was received from the NIHR Cambridge Biomedical Research Centre. CCH is supported by a Parke Davis Fellowship from the University of Cambridge and resides at Columbia University.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; Alexander-Bloch A, 2012, NEUROIMAGE, V59, P3889, DOI 10.1016/j.neuroimage.2011.11.035; [Anonymous], 1964, SPECTRAL ANAL EC TIM; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Casanova MF, 2009, PHILOS T R SOC B, V364, P1433, DOI 10.1098/rstb.2008.0331; Chandana SR, 2005, INT J DEV NEUROSCI, V23, P171, DOI 10.1016/j.ijdevneu.2004.08.002; Chang C, 2009, NEUROIMAGE, V44, P857, DOI 10.1016/j.neuroimage.2008.09.029; Connolly CG, 2013, BIOL PSYCHIAT, V74, P898, DOI 10.1016/j.biopsych.2013.05.036; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Currie J, 2010, CHILD MALTREATMENT, V15, P111, DOI 10.1177/1077559509355316; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dougherty ER, 2007, CURR GENOMICS, V8, P351, DOI 10.2174/138920207783406505; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eyler LT, 2012, BRAIN, V135, P949, DOI 10.1093/brain/awr364; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; GALVIN F, 1991, AM MATH MON, V98, P620, DOI 10.2307/2324928; Granger C, 1994, J TIME SER ANAL, V15, P371, DOI DOI 10.1111/J.1467-9892.1994.TB00200.X; Hagan CC, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-247; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hyder F, 2010, PNAS, V107; Itahashi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094115; Johnson SM, 1954, NAV RES LOG, V1, P8; Kalcher K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093375; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Li BJ, 2013, BIOL PSYCHIAT, V74, P48, DOI 10.1016/j.biopsych.2012.11.007; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Mana S, 2010, EUR PSYCHIAT, V25, P345, DOI 10.1016/j.eurpsy.2010.04.010; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Meng C, 2014, BRAIN, V137, P598, DOI 10.1093/brain/awt290; Muller RA, 2011, CEREB CORTEX, V21, P2233, DOI 10.1093/cercor/bhq296; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Patel AX, 2014, NEUROIMAGE, V95, P287, DOI 10.1016/j.neuroimage.2014.03.012; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rocha L, 2002, 026557 LAUR LOS AL N; Rocha LM, 2005, 2005 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE, PROCEEDINGS, P565, DOI 10.1109/WI.2005.106; Rocha LM, 2002, INT SERIES FRONTIERS, P137; Roiser JP, 2012, NEUROPSYCHOPHARMACOL, V37, P117, DOI 10.1038/npp.2011.183; Rojas DC, 2005, J AUTISM DEV DISORD, V35, P479, DOI 10.1007/s10803-005-5038-7; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Schumann CM, 2006, J NEUROSCI, V26, P7674, DOI 10.1523/JNEUROSCI.1285-06.2006; Simas T, 2013, NETWORK SCI, V3, P227; Simas T., 2012, STOCHASTIC MODELS TR; Simas T, 2015, NETW SCI, V3, P227, DOI 10.1017/nws.2015.11; Simas T, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00904; Simas T, 2012, 2012 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE AND INTELLIGENT AGENT TECHNOLOGY WORKSHOPS (WI-IAT WORKSHOPS 2012), VOL 3, P175, DOI 10.1109/WI-IAT.2012.245; Skidmore F, 2011, NEUROSCI LETT, V499, P47, DOI 10.1016/j.neulet.2011.05.030; Spencer MD, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.18; Strata P, 2011, PHYSIOL RES, V60, pS39, DOI 10.33549/physiolres.932169; Supekar K, 2013, CELL REP, V5, P738, DOI 10.1016/j.celrep.2013.10.001; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Whitaker-Azmitia PM, 2001, BRAIN RES BULL, V56, P479, DOI 10.1016/S0361-9230(01)00615-3; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	65	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136388	10.1371/journal.pone.0136388	http://dx.doi.org/10.1371/journal.pone.0136388			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LO	26308854	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400118
J	van der Borg, JAM; Schilder, MBH; Vinke, CM; de Vries, H				van der Borg, Joanne A. M.; Schilder, Matthijs B. H.; Vinke, Claudia M.; de Vries, Han			Dominance in Domestic Dogs: A Quantitative Analysis of Its Behavioural Measures	PLOS ONE			English	Article							CANIS-FAMILIARIS; SOCIAL-DOMINANCE; HIERARCHIES; AGGRESSION; STEEPNESS; WOLF; CONSISTENCY; LINEARITY; SOCIETIES; CAPTIVITY	A dominance hierarchy is an important feature of the social organisation of group living animals. Although formal and/or agonistic dominance has been found in captive wolves and free-ranging dogs, applicability of the dominance concept in domestic dogs is highly debated, and quantitative data are scarce. Therefore, we investigated 7 body postures and 24 behaviours in a group of domestic dogs for their suitability as formal status indicators. The results showed that high posture, displayed in most dyadic relationships, and muzzle bite, displayed exclusively by the highest ranking dogs, qualified best as formal dominance indicators. The best formal submission indicator was body tail wag, covering most relationships, and two low postures, covering two-thirds of the relationships. In addition, both mouth lick, as included in Schenkel's active submission, and pass under head qualified as formal submission indicators but were shown almost exclusively towards the highest ranking dogs. Furthermore, a status assessment based on changes in posture displays, i.e., lowering of posture (LoP) into half-low, low, low-on-back or on-back, was the best status indicator for most relationships as it showed good coverage (91% of the dyads), a nearly linear hierarchy (h' = 0.94, p<0.003) and strong unidirectionality (DCI = 0.97). The associated steepness of 0.79 (p<0.0001) indicated a tolerant dominance style for this dog group. No significant correlations of rank with age or weight were found. Strong co-variation between LoP, high posture, and body tail wag justified the use of dominance as an intervening variable. Our results are in line with previous findings for captive wolves and free-ranging dogs, for formal dominance with strong linearity based on submission but not aggression. They indicate that the ethogram for dogs is best redefined by distinguishing body postures from behavioural activities. A good insight into dominance hierarchies and its indicators will be helpful in properly interpreting dog-dog relationships and diagnosing problem behaviour in dogs.	[van der Borg, Joanne A. M.] Wageningen Univ, Behav Ecol Grp, Dept Anim Sci, NL-6700 AH Wageningen, Netherlands; [Schilder, Matthijs B. H.; Vinke, Claudia M.] Univ Utrecht, Fac Vet Med, Dept Anim Sci & Soc, NL-3508 TD Utrecht, Netherlands; [de Vries, Han] Univ Utrecht, Anim Ecol Grp, Dept Biol, NL-3584 CH Utrecht, Netherlands	Wageningen University & Research; Utrecht University; Utrecht University	van der Borg, JAM (corresponding author), Wageningen Univ, Behav Ecol Grp, Dept Anim Sci, POB 338, NL-6700 AH Wageningen, Netherlands.	joanne.vanderborg@wur.nl	Vinke, Claudia Maureen/AAK-2744-2020; de Vries, Han/B-9359-2011	Vinke, Claudia Maureen/0000-0002-3271-6535; van der Borg, Joanne A.M./0000-0003-1052-2817				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2014, THE SOCIAL DOG; Balasubramaniam KN, 2013, AM J PRIMATOL, V75, P959, DOI 10.1002/ajp.22160; Balasubramaniam KN, 2012, AM J PRIMATOL, V74, P915, DOI 10.1002/ajp.22044; Bauer EB, 2007, ANIM BEHAV, V73, P489, DOI 10.1016/j.anbehav.2006.09.006; BERNSTEIN IS, 1981, BEHAV BRAIN SCI, V4, P419, DOI 10.1017/S0140525X00009614; Bradshaw JWS, 2009, J VET BEHAV, V4, P135, DOI 10.1016/j.jveb.2008.08.004; Cafazzo S, 2010, BEHAV ECOL, V21, P443, DOI 10.1093/beheco/arq001; Chase ID, 2011, ADV GENET, V75, P52; CREEL S, 1995, ADV STUD BEHAV, V24, P203, DOI 10.1016/S0065-3454(08)60395-2; DAVID HA, 1987, BIOMETRIKA, V74, P432, DOI 10.2307/2336160; De Palma C, 2005, BEHAVIOUR, V142, P1307, DOI 10.1163/156853905774539337; De Vries H, 2006, ANIM BEHAV, V71, P585, DOI 10.1016/j.anbehav.2005.05.015; De Vries H, 1998, ANIM BEHAV, V55, P827, DOI 10.1006/anbe.1997.0708; De Waal FBM., 1989, COMP SOCIOECOLOGY, P243; Derix R., 1994, THESIS U UTRECHT; DEVRIES H, 1995, ANIM BEHAV, V50, P1375, DOI 10.1016/0003-3472(95)80053-0; DEWAAL FBM, 1985, AM J PRIMATOL, V9, P73, DOI 10.1002/ajp.1350090202; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; Duffy DL, 2008, APPL ANIM BEHAV SCI, V114, P441, DOI 10.1016/j.applanim.2008.04.006; Fatjo J, 2007, APPL ANIM BEHAV SCI, V105, P274, DOI 10.1016/j.applanim.2006.11.009; Feddersen-Petersen D., 2004, HUNDEPSYCHOLOGIE SOZ; Feddersen-Petersen DU, 2007, BEHAVIOURAL BIOLOGY OF DOGS, P105, DOI 10.1079/9781845931872.0105; Flack J.C., 2004, MACAQUE SOC, P157; FOX MW, 1969, BEHAVIOUR, V35, P242, DOI 10.1163/156853969X00224; Fox MW., 1970, BEHAVIOUR, V36, P4; Gammell MP, 2003, ANIM BEHAV, V66, P601, DOI 10.1006/anbe.2003.2226; Goodwin D, 1997, ANIM BEHAV, V53, P297, DOI 10.1006/anbe.1996.0370; Harrington Fred H., 2003, P66; Hemelrijk CK, 2002, BIOL BULL-US, V202, P283, DOI 10.2307/1543480; Hinde RA, 1978, J SOC BIOL STRUCT, V1, P27, DOI [10.1016/0140-1750(78)90016-7, DOI 10.1016/0140-1750(78)90016-7]; JARAM Van Hooff, 1987, MAN WOLF, P219; Klass K, 2011, BEHAV PROCESS, V88, P168, DOI 10.1016/j.beproc.2011.09.003; Langbein J, 2004, APPL ANIM BEHAV SCI, V87, P293, DOI 10.1016/j.applanim.2004.01.007; Leiva D, 2012, STEEPNESS R PACKAGE; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; MacFarland D., 1985, ANIMAL BEHAV PSYCHOB; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; Mech L. David, 2003, P1; Mech LD, 2010, CAN FIELD NAT, V124, P215, DOI 10.22621/cfn.v124i3.1076; Mech LD, 1999, CAN J ZOOL, V77, P1196, DOI 10.1139/cjz-77-8-1196; Mehrkam LR, 2014, APPL ANIM BEHAV SCI, V155, P12, DOI 10.1016/j.applanim.2014.03.005; Packard Jane M., 2003, P35; Pal SK, 1998, APPL ANIM BEHAV SCI, V59, P331, DOI 10.1016/S0168-1591(98)00108-7; ROWELL TE, 1974, BEHAV BIOL, V11, P131, DOI 10.1016/S0091-6773(74)90289-2; Sapolsky RM, 2004, ANNU REV ANTHROPOL, V33, P393, DOI 10.1146/annurev.anthro.33.070203.144000; Schenkel R., 1947, Behaviour Leiden, V1, P81; SCHENKEL R, 1967, AM ZOOL, V7, P319; Schilder MBH, 2014, J VET BEHAV, V9, P184, DOI 10.1016/j.jveb.2014.04.005; SCHILDER MBH, 1988, BEHAVIOUR, V104, P300, DOI 10.1163/156853988X00566; Schjelderup-Ebbe T., 1922, Zeitschrift fuer Psychologie Leipzig, V88, P225; Scott JP., 1965, GENETICS SOCIAL BEHA; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Spotte S, 2012, SOCIETIES OF WOLVES AND FREE-RANGING DOGS, P1, DOI 10.1017/CBO9781139057769; Svartberg K, 2005, ANIM BEHAV, V69, P283, DOI 10.1016/j.anbehav.2004.04.011; SYME GJ, 1974, ANIM BEHAV, V22, P931, DOI 10.1016/0003-3472(74)90016-5; Thierry B, 2007, EVOL ANTHROPOL, V16, P224, DOI 10.1002/evan.20147; Trisko R.K., 2011, THESIS U MICHIGAN; VanDierendonck MC, 1995, NETH J ZOOL, V45, P362; Vervaecke H, 2000, INT J PRIMATOL, V21, P47, DOI 10.1023/A:1005471512788; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; ZIMEN E, 1976, Z TIERPSYCHOL, V40, P300; Zimen E., 1975, P336; Zimen E, 1971, THESIS CHRISTIAN ALB	64	29	29	1	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0133978	10.1371/journal.pone.0133978	http://dx.doi.org/10.1371/journal.pone.0133978			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309101	gold, Green Submitted, Green Published			2022-12-27	WOS:000360069400017
J	Cereijo, R; Gallego-Escuredo, JM; Moure, R; Villarroya, J; Domingo, JC; Fontdevila, J; Martinez, E; Gutierrez, MD; Mateo, MG; Giralt, M; Domingo, P; Villarroya, F				Cereijo, Ruben; Miguel Gallego-Escuredo, Jose; Moure, Ricardo; Villarroya, Joan; Carles Domingo, Joan; Fontdevila, Joan; Martinez, Esteban; del Mar Gutierrez, Maria; Gracia Mateo, Maria; Giralt, Marta; Domingo, Pere; Villarroya, Francesc			The Molecular Signature of HIV-1-Associated Lipomatosis Reveals Differential Involvement of Brown and Beige/Brite Adipocyte Cell Lineages	PLOS ONE			English	Article							ADIPOSE-TISSUE; GENE-EXPRESSION; BUFFALO HUMP; HIV-1 INFECTION; LIPODYSTROPHY; FAT; DISTINCT; WHITE; LMNA; PREVALENCE	Highly active antiretroviral therapy has remarkably improved quality of life of HIV-1-infected patients. However, this treatment has been associated with the so-called lipodystrophic syndrome, which conveys a number of adverse metabolic effects and morphological alterations. Among them, lipoatrophy of subcutaneous fat in certain anatomical areas and hypertrophy of visceral depots are the most common. Less frequently, lipomatous enlargements of subcutaneous fat at distinct anatomic areas occur. Lipomatous adipose tissue in the dorso-cervical area ("buffalo hump") has been associated with a partial white-to-brown phenotype transition and with increased cell proliferation, but, to date, lipomatous enlargements arising in other parts of the body have not been characterized. In order to establish the main molecular events associated with the appearance of lipomatosis in HIV-1 patients, we analyzed biopsies of lipomatous tissue from "buffalo hump" and from other anatomical areas in patients, in comparison with healthy subcutaneous adipose tissue, using a marker gene expression approach. Both buffalo-hump and non-buffalo-hump lipomatous adipose tissues exhibited similar patterns of non-compromised adipogenesis, unaltered inflammation, non-fibrotic phenotype and proliferative activity. Shorter telomere length, prelamin A accumulation and SA-beta-Gal induction, reminiscent of adipocyte senescence, were also common to both types of lipomatous tissues. Buffalo hump biopsies showed expression of marker genes of brown adipose tissue (e.g. UCP1) and, specifically, of "classical" brown adipocytes (e.g. ZIC1) but not of beige/brite adipocytes. No such brown fat-related gene expression occurred in lipomatous tissues at other anatomical sites. In conclusion, buffalo hump and other subcutaneous adipose tissue enlargements from HIV-1-infected patients share a similar lipomatous character. However, a distorted induction of white-to-" classical brown adipocyte" phenotype appears unique of dorso-cervical lipomatosis. Thus, the insults caused by HIV-1 viral infection and/or antiretroviral therapy leading to lipomatosis are acting in a location- and adipocyte lineage-dependent manner.	[Cereijo, Ruben; Miguel Gallego-Escuredo, Jose; Moure, Ricardo; Villarroya, Joan; Carles Domingo, Joan; Giralt, Marta; Villarroya, Francesc] Univ Barcelona, Inst Biomed, Dept Biochem & Mol Biol, Barcelona, Catalonia, Spain; [Cereijo, Ruben; Miguel Gallego-Escuredo, Jose; Moure, Ricardo; Villarroya, Joan; Carles Domingo, Joan; Giralt, Marta; Villarroya, Francesc] CIBER Fisiopatol Obesidad & Nutr, Barcelona, Catalonia, Spain; [Villarroya, Joan; del Mar Gutierrez, Maria; Gracia Mateo, Maria; Domingo, Pere] Hosp Santa Creu & Sant Pau, Infect Dis Unit, Barcelona, Spain; [Villarroya, Joan; del Mar Gutierrez, Maria; Gracia Mateo, Maria; Domingo, Pere] Inst Salud Carlos III, Red Invest SIDA, Madrid, Spain; [Fontdevila, Joan] Hosp Clin Barcelona, Dept Plast Surg, Barcelona, Catalonia, Spain; [Martinez, Esteban] Univ Barcelona, Fac Med, Hosp Clin Barcelona, Infect Dis Unit, Barcelona 7, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Hospital of Santa Creu i Sant Pau; Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Villarroya, F (corresponding author), Univ Barcelona, Inst Biomed, Dept Biochem & Mol Biol, Barcelona, Catalonia, Spain.	fvillarroya@ub.edu	Villarroya, Francesc/K-4357-2014; Domingo, Pere/CAF-3577-2022; Villarroya, Joan/W-4066-2018; Cereijo, Rubén/K-3556-2017; Giralt, Marta/A-4756-2013; Domingo, Pere/AAP-7571-2021; Pedrol, Joan Carles C Domingo/A-4856-2019	Villarroya, Joan/0000-0002-7859-1109; Cereijo, Rubén/0000-0002-1108-230X; Giralt, Marta/0000-0001-7968-4190; Domingo, Pere/0000-0003-1138-5770; Pedrol, Joan Carles C Domingo/0000-0002-6356-0836; Moure, Ricardo/0000-0003-2508-2535; Villarroya, Francesc/0000-0003-1266-9142; Fontdevila, Joan/0000-0003-4213-8190; GALLEGO-ESCUREDO, JOSE MIGUEL/0000-0001-7899-8585	Instituto de Salud Carlos III [PI11/02512, PI11/00376, PI14/00700, PI14/00063]; Ministerio de Economia y Competitividad of the Spanish Government [SAF2011/23636]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Economia y Competitividad of the Spanish Government(Spanish Government)	This study was funded by projects PI11/02512, PI11/00376, PI14/00700 and PI14/00063 from the Instituto de Salud Carlos III (http://www.isciii.es/) and by project SAF2011/23636 from the Ministerio de Economia y Competitividad (http://www.mineco.gob.es/portal/site/mineco) of the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo-Vilar D, 2012, CLIN ENDOCRINOL, V76, P816, DOI 10.1111/j.1365-2265.2011.04208.x; Aubert G, 2014, PROG MOL BIOL TRANSL, V125, P89, DOI 10.1016/B978-0-12-397898-1.00004-9; Bengtsson T, 1996, J BIOL CHEM, V271, P33366, DOI 10.1074/jbc.271.52.33366; Bereziat V, 2011, AM J PATHOL, V179, P2443, DOI 10.1016/j.ajpath.2011.07.049; Caron-Debarle M, 2010, TRENDS MOL MED, V16, P218, DOI 10.1016/j.molmed.2010.03.002; Ceccarelli Giancarlo, 2011, J Med Case Rep, V5, P70, DOI 10.1186/1752-1947-5-70; CHADENEAU C, 1995, CANCER RES, V55, P2533; Coffinier C, 2007, P NATL ACAD SCI USA, V104, P13432, DOI 10.1073/pnas.0704212104; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; de Jong JMA, 2015, AM J PHYSIOL-ENDOC M, V308, pE1085, DOI 10.1152/ajpendo.00023.2015; de la Concepcion MLR, 2004, AIDS, V18, P959, DOI 10.1097/01.aids.0000125917.72550.14; Feng B, 2013, ANN NY ACAD SCI, V1281, P160, DOI 10.1111/nyas.12009; Gallego-Escuredo JM, 2013, ANTIVIR THER, V18, P635, DOI 10.3851/IMP2528; Giralt M, 2006, ANTIVIR THER, V11, P729; Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403; Guallar JP, 2008, AIDS, V22, P575, DOI 10.1097/QAD.0b013e3282f56b40; Guaraldi G, 2007, JAIDS-J ACQ IMM DEF, V45, P72, DOI 10.1097/QAI.0b013e31804a85b0; Hammond E, 2010, CLIN INFECT DIS, V51, P591, DOI 10.1086/655765; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Kersten S, 2014, BBA-MOL CELL BIOL L, V1841, P919, DOI 10.1016/j.bbalip.2014.03.013; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Lo JC, 1998, LANCET, V351, P867, DOI 10.1016/S0140-6736(97)11443-X; Mallewa JE, 2008, J ANTIMICROB CHEMOTH, V62, P648, DOI 10.1093/jac/dkn251; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moreno-Navarrete JM, 2010, INT J OBESITY, V34, P1345, DOI 10.1038/ijo.2010.49; O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3; Palella FJ, 2006, JAMA-J AM MED ASSOC, V296, P766, DOI 10.1001/jama.296.7.766; Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Reddy S, 2012, EXP CELL RES, V318, P1, DOI 10.1016/j.yexcr.2011.08.009; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Scheele C, 2014, ADIPOCYTE, V3, P54, DOI 10.4161/adip.26520; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shikuma CM, 2014, JAIDS-J ACQ IMM DEF, V65, P151, DOI 10.1097/01.qai.0000435599.27727.6c; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Tierney EP, 2010, ARCH DERMATOL, V146, P1279, DOI 10.1001/archdermatol.2010.341; Torriani M, 2012, J CLIN ENDOCR METAB, V97, pE602, DOI 10.1210/jc.2011-2951; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; Vigouroux C, 1999, DIABETES METAB, V25, P383; Villarroya F, 2007, INT J OBESITY, V31, P1763, DOI 10.1038/sj.ijo.0803698; Villarroya F, 2010, BBA-MOL CELL BIOL L, V1801, P392, DOI 10.1016/j.bbalip.2009.09.018; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	48	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136571	10.1371/journal.pone.0136571	http://dx.doi.org/10.1371/journal.pone.0136571			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305325	Green Submitted, Green Published, gold			2022-12-27	WOS:000359995500093
J	Furer, A; Afek, A; Beer, Z; Derazne, E; Tzur, D; Pinhas-Hamiel, O; Reichman, B; Twig, G				Furer, Ariel; Afek, Arnon; Beer, Zivan; Derazne, Estela; Tzur, Dorit; Pinhas-Hamiel, Orit; Reichman, Brian; Twig, Gilad			Height at Late Adolescence and Incident Diabetes among Young Men	PLOS ONE			English	Article							HEART-DISEASE RISK; BODY-MASS INDEX; HIP CIRCUMFERENCE; INSULIN-RESISTANCE; FOLLOW-UP; FASTING GLUCOSE; NATIONAL-HEALTH; ADULT HEIGHT; TYPE-2; ASSOCIATIONS	Background Short stature was suggested as a risk factor for diabetes onset among middle age individuals, but whether this is the case among young adults is unclear. Our goal was to assess the association between height and incident diabetes among young men. Methods and Findings Incident diabetes was assessed among 32,055 men with no history of diabetes, from the prospectively followed young adults of the MELANY cohort. Height was measured at two time points; at adolescence (mean age 17.4 +/- 0.3 years) and grouped according to the USCDC percentiles and at young adulthood (mean age 31.0 +/- 5.6 years). Cox proportional hazards models were applied. There were 702 new cases of diabetes during a mean follow-up of 6.3 +/- 4.3 years. There was a significant increase in the crude diabetes incidence rate with decreasing adolescent height percentile, from 4.23 cases/10(4) person-years in the <10th percentile group to 2.44 cases/104 person-years in the 75th <= percentile group. These results persisted when clinical and biochemical diabetes risk factors were included in multivariable models. Compared to the 75th <= percentile group, height below the 10th percentile was associated with a hazard ratio (HR) of 1.64 (95% CI 1.09-2.46, p = 0.017) for incident diabetes after adjustment for age, body mass index (BMI), fasting plasma glucose, HDL-cholesterol and triglyceride levels, white blood cells count, socioeconomic status, country of origin, family history of diabetes, sleep quality and physical activity. At age 30 years, each 1-cm decrement in adult height was associated with a 2.5% increase in diabetes adjusted risk (HR 1.025, 95% CI 1.01-1.04, p = 0.001). Conclusions Shorter height at late adolescence or young adulthood was associated with an increased risk of incident diabetes among young men, independent of BMI and other diabetes risk factors.	[Furer, Ariel; Beer, Zivan] Tel Aviv Med Ctr & Sch Med, Dept Med 1, Tel Aviv, Israel; [Furer, Ariel; Beer, Zivan; Derazne, Estela; Tzur, Dorit; Twig, Gilad] Chaim Sheba Med Ctr, Israel Def Forces Med Corps, IL-52621 Tel Hashomer, Israel; [Afek, Arnon] Israel Minist Hlth, Jerusalem, Israel; [Afek, Arnon; Derazne, Estela; Pinhas-Hamiel, Orit; Reichman, Brian; Twig, Gilad] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Pinhas-Hamiel, Orit] Chaim Sheba Med Ctr, Edmond & Lily Safra Childrens Hosp, Pediat Endocrinol & Metab Unit, IL-52621 Tel Hashomer, Israel; [Reichman, Brian] Gertner Inst, Women & Childrens Hlth Res Unit, Tel Hashomer, Israel; [Twig, Gilad] Chaim Sheba Med Ctr, Dept Med B, IL-52621 Tel Hashomer, Israel; [Twig, Gilad] Chaim Sheba Med Ctr, Dr Pinchas Bornstein Talpiot Med Leadership Progr, IL-52621 Tel Hashomer, Israel	Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Twig, G (corresponding author), Chaim Sheba Med Ctr, Israel Def Forces Med Corps, IL-52621 Tel Hashomer, Israel.	Gilad.Twig@gmail.com	Twig, Gilad/C-4373-2018; Pinhas-Hamiel, Orit/K-5198-2013; /AAB-7734-2022	Twig, Gilad/0000-0003-2829-3645; 	IDF Medical Corp; Israeli ministry of defense	IDF Medical Corp; Israeli ministry of defense	This study was supported by the IDF Medical Corp and the Israeli ministry of defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asao K, 2006, DIABETES CARE, V29, P1632, DOI 10.2337/dc05-1997; Batty GD, 2002, EUR J PUBLIC HEALTH, V12, P263, DOI 10.1093/eurpub/12.4.263; Beagley J, 2014, DIABETES RES CLIN PR, V103, P150, DOI 10.1016/j.diabres.2013.11.001; Bozorgmanesh M, 2011, DIABETIC MED, V28, P1330, DOI 10.1111/j.1464-5491.2011.03343.x; BROWN DC, 1991, DIABETOLOGIA, V34, P531, DOI 10.1007/BF00403292; Bullard KM, 2013, DIABETES CARE, V36, P2286, DOI 10.2337/dc12-2563; Chernausek SD, 2012, J CLIN ENDOCR METAB, V97, P689, DOI 10.1210/jc.2011-2741; Conway B, 2011, ANN EPIDEMIOL, V21, P358, DOI 10.1016/j.annepidem.2011.02.005; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Espelt A, 2008, DIABETOLOGIA, V51, P1971, DOI 10.1007/s00125-008-1146-1; Goldstein A, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.6.e108; Han TS, 1998, DIABETIC MED, V15, P129, DOI 10.1002/(SICI)1096-9136(199802)15:2<129::AID-DIA535>3.3.CO;2-U; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Janghorbani M, 2012, OBES REV, V13, P1172, DOI 10.1111/j.1467-789X.2012.01030.x; Janghorbani M, 2012, ACTA DIABETOL, V49, pS107, DOI 10.1007/s00592-011-0351-4; Jousilahti P, 2000, AM J EPIDEMIOL, V151, P1112, DOI 10.1093/oxfordjournals.aje.a010155; Keith SW, 2011, INT J OBESITY, V35, P401, DOI 10.1038/ijo.2010.148; Koskinen J, 2014, DIABETES CARE, V37, P1870, DOI 10.2337/dc14-0008; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873; Lawlor DA, 2002, DIABETOLOGIA, V45, P1097, DOI 10.1007/s00125-002-0887-5; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Liu J, 2009, DIABETES CARE, V32, P739, DOI 10.2337/dc08-1547; Lorenzo C, 2009, METABOLISM, V58, P1530, DOI 10.1016/j.metabol.2009.04.030; Melamed S, 2002, SLEEP, V25, P315, DOI 10.1093/sleep/25.3.315; Menke A, 2014, ANN INTERN MED, V161, P328, DOI 10.7326/M14-0286; Njolstad I, 1998, AM J EPIDEMIOL, V147, P49; Ortlepp JR, 2003, DIABETIC MED, V20, P451, DOI 10.1046/j.1464-5491.2003.00971.x; Parker ED, 2009, AM J EPIDEMIOL, V169, P837, DOI 10.1093/aje/kwn395; Nguyen QM, 2011, DIABETES CARE, V34, P2603, DOI 10.2337/dc11-0919; Reichenberg A, 2005, ARCH GEN PSYCHIAT, V62, P1297, DOI 10.1001/archpsyc.62.12.1297; Sandhu MS, 2002, LANCET, V359, P1740, DOI 10.1016/S0140-6736(02)08655-5; Schulze MB, 2006, DIABETES CARE, V29, P1921, DOI 10.2337/dc06-0895; Smith GD, 2001, J EPIDEMIOL COMMUN H, V55, P867, DOI 10.1136/jech.55.12.867; Snijder MB, 2003, AM J CLIN NUTR, V77, P1192, DOI 10.1093/ajcn/77.5.1192; Snijder MB, 2004, INT J OBESITY, V28, P402, DOI 10.1038/sj.ijo.0802567; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Tsur A, 2013, DIABETES CARE, V36, P1361, DOI 10.2337/dc12-1050; Twig G, 2015, ACTA DIABETOL IN PRE; Twig G, 2015, EUR J ENDOCRINOL, V173, P305, DOI 10.1530/EJE-15-0284; Twig G, 2014, DIABETES CARE, V37, P2982, DOI 10.2337/dc14-0715; Twig G, 2014, DIABETES CARE, V37, P2989, DOI 10.2337/dc14-0869; Twig G, 2014, J CLIN ENDOCR METAB, V99, P2095, DOI 10.1210/jc.2014-1213; Twig G, 2013, DIABETES CARE, V36, P276, DOI 10.2337/dc11-2298; Vassy JL, 2014, DIABETES, V63, P2172, DOI 10.2337/db13-1663; Vassy JL, 2012, PEDIATRICS, V130, pE1235, DOI 10.1542/peds.2012-1132; Wang SL, 1997, DIABETOLOGIA, V40, P1431, DOI 10.1007/s001250050846; Zhang XP, 2008, DIABETES CARE, V31, P1748, DOI 10.2337/dc08-0572	48	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136464	10.1371/journal.pone.0136464	http://dx.doi.org/10.1371/journal.pone.0136464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305680	Green Published, gold			2022-12-27	WOS:000359995500079
J	Nalabothula, N; Al-Jumaily, T; Eteleeb, AM; Flight, RM; Shao, XR; Moseley, H; Rouchka, EC; Fondufe-Mittendorf, YN				Nalabothula, Narasimharao; Al-Jumaily, Taha; Eteleeb, Abdallah M.; Flight, Robert M.; Shao Xiaorong; Moseley, Hunter; Rouchka, Eric C.; Fondufe-Mittendorf, Yvonne N.			Genome-Wide Profiling of PARP1 Reveals an Interplay with Gene Regulatory Regions and DNA Methylation	PLOS ONE			English	Article							CHROMATIN-STRUCTURE; HYPERSENSITIVE SITES; HISTONE H1; BINDING; POLY(ADP-RIBOSE); EXPRESSION; TRANSCRIPTION; ACTIVATION; DATABASE; CELLS	Poly (ADP-ribose) polymerase-1 (PARP1) is a nuclear enzyme involved in DNA repair, chromatin remodeling and gene expression. PARP1 interactions with chromatin architectural multi-protein complexes (i.e. nucleosomes) alter chromatin structure resulting in changes in gene expression. Chromatin structure impacts gene regulatory processes including transcription, splicing, DNA repair, replication and recombination. It is important to delineate whether PARP1 randomly associates with nucleosomes or is present at specific nucleosome regions throughout the cell genome. We performed genome-wide association studies in breast cancer cell lines to address these questions. Our studies show that PARP1 associates with epigenetic regulatory elements genome-wide, such as active histone marks, CTCF and DNase hypersensitive sites. Additionally, the binding of PARP1 to chromatin genome-wide is mutually exclusive with DNA methylation pattern suggesting a functional interplay between PARP1 and DNA methylation. Indeed, inhibition of PARylation results in genome-wide changes in DNA methylation patterns. Our results suggest that PARP1 controls the fidelity of gene transcription and marks actively transcribed gene regions by selectively binding to transcriptionally active chromatin. These studies provide a platform for developing our understanding of PARP1' s role in gene regulation.	[Nalabothula, Narasimharao; Al-Jumaily, Taha; Flight, Robert M.; Moseley, Hunter; Fondufe-Mittendorf, Yvonne N.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA; [Eteleeb, Abdallah M.; Rouchka, Eric C.] Univ Louisville, Dept Comp Engn & Comp Sci, Louisville, KY 40292 USA; [Eteleeb, Abdallah M.] Washington Univ, McDonnell Genome Inst, St Louis, MO USA; [Shao Xiaorong] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA	University of Kentucky; University of Louisville; Washington University (WUSTL); University of California System; University of California Berkeley	Fondufe-Mittendorf, YN (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA.	y.fondufe-mittendorf@uky.edu		Moseley, Hunter/0000-0003-3995-5368; Flight, Robert/0000-0001-8141-7788	NIH from the National Center for Research Resources [P20GM103436, 2P20 RR020171]; International Rett Syndrome Foundation grant;  [1R01ES024478];  [NSF1517986]; Direct For Biological Sciences [1517986] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1419282] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103436] Funding Source: NIH RePORTER	NIH from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); International Rett Syndrome Foundation grant; ; ; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH grants P20GM103436 (ECR); 2P20 RR020171 (YNFM) (from the National Center for Research Resources), 1R01ES024478, NSF1517986 and International Rett Syndrome Foundation grant (YNFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus FR, 2005, ONCOGENE, V24, P11, DOI 10.1038/sj.onc.1208382; Bai P, 2012, CELL METAB, V16, P290, DOI 10.1016/j.cmet.2012.06.016; Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Blahnik KR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017121; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Burkle A, 2005, INT J BIOCHEM CELL B, V37, P1043, DOI 10.1016/j.biocel.2004.10.006; Caiafa P, 2009, FASEB J, V23, P672, DOI 10.1096/fj.08-123265; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Ciccarone F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046927; Clark NJ, 2012, J BIOL CHEM, V287, P32430, DOI 10.1074/jbc.M112.397067; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; De Vos M, 2012, BIOCHEM PHARMACOL, V84, P137, DOI 10.1016/j.bcp.2012.03.018; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Farrar D, 2010, MOL CELL BIOL, V30, P1199, DOI 10.1128/MCB.00827-09; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Flight R., 2015, FMDATABREASTCAPARP1; Flight R., 2015, FM PARP1 CORRELATION; Flight R., 2015, FMCORRELATIONBREASTC; Flight RM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00098; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Fuchs G, 2014, GENOME RES; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Gits CMM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-429; Gits CMM, 2014, INT J CANCER, V135, P348, DOI 10.1002/ijc.28694; Acuna LIG, 2013, WIRES RNA, V4, P77, DOI 10.1002/wrna.1142; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Guastafierro T, 2008, J BIOL CHEM, V283, P21873, DOI 10.1074/jbc.M801170200; Guerrero PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016401; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pD75, DOI 10.1093/nar/gkq942; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Ji YBA, 2010, CURR OPIN GENET DEV, V20, P512, DOI 10.1016/j.gde.2010.06.001; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Johansson HJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3175; Johnson LM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000280; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kaplan N, 2010, NAT STRUCT MOL BIOL, V17, P918, DOI 10.1038/nsmb0810-918; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lokk K, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r54; Melnikov AA, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni092; Nalabothula N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-92; Nguyen CT, 2002, CANCER RES, V62, P6456; Nusinow DA, 2007, J BIOL CHEM, V282, P12851, DOI 10.1074/jbc.M610502200; O'Geen H, 2011, METHODS MOL BIOL, V791, P265, DOI 10.1007/978-1-61779-316-5_20; Ogino H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-41; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Orlando V, 2006, CSH PROTOC; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Petesch SJ, 2012, TRENDS GENET, V28, P285, DOI 10.1016/j.tig.2012.02.005; Petesch SJ, 2012, MOL CELL, V45, P64, DOI 10.1016/j.molcel.2011.11.015; Polach KJ, 1996, J MOL BIOL, V258, P800, DOI 10.1006/jmbi.1996.0288; Polach KJ, 2000, J MOL BIOL, V298, P211, DOI 10.1006/jmbi.2000.3644; Ragab A, 2003, NUCLEIC ACIDS RES, V31, P7083, DOI 10.1093/nar/gkg923; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Simbulan-Rosenthal CM, 2000, P NATL ACAD SCI USA, V97, P11274, DOI 10.1073/pnas.200285797; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Vahdati A, 2014, J MECH BEHAV BIOMED, V30, P244, DOI 10.1016/j.jmbbm.2013.11.015; van de Garde MDB, 2014, J IMMUNOL, V192, P1196, DOI 10.4049/jimmunol.1302138; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Zampieri M, 2012, BIOCHEM J, V441, P645, DOI 10.1042/BJ20111417; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Ziebarth JD, 2013, NUCLEIC ACIDS RES, V41, pD188, DOI 10.1093/nar/gks1165	90	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135410	10.1371/journal.pone.0135410	http://dx.doi.org/10.1371/journal.pone.0135410			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305327	Green Submitted, Green Published, gold			2022-12-27	WOS:000359995500021
J	Xie, HF; Shen, SP; Qian, MK; Zhang, FM; Chen, C; Tay, FR				Xie, Haifeng; Shen, Shuping; Qian, Mengke; Zhang, Feimin; Chen, Chen; Tay, Franklin R.			Effects of Acid Treatment on Dental Zirconia: An In Vitro Study	PLOS ONE			English	Article							FIXED PARTIAL DENTURES; TETRAGONAL ZIRCONIA; Y-TZP; STRUCTURAL STABILITY; FLEXURAL STRENGTH; CERAMICS; TEMPERATURE; SURFACE; RELIABILITY; PERFORMANCE	The aim of this study was to evaluate the effects of hydrofluoric (HF) acid, acetic acid, and citric acid treatments on the physical properties and structure of yttria-stabilized tetragonal zirconia polycrystal (Y-TZP) at ambient temperature. In total, 110 bar-shaped zirconia specimens were randomly assigned to 11 groups. The specimens in the control group (C) received no surface treatment, while those in the Cage group were hydrothermally aged at 134 degrees C and 0.2 MPa for 20 h. Ten specimens each were immersed at ambient temperature in 5% and 40% HF acid for 2 h (40HF0), 1 day (5HF1, 40HF1), and 5 days (5HF5, 40HF5), while 10 each were immersed at ambient temperature in 10% acetic acid and 20% citric acid for 7 (AC7, CI7) and 14 days (AC14, CI14). X-ray diffraction (XRD) was used to quantitatively estimate the monoclinic phase. Furthermore, flexural strength, surface roughness, and surface Vickers hardness were measured after treatment. Scanning electron microscopy (SEM) was used to characterize the surface morphology. The Cage group specimens exhibited an increased monoclinic phase and flexural strength. Furthermore, 40% HF acid immersion decreased the flexural strength and surface hardness and deteriorated the surface finish, while 5% HF acid immersion only decreased the surface hardness. All the HF acid-immersed specimens showed an etched surface texture on SEM observations, while the other groups did not. These findings suggest that the treatment of Y-TZP with 40% HF acid at ambient temperature causes potential damage, while treatment with 5% HF acid, acetic acid, and citric acid is safe.	[Xie, Haifeng; Shen, Shuping; Qian, Mengke; Zhang, Feimin] Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Prosthodont, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China; [Chen, Chen] Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Endodont, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China; [Tay, Franklin R.] Georgia Regents Univ, Dept Endodont, Coll Dent Med, Augusta, GA USA	Nanjing Medical University; Nanjing Medical University; University System of Georgia; Augusta University	Chen, C (corresponding author), Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Endodont, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China.	ccchicy@njmu.edu.cn; ftay@gru.edu	Chen, Chen/AAR-4565-2021; Xie, Haifeng/AAR-2559-2021	Chen, Chen/0000-0002-2989-180X; Xie, Haifeng/0000-0003-2008-3846; Tay, Franklin/0000-0003-3769-0626	Priority Academic Program Development Foundation; Natural Science Foundation of Jiangsu Higher Education Institutions [2014-37, 15KJB320003]; Jiangsu Student's Platform for Innovation and Entrepreneurship Training Program [201410312012Z]; National Natural Science Foundation of China [81400539]; Natural Science Foundation of Jiangsu Province, China [BK20140913]; Priority Academic Program Development of Jiangsu Higher Education Institutions [2014-37]	Priority Academic Program Development Foundation; Natural Science Foundation of Jiangsu Higher Education Institutions; Jiangsu Student's Platform for Innovation and Entrepreneurship Training Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the Priority Academic Program Development Foundation and Natural Science Foundation of Jiangsu Higher Education Institutions [grant number 2014-37 and 15KJB320003], the Jiangsu Student's Platform for Innovation and Entrepreneurship Training Program [grant number 201410312012Z], the National Natural Science Foundation of China [grant number 81400539] and the Natural Science Foundation of Jiangsu Province, China [grant number BK20140913]. The original funding was from the Priority Academic Program Development of Jiangsu Higher Education Institutions [grant number 2014-37], the Jiangsu Student's Platform for Innovation and Entrepreneurship Training Program [grant number 201410312012Z], the National Natural Science Foundation of China [grant number 81400539] and the Natural Science Foundation of Jiangsu Province, China [grant number BK20140913].	Alghazzawi TF, 2012, J PROSTHODONT, V21, P363, DOI 10.1111/j.1532-849X.2011.00838.x; [Anonymous], 133562008 ISO; Ardlin BI, 2002, DENT MATER, V18, P590, DOI 10.1016/S0109-5641(01)00095-1; Casucci A, 2009, J DENT, V37, P891, DOI 10.1016/j.jdent.2009.06.013; Cotes C, 2014, DENT MATER, V30, pE396, DOI 10.1016/j.dental.2014.08.380; Egilmez F, 2014, J MECH BEHAV BIOMED, V37, P78, DOI 10.1016/j.jmbbm.2014.05.013; Flinn BD, 2012, J PROSTHET DENT, V108, P223, DOI 10.1016/S0022-3913(12)60166-8; GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x; Giordano Russell, 2010, Compend Contin Educ Dent, V31, P710; Guo X, 2004, J AM CERAM SOC, V87, P746, DOI 10.1111/j.1551-2916.2004.00746.x; Guo X, 1999, J PHYS CHEM SOLIDS, V60, P539, DOI 10.1016/S0022-3697(98)00301-1; Iijima T, 2013, DENT MATER J, V32, P274, DOI 10.4012/dmj.2012-247; ISO, 68722015 ISO; Keuper M, 2014, ACTA BIOMATER, V10, P951, DOI 10.1016/j.actbio.2013.09.033; Kosmac T, 2000, J BIOMED MATER RES, V53, P304, DOI 10.1002/1097-4636(2000)53:4<304::AID-JBM4>3.0.CO;2-S; Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006; Sailer I, 2007, INT J PROSTHODONT, V20, P383; Siarampi E, 2014, DENT MATER, V30, pE306, DOI 10.1016/j.dental.2014.05.033; Sriamporn T, 2014, DENT MATER J, V33, P79, DOI 10.4012/dmj.2013-243; Tinschert J, 2000, J DENT, V28, P529, DOI 10.1016/S0300-5712(00)00030-0; Triwatana P, 2012, J ADV PROSTHODONT, V4, P76, DOI 10.4047/jap.2012.4.2.76; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; Xie HF, 2013, DENT MATER J, V32, P928, DOI 10.4012/dmj.2013-010; Zhang F, 2015, ACTA MATER, V92, P290, DOI 10.1016/j.actamat.2015.04.001	24	13	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136263	10.1371/journal.pone.0136263	http://dx.doi.org/10.1371/journal.pone.0136263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301413	Green Submitted, Green Published, gold			2022-12-27	WOS:000359951900053
J	Lee, HY; Chen, CL; Liu, SY; Yan, YS; Chang, CJ; Chiu, CH				Lee, Hao-Yuan; Chen, Chyi-Liang; Liu, Shu-Ying; Yan, Yu-Shan; Chang, Chee-Jen; Chiu, Cheng-Hsun			Impact of Molecular Epidemiology and Reduced Susceptibility to Glycopeptides and Daptomycin on Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia	PLOS ONE			English	Article							MINIMUM INHIBITORY CONCENTRATION; BLOOD-STREAM INFECTIONS; RAPID IDENTIFICATION; VANCOMYCIN; MEC; THERAPY; MORTALITY; TAIWAN; RISK; ENDOCARDITIS	Background Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia was associated with high mortality, but the risk factors associated with mortality remain controversial. Methods A retrospective cohort study was designed. All patients with MRSA bacteremia admitted were screened and collected for their clinical presentations and laboratory characteristics. Minimum inhibitory concentration (MIC) and staphylococcal cassette chromosome mec (SCCmec) type of bacterial isolates were determined. Risk factors for mortality were analyzed. Results Most MRSA isolates from the 189 enrolled patients showed reduced susceptibility to antibiotics, including MIC of vancomycin >= 1.5 mg/L (79.9%), teicoplanin >= 2 mg/L (86.2%), daptomycin >= 0.38 mg/ L (73.0%) and linezolid >= 1.5 mg/ L (64.0%). MRSA with vancomycin MIC >= 1.5 mg/ L and inappropriate initial therapy were the two most important risk factors for mortality (both P < 0.05; odds ratio = 7.88 and 6.78). Hospital-associated MRSA (HAMRSA), carrying SCCmec type I, II, or III, was associated with reduced susceptibility to vancomycin, teicoplanin or daptomycin and also with higher attributable mortality (all P < 0.05). Creeping vancomycin MIC was linked to higher MIC of teicoplanin and daptomycin (both P < 0.001), but not linezolid (P = 0.759). Conclusions Giving empirical broad-spectrum antibiotics for at least 5 days to treat catheter-related infections, pneumonia, soft tissue infection and other infections was the most important risk factor for acquiring subsequent HA-MRSA infection. Choice of effective anti-MRSA agents for treating MRSA bacteremia should be based on MIC of vancomycin, teicoplanin and daptomycin. Initiation of an effective anti-MRSA agent without elevated MIC in 2 days is crucial for reducing mortality.	[Lee, Hao-Yuan; Chang, Chee-Jen; Chiu, Cheng-Hsun] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Lee, Hao-Yuan; Chen, Chyi-Liang; Chiu, Cheng-Hsun] Chang Gung Univ, Coll Med, Chang Gung Childrens Hosp, Dept Pediat, Taoyuan, Taiwan; [Lee, Hao-Yuan; Chen, Chyi-Liang; Yan, Yu-Shan; Chiu, Cheng-Hsun] Chang Gung Univ, Coll Med, Chang Gung Childrens Hosp, Mol Infect Dis Res Ctr, Taoyuan, Taiwan; [Liu, Shu-Ying; Yan, Yu-Shan] Da Yeh Univ, Dept Mol Biotechnol, Changhua, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Da Yeh University	Chiu, CH (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan.	chchiu@adm.cgmh.org.tw	Chen, Chyi-Liang/GVT-1758-2022	Chen, Chyi-Liang/0000-0003-4591-0924; Chang, Chee Jen/0000-0002-7725-7555	Ministry of Science and Technology, Taiwan [97-2314-B-182A-019-MY3, 102-2314-B-182A- 023]; Chang Gung Memorial Hospital, Taiwan [CMRPG390702, CMRPG490052, CMRPG4C0031, CMRPG3E0481]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This work was supported by grants from Ministry of Science and Technology, Executive Yuan, Taiwan (97-2314-B-182A-019-MY3 and 102-2314-B-182A- 023) and Chang Gung Memorial Hospital, Taiwan (CMRPG390702, CMRPG490052, CMRPG4C0031 and CMRPG3E0481).	Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Chang HJ, 2012, J ANTIMICROB CHEMOTH, V67, P736, DOI 10.1093/jac/dkr531; Chen CJ, 2009, DIAGN MICR INFEC DIS, V65, P199, DOI 10.1016/j.diagmicrobio.2009.05.020; Chen SY, 2012, CLIN INFECT DIS, V55, P1329, DOI 10.1093/cid/cis717; Clinical and Laboratory Standards Institute, 2014, CLSI DOCUMENT M100 S; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Couderc C, 2014, CLIN INFECT DIS, V59, P206, DOI 10.1093/cid/ciu236; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Fang CT, 2006, J ANTIMICROB CHEMOTH, V57, P511, DOI 10.1093/jac/dkl006; Fowler VG, 2006, NEW ENGL J MED, V355, P653, DOI 10.1056/NEJMoa053783; Han JH, 2012, J ANTIMICROB CHEMOTH, V67, P2346, DOI 10.1093/jac/dks255; Holland TL, 2011, J INFECT DIS, V204, P329, DOI 10.1093/infdis/jir275; Holmes NE, 2013, CLIN MICROBIOL INFEC, V19, P1163, DOI 10.1111/1469-0691.12168; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Jang HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049136; Kalil AC, 2014, JAMA-J AM MED ASSOC, V312, P1552, DOI 10.1001/jama.2014.6364; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Kullar R, 2014, CLIN INFECT DIS, V59, P1455, DOI 10.1093/cid/ciu583; Lee HY, 2014, CRIT CARE MED, V42, P1081, DOI 10.1097/CCM.0000000000000125; Lee HY, 2012, INT J ANTIMICROB AG, V40, P163, DOI 10.1016/j.ijantimicag.2012.04.018; Lodise TP, 2008, ANTIMICROB AGENTS CH, V52, P3315, DOI 10.1128/AAC.00113-08; Miller CE, 2012, CLIN INFECT DIS, V54, P591, DOI 10.1093/cid/cir858; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Paladino JA, 2014, INT J ANTIMICROB AG, V44, P557, DOI 10.1016/j.ijantimicag.2014.07.024; Paul M, 2010, J ANTIMICROB CHEMOTH, V65, P2658, DOI 10.1093/jac/dkq373; Reed SD, 2005, INFECT CONT HOSP EP, V26, P175, DOI 10.1086/502523; Tenover FC, 2007, CLIN INFECT DIS, V44, P1208, DOI 10.1086/513203; van Hal SJ, 2012, CLIN INFECT DIS, V54, P755, DOI 10.1093/cid/cir935; van Hal SJ, 2011, EUR J CLIN MICROBIOL, V30, P603, DOI 10.1007/s10096-010-1128-3; Zhang H, 2015, INT J ANTIMICROB AG, V45, P347, DOI 10.1016/j.ijantimicag.2014.12.014	30	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136171	10.1371/journal.pone.0136171	http://dx.doi.org/10.1371/journal.pone.0136171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295150	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900079
J	Lee, HJ; Kang, SW; Byun, HS; Jeon, J; Park, KA; Kang, KD; Seo, WY; Won, MH; Seok, JH; Han, MD; Shen, HM; Hur, GM				Lee, Hyunji; Kang, Seong Wook; Byun, Hee Sun; Jeon, Juhee; Park, Kyeong Ah; Kang, Kidong; Seo, Wonhyoung; Won, Minho; Seok, Jeong Ho; Han, Man-Deuk; Shen, Han-Ming; Hur, Gang Min			Brazilin Limits Inflammatory Responses through Induction of Prosurvival Autophagy in Rheumatoid Fibroblast-Like Synoviocytes	PLOS ONE			English	Article							SYNOVIAL FIBROBLASTS; ARTHRITIS; CELLS; APOPTOSIS; IMMUNITY; DISEASE; AUTOIMMUNITY; PATHOGENESIS; SUPPRESSION; PATHWAY	Brazilin is an active compound of Caesalpinia sappan L. (Leguminosae), which possesses pro-apoptotic and anti-inflammation potentials depending on the specific cell type. However, it is largely unknown whether autophagy is implicated in the mechanism underlying its chemotherapeutic and anti-inflammatory effects in rheumatoid arthritis (RA). Here, we show that treatment of RA fibroblast-like synoviocytes (FLS) with brazilin results in enhanced level of autophagic flux, evidenced by accumulation of autophagosome and increased level of lipidated LC3 (LC3-II), which is mainly mediated by enhanced production of reactive oxygen species (ROS). Interestingly, long-term exposure of brazilin was able to restore cell survival against the cytotoxity, exclusively in RA FLS, but not in normal fibroblast. Importantly, such a restoration from brazilin-induced cytotoxity in RA FLS was completely abrogated after co-treatment with autophagy inhibitors including NH4Cl or chloroquine. Furthermore, we found that the pretreatment of RA FLS with brazilin reduced LPS- or TNF-induced NF-kappa B activation and the secretion of inflammatory cytokines in parallel with the enhanced autophagic flux. Such anti-NF-kappa B potentials of brazilin were drastically masked in RA FLS when autophagy was suppressed. These results suggest that brazilin is capable of activating autophagy exclusively in RA FLS, and such inducible autophagy promotes cell survival and limits inflammatory response.	[Lee, Hyunji; Byun, Hee Sun; Jeon, Juhee; Park, Kyeong Ah; Kang, Kidong; Seo, Wonhyoung; Won, Minho; Seok, Jeong Ho; Hur, Gang Min] Chungnam Natl Univ, Coll Med, Dept Pharmacol, Taejon, South Korea; [Kang, Seong Wook] Chungnam Natl Univ, Div Rheumatol, Dept Internal Med, Coll Med, Taejon, South Korea; [Han, Man-Deuk] Soonchunhyang Univ, Dept Biol, Asan, Chungnam, South Korea; [Shen, Han-Ming] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore	Chungnam National University; Chungnam National University; Soonchunhyang University; National University of Singapore	Hur, GM (corresponding author), Chungnam Natl Univ, Coll Med, Dept Pharmacol, Taejon, South Korea.	gmhur@cnu.ac.kr	JEON, Juhee/AAJ-8024-2020; SHEN, Han-Ming/B-5942-2011; Hur, Gang-min/ABF-9263-2021	SHEN, Han-Ming/0000-0001-7369-5227; Hur, Gang-min/0000-0003-4870-6574; Won, Minho/0000-0002-5873-5216; Kang, Seong Wook/0000-0002-0076-0822	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2014R1A2A1A01004363, 2007-0054932]; Chungnam National University	National Research Foundation of Korea (NRF) - Korea government (MSIP); Chungnam National University	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2014R1A2A1A01004363), (No. 2007-0054932), and research fund of Chungnam National University.	An DS, 2003, HUM GENE THER, V14, P1207, DOI 10.1089/104303403322168037; Bae IK, 2005, EUR J PHARMACOL, V513, P237, DOI 10.1016/j.ejphar.2005.03.011; Bhattacharya A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00088; Brain O, 2012, INFLAMM BOWEL DIS, V18, P778, DOI 10.1002/ibd.21832; Carames B, 2012, ANN RHEUM DIS, V71, P575, DOI 10.1136/annrheumdis-2011-200557; Connor AM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3778; Deng ZP, 2013, BIOMED CHROMATOGR, V27, P802, DOI 10.1002/bmc.2863; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gros F, 2014, BRIT J PHARMACOL, V171, P4337, DOI 10.1111/bph.12792; Guo JY, 2013, CELL, V155, P1216, DOI 10.1016/j.cell.2013.11.019; Hoefkens E, 2013, AUTOPHAGY, V9, P2046, DOI 10.4161/auto.26337; Huang J, 2011, ANTIOXID REDOX SIGN, V14, P2215, DOI 10.1089/ars.2010.3554; Jayakumar T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/403703; Jeon J, 2014, BIOCHEM PHARMACOL, V89, P515, DOI 10.1016/j.bcp.2014.04.004; Jung EG, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0648-x; Kenific CM, 2015, TRENDS CELL BIOL, V25, P37, DOI 10.1016/j.tcb.2014.09.001; Kim B, 2012, J AGR FOOD CHEM, V60, P9882, DOI 10.1021/jf302527p; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Lee DY, 2013, MOLECULES, V18, P2449, DOI 10.3390/molecules18022449; Lee YR, 2012, EUR J PHARMACOL, V674, P80, DOI 10.1016/j.ejphar.2011.10.016; Leech MT, 2013, CURR OPIN PHARMACOL, V13, P565, DOI 10.1016/j.coph.2013.04.001; Lefevre S, 2015, CURR PHARM DESIGN, V21, P130; Lin NY, 2013, AUTOPHAGY, V9, P1253, DOI 10.4161/auto.25467; Lin NY, 2013, ANN RHEUM DIS, V72, P761, DOI 10.1136/annrheumdis-2012-201671; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Pierdominici M, 2012, FASEB J, V26, P1400, DOI 10.1096/fj.11-194175; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Shen HM, 2012, EXP CELL RES, V318, P1304, DOI 10.1016/j.yexcr.2012.02.006; Tran Chinh N, 2005, Pathophysiology, V12, P183, DOI 10.1016/j.pathophys.2005.07.005; Turner JD, 2015, CURR OPIN RHEUMATOL, V27, P175, DOI 10.1097/BOR.0000000000000148; Wang YZ, 2011, J ETHNOPHARMACOL, V136, P271, DOI 10.1016/j.jep.2011.04.061; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Xu K, 2013, INFLAMM RES, V62, P229, DOI 10.1007/s00011-012-0572-1; Zhang T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3062; Zhou XJ, 2012, AUTOPHAGY, V8, P1286, DOI 10.4161/auto.21212	37	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136122	10.1371/journal.pone.0136122	http://dx.doi.org/10.1371/journal.pone.0136122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295477	gold, Green Published, Green Submitted			2022-12-27	WOS:000359926900072
J	Muyan, M; Gupur, G; Yasar, P; Ayaz, G; User, SD; Kazan, HH; Huang, YF				Muyan, Mesut; Gupur, Gizem; Yasar, Pelin; Ayaz, Gamze; User, Sirma Damla; Kazan, Hasan Huseyin; Huang, Yanfang			Modulation of Estrogen Response Element-Driven Gene Expressions and Cellular Proliferation with Polar Directions by Designer Transcription Regulators	PLOS ONE			English	Article							HUMAN-BREAST-CANCER; ZINC-FINGER PROTEINS; RECEPTOR-ALPHA; ER-ALPHA; ACTIVATION FUNCTIONS; REPRESSION; ESTRADIOL; BINDING; DOMAIN; CELLS	Estrogen receptor a (ER alpha), as a ligand-dependent transcription factor, mediates 17 beta-estradiol (E2) effects. ERa is a modular protein containing a DNA binding domain (DBD) and transcription activation domains (AD) located at the amino-and carboxyl-termini. The interaction of the E2-activated ERa dimer with estrogen response elements (EREs) of genes constitutes the initial step in the ERE-dependent signaling pathway necessary for alterations of cellular features. We previously constructed monomeric transcription activators, or monotransactivators, assembled from an engineered ERE-binding module (EBM) using the ER alpha-DBD and constitutively active ADs from other transcription factors. Monotransactivators modulated cell proliferation by activating and repressing ERE-driven gene expressions that simulate responses observed with E2-ER alpha. We reasoned here that integration of potent heterologous repression domains (RDs) into EBM could generate monotransrepressors that alter ERE-bearing gene expressions and cellular proliferation in directions opposite to those observed with E2-ER alpha or monotransactivators. Consistent with this, monotransrepressors suppressed reporter gene expressions that emulate the ERE-dependent signaling pathway. Moreover, a model monotransrepressor regulated DNA synthesis, cell cycle progression and proliferation of recombinant adenovirus infected ER-negative cells through decreasing as well as increasing gene expressions with polar directions compared with E2-ER alpha or monotransactivator. Our results indicate that an 'activator' or a 'repressor' possesses both transcription activating/enhancing and repressing/decreasing abilities within a chromatin context. Offering a protein engineering platform to alter signal pathway-specific gene expressions and cell growth, our approach could also be used for the development of tools for epigenetic modifications and for clinical interventions wherein multigenic de-regulations are an issue.	[Muyan, Mesut; Gupur, Gizem; Yasar, Pelin; Ayaz, Gamze; User, Sirma Damla; Kazan, Hasan Huseyin] Middle E Tech Univ, Dept Biol Sci, TR-06800 Ankara, Turkey; [Muyan, Mesut; Huang, Yanfang] Univ Rochester, Dept Biochem & Biophys, Rochester, NY 14619 USA	Middle East Technical University; University of Rochester	Muyan, M (corresponding author), Middle E Tech Univ, Dept Biol Sci, TR-06800 Ankara, Turkey.	mmuyan@metu.edu.tr	Muyan, Mesut/AAZ-4888-2020	Muyan, Mesut/0000-0003-3058-6228; Yasar, Pelin/0000-0003-3027-9842	Turkiye Bilimsel ve Teknolojik Arastirma Kurumu [TUBITAK-KBAG 212T031]; Middle East Technical University [METU-BAP-08-11-2012-125]	Turkiye Bilimsel ve Teknolojik Arastirma Kurumu(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Middle East Technical University(Middle East Technical University)	This work was supported by Turkiye Bilimsel ve Teknolojik Arastirma Kurumu, TUBITAK-KBAG 212T031, and Middle East Technical University, METU-BAP-08-11-2012-125. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUGEREAU P, 1994, MOL ENDOCRINOL, V8, P693, DOI 10.1210/me.8.6.693; Ayer DE, 1996, MOL CELL BIOL, V16, P5772; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; Bai YL, 2003, MOL ENDOCRINOL, V17, P589, DOI 10.1210/me.2002-0351; BATES SE, 1988, MOL ENDOCRINOL, V2, P543, DOI 10.1210/mend-2-6-543; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; BERRY M, 1989, P NATL ACAD SCI USA, V86, P1218, DOI 10.1073/pnas.86.4.1218; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; ElAshry D, 1996, J STEROID BIOCHEM, V59, P261, DOI 10.1016/S0960-0760(96)00118-5; Falahi F, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00022; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Gersbach CA, 2014, ACCOUNTS CHEM RES, V47, P2309, DOI 10.1021/ar500039w; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Huang J, 2005, MOL ENDOCRINOL, V19, P2696, DOI 10.1210/me.2005-0120; Huang J, 2004, MOL CELL ENDOCRINOL, V218, P65, DOI 10.1016/j.mce.2003.12.005; Huang Jing, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P379, DOI 10.2174/156800805774912944; Huang YF, 2011, ENDOCRINE, V39, P48, DOI 10.1007/s12020-010-9411-8; Inaoka T, 2003, J BIOL CHEM, V278, P2169, DOI 10.1074/jbc.M208722200; Juarez-Moreno K, 2013, EPIGENETICS-US, V8, P164, DOI 10.4161/epi.23503; Kasten MM, 1996, MOL CELL BIOL, V16, P4215; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Krishnamurthy M, 2011, ACS CHEM BIOL, V6, P1321, DOI 10.1021/cb200308e; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Levenson AS, 1998, BRIT J CANCER, V78, P88, DOI 10.1038/bjc.1998.447; Li XD, 2004, MOL CELL BIOL, V24, P7681, DOI 10.1128/MCB.24.17.7681-7694.2004; Li XD, 2008, J MOL ENDOCRINOL, V40, P211, DOI 10.1677/JME-07-0156; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lupo A, 2013, CURR GENOMICS, V14, P268, DOI 10.2174/13892029113149990002; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Margueron R, 2003, J ENDOCRINOL, V179, P41, DOI 10.1677/joe.0.1790041; McDonnell DP, 2010, CURR OPIN PHARMACOL, V10, P620, DOI 10.1016/j.coph.2010.09.007; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; MOORE PA, 1993, MOL CELL BIOL, V13, P1666, DOI 10.1128/MCB.13.3.1666; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Moosmann P, 1997, BIOL CHEM, V378, P669, DOI 10.1515/bchm.1997.378.7.669; Murakami Y, 2005, J REPROD DEVELOP, V51, P639, DOI 10.1262/jrd.17029; Mussolino C, 2012, CURR OPIN BIOTECH, V23, P644, DOI 10.1016/j.copbio.2012.01.013; Muyan M, 2001, MOL CELL ENDOCRINOL, V182, P249, DOI 10.1016/S0303-7207(01)00493-2; Norris JD, 1996, MOL ENDOCRINOL, V10, P1605, DOI 10.1210/mend.10.12.8961270; Nott SL, 2010, MOL MED, V16, P10, DOI 10.2119/molmed.2009.00107; Nott SL, 2009, J BIOL CHEM, V284, P15277, DOI 10.1074/jbc.M900365200; O'Shea JM, 2008, BIOCHEM SOC T, V36, P603, DOI 10.1042/BST0360603; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Reynolds N, 2013, DEVELOPMENT, V140, P505, DOI 10.1242/dev.083105; Sadowski I, 1988, NATURE, V335; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; Sathya G, 2002, MOL CELL ENDOCRINOL, V192, P171, DOI 10.1016/S0303-7207(01)00673-6; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; Soulez M, 2001, J MOL ENDOCRINOL, V27, P259, DOI 10.1677/jme.0.0270259; THIESEN HJ, 1991, NUCLEIC ACIDS RES, V19, P3996, DOI 10.1093/nar/19.14.3996; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; Yi P, 2002, MOL ENDOCRINOL, V16, P674, DOI 10.1210/me.16.4.674; Yi P, 2002, MOL ENDOCRINOL, V16, P1810, DOI 10.1210/me.2001-0323; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052	58	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136423	10.1371/journal.pone.0136423	http://dx.doi.org/10.1371/journal.pone.0136423			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295471	gold, Green Published, Green Submitted			2022-12-27	WOS:000359926900108
J	Yuan, DD; Cui, XM; Wang, Y; Zhao, YL; Li, HY; Hu, SJ; Chu, XD; Li, Y; Li, Q; Liu, Q; Zhu, WL				Yuan, Dandan; Cui, Xiaomeng; Wang, Yang; Zhao, Yilei; Li, Huiying; Hu, Suangjiu; Chu, Xiaodan; Li, Yan; Li, Qiang; Liu, Qian; Zhu, Wenliang			Enrichment Analysis Identifies Functional MicroRNA-Disease Associations in Humans	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OVARIAN; CELLS; PROLIFERATION; EXPRESSION; APOPTOSIS; SERUM	Substantial evidence has shown that microRNAs (miRNAs) may be causally linked to the occurrence and progression of human diseases. Herein, we conducted an enrichment analysis to identify potential functional miRNA-disease associations (MDAs) in humans by integrating currently known biological data: miRNA-target interactions (MTIs), protein-protein interactions, and gene-disease associations. Two contributing factors to functional miRNA-disease associations were quantitatively considered: the direct effects of miRNA that target disease-related genes, and indirect effects triggered by protein-protein interactions. Ninety-nine miRNAs were scanned for possible functional association with 2223 MeSH-defined human diseases. Each miRNA was experimentally validated to target >= 10 mRNA genes. Putative MDAs were identified when at least one MTI was confidently validated for a disease. Overall, 19648 putative MDAs were found, of which 10.0% was experimentally validated. Further results suggest that filtering for miRNAs that target a greater number of disease-related genes (n >= 8) can significantly enrich for true MDAs from the set of putative associations (enrichment rate = 60.7%, adjusted hypergeometric p = 2.41x10(-91)). Considering the indirect effects of miRNAs further elevated the enrichment rate to 72.6%. By using this method, a novel MDA between miR-24 and ovarian cancer was found. Compared with scramble miRNA overexpression of miR-24 was validated to remarkably induce ovarian cancer cells apoptosis. Our study provides novel insight into factors contributing to functional MDAs by integrating large quantities of previously generated biological data, and establishes a feasible method to identify plausible associations with high confidence.	[Yuan, Dandan; Hu, Suangjiu; Chu, Xiaodan; Li, Yan; Liu, Qian] Harbin Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Harbin, Peoples R China; [Cui, Xiaomeng] Harbin Univ Sci & Technol, Sch Measurement & Control Technol & Commun Engn, Harbin, Peoples R China; [Wang, Yang; Zhao, Yilei] Harbin Med Univ, Affiliated Hosp 1, Dept Pharm, Harbin, Peoples R China; [Li, Huiying] Mudanjiang Med Univ, Hongqi Hosp, Dept Obstet & Gynecol, Mudanjiang, Peoples R China; [Li, Qiang] Harbin Med Univ, Affiliated Hosp 2, Dept Gen Surg, Harbin, Peoples R China; [Zhu, Wenliang] Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Peoples R China	Harbin Medical University; Harbin University of Science & Technology; Harbin Medical University; Mudanjiang Medical University; Harbin Medical University; Harbin Medical University	Liu, Q (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Harbin, Peoples R China.	luoluo_liu@sina.com; wenzwl@yeah.net			Foundation of Heilongjiang Educational Committee [12541380]; National Natural Science Youth Foundation of China [81401502, 31301095]	Foundation of Heilongjiang Educational Committee; National Natural Science Youth Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Foundation of Heilongjiang Educational Committee (No. 12541380) and National Natural Science Youth Foundation of China (No. 81401502, No. 31301095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bauer-Mehren A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020284; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen HL, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-12; Chen X, 2012, MOL BIOSYST, V8, P2792, DOI 10.1039/c2mb25180a; Corral-Fernandez NE, 2013, EXP CLIN ENDOCR DIAB, V121, P347, DOI 10.1055/s-0033-1341516; De Cecco Loris, 2013, Critical Reviews in Oncogenesis, V18, P273; Gargalionis AN, 2013, CURR TOP MED CHEM, V13, P1493, DOI 10.2174/15680266113139990098; Gray KA, 2013, NUCLEIC ACIDS RES, V41, pD545, DOI 10.1093/nar/gks1066; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Jiang QQ, 2013, ASIAN PAC J CANCER P, V14, P4127, DOI 10.7314/APJCP.2013.14.7.4127; Jiang QH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S2; Kadera BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071978; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Li JY, 2013, INT J SURG ONCOL, V2013, DOI 10.1155/2013/875078; Li Y, 2014, NUCLEIC ACIDS RES, V42, pD1070, DOI 10.1093/nar/gkt1023; Liu Q, 2012, J RECEPT SIG TRANSD, V32, P120, DOI 10.3109/10799893.2012.660534; Liu W, 2012, NEUROBIOL AGING, V33, P522, DOI 10.1016/j.neurobiolaging.2010.04.034; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Maciotta S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00265; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Mir R, 2013, INT J CANCER, V132, P1525, DOI 10.1002/ijc.27832; Mishra PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008445; Mork S, 2014, BIOINFORMATICS, V30, P392, DOI 10.1093/bioinformatics/btt677; Mutch DG, 2014, GYNECOL ONCOL, V133, P401, DOI 10.1016/j.ygyno.2014.04.013; Olson EN, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009008; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Sato T, 2010, AM J RESP CRIT CARE, V182, P1020, DOI 10.1164/rccm.201001-0055OC; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Skommer J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.287; Spinetti G, 2013, CIRC RES, V112, DOI 10.1161/CIRCRESAHA.111.300418; Wang Q, 2008, BLOOD, V111, P588, DOI 10.1182/blood-2007-05-092718; Wu XB, 2014, INT J CLIN EXP MED, V7, P1307; Xie LH, 2014, MOL BIOSYST, V10, P1072, DOI 10.1039/c3mb70564a; Yang Y, 2014, ONCOL REP, V31, P2759, DOI 10.3892/or.2014.3127; Zhu JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046551; Zhu WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063342	39	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136285	10.1371/journal.pone.0136285	http://dx.doi.org/10.1371/journal.pone.0136285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296081	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900095
J	Akkari, N; Enghoff, H; Metscher, BD				Akkari, Nesrine; Enghoff, Henrik; Metscher, Brian D.			A New Dimension in Documenting New Species: High-Detail Imaging for Myriapod Taxonomy and First 3D Cybertype of a New Millipede Species (Diplopoda, Julida, Julidae)	PLOS ONE			English	Article							MICRO-COMPUTED TOMOGRAPHY; CHARACTERS; MORPHOLOGY; CHILOPODA; PHYLOGENY; AMBER	We review the state-of-the-art approaches currently applied in myriapod taxonomy, and we describe, for the first time, a new species of millipede (Ommatoiulus avatar n. sp., family Julidae) using high-resolution X-ray microtomography (microCT) as a substantive adjunct to traditional morphological examination. We present 3D models of the holotype and paratype specimens and discuss the potential of this non-destructive technique in documenting new species of millipedes and other organisms. The microCT data have been uploaded to an open repository (Dryad) to serve as the first actual millipede cybertypes to be published.	[Akkari, Nesrine] Nat Hist Museum Vienna, Dept Zool 3, A-1010 Vienna, Austria; [Enghoff, Henrik] Nat Hist Museum Denmark, DK-2100 Copenhagen O, Denmark; [Metscher, Brian D.] Univ Vienna, Dept Theoret Biol, A-1090 Vienna, Austria	University of Vienna	Akkari, N (corresponding author), Nat Hist Museum Vienna, Dept Zool 3, Burgring 7, A-1010 Vienna, Austria.	nesrine.akkari@nhm-wien.ac.at	Akkari, Nesrine/X-5416-2019; Enghoff, Henrik/A-5796-2013; Metscher, Brian/I-1238-2019	Metscher, Brian/0000-0002-6514-4406; Akkari, Nesrine/0000-0001-5019-4833	Open Access Publishing Fund of the University of Vienna	Open Access Publishing Fund of the University of Vienna	This work was supported by the Open Access Publishing Fund of the University of Vienna. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkari N, 2012, ZOOTAXA, P1; Akkari N, 2013, ZOOKEYS, P5, DOI 10.3897/zookeys.328.5763; Akkari N, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.156.2134; Ang YC, 2013, ZOOKEYS, P9, DOI 10.3897/zookeys.355.6013; Berlese A, 1882, ACARI MIRIAPODI SCOR; Blanke A, 2014, ARTHROPOD STRUCT DEV, V43, P63, DOI 10.1016/j.asd.2013.10.003; Bonato L, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.443.7530; Bonato L, 2014, PALAEONTOLOGY, V57, P97, DOI 10.1111/pala.12051; Brewer MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079935; Brewer MS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068005, 10.1371/journal.pone.0079935]; Brewer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037240; Brolemann HW, 1930, IMPRIMERIE TOULOUSAI, V1, P405; Cheung DKB, 2013, ZOOKEYS, P47, DOI 10.3897/zookeys.328.5768; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; Edgecombe GD, 2005, ZOOTAXA, P1; Edgecombe GD, 2009, GEODIVERSITAS, V31, P29, DOI 10.5252/g2009n1a3; ENGHOFF H, 1979, Steenstrupia, V5, P149; ENGHOFF H, 1979, Steenstrupia, V5, P161; Enghoff H., 1982, ENTOMOL SCAND, V18, P1; Enghoff H, 2013, FAUNA EUROPAEA DIPLO; Enghoff H, 2014, EUR J TAXON, V100, P1, DOI 10.5852/ejt.2014.100; Faulwetter S, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.263.4261; Fernandez R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096617; Fernandez R, 2014, MOL BIOL EVOL, V31, P1500, DOI 10.1093/molbev/msu108; Fisher J. Ray, 2010, Acarologia (Paris), V50, P395, DOI 10.1051/acarologia/20101981; Hauser Harald, 2000, Fragmenta Faunistica (Warsaw), V43, P131; Karolyi F, 2014, ARTHROPOD STRUCT DEV, V43, P403, DOI 10.1016/j.asd.2014.07.003; Latzel R., 1884, MYRIOPODEN OSTERREIC, P1; Lewis John G. E., 2009, Soil Organisms, V81, P505; LINNAEUS C, 1958, SYSTEMA NATURAE REGN; Loomis H. F., 1938, Proceedings of the United States National Museum, V86, P27; Loomis HF., 1937, P US NATL MUS, V3006, P97; Mesibov R, 2010, ZOOKEYS, P31, DOI 10.3897/zookeys.41.420; Metscher Brian D, 2011, Cold Spring Harb Protoc, V2011, P1462, DOI 10.1101/pdb.prot067033; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Michalik P, 2013, ZOOKEYS, P117, DOI 10.3897/zookeys.352.6021; MINELLI A, 2006, CHILOBASE WEB RESOUR; Nguyen CV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094346; Penev L, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.21.274; Pimvichai P, 2009, ZOOTAXA, P17, DOI 10.11646/zootaxa.2016.1.2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneeberg K, 2011, ARTHROPOD STRUCT DEV, V40, P93, DOI 10.1016/j.asd.2010.07.002; Shear WA, 1977, PROBLEMI ATTUALI SCI, V171, P235; Sombke A, 2015, J COMP NEUROL, V523, P1281, DOI 10.1002/cne.23741; Stoev Pavel, 2013, Biodivers Data J, pe1013, DOI 10.3897/BDJ.1.e1013; Stoev P, 2010, ZOOKEYS, P29, DOI 10.3897/zookeys.50.504; VERHOEFF K. W., 1939, ZOOL ANZ, V128, P257; VERHOEFF KARL W., 1931, ZOOL JAHRB ABT SYST OKOL U GEOGR TIERE, V62, P263; Walter T, 2010, NAT METHODS, V7, pS26, DOI [10.1038/nmeth.1431, 10.1038/NMETH.1431]; Wheeler QD, 2012, SYST BIODIVERS, V10, P1, DOI 10.1080/14772000.2012.665095; Wipfler B, 2011, SYST ENTOMOL, V36, P241, DOI 10.1111/j.1365-3113.2010.00556.x; Wojcieszek JM, 2012, J ZOOL, V287, P91, DOI 10.1111/j.1469-7998.2011.00892.x; Zimmermann D, 2011, ARTHROPOD STRUCT DEV, V40, P571, DOI 10.1016/j.asd.2011.06.003	53	59	59	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135243	10.1371/journal.pone.0135243	http://dx.doi.org/10.1371/journal.pone.0135243			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309113	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400056
J	Kim, M; Yang, H; Kim, S; Lee, C; Jung, H				Kim, Miroo; Yang, Huisuk; Kim, Suyong; Lee, Chisong; Jung, Hyungil			The Troy Microneedle: A Rapidly Separating, Dissolving Microneedle Formed by Cyclic Contact and Drying on the Pillar (CCDP)	PLOS ONE			English	Article							TRANSDERMAL DRUG-DELIVERY; DRAWING LITHOGRAPHY; SKIN; FABRICATION; PATCHES	In dissolving microneedle (DMN)-mediated therapy, complete and rapid delivery of DMNs is critical for the desired efficacy. Traditional patch-based DMN delivery, however, may fail due to incomplete delivery from insufficient skin insertion or rapid separation of microneedles due to their strong bond to the backing film. Here, we introduce the Troy microneedle, which was created by cyclic contact and drying on the pillar (CCDP), and which enabled simultaneous complete and rapid delivery of DMN. This CCDP process could be flexibly repeated to achieve a specific desired drug dose in a DMN. We evaluated DMN separation using agarose gel, and the Troy microneedle achieved more complete and rapid separation than other, more deeply dipped DMN, primarily because of the Troy's minimal junction between the DMN and pillar. When Troy microneedles were applied to pig cadaver skin, it took only 15 s for over 90% of encapsulated rhodamine B to be delivered, compared to 2 h with application of a traditional DMN patch. In vivo skin penetration studies demonstrated rapid DMN-separation of Troy microneedles still in solid form before dissolution. The Troy microneedle overcomes critical issues associated with the low penetration efficiency of flat patch-based DMN and provides an innovative route for DMN-mediated therapy, combining patient convenience with the desire drug efficacy.	[Kim, Miroo; Yang, Huisuk; Kim, Suyong; Lee, Chisong; Jung, Hyungil] Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea	Yonsei University	Jung, H (corresponding author), Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea.	hijung@yonsei.ac.kr		Kim, Suyong/0000-0003-3775-3594	R&D program of MSIP/COMPA	R&D program of MSIP/COMPA	This work was supported by the R&D program of MSIP/COMPA [Title: Development of minimal pain multi-micro lancets for one-touch-smart diagnostic sensor]	Chen MC, 2013, BIOMATERIALS, V34, P3077, DOI 10.1016/j.biomaterials.2012.12.041; Chu LY, 2011, J CONTROL RELEASE, V149, P242, DOI 10.1016/j.jconrel.2010.10.033; Crichton ML, 2011, BIOMATERIALS, V32, P4670, DOI 10.1016/j.biomaterials.2011.03.012; Davidson A, 2008, CHEM ENG RES DES, V86, P1196, DOI 10.1016/j.cherd.2008.06.002; Davis SP, 2004, J BIOMECH, V37, P1155, DOI 10.1016/j.jbiomech.2003.12.010; Fukushima K, 2011, PHARM RES-DORDR, V28, P7, DOI 10.1007/s11095-010-0097-7; Gomaa YA, 2010, TOXICOL IN VITRO, V24, P1971, DOI 10.1016/j.tiv.2010.08.012; Kim JD, 2013, J CONTROL RELEASE, V170, P430, DOI 10.1016/j.jconrel.2013.05.026; Kim M, 2014, INT J COSMETIC SCI, V36, P207, DOI 10.1111/ics.12115; Lee JW, 2008, BIOMATERIALS, V29, P2113, DOI 10.1016/j.biomaterials.2007.12.048; Lee K, 2012, BIOMATERIALS, V33, P7309, DOI 10.1016/j.biomaterials.2012.06.065; Lee K, 2011, BIOMATERIALS, V32, P7705, DOI 10.1016/j.biomaterials.2011.06.058; Lee K, 2011, BIOMATERIALS, V32, P3134, DOI 10.1016/j.biomaterials.2011.01.014; Lee K, 2010, ADV MATER, V22, P483, DOI 10.1002/adma.200902418; Moga KA, 2013, ADV MATER, V25, P5060, DOI 10.1002/adma.201300526; Sasseville D, 1997, DERMATITIS, V8, P236	16	20	21	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136513	10.1371/journal.pone.0136513	http://dx.doi.org/10.1371/journal.pone.0136513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308945	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400132
J	Takamitsu, E; Otsuka, M; Haebara, T; Yano, M; Matsuzaki, K; Kobuchi, H; Moriya, K; Utsumi, T				Takamitsu, Emi; Otsuka, Motoaki; Haebara, Tatsuki; Yano, Manami; Matsuzaki, Kanako; Kobuchi, Hirotsugu; Moriya, Koko; Utsumi, Toshihiko			Identification of Human N-Myristoylated Proteins from Human Complementary DNA Resources by Cell-Free and Cellular Metabolic Labeling Analyses	PLOS ONE			English	Article							CYTOCHROME B(5) REDUCTASE; MYRISTIC ACID; OUTER MITOCHONDRIAL; MEMBRANE; LIPIDATION; ENZYMOLOGY; MECHANISM; CLEAVAGE; SEQUENCE; BIOLOGY	To identify physiologically important human N-myristoylated proteins, 90 cDNA clones predicted to encode human N-myristoylated proteins were selected from a human cDNA resource (4,369 Kazusa ORFeome project human cDNA clones) by two bioinformatic N-myristoylation prediction systems, NMT-The MYR Predictor and Myristoylator. After database searches to exclude known human N-myristoylated proteins, 37 cDNA clones were selected as potential human N-myristoylated proteins. The susceptibility of these cDNA clones to protein N-myristoylation was first evaluated using fusion proteins in which the N-terminal ten amino acid residues were fused to an epitope-tagged model protein. Then, protein N-myristoylation of the gene products of full-length cDNAs was evaluated by metabolic labeling experiments both in an insect cell-free protein synthesis system and in transfected human cells. As a result, the products of 13 cDNA clones (FBXL7, PPM1B, SAMM50, PLEKHN, AIFM3, C22orf42, STK32A, FAM131C, DRICH1, MCC1, HID1, P2RX5, STK32B) were found to be human N-myristoylated proteins. Analysis of the role of protein N-myristoylation on the intracellular localization of SAMM50, a mitochondrial outer membrane protein, revealed that protein N-myristoylation was required for proper targeting of SAMM50 to mitochondria. Thus, the strategy used in this study is useful for the identification of physiologically important human N-myristoylated proteins from human cDNA resources.	[Takamitsu, Emi; Otsuka, Motoaki; Haebara, Tatsuki; Yano, Manami; Matsuzaki, Kanako; Moriya, Koko; Utsumi, Toshihiko] Yamaguchi Univ, Grad Sch Med, Appl Mol Biosci, Yamaguchi 7538515, Japan; [Utsumi, Toshihiko] Yamaguchi Univ, Dept Biol Chem, Fac Agr, Yamaguchi 7538515, Japan; [Kobuchi, Hirotsugu] Okayama Univ, Dept Cell Chem, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan	Yamaguchi University; Yamaguchi University; Okayama University	Utsumi, T (corresponding author), Yamaguchi Univ, Grad Sch Med, Appl Mol Biosci, Yamaguchi 7538515, Japan.	utsumi@yamaguchi-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23580136, 26450125]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (No. 23580136 and No. 26450125, https://www.jsps.go.jp/j-grantsinaid/index.html) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to TU). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Boisson B, 2003, J BIOL CHEM, V278, P43418, DOI 10.1074/jbc.M307321200; Bologna G, 2004, PROTEOMICS, V4, P1626, DOI 10.1002/pmic.200300783; BORGESE N, 1990, BIOCHEM J, V266, P341, DOI 10.1042/bj2660341; Borgese N, 1996, J CELL BIOL, V135, P1501, DOI 10.1083/jcb.135.6.1501; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Broncel M, 2015, ANGEW CHEM INT EDIT, V54, P5948, DOI 10.1002/anie.201500342; Burnaevskiy N, 2013, NATURE, V496, P106, DOI 10.1038/nature12004; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chida T, 2013, BIOCHEM J, V449, P741, DOI 10.1042/BJ20121201; Colombo S, 2005, J CELL BIOL, V168, P735, DOI 10.1083/jcb.200407082; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; Dukanovic J, 2011, BBA-BIOMEMBRANES, V1808, P971, DOI 10.1016/j.bbamem.2010.06.021; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Ezure T, 2006, BIOTECHNOL PROGR, V22, P1570, DOI 10.1021/bp060110v; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Frearson JA, 2010, NATURE, V464, P728, DOI 10.1038/nature08893; Grammel M, 2013, NAT CHEM BIOL, V9, P475, DOI 10.1038/nchembio.1296; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Martin DDO, 2011, BIOCHIMIE, V93, P18, DOI 10.1016/j.biochi.2010.10.018; Martinez A, 2008, PROTEOMICS, V8, P2809, DOI 10.1002/pmic.200701191; Maurer-Stroh S, 2002, J MOL BIOL, V317, P541, DOI 10.1006/jmbi.2002.5426; Moriya K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078235; Moriya K, 2012, BIOSCI BIOTECH BIOCH, V76, P1201, DOI 10.1271/bbb.120069; OZOLS J, 1984, J BIOL CHEM, V259, P3349; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 2012, TRENDS MOL MED, V18, P206, DOI 10.1016/j.molmed.2012.01.007; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; ROCQUE WJ, 1993, J BIOL CHEM, V268, P9964; Sakurai N, 2007, ANAL BIOCHEM, V362, P236, DOI 10.1016/j.ab.2006.12.030; Sakurai N, 2006, J BIOL CHEM, V281, P14288, DOI 10.1074/jbc.M510338200; SPIEGEL AM, 1991, TRENDS BIOCHEM SCI, V16, P338, DOI 10.1016/0968-0004(91)90139-M; Suzuki T, 2006, J BIOSCI BIOENG, V102, P69, DOI 10.1263/jbb.102.69; Suzuki T, 2010, PROTEOMICS, V10, P1780, DOI 10.1002/pmic.200900783; Takamitsu E, 2014, ANAL BIOCHEM, V464, P83, DOI 10.1016/j.ab.2014.07.006; Tate EW, 2015, CURR OPIN CHEM BIOL, V24, P48, DOI 10.1016/j.cbpa.2014.10.016; Thinon E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5919; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; Utsumi T, 2004, EUR J BIOCHEM, V271, P863, DOI 10.1111/j.1432-1033.2004.03991.x; Utsumi T, 2003, FEBS LETT, V539, P37, DOI 10.1016/S0014-5793(03)00180-7; Utsumi T, 2001, J BIOL CHEM, V276, P10505, DOI 10.1074/jbc.M006134200; Wang LF, 2011, PROTEIN CELL, V2, P74, DOI 10.1007/s13238-011-1008-3; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Wright Megan H, 2010, J Chem Biol, V3, P19, DOI 10.1007/s12154-009-0032-8; Yamauchi S, 2010, FEBS J, V277, P3596, DOI 10.1111/j.1742-4658.2010.07768.x; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	46	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136360	10.1371/journal.pone.0136360	http://dx.doi.org/10.1371/journal.pone.0136360			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308446	gold, Green Submitted, Green Published			2022-12-27	WOS:000360069400114
J	Yazdi, PG; Pedersen, BA; Taylor, JF; Khattab, OS; Chen, YH; Chen, Y; Jacobsen, SE; Wang, PH				Yazdi, Puya G.; Pedersen, Brian A.; Taylor, Jared F.; Khattab, Omar S.; Chen, Yu-Han; Chen, Yumay; Jacobsen, Steven E.; Wang, Ping H.			Increasing Nucleosome Occupancy Is Correlated with an Increasing Mutation Rate so Long as DNA Repair Machinery Is Intact	PLOS ONE			English	Article							READ ALIGNMENT; ORGANIZATION; CANCER; LANDSCAPE; METHYLATION; NUCLEOTIDE; CONSTRAINT; DISCOVERY; FRAMEWORK; CYTOSINE	Deciphering the multitude of epigenomic and genomic factors that influence the mutation rate is an area of great interest in modern biology. Recently, chromatin has been shown to play a part in this process. To elucidate this relationship further, we integrated our own ultra-deep sequenced human nucleosomal DNA data set with a host of published human genomic and cancer genomic data sets. Our results revealed, that differences in nucleosome occupancy are associated with changes in base-specific mutation rates. Increasing nucleosome occupancy is associated with an increasing transition to transversion ratio and an increased germline mutation rate within the human genome. Additionally, cancer single nucleotide variants and microindels are enriched within nucleosomes and both the coding and non-coding cancer mutation rate increases with increasing nucleosome occupancy. There is an enrichment of cancer indels at the theoretical start (74 bp) and end (115 bp) of linker DNA between two nucleosomes. We then hypothesized that increasing nucleosome occupancy decreases access to DNA by DNA repair machinery and could account for the increasing mutation rate. Such a relationship should not exist in DNA repair knockouts, and we thus repeated our analysis in DNA repair machinery knockouts to test our hypothesis. Indeed, our results revealed no correlation between increasing nucleosome occupancy and increasing mutation rate in DNA repair knockouts. Our findings emphasize the linkage of the genome and epigenome through the nucleosome whose properties can affect genome evolution and genetic aberrations such as cancer.	[Yazdi, Puya G.; Pedersen, Brian A.; Taylor, Jared F.; Khattab, Omar S.; Chen, Yu-Han; Chen, Yumay; Wang, Ping H.] Univ Calif Irvine, UC Irvine Diabet Ctr, Irvine, CA 92697 USA; [Yazdi, Puya G.; Pedersen, Brian A.; Taylor, Jared F.; Khattab, Omar S.; Chen, Yu-Han; Chen, Yumay; Wang, Ping H.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA USA; [Yazdi, Puya G.; Pedersen, Brian A.; Taylor, Jared F.; Chen, Yu-Han; Chen, Yumay; Wang, Ping H.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Wang, Ping H.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Wang, Ping H.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Wang, PH (corresponding author), Univ Calif Irvine, UC Irvine Diabet Ctr, Irvine, CA 92697 USA.	phwang@uci.edu		Yazdi, Puya/0000-0003-3456-8043	Ko Family Foundation; Oxnard Foundation; California Institute of Regenerative Medicine [CIRM TG2-01152]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER	Ko Family Foundation; Oxnard Foundation; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Ko Family Foundation and Oxnard Foundation (to P.H.W.). S.E.J is an investigator of the Howard Hughes Medical Institute. P.G.Y. and B.A.P. are recipients of fellowship awards from the California Institute of Regenerative Medicine (CIRM TG2-01152).	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Allan J, 2012, J MOL BIOL, V417, P152, DOI 10.1016/j.jmb.2012.01.043; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Cadet J, 2008, ACCOUNTS CHEM RES, V41, P1075, DOI 10.1021/ar700245e; Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112; Chen XS, 2012, SCIENCE, V335, P1235, DOI 10.1126/science.1217580; CHENG KC, 1992, J BIOL CHEM, V267, P166; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; De S, 2011, NAT BIOTECHNOL, V29, P1103, DOI 10.1038/nbt.2030; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duguid JG, 1996, BIOPHYS J, V71, P3350, DOI 10.1016/S0006-3495(96)79528-0; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Gaffney DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003036; Gammie AE, 2007, GENETICS, V177, P707, DOI 10.1534/genetics.107.071084; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; KAMIYA H, 1995, J BIOL CHEM, V270, P19446, DOI 10.1074/jbc.270.33.19446; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kenigsberg E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001039; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lang GI, 2013, G3-GENES GENOM GENET, V3, P1453, DOI 10.1534/g3.113.006429; Langley SA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004457; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; LEROY JL, 1988, J MOL BIOL, V200, P223, DOI 10.1016/0022-2836(88)90236-7; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2502; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nahkuri S, 2009, CELL CYCLE, V8, P3420, DOI 10.4161/cc.8.20.9916; North JA, 2012, NUCLEIC ACIDS RES, V40, P10215, DOI 10.1093/nar/gks747; Polak P, 2015, NATURE, V518, P360, DOI 10.1038/nature14221; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tang Y, 2012, ANAL CHEM, V84, P7249, DOI 10.1021/ac301727c; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tolstorukov MY, 2011, NAT STRUCT MOL BIOL, V18, P510, DOI 10.1038/nsmb.2012; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Warnecke T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003373; Weghorn D, 2013, P NATL ACAD SCI USA, V110, P10988, DOI 10.1073/pnas.1210887110; West JA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5719; Yang XL, 1998, BIOPHYS J, V75, P1163, DOI 10.1016/S0006-3495(98)74035-4; Yen KY, 2012, CELL, V149, P1461, DOI 10.1016/j.cell.2012.04.036; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	70	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136574	10.1371/journal.pone.0136574	http://dx.doi.org/10.1371/journal.pone.0136574			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308346	Green Published, gold			2022-12-27	WOS:000360069400139
J	Whitfield-Cargile, CM; Cohen, ND; Suchodolski, J; Chaffin, MK; McQueen, CM; Arnold, CE; Dowd, SE; Blodgett, GP				Whitfield-Cargile, Canaan M.; Cohen, Noah D.; Suchodolski, Jan; Chaffin, M. Keith; McQueen, Cole M.; Arnold, Carolyn E.; Dowd, Scot E.; Blodgett, Glenn P.			Composition and Diversity of the Fecal Microbiome and Inferred Fecal Metagenome Does Not Predict Subsequent Pneumonia Caused by Rhodococcus equi in Foals	PLOS ONE			English	Article							SUBCLINICAL PULMONARY ABSCESSES; HORSE BREEDING FARMS; R-EQUI; EPIDEMIOLOGY; ASSOCIATION; INFECTIONS; AZITHROMYCIN; GREENGENES; BACTERIA; EFFICACY	In equids, susceptibility to disease caused by Rhodococcus equi occurs almost exclusively in foals. This distribution might be attributable to the age-dependent maturation of immunity following birth undergone by mammalian neonates that renders them especially susceptible to infectious diseases. Expansion and diversification of the neonatal microbiome contribute to development of immunity in the gut. Moreover, diminished diversity of the gastrointestinal microbiome has been associated with risk of infections and immune dysregulation. We thus hypothesized that varying composition or reduced diversity of the intestinal microbiome of neonatal foals would contribute to increased susceptibility of their developing R. equi pneumonia. The composition and diversity indices of the fecal microbiota at 3 and 5 weeks of age were compared among 3 groups of foals: 1) foals that subsequently developed R. equi pneumonia after sampling; 2) foals that subsequently developed ultrasonographic evidence of pulmonary abscess formation or consolidation but not clinical signs (subclinical group); and, 3) foals that developed neither clinical signs nor ultrasonographic evidence of pulmonary abscess formation or consolidation. No significant differences were found among groups at either sampling time, indicating absence of evidence of an influence of composition or diversity of the fecal microbiome, or predicted fecal metagenome, on susceptibility to subsequent R. equi pneumonia. A marked and significant difference identified between a relatively short interval of time appeared to reflect ongoing adaptation to transition from a milk diet to a diet including available forage (including hay) and access to concentrate fed to the mare.	[Whitfield-Cargile, Canaan M.; Cohen, Noah D.; Chaffin, M. Keith; McQueen, Cole M.; Arnold, Carolyn E.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX 77843 USA; [Suchodolski, Jan] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX USA; [Dowd, Scot E.] Mol Res DNA Lab MR DNA, Shallowater, TX USA; [Blodgett, Glenn P.] 6666 Ranch, Guthrie, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Cohen, ND (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX 77843 USA.	ncohen@cvm.tamu.edu	Dowd, Scot E/M-5386-2017	Dowd, Scot E/0000-0002-6296-1427; Suchodolski, Jan/0000-0002-2176-6932; Mcqueen, Cole/0000-0002-9557-3068	Boehringer Ingelheim [01072014]; Link Equine Research Endowment; American Quarter Horse Foundation; Molecular Research DNA Laboratory (MR DNA); 6666 Ranch	Boehringer Ingelheim(Boehringer Ingelheim); Link Equine Research Endowment; American Quarter Horse Foundation; Molecular Research DNA Laboratory (MR DNA); 6666 Ranch	This work was supported by a grant from Boehringer Ingelheim (Grant number 01072014) http://www.boehringeringelheim.com/. Additional funding was provided by the Link Equine Research Endowment. Fecal sample collection was made possible by a grant from the American Quarter Horse Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Scot E. Dowd is employed by Molecular Research DNA Laboratory (MR DNA). Molecular Research DNA Laboratory (MR DNA) provided support in the form of salary for author SED, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific Cover Letter 2 role of this author is articulated in the 'author contributions' section. Glenn P. Blodgett is employed by 6666 Ranch. 6666 Ranch provided support in the form of salary for author GPB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; ARGENZIO RA, 1974, AM J PHYSIOL, V226, P1043, DOI 10.1152/ajplegacy.1974.226.5.1043; Bordin AI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066640; Boyd NK, 2003, VET IMMUNOL IMMUNOP, V92, P75, DOI 10.1016/S0165-2427(03)00021-7; Bray JR, 1957, ECOL MONOGR, V27, P24; Buntain S, 2010, J EQUINE VET SCI, V30, P191, DOI 10.1016/j.jevs.2010.02.005; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaffin MK, 2008, JAVMA-J AM VET MED A, V232, P1035, DOI 10.2460/javma.232.7.1035; Chaffin MK., 2012, J EQUINE VET SCI, V32, pS20; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cohen ND, 2003, AM J VET RES, V64, P153, DOI 10.2460/ajvr.2003.64.153; Cohen ND, 2008, AM J VET RES, V69, P385, DOI 10.2460/ajvr.69.3.385; Cohen ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109865; Cohen ND, 2013, AM J VET RES, V74, P102, DOI 10.2460/ajvr.74.1.102; Cohen ND, 2012, AM J VET RES, V73, P1603, DOI 10.2460/ajvr.73.10.1603; CROWELLDAVIS SL, 1985, J ANIM SCI, V60, P883, DOI 10.2527/jas1985.604883x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dougal K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077660; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faubladier C, 2014, ANAEROBE, V25, P61, DOI 10.1016/j.anaerobe.2013.11.010; Giguere S, 2011, J VET INTERN MED, V25, P1209, DOI 10.1111/j.1939-1676.2011.00835.x; Grimm MB, 2007, AM J VET RES, V68, P63, DOI 10.2460/ajvr.68.1.63; Guo FD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071714, 10.1371/journal.pone.0076185]; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hildebrand F, 2015, J VET INTERN MED, V29, P333, DOI 10.1111/jvim.12504; Horowitz ML, 2001, J VET INTERN MED, V15, P171, DOI 10.1892/0891-6640(2001)015&lt;0171:AOSMLD&gt;2.3.CO;2; Inman CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033707; Kachroo P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062879; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, P7; Kuskie K, 2011, J EQUINE VET SCI, V31, P6; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mizrahi-Man O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053608; Morton AC, 2001, APPL ENVIRON MICROB, V67, P2167, DOI 10.1128/AEM.67.5.2167-2175.2001; Mshvildadze M, 2010, EARLY HUM DEV, V86, pS67, DOI 10.1016/j.earlhumdev.2010.01.018; Muscatello G, 2007, EQUINE VET J, V39, P470, DOI 10.2746/042516407X209217; Muscatello G, 2006, APPL ENVIRON MICROB, V72, P6152, DOI 10.1128/AEM.00495-06; Muscatello G, 2006, EQUINE VET J, V38, P263, DOI 10.2746/042516406776866480; Myles IA, 2013, J IMMUNOL, V191, P3200, DOI 10.4049/jimmunol.1301057; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Perkins GA, 2015, EQUINE VET J, V47, P267, DOI 10.1111/evj.12387; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; PRESCOTT JF, 1991, CLIN MICROBIOL REV, V4, P20, DOI 10.1128/CMR.4.1.20-34.1991; Sanz M, 2013, VET MICROBIOL, V167, P623, DOI 10.1016/j.vetmic.2013.09.018; Takai S, 1997, VET MICROBIOL, V56, P167, DOI 10.1016/S0378-1135(97)00085-0; Torrazza RM, 2011, J PERINATOL, V31, pS29, DOI 10.1038/jp.2010.172; Venner M, 2013, VET REC, V173, P397, DOI 10.1136/vr.101867; Venner M, 2013, J VET INTERN MED, V27, P171, DOI 10.1111/jvim.12030; Venner M, 2012, VET J, V192, P293, DOI 10.1016/j.tvjl.2011.07.004; Willing BP, 2007, J ANIM SCI, V85, P3256, DOI 10.2527/jas.2007-0320	54	11	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136586	10.1371/journal.pone.0136586	http://dx.doi.org/10.1371/journal.pone.0136586			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305682	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500097
J	Willias, SP; Chauhan, S; Lo, CC; Chain, PSG; Motin, VL				Willias, Stephan P.; Chauhan, Sadhana; Lo, Chien-Chi; Chain, Patrick S. G.; Motin, Vladimir L.			CRP-Mediated Carbon Catabolite Regulation of Yersinia pestis Biofilm Formation Is Enhanced by the Carbon Storage Regulator Protein, CsrA	PLOS ONE			English	Article							ESCHERICHIA-COLI; GLYCOGEN BIOSYNTHESIS; HMS(+) PHENOTYPE; GLOBAL REGULATOR; PLAGUE; EXPRESSION; GENE; RNA; TRANSMISSION; TRANSLATION	The natural transmission of Yersinia pestis is reliant upon biofilm blockage of the flea vector. However, the environmentally-responsive adaptive regulators which facilitate Y. pestis biofilm production in accordance with the flea midgut milieu are not well understood. We seek to establish the impact of available carbon source metabolism and storage upon Y. pestis biofilm production. Our findings demonstrate that Y. pestis biofilm production is subject to carbon catabolite regulation in which the presence of glucose impairs biofilm production; whereas, the sole metabolism of alternate carbon sources promotes robust biofilm formation. This observation is facilitated by the cAMP receptor protein, CRP. In accordance with a stark growth defect, deletion of crp in both CO92 and KIM6+ Y. pestis strains significantly impaired biofilm production when solely utilizing alternate carbon sources. Media supplementation with cAMP, a small-molecule activator of CRP, did not significantly alter Y. pestis biofilm production. Furthermore, CRP did not alter mRNA abundance of previously-characterized hms biofilm synthesis and regulation factors. Therefore, our findings indicate CRP does not confer a direct stimulatory effect, but may indirectly promote Y. pestis biofilm production by facilitating the alternate carbon source expression profile. Additionally, we assessed the impact of the carbon storage regulator protein, CsrA, upon Y. pestis biofilm production. Contrary to what has been described for E. coli, Y. pestis biofilm formation was found to be enhanced by CsrA. Regardless of media composition and available carbon source, deletion of csrA significantly impaired Y. pestis biofilm production. CsrA was found to promote Y. pestis biofilm production independent of glycogen regulation. Loss of csrA did not significantly alter relative hmsH, hmsP, or hmsT mRNA abundance. However, deletion of hmsP in the csrA-deficient mutant enabled excessive biofilm production, suggesting CsrA enables potent Y. pestis biofilm production through cyclic diguanylate regulation.	[Willias, Stephan P.; Motin, Vladimir L.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Chauhan, Sadhana; Motin, Vladimir L.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Lo, Chien-Chi; Chain, Patrick S. G.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; United States Department of Energy (DOE); Los Alamos National Laboratory	Motin, VL (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	vlmotin@utmb.edu	Motin, Vladimir L/O-1535-2013; Chain, Patrick/O-4140-2019	Chain, Patrick/0000-0003-3949-3634; Lo, Chien-Chi/0000-0003-3470-1078; Motin, Vladimir/0000-0002-4762-457X	NIH/NIAID [Y01 AI008401, T32 AI007526]; UTMB McLaughlin pre-doctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI008401, R22AI008401, T32AI007526] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UTMB McLaughlin pre-doctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NIAID, Y01 AI008401; NIH/NIAID, T32 AI007526; and UTMB McLaughlin pre-doctoral fellowship to SPW, http://www.utmb.edu/mclaughlin/predoctoral.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V85, P40; Bacot A W, 1914, J Hyg (Lond), V13, P423; Baker CS, 2007, J BACTERIOL, V189, P5472, DOI 10.1128/JB.00529-07; Baker CS, 2002, MOL MICROBIOL, V44, P1599, DOI 10.1046/j.1365-2958.2002.02982.x; Bellows LE, 2012, MOL MICROBIOL, V86, P661, DOI 10.1111/mmi.12011; Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036; Bobrov AG, 2008, ENVIRON MICROBIOL, V10, P1419, DOI 10.1111/j.1462-2920.2007.01554.x; Bobrov AG, 2011, MOL MICROBIOL, V79, P533, DOI 10.1111/j.1365-2958.2010.07470.x; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chouikha I, 2012, CURR OPIN MICROBIOL, V15, P239, DOI 10.1016/j.mib.2012.02.003; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DOLL JM, 1994, AM J TROP MED HYG, V51, P109, DOI 10.4269/ajtmh.1994.51.109; Dubey AK, 2003, J BACTERIOL, V185, P4450, DOI 10.1128/JB.185.15.4450-4460.2003; Eisen RJ, 2006, P NATL ACAD SCI USA, V103, P15380, DOI 10.1073/pnas.0606831103; Eisen RJ, 2009, VET RES, V40, DOI 10.1051/vetres:2008039; Fang N, 2015, SCI REP-UK, V5, DOI 10.1038/srep09566; FOWLER JM, 1994, INFECT IMMUN, V62, P5234, DOI 10.1128/IAI.62.12.5234-5241.1994; Girish V, 2004, Indian J Cancer, V41, P47; Heroven AK, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00158; Hinnebusch BJ, 2008, CURR TOP MICROBIOL, V322, P229; Hinnebusch BJ, 2005, CURR ISSUES MOL BIOL; Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002; Jonas K, 2008, MOL MICROBIOL, V70, P236, DOI 10.1111/j.1365-2958.2008.06411.x; Jones HA, 1999, MICROBIOL-SGM, V145, P2117, DOI 10.1099/13500872-145-8-2117; Kirillina O, 2004, MOL MICROBIOL, V54, P75, DOI 10.1111/j.1365-2958.2004.04253.x; LeGrand K, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0343-6; Liu MY, 1997, J BIOL CHEM, V272, P17502, DOI 10.1074/jbc.272.28.17502; Perry RD, 2004, J BACTERIOL, V186, P1638, DOI 10.1128/JB.186.6.1638-1647.2004; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; PERRY RD, 1990, J BACTERIOL, V172, P5929, DOI 10.1128/jb.172.10.5929-5937.1990; Rahimpour M, 2013, BIOCHEM J, V452, P559, DOI 10.1042/BJ20130154; ROMEO T, 1993, J BACTERIOL, V175, P4744, DOI 10.1128/JB.175.15.4744-4755.1993; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Sun FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052392; Sun W, 2008, APPL ENVIRON MICROB, V74, P4241, DOI 10.1128/AEM.00940-08; Sun YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019267; SURGALLA MJ, 1969, APPL MICROBIOL, V18, P834, DOI 10.1128/AEM.18.5.834-837.1969; Turatsinze JV, 2008, NAT PROTOC, V3, P1578, DOI 10.1038/nprot.2008.97; Vadyvaloo V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000783; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Weilbacher T, 2003, MOL MICROBIOL, V48, P657, DOI 10.1046/j.1365-2958.2003.03459.x; Willias SP, 2014, MICROB PATHOGENESIS, V76, P33, DOI 10.1016/j.micpath.2014.08.010; Yakhnin AV, 2013, MOL MICROBIOL, V87, P851, DOI 10.1111/mmi.12136; Yang HH, 1996, J BACTERIOL, V178, P1012, DOI 10.1128/jb.178.4.1012-1017.1996; Young GM, 1999, J BACTERIOL, V181, P2823, DOI 10.1128/JB.181.9.2823-2833.1999; Zhan LJ, 2008, INFECT IMMUN, V76, P5028, DOI 10.1128/IAI.00370-08	48	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135481	10.1371/journal.pone.0135481	http://dx.doi.org/10.1371/journal.pone.0135481			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305456	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500023
J	Aldridge, RW; Shaji, K; Hayward, AC; Abubakar, I				Aldridge, Robert W.; Shaji, Kunju; Hayward, Andrew C.; Abubakar, Ibrahim			Accuracy of Probabilistic Linkage Using the Enhanced Matching System for Public Health and Epidemiological Studies	PLOS ONE			English	Article							RECORD-LINKAGE; TUBERCULOSIS; CARE	Background The Enhanced Matching System (EMS) is a probabilistic record linkage program developed by the tuberculosis section at Public Health England to match data for individuals across two datasets. This paper outlines how EMS works and investigates its accuracy for linkage across public health datasets. Methods EMS is a configurable Microsoft SQL Server database program. To examine the accuracy of EMS, two public health databases were matched using National Health Service (NHS) numbers as a gold standard unique identifier. Probabilistic linkage was then performed on the same two datasets without inclusion of NHS number. Sensitivity analyses were carried out to examine the effect of varying matching process parameters. Results Exact matching using NHS number between two datasets (containing 5931 and 1759 records) identified 1071 matched pairs. EMS probabilistic linkage identified 1068 record pairs. The sensitivity of probabilistic linkage was calculated as 99.5% (95% CI: 98.9, 99.8), specificity 100.0% (95% CI: 99.9, 100.0), positive predictive value 99.8% (95% CI: 99.3, 100.0), and negative predictive value 99.9% (95% CI: 99.8, 100.0). Probabilistic matching was most accurate when including address variables and using the automatically generated threshold for determining links with manual review. Conclusion With the establishment of national electronic datasets across health and social care, EMS enables previously unanswerable research questions to be tackled with confidence in the accuracy of the linkage process. In scenarios where a small sample is being matched into a very large database (such as national records of hospital attendance) then, compared to results presented in this analysis, the positive predictive value or sensitivity may drop according to the prevalence of matches between databases. Despite this possible limitation, probabilistic linkage has great potential to be used where exact matching using a common identifier is not possible, including in low-income settings, and for vulnerable groups such as homeless populations, where the absence of unique identifiers and lower data quality has historically hindered the ability to identify individuals across datasets.	[Aldridge, Robert W.; Hayward, Andrew C.] UCL, Inst Hlth Informat, London, England; [Aldridge, Robert W.; Shaji, Kunju; Abubakar, Ibrahim] Publ Hlth England, Ctr Infect Dis Surveillance & Control, London, England; [Abubakar, Ibrahim] UCL, Dept Infect & Populat Hlth, London, England; [Abubakar, Ibrahim] UCL, MRC, Clin Trials Unit, London, England	University of London; University College London; Public Health England; University of London; University College London; Medical Research Council Clinical Trials Unit; University of London; University College London	Aldridge, RW (corresponding author), Farr Inst Hlth Informat Res, London, England.	r.aldridge@ucl.ac.uk	Hayward, Andrew C/C-3268-2013	Hayward, Andrew C/0000-0002-3549-6232; Aldridge, Robert/0000-0003-0542-0816; Abubakar, Ibrahim/0000-0002-0370-1430	Wellcome Trust [097980/Z/11/Z]; NIHR Programme Grant for Applied Research [RP-PG-0407-10340]; NIHR [HTA - 08\68\01]; MRC; Public Health England; Medical Research Council [MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [CL-2015-18-011, SRF-2011-04-001, 08/68/01, ACF-2009-18-028, RP-PG-0407-10340] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Programme Grant for Applied Research; NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Public Health England; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	RWA is funded by a Wellcome Trust research training fellowship (097980/Z/11/Z). ACH is supported by funds from NIHR Programme Grant for Applied Research (RP-PG-0407-10340). IA is supported by NIHR, MRC and Public Health England. The views expressed are those of the authors and not necessarily those of the Wellcome Trust, NIHR, Department of Health, or Public Health England. The development of the probabilistic matching software was supported by funds from NIHR Programme Grant for Applied Research (RP-PG-0407-10340) and NIHR HTA Prognostic value of interferon gamma release assays in predicting active tuberculosis among individuals with, or at risk of, latent tuberculosis infection (HTA - 08\68\01). The study sponsors had no role in study design; in the collection, analysis, and interpretation of data. The corresponding author (RWA) confirms that he had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Blakely T, 2002, INT J EPIDEMIOL, V31, P1246, DOI 10.1093/ije/31.6.1246; Bradley CJ, 2010, HEALTH SERV RES, V45, P1468, DOI 10.1111/j.1475-6773.2010.01142.x; Callaway E, 2013, NATURE, V502, P283, DOI 10.1038/502283a; COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408; Coutinho Evandro Silva Freire, 2006, Cad. Saúde Pública, V22, P2249, DOI 10.1590/S0102-311X2006001000031; da Silveira DP, 2009, REV SAUDE PUBL, V43, P875, DOI 10.1590/S0034-89102009005000060; FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061; Gill M, 2006, BRIT MED J, V333, P73, DOI 10.1136/bmj.38883.593831.4F; Goldacre MJ, 2003, J PUBLIC HEALTH MED, V25, P249, DOI 10.1093/pubmed/fdg058; Grannis Shaun J, 2003, AMIA Annu Symp Proc, P259; Howe GR, 1998, EPIDEMIOL REV, V20, P112, DOI 10.1093/oxfordjournals.epirev.a017966; Jit M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5376; Lyons RA, 2014, LANCET, V383, P1517, DOI 10.1016/S0140-6736(13)61750-X; Maguire H, 2011, EURO SURVEILANCE B E, V16; Nagle Christina M, 2006, Asian Pac J Cancer Prev, V7, P41; Newcombe HB., 1988, HDB RECORD LINKAGE M; Potz N, 2006, HLTH PROT AG ANN C W; Story A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-44; van Hest NAH, 2008, EPIDEMIOL INFECT, V136, P1606, DOI 10.1017/S0950268808000496; WHO, ASS TUB UND REP INV	20	53	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136179	10.1371/journal.pone.0136179	http://dx.doi.org/10.1371/journal.pone.0136179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5VA	26302242	gold, Green Published, Green Submitted			2022-12-27	WOS:000359951900049
J	Aloui, A; Briki, W; Baklouti, H; Chtourou, H; Driss, T; Chaouachi, A; Chamari, K; Souissi, N				Aloui, Asma; Briki, Walid; Baklouti, Hana; Chtourou, Hamdi; Driss, Tarak; Chaouachi, Anis; Chamari, Karim; Souissi, Nizar			Listening to Music during Warming-Up Counteracts the Negative Effects of Ramadan Observance on Short-Term Maximal Performance	PLOS ONE			English	Article							SPRINT PERFORMANCE; PERCEIVED EXERTION; ANAEROBIC PERFORMANCES; DIURNAL-VARIATIONS; POWER OUTPUT; EXERCISE; INTENSITY; STRENGTH; ANXIETY	Aim The aim of the present study was to examine whether listening to music during warming-up might influence short-term maximal performance (STMP), cognitive anxiety, self-confidence, and enjoyment during Ramadan, and whether these affects might predict STMP. Methods Nine male physical education students (age: 21 +/- 1.1 years; height: 1.8 +/- 0.04 m; body mass: 83 +/- 5 kg) volunteered to participate in the present study. A within-subjects design consisted of four experimental sessions: Two sessions occurred one week before Ramadan and two others took place during Ramadan. They were scheduled at 5 p.m. and were conducted as follows: After a 10-minute warm-up either with or without listening to music, each participant performed a 5-m multiple shuttle run test, after which he was asked to answer items intended to assess his affective state during the experimental task. Results Our findings revealed that STMP was lower during Ramadan than before Ramadan in the no-music condition. Additionally, it was found that STMP was higher in the music condition than in the no-music condition during Ramadan, and that STMP measured before Ramadan did not differ from that measured during Ramadan in the music condition. Regarding affects, the findings revealed that enjoyment was lower during Ramadan than before Ramadan in the music condition, and that cognitive anxiety was lower in the music condition than in the no-music condition before Ramadan. Self-confidence was not influenced by the experimental conditions. Conclusion This study showed that listening to music during warming-up not only would be beneficial for STMP in Ramadan fasters, but also would counteract the negative effects of Ramadan observance on STMP.	[Aloui, Asma; Baklouti, Hana; Chtourou, Hamdi; Chaouachi, Anis; Souissi, Nizar] Natl Ctr Med & Sci Sport, Res Lab Sport Performance Optimizat, Tunis, Tunisia; [Aloui, Asma] Univ Gafsa, High Inst Sport & Phys Educ Gafsa, Gafsa, Tunisia; [Briki, Walid] Qatar Univ, Coll Arts & Sci, Sport Sci Program, Doha, Qatar; [Chtourou, Hamdi] Univ Sfax, High Inst Sport & Phys Educ Sfax, Sfax, Tunisia; [Driss, Tarak] Univ Paris Ouest Nanterre La Def, UFR STAPS, Equipe Physiol Biomecan & Imagerie Mouvement, Lab CeRSM,EA 2931, Nanterre, France; [Chamari, Karim] Qatar Orthoped & Sports Med Hosp, Athlete Hlth & Performance Res Ctr, ASPETAR, Doha, Qatar	Centre National de la Medecine Sciences des Sports; Universite de Gafsa; Qatar University; Universite de Sfax; Universite Paris Nanterre; Aspetar Orthopaedic & Sports Medicine Hospital	Briki, W (corresponding author), Qatar Univ, Coll Arts & Sci, Sport Sci Program, Doha, Qatar.	briki.w@gmail.com	CHAMARI, Karim/AAJ-7938-2021; DRISS, Tarak/AAR-2823-2020; Nizar, Souissi/AAF-4490-2019; Chtourou, Hamdi/GVU-1967-2022; Aloui, Asma/J-1300-2019	CHAMARI, Karim/0000-0001-9178-7678; DRISS, Tarak/0000-0001-6109-7393; Nizar, Souissi/0000-0003-1227-8221; Chtourou, Hamdi/0000-0002-5482-9151; Aloui, Asma/0000-0001-5054-1540; Briki, Walid/0000-0002-6298-811X				Aloui A, 2013, INT J SPORT PHYSIOL, V8, P254, DOI 10.1123/ijspp.8.3.254; BECKER N, 1994, PERCEPT MOTOR SKILL, V79, P1043, DOI 10.2466/pms.1994.79.2.1043; BENWARE CA, 1984, AM EDUC RES J, V21, P755, DOI 10.3102/00028312021004755; Boddington MK, 2001, J SPORT SCI, V19, P223, DOI 10.1080/026404101750095394; BROWNLEY KA, 1995, INT J PSYCHOPHYSIOL, V19, P193, DOI 10.1016/0167-8760(95)00007-F; Chtourou H, 2012, INT J SPORTS MED, V33, P142, DOI 10.1055/s-0031-1286251; Chtourou H, 2012, INT J SPORTS MED, V33, P43, DOI 10.1055/s-0031-1284398; Chtourou Hamdi, 2011, Asian J Sports Med, V2, P177; Cooke A, 2013, J SPORT EXERCISE PSY, V35, P132, DOI 10.1123/jsep.35.2.132; Cooke A, 2011, BIOL PSYCHOL, V86, P370, DOI 10.1016/j.biopsycho.2011.01.009; Dyrlund AK, 2008, J MUSIC THER, V45, P114, DOI 10.1093/jmt/45.2.114; Elliott D., 2005, EUR J SPORT SCI, V5, P97, DOI [10.1080/17461390500171310, DOI 10.1080/17461390500171310]; Ghaderi M, 2009, S AFR J RES SPORT PH, V31, P29; Gillet N, 2010, PSYCHOL SPORT EXERC, V11, P155, DOI 10.1016/j.psychsport.2009.10.004; Girard O, 2012, SCI SPORT, V27, P237, DOI 10.1016/j.scispo.2011.09.006; GROLNICK WS, 1987, J PERS SOC PSYCHOL, V52, P890, DOI 10.1037/0022-3514.52.5.890; Hammoudi-Nassib S, 2014, J STRENGTH COND RES, V28, P3245, DOI 10.1519/JSC.0000000000000530; Hamouda O, 2012, BIOL RHYTHM RES, V43, P177, DOI 10.1080/09291016.2011.560050; Jarraya Mohamed, 2012, Asian J Sports Med, V3, P233; Judelson DA, 2007, SPORTS MED, V37, P907, DOI 10.2165/00007256-200737100-00006; Karageorghis C, 2008, INT J SPORTS MED, V29, P613, DOI 10.1055/s-2007-989266; Karageorghis C. I., 1997, Journal of Sport Behavior, V20, P54; Karageorghis C.I., 2009, SPORTING SOUNDS RELA, P13; Karageorghis CI, 1996, PERCEPT MOTOR SKILL, V83, P1347, DOI 10.2466/pms.1996.83.3f.1347; KRANE V, 1994, SPORT PSYCHOL, V8, P189, DOI 10.1123/tsp.8.2.189; Nakamura PM, 2010, PERCEPT MOTOR SKILL, V110, P257, DOI 10.2466/PMS.110.1.257-264; Potteiger JA, 2000, PERCEPT MOTOR SKILL, V91, P848, DOI 10.2466/PMS.91.7.848-854; RYAN RM, 1982, J PERS SOC PSYCHOL, V43, P450, DOI 10.1037/0022-3514.43.3.450; Simpson SD, 2006, J SPORT SCI, V24, P1095, DOI 10.1080/02640410500432789; Souissi N, 2007, CHRONOBIOL INT, V24, P991, DOI 10.1080/07420520701661914; Szmedra L, 1998, INT J SPORTS MED, V19, P32, DOI 10.1055/s-2007-971876; Woodman T, 2003, J SPORT SCI, V21, P443, DOI 10.1080/0264041031000101809; Yamashita S, 2006, J SPORT MED PHYS FIT, V46, P425	33	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136400	10.1371/journal.pone.0136400	http://dx.doi.org/10.1371/journal.pone.0136400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5VA	26301508	Green Published, gold, Green Submitted			2022-12-27	WOS:000359951900067
J	Liu, BY; Luo, L; Yan, SY; Wen, TC; Bai, WJ; Li, HJ; Zhang, GL; Lu, XY; Liu, Y; He, LY				Liu, Baoyan; Luo, Lin; Yan, Shiyan; Wen, Tiancai; Bai, Wenjing; Li, Hongjiao; Zhang, Guoliang; Lu, Xiaoying; Liu, Yan; He, Liyun			Clinical Features for Mild Hand, Foot and Mouth Disease in China	PLOS ONE			English	Article							ENTEROVIRUS 71 INFECTION; OUTBREAK; SINGAPORE; TAIWAN; EPIDEMIOLOGY; CHILDREN	Background Mild hand, foot and mouth disease (HFMD) is at a critical stage owing to its ease of communicability and a higher risk of developing severe complications and death. Clinical diagnosis of mild HFMD was made by the presenting symptoms and signs (symptoms in brief) alone. We aim to evaluate the frequencies of symptoms in a retrospective case series study. Methods We collected epidemiological, demographic, clinical, and laboratory data from outpatient and inpatient settings on the clinical data warehouse system. We principally described the frequencies of symptoms of mild HFMD. Correlations between symptoms with laboratory-confirmed cases were then analyzed. Results The clinical data warehouse system included 3649 probable cases, between 2010 and 2012, of which 956 (26.20%) were laboratory confirmed. The peak incidence was identified in children 2 years of age. A total of 370 of the 956 laboratory confirmed cases (38.70%) were associated with enterovirus 71 (EV71). Logistic regression analysis adjusted for geographical variables, age, sex, month of onset, and time from onset to diagnosis showed that the clinical features constipation (P<0.0001; adjusted OR, 95%CI (2.99, 2.28-3.91)), and blisters (P<0.0001; adjusted OR, 95%CI (2.16, 1.82-2.56)) were positively correlated with the confirmed cases. Conclusions This is the largest case series study, including all the guideline-mentioned symptoms of mild HFMD. Our findings suggest that blisters and constipation should be considered as potential warning signs while front-line clinicians manage surges of children diagnosed with mild HFMD during a pandemic.	[Liu, Baoyan] China Acad Chinese Med Sci, Beijing, Peoples R China; [Luo, Lin; Yan, Shiyan; Wen, Tiancai; Bai, Wenjing; Li, Hongjiao; Lu, Xiaoying; Liu, Yan; He, Liyun] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China; [Zhang, Guoliang] Anhui Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Infect Dis, Hefei, Peoples R China; [Liu, Baoyan] China Acad Chinese Med Sci, Tradit Chinese Med Data Ctr, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS; Anhui University of Chinese Medicine; China Academy of Chinese Medical Sciences	Liu, Y (corresponding author), China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China.	liuyan8591@163.com; helyjornal@163.com	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	State Administration of Traditional Chinese Medicine of China Support Project [200907001]	State Administration of Traditional Chinese Medicine of China Support Project	The study was supported by State Administration of Traditional Chinese Medicine of China Support Project (no. 200907001).	Ahmad K, 2000, LANCET, V356, P1338, DOI 10.1016/S0140-6736(05)74253-7; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Clarke TM, 1964, BR MED J; Fujimoto T, 2012, EMERG INFECT DIS, V18, P337, DOI 10.3201/eid1802.111147; GOH KT, 1982, B WORLD HEALTH ORGAN, V60, P965; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang WC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-209; Kar BR, 2013, INDIAN PEDIATR, V50, P139, DOI 10.1007/s13312-013-0033-0; Li YB, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/270450; Liang ZL, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.24; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; MAGOFFIN RL, 1961, JAMA-J AM MED ASSOC, V175, P441, DOI 10.1001/jama.1961.03040060015004; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; MORI I, 1995, J INFECTION, V31, P219, DOI 10.1016/S0163-4453(95)80030-1; Ooi MH, 2007, CLIN INFECT DIS, V44, P646, DOI 10.1086/511073; ROBINSON C R, 1958, Can Med Assoc J, V79, P615; Sanchez G, DATA ANAL VISUALLY E; Shah VA, 2003, ANN ACAD MED SINGAP, V32, P381; Shang LQ, 2013, ANTIVIR RES, V97, P183, DOI 10.1016/j.antiviral.2012.12.005; The Ministry of Health of the People's Republic of China, 2010, GUID DIAGN TREATM HA; The Ministry of Health of the People's Republic of China, NAT STAT EP SIT INF; The State Administration of Traditional Chinese Medicine (China, IND TRAD CHIN MED SC; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang Y, 2011, EPIDEMIOLOGY, V22, P781, DOI 10.1097/EDE.0b013e318231d67a; WHO Regional Office for the Western Pacific, GUID CLIN MAN PUBL H; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Yang F, 2011, CLIN INFECT DIS, V53, P400, DOI 10.1093/cid/cir346; Zeng M, 2012, EPIDEMIOL INFECT, V140, P1122, DOI 10.1017/S0950268811001622; Zhang GL, 2009, CLIN J TRADITIONAL C, V21, P569; Zhou XZ, 2014, FRONT MED-PRC, V8, P337, DOI 10.1007/s11684-014-0349-8; Zhou XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5212; Zhou XZ, 2010, ARTIF INTELL MED, V48, P139, DOI 10.1016/j.artmed.2009.07.012	36	24	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135503	10.1371/journal.pone.0135503	http://dx.doi.org/10.1371/journal.pone.0135503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302092	Green Published, gold, Green Submitted			2022-12-27	WOS:000359951900022
J	Park, MH; Shim, HS; Kim, WH; Kim, HJ; Kim, DJ; Lee, SH; Kim, CS; Gwak, MS; Kim, GS				Park, Mi Hye; Shim, Haeng Seon; Kim, Won Ho; Kim, Hyo-Jin; Kim, Dong Joon; Lee, Seong-Ho; Kim, Chung Su; Gwak, Mi Sook; Kim, Gaab Soo			Clinical Risk Scoring Models for Prediction of Acute Kidney Injury after Living Donor Liver Transplantation: A Retrospective Observational Study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; INTENSIVE INSULIN THERAPY; POSTREPERFUSION SYNDROME; MYCOPHENOLATE-MOFETIL; GLUCOSE CONTROL; INTRAOPERATIVE HYPERGLYCEMIA; CARDIAC-SURGERY; RIFLE CRITERIA; SEVERE SEPSIS; DYSFUNCTION	Acute kidney injury (AKI) is a frequent complication of liver transplantation and is associated with increased mortality. We identified the incidence and modifiable risk factors for AKI after living-donor liver transplantation (LDLT) and constructed risk scoring models for AKI prediction. We retrospectively reviewed 538 cases of LDLT. Multivariate logistic regression analysis was used to evaluate risk factors for the prediction of AKI as defined by the RIFLE criteria (RIFLE = risk, injury, failure, loss, end stage). Three risk scoring models were developed in the retrospective cohort by including all variables that were significant in univariate analysis, or variables that were significant in multivariate analysis by backward or forward stepwise variable selection. The risk models were validated by way of cross-validation. The incidence of AKI was 27.3%(147/538) and 6.3%(34/538) required postoperative renal replacement therapy. Independent risk factors for AKI by multivariate analysis of forward stepwise variable selection included: body-mass index > 27.5 kg/m(2) [odds ratio (OR) 2.46, 95% confidence interval (CI) 1.32-4.55], serum albumin < 3.5 mg/dl (OR 1.76, 95% CI 1.05-2.94), MELD (model for end-stage liver disease) score > 20 (OR 2.01, 95% CI 1.17-3.44), operation time > 600 min (OR 1.81, 95% CI 1.07-3.06), warm ischemic time > 40 min (OR 2.61, 95% CI 1.55-4.38), postreperfusion syndrome (OR 2.96, 95% CI 1.55-4.38), mean blood glucose during the day of surgery > 150 mg/dl (OR 1.66, 95% CI 1.01-2.70), cryoprecipitate > 6 units (OR 4.96, 95% CI 2.84-8.64), blood loss/body weight > 60 ml/kg (OR 4.05, 95% CI 2.28-7.21), and calcineurin inhibitor use without combined mycophenolate mofetil (OR 1.87, 95% CI 1.14-3.06). Our risk models performed better than did a previously reported score by Utsumi et al. in our study cohort. Doses of calcineurin inhibitor should be reduced by combined use of mycophenolate mofetil to decrease postoperative AKI. Prospective randomized trials are required to address whether artificial modification of hypoalbuminemia, hyperglycemia and postreperfusion syndrome would decrease postoperative AKI in LDLT.	[Park, Mi Hye; Kim, Chung Su; Gwak, Mi Sook; Kim, Gaab Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Shim, Haeng Seon; Kim, Won Ho; Kim, Hyo-Jin; Kim, Dong Joon; Lee, Seong-Ho] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Anesthesiol & Pain Med, Chang Won, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, WH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Anesthesiol & Pain Med, Chang Won, South Korea.	wonhokim.ane@gmail.com	Kim, Won Ho/S-8671-2019	Kim, Won Ho/0000-0003-1748-1296	Samsung Biomedical Research Institute	Samsung Biomedical Research Institute(Samsung)	This study was supported by Samsung Biomedical Research Institute grant.	Akamatsu N, 2006, TRANSPL P, V38, P1474, DOI 10.1016/j.transproceed.2006.03.031; Ammori JB, 2007, J SURG RES, V140, P227, DOI 10.1016/j.jss.2007.02.019; Barri YM, 2009, LIVER TRANSPLANT, V15, P475, DOI 10.1002/lt.21682; Bojan M, 2012, KIDNEY INT, V82, P474, DOI 10.1038/ki.2012.172; Borthwick E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3365; Burns KEA, 2005, JAMA-J AM MED ASSOC, V294, P342, DOI 10.1001/jama.294.3.342; Cabezuelo JB, 2006, KIDNEY INT, V69, P1073, DOI 10.1038/sj.ki.5000216; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Cantarovich M, 2003, TRANSPLANTATION, V76, P98, DOI 10.1097/01.TP.0000054367.57978.4C; Chen J, 2011, TRANSPLANTATION, V91, P348, DOI 10.1097/TP.0b013e31820437da; Cittanova ML, 1996, LANCET, V348, P1620, DOI 10.1016/S0140-6736(96)07588-5; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; Dahm F, 2005, AM J TRANSPLANT, V5, P2605, DOI 10.1111/j.1600-6143.2005.01081.x; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dixon R, 1999, J AM SOC NEPHROL, V10, P1487; Ferreira AC, 2010, CLIN TRANSPLANT, V24, P394, DOI 10.1111/j.1399-0012.2009.01087.x; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Fukazawa K, 2014, J CARDIOTHOR VASC AN, V28, P994, DOI 10.1053/j.jvca.2014.02.017; Fukazawa K, 2014, J AM SOC NEPHROL, V25, P884, DOI 10.1681/ASN.2013111215; Gallardo ML, 2004, LIVER TRANSPLANT, V10, P1379, DOI 10.1002/lt.20215; Gassanov N, 2014, J AM SOC NEPHROL, V25, P216, DOI 10.1681/ASN.2013070708; Gonwa TA, 2001, TRANSPLANTATION, V72, P1934, DOI 10.1097/00007890-200112270-00012; Griesdale DEG, 2009, CAN MED ASSOC J, V180, P821, DOI 10.1503/cmaj.090206; Guitard J, 2006, CLIN NEPHROL, V65, P103; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hilmi IA, 2015, BRIT J ANAESTH, V114, P919, DOI 10.1093/bja/aeu556; Hilmi I, 2008, LIVER TRANSPLANT, V14, P504, DOI 10.1002/lt.21381; Igleslas J, 1999, AM J PHYSIOL-RENAL, V277, pF711, DOI 10.1152/ajprenal.1999.277.5.F711; Inoue Y, 2012, CLIN TRANSPLANT, V26, pE530, DOI 10.1111/ctr.12027; JUSKO WJ, 1995, THER DRUG MONIT, V17, P606, DOI 10.1097/00007691-199512000-00011; KAUFMANN MA, 1995, J PHARMACOL EXP THER, V273, P855; Kim SG, 2004, TRANSPL P, V36, P2318, DOI 10.1016/j.transproceed.2004.06.042; Kim WH, 2014, LIVER TRANSPLANT, V20, P1383, DOI 10.1002/lt.23960; Koch RO, 2004, TRANSPL INT, V17, P518, DOI 10.1007/s00147-004-0749-9; Kundakci A, 2010, TRANSPL P, V42, P4171, DOI 10.1016/j.transproceed.2010.09.137; Lecomte P, 2008, CRIT CARE, V12, DOI 10.1186/cc7145; LeDell E, 2012, COMPUTATIONALLY EFFI; Lee SK, 2007, TRANSPL P, V39, P1517, DOI 10.1016/j.transproceed.2006.11.018; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LINDHOLM A, 1995, THER DRUG MONIT, V17, P631, DOI 10.1097/00007691-199512000-00015; Marvin Michael R, 2009, J Diabetes Sci Technol, V3, P1365; O'Riordan A, 2007, AM J TRANSPLANT, V7, P168, DOI 10.1111/j.1600-6143.2006.01602.x; Ouattara A, 2005, ANESTHESIOLOGY, V103, P687, DOI 10.1097/00000542-200510000-00006; Paramesh AS, 2004, CLIN TRANSPLANT, V18, P94, DOI 10.1046/j.1399-0012.2003.00132.x; Park C, 2009, TRANSPLANTATION, V87, P1031, DOI 10.1097/TP.0b013e31819cc3e6; Paugam-Burtz C, 2009, LIVER TRANSPLANT, V15, P522, DOI 10.1002/lt.21730; Pfitzmann R, 2002, TRANSPLANT P, V34, P2936, DOI 10.1016/S0041-1345(02)03495-4; Ramsay M, 2008, LIVER TRANSPLANT, V14, P412, DOI 10.1002/lt.21418; Romano TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064089; Ryu HG, 2011, AM J TRANSPLANT, V11, P977, DOI 10.1111/j.1600-6143.2011.03514.x; Ryu HG, 2012, LIVER TRANSPLANT, V18, P1430, DOI 10.1002/lt.23511; Selzner M, 2010, ANN SURG, V251, P153, DOI 10.1097/SLA.0b013e3181bc9c6a; Siegert S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076813; Thomas ME, 2015, KIDNEY INT, V87, P62, DOI 10.1038/ki.2014.328; Umbro I, 2011, TRANSPL P, V43, P1139, DOI 10.1016/j.transproceed.2011.02.045; Utsumi M, 2013, TRANSPL INT, V26, P842, DOI 10.1111/tri.12138; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Varrier M, 2014, CURR OPIN NEPHROL HY, V23, P560, DOI 10.1097/MNH.0000000000000061; Yoo YC, 2014, KIDNEY INT, V86, P414, DOI 10.1038/ki.2013.532; Zhu M, 2010, TRANSPL P, V42, P3634, DOI 10.1016/j.transproceed.2010.08.059	62	59	64	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136230	10.1371/journal.pone.0136230	http://dx.doi.org/10.1371/journal.pone.0136230			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302370	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900050
J	Wang, C; Kao, WH; Hsiao, CK				Wang, Charlotte; Kao, Wen-Hsin; Hsiao, Chuhsing Kate			Using Hamming Distance as Information for SNP-Sets Clustering and Testing in Disease Association Studies	PLOS ONE			English	Article							MULTIPLE GENES; RARE; REGRESSION; VARIANTS; NUMBER	The availability of high-throughput genomic data has led to several challenges in recent genetic association studies, including the large number of genetic variants that must be considered and the computational complexity in statistical analyses. Tackling these problems with a marker-set study such as SNP-set analysis can be an efficient solution. To construct SNP-sets, we first propose a clustering algorithm, which employs Hamming distance to measure the similarity between strings of SNP genotypes and evaluates whether the given SNPs or SNP-sets should be clustered. A dendrogram can then be constructed based on such distance measure, and the number of clusters can be determined. With the resulting SNP-sets, we next develop an association test HDAT to examine susceptibility to the disease of interest. This proposed test assesses, based on Hamming distance, whether the similarity between a diseased and a normal individual differs from the similarity between two individuals of the same disease status. In our proposed methodology, only genotype information is needed. No inference of haplotypes is required, and SNPs under consideration do not need to locate in nearby regions. The proposed clustering algorithm and association test are illustrated with applications and simulation studies. As compared with other existing methods, the clustering algorithm is faster and better at identifying sets containing SNPs exerting a similar effect. In addition, the simulation studies demonstrated that the proposed test works well for SNP-sets containing a large proportion of neutral SNPs. Furthermore, employing the clustering algorithm before testing a large set of data improves the knowledge in confining the genetic regions for susceptible genetic markers.	[Wang, Charlotte; Kao, Wen-Hsin; Hsiao, Chuhsing Kate] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 100, Taiwan; [Hsiao, Chuhsing Kate] Natl Taiwan Univ, Res Ctr Med Excellence, Div Genom Med, Bioinformat & Biostat Core, Taipei 100, Taiwan; [Hsiao, Chuhsing Kate] Natl Taiwan Univ, Dept Publ Hlth, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Hsiao, CK (corresponding author), Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 100, Taiwan.	ckhsiao@ntu.edu.tw		hsiao, chuhsing kate/0000-0003-4905-8484; Wei, Zhi/0000-0001-6059-4267	Ministry of Science and Technology in Taiwan	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	CK Hsiao received the funding from the Ministry of Science and Technology in Taiwan. The serial number is NSC 100-2314-B-002-107-MY3 and MOST 103-2314-B-002-039-MY3.	Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Derkach A, 2014, STAT SCI, V29, P302, DOI 10.1214/13-STS456; EMRICH LJ, 1991, AM STAT, V45, P302, DOI 10.2307/2684460; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Huang HL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002177; Huang XZ, 1997, DATA MIN KNOWL DISC, V2, P283; Huang YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021890; Huson DH, 2010, PHYLOGENETIC NETWORK; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Khan SS, 2013, EXPERT SYST APPL, V40, P7444, DOI 10.1016/j.eswa.2013.07.002; Lee MH, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-48; Liu Y, 2010, J BIOMED INFORM, V43, P233, DOI 10.1016/j.jbi.2009.11.004; Ma L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003321; Nguyen LB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002026; Petersen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062161; Pinheiro HP, 2005, J STAT PLAN INFER, V130, P325, DOI 10.1016/j.jspi.2003.03.002; Schaid DJ, 2005, AM J HUM GENET, V76, P780, DOI 10.1086/429838; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Selinski S, 2008, J TOXICOL ENV HEAL A, V71, P835, DOI 10.1080/15287390801985828; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tjaden B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-17; Tzeng JY, 2011, AM J HUM GENET, V89, P277, DOI 10.1016/j.ajhg.2011.07.007; Tzeng JY, 2009, BIOMETRICS, V65, P822, DOI 10.1111/j.1541-0420.2008.01176.x; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wei Z, 2008, ANN HUM GENET, V72, P821, DOI 10.1111/j.1469-1809.2008.00473.x; Wessel J, 2006, AM J HUM GENET, V79, P792, DOI 10.1086/508346; Witten DM, 2010, J AM STAT ASSOC, V105, P713, DOI 10.1198/jasa.2010.tm09415; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Yan M, 2007, BIOMETRICS, V63, P1031, DOI 10.1111/j.1541-0420.2007.00784.x; Zhang P, 2006, J AM STAT ASSOC, V101, P355, DOI 10.1198/016214505000000312	34	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135918	10.1371/journal.pone.0135918	http://dx.doi.org/10.1371/journal.pone.0135918			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302001	gold, Green Submitted, Green Published			2022-12-27	WOS:000359951900034
J	Xiao, WK; Ye, P; Cao, RH; Yang, X; Bai, YY; Wu, HM				Xiao, Wenkai; Ye, Ping; Cao, Ruihua; Yang, Xu; Bai, Yongyi; Wu, Hongmei			Urine Albumin Excretion Is Associated with Cardiac Troponin T Detected with a Highly Sensitive Assay in a Community-Based Population	PLOS ONE			English	Article							LOW-GRADE ALBUMINURIA; CHRONIC KIDNEY-DISEASE; HEART-FAILURE; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR EVENTS; HYPERTENSIVE PATIENTS; MORTALITY; RISK; MICROALBUMINURIA; MARKERS	Background Urine albumin excretion is an important predictor of adverse cardiovascular events. Minimally elevated levels of serum cardiac troponin T (cTnT), a marker of cardiomyocyte micro-necrosis, can be detected with high sensitivity cTnT (hs-cTnT) assays. The purpose of this study was to investigate the relationship between alterations in albuminuria and serum hs-cTnT levels in a community-based population. Methods We examined the association between the urine albumin/creatinine ratio (UACR) and hs-cTnT levels in 1354 participants without overt cardiovascular disease in a community-based, cross-sectional study in Beijing, China. Results With the highly sensitive assay, cTnT levels were detectable in 90.5% of our subjects. The median (interquartile range) concentrations of hs-cTnT were 7 (5-10) pg/mL. After adjustment for several factors, UACR (odds ratio: 1.40; 95% confidence interval: 1.08-1.65; P = 0.002) was associated with a higher likelihood of elevated hs-cTnT (>= 14 pg/mL), whereas the relationship between UACR and a higher presence of detectable hs-cTnT (>= 3 pg/mL) was not significant. In addition, a fully adjusted logistic regression analysis revealed that compared with participants in the lowest UACR quartile, those in the highest quartile had a 2.43-fold (95% CI: 1.25-5.08; P = 0.006) increased risk of elevated hs-cTnT. Conclusions Higher urine albumin excretion is associated with elevated hs-cTnT among persons without clinically evident cardiovascular disease, suggesting that albuminuria may be a potential risk factor for subclinical cardiovascular disease in the general population.	[Xiao, Wenkai; Ye, Ping; Cao, Ruihua; Yang, Xu; Bai, Yongyi; Wu, Hongmei] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital	Ye, P (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, 28 Fuxing Rd, Beijing 100853, Peoples R China.	yeping@sina.com	Wang, Dapeng/HGD-4818-2022		Key National Basic Research Program of China [2012CB517503, 2013CB530804]; Key Science and Technology Foundation of China [2012ZX09303004-002]	Key National Basic Research Program of China(National Basic Research Program of China); Key Science and Technology Foundation of China	This research is supported by a grant from the Key National Basic Research Program of China (2012CB517503, 2013CB530804) and the Key Science and Technology Foundation of China (2012ZX09303004-002) to Dr. Ping Ye. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki S, 2007, DIABETES, V56, P1727, DOI 10.2337/db06-1646; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Bakris GL, 2005, HYPERTENSION, V46, P1309, DOI 10.1161/01.HYP.0000190585.54734.48; Barbier CE, 2006, J AM COLL CARDIOL, V48, P765, DOI 10.1016/j.jacc.2006.05.041; Clausen P, 2001, CIRCULATION, V103, P1869; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; deFilippi C, 2012, CLIN CHEM, V58, P1342, DOI 10.1373/clinchem.2012.185322; deFilippi CR, 2010, JAMA-J AM MED ASSOC, V304, P2494, DOI 10.1001/jama.2010.1708; Dubin RF, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-229; Eknoyan G, 2003, AM J KIDNEY DIS, V42, P617, DOI 10.1016/S0272-6386(03)00826-6; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Giannitsis E, 2010, CLIN CHEM, V56, P254, DOI 10.1373/clinchem.2009.132654; Hellemons ME, 2013, J HYPERTENS, V31, P805, DOI 10.1097/HJH.0b013e32835eb5e8; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hiramoto JS, 2012, AM J KIDNEY DIS, V60, P225, DOI 10.1053/j.ajkd.2012.02.335; Hong YJ, 2011, CIRC J, V75, P2893, DOI 10.1253/circj.CJ-11-0663; Huang Y, 2010, J CLIN ENDOCR METAB, V95, P5122, DOI 10.1210/jc.2010-0544; Ibsen H, 2005, HYPERTENSION, V45, P198, DOI 10.1161/01.HYP.0000154082.72286.2a; Jackson CE, 2009, LANCET, V374, P543, DOI 10.1016/S0140-6736(09)61378-7; Katz DH, 2014, CIRCULATION, V129, P42, DOI 10.1161/CIRCULATIONAHA.113.003429; Lee M, 2010, STROKE, V41, P2625, DOI 10.1161/STROKEAHA.110.581215; Lopes-Virella MF, 2013, DIABETES CARE, V36, P2317, DOI 10.2337/dc12-2521; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Morrow DA, 2009, CLIN CHEM, V55, P5, DOI 10.1373/clinchem.2008.117218; Nakamura Y, 2014, CIRC J, V78, P890, DOI 10.1253/circj.CJ-13-1372; Neeland IJ, 2013, J AM COLL CARDIOL, V61, P187, DOI 10.1016/j.jacc.2012.10.012; Otsuka T, 2010, AM HEART J, V159, P972, DOI 10.1016/j.ahj.2010.02.036; Rein P, 2011, AM J CARDIOL, V107, P1144, DOI 10.1016/j.amjcard.2010.12.011; Sacks David B, 2011, Diabetes Care, V34, pe61, DOI 10.2337/dc11-9998; Satoh M, 2012, CLIN EXP NEPHROL, V16, P518, DOI 10.1007/s10157-012-0646-y; Saunders JT, 2011, CIRCULATION, V123, P1367, DOI 10.1161/CIRCULATIONAHA.110.005264; Scheven L, 2012, EUR HEART J, V33, P2272, DOI 10.1093/eurheartj/ehs163; Schmieder RE, 2007, CLIN RES CARDIOL, V96, P247, DOI 10.1007/s00392-007-0510-3; Siddiqi FS, 2013, DIABETES, V62, P3647, DOI 10.2337/db13-0795; Takashio S, 2013, J AM COLL CARDIOL, V62, P632, DOI 10.1016/j.jacc.2013.03.065; Wallace TW, 2006, CIRCULATION, V113, P1958, DOI 10.1161/CIRCULATIONAHA.105.609974; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038218; Witte EC, 2009, J AM SOC NEPHROL, V20, P436, DOI 10.1681/ASN.2008030292; Xiao WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085938; Yun L, 2014, INT HEART J, V55, P153, DOI 10.1536/ihj.13-232	41	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135747	10.1371/journal.pone.0135747	http://dx.doi.org/10.1371/journal.pone.0135747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301504	Green Published, gold, Green Submitted			2022-12-27	WOS:000359951900028
J	Heo, YJ; Kim, HS; Park, JE; Choi, CG; Kim, SJ				Heo, Young Jin; Kim, Ho Sung; Park, Ji Eun; Choi, Choong-Gon; Kim, Sang Joon			Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; PREDICTION; BRAIN; GRADE	Purpose The purpose of this study was to evaluate the accuracy of diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE) perfusion MR imaging for distinguishing tumor recurrence from post-treatment effect as alternatives to dynamic-susceptibility contrast-enhanced (DSC) perfusion MR imaging when the DSC image is uninterpretable. Materials and Methods This retrospective study was approved by our institutional review board. Seventy one post-treatment glioblastoma patients who showed enlarged contrast-enhancing lesions on follow- up MR images after concurrent chemoradiotherapy and uninterpretable DSC images for corresponding enhancing lesions, underwent additional DWI and DCE MR imaging. The primary outcome was the frequency of interpretable DWI and DCE MR cases in these 71 patients. The secondary outcome was the area under the receiver operating characteristic curve (AUC) of DWI and DCE imaging parameters for distinguishing tumor recurrence from post-treatment effect in selected patients with interpretable DWI and DCE images. The imaging parameters were quantified as 10% cumulative histogram cutoff of apparent diffusion coefficient (ADC10) and 90% cumulative histogram cutoff of initial area under the time signal intensity curve (IAUC90). The AUCs were cross-validated by using leave-one-out method. Results Of the 71 patients, the uninterpretable DSC images were associated with treatment-related hemorrhage within the corresponding enhancing lesions (n = 54, 76.1%) and a near skull base location (n = 17, 23.9%). The frequencies of interpretable DWI and DCE image were 51 (71.8%) and 59 (83.1%) of the 71 cases with uninterpretable DSC images, respectively. Of the 45 selected patients with interpretable DWI and DCE images, the combination of DWI with DCE imaging showed a superior diagnostic performance than DWI or DCE imaging alone for differentiating tumor recurrence from post-treatment effect (cross-validated AUC: 0.78 versus 0.55 and 0.73 for reader 1; cross-validated AUC: 0.78 versus 0.53 and 0.75 for reader 2, respectively). Cross-validated accuracy of the single and combined imaging parameters also showed the highest for the combination of DWI with DCE MR imaging (72.9% for reader 1; 72.5% for reader 2) and the lowest for DWI alone (54.0% for reader 1; 56.4% for reader 2). Inter-reader agreement for DCE imaging was higher than that for DWI (intraclass correlation coefficient: 0.95 versus 0.87). Conclusion DCE MR imaging could be a superior and more reproducible imaging biomarker than DWI for differentiating tumor recurrence from post-treatment effect in patients with post-treatment glioblastoma when DSC MR images are not interpretable.	[Kim, Ho Sung; Park, Ji Eun; Choi, Choong-Gon; Kim, Sang Joon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Ho Sung; Park, Ji Eun; Choi, Choong-Gon; Kim, Sang Joon] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea; [Heo, Young Jin] Inje Univ, Busan Paik Hosp, Dept Radiol, Busan, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Inje University	Kim, HS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea.	radhskim@gmail.com						Barajas RF, 2009, RADIOLOGY, V253, P486, DOI 10.1148/radiol.2532090007; Cheng HLM, 2007, J MAGN RESON IMAGING, V25, P1073, DOI 10.1002/jmri.20898; Chung WJ, 2013, RADIOLOGY, V269, P560, DOI 10.1148/radiol.13130016; Cordes D, 2000, MAGN RESON IMAGING, V18, P1055, DOI 10.1016/S0730-725X(00)00199-5; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dzik-Jurasz A, 2002, LANCET, V360, P307, DOI 10.1016/S0140-6736(02)09520-X; Fluckiger JU, 2009, MAGN RESON MED, V62, P1477, DOI 10.1002/mrm.22101; Hamstra DA, 2007, J CLIN ONCOL, V25, P4104, DOI 10.1200/JCO.2007.11.9610; HEILAND S, 2003, IMAGING DECISIONS MR, V7, P4; Hu LS, 2009, AM J NEURORADIOL, V30, P552, DOI 10.3174/ajnr.A1377; Kim HS, 2014, RADIOLOGY, V273, P831, DOI 10.1148/radiol.14132868; Law M, 2007, AM J NEURORADIOL, V28, P761; Law M, 2004, AM J NEURORADIOL, V25, P746; LEVIN JM, 1995, MAGN RESON MED, V34, P655, DOI 10.1002/mrm.1910340503; Levin JM, 1998, J MAGN RESON, V130, P292, DOI 10.1006/jmre.1997.1317; Liang LX, 1999, AM J NEURORADIOL, V20, P1527; Lin DD, 2011, AM J NEURORADIOL, V22, P1275; Lupo JM, 2006, J MAGN RESON IMAGING, V24, P520, DOI 10.1002/jmri.20673; Narang J, 2011, NEURO-ONCOLOGY, V13, P1037, DOI 10.1093/neuonc/nor075; RUNGE VM, 1994, J MAGN RESON IMAGING, V4, P457, DOI 10.1002/jmri.1880040335; Suh CH, 2013, AM J NEURORADIOL, V34, P2278, DOI 10.3174/ajnr.A3634	21	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136380	10.1371/journal.pone.0136380	http://dx.doi.org/10.1371/journal.pone.0136380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296086	gold, Green Submitted, Green Published			2022-12-27	WOS:000359926900104
J	Herremans, SC; Van Schuerbeek, P; De Raedt, R; Matthys, F; Buyl, R; De Mey, J; Baeken, C				Herremans, Sarah C.; Van Schuerbeek, Peter; De Raedt, Rudi; Matthys, Frieda; Buyl, Ronald; De Mey, Johan; Baeken, Chris			The Impact of Accelerated Right Prefrontal High-Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) on Cue-Reactivity: An fMRI Study on Craving in Recently Detoxified Alcohol-Dependent Patients	PLOS ONE			English	Article							COMPULSIVE DRINKING SCALE; HF-RTMS; EMOTIONAL INFORMATION; ABSTINENT ALCOHOLICS; TALAIRACH ATLAS; CORTEX; ADDICTION; URGES; METAANALYSIS; VALIDATION	In alcohol-dependent patients craving is a difficult-to-treat phenomenon. It has been suggested that high-frequency (HF) repetitive transcranial magnetic stimulation (rTMS) may have beneficial effects. However, exactly how this application exerts its effect on the underlying craving neurocircuit is currently unclear. In an effort to induce alcohol craving and to maximize detection of HF-rTMS effects to cue-induced alcohol craving, patients were exposed to a block and event-related alcohol cue-reactivity paradigm while being scanned with fMRI. Hence, we assessed the effect of right dorsolateral prefrontal cortex (DLPFC) stimulation on cue-induced and general alcohol craving, and the related craving neurocircuit. Twenty-six recently detoxified alcohol-dependent patients were included. First, we evaluated the impact of one sham-controlled stimulation session. Second, we examined the effect of accelerated right DLPFC HF-rTMS treatment: here patients received 15 sessions in an open label accelerated design, spread over 4 consecutive days. General craving significantly decreased after 15 active HF-rTMS sessions. However, cue-induced alcohol craving was not altered. Our brain imaging results did not show that the cue-exposure affected the underlying craving neurocircuit after both one and fifteen active HF-rTMS sessions. Yet, brain activation changes after one and 15 HF-rTMS sessions, respectively, were observed in regions associated with the extended reward system and the default mode network, but only during the presentation of the event-related paradigm. Our findings indicate that accelerated HF-rTMS applied to the right DLPFC does not manifestly affect the craving neurocircuit during an alcohol-related cue-exposure, but instead it may influence the attentional network.	[Herremans, Sarah C.; Matthys, Frieda; Baeken, Chris] Vrije Univ Brussel, Dept Psychiat, Univ Ziekenhuis Brussel UZ Brussel, Brussels, Belgium; [Van Schuerbeek, Peter; De Mey, Johan] Vrije Univ Brussel, Dept Radiol, Univ Ziekenhuis Brussel UZ Brussel, Brussels, Belgium; [De Raedt, Rudi] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Buyl, Ronald] Vrije Univ Brussel, Dept Biostat & Med Informat, Brussels, Belgium; [Baeken, Chris] Univ Ghent, Dept Psychiat & Med Psychol, Univ Ziekenhuis Gent, B-9000 Ghent, Belgium	University Hospital Brussels; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University Hospital Brussels; Ghent University; Vrije Universiteit Brussel; Ghent University; Ghent University Hospital	Herremans, SC (corresponding author), Vrije Univ Brussel, Dept Psychiat, Univ Ziekenhuis Brussel UZ Brussel, Brussels, Belgium.	sarah.herremans@uzbrussel.be	Baeken, Chris/D-6790-2013; De Raedt, Rudi/A-3269-2012; De Raedt, Rudi/AAL-4093-2021; Buyl, Ronald/F-3862-2015; de Mey, Johan/F-3602-2011; matthys, frieda/AAW-2305-2021; de Mey, Johan/AAL-9312-2021	De Raedt, Rudi/0000-0001-6781-4808; De Raedt, Rudi/0000-0001-6781-4808; Buyl, Ronald/0000-0002-6598-9505; matthys, frieda/0000-0002-0900-1478; Van Schuerbeek, Peter/0000-0003-3647-4446; de Mey, Johan/0000-0002-3601-3212	Scientific Fund Willy Gepts [2012-03]	Scientific Fund Willy Gepts	This work was funded by Scientific Fund Willy Gepts 2012-03 (CB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro E, 2006, BRAIN COGNITION, V60, P220, DOI 10.1016/j.bandc.2005.11.009; Amiaz R, 2009, ADDICTION, V104, P653, DOI 10.1111/j.1360-0443.2008.02448.x; ANTON RF, 1995, ALCOHOL CLIN EXP RES, V19, P92, DOI 10.1111/j.1530-0277.1995.tb01475.x; Baeken C, 2013, J AFFECT DISORDERS, V151, P625, DOI 10.1016/j.jad.2013.07.008; Bauer J, 2013, NEUROPSYCHOPHARMACOL, V38, P1401, DOI 10.1038/npp.2013.45; Beck A, 2012, ARCH GEN PSYCHIAT, V69, P842, DOI 10.1001/archgenpsychiatry.2011.2026; Bellamoli E, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/815215; Bennett CM, 2009, SOC COGN AFFECT NEUR, V4, P417, DOI 10.1093/scan/nsp053; Berlim MT, 2013, INT J NEUROPSYCHOPH, V16, P1173, DOI 10.1017/S1461145712001691; Berridge KC, 2013, CURR OPIN NEUROBIOL, V23, P294, DOI 10.1016/j.conb.2013.01.017; BOHN MJ, 1995, ALCOHOL CLIN EXP RES, V19, P600, DOI 10.1111/j.1530-0277.1995.tb01554.x; Camprodon JA, 2007, DRUG ALCOHOL DEPEN, V86, P91, DOI 10.1016/j.drugalcdep.2006.06.002; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; De Raedt R, 2010, BIOL PSYCHOL, V85, P487, DOI 10.1016/j.biopsycho.2010.09.015; de Wildt WAJM, 2005, ALCOHOL CLIN EXP RES, V29, P509, DOI 10.1097/01.ALC.0000158844.35608.48; Di X, 2014, NEUROIMAGE, V86, P53, DOI 10.1016/j.neuroimage.2013.07.071; Drummond DC, 2002, ADDICTION, V97, P1465, DOI 10.1046/j.1360-0443.2002.00252.x; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Grall-Bronnec M, 2014, NEUROSCI BIOBEHAV R, V47, P592, DOI 10.1016/j.neubiorev.2014.10.013; Grusser SM, 2004, PSYCHOPHARMACOLOGY, V175, P296, DOI 10.1007/s00213-004-1828-4; Hayashi T, 2013, P NATL ACAD SCI USA, V110, P4422, DOI 10.1073/pnas.1212185110; Heinz A, 2003, ALCOHOL ALCOHOLISM, V38, P35, DOI 10.1093/alcalc/agg005; Heinz A, 2009, ADDICT BIOL, V14, P108, DOI 10.1111/j.1369-1600.2008.00136.x; Herremans SC, 2012, DRUG ALCOHOL DEPEN, V120, P209, DOI 10.1016/j.drugalcdep.2011.07.021; Herremans SC, 2012, PSYCHIAT DANUB, V24, pS14; Hoppner J, 2011, WORLD J BIOL PSYCHIA, V12, P57, DOI 10.3109/15622975.2011.598383; Holtzheimer PE, 2010, DEPRESS ANXIETY, V27, P960, DOI 10.1002/da.20731; Jansen JM, 2013, NEUROSCI BIOBEHAV R, V37, P2472, DOI 10.1016/j.neubiorev.2013.07.009; Jasinska AJ, 2014, NEUROSCI BIOBEHAV R, V38, P1, DOI 10.1016/j.neubiorev.2013.10.013; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kuhn S, 2012, ADDICT BIOL, V18, P121, DOI [10.1111/j.1460-9568.2010.07590.x, DOI 10.1111/J.1460-9568.2010.07590.X]; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Langosch JM, 2012, J CLIN PSYCHOPHARM, V32, P661, DOI 10.1097/JCP.0b013e318267b586; Leyman L, 2009, PSYCHOL MED, V39, P1019, DOI 10.1017/S0033291708004431; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Lukas SE, 2013, NEUROIMAGE, V78, P176, DOI 10.1016/j.neuroimage.2013.03.055; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mishra BR, 2010, ADDICTION, V105, P49, DOI 10.1111/j.1360-0443.2009.02777.x; Mishra BR, 2015, J NEUROPSYCH CLIN N, V27, pE54, DOI 10.1176/appi.neuropsych.13010013; Naqvi NH, 2010, BRAIN STRUCT FUNCT, V214, P435, DOI 10.1007/s00429-010-0268-7; Paret C, 2014, NEUROIMAGE, V103, P522, DOI 10.1016/j.neuroimage.2014.08.054; Paus T, 2004, J PSYCHIATR NEUROSCI, V29, P268; Peleman K, 2010, WORLD J BIOL PSYCHIA, V11, P425, DOI [10.1080/15622970802669564, 10.3109/15622970802669564]; Politi E, 2008, AM J ADDICTION, V17, P345, DOI 10.1080/10550490802139283; Ross S, 2009, CLIN NEUROPHARMACOL, V32, P277, DOI 10.1097/WNF.0b013e3181a91655; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rudebeck PH, 2013, NAT NEUROSCI, V16, P1140, DOI 10.1038/nn.3440; Schacht JP, 2013, ADDICT BIOL, V18, P121, DOI 10.1111/j.1369-1600.2012.00464.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sheffer CE, 2013, J SUBST ABUSE TREAT, V45, P206, DOI 10.1016/j.jsat.2013.01.012; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; Summerlin JL., 1997, NEUROIMAGE, V5, pS633, DOI DOI 10.1002/(SICI)1097-0193(1997)5:4<238:AID-HBM6>3.0.C0;2-4; Sutherland MT, 2012, NEUROIMAGE, V62, P2281, DOI 10.1016/j.neuroimage.2012.01.117; TIFFANY ST, 1990, PSYCHOL REV, V97, P147, DOI 10.1037/0033-295X.97.2.147; Tiffany ST, 2012, ANN NY ACAD SCI, V1248, P1, DOI 10.1111/j.1749-6632.2011.06298.x; Vanderhasselt MA, 2007, BRAIN RES, V1137, P111, DOI 10.1016/j.brainres.2006.12.050; Wilson SJ, 2004, NAT NEUROSCI, V7, P211, DOI 10.1038/nn1200; Yalachkov Y, 2010, BEHAV BRAIN RES, V207, P215, DOI 10.1016/j.bbr.2009.09.015	62	42	42	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136182	10.1371/journal.pone.0136182	http://dx.doi.org/10.1371/journal.pone.0136182			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295336	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900080
J	Mandel, JR; McCauley, DE				Mandel, Jennifer R.; McCauley, David E.			Pervasive Mitochondrial Sequence Heteroplasmy in Natural Populations of Wild Carrot, Daucus carota spp. carota L	PLOS ONE			English	Article							PLANT SILENE-VULGARIS; GYNODIOECIOUS PLANT; PATERNAL LEAKAGE; FERTILE CARROTS; MALE-STERILITY; SSP CAROTA; ATP9 GENES; GENOMES; RECOMBINATION; INHERITANCE	Exceptions to the generally accepted rules that plant mitochondrial genomes are strictly maternally inherited and that within-individual sequence diversity in those genomes, i.e., heteroplasmy, should be minimal are becoming increasingly apparent especially with regard to sequence-level heteroplasmy. These findings raise questions about the potential significance of such heteroplasmy for plant mitochondrial genome evolution. Still studies quantifying the amount and consequences of sequence heteroplasmy in natural populations are rare. In this study, we report pervasive sequence heteroplasmy in natural populations of wild carrot, a close relative of the cultivated crop. In order to assay directly for this heteroplasmy, we implemented a quantitative PCR assay that can detect and quantify intra-individual SNP variation in two mitochondrial genes (Cox1 and Atp9). We found heteroplasmy in >60% of all wild carrot populations surveyed and in >30% of the 140 component individuals that were genotyped. Heteroplasmy ranged from a very small proportion of the total genotype (e.g., 0.995:0.005) to near even mixtures (e.g., 0.590:0.410) in some individuals. These results have important implications for the role of intra-genomic recombination in the generation of plant mitochondrial genome genotypic novelty. The consequences of such recombination are evident in the results of this study through analysis of the degree of linkage disequilibrium (LD) between the SNP sites at the two genes studied.	[Mandel, Jennifer R.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Mandel, Jennifer R.] Univ Memphis, W Harry Feinstone Ctr Genom Res, Memphis, TN 38152 USA; [McCauley, David E.] Vanderbilt Univ, Dept Biol Sci, VU Stn B, Nashville, TN 37235 USA	University of Memphis; University of Memphis; Vanderbilt University	Mandel, JR (corresponding author), Univ Memphis, Dept Biol Sci, 3700 Walker Ave, Memphis, TN 38152 USA.	jmandel@memphis.edu		Mandel, Jennifer/0000-0003-3539-2991	United States Department of Agriculture-National Institute of Food and Agriculture [2014-33522-21826]	United States Department of Agriculture-National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was supported by United States Department of Agriculture-National Institute of Food and Agriculture (http://nifa.usda.gov/) grant 2014-33522-21826 to JRM and DEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach IC, 2002, EUPHYTICA, V127, P353, DOI 10.1023/A:1020314802236; Bentley KE, 2010, GENETICS, V185, P961, DOI 10.1534/genetics.110.115360; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Burt A., 2006, GENES IN CONFLICT; Hauser TP, 2001, GENET RESOUR CROP EV, V48, P499, DOI 10.1023/A:1012051731933; Hedrick PW., 2009, GENETICS POPULATIONS; HUDSON RR, 1985, GENETICS, V111, P147; Mackenzie S, 1999, PLANT CELL, V11, P571, DOI 10.1105/tpc.11.4.571; Mandel JR, 2012, J HERED, V103, P418, DOI 10.1093/jhered/esr142; McCauley DE, 2008, EVOLUTION, V62, P823, DOI 10.1111/j.1558-5646.2008.00331.x; McCauley DE, 2013, NEW PHYTOL, V200, P966, DOI 10.1111/nph.12431; Pearl SA, 2009, MOL BIOL EVOL, V26, P537, DOI 10.1093/molbev/msn273; Richards A.J., 1986, PLANT BREEDING SYSTE; RONFORT J, 1995, THEOR APPL GENET, V91, P150, DOI 10.1007/BF00220872; Schnable PS, 1998, TRENDS PLANT SCI, V3, P175, DOI 10.1016/S1360-1385(98)01235-7; Sokal RR, 1995, BIOMETRY; Szklarczyk M, 2000, THEOR APPL GENET, V100, P263, DOI 10.1007/s001220050035; Szklarczyk M, 2014, THEOR APPL GENET, V127, P1689, DOI 10.1007/s00122-014-2331-x; Welch ME, 2006, GENETICS, V174, P829, DOI 10.1534/genetics.106.059246; Woloszynska M, 2010, J EXP BOT, V61, P657, DOI 10.1093/jxb/erp361	21	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136303	10.1371/journal.pone.0136303	http://dx.doi.org/10.1371/journal.pone.0136303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295342	Green Submitted, Green Published, gold			2022-12-27	WOS:000359926900098
J	Nguyen, HH; Van Hare, GF; Rudokas, M; Bowman, T; Silva, JNA				Nguyen, Hoang H.; Van Hare, George F.; Rudokas, Michael; Bowman, Tammy; Silva, Jennifer N. A.			SPEAR Trial: Smartphone Pediatric ElectrocARdiogram Trial	PLOS ONE			English	Article								Objectives Smartphone-enabled ECG devices have the potential to improve patient care by enabling remote ECG assessment of patients with potential and diagnosed arrhythmias. This prospective study aimed to assess the usefulness of pediatric ECG tracings generated by the AliveCor device (Oklahoma City, OK) and to assess user satisfaction. Study Design Enrolled pediatric patients with documented paroxysmal arrhythmia used the AliveCor device over a yearlong study period. Pediatric electrophysiologists reviewed all transmitted ECG tracings. Patient completed surveys were analyzed to assess user satisfaction. Results 35 patients were enrolled with the following diagnoses: supraventricular tachycardia (SVT, 57%), atrial fibrillation (AF, 11%), ectopic atrial tachycardia (EAT, 6%), atrial tachycardia (AT, 3%), and ventricular tachycardia (VT, 23%). A total of 238 tracings were received from 20 patients, 96% of which were of diagnostic quality for sinus rhythm, sinus tachycardia, SVT, and AF. 126 patient satisfaction surveys (64% from parents) were completed. 98% of the survey responses indicated that it was easy to obtain tracings, 93% found it easy to transmit the tracings, 98% showed added comfort in managing arrhythmia by having the device, and 93% showed interest in continued use of the device after the study period ended. Conclusions Smartphone-enabled ECG devices can generate tracings of diagnostic quality in children. User satisfaction was extremely positive. Use of the device to manage certain patients with AF and SVT showcases the future role of remote ECGs in the successful outpatient management of arrhythmias in children by potentially reducing Emergency Department visits and healthcare costs.	[Nguyen, Hoang H.; Van Hare, George F.; Rudokas, Michael; Bowman, Tammy; Silva, Jennifer N. A.] Washington Univ, Sch Med, Dept Pediat, Div Cardiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Silva, JNA (corresponding author), Washington Univ, Sch Med, Dept Pediat, Div Cardiol, St Louis, MO 63110 USA.	silva_j@kids.wustl.edu	Nguyen, Hoang/AAA-7038-2020; Silva, Jennifer/HGD-1346-2022	Nguyen, Hoang/0000-0001-6891-9951; 	AliveCor (Alivecor.com)	AliveCor (Alivecor.com)	This work was supported by AliveCor (Alivecor.com) who provided the devices used in this study. AliveCor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MOB TECHN FACT SHEET; Crossley GH, 2011, J AM COLL CARDIOL, V57, P1181, DOI 10.1016/j.jacc.2010.12.012; Lau JK, 2013, INT J CARDIOL, V165, P193, DOI 10.1016/j.ijcard.2013.01.220; MOLLER JH, 1993, CIRCULATION, V88, P2479, DOI 10.1161/01.CIR.88.5.2479; Pew Research Internet and American Life Project, 2013, TEENS TECHN 2013; Rimmer L K, 1998, Am J Crit Care, V7, P346; Singh A, 2014, J PEDIATR-US, V165, P606, DOI 10.1016/j.jpeds.2014.05.037; Wackel P, 2014, J PEDIATR-US, V164, P1133, DOI 10.1016/j.jpeds.2014.01.047; Zimetbaum P, 2010, CIRCULATION, V122, P1629, DOI 10.1161/CIRCULATIONAHA.109.925610	9	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136256	10.1371/journal.pone.0136256	http://dx.doi.org/10.1371/journal.pone.0136256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295569	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900091
J	Yang, Y; Tang, BS; Weng, L; Li, N; Shen, L; Wang, J; Zuo, CT; Yan, XX; Xia, K; Guo, JF				Yang, Yang; Tang, Bei-sha; Weng, Ling; Li, Nan; Shen, Lu; Wang, Jian; Zuo, Chuan-tao; Yan, Xin-xiang; Xia, Kun; Guo, Ji-feng			Genetic Identification Is Critical for the Diagnosis of Parkinsonism: A Chinese Pedigree with Early Onset of Parkinsonism	PLOS ONE			English	Article							FRONTOTEMPORAL DEMENTIA; TAU GENE; PROTEIN-TAU; DISEASE; MUTATION; PET; DEGENERATION; NETWORK; CHROMOSOME-17; PROGRESSION	Background A number of hereditary neurological diseases display indistinguishable features at the early disease stage. Parkinsonian symptoms can be found in numerous diseases, making it difficult to get a definitive early diagnosis of primary causes for patients with onset of parkinsonism. The accurate and early diagnosis of the causes of parkinsonian patients is important for effective treatments of these patients. Methods We have identified a Chinese family (82 family members over four generations with 21 affected individuals) that manifested the characterized symptoms of parkinsonism and was initially diagnosed as Parkinson's disease. We followed up with the family for two years, during which we carried out clinical observations, Positron Emission Tomography-Computed Tomography neuroimaging analysis, and exome sequencing to correctly diagnose the case. Results During the two-year follow-up period, we performed comprehensive medical history collection, physical examination, and structural and functional neuroimaging studies of this Chinese family. We found that the patient exhibited progressive deteriorated parkinsonism with Parkinson disease-like neuropathology and also had a good response to the initial levodopa treatment. However, exome sequencing identified a missense mutation, N279K, in exon 10 of MAPT gene, verifying that the early parkinsonian symptoms in this family are caused by the genetic mutation for hereditary frontotemporal lobar dementia. Conclusions For the inherited parkinsonian patients who even show the neuropathology similar to that in Parkinson's disease and have initial response to levodopa treatment, genetic identification of the molecular basis for the disease is still required for defining the early diagnosis and correct treatment.	[Yang, Yang; Tang, Bei-sha; Weng, Ling; Li, Nan; Shen, Lu; Yan, Xin-xiang; Guo, Ji-feng] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China; [Tang, Bei-sha; Shen, Lu; Xia, Kun; Guo, Ji-feng] State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Tang, Bei-sha; Li, Nan; Shen, Lu; Yan, Xin-xiang; Guo, Ji-feng] Cent S Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha 410008, Hunan, Peoples R China; [Tang, Bei-sha; Li, Nan; Shen, Lu; Yan, Xin-xiang; Guo, Ji-feng] Cent S Univ, Neurodegenerat Disorders Res Ctr, Changsha 410008, Hunan, Peoples R China; [Wang, Jian] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200040, Peoples R China; [Zuo, Chuan-tao] Fudan Univ, Huashan Hosp, PET Ctr, Shanghai 200040, Peoples R China	Central South University; Central South University; Central South University; Fudan University; Fudan University	Guo, JF (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China.	guojifeng2003@163.com	XIA, KUN/AAO-3525-2020; Zuo, Chuantao/AAD-9940-2022		Major State Basic Research Development Program of China (973 Program) [2011CB510000]; National Natural Science Foundation of China [81430023, 81130021, 81171198, 81371405, 81361120404, 81300980]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Major State Basic Research Development Program of China http://www.most.gov.cn (973 Program) (grant number 2011CB510000 to Bei-sha Tang), National Natural Science Foundation of China http://www.nsfc.gov.cn/ (grant number 81430023 to Bei-sha Tang, grant number 81130021 to Bei-sha Tang, grant number 81171198 to Xin-xiang Yan, grant number 81371405 to Ji-feng Guo, grant number 81361120404 to Bei-sha Tang, grant number 81300980 to Nan Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcalay RN, 2010, ARCH NEUROL-CHICAGO, V67, P1116, DOI 10.1001/archneurol.2010.194; Arima K, 2000, NEUROLOGY, V54, P1787, DOI 10.1212/WNL.54.9.1787; Asanuma K, 2006, BRAIN, V129, P2667, DOI 10.1093/brain/awl162; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Fujioka S, 2012, NEURODEGENER DIS, V10, P257, DOI 10.1159/000334285; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; Huang CR, 2007, BRAIN, V130, P1834, DOI 10.1093/brain/awm086; Karimi M, 2013, ANN NEUROL, V73, P390, DOI 10.1002/ana.23798; Kim JY, 2008, MOVEMENT DISORD, V23, P207, DOI 10.1002/mds.21787; Kumar A, 2003, BRAIN, V126, P2648, DOI 10.1093/brain/awg270; Langston JW, 2006, ANN NEUROL, V59, P591, DOI 10.1002/ana.20834; Levy SF, 2005, J BIOL CHEM, V280, P13520, DOI 10.1074/jbc.M413490200; Nasrallah I, 2013, SEMIN NUCL MED, V43, P449, DOI 10.1053/j.semnuclmed.2013.06.003; Pavese N, 2009, MOVEMENT DISORD, V24, P2260, DOI 10.1002/mds.22817; Piguet O, 2011, LANCET NEUROL, V10, P162, DOI 10.1016/S1474-4422(10)70299-4; Siuda J, 2014, PARKINSONISM RELAT D, V20, P957, DOI 10.1016/j.parkreldis.2014.06.004; Soliveri P, 2003, ARCH NEUROL-CHICAGO, V60, P1454, DOI 10.1001/archneur.60.10.1454; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Tsuboi Y, 2002, ARCH NEUROL-CHICAGO, V59, P943, DOI 10.1001/archneur.59.6.943; Wang JL, 2011, BRAIN, V134, P3490, DOI 10.1093/brain/awr289; Wszolek ZK, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-30; Wu P, 2013, PARKINSONISM RELAT D, V19, P622, DOI 10.1016/j.parkreldis.2013.02.013; Yasuda M, 1999, NEUROLOGY, V53, P864, DOI 10.1212/WNL.53.4.864	24	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136245	10.1371/journal.pone.0136245	http://dx.doi.org/10.1371/journal.pone.0136245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295349	gold, Green Published, Green Submitted			2022-12-27	WOS:000359926900089
J	Berenguer, E; Gardner, TA; Ferreira, J; Aragao, LEOC; Camargo, PB; Cerri, CE; Durigan, M; Oliveira, RC; Vieira, ICG; Barlow, J				Berenguer, Erika; Gardner, Toby A.; Ferreira, Joice; Aragao, Luiz E. O. C.; Camargo, Plinio B.; Cerri, Carlos E.; Durigan, Mariana; Oliveira Junior, Raimundo C.; Vieira, Ima C. G.; Barlow, Jos			Developing Cost-Effective Field Assessments of Carbon Stocks in Human-Modified Tropical Forests	PLOS ONE			English	Article							ABOVEGROUND BIOMASS; LOGGED FORESTS; BIODIVERSITY; DEFORESTATION; STORAGE; FRAGMENTATION; CONSERVATION; REGENERATION; DEGRADATION; ALLOCATION	Across the tropics, there is a growing financial investment in activities that aim to reduce emissions from deforestation and forest degradation, such as REDD+. However, most tropical countries lack on-the-ground capacity to conduct reliable and replicable assessments of forest carbon stocks, undermining their ability to secure long-term carbon finance for forest conservation programs. Clear guidance on how to reduce the monetary and time costs of field assessments of forest carbon can help tropical countries to overcome this capacity gap. Here we provide such guidance for cost-effective one-off field assessments of forest carbon stocks. We sampled a total of eight components from four different carbon pools (i.e. aboveground, dead wood, litter and soil) in 224 study plots distributed across two regions of eastern Amazon. For each component we estimated survey costs, contribution to total forest carbon stocks and sensitivity to disturbance. Sampling costs varied thirty-one-fold between the most expensive component, soil, and the least, leaf litter. Large live stems (>= 10 cm DBH), which represented only 15% of the overall sampling costs, was by far the most important component to be assessed, as it stores the largest amount of carbon and is highly sensitive to disturbance. If large stems are not taxonomically identified, costs can be reduced by a further 51%, while incurring an error in aboveground carbon estimates of only 5% in primary forests, but 31% in secondary forests. For rapid assessments, necessary to help prioritize locations for carbon-conservation activities, sampling of stems >= 20cm DBH without taxonomic identification can predict with confidence (R-2 = 0.85) whether an area is relatively carbon-rich or carbon-poor-an approach that is 74% cheaper than sampling and identifying all the stems >= 10cm DBH. We use these results to evaluate the reliability of forest carbon stock estimates provided by the IPCC and FAO when applied to human-modified forests, and to highlight areas where cost savings in carbon stock assessments could be most easily made.	[Berenguer, Erika; Barlow, Jos] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Gardner, Toby A.] Stockholm Environm Inst, Stockholm, Sweden; [Gardner, Toby A.] Int Inst Sustainabil, Rio De Janeiro, Brazil; [Ferreira, Joice] Embrapa Amazonia Oriental, Belem, Para, Brazil; [Aragao, Luiz E. O. C.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Aragao, Luiz E. O. C.] Natl Inst Space Res INPE, Remote Sensing Div, Trop Ecosyst & Environm Sci Grp TREES, Sao Paulo, Brazil; [Camargo, Plinio B.] Univ Sao Paulo, Ctr Energia Nucl Agr, Sao Paulo, Brazil; [Cerri, Carlos E.; Durigan, Mariana] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz Esalq, Dept Ciencia Solo, Sao Paulo, Brazil; [Oliveira Junior, Raimundo C.] Embrapa Amazonia Oriental, Nucl Medio Amazonas, Santarem, Para, Brazil; [Vieira, Ima C. G.; Barlow, Jos] MCT Museu Paraense Emilio Goeldi, Belem, Para, Brazil	Lancaster University; Stockholm Environment Institute; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Exeter; Instituto Nacional de Pesquisas Espaciais (INPE); Universidade de Sao Paulo; Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Museu Paraense Emilio Goeldi	Berenguer, E (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster, England.	erikaberenguer@gmail.com	de Camargo, Plínio B./D-6635-2012; Barlow, Jos/E-7861-2014; aragao, luiz eoc/G-8387-2012; Barlow, Jos/HGE-9486-2022; Cerri, Carlos Eduardo p/C-5039-2012; Vieira, Ima C.G./H-6897-2012	de Camargo, Plínio B./0000-0002-0696-3778; aragao, luiz eoc/0000-0002-4134-6708; Cerri, Carlos Eduardo p/0000-0002-4374-4056; Vieira, Ima C.G./0000-0003-1233-318X	Instituto Nacional de Ciencia e Tecnologia - Biodiversidade e Uso da Terra na Amazonia [CNPq 574008/2008-0]; Empresa Brasileira de Pesquisa Agropecuria - Embrapa [SEG:02.08.06.005.00]; United Kingdom government Darwin Initiative [17-023]; Nature Conservancy; United Kingdom Natural Environment Research Council (NERC) [NE/F01614X/1, NE/G000816/1, NE/K016431/1, NE/F015356/2, NE/l018123/1]; Lancaster University; Santander; Science Without Borders Program's Fellowship; Swedish Research Council Formas [2013-1571]; Natural Environment Research Council [NE/G000816/1, NE/F015356/2, NE/K016431/1, NE/F01614X/1, ceh010010] Funding Source: researchfish; NERC [NE/K016431/1, NE/G000816/1, NE/F015356/2, NE/F01614X/1] Funding Source: UKRI	Instituto Nacional de Ciencia e Tecnologia - Biodiversidade e Uso da Terra na Amazonia; Empresa Brasileira de Pesquisa Agropecuria - Embrapa(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); United Kingdom government Darwin Initiative; Nature Conservancy; United Kingdom Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Lancaster University; Santander; Science Without Borders Program's Fellowship; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors are grateful to the following for financial support: Instituto Nacional de Ciencia e Tecnologia - Biodiversidade e Uso da Terra na Amazonia (CNPq 574008/2008-0), Empresa Brasileira de Pesquisa Agropecuria - Embrapa (SEG:02.08.06.005.00), the United Kingdom government Darwin Initiative (17-023), The Nature Conservancy, United Kingdom Natural Environment Research Council (NERC; NE/F01614X/1, NE/G000816/1, NE/K016431/1, NE/F015356/2 and NE/l018123/1). E. B. was supported by a university scholarship from Lancaster University and a research grant from Santander. L. E. O. C. A. was supported by the Science Without Borders Program's Fellowship. T. A. G. was funded by the Swedish Research Council Formas (2013-1571). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Asner GP, 2006, P NATL ACAD SCI USA, V103, P12947, DOI 10.1073/pnas.0604093103; Asner GP, 2014, P NATL ACAD SCI USA, V111, pE5016, DOI 10.1073/pnas.1419550111; Asner GP, 2014, REMOTE SENS ENVIRON, V140, P614, DOI 10.1016/j.rse.2013.09.023; Asner Gregory P, 2013, Carbon Balance Manag, V8, P7, DOI 10.1186/1750-0680-8-7; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Barlow J, 2012, BIOL CONSERV, V154, P1, DOI 10.1016/j.biocon.2012.03.034; Barlow J, 2010, BIOTROPICA, V42, P405, DOI 10.1111/j.1744-7429.2010.00646.x; Berenguer E, 2014, GLOBAL CHANGE BIOL, V20, P3713, DOI 10.1111/gcb.12627; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; Chao KJ, 2009, BIOGEOSCIENCES, V6, P1615, DOI 10.5194/bg-6-1615-2009; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Cochrane MA, 1998, CONSERV BIOL, V12, P948, DOI 10.1046/j.1523-1739.1998.012005948.x; Cummings DL, 2002, FOREST ECOL MANAG, V163, P293, DOI 10.1016/S0378-1127(01)00587-4; d'Oliveira MVN, 2011, FOREST ECOL MANAG, V261, P1722, DOI 10.1016/j.foreco.2011.01.020; Daniels MJ, 2006, MAMMAL REV, V36, P235, DOI 10.1111/j.1365-2907.2006.00091.x; FAO, 2020, GLOBAL FOREST RESOUR; Franco AMA, 2007, BIOL CONSERV, V134, P96, DOI 10.1016/j.biocon.2006.08.008; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gardner TA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0166; Gardner TA, 2012, BIOL CONSERV, V154, P61, DOI 10.1016/j.biocon.2011.11.018; Gerwing JJ, 2000, J TROP ECOL, V16, P327, DOI 10.1017/S0266467400001437; Girardin CAJ, 2014, PLANT ECOL DIVERS, V7, P161, DOI 10.1080/17550874.2013.820806; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harmon ME, 1996, GUIDELINES FOR MEASU; Herold M., 2009, REPORT FOR THE PRINC; Hughes RF, 1999, ECOLOGY, V80, P1892; Imai N, 2012, PLANT ECOL, V213, P1413, DOI 10.1007/s11258-012-0100-y; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; IPCC, 2006, IPCC GUIDELINES FOR; ITTO, 2002, POLICY DEV SER, V13; Keller M, 2004, GLOBAL CHANGE BIOL, V10, P784, DOI 10.1111/j.1529-8817.2003.00770.x; Kuemmerle T, 2011, J APPL ECOL, V48, P317, DOI 10.1111/j.1365-2664.2010.01954.x; Laurance William F, 2006, Ecology, V87, P469, DOI 10.1890/05-0064; Lewis SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0295; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Malhi Y, 2009, GLOBAL CHANGE BIOL, V15, P1255, DOI 10.1111/j.1365-2486.2008.01780.x; Mandelik Y, 2010, J APPL ECOL, V47, P1179, DOI 10.1111/j.1365-2664.2010.01864.x; Melo FPL, 2013, TRENDS ECOL EVOL, V28, P462, DOI 10.1016/j.tree.2013.01.001; Mertz O, 2012, GEOGR TIDSSKR-DEN, V112, P63, DOI 10.1080/00167223.2012.709678; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Moore S, 2013, NATURE, V493, P660, DOI 10.1038/nature11818; Nascimento HEM, 2004, ECOL APPL, V14, pS127; Lima AJN, 2012, FOREST ECOL MANAG, V277, P163, DOI 10.1016/j.foreco.2012.04.028; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Page SE, 2011, GLOBAL CHANGE BIOL, V17, P798, DOI 10.1111/j.1365-2486.2010.02279.x; Park A, 2005, FOREST ECOL MANAG, V217, P147, DOI 10.1016/j.foreco.2005.05.056; Parrotta J.A., 2012, IUFRO WORLD SERIES; Putz FE, 2012, CONSERV LETT, V5, P296, DOI 10.1111/j.1755-263X.2012.00242.x; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Romijn E, 2012, ENVIRON SCI POLICY, V19-20, P33, DOI 10.1016/j.envsci.2012.01.005; Santos BA, 2008, BIOL CONSERV, V141, P249, DOI 10.1016/j.biocon.2007.09.018; Sist P, 1998, FOREST ECOL MANAG, V108, P251, DOI 10.1016/S0378-1127(98)00228-X; Stern N, 2007, REVIEW LITERATURE AN; Strassburg BBN, 2010, CONSERV LETT, V3, P98, DOI 10.1111/j.1755-263X.2009.00092.x; UNFCCC, 2011, REPORT OF THE CONFER; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671; Venter O, 2012, ANN NY ACAD SCI, V1249, P137, DOI 10.1111/j.1749-6632.2011.06306.x; Zanne A.E., 2009, GLOBAL WOOD DENSITY, DOI [DOI 10.5061/DRYAD.234, 10.5061/dryad.234]	62	11	11	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0133139	10.1371/journal.pone.0133139	http://dx.doi.org/10.1371/journal.pone.0133139			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308074	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000360069400007
J	Chen, YH; Chen, HL; Chien, CS; Wu, SH; Ho, YT; Yu, CH; Chang, MH				Chen, Ya-Hui; Chen, Hui-Ling; Chien, Chin-Sung; Wu, Shang-Hsin; Ho, Yi-Tian; Yu, Chun-Hsien; Chang, Mei-Hwei			Contribution of Mature Hepatocytes to Biliary Regeneration in Rats with Acute and Chronic Biliary Injury	PLOS ONE			English	Article							SEVERE HEPATIC-INJURY; LIVER-REGENERATION; PROGENITOR CELLS; OVAL CELLS; DUCTULAR CELLS; MOUSE-LIVER; ADULT LIVER; STEM-CELLS; BILE-DUCTS; DIFFERENTIATION	Whether hepatocytes can convert into biliary epithelial cells (BECs) during biliary injury is much debated. To test this concept, we traced the fate of genetically labeled [dipeptidyl peptidase IV (DPPIV)-positive] hepatocytes in hepatocyte transplantation model following acute hepato-biliary injury induced by 4,4'-methylene-dianiline (DAPM) and D-galactosamine (DAPM+D-gal) and in DPPIV-chimeric liver model subjected to acute (DAPM+D-gal) or chronic biliary injury caused by DAPM and bile duct ligation (DAPM+BDL). In both models before biliary injury, BECs are uniformly DPPIV-deficient and proliferation of DPPIV-deficient hepatocytes is restricted by retrorsine. We found that mature hepatocytes underwent a stepwise conversion into BECs after biliary injury. In the hepatocyte transplantation model, DPPIV-positive hepatocytes entrapped periportally proliferated, and formed two-layered plates along portal veins. Within the two-layered plates, the hepatocytes gradually lost their hepatocytic identity, proceeded through an intermediate state, acquired a biliary phenotype, and subsequently formed bile ducts along the hilum-to-periphery axis. In DPPIV-chimeric liver model, periportal hepatocytes expressing hepatocyte nuclear factor-1 beta (HNF-1 beta) were exclusively DPPIV-positive and were in continuity to DPPIV-positives bile ducts. Inhibition of hepatocyte proliferation by additional doses of retrorsine in DPPIV-chimeric livers prevented the appearance of DPPIV-positive BECs after biliary injury. Moreover, enriched DPPIV-positive BEC/hepatic oval cell transplantation produced DPPIV-positive BECs or bile ducts in unexpectedly low frequency and in mid-lobular regions. These results together suggest that mature hepatocytes but not contaminating BECs/hepatic oval cells are the sources of periportal DPPIV-positive BECs. We conclude that mature hepatocytes contribute to biliary regeneration in the environment of acute and chronic biliary injury through a ductal plate configuration without the need of exogenously genetic or epigenetic manipulation.	[Chen, Ya-Hui; Yu, Chun-Hsien] Buddhist Tzuchi Med Fdn, Taipei Tzu Chi Hosp, Dept Pediat, Taipei, Taiwan; [Chen, Ya-Hui; Yu, Chun-Hsien] Buddhist Tzu Chi Univ, Dept Pediat, Coll Med, Hualien, Taiwan; [Chen, Ya-Hui; Chien, Chin-Sung; Wu, Shang-Hsin; Chang, Mei-Hwei] Natl Taiwan Univ Hosp, Grad Inst Clin Med, Taipei, Taiwan; [Chen, Ya-Hui; Chen, Hui-Ling; Chien, Chin-Sung; Wu, Shang-Hsin; Ho, Yi-Tian; Chang, Mei-Hwei] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chen, Hui-Ling; Ho, Yi-Tian; Chang, Mei-Hwei] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan; [Chang, Mei-Hwei] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan	Tzu Chi University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Yu, CH (corresponding author), Buddhist Tzuchi Med Fdn, Taipei Tzu Chi Hosp, Dept Pediat, Taipei, Taiwan.	chryu@mail.tcu.edu.tw; changmh@ntu.edu.tw		Chen, Hui-Ling/0000-0002-2572-0595; Wu, Shang-Hsin/0000-0002-6204-7950; Chang, Mei Hwei/0000-0002-3648-9261	National Science Council of the Republic of China [NSC97-2321-B-002-021-MY2, NSC99-2314-B-002-041, NSC99-2628-B-002-069-MY3, NSC 101-2314-B-303 -022-1, NSC102-2314-B-002-129]; Taipei Tzu-Chi Hospital [TCRD-TPE-103-RT-8]; National Health Research Institute [NHRI-EX103-10001BI]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Taipei Tzu-Chi Hospital; National Health Research Institute(National Health Research Institutes - Taiwan)	This study was supported by grants from the National Science Council of the Republic of China (NSC97-2321-B-002-021-MY2 (HLC), NSC99-2314-B-002-041 (MHC), NSC99-2628-B-002-069-MY3 (HLC), NSC 101-2314-B-303 -022-1 (CHY), NSC102-2314-B-002-129 (HLC)), Taipei Tzu-Chi Hospital (TCRD-TPE-103-RT-8) (CHY), and the National Health Research Institute (NHRI-EX103-10001BI) (MHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Chen YH, 2013, HEPATOLOGY, V57, P1215, DOI 10.1002/hep.26104; DABEVA MD, 1993, AM J PATHOL, V143, P1606; Desmet VJ, 2011, VIRCHOWS ARCH, V458, P261, DOI 10.1007/s00428-011-1049-2; FACTOR VM, 1994, AM J PATHOL, V145, P409; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Feranchak AP, 2001, SEMIN LIVER DIS, V21, P471, DOI 10.1055/s-2001-19030; Fukuda K, 2004, CELL TRANSPLANT, V13, P27, DOI 10.3727/000000004772664860; Godoy P, 2009, HEPATOLOGY, V49, P2031, DOI 10.1002/hep.22880; Holic N, 2000, AM J PATHOL, V157, P537, DOI 10.1016/S0002-9440(10)64564-6; Isse K, 2013, HEPATOLOGY, V57, P1632, DOI 10.1002/hep.26131; Koenig S, 2007, HISTOCHEM CELL BIOL, V128, P105, DOI 10.1007/s00418-007-0301-y; Kuwahara R, 2008, HEPATOLOGY, V47, P1994, DOI 10.1002/hep.22218; Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5; Liu LP, 2012, HEPATOLOGY, V55, P1529, DOI 10.1002/hep.24815; Lorenzini S, 2010, GUT, V59, P645, DOI 10.1136/gut.2009.182345; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Michalopoulos GK, 2014, AM J PATHOL, V184, P1263, DOI 10.1016/j.ajpath.2014.02.020; Michalopoulos George K, 2012, Hepatology, V55, P2024, DOI 10.1002/hep.25703; Michalopoulos GK, 2005, HEPATOLOGY, V41, P535, DOI 10.1002/hep.20600; Michalopoulos GK, 2002, HEPATOLOGY, V36, P278, DOI 10.1053/jhep.2002.34858; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Nishikawa Y, 2005, AM J PATHOL, V166, P1077, DOI 10.1016/S0002-9440(10)62328-0; Paku S, 2004, HEPATOLOGY, V39, P1353, DOI 10.1002/hep.20178; Petersen BE, 1997, AM J PATHOL, V151, P905; Rajvanshi P, 1996, HEPATOLOGY, V23, P482; RUTENBURG AM, 1969, J HISTOCHEM CYTOCHEM, V17, P517, DOI 10.1177/17.8.517; Sandhu JS, 2001, AM J PATHOL, V159, P1323, DOI 10.1016/S0002-9440(10)62519-9; Sekiya S, 2014, AM J PATHOL, V184, P1468, DOI 10.1016/j.ajpath.2014.01.005; Sell S, 2001, HEPATOLOGY, V33, P738, DOI 10.1053/jhep.2001.21900; Simper-Ronan R, 2006, DEVELOPMENT, V133, P4269, DOI 10.1242/dev.02589; Strick-Marchand H, 2004, P NATL ACAD SCI USA, V101, P8360, DOI 10.1073/pnas.0401092101; Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Watanabe H, 2008, PATHOLOGY, V40, P272, DOI 10.1080/00313020801911546; Wu YM, 2008, HEPATOLOGY, V47, P279, DOI 10.1002/hep.21937; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Yovchev MI, 2008, HEPATOLOGY, V47, P636, DOI 10.1002/hep.22047; Yu CH, 2004, J BIOMED SCI, V11, P756, DOI 10.1159/000081822; Yu CH, 2010, CELL TRANSPLANT, V19, P231, DOI 10.3727/096368909X479848; Yu CH, 2009, CELL TRANSPLANT, V18, P1081, DOI 10.3727/096368909X12483162196647; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	45	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134327	10.1371/journal.pone.0134327	http://dx.doi.org/10.1371/journal.pone.0134327			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308208	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400021
J	Condie, AG; Yan, Y; Gerson, SL; Wang, YM				Condie, Allison G.; Yan, Yan; Gerson, Stanton L.; Wang, Yanming			A Fluorescent Probe to Measure DNA Damage and Repair	PLOS ONE			English	Article							BASE EXCISION-REPAIR; ABASIC SITES; THYMIDYLATE SYNTHETASE; URACIL; 5-FLUOROURACIL; GLYCOSYLASE; CHEMISTRY; MECHANISM; TEMOZOLOMIDE; AGENTS	DNA damage and repair is a fundamental process that plays an important role in cancer treatment. Base excision repair (BER) is a major repair pathway that often leads to drug resistance in DNA-targeted cancer chemotherapy. In order to measure BER, we have developed a near infrared (NIR) fluorescent probe. This probe binds to a key intermediate, termed apurinic/apyrimidinic (AP) site, in the BER pathway where DNA damage and repair occurs. We have developed an assay to show the efficacy of the probe binding to AP sites and have shown that it can distinguish AP sites in DNA extract from chemotherapy treated cells. This probe has potential application in monitoring patient response to chemotherapy and evaluating new drugs in development.	[Condie, Allison G.; Wang, Yanming] Case Western Reserve Univ, Dept Radiol Chem & Biomed Engn, Cleveland, OH 44106 USA; [Yan, Yan] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Gerson, Stanton L.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Dept Hematol & Oncol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Wang, YM (corresponding author), Case Western Reserve Univ, Dept Radiol Chem & Biomed Engn, Cleveland, OH 44106 USA.	yxw91@case.edu			National Cancer Institute [P30 CA043703]; Training Program in Cancer Pharmacology [R25 CA1485052]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Training Program in Cancer Pharmacology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding provided by the National Cancer Institute (P30 CA043703, Stanton.Gerson.) and the Training Program in Cancer Pharmacology (R25 CA1485052, Noa Noy). National Multiple Sclerosis Society, RG 5174-A-4, Yanming Wang.	AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; An N, 2012, P NATL ACAD SCI USA, V109, P11504, DOI 10.1073/pnas.1201669109; Boturyn D, 1997, TETRAHEDRON, V53, P5485, DOI 10.1016/S0040-4020(97)00235-4; Bowler FR, 2010, ANGEW CHEM INT EDIT, V49, P1809, DOI 10.1002/anie.200905699; Brozmanova J, 2001, NEOPLASMA, V48, P85; Bulgar AD, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.135; Buzzeo MC, 2008, BIOCONJUGATE CHEM, V19, P2110, DOI 10.1021/bc800339y; CARADONNA SJ, 1980, MOL PHARMACOL, V18, P513; Chowdhury G, 2009, CHEM RES TOXICOL, V22, P1310, DOI 10.1021/tx900115z; FEIG DI, 1994, CANCER RES, V54, pS1890; GENTIL A, 1990, BIOCHEM BIOPH RES CO, V173, P704, DOI 10.1016/S0006-291X(05)80092-0; Haynes WM, 2014, CRC HDB CHEM PHYS, P94; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Ide H, 2004, BIOL PHARM BULL, V27, P480, DOI 10.1248/bpb.27.480; INGRAHAM HA, 1980, CANCER RES, V40, P998; Jakobsen U, 2010, J AM CHEM SOC, V132, P10424, DOI 10.1021/ja102797k; KEMENY N, 1992, CANCER, V69, P327, DOI 10.1002/1097-0142(19920115)69:2<327::AID-CNCR2820690209>3.0.CO;2-U; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; KUBO K, 1992, BIOCHEMISTRY-US, V31, P3703, DOI 10.1021/bi00129a020; LANGENBACH RJ, 1972, BIOCHEM BIOPH RES CO, V48, P1565, DOI 10.1016/0006-291X(72)90892-3; Lee SH, 2012, CHEM COMMUN, V48, P8069, DOI 10.1039/c2cc34060g; Lhomme J, 1999, BIOPOLYMERS, V52, P65, DOI 10.1002/1097-0282(1999)52:2<65::AID-BIP1>3.0.CO;2-U; Licha K, 2000, PHOTOCHEM PHOTOBIOL, V72, P392, DOI 10.1562/0031-8655(2000)072<0392:HCDACA>2.0.CO;2; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Liu LL, 2002, CLIN CANCER RES, V8, P2985; MAJOR PP, 1982, CANCER RES, V42, P3005; Matuo R, 2010, BIOCHEM PHARMACOL, V79, P147, DOI 10.1016/j.bcp.2009.08.016; MAURO DJ, 1993, MOL PHARMACOL, V43, P854; Meyers M, 2003, ONCOGENE, V22, P7376, DOI 10.1038/sj.onc.1206941; Miller DR, 2006, BRIT J HAEMATOL, V134, P20, DOI 10.1111/j.1365-2141.2006.06119.x; Pandey RK, 2008, TOP HETEROCYCL CHEM, V14, P41, DOI 10.1007/7081_2008_113; Parikh SS, 2000, MUTAT RES-DNA REPAIR, V460, P183, DOI 10.1016/S0921-8777(00)00026-4; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Rurack K, 2011, ANAL CHEM, V83, P1232, DOI 10.1021/ac101329h; Salisbury CM, 2002, J AM CHEM SOC, V124, P14868, DOI 10.1021/ja027477q; Sancar A, 1995, ANNU REV GENET, V29, P69, DOI 10.1146/annurev.ge.29.120195.000441; SANTI DV, 1974, BIOCHEMISTRY-US, V13, P471, DOI 10.1021/bi00700a012; SCHAAPER RM, 1983, P NATL ACAD SCI-BIOL, V80, P487, DOI 10.1073/pnas.80.2.487; Scharer OD, 2003, ANGEW CHEM INT EDIT, V42, P2946, DOI 10.1002/anie.200200523; Sun HB, 2001, ANAL CHEM, V73, P2229, DOI 10.1021/ac0013249; Taverna P, 2001, MUTAT RES-DNA REPAIR, V485, P269, DOI 10.1016/S0921-8777(01)00076-3; Trivedi RN, 2005, CANCER RES, V65, P6394, DOI 10.1158/0008-5472.CAN-05-0715; Wang YM, 2009, NUCL MED BIOL, V36, P975, DOI 10.1016/j.nucmedbio.2009.07.007; Woods D, 2013, CANCER BIOL THER, V14, P379, DOI 10.4161/cbt.23761; Wu WH, 2015, SENSOR ACTUAT B-CHEM, V206, P449, DOI 10.1016/j.snb.2014.09.090; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e	48	19	19	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0131330	10.1371/journal.pone.0131330	http://dx.doi.org/10.1371/journal.pone.0131330			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309022	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400003
J	Jalan, S; Kanhaiya, K; Rai, A; Bandapalli, OR; Yadav, A				Jalan, Sarika; Kanhaiya, Krishna; Rai, Aparna; Bandapalli, Obul Reddy; Yadav, Alok			Network Topologies Decoding Cervical Cancer	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; NUCLEAR ANTIGEN PCNA; FACTOR-C EXPRESSION; HUMAN-PAPILLOMAVIRUS; P53 PROTEIN; COMPLEX; GROWTH; KINASE; GENE; POLYMORPHISMS	According to the GLOBOCAN statistics, cervical cancer is one of the leading causes of death among women worldwide. It is found to be gradually increasing in the younger population, specifically in the developing countries. We analyzed the protein-protein interaction networks of the uterine cervix cells for the normal and disease states. It was found that the disease network was less random than the normal one, providing an insight into the change in complexity of the underlying network in disease state. The study also portrayed that, the disease state has faster signal processing as the diameter of the underlying network was very close to its corresponding random control. This may be a reason for the normal cells to change into malignant state. Further, the analysis revealed VEGFA and IL-6 proteins as the distinctly high degree nodes in the disease network, which are known to manifest a major contribution in promoting cervical cancer. Our analysis, being time proficient and cost effective, provides a direction for developing novel drugs, therapeutic targets and biomarkers by identifying specific interaction patterns, that have structural importance.	[Jalan, Sarika; Kanhaiya, Krishna; Rai, Aparna] Indian Inst Technol Indore, Ctr Biosci & Biomed Engn, Indore 452017, Madhya Pradesh, India; [Jalan, Sarika; Yadav, Alok] Indian Inst Technol Indore, Sch Basic Sci, Discipline Phys, Complex Syst Lab, Indore 452017, Madhya Pradesh, India; [Bandapalli, Obul Reddy] Heidelberg Univ, EMBL, Mol Med Partnership Unit, Heidelberg, Germany	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Indore; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Indore; European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg	Jalan, S (corresponding author), Indian Inst Technol Indore, Ctr Biosci & Biomed Engn, Indore 452017, Madhya Pradesh, India.	sarikajalan9@gmail.com	Rai, Aparna/AAS-5674-2021; Yadav, Alok/AAF-4168-2019; Jalan, Sarika/L-1732-2017; Jalan, Sarika/AAJ-4908-2021; Bandapalli, Obul Reddy/A-8668-2012	Rai, Aparna/0000-0001-5345-8590; Jalan, Sarika/0000-0002-9984-6107; Bandapalli, Obul Reddy/0000-0002-1132-1745; Yadav, Alok/0000-0003-1008-057X	Department of Science and Technology, Government of India [SR/FTP/PS-067/2011]; Council of Scientific and Industrial Research, India [25(0205)/12/EMR-II]	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Department of Science and Technology, Government of India grant number: SR/FTP/PS-067/2011 and Council of Scientific and Industrial Research, India project grant: 25(0205)/12/EMR-II.	Agarwal SM, 2011, NUCLEIC ACIDS RES, V39, pD975, DOI 10.1093/nar/gkq1024; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alon U., 2006, INTRO SYSTEMS BIOL D; Alsbeih G, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-15; Amirian ES, 2013, CANCER LETT, V336, P18, DOI 10.1016/j.canlet.2013.04.023; [Anonymous], 2014, Cancer Discov, V4, pOF7, DOI 10.1158/2159-8290.CD-NB2014-006; Astudillo H, 2003, ANN NY ACAD SCI, V1010, P771, DOI 10.1196/annals.1299.138; Avruch J, 2001, RECENT PROG HORM RES, V56, P127, DOI 10.1210/rp.56.1.127; Bahnassy AA, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-22; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Best A, 2013, INT J CELL BIOL, V2013; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bondi J, 2005, J CLIN PATHOL, V58, P509, DOI 10.1136/jcp.2004.020347; Branca M, 2007, EUR J OBSTET GYN R B, V130, P223, DOI 10.1016/j.ejogrb.2006.10.007; Breitkreutz D, 2012, P NATL ACAD SCI USA, V109, P9209, DOI 10.1073/pnas.1201416109; Bruni L, 20150408 HUM PAP REL; Carleton M, 2006, MOL CELL BIOL, V26, P3853, DOI 10.1128/MCB.26.10.3853-3863.2006; Higareda-Almaraz JC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-96; Casella C, 2010, THESIS U STUDI PADOV; Chen BH, 2014, TUMOR BIOL, V35, P11587, DOI 10.1007/s13277-014-2463-2; Choi JK, 2005, BIOINFORMATICS, V21, P4348, DOI 10.1093/bioinformatics/bti722; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Del Genio CI, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.178701; Dwivedi SK, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.032803; Fountoulakis M, 2004, J CHROMATOGR A, V1038, P247, DOI 10.1016/j.chroma.2004.03.032; GLOBOCAN, 2012, GLOBOCAN CANC FACT S; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Goel M, 2012, J OBSTET GYN INDIA, V62, P557, DOI 10.1007/s13224-012-0180-6; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gracie S, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-71; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; GUILLOUF C, 1995, ONCOGENE, V10, P2263; Han DD, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/28006; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Handa K, 1999, INT J CANCER, V84, P225, DOI 10.1002/(SICI)1097-0215(19990621)84:3<225::AID-IJC5>3.0.CO;2-A; Hashimoto I, 2001, BRIT J CANCER, V85, P93, DOI 10.1054/bjoc.2001.1846; HORTSCH M, 1988, BIOCHEM BIOPH RES CO, V150, P111, DOI 10.1016/0006-291X(88)90493-7; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Jalan S, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48010; Ji Y, 2013, INT J BIOCHEM CELL B, V45, P645, DOI 10.1016/j.biocel.2012.12.002; Jiang H, 2005, J BIOL CHEM, V280, P20651, DOI 10.1074/jbc.M413431200; Jiang H, 2009, CELL RES, V19, P458, DOI 10.1038/cr.2009.14; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P4279; Kirn V, 2014, ANTICANCER RES, V34, P723; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Kubohara Y, 2014, BIOL OPEN, V3, P289, DOI 10.1242/bio.20146585; MacIntyre DA, 2012, J MATERN-FETAL NEO M, V25, P17, DOI 10.3109/14767058.2012.666114; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Mathonnet G, 2003, BRIT J HAEMATOL, V123, P45, DOI 10.1046/j.1365-2141.2003.04551.x; Mitsuhashi A, 2005, CANCER-AM CANCER SOC, V103, P724, DOI 10.1002/cncr.20819; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Murphy N, 2005, J CLIN PATHOL, V58, P525, DOI 10.1136/jcp.2004.018895; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Noordhuis MG, 2011, CLIN CANCER RES, V17, P1317, DOI 10.1158/1078-0432.CCR-10-2320; O'Brien SL, 2007, INT J CANCER, V120, P1434, DOI 10.1002/ijc.22413; Petricoin EF, 2005, J CLIN ONCOL, V23, P3614, DOI 10.1200/JCO.2005.02.509; Pleissner KP, 2D PAGE; POWELL SN, 1995, CANCER RES, V55, P1643; Rashmi Ramachandran, 2014, PLoS One, V9, pe92948, DOI 10.1371/journal.pone.0092948; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Ren CX, 2013, EUR J CANCER, V49, P3889, DOI 10.1016/j.ejca.2013.07.140; Sanz-Pamplona R, 2012, CLIN TRANSL ONCOL, V14, P3, DOI 10.1007/s12094-012-0755-9; Sasieni PD, 1996, BRIT J CANCER, V73, P1001, DOI 10.1038/bjc.1996.196; Shi TY, 2013, HUM GENET, V132, P301, DOI 10.1007/s00439-012-1245-4; Slettenaar VIF, 2006, ADV DRUG DELIVER REV, V58, P962, DOI 10.1016/j.addr.2006.03.012; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; TAJIMA S, 1986, J CELL BIOL, V103, P1167, DOI 10.1083/jcb.103.4.1167; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Tommasino M, 2003, HUM MUTAT, V21, P307, DOI 10.1002/humu.10178; Turkcuoglu I, 2007, EUR J GYNAECOL ONCOL, V28, P290; Uchimura Y, 2006, J BIOL CHEM, V281, P23180, DOI 10.1074/jbc.M602280200; Ueda M, 2002, INT J CANCER, V98, P335, DOI 10.1002/ijc.10193; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vigodner M, 2009, CELL TISSUE RES, V336, P277, DOI 10.1007/s00441-009-0775-0; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Welner S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-95; Whitlock EP, 2011, ANN INTERN MED, V155, P687, DOI 10.7326/0003-4819-155-10-201111150-00376; Willmott LJ, 2010, J NATL COMPR CANC NE, V8, P1417, DOI 10.6004/jnccn.2010.0105; Wu YF, 2014, TUMOR BIOL, V35, P6913, DOI 10.1007/s13277-014-1929-6; Xiong XD, 2010, INT J GYNECOL CANCER, V20, P856, DOI 10.1111/IGC.0b013e3181df3cab; Yang L, 2014, INT J BIOL SCI, V10, P677, DOI 10.7150/ijbs.8430; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Zhai YL, 2010, AM J PATHOL, V177, P884, DOI 10.2353/ajpath.2010.091166; Zhang CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023849; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	99	7	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135183	10.1371/journal.pone.0135183	http://dx.doi.org/10.1371/journal.pone.0135183			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308848	Green Submitted, Green Published, gold			2022-12-27	WOS:000360069400053
J	Knowlton, S; Yu, CH; Jain, N; Ghiran, IC; Tasoglu, S				Knowlton, Stephanie; Yu, Chu Hsiang; Jain, Nupur; Ghiran, Ionita Calin; Tasoglu, Savas			Smart-Phone Based Magnetic Levitation for Measuring Densities	PLOS ONE			English	Article							CELL-SEPARATION; BINDING; HYDROGELS; PROTEIN; ASSAYS	Magnetic levitation, which uses a magnetic field to suspend objects in a fluid, is a powerful and versatile technology. We develop a compact magnetic levitation platform compatible with a smart-phone to separate micro-objects and estimate the density of the sample based on its levitation height. A 3D printed attachment is mechanically installed over the existing camera unit of a smart-phone. Micro-objects, which may be either spherical or irregular in shape, are suspended in a paramagnetic medium and loaded in a microcapillary tube which is then inserted between two permanent magnets. The micro-objects are levitated and confined in the microcapillary at an equilibrium height dependent on their volumetric mass densities (causing a buoyancy force toward the edge of the microcapillary) and magnetic susceptibilities (causing a magnetic force toward the center of the microcapillary) relative to the suspending medium. The smart-phone camera captures magnified images of the levitating micro-objects through an additional lens positioned between the sample and the camera lens cover. A custom-developed Android application then analyzes these images to determine the levitation height and estimate the density. Using this platform, we were able to separate microspheres with varying densities and calibrate their levitation heights to known densities to develop a technique for precise and accurate density estimation. We have also characterized the magnetic field, the optical imaging capabilities, and the thermal state over time of this platform.	[Knowlton, Stephanie; Tasoglu, Savas] Univ Connecticut, Dept Biomed Engn, Storrs, CT 06269 USA; [Yu, Chu Hsiang; Tasoglu, Savas] Univ Connecticut, Dept Mech Engn, Storrs, CT 06269 USA; [Jain, Nupur] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA; [Ghiran, Ionita Calin] Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	University of Connecticut; University of Connecticut; University of Connecticut; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Tasoglu, S (corresponding author), Univ Connecticut, Dept Biomed Engn, Storrs, CT 06269 USA.	savas@engr.uconn.edu		Tasoglu, Savas/0000-0003-4604-217X	American Heart Association Scientist Development Grant [15SDG25080056]; University of Connecticut;  [R01 HL096795];  [R21 TW009915]; FOGARTY INTERNATIONAL CENTER [R21TW009915] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096795] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); University of Connecticut; ; ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	ST acknowledges the American Heart Association Scientist Development Grant (15SDG25080056), the University of Connecticut Startup Package, and the University of Connecticut Research Excellence Program award for financial support of this research. ICG acknowledges the R01 HL096795 and R21 TW009915.	Atkinson MBJ, 2013, ANGEW CHEM INT EDIT, V52, P10208, DOI 10.1002/anie.201305549; Gurkan UA, 2012, ADV HEALTHC MATER, V1, P149, DOI 10.1002/adhm.201200011; Kose AR, 2009, P NATL ACAD SCI USA, V106, P21478, DOI 10.1073/pnas.0912138106; Kose AR, 2012, LAB CHIP, V12, P190, DOI 10.1039/c1lc20864k; Lim B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4846; Lin YH, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3671078; Lockett MR, 2013, J FORENSIC SCI, V58, P40, DOI 10.1111/j.1556-4029.2012.02221.x; McCloskey KE, 2003, ANAL CHEM, V75, P6868, DOI 10.1021/ac034315j; Mirica KA, 2011, ADV MATER, V23, P4134, DOI 10.1002/adma.201101917; Mirica KA, 2010, J AGR FOOD CHEM, V58, P6565, DOI 10.1021/jf100377n; Mirica KA, 2009, J AM CHEM SOC, V131, P10049, DOI 10.1021/ja900920s; Mirica KA, 2008, J AM CHEM SOC, V130, P17678, DOI 10.1021/ja8074727; Shapiro ND, 2012, ANAL CHEM, V84, P6166, DOI 10.1021/ac301121z; Shapiro ND, 2012, J AM CHEM SOC, V134, P5637, DOI 10.1021/ja211788e; Subramaniam AB, 2015, LAB CHIP, V15, P1009, DOI 10.1039/c4lc01161a; Subramaniam AB, 2014, P NATL ACAD SCI USA, V111, P12980, DOI 10.1073/pnas.1408705111; Tasoglu S, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms5702, 10.1038/ncomms4124]; Tasoglu S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4124; Tasoglu S, 2015, ADV HEALTHC MATER, V4, P1469, DOI 10.1002/adhm.201500092; Tasoglu S, 2015, ADV MATER, V27, P3901, DOI 10.1002/adma.201405660; Tasoglu S, 2013, CHEM SOC REV, V42, P5788, DOI 10.1039/c3cs60042d; Tasoglu S, 2013, ADV MATER, V25, P1137, DOI 10.1002/adma.201200285; Wang SQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03796; Winkleman A, 2007, ANAL CHEM, V79, P6542, DOI 10.1021/ac070500b; Yang Y, 2013, ACS NANO, V7, P2705, DOI 10.1021/nn400118e; Yang Y, 2011, NANO LETT, V11, P1681, DOI 10.1021/nl200189w; Zborowski M, 1999, J MAGN MAGN MATER, V194, P224, DOI 10.1016/S0304-8853(98)00581-2	27	37	37	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134400	10.1371/journal.pone.0134400	http://dx.doi.org/10.1371/journal.pone.0134400			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308615	Green Submitted, Green Published, gold			2022-12-27	WOS:000360069400025
J	Ryu, KA; Lyu, AR; Park, H; Choi, JW; Hur, GM; Park, YH				Ryu, Kyeung A.; Lyu, Ah-Ra; Park, Heesung; Choi, Jin Woong; Hur, Gang Min; Park, Yong-Ho			Intracochlear Bleeding Enhances Cochlear Fibrosis and Ossification: An Animal Study	PLOS ONE			English	Article							HUMAN TEMPORAL BONES; ELECTRIC-ACOUSTIC STIMULATION; ROUND WINDOW APPROACH; INDUCED HEARING-LOSS; GUINEA-PIG MODEL; RESIDUAL HEARING; INSERTION TRAUMA; CONSERVES HEARING; IMPLANT-SURGERY; DEXAMETHASONE	The aim of this study was to investigate the effects of intracochlear bleeding during cochleostomy on cochlear inflammatory response and residual hearing in a guinea pig animal model. Auditory brainstem response threshold shifts were greater in blood injected ears (p<0.05). Interleukin-1 beta, interleukin-10, tumor necrosis factor-alpha and nitric oxide synthase 2, cytokines that are related to early stage inflammation, were significantly increased in blood injected ears compared to normal and cochleostomy only ears at 1 day after surgery; with the increased IL-1 beta being sustained until 3 days after the surgery (p<0.05). Hair cells were more severely damaged in blood injected ears than in cochleostomy only ears. Histopathologic examination revealed more extensive fibrosis and ossification in blood injected ears than cochleostomy only ears. These results show that intracochlear bleeding enhanced cochlear inflammation resulting in increased fibrosis and ossification in an experimental animal model.	[Ryu, Kyeung A.; Lyu, Ah-Ra; Park, Heesung; Choi, Jin Woong; Park, Yong-Ho] Chungnam Natl Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Daejeon, South Korea; [Hur, Gang Min] Chungnam Natl Univ, Coll Med, Dept Pharmacol, Daejeon, South Korea; [Park, Yong-Ho] Chungnam Natl Univ, Coll Med, Brain Res Inst, Daejeon, South Korea	Chungnam National University; Chungnam National University; Chungnam National University	Park, YH (corresponding author), Chungnam Natl Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Daejeon, South Korea.	parkyh@cnu.ac.kr	Hur, Gang-min/ABF-9263-2021	Hur, Gang-min/0000-0003-4870-6574; Choi, Jin Woong/0000-0003-3101-6841; Park, Yong-Ho/0000-0003-2106-3791	Chungnam National University	Chungnam National University	This work was supported by a research fund from the Chungnam National University.	Adunka O, 2005, CLIN OTOLARYNGOL, V30, P121, DOI 10.1111/j.1365-2273.2004.00935.x; Adunka O, 2004, ORL J OTO-RHINO-LARY, V66, P306, DOI 10.1159/000081887; Adunka O, 2004, ACTA OTO-LARYNGOL, V124, P807, DOI 10.1080/00016480410018179; Adunka O, 2004, LARYNGOSCOPE, V114, P1237, DOI 10.1097/00005537-200407000-00018; Adunka OF, 2014, OTOL NEUROTOL, V35, P613, DOI 10.1097/MAO.0000000000000269; Backous Douglas D, 2014, Neurosurg Focus, V36, P1, DOI 10.3171/2014.V1.FOCUS13537; Balkany TJ, 2006, OTOL NEUROTOL, V27, P1083, DOI 10.1097/01.mao.0000244355.34577.85; Barbara M, 2003, J LARYNGOL OTOL, V117, P850, DOI 10.1258/002221503322542836; Bohl A, 2012, J MATER SCI-MATER M, V23, P2151, DOI 10.1007/s10856-012-4698-z; Choi CH, 2005, HEARING RES, V205, P193, DOI 10.1016/j.heares.2005.03.018; Clark G M, 1995, Ann Otol Rhinol Laryngol Suppl, V166, P40; CLARK GM, 1977, J LARYNGOL OTOL, V91, P185, DOI 10.1017/S0022215100083560; Eastwood H, 2010, HEARING RES, V265, P25, DOI 10.1016/j.heares.2010.03.006; Erixon E, 2012, ACTA OTO-LARYNGOL, V132, P923, DOI 10.3109/00016489.2012.680198; Eshraghi AA, 2005, OTOL NEUROTOL, V26, P442, DOI 10.1097/01.mao.0000169791.53201.e1; Eshraghi AA, 2003, LARYNGOSCOPE, V113, P415, DOI 10.1097/00005537-200303000-00005; Eshraghi Adrien A, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P323, DOI 10.1097/01.moo.0000244189.74431.df; Eshraghi AA, 2007, OTOL NEUROTOL, V28, P842, DOI 10.1097/MAO.0b013e31805778fc; FAYAD J, 1991, ANN OTO RHINOL LARYN, V100, P807, DOI 10.1177/000348949110001004; Fayad JN, 2009, OTOLARYNG HEAD NECK, V141, P247, DOI 10.1016/j.otohns.2009.03.031; Golubicic TT J, 2008, CURR OPIN PULM MED, V14, P488, DOI [10.1097/MCP.0b013e3283043e1b, DOI 10.1097/MCP.0B013E3283043E1B]; Gstoettner Wolfgang K, 2006, Audiol Neurootol, V11 Suppl 1, P49, DOI 10.1159/000095614; Havenith S, 2013, OTOL NEUROTOL, V34, P667, DOI 10.1097/MAO.0b013e318288643e; Hsing CM, 2009, CHEST, V136, P35; James DP, 2008, AUDIOL NEURO-OTOL, V13, P86, DOI 10.1159/000111780; Kawano A, 1995, Ann Otol Rhinol Laryngol Suppl, V166, P54; Kawano A, 1998, ACTA OTO-LARYNGOL, V118, P313; Lee J, 2013, AUDIOL NEURO-OTOL, V18, P392, DOI 10.1159/000353582; Lee J, 2011, AUDIOL NEURO-OTOL, V16, P69, DOI 10.1159/000316445; LINTHICUM FH, 1983, ANN OTO RHINOL LARYN, V92, P610, DOI 10.1177/000348948309200615; LINTHICUM FH, 1991, AM J OTOL, V12, P245; LINTHICUM FH, 1991, AM J OTOL, V12, P8; Nadol JB, 2001, ANN OTO RHINOL LARYN, V110, P883, DOI 10.1177/000348940111000914; Naranjo MW, 2009, CHEST, V136, P19; O'Leary SJ, 2013, HEARING RES, V298, P27, DOI 10.1016/j.heares.2013.01.012; OLEARY MJ, 1991, ANN OTO RHINOL LARYN, V100, P695, DOI 10.1177/000348949110000901; Rajan GP, 2012, LARYNGOSCOPE, V122, P190, DOI 10.1002/lary.22142; SHEPHERD RK, 1985, ANN OTO RHINOL LARYN, V94, P55, DOI 10.1177/000348948509400112; SHEPHERD RK, 1995, AM J OTOL, V16, P186; Skarzynski H, 2010, ACTA OTO-LARYNGOL, V130, P435, DOI 10.3109/00016480903283733; Stathopoulos Dimitra, 2014, Cochlear Implants Int, V15, P254, DOI 10.1179/1754762813Y.0000000054; Takumi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110238; Verbist BM, 2009, OTOL NEUROTOL, V30, P471, DOI 10.1097/MAO.0b013e3181a32c0d; Vivero RJ, 2008, LARYNGOSCOPE, V118, P2028, DOI 10.1097/MLG.0b013e31818173ec; WELLING DB, 1993, LARYNGOSCOPE, V103, P995; Woodson EA, 2010, ADV OTO-RHINO-LARYNG, V67, P125, DOI 10.1159/000262604; Wright CG, 2013, OTOL NEUROTOL, V34, P402, DOI 10.1097/MAO.0b013e318278509a; Wrzeszcz A, 2015, J BIOMED MATER RES B, V103, P169, DOI 10.1002/jbm.b.33187; Wrzeszcz A, 2014, J BIOMED MATER RES A, V102, P442, DOI 10.1002/jbm.a.34719	49	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136617	10.1371/journal.pone.0136617	http://dx.doi.org/10.1371/journal.pone.0136617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308864	Green Submitted, Green Published, gold			2022-12-27	WOS:000360069400144
J	Shimizu, S; Shimizu, T; Tsounapi, P; Higashi, Y; Martin, DT; Nakamura, K; Honda, M; Inoue, K; Saito, M				Shimizu, Shogo; Shimizu, Takahiro; Tsounapi, Panagiota; Higashi, Youichirou; Martin, Darryl T.; Nakamura, Kumiko; Honda, Masashi; Inoue, Keiji; Saito, Motoaki			Effect of Silodosin, an Alpha1A-Adrenoceptor Antagonist, on Ventral Prostatic Hyperplasia in the Spontaneously Hypertensive Rat	PLOS ONE			English	Article							LOWER URINARY-TRACT; CELL-PROLIFERATION; METABOLIC SYNDROME; STROMAL CELLS; BLOOD-FLOW; DOXAZOSIN; EXPRESSION; TERAZOSIN; APOPTOSIS; SYMPTOMS	Background A decreased prostatic blood flow could be one of the risk factors for benign prostatic hyperplasia/benign prostatic enlargement. The spontaneously hypertensive rat (SHR) shows a chronic prostatic ischemia and hyperplastic morphological abnormalities in the ventral prostate. The effect of silodosin, a selective alpha(1A)-adrenoceptor antagonist, was investigated in the SHR prostate as a prostatic hyperplasia model focusing on prostatic blood flow. Methods Twelve-week-old male SHRs were administered perorally with silodosin (100 mu g/kg/day) or vehicle once daily for 6 weeks. Wistar Kyoto (WKY) rats were used as normotensive controls and were treated with the vehicle. The effect of silodosin on blood pressure and prostatic blood flow were estimated and then the prostates were removed and weighed. The tissue levels of malondialdehyde (MDA), interleukin-6 (IL-6), chemokine (C-X-C motif) ligand 1/cytokine-induced neutrophil chemoattractant 1 (CXCL1/CINC1), tumor necrosis factor-alpha (TNF-alpha), transforming growth factor beta 1 (TGF-beta 1), basic fibroblast growth factor (bFGF) and alpha-smooth muscle actin (alpha-SMA) were measured. The histological evaluation was also performed by hematoxylin and eosin staining. Results There was a significant increase in blood pressure, prostate weight, prostate body weight ratio (PBR), tissue levels of MDA, IL-6, CXCL1/CINC1, TNF-alpha, TGF-beta 1, bFGF and alpha-SMA in the SHR compared to the WKY rat. The ventral prostate in the SHR showed the morphological abnormalities compared to the WKY rat. Prostatic blood flow was decreased in the SHR. However, treatment with silodosin significantly restored the decreased prostatic blood flow in the SHR. Moreover, silodosin normalized tissue levels of MDA, IL-6, CXCL1/CINC1, TNF-alpha, TGF-beta 1, bFGF and alpha-SMA, and it ameliorated ventral prostatic hyperplasia in the SHR excluding blood pressure. Silodosin decreased PBR but not prostate weight in the SHR. Conclusions Silodosin can inhibit the progression of prostatic hyperplasia through a recovery of prostatic blood flow.	[Shimizu, Shogo; Shimizu, Takahiro; Higashi, Youichirou; Nakamura, Kumiko; Saito, Motoaki] Kochi Univ, Kochi Med Sch, Dept Pharmacol, Nankoku, Kochi, Japan; [Tsounapi, Panagiota; Honda, Masashi] Tottori Univ, Sch Med, Dept Surg, Div Urol, Yonago, Tottori 683, Japan; [Martin, Darryl T.] Yale Univ, Sch Med, Dept Urol, New Haven, CT USA; [Inoue, Keiji] Kochi Univ, Kochi Med Sch, Dept Urol, Nankoku, Kochi, Japan	Kochi University; Tottori University; Yale University; Kochi University	Saito, M (corresponding author), Kochi Univ, Kochi Med Sch, Dept Pharmacol, Nankoku, Kochi, Japan.	saitomo@kochi-u.ac.jp			JSPS KAKENHI [24592431, 20591880]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI (to MS; grant no. 24592431 and 20591880).	Andersson KE, 1997, PROSTATE, V30, P202; Atawia RT, 2014, N-S ARCH PHARMACOL, V387, P1131, DOI 10.1007/s00210-014-1040-y; Barnard RJ, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.12.1752; Chon JK, 1999, J UROLOGY, V161, P2002, DOI 10.1016/S0022-5347(05)68873-8; De Nunzio C, 2012, EUR UROL, V61, P560, DOI 10.1016/j.eururo.2011.11.013; De Nunzio C, 2011, EUR UROL, V60, P106, DOI 10.1016/j.eururo.2011.03.055; Gacci M, 2015, BJU INT, V115, P24, DOI 10.1111/bju.12728; Gandaglia G, 2013, BJU INT, V112, P432, DOI 10.1111/bju.12118; Glassman DT, 2001, PROSTATE, V46, P45, DOI 10.1002/1097-0045(200101)46:1<45::AID-PROS1007>3.0.CO;2-U; Goi Y, 2013, J UROLOGY, V190, P1116, DOI 10.1016/j.juro.2013.03.110; Golomb E, 2000, J ANDROL, V21, P58; Hennenberg M, 2015, LIFE SCI, V123, P18, DOI 10.1016/j.lfs.2014.12.006; Inoue S, 2012, BJU INT, V110, pE118, DOI 10.1111/j.1464-410X.2011.10814.x; Kawabe K, 2006, BJU INT, V98, P1019, DOI 10.1111/j.1464-410X.2006.06448.x; Kramer G, 2007, EUR UROL, V51, P1202, DOI 10.1016/j.eururo.2006.12.011; Kyprianou N, 1998, J UROLOGY, V159, P1810, DOI 10.1016/S0022-5347(01)63162-8; Lewandowski J, 2013, UROLOGY, V82, P660, DOI 10.1016/j.urology.2013.03.087; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Morelli A, 2011, J SEX MED, V8, P2746, DOI 10.1111/j.1743-6109.2011.02416.x; Nakamura H, 1992, J TOXICOL PATHOL, V5, P101; Nickel JC, 1999, BJU INT, V84, P976; Paick JS, 2008, J KOREAN MED SCI, V23, P509, DOI 10.3346/jkms.2008.23.3.509; Pinggera GM, 2008, BJU INT, V101, P319, DOI 10.1111/j.1464-410X.2007.07339.x; Quiles MT, 2010, PROSTATE, V70, P1044, DOI 10.1002/pros.21138; Roehrborn CG, 2006, PROSTATE CANCER P D, V9, P121, DOI 10.1038/sj.pcan.4500849; Roehrborn CG, 2010, EUR UROL, V57, P123, DOI 10.1016/j.eururo.2009.09.035; Saito M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03822; Sarma AV, 2012, NEW ENGL J MED, V367, P248, DOI 10.1056/NEJMcp1106637; Sauver JLS, 2008, UROLOGY, V71, P475, DOI 10.1016/j.urology.2007.11.155; Schilit S, 2009, CLIN THER, V31, P2489, DOI 10.1016/j.clinthera.2009.11.024; Shimizu S, 2014, INT J UROL, V21, P856, DOI 10.1111/iju.12501; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Wolak T, 2014, J HYPERTENS, V32, P1132, DOI 10.1097/HJH.0000000000000119; Yamashita M, 2003, UROLOGY, V61, P484, DOI 10.1016/S0090-4295(02)02167-2; Yang X, 2014, J ETHNOPHARMACOL, V157, P105, DOI 10.1016/j.jep.2014.09.025; Yono M, 2007, LIFE SCI, V81, P218, DOI 10.1016/j.lfs.2007.05.004; Zarifpour M, 2015, PROSTATE, V75, P233, DOI 10.1002/pros.22909	38	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0133798	10.1371/journal.pone.0133798	http://dx.doi.org/10.1371/journal.pone.0133798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308715	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400013
J	Surm, JM; Prentis, PJ; Pavasovic, A				Surm, Joachim M.; Prentis, Peter J.; Pavasovic, Ana			Comparative Analysis and Distribution of Omega-3 lcPUFA Biosynthesis Genes in Marine Molluscs	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; ACYL DELTA-6 DESATURASE; FUNCTIONAL-CHARACTERIZATION; CRASSOSTREA-GIGAS; HEALTH; TRANSCRIPTOME; METABOLISM; ELONGASE; OMEGA-3-FATTY-ACIDS; INVERTEBRATES	Recent research has identified marine molluscs as an excellent source of omega-3 long-chain polyunsaturated fatty acids (lcPUFAs), based on their potential for endogenous synthesis of lcPUFAs. In this study we generated a representative list of fatty acyl desaturase (Fad) and elongation of very long-chain fatty acid (Elovl) genes from major orders of Phylum Mollusca, through the interrogation of transcriptome and genome sequences, and various publicly available databases. We have identified novel and uncharacterised Fad and Elovl sequences in the following species: Anadara trapezia, Nerita albicilla, Nerita melanotragus, Crassostrea gigas, Lottia gigantea, Aplysia californica, Loligo pealeii and Chlamys farreri. Based on alignments of translated protein sequences of Fad and Elovl genes, the haeme binding motif and histidine boxes of Fad proteins, and the histidine box and seventeen important amino acids in Elovl proteins, were highly conserved. Phylogenetic analysis of aligned reference sequences was used to reconstruct the evolutionary relationships for Fad and Elovl genes separately. Multiple, well resolved clades for both the Fad and Elovl sequences were observed, suggesting that repeated rounds of gene duplication best explain the distribution of Fad and Elovl proteins across the major orders of molluscs. For Elovl sequences, one clade contained the functionally characterised Elovl5 proteins, while another clade contained proteins hypothesised to have Elovl4 function. Additional well resolved clades consisted only of uncharacterised Elovl sequences. One clade from the Fad phylogeny contained only uncharacterised proteins, while the other clade contained functionally characterised delta-5 desaturase proteins. The discovery of an uncharacterised Fad clade is particularly interesting as these divergent proteins may have novel functions. Overall, this paper presents a number of novel Fad and Elovl genes suggesting that many mollusc groups possess most of the required enzymes for the synthesis of lcPUFAs.	[Surm, Joachim M.; Pavasovic, Ana] Queensland Univ Technol, Fac Hlth, Sch Biomed Sci, Brisbane, Qld 4000, Australia; [Prentis, Peter J.] Queensland Univ Technol, Sch Earth Environm & Biol Sci, Fac Sci & Engn, Brisbane, Qld 4000, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Surm, JM (corresponding author), Queensland Univ Technol, Fac Hlth, Sch Biomed Sci, 2 George St, Brisbane, Qld 4000, Australia.	joachim.surm@hdr.qut.edu.au		Prentis, Peter/0000-0001-6587-8875; Surm, Joachim/0000-0001-6970-029X				Alkarkhi FMA, 2008, J HAZARD MATER, V150, P783, DOI 10.1016/j.jhazmat.2007.05.035; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Burri L, 2012, INT J MOL SCI, V13, P15401, DOI 10.3390/ijms131115401; Cai YF, 2014, GENE, V551, P261, DOI 10.1016/j.gene.2014.09.003; Calder PC, 2014, EUR J LIPID SCI TECH, V116, P1280, DOI 10.1002/ejlt.201400025; Calder PC, 2009, BIOFACTORS, V35, P266, DOI 10.1002/biof.42; Carmona-Antonanzas G, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-85; Castro LFC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031950; Du XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104960; Ekblom R, 2011, IMMUNOGENETICS, V63, P523, DOI [10.1007/s00251-011-0525-9, 10.1007/s00251-011-0528-6]; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Giri A, 2012, ADV FOOD NUTR RES, V65, P73, DOI 10.1016/B978-0-12-416003-3.00005-6; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Green CD, 2010, J LIPID RES, V51, P1871, DOI 10.1194/jlr.M004747; Hall T, 2005, BIOEDIT V 7 0 5 BIOL; Hastings N, 2001, P NATL ACAD SCI USA, V98, P14304, DOI 10.1073/pnas.251516598; Helm RR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-266; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee JH, 2009, NAT REV CARDIOL, V6, P753, DOI 10.1038/nrcardio.2009.188; Leonard AE, 2004, PROG LIPID RES, V43, P36, DOI 10.1016/S0163-7827(03)00040-7; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li MZ, 2013, AQUACULTURE, V416, P48, DOI 10.1016/j.aquaculture.2013.08.030; Liu HL, 2014, J AGR FOOD CHEM, V62, P12384, DOI 10.1021/jf504648f; Liu HL, 2014, MOL BIOL REP, V41, P7437, DOI 10.1007/s11033-014-3633-4; Liu HL, 2013, AQUACULTURE, V416, P146, DOI 10.1016/j.aquaculture.2013.09.015; Monroig O, 2013, MAR DRUGS, V11, P3998, DOI 10.3390/md11103998; Monroig O, 2012, AQUACULTURE, V360, P45, DOI 10.1016/j.aquaculture.2012.07.016; Monroig O, 2012, AQUACULTURE, V350, P63, DOI 10.1016/j.aquaculture.2012.04.017; Monroig O, 2012, MAR BIOTECHNOL, V14, P411, DOI 10.1007/s10126-011-9423-2; Mozaffarian D, 2012, J NUTR, V142, p614S, DOI 10.3945/jn.111.149633; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; NELL JA, 1994, AQUACULTURE, V119, P149, DOI 10.1016/0044-8486(94)90171-6; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Patterson E, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/539426; Pereira SL, 2003, PROSTAG LEUKOTR ESS, V68, P97, DOI 10.1016/S0952-3278(02)00259-4; Prentis PJ, 2014, MAR GENOM, V18, P113, DOI 10.1016/j.margen.2014.08.004; Prentis PJ, 2010, ANN BOT-LONDON, V106, P1009, DOI 10.1093/aob/mcq201; Przeslawski R, 2008, MAR FRESHWATER RES, V59, P457, DOI 10.1071/MF07229; Reis DB, 2014, AQUACULTURE, V431, P28, DOI 10.1016/j.aquaculture.2014.05.016; Riesgo A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-33; Saito H, 2014, FOOD CHEM, V145, P135, DOI 10.1016/j.foodchem.2013.08.011; Saito H, 2010, J OLEO SCI, V59, P281, DOI 10.5650/jos.59.281; Simopoulos AP, 2011, MOL NEUROBIOL, V44, P203, DOI 10.1007/s12035-010-8162-0; Stoger I, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/407072; Swanson D, 2012, ADV NUTR, V3, P1, DOI 10.3945/an.111.000893; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vannice G, 2014, J ACAD NUTR DIET, V114, P136, DOI 10.1016/j.jand.2013.11.001; WALDOCK MJ, 1984, LIPIDS, V19, P332, DOI 10.1007/BF02534783; Zheng X, 2004, COMP BIOCHEM PHYS B, V139, P269, DOI 10.1016/j.cbpc.2004.08.003; Zheng XZ, 2009, AQUACULTURE, V290, P122, DOI 10.1016/j.aquaculture.2009.02.010	58	23	24	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136301	10.1371/journal.pone.0136301	http://dx.doi.org/10.1371/journal.pone.0136301			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308548	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400102
J	Umemura, A; Oeda, T; Yamamoto, K; Tomita, S; Kohsaka, M; Park, K; Sugiyama, H; Sawada, H				Umemura, Atsushi; Oeda, Tomoko; Yamamoto, Kenji; Tomita, Satoshi; Kohsaka, Masayuki; Park, Kwiyoung; Sugiyama, Hiroshi; Sawada, Hideyuki			Baseline Plasma C-Reactive Protein Concentrations and Motor Prognosis in Parkinson Disease	PLOS ONE			English	Article							ALZHEIMER-DISEASE; PERIPHERAL-BLOOD; RISK; NEURODEGENERATION; INFLAMMATION; BRAIN; PROGRESSION; POPULATION; IMPAIRMENT; DISABILITY	Background C-reactive protein (CRP), a blood inflammatory biomarker, is associated with the development of Alzheimer disease. In animal models of Parkinson disease (PD), systemic inflammatory stimuli can promote neuroinflammation and accelerate dopaminergic neurodegeneration. However, the association between long-term systemic inflammations and neurodegeneration has not been assessed in PD patients. Objective To investigate the longitudinal effects of baseline CRP concentrations on motor prognosis in PD. Design, Setting, and Participants Retrospective analysis of 375 patients (mean age, 69.3 years; mean PD duration, 6.6 years). Plasma concentrations of high-sensitivity CRP were measured in the absence of infections, and the Unified Parkinson's Disease Rating Scale Part III (UPDRS-III) scores were measured at five follow-up intervals (Days 1-90, 91-270, 271-450, 451-630, and 631-900). Main Outcome Measure Change of UPDRS-III scores from baseline to each of the five follow-up periods. Results Change in UPDRS-III scores was significantly greater in PD patients with CRP concentrations >= 0.7 mg/L than in those with CRP concentrations <0.7 mg/L, as determined by a generalized estimation equation model (P = 0.021) for the entire follow-up period and by a generalized regression model (P = 0.030) for the last follow-up interval (Days 631-900). The regression coefficients of baseline CRP for the two periods were 1.41 (95% confidence interval [CI] 0.21-2.61) and 2.62 (95% CI 0.25-4.98), respectively, after adjusting for sex, age, baseline UPDRS-III score, dementia, and incremental L-dopa equivalent dose. Conclusion Baseline plasma CRP levels were associated with motor deterioration and predicted motor prognosis in patients with PD. These associations were independent of sex, age, PD severity, dementia, and anti-Parkinsonian agents, suggesting that subclinical systemic inflammations could accelerate neurodegeneration in PD.	[Sawada, Hideyuki] Natl Hosp Org, Natl Utano Hosp, Dept Neurol, Kyoto, Japan; Natl Hosp Org, Natl Utano Hosp, Clin Res Ctr, Kyoto, Japan		Sawada, H (corresponding author), Natl Hosp Org, Natl Utano Hosp, Dept Neurol, Kyoto, Japan.	sawada@unh.hosp.go.jp	Umemura, Atsushi/ABC-4716-2021; Yamamoto, Kenji/AAD-8766-2019	Umemura, Atsushi/0000-0001-8557-6014; Yamamoto, Kenji/0000-0003-1240-6369; Tomita, Satoshi/0000-0003-4410-6539; Sawada, Hideyuki/0000-0002-5909-3366	National Hospital Organization; Grants-in-Aid for Scientific Research [26461287] Funding Source: KAKEN	National Hospital Organization; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by the Research grant from National Hospital Organization.	Alves G, 2005, NEUROLOGY, V65, P1436, DOI 10.1212/01.wnl.0000183359.50822.f2; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Chen H, 2008, AM J EPIDEMIOL, V167, P90, DOI 10.1093/aje/kwm260; Closhen D, 2010, CYTOKINE, V50, P117, DOI 10.1016/j.cyto.2010.02.011; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; Daniel S E, 1993, J Neural Transm Suppl, V39, P165; Dursun E, 2015, J NEUROIMMUNOL, V283, P50, DOI 10.1016/j.jneuroim.2015.04.014; Emberson JR, 2004, EUR J CARDIOV PREV R, V11, P125, DOI 10.1097/01.hjr.0000114967.39211.e5; Haaxma CA, 2007, J NEUROL NEUROSUR PS, V78, P819, DOI 10.1136/jnnp.2006.103788; Haider DG, 2006, CLIN EXP IMMUNOL, V146, P533, DOI 10.1111/j.1365-2249.2006.03224.x; Hassin-Baer S, 2011, J NEURAL TRANSM, V118, P539, DOI 10.1007/s00702-010-0535-z; Hirsch EC, 2003, ANN NY ACAD SCI, V991, P214; Kimura H, 2010, SOGO RINSHO, V59, P2371; Koprich JB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-8; Li YN, 2008, J NEUROSCI RES, V86, P3556, DOI 10.1002/jnr.21810; Lindqvist D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047387; Macchi B, 2015, CNS NEUROL DISORD-DR, V14, P313, DOI 10.2174/1871527314666150225124928; Marras C, 2002, ARCH NEUROL-CHICAGO, V59, P1724, DOI 10.1001/archneur.59.11.1724; McCullagh P, 1989, GEN LINEAR MODELS; McGeer PL, 2004, PARKINSONISM RELAT D, V10, pS3, DOI 10.1016/j.parkreldis.2004.01.005; McGeer PL, 2000, J NEURAL TRANSM-SUPP, P53; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Mortensen RF, 2000, J LEUKOCYTE BIOL, V67, P495, DOI 10.1002/jlb.67.4.495; Parashos SA, 2014, JAMA NEUROL, V71, P710, DOI 10.1001/jamaneurol.2014.391; Godoy MCP, 2008, BRAIN, V131, P1880, DOI 10.1093/brain/awn101; Godoy MCP, 2010, J NEUROIMMUNOL, V222, P29, DOI 10.1016/j.jneuroim.2010.02.018; Roubenoff R, 1998, J GERONTOL A-BIOL, V53, pM20, DOI 10.1093/gerona/53A.1.M20; Sawada H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085886; Scalzo P, 2010, NEUROSCI LETT, V468, P56, DOI 10.1016/j.neulet.2009.10.062; Schmidt R, 2002, ANN NEUROL, V52, P168, DOI 10.1002/ana.10265; Shulman LM, 2010, ARCH NEUROL-CHICAGO, V67, P64, DOI 10.1001/archneurol.2009.295; Suk HJ, 2005, ATHEROSCLEROSIS, V178, P139, DOI 10.1016/j.atherosclerosis.2004.07.033; Tan ZS, 2007, NEUROLOGY, V68, P1902, DOI 10.1212/01.wnl.0000263217.36439.da; Taniguchi Akira, 2008, Rinsho Shinkeigaku, V48, P106; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Umemura A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094944; Villaran RF, 2010, J NEUROCHEM, V114, P1687, DOI 10.1111/j.1471-4159.2010.06879.x; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Yasojima K, 2000, BRAIN RES, V887, P80, DOI 10.1016/S0006-8993(00)02970-X; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028432, 10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953]	41	20	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136722	10.1371/journal.pone.0136722	http://dx.doi.org/10.1371/journal.pone.0136722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308525	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400154
J	Bracher, A; Hauser, T; Liu, CM; Hartl, FU; Hayer-Hartl, M				Bracher, Andreas; Hauser, Thomas; Liu, Cuimin; Hartl, F. Ulrich; Hayer-Hartl, Manajit			Structural Analysis of the Rubisco-Assembly Chaperone RbcX-II from Chlamydomonas reinhardtii	PLOS ONE			English	Article							ESCHERICHIA-COLI; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; THERMOSYNECHOCOCCUS-ELONGATUS; HEXADECAMERIC RUBISCO; ARABIDOPSIS-THALIANA; FORM-I; PROTEIN; BIOGENESIS; TOOLS; PLANT	The most prevalent form of the Rubisco enzyme is a complex of eight catalytic large sub-units (RbcL) and eight regulatory small subunits (RbcS). Rubisco biogenesis depends on the assistance by specific molecular chaperones. The assembly chaperone RbcX stabilizes the RbcL subunits after folding by chaperonin and mediates their assembly to the RbcL(8) core complex, from which RbcX is displaced by RbcS to form active holoenzyme. Two isoforms of RbcX are found in eukaryotes, RbcX-I, which is more closely related to cyanobacterial RbcX, and the more distant RbcX-II. The green algae Chlamydomonas reinhardtii contains only RbcX-II isoforms, CrRbcX-IIa and CrRbcX-IIb. Here we solved the crystal structure of CrRbcX-IIa and show that it forms an arc-shaped dimer with a central hydrophobic cleft for binding the C-terminal sequence of RbcL. Like other RbcX proteins, CrRbcX-IIa supports the assembly of cyanobacterial Rubisco in vitro, albeit with reduced activity relative to cyanobacterial RbcX-I. Structural analysis of a fusion protein of CrRbcX-IIa and the C-terminal peptide of RbcL suggests that the peptide binding mode of RbcX-II may differ from that of cyanobacterial RbcX. RbcX homologs appear to have adapted to their cognate Rubisco clients as a result of co-evolution.	[Bracher, Andreas; Hauser, Thomas; Liu, Cuimin; Hartl, F. Ulrich; Hayer-Hartl, Manajit] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Max Planck Society	Bracher, A (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	bracher@biochem.mpg.de; mhartl@biochem.mpg.de	Hayer-Hartl, Manajit/V-8078-2017; Hartl, F. Ulrich/Y-8206-2019	Hayer-Hartl, Manajit/0000-0001-8213-6742; 				Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; Asamizu E, 2004, PHYCOLOGIA, V43, P722, DOI 10.2216/i0031-8884-43-6-722.1; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; BARRACLOUGH R, 1980, BIOCHIM BIOPHYS ACTA, V608, P18; Bracher A, 2011, NAT STRUCT MOL BIOL, V18, P875, DOI 10.1038/nsmb.2090; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Emlyn-Jones D, 2006, PLANT CELL PHYSIOL, V47, P1630, DOI 10.1093/pcp/pcl028; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P.R., 1997, JOINT CCP4 ESF EACBM, V33, P22; Feiz L, 2014, PLANT J, V80, P862, DOI 10.1111/tpj.12686; Feiz L, 2012, PLANT CELL, V24, P3435, DOI 10.1105/tpc.112.102012; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hauser T, 2015, NAT STRUCT MOL BIOL; Hauser T, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2015.65, 10.1038/nplants.2015.65]; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kleywegt G.J., 1994, PROTEIN CRYSTALLOGR, V31, P9; Kolesinski P, 2014, FEBS J, V281, P3920, DOI 10.1111/febs.12928; Kolesinski P, 2013, BBA-GEN SUBJECTS, V1830, P2899, DOI 10.1016/j.bbagen.2012.12.025; Kolesinski P, 2011, PLANT MOL BIOL, V77, P447, DOI 10.1007/s11103-011-9823-8; LARIMER FW, 1993, GENE, V126, P85, DOI 10.1016/0378-1119(93)90593-R; Liu CM, 2010, NATURE, V463, P197, DOI 10.1038/nature08651; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Onizuka T, 2004, PLANT CELL PHYSIOL, V45, P1390, DOI 10.1093/pcp/pch160; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Saschenbrecker S, 2007, CELL, V129, P1189, DOI 10.1016/j.cell.2007.04.025; Schrodinger L, 2010, THE PYMOL MOLECULAR; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Strittmatter P, 2010, METHODS MOL BIOL, V619, P307, DOI 10.1007/978-1-60327-412-8_18; Tabita FR, 2008, J EXP BOT, V59, P1515, DOI 10.1093/jxb/erm361; Tabita FR, 2007, CELL, V129, P1039, DOI 10.1016/j.cell.2007.06.002; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; Tanaka S, 2007, ACTA CRYSTALLOGR D, V63, P1109, DOI 10.1107/S090744490704228X; Tarnawski M, 2011, ACTA CRYSTALLOGR F, V67, P851, DOI 10.1107/S1744309111018860; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wheatley NM, 2014, J BIOL CHEM, V289, P7973, DOI 10.1074/jbc.M113.531236; Whitney SM, 2015, P NATL ACAD SCI USA, V112, P3564, DOI 10.1073/pnas.1420536112; Wilson K., 1978, ACTA CRYSTALLOGR A, V34, P517, DOI DOI 10.1107/S0567739478001114	43	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135448	10.1371/journal.pone.0135448	http://dx.doi.org/10.1371/journal.pone.0135448			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305355	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500022
J	Guo, W; Ren, J; Wang, BY; Zhu, Q				Guo, Wei; Ren, Jie; Wang, Biye; Zhu, Qin			Effects of Relaxing Music on Mental Fatigue Induced by a Continuous Performance Task: Behavioral and ERPs Evidence	PLOS ONE			English	Article							RESPONSE-INHIBITION; COGNITIVE PERFORMANCE; ATTENTION; TIME; N2; WAKEFULNESS; CHRONOMETRY; COMPONENTS; BENEFITS; LATENCY	The purpose of this study was to investigate whether listening to relaxing music would help reduce mental fatigue and to maintain performance after a continuous performance task. The experiment involved two fatigue evaluation phases carried out before and after a fatigue inducing phase. A 1-hour AX-continuous performance test was used to induce mental fatigue in the fatigue-inducing phase, and participants' subjective evaluation on the mental fatigue, as well as their neurobehavioral performance in a Go/NoGo task, were measured before and after the fatigue-inducing phase. A total of 36 undergraduate students (18-22 years) participated in the study and were randomly assigned to the music group and control group. The music group performed the fatigue-inducing task while listening to relaxing music, and the control group performed the same task without any music. Our results revealed that after the fatigue-inducing phase, (a) the music group demonstrated significantly less mental fatigue than control group, (b) reaction time significantly increased for the control group but not for the music group, (c) larger Go-P3 and NoGo-P3 amplitudes were observed in the music group, although larger NoGo-N2 amplitudes were detected for both groups. These results combined to suggest that listening to relaxing music alleviated the mental fatigue associated with performing an enduring cognitive-motor task.	[Guo, Wei; Wang, Biye] Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China; [Ren, Jie] Shanghai Univ Sport, China Table Tennis Coll, Shanghai, Peoples R China; [Zhu, Qin] Univ Wyoming, Div Kinesiol & Hlth, Laramie, WY 82071 USA	Shanghai University of Sport; Shanghai University of Sport; University of Wyoming	Ren, J (corresponding author), Shanghai Univ Sport, China Table Tennis Coll, Shanghai, Peoples R China.	renjie@sus.edu.cn		Guo, Wei/0000-0001-5487-0720	First-class Disciplines of Shanghai Colleges and Universities (Psychology)	First-class Disciplines of Shanghai Colleges and Universities (Psychology)	This study was supported by the First-class Disciplines of Shanghai Colleges and Universities (Psychology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikan MK, 1999, NEUROSCI LETT, V268, P21; AUZOU P, 1995, NEUROPSYCHOLOGIA, V33, P25, DOI 10.1016/0028-3932(94)00100-4; Baulk SD, 2007, SLEEP BIOL RHYTHMS, V5, P74, DOI 10.1111/j.1479-8425.2006.00249.x; Bekker EM, 2004, CLIN NEUROPHYSIOL, V115, P2001, DOI 10.1016/j.clinph.2004.04.008; Boksem MAS, 2006, BIOL PSYCHOL, V72, P123, DOI 10.1016/j.biopsycho.2005.08.007; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Bruin KJ, 2001, CLIN NEUROPHYSIOL, V112, P1660, DOI 10.1016/S1388-2457(01)00601-0; Caldwell JA, 2004, MIL PSYCHOL, V16, P163, DOI 10.1207/s15327876mp1603_2; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; DINGES DF, 1988, WORK STRESS, V2, P139, DOI 10.1080/02678378808259158; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; DUNCANJOHNSON CC, 1981, PSYCHOPHYSIOLOGY, V18, P207; Faber LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048073; Falkenstein M, 2002, J PSYCHOPHYSIOL, V16, P167, DOI 10.1027//0269-8803.16.3.167; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Gow RV, 2012, J CLIN NEUROPHYSIOL, V29, P181, DOI 10.1097/WNP.0b013e31824e1025; Jing L, 2008, J SPORT MED PHYS FIT, V48, P102; JODO E, 1992, ELECTROEN CLIN NEURO, V82, P477, DOI 10.1016/0013-4694(92)90054-L; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Kato Y, 2012, ERGONOMICS, V55, P1, DOI 10.1080/00140139.2011.633175; Kato Y, 2009, INT J PSYCHOPHYSIOL, V72, P204, DOI 10.1016/j.ijpsycho.2008.12.008; Kennedy DO, 2008, APPETITE, V50, P506, DOI 10.1016/j.appet.2007.10.007; Kennedy DO, 2010, PSYCHOPHARMACOLOGY, V211, P55, DOI 10.1007/s00213-010-1870-3; Kok A, 1997, BIOL PSYCHOL, V45, P19, DOI 10.1016/S0301-0511(96)05221-0; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Matthews G, 2002, Q J EXP PSYCHOL-A, V55, P659, DOI 10.1080/02724980143000505; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; Sarnthein J, 1997, NEUROL RES, V19, P107; Savitha D, 2010, Indian J Physiol Pharmacol, V54, P32; Tanaka M, 2014, BRAIN RES, V1561, P60, DOI 10.1016/j.brainres.2014.03.009; van der Linden D, 2006, INT J PSYCHOPHYSIOL, V62, P168, DOI 10.1016/j.ijpsycho.2006.04.001; Verleger R, 1997, PSYCHOPHYSIOLOGY, V34, P131, DOI 10.1111/j.1469-8986.1997.tb02125.x; Yeung N, 2006, PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-9280.2006.01680.x	36	27	27	6	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136446	10.1371/journal.pone.0136446	http://dx.doi.org/10.1371/journal.pone.0136446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6KK	26305353	Green Submitted, gold, Green Published			2022-12-27	WOS:000359995500076
J	Santoro, A; Conde, J; Scotece, M; Abella, V; Lois, A; Lopez, V; Pino, J; Gomez, R; Gomez-Reino, JJ; Gualillo, O				Santoro, Anna; Conde, Javier; Scotece, Morena; Abella, Vanessa; Lois, Ana; Lopez, Veronica; Pino, Jesus; Gomez, Rodolfo; Gomez-Reino, Juan J.; Gualillo, Oreste			SERPINE2 Inhibits IL-1 alpha-Induced MMP-13 Expression in Human Chondrocytes: Involvement of ERK/NF-kappa B/AP-1 Pathways	PLOS ONE			English	Article							SYNTHASE TYPE-II; C6 GLIOMA-CELLS; PROTEASE NEXIN-1; ARTICULAR CHONDROCYTES; PLASMINOGEN-ACTIVATOR; RHEUMATIC-DISEASES; KAPPA-B; CARTILAGE; DEGRADATION; MATRIX	Objectives Osteoarthritis (OA) is a chronic joint disease, characterized by a progressive loss of articular cartilage. During OA, proinflammatory cytokines, such as interleukin IL-1, induce the expression of matrix metalloproteinases (MMPs) in chondrocytes, contributing thus to the extracellular matrix (ECM) degradation. Members of Serpine family, including plasminogen activator inhibitors have been reported to participate in ECM regulation. The aim of this study was to assess the expression of serpin peptidase inhibitor clade E member 2 (SERPINE2), under basal conditions and in response to increasing doses of IL-1 alpha, in human cultured chondrocytes. We also examined the effects of SERPINE2 on IL-1 alpha-induced MMP-13 expression. For completeness, the signaling pathway involved in this process was also explored. Methods SERPINE2 mRNA and protein expression were evaluated by RT-qPCR and western blot analysis in human T/C-28a2 cell line and human primary chondrocytes. These cells were treated with human recombinant SERPINE2, alone or in combination with IL-1 alpha. ERK 1/2, NF kappa B and AP-1 activation were assessed by western blot analysis. Results Human cultured chondrocytes express SERPINE2 in basal condition. This expression increased in response to IL-1 alpha stimulation. In addition, recombinant SERPINE2 induced a clear inhibition of MMP-13 expression in IL-1 alpha-stimulated chondrocytes. This inhibitory effect is likely regulated through a pathway involving ERK 1/2, NF-kappa B and AP-1. Conclusions Taken together, these data demonstrate that SERPINE2 might prevent cartilage catabolism by inhibiting the expression of MMP-13, one of the most relevant collagenases, involved in cartilage breakdown in OA.	[Santoro, Anna; Conde, Javier; Scotece, Morena; Abella, Vanessa; Lois, Ana; Lopez, Veronica; Gomez, Rodolfo; Gomez-Reino, Juan J.; Gualillo, Oreste] Univ Santiago, Clin Hosp, SERGAS Serv Galego Saude, Santiago De Compostela, Spain; [Santoro, Anna; Conde, Javier; Scotece, Morena; Abella, Vanessa; Lois, Ana; Lopez, Veronica; Gomez, Rodolfo; Gualillo, Oreste] Univ Santiago, Clin Hosp, IDIS Inst Invest Sanitaria Santiago, Res Lab 9,NEIRID Lab Neuroendocrine Interact Rheu, Santiago De Compostela, Spain; [Abella, Vanessa] Univ Coruna UDC, Dept Mol & Cellular Biol, La Coruna, Spain; [Santoro, Anna] Univ Naples Federico II, Dept Pharm, I-80138 Naples, Italy; [Pino, Jesus] Univ Santiago, Clin Hosp, Div Orthopaed Surg & Traumatol, SERGAS Serv Galego Saude, Santiago De Compostela, Spain; [Gomez-Reino, Juan J.] Univ Santiago de Compostela, Dept Med, Santiago De Compostela, Spain; [Gomez-Reino, Juan J.] Univ Santiago, Clin Hosp, IDIS Inst Invest Sanitaria Santiago, Div Rheumatol, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade da Coruna; University of Naples Federico II; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela	Gualillo, O (corresponding author), Univ Santiago, Clin Hosp, SERGAS Serv Galego Saude, Santiago De Compostela, Spain.	oreste.gualillo@sergas.es	Scotece, Morena/ABI-6561-2020; Gualillo, Oreste/B-8223-2008; Aranda, Javier Conde/P-5537-2015; Gomez-Reino, Juan/ABI-2853-2020; Gomez, Rodolfo/B-4642-2012	Scotece, Morena/0000-0002-1150-2933; Gualillo, Oreste/0000-0002-7154-1328; Aranda, Javier Conde/0000-0002-2187-479X; Gomez, Rodolfo/0000-0002-1309-1023; Santoro, Anna/0000-0002-2276-5659; Pino, Jesus/0000-0002-1847-1199; Gomez-Reino, Juan/0000-0001-5229-6294; Lois, Ana/0000-0002-3042-1645; Abella Cajigal, Vanessa/0000-0002-3658-7208	RETICS Programme, (RIER: Red de Investigacion en Inflamacion y Enfermedades Reumticas) via Instituto de Salud Carlos III (ISCIII) [RD12/0009/0008]; Instituto de Salud Carlos III; FEDER (European Fund of Regional Development) [PI14/00016, PIE13/00024]; ESF (European Social Fund) grant from Xunta de Galicia; Foundation IDIS-Ramon Dominguez	RETICS Programme, (RIER: Red de Investigacion en Inflamacion y Enfermedades Reumticas) via Instituto de Salud Carlos III (ISCIII); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER (European Fund of Regional Development)(European Commission); ESF (European Social Fund) grant from Xunta de Galicia; Foundation IDIS-Ramon Dominguez	Oreste Gualillo is Staff Personnel of Xunta de Galicia (SERGAS) through a research-staff stabilization contract (ISCIII/SERGAS). OG is a member of RETICS Programme, RD12/0009/0008 (RIER: Red de Investigacion en Inflamacion y Enfermedades Reumticas) via Instituto de Salud Carlos III (ISCIII). The OG work was funded by Instituto de Salud Carlos III and FEDER (European Fund of Regional Development) (grants PI14/00016 and PIE13/00024). Vanessa Abella is a recipient of a predoctoral fellowship from ESF (European Social Fund) grant from Xunta de Galicia through a contract signed with University of Coruna. Morena Scotece is a recipient of the "FPU" Program of the Spanish Ministry of Education. Javier Conde is a recipient of a fellowship from the Foundation IDIS-Ramon Dominguez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta H, 2015, DEVELOPMENT, V142, P1146, DOI 10.1242/dev.113886; Boulaftali Y, 2013, ARTERIOSCL THROM VAS, V33, P1647, DOI 10.1161/ATVBAHA.113.301494; Conde J, 2013, DISCOV MED, V15, P73; Conde J, 2011, ANN RHEUM DIS, V70, P551, DOI 10.1136/ard.2010.132399; Dreier R, 2001, J CELL SCI, V114, P3813; Fan ZY, 2006, RHEUMATOL INT, V26, P900, DOI 10.1007/s00296-006-0114-7; Fayard B, 2009, CANCER RES, V69, P5690, DOI 10.1158/0008-5472.CAN-08-4573; Fosang AJ, 1996, FEBS LETT, V380, P17, DOI 10.1016/0014-5793(95)01539-6; Goldring MB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2592; GUTTRIDGE DC, 1993, J BIOL CHEM, V268, P18966; Heinegard D, 2011, NAT REV RHEUMATOL, V7, P50, DOI 10.1038/nrrheum.2010.198; Hunter DJ, 2006, BMJ-BRIT MED J, V332, P639, DOI 10.1136/bmj.332.7542.639; Lim H, 2011, ARCH PHARM RES, V34, P109, DOI 10.1007/s12272-011-0113-4; MANSUY IM, 1993, DEVELOPMENT, V119, P1119; MARTELPELLETIER J, 1991, J RHEUMATOL, V18, P1863; Miwa HE, 2006, BBA-GEN SUBJECTS, V1760, P472, DOI 10.1016/j.bbagen.2005.12.003; Oleksyszyn J, 1996, INFLAMM RES, V45, P464, DOI 10.1007/BF02252318; Otero M, 2005, ARTHRITIS RES THER, V7, pR581, DOI 10.1186/ar1708; Otero M, 2012, J BIOL CHEM, V287, P3559, DOI 10.1074/jbc.M111.265744; Pagliara V, 2014, BBA-MOL CELL RES, V1843, P2631, DOI 10.1016/j.bbamcr.2014.07.008; RAO JS, 1989, MUSCLE NERVE, V12, P640, DOI 10.1002/mus.880120805; Raso GM, 2006, NEUROSCI LETT, V396, P121, DOI 10.1016/j.neulet.2005.11.022; Schwab W, 2004, HISTOL HISTOPATHOL, V19, P105, DOI 10.14670/HH-19.105; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; SOMMER J, 1987, BIOCHEMISTRY-US, V26, P6407, DOI 10.1021/bi00394a016; Stevens P, 1993, Agents Actions Suppl, V39, P173; VAUGHAN PJ, 1993, J BIOL CHEM, V268, P3720; Wang JJ, 2013, ARCH MED SCI, V9, P332, DOI 10.5114/aoms.2012.30949; Xu DM, 2010, CANCER RES, V70, P6988, DOI 10.1158/0008-5472.CAN-10-0242	29	32	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135979	10.1371/journal.pone.0135979	http://dx.doi.org/10.1371/journal.pone.0135979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305372	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500040
J	Ivy, JR; Drechsler, M; Catterson, JH; Bodmer, R; Ocorr, K; Paululat, A; Hartley, PS				Ivy, Jessica R.; Drechsler, Maik; Catterson, James H.; Bodmer, Rolf; Ocorr, Karen; Paululat, Achim; Hartley, Paul S.			Klf15 Is Critical for the Development and Differentiation of Drosophila Nephrocytes	PLOS ONE			English	Article							PERICARDIAL CELLS; CARDIAC-FUNCTION; GENE-EXPRESSION; HEART; ULTRASTRUCTURE; REGULATOR; INSECT; DYNAMICS; ENHANCER; CUBILIN	Insect nephrocytes are highly endocytic scavenger cells that represent the only invertebrate model for the study of human kidney podocytes. Despite their importance, nephrocyte development is largely uncharacterised. This work tested whether the insect ortholog of mammalian Kidney Kruppel-Like Factor (Klf15), a transcription factor required for mammalian podocyte differentiation, was required for insect nephrocyte development. It was found that expression of Drosophila Klf15 (dKlf15, previously known as Bteb2) was restricted to the only two nephrocyte populations in Drosophila, the garland cells and pericardial nephrocytes. Loss of dKlf15 function led to attrition of both nephrocyte populations and sensitised larvae to the xenotoxin silver nitrate. Although pericardial nephrocytes in dKlf15 loss of function mutants were specified during embryogenesis, they failed to express the slit diaphragm gene sticks and stones and did not form slit diaphragms. Conditional silencing of dKlf15 in adults led to reduced surface expression of the endocytic receptor Amnionless and loss of in vivo scavenger function. Over-expression of dKlf15 increased nephrocyte numbers and rescued age-dependent decline in nephrocyte function. The data place dKlf15 upstream of sns and Amnionless in a nephrocyte-restricted differentiation pathway and suggest dKlf15 expression is both necessary and sufficient to sustain nephrocyte differentiation. These findings explain the physiological relevance of dKlf15 in Drosophila and imply that the role of KLF15 in human podocytes is evolutionarily conserved.	[Ivy, Jessica R.; Catterson, James H.] Univ Edinburgh, Queens Med Res Inst, British Heart Fdn, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland; [Drechsler, Maik; Paululat, Achim] Univ Osnabruck, Dept Zool & Dev Biol, D-49069 Osnabruck, Germany; [Bodmer, Rolf; Ocorr, Karen] Sanford Burnham Med Res Inst, Neurosci & Aging Res Ctr, La Jolla, CA 92037 USA; [Hartley, Paul S.] Bournemouth Univ, Dept Life & Environm Sci, Poole BH12 5BB, Dorset, England	University of Edinburgh; University Osnabruck; Sanford Burnham Prebys Medical Discovery Institute; Bournemouth University	Hartley, PS (corresponding author), Bournemouth Univ, Dept Life & Environm Sci, Talbot Campus, Poole BH12 5BB, Dorset, England.	phartley@bournemouth.ac.uk	Ivy, Jessica/AAY-6150-2021	Paululat, Achim/0000-0002-8845-6859; Catterson, James/0000-0003-4231-0114; Hartley, Paul/0000-0003-2782-0490; Ivy, Jessica/0000-0003-1004-4376	British Heart Foundation Intermediate Basic Science Fellowship [FS/13/17/29905]; British Heart Foundation Centre of Research Excellence (CoRE) award; Scottish Universities Life Science Alliance (SULSA); American Heart Association [0835243N]; AHA [14GRNT20490239]; NIH [R01 HL054732, P01 HL098053, P01 AG033561]; DFG [SFB944]; DAAD/IPID program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098053, R01HL054732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG033561] Funding Source: NIH RePORTER; British Heart Foundation [FS/13/17/29905] Funding Source: researchfish	British Heart Foundation Intermediate Basic Science Fellowship; British Heart Foundation Centre of Research Excellence (CoRE) award; Scottish Universities Life Science Alliance (SULSA); American Heart Association(American Heart Association); AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); DAAD/IPID program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation)	PSH is supported by a British Heart Foundation Intermediate Basic Science Fellowship (FS/13/17/29905). This work was also supported by a British Heart Foundation Centre of Research Excellence (CoRE) award to the University of Edinburgh and by a subsistence grant from the Scottish Universities Life Science Alliance (SULSA) to PSH. KO is supported by American Heart Association award 0835243N. KO is supported by AHA grant 14GRNT20490239. RB is supported by NIH grants R01 HL054732, P01 HL098053, P01 AG033561. A.P. received support from the DFG (SFB944) and the DAAD/IPID program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGARWAL SK, 1967, PROTOPLASMA, V63, P343, DOI 10.1007/BF01252944; Alvarez AD, 2003, DEVELOPMENT, V130, P3015, DOI 10.1242/dev.00488; Arshavsky VY, 2010, CURR BIOL, V20, pR96, DOI 10.1016/j.cub.2009.12.039; Brown JL, 2005, NUCLEIC ACIDS RES, V33, P5181, DOI 10.1093/nar/gki827; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Catterson JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062958; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; CROSSLEY AC, 1972, TISSUE CELL, V4, P529, DOI 10.1016/S0040-8166(72)80029-6; Das D, 2008, EXP CELL RES, V314, P1804, DOI 10.1016/j.yexcr.2008.02.009; Das D, 2008, CELL TISSUE RES, V331, P565, DOI 10.1007/s00441-007-0518-z; Soukup SF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000532; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Gao XA, 2011, KIDNEY INT, V79, P987, DOI 10.1038/ki.2010.539; Grahammer F, 2013, NAT REV NEPHROL, V9, P587, DOI 10.1038/nrneph.2013.169; Halme A, 2010, CURR BIOL, V20, P458, DOI 10.1016/j.cub.2010.01.038; Han Z, 2006, DEVELOPMENT, V133, P1175, DOI 10.1242/dev.02285; Han Z, 2003, DEVELOPMENT, V130, P3039, DOI 10.1242/dev.00484; Haralalka S, 2011, DEVELOPMENT, V138, P1551, DOI 10.1242/dev.057653; He QC, 2005, BLOOD, V106, P1447, DOI 10.1182/blood-2005-03-1197; Helmstadter M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040300; Jeyaraj D, 2012, CELL METAB, V15, P311, DOI 10.1016/j.cmet.2012.01.020; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Kimbrell DA, 2002, GENESIS, V34, P23, DOI 10.1002/gene.10134; Lehmacher C, 2012, ARTHROPOD STRUCT DEV, V41, P459, DOI 10.1016/j.asd.2012.02.002; LEISS D, 1988, DEVELOPMENT, V104, P525; Lim HY, 2014, CELL REP, V7, P35, DOI 10.1016/j.celrep.2014.02.029; Mallipattu SK, 2012, J BIOL CHEM, V287, P19122, DOI 10.1074/jbc.M112.345983; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Sasse SK, 2013, MOL CELL BIOL, V33, P2104, DOI 10.1128/MCB.01474-12; Sellin J, 2006, GENE EXPR PATTERNS, V6, P360, DOI 10.1016/j.modgep.2005.09.012; Sellin J, 2009, DEV BIOL, V326, P444, DOI 10.1016/j.ydbio.2008.10.041; Sorensen KK, 2012, AM J PHYSIOL-REG I, V303, pR1217, DOI 10.1152/ajpregu.00686.2011; Togel M, 2008, DEV BIOL, V318, P29, DOI 10.1016/j.ydbio.2008.02.043; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Tutor AS, 2014, DEVELOPMENT, V141, P367, DOI 10.1242/dev.099408; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang B, 2008, J MOL CELL CARDIOL, V45, P193, DOI 10.1016/j.yjmcc.2008.05.005; Ward EJ, 2000, MECH DEVELOP, V96, P233, DOI 10.1016/S0925-4773(00)00389-0; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526; WIGGLESWORTH VB, 1970, J RETICULOENDOTH SOC, V7, P208; Zaffran S, 2006, DEVELOPMENT, V133, P4073, DOI 10.1242/dev.02586; Zhang FJ, 2013, J AM SOC NEPHROL, V24, P209, DOI 10.1681/ASN.2012080795; Zhu Liping, 2011, Shengwu Jiagong Guocheng, V9, P11, DOI 10.3969/j.issn.1672-3678.2011.05.003; Zhuang SF, 2009, DEVELOPMENT, V136, P2335, DOI 10.1242/dev.031609	46	37	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0134620	10.1371/journal.pone.0134620	http://dx.doi.org/10.1371/journal.pone.0134620			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301956	Green Accepted, Green Published, gold			2022-12-27	WOS:000359951900007
J	Nakagawa, J; Takahashi, M; Okada, R; Matsushima, E; Matsuda, T				Nakagawa, Jun; Takahashi, Muneyoshi; Okada, Rieko; Matsushima, Eisuke; Matsuda, Tetsuya			Women's Preference for a Male Acquaintance Enhances Social Reward Processing of Material Goods in the Anterior Cingulate Cortex	PLOS ONE			English	Article							DECISION-MAKING; ROMANTIC LOVE; ORBITOFRONTAL CORTEX; NEURAL BASIS; GIFTS; BEHAVIOR; SYSTEMS; BRAIN; FACE; SCHIZOPHRENIA	Men, like the male of many animal species, use gifts to build satisfactory relationships with a desired woman. From the woman's perspective, all gifts are not always equally rewarding; the reward value of a gift depends on two factors: (1) the giver and (2) the type of the gift (the gift's social meaning). In this study, we investigated how these two factors interactively determine the reward value of a gift. Specifically, we examined how the neural processing for understanding a gift's social meaning is modulated by preferences for the giver. We performed a functional magnetic resonance imaging (fMRI) study in which a female participant was asked to judge a gift from a male she was acquainted with in real life. We examined the interactive effects between (1) the female participant's attitude toward the male acquaintance (liked vs. uninteresting) and (2) the type of the gift (romantic [e.g., bouquet, earrings, and perfumes] vs. non-romantic [e.g., pencils, memo pad, and moneybox]). We found that preference for an acquaintance selectively modulated activity in the anterior cingulate cortex (ACC) in response to romantic gifts, compared to non-romantic gifts. In contrast, if the woman was indifferent toward an acquaintance, no activity modulation was observed in this area for the same gifts. In addition, the ACC showed functional connectivity with the supplementary motor area/dorsal ACC (SMA/dACC), an area within the dorsal mediofrontal cortex, suggesting that it integrates action monitoring and emotional and cognitive processing in decision-making. These results suggest that attitude toward an opposite sex member has a modulatory role in recognizing the social meaning of material goods-preference for the member is a powerful modulator of social reward processing.	[Nakagawa, Jun; Matsushima, Eisuke] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Liaison Psychiat & Palliat Med, Bunkyo Ku, Tokyo, Japan; [Nakagawa, Jun; Takahashi, Muneyoshi; Okada, Rieko; Matsuda, Tetsuya] Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Matsuda, T (corresponding author), Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan.	tetsuya@lab.tamagawa.ac.jp			MEXT (Ministry of Education, Culture, Sports, Science and Technology) Kakenhi [24653160, 24659546]; MEXT	MEXT (Ministry of Education, Culture, Sports, Science and Technology) Kakenhi; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by MEXT (Ministry of Education, Culture, Sports, Science and Technology) Kakenhi grants to TM (#24653160 and #24659546). It was also supported by a grant of MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017. The MEXT website can be found at http://www.mext.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron A, 2005, J NEUROPHYSIOL, V94, P327, DOI 10.1152/jn.00838.2004; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Behrens TEJ, 2009, SCIENCE, V324, P1160, DOI 10.1126/science.1169694; Belk R. W., 1979, RES MARKETING, V2, P95; BELK RW, 1991, ADV CONSUM RES, V18, P521; BRUMBAUGH AM, 1993, ADV CONSUM RES, V20, P159; CHEAL D, 1987, SOCIOL REV, V35, P150, DOI 10.1111/j.1467-954X.1987.tb00007.x; Csukly G, 2011, PSYCHIAT RES, V187, P11, DOI 10.1016/j.psychres.2010.10.005; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Fisher HE., 1992, ANATOMY LOVE NATURAL; Fisher HE, 2006, PHILOS T R SOC B, V361, P2173, DOI 10.1098/rstb.2006.1938; Gasquoine PG, 2013, NEUROSCI BIOBEHAV R, V37, P340, DOI 10.1016/j.neubiorev.2013.01.002; Harrison G., 2001, ASIA PACIFIC ADV CON, V4, P217; HOLM S, 1979, SCAND J STAT, V6, P65; Huang MH, 2000, J CONSUM PSYCHOL, V9, P179, DOI 10.1207/S15327663JCP0903_5; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kim H, 2007, P NATL ACAD SCI USA, V104, P18253, DOI 10.1073/pnas.0703101104; Koban L, 2014, NEUROSCI BIOBEHAV R, V46, P71, DOI 10.1016/j.neubiorev.2014.02.014; Krach S, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00022; Lewis S, 2011, CURR BIOL, V21, pR644, DOI 10.1016/j.cub.2011.05.046; Mauss M., 1966, GIFT FORMS FUNCTIONS; McLaren DG, 2012, NEUROIMAGE, V61, P1277, DOI 10.1016/j.neuroimage.2012.03.068; MICK DG, 1990, J CONSUM RES, V17, P322, DOI 10.1086/208560; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ortigue S, 2007, J COGNITIVE NEUROSCI, V19, P1218, DOI 10.1162/jocn.2007.19.7.1218; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ruff CC, 2014, NAT REV NEUROSCI, V15, P549, DOI 10.1038/nrn3776; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Saad G, 2003, PSYCHOL MARKET, V20, P765, DOI 10.1002/mar.10096; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; SHAVER PR, 1988, J SOC PERS RELAT, V5, P473, DOI 10.1177/0265407588054005; Sprong M, 2007, BRIT J PSYCHIAT, V191, P5, DOI 10.1192/bjp.bp.107.035899; Szczepanski SM, 2014, NEURON, V83, P1002, DOI 10.1016/j.neuron.2014.08.011; Todorov A, 2008, ANN NY ACAD SCI, V1124, P208, DOI 10.1196/annals.1440.012; Treadway MT, 2014, NAT NEUROSCI, V17, P1270, DOI 10.1038/nn.3781; Tsao DY, 2008, ANNU REV NEUROSCI, V31, P411, DOI 10.1146/annurev.neuro.30.051606.094238; Xu XM, 2011, HUM BRAIN MAPP, V32, P249, DOI 10.1002/hbm.21017; Yamada M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1757	41	1	1	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136168	10.1371/journal.pone.0136168	http://dx.doi.org/10.1371/journal.pone.0136168			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5VA	26301954	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900046
J	Oba, C; Morifuji, M; Ichikawa, S; Ito, K; Kawahata, K; Yamaji, T; Asami, Y; Itou, H; Sugawara, T				Oba, Chisato; Morifuji, Masashi; Ichikawa, Satomi; Ito, Kyoko; Kawahata, Keiko; Yamaji, Taketo; Asami, Yukio; Itou, Hiroyuki; Sugawara, Tatsuya			Dietary Milk Sphingomyelin Prevents Disruption of Skin Barrier Function in Hairless Mice after UV-B Irradiation	PLOS ONE			English	Article							EPIDERMAL PERMEABILITY BARRIER; COVALENTLY BOUND CERAMIDES; TRANSEPIDERMAL WATER-LOSS; CORNIFIED CELL-ENVELOPE; PROTEIN KINASE-C; GLUCOSYLCERAMIDE IMPROVES; OMEGA-HYDROXYCERAMIDES; HUMAN KERATINOCYTES; ATOPIC-DERMATITIS; STRATUM-CORNEUM	Exposure to ultraviolet-B (UV-B) irradiation causes skin barrier defects. Based on earlier findings that milk phospholipids containing high amounts of sphingomyelin (SM) improved the water content of the stratum corneum (SC) in normal mice, here we investigated the effects of dietary milk SM on skin barrier defects induced by a single dose of UV-B irradiation in hairless mice. Nine week old hairless mice were orally administrated SM (146 mg/kg BW/day) for a total of ten days. After seven days of SM administration, the dorsal skin was exposed to a single dose of UV-B (20 mJ/cm(2)). Administration of SM significantly suppressed an increase in transepidermal water loss and a decrease in SC water content induced by UV-B irradiation. SM supplementation significantly maintained covalently-bound omega-hydroxy ceramide levels and down-regulated mRNA levels of acute inflammation-associated genes, including thymic stromal lymphopoietin, interleukin-1 beta, and interleukin-6. Furthermore, significantly higher levels of loricrin and transglutaminase-3 mRNA were observed in the SM group. Our study shows for the first time that dietary SM modulates epidermal structures, and can help prevent disruption of skin barrier function after UV-B irradiation.	[Oba, Chisato; Morifuji, Masashi; Ichikawa, Satomi; Ito, Kyoko; Kawahata, Keiko; Yamaji, Taketo; Asami, Yukio; Itou, Hiroyuki] Meiji Co Ltd, Food Sci Res Labs, Odawara, Kanagawa 2500862, Japan; [Sugawara, Tatsuya] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Sakyo Ku, Kyoto 6068502, Japan	Meiji Holdings Co., Ltd.; Kyoto University	Oba, C (corresponding author), Meiji Co Ltd, Food Sci Res Labs, 540 Naruda, Odawara, Kanagawa 2500862, Japan.	chisato.ohba@meiji.com		Sugawara, Tatsuya/0000-0002-1203-5521	Meiji Co., Ltd.	Meiji Co., Ltd.	The authors received no specific funding for this work. Meiji Co., Ltd. provided support in the form of salaries for authors CO, MM, SI, KI, KK, TY YA, and HI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ABE T, 1979, CHEM PHARM BULL, V27, P458; Applied Biosystems, 1997, APPL BIOS US B; Bashir MM, 2009, J INVEST DERMATOL, V129, P994, DOI 10.1038/jid.2008.332; Behne M, 2000, J INVEST DERMATOL, V114, P185, DOI 10.1046/j.1523-1747.2000.00846.x; Bernerd F, 1997, DEV BIOL, V183, P123, DOI 10.1006/dbio.1996.8465; BISSETT DL, 1987, PHOTOCHEM PHOTOBIOL, V46, P367, DOI 10.1111/j.1751-1097.1987.tb04783.x; BROD J, 1991, INT J DERMATOL, V30, P84, DOI 10.1111/j.1365-4362.1991.tb04216.x; Candi E, 1999, J BIOL CHEM, V274, P7226, DOI 10.1074/jbc.274.11.7226; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Costin GE, 2007, FASEB J, V21, P976, DOI 10.1096/fj.06-6649rev; Duan JJ, 2012, EXP DERMATOL, V21, P448, DOI 10.1111/j.1600-0625.2012.01501.x; Eckert RL, 2005, J INVEST DERMATOL, V124, P481, DOI 10.1111/j.0022-202X.2005.23627.x; ELIAS PM, 1991, ADV LIPID RES, V24, P1; GUPTA AK, 1988, J INVEST DERMATOL, V91, P486, DOI 10.1111/1523-1747.ep12476635; HANNUN YA, 1989, CLIN CHIM ACTA, V185, P333, DOI 10.1016/0009-8981(89)90224-6; Haratake A, 1997, J INVEST DERMATOL, V108, P769, DOI 10.1111/1523-1747.ep12292163; Haruta Y, 2008, BIOSCI BIOTECH BIOCH, V72, P2151, DOI 10.1271/bbb.80212; Haruta-Ono Y, 2012, J DERMATOL SCI, V68, P56, DOI 10.1016/j.jdermsci.2012.07.006; Haruta-Ono Y, 2012, ANIM SCI J, V83, P178, DOI 10.1111/j.1740-0929.2011.00940.x; Hasegawa T, 2011, LIPIDS, V46, P529, DOI 10.1007/s11745-011-3546-0; Hitomi K, 2005, EUR J DERMATOL, V15, P313; HOHL D, 1991, J BIOL CHEM, V266, P6626; Holleran WM, 1997, PHOTODERMATOL PHOTO, V13, P117, DOI 10.1111/j.1600-0781.1997.tb00214.x; Ideta R, 2011, BIOSCI BIOTECH BIOCH, V75, P1516, DOI 10.1271/bbb.110215; Irnokawa G, 2008, ARCH DERMATOL RES, V300, pS7, DOI 10.1007/s00403-007-0798-x; Kalinin A, 2001, J CELL SCI, V114, P3069; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; KONDO S, 1993, J INVEST DERMATOL, V101, P690, DOI 10.1111/1523-1747.ep12371677; Kulms D, 2000, J BIOL CHEM, V275, P15060, DOI 10.1074/jbc.M910113199; KUPPER TS, 1987, J CLIN INVEST, V80, P430, DOI 10.1172/JCI113090; Macheleidt O, 2002, J INVEST DERMATOL, V119, P166, DOI 10.1046/j.1523-1747.2002.01833.x; Meguro S, 2000, ARCH DERMATOL RES, V292, P463, DOI 10.1007/s004030000160; Morifuji M, 2015, J DERMATOL SCI, V78, P224, DOI 10.1016/j.jdermsci.2015.02.017; Nemes Z, 1999, EXP MOL MED, V31, P5, DOI 10.1038/emm.1999.2; Oba C, 2013, PHOTODERMATOL PHOTO, V29, P204, DOI 10.1111/phpp.12051; ROOP D, 1995, SCIENCE, V267, P474, DOI 10.1126/science.7529942; Sawada E, 2012, J DERMATOL SCI, V68, P25, DOI 10.1016/j.jdermsci.2012.07.004; SCHMELZ EM, 1994, J NUTR, V124, P702, DOI 10.1093/jn/124.5.702; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHURER NY, 1991, ADV LIPID RES, V24, P27; Skovgaard GRL, 2006, EUR J CLIN NUTR, V60, P1201, DOI 10.1038/sj.ejcn.1602438; STEVEN AC, 1994, J CELL SCI, V107, P693; Sugawara T, 2003, J NUTR, V133, P2777, DOI 10.1093/jn/133.9.2777; Takagi Y, 2004, J INVEST DERMATOL, V123, P1102, DOI 10.1111/j.0022-202X.2004.23491.x; Uchiyama T, 2008, J HEALTH SCI, V54, P559, DOI 10.1248/jhs.54.559	45	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136377	10.1371/journal.pone.0136377	http://dx.doi.org/10.1371/journal.pone.0136377			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302442	Green Submitted, Green Published, gold			2022-12-27	WOS:000359951900065
J	Rossetti, L; Digiuni, M; Giovanni, M; Centofanti, M; Fea, AM; Iester, M; Frezzotti, P; Figus, M; Ferreras, A; Oddone, F; Tanga, L; Rolle, T; Battaglino, V; Posarelli, C; Motolese, I; Mittica, P; Bagaglia, SA; Menicacci, C; De Cilla, S; Autelitano, A; Fogagnolo, P				Rossetti, Luca; Digiuni, Maurizio; Giovanni, Montesano; Centofanti, Marco; Fea, Antonio M.; Iester, Michele; Frezzotti, Paolo; Figus, Michele; Ferreras, Antonio; Oddone, Francesco; Tanga, Lucia; Rolle, Teresa; Battaglino, Valentina; Posarelli, Chiara; Motolese, Ilaria; Mittica, Pietro; Bagaglia, Simone Alex; Menicacci, Cristina; De Cilla, Stefano; Autelitano, Alessandro; Fogagnolo, Paolo			Blindness and Glaucoma: A Multicenter Data Review from 7 Academic Eye Clinics	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; VISUAL-FIELD LOSS; LONG-TERM PROGRESSION; RISK-FACTORS; INTRAOCULAR-PRESSURE; MODELS	Purpose To evaluate frequency, conversion rate, and risk factors for blindness in glaucoma patients treated in European Universities. Methods This multicenter retrospective study included 2402 consecutive patients with glaucoma in at least one eye. Medical charts were inspected and patients were divided into those blind and the remainder ('controls'). Blindness was defined as visual acuity <= 0.05 and/or visual field loss to less than 10 degrees. Results Unilateral and bilateral blindness were respectively 11.0% and 1.6% at the beginning, and 15.5% and 3.6% at the end of the observation period (7.5 +/- 5.5 years, range: 1-25 years); conversion to blindness (at least unilateral) was 1.1%/year. 134 eyes (97 patients) developed blindness by POAG during the study. At the first access to study centre, they had mean deviation (MD) of -17.1 +/- 8.3 dB and treated intraocular pressure (IOP) of 17.1 +/- 6.6 mmHg. During follow-up the IOP decreased by 14% in these eyes but MD deteriorated by 1.1 +/- 3.5 dB/year, which was 5-fold higher than controls (0.2 +/- 1.6 dB/year). In a multivariate model, the best predictors for blindness by glaucoma were initial MD (p<0.001), initial IOP (p<0.001), older age at the beginning of follow-up (p<0.001), whereas final IOP was found to be protective (p<0.05). Conclusions In this series of patients, blindness occurred in about 20%. Blindness by glaucoma had 2 characteristics: late diagnosis and/or late referral, and progression of the disease despite in most cases IOP was within the range of normality and target IOP was achieved; it could be predicted by high initial MD, high initial IOP, and old age.	[Rossetti, Luca; Digiuni, Maurizio; Giovanni, Montesano; De Cilla, Stefano; Autelitano, Alessandro; Fogagnolo, Paolo] Univ Milan, San Paolo Hosp, Dipartimento Testa Collo, Milan, Italy; [Centofanti, Marco; Oddone, Francesco; Tanga, Lucia] GB Bietti Fdn IRCCS, Rome, Italy; [Fea, Antonio M.; Rolle, Teresa; Battaglino, Valentina] Univ Turin, Turin, Italy; [Iester, Michele] Univ Genoa, Clin Oculist, Genoa, Italy; [Frezzotti, Paolo; Motolese, Ilaria; Mittica, Pietro; Bagaglia, Simone Alex; Menicacci, Cristina] Univ Siena, Dipartimento Sci Oftalmol & Neurochirurg, I-53100 Siena, Italy; [Figus, Michele; Posarelli, Chiara] Univ Pisa, Dept Neurosci, Eye Clin, Pisa, Italy; [Ferreras, Antonio] Univ Zaragoza, Dept Ophthalmol, Miguel Servet Univ Hosp, Zaragoza, Spain; [De Cilla, Stefano] Osped Maggiore La Carita, Unit Ophthalmol, Novara, Italy	San Paolo-Polo Universitaria Hospital; University of Milan; IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia; University of Turin; University of Genoa; University of Siena; University of Pisa; Miguel Servet University Hospital; University of Zaragoza	Rossetti, L (corresponding author), Univ Milan, San Paolo Hosp, Dipartimento Testa Collo, Milan, Italy.	luca.rossetti@unimi.it	Oddone, Francesco/K-8876-2016; Figus, Michele/AAA-9808-2019; Ferreras, Antonio/AAF-4220-2020; Montesano, Giovanni/AAS-9356-2020; Posarelli, Chiara/AAW-9528-2020; Posarelli, Chiara/AAA-8278-2019; Figus, Michele/AAD-6850-2020	Oddone, Francesco/0000-0002-2504-0004; Figus, Michele/0000-0003-2243-9033; Montesano, Giovanni/0000-0002-9148-2804; Posarelli, Chiara/0000-0003-0222-5177; Rossetti, Luca/0000-0002-7027-3173; Ferreras, Antonio/0000-0002-2914-2593; Iester, Michele/0000-0002-0524-2637; AUTELITANO, ALESSANDRO/0000-0001-9380-2173				Bhargava JS, 2006, INVEST OPHTH VIS SCI, V47, P2885, DOI 10.1167/iovs.05-1244; Blomdahl S, 1997, ACTA OPHTHALMOL SCAN, V75, P589; Bourne RRA, 2014, BRIT J OPHTHALMOL, V98, P629, DOI 10.1136/bjophthalmol-2013-304033; Broman AT, 2008, INVEST OPHTH VIS SCI, V49, P66, DOI 10.1167/iovs.07-0866; Chang Li-Chun, 2005, Chang Gung Med J, V28, P492; Chauhan BC, 2010, ARCH OPHTHALMOL-CHIC, V128, P1249, DOI 10.1001/archophthalmol.2010.196; Chen PP, 2003, OPHTHALMOLOGY, V110, P726, DOI 10.1016/S0161-6420(02)01974-7; Chen PP, CURR OPIN OPHTHALMOL, V15, P107; Figus M, 2011, EYE, V25, P1057, DOI 10.1038/eye.2011.119; Forsman E, 2007, J GLAUCOMA, V16, P313, DOI 10.1097/IJG.0b013e318033500f; Fraser S, 1999, INVEST OPHTH VIS SCI, V40, P2251; GRANT WM, 1982, OPHTHALMOLOGY, V89, P991; Hattenhauer MG, 1998, OPHTHALMOLOGY, V105, P2099, DOI 10.1016/S0161-6420(98)91133-2; Heijl A, 2011, BMC OPHTHALMOL, V11, DOI 10.1186/1471-2415-11-31; Iester M, 2002, EYE, V16, P44, DOI 10.1038/sj.eye.6700036; Jampel HD, 2002, J GLAUCOMA, V11, P154, DOI 10.1097/00061198-200204000-00012; Janz NK, 2007, OPHTHALMOLOGY, V114, P2213, DOI 10.1016/j.ophtha.2007.02.014; KATZ LJ, 1989, AM J OPHTHALMOL, V107, P485, DOI 10.1016/0002-9394(89)90492-3; Kolker A E, 1977, Trans Am Ophthalmol Soc, V75, P539; Kooner KS, 2008, CLIN OPHTHALMOL, V2, P757; Kotecha A, 2009, INVEST OPHTH VIS SCI, V50, P4693, DOI 10.1167/iovs.08-3115; Kwon YH, 2001, AM J OPHTHALMOL, V132, P47, DOI 10.1016/S0002-9394(01)00912-6; Lin H, 2002, MODELING SURVIVAL DA, V44, P85; OBRIEN C, 1991, AM J OPHTHALMOL, V111, P491, DOI 10.1016/S0002-9394(14)72386-4; Oliver JE, 2002, AM J OPHTHALMOL, V133, P764, DOI 10.1016/S0002-9394(02)01403-4; Pararajasegaram R, 1999, AM J OPHTHALMOL, V128, P359; Peters D, 2013, AM J OPHTHALMOL, V156, P724, DOI 10.1016/j.ajo.2013.05.027; Quek DTL, 2011, AM J OPHTHALMOL, V152, P463, DOI 10.1016/j.ajo.2011.02.023; Quigley HA, 1996, AM J OPHTHALMOL, V122, P355, DOI 10.1016/S0002-9394(14)72062-8; QUIGLEY HA, 1994, ARCH OPHTHALMOL-CHIC, V112, P644, DOI 10.1001/archopht.1994.01090170088028; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Racette L, 2003, SURV OPHTHALMOL, V48, P295, DOI 10.1016/S0039-6257(03)00028-6; Ripatti S, 2000, BIOMETRICS, V56, P1016, DOI 10.1111/j.0006-341X.2000.01016.x; Spaeth GL., PATHOGENESIS VISUAL; Stewart WC, 2000, AM J OPHTHALMOL, V130, P274, DOI 10.1016/S0002-9394(00)00487-6; Therneau T, 2014, PACKAGE SURVIVAL ANA; Therneau TM, 2003, J COMPUT GRAPH STAT, V12, P156, DOI 10.1198/1061860031365; Traverso CE, 2005, BRIT J OPHTHALMOL, V89, P1245, DOI 10.1136/bjo.2005.067355; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429	39	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136632	10.1371/journal.pone.0136632	http://dx.doi.org/10.1371/journal.pone.0136632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302445	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900077
J	da Cunha, MGMCM; Zia, S; Arcolino, FO; Carlon, MS; Beckmann, DV; Pippi, NL; Graca, DL; Levtchenko, E; Deprest, J; Toelen, J				Carvalho Mori da Cunha, Marina Gabriela Monteiro; Zia, Silvia; Arcolino, Fanny Oliveira; Carlon, Marianne Sylvia; Beckmann, Diego Vilibaldo; Pippi, Ney Luis; Graca, Dominguita Luhers; Levtchenko, Elena; Deprest, Jan; Toelen, Jaan			Amniotic Fluid Derived Stem Cells with a Renal Progenitor Phenotype Inhibit Interstitial Fibrosis in Renal Ischemia and Reperfusion Injury in Rats	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; MESENCHYMAL STROMAL CELLS; CADHERIN GENE PROMOTER; ISCHEMIA/REPERFUSION INJURY; IN-VITRO; HEME OXYGENASE-1; GRAFT FUNCTION; CONTRIBUTE; REPAIR; TRANSPLANTATION	Objectives Mesenchymal stem cells derived from human amniotic fluid (hAFSCs) are a promising source for cellular therapy, especially for renal disorders, as a subpopulation is derived from the fetal urinary tract. The purpose of this study was to evaluate if hAFSCs with a renal progenitor phenotype demonstrate a nephroprotective effect in acute ischemia reperfusion (I/R) model and prevent late stage fibrosis. Methods A total of 45 male 12-wk-old Wistar rats were divided into three equal groups;: rats subjected to I/R injury and treated with Chang Medium, rats subjected to I/R injury and treated with hAFSCs and sham-operated animals. In the first part of this study, hAFSCs that highly expressed CD24, CD117, SIX2 and PAX2 were isolated and characterized. In the second part, renal I/R injury was induced in male rats and cellular treatment was performed 6 hours later via arterial injection. Functional and histological analyses were performed 24 hours, 48 hours and 2 months after treatment using serum creatinine, urine protein to creatinine ratio, inflammatory and regeneration markers and histomorphometric analysis of the kidney. Statistical analysis was performed by analysis of variance followed by the Tukey's test for multiple comparisons or by nonparametric Kruskal-Wallis followed by Dunn. Statistical significance level was defined as p<0.05. Results hAFSCs treatment resulted in significantly reduced serum creatinine level at 24 hours, less tubular necrosis, less hyaline cast formation, higher proliferation index, less inflammatory cell infiltration and less myofibroblasts at 48h. The treated group had less fibrosis and proteinuria at 2 months after injury. Conclusion hAFSCs contain a renal progenitor cell subpopulation that has a nephroprotective effect when delivered intra-arterially in rats with renal I/R injury, and reduces interstitial fibrosis on long term follow-up.	[Carvalho Mori da Cunha, Marina Gabriela Monteiro; Zia, Silvia; Deprest, Jan; Toelen, Jaan] Katholieke Univ Leuven, Dept Dev & Regenerat, Organ Syst Cluster, Fetal Therapy Grp,Grp Biomed Sci, Leuven, Belgium; [Carvalho Mori da Cunha, Marina Gabriela Monteiro; Beckmann, Diego Vilibaldo; Pippi, Ney Luis; Graca, Dominguita Luhers] Univ Fed Santa Maria, Expt Vet Surg Lab, BR-97119900 Santa Maria, RS, Brazil; [Arcolino, Fanny Oliveira; Levtchenko, Elena] Katholieke Univ Leuven, Dept Dev & Regenerat, Organ Syst Cluster, Lab Pediat Nephrol,Grp Biomed Sci, Leuven, Belgium; [Carlon, Marianne Sylvia] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Virol & Gene Therapy, Grp Biomed Sci, Leuven, Belgium; [Deprest, Jan] Univ Hosp Leuven, Dept Obstet & Gynecol, Leuven, Belgium; [Levtchenko, Elena; Toelen, Jaan] Univ Hosp Leuven, Dept Pediat, Leuven, Belgium	KU Leuven; Universidade Federal de Santa Maria (UFSM); KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Toelen, J (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Organ Syst Cluster, Fetal Therapy Grp,Grp Biomed Sci, Leuven, Belgium.	jaan.toelen@uzleuven.be	Levtchenko, Elena/AAO-7125-2020; da Cunha, Marina Gabriela Monteiro Carvalho Mori/AAH-8673-2019; Carlon, Marianne/AAY-3211-2020; Arcolino, Fanny Oliveira/L-2367-2018	da Cunha, Marina Gabriela Monteiro Carvalho Mori/0000-0001-6658-7797; Carlon, Marianne/0000-0002-8263-0350; Arcolino, Fanny Oliveira/0000-0003-2207-9699; Deprest, Jan/0000-0002-4920-945X	Agency for Innovation by Science and technology (IWT)-Vlaanderen; European Commission grant of Diagnostic Molecular Imaging (DIMI) [LSHB11 CT-2005-512146]; In vivo Molecular Imaging Research (IMIR) program from the KU Leuven	Agency for Innovation by Science and technology (IWT)-Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); European Commission grant of Diagnostic Molecular Imaging (DIMI); In vivo Molecular Imaging Research (IMIR) program from the KU Leuven	Research was funded by the Agency for Innovation by Science and technology (IWT)-Vlaanderen, by the European Commission grant of Diagnostic Molecular Imaging (DIMI) (LSHB11 CT-2005-512146) and by the In vivo Molecular Imaging Research (IMIR) program from the KU Leuven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam TV, 2003, KIDNEY INT, V63, P134, DOI 10.1046/j.1523-1755.2003.00737.x; Bai Y, 2002, AM J PHYSIOL-RENAL, V283, pF839, DOI 10.1152/ajprenal.00128.2002; Baulier E, 2014, STEM CELL TRANSL MED, V3, P809, DOI 10.5966/sctm.2013-0186; Bayrak O, 2008, WORLD J UROL, V26, P285, DOI 10.1007/s00345-008-0253-4; Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Bieback K, 2010, TISSUE ENG PT A, V16, P3467, DOI [10.1089/ten.tea.2009.0727, 10.1089/ten.TEA.2009.0727]; Bonventre JV, 2009, J AM SOC NEPHROL, V20, P927, DOI 10.1681/ASN.2009030322; Brady PD, 2014, GENET MED, V16, P469, DOI 10.1038/gim.2013.168; Bucaloiu ID, 2012, KIDNEY INT, V81, P477, DOI 10.1038/ki.2011.405; Cai JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092347; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; da Cunha MGMCM, 2013, EUR SURG RES, V51, P58, DOI 10.1159/000354389; Chen J, 2008, KIDNEY INT, V74, P879, DOI 10.1038/ki.2008.304; Da Sacco S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081812; Da Sacco S, 2011, CURR OPIN ORGAN TRAN, V16, P101, DOI 10.1097/MOT.0b013e3283424f6e; Da Sacco S, 2010, J UROLOGY, V183, P1193, DOI 10.1016/j.juro.2009.11.006; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Dobreva MP, 2010, INT J DEV BIOL, V54, P761, DOI 10.1387/ijdb.092935md; Du T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt215; Du T, 2012, CYTOTHERAPY, V14, P1215, DOI 10.3109/14653249.2012.711471; Duffield JS, 2005, KIDNEY INT, V68, P1956, DOI 10.1111/j.1523-1755.2005.00629.x; Duplomb L, 2007, STEM CELLS, V25, P544, DOI 10.1634/stemcells.2006-0395; Feng Z, 2010, NEPHROL DIAL TRANSPL, V25, P3874, DOI 10.1093/ndt/gfq603; Geng YQ, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt469; GILBERT WM, 1993, SEMIN PERINATOL, V17, P150; Giraud S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/532127; Glenn Justin D, 2014, World J Stem Cells, V6, P526, DOI 10.4252/wjsc.v6.i5.526; Griffin MD, 2010, HUM GENE THER, V21, P1641, DOI 10.1089/hum.2010.156; Hara Y, 2011, TRANSPL INT, V24, P1112, DOI 10.1111/j.1432-2277.2011.01328.x; Hauser PV, 2010, AM J PATHOL, V177, P2011, DOI 10.2353/ajpath.2010.091245; Herrera MB, 2004, INT J MOL MED, V14, P1035; HEUKESHOVEN J, 1985, J CHROMATOGR, V326, P91, DOI 10.1016/S0021-9673(01)87434-3; Humphreys BD, 2008, ANNU REV MED, V59, P311, DOI 10.1146/annurev.med.59.061506.154239; Jang HR, 2009, J MOL MED, V87, P859, DOI 10.1007/s00109-009-0491-y; Kaviani A, 2001, J PEDIATR SURG, V36, P1662, DOI 10.1053/jpsu.2001.27945; Kortekaas KA, 2013, INFLAMM RES, V62, P53, DOI 10.1007/s00011-012-0550-7; Kotsch K, 2007, ANTIOXID REDOX SIGN, V9, P2049, DOI 10.1089/ars.2007.1801; Kreidberg JA, 2010, ORGANOGENESIS, V6, P61, DOI 10.4161/org.6.2.11928; Krolewski AS, 2014, DIABETES CARE, V37, P226, DOI 10.2337/dc13-0985; Lam AQ, 2014, J AM SOC NEPHROL, V25, P1211, DOI 10.1681/ASN.2013080831; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; Lassailly F, 2010, BLOOD, V115, P5347, DOI 10.1182/blood-2009-05-224030; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Li L, 2007, J AM SOC NEPHROL, V18, P3067, DOI 10.1681/ASN.2007030284; Li P, 2013, STEM CELLS DEV, V22, P340, DOI 10.1089/scd.2012.0357; Lin FM, 2003, J AM SOC NEPHROL, V14, P1188, DOI 10.1097/01.ASN.0000061595.28546.A0; Liu MC, 2008, J AM SOC NEPHROL, V19, P1360, DOI 10.1681/ASN.2007080901; Mitka M, 2001, JAMA-J AM MED ASSOC, V286, P2083, DOI 10.1001/jama.286.17.2083; Moncada S, 1997, ANN NY ACAD SCI, V811, P60, DOI 10.1111/j.1749-6632.1997.tb51989.x; Morigi M, 2008, STEM CELLS, V26, P2075, DOI 10.1634/stemcells.2007-0795; Morigi M, 2010, STEM CELLS, V28, P513, DOI 10.1002/stem.293; Morizane R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064843; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; Perin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009357; Pratschke J, 2001, TRANSPLANT P, V33, P693, DOI 10.1016/S0041-1345(00)02207-7; Prusa AR, 2004, AM J OBSTET GYNECOL, V191, P309, DOI 10.1016/j.ajog.2003.12.014; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Reinders MEJ, 2013, STEM CELL TRANSL MED, V2, P107, DOI 10.5966/sctm.2012-0114; Reis LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044092; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Saenz-Morales D, 2010, KIDNEY INT, V77, P781, DOI 10.1038/ki.2010.10; Salahudeen AK, 2004, J INVEST MED, V52, P296, DOI 10.1136/jim-52-05-28; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Schroppell B, 2014, KIDNEY INT, V86, P251, DOI 10.1038/ki.2014.18; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Semedo P, 2007, TRANSPL P, V39, P421, DOI 10.1016/j.transproceed.2007.01.036; Singbartl K, 2012, KIDNEY INT, V81, P819, DOI 10.1038/ki.2011.339; Tan JM, 2012, JAMA-J AM MED ASSOC, V307, P1169, DOI 10.1001/jama.2012.316; Togel F, 2008, AM J PHYSIOL-RENAL, V295, pF315, DOI 10.1152/ajprenal.00098.2008; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Turgut F, 2008, INT UROL NEPHROL, V40, P453, DOI [10.1007/s11255-008-9365-4, 10.1007/s11255-008-9445-5]; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; Wald R, 2012, AM J MED, V125, P585, DOI 10.1016/j.amjmed.2012.01.016; Warnock DG, 2005, J AM SOC NEPHROL, V16, P3149, DOI 10.1681/ASN.2005090934; Whyte DA, 1999, AM J PHYSIOL-RENAL, V277, pF587, DOI 10.1152/ajprenal.1999.277.4.F587; Yamashita T, 2012, FASEB J, V26, P1559, DOI 10.1096/fj.11-183194; Yuan L, 2011, AM J PHYSIOL-RENAL, V300, pF207, DOI 10.1152/ajprenal.00073.2010; Zarjou A, 2011, AM J PHYSIOL-RENAL, V300, pF254, DOI 10.1152/ajprenal.00594.2010; Zia S, 2013, PRENATAL DIAG, V33, P921, DOI 10.1002/pd.4162; Zonta S, 2010, TRANSPL P, V42, P1336, DOI 10.1016/j.transproceed.2010.03.081	81	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136145	10.1371/journal.pone.0136145	http://dx.doi.org/10.1371/journal.pone.0136145			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295710	gold, Green Published, Green Submitted			2022-12-27	WOS:000359926900074
J	Jiang, F; Chen, ZY; Bi, H; Ekure, E; Su, BB; Wu, HR; Huang, YF; Zhang, B; Jiang, J				Jiang, Feng; Chen, Zheyi; Bi, Hua; Ekure, Edgar; Su, Binbin; Wu, Haoran; Huang, Yifei; Zhang, Bin; Jiang, Jun			Association between Ocular Sensory Dominance and Refractive Error Asymmetry	PLOS ONE			English	Article							CONVERGENCE EYE-MOVEMENTS; SPHERICAL/ASTIGMATIC ANISOMETROPIA; INTEROCULAR SUPPRESSION; MONOVISION PSEUDOPHAKIA; PATIENT SATISFACTION; DYNAMIC ASYMMETRIES; CONTACT-LENS; SEX ANALYSIS; MYOPIA; INDIVIDUALS	Purpose To investigate the association between ocular sensory dominance and interocular refractive error difference (IRED). Methods A total of 219 subjects were recruited. The refractive errors were determined by objective refraction with a fixation target located 6 meters away. 176 subjects were myopic, with 83 being anisometropic (IRED >= 0.75 D). 43 subjects were hyperopic, with 22 being anisometropic. Sensory dominance was measured with a continuous flashing technique with the tested eye viewing a Gabor increasing in contrast and the fellow eye viewing a Mondrian noise decreasing in contrast. The log ratio of Mondrian to Gabor's contrasts was recorded when a subject just detected the tilting direction of the Gabor during each trial. T-test was used to compare the 50 values collected from each eye, and the t-value was used as a subject's ocular dominance index (ODI) to quantify the degree of ocular dominance. A subject with ODI >= 2 (p < 0.05) had clear dominance and the eye with larger mean ratio was the dominant one. Otherwise, a subject had an unclear dominance. Results The anisometropic subjects had stronger ocular dominance in comparison to non-anisometropic subjects (rank-sum test, p < 0.01 for both myopic and hyperopic subjects). In anisometropic subjects with clear dominance, the amplitude of the anisometropia was correlated with ODI values (R = 0.42, p < 0.01 in myopic anisometropic subjects; R = 0.62, p < 0.01 in hyperopic anisometropic subjects). Moreover, the dominant eyes were more myopic in myopic anisometropic subjects (sign-test, p < 0.05) and less hyperopic in hyperopic anisometropic subjects (sign-test, p < 0.05). Conclusion The degree of ocular sensory dominance is associated with interocular refractive error difference.	[Jiang, Feng; Huang, Yifei] Chinese PLA, Sch Med, Beijing, Peoples R China; [Jiang, Feng] Jinling Hosp, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China; [Chen, Zheyi; Su, Binbin; Wu, Haoran; Zhang, Bin; Jiang, Jun] Wenzhou Med Univ, Hosp Eye, Wenzhou, Peoples R China; [Bi, Hua; Ekure, Edgar; Zhang, Bin] Nova SE Univ, Coll Optometry, Davie, FL USA	Wenzhou Medical University; Nova Southeastern University	Zhang, B (corresponding author), Wenzhou Med Univ, Hosp Eye, Wenzhou, Peoples R China.	bz52@nova.edu; jjhsj@hotmail.com	Huang, Yifei/ABE-4692-2020; Zhang, Bin/GOH-1376-2022; Huang, Yifei/ABE-7566-2020; bi, huaqiang/GYJ-5005-2022	Huang, Yifei/0000-0002-7089-6426; Wu, Haoran/0000-0002-2248-3547				Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Braun EHP, 2008, OPHTHALMOLOGY, V115, P1196, DOI 10.1016/j.ophtha.2007.09.018; Cheng CY, 2004, INVEST OPHTH VIS SCI, V45, P2856, DOI 10.1167/iovs.03-0878; Chia A, 2007, INVEST OPHTH VIS SCI, V48, P3533, DOI 10.1167/iovs.06-1489; Evans BJW, 2007, OPHTHAL PHYSL OPT, V27, P417, DOI 10.1111/j.1475-1313.2007.00488.x; Fink WH, 1938, ARCH OPHTHALMOL-CHIC, V19, P555, DOI 10.1001/archopht.1938.00850160081005; Greenbaum S, 2002, J CATARACT REFR SURG, V28, P1439, DOI 10.1016/S0886-3350(02)01218-X; Gupta N, 2009, OPTOMETRY VISION SCI, V86, P98; Handa T, 2004, J CATARACT REFR SURG, V30, P769, DOI 10.1016/j.jcrs.2003.07.013; Hom M M, 1999, J Am Optom Assoc, V70, P117; Horng JL, 1998, VISION RES, V38, P2761, DOI 10.1016/S0042-6989(97)00453-7; Ito M, 2013, J REFRACT SURG, V29, P717, DOI 10.3928/1081597X-20130813-02; Kawata H, 2001, JPN J OPHTHALMOL, V45, P437, DOI 10.1016/S0021-5155(01)00405-1; Linke SJ, 2012, INVEST OPHTH VIS SCI, V53, P5362, DOI 10.1167/iovs.11-8781; Linke SJ, 2011, INVEST OPHTH VIS SCI, V52, P9166, DOI 10.1167/iovs.11-8131; Mapp AP, 2003, PERCEPT PSYCHOPHYS, V65, P310, DOI 10.3758/BF03194802; MONEY J, 1972, Q J EXP PSYCHOL, V24, P454, DOI 10.1080/14640747208400305; Morgan PB, 2011, CONTACT LENS ANTERIO, V34, P223, DOI 10.1016/j.clae.2011.08.001; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PORAC C, 1976, PSYCHOL BULL, V83, P880, DOI 10.1037/0033-2909.83.5.880; Reiss M R, 1997, Laterality, V2, P7, DOI 10.1080/135765097397602; Schaeffel F, 2013, OPHTHAL PHYSL OPT, V33, P362, DOI 10.1111/opo.12058; SENGPIEL F, 1994, J NEUROSCI, V14, P6855; Sridhar D, 2011, VISION RES, V51, P1075, DOI 10.1016/j.visres.2011.02.023; Wallman J, 2004, NEURON, V43, P447, DOI 10.1016/j.neuron.2004.08.008; Wildsoet CE, 2003, CURR EYE RES, V27, P371, DOI 10.1076/ceyr.27.6.371.18188; Wright KW, 1999, J CATARACT REFR SURG, V25, P177, DOI 10.1016/S0886-3350(99)80123-0; Yang E, 2010, INVEST OPHTH VIS SCI, V51, P588, DOI 10.1167/iovs.08-3076; Yang ZK, 2008, INVEST OPHTH VIS SCI, V49, P4779, DOI 10.1167/iovs.07-1616; Zhang FX, 2011, J CATARACT REFR SURG, V37, P853, DOI 10.1016/j.jcrs.2010.12.041	30	18	23	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136222	10.1371/journal.pone.0136222	http://dx.doi.org/10.1371/journal.pone.0136222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295803	gold, Green Published, Green Submitted			2022-12-27	WOS:000359926900084
J	Julian, TR; Pickering, AJ				Julian, Timothy R.; Pickering, Amy J.			A Pilot Study on Integrating Videography and Environmental Microbial Sampling to Model Fecal Bacterial Exposures in Peri-Urban Tanzania	PLOS ONE			English	Article							CONTAMINATION; CHILDREN; WATER; QUANTIFICATION; INGESTION; RATES; RISK; HAND	Diarrheal diseases are a leading cause of under-five mortality and morbidity in sub-Saharan Africa. Quantitative exposure modeling provides opportunities to investigate the relative importance of fecal-oral transmission routes (e.g. hands, water, food) responsible for diarrheal disease. Modeling, however, requires accurate descriptions of individuals' interactions with the environment (i.e., activity data). Such activity data are largely lacking for people in low-income settings. In the present study, we collected activity data and microbiological sampling data to develop a quantitative microbial exposure model for two female caretakers in peri-urban Tanzania. Activity data were combined with microbiological data of contacted surfaces and fomites (e.g. broom handle, soil, clothing) to develop example exposure profiles describing second-by-second estimates of fecal indicator bacteria (E. coli and enterococci) concentrations on the caretaker's hands. The study demonstrates the application and utility of video activity data to quantify exposure factors for people in low-income countries and apply these factors to understand fecal contamination exposure pathways. This study provides both a methodological approach for the design and implementation of larger studies, and preliminary data suggesting contacts with dirt and sand may be important mechanisms of hand contamination. Increasing the scale of activity data collection and modeling to investigate individual-level exposure profiles within target populations for specific exposure scenarios would provide opportunities to identify the relative importance of fecal-oral disease transmission routes.	[Julian, Timothy R.; Pickering, Amy J.] Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; [Pickering, Amy J.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA	Stanford University; Stanford University	Julian, TR (corresponding author), Eawag, Dept Environm Microbiol, Dubendorf, Switzerland.	tim.julian@eawag.ch		Julian, Timothy/0000-0003-1000-0306	Stanford University's School of Earth Sciences, Center for African Studies and Woods Institute for the Environment; United States Environmental Protection Agency (EPA)	Stanford University's School of Earth Sciences, Center for African Studies and Woods Institute for the Environment; United States Environmental Protection Agency (EPA)(United States Environmental Protection Agency)	This work was funded by Stanford University's School of Earth Sciences, Center for African Studies and Woods Institute for the Environment. TRJ received support from the United States Environmental Protection Agency (EPA); EPA has not officially endorsed this publication, and the views expressed herein may not reflect the views of the EPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency UEP, 2002, 821R02022 EPA AG UEP; Agency UEP, 2002, 821R02024 EPA AG UEP; Agency UEP, 2006, 600R06096A EPA AG UE; AuYeung W, 2007, THESIS STANFORD U ST; Beamer P, 2008, ENVIRON RES, V108, P239, DOI 10.1016/j.envres.2008.07.007; Beamer PI, 2009, ENVIRON INT, V35, P1202, DOI 10.1016/j.envint.2009.08.003; Cardoso CC, 2000, INFECT CONT HOSP EP, V21, P248, DOI 10.1086/503216; Chen YH, 2001, J FOOD PROTECT, V64, P72, DOI 10.4315/0362-028X-64.1.72; Fathi A, 2012, PROC CVPR IEEE, P1226, DOI 10.1109/CVPR.2012.6247805; FEACHEM RG, 1984, B WORLD HEALTH ORGAN, V62, P467; Ferguson AC, 2006, J EXPO SCI ENV EPID, V16, P287, DOI 10.1038/sj.jea.7500459; Gerardo U., 2013, APPL ENVIRON MICROB, V79, P5728, DOI [10.1128/AEM.01030-13, DOI 10.1128/AEM.01030-13]; Gibson LL, 1999, AM J INFECT CONTROL, V27, pS34, DOI 10.1016/S0196-6553(99)70040-4; Haas C.N., 1999, QUANTITATIVE MICROBI; HEINZE JE, 1988, EPIDEMIOL INFECT, V101, P135, DOI 10.1017/S0950268800029290; Hubal EAC, 2008, ENVIRON SCI TECHNOL, V42, P934, DOI 10.1021/es071668h; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Jones RM, 2012, RISK ANAL; Julian TR, 2013, AM J TROP MED HYG, V89, P869, DOI 10.4269/ajtmh.12-0425; Julian TR, 2009, RISK ANAL, V29, P617, DOI 10.1111/j.1539-6924.2008.01193.x; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Mattioli MC, 2013, ENVIRON SCI TECHNOL, V47, P355, DOI 10.1021/es303878d; Mattioli MCM, 2015, ENVIRON SCI TECHNOL, V49, P1912, DOI 10.1021/es505555f; Moore G, 2007, J APPL MICROBIOL, V103, P1090, DOI 10.1111/j.1365-2672.2007.03330.x; Ngure F, 2012, ENV HYGIENE FOOD SAF; Nicas M, 2006, RISK ANAL, V26, P1085, DOI 10.1111/j.1539-6924.2006.00802.x; Nicas M, 2009, RISK ANAL, V29, P1292, DOI 10.1111/j.1539-6924.2009.01253.x; O'Toole J, 2009, APPL ENVIRON MICROB, V75, P1256, DOI 10.1128/AEM.01923-08; Perez-Rodriguez F, 2008, TRENDS FOOD SCI TECH, V19, P131, DOI 10.1016/j.tifs.2007.08.003; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P5736, DOI 10.1021/es300022c; Pickering AJ, 2011, TROP MED INT HEALTH, V16, P233, DOI 10.1111/j.1365-3156.2010.02677.x; Pickering AJ, 2010, ENVIRON SCI TECHNOL, V44, P3267, DOI 10.1021/es903524m; PINFOLD JV, 1990, EPIDEMIOL INFECT, V105, P363, DOI 10.1017/S0950268800047956; Rusin P, 2002, J APPL MICROBIOL, V93, P585, DOI 10.1046/j.1365-2672.2002.01734.x; Shalat SL, 2011, ENVIRON SCI TECHNOL, V45, P2945, DOI 10.1021/es1033876; Sinclair RG, 2011, LETT APPL MICROBIOL, V52, P144, DOI 10.1111/j.1472-765X.2010.02978.x; US EPA, 2011, EXPOSURE FACTORS HDB, DOI DOI 10.2903/J.EFSA.2011.2392.2011.EPA/600/R-09/052F; ZARTARIAN VG, 1995, J EXPO ANAL ENV EPID, V5, P21	38	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136158	10.1371/journal.pone.0136158	http://dx.doi.org/10.1371/journal.pone.0136158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295964	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900076
J	Peterson, KE; Spadano-Gasbarro, JL; Greaney, ML; Austin, SB; Mezgebu, S; Hunt, AT; Blood, EA; Horan, C; Feldman, HA; Osganian, SK; Bettencourt, MF; Richmond, TK				Peterson, Karen E.; Spadano-Gasbarro, Jennifer L.; Greaney, Mary L.; Austin, S. Bryn; Mezgebu, Solomon; Hunt, Anne T.; Blood, Emily A.; Horan, Chrissy; Feldman, Henry A.; Osganian, Stavroula K.; Bettencourt, Maria F.; Richmond, Tracy K.			Three-Year Improvements in Weight Status and Weight-Related Behaviors in Middle School Students: The Healthy Choices Study	PLOS ONE			English	Article							OBESITY PREVENTION PROGRAMS; PHYSICAL-ACTIVITY; CHILDHOOD OBESITY; INTERVENTIONS; FRAMEWORK; IMPLEMENTATION; OVERWEIGHT; NUTRITION; PROMOTION; SYSTEM	Introduction Few dissemination evaluations exist to document the effectiveness of evidence-based childhood obesity interventions outside the research setting. Objective Evaluate Healthy Choices (HC), a multi-component obesity prevention program, by examining school-level changes in weight-related behaviors and weight status and the association of implementation components with odds of overweight/obesity. Methods We compared baseline and Year 3 school-level behavioral and weight status outcomes with paired t-tests adjusted for schools' socio-demographic characteristics. We used generalized estimating equations to examine the odds of overweight/obesity associated with program components. Setting/Participants Consecutive sample of 45 of 51 middle schools participating in the HC program with complete baseline and follow-up survey data including a subsample of 35 schools with measured anthropomentry for 5,665 7th grade students. Intervention Schools developed a multi-disciplinary team and implemented an obesity prevention curriculum, before and after school activities, environmental and policy changes and health promotions targeting a 5-2-1 theme: eat >= 5 servings/day of fruits and vegetables (FV), watch <= 2 hours of television (TV) and participate in >= 1 hours/day of physical activity (PA) on most days Main Outcome Measures 1) School-level percent of students achieving targeted behaviors and percent overweight/obese; and 2) individual odds of overweight/obesity. Results The percent achieving behavioral goals over three years increased significantly for FV: 16.4 to 19.4 (p = 0.001), TV: 53.4 to 58.2 (p = 0.003) and PA: 37.1 to 39.9 (p = 0.02), adjusting for school size, baseline mean age and percent female, non-Hispanic White, and eligible for free and reduced price lunch. In 35 schools with anthropometry, the percent of overweight/obese 7th grade students decreased from 42.1 to 38.4 (p = 0.016). Having a team that met the HC definition was associated with lower odds of overweight/obesity (OR = 0.83, CI: 0.71-0.98). Conclusions and Relevance The HC multi-component intervention demonstrated three-year improvements in weight-related behaviors and weight status across diverse middle schools. Team building appears important to the program's effectiveness.	[Peterson, Karen E.] Univ Michigan, Sch Publ Hlth, Dept Nutr Sci, Ann Arbor, MI 48109 USA; [Peterson, Karen E.] Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA; [Peterson, Karen E.; Spadano-Gasbarro, Jennifer L.; Greaney, Mary L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Peterson, Karen E.; Austin, S. Bryn] Harvard Univ, TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Greaney, Mary L.] Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA; [Greaney, Mary L.] Univ Rhode Isl, Dept Kinesiol, Kingston, RI 02881 USA; [Austin, S. Bryn; Richmond, Tracy K.] Boston Childrens Hosp, Div Adolescent & Young Adult Med, Dept Med, Boston, MA 02115 USA; [Mezgebu, Solomon] Tufts Univ, USDA, Nutr Program North East Reg, Boston, MA 02111 USA; [Hunt, Anne T.] Hunt Consulting Associates, Logan, UT USA; [Blood, Emily A.; Feldman, Henry A.; Osganian, Stavroula K.] Boston Childrens Hosp, Clin Res Ctr, Boston, MA USA; [Blood, Emily A.; Feldman, Henry A.; Osganian, Stavroula K.] Harvard Univ, Sch Med, Boston, MA USA; [Horan, Chrissy] Harvard Univ, Sch Med, Dept Populat Med, Obes Prevent Program, Boston, MA USA; [Horan, Chrissy] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Bettencourt, Maria F.] Massachusetts Dept Publ Hlth, Boston, MA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; University of Rhode Island; Harvard University; Boston Children's Hospital; Tufts University; United States Department of Agriculture (USDA); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Massachusetts Department of Public Health	Richmond, TK (corresponding author), Boston Childrens Hosp, Div Adolescent & Young Adult Med, Dept Med, Boston, MA 02115 USA.	tracy.richmond@childrens.harvard.edu	Feldman, Henry/M-2302-2013		Massachusetts Department of Public Health; International Nutrition Foundation, Inc.; Centers for Disease Control and Prevention [U58/CCU12282]; Leadership Education in Adolescent Health project, Maternal and Child Health Bureau, Health Resources and Services Administration [6T71-MC00009]; NIH Career Development Award [K01 HD058042]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K01HD058042] Funding Source: NIH RePORTER	Massachusetts Department of Public Health; International Nutrition Foundation, Inc.; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Leadership Education in Adolescent Health project, Maternal and Child Health Bureau, Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NIH Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding for this project was provided by the Massachusetts Department of Public Health in collaboration with the International Nutrition Foundation, Inc. Additional funding was provided by cooperative agreement no. U58/CCU12282 with the Centers for Disease Control and Prevention. S. Bryn Austin and Tracy K. Richmond are supported by the Leadership Education in Adolescent Health project, Maternal and Child Health Bureau, Health Resources and Services Administration grant no. 6T71-MC00009. T.K. Richmond was supported by an NIH Career Development Award (K01 HD058042). Coauthor Anne Hunt is a paid statistical consultant operating under her own consulting firm, Hunt Consulting Associates. Hunt Consulting Associates had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript through the participation of co-author Anne Hunt. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], H75CCH117492011 MASS; Austin S Bryn, 2006, Prev Chronic Dis, V3, pA35; Austin SB, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120111; Beets MW, 2009, AM J PREV MED, V36, P527, DOI 10.1016/j.amepre.2009.01.033; Brown T, 2009, OBES REV, V10, P110, DOI 10.1111/j.1467-789X.2008.00515.x; Budd GM, 2006, J SCHOOL HEALTH, V76, P485, DOI 10.1111/j.1746-1561.2006.00149.x; Carter J, 2007, PLANET HLTH INTERDIS; Centers for Disease Control and Prevention, 2016, YOUTH RISK BEHAV SUR; Centers for Disease Control and Prevention, 2012, SCH HLTH IND SELF AS; Centers for Disease Control and Prevention, 2011, SAS PROGR CDC GROWTH; Dreisinger ML, 2012, HEALTH EDUC RES, V27, P292, DOI 10.1093/her/cyr063; Dzewaltowski DA, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-90; Egger G, 1997, BRIT MED J, V315, P477, DOI 10.1136/bmj.315.7106.477; Food and Nutrition Services US Department of Agiriculture, 2010, NUTR ED PROM ROL FNS; Gortmaker SL, 1999, ARCH PEDIAT ADOL MED, V153, P409, DOI 10.1001/archpedi.153.4.409; Greaney M, 2007, AM J HEALTH EDUC, V38, P250, DOI 10.1080/19325037.2007.10598979; Hastmann TJ, 2013, J NUTR EDUC BEHAV, V45, P60, DOI 10.1016/j.jneb.2012.06.005; Hoelscher DM, 2013, J ACAD NUTR DIET, V113, P1375, DOI 10.1016/j.jand.2013.08.004; Institute of Medicine, 2012, ACC PROGR OB PREV SO; Katz David L., 2005, Morbidity and Mortality Weekly Report, V54, P1; Kropski JA, 2008, OBESITY, V16, P1009, DOI 10.1038/oby.2008.29; Leeman J, 2011, J PUBLIC HEALTH MAN, V17, P133, DOI 10.1097/PHH.0b013e3181e39eaa; Let's Move!, AM MOV RAIS HEALTH G; Levine E, 2002, J NUTR EDUC BEHAV, V34, P109, DOI 10.1016/S1499-4046(06)60076-6; Luepker RV, 1996, JAMA-J AM MED ASSOC, V275, P768, DOI 10.1001/jama.275.10.768; Malepati S, 2007, CHILDHOOD OBESITY HA; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; NCES National Center for Education Statistics, COMM COR DAT BUILD T; Nihiser AJ, 2009, PEDIATRICS, V124, pS89, DOI 10.1542/peds.2008-3586L; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Pearlman Deborah N, 2005, Prev Chronic Dis, V2 Spec no, pA09; Peterson KE, 2007, J LAW MED ETHICS, V35, P113, DOI 10.1111/j.1748-720X.2007.00116.x; Ritchie LD, 2006, J AM DIET ASSOC, V106, P925, DOI 10.1016/j.jada.2006.03.001; Sallis JF, 2000, ANN BEHAV MED, V22, P294, DOI 10.1007/BF02895665; Simmons A, 2009, HEALTH PROMOT INT, V24, P311, DOI 10.1093/heapro/dap029; Slusser WM, 2013, J HEALTH CARE POOR U, V24, P12, DOI 10.1353/hpu.2013.0111; Story M, 2006, FUTURE CHILD, V16, P109, DOI 10.1353/foc.2006.0007; Story Mary, 2003, Ethn Dis, V13, pS54; Suarez-Balcazar Y, 2006, AM J COMMUN PSYCHOL, V38, P113, DOI 10.1007/s10464-006-9067-y; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Swinburn B, 2005, OBES REV, V6, P23, DOI 10.1111/j.1467-789X.2005.00184.x; U.S. Department of Health and Human Services Health Research and Services Administration Maternal and Child Health Bureau, 2006, GROWTH CHARTS TRAIN; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; Ward DS, 2006, HEALTH EDUC RES, V21, P896, DOI 10.1093/her/cyl134; Wiecha JL, 2004, J PEDIATR PSYCHOL, V29, P467, DOI 10.1093/jpepsy/jsh050; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454	46	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0134470	10.1371/journal.pone.0134470	http://dx.doi.org/10.1371/journal.pone.0134470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26295837	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900012
J	Wood, HE; Marlin, N; Mudway, IS; Bremner, SA; Cross, L; Dundas, I; Grieve, A; Grigg, J; Jamaludin, JB; Kelly, FJ; Lee, T; Sheikh, A; Walton, R; Griffiths, CJ				Wood, Helen E.; Marlin, Nadine; Mudway, Ian S.; Bremner, Stephen A.; Cross, Louise; Dundas, Isobel; Grieve, Andrew; Grigg, Jonathan; Jamaludin, Jeenath B.; Kelly, Frank J.; Lee, Tak; Sheikh, Aziz; Walton, Robert; Griffiths, Christopher J.			Effects of Air Pollution and the Introduction of the London Low Emission Zone on the Prevalence of Respiratory and Allergic Symptoms in Schoolchildren in East London: A Sequential Cross-Sectional Study	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; CHILDHOOD ISAAC; ASTHMA; EXPOSURE; HEALTH; ECZEMA; PATY; UK	The adverse effects of traffic-related air pollution on children's respiratory health have been widely reported, but few studies have evaluated the impact of traffic-control policies designed to reduce urban air pollution. We assessed associations between traffic-related air pollutants and respiratory/allergic symptoms amongst 8-9 year-old schoolchildren living within the London Low Emission Zone (LEZ). Information on respiratory/allergic symptoms was obtained using a parent-completed questionnaire and linked to modelled annual air pollutant concentrations based on the residential address of each child, using a multivariable mixed effects logistic regression analysis. Exposure to traffic-related air pollutants was associated with current rhinitis: NOx (OR 1.01, 95% CI 1.00-1.02), NO2 (1.03, 1.00-1.06), PM10 (1.16, 1.04-1.28) and PM2.5 (1.38, 1.08-1.78), all per mu g/m(3) of pollutant, but not with other respiratory/allergic symptoms. The LEZ did not reduce ambient air pollution levels, or affect the prevalence of respiratory/allergic symptoms over the period studied. These data confirm the previous association between traffic-related air pollutant exposures and symptoms of current rhinitis. Importantly, the London LEZ has not significantly improved air quality within the city, or the respiratory health of the resident population in its first three years of operation. This highlights the need for more robust measures to reduce traffic emissions.	[Wood, Helen E.; Mudway, Ian S.; Grieve, Andrew; Jamaludin, Jeenath B.] Kings Coll London, MRC PHE Ctr Environm & Hlth, London WC2R 2LS, England; [Marlin, Nadine; Bremner, Stephen A.; Cross, Louise; Walton, Robert; Griffiths, Christopher J.] Queen Mary Univ London, Blizard Inst, Asthma UK Ctr Appl Asthma Res, Ctr Primary Care & Publ Hlth, London, England; [Dundas, Isobel; Grigg, Jonathan] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England; [Jamaludin, Jeenath B.] Univ Sains Malaysia, Inst Res Mol Med INFORMM, Kelantan, Malaysia; [Lee, Tak] Kings Coll London, MRC & Asthma UK Ctr Allerg Mech Asthma, London WC2R 2LS, England; [Lee, Tak] HK Sanat & Hosp, Allergy Ctr, Hong Kong, Hong Kong, Peoples R China; [Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh, Midlothian, Scotland; [Sheikh, Aziz] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gen Internal Med & Primary Care, Boston, MA 02115 USA	University of London; King's College London; University of London; Queen Mary University London; University of London; Queen Mary University London; Universiti Sains Malaysia; University of London; King's College London; University of Edinburgh; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Mudway, IS (corresponding author), Kings Coll London, MRC PHE Ctr Environm & Hlth, London WC2R 2LS, England.	ian.mudway@kcl.ac.uk	Kelly, Frank J/C-6125-2009; Lee, Tak/AAA-9526-2020; Bremner, Stephen/R-4038-2016; Kelly, Frank/ABG-3411-2021	Kelly, Frank J/0000-0003-2558-8392; Lee, Tak/0000-0002-7554-4059; Bremner, Stephen/0000-0003-0790-7070; Kelly, Frank/0000-0003-2558-8392; Mudway, Ian/0000-0003-1239-5014; Walton, Robert/0000-0001-7700-1907; Grigg, Jonathan/0000-0003-3109-6028; Marlin, Nadine/0000-0002-2841-4825; Sheikh, Aziz/0000-0001-7022-3056	National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; Dr. and Mrs. Lee Iu Cheung Fund; Hackney Primary Care Trust (PCT); Medical Research Council [G1000758, MC_U190092710, G1000758B, MR/K007017/1, MR/L01341X/1, MR/K010727/1] Funding Source: researchfish; National Institute for Health Research [RP-PG-0609-10181] Funding Source: researchfish; Natural Environment Research Council [NE/I008039/1] Funding Source: researchfish; Asthma UK [AUK-AC-2012-01] Funding Source: researchfish; MRC [MR/K010727/1, MC_U190092710, MR/L01341X/1, MR/K007017/1] Funding Source: UKRI; NERC [NE/I008039/1] Funding Source: UKRI	National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; Dr. and Mrs. Lee Iu Cheung Fund; Hackney Primary Care Trust (PCT); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded/supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London, Dr. and Mrs. Lee Iu Cheung Fund, and Hackney Primary Care Trust (PCT). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HR, 2010, OCCUP ENVIRON MED, V67, P293, DOI 10.1136/oem.2009.048785; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Austin JB, 1999, ARCH DIS CHILD, V81, P225, DOI 10.1136/adc.81.3.225; Beevers SD, 2013, J EXPO SCI ENV EPID, V23, P647, DOI 10.1038/jes.2013.6; Boezen HM, 1999, LANCET, V353, P874, DOI 10.1016/S0140-6736(98)06311-9; Brunekreef B, 2009, ENVIRON HEALTH PERSP, V117, P1791, DOI 10.1289/ehp.0800467; Cames Michel, 2013, Environmental Sciences Europe, V25, P15, DOI 10.1186/2190-4715-25-15; Carslaw DC, 2011, ATMOS ENVIRON, V45, P7053, DOI 10.1016/j.atmosenv.2011.09.063; Carslaw DC, 2011, DEFRA URBAN MODEL EV, V1; Cesaroni G, 2012, OCCUP ENVIRON MED, V69, P133, DOI 10.1136/oem.2010.063750; Dales R, 2009, J OCCUP ENVIRON MED, V51, P654, DOI 10.1097/JOM.0b013e3181a0363c; Department for Communities and Local Government, ENGL IND DEPR 2010 2; Environmental Research Group KsCL, LOND AIR; Green DC, 2009, ATMOS ENVIRON, V43, P2132, DOI 10.1016/j.atmosenv.2009.01.024; HEI Panel on the Health Effects of Traffic-Related Air Pollution, 2010, TRAFF REL AIR POLL C; HENDERSON FW, 1989, AM REV RESPIR DIS, V140, P197, DOI 10.1164/ajrccm/140.1.197; Hoek G, 2012, EUR RESPIR J, V40, P538, DOI 10.1183/09031936.00002611; Janssen NAH, 2003, ENVIRON HEALTH PERSP, V111, P1512, DOI 10.1289/ehp.6243; Kaur B, 1998, BRIT MED J, V316, P118; Kelly F, 2011, LONDON LOW EMISSION; Office for National Statistics, 2012, POP EST ENGL WAL MID; Oosterlee A, 1996, OCCUP ENVIRON MED, V53, P241, DOI 10.1136/oem.53.4.241; Pattenden S, 2006, OCCUP ENVIRON MED, V63, P828, DOI 10.1136/oem.2006.025213; Penard-Morand C, 2010, EUR RESPIR J, V36, P33, DOI 10.1183/09031936.00116109; Transport for London (TfL), 2008, LOND LOW EM ZON IMP; van der Zee SC, 1999, OCCUP ENVIRON MED, V56, P802, DOI 10.1136/oem.56.12.802; Weiland Stephan K., 1994, Annals of Epidemiology, V4, P243; WHO, 2006, INDIAN J MED RES; WJST M, 1993, BRIT MED J, V307, P596, DOI 10.1136/bmj.307.6904.596; Zuraimi MS, 2011, PEDIAT ALLERG IMM-UK, V22, pe112, DOI 10.1111/j.1399-3038.2010.00992.x	30	26	27	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0109121	10.1371/journal.pone.0109121	http://dx.doi.org/10.1371/journal.pone.0109121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295579	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000359926900001
J	Yu, YP; Liu, S; Huo, ZG; Martin, A; Nelson, JB; Tseng, GC; Luo, JH				Yu, Yan P.; Liu, Silvia; Huo, Zhiguang; Martin, Amantha; Nelson, Joel B.; Tseng, George C.; Luo, Jian-Hua			Genomic Copy Number Variations in the Genomes of Leukocytes Predict Prostate Cancer Clinical Outcomes	PLOS ONE			English	Article							METASTASIS; CARCINOMA; RELAPSE; CELLS; MYOPODIN; ANTIGEN; GROWTH; GENE	Accurate prediction of prostate cancer clinical courses remains elusive. In this study, we performed whole genome copy number analysis on leukocytes of 273 prostate cancer patients using Affymetrix SNP6.0 chip. Copy number variations (CNV) were found across all chromosomes of the human genome. An average of 152 CNV fragments per genome was identified in the leukocytes from prostate cancer patients. The size distributions of CNV in the genome of leukocytes were highly correlative with prostate cancer aggressiveness. A prostate cancer outcome prediction model was developed based on large size ratio of CNV from the leukocyte genomes. This prediction model generated an average prediction rate of 75.2%, with sensitivity of 77.3% and specificity of 69.0% for prostate cancer recurrence. When combined with Nomogram and the status of fusion transcripts, the average prediction rate was improved to 82.5% with sensitivity of 84.8% and specificity of 78.2%. In addition, the leukocyte prediction model was 62.6% accurate in predicting short prostate specific antigen doubling time. When combined with Gleason's grade, Nomogram and the status of fusion transcripts, the prediction model generated a correct prediction rate of 77.5% with 73.7% sensitivity and 80.1% specificity. To our knowledge, this is the first study showing that CNVs in leukocyte genomes are predictive of clinical outcomes of a human malignancy.	[Yu, Yan P.; Martin, Amantha; Luo, Jian-Hua] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Liu, Silvia; Huo, Zhiguang; Tseng, George C.] Univ Pittsburgh, Dept Biostat, Sch Med, Pittsburgh, PA 15261 USA; [Nelson, Joel B.] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Luo, JH (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	luoj@msx.upmc.edu	Luo, jian/HGE-7331-2022	Huo, Zhiguang/0000-0002-8032-4392	National Cancer Institute [RO1 CA098249]; University of Pittsburgh Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA098249] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Pittsburgh Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by a grant from National Cancer Institute to JHL (RO1 CA098249) and a grant from University of Pittsburgh Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonarakis ES, 2012, CANCER-AM CANCER SOC, V118, P1533, DOI 10.1002/cncr.26437; Bettendorf O, 2005, INT J ONCOL, V26, P267; Freedland SJ, 2007, J CLIN ONCOL, V25, P1765, DOI 10.1200/JCO.2006.08.0572; GITTES RF, 1991, NEW ENGL J MED, V324, P236, DOI 10.1056/NEJM199101243240406; Hieronymus H, 2014, P NATL ACAD SCI USA, V111, P11139, DOI 10.1073/pnas.1411446111; Isaacs JT, 1997, AM J PATHOL, V150, P1511; Kraus J, 2003, GENE CHROMOSOME CANC, V36, P159, DOI 10.1002/gcc.10160; Lin F, 2001, AM J PATHOL, V159, P1603, DOI 10.1016/S0002-9440(10)63006-4; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Luo JH, 2002, MOL CARCINOGEN, V33, P25, DOI 10.1002/mc.10018; Luo Jian-Hua, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006057; Luo JH, 2013, AM J PATHOL, V182, P2028, DOI 10.1016/j.ajpath.2013.02.040; Macoska JA, 2004, CANCER GENET CYTOGEN, V154, P36, DOI 10.1016/j.cancergencyto.2004.02.013; Matsui SI, 2005, CANCER GENET CYTOGEN, V159, P18, DOI 10.1016/j.cancergencyto.2004.09.010; Pang ST, 2006, PROSTATE, V66, P157, DOI 10.1002/pros.20328; PARTIN AW, 1993, J UROLOGY, V150, P110, DOI 10.1016/S0022-5347(17)35410-1; POTOSKY AL, 1995, JAMA-J AM MED ASSOC, V273, P548, DOI 10.1001/jama.273.7.548; Ren B, 2006, ONCOGENE, V25, P1090, DOI 10.1038/sj.onc.1209134; Ren BG, 2007, J NATL CANCER I, V99, P868, DOI 10.1093/jnci/djk199; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Teixeira MR, 2004, CANCER, V101, P1786, DOI 10.1002/cncr.20527; Xia S, 2015, ONCOTARGET; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006; Yu GY, 2006, AM J PATHOL, V168, P597, DOI 10.2353/ajpath.2006.050620; Yu YP, 2007, HISTOL HISTOPATHOL, V22, P1291, DOI 10.14670/HH-22.1291; Yu YP, 2007, CANCER RES, V67, P8043, DOI 10.1158/0008-5472.CAN-07-0648; Yu YP, 2014, AM J PATHOL, V184, P2840, DOI 10.1016/j.ajpath.2014.06.025; Yu YP, 2012, AM J PATHOL, V180, P2240, DOI 10.1016/j.ajpath.2012.03.008; Yu YP, 2006, UROLOGY, V68, P578, DOI 10.1016/j.urology.2006.03.027; Yu YP, 2005, CARCINOGENESIS, V26, P471, DOI 10.1093/carcin/bgh310; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871; Zhou W, 2015, PLOS ONE, V9	34	6	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135982	10.1371/journal.pone.0135982	http://dx.doi.org/10.1371/journal.pone.0135982			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295840	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000359926900057
J	Delloye, J; Peeters, D; Thomas, I				Delloye, Justin; Peeters, Dominique; Thomas, Isabelle			On the Morphology of a Growing City: A Heuristic Experiment Merging Static Economics with Dynamic Geography	PLOS ONE			English	Article							URBAN; EQUILIBRIUM	In this paper, we aim at exploring how individual location decisions affect the shape of a growing city and, more precisely, how they may add up to a configuration that diverges from equilibrium configurations formulated ex-ante. To do so, we provide a two-sector city model merging a static equilibrium analysis with agent-based simulations. Results show that under strong agglomeration effects, urban development is monotonic and ends up with circular, monocentric long-term configurations. For low agglomeration effects however, elongated and multicentric urban configurations may emerge. The occurrence and underlying dynamics of these configurations are also discussed regarding commuting costs and the distance-decay of agglomeration economies between firms. To sum up, our paper warns urban planning policy makers against the difference that may stand between appropriate long-term perspectives, represented here by analytic equilibrium configurations, and short-term urban configurations, simulated here by a multi-agent system.	[Delloye, Justin; Peeters, Dominique; Thomas, Isabelle] Catholic Univ Louvain, Ctr Operat Res & Econometr, Louvain La Neuve, Belgium	Universite Catholique Louvain	Delloye, J (corresponding author), Catholic Univ Louvain, Ctr Operat Res & Econometr, Louvain La Neuve, Belgium.	justin.delloye@uclouvain.be	Delloye, Justin/Q-6181-2019	Delloye, Justin/0000-0003-3523-706X; THOMAS, Isabelle/0000-0003-3386-2427	"Fonds pour la Recherche en Sciences Humaines" (FRESH) [24412569]; "Fonds de la Recherche Scientifique - FNRS"	"Fonds pour la Recherche en Sciences Humaines" (FRESH); "Fonds de la Recherche Scientifique - FNRS"(Fonds de la Recherche Scientifique - FNRS)	This research was partially funded by the "Fonds pour la Recherche en Sciences Humaines" (FRESH Grant No 24412569) and the "Fonds de la Recherche Scientifique - FNRS" (http://www.fnrs.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso W., 1964, LOCATION LAND USE; Anas A, 2013, ENVIRON PLANN B, V40, P955, DOI 10.1068/b4006c; [Anonymous], 2014, ECONOMIST, P43; [Anonymous], 2014, COMMUNICATION    DEC; Bai XM, 2014, NATURE, V509, P158, DOI 10.1038/509158a; Barthelemy M, 2013, SCI REP; Brueckner JK, 1987, HDB REGIONAL URBAN E, V2; Carlier G, 2007, NONLINEAR ANAL-REAL, V8, P725, DOI 10.1016/j.nonrwa.2006.02.008; Delloye J., 2014, 2 DIMENSIONAL NONCIR; FUJITA M, 1982, REG SCI URBAN ECON, V12, P161, DOI 10.1016/0166-0462(82)90031-X; Fujita M, 2005, PAP REG SCI, V84, P377, DOI 10.1111/j.1435-5957.2005.00021.x; Fujita M., 1999, SPATIAL EC CITIES RE; Fujita M, 2013, EC AGGLOMERATION, Vsecond; Fujita M, 1983, SISTEMI URBANI, V3, P411; Garreau Joel, 1991, EDGE CITY LIFE NEW F; Glaeser E.L., 2008, CITIES AGGLOMERATION; Glaeser EL, 2010, J URBAN ECON, V67, P404, DOI 10.1016/j.jue.2009.11.006; Glaeser EL, 2011, TRIUMPH CITY OUR GRE; Heikkila EJ, 2009, ENVIRON PLANN B, V36, P741, DOI 10.1068/b34080; Howard E, 1902, GARDEN CITIES TOMORR; KRUGMAN P, 1993, EUR ECON REV, V37, P293, DOI 10.1016/0014-2921(93)90017-5; Krugman P., 1996, SELF ORG EC; Li Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058270, DOI 10.1371/J0URNAL.P0NE.0058270]; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; Lucas RE, 2002, ECONOMETRICA, V70, P1445, DOI 10.1111/1468-0262.00338; Manson S. M., 2012, AGENT BASED MODELS G, P125, DOI [10.1007/978-90-481-8927-4_7, DOI 10.1007/978-90-481-8927-4]; MathWorks, 2010, MATLAB 7 10 0 499 R2; Mills E.S., 1972, STUDIES STRUCTURE UR; Miyao T., 1987, HDB REGIONAL URBAN E, V2, P877; Muth R. F., 1969, CITIEHOUSING SPATI; OGAWA H, 1989, ENVIRON PLANN A, V21, P363, DOI 10.1068/a210363; Simmonds D, 2013, ENVIRON PLANN B, V40, P1051, DOI 10.1068/b38208; Tesfatsion L, 2003, INFORM SCIENCES, V149, P263, DOI 10.1016/S0020-0255(02)00280-3; Tesfatsion L., 2006, HDB COMPUTATIONAL EC, V2; United Nations, 2014, DEMOGR RES; VOLTERRA VITO, 1926, MEM R ACCAD NAZ LINCEI CL FIS MAT E NAT, V2, P31; von Thunen JH, 1842, ISOLIERTE STAAT BEZI, P352; Wegener Michael, 1986, ADV URBAN SYSTEMS MO, P175; Wenban-Smith HB, 2011, RECH ECON LOUVAIN, V77, P23, DOI 10.3917/rel.772.0023; Wilensky U., 1999, NETLOGO; World Bank, 2015, WORLD BANK OP DAT; Yang JH, 2012, JASSS-J ARTIF SOC S, V15, DOI 10.18564/jasss.2100	42	1	1	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135871	10.1371/journal.pone.0135871	http://dx.doi.org/10.1371/journal.pone.0135871			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LO	26308858	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400079
J	Fagerlund, A; Cormio, L; Palangi, L; Lewin, R; di Pompeo, FS; Elander, A; Selvaggi, G				Fagerlund, Anders; Cormio, Luigi; Palangi, Lina; Lewin, Richard; di Pompeo, Fabio Santanelli; Elander, Anna; Selvaggi, Gennaro			Gynecomastia in Patients with Prostate Cancer: A Systematic Review	PLOS ONE			English	Review							BICALUTAMIDE-INDUCED GYNECOMASTIA; PROPHYLACTIC BREAST IRRADIATION; TAMOXIFEN; PAIN; RADIOTHERAPY; PREVENTION; TRIAL; ANASTROZOLE; MONOTHERAPY; EFFICACY	Introduction Gynecomastia and/or mastodynia is a common medical problem in patients receiving antiandrogen (bicalutamide or flutamide) treatment for prostate cancer; up to 70% of these patients result to be affected; furthermore, this can jeopardise patients' quality of life. Aims To systematically review the quality of evidence of the current literature regarding treatment options for bicalutamide-induced gynecomastia, including efficacy, safety and patients' quality of life. Methods The PubMed, Medline, Scopus, The Cochrane Library and SveMed+ databases were systematically searched between January 1, 2000 and December 31, 2014. All searches were undertaken between January and February 2015. The search phrase used was:"gynecomastia AND treatment AND prostate cancer". Two reviewers assessed 762 titles and abstracts identified. The search and review process was done in accordance with the PRISMA statement. The PICOS (patients, intervention, comparator, outcomes and study design) process was used to specify inclusion criteria. Quality of evidence was rated according to GRADE. Main Outcome Measures Primary outcomes were: treatment effects, number of complications and side effects. Secondary outcome was: Quality of Life. Results Eleven studies met the inclusion criteria and are analysed in this review. Five studies reported pharmacological intervention with tamoxifen and/or anastrozole, either as prophylactic or therapeutic treatment. Four studies reported radiotherapy as prophylactic and/or therapeutic treatment. Two studies compared pharmacological treatment to radiotherapy. Most of the studies were randomized with varying risk of bias. According to GRADE, quality of evidence was moderate to high. Conclusions Bicalutamide-induced gynecomastia and/or mastodynia can effectively be managed by oral tamoxifen (10-20 mg daily) or radiotherapy without relevant side effects. Prophylaxis or therapeutic treatment with tamoxifen results to be more effective than radiotherapy.	[Fagerlund, Anders; Palangi, Lina; Lewin, Richard; Elander, Anna; Selvaggi, Gennaro] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Plast Surg,Inst Clin Sci, Gothenburg, Sweden; [Cormio, Luigi] Univ Foggia, Dept Urol & Renal Transplantat, Foggia, Italy; [di Pompeo, Fabio Santanelli] Univ Roma La Sapienza, St Andrea Hosp, Plast Surg Unit, I-00185 Rome, Italy	Sahlgrenska University Hospital; University of Gothenburg; University of Foggia; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Selvaggi, G (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Plast Surg,Inst Clin Sci, Gothenburg, Sweden.	selvaggigennaro@yahoo.it		Santanelli di Pompeo, Fabio/0000-0002-1217-3668				Bedognetti D, 2010, EUR UROL, V57, P238, DOI 10.1016/j.eururo.2009.05.019; Boccardo F, 2005, J CLIN ONCOL, V23, P808, DOI 10.1200/JCO.2005.12.013; Braunstein GD, 1999, ENDOCR-RELAT CANCER, V6, P315, DOI 10.1677/erc.0.0060315; Di Lorenzo G, 2005, J UROLOGY, V174, P2197, DOI 10.1097/01.ju.0000181824.28382.5c; Fagerlund A, 2015, J PLASTIC S IN PRESS; Fradet Y, 2007, EUR UROL, V52, P106, DOI 10.1016/j.eururo.2007.01.031; Group Gw, 2013, GRAD QUAL EV STRENGT; Heidenreich A, 2014, EUR UROL, V65, P467, DOI 10.1016/j.eururo.2013.11.002; Higgins J, 2005, COCHRANE LIB, V4; Ozen H, 2010, J UROLOGY, V184, P519, DOI 10.1016/j.juro.2010.03.137; Perdona S, 2005, LANCET ONCOL, V6, P295, DOI 10.1016/S1470-2045(05)70103-0; Saltzstein D, 2005, PROSTATE CANCER P D, V8, P75, DOI 10.1038/sj.pcan.4500782; Davanco RAS, 2009, AESTHET PLAST SURG, V33, P514, DOI 10.1007/s00266-008-9213-z; Serretta V, 2012, CLIN GENITOURIN CANC, V10, P174, DOI 10.1016/j.clgc.2012.03.002; de Barros ACSD, 2012, SAO PAULO MED J, V130, P187, DOI 10.1590/S1516-31802012000300009; Tyrrell CJ, 2004, INT J RADIAT ONCOL, V60, P476, DOI 10.1016/j.ijrobp.2004.03.022; Van Poppel H, 2005, EUR UROL, V47, P587, DOI 10.1016/j.eururo.2004.12.003; Widmark A, 2003, UROLOGY, V61, P145, DOI 10.1016/S0090-4295(02)02107-6	18	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136094	10.1371/journal.pone.0136094	http://dx.doi.org/10.1371/journal.pone.0136094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308532	gold, Green Submitted, Green Published			2022-12-27	WOS:000360069400089
J	Gledhill, K; Guo, ZY; Umegaki-Arao, N; Higgins, CA; Itoh, M; Christiano, AM				Gledhill, Karl; Guo, Zongyou; Umegaki-Arao, Noriko; Higgins, Claire A.; Itoh, Munenari; Christiano, Angela M.			Melanin Transfer in Human 3D Skin Equivalents Generated Exclusively from Induced Pluripotent Stem Cells	PLOS ONE			English	Article							PROTEINASE-ACTIVATED RECEPTOR-2; KERATINOCYTE GROWTH-FACTOR; DISTRIBUTION PATTERNS; MELANOSOME TRANSFER; MELANOCYTES; PIGMENTATION; FIBROBLASTS; CULTURE; MODEL	The current utility of 3D skin equivalents is limited by the fact that existing models fail to recapitulate the cellular complexity of human skin. They often contain few cell types and no appendages, in part because many cells found in the skin are difficult to isolate from intact tissue and cannot be expanded in culture. Induced pluripotent stem cells (iPSCs) present an avenue by which we can overcome this issue due to their ability to be differentiated into multiple cell types in the body and their unlimited growth potential. We previously reported generation of the first human 3D skin equivalents from iPSC-derived fibroblasts and iPSC-derived keratinocytes, demonstrating that iPSCs can provide a foundation for modeling a complex human organ such as skin. Here, we have increased the complexity of this model by including additional iPSC-derived melanocytes. Epidermal melanocytes, which are largely responsible for skin pigmentation, represent the second most numerous cell type found in normal human epidermis and as such represent a logical next addition. We report efficient melanin production from iPSC-derived melanocytes and transfer within an entirely iPSC-derived epidermal-melanin unit and generation of the first functional human 3D skin equivalents made from iPSC-derived fibroblasts, keratinocytes and melanocytes.	[Gledhill, Karl; Guo, Zongyou; Umegaki-Arao, Noriko; Higgins, Claire A.; Itoh, Munenari; Christiano, Angela M.] Columbia Univ, Dept Dermatol, New York, NY 10027 USA; [Christiano, Angela M.] Columbia Univ, Dept Genet & Dev, New York, NY USA	Columbia University; Columbia University	Christiano, AM (corresponding author), Columbia Univ, Dept Dermatol, New York, NY 10027 USA.	amc65@columbia.edu		Higgins, Claire/0000-0002-9742-5149; Itoh, Munenari/0000-0003-3640-6355	NIH/NCATS Microphysiological Systems Program [U18TR000561]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U18TR000561] Funding Source: NIH RePORTER	NIH/NCATS Microphysiological Systems Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors are extremely grateful to the NIH/NCATS Microphysiological Systems Program (http://www.ncats.nih.gov) for grant funding (GRANT NUMBER U18TR000561) to AC for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Ando H, 2010, PIGM CELL MELANOMA R, V23, P129, DOI 10.1111/j.1755-148X.2009.00640.x; ARCHAMBAULT M, 1995, J INVEST DERMATOL, V104, P859, DOI 10.1111/1523-1747.ep12607034; Canton I, 2007, TISSUE ENG, V13, P1013, DOI 10.1089/ten.2006.0357; Cardinali G, 2005, J INVEST DERMATOL, V125, P1190, DOI 10.1111/j.0022-202X.2005.23929.x; COOPER KD, 1986, J INVEST DERMATOL, V86, P363, DOI 10.1111/1523-1747.ep12285600; Costin G. E., 2013, Romanian Journal of Biochemistry, V50, P15; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Duval C, 2012, TISSUE ENG PART C-ME, V18, P947, DOI [10.1089/ten.tec.2011.0676, 10.1089/ten.TEC.2011.0676]; Emoto C, 2007, XENOBIOTICA, V37, P986, DOI 10.1080/00498250701620692; Fang D, 2006, STEM CELLS, V24, P1668, DOI 10.1634/stemcells.2005-0414; FITZPATRICK T B, 1963, Dermatol Wochenschr, V147, P481; Fradette J, 2003, J INVEST DERMATOL, V120, P313, DOI 10.1046/j.1523-1747.2003.12024.x; HALABAN R, 1984, IN VITRO CELL DEV B, V20, P447; Itoh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077673; Itoh M, 2011, P NATL ACAD SCI USA, V108, P8797, DOI 10.1073/pnas.1100332108; Jones JC, 2013, J INVEST DERMATOL, V133, P2104, DOI 10.1038/jid.2013.139; KONRAD K, 1973, ARCH DERMATOL, V107, P853; Kuehle J, 2014, MOL THER, V22, P919, DOI 10.1038/mt.2014.4; Li L, 2011, JOVE-J VIS EXP, DOI 10.3791/2937; Mathes SH, 2014, ADV DRUG DELIVER REV, V69, P81, DOI 10.1016/j.addr.2013.12.006; Merling RK, 2013, BLOOD, V121, pE98, DOI 10.1182/blood-2012-03-420273; Mica Y, 2013, CELL REP, V3, P1140, DOI 10.1016/j.celrep.2013.03.025; Minwalla L, 2001, J INVEST DERMATOL, V117, P341, DOI 10.1046/j.0022-202x.2001.01411.x; Nissan X, 2011, P NATL ACAD SCI USA, V108, P14861, DOI 10.1073/pnas.1019070108; Ohta Shigeki, 2013, Methods Mol Biol, V989, P193, DOI 10.1007/978-1-62703-330-5_16; Paine C, 2001, J INVEST DERMATOL, V116, P587, DOI 10.1046/j.1523-1747.2001.01291.x; Rao MS, 2012, J CELL BIOCHEM, V113, P3061, DOI 10.1002/jcb.24183; Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503; Scott G, 2003, J INVEST DERMATOL, V121, P529, DOI 10.1046/j.1523-1747.2003.12427.x; Singh SK, 2008, EXP DERMATOL, V17, P418, DOI 10.1111/j.1600-0625.2008.00702.x; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Steichen C, 2014, STEM CELL TRANSL MED, V3, P686, DOI 10.5966/sctm.2013-0158; Steinhoff M, 1999, EXP DERMATOL, V8, P282; SZABO G, 1969, NATURE, V222, P1082, DOI 10.1038/2221081a0; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Yang RF, 2011, J INVEST DERMATOL, V131, P2458, DOI 10.1038/jid.2011.242	37	63	69	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136713	10.1371/journal.pone.0136713	http://dx.doi.org/10.1371/journal.pone.0136713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308443	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400153
J	Guo, YN; Wolter, T; Kubar, T; Sumser, M; Trauner, D; Elstner, M				Guo, Yanan; Wolter, Tino; Kubar, Tomas; Sumser, Martin; Trauner, Dirk; Elstner, Marcus			Molecular Dynamics Investigation of gluazo, a Photo-Switchable Ligand for the Glutamate Receptor GluK2	PLOS ONE			English	Article							2-DIMENSIONAL COMPLEX DIAGRAMS; LOWEST ELECTRONIC STATES; KAINATE RECEPTORS; BINDING DOMAIN; PHOTOSWITCHABLE PEPTIDE; PHOTOCHROMIC AGONIST; CRYSTAL-STRUCTURES; AMPA RECEPTORS; SIMULATION; ACID	Photochromic ligands (PCLs), defined as photoswitchable molecules that are able to endow native receptors with a sensitivity towards light, have become a promising photo-harmacological tool for various applications in biology. In general, PCLs consist of a ligand of the target receptor covalently linked to an azobenzene, which can be reversibly switched between two configurations upon light illumination. Gluazo, as a PCL that targets excitatory amino acid receptors, in its dark-adapted trans iso-form was characterized to be a partial agonist of the kainate glutamate receptor GluK2. Application of UV light leads to the formation of the cis form, with remarkedly reduced affinity towards GluK2. The mechanism of the change of ligand affinity induced by the photoisomerization was unresolved. The presented computational study explains how the isomerization of such a PCL affects the structural changes in the target receptor that lead to its activation.	[Guo, Yanan; Wolter, Tino; Kubar, Tomas; Elstner, Marcus] Karlsruhe Inst Technol, Inst Phys Chem, Dept Theoret Chem Biol, D-76131 Karlsruhe, Germany; [Sumser, Martin; Trauner, Dirk] Univ Munich, Dept Chem, D-81377 Munich, Germany; [Sumser, Martin; Trauner, Dirk] Ctr Integrated Prot Sci, D-81377 Munich, Germany	Helmholtz Association; Karlsruhe Institute of Technology; University of Munich; University of Munich	Elstner, M (corresponding author), Karlsruhe Inst Technol, Inst Phys Chem, Dept Theoret Chem Biol, Kaiserstr 12, D-76131 Karlsruhe, Germany.	marcus.elstner@kit.edu	Elstner, Marcus/H-3463-2013; Sumser, Martin/N-1747-2015	Sumser, Martin/0000-0002-1760-8026	Deutsche Forschungemeinschaft [EL 2006/9-2]	Deutsche Forschungemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungemeinschaft (project EL 2006/9-2). Y.G. gratefully acknowledges the China Scholarship Council.	Abele R, 2000, J BIOL CHEM, V275, P21355, DOI 10.1074/jbc.M909883199; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bjerrum EJ, 2008, PROTEINS, V72, P434, DOI 10.1002/prot.21941; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Cembran A, 2004, J AM CHEM SOC, V126, P3234, DOI 10.1021/ja038327y; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; Contractor A, 2011, TRENDS NEUROSCI, V34, P154, DOI 10.1016/j.tins.2010.12.002; Frisch M.J., 2016, GAUSSIAN16 REV B01; Gagliardi L, 2004, THEOR CHEM ACC, V111, P363, DOI 10.1007/s00214-003-0528-1; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huxter JR, 2007, J NEUROSCI, V27, P2212, DOI 10.1523/JNEUROSCI.3954-06.2007; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Lampinen M, 1998, EMBO J, V17, P4704, DOI 10.1093/emboj/17.16.4704; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Mankiewicz KA, 2008, BIOCHEMISTRY-US, V47, P398, DOI 10.1021/bi702004b; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Nanao MH, 2005, P NATL ACAD SCI USA, V102, P1708, DOI 10.1073/pnas.0409573102; Nayeem N, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130051; Nayeem N, 2011, J NEUROSCI, V31, P2916, DOI 10.1523/JNEUROSCI.4771-10.2011; Nayeem N, 2009, MOL PHARMACOL, V76, P534, DOI 10.1124/mol.109.056598; Nguyen PH, 2006, CHEM PHYS, V323, P36, DOI 10.1016/j.chemphys.2005.08.047; Nguyen PH, 2006, BIOPHYS J, V91, P1224, DOI 10.1529/biophysj.106.084996; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Pinheiro P, 2006, CELL TISSUE RES, V326, P457, DOI 10.1007/s00441-006-0265-6; Purves D., 2007, NEUROSCIENCE; Reiter A, 2013, BIOCHEMISTRY-US, V52, P8972, DOI 10.1021/bi4014402; Sagui C, 1999, ANNU REV BIOPH BIOM, V28, P155, DOI 10.1146/annurev.biophys.28.1.155; SEEBURG PH, 1993, TRENDS PHARMACOL SCI, V14, P297, DOI 10.1016/0165-6147(93)90047-N; Shou XH, 2004, EXPERT OPIN THER PAT, V14, P471, DOI 10.1517/13543776.14.4.471; Stawski P, 2012, ANGEW CHEM INT EDIT, V51, P5748, DOI 10.1002/anie.201109265; Stierand K, 2007, CHEMMEDCHEM, V2, P853, DOI 10.1002/cmdc.200700010; Stierand K, 2006, BIOINFORMATICS, V22, P1710, DOI 10.1093/bioinformatics/btl150; Stierand K, 2010, ACS MED CHEM LETT, V1, P540, DOI 10.1021/ml100164p; Swanson GT, 1997, NEURON, V19, P913, DOI 10.1016/S0896-6273(00)80972-1; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Volgraf M, 2007, J AM CHEM SOC, V129, P260, DOI 10.1021/ja067269o; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wolter T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092716; Wolter T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058774	47	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135399	10.1371/journal.pone.0135399	http://dx.doi.org/10.1371/journal.pone.0135399			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308344	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400061
J	Hu, JP; Zuo, Z; Huang, ZP; Dong, Z				Hu, Junpeng; Zuo, Zhen; Huang, Zhiping; Dong, Zhi			Dynamic Digital Channelizer Based on Spectrum Sensing	PLOS ONE			English	Article							EIGENVALUE; ALGORITHMS; DESIGN	The ability to efficiently channelize a received signal with dynamic sub-channel bandwidths is a key requirement of software defined radio (SDR) systems. The digital channelizer, which is used to split the received signal into a number of sub-channels, plays an important role in SDR systems. In this paper, a design of dynamic digital channelizer is presented. The proposed method is novel in that it employs a cosine modulated filter bank (CMFB) to divide the received signal into multiple frequency sub-bands and a spectrum sensing technique, which is mostly used in cognitive radio, is introduced to detect the presence of signal of each sub-band. The method of spectrum sensing is carried out based on the eigenvalues of covariance matrix of received signal. The ratio of maximum-minimum eigenvalue of each sub-band is vulnerable to noise fluctuation. This paper suggests an optimized method to calculate the ratio of maximum-minimum eigenvalue. The simulation results imply that the design of digital channelizer can effectively separate the received signal with dynamically changeable sub-channel signals.	[Hu, Junpeng; Zuo, Zhen; Huang, Zhiping; Dong, Zhi] Natl Univ Def Technol, Sch Mechatron Engn & Automat, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Hu, JP (corresponding author), Natl Univ Def Technol, Sch Mechatron Engn & Automat, Changsha, Hunan, Peoples R China.	hujunpeng332@hotmail.com			Natural Science Foundation of China (NSFC) [61374008]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (NSFC) under Grant No. 61374008.	Abu-Al-Saud WA, 2004, IEEE T SIGNAL PROCES, V52, P2807, DOI 10.1109/TSP.2004.834242; Ambede A, 2013, CIRC SYST SIGNAL PR, V32, P2543, DOI 10.1007/s00034-012-9532-9; Atapattu S, 2011, IEEE T WIREL COMMUN, V10, P1232, DOI 10.1109/TWC.2011.012411.100611; Bres CS, 2011, OPT EXPRESS, V19, P3531, DOI 10.1364/OE.19.003531; Chen H. -S., 2007, IEEE INT C COMM ICC; Darak SJ, 2012, J SIGNAL PROCESS SYS, V68, P95, DOI 10.1007/s11265-011-0579-9; Harris F, 2012, MIDWEST SYMP CIRCUIT, P1140, DOI 10.1109/MWSCAS.2012.6292226; Johnstone IM, 2001, ANN STAT, V29, P295, DOI 10.1214/aos/1009210544; Li B, 2008, EUR T TELECOMMUN, V19, P273, DOI 10.1002/ett.1195; Mahesh R, 2011, IEEE T AERO ELEC SYS, V47, P1241, DOI 10.1109/TAES.2011.5751255; Mahesh R, 2011, J SIGNAL PROCESS SYS, V62, P157, DOI 10.1007/s11265-008-0327-y; Michael N, 2015, J SIGNAL PROCESS SYS, V78, P171, DOI 10.1007/s11265-013-0849-9; Penna F, 2009, IEEE COMMUN LETT, V13, P507, DOI 10.1109/LCOMM.2009.090425; Soni RK, 2013, AEU-INT J ELECTRON C, V67, P130, DOI 10.1016/j.aeue.2012.07.005; Sutton PD, 2008, IEEE J SEL AREA COMM, V26, P13, DOI 10.1109/JSAC.2008.080103; Vinod AP, 2003, P 14 IEEE INT S PERS; Wang M, 2012, PROCEDIA ENGINEER, V29, P435, DOI 10.1016/j.proeng.2011.12.737; Xie XM, 2008, PROG NAT SCI-MATER, V18, P1293, DOI 10.1016/j.pnsc.2008.05.008; Yucek T, 2009, IEEE COMMUN SURV TUT, V11, P116, DOI 10.1109/SURV.2009.090109; Zeng YH, 2010, EURASIP J ADV SIG PR, DOI 10.1155/2010/381465; Zeng YH, 2009, IEEE T COMMUN, V57, P1784, DOI 10.1109/TCOMM.2009.06.070402; Zeng YH, 2009, IEEE T VEH TECHNOL, V58, P1804, DOI 10.1109/TVT.2008.2005267; Zhang W, 2009, IEEE T WIREL COMMUN, V8, P5761, DOI 10.1109/TWC.2009.12.081710	23	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136349	10.1371/journal.pone.0136349	http://dx.doi.org/10.1371/journal.pone.0136349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308210	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400112
J	Urquia, ML; Vang, ZM; Bolumar, F				Urquia, Marcelo L.; Vang, Zoua M.; Bolumar, Francisco			Birth Outcomes of Latin Americans in Two Countries with Contrasting Immigration Admission Policies: Canada and Spain	PLOS ONE			English	Article							PERINATAL HEALTH; UNITED-STATES; FOREIGN-BORN; WEIGHT; PREGNANCY; MIGRATION; SELECTION	Background We delved into the selective migration hypothesis on health by comparing birth outcomes of Latin American immigrants giving birth in two receiving countries with dissimilar immigration admission policies: Canada and Spain. We hypothesized that a stronger immigrant selection in Canada will reflect more favourable outcomes among Latin Americans giving birth in Canada than among their counterparts giving birth in Spain. Materials and Methods We conducted a cross-sectional bi-national comparative study. We analyzed birth data of singleton infants born in Canada (2000-2005) (N = 31,767) and Spain (1998-2007) (N = 150,405) to mothers born in Spanish-speaking Latin American countries. We compared mean birthweight at 37-41 weeks gestation, and low birthweight and preterm birth rates between Latin American immigrants to Canada vs. Spain. Regression analysis for aggregate data was used to obtain Odds Ratios and Mean birthweight differences adjusted for infant sex, maternal age, parity, marital status, and father born in same source country. Results Latin American women in Canada had heavier newborns than their same-country counterparts giving birth in Spain, overall [adjusted mean birthweight difference: 101 grams; 95% confidence interval (CI): 98, 104], and within each maternal country of origin. Latin American women in Canada had fewer low birthweight and preterm infants than those giving birth in Spain [adjusted Odds Ratio: 0.88; 95% CI: 0.82, 0.94 for low birthweight, and 0.88; 95% CI: 0.84, 0.93 for preterm birth, respectively]. Conclusion Latin American immigrant women had better birth outcomes in Canada than in Spain, suggesting a more selective migration in Canada than in Spain.	[Urquia, Marcelo L.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Urquia, Marcelo L.] Univ Toronto, Dalla Lana Fac Publ Hlth, Toronto, ON, Canada; [Urquia, Marcelo L.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Vang, Zoua M.] McGill Univ, Dept Sociol, Montreal, PQ H3A 2T5, Canada; [Bolumar, Francisco] CIBERESP, Madrid, Spain; [Bolumar, Francisco] Univ Alcala, Madrid, Spain; [Bolumar, Francisco] CUNY Hunter Coll, Sch Publ Hlth, New York, NY 10021 USA	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; McGill University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidad de Alcala; City University of New York (CUNY) System; Hunter College (CUNY)	Urquia, ML (corresponding author), St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, 30 Bond St, Toronto, ON M5B 1W8, Canada.	urquiam@smh.ca		Urquia, Marcelo/0000-0002-8289-8090; Francisco, Bolumar Montrull/0000-0001-8007-3231	Social Science and Humanities research Council (SSHRC); Canadian Foundation for Innovation (CFI); Statistics Canada; Ontario Ministry of Health and Long-Term Care; Canadian Institutes of Health Research (CIHR) [MOP 123267]; Fonds de recherche du Quebec-Societe et culture	Social Science and Humanities research Council (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Statistics Canada; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec-Societe et culture	This research was supported by funds to the Canadian Research Data Centre Network (CRDCN) from the Social Science and Humanities research Council (SSHRC), the Canadian Foundation for Innovation (CFI) and Statistics Canada. Although the research and analysis are based on data from Statistics Canada, the opinions expressed do not represent the views of Statistics Canada or the Canadian Research Data Centre Network (CRDCN). The study was also possible thanks to the Institute for Clinical Evaluative Sciences (ICES), which is supported by an annual grant from the Ontario Ministry of Health and Long-Term Care. The opinions, results, and conclusions reported in this article are those of the authors and are independent from the funding sources. The study was partially funded by a Canadian Institutes of Health Research (CIHR) grant (MOP 123267). MLU holds a CIHR New Investigator award. Funding for ZMV was provided by a grant from the Fonds de recherche du Quebec-Societe et culture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Garcia D, 2005, PEDIATRICS, V115, pE20, DOI 10.1542/peds.2004-1306; Akresh IR, 2008, AM J PUBLIC HEALTH, V98, P2058, DOI 10.2105/AJPH.2006.100974; Angel RJ, 2008, J AGING HEALTH, V20, P3, DOI 10.1177/0898264307309924; Arango J, 2005, REGULARIZING IMMIGRA; Benach J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001043; Bostean G, 2013, J IMMIGR MINOR HEALT, V15, P624, DOI 10.1007/s10903-012-9646-y; Canada Border Services Agency, 2008, REP AUD GEN CAN HOUS; Committee on Understanding Premature Birth and Assuring Healthy Outcomes Board on Health Sciences Policy, 2007, PRETERM BIRTH CAUSES; Figueras F, 2008, EUR J OBSTET GYN R B, V138, P171, DOI 10.1016/j.ejogrb.2007.09.005; Gagnon AJ, 2009, SOC SCI MED; Garcia-Subirats I, 2011, MATERN CHILD HLTH J, V15, P561, DOI 10.1007/s10995-010-0614-7; GARDOSI J, 1995, ULTRASOUND OBST GYN, V6, P168, DOI 10.1046/j.1469-0705.1995.06030168.x; Gissler M, 2003, SOC SCI MED, V57, P1443, DOI 10.1016/S0277-9536(02)00402-1; Gissler M, 2009, ACTA OBSTET GYN SCAN, V88, P134, DOI 10.1080/00016340802603805; Guendelman S, 2015, J EPIDEMIOL COMMUN H, V69, P35, DOI 10.1136/jech-2014-204020; Institute for Clinical Evaluative Sciences (ICES), 2015, PRIV AT ICES; Janevic T, 2011, SOC SCI MED, V73, P429, DOI 10.1016/j.socscimed.2011.05.041; Jasso G., 2004, CRITICAL SPEC TIVES, P227; Joseph KS, 2007, OBSTET GYNECOL, V109, P813, DOI 10.1097/01.AOG.0000255661.13792.c1; Juarez S, 2012, PAEDIATR PERINAT EP, V26, P310, DOI 10.1111/j.1365-3016.2012.01287.x; Kelaher M, 2002, SOC SCI MED, V55, P2171, DOI 10.1016/S0277-9536(01)00360-4; Knowles Valerie., 2007, STRANGERS OUR GATES; Kramer MS, 2000, PAEDIATR PERINAT EP, V14, P194, DOI 10.1046/j.1365-3016.2000.00266.x; Kreienbrink A, 2008, FOCUS MIGRATION COUN; Landale NS, 1999, CHILDREN IMMIGRANTS, P244; Llacer A, 2009, J EPIDEMIOL COMMUN H, V63, P766, DOI 10.1136/jech.2008.085530; Mehta NK, 2012, DEMOGRAPHY, V49, P425, DOI 10.1007/s13524-012-0099-7; Moineddin R, 2014, EPIDEMIOLOGY, V25, P929, DOI 10.1097/EDE.0000000000000172; Riosmena F, 2013, DEMOGRAPHY, V50, P1039, DOI 10.1007/s13524-012-0178-9; Rubalcava LN, 2008, AM J PUBLIC HEALTH, V98, P78, DOI 10.2105/AJPH.2006.098418; Sorbye IK, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-239; Sousa E, 2010, INT J PUBLIC HEALTH, V55, P443, DOI 10.1007/s00038-010-0141-8; Spanish Commission for Refugee Help, 2012, SIT REF SPAIN 2012 R; State Bank of Pakistan, 2007, IMM CAN PORTR FOR BO, P1; Urquia ML, 2010, BJOG-INT J OBSTET GY, V117, P591, DOI 10.1111/j.1471-0528.2010.02523.x; Urquia ML, 2012, ANN EPIDEMIOL, V22, P151, DOI 10.1016/j.annepidem.2012.01.006; Urquia ML, 2011, J EPIDEMIOL COMMUN H, V65, P467, DOI 10.1136/jech.2010.109405; Urquia ML, 2010, SOC SCI MED, V71, P1620, DOI 10.1016/j.socscimed.2010.08.006; Vintzileos AM, 2014, AM J OBSTET GYNECOL, V210, P112, DOI 10.1016/j.ajog.2013.09.002; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233	40	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136308	10.1371/journal.pone.0136308	http://dx.doi.org/10.1371/journal.pone.0136308			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LO	26308857	Green Published, gold			2022-12-27	WOS:000360069400105
J	Corbin, KR; Byrt, CS; Bauer, S; DeBolt, S; Chambers, D; Holtum, JAM; Karem, G; Henderson, M; Lahnstein, J; Beahan, CT; Bacic, A; Fincher, GB; Betts, NS; Burton, RA				Corbin, Kendall R.; Byrt, Caitlin S.; Bauer, Stefan; DeBolt, Seth; Chambers, Don; Holtum, Joseph A. M.; Karem, Ghazwan; Henderson, Marilyn; Lahnstein, Jelle; Beahan, Cherie T.; Bacic, Antony; Fincher, Geoffrey B.; Betts, Natalie S.; Burton, Rachel A.			Prospecting for Energy-Rich Renewable Raw Materials: Agave Leaf Case Study	PLOS ONE			English	Article							CRASSULACEAN ACID METABOLISM; SACCHAROMYCES-CEREVISIAE; BIOETHANOL PRODUCTION; WALL POLYSACCHARIDES; CHEMICAL-COMPOSITION; BIOFUEL FEEDSTOCK; FERMENTABLE SUGAR; CALCIUM-OXALATE; PICHIA-STIPITIS; CELL-WALLS	Plant biomass from different species is heterogeneous, and this diversity in composition can be mined to identify materials of value to fuel and chemical industries. Agave produces high yields of energy-rich biomass, and the sugar-rich stem tissue has traditionally been used to make alcoholic beverages. Here, the compositions of Agave americana and Agave tequilana leaves are determined, particularly in the context of bioethanol production. Agave leaf cell wall polysaccharide content was characterized by linkage analysis, non-cellulosic polysaccharides such as pectins were observed by immuno-microscopy, and leaf juice composition was determined by liquid chromatography. Agave leaves are fruit-like-rich in moisture, soluble sugars and pectin. The dry leaf fiber was composed of crystalline cellulose (47-50% w/w) and non-cellulosic polysaccharides (16-22% w/w), and whole leaves were low in lignin (9-13% w/w). Of the dry mass of whole Agave leaves, 85-95% consisted of soluble sugars, cellulose, non-cellulosic polysaccharides, lignin, acetate, protein and minerals. Juice pressed from the Agave leaves accounted for 69% of the fresh weight and was rich in glucose and fructose. Hydrolysis of the fructan oligosaccharides doubled the amount of fermentable fructose in A. tequilana leaf juice samples and the concentration of fermentable hexose sugars was 41-48 g/L. In agricultural production systems such as the tequila making, Agave leaves are discarded as waste. Theoretically, up to 4000 L/ha/yr of bioethanol could be produced from juice extracted from waste Agave leaves. Using standard Saccharomyces cerevisiae strains to ferment Agave juice, we observed ethanol yields that were 66% of the theoretical yields. These data indicate that Agave could rival currently used bioethanol feedstocks, particularly if the fermentation organisms and conditions were adapted to suit Agave leaf composition.	[Corbin, Kendall R.; Byrt, Caitlin S.; Karem, Ghazwan; Henderson, Marilyn; Lahnstein, Jelle; Fincher, Geoffrey B.; Betts, Natalie S.; Burton, Rachel A.] Univ Adelaide, Sch Agr Food & Wine, Australian Res Council, Ctr Excellence Plant Cell Walls, Adelaide, SA, Australia; [Bauer, Stefan] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [DeBolt, Seth] Univ Kentucky, Dept Hort, Lexington, KY 40546 USA; [Chambers, Don] AUSAGAVE, Aldgate, SA, Australia; [Holtum, Joseph A. M.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Beahan, Cherie T.; Bacic, Antony] Univ Melbourne, Sch Bot, Australian Res Council, Ctr Excellence Plant Cell Walls, Melbourne, Vic, Australia	University of Adelaide; University of California System; University of California Berkeley; University of Kentucky; James Cook University; University of Melbourne	Burton, RA (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Australian Res Council, Ctr Excellence Plant Cell Walls, Adelaide, SA, Australia.	rachel.burton@adelaide.edu.au	Betts, Natalie/F-2794-2012; Burton, Rachel A/C-4441-2011; Byrt, Caitlin/I-9785-2018	Betts, Natalie/0000-0002-3345-8160; Burton, Rachel A/0000-0002-0638-4709; Byrt, Caitlin/0000-0001-8549-2873; Bacic, Tony/0000-0001-7483-8605	Australian Research Council Centre of Excellence in Plant Cell Walls [CE110001007]; National Science Foundation [135488]	Australian Research Council Centre of Excellence in Plant Cell Walls(Australian Research Council); National Science Foundation(National Science Foundation (NSF))	This work was supported by Australian Research Council Centre of Excellence in Plant Cell Walls CE110001007 (GF and RB) (http://www.arc.gov.au/), and National Science Foundation 135488 (SD) (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PR, 2006, AGRON J, V98, P1518, DOI 10.2134/agronj2005.0351; Adney B, 1996, NRELTP51042628; Almeida JRM, 2007, J CHEM TECHNOL BIOT, V82, P340, DOI 10.1002/jctb.1676; Alvira P, 2010, BIORESOURCE TECHNOL, V101, P4851, DOI 10.1016/j.biortech.2009.11.093; Anderson CT, 2013, FRONT PLANT SCI, P4; Arrizon J, 2012, BIORESOURCE TECHNOL, V110, P560, DOI 10.1016/j.biortech.2012.01.112; Arrizon J, 2011, BIORESOURCE TECHNOL, V102, P3298, DOI 10.1016/j.biortech.2010.10.071; Aurion Immunogold Reagents & Accessories, 2013, SPEC LOC METH, P3; Bauer S, 2014, BIOTECHNOL BIOENG, V111, P2355, DOI 10.1002/bit.25276; Borland AM, 2009, J EXP BOT, V60, P2879, DOI 10.1093/jxb/erp118; Burton RA, 2000, PLANT CELL, V12, P691, DOI 10.1105/tpc.12.5.691; Burton RA, 2011, PLANT BIOTECHNOL J, V9, P117, DOI 10.1111/j.1467-7652.2010.00532.x; Byrt CS, 2011, J INTEGR PLANT BIOL, V53, P120, DOI 10.1111/j.1744-7909.2010.01023.x; CEDENO M, 1995, CRIT REV BIOTECHNOL, V15, P1, DOI 10.1080/07388550490465817; Comino P, 2013, J AGR FOOD CHEM, V61, P12111, DOI 10.1021/jf403558u; Davis SC, 2011, GCB BIOENERGY, V3, P68, DOI 10.1111/j.1757-1707.2010.01077.x; Davis SC, 2011, GCB BIOENERGY, V3, P1, DOI 10.1111/j.1757-1707.2010.01085.x; Ehrman T, 1996, CHEM ANAL TESTING TA, P4; Escamilla-Trevino LL, 2012, BIOENERG RES, V5, P1, DOI 10.1007/s12155-011-9159-x; Favaro L, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-168; FRANCESCHI VR, 1980, BOT REV, V46, P361, DOI 10.1007/BF02860532; Gharieb MM, 1999, MYCOL RES, V103, P473, DOI 10.1017/S0953756298007382; Gille S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00012; Hames B, 2008, NRELTP5104625; Harris D, 2009, GCB BIOENERGY, V1, P51, DOI 10.1111/j.1757-1707.2009.01000.x; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Holtum J., 2010, RIRDC PUBLICATION, V10/104; Holtum JAM, 2011, GCB BIOENERGY, V3, P58, DOI 10.1111/j.1757-1707.2010.01083.x; Huber GW, 2006, CHEM REV, V106, P4044, DOI 10.1021/cr068360d; Iniguez-Covarrubias G, 2001, BIORESOURCE TECHNOL, V77, P101, DOI 10.1016/S0960-8524(00)00167-X; Kabel MA, 2007, CARBOHYD POLYM, V69, P94, DOI 10.1016/j.carbpol.2006.09.006; Kelley SS, 2004, BIOMASS BIOENERG, V27, P77, DOI 10.1016/j.biombioe.2003.11.005; Li HJ, 2012, RSC ADV, V2, P4951, DOI 10.1039/c2ra20557b; Liccioli T, 2011, APPL MICROBIOL BIOT, V89, P1621, DOI 10.1007/s00253-010-2992-6; Lin Y, 2006, APPL MICROBIOL BIOT, V69, P627, DOI 10.1007/s00253-005-0229-x; Lopez-Banuelos RH, 2012, POLYM ENG SCI, V52, P2489, DOI 10.1002/pen.23168; Mancilla-Margalli NA, 2006, J AGR FOOD CHEM, V54, P7832, DOI 10.1021/jf060354v; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; McLaughlin SB, 2005, BIOMASS BIOENERG, V28, P515, DOI 10.1016/j.biombioe.2004.05.006; Meneses FJ, 2002, J I BREWING, V108, P310, DOI 10.1002/j.2050-0416.2002.tb00556.x; Mylsamy K, 2010, J REINF PLAST COMP, V29, P2925, DOI 10.1177/0731684410362817; Nigam JN, 2001, J BIOTECHNOL, V87, P17, DOI 10.1016/S0168-1656(00)00385-0; NOBEL PS, 1985, PHYSIOL PLANTARUM, V65, P397, DOI 10.1111/j.1399-3054.1985.tb08663.x; NOBEL PS, 1987, AGR FOREST METEOROL, V39, P319, DOI 10.1016/0168-1923(87)90024-4; Nobel PS, 1988, ENV BIOL AGAVES CACT; Owen NA, 2014, GCB BIOENERGY, V6, P687, DOI 10.1111/gcbb.12094; Pettolino FA, 2001, PLANTA, V214, P235, DOI 10.1007/s004250100606; Pettolino FA, 2012, NAT PROTOC, V7, P1590, DOI 10.1038/nprot.2012.081; Poznyak V., 2014, GUID EST WHEAT STRAW, P1; REITER WD, 1993, SCIENCE, V261, P1032, DOI 10.1126/science.261.5124.1032; Richard P, 2009, APPL MICROBIOL BIOT, V82, P597, DOI 10.1007/s00253-009-1870-6; Ruggeberg M, 2008, P ROY SOC B-BIOL SCI, V275, P2221, DOI 10.1098/rspb.2008.0531; Santos JDG, 2013, CARBOHYD POLYM, V92, P1997, DOI 10.1016/j.carbpol.2012.11.089; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Selig M., 2008, ENZYMATIC SACCHARIFI; SELVENDRAN RR, 1979, ANAL BIOCHEM, V96, P282, DOI 10.1016/0003-2697(79)90583-9; Singha AS, 2013, J THERMOPLAST COMPOS, V26, P513, DOI 10.1177/0892705711425848; Sluiter A., 2008, NATL RENEWABLE ENERG, P18; Sluiter A, 2006, NRELTP51042623; Sluiter A, 2008, NRELTP51042618; Sluiter A., 2005, NRELTP51042619; SMITH GA, 1987, CROP SCI, V27, P788, DOI 10.2135/cropsci1987.0011183X002700040037x; SMITH JAC, 1987, PLANT CELL ENVIRON, V10, P639, DOI 10.1111/j.1365-3040.1987.tb01846.x; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Sun XZ, 2011, ANIM FEED SCI TECH, V166-67, P391, DOI 10.1016/j.anifeedsci.2011.04.027; Thompson B, 2014, CURR OPIN BIOTECH, V30, P17, DOI 10.1016/j.copbio.2014.04.005; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; U. S. Department of Energy Efficiency and & Renewable Energy, 2003, THEOR ETH YIELD CALC; United States Department of Energy: Energy Efficiency and Renewable Energy, 2013, BIOM FEEDST COMP PRO, V10; VANZYL C, 1991, ENZYME MICROB TECH, V13, P82, DOI 10.1016/0141-0229(91)90193-E; Verhertbruggen Y, 2009, CARBOHYD RES, V344, P1858, DOI 10.1016/j.carres.2008.11.010; Vieira MC, 2002, CELLULOSE, V9, P203, DOI 10.1023/A:1020158128506; WATTENDORFF J, 1976, PLANTA, V128, P163, DOI 10.1007/BF00390318; Wheal MS, 2011, ANAL METHODS-UK, V3, P2854, DOI 10.1039/c1ay05430a; WHISTLER RL, 1973, ADV CHEM SER, P242; Wilson SM, 2006, PLANTA, V224, P655, DOI 10.1007/s00425-006-0244-x; Yasuda S, 2001, J WOOD SCI, V47, P69, DOI 10.1007/BF00776648; Zhao YL, 2009, FIELD CROP RES, V111, P55, DOI 10.1016/j.fcr.2008.10.006; [No title captured]	79	53	58	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135382	10.1371/journal.pone.0135382	http://dx.doi.org/10.1371/journal.pone.0135382			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305101	Green Published, gold			2022-12-27	WOS:000359995500019
J	Koetsenruijter, J; van Lieshout, J; Lionis, C; Portillo, MC; Vassilev, I; Todorova, E; Foss, C; Gil, MS; Knutsen, IR; Angelaki, A; Mujika, A; Roukova, P; Kennedy, A; Rogers, A; Wensing, M				Koetsenruijter, Jan; van Lieshout, Jan; Lionis, Christos; Carmen Portillo, Maria; Vassilev, Ivo; Todorova, Elka; Foss, Christina; Serrano Gil, Manuel; Knutsen, Ingrid Ruud; Angelaki, Agapi; Mujika, Agurtzane; Roukova, Poli; Kennedy, Anne; Rogers, Anne; Wensing, Michel			Social Support and Health in Diabetes Patients: An Observational Study in Six European Countries in an Era of Austerity	PLOS ONE			English	Article							ILLNESS SELF-MANAGEMENT; CARE; MORTALITY; NETWORK; INTERVENTIONS; SYSTEMS; SPREAD; PEOPLE; ACCESS	Introduction Support from individual social networks, community organizations and neighborhoods is associated with better self-management and health outcomes. This international study examined the relative impact of different types of support on health and health-related behaviors in patients with type 2 diabetes. Methods Observational study (using interviews and questionnaires) in a sample of 1,692 type 2 diabetes patients with 5,433 connections from Bulgaria, Greece, Netherlands, Norway, Spain, and the United Kingdom. Outcomes were patient-reported health status (SF-12), physical exercise (RAPA), diet and smoking (SDCSCA). Random coefficient regression models were used to examine linkages with individual networks, community organizations, and neighborhood type (deprived rural, deprived urban, or affluent urban). Results Patients had a median of 3 support connections and 34.6% participated in community organizations. Controlled for patients' age, sex, education, income and comorbidities, large emotional support networks were associated with decrease of non-smoking (OR = 0.87). Large practical support networks were associated with worse physical and mental health (B = -0.46 and -0.27 respectively) and less physical activity (OR = 0.90). Participation in community organizations was associated with better physical and mental health (B = 1.39 and 1.22, respectively) and, in patients with low income, with more physical activity (OR = 1.53). Discussion Participation in community organizations was most consistently related to better health status. Many diabetes patients have individual support networks, but this study did not provide evidence to increase their size as a public health strategy. The consistent association between participation in community organizations and health status provides a clear target for interventions and policies.	[Koetsenruijter, Jan; van Lieshout, Jan; Wensing, Michel] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept IQ Healthcare, Nijmegen, Netherlands; [Lionis, Christos; Angelaki, Agapi] Univ Crete, Fac Med, Clin Social & Family Med, Iraklion, Greece; [Carmen Portillo, Maria; Mujika, Agurtzane] Univ Navarra, Sch Nursing, E-31080 Pamplona, Spain; [Vassilev, Ivo; Kennedy, Anne; Rogers, Anne] Univ Southampton, Fac Hlth Sci, NIHR Wessex CLAHRC, Southampton SO9 5NH, Hants, England; [Todorova, Elka] Univ Natl & World Econ, Dept Econ Sociol, Sofia, Bulgaria; [Foss, Christina; Knutsen, Ingrid Ruud; Roukova, Poli] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Serrano Gil, Manuel] Educ Hlth & Soc Fdn, Murcia, Spain	Radboud University Nijmegen; University of Crete; University of Navarra; University of Southampton; University of National & World Economics - Bulgaria; University of Oslo	Koetsenruijter, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept IQ Healthcare, Nijmegen, Netherlands.	Jan.Koetsenruijter@radboudumc.nl	Van Lieshout, J./L-4490-2015; Wensing, Michel/H-8113-2014; Mujika, Agurtzane/AAF-3653-2019	Wensing, Michel/0000-0001-6569-8137; Mujika, Agurtzane/0000-0002-9470-1048; Vassilev, Ivaylo/0000-0002-2206-8247; Angelaki, Agapi/0000-0002-8385-8429; Koetsenruijter, Jan/0000-0003-4632-5129	European Union's Seventh Framework Programme for research, technological development and demonstration [279081]; National Institute for Health Research [NF-SI-0513-10103] Funding Source: researchfish	European Union's Seventh Framework Programme for research, technological development and demonstration; National Institute for Health Research(National Institute for Health Research (NIHR))	The project was supported by the European Union's Seventh Framework Programme for research, technological development and demonstration [grant agreement no 279081]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONUCCI TC, 1987, SEX ROLES, V17, P737, DOI 10.1007/BF00287685; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Christakis NA, 2013, STAT MED, V32, P556, DOI 10.1002/sim.5408; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Derose KP, 2009, MED CARE RES REV, V66, P272, DOI 10.1177/1077558708330428; Eakin EG, 2002, DIABETES-METAB RES, V18, P26, DOI 10.1002/dmrr.266; Engedal K, 1996, INT J GERIATR PSYCH, V11, P467, DOI 10.1002/(SICI)1099-1166(199605)11:5<467::AID-GPS338>3.0.CO;2-S; Fernandez A, 2015, BRIT J GEN PRACT, V65, pE198, DOI 10.3399/bjgp15X684025; Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030; Glazier RH, 2006, DIABETES CARE, V29, P1675, DOI 10.2337/dc05-1942; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Hinder S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-83; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Ifanti AA, 2013, HEALTH POLICY, V113, P8, DOI 10.1016/j.healthpol.2013.05.017; International Diabetes Federation, 2009, DIABETES ATLAS; Kennedy A, 2007, BMJ-BRIT MED J, V335, P968, DOI 10.1136/bmj.39372.540903.94; Kennedy A, 2015, HEALTH EXPECT, V18, P3172, DOI 10.1111/hex.12306; Kennedy A, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-7; Koetsenruijter J, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-29; Laumann E.O., 1966, PRESTIGE ASS URBAN C; LIN N, 1986, SOC NETWORKS, V8, P365, DOI 10.1016/0378-8733(86)90003-1; Mohnen SM, 2011, SOC SCI MED, V72, P660, DOI 10.1016/j.socscimed.2010.12.004; Penninx BWJH, 1997, AM J EPIDEMIOL, V146, P510, DOI 10.1093/oxfordjournals.aje.a009305; Putnam RD., 2000, BOWLING ALONE COLLAP; Reeves D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098340; Rodriguez-Artalejo F, 2006, J CARD FAIL, V12, P621, DOI 10.1016/j.cardfail.2006.06.471; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; Stopford R, 2013, PATIENT EDUC COUNS, V93, P549, DOI 10.1016/j.pec.2013.08.016; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943; Topolski T. D., 2006, Preventing Chronic Disease, V3, pA118; van Dam HA, 2005, PATIENT EDUC COUNS, V59, P1, DOI 10.1016/j.pec.2004.11.001; Van Der Gaag M, 2005, SOC NETWORKS, V27, P1, DOI 10.1016/j.socnet.2004.10.001; Vassilev I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-719; Vassilev I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059723; Vassilev I, 2011, CHRONIC ILLN, V7, P60, DOI 10.1177/1742395310383338; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	37	33	33	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135079	10.1371/journal.pone.0135079	http://dx.doi.org/10.1371/journal.pone.0135079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6KK	26305559	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500015
J	Lin, SC; Gan, ZH; Yao, Y; Min, DL				Lin, Shu Chen; Gan, Zhi Hua; Yao, Yang; Min, Da Liu			The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis	PLOS ONE			English	Article							REGULATORY T-CELLS; TUMOR-INFILTRATING LYMPHOCYTES; FOXP3 EXPRESSION; ESTROGEN-RECEPTOR; PUBLICATION BIAS; GASTRIC-CANCER; SURVIVAL; PROLIFERATION; ANGIOGENESIS; CHEMOTHERAPY	Background Recent studies have shown that the forkhead box P3 (FOXP3) protein has a prognostic role in breast cancer. However, these results are controversial. Therefore, the aim of this metaanalysis was to clarify the prognostic role of FOXP3 expression in operable breast cancer cases. Methods Eligible studies describing the use of FOXP3 as a prognostic factor for operable breast cancer cases were identified. Clinicopathological features, disease-free survival (DFS), and overall survival (OS) data were collected from these studies and were analyzed using Stata software. Results A total of 16 articles containing data from 13,217 breast cancer patients met the inclusion criteria established for this study. The subsequent meta-analysis that was performed showed that high levels of FOXP3 are not significantly associated with DFS and OS with significant heterogeneity. An additional subgroup analysis demonstrated that intratumoral FOXP3+ regulatory T cells (Tregs) were positively correlated with adverse clinicopathological parameters, yet they did not show an association with DFS or OS. For tumor cells, the pooled results revealed that FOXP3 is significantly associated with DFS (HR: 2.55, 95% CI: 1.23-5.30) but is not associated with clinicopathological parameters or OS. We also observed a significant correlation between FOXP3 expression and survival in the estrogen receptor-positive (ER)+ subgroup (HR: 1.83, 95% CI: 1.36-2.47 for DFS, HR: 1.87, 95% CI 1.28-2.73 for OS), in the Asian region (HR: 1.98, 95% CI: 1.56-2.50 for DFS, HR: 1.93, 95% CI: 1.12-3.35 for OS) and using the median as the FOXP3-positive cut-off value (HR: 1.94, 95% CI: 1.57-2.39 for DFS, HR: 2.06; 95% CI: 1.36-3.11 for OS). Conclusion This meta-analysis indicates that a prognostic role for FOXP3 expression in operable breast cancer cases depends on the FOXP3-positive region, ER status, geographic region and the FOXP3-positive cut-off value.	[Lin, Shu Chen; Gan, Zhi Hua; Min, Da Liu] Shanghai Jiao Tong Univ, Dept Oncol, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China; [Yao, Yang] Shanghai Jiao Tong Univ, Dept Oncol, Peoples Hosp 6, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Min, DL (corresponding author), Shanghai Jiao Tong Univ, Dept Oncol, Shanghai Peoples Hosp 6, East Campus, Shanghai 200030, Peoples R China.	scl543042177@163.com						Ali HR, 2014, ANN ONCOL, V25, P1536, DOI 10.1093/annonc/mdu191; Ali HR, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3061; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Chu R, 2015, MOL CELL ENDOCRINOL, V399, P228, DOI 10.1016/j.mce.2014.10.006; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Devaud C, 2014, CANCER IMMUNOL IMMUN, V63, P869, DOI 10.1007/s00262-014-1581-4; Droeser R, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-134; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Earl HM, 2012, BRIT J CANCER, V107, P1257, DOI 10.1038/bjc.2012.370; Facciabene A, 2012, CANCER RES, V72, P2162, DOI 10.1158/0008-5472.CAN-11-3687; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189; Gupta S, 2007, ACTA ONCOL, V46, P792, DOI 10.1080/02841860701233443; Hao Q, 2014, CELL SIGNAL, V26, P564, DOI 10.1016/j.cellsig.2013.11.030; Kim MH, 2013, ONCOLOGY-BASEL, V85, P128, DOI 10.1159/000351473; Kim ST, 2013, AM J CLIN ONCOL-CANC, V36, P224, DOI 10.1097/COC.0b013e3182467d90; Kim S, 2014, J BREAST CANCER, V17, P8, DOI 10.4048/jbc.2014.17.1.8; Ladoire S, 2012, ANN ONCOL, V23, P2552, DOI 10.1093/annonc/mds028; Ladoire S, 2008, CLIN CANCER RES, V14, P2413, DOI 10.1158/1078-0432.CCR-07-4491; Ladoire S, 2011, CANCER IMMUNOL IMMUN, V60, P909, DOI 10.1007/s00262-011-1046-y; Liu FF, 2011, BREAST CANCER RES TR, V130, P645, DOI 10.1007/s10549-011-1647-3; Liu SZ, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0432-8; Ma GF, 2014, BRIT J CANCER, V110, P1552, DOI 10.1038/bjc.2014.47; Maeda N, 2014, ANN SURG ONCOL, V21, pS546, DOI 10.1245/s10434-014-3564-2; Mahmoud SMA, 2011, BREAST CANCER RES TR, V127, P99, DOI 10.1007/s10549-010-0987-8; Merlo A, 2009, J CLIN ONCOL, V27, P1746, DOI 10.1200/JCO.2008.17.9036; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; Ohara M, 2009, CANCER IMMUNOL IMMUN, V58, P441, DOI 10.1007/s00262-008-0570-x; Paulsson J, 2014, SEMIN CANCER BIOL, V25, P61, DOI 10.1016/j.semcancer.2014.02.006; Prieto GA, 2006, IMMUNOLOGY, V118, P58, DOI 10.1111/j.1365-2567.2006.02339.x; Stockmann C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00069; Sun SY, 2014, CANCER IMMUNOL IMMUN, V63, P395, DOI 10.1007/s00262-014-1519-x; Takenaka M, 2013, MOL CLIN ONCOL, V1, P625, DOI 10.3892/mco.2013.107; Tan B, 2014, ONCOTARGET, V5, P264, DOI 10.18632/oncotarget.1600; Tanchot C, 2013, CANCER MICROENVIRON, V6, P147, DOI 10.1007/s12307-012-0122-y; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Triulzi T, 2013, J CELL PHYSIOL, V228, P30, DOI 10.1002/jcp.24125; Weller P, 2014, EUR J CANCER, V50, P1291, DOI 10.1016/j.ejca.2014.02.016; Wells GA, 2003, 11 INT COCHR C BARC, VO-63, P26; West NR, 2013, BRIT J CANCER, V108, P155, DOI 10.1038/bjc.2012.524; Won KY, 2013, PATHOL RES PRACT, V209, P767, DOI 10.1016/j.prp.2013.08.010; Yan M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2869; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	45	8	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136374	10.1371/journal.pone.0136374	http://dx.doi.org/10.1371/journal.pone.0136374			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305693	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500070
J	Zhang, C; Fu, JX; Wang, YG; Bao, ZY; Zhao, HB				Zhang, Chao; Fu, Jianxin; Wang, Yiguang; Bao, Zhiyi; Zhao, Hongbo			Identification of Suitable Reference Genes for Gene Expression Normalization in the Quantitative Real-Time PCR Analysis of Sweet Osmanthus (Osmanthus fragrans Lour.)	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RT-PCR; HOUSEKEEPING GENES; FLORAL DEVELOPMENT; INTERNAL CONTROL; QPCR ANALYSIS; TARGET GENES; GREEN-I; VALIDATION; SELECTION	Quantitative real-time PCR (RT-qPCR), a sensitive technique for quantifying gene expression, depends on the stability of the reference gene(s) used for data normalization. Several studies examining the selection of reference genes have been performed in ornamental plants but none in sweet osmanthus (Osmanthus fragrans Lour.). Based on transcriptomic sequencing data from O. fragrans buds at four developmental stages, six reference genes (OfACT, OfEF1 alpha, OfIDH, OfRAN1, OfTUB, and OfUBC2) with stable expression (0.5 to 2 fold change in expression levels between any two developmental stages), as well as the commonly used reference gene Of18S, were selected as candidates for gene expression normalization in the RT-qPCR analysis of O. fragrans. For the normalization of RT-qPCR with two dyes, SYBR Green and EvaGreen, the expressional stability of seven candidate reference genes in 43 O. fragrans samples was analyzed using geNorm, NormFinder and BestKeeper. For RT-qPCR using SYBR Green, OfRAN1 and OfUBC2 were the optimal reference genes for all samples and different cultivars, OfACT and OfEF1a were suitable for different floral developmental stages, and OfACT was the optimal reference gene for different temperature treatments. The geometric mean values of the optimal reference gene pairs for the normalization of RT-qPCR are recommended to be used for all samples, different cultivars and different floral developmental stages in O. fragrans. For RT-qPCR using EvaGreen, OfUBC2 was the optimal reference gene for all samples and different cultivars, and OfACT was the optimal reference gene for different floral developmental stages and different temperature treatments. As the worst reference gene, Of18S should not be used as a reference gene in O. fragrans in the future. Our results provide a reference gene application guideline for O. fragrans gene expression characterization using RT-qPCR.	[Zhang, Chao; Fu, Jianxin; Wang, Yiguang; Bao, Zhiyi; Zhao, Hongbo] Zhejiang Agr & Forestry Univ, Sch Landscape Architecture, Dept Ornamental Hort, Linan, Zhejiang, Peoples R China; [Zhao, Hongbo] Zhejiang Agr & Forestry Univ, Nurturing Stn State Key Lab Subtrop Silviculture, Linan, Zhejiang, Peoples R China	Zhejiang A&F University; Zhejiang A&F University	Zhao, HB (corresponding author), Zhejiang Agr & Forestry Univ, Sch Landscape Architecture, Dept Ornamental Hort, Linan, Zhejiang, Peoples R China.	zhaohb@zafu.edu.cn	Zhang, Chao/GPW-9252-2022; /ABF-6585-2021; Zhang, Daniel/HCI-1939-2022	Zhang, Chao/0000-0001-8118-5251; 	National Natural Science Foundation of China [31170656, 31101571]; Zhejiang Provincial Natural Science Foundation of China [LQ15C160004]; Zhejiang Provincial Major Program of New Cultivar Breeding [2012C12909-9, 2012C12909-19]; Open Foundation of Top Key Discipline of Forestry, Zhejiang Province [KF201321, KF201324]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Major Program of New Cultivar Breeding; Open Foundation of Top Key Discipline of Forestry, Zhejiang Province	This research was supported by the National Natural Science Foundation of China (Grant No. 31170656 and 31101571)(http://www.nsfc.gov.cn/), Zhejiang Provincial Natural Science Foundation of China (Grant No. LQ15C160004)(http://www.zjnsf.gov.cn/), Zhejiang Provincial Major Program of New Cultivar Breeding (Grant No. 2012C12909-9 and 2012C12909-19) and Open Foundation of Top Key Discipline of Forestry, Zhejiang Province (KF201321 and KF201324).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Baldermann S, 2010, J EXP BOT, V61, P2967, DOI 10.1093/jxb/erq123; Bey M, 2004, PLANT CELL, V16, P3197, DOI 10.1105/tpc.104.026724; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Ciciarello M, 2007, CELL MOL LIFE SCI, V64, P1891, DOI 10.1007/s00018-007-6568-2; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Delgado-Benarroch L, 2009, PLANTA, V229, P1219, DOI 10.1007/s00425-009-0910-x; Eischeid Anne C, 2011, BMC Res Notes, V4, P263, DOI 10.1186/1756-0500-4-263; Fiore BD, 2004, CELL CYCLE, V3, P303; Fu JX, 2013, MOL BREEDING, V31, P205, DOI 10.1007/s11032-012-9784-x; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Giglio S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng135; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Han YJ, 2014, TREE GENET GENOMES, V10, P329, DOI 10.1007/s11295-013-0687-8; Han YJ, 2013, BIOLOGIA, V68, P258, DOI 10.2478/s11756-013-0002-z; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jin XH, 2013, SCI HORTIC-AMSTERDAM, V153, P64, DOI 10.1016/j.scienta.2013.01.023; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090612; Lin LY, 2013, MOL GENET GENOMICS, V288, P727, DOI 10.1007/s00438-013-0785-1; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Mao F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-76; Meng YL, 2013, SCI HORTIC-AMSTERDAM, V158, P16, DOI 10.1016/j.scienta.2013.04.019; Nath K, 2000, J BIOCHEM BIOPH METH, V42, P15, DOI 10.1016/S0165-022X(99)00033-0; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Thellin O, 2009, BIOTECHNOL ADV, V27, P323, DOI 10.1016/j.biotechadv.2009.01.010; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang T, 2014, J AM SOC HORTIC SCI, V139, P113, DOI 10.21273/JASHS.139.2.113; Wang YJ, 2013, PLANT CELL TISS ORG, V112, P181, DOI 10.1007/s11240-012-0220-z; Wang YanJie, 2012, Journal of Agricultural Biotechnology, V20, P521; Wei LB, 2013, PLANTA, V237, P873, DOI 10.1007/s00425-012-1805-9; Xiang Q, 2007, AN ILLUSTRATED MONOG; Xu PP, 2014, J EXP BOT, V65, P3277, DOI 10.1093/jxb/eru178; Xu XY, 2014, ACTA PHYSIOL PLANT, V36, P809, DOI 10.1007/s11738-013-1437-0; Yang YF, 2010, MOL BIOL REP, V37, P507, DOI 10.1007/s11033-009-9703-3; Zhang C, 2015, POSTHARVEST BIOL TEC, V101, P73, DOI 10.1016/j.postharvbio.2014.11.009; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8	49	44	61	9	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136355	10.1371/journal.pone.0136355	http://dx.doi.org/10.1371/journal.pone.0136355			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302211	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900062
J	Chemaitelly, H; Chaabna, K; Abu-Raddad, LJ				Chemaitelly, Hiam; Chaabna, Karima; Abu-Raddad, Laith J.			The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; INJECTING DRUG-USERS; HEMODIALYSIS-PATIENTS; BLOOD-DONORS; MIDDLE-EAST; GLOBAL EPIDEMIOLOGY; HCV INFECTION; HEPATOCELLULAR-CARCINOMA; SEROLOGICAL DIAGNOSIS; LEBANESE PATIENTS	Objective To characterize hepatitis C virus (HCV) epidemiology in countries of the Fertile Crescent region of the Middle East and North Africa (MENA), namely Iraq, Jordan, Lebanon, Palestine, and Syria. Methods We systematically reviewed and synthesized available records of HCV incidence and prevalence following PRISMA guidelines. Meta-analyses were implemented using a DerSimonian-Laird random effects model with inverse weighting to estimate the country-specific HCV prevalence among the various at risk population groups. Results We identified eight HCV incidence and 240 HCV prevalence measures in the Fertile Crescent. HCV sero-conversion risk among hemodialysis patients was 9.2% in Jordan and 40.3% in Iraq, and ranged between 0% and 3.5% among other populations in Iraq over different follow-up times. Our meta-analyses estimated HCV prevalence among the general population at 0.2% in Iraq (range: 0-7.2%; 95% CI: 0.1-0.3%), 0.3% in Jordan (range: 0-2.0%; 95% CI: 0.1-0.5%), 0.2% in Lebanon (range: 0-3.4%; 95% CI: 0.1-0.3%), 0.2% in Palestine (range: 0-9.0%; 95% CI: 0.2-0.3%), and 0.4% in Syria (range: 0.3-0.9%; 95% CI: 0.4-0.5%). Among populations at high risk, HCV prevalence was estimated at 19.5% in Iraq (range: 0-67.3%; 95% CI: 14.9-24.5%), 37.0% in Jordan (range: 21-59.5%; 95% CI: 29.3-45.0%), 14.5% in Lebanon (range: 0-52.8%; 95% CI: 5.6-26.5%), and 47.4% in Syria (range: 21.0-75.0%; 95% CI: 32.5-62.5%). Genotypes 4 and 1 appear to be the dominant circulating strains. Conclusions HCV prevalence in the population at large appears to be below 1%, lower than that in other MENA sub-regions, and tending towards the lower end of the global range. However, there is evidence for ongoing HCV transmission within medical facilities and among people who inject drugs (PWID). Migration dynamics appear to have played a role in determining the circulating genotypes. HCV prevention efforts should be targeted, and focus on infection control in clinical settings and harm reduction among PWID.	[Chemaitelly, Hiam; Chaabna, Karima; Abu-Raddad, Laith J.] Cornell Univ, Qatar Fdn, Weill Cornell Med Coll Qatar, Infect Dis Epidemiol Grp, Doha, Qatar; [Chaabna, Karima; Abu-Raddad, Laith J.] Cornell Univ, Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY 10021 USA	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University	Chemaitelly, H (corresponding author), Cornell Univ, Qatar Fdn, Weill Cornell Med Coll Qatar, Infect Dis Epidemiol Grp, Doha, Qatar.	hsc2001@qatar-med.cornell.edu	Chaabna, Karima/H-9986-2019; Abu-Raddad, Laith J/AAY-1441-2020	Chaabna, Karima/0000-0002-1443-207X; Abu-Raddad, Laith J/0000-0003-0790-0506; Chemaitelly, Hiam/0000-0002-8756-6968	NPRP grant from the Qatar National Research Fund (Qatar Foundation) [4-924-3-251]; Biostatistics, Epidemiology, and Biomathematics Research Core at the Weill Cornell Medical College in Qatar	NPRP grant from the Qatar National Research Fund (Qatar Foundation); Biostatistics, Epidemiology, and Biomathematics Research Core at the Weill Cornell Medical College in Qatar	This publication was made possible by NPRP grant number 4-924-3-251 from the Qatar National Research Fund (a member of Qatar Foundation), url:http://www.qnrf.org/en-us/. Additional support was provided by the Biostatistics, Epidemiology, and Biomathematics Research Core at the Weill Cornell Medical College in Qatar, url: http://qatar-weill.cornell.edu/research/laboratories/biostatistics.html. The statements made herein are solely the responsibility of the authors. The funders had no role in the design, conduct, or analysis of the study.	Abbas Y. A., 2013, AL QADISIAH MED J, V9, P250; Abdelnour GE, 1997, EUR J EPIDEMIOL, V13, P863, DOI 10.1023/A:1007468322940; Abdul-Aziz M, 2001, AL TAQANI, V23, P6; Abdul-Karim E. T., 2011, J ARAB BOARD HLTH SP, V12, P9; Abdulkarim AS, 1998, AM J TROP MED HYG, V59, P571, DOI 10.4269/ajtmh.1998.59.571; Abdullah AM, 2012, DIYALA J MED, V3, P9; Abdullah B. A, 2012, SCI J THI QAR, V3, P55; Abed B. A., 2010, J AL NAHRAIN U, V13, P121; Abu-Raddad L. J., 2010, Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: time for strategic action; Abu-Raddad LJ, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000386729.56683.33; Al Abaddi B, 2014, WORLD FAM MED, V12, P10, DOI 10.5742/MEWFM.2014.92532; Al Quadan FA, 2002, MICROBIOLOGICA, V25, P269; Al Wtaify AS, 2000, QATAR MED J, V9, P58; Al-Ali N. AA., 2014, IRAQI POSTGRADUATE M, V13, P262; Al-Ani M. H., 2011, J ARAB BORAD HLTH SP, V12, P21; Al-Azmeh J, 1999, INFECTION, V27, P221, DOI 10.1007/BF02561535; Al-Azzawi M. K. K., 2006, J DIYALA HUMANITY RE, V22, P106; Al-Barzinji R M, 2006, IRAQI POSTGRADUAGE M, V5, P442; Al-Beldawi D. H., 2010, J FM BAGHDAD, V52, P4; Al-Doori A. M., 2006, J FACULTY MED BADHAD, V48, P149; Al-Dulaimi S. B. K., 2012, IRAQI AL MUSTANIRIYA, V23, P33; Al-Duliami A. A., 2012, DIYALA J MED, V3, P51; Al-Gani F.A., 2011, INT J BIOL MED RES, V2, P912; Al-Greti S. H. H., 2013, J BABYLON U PURE APP, V21, P2801; Al-Hamdani A. H., 2012, IRAQI J COMMUNITY ME, V3, P186; Al-hemiary R. M., 2012, IRAQ J MARKET RES CO, V4, P159; Al-Jadiry M., 2008, J FM BAGHDAD, V50, P223; Al-Jamal M, 2009, SAUDI J KIDNEY DIS T, V20, P488; Al-Jebori A. S., 2010, DIYALA J PURE SCI, V6, P292; Al-Juboori L. F., 2012, MED J TIKRIT, V1, P95; Al-Juboury A.W.F., 2010, MED J BABYLON, V7, P1; Al-Kamil E. A., 2011, J ARAB BOARD HLTH SP, V12, P35; Al-Kubaisy W. A., 2006, Eastern Mediterranean Health Journal, V12, P264; Al-Kubaisy W A, 2002, East Mediterr Health J, V8, P239; Al-Kubaisy W. A., 2006, Eastern Mediterranean Health Journal, V12, P204; Al-Kubaisy W. A., 2000, J ARAB BOARD HLTH SP, V2; Al-Kubaisy WA, 2014, ASIAN PAC J CANCER P, V15, P7725, DOI 10.7314/APJCP.2014.15.18.7725; Al-Marzoqi A. H., 2009, J AL QADISIYAH PURE, V14, P1; Al- Mashhadani J. I., 2009, J FM BAGHDAD, V51, P308; Al-Mashhadani JI, 2007, IRAQI J COMMUNITY ME, V20, P20; Al-Rubaie H. MH., 2011, IRAQI J MED SCI, V9, P343; Al-Saad T, 2009, AL ANBAR MED J, V7, P68; Al-Sheyyab M, 2001, J TROP PEDIATRICS, V47, P239, DOI 10.1093/tropej/47.4.239; Al-Sweedan SA, 2011, TURK J HEMATOL, V28, P47, DOI 10.5152/tjh.2011.05; Al-Thwani A. N., 2006, IRAQI J BIOTECHNOLOG, V5, P70; Al-Zamili A. H., 2009, AL QADISIAH MED J, V5, P89; Albahadle AK. J., 2013, AL QADISIAH MED J, V9, P73; Albaitushi A., 2011, J BIOTECHNOLOGY RES, V5, P29; Ali MK, 2009, J FM BAGHDAD U, V51, P419; Ali T, 2012, HAEMOPHILIA, V18, P851, DOI 10.1111/j.1365-2516.2012.02862.x; Ali T, 2010, DAMSCUS U J HLTH SCI, V26, P107; Aljooani OAA, 2012, J FACULTY MED BAGHDA, V54, P52; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Amin RM, 2012, AL TAQANI, V25, P70; [Anonymous], 2014, ADD CONTR LEV DAT PR; [Anonymous], 2014, GASTROENTEROLOGY S1, V10, P1; Antaki N, 2009, EPIDEMIOL INFECT, V137, P79, DOI 10.1017/S095026880800054X; Araj G F, 1995, J Med Liban, V43, P11; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Ataallah TM, 2011, SAUDI MED J, V32, P1046; Ayesh BM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-105; Baddoura R, 2002, East Mediterr Health J, V8, P150; Batchoun RG, 2011, SAUDI J KIDNEY DIS T, V22, P682; Batieha A., 2007, Eastern Mediterranean Health Journal, V13, P654; Bdour S, 2002, J MED MICROBIOL, V51, P700, DOI 10.1099/0022-1317-51-8-700; Benova L, 2015, HEPATOLOGY, V61, P834, DOI 10.1002/hep.27596; Borenstein M, 2009, INTRO METAANALYSIS, Vxxviii; Centers for Disease Control and Prevention, HEP C ATL; Chaabna K, 2014, PROTOCOL SYSTEMATIC; Chaabna K, 2015, HEPATITIS C VIR UNPU; Chaabna K, 2014, SYST REV, V3, DOI 10.1186/2046-4053-3-146; Chemaitelly H, 2015, EPIDEMIOLOGY H UNPUB; Chemaitelly H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069803; Chiad I. A., 2009, IRAQI J COMMUNITY ME, V22, P215; Chironna M, 2003, INFECTION, V31, P70, DOI 10.1007/s15010-002-3100-3; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Collaboration C, 2008, COCHRANE HDB SYSTEMA; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Cuadros DF, 2014, HEPATOLOGY, V60, P1150, DOI 10.1002/hep.27248; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Dumaidi K, 2014, J MED VIROL, V86, P1694, DOI 10.1002/jmv.24008; Easa Z. O., 2009, KUFA MED J, V12, P243; El-Ghitany EM, 2015, LIVER INT, V35, P489, DOI 10.1111/liv.12617; El-Ottol AEY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-210; El-Zanaty F., 2009, EGYPT DEMOGRAPHIC HL, DOI DOI 10.1177/0049475514561330; Fadhil R. S., 2012, IRAQI J CANC MED GEN, V5, P59; Fadlalla FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121873; Fawzi N., 2011, IRAQI MED J, V57, P119; FEILER G, 1991, POPUL DEV REV, V17, P134, DOI 10.2307/1972356; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Ghunaimat M., 2007, J ROYAL MED SERVICES, V14, P63; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Guerra J, 2012, J VIRAL HEPATITIS, V19, P560, DOI 10.1111/j.1365-2893.2011.01576.x; Hamim S. S., 2012, J COLL ED PURE SCI, V2, P125; Hamim S. S., 2012, J COLL ED PURE SCI, V2, P262; Hamoudi W, 2013, J EPIDEMIOL GLOB HEA, V3, P67, DOI 10.1016/j.jegh.2013.02.003; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hashem N. A., 2013, AL MUSTANSIRIYAH J S, V24, P51; Hassan A. S., 2008, J FM BAGHDAD, V50, P467; Hassan ZM, 2008, INT NURS REV, V55, P142, DOI 10.1111/j.1466-7657.2007.00583.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Humphrey M, 1993, Middle East Rep, P2; Hussain A. K., 2008, IRAQI POSTGRADUATE M, V7, P362; Hussain AI, 2008, J AL ANBAR U PURE SC, V2, P18; Hussain S. M., 2010, DIYALA J PURE SCI, V6, P140; Hussein A. H., 2010, J ZANKOY SULAIMANI, V13, P15; IBM Corp Released, 2021, IBM SPSS STAT WINDOW; Inati A, 2005, BRIT J HAEMATOL, V130, P644, DOI 10.1111/j.1365-2141.2005.05645.x; INATI A, 2009, HAEMATOL HEMATOL S2, V94, P511; International Organization for Migration, 2010, MIGR DEV EG; Irani-Hakime N, 2001, AM J INFECT CONTROL, V29, P20, DOI 10.1067/mic.2001.110777; Irani-Hakime N, 2001, CLIN LAB HAEMATOL, V23, P317, DOI 10.1046/j.1365-2257.2001.00409.x; Irani-Hakime N, 2006, AM J INFECT CONTROL, V34, P241, DOI 10.1016/j.ajic.2005.06.009; Irani-Hakime Noha, 2003, J Med Liban, V51, P121; Jassim A. N., 2011, J BAGHDAD SCI, V8, P23; Jbara I., 2006, Jordan Medical Journal, V40, P190; Karadat A., 2015, HEPATOLOGY INT S1, V9, pS276; Khaled M. D., 2014, Journal of Biotechnology Research Center, V8, P11; Khaleel H. A., 2014, EPIDEMIOLOGY REPORTS, V1, DOI [10.7243/2054-9911-1-1, DOI 10.7243/2054-9911-1-1]; Khalid M. D., 2012, IRQI J BIOTECHNOLOGY, V11, P475; Khalid MD, 2012, J LIFE SCI, V6, P489; Khattab O. S., 2010, IRAI POSTGRADUATE ME, V9, P31; Khattab Omar Salem, 2008, Saudi J Kidney Dis Transpl, V19, P110; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Mahfoud Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-96; Mahfoud Z, 2010, J INFECT DEV COUNTR, V4, P144, DOI 10.3855/jidc.517; Mahmud S, 2015, EPIDEMIOLOGY H UNPUB; Matar GM, 1996, J CLIN MICROBIOL, V34, P2623, DOI 10.1128/JCM.34.10.2623-2624.1996; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Miller FD, 2010, P NATL ACAD SCI USA, V107, P14757, DOI 10.1073/pnas.1008877107; Mnuti J. K., 2011, IRAQI POSTGRADUATE M, V10, P460; Mohamoud YA, 2015, EPIDEMIOLOGY H UNPUB; Mohamoud YA, 2014, WORLD J GASTROENTERO, V20, P12734, DOI 10.3748/wjg.v20.i36.12734; Mohamoud YA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-288; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moukeh G, 2009, SAUDI J KIDNEY DIS T, V20, P140; Muhsin M. A., 2013, MED J BABYLON, V10, P445; Mumtaz GR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001663; Mustafa B., 2010, IRAQI J PHARM, V10, P66; Nabulsi Mona M., 1997, Journal of Obstetrics and Gynaecology (Abingdon), V17, P548; Naji MY, 2013, KUFA J NURSING SCI, V3; Naman R E, 1996, J Med Liban, V44, P4; National AIDS Programme and Central Statistics Bureau (of Syrian Ministry of Health), KNOWL ATT PROF BEH H; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Neyeloff Jeruza L, 2012, BMC Res Notes, V5, P52, DOI 10.1186/1756-0500-5-52; Noaman N. G., 2012, DIYALA J MED, V2, P46; Novack L, 2007, TROP MED INT HEALTH, V12, P415, DOI 10.1111/j.1365-3156.2006.01810.x; Obied H. M., 2014, INT J ADV RES, V2, P295; Omer AR, 2011, SAUDI MED J, V32, P55; Omer W. A., 2011, IRAQI MED J, V57, P106; Othman Adil A, 2014, Asian J Transfus Sci, V8, P32, DOI 10.4103/0973-6247.126687; Othman B, 2001, INFECTION, V29, P262, DOI 10.1007/s15010-001-9156-7; Othman BM, 2002, SAUDI MED J, V23, P393; Othman BM, 2001, SAUDI MED J, V22, P603; Otrock ZK, 2013, PATHOL ONCOL RES, V19, P715, DOI 10.1007/s12253-013-9634-0; Palestinian Health Information Center, 2010, HLTH ANN REP 2009; Palestinian Health Information Center, 2014, HLTH ANN REP 2013; Palestinian Health Information Center, 2004, HLTH ANN REP 2003; Palestinian Health Information Center, 2007, HLTH ANN REP 2006; Palestinian Health Information Center, 2006, HLTH ANN REP 2005; Palestinian Health Information Center, 2008, HLTH ANN REP 2007; PAWLOTSKY JM, 1995, J INFECT DIS, V171, P1607, DOI 10.1093/infdis/171.6.1607; Qureshi H, 2010, East Mediterr Health J, V16 Suppl, pS15; R Core Team, 2014, R 3 2 1 LANG ENV STA; Raham TF, 2011, AL TAQANI, V24, P113; Ramia S, 2006, INT J INFECT DIS, V10, P272, DOI 10.1016/j.ijid.2005.07.008; Ramia S, 2005, EPIDEMIOL INFECT, V133, P695, DOI 10.1017/S0950268805003948; Ramia S, 2003, ANN TROP MED PARASIT, V97, P187, DOI 10.1179/000349803235001363; Ramia S, 2002, ANN TROP MED PARASIT, V96, P197, DOI 10.1179/000349802125000439; Ramzi Z. S., 2010, ZANCO J MED SCI, V14, P44; Rashdan A., 2008, Jordan Medical Journal, V42, P179; Richter C, 2014, EPIDEMIOL INFECT, V142, P2140, DOI 10.1017/S0950268813003415; Saadoon A. A., 2012, THI QAR MED J, V6, P79; Saadoon I. H., 2008, MED J TIKRIT, V1, P161; Said R A, 1995, Saudi J Kidney Dis Transpl, V6, P140; Salem Z, 2003, EUR J EPIDEMIOL, V18, P251, DOI 10.1023/A:1023380316098; Salih N. I., 2007, TIKRIT J PHARM SCI, V3, P138; Salman YG, 2007, TIK J PHARM SCI, V3, P102; Shannon CE, 1997, M D COMPUT, V14, P306; Sharara AI, 2007, EPIDEMIOL INFECT, V135, P427, DOI 10.1017/S0950268806006911; Shemer-Avni Y, 1998, J MED VIROL, V56, P230, DOI 10.1002/(SICI)1096-9071(199811)56:3&lt;230::AID-JMV9&gt;3.0.CO;2-8; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shihab SS, 2014, EUR J EXP BIOL, V4, P106; Stulhofer A, 2012, J URBAN HEALTH, V89, P671, DOI 10.1007/s11524-012-9672-z; Syria Mental Health Directorate and National AIDS Programme (of Syrian Ministry of Health), 2008, ASS HIV RISK SER PRE; Tamim H, 2001, TRANSFUS APHER SCI, V24, P29, DOI 10.1016/S0955-3886(00)00124-7; Tarky A. M., 2013, ZANCO J MED SCI, V17, P370; Tawfeeq WF, 2013, MED J BABYLON, V10, P25; Taylor E., EGYPTIAN MIGRATION P; Toffik K. A., 2006, J ARAB BOARD MED SPE, V8, P105; Umar M, 2010, HEPAT MON, V10, P205; World Health Organization, 2014, EMERGENCY RISK MANAG, V19; World Health Organization, 2014, CONFL HUM CRIS IR GE; World Health Organization, HEP C FACT SHEET GEN; World Health Organization, 2013, ANN REP REG DIR 2013; World Health Organization, 2015, WHOHISSDS20155; Yaghi C, 2006, WORLD J GASTROENTERO, V12, P3575, DOI 10.3748/wjg.v12.i22.3575; Zou SM, 2010, TRANSFUSION, V50, P1495, DOI 10.1111/j.1537-2995.2010.02622.x	199	40	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135281	10.1371/journal.pone.0135281	http://dx.doi.org/10.1371/journal.pone.0135281			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296200	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900024
J	Lepine, A; Nundy, N; Kilbourne-Brook, M; Siapka, M; Terris-Prestholt, F				Lepine, Aurelia; Nundy, Neeti; Kilbourne-Brook, Maggie; Siapka, Mariana; Terris-Prestholt, Fern			Cost-Effectiveness of Introducing the SILCS Diaphragm in South Africa	PLOS ONE			English	Article							CONTRACEPTIVES	Background Though South Africa has high contraceptive use, unintended pregnancies are still widespread. The SILCS diaphragm could reduce the number of women with unmet need by introducing a discreet, woman-initiated, non-hormonal barrier method to the contraceptive method mix. Methods A decision model was built to estimate the impact and cost-effectiveness of the introduction of the SILCS diaphragm in Gauteng among women with unmet need for contraception in terms of unintended and mistimed pregnancies averted, assuming that the available contraceptives on the market were not a satisfying option for those women. Full costs were estimated both from a provider's and user's perspective, which also accounts for women's travel and opportunity cost of time, assuming a 5% uptake among women with unmet contraceptive need. The incremental cost-effectiveness ratio is computed at five and 10 years after introduction to allow for a distribution of fixed costs over time. A probabilistic sensitivity analysis was conducted to incorporate decision uncertainty. Results The introduction of the SILCS diaphragm in Gauteng could prevent an estimated 8,365 unintended pregnancies and 2,117 abortions over five years, at an annual estimated cost of US$55 per woman. This comes to a cost per pregnancy averted of US$153 and US$171 from a user's and provider's perspectives, respectively, with slightly lower unit costs at 10 years. Major cost drivers will be the price of the SILCS diaphragm and the contraceptive gel, given their large contribution to total costs (around 60%). Conclusions The introduction of the SILCS diaphragm in the public sector is likely to provide protection for some women for whom current contraceptive technologies are not an option. However to realize its potential, targeting will be needed to reach women with unmet need and those with likely high adherence. Further analyses are needed among potential users to optimize the introduction strategy.	[Lepine, Aurelia; Siapka, Mariana; Terris-Prestholt, Fern] London Sch Hyg & Trop Med, Global Hlth & Dev Dept, London WC1, England; [Nundy, Neeti; Kilbourne-Brook, Maggie] PATH, Seattle, WA USA	University of London; London School of Hygiene & Tropical Medicine	Lepine, A (corresponding author), London Sch Hyg & Trop Med, Global Hlth & Dev Dept, London WC1, England.	aurelia.lepine@lshtm.ac.uk		Terris-Prestholt, Fern/0000-0003-1693-5196; Lepine, Aurelia/0000-0002-9237-2914	United States Agency for International Development (USAID) [AID-OAA-A-11-00051]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	Support for this project was made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of the HealthTech Cooperative Agreement #AID-OAA-A-11-00051. The contents are the responsibility of PATH and the London School of Hygiene and Tropical Medicine and do not necessarily reflect the views of USAID or the US Government.	[Anonymous], 2004, NAT PRIM HLTH CAR FA; [Anonymous], FAM PLANN GLOB HDB P; Becker GS., 1960, DEMOGRAPHIC EC CHANG, P209; BRONARS SG, 1994, AM ECON REV, V84, P1141; Chiou CF, 2003, CONTRACEPTION, V68, P3, DOI 10.1016/S0010-7824(03)00078-7; CONRAD, 2011, 48 ANN M ASS REPR HL; Duflo E, 2011, HIV EARLY FERTILITY; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Foss A, 2014, BMC INFECT DIS, V14; Grant MJ, 2008, STUD FAMILY PLANN, V39, P369, DOI 10.1111/j.1728-4465.2008.00181.x; International M, 2003, DEMOGRAPHIC HLTH SUR; Maja T, 2004, CONTRACEPTIVE PRACTI; Meyer-Rath G, 2012, JAIDS JOURNAL OF ACQ, V61, P25; Moench TR, 2001, AIDS, V15, P1595, DOI 10.1097/00002030-200109070-00001; Owusu-Edusei K, 2011, SEX TRANSM DIS, V38, P997, DOI 10.1097/OLQ.0b013e3182260987; Piper A., 2010, EARLY EFFECTS ENV CO; Reddy SP, 2010, UMTHENTE UHLABA USAM; Robert J., 2011, S AFRICA ABORTION RA; Rosen S, 2007, SAMJ S AFR MED J, V97, P524; Rydzak CE, 2008, SEX TRANSM DIS, V35, P775, DOI 10.1097/OLQ.0b013e318176196d; Schwartz JL, 2008, CONTRACEPTION, V78, P237, DOI 10.1016/j.contraception.2008.04.118; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Smit J, 2013, MPT INT C FAM PLANN; SONFIELD A, 2006, GUTTMACHER POLICY RE, V9; South African Department of Health Medical Research Council Macro O., 2007, S AFR DEM HLTH SURV; Terris-Prestholt F, 2006, SEXUALLY TRANSMITTED, V33, P133; TRUSSELL J, 1995, AM J PUBLIC HEALTH, V85, P494, DOI 10.2105/AJPH.85.4.494; Trussell J, 2008, EUR J CONTRACEP REPR, V13, P219, DOI 10.1080/13625180802359263; Trussell J, 2009, CONTRACEPTION, V79, P5, DOI 10.1016/j.contraception.2008.08.003; United Nations Department of Economic and Social Affairs, 2012, WORLD CONTR US 2012; United Nations - Department of Economic and Social Affairs - Population Division, 2012, WORLD POP PROSP 2012; Williamson Lisa M, 2009, Reprod Health, V6, P3, DOI 10.1186/1742-4755-6-3; World Bank, 2012, WORLD DEV IND WORLD	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0134510	10.1371/journal.pone.0134510	http://dx.doi.org/10.1371/journal.pone.0134510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26295955	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000359926900013
J	Davis, WW; Mullany, LC; Oo, EKS; Richards, AK; Iacopino, V; Beyrer, C				Davis, William W.; Mullany, Luke C.; Oo, Eh Kalu Shwe; Richards, Adam K.; Iacopino, Vincent; Beyrer, Chris			Health and Human Rights in Karen State, Eastern Myanmar	PLOS ONE			English	Article							BURMA; CONFLICTS; MORTALITY	Background Decades of conflict in eastern Myanmar have resulted in high prevalence of human rights violations and poor health outcomes. While recent ceasefire agreements have reduced conflict in this area, it is unknown whether this has resulted in concomitant reductions in human rights violations. Methods and Findings We conducted a two-stage cluster survey of 686 households in eastern Myanmar to assess health status, access to healthcare, food security, exposure to human rights violations and identification of alleged perpetrators over the 12 months prior to January 2012, a period of near-absence of conflict in this region. Household hunger (FANTA-2 scale) was moderate/high in 91 (13.2%) households, while the proportion of households reporting food shortages in each month of 2011 ranged from 19.9% in December to 47.0% in September, with food insecurity peaking just prior to the harvest. Diarrhea prevalence in children was 14.2% and in everyone it was 5.8%. Forced labor was the most common human rights violation (185 households, 24.9%), and 210 households (30.6%) reported experiencing one or more human rights violations in 2011. Multiple logistic regression analysis identified associations between human rights violations and poor health outcomes. Conclusion Human rights violations and their health consequences persist despite reduced intensity of conflict in eastern Myanmar. Ceasefire agreements should include language that protects human rights, and reconciliation efforts should address the health consequences of decades of human rights violations.	[Davis, William W.; Mullany, Luke C.; Beyrer, Chris] Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD USA; [Oo, Eh Kalu Shwe] Karen Dept Hlth & Welf, Mae Sot, Thailand; [Richards, Adam K.] Univ Calif Los Angeles, Div Gen Internal Med, Los Angeles, CA USA; [Richards, Adam K.] Univ Calif Los Angeles, Hlth Serv Res, Los Angeles, CA USA; [Richards, Adam K.] Community Partners Int, Berkeley, CA 94710 USA; [Iacopino, Vincent] Physicians Human Rights, New York, NY USA; [Iacopino, Vincent] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Iacopino, Vincent] Univ Calif Berkeley, Human Rights Ctr, Berkeley, CA 94720 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley	Davis, WW (corresponding author), Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD USA.	wdavis29@jhu.edu	richards, adam/ABF-8189-2021	richards, adam/0000-0002-7098-0513	Open Society Institute; National Endowment for Democracy; Oak Foundation	Open Society Institute; National Endowment for Democracy; Oak Foundation	Physicians for Human Rights received funding for this project from the Open Society Institute, the National Endowment for Democracy, and the Oak Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P., 2009, SAGE HDB QUANTITATIV; [Anonymous], 2007, STATE OF TERROR; [Anonymous], 2012, SAF HUM RIGHTS POST; [Anonymous], 2011, DISPLACEMENT POVERTY; [Anonymous], 2011, DEAD MEN WALK; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Beyrer C, 2007, LANCET, V370, P1465, DOI 10.1016/S0140-6736(07)61615-8; Beyrer C, 2007, LANCET, V370, P619, DOI 10.1016/S0140-6736(07)61301-4; Bilinsky P., 2007, MONTHS ADEQUATE HOUS; Brown V, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-9; Checchi F, 2010, LANCET, V375, P255, DOI 10.1016/S0140-6736(09)62128-0; de Ville de Goyet C., 1978, MANAGEMENT NUTR EMER; Deitcher M, 2011, INTRO SIMPLE METHOD; Depoortere E, 2006, LANCET, V367, P7, DOI 10.1016/S0140-6736(06)67900-2; Fischer Walker CL, 2012, BMC PUBLIC HEALTH, V12; Grais RF, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-8; Karen Human Rights Group, 2010, SELF PROT STRAIN TAR; Karen Human Rights Group, 2008, GROW MIL AB AG CHILD; Lee TJ, 2006, TROP MED INT HEALTH, V11, P1119, DOI 10.1111/j.1365-3156.2006.01651.x; Loyer AB, 2014, J HEALTH POPUL NUTR, V32, P471; Mahn M, 2008, Glob Public Health, V3, P165, DOI 10.1080/17441690801942821; Mullany LC, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.055087; Mullany LC, 2008, REPROD HEALTH MATTER, V16, P44, DOI 10.1016/S0968-8080(08)31341-X; Mullany LC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000317; Mullany LC, 2008, PLOS MED, V5, P1689, DOI 10.1371/journal.pmed.0050242; Parmar P, 2015, PLOS ONE IN PRESS; Prudhon C, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-10; Purdin S, 2009, PREHOSP DISASTER MED, V24, pE202, DOI 10.1017/S1049023X00021592; Rose AMC, 2006, B WORLD HEALTH ORGAN, V84, P290, DOI 10.2471/BLT.05.029181; Sollom R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001007; South A, 2011, BURMAS LONGEST RUNNI; Spiegel PB, 2010, JAMA-J AM MED ASSOC, V304, P567, DOI 10.1001/jama.2010.1094; Suwanvanichkij Voravit, 2008, Confl Health, V2, P4, DOI 10.1186/1752-1505-2-4; Teela KC, 2009, SOC SCI MED, V68, P1332, DOI 10.1016/j.socscimed.2009.01.033; [No title captured]	35	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0133822	10.1371/journal.pone.0133822	http://dx.doi.org/10.1371/journal.pone.0133822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308850	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400014
J	Jiao, HX; Wang, K; Yang, FH; Grant, SFA; Hakonarson, H; Price, RA; Li, WD				Jiao, Hongxiao; Wang, Kai; Yang, Fuhua; Grant, Struan F. A.; Hakonarson, Hakon; Price, R. Arlen; Li, Wei-Dong			Pathway-Based Genome-Wide Association Studies for Plasma Triglycerides in Obese Females and Normal-Weight Controls	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; SET ENRICHMENT ANALYSIS; BLOOD; GENE; HOMOCYSTEINE; INFLAMMATION; LOCI; TRANSCRIPTION; ASTROTACTIN; BCL-6	Pathway-based analysis as an alternative approach can provide complementary information to single-marker genome-wide association studies (GWASs), which always ignore the epistasis and does not have sufficient power to find rare variants. In this study, using genotypes from a genome-wide association study (GWAS), pathway-based association studies were carried out by a modified Gene Set Enrichment Algorithm (GSEA) method (GenGen) for triglyceride in 1028 unrelated European-American extremely obese females (BMI >= 35kg/m(2)) and normal-weight controls (BMI<25kg/m(2)), and another pathway association analysis (ICSNPathway) was also used to verify the GenGen result in the same data. The GO0009110 pathway (vitamin anabolism) was among the strongest associations with triglyceride (empirical P<0.001); the result remained significant after FDR correction (P = 0.022). MMAB, an obesity-related locus, included in this pathway. The ABCG1 and BCL6 gene was found in several triglyceride-related pathways (empirical P<0.05), which were also replicated by ICSNPathway (empirical P<0.05, FDR<0.05). We also performed single-marked GWAS using PLINK for TG levels (log-transformed). Significant associations were found between ASTN2 gene SNPs and plasma triglyceride levels (rs7035794, P = 2.24x10(-10)). Our study suggested that vitamin anabolism pathway, BCL6 gene pathways and ASTN2 gene may contribute to the genetic variation of plasma triglyceride concentrations.	[Jiao, Hongxiao; Yang, Fuhua] Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin 300070, Peoples R China; [Wang, Kai] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Wang, Kai] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA USA; [Price, R. Arlen; Li, Wei-Dong] Univ Penn, Perelman Sch Med, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA	Tianjin Medical University; University of Southern California; University of Southern California; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Price, RA (corresponding author), Univ Penn, Perelman Sch Med, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA.	arlen@exchange.upenn.edu; liweidong98@tijmu.edu.cn		Li, Wei-Dong/0000-0003-0521-7412	National Institutes of Health [R01DK44073, R01DK56210, R01DK076023]; Scientist Development Grant from the American Heart Association [0630188N]; National Natural Science Foundation of China [81070576]; Tianjin Municipal Science and Technology Commission [12JCZDJC24700]; National Institutes of Health / National Human Genome Research Institute [HG006037]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044073, R01DK056210, R01DK076023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scientist Development Grant from the American Heart Association(American Heart Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission; National Institutes of Health / National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health grants R01DK44073, R01DK56210, and R01DK076023 to RAP and by a Scientist Development Grant (0630188N) from the American Heart Association, grant 81070576 from the National Natural Science Foundation of China, and grant 12JCZDJC24700 from Tianjin Municipal Science and Technology Commission to WDL and National Institutes of Health / National Human Genome Research Institute HG006037 to KW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NC, 2002, DEVELOPMENT, V129, P965; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Clarke R, 2000, SEMIN THROMB HEMOST, V26, P341, DOI 10.1055/s-2000-8101; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Fogarty MP, 2010, HUM MOL GENET, V19, P1921, DOI 10.1093/hmg/ddq067; Glauser DA, 2007, J ENDOCRINOL, V193, P195, DOI 10.1677/JOE-06-0191; Glauser DA, 2009, J RECEPT SIG TRANSD, V29, P293, DOI 10.3109/10799890903241824; Jonkers IJ, 2002, AM J MED, V112, P275, DOI 10.1016/S0002-9343(01)01123-8; Junyent M, 2009, AM J CLIN NUTR, V90, P686, DOI 10.3945/ajcn.2009.27738; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kim KZ, 2013, GENES GENOM, V35, P59, DOI 10.1007/s13258-013-0059-7; Kim YS, 2001, J LAB CLIN MED, V138, P59, DOI 10.1067/mlc.2001.115494; Kondos SC, 2010, TISSUE ANTIGENS, V76, P341, DOI 10.1111/j.1399-0039.2010.01566.x; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Lee DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058748; Lee HS, 2004, AM J PHYSIOL-RENAL, V287, pF665, DOI 10.1152/ajprenal.00034.2004; Lesch KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/s00702-008-0119-3; Li MC, 2004, WORLD J GASTROENTERO, V10, P620, DOI 10.3748/wjg.v10.i5.620; Li WD, 2005, J LIPID RES, V46, P432, DOI 10.1194/jlr.M400391-JLR200; Li WD, 2004, DIABETES, V53, P812, DOI 10.2337/diabetes.53.3.812; Liu YJ, 2010, OBESITY, V18, P2339, DOI 10.1038/oby.2010.83; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Maiti N, 1999, J BIOL CHEM, V274, P32733, DOI 10.1074/jbc.274.46.32733; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Miller M, 1999, CLIN CARDIOL, V22, pII1; Patel A, 2004, CIRCULATION, V110, P2678, DOI 10.1161/01.CIR.0000145615.33955.83; Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schwartz MW, 2001, J CLIN INVEST, V108, P963, DOI 10.1172/JCI200114127; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shen GQ, 2012, ANN HUM GENET, V76, P193, DOI 10.1111/j.1469-1809.2012.00705.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; Vogel RA, 1997, AM J CARDIOL, V79, P350, DOI 10.1016/S0002-9149(96)00760-6; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018939; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang K, 2010, DIABETES, V59, P2690, DOI 10.2337/db10-0192; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Wang LM, 2009, J LIPID RES, V50, P204, DOI 10.1194/jlr.M700505-JLR200; Wei EH, 2010, CELL METAB, V11, P183, DOI 10.1016/j.cmet.2010.02.005; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wilson PM, 2010, J NEUROSCI, V30, P8529, DOI 10.1523/JNEUROSCI.0032-10.2010; Yaspan BL, 2011, STRATEGIES PATHWAY A; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhang KL, 2011, NUCLEIC ACIDS RES, V39, pW437, DOI 10.1093/nar/gkr391; Zhang KL, 2010, NUCLEIC ACIDS RES, V38, pW90, DOI 10.1093/nar/gkq324	56	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134923	10.1371/journal.pone.0134923	http://dx.doi.org/10.1371/journal.pone.0134923			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308950	Green Submitted, gold, Green Published			2022-12-27	WOS:000360069400041
J	Sawler, J; Stout, JM; Gardner, KM; Hudson, D; Vidmar, J; Butler, L; Page, JE; Myles, S				Sawler, Jason; Stout, Jake M.; Gardner, Kyle M.; Hudson, Darryl; Vidmar, John; Butler, Laura; Page, Jonathan E.; Myles, Sean			The Genetic Structure of Marijuana and Hemp	PLOS ONE			English	Article							WHOLE-GENOME; CANNABIS	Despite its cultivation as a source of food, fibre and medicine, and its global status as the most used illicit drug, the genus Cannabis has an inconclusive taxonomic organization and evolutionary history. Drug types of Cannabis (marijuana), which contain high amounts of the psychoactive cannabinoid Delta(9)-tetrahydrocannabinol (THC), are used for medical purposes and as a recreational drug. Hemp types are grown for the production of seed and fibre, and contain low amounts of THC. Two species or gene pools (C. sativa and C. indica) are widely used in describing the pedigree or appearance of cultivated Cannabis plants. Using 14,031 single-nucleotide polymorphisms (SNPs) genotyped in 81 marijuana and 43 hemp samples, we show that marijuana and hemp are significantly differentiated at a genome-wide level, demonstrating that the distinction between these populations is not limited to genes underlying THC production. We find a moderate correlation between the genetic structure of marijuana strains and their reported C. sativa and C. indica ancestry and show that marijuana strain names often do not reflect a meaningful genetic identity. We also provide evidence that hemp is genetically more similar to C. indica type marijuana than to C. sativa strains.	[Sawler, Jason; Gardner, Kyle M.; Butler, Laura; Myles, Sean] Dalhousie Univ, Fac Agr, Dept Plant & Anim Sci, Truro, NS B2N 5E3, Canada; [Sawler, Jason; Page, Jonathan E.] Anandia Labs, Vancouver, BC V6T 1Z4, Canada; [Stout, Jake M.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB R3T 2N2, Canada; [Hudson, Darryl] DOC Solut, Hamilton, ON L9C 5H3, Canada; [Vidmar, John] Alberta Innovates Technol Futures, Vegreville, AB T9C 1T4, Canada; [Page, Jonathan E.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada	Dalhousie University; University of Manitoba; Alberta Innovates; University of British Columbia	Page, JE (corresponding author), Anandia Labs, 2259 Lower Mall, Vancouver, BC V6T 1Z4, Canada.	jon.page@botany.ubc.ca; sean.myles@dal.ca		Myles, Sean/0000-0001-9754-5987; Stout, Jake/0000-0002-0193-9066	Canada Research Chairs; Anandia Labs; DOC Solutions; Natural Sciences and Engineering Research Council of Canada	Canada Research Chairs(Canada Research ChairsCGIAR); Anandia Labs; DOC Solutions; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	SM received funding from the Canada Research Chairs (http://www.chairs-chaires.gc.ca/chairholders-titulaires/profile-eng.aspx?profileId=2853) in the form of a Tier 2 Chair Award. Anandia Labs provided support in the form of salaries for authors JS and JEP, and The DOC Solutions provided financial support for author DH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. SM received funding from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) in the form of a Discovery Grant. Anandia Labs provided funds for DNA sequencing of cannabis samples via a contract to the SM lab at Dalhousie University.	Bostwick JM, 2012, MAYO CLIN PROC, V87, P172, DOI 10.1016/j.mayocp.2011.10.003; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; de Meijer E, 2014, CHEM PHENOTYPES CHEM, P89; de Meijer EPM, 2003, GENETICS, V163, P335; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Franz-Warkentin P., HEMP PRODUCTION SEES; Gardner KM, 2014, G3-GENES GENOM GENET, V4, P1681, DOI 10.1534/g3.114.011023; Hazekamp A, 2012, DRUG TEST ANAL, V4, P660, DOI 10.1002/dta.407; Hillig KW, 2005, GENET RESOUR CROP EV, V52, P161, DOI 10.1007/s10722-003-4452-y; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Meynert AM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-247; Piluzza G, 2013, GENET RESOUR CROP EV, V60, P2331, DOI 10.1007/s10722-013-0001-5; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raj A, 2014, GENETICS; Salentijn EMJ, 2015, IND CROP PROD, V68, P32, DOI 10.1016/j.indcrop.2014.08.011; SMALL E, 1976, TAXON, V25, P405, DOI 10.2307/1220524; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; van Bakel H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r102; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	19	148	148	4	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0133292	10.1371/journal.pone.0133292	http://dx.doi.org/10.1371/journal.pone.0133292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308334	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400009
J	Strubbe, S; Sturzl, W; Egelhaaf, M				Struebbe, Simon; Stuerzl, Wolfgang; Egelhaaf, Martin			Insect-Inspired Self-Motion Estimation with Dense Flow Fields-An Adaptive Matched Filter Approach	PLOS ONE			English	Article							SENSITIVE NEURON; BLOWFLY FLIGHT; ADAPTATION; RESPONSES; CONTRAST; SPEED; INFORMATION; OBJECT	The control of self-motion is a basic, but complex task for both technical and biological systems. Various algorithms have been proposed that allow the estimation of self-motion from the optic flow on the eyes. We show that two apparently very different approaches to solve this task, one technically and one biologically inspired, can be transformed into each other under certain conditions. One estimator of self-motion is based on a matched filter approach; it has been developed to describe the function of motion sensitive cells in the fly brain. The other estimator, the Koenderink and van Doorn (KvD) algorithm, was derived analytically with a technical background. If the distances to the objects in the environment can be assumed to be known, the two estimators are linear and equivalent, but are expressed in different mathematical forms. However, for most situations it is unrealistic to assume that the distances are known. Therefore, the depth structure of the environment needs to be determined in parallel to the self-motion parameters and leads to a non-linear problem. It is shown that the standard least mean square approach that is used by the KvD algorithm leads to a biased estimator. We derive a modification of this algorithm in order to remove the bias and demonstrate its improved performance by means of numerical simulations. For self-motion estimation it is beneficial to have a spherical visual field, similar to many flying insects. We show that in this case the representation of the depth structure of the environment derived from the optic flow can be simplified. Based on this result, we develop an adaptive matched filter approach for systems with a nearly spherical visual field. Then only eight parameters about the environment have to be memorized and updated during self-motion.	[Struebbe, Simon; Egelhaaf, Martin] Univ Bielefeld, Dept Neurobiol, D-33615 Bielefeld, Germany; [Struebbe, Simon; Egelhaaf, Martin] Univ Bielefeld, CITEC, D-33615 Bielefeld, Germany; [Stuerzl, Wolfgang] German Aerosp Ctr DLR, Inst Robot & Mechatron, Wessling, Germany	University of Bielefeld; University of Bielefeld; Helmholtz Association; German Aerospace Centre (DLR)	Strubbe, S (corresponding author), Univ Bielefeld, Dept Neurobiol, D-33615 Bielefeld, Germany.	simon.struebbe@uni-bielefeld.de	Egelhaaf, Martin/A-9824-2010	Egelhaaf, Martin/0000-0002-9336-4270	department of neurobiology, Bielefeld University; Deutsche Forschungsgemeinschaft (DFG)	department of neurobiology, Bielefeld University; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	S.S. was financed from the budget of the department of neurobiology, Bielefeld University. W.S. was financed by the Deutsche Forschungsgemeinschaft (DFG) while working at Bielefeld University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird E, 2005, J EXP BIOL, V208, P3895, DOI 10.1242/jeb.01818; Baird E, 2010, J EXP BIOL, V213, P1625, DOI 10.1242/jeb.038802; Baker S, 2004, INT J COMPUT VISION, V56, P221, DOI 10.1023/B:VISI.0000011205.11775.fd; Boeddeker N, 2010, P ROY SOC B-BIOL SCI, V277, P1899, DOI 10.1098/rspb.2009.2326; Borst A, 2003, VISION RES, V43, P1309, DOI 10.1016/S0042-6989(03)00092-0; Borst A, 2002, J COMP PHYSIOL A, V188, P419, DOI 10.1007/s00359-002-0316-8; Borst Alexander, 1993, Reviews of Oculomotor Research, V5, P3; Borst A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016303; Britten KH, 2008, ANNU REV NEUROSCI, V31, P389, DOI 10.1146/annurev.neuro.29.051605.112953; Chen AH, 2010, J NEUROSCI, V30, P3022, DOI 10.1523/JNEUROSCI.4029-09.2010; Chipman J. S, 2011, INT ENCY STAT SCI, P577, DOI [10.1007/978-3-642-04898-2270, DOI 10.1007/978-3-642-04898-2270]; Dahmen HJ, 2001, MOTION VISION, P143; Egelhaaf M, 2002, TRENDS NEUROSCI, V25, P96, DOI 10.1016/S0166-2236(02)02063-5; Egelhaaf M, 2006, INVERTEBRATE VISION, P399; Egelhaaf M, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00127; Egelhaaf M, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00108; Franz MO, 2000, BIOL CYBERN, V83, P185, DOI 10.1007/s004220000163; Franz MO, 2004, NEURAL COMPUT, V16, P2245, DOI 10.1162/0899766041941899; Franz MO, 2002, LECT NOTES COMPUT SC, V2525, P171; Franz MO, 2003, ADV NEURAL INFORM PR, V15, P1; FROST BJ, 1990, VISION RES, V30, P1677, DOI 10.1016/0042-6989(90)90152-B; Harris RA, 2000, NEURON, V28, P595, DOI 10.1016/S0896-6273(00)00136-7; Hausen K., 1989, P391; Hausen K., 1984, PHOTORECEPTION VISIO, V74, P523; Kern R, 2012, J EXP BIOL, V215, P2501, DOI 10.1242/jeb.061713; KOENDERINK JJ, 1987, BIOL CYBERN, V56, P247, DOI 10.1007/BF00365219; Krapp H G, 2000, Int Rev Neurobiol, V44, P93; Krapp HG, 2001, J NEUROPHYSIOL, V85, P724, DOI 10.1152/jn.2001.85.2.724; Kurtz R, 2012, FRONTIERS IN SENSING: FROM BIOLOGY TO ENGINEERING, P115; Kurtz R, 2009, P ROY SOC B-BIOL SCI, V276, P3711, DOI 10.1098/rspb.2009.0596; Liang P, 2008, J NEUROSCI, V28, P11328, DOI 10.1523/JNEUROSCI.0203-08.2008; Liang P, 2011, J NEUROPHYSIOL, V105, P1825, DOI 10.1152/jn.00359.2010; Luong QT, 1997, INT J COMPUT VISION, V22, P261, DOI 10.1023/A:1007982716991; MADDESS T, 1985, PROC R SOC SER B-BIO, V225, P251, DOI 10.1098/rspb.1985.0061; Muller C., 1966, LECT NOTES MATH, V17; Reichardt W, 1961, SENS COMMUN, P303; Reisenman C, 2003, VISION RES, V43, P1291, DOI 10.1016/S0042-6989(03)00091-9; Roberts R, 2009, PROC CVPR IEEE, P57, DOI 10.1109/CVPRW.2009.5206538; Schilstra C, 1999, J EXP BIOL, V202, P1481; Schwegmann A, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00083; SRINIVASAN MV, 1991, VISUAL NEUROSCI, V6, P519, DOI 10.1017/S095252380000136X; Stuerzl W, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/3/036002; Sturzl W, 2007, BIOL CYBERN, V96, P519, DOI 10.1007/s00422-007-0147-3; Taylor GK, 2007, ADV INSECT PHYSIOL, V34, P231, DOI 10.1016/S0065-2806(07)34005-8; TURIN GL, 1960, IRE T INFORM THEOR, V6, P311, DOI 10.1109/TIT.1960.1057571; Ullrich TW, 2015, BIOL OPEN, V4, P13, DOI 10.1242/bio.20149449; Van Hateren JH, 1999, J EXP BIOL, V202, P1491; WERNER D., 2005, FUNKTIONALANALYSIS; Wylie DRW, 2000, NEUROSCI LETT, V291, P9, DOI 10.1016/S0304-3940(00)01367-7	51	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0128413	10.1371/journal.pone.0128413	http://dx.doi.org/10.1371/journal.pone.0128413			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308839	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000360069400001
J	Tenopir, C; Dalton, ED; Allard, S; Frame, M; Pjesivac, I; Birch, B; Pollock, D; Dorsett, K				Tenopir, Carol; Dalton, Elizabeth D.; Allard, Suzie; Frame, Mike; Pjesivac, Ivanka; Birch, Ben; Pollock, Danielle; Dorsett, Kristina			Changes in Data Sharing and Data Reuse Practices and Perceptions among Scientists Worldwide	PLOS ONE			English	Article							ACCESS	The incorporation of data sharing into the research lifecycle is an important part of modern scholarly debate. In this study, the DataONE Usability and Assessment working group addresses two primary goals: To examine the current state of data sharing and reuse perceptions and practices among research scientists as they compare to the 2009/2010 baseline study, and to examine differences in practices and perceptions across age groups, geographic regions, and subject disciplines. We distributed surveys to a multinational sample of scientific researchers at two different time periods (October 2009 to July 2010 and October 2013 to March 2014) to observe current states of data sharing and to see what, if any, changes have occurred in the past 3-4 years. We also looked at differences across age, geographic, and discipline-based groups as they currently exist in the 2013/2014 survey. Results point to increased acceptance of and willingness to engage in data sharing, as well as an increase in actual data sharing behaviors. However, there is also increased perceived risk associated with data sharing, and specific barriers to data sharing persist. There are also differences across age groups, with younger respondents feeling more favorably toward data sharing and reuse, yet making less of their data available than older respondents. Geographic differences exist as well, which can in part be understood in terms of collectivist and individualist cultural differences. An examination of subject disciplines shows that the constraints and enablers of data sharing and reuse manifest differently across disciplines. Implications of these findings include the continued need to build infrastructure that promotes data sharing while recognizing the needs of different research communities. Moving into the future, organizations such as DataONE will continue to assess, monitor, educate, and provide the infrastructure necessary to support such complex grand science challenges.	[Tenopir, Carol; Allard, Suzie; Birch, Ben; Pollock, Danielle; Dorsett, Kristina] Univ Tennessee, Sch Informat Sci, Knoxville, TN USA; [Dalton, Elizabeth D.] Univ Tennessee, Ctr Informat & Commun Studies, Knoxville, TN 37996 USA; [Frame, Mike] US Geol Survey, Oak Ridge, TN USA; [Pjesivac, Ivanka] Univ Georgia, Grady Coll Journalism & Mass Commun, Athens, GA 30602 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; United States Department of the Interior; United States Geological Survey; University System of Georgia; University of Georgia	Dalton, ED (corresponding author), Univ Tennessee, Ctr Informat & Commun Studies, Knoxville, TN 37996 USA.	eddalton@utk.edu	Pollock, Danielle/AAP-4945-2020	Pollock, Danielle/0000-0003-3542-149X; Dorsett, Kristina/0000-0002-0820-6295; Allard, Suzie/0000-0001-9421-3848	National Science Foundation, Division of Cyberinfrastructure; Data Observation Network for Earth (DataONE) NSF award under a Cooperative Agreement [0830944]; Office of Advanced Cyberinfrastructure (OAC) [1430508] Funding Source: National Science Foundation	National Science Foundation, Division of Cyberinfrastructure; Data Observation Network for Earth (DataONE) NSF award under a Cooperative Agreement(National Science Foundation (NSF)); Office of Advanced Cyberinfrastructure (OAC)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The project was funded as part of the National Science Foundation, Division of Cyberinfrastructure (http://www.nsf.gov/div/index.jsp?div=ACI), Data Observation Network for Earth (DataONE) NSF award #0830944 under a Cooperative Agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AUST RES COUNC, 2013, ARC OP ACC POL; Bisol GD, 2014, J ANTHROPOL SCI, V92, P179, DOI 10.4436/JASS.92006; Borgman CL, 2012, J AM SOC INF SCI TEC, V63, P1059, DOI 10.1002/asi.22634; Campbell P., 2008, NATURE, V455, P1, DOI DOI 10.1038/NATURE08077; CAMPBELL P, 2009, NATURE, V461, P145; Carlson J, 2013, PORTAL-LIBR ACAD, V13, P343, DOI 10.1353/pla.2013.0034; CUKIER K, 2010, ECONOMIST       0225; Dallmeier-Tiessen Suenje, 2014, New Review of Information Networking, V19, P16, DOI 10.1080/13614576.2014.883936; *DATAONE, 2011, US ASS WORK GROUP CH; *DATAONE, WHAT DATAONE; Eschenfelder KR, 2014, J ASSOC INF SCI TECH, V65, P1757, DOI 10.1002/asi.23086; European Commission, 2012, COMM REC 17 7 2012 A; Faniel IM., 2011, INT J DIGIT CURATION, V6, P58, DOI [10.2218/ijdc.v6i1.172, DOI 10.2218/IJDC.V6I1.172]; Gorgolewski KJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00009; Haendel MA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001339; Hey T., 2009, MICROSOFT RES; HOFSTEDE G, 1980, CULT CONS INT DIFFER; HOLDREN J, 2013, INCR ACC RES FED FUN; HUI CH, 1988, J RES PERS, V22, P17, DOI 10.1016/0092-6566(88)90022-0; KIM Y, 2013, J COMPUT SCI EDUC, V3, P47; Kooij DTAM, 2011, J ORGAN BEHAV, V32, P197, DOI 10.1002/job.665; Kum HC, 2011, SCIENCE, V332, P1263, DOI 10.1126/science.332.6035.1263-a; Mauthner NS, 2013, SOC EPISTEMOL, V27, P47, DOI 10.1080/02691728.2012.760663; Miller Michael J., 2011, 2011 IEEE Hot Chips 23 Symposium (HCS), P1, DOI 10.1109/HOTCHIPS.2011.7477493; *NAT SCI FDN, 2011, GRANT PROP GUID; Pampel H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078080; PARSONS MA, 2013, DATA SCI J, V12; Parsons MA, 2011, J INF SCI, V37, P555, DOI 10.1177/0165551511412705; PJESIVAC I, 2015, 65 ANN INT COMM ASS; PUNIEWSKA M, 2014, ATLANTIC        1215; *RE3DAT ORG, 2014, OV 1000 RES DATA REP; Reichman OJ, 2011, SCIENCE, V331, P703, DOI 10.1126/science.1197962; Research Councils, 2013, RCUK POL OP ACC SUPP; Rodriguez V, 2009, NEW GENET SOC, V28, P67, DOI 10.1080/14636770802670274; Sayogo DS, 2013, GOV INFORM Q, V30, pS19, DOI 10.1016/j.giq.2012.06.011; Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101; The royal society, 2012, SCI OP ENT; Volk CJ, 2014, ENVIRON MANAGE, V53, P883, DOI 10.1007/s00267-014-0258-2; Wallis JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067332; WATERMAN AS, 1984, PSYCHOL INDIVIDUAL	40	181	185	11	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134826	10.1371/journal.pone.0134826	http://dx.doi.org/10.1371/journal.pone.0134826			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308551	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400037
J	Anopa, Y; McMahon, AD; Conway, DI; Ball, GE; McIntosh, E; Macpherson, LMD				Anopa, Yulia; McMahon, Alex D.; Conway, David I.; Ball, Graham E.; McIntosh, Emma; Macpherson, Lorna M. D.			Improving Child Oral Health: Cost Analysis of a National Nursery Toothbrushing Programme	PLOS ONE			English	Article							ECONOMIC-EVALUATION; DENTAL-CARIES; IMPROVEMENT PROGRAM; SCHOOLCHILDREN; PREVENTION; TRIAL	Dental caries is one of the most common diseases of childhood. The aim of this study was to compare the cost of providing the Scotland-wide nursery toothbrushing programme with associated National Health Service (NHS) cost savings from improvements in the dental health of five-year-old children: through avoided dental extractions, fillings and potential treatments for decay. Methods Estimated costs of the nursery toothbrushing programme in 2011/12 were requested from all Scottish Health Boards. Unit costs of a filled, extracted and decayed primary tooth were calculated using verifiable sources of information. Total costs associated with dental treatments were estimated for the period from 1999/00 to 2009/10. These costs were based on the unit costs above and using the data of the National Dental Inspection Programme and then extrapolated to the population level. Expected cost savings were calculated for each of the subsequent years in comparison with the 2001/02 dental treatment costs. Population standardised analysis of hypothetical cohorts of 1000 children per deprivation category was performed. Results The estimated cost of the nursery toothbrushing programme in Scotland was (sic)1,762,621 per year. The estimated cost of dental treatments in the baseline year 2001/02 was (sic)8,766,297, while in 2009/10 it was (sic)4,035,200. In 2002/03 the costs of dental treatments increased by (sic)213,380 (2.4%). In the following years the costs decreased dramatically with the estimated annual savings ranging from (sic)1,217,255 in 2003/04 (13.9% of costs in 2001/02) to (sic)4,731,097 in 2009/10 (54.0%). Population standardised analysis by deprivation groups showed that the largest decrease in modelled costs was for the most deprived cohort of children. Conclusions The NHS costs associated with the dental treatments for five-year-old children decreased over time. In the eighth year of the toothbrushing programme the expected savings were more than two and a half times the costs of the programme implementation.	[Anopa, Yulia; McMahon, Alex D.; Conway, David I.; Macpherson, Lorna M. D.] Univ Glasgow, Sch Dent, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Anopa, Yulia; McIntosh, Emma] Univ Glasgow, Coll Med Vet & Life Sci, Hlth Econ & Hlth Technol Assessment, Glasgow, Lanark, Scotland; [Ball, Graham E.] NHS Fife, Leven, Scotland	University of Glasgow; University of Glasgow	Anopa, Y (corresponding author), Univ Glasgow, Sch Dent, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	yulia.anopa@glasgow.ac.uk	Anopa, Yulia/J-8947-2019	McIntosh, Emma/0000-0001-6340-3083; Conway, David/0000-0001-7762-4063	Childsmile; Scottish Government Health Directorate	Childsmile; Scottish Government Health Directorate	The research was funded by Childsmile (grant holders: LMDM DC). Childsmile is funded by the Scottish Government Health Directorate (http://www.sehd.scot.nhs.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkarimi HA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-706; [Anonymous], 2013, MID EST POP SEX SING; Care Inspectorate, CAR INSP CHILDC STAT; Casamassimo PS, 2009, J AM DENT ASSOC, V140, P650, DOI 10.14219/jada.archive.2009.0250; Coventry R., 2012, PILOT STUDY EC COSTI; Curtis L., 2012, UNIT COSTS HLTH SOCI; Davies G M, 2002, Community Dent Health, V19, P131; Davies G M, 2003, Community Dent Health, V20, P207; Eckersley A J, 2001, Int J Paediatr Dent, V11, P103, DOI 10.1046/j.1365-263x.2001.00249.x; Feng SF, 2021, THESIS NATL CHI NAN; Filstrup Sara L, 2003, Pediatr Dent, V25, P431; Gift H C, 1995, Med Care, V33, pNS57, DOI 10.1097/00005650-199511001-00008; Hietasalo P, 2009, EUR J ORAL SCI, V117, P728, DOI 10.1111/j.1600-0722.2009.00687.x; Husereau D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-80; Information Services Division, 2012, ALL SDR ITEM SERV TR; Information Services Division, 2011, R042X SPEC GROUP COS; International Health Economics Association, 2013, 9 WORLD C HLTH EC CE; ISD Scotland, 2013, TREATM PROV DENT ISD; ISD Scotland, 2014, REP 2014 DET NAT DEN; Jameson K, 2007, Br Dent J, V203, pE13, DOI 10.1038/bdj.2007.631; Kallestal C, 2003, ACTA ODONTOL SCAND, V61, P341, DOI 10.1080/00016350310007815; Levine RS, 2002, BRIT DENT J, V193, P99, DOI 10.1038/sj.bdj.4801495; Macpherson LMD, 2013, J DENT RES, V92, P109, DOI 10.1177/0022034512470690; Macpherson LMD, 2010, BRIT DENT J, V209, P73, DOI 10.1038/sj.bdj.2010.628; Maes L, 2006, INT DENT J, V56, P159; MANAU C, 1987, COMMUNITY DENT ORAL, V15, P297, DOI 10.1111/j.1600-0528.1987.tb01738.x; Marino R, 2012, COMMUNITY DENT HLTH, V29, P302, DOI 10.1922/CDH_2893Marino07; McLoone P., 2004, CARSTAIRS SCORES SCO; Morgan M, 2012, COMMUNITY DENT ORAL, V40, P117, DOI 10.1111/j.1600-0528.2012.00730.x; National Institute for Health and Clinical Excellence (NICE), 2010, SED CHILDR YOUNG PEO; NDIP, NAT DENT INSP PROGR; NHS Scotland, CHILDSM 2013; Office of Manpower Statistics, 2001, OFF MANP STAT REP; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; PSSRU, 2012, UN COSTS HLTH SOC CA; Scottish Government, SCOTT GOV HLTH SERV; Scottish Government, SCOTT GOV URB RUR CL; Scottish Government, 2011, COMM FUT DEL PUBL SE; SDCEP, SCOTT DENT CLIN EFF; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; SHBDEP, SCOTT HLTH BOARDS DE; Taylor M., 2013, ANN REP CHIEF DENT O; Turner S, 2010, BRIT DENT J, V209, P79, DOI 10.1038/sj.bdj.2010.629; U.S. Department of Health and Human Services, 2000, OR HLTH AM REP SURG; Yee Robert, 2004, Community Dent Health, V21, P265	45	27	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136211	10.1371/journal.pone.0136211	http://dx.doi.org/10.1371/journal.pone.0136211			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305577	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000359995500051
J	Dorado-Garcia, A; Graveland, H; Bos, MEH; Verstappen, KM; Van Cleef, BAGL; Kluytmans, JAJW; Wagenaar, JA; Heederik, DJJ				Dorado-Garcia, Alejandro; Graveland, Haitske; Bos, Marian E. H.; Verstappen, Koen M.; Van Cleef, Brigitte A. G. L.; Kluytmans, Jan A. J. W.; Wagenaar, Jaap A.; Heederik, Dick J. J.			Effects of Reducing Antimicrobial Use and Applying a Cleaning and Disinfection Program in Veal Calf Farming: Experiences from an Intervention Study to Control Livestock-Associated MRSA	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PREVALENCE; SENSITIVITY; BOVINE; GENES	With the ultimate aim of containing the emergence of resistant bacteria, a Dutch policy was set in place in 2010 promoting a reduction of antimicrobial use (AMU) in food-producing animals. In this context, a study evaluated strategies to curb livestock-associated methicillin resistant Staphylococcus aureus (LA-MRSA). Fifty-one veal calf farms were assigned to one of 3 study arms: RAB farms reducing antimicrobials by protocol; RAB-CD farms reducing antimicrobials by protocol and applying a cleaning and disinfection program; and Control farms without interventions. MRSA carriage was tested in week 0 and week 12 of 2 consecutive production cycles in farmers, family members and veal calves. Interventions were validated and a cyclic rise in MRSA-prevalence in animals was shown with a more moderate increase in RAB farms. Prevalence in humans declined parallel over time in the study arms but RAB farms were at the lowest MRSA levels from the beginning of the study. In RAB-CD farms, human and animal prevalence did not differ from Control farms and MRSA air loads were significantly higher than in the other study arms. Mimicking the national trend, an overall AMU decrease (daily dosages per animal per cycle (DDDA/C)) was observed over 4 pre-study and the 2 study cycles; this trend did not have a significant effect on a set of evaluated farm technical parameters. AMU was positively associated with MRSA across study arms (ORs per 10 DDDA/C increase = 1.26 for both humans (p = 0.07) and animals (p = 0.12 in first cycle)). These results suggest that AMU reduction might be a good strategy for curbing MRSA in veal calf farming, however the specific cleaning and disinfecting program in RAB-CD farms was not effective. The drop in MRSA prevalence in people during the study could be attributed to the observed long-term AMU decreasing trend.	[Dorado-Garcia, Alejandro; Bos, Marian E. H.; Heederik, Dick J. J.] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [Dorado-Garcia, Alejandro; Graveland, Haitske; Verstappen, Koen M.; Wagenaar, Jaap A.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Van Cleef, Brigitte A. G. L.; Kluytmans, Jan A. J. W.] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Van Cleef, Brigitte A. G. L.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, NL-3720 BA Bilthoven, Netherlands; [Kluytmans, Jan A. J. W.] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands; [Wagenaar, Jaap A.] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands	Utrecht University; Utrecht University; Amphia Hospital; Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; Wageningen University & Research	Dorado-Garcia, A (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands.	a.doradogarcia@uu.nl		Dorado-Garcia, Alejandro/0000-0003-4981-6927; Heederik, Dick/0000-0002-4550-1437	Dutch Product Boards for Livestock, Meat and Eggs; Dutch Ministry of Agriculture, Nature and Food Quality (ZonMw) [125020009]	Dutch Product Boards for Livestock, Meat and Eggs; Dutch Ministry of Agriculture, Nature and Food Quality (ZonMw)	The study was supported by the Dutch Product Boards for Livestock, Meat and Eggs and the Dutch Ministry of Agriculture, Nature and Food Quality (ZonMw) (grant number 125020009, recipient JAJWK) (link: http://www.zonmw.nl/nl/projecten/project-detail/methicillin-resistant-staphylococcusaureus-occupational-exposure-dynamics-of-carriageand-associa/algemeen/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Bjorland J, 2005, J CLIN MICROBIOL, V43, P4363, DOI 10.1128/JCM.43.9.4363-4368.2005; Bjorland J, 2001, J CLIN MICROBIOL, V39, P3999, DOI 10.1128/JCM.39.11.3999-4004.2001; Bos MEH, 2016, J EXPO SCI ENV EPID, V26, P263, DOI 10.1038/jes.2014.85; Bos MEH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077525; Bos MEH, 2012, PREV VET MED, V105, P155, DOI 10.1016/j.prevetmed.2012.01.002; Costa Sofia Santos, 2013, Open Microbiol J, V7, P59, DOI 10.2174/1874285801307010059; Cowling DW, 1999, PREV VET MED, V39, P211, DOI 10.1016/S0167-5877(98)00131-7; Dorado-Garcia A, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2013-003272, DOI 10.1136/BMJ0PEN-2013-003272]; Dorado-Garcia A, 2015, EMERG INFECT DIS, V21, P950, DOI 10.3201/eid2106.140706; [Dutch Food and Consumer Product Safety Authority (NVWA) Central Veterinary institute of Wageningen University], 2014, MON ANT RES ANT US A; [Dutch National Institute for Public Health and the Environment (RIVM) Dutch Working Party on Antibiotic Policy (SWAB)], 2014, NETHMAP 2014 CONS AN; Graveland H, 2012, PREV VET MED, V107, P180, DOI 10.1016/j.prevetmed.2012.06.006; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Graveland H, 2009, VET MICROBIOL, V139, P121, DOI 10.1016/j.vetmic.2009.05.019; Hamscher G, 2003, ENVIRON HEALTH PERSP, V111, P1590, DOI 10.1289/ehp.6288; Jordan D, 2005, PREV VET MED, V70, P59, DOI 10.1016/j.prevetmed.2005.02.013; Munoz-Zanzi C, 2006, PREV VET MED, V74, P309, DOI 10.1016/j.prevetmed.2005.12.006; Noss I, 2008, APPL ENVIRON MICROB, V74, P5621, DOI 10.1128/AEM.00619-08; Slingerland BCGC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048896; The Netherlands Veterinary Medicines Authority (SDa), 2014, US ANT AGR LIV NETH; van Cleef BAGL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073096; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wageningen UR, MON ANT RES ANT US A; Zhang M, 2011, J HOSP INFECT, V78, P113, DOI 10.1016/j.jhin.2011.02.018	29	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135826	10.1371/journal.pone.0135826	http://dx.doi.org/10.1371/journal.pone.0135826			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305895	Green Published, gold			2022-12-27	WOS:000359995500036
J	Mao, YH; Ma, JC; Li, F; Hu, Z; Wang, HH				Mao, Ya-Hui; Ma, Jin-Cheng; Li, Feng; Hu, Zhe; Wang, Hai-Hong			Ralstonia solanacearum RSp0194 Encodes a Novel 3-Keto-Acyl Carrier Protein Synthase III	PLOS ONE			English	Article							FATTY-ACID BIOSYNTHESIS; PSEUDOMONAS-AERUGINOSA; GENOME SEQUENCE; LIPOIC ACID; FABH; IDENTIFICATION; SYNTHETASE; EXPRESSION; DIVERSITY; VIRULENCE	Fatty acid synthesis (FAS), a primary metabolic pathway, is essential for survival of bacteria. Ralstonia solanacearum, a beta-proteobacteria member, causes a bacterial wilt affecting more than 200 plant species, including many economically important plants. However, thus far, the fatty acid biosynthesis pathway of R. solanacearum has not been well studied. In this study, we characterized two forms of 3-keto-ACP synthase III, RsFabH and RsFabW, in R. solanacearum. RsFabH, the homologue of Escherichia coli FabH, encoded by the chromosomal RSc1050 gene, catalyzes the condensation of acetyl-CoA with malonyl-ACP in the initiation steps of fatty acid biosynthesis in vitro. The RsfabH mutant lost de novo fatty acid synthetic ability, and grows in medium containing free fatty acids. RsFabW, a homologue of Pseudomonas aeruginosa PA3286, encoded by a megaplasmid gene, RSp0194, condenses acyl-CoA (C-2-CoA to C-10-CoA) with malonyl-ACP to produce 3-keto-acyl-ACP in vitro. Although the RsfabW mutant was viable, RsfabWwas responsible for RsfabH mutant growth on medium containing free fatty acids. Our results also showed that RsFabW could condense acyl-ACP (C-4-ACP to C-8-ACP) with malonyl-ACP, to produce 3-keto-acyl-ACP in vitro, which implies that RsFabW plays a special role in fatty acid synthesis of R. solanacearum. All of these data confirm that R. solanacearum not only utilizes acetyl-CoA, but also, utilizes medium-chain acyl-CoAs or acyl-ACPs as primers to initiate fatty acid synthesis.	[Mao, Ya-Hui; Ma, Jin-Cheng; Li, Feng; Hu, Zhe; Wang, Hai-Hong] South China Agr Univ, Coll Life Sci, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University	Wang, HH (corresponding author), South China Agr Univ, Coll Life Sci, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou 510642, Guangdong, Peoples R China.	wanghh36@scau.edu.cn			National Natural Science Foundation of China [31200028, 31471743]; National Key Project for Basic Research of China [20104404110005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project for Basic Research of China(National Basic Research Program of China)	National Natural Science Foundation of China: 31200028 J-CM, 31471743 H-HW. National Key Project for Basic Research of China: 20104404110005 H-HW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi HK, 2012, MOL MICROBIOL, V83, P840, DOI 10.1111/j.1365-2958.2012.07968.x; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; Chen N, 2012, PLOS ONE, P7, DOI [10.1371/journal.pone.0042519, DOI 10.1371/J0URNAL.P0NE.0042519]; Cheng JL, 2012, APPL ENVIRON MICROB, V78, P1563, DOI 10.1128/AEM.07335-11; Choi KH, 2000, J BACTERIOL, V182, P365, DOI 10.1128/JB.182.2.365-370.2000; Cronan JE, 2005, ADV MICROB PHYSIOL, V50, P103, DOI 10.1016/S0065-2911(05)50003-1; Flavier AB, 1997, MOL MICROBIOL, V26, P251, DOI 10.1046/j.1365-2958.1997.5661945.x; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; HEATH RJ, 1995, J BIOL CHEM, V270, P15531, DOI 10.1074/jbc.270.26.15531; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Heath RJ, 2001, PROG LIPID RES, V40, P467, DOI 10.1016/S0163-7827(01)00012-1; Isabella VM, 2011, MOL MICROBIOL, V82, P489, DOI 10.1111/j.1365-2958.2011.07826.x; Jiang YF, 2006, BIOCHEMISTRY-US, V45, P10008, DOI 10.1021/bi060842w; Jiang YF, 2010, BIOCHEMISTRY-US, V49, P718, DOI 10.1021/bi901890a; Khan SR, 2008, APPL ENVIRON MICROB, V74, P5053, DOI 10.1128/AEM.01098-08; Lai CY, 2003, J BIOL CHEM, V278, P51494, DOI 10.1074/jbc.M308638200; Li ZF, 2011, J BACTERIOL, V193, P6088, DOI 10.1128/JB.06009-11; Lin S, 2012, J BIOL CHEM, V287, P37010, DOI 10.1074/jbc.M112.410290; Lin S, 2011, MOL BIOSYST, V7, P1811, DOI 10.1039/c1mb05022b; Lu YJ, 2004, BIOCHEM CELL BIOL, V82, P145, DOI 10.1139/o03-076; Marrakchi H, 2002, BIOCHEM SOC T, V30, P1050, DOI 10.1042/bst0301050; Mole BM, 2007, TRENDS MICROBIOL, V15, P363, DOI 10.1016/j.tim.2007.06.005; Revill WP, 2001, J BACTERIOL, V183, P3526, DOI 10.1128/JB.183.11.3526-3530.2001; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Singh AK, 2009, FEMS MICROBIOL LETT, V301, P188, DOI 10.1111/j.1574-6968.2009.01814.x; STEAD DE, 1992, INT J SYST BACTERIOL, V42, P281, DOI 10.1099/00207713-42-2-281; Wang HH, 2003, J BACTERIOL, V185, P4930, DOI 10.1128/JB.185.16.4930-4937.2003; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Yoshimochi T, 2009, J BACTERIOL, V191, P3424, DOI 10.1128/JB.01113-08; Yuan YQ, 2012, J BACTERIOL, V194, P5171, DOI 10.1128/JB.00792-12; Yuan YQ, 2012, J BACTERIOL, V194, P5185, DOI 10.1128/JB.00860-12; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zhao X, 2005, BIOCHEMISTRY-US, V44, P16737, DOI 10.1021/bi051865y; Zhu L, 2013, MBIO, V4, DOI 10.1128/mBio.00613-13; Zhu L, 2010, ANTIMICROB AGENTS CH, V54, P689, DOI 10.1128/AAC.01152-09	36	15	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136261	10.1371/journal.pone.0136261	http://dx.doi.org/10.1371/journal.pone.0136261			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305336	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500057
J	Milanovic, Z; Pantelic, S; Sporis, G; Mohr, M; Krustrup, P				Milanovic, Zoran; Pantelic, Sasa; Sporis, Goran; Mohr, Magni; Krustrup, Peter			Health-Related Physical Fitness in Healthy Untrained Men: Effects on VO(2)max, Jump Performance and Flexibility of Soccer and Moderate-Intensity Continuous Running	PLOS ONE			English	Article							PHYSIOLOGICAL-RESPONSE; RECREATIONAL FOOTBALL; AEROBIC CAPACITY; BODY-COMPOSITION; ACTIVITY PROFILE; EXERCISE; ENDURANCE; STRENGTH; MORTALITY; PROGRAM	The purpose of this study was to determine the effects of recreational soccer (SOC) compared to moderate-intensity continuous running (RUN) on all health-related physical fitness components in healthy untrained men. Sixty-nine participants were recruited and randomly assigned to one of three groups, of which sixty-four completed the study: a soccer training group (SOC; n = 20, 34 +/- 4 (means +/- SD) years, 78.1 +/- 8.3 kg, 179 +/- 4 cm); a running group (RUN; n = 21, 32 +/- 4 years, 78.0 +/- 5.5 kg, 179 +/- 7 cm); or a passive control group (CON; n = 23, 30 +/- 3 years, 76.6 +/- 12.0 kg, 178 +/- 8 cm). The training intervention lasted 12 weeks and consisted of three 60-min sessions per week. All participants were tested for each of the following physical fitness components: maximal aerobic power, minute ventilation, maximal heart rate, squat jump (SJ), countermovement jump with arm swing (CMJ), sit-and-reach flexibility, and body composition. Over the 12 weeks, VO(2)max relative to body weight increased more (p<0.05) in SOC (24.2%, ES = 1.20) and RUN (21.5%, ES = 1.17) than in CON (-5.0%, ES = -0.24), partly due to large changes in body mass (-5.9, -5.7 and +2.6 kg, p<0.05 for SOC, RUN and CON, respectively). Over the 12 weeks, SJ and CMJ performance increased more (p<0.05) in SOC (14.8 and 12.1%, ES = 1.08 and 0.81) than in RUN (3.3 and 3.0%, ES = 0.23 and 0.19) and CON (0.3 and 0.2%), while flexibility also increased more (p<0.05) in SOC (94%, ES = 0.97) than in RUN and CON (0-2%). In conclusion, untrained men displayed marked improvements in maximal aerobic power after 12 weeks of soccer training and moderate-intensity running, partly due to large decreases in body mass. Additionally soccer training induced pronounced positive effects on jump performance and flexibility, making soccer an effective broad-spectrum fitness training intervention.	[Milanovic, Zoran; Pantelic, Sasa] Univ Nis, Fac Sport & Phys Educ, Nish, Serbia; [Sporis, Goran] Univ Zagreb, Fac Kinesiol, Zagreb 41000, Croatia; [Mohr, Magni; Krustrup, Peter] Univ Exeter, Coll Life & Environm Sci, Sport & Hlth Sci, Exeter, Devon, England; [Mohr, Magni] Univ Gothenburg, Dept Food & Nutr & Sport Sci, Ctr Hlth & Human Performance, Gothenburg, Sweden; [Mohr, Magni] Univ Faroe Isl, Fac Nat & Hlth Sci, Torshavn, Faroe Islands, Denmark; [Krustrup, Peter] Univ Copenhagen, Copenhagen Ctr Team Sport & Hlth, Dept Nutr Exercise & Sports, Copenhagen, Denmark	University of Nis; University of Zagreb; University of Zagreb, Faculty of Kinesiology; University of Exeter; University of Gothenburg; University of Copenhagen	Milanovic, Z (corresponding author), Univ Nis, Fac Sport & Phys Educ, Nish, Serbia.	zoooro_85@yahoo.com	Sporiš, Goran/AAB-6582-2020; Milanovic, Zoran/ABE-5835-2020; Krustrup, Peter/D-2659-2019	Milanovic, Zoran/0000-0002-3224-0506; Krustrup, Peter/0000-0002-1461-9838; Sporis, Goran/0000-0002-8372-7728; Pantelic, Sasa/0000-0002-4356-1874				ACSM, 2013, ACSMS HEALTH RELATED; Armstrong L, 2006, ACSMS GUIDELINES FOR; Bacon AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073182; Bangsbo J., 2006, J EXERC SCI FIT; Barene S, 2014, J SPORT SCI, V32, P1539, DOI 10.1080/02640414.2014.906043; Boutcher Stephen H, 2011, J Obes, V2011, P868305, DOI 10.1155/2011/868305; Chen W, 2002, Obes Rev, V3, P225, DOI 10.1046/j.1467-789X.2002.00064.x; Chtara M, 2005, BRIT J SPORT MED, V39, P555, DOI 10.1136/bjsm.2004.015248; Ciolac EG, 2010, HYPERTENS RES, V33, P836, DOI 10.1038/hr.2010.72; Donnelly JE, 2013, OBESITY, V21, pE219, DOI 10.1002/oby.20145; Gist NH, 2014, SPORTS MED, V44, P269, DOI 10.1007/s40279-013-0115-0; Gormley SE, 2008, MED SCI SPORT EXER, V40, P1336, DOI 10.1249/MSS.0b013e31816c4839; Helge EW, 2010, SCAND J MED SCI SPOR, V20, P31, DOI 10.1111/j.1600-0838.2010.01107.x; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hottenrott K, 2012, J SPORT SCI MED, V11, P483; Jakobsen MD, 2011, EUR J APPL PHYSIOL, V111, P521, DOI 10.1007/s00421-010-1669-2; Kallerud H, 2013, SPORTS MED, V43, P733, DOI 10.1007/s40279-013-0053-x; Krustrup P, 2010, SCAND J MED SCI SPOR, V20, P132, DOI 10.1111/j.1600-0838.2010.01106.x; Krustrup P, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01108.x; Krustrup P, 2009, BRIT J SPORT MED, V43, P825, DOI 10.1136/bjsm.2008.053124; Krustrup P, 2006, MED SCI SPORT EXER, V38, P1165, DOI 10.1249/01.mss.0000222845.89262.cd; Krustrup P, 2010, EUR J APPL PHYSIOL, V108, P1247, DOI 10.1007/s00421-009-1319-8; Lee DC, 2011, CIRCULATION, V124, P2483, DOI 10.1161/CIRCULATIONAHA.111.038422; Lee DC, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/1359786810382057; Lo MS, 2011, J STRENGTH COND RES, V25, P2246, DOI 10.1519/JSC.0b013e3181e8a4be; Midgley AW, 2006, SPORTS MED, V36, P117, DOI 10.2165/00007256-200636020-00003; Milanovic Z, 2015, CONTINUOUS ENDURANCE; Milanovic Z, 2015, SPORTS MED, V45, P1469, DOI 10.1007/s40279-015-0365-0; Milanovic Z, 2012, HEALTHMED, V6, P2171; Mohr M, 2014, SCAND J MED SCI SPOR, V24, P36, DOI 10.1111/sms.12278; Nader GA, 2006, MED SCI SPORT EXER, V38, P1965, DOI 10.1249/01.mss.0000233795.39282.33; Nybo L, 2010, MED SCI SPORT EXER, V42, P1951, DOI 10.1249/MSS.0b013e3181d99203; Osei-Tutu KB, 2005, PREV MED, V40, P92, DOI 10.1016/j.ypmed.2004.05.005; Pedersen MT, 2009, J STRENGTH COND RES, V23, P2621, DOI 10.1519/JSC.0b013e3181c701b6; Pietrobelli A, 2004, EUR J CLIN NUTR, V58, P1479, DOI 10.1038/sj.ejcn.1601993; Randers MB, 2014, SCAND J MED SCI SPOR, V24, P130, DOI 10.1111/sms.12232; Randers MB, 2010, SCAND J MED SCI SPOR, V20, P80, DOI 10.1111/j.1600-0838.2010.01091.x; Randers MB, 2010, SCAND J MED SCI SPOR, V20, P14, DOI 10.1111/j.1600-0838.2010.01069.x; Randers MB, 2012, EUR J APPL PHYSIOL, V112, P2097, DOI 10.1007/s00421-011-2171-1; Rech CR, 2008, ARQ BRAS ENDOCRINOL, V52, P1163, DOI 10.1590/S0004-27302008000700013; Rodiguez A, 2015, J SPORTS MED PHYS FI; Skelly LE, 2014, APPL PHYSIOL NUTR ME, V39, P845, DOI 10.1139/apnm-2013-0562; Sporis G, 2011, J STRENGTH COND RES, V25, P1168, DOI 10.1519/JSC.0b013e3181cc2334; Trapp EG, 2008, INT J OBESITY, V32, P684, DOI 10.1038/sj.ijo.0803781; Tremblay A, 2004, BRIT J NUTR, V92, pS63, DOI 10.1079/BJN20041144; Weston M, 2014, SPORTS MED, V44, P1005, DOI 10.1007/s40279-014-0180-z; Wisloff U, 2004, BRIT J SPORT MED, V38, P285, DOI 10.1136/bjsm.2002.002071	47	23	25	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135319	10.1371/journal.pone.0135319	http://dx.doi.org/10.1371/journal.pone.0135319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305880	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500018
J	Shinzato, T; Yasuda, M				Shinzato, Takashi; Yasuda, Muneki			Belief Propagation Algorithm for Portfolio Optimization Problems	PLOS ONE			English	Article								The typical behavior of optimal solutions to portfolio optimization problems with absolute deviation and expected shortfall models using replica analysis was pioneeringly estimated by S. Ciliberti et al. [Eur. Phys. B. 57, 175 (2007)]; however, they have not yet developed an approximate derivation method for finding the optimal portfolio with respect to a given return set. In this study, an approximation algorithm based on belief propagation for the portfolio optimization problem is presented using the Bethe free energy formalism, and the consistency of the numerical experimental results of the proposed algorithm with those of replica analysis is confirmed. Furthermore, the conjecture of H. Konno and H. Yamazaki, that the optimal solutions with the absolute deviation model and with the mean- variance model have the same typical behavior, is verified using replica analysis and the belief propagation algorithm.	[Shinzato, Takashi] Hitotsubashi Univ, Mori Arinori Ctr Higher Educ & Global Mobil, Kunitachi, Tokyo 186, Japan; [Yasuda, Muneki] Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata, Japan	Hitotsubashi University; Yamagata University	Shinzato, T (corresponding author), Hitotsubashi Univ, Mori Arinori Ctr Higher Educ & Global Mobil, Kunitachi, Tokyo 186, Japan.	takashi.shinzato@r.hit-u.ac.jp		Shinzato, Takashi/0000-0001-9719-454X	Akita prefectural university; National Institute of Informatics, Japan [50]; Japan Institute of Life Insurance; Kyoto university institute of economic research foundation; Zengin Foundation for Studies on Economics and Finance [1414]; institute of statistical mathematics [2068]; Kampo foundation;  [24710169];  [15K20999]; Grants-in-Aid for Scientific Research [15H03699] Funding Source: KAKEN	Akita prefectural university; National Institute of Informatics, Japan; Japan Institute of Life Insurance; Kyoto university institute of economic research foundation; Zengin Foundation for Studies on Economics and Finance; institute of statistical mathematics; Kampo foundation; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Young Scientists (B) Research Project Number: 24710169, https://kaken.nii.ac.jp/d/p/24710169.en.html 2. Akita prefectural university, (2014). President project for young scientists 3. Grant-in-Aid for Young Scientists (B) Research Project Number: 15K20999, https://kaken.nii.ac.jp/d/p/15K20999.en.html 4. The National Institute of Informatics, Japan, (2014). Research Project Number: 50, http://www.nii.ac.jp/kenkyou/files/b/1234/kyoudoukenkyu_ichiran/h26_ichiran.pdf 5. Japan Institute of Life Insurance, (2015). Research Project Number: 5, http://www.jili.or.jp/pdf/150604.pdf 6. Kyoto university institute of economic research foundation, (2015). http://www.fd.kier.kyoto-u.ac.jp/grant/grant.html 7. Zengin Foundation for Studies on Economics and Finance, (2015). Research Project Number: 1414, http://www.jade.dti.ne.jp/bankfund/table2014.pdf 8. The institute of statistical mathematics, (2015). Research Project Number: 2068, http://kyodo.ism.ac.jp/public_system/member/saitaku-kadai.php?n=H27 9. Kampo foundation, (2015). Research Project Number: 2, http://www.kampozaidan.or.jp/CL01_02/185_S1.pdf.	Cakmak B, 2014, INFO THEOR WORKSH, P192, DOI 10.1109/ITW.2014.6970819; Ciliberti S, 2007, EUR PHYS J B, V57, P175, DOI 10.1140/epjb/e2007-00130-7; Kabashima Y, 2005, J PHYS SOC JPN, V74, P2133, DOI 10.1143/JPSJ.74.2133; KONNO H, 1991, MANAGE SCI, V37, P519, DOI 10.1287/mnsc.37.5.519; Markowitz H. M., 1959, PORTFOLIO SELECTION; Minka T. P., 2001, P 17 C UNC ART INT, P362; Opper M, 2001, PHYS REV LETT, V86, P3695, DOI 10.1103/PhysRevLett.86.3695; Opper M, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.056131; Shinzato T., 2015, PLOS ONE, DOI [10.1371/journal.pone.0133846, DOI 10.1371/J0URNAL.P0NE.0133846]; Shinzato T, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/32/324013	10	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0134968	10.1371/journal.pone.0134968	http://dx.doi.org/10.1371/journal.pone.0134968			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305462	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500014
J	Sung, DK; Chang, YS; Ahn, SY; Sung, SI; Yoo, HS; Choi, SJ; Kim, SY; Park, WS				Sung, Dong Kyung; Chang, Yun Sil; Ahn, So Yoon; Sung, Se In; Yoo, Hye Soo; Choi, Soo Jin; Kim, Soo Yoon; Park, Won Soon			Optimal Route for Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation to Protect Against Neonatal Hyperoxic Lung Injury: Gene Expression Profiles and Histopathology	PLOS ONE			English	Article							INTRATRACHEAL TRANSPLANTATION; BRONCHOPULMONARY DYSPLASIA; ANIMAL-MODELS; GROWTH; RATS	The aim of this study was to determine the optimal route of mesenchymal stem cell (MSC) transplantation. To this end, gene expression profiling was performed to compare the effects of intratracheal (IT) versus intravenous (IV) MSC administration. Furthermore, the therapeutic efficacy of each route to protect against neonatal hyperoxic lung injury was also determined. Newborn Sprague-Dawley rats were exposed to hyperoxia (90% oxygen) from birth for 14 days. Human umbilical cord blood-derived MSCs labeling with PKH26 were transplanted through either the IT (5x10(5)) or IV (2x10(6)) route at postnatal day (P) 5. At P14, lungs were harvested for histological, biochemical and microarray analyses. Hyperoxic conditions induced an increase in the mean linear intercept and mean alveolar volume (MAV), indicative of impaired alveolarization. The number of ED-1 positive cells was significantly decreased by both IT and IV transplantations. However, IT administration of MSCs resulted in a greater decrease in MAV and ED-1 positive cells compared to IV administration. Moreover, the number of TUNEL-positive cells was significantly decreased in the IT group, but not in the IV group. Although the IT group received only one fourth of the number of MSCs that the IV group did, a significantly higher number of donor cell-derived red PKH 26 positivity were recovered in the IT group. Hyperoxic conditions induced the up regulation of genes associated with the inflammatory response, such as macrophage inflammatory protein-1 alpha, tumor necrosis factor-alpha and inter leukin-6; genes associated with cell death, such as p53 and caspases; and genes associated with fibrosis, such as connective tissue growth factor. In contrast, hyperoxic conditions induced the dwon-regulation of vascular endothelial growth factor and hepatocyte growth factor. These hyperoxia-induced changes in gene expression were decreased in the IT group, but not in the IV group. Thus, local IT MSC transplantation was more effective than systemic IV MSC administration in protecting against neonatal hyperoxic lung injury.	[Sung, Dong Kyung; Chang, Yun Sil; Ahn, So Yoon; Sung, Se In; Yoo, Hye Soo; Park, Won Soon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea; [Chang, Yun Sil; Ahn, So Yoon; Kim, Soo Yoon; Park, Won Soon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Biomed Res Inst, Seoul, South Korea; [Choi, Soo Jin] MEDIPOST Co Ltd, Biomed Res Inst, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; MEDIPOST	Park, WS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea.	ws123.park@samsung.com			Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A121968]; MEDIPOST Co., Ltd.	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; MEDIPOST Co., Ltd.	This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A121968). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 'MEDIPOST Co., Ltd.,' provided support in the form of salaries for author Soo Jin Choi, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author (Soo Jin Choi) are articulated in the 'author contributions' section.	Ahn SY, 2013, YONSEI MED J, V54, P416, DOI 10.3349/ymj.2013.54.2.416; Ahn SY, 2013, STROKE, V44, P497, DOI 10.1161/STROKEAHA.112.679092; Ahn SY, 2015, CYTOTHERAPY; Aslam M, 2009, AM J RESP CRIT CARE, V180, P1122, DOI 10.1164/rccm.200902-0242OC; Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; Bhandari A, 2006, SEMIN PERINATOL, V30, P219, DOI 10.1053/j.semperi.2006.05.009; Bhandari V, 2006, FREE RADICAL BIO MED, V41, P4, DOI 10.1016/j.freeradbiomed.2006.01.027; Bland RD, 2005, BIOL NEONATE, V88, P181, DOI 10.1159/000087581; BUCHER JR, 1981, PEDIATR RES, V15, P999, DOI 10.1203/00006450-198107000-00005; Chang YS, 2014, AM J RESP CELL MOL, V51, P391, DOI 10.1165/rcmb.2013-0385OC; Chang YS, 2014, J PEDIATR-US, V164, P966, DOI 10.1016/j.jpeds.2013.12.011; Chang YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052419; Chang YS, 2011, CELL TRANSPLANT, V20, P1843, DOI 10.3727/096368911X565038; Chang YS, 2009, CELL TRANSPLANT, V18, P869, DOI 10.3727/096368909X471189; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; Grisafi D, 2013, PEDIATR PULM, V48, P1070, DOI 10.1002/ppul.22791; Herault O, 2001, CYTOMETRY, V45, P277, DOI 10.1002/1097-0320(20011201)45:4<277::AID-CYTO10017>3.0.CO;2-#; Jang YK, 2006, ANN HEMATOL, V85, P212, DOI 10.1007/s00277-005-0047-3; O'Reilly M, 2014, AM J PHYSIOL-LUNG C, V307, pL948, DOI 10.1152/ajplung.00160.2014; Prockop DJ, 2012, J CELL BIOCHEM, V113, P1460, DOI 10.1002/jcb.24046; Yang SE, 2004, CYTOTHERAPY, V6, P476, DOI 10.1080/14653240410005041	21	39	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135574	10.1371/journal.pone.0135574	http://dx.doi.org/10.1371/journal.pone.0135574			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305093	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500028
J	Liao, KP; Ananthakrishnan, AN; Kumar, V; Xia, ZQ; Cagan, A; Gainer, VS; Goryachev, S; Chen, P; Savova, GK; Agniel, D; Churchill, S; Lee, JY; Murphy, SN; Plenge, RM; Szolovits, P; Kohane, I; Shaw, SY; Karlson, EW; Cai, TX				Liao, Katherine P.; Ananthakrishnan, Ashwin N.; Kumar, Vishesh; Xia, Zongqi; Cagan, Andrew; Gainer, Vivian S.; Goryachev, Sergey; Chen, Pei; Savova, Guergana K.; Agniel, Denis; Churchill, Susanne; Lee, Jaeyoung; Murphy, Shawn N.; Plenge, Robert M.; Szolovits, Peter; Kohane, Isaac; Shaw, Stanley Y.; Karlson, Elizabeth W.; Cai, Tianxi			Methods to Develop an Electronic Medical Record Phenotype Algorithm to Compare the Risk of Coronary Artery Disease across 3 Chronic Disease Cohorts	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; HEALTH RECORDS; PREDICTION; EQUIVALENT; EVENTS; ONSET	Background Typically, algorithms to classify phenotypes using electronic medical record (EMR) data were developed to perform well in a specific patient population. There is increasing interest in analyses which can allow study of a specific outcome across different diseases. Such a study in the EMR would require an algorithm that can be applied across different patient populations. Our objectives were: (1) to develop an algorithm that would enable the study of coronary artery disease (CAD) across diverse patient populations; (2) to study the impact of adding narrative data extracted using natural language processing (NLP) in the algorithm. Additionally, we demonstrate how to implement CAD algorithm to compare risk across 3 chronic diseases in a preliminary study. Methods and Results We studied 3 established EMR based patient cohorts: diabetes mellitus (DM, n = 65,099), inflammatory bowel disease (IBD, n = 10,974), and rheumatoid arthritis (RA, n = 4,453) from two large academic centers. We developed a CAD algorithm using NLP in addition to structured data (e.g. ICD9 codes) in the RA cohort and validated it in the DM and IBD cohorts. The CAD algorithm using NLP in addition to structured data achieved specificity >95% with a positive predictive value (PPV) 90% in the training (RA) and validation sets (IBD and DM). The addition of NLP data improved the sensitivity for all cohorts, classifying an additional 17% of CAD subjects in IBD and 10% in DM while maintaining PPV of 90%. The algorithm classified 16,488 DM (26.1%), 457 IBD (4.2%), and 245 RA (5.0%) with CAD. In a cross-sectional analysis, CAD risk was 63% lower in RA and 68% lower in IBD compared to DM(p<0.0001) after adjusting for traditional cardiovascular risk factors. Conclusions We developed and validated a CAD algorithm that performed well across diverse patient populations. The addition of NLP into the CAD algorithm improved the sensitivity of the algorithm, particularly in cohorts where the prevalence of CAD was low. Preliminary data suggest that CAD risk was significantly lower in RA and IBD compared to DM.	[Liao, Katherine P.; Plenge, Robert M.; Karlson, Elizabeth W.] Brigham & Womens Hosp, Div Rheumatol, 75 Francis St, Boston, MA 02115 USA; [Liao, Katherine P.; Ananthakrishnan, Ashwin N.; Kumar, Vishesh; Xia, Zongqi; Savova, Guergana K.; Murphy, Shawn N.; Plenge, Robert M.; Kohane, Isaac; Shaw, Stanley Y.; Karlson, Elizabeth W.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Ananthakrishnan, Ashwin N.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Kumar, Vishesh; Shaw, Stanley Y.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Xia, Zongqi] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Cagan, Andrew; Gainer, Vivian S.; Goryachev, Sergey] Partners Healthcare, Res Comp, Charlestown, MA 02125 USA; [Chen, Pei; Savova, Guergana K.; Kohane, Isaac; Cai, Tianxi] Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA 02115 USA; [Agniel, Denis] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Churchill, Susanne] Partners Healthcare Informat Syst, Boston, MA 02115 USA; [Lee, Jaeyoung] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Murphy, Shawn N.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Plenge, Robert M.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Szolovits, Peter] MIT, CSAIL, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Partners Healthcare System; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Partners Healthcare System; Tufts University; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT)	Liao, KP (corresponding author), Brigham & Womens Hosp, Div Rheumatol, 75 Francis St, Boston, MA 02115 USA.	kliao@partners.org	Xia, Zongqi/AAX-3091-2020; Xia, Zongqi/AAB-1565-2022	Xia, Zongqi/0000-0003-1500-2589; Xia, Zongqi/0000-0003-1500-2589; Szolovits, Peter/0000-0001-8411-6403	National Institutes of Health (NIH) [U54LM008748]; NIH [K23 DK097142, K08 AR060257, K24 AR052403]; Harold and Duval Bowen Fund; Merck Research Laboratories; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR052403, K08AR060257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK097142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS079493] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harold and Duval Bowen Fund; Merck Research Laboratories(Merck & Company); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	All aspects of this study were funded by the National Institutes of Health (NIH) U54LM008748, Informatics for Integrating Biology and the Bedside Project (i2b2). ANA is supported by NIH K23 DK097142, KPL by NIH K08 AR060257 and the Harold and Duval Bowen Fund and EWK is supported by the NIH K24 AR052403. RMP is currently employed by Merck Research Laboratories. The majority of this study was conducted while RMP was a faculty member at Harvard Medical School and Brigham and Women's Hospital. RMP was employed at Merck during the drafting of the manuscript only. Merck Research Laboratories provided support in the form of salary for author RMP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	Ananthakrishnan AN, 2014, CLIN GASTROENTEROL H, V12, P1905, DOI 10.1016/j.cgh.2014.02.034; Ananthakrishnan AN, 2013, INFLAMM BOWEL DIS, V19, P1411, DOI 10.1097/MIB.0b013e31828133fd; Avina-Zubieta JA, 2012, ANN RHEUM DIS, V71, P1524, DOI 10.1136/annrheumdis-2011-200726; Carroll RJ, 2012, J AM MED INFORM ASSN, V19, pE162, DOI 10.1136/amiajnl-2011-000583; CDC, 2012, AG ADJ PERC PEOP DIA; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Grant RW, 2004, DIABETES CARE, V27, P2299, DOI 10.2337/diacare.27.10.2299; Hivert MF, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-170; Holmqvist ME, 2009, ARTHRITIS RHEUM, V60, P2861, DOI 10.1002/art.24855; John H, 2011, CURR OPIN CARDIOL, V26, P327, DOI 10.1097/HCO.0b013e32834703b5; Johnston RD, 2008, INFLAMM BOWEL DIS, V14, pS4, DOI 10.1002/ibd.20545; Kho AN, 2012, J AM MED INFORM ASSN, V19, P212, DOI 10.1136/amiajnl-2011-000439; Liao KP, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1885; Liao KP, 2010, ARTHRIT CARE RES, V62, P1120, DOI 10.1002/acr.20184; Lindhardsen J, 2011, ANN RHEUM DIS, V70, P929, DOI 10.1136/ard.2010.143396; Naranjo A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2383; Rasmussen LV, 2014, J BIOMED INFORM, V51, P280, DOI 10.1016/j.jbi.2014.06.007; Singh S, 2013, CLIN GASTROENTEROL H; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; The American Heart Association/American College of Cardiology Secondary Prevention Guidelines: ICD-9 Diagnosis Code Definitions for GWTG-CAD, 2009, AM HEART ASS AM COLL; van Halm VP, 2009, ANN RHEUM DIS, V68, P1395, DOI 10.1136/ard.2008.094151; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Xia ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078927; Zeng Qing T, 2006, BMC Med Inform Decis Mak, V6, P30, DOI 10.1186/1472-6947-6-30; Zhang J, 2014, ARTHRITIS RHEUMATOL, V66, pS371; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	26	48	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136651	10.1371/journal.pone.0136651	http://dx.doi.org/10.1371/journal.pone.0136651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301417	Green Submitted, Green Published, gold			2022-12-27	WOS:000359951900079
J	Liu, SH; Erion, G; Novitsky, V; De Gruttola, V				Liu, Shelley H.; Erion, Gabriel; Novitsky, Vladimir; De Gruttola, Victor			Viral Genetic Linkage Analysis in the Presence of Missing Data	PLOS ONE			English	Article							TRANSMISSION NETWORKS; HIV-1; MEN; SEX; DESIGN	Analyses of viral genetic linkage can provide insight into HIV transmission dynamics and the impact of prevention interventions. For example, such analyses have the potential to determine whether recently-infected individuals have acquired viruses circulating within or outside a given community. In addition, they have the potential to identify characteristics of chronically infected individuals that make their viruses likely to cluster with others circulating within a community. Such clustering can be related to the potential of such individuals to contribute to the spread of the virus, either directly through transmission to their partners or indirectly through further spread of HIV from those partners. Assessment of the extent to which individual (incident or prevalent) viruses are clustered within a community will be biased if only a subset of subjects are observed, especially if that subset is not representative of the entire HIV infected population. To address this concern, we develop a multiple imputation framework in which missing sequences are imputed based on a model for the diversification of viral genomes. The imputation method decreases the bias in clustering that arises from informative missingness. Data from a household survey conducted in a village in Botswana are used to illustrate these methods. We demonstrate that the multiple imputation approach reduces bias in the overall proportion of clustering due to the presence of missing observations.	[Liu, Shelley H.; De Gruttola, Victor] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Erion, Gabriel] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Novitsky, Vladimir] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Liu, SH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	shelleyliu@fas.harvard.edu		Erion, Gabriel/0000-0001-8741-131X; Liu, Shelley Han/0000-0003-2171-059X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083036, R37AI051164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM074897] Funding Source: NIH RePORTER; NCI NIH HHS [R35 CA197449] Funding Source: Medline; NIAID NIH HHS [R37 AI051164, R01 AI083036] Funding Source: Medline; NIGMS NIH HHS [T32 GM074897] Funding Source: Medline; PHS HHS [R37 51164] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bezemer D, 2014, AIDS RES HUM RETROV, V30, P118, DOI [10.1089/aid.2013.0171, 10.1089/AID.2013.0171]; Bezemer D, 2010, AIDS, V24, P271, DOI 10.1097/QAD.0b013e328333ddee; Brenner B, 2013, AIDS, V27, P1045, DOI 10.1097/QAD.0b013e32835cffd9; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Carnegie NB, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003430; Central Intelligence Agency, 2013, WORLD FACTBOOK; Chia J, 2014, ONGOING CROSS SPECIE; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; DeGruttola V, 2010, CLIN INFECT DIS, V50, pS102, DOI 10.1086/651480; Delatorre EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041904; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faria N, 2014, MIGRATION HIV 1 SUBT; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gao F, 2004, J VIROL, V78, P2426, DOI 10.1128/JVI.78.5.2426-2433.2004; Grabowski MK, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001610; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; JUKES T H, 1969, P21; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; Leventhal GE, 2014, MOL BIOL EVOL, V31, P6, DOI 10.1093/molbev/mst172; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Little SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098443; Novitsky V, COMMUNICATION; Novitsky V, 2014, AIDS RES HUM RETROV, V30, P1226, DOI 10.1089/aid.2014.0173; Novitsky V, 2010, VIRUSES-BASEL, V2, P33, DOI 10.3390/v2010033; Novitsky V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080589; Rubin D, 1996, JASA, V91, P437; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Schwarz R, 1979, ATLAS PROTEIN SEQUEN, P353, DOI DOI 10.2307/2408678; Stadler T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0198; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Volz EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001568; Volz EM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002947; Volz EM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002552; Volz EM, 2009, GENETICS, V183, P1421, DOI 10.1534/genetics.109.106021; Vrancken B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003505; Wang R, 2014, CLIN TRIALS, V11, P309, DOI 10.1177/1740774514523351; Wertheim JO, 2014, J INFECT DIS, V209, P304, DOI 10.1093/infdis/jit524; Wertheim JO, 2013, J INFECT DIS, V207, P1181, DOI 10.1093/infdis/jit021; Wertheim JO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027775; Ziraba A, 2010, POPULATION HLTH METR, V22	43	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135469	10.1371/journal.pone.0135469	http://dx.doi.org/10.1371/journal.pone.0135469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301919	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900020
J	Sullivan, LC; Westall, GP; Widjaja, JML; Mifsud, NA; Nguyen, THO; Meehan, AC; Kotsimbos, TC; Brooks, AG				Sullivan, Lucy C.; Westall, Glen P.; Widjaja, Jacqueline M. L.; Mifsud, Nicole A.; Nguyen, Thi H. O.; Meehan, Aislin C.; Kotsimbos, Tom C.; Brooks, Andrew G.			The Presence of HLA-E-Restricted, CMV-Specific CD8(+) T Cells in the Blood of Lung Transplant Recipients Correlates with Chronic Allograft Rejection	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; BRONCHIOLITIS-OBLITERANS-SYNDROME; INHIBITORY RECEPTOR; SURFACE EXPRESSION; RECOGNITION; LYMPHOCYTES; CD94/NKG2A; PEPTIDES; ANTIGEN; IDENTIFICATION	The human cytomegalovirus (CMV) immune evasion protein, UL40, shares an identical peptide sequence with that found in the leader sequence of many human leukocyte antigen (HLA)-C alleles and when complexed with HLA-E, can modulate NK cell functions via interactions with the CD94-NKG2 receptors. However the UL40-derived sequence can also be immunogenic, eliciting robust CD8+ T cell responses. In the setting of solid organ transplantation these T cells may not only be involved in antiviral immunity but also can potentially contribute to allograft rejection when the UL40 epitope is also present in allograft-encoded HLA. Here we assessed 15 bilateral lung transplant recipients for the presence of HLA-E-restricted UL40 specific T cells by tetramer staining of peripheral blood mononuclear cells (PBMC). UL40-specific T cells were observed in 7 patients post-transplant however the magnitude of the response varied significantly between patients. Moreover, unlike healthy CMV seropositive individuals, longitudinal analyses revealed that proportions of such T cells fluctuated markedly. Nine patients experienced low-grade acute cellular rejection, of which 6 also demonstrated UL40-specific T cells. Furthermore, the presence of UL40-specific CD8(+) T cells in the blood was significantly associated with allograft dysfunction, which manifested as Bronchiolitis Obliterans Syndrome (BOS). Therefore, this study suggests that minor histocompatibility antigens presented by HLA-E can represent an additional risk factor following lung transplantation.	[Sullivan, Lucy C.; Widjaja, Jacqueline M. L.; Brooks, Andrew G.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Westall, Glen P.; Mifsud, Nicole A.; Nguyen, Thi H. O.; Meehan, Aislin C.; Kotsimbos, Tom C.] Monash Univ, Cent Clin Sch, Alfred Ctr, Dept Med, Melbourne, Vic 3004, Australia; [Westall, Glen P.; Mifsud, Nicole A.; Nguyen, Thi H. O.; Meehan, Aislin C.; Kotsimbos, Tom C.] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia	University of Melbourne; Monash University; Florey Institute of Neuroscience & Mental Health	Sullivan, LC (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	lcsull@unimelb.edu.au; agbrooks@unimelb.edu.au	Nguyen, Thi Hoang Oanh/AAM-6827-2021	Nguyen, Thi Hoang Oanh/0000-0002-9294-7693; Widjaja, Jacqueline/0000-0002-4946-5584; Mifsud, Nicole/0000-0001-8647-2102; Sullivan, Lucy/0000-0003-2907-4989; Chen, Peter/0000-0002-5330-1718; Westall, Glen/0000-0002-3711-068X; Brooks, Andrew/0000-0002-4085-9683	National Health and Medical Research Council [APP1016629, APP0509179, GNT0566571]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (nhmrc.gov.au) to AGB, Grant# APP1016629, the National Health and Medical Research Council (nhmrc.gov.au) to AGB, Grant# APP0509179, and the National Health and Medical Research Council (nhmrc.gov.au) to LCS, Grant# GNT0566571. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Carretero M, 1998, EUR J IMMUNOL, V28, P1280, DOI 10.1002/(SICI)1521-4141(199804)28:04<1280::AID-IMMU1280>3.0.CO;2-O; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Garrigue I, 2008, TRANSPLANTATION, V86, P826, DOI 10.1097/TP.0b013e3181859edd; Grimsley C, 2002, TISSUE ANTIGENS, V60, P206, DOI 10.1034/j.1399-0039.2002.600302.x; Heatley SL, 2013, J BIOL CHEM, V288, P8679, DOI 10.1074/jbc.M112.409672; Heinzel AS, 2002, J EXP MED, V196, P1473, DOI 10.1084/jem.20020609; Hoare HL, 2006, NAT IMMUNOL, V7, P256, DOI 10.1038/ni1312; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Llano M, 1998, EUR J IMMUNOL, V28, P2854, DOI 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W; Michaelsson J, 2002, J EXP MED, V196, P1403, DOI 10.1084/jem.20020797; Nattermann J, 2005, AM J PATHOL, V166, P443, DOI 10.1016/S0002-9440(10)62267-5; Nguyen THO, 2010, IMMUNOL CELL BIOL, V88, P676, DOI 10.1038/icb.2010.20; Pietra G, 2003, P NATL ACAD SCI USA, V100, P10896, DOI 10.1073/pnas.1834449100; Pietra G, 2001, EUR J IMMUNOL, V31, P3687, DOI 10.1002/1521-4141(200112)31:12<3687::AID-IMMU3687>3.0.CO;2-C; Romagnani C, 2002, P NATL ACAD SCI USA, V99, P11328, DOI 10.1073/pnas.172369799; Salerno-Goncalves R, 2004, J IMMUNOL, V173, P5852, DOI 10.4049/jimmunol.173.9.5852; Stevens J, 2001, BMC Immunol, V2, P5, DOI 10.1186/1471-2172-2-5; Sullivan LC, 2008, TISSUE ANTI IN PRESS; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; Westall GP, 2003, TRANSPLANTATION, V75, P2064, DOI 10.1097/01.TP.0000069234.04901.A3; Yousem SA, 1996, J HEART LUNG TRANSPL, V15, P1	24	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135972	10.1371/journal.pone.0135972	http://dx.doi.org/10.1371/journal.pone.0135972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302084	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900035
J	Szulwach, KE; Chen, PL; Wang, XH; Wang, J; Weaver, LS; Gonzales, ML; Sun, G; Unger, MA; Ramakrishnan, R				Szulwach, Keith E.; Chen, Peilin; Wang, Xiaohui; Wang, Jing; Weaver, Lesley S.; Gonzales, Michael L.; Sun, Gang; Unger, Marc A.; Ramakrishnan, Ramesh			Single-Cell Genetic Analysis Using Automated Microfluidics to Resolve Somatic Mosaicism	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; COPY NUMBER VARIATION; CLONAL EVOLUTION; SEQUENCING DATA; CANCER; GENOME; MUTATION; NUCLEOTIDE; DISCOVERY; ALIGNMENT	Somatic mosaicism occurs throughout normal development and contributes to numerous disease etiologies, including tumorigenesis and neurological disorders. Intratumor genetic heterogeneity is inherent to many cancers, creating challenges for effective treatments. Unfortunately, analysis of bulk DNA masks subclonal phylogenetic architectures created by the acquisition and distribution of somatic mutations amongst cells. As a result, single-cell genetic analysis is becoming recognized as vital for accurately characterizing cancers. Despite this, methods for single-cell genetics are lacking. Here we present an automated microfluidic workflow enabling efficient cell capture, lysis, and whole genome amplification (WGA). We find that similar to 90% of the genome is accessible in single cells with improved uniformity relative to current single-cell WGA methods. Allelic dropout (ADO) rates were limited to 13.75% and variant false discovery rates (SNV FDR) were 4.11x10(-6), on average. Application to ER-/PR-/HER2+ breast cancer cells and matched normal controls identified novel mutations that arose in a subpopulation of cells and effectively resolved the segregation of known cancer-related mutations with single-cell resolution. Finally, we demonstrate effective cell classification using mutation profiles with 10X average exome coverage depth per cell. Our data demonstrate an efficient automated microfluidic platform for single-cell WGA that enables the resolution of somatic mutation patterns in single cells.	[Szulwach, Keith E.; Chen, Peilin; Wang, Xiaohui; Wang, Jing; Weaver, Lesley S.; Gonzales, Michael L.; Sun, Gang; Unger, Marc A.; Ramakrishnan, Ramesh] Fluidigm Corp, San Francisco, CA 94080 USA		Ramakrishnan, R (corresponding author), Fluidigm Corp, San Francisco, CA 94080 USA.	ramesh.ramakrishnan@fluidigm.com			Fluidigm Corporation	Fluidigm Corporation	All funding was provided by Fluidigm Corporation who provided support in the form of salaries for all authors [KES, PC, XW, JW, LSW, MG, GS, MAU and RR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Bulusu KC, 2014, NUCLEIC ACIDS RES, V42, pD1040, DOI 10.1093/nar/gkt1182; de Bourcy CFA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105585; Ding JR, 2012, BIOINFORMATICS, V28, P167, DOI 10.1093/bioinformatics/btr629; Eirew P, 2015, NATURE, V518, P422, DOI 10.1038/nature13952; Gawad C, 2014, P NATL ACAD SCI USA, V111, P17947, DOI 10.1073/pnas.1420822111; Gole J, 2013, NAT BIOTECHNOL, V31, P1126, DOI 10.1038/nbt.2720; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Lohr JG, 2014, NAT BIOTECHNOL, V32, P479, DOI 10.1038/nbt.2892; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Melchor L, 2014, LEUKEMIA, V28, P1705, DOI 10.1038/leu.2014.13; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Ni XH, 2013, P NATL ACAD SCI USA, V110, P21083, DOI 10.1073/pnas.1320659110; Pan XH, 2008, P NATL ACAD SCI USA, V105, P15499, DOI 10.1073/pnas.0808028105; Potter NE, 2013, GENOME RES, V23, P2115, DOI 10.1101/gr.159913.113; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	30	35	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135007	10.1371/journal.pone.0135007	http://dx.doi.org/10.1371/journal.pone.0135007			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302375	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900011
J	Lei, WW; Guo, XF; Fu, SH; Feng, Y; Nie, K; Song, JD; Li, Y; Ma, XJ; Liang, GD; Zhou, HN				Lei, Wenwen; Guo, Xiaofang; Fu, Shihong; Feng, Yun; Nie, Kai; Song, Jingdong; Li, Yang; Ma, Xuejun; Liang, Guodong; Zhou, Hongning			Isolation of Tibet orbivirus, TIBOV, from Culicoides Collected in Yunnan, China	PLOS ONE			English	Article							VIRUS; MOSQUITOS; CELLS; BORNE	We isolated a novel virus strain (YN12246) from Culicoides spp. specimens collected at the China-Laos-Myanmar border in southern Yunnan Province. This virus had a cytopathic effect (CPE) on both insect cells (C6/36) and mammalian cells (BHK-21). Electron microscopy revealed the structure of the virions to be spherical with a diameter of 75 nm. Polyacrylamide gel analysis demonstrated that the viral genome consisted of 10 segments of double-stranded RNA (dsRNA), with a distribution pattern of 3-3-3-1. The coding sequences of 9 genome segments of YN12246 (Seg1, Seg3-Seg10) were obtained by high-throughput sequencing and Sanger sequencing. Comparisons of conserved genome segments 1 and 3 (Seg1 and Seg3), encoding the polymerase-VP1 and sub-core T2 protein, respectively, showed that YN12246 groups with the Culicoides-borne orbiviruses. The highest levels of sequence identity were detected between YN12246 and Tibet orbivirus (TIBOV), indicating that they belong to the same virus species (with amino acid identity of 98.8% and 96.4% for the polymerase and T2 protein, respectively). The data presented here confirm that YN12246 is a member of the TIBOV species, which was first isolated from mosquitoes in 2009. This is the first report of the isolation of TIBOV from Culicoides.	[Lei, Wenwen; Fu, Shihong; Nie, Kai; Song, Jingdong; Li, Yang; Ma, Xuejun; Liang, Guodong] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Lei, Wenwen; Fu, Shihong; Liang, Guodong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Guo, Xiaofang; Zhou, Hongning] Yunnan Inst Parasit Dis, Puer, Yunnan, Peoples R China; [Feng, Yun] Yunnan Prov Ctr Virus & Rickettsia Res, Yunnan Inst Endem Dis Control & Prevent, Dali, Yunnan, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Yunnan Institute for Endemic Disease Control & Prevention	Liang, GD (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	gdliang@hotmail.com; zhhn@yipd.org	Nie, Kai/L-5389-2019	li, yang/0000-0001-8771-7044	National Natural Science Foundation of China [81290342]; Ministry of Science and Technology, China [2011CB504702]; State Key Laboratory for Infectious Disease Prevention and Control [2014SKLID103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, China(Ministry of Science and Technology, China); State Key Laboratory for Infectious Disease Prevention and Control	This work was supported by grants from National Natural Science Foundation of China (81290342), The Ministry of Science and Technology, China (2011CB504702) and Development Grant of State Key Laboratory for Infectious Disease Prevention and Control (2014SKLID103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2006, J GEN VIROL, V87, P199, DOI 10.1099/vir.0.81294-0; Attoui H, 2005, J GEN VIROL, V86, P3409, DOI 10.1099/vir.0.81258-0; Attoui H, 2001, J GEN VIROL, V82, P795, DOI 10.1099/0022-1317-82-4-795; Attoui H, 2011, FAMILY REOVIRIDAE, P541; Attoui H, 2009, BIOL ANIM INFECT, P23, DOI 10.1016/B978-012369368-6.50007-1; Attoui H, 2009, VIROLOGY, V394, P298, DOI 10.1016/j.virol.2009.08.032; Belaganahalli MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031911; Belaganahalli MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023605; BREMER C W, 1976, Onderstepoort Journal of Veterinary Research, V43, P193; Karabatsos N., 1985, INT CATALOGUE ARBOVI; Li MH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001231; Li MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088738; LIBIKOVA H, 1978, MED MICROBIOL IMMUN, V166, P255, DOI 10.1007/BF02121159; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Mertens P P C, 2004, Vet Ital, V40, P426; Mertens PPC., 2005, VIRUS TAXONOMY, P466; Mertens PPC, 1999, ENCY VIROLOGY, V2nd, P1043; MOSS SR, 1992, J GEN VIROL, V73, P2585, DOI 10.1099/0022-1317-73-10-2585; Pfeffer M, 1997, AM J TROP MED HYG, V57, P709, DOI 10.4269/ajtmh.1997.57.709; Sun Xiao-hong, 2009, Chinese Journal of Virology, V25, P173; Wang JL, 2011, AM J TROP MED HYG, V84, P738, DOI 10.4269/ajtmh.2011.10-0294; Zhai Y, 2010, J GEN VIROL, V91, P2836, DOI 10.1099/vir.0.024794-0	22	17	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136257	10.1371/journal.pone.0136257	http://dx.doi.org/10.1371/journal.pone.0136257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295700	Green Submitted, gold, Green Published			2022-12-27	WOS:000359926900092
J	Seward, N; Prost, A; Copas, A; Corbin, M; Li, L; Colbourn, T; Osrin, D; Neuman, M; Azad, K; Kuddus, A; Nair, N; Tripathy, P; Manandhar, D; Costello, A; Cortina-Borja, M				Seward, Nadine; Prost, Audrey; Copas, Andrew; Corbin, Marine; Li, Leah; Colbourn, Tim; Osrin, David; Neuman, Melissa; Azad, Kishwar; Kuddus, Abdul; Nair, Nirmala; Tripathy, Prasanta; Manandhar, Dharma; Costello, Anthony; Cortina-Borja, Mario			Using Observational Data to Estimate the Effect of Hand Washing and Clean Delivery Kit Use by Birth Attendants on Maternal Deaths after Home Deliveries in Rural Bangladesh, India and Nepal	PLOS ONE			English	Article							SENSITIVITY-ANALYSIS; MULTIPLE IMPUTATION; CONFIDENCE-INTERVALS; MISSING DATA; MORTALITY; SETTINGS; TRIALS; POWER; CORD	Background Globally, puerperal sepsis accounts for an estimated 8-12% of maternal deaths, but evidence is lacking on the extent to which clean delivery practices could improve maternal survival. We used data from the control arms of four cluster-randomised controlled trials conducted in rural India, Bangladesh and Nepal, to examine associations between clean delivery kit use and hand washing by the birth attendant with maternal mortality among home deliveries. Methods We tested associations between clean delivery practices and maternal deaths, using a pooled dataset for 40,602 home births across sites in the three countries. Cross-sectional data were analysed by fitting logistic regression models with and without multiple imputation, and confounders were selected a priori using causal directed acyclic graphs. The robustness of estimates was investigated through sensitivity analyses. Results Hand washing was associated with a 49% reduction in the odds of maternal mortality after adjusting for confounding factors (adjusted odds ratio (AOR) 0.51, 95% CI 0.28-0.93). The sensitivity analysis testing the missing at random assumption for the multiple imputation, as well as the sensitivity analysis accounting for possible misclassification bias in the use of clean delivery practices, indicated that the association between hand washing and maternal death had been over estimated. Clean delivery kit use was not associated with a maternal death (AOR 1.26, 95% CI 0.62-2.56). Conclusions Our evidence suggests that hand washing in delivery is critical for maternal survival among home deliveries in rural South Asia, although the exact magnitude of this effect is uncertain due to inherent biases associated with observational data from low resource settings. Our findings indicating kit use does not improve maternal survival, suggests that the soap is not being used in all instances that kit use is being reported.	[Seward, Nadine; Prost, Audrey; Colbourn, Tim; Osrin, David; Neuman, Melissa; Costello, Anthony] UCL Inst Global Hlth, London, England; [Copas, Andrew] UCL Inst Epidemiol & Hlth Care, Ctr Sexual Hlth & HIV Res, London, England; [Corbin, Marine] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [Corbin, Marine] Univ Turin, Dept Med Sci, Canc Epidemiol Unit, CeRMS & CPO Piemonte, Turin, Italy; [Li, Leah] UCL Inst Child Hlth, Populat Policy & Practice Programme, London, England; [Azad, Kishwar; Kuddus, Abdul] PCP, Dhaka, Bangladesh; [Nair, Nirmala; Tripathy, Prasanta] Ekjut, Chakradharpur, Jharkhand, India; [Manandhar, Dharma] MIRA, Kathmandu, Nepal	University of London; University College London; University of London; University College London; Massey University; University of Turin; University of London; University College London	Seward, N (corresponding author), UCL Inst Global Hlth, London, England.	nadineseward@yahoo.com	Colbourn, Tim/AAE-6645-2019; Borja, Mario Cortina/A-3847-2009	Colbourn, Tim/0000-0002-6917-6552; Borja, Mario Cortina/0000-0003-0627-2624; Neuman, Melissa/0000-0002-8870-6504; Copas, Andrew/0000-0001-8968-5963; Seward, Nadine/0000-0002-4821-9437	Wellcome Trust under a Strategic Award [085417MA/Z/08/Z]; Health Foundation (UK); Women and Children First (UK); UK Big Lottery Fund; Saving Newborn Lives; UK Department for International Development; United Nations Children's Fund; United Nations Fund for Population Activities; Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme	Wellcome Trust under a Strategic Award(Wellcome Trust); Health Foundation (UK); Women and Children First (UK); UK Big Lottery Fund; Saving Newborn Lives; UK Department for International Development; United Nations Children's Fund; United Nations Fund for Population Activities; Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR))	This work was primarily supported by the Wellcome Trust under a Strategic Award [085417MA/Z/08/Z]. Partner sites have received funding from the Health Foundation (UK), Women and Children First (UK), the UK Big Lottery Fund, Saving Newborn Lives, the UK Department for International Development, the United Nations Children's Fund, and the United Nations Fund for Population Activities. University College London's Institute of Child Health receives a proportion of funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, ROAD MAP IMPL UN MIL; Azad K, 2010, LANCET, V375, P1193, DOI 10.1016/S0140-6736(10)60142-0; Barnett S, 2008, BMC PREGNANCY CHILDB, V8, P1, DOI DOI 10.1186/1471-2393-8-6; Beun MH, 2003, J HEALTH POPUL NUTR, V21, P367; Carpenter J, 2002, STAT MED, V21, P1043, DOI 10.1002/sim.1065; Carpenter JR, 2007, STAT METHODS MED RES, V16, P259, DOI 10.1177/0962280206075303; Colegrave N, 2003, BEHAV ECOL, V14, P446, DOI 10.1093/beheco/14.3.446; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Dangour AD, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009382.pub2; Darmstadt GL, 2009, J HEALTH POPUL NUTR, V27, P746; Fottrell E, 2013, JAMA PEDIAT, V20, P1; GOODMAN SN, 1994, ANN INTERN MED, V121, P200, DOI 10.7326/0003-4819-121-3-199408010-00008; Greenland S, 2005, J R STAT SOC A STAT, V168, P267, DOI 10.1111/j.1467-985X.2004.00349.x; Heraud-Bousquet V, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-73; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Hundley VA, 2013, BJOG-INT J OBSTET GY, V120, P277, DOI 10.1111/1471-0528.12049; Hundley VA, 2012, MIDWIFERY, V28, P204, DOI 10.1016/j.midw.2011.03.004; Hussein J, 2010, MATERNAL INFANT DEAT; International Institute for Population Sciences and ORC Macro, 2007, NAT FAM HLTH SURV NF; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Kassebaum N.J, 2014, LANCET; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lawlor DA, 2004, LANCET, V363, P1724, DOI 10.1016/S0140-6736(04)16260-0; Lee KJ, 2010, AM J EPIDEMIOL, V171, P624, DOI 10.1093/aje/kwp425; Loudon I., 1992, DEATH CHILDBIRTH INT; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Lyles RH, 2010, STAT MED, V29, P2297, DOI 10.1002/sim.3971; Maharaj D, 2007, OBSTET GYNECOL SURV, V62, P393, DOI 10.1097/01.ogx.0000265998.40912.5e; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Ministry of Health and Population (MOPH) [Nepal] New ERA and ICF International Inc, 2012, NEP DEM HLTH SURV 20; NIPORT Mitra and Associates ICF International and ICBBRB, 2012, BANGL MAT MORT HLTH; Ordi J, 2009, PLOS MED, V6, P174, DOI 10.1371/journal.pmed.1000036; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Rubin DB, 2004, MULTIPLE IMPUTATION; SAS Institute Inc, 2009, SAS STAT 9 3; Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3; Seward N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001180; StataCorp, 2009, STAT STAT SOFTW REL; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; van den Broek NR, 2011, BRIT MED BULL, V99, P25, DOI 10.1093/bmb/ldr033; van Dillen J, 2010, CURR OPIN INFECT DIS, V23, P249, DOI 10.1097/QCO.0b013e328339257c; Winani S, 2007, J MIDWIFERY WOM HEAL, V52, P37, DOI 10.1016/j.jmwh.2006.09.004; World Health Organisation, 1994, ESS NEWB CAR REP TEC; World Health Organization, 2007, INT CLASS DIS	46	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136152	10.1371/journal.pone.0136152	http://dx.doi.org/10.1371/journal.pone.0136152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295838	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000359926900075
J	Stefanowicz-Hajduk, J; Bartoszewski, R; Bartoszewska, S; Kochan, K; Adamska, A; Kosinski, I; Ochocka, JR				Stefanowicz-Hajduk, Justyna; Bartoszewski, Rafal; Bartoszewska, Sylwia; Kochan, Kinga; Adamska, Anna; Kosinski, Igor; Ochocka, J. Renata			Pennogenyl Saponins from Paris quadrifolia L. Induce Extrinsic and Intrinsic Pathway of Apoptosis in Human Cervical Cancer HeLa Cells	PLOS ONE			English	Article							TIME PCR DATA; STEROIDAL SAPONINS; HEMOLYTIC-ACTIVITY; RHIZOMA-PARIDIS; GROWTH-INHIBITION; CYCLE ARREST; IN-VITRO; CYTOTOXICITY; DEATH; MITOCHONDRIA	Pennogenyl saponins are the active compounds of large number of plant species and consequently many polyherbal formulations. Hence, great interest has been shown in their characterization and in the investigation of their pharmacological and biological properties, especially anticancer. This present study reports on the evaluation of cytotoxic effects and explanation of the molecular mechanisms of action of the two pennogenyl saponins (PS 1 and PS 2) isolated from Paris quadrifolia L. rhizomes on human cervical adenocarcinoma cell line HeLa. To determine the viability of the cells treated with the compounds we used real-time cell proliferation analysis and found that the pennogenyl saponins PS 1 and PS 2 strongly inhibited the tumor cells growth with IC50 values of 1.11 +/- 0.04 mu g/ml and 0.87 +/- 0.05 mu g/ml, respectively. The flow cytometry analysis indicated that the two compounds induced apoptosis in a dose-dependent manner and decreased mitochondrial membrane potential in HeLa cells in the early stage of apoptosis. Quantitative PCR and Western Blot analysis showed that the two saponins significantly increased mRNA expression of FADD and BID as well as induced caspase-8 via increased of procaspase-8 processing in the treated cells. The results of this study suggest that both the extrinsic death receptor and intrinsic mitochondrial pathways are involved in the programmed cell death.	[Stefanowicz-Hajduk, Justyna; Bartoszewski, Rafal; Kochan, Kinga; Adamska, Anna; Kosinski, Igor; Ochocka, J. Renata] Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Gdansk, Poland; [Bartoszewska, Sylwia] Med Univ Gdansk, Dept Inorgan Chem, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Stefanowicz-Hajduk, J (corresponding author), Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Gdansk, Poland.	justynastef@gumed.edu.pl	Bartoszewski, Rafal A/D-6311-2011; Bartoszewska, Sylwia/L-3922-2019	Bartoszewski, Rafal A/0000-0002-2864-6757; Bartoszewska, Sylwia/0000-0001-8063-1272	Polish Ministry of Science and Higher Education [N N405 669140]; quality - promoting subsidy under the Leading National Research Centre (KNOW) programme	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); quality - promoting subsidy under the Leading National Research Centre (KNOW) programme	This research was supported by the Polish Ministry of Science and Higher Education under grant Nr N N405 669140 (to J.R. Ochocka) and from the quality - promoting subsidy under the Leading National Research Centre (KNOW) programme for the years 2012-2017. The funders had no role in study design, data collection and analysis, decicion to publish, or preparation of the manuscript.	Bartoszewski R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092128; Bartoszewski R, 2011, METHOD ENZYMOL, V491, P3, DOI 10.1016/B978-0-12-385928-0.00001-8; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Chen YS, 2014, STEROIDS, V83, P39, DOI 10.1016/j.steroids.2014.01.014; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Deng DW, 2008, PLANTA MED, V74, P1397, DOI 10.1055/s-2008-1081345; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gajdus J, 2014, PHARMACOGN MAG, V10, P324, DOI 10.4103/0973-1296.133289; Gauthier C, 2009, BIOORGAN MED CHEM, V17, P2002, DOI 10.1016/j.bmc.2009.01.022; Gonzalez AG, 2003, J NAT PROD, V66, P793, DOI 10.1021/np020517j; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hostettmann K., 1995, SAPONINS, DOI 10.1017/CBO9780511565113; Huang XX, 2011, LAT AM J PHARM, V30, P540; Huang Y, 2007, CHEM NAT COMPD+, V43, P672, DOI 10.1007/s10600-007-0225-8; JUN Z, 1989, PURE APPL CHEM, V61, P457, DOI 10.1351/pac198961030457; Kaskiw MJ, 2009, BIOORGAN MED CHEM, V17, P7670, DOI 10.1016/j.bmc.2009.09.046; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Krysko DV, 2001, J HISTOCHEM CYTOCHEM, V49, P1277, DOI 10.1177/002215540104901010; Kustermann S, 2013, TOXICOL IN VITRO, V27, P1589, DOI 10.1016/j.tiv.2012.08.019; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lee MS, 2005, CANCER BIOL THER, V4, P1248, DOI 10.4161/cbt.4.11.2136; Li Y, 2013, MOLECULES, V18, P12916, DOI 10.3390/molecules181012916; Limame R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046536; Liu Z, 2013, J ETHNOPHARMACOL, V149, P422, DOI 10.1016/j.jep.2013.06.033; Liu Z, 2012, J ETHNOPHARMACOL, V144, P67, DOI 10.1016/j.jep.2012.08.027; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Long FY, 2015, J ETHNOPHARMACOL, V162, P112, DOI 10.1016/j.jep.2014.12.065; Lu C, 2011, AFR J PHARM PHARMACO, V5, P1086; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; MacKenzie SH, 2008, CURR CANCER DRUG TAR, V8, P98; Man SL, 2013, CHIN HERB MED, V5, P33, DOI 10.7501/j.issn.1674-6384.2013.01.004; Man SL, 2011, J ETHNOPHARMACOL, V137, P1221, DOI 10.1016/j.jep.2011.07.045; Man SL, 2011, ARCH PHARM RES, V34, P43, DOI 10.1007/s12272-011-0105-4; Man SL, 2010, J CHROMATOGR B, V878, P2943, DOI 10.1016/j.jchromb.2010.08.033; Micheau O, 1997, J NATL CANCER I, V89, P783, DOI 10.1093/jnci/89.11.783; National Pharmacopoeia Committee, 2010, PHARM PEOPL REP CH 1, P243; Pan TH, 2013, ANAL CHIM ACTA, V764, P44, DOI 10.1016/j.aca.2012.12.047; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stefanowicz-Hajduk J, 2011, ACTA BIOL CRACOV BOT, V53, P127, DOI 10.2478/v10182-011-0024-1; Trouillas P, 2005, BIOORGAN MED CHEM, V13, P1141, DOI 10.1016/j.bmc.2004.11.031; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang HY, 2013, FOOD CHEM TOXICOL, V55, P396, DOI 10.1016/j.fct.2012.12.059; Wang XD, 2001, GENE DEV, V15, P2922; Wang YX, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-71; Wang YB, 2007, BIOORGAN MED CHEM, V15, P2528, DOI 10.1016/j.bmc.2007.01.058; Wen FY, 2012, FITOTERAPIA, V83, P627, DOI 10.1016/j.fitote.2012.01.003; [武珊珊 Wu Shanshan], 2004, [中草药, Chinese Traditional and Herbal Drugs], V35, P344; Yi M, 2014, INT J ONCOL, V44, P327, DOI 10.3892/ijo.2013.2162; Zhang WJ, 2014, EUR J MED RES, V19, DOI 10.1186/2047-783X-19-41; Zhu LC, 2011, IRAN J PHARM RES, V10, P279; 王艳霞, 2005, [中草药, Chinese Traditional and Herbal Drugs], V36, P628	58	15	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135993	10.1371/journal.pone.0135993	http://dx.doi.org/10.1371/journal.pone.0135993			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295969	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900058
J	Yao, SH; Wang, T; Shen, WM; Pan, SM; Chong, YW; Ding, F				Yao, Shihong; Wang, Tao; Shen, Weiming; Pan, Shaoming; Chong, Yanwen; Ding, Fei			Feature Selection and Pedestrian Detection Based on Sparse Representation	PLOS ONE			English	Article							PROJECTIONS; RECOGNITION	Pedestrian detection have been currently devoted to the extraction of effective pedestrian features, which has become one of the obstacles in pedestrian detection application according to the variety of pedestrian features and their large dimension. Based on the theoretical analysis of six frequently-used features, SIFT, SURF, Haar, HOG, LBP and LSS, and their comparison with experimental results, this paper screens out the sparse feature subsets via sparse representation to investigate whether the sparse subsets have the same description abilities and the most stable features. When any two of the six features are fused, the fusion feature is sparsely represented to obtain its important components. Sparse subsets of the fusion features can be rapidly generated by avoiding calculation of the corresponding index of dimension numbers of these feature descriptors; thus, the calculation speed of the feature dimension reduction is improved and the pedestrian detection time is reduced. Experimental results show that sparse feature subsets are capable of keeping the important components of these six feature descriptors. The sparse features of HOG and LSS possess the same description ability and consume less time compared with their full features. The ratios of the sparse feature subsets of HOG and LSS to their full sets are the highest among the six, and thus these two features can be used to best describe the characteristics of the pedestrian and the sparse feature subsets of the combination of HOG-LSS show better distinguishing ability and parsimony.	[Yao, Shihong; Wang, Tao; Shen, Weiming; Pan, Shaoming; Chong, Yanwen] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan 430072, Peoples R China; [Ding, Fei] Shanghai Inst Satellite Engn, Informat Proc & Commun Technol Lab, Shanghai, Peoples R China	Wuhan University	Chong, YW (corresponding author), Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan 430072, Peoples R China.	ywchong@whu.edu.cn	Shen, Weiming/B-7400-2013	Shen, Weiming/0000-0001-5204-7992	Foundation Research Funds for the Central Universities [204201kf0242, 204201kf0263]; National Natural Science Foundation of China [41271398]; Natural Science Foundation of Hubei Province of China [2012FFB04204]; Shanghai Aerospace Science and Technology Innovation Fund Projects [SAST201425]	Foundation Research Funds for the Central Universities; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Shanghai Aerospace Science and Technology Innovation Fund Projects	This paper was supported by the Foundation Research Funds for the Central Universities (204201kf0242, SMP, 204201kf0263, YWC), National Natural Science Foundation of China (41271398, SMP), Natural Science Foundation of Hubei Province of China (2012FFB04204), and Shanghai Aerospace Science and Technology Innovation Fund Projects (SAST201425, YWC). YWC had a role in study design, data analysis and decision to publish. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Chong YW, 2012, COMM COM INF SC, V304, P280; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Dollar P, 2012, IEEE T PATTERN ANAL, V34, P743, DOI 10.1109/TPAMI.2011.155; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; FELZENSZWALB PF, 2010, PROC CVPR IEEE, P2241, DOI DOI 10.1109/CVPR.2010.5539906; Forman G., 2003, Journal of Machine Learning Research, V3, P1289, DOI 10.1162/153244303322753670; Freeman W. T., 1995, INT WORKSH AUT FAC G, V12, P296; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Huang YZ, 2008, PROC CVPR IEEE, P2000; Kittipanya-Ngam P, 2011, LECT NOTES COMPUT SC, V6468, P143; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Labusch K, 2008, IEEE T NEURAL NETWOR, V19, P1985, DOI 10.1109/TNN.2008.2005830; Liu J, 2012, NEURAL COMPUT APPL, V21, P1827, DOI 10.1007/s00521-010-0519-9; Liu JN, 2012, OPT COMMUN, V285, P2549, DOI 10.1016/j.optcom.2012.01.065; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Maji Subhransu, 2008, CVPR, DOI DOI 10.1109/CVPR.2008.4587630; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Omidiran D, 2010, J MACH LEARN RES, V11, P2361; Qiao LS, 2010, PATTERN RECOGN, V43, P331, DOI 10.1016/j.patcog.2009.05.005; Rodriguez-Lujan I, 2010, J MACH LEARN RES, V11, P1491; Sabzmeydani P, 2007, P IEEE C COMP VIS PA, P1; Shechtman E, 2007, IEEE C COMP VIS PATT, P1, DOI DOI 10.1109/CVPR.2007.383198; Song L., 2007, P 24 INT C MACHINE L, P823, DOI [10.1145/1273496.1273600, DOI 10.1145/1273496.1273600]; Tuv E, 2009, J MACH LEARN RES, V10, P1341; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Walk S, 2010, PROC CVPR IEEE, P1030, DOI 10.1109/CVPR.2010.5540102; Wang XY, 2009, IEEE I CONF COMP VIS, P32, DOI 10.1109/iccv.2009.5459207; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Wu B. Q., 2008, 2008 AS PAC MICR C M, P1, DOI [DOI 10.1109/GLOCOM.2008.ECP.519, 10.1109/APMC.2008.4958141, DOI 10.1109/APMC.2008.4958141]; Wu XD, 2013, IEEE T PATTERN ANAL, V35, P1178, DOI 10.1109/TPAMI.2012.197; Xia H, 2012, J COMPUT INF SYST, V8, P425; Xin  Y., 2011, P 3 INT WORKSH INT S, P1, DOI DOI 10.1109/ISA.2011; Yao SH, 2015, NEUROCOMPUTING, V151, P1006, DOI 10.1016/j.neucom.2014.08.080; Yu L, 2004, J MACH LEARN RES, V5, P1205; Zhang T, 2009, J MACH LEARN RES, V10, P555; Zhao P, 2006, J MACH LEARN RES, V7, P2541	39	12	12	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0134242	10.1371/journal.pone.0134242	http://dx.doi.org/10.1371/journal.pone.0134242			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295480	gold, Green Published, Green Submitted			2022-12-27	WOS:000359926900009
J	Sanchez, C; Horcajada, MN; Scalfo, FM; Ameye, L; Offord, E; Henrotin, Y				Sanchez, Christelle; Horcajada, Marie-Noelle; Scalfo, Fanny Membrez; Ameye, Laurent; Offord, Elizabeth; Henrotin, Yves			Carnosol Inhibits Pro-Inflammatory and Catabolic Mediators of Cartilage Breakdown in Human Osteoarthritic Chondrocytes and Mediates Cross-Talk between Subchondral Bone Osteoblasts and Chondrocytes	PLOS ONE			English	Article							ARTICULAR CHONDROCYTES; ONCOSTATIN-M; INTERLEUKIN-6; TRANSCRIPTION; PATHWAY; ANTIOXIDANT; EXPRESSION; AGGRECAN; ROSEMARY; CELLS	Aim The aim of this work was to evaluate the effects of carnosol, a rosemary polyphenol, on pro-inflammatory and catabolic mediators of cartilage breakdown in chondrocytes and via bone-cartilage crosstalk. Materials and Methods Osteoarthritic (OA) human chondrocytes were cultured in alginate beads for 4 days in presence or absence of carnosol (6 nM to 9 mu M). The production of aggrecan, matrix metalloproteinase (MMP)-3, tissue inhibitor of metalloproteinase (TIMP)-1, interleukin (IL)-6 and nitric oxide (NO) and the expression of type II collagen and ADAMTS-4 and -5 were analyzed. Human osteoblasts from sclerotic (SC) or non-sclerotic (NSC) subchondral bone were cultured for 3 days in presence or absence of carnosol before co-culture with chondrocytes. Chondrocyte gene expression was analyzed after 4 days of co-culture. Results In chondrocytes, type II collagen expression was significantly enhanced in the presence of 3 mu M carnosol (p = 0.008). MMP-3, IL-6, NO production and ADAMTS-4 expression were down-regulated in a concentration-dependent manner by carnosol (p<0.01). TIMP-1 production was slightly increased at 3 mu M (p = 0.02) and ADAMTS-5 expression was decreased from 0.2 to 9 mu M carnosol (p<0.05). IL-6 and PGE(2) production was reduced in the presence of carnosol in both SC and NSC osteoblasts while alkaline phosphatase activity was not changed. In co-culture experiments preincubation of NSC and SC osteoblasts wih carnosol resulted in similar effects to incubation with anti-IL-6 antibody, namely a significant increase in aggrecan and decrease in MMP-3, ADAMTS-4 and -5 gene expression by chondrocytes. Conclusions Carnosol showed potent inhibition of pro-inflammatory and catabolic mediators of cartilage breakdown in chondrocytes. Inhibition of matrix degradation and enhancement of formation was observed in chondrocytes cocultured with subchondral osteoblasts preincubated with carnosol indicating a cross-talk between these two cellular compartments, potentially mediated via inhibition of IL-6 in osteoblasts as similar results were obtained with anti-IL-6 antibody.	[Sanchez, Christelle; Henrotin, Yves] Univ Liege, Bone & Cartilage Res Unit, Arthropole Liege, Liege, Belgium; [Horcajada, Marie-Noelle; Scalfo, Fanny Membrez; Ameye, Laurent; Offord, Elizabeth] Nestle Res Ctr, Nutr & Hlth, CH-1000 Lausanne, Switzerland; [Henrotin, Yves] Princess Paola Hosp, Phys Therapy & Rehabil Dept, Marche En Famenne, Belgium	University of Liege; Nestle SA	Henrotin, Y (corresponding author), Univ Liege, Bone & Cartilage Res Unit, Arthropole Liege, Liege, Belgium.	yhenrotin@ulg.ac.be		Henrotin, Yves/0000-0003-1073-449X; sanchez, christelle/0000-0002-1005-8172	Nestec; Nestle	Nestec(European CommissionEuropean Commission Joint Research Centre); Nestle(Nestle SA)	This project received a grant from Nestec. Nestec chose the compounds and doses evaluated in this study. Yves Henrotin who is the head of BCRU, received the funding. The funders also participated in study design, decision to publish and preparation of the manuscript preparation. Nestle provided support in the form of salaries for authors MNH, FMS, LA and EO, but did not have role in the data collection and analysis.	GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guevremont M, 2003, J BONE MINER RES, V18, P1073, DOI 10.1359/jbmr.2003.18.6.1073; Hilal G, 1998, ARTHRITIS RHEUM, V41, P891, DOI 10.1002/1529-0131(199805)41:5<891::AID-ART17>3.0.CO;2-X; Huang SC, 2005, BIOCHEM PHARMACOL, V69, P221, DOI 10.1016/j.bcp.2004.09.019; Jiang J, 2005, BIOCHEM BIOPH RES CO, V338, P762, DOI 10.1016/j.bbrc.2005.10.025; Johnson JJ, 2011, CANCER LETT, V305, P1, DOI 10.1016/j.canlet.2011.02.005; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Legendre F, 2003, J BIOL CHEM, V278, P2903, DOI 10.1074/jbc.M110773200; Liu-Bryan R, 2015, NAT REV RHEUMATOL, V11, P35, DOI 10.1038/nrrheum.2014.162; Lo AH, 2002, CARCINOGENESIS, V23, P983, DOI 10.1093/carcin/23.6.983; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Lopez-Jimenez A, 2013, EUR J NUTR, V52, P85, DOI 10.1007/s00394-011-0289-x; Martel-Pelletier J, 1999, OSTEOARTHRITIS CLIN, P156, DOI DOI 10.1007/978-3-642-60026-5_9; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; Massicotte F, 2002, OSTEOARTHR CARTILAGE, V10, P491, DOI 10.1053/joca.2002.0528; NIETFELD JJ, 1990, ARTHRITIS RHEUM, V33, P1695, DOI 10.1002/art.1780331113; OFFORD E, 2004, OXIDAT STRESS DIS, P457; Pesesse L, 2011, JOINT BONE SPINE, V78, P144, DOI 10.1016/j.jbspin.2010.07.001; Prasadam I, 2012, J RHEUMATOL, V39, P621, DOI 10.3899/jrheum.110777; Vaquero MR, 2013, MOL NUTR FOOD RES, V57, P1834, DOI 10.1002/mnfr.201300052; Sanchez C, 2005, OSTEOARTHR CARTILAGE, V13, P988, DOI 10.1016/j.joca.2005.07.012; Sanchez C, 2005, OSTEOARTHR CARTILAGE, V13, P979, DOI 10.1016/j.joca.2005.03.008; Sanchez C, 2004, OSTEOARTHR CARTILAGE, V12, P801, DOI 10.1016/j.joca.2004.06.011; Sanchez C, 2003, BIOCHEM PHARMACOL, V65, P377, DOI 10.1016/S0006-2952(02)01485-5; Sanchez C, 2008, ARTHRITIS RHEUM-US, V58, P442, DOI 10.1002/art.23159; SERTEYN D, 1988, VET RES COMMUN, V12, P219, DOI 10.1007/BF00362803; Subbaramaiah K, 2002, CANCER RES, V62, P2522; Takaki I, 2008, J MED FOOD, V11, P741, DOI 10.1089/jmf.2007.0524	28	22	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136118	10.1371/journal.pone.0136118	http://dx.doi.org/10.1371/journal.pone.0136118			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292290	gold, Green Submitted, Green Published			2022-12-27	WOS:000359919900057
J	Aguilar, J; Gramig, GG; Hendrickson, JR; Archer, DW; Forcella, F; Liebig, MA				Aguilar, Jonathan; Gramig, Greta G.; Hendrickson, John R.; Archer, David W.; Forcella, Frank; Liebig, Mark A.			Crop Species Diversity Changes in the United States: 1978-2012	PLOS ONE			English	Article							AGRICULTURAL LANDSCAPE; GENETIC DIVERSITY; BIODIVERSITY; DIVERSIFICATION; MANAGEMENT; FOOD	Anecdotal accounts regarding reduced US cropping system diversity have raised concerns about negative impacts of increasingly homogeneous cropping systems. However, formal analyses to document such changes are lacking. Using US Agriculture Census data, which are collected every five years, we quantified crop species diversity from 1978 to 2012, for the contiguous US on a county level basis. We used Shannon diversity indices expressed as effective number of crop species (ENCS) to quantify crop diversity. We then evaluated changes in county-level crop diversity both nationally and for each of the eight Farm Resource Regions developed by the National Agriculture Statistics Service. During the 34 years we considered in our analyses, both national and regional ENCS changed. Nationally, crop diversity was lower in 2012 than in 1978. However, our analyses also revealed interesting trends between and within different Resource Regions. Overall, the Heartland Resource Region had the lowest crop diversity whereas the Fruitful Rim and Northern Crescent had the highest. In contrast to the other Resource Regions, the Mississippi Portal had significantly higher crop diversity in 2012 than in 1978. Also, within regions there were differences between counties in crop diversity. Spatial autocorrelation revealed clustering of low and high ENCS and this trend became stronger over time. These results show that, nationally counties have been clustering into areas of either low diversity or high diversity. Moreover, a significant trend of more counties shifting to lower rather than to higher crop diversity was detected. The clustering and shifting demonstrates a trend toward crop diversity loss and attendant homogenization of agricultural production systems, which could have far-reaching consequences for provision of ecosystem system services associated with agricultural systems as well as food system sustainability.	[Aguilar, Jonathan] Kansas State Univ, Southwest Res & Extens Ctr, Garden City, KS USA; [Gramig, Greta G.] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; [Hendrickson, John R.; Archer, David W.; Liebig, Mark A.] ARS, No Great Plains Res Lab, USDA, Mandan, ND USA; [Forcella, Frank] ARS, N Cent Soil Conservat Res Lab, USDA, Morris, MN USA	Kansas State University; North Dakota State University Fargo; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Hendrickson, JR (corresponding author), ARS, No Great Plains Res Lab, USDA, Mandan, ND USA.	john.hendrickson@ars.usda.gov	Hendrickson, John/M-1999-2019; Archer, David/I-7263-2019	Hendrickson, John/0000-0001-8600-9214; Archer, David/0000-0002-4816-7040	USDA-ARS Headquarters; Kansas State University Open Access Publishing Fund; ARS [ARS-0425378] Funding Source: Federal RePORTER	USDA-ARS Headquarters; Kansas State University Open Access Publishing Fund; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Jonathan Aguilar's salary was partially paid for by the USDA-ARS Headquarters Funded PostDoctoral Associate Program. Also, publication of this article was funded in part by the Kansas State University Open Access Publishing Fund.	Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Bowman MS, 2013, ECOL SOC, V18, DOI 10.5751/ES-05574-180133; Carr PM, 2002, P 4 STAT CROPP SYST; Di Falco S, 2005, ECOL ECON, V55, P459, DOI 10.1016/j.ecolecon.2004.12.005; Di Falco S, 2003, SCOT J POLIT ECON, V50, P207, DOI 10.1111/1467-9485.5002006; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Economic Research Service, 2000, USDA AG INF B, V760; Frison EA, 2011, SUSTAINABILITY-BASEL, V3, P238, DOI 10.3390/su3010238; Gaudin ACM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113261; Goodchild M. F, 1986, SPATIAL AUTOCORRELAT, V47; Gotelli N, 2013, ENCY BIODIVERSITY, V5; Grassini P, 2015, CROP PHYSIOLOGY: APPLICATIONS FOR GENETIC IMPROVEMENT AND AGRONOMY, 2ND EDITION, P17, DOI 10.1016/B978-0-12-417104-6.00002-9; Hajjar R, 2008, AGR ECOSYST ENVIRON, V123, P261, DOI 10.1016/j.agee.2007.08.003; Hendrickson JR, 2008, RENEW AGR FOOD SYST, V23, P304, DOI 10.1017/S1742170508002329; Hendrickson JR, 2008, RENEW AGR FOOD SYST, V23, P265, DOI 10.1017/S1742170507001718; Hoppe RA, 2010, 66 EIB USDA EC RES S; Howden SM, 2007, P NATL ACAD SCI USA, V104, P19691, DOI 10.1073/pnas.0701890104; Jackson LE, 2007, AGR ECOSYST ENVIRON, V121, P196, DOI 10.1016/j.agee.2006.12.017; Jekanowski M., 2013, CROP OUTLOOK REFLECT; Khoury CK, 2014, P NATL ACAD SCI USA, V111, P4001, DOI 10.1073/pnas.1313490111; Lin BB, 2011, BIOSCIENCE, V61, P183, DOI 10.1525/bio.2011.61.3.4; McGrath D, 2003, APPL GEOCHEM, V18, P1629, DOI 10.1016/S0883-2927(03)00045-3; Meehan TD, 2011, P NATL ACAD SCI USA, V108, P11500, DOI 10.1073/pnas.1100751108; Nagendra H, 2002, APPL GEOGR, V22, P175, DOI 10.1016/S0143-6228(02)00002-4; Nganje WE, 2004, REV AGR ECON, V26, P332, DOI 10.1111/j.1467-9353.2004.00183.x; Nickerson C, 2012, USDA ERS EC INFO B, V92; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Peterson GA, 1996, J PROD AGRIC, V9, P180, DOI 10.2134/jpa1996.0180; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; USDA-Economic Research Service, COTT WOOL BACKGR; Weibull AC, 2000, ECOGRAPHY, V23, P743, DOI 10.1034/j.1600-0587.2000.230611.x; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110; Zentner RP, 2002, AGRON J, V94, P216, DOI 10.2134/agronj2002.0216; Zhang CS, 2008, SCI TOTAL ENVIRON, V398, P212, DOI 10.1016/j.scitotenv.2008.03.011	36	69	69	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136580	10.1371/journal.pone.0136580	http://dx.doi.org/10.1371/journal.pone.0136580			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308552	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400141
J	Aravena, C; Labarca, G; Venegas, C; Arenas, A; Rada, G				Aravena, Carlos; Labarca, Gonzalo; Venegas, Carmen; Arenas, Alex; Rada, Gabriel			Pirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							ACETYLCYSTEINE; TRIAL; PREDNISONE; AGENT	Idiopathic pulmonary fibrosis (IPF) is a progressive disease with poor prognosis. In the last decades pirfenidone an anti-inflammatory and anti-fibrotic agent has shown benefit in inhibit collagen production and has also demonstrated benefit in decline progression in IPF in physiological outcomes as Forced vital capacity (FVC), in clinical outcomes such as progression free survival (PFS) and a benefit in mortality but no in clinically relevant outcomes as exacerbations or worsening of IPF. Methods: We conducted a systematic review to evaluate the effectiveness of physiological and clinical outcomes of pirfenidone compared to placebo in IPF. We performed a search with no language restriction. Two researchers performed literature search, quality assessment, data extraction and analysis. And was performed a summary of findings table following the GRADE approach. Results: We included 5 RCTs (Randomized controlled trials) in analysis. The meta-analysis resulted in a decrease in all cause-mortality (RR 0.52 IC 0.32-0.88) and IPF related mortality (RR 0.32 IC 0.14-0.75); other outcomes evaluated were worsening of IPF (RR 0.64 IC 0.50-0.83) and acute exacerbation (RR: 0.72 IC 0.30-1.66 respectively). Also there was a decrease in progression free survival (PFS) (RR 0.83 IC 0.74-0.92) compared to placebo. Conclusions: We observed significant differences in physiologic and clinically relevant outcomes such as reduction in all-cause mortality, IPF related mortality, worsening and exacerbation of IPF and PFS. So pirfenidone treatment should be considered not only for its benefits in pulmonary function tests but also by its clinically relevant outcomes.	[Aravena, Carlos; Venegas, Carmen] Pontificia Univ Catolica Chile, Fac Med, Dept Resp Dis, Santiago, Chile; [Labarca, Gonzalo; Arenas, Alex; Rada, Gabriel] Pontificia Univ Catolica Chile, Fac Med, Dept Internal Med, Santiago, Chile; [Labarca, Gonzalo; Rada, Gabriel] Pontificia Univ Catolica Chile, Fac Med, Evidence Based Hlth Care Program, Santiago, Chile; [Rada, Gabriel] Epistemonikos Fdn, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Aravena, C (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Dept Resp Dis, Marcoleta 350, Santiago, Chile.	caravenal@med.puc.cl	Labarca, Gonzalo/X-6461-2019; Aravena Leon, Carlos/AAZ-5319-2021	Labarca, Gonzalo/0000-0002-0069-3420; Aravena Leon, Carlos/0000-0002-8105-593X; Rada, Gabriel/0000-0003-2435-0710				Antoniou KM, 2013, EUR RESPIR REV, V22, P281, DOI 10.1183/09059180.00002113; Azuma A, 2005, AM J RESP CRIT CARE, V171, P1040, DOI 10.1164/rccm.200404-571OC; Azuma A, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-143; Carter NJ, 2011, DRUGS, V71, P1721, DOI 10.2165/11207710-000000000-00000; Demedts M, 2005, NEW ENGL J MED, V353, P2229, DOI 10.1056/NEJMoa042976; Douglas WW, 1998, AM J RESP CRIT CARE, V158, P220, DOI 10.1164/ajrccm.158.1.9709089; Iyer SN, 1998, EXP LUNG RES, V24, P119, DOI 10.3109/01902149809046058; Kaneko M, 1998, CLIN EXP IMMUNOL, V113, P72, DOI 10.1046/j.1365-2249.1998.00618.x; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; King TE, 2014, AM J RESP CRIT CARE, V189, P825, DOI 10.1164/rccm.201311-1951OC; Lee BS, 1998, J CLIN ENDOCR METAB, V83, P219, DOI 10.1210/jc.83.1.219; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Loveman E, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-63; Martinez FJ, 2014, NEW ENGL J MED, V370, P2093, DOI 10.1056/NEJMoa1401739; Misra HP, 2000, MOL CELL BIOCHEM, V204, P119, DOI 10.1023/A:1007023532508; Nagai S, 2002, INTERNAL MED, V41, P1118, DOI 10.2169/internalmedicine.41.1118; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Oku H, 2002, EUR J PHARMACOL, V446, P167, DOI 10.1016/S0014-2999(02)01757-0; Oku H, 2008, EUR J PHARMACOL, V590, P400, DOI 10.1016/j.ejphar.2008.06.046; Rada G, 2013, STUD HEALTH TECHNOL, V192, P486, DOI 10.3233/978-1-61499-289-9-486; Raghu G, 1999, AM J RESP CRIT CARE, V159, P1061, DOI 10.1164/ajrccm.159.4.9805017; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ryerson CJ, 2014, THORAX, V69, P791, DOI 10.1136/thoraxjnl-2014-205892; Shuster JJ, 2011, REV COCHRANE HDB SYS; Spagnolo P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003134.pub2; Taniguchi H, 2010, EUR RESPIR J, V35, P821, DOI 10.1183/09031936.00005209; Taniguchi H, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-93; Vancheri C, 2010, EUR RESPIR J, V35, P496, DOI 10.1183/09031936.00077309	30	42	44	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136160	10.1371/journal.pone.0136160	http://dx.doi.org/10.1371/journal.pone.0136160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308723	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400091
J	Piacenza, SE; Barner, AK; Benkwitt, CE; Boersma, KS; Cerny-Chipman, EB; Ingeman, KE; Kindinger, TL; Lee, JD; Lindsley, AJ; Reimer, JN; Rowe, JC; Shen, CC; Thompson, KA; Thurman, LL; Heppell, SS				Piacenza, Susan E.; Barner, Allison K.; Benkwitt, Cassandra E.; Boersma, Kate S.; Cerny-Chipman, Elizabeth B.; Ingeman, Kurt E.; Kindinger, Tye L.; Lee, Jonathan D.; Lindsley, Amy J.; Reimer, Jessica N.; Rowe, Jennifer C.; Shen, Chenchen; Thompson, Kevin A.; Thurman, Lindsey L.; Heppell, Selina S.			Patterns and Variation in Benthic Biodiversity in a Large Marine Ecosystem	PLOS ONE			English	Article							LATITUDINAL DIVERSITY GRADIENT; FUNCTIONAL DIVERSITY; SPECIES RICHNESS; DEEP-SEA; CONTINENTAL-SLOPE; GLOBAL PATTERNS; WEST-COAST; COMMUNITY; ECOLOGY; VARIABILITY	While there is a persistent inverse relationship between latitude and species diversity across many taxa and ecosystems, deviations from this norm offer an opportunity to understand the conditions that contribute to large-scale diversity patterns. Marine systems, in particular, provide such an opportunity, as marine diversity does not always follow a strict latitudinal gradient, perhaps because several hypothesized drivers of the latitudinal diversity gradient are uncorrelated in marine systems. We used a large scale public monitoring dataset collected over an eight year period to examine benthic marine faunal biodiversity patterns for the continental shelf (55-183 m depth) and slope habitats (184-1280 m depth) off the US West Coast (47 degrees 200N-32 degrees 40'N). We specifically asked whether marine biodiversity followed a strict latitudinal gradient, and if these latitudinal patterns varied across depth, in different benthic substrates, and over ecological time scales. Further, we subdivided our study area into three smaller regions to test whether coast-wide patterns of biodiversity held at regional scales, where local oceanographic processes tend to influence community structure and function. Overall, we found complex patterns of biodiversity on both the coast-wide and regional scales that differed by taxonomic group. Importantly, marine biodiversity was not always highest at low latitudes. We found that latitude, depth, substrate, and year were all important descriptors of fish and invertebrate diversity. Invertebrate richness and taxonomic diversity were highest at high latitudes and in deeper waters. Fish richness also increased with latitude, but exhibited a hump-shaped relationship with depth, increasing with depth up to the continental shelf break, similar to 200 m depth, and then decreasing in deeper waters. We found relationships between fish taxonomic and functional diversity and latitude, depth, substrate, and time at the regional scale, but not at the coast-wide scale, suggesting that coast-wide patterns can obscure important correlates at smaller scales. Our study provides insight into complex diversity patterns of the deep water soft substrate benthic ecosystems off the US West Coast.	[Piacenza, Susan E.; Lindsley, Amy J.; Rowe, Jennifer C.; Thompson, Kevin A.; Thurman, Lindsey L.; Heppell, Selina S.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Barner, Allison K.; Benkwitt, Cassandra E.; Boersma, Kate S.; Cerny-Chipman, Elizabeth B.; Ingeman, Kurt E.; Kindinger, Tye L.; Reimer, Jessica N.; Shen, Chenchen] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Lee, Jonathan D.] Oregon State Univ, Dept Geog Informat Sci, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Piacenza, SE (corresponding author), Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA.	susan.hilber@oregonstate.edu	Reimer, Jessica/GQZ-4144-2022; Thurman, Lindsey/AAF-7056-2020	Rowe, Jennifer/0000-0002-5253-2223; Thurman, Lindsey/0000-0003-3142-4909; Barner, Allison/0000-0001-9909-5713; Benkwitt, Cassandra/0000-0001-6756-7958	National Science Foundation [1050680]; Thomas G. Scott Publication Fund; University of Washington	National Science Foundation(National Science Foundation (NSF)); Thomas G. Scott Publication Fund; University of Washington(University of Washington)	Funding was provided by a National Science Foundation grant to Sandy Andelman and Julia Parrish: The Dimensions of Biodiversity Distributed Graduate Seminar (1050680). A sub-grant, via the University of Washington, was provided to SSH. Publication of this paper was supported, in part, by the Thomas G. Scott Publication Fund [http://www.nsf.gov/awardsearch/showAward?AWD_ID=1050680&HistoricalAwards=false]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Active Tectonics and Seafloor Mapping Lab Oregon State University and Center for Habitat Studies Moss Landing Marine Laboratories, 2004, SURF GEOL HAB MAP WA; Allen AP, 2006, ECOL LETT, V9, P947, DOI 10.1111/j.1461-0248.2006.00946.x; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Aquarone M, 2009, UNEP LARGE MARINE EC, P851; Baker KD, 2009, ENVIRON BIOL FISH, V85, P79, DOI 10.1007/s10641-009-9465-8; Barton K., 2011, MUMIN MULTIMODEL INF; Bianchi G, 2000, ICES J MAR SCI, V57, P558, DOI 10.1006/jmsc.2000.0727; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Bradburn MJ, 2011, 2003 2008 US BOTTOM, P323; Broitman BR, 2008, ECOL MONOGR, V78, P403, DOI 10.1890/06-1805.1; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cheung WWL, 2007, MAR ECOL PROG SER, V333, P1, DOI 10.3354/meps333001; Colloca F, 2004, MAR BIOL, V145, P1129, DOI 10.1007/s00227-004-1405-8; Compte J, 2012, J EXP MAR BIOL ECOL, V418, P1, DOI 10.1016/j.jembe.2012.03.004; Cryer M, 2002, ECOL APPL, V12, P1824, DOI 10.1890/1051-0761(2002)012[1824:MOMBBT]2.0.CO;2; Danovaro R, 2009, OCEANOGRAPHY, V22, P16, DOI 10.5670/oceanog.2009.02; Dobzhansky T., 1950, American Scientist, V38, P209; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Ellingsen KE, 2002, J ANIM ECOL, V71, P373, DOI 10.1046/j.1365-2656.2002.00606.x; Engel J, 1998, CONSERV BIOL, V12, P1204, DOI 10.1046/j.1523-1739.1998.0120061204.x; ETTER RJ, 1992, NATURE, V360, P576, DOI 10.1038/360576a0; Etter RJ, 2001, MARINE COMMUNITY ECOLOGY, P367; Fisher JAD, 2010, GLOBAL ECOL BIOGEOGR, V19, P1, DOI 10.1111/j.1466-8238.2009.00482.x; Francis RC, 1998, FISH OCEANOGR, V7, P1, DOI 10.1046/j.1365-2419.1998.00052.x; FREEDMAN DA, 1983, AM STAT, V37, P152, DOI 10.2307/2685877; FROESE R, 2000, FISHBASE 2000 CONCEP; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Furrer R, 2011, FIELDS TOOLS SPATIAL; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Gleason M, 2013, OCEAN COAST MANAGE, V74, P90, DOI 10.1016/j.ocecoaman.2012.08.013; Goldfinger C, 2005, INTERIM SEAFLOOR LIT; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hawkins SJ, 2013, MAR POLICY, V42, P91, DOI 10.1016/j.marpol.2013.02.001; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; Hixon MA, 2007, J EXP MAR BIOL ECOL, V344, P23, DOI 10.1016/j.jembe.2006.12.026; Hobbs NT, 2006, ECOL APPL, V16, P5, DOI 10.1890/04-0645; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Hunter WR, 2009, ICES J MAR SCI, V66, P691, DOI 10.1093/icesjms/fsp058; Hurlbert AH, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00420; JABLONSKI D, 1993, NATURE, V364, P142, DOI 10.1038/364142a0; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Jansson R, 2013, EVOLUTION, V67, P1741, DOI 10.1111/evo.12089; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jennings S., 2001, MARINE FISHERIES ECO; Jeppesen E, 2000, FRESHWATER BIOL, V45, P201, DOI 10.1046/j.1365-2427.2000.00675.x; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Keith SA, 2014, GLOBAL ECOL BIOGEOGR, V23, P517, DOI 10.1111/geb.12132; Keller AA, 2014, MAR ECOL PROG SER, V501, P169, DOI 10.3354/meps10674; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; KENDALL MA, 1993, J EXP MAR BIOL ECOL, V172, P157, DOI 10.1016/0022-0981(93)90095-6; KLOPFER PH, 1959, AM NAT, V93, P337, DOI 10.1086/282092; Lamanna C, 2014, P NATL ACAD SCI USA, V111, P13745, DOI 10.1073/pnas.1317722111; Lefcheck JS, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00284.1; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Love M, 1996, PROBABLY MORE YOU WA; Lukacs PM, 2010, ANN I STAT MATH, V62, P117, DOI 10.1007/s10463-009-0234-4; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Mannion PD, 2014, TRENDS ECOL EVOL, V29, P42, DOI 10.1016/j.tree.2013.09.012; Mason NWH, 2013, J VEG SCI, V24, P777, DOI 10.1111/jvs.12097; Maurer Brian A., 2011, P55; McClain CR, 2012, P ROY SOC B-BIOL SCI, V279, P1993, DOI 10.1098/rspb.2011.2166; Menge BA, 2004, ECOL MONOGR, V74, P663, DOI 10.1890/03-4060; Menge BA, 2009, ECOL MONOGR, V79, P379, DOI 10.1890/08-2086.1; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; Mueller M, 2011, J APPL ECOL, V48, P1450, DOI 10.1111/j.1365-2664.2011.02035.x; National Oceanic and Atmospheric Administration, 2013, MULT ENSO IND MEI; O'Hara TD, 2011, CURR BIOL, V21, P226, DOI 10.1016/j.cub.2011.01.002; Pelc RA, 2009, J BIOGEOGR, V36, P1881, DOI 10.1111/j.1365-2699.2009.02138.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Piacenza SE, PLOS ONE IN PRESS; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Renaud PE, 2009, MAR ECOL PROG SER, V382, P239, DOI 10.3354/meps07963; Rex MA, 2000, P NATL ACAD SCI USA, V97, P4082, DOI 10.1073/pnas.050589497; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Sebens KP, 1991, HABITAT STRUCTURE PH, P438; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stebbins G. L., 1974, Flowering plants. Evolution above the species level.; Stephens PA, 2005, J APPL ECOL, V42, P4, DOI 10.1111/j.1365-2664.2005.01002.x; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Stevens RD, 2002, ECOLOGY, V83, P545, DOI 10.1890/0012-9658(2002)083[0545:GEATCL]2.0.CO;2; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Sumaila U. Rashid, 2007, Journal of Bioeconomics, V9, P39, DOI 10.1007/s10818-007-9015-4; Sydeman WJ, 2013, GLOBAL CHANGE BIOL, V19, P1662, DOI 10.1111/gcb.12165; TERBORGH J, 1973, AM NAT, V107, P481, DOI 10.1086/282852; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tolimieri N, 2007, ENVIRON BIOL FISH, V78, P241, DOI 10.1007/s10641-006-9093-5; Tolimieri N, 2006, T AM FISH SOC, V135, P317, DOI 10.1577/T05-092.1; TRUJILLO A.P., 2008, ESSENTIALS OCEANOGRA; Valdovinos C, 2003, ECOGRAPHY, V26, P139, DOI 10.1034/j.1600-0587.2003.03349.x; Valentine JW, 2015, J BIOGEOGR, V42, P997, DOI 10.1111/jbi.12515; Vanney J.R., 1983, SHELF BREAK CRITICAL, V33, P1; Wallace A. R., 1878, P356; Wares JP, 2001, EVOLUTION, V55, P295; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; Wenzel L, 2012, ANAL US MARINE PROTE, P4; Wiedmann MA, 2014, MAR ECOL PROG SER, V495, P205, DOI 10.3354/meps10558; WILHM JL, 1968, ECOLOGY, V49, P153, DOI 10.2307/1933573; Williams A, 2001, MAR ECOL PROG SER, V212, P247, DOI 10.3354/meps212247; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Witman JD, 2004, P NATL ACAD SCI USA, V101, P15664, DOI 10.1073/pnas.0404300101; Woolley SNC, 2013, DIVERS DISTRIB, V19, P1506, DOI 10.1111/ddi.12119; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109; Zeller D, 2005, MAR POLICY, V29, P69, DOI 10.1016/j.marpol.2004.02.003	117	20	21	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135135	10.1371/journal.pone.0135135	http://dx.doi.org/10.1371/journal.pone.0135135			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308521	Green Submitted, Green Published, gold			2022-12-27	WOS:000360069400050
J	Hornig, T; Sturm, L; Fiebich, B; van Elst, LT				Hornig, Tobias; Sturm, Lukas; Fiebich, Bernd; van Elst, Ludger Tebartz			Increased Blood-Reelin-Levels in First Episode Schizophrenia	PLOS ONE			English	Article							CORTICAL PYRAMIDAL NEURONS; SYNAPTIC PLASTICITY; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; MOOD DISORDERS; ALTERED LEVELS; EXPRESSION; GENE; RECEPTOR; CORTEX	Background Reelin is an extracellular glycoprotein involved in several functions of brain development, synaptogenesis and dendritic proliferation. Numerous studies found perturbation in the reelin system and altered serum reelin levels in neuropsychiatric patients using the western blot procedure. In the international literature, this is the first study that made use of an enzyme-linked immunosorbent assay to analyze serum reelin protein concentration quantitatively. Rationale In order to study possible alterations in reelin blood levels in schizophrenia, we analyzed this signal in schizophrenic patients with a first episode hallucinatory and paranoid syndrome and control subjects in a pilot study design. Results We found increased blood reelin protein concentration in schizophrenic patients compared to healthy controls. Discussion Our findings point to a relevant role of reelin metabolism in the pathogenesis of schizophrenia. Reelin could be a biomarker for the course of disease or psychopharmacological treatment. Conclusion We conclude that the reelin protein blood concentration might be a relevant signal with respect to the pathophysiology of schizophrenia.	[Hornig, Tobias; Sturm, Lukas; Fiebich, Bernd; van Elst, Ludger Tebartz] Univ Freiburg, Dept Psychiat, D-79104 Freiburg, Germany	University of Freiburg	Hornig, T (corresponding author), Univ Freiburg, Dept Psychiat, Hauptstr 5, D-79104 Freiburg, Germany.	tobias.hornig@uniklinik-freiburg.de		Fiebich, Bernd L./0000-0002-9261-6771	University Hospital of Freiburg, Department of Psychiatry and Psychotherapy	University Hospital of Freiburg, Department of Psychiatry and Psychotherapy	This work was supported by the University Hospital of Freiburg, Department of Psychiatry and Psychotherapy.	Alcantara S, 1998, J NEUROSCI, V18, P7779; Archer T, 2010, EXPERT REV NEUROTHER, V10, P1131, DOI [10.1586/ern.09.152, 10.1586/ERN.09.152]; Balu DT, 2011, NEUROSCI BIOBEHAV R, V35, P848, DOI 10.1016/j.neubiorev.2010.10.005; Barr AM, 2007, BEHAV NEUROSCI, V121, P1101, DOI 10.1037/0735-7044.121.5.1101; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Bleuler, 1950, DEMENTIA PRAECOX OR, P1911; Botella-Lopez A, 2006, P NATL ACAD SCI USA, V103, P5573, DOI 10.1073/pnas.0601279103; Bowie CR, 2006, CURR OPIN INVESTIG D, V7, P608; Brummelte S, 2013, DEV PSYCHOBIOL, V55, P518, DOI 10.1002/dev.21056; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; Chameau P, 2009, P NATL ACAD SCI USA, V106, P7227, DOI 10.1073/pnas.0810764106; Chen Y, 2002, NUCLEIC ACIDS RES, V30, P2930, DOI 10.1093/nar/gkf401; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; de Rouvroit CL, 1999, EXP NEUROL, V156, P214, DOI 10.1006/exnr.1998.7007; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Dong E, 2008, P NATL ACAD SCI USA, V105, P13614, DOI 10.1073/pnas.0805493105; Fatemi SH, 2009, SCHIZOPHR RES, V111, P138, DOI 10.1016/j.schres.2009.03.002; Fatemi SH, 2005, MOL PSYCHIATR, V10, P251, DOI 10.1038/sj.mp.4001613; Fatemi SH, 2005, SCHIZOPHR RES, V72, P109, DOI 10.1016/j.schres.2004.02.017; Fatemi SH, 2001, NEUROREPORT, V12, P3209, DOI 10.1097/00001756-200110290-00014; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Folsom TD, 2013, NEUROPHARMACOLOGY, V68, P122, DOI 10.1016/j.neuropharm.2012.08.015; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Grayson DR, 2006, PHARMACOL THERAPEUT, V111, P272, DOI 10.1016/j.pharmthera.2005.01.007; Gross G, 2008, FORTSCHR NEUROL PSYC, V76, pS57, DOI 10.1055/s-2008-1038153; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Guidotti A, 2007, NEUROREPORT, V18, P57, DOI 10.1097/WNR.0b013e32800fefd7; Habl G, 2012, NEUROPSYCHOBIOLOGY, V66, P57, DOI 10.1159/000337129; HOFFARTH RM, 1995, J NEUROSCI, V15, P4838; Ignatova N, 2004, NEUROBIOL DIS, V15, P326, DOI 10.1016/j.nbd.2003.11.008; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Jossin Y, 2004, MOL NEUROBIOL, V30, P225, DOI 10.1385/MN:30:3:225; Keefe Richard S E, 2012, Handb Exp Pharmacol, P11, DOI 10.1007/978-3-642-25758-2_2; Kelemenova S, 2009, NEUROENDOCRINOL LETT, V30, P429; Knuesel I, 2010, PROG NEUROBIOL, V91, P257, DOI 10.1016/j.pneurobio.2010.04.002; KRAEPELIN E, 1971, DEMENTIA PRAECOX PAR, P1919; Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5; Merwick A, 2012, EPILEPSIA, V53, P81, DOI 10.1111/j.1528-1167.2012.03617.x; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; PARK S, 1993, SCHIZOPHR RES, V11, P55, DOI 10.1016/0920-9964(93)90038-K; PARK S, 1992, ARCH GEN PSYCHIAT, V49, P975; Pesold C, 1998, P NATL ACAD SCI USA, V95, P3221, DOI 10.1073/pnas.95.6.3221; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Psychiatrie AfMuDind, 2006, DAS AMDP SYSTEM MANU; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; Rogers JT, 2013, J PSYCHOPHARMACOL, V27, P386, DOI 10.1177/0269881112463468; Roth TL, 2009, BBA-GEN SUBJECTS, V1790, P869, DOI 10.1016/j.bbagen.2009.06.009; Rund BR, 2009, NORD J PSYCHIAT, V63, P196, DOI 10.1080/08039480902767286; Saez-Valero J, 2003, J NEUROSCI RES, V72, P132, DOI 10.1002/jnr.10554; Saillour Y, 2009, ARCH NEUROL-CHICAGO, V66, P1007, DOI 10.1001/archneurol.2009.149; Shariati GR, 2009, IRAN J ALLERGY ASTHM, V8, P135, DOI 08.03/ijaai.135139; Smalheiser NR, 2000, P NATL ACAD SCI USA, V97, P1281, DOI 10.1073/pnas.97.3.1281; Smit-Rigter LA, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00064; Sohal APS, 2012, PEDIATR NEUROL, V46, P127, DOI 10.1016/j.pediatrneurol.2011.11.017; Teixeira CM, 2012, J NEUROSCI, V32, P12051, DOI 10.1523/JNEUROSCI.1857-12.2012; Tinnes S, 2013, FASEB J, V27, P2542, DOI 10.1096/fj.12-224899; Tremolizzo L, 2005, BIOL PSYCHIAT, V57, P500, DOI 10.1016/j.biopsych.2004.11.046; Underhill GH, 2003, BLOOD, V101, P4013, DOI 10.1182/blood-2002-08-2673; van der Velden L, 2012, J NEUROPHYSIOL, V108, P1521, DOI 10.1152/jn.00829.2011; Veldic M, 2005, P NATL ACAD SCI USA, V102, P2152, DOI 10.1073/pnas.0409665102; Voineskos D, 2013, CAN J PSYCHIAT, V58, P86, DOI 10.1177/070674371305800205; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Willemsen MH, 2012, J MED GENET, V49, P179, DOI 10.1136/jmedgenet-2011-100542; Yin DM, 2012, ADV EXP MED BIOL, V970, P493, DOI 10.1007/978-3-7091-0932-8_22	65	11	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0134671	10.1371/journal.pone.0134671	http://dx.doi.org/10.1371/journal.pone.0134671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305216	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500011
J	Lee, HA; Song, MJ; Seok, YM; Kang, SH; Kim, SY; Kim, I				Lee, Hae-Ahm; Song, Min-Ji; Seok, Young-Mi; Kang, Seol-Hee; Kim, Sang-Yeob; Kim, Inkyeom			Histone Deacetylase 3 and 4 Complex Stimulates the Transcriptional Activity of the Mineralocorticoid Receptor	PLOS ONE			English	Article							PROTEIN-KINASE-A; CLASS-I; ACETYLATION; PHOSPHORYLATION; ALDOSTERONE; MUSCLE; CAMP; LOCALIZATION; INHIBITORS; SYSTEM	Histone deacetylases (HDACs) act as corepressors in gene transcription by altering the acetylation of histones, resulting in epigenetic gene silencing. We previously reported that HDAC3 acts as a coactivator of the mineralocorticoid receptor (MR). Although HDAC3 forms complexes with class II HDACs, their potential role in the transcriptional activity of MR is unclear. We hypothesized that HDAC4 of the class II family stimulates the transcriptional activity of MR. The expression of MR target genes was measured by quantitative real-time PCR. MR and RNA polymerase II recruitment to promoters of MR target genes was analyzed by chromatin immunoprecipitation. The association of MR with HDACs was investigated by co-immunoprecipitation. MR acetylation was determined with an anti-acetyl-lysine antibody after immunoprecipitation with an anti-MR antibody. Among the class II HDACs, HDAC4 interacted with both MR and HDAC3 after aldosterone stimulation. The nuclear translocation of HDAC4 was mediated by protein kinase A (PKA) and protein phosphatases (PP). The transcriptional activity of MR was significantly decreased by inhibitors of PKA (H89), PP1/2 (calyculin A), class I HDACs (MS-275), but not class II HDACs (MC1568). MR acetylation was increased by H89, calyculin A, and MS-275, but not by MC1568. Interaction between MR and HDAC3 was significantly decreased by H89, calyculin A, and HDAC4 siRNA. A non-genomic effect of MR via PKA and PP1/2 induced nuclear translocation of HDAC4 to facilitate the interaction between MR and HDAC3. Thus, we have uncovered a crucial role for a class II HDAC in the activation of MR-dependent transcription.	[Lee, Hae-Ahm; Song, Min-Ji; Seok, Young-Mi; Kang, Seol-Hee; Kim, Inkyeom] Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Daegu 41944, South Korea; [Lee, Hae-Ahm; Seok, Young-Mi; Kim, Inkyeom] Kyungpook Natl Univ, Sch Med, Cardiovasc Res Inst, Daegu 41944, South Korea; [Lee, Hae-Ahm; Kim, Inkyeom] Kyungpook Natl Univ, Sch Med, Cell & Matrix Res Inst, Daegu 41944, South Korea; [Seok, Young-Mi] Korea Promot Inst Tradit Med Ind, Gyongsan 712260, Gyeongbuk, South Korea; [Kim, Sang-Yeob] Asan Med Ctr, Asan Inst Life Sci, Seoul 138736, South Korea; [Kim, Sang-Yeob] Univ Ulsan, Coll Med, Dept Med, Seoul 138736, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; University of Ulsan; Asan Medical Center; University of Ulsan	Kim, I (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Daegu 41944, South Korea.	inkim@knu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2013R1A1A4A01011216, 2013R1A2A2A01005155]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C1527]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A4A01011216, 2013R1A2A2A01005155), and the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C1527). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bertrand P, 2010, EUR J MED CHEM, V45, P2095, DOI 10.1016/j.ejmech.2010.02.030; Christ M, 1999, CIRCULATION, V99, P1485, DOI 10.1161/01.CIR.99.11.1485; Di Marcotullio L, 2011, BBA-REV CANCER, V1815, P241, DOI 10.1016/j.bbcan.2011.01.002; Dodge-Kafka KL, 2010, J BIOL CHEM, V285, P11078, DOI 10.1074/jbc.M109.034868; Du M, 2008, MOL CELL BIOL, V28, P2952, DOI 10.1128/MCB.00248-08; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Iyer A, 2012, IMMUNOL CELL BIOL, V90, P39, DOI 10.1038/icb.2011.99; Kadiyala V, 2013, J BIOL CHEM, V288, P28900, DOI 10.1074/jbc.M113.505115; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lastra G, 2010, NAT REV CARDIOL, V7, P577, DOI 10.1038/nrcardio.2010.123; Lauffer BEL, 2013, J BIOL CHEM, V288, P26926, DOI 10.1074/jbc.M113.490706; Lee HA, 2013, CIRC RES, V112, P1004, DOI 10.1161/CIRCRESAHA.113.301071; Ling SK, 2012, CIRCULATION, V126, P3028, DOI 10.1161/CIRCULATIONAHA.112.102780; Liu YW, 2013, J PHYSIOL-LONDON, V591, P3605, DOI 10.1113/jphysiol.2013.256263; Mielcarek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080849; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Morris MJ, 2013, INT J DEV NEUROSCI, V31, P370, DOI 10.1016/j.ijdevneu.2013.02.005; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; Paroni G, 2008, MOL BIOL CELL, V19, P655, DOI 10.1091/mbc.E07-06-0623; Parra M, 2010, CURR OPIN PHARMACOL, V10, P454, DOI 10.1016/j.coph.2010.04.004; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; Sheader EA, 2002, J ENDOCRINOL, V175, P343, DOI 10.1677/joe.0.1750343; Spiegel S, 2012, ONCOGENE, V31, P537, DOI 10.1038/onc.2011.267; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Walkinshaw DR, 2013, J BIOL CHEM, V288, P5591, DOI 10.1074/jbc.M112.445668; Xie SZ, 2011, J BIOL CHEM, V286, P21129, DOI 10.1074/jbc.M110.208181; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005	33	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136801	10.1371/journal.pone.0136801	http://dx.doi.org/10.1371/journal.pone.0136801			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305553	gold, Green Published, Green Submitted			2022-12-27	WOS:000359995500114
J	Hoek, P; Grandjean, I; Verhagen, CAHHVM; Jansen-Landheer, MLEA; Schers, HJ; Galesloot, C; Vissers, KCP; Engels, Y; Hasselaar, JGJ				Hoek, Patrick; Grandjean, Ilse; Verhagen, Constans A. H. H. V. M.; Jansen-Landheer, Marlies L. E. A.; Schers, Henk J.; Galesloot, Cilia; Vissers, Kris C. P.; Engels, Yvonne; Hasselaar, Jeroen G. J.			Addressing Palliative Sedation during Expert Consultation: A Descriptive Analysis of the Practice of Dutch Palliative Care Consultation Teams	PLOS ONE			English	Article							CONTINUOUS DEEP SEDATION; TERMINALLY-ILL PATIENTS; PATIENTS NEARING DEATH; OF-LIFE PRACTICES; REFRACTORY SYMPTOMS; CANCER-PATIENTS; EUTHANASIA LAW; END; NETHERLANDS; PATTERNS	Main Objective Since palliative sedation is considered a complex intervention, consultation teams are increasingly established to support general practice. This study aims to offer insight into the frequency and characteristics of expert consultations regarding palliative sedation. Methods We performed a retrospective analysis of a longitudinal database. This database contained all patient-related consultations by Dutch Palliative Care Consultation teams, that were requested between 2004 and 2011. We described the frequency and characteristics of these consultations, in particular of the subgroup of consultations in which palliative sedation was addressed (i.e. PSa consultations). We used multivariate regression analysis to explore consultation characteristics associated with a higher likelihood of PSa consultations. Main Results and Their Significance Of the 44,443 initial consultations, most were requested by general practitioners (73%) and most concerned patients with cancer (86%). Palliative sedation was addressed in 18.1% of all consultations. Palliative sedation was relatively more often discussed during consultations for patients with a neurologic disease (OR 1.79; 95% CI: 1.51-2.12) or COPD (OR 1.39; 95% CI: 1.15-1.69) than for patients with cancer. We observed a higher likelihood of PSa consultations if the following topics were also addressed during consultation: dyspnoea (OR 1.30; 95% CI: 1.22-1.40), agitation/delirium (OR 1.57; 95% CI: 1.47-1.68), exhaustion (OR 2.89; 95% CI: 2.61-3.20), euthanasia-related questions (OR 2.65; 95% CI: 2.37-2.96) or existential issues (OR 1.55; 95% CI: 1.31-1.83). Conclusion In conclusion, PSa consultations accounted for almost one-fifth of all expert consultations and were associated with several case-related characteristics. These characteristics may help clinicians in identifying patients at risk for a more complex disease trajectory at the end of life.	[Hoek, Patrick; Verhagen, Constans A. H. H. V. M.; Vissers, Kris C. P.; Engels, Yvonne; Hasselaar, Jeroen G. J.] Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Med, Nijmegen, Netherlands; [Grandjean, Ilse; Jansen-Landheer, Marlies L. E. A.; Galesloot, Cilia] Comprehens Canc Ctr Netherlands, Utrecht, Netherlands; [Schers, Henk J.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Hoek, P (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Med, Nijmegen, Netherlands.	Patrick.Hoek@Radboudumc.nl	Vissers, Kris/H-8110-2014; Verhagen, C.A.H.H.V.M./L-4710-2015; Hoek, Patrick D/P-6160-2015; Hasselaar, Jeroen/C-9446-2011; Schers, H.J./L-4631-2015; Vissers, Kris C.P./D-3569-2009; Engels, Yvonne/I-1814-2015	Vissers, Kris/0000-0002-2919-6356; Hoek, Patrick D/0000-0001-8905-3472; Schers, H.J./0000-0002-9362-9451; Vissers, Kris C.P./0000-0002-2919-6356; Engels, Yvonne/0000-0002-7669-1018				Anquinet L, 2011, EUR J GEN PRACT, V17, P5, DOI 10.3109/13814788.2010.536529; Beernaert K, 2013, RESP MED, V107, P1731, DOI 10.1016/j.rmed.2013.06.003; Bilsen J, 2009, NEW ENGL J MED, V361, P1119, DOI 10.1056/NEJMc0904292; Brinkkemper T, 2011, J ADV NURS, V67, P1719, DOI 10.1111/j.1365-2648.2011.05614.x; Broeckaert, 2012, RICHTLIJN PALLIATIEV; Bush SH, 2014, J PAIN SYMPTOM MANAG, V48, P215, DOI 10.1016/j.jpainsymman.2014.05.009; Chambaere K, 2010, ARCH INTERN MED, V170, P490, DOI 10.1001/archinternmed.2009.542; Cherny NI, 2014, ANN ONCOL, V25, P143, DOI 10.1093/annonc/mdu238; Cherny NI, 2009, PALLIATIVE MED, V23, P581, DOI 10.1177/0269216309107024; Chiu TY, 2001, J PAIN SYMPTOM MANAG, V21, P467, DOI 10.1016/S0885-3924(01)00286-X; De Graeff A, 2007, J PALLIAT MED, V10, P67, DOI 10.1089/jpm.2006.0139; Dean MM, 2012, J PALLIAT MED, V15, P870, DOI 10.1089/jpm.2011.0498; Donker GA, 2013, BRIT J GEN PRACT, V63, pE669, DOI 10.3399/bjgp13X673676; Fainsinger RL, 2000, PALLIATIVE MED, V14, P257, DOI 10.1191/026921600666097479; Grandjean I, 2013, CONSULTATIE PALLIATI; Hasselaar JGJ, 2007, ARCH INTERN MED, V167, P1166, DOI 10.1001/archinte.167.11.1166; Hasselaar JGJ, 2009, ARCH INTERN MED, V169, P430, DOI 10.1001/archinternmed.2008.613; Kirk TW, 2010, J PAIN SYMPTOM MANAG, V39, P914, DOI 10.1016/j.jpainsymman.2010.01.009; Kohara Hiroyuki, 2005, J Palliat Med, V8, P20, DOI 10.1089/jpm.2005.8.20; Koper I, 2014, SUPPORT CARE CANCER, V22, P225, DOI 10.1007/s00520-013-1972-7; Lo B, 2005, JAMA-J AM MED ASSOC, V294, P1810, DOI 10.1001/jama.294.14.1810; Maltoni M, 2012, J CLIN ONCOL, V30, P1378, DOI 10.1200/JCO.2011.37.3795; Miccinesi G, 2006, J PAIN SYMPTOM MANAG, V31, P122, DOI 10.1016/j.jpainsymman.2005.07.004; Morita T, 2004, SUPPORT CARE CANCER, V12, P584, DOI 10.1007/s00520-004-0603-8; Morita T, 2002, J PAIN SYMPTOM MANAG, V24, P447, DOI 10.1016/S0885-3924(02)00499-2; Morita Tatsuya, 2005, J Palliat Med, V8, P716, DOI 10.1089/jpm.2005.8.716; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Onwuteaka-Philipsen BD, 2012, LANCET, V380, P908, DOI 10.1016/S0140-6736(12)61034-4; Papavasiliou EE, 2014, SUPPORT CARE CANC; Potter J, 2003, PALLIATIVE MED, V17, P310, DOI 10.1191/0269216303pm760oa; Report of the Council on Ethical and Judicial Affairs, 2008, 5A08 CEJA; Rietjens JAC, 2006, ARCH INTERN MED, V166, P749, DOI 10.1001/archinte.166.7.749; Rietjens JAC, 2004, ANN INTERN MED, V141, P178, DOI 10.7326/0003-4819-141-3-200408030-00006; Rietjens J, 2008, BRIT MED J, V336, P810, DOI 10.1136/bmj.39504.531505.25; Robijn L, 2014, SUPPORT CARE CANC; Royal Dutch Medical Association (KNMG), 2009, GUID PALL SED; Schrijnemaekers V, 2005, J PAIN SYMPTOM MANAG, V29, P552, DOI 10.1016/j.jpainsymman.2004.09.002; Seale C, 2010, J PAIN SYMPTOM MANAG, V39, P44, DOI 10.1016/j.jpainsymman.2009.06.007; Seymour J, 2014, PALLIAT MED; Swart S, 2012, BMJ SUPPORTIVE PALLI; Swart SJ, 2012, J PAIN SYMPTOM MANAG, V43, P172, DOI 10.1016/j.jpainsymman.2011.04.004; Tsai JS, 2006, PALLIATIVE MED, V20, P617, DOI 10.1177/0269216306071065; van der Heide A., 2010, HAAG ZONMW, V2012, P70	43	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136309	10.1371/journal.pone.0136309	http://dx.doi.org/10.1371/journal.pone.0136309			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301746	Green Submitted, Green Published, gold			2022-12-27	WOS:000359951900057
J	Goel, R; Kofman, I; Jeevarajan, J; De Dios, Y; Cohen, HS; Bloomberg, JJ; Mulavara, AP				Goel, Rahul; Kofman, Igor; Jeevarajan, Jerome; De Dios, Yiri; Cohen, Helen S.; Bloomberg, Jacob J.; Mulavara, Ajitkumar P.			Using Low Levels of Stochastic Vestibular Stimulation to Improve Balance Function	PLOS ONE			English	Article							SENSORIMOTOR INTEGRATION; MOTILE RESPONSES; NERVE AFFERENTS; HAIR-CELLS; NOISE; RESONANCE; PSYCHOPHYSICS; REDUCTION; BRAIN	Low-level stochastic vestibular stimulation (SVS) has been associated with improved postural responses in the medio-lateral (ML) direction, but its effect in improving balance function in both the ML and anterior-posterior (AP) directions has not been studied. In this series of studies, the efficacy of applying low amplitude SVS in 0-30 Hz range between the mastoids in the ML direction on improving cross-planar balance function was investigated. Forty-five (45) subjects stood on a compliant surface with their eyes closed and were instructed to maintain a stable upright stance. Measures of stability of the head, trunk, and whole body were quantified in ML, AP and combined APML directions. Results show that binaural bipolar SVS given in the ML direction significantly improved balance performance with the peak of optimal stimulus amplitude predominantly in the range of 100-500 mu A for all the three directions, exhibiting stochastic resonance (SR) phenomenon. Objective perceptual and body motion thresholds as estimates of internal noise while subjects sat on a chair with their eyes closed and were given 1 Hz bipolar binaural sinusoidal electrical stimuli were also measured. In general, there was no significant difference between estimates of perceptual and body motion thresholds. The average optimal SVS amplitude that improved balance performance (peak SVS amplitude normalized to perceptual threshold) was estimated to be 46% in ML, 53% in AP, and 50% in APML directions. A miniature patch-type SVS device may be useful to improve balance function in people with disabilities due to aging, Parkinson's disease or in astronauts returning from long-duration space flight.	[Goel, Rahul] Univ Houston, Dept Hlth & Human Performance, Houston, TX USA; [Kofman, Igor; De Dios, Yiri] Wyle Sci, Technol & Engn Grp, Houston, TX USA; [Jeevarajan, Jerome; Bloomberg, Jacob J.] NASA, Lyndon B Johnson Space Ctr, Neurosci Lab, Houston, TX 77058 USA; [Cohen, Helen S.] Baylor Coll Med, Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Mulavara, Ajitkumar P.] Univ Space Res Assoc, Houston, TX 77058 USA	University of Houston System; University of Houston; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Baylor College of Medicine; Universities Space Research Association (USRA)	Mulavara, AP (corresponding author), Univ Space Res Assoc, Houston, TX 77058 USA.	ajitkumar.p.mulavara@nasa.gov	Goel, Rahul/C-4480-2016	Goel, Rahul/0000-0002-3516-6938; Cohen, Helen/0000-0002-1605-640X; Jeevarajan, Jerome/0000-0002-6285-9350	National Space Biomedical Research Institute through NASA [NCC 9-58-SA 02801]; NASA [NCC 9-58-SA 02001]; National Institute of Health [RO1-DC009031]; Wyle Science, Technology and Engineering Group	National Space Biomedical Research Institute through NASA; NASA(National Aeronautics & Space Administration (NASA)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wyle Science, Technology and Engineering Group	This study was supported in part by a grant from the National Space Biomedical Research Institute through NASA NCC 9-58-SA 02801 to Jacob Bloomberg, NASA NCC 9-58-SA 02001 to Ajitkumar Mulavara and by a grant from the National Institute of Health through RO1-DC009031 to Helen Cohen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Wyle Science, Technology and Engineering Group provided support in the form of salaries for authors IK and YD but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aihara T, 2008, VISION RES, V48, P1569, DOI 10.1016/j.visres.2008.04.022; Aihara T, 2010, CHEM PHYS, V375, P616, DOI 10.1016/j.chemphys.2010.04.027; Avila I, 2010, EXP NEUROL, V221, P307, DOI 10.1016/j.expneurol.2009.11.016; Bent LR, 2004, J NEUROPHYSIOL, V92, P1269, DOI 10.1152/jn.01260.2003; Cohen Bernard, 2011, Front Neurol, V2, P90, DOI 10.3389/fneur.2011.00090; Collins JJ, 2003, IEEE ENG MED BIOL, V22, P76, DOI 10.1109/MEMB.2003.1195700; Curthoys Ian S, 2012, Front Neurol, V3, P117, DOI 10.3389/fneur.2012.00117; Dakin CJ, 2007, J PHYSIOL-LONDON, V583, P1117, DOI 10.1113/jphysiol.2007.133264; Dilda V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112131; Dilda V, 2012, EXP BRAIN RES, V216, P275, DOI 10.1007/s00221-011-2929-z; Ehtemam F, 2012, IEEE T BIO-MED ENG, V59, P1978, DOI 10.1109/TBME.2012.2195178; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Feusner JD, 2012, BRAIN BEHAV, V2, P211, DOI 10.1002/brb3.45; Fitzpatrick R, 1996, J NEUROPHYSIOL, V76, P3994, DOI 10.1152/jn.1996.76.6.3994; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; GOLDBERG JM, 1984, J NEUROPHYSIOL, V51, P1236, DOI 10.1152/jn.1984.51.6.1236; GOLDBERG JM, 1982, BRAIN RES, V252, P156, DOI 10.1016/0006-8993(82)90990-8; Gravelle DC, 2002, NEUROREPORT, V13, P1853, DOI 10.1097/00001756-200210280-00004; HLAVACKA F, 1985, ACTA OTO-LARYNGOL, V99, P107, DOI 10.3109/00016488509119152; Jian BJ, 2002, EXP BRAIN RES, V144, P247, DOI 10.1007/s00221-002-1042-8; Kim DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069055; Kim J, 2004, BRAIN RES BULL, V64, P265, DOI 10.1016/j.brainresbull.2004.07.008; Lopez C, 2010, CONSCIOUS COGN, V19, P33, DOI 10.1016/j.concog.2009.12.003; MacDougall HG, 2006, EXP BRAIN RES, V172, P208, DOI 10.1007/s00221-005-0329-y; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; Merfeld DM, 2011, EXP BRAIN RES, V210, P389, DOI 10.1007/s00221-011-2557-7; Mian OS, 2010, J PHYSIOL-LONDON, V588, P4441, DOI 10.1113/jphysiol.2010.195222; Moore ST, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00088; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; Mulavara AP, 2011, EXP BRAIN RES, V210, P303, DOI 10.1007/s00221-011-2633-z; Pal S, 2009, J VESTIBUL RES-EQUIL, V19, P137, DOI 10.3233/VES-2009-0360; Pavlik AE, 1999, EXP BRAIN RES, V124, P273, DOI 10.1007/s002210050623; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Priplata AA, 2006, ANN NEUROL, V59, P4, DOI 10.1002/ana.20670; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Rorsman I, 1999, SCAND J REHABIL MED, V31, P117; Ross SE, 2013, J ATHL TRAINING, V48, P463, DOI 10.4085/1062-6050-48.3.12; Samoudi G, 2015, BRAIN STIMUL, V8, P474, DOI 10.1016/j.brs.2014.11.019; Samoudi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029308; Schmidt L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00090; Scinicariello AP, 2001, BIOL CYBERN, V84, P475, DOI 10.1007/PL00007991; Soma R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.078101; Songer JE, 2013, J NEUROSCI, V33, P3706, DOI 10.1523/JNEUROSCI.4067-12.2013; TREUTWEIN B, 1995, VISION RES, V35, P2503, DOI 10.1016/0042-6989(95)00016-X; Utz KS, 2011, BRAIN INJURY, V25, P1058, DOI 10.3109/02699052.2011.607789; Ward LM, 2004, FLUCT NOISE LETT, V4, pL11, DOI 10.1142/S0219477504001616; Weiss D, 2013, BRAIN, V136, P2098, DOI 10.1093/brain/awt122; Wilkinson D, 2005, J INT NEUROPSYCH SOC, V11, P925, DOI 10.1017/S1355617705051076; Wilkinson D, 2008, EXP BRAIN RES, V189, P243, DOI 10.1007/s00221-008-1463-0; Yamamoto Y, 2005, ANN NEUROL, V58, P175, DOI 10.1002/ana.20574; Zenner H P, 1992, J Vestib Res, V2, P181; ZENNER HP, 1991, ACTA OTO-LARYNGOL, V111, P291, DOI 10.3109/00016489109137390	53	49	50	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136335	10.1371/journal.pone.0136335	http://dx.doi.org/10.1371/journal.pone.0136335			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295807	Green Submitted, Green Published, gold			2022-12-27	WOS:000359926900102
J	Li, W; Cheng, JM; Yu, KL; Epstein, HE; Guo, L; Jing, GH; Zhao, J; Du, GZ				Li, Wei; Cheng, Ji-Min; Yu, Kai-Liang; Epstein, Howard E.; Guo, Liang; Jing, Guang-Hua; Zhao, Jie; Du, Guo-Zhen			Plant Functional Diversity Can Be Independent of Species Diversity: Observations Based on the Impact of 4-Yrs of Nitrogen and Phosphorus Additions in an Alpine Meadow	PLOS ONE			English	Article							TRAIT CONVERGENCE; BIODIVERSITY LOSS; FIELD EXPERIMENT; COMMUNITY; PRODUCTIVITY; COMPETITION; DIVERGENCE; RICHNESS; STABILITY; RESPONSES	Past studies have widely documented the decrease in species diversity in response to addition of nutrients, however functional diversity is often independent from species diversity. In this study, we conducted a field experiment to examine the effect of nitrogen and phosphorus fertilization ((NH4)(2) HPO4) at 0, 15, 30 and 60 g m(-2) yr(-1) (F0, F15, F30 and F60) after 4 years of continuous fertilization on functional diversity and species diversity, and its relationship with productivity in an alpine meadow community on the Tibetan Plateau. To this purpose, three community-weighted mean trait values (specific leaf area, SLA; mature plant height, MPH; and seed size, SS) for 30 common species in each fertilization level were determined; three components of functional diversity (functional richness, FRic; functional evenness, FEve; and Rao's index of quadratic entropy, FRao) were quantified. Our results showed that: (i) species diversity sharply decreased, but functional diversity remained stable with fertilization; (ii) community-weighted mean traits (SLA and MPH) had a significant increase along the fertilization level; (iii) aboveground biomass was not correlated with functional diversity, but it was significantly correlated with species diversity and MPH. Our results suggest that decreases in species diversity due to fertilization do not result in corresponding changes in functional diversity. Functional identity of species may be more important than functional diversity in influencing aboveground productivity in this alpine meadow community, and our results also support the mass ratio hypothesis; that is, the traits of the dominant species influenced the community biomass production.	[Li, Wei; Cheng, Ji-Min; Guo, Liang] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Peoples R China; [Li, Wei; Cheng, Ji-Min; Guo, Liang; Jing, Guang-Hua] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling 712100, Peoples R China; [Li, Wei; Cheng, Ji-Min; Guo, Liang; Jing, Guang-Hua] Minist Water Resource, Yangling 712100, Peoples R China; [Yu, Kai-Liang; Epstein, Howard E.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; [Zhao, Jie] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Peoples R China; [Du, Guo-Zhen] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; University of Virginia; Northwest A&F University - China; Lanzhou University	Li, W (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Peoples R China.	liwei2013@nwsuaf.edu.cn			Key Program of National Natural Science Foundation of China [40930533]; Natural Science Foundation of China [41230852]; Key Program of Chinese Academy of Sciences [KJZD-EW-TZ-G10]; Northwest A F University [Z109021107, Z109021307, QN2013070]; West Light Foundation of Chinese Academy of Sciences [K318021305]; China Scholarship Council	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Northwest A F University; West Light Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences); China Scholarship Council(China Scholarship Council)	This study was supported by Key Program of National Natural Science Foundation of China (40930533), Natural Science Foundation of China (41230852), Key Program of Chinese Academy of Sciences (KJZD-EW-TZ-G10), Northwest A & F University (Z109021107, Z109021307, QN2013070), West Light Foundation of Chinese Academy of Sciences (K318021305) and the China Scholarship Council.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Casanoves F, 2011, METHODS ECOL EVOL, V2, P233, DOI 10.1111/j.2041-210X.2010.00082.x; Chalcraft DR, 2008, ECOLOGY, V89, P2165, DOI 10.1890/07-0971.1; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; de Bello F, 2006, ECOGRAPHY, V29, P801, DOI 10.1111/j.2006.0906-7590.04683.x; de Bello F, 2011, METHODS ECOL EVOL, V2, P163, DOI 10.1111/j.2041-210X.2010.00071.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Dickson TL, 2014, ECOLOGY, V95, P2443, DOI 10.1890/13-1875.1; Du MY, 2004, GLOBAL PLANET CHANGE, V41, P241, DOI 10.1016/j.gloplacha.2004.01.010; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gillman LN, 2006, ECOLOGY, V87, P1234, DOI 10.1890/0012-9658(2006)87[1234:TIOPOT]2.0.CO;2; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Isbell F, 2013, P NATL ACAD SCI USA, V110, P11911, DOI 10.1073/pnas.1310880110; Isbell FI, 2009, ECOL LETT, V12, P443, DOI 10.1111/j.1461-0248.2009.01299.x; Jiang L, 2009, J ECOL, V97, P603, DOI 10.1111/j.1365-2745.2009.01503.x; Klein JA, 2007, ECOL APPL, V17, P541, DOI 10.1890/05-0685; Laughlin DC, 2011, J ECOL, V99, P1091, DOI 10.1111/j.1365-2745.2011.01856.x; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Li W, 2011, J PLANT ECOL, V4, P138, DOI 10.1093/jpe/rtq031; Luo YJ, 2006, J VEG SCI, V17, P417, DOI 10.1658/1100-9233(2006)17[417:IOATAF]2.0.CO;2; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Mason NWH, 2011, J ECOL, V99, P788, DOI 10.1111/j.1365-2745.2011.01801.x; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mayfield MM, 2010, GLOBAL ECOL BIOGEOGR, V19, P423, DOI 10.1111/j.1466-8238.2010.00532.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Mokany K, 2008, J ECOL, V96, P884, DOI 10.1111/j.1365-2745.2008.01395.x; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Naeem S, 1998, CONSERV BIOL, V12, P39, DOI 10.1046/j.1523-1739.1998.96379.x; Niu KC, 2008, BASIC APPL ECOL, V9, P485, DOI 10.1016/j.baae.2007.06.015; Pakeman RJ, 2011, J ECOL, V99, P1143, DOI 10.1111/j.1365-2745.2011.01853.x; Rajaniemi TK, 2003, J ECOL, V91, P407, DOI 10.1046/j.1365-2745.2003.00768.x; Ricotta C, 2005, ACTA BIOTHEOR, V53, P29, DOI 10.1007/s10441-005-7001-6; Roscher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036760; Schmid B, 2004, BASIC APPL ECOL, V5, P535, DOI 10.1016/j.baae.2004.07.001; Schumacher J, 2009, OIKOS, V118, P1659, DOI 10.1111/j.1600-0706.2009.17711.x; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; Silvertown J, 2006, J ECOL, V94, P801, DOI 10.1111/j.1365-2745.2006.01145.x; Silvertown J, 2006, ECOLOGY, V87, pS39, DOI 10.1890/0012-9658(2006)87[39:PATHOO]2.0.CO;2; Stevens MHH, 1999, J ECOL, V87, P490, DOI 10.1046/j.1365-2745.1999.00374.x; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Yang HJ, 2012, ECOL LETT, V15, P619, DOI 10.1111/j.1461-0248.2012.01778.x	56	18	23	12	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136040	10.1371/journal.pone.0136040	http://dx.doi.org/10.1371/journal.pone.0136040			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295345	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900062
J	Penaluna, BE; Dunham, JB; Railsback, SF; Arismendi, I; Johnson, SL; Bilby, RE; Safeeq, M; Skaugset, AE				Penaluna, Brooke E.; Dunham, Jason B.; Railsback, Steve F.; Arismendi, Ivan; Johnson, Sherri L.; Bilby, Robert E.; Safeeq, Mohammad; Skaugset, Arne E.			Local Variability Mediates Vulnerability of Trout Populations to Land Use and Climate Change	PLOS ONE			English	Article							LONG-TERM TRENDS; CUTTHROAT TROUT; STREAM TEMPERATURES; SPECIES ABUNDANCE; FOREST HARVEST; CHANGE IMPACTS; MODELS; RESPONSES; HABITAT; CREEK	Land use and climate change occur simultaneously around the globe. Fully understanding their separate and combined effects requires a mechanistic understanding at the local scale where their effects are ultimately realized. Here we applied an individual-based model of fish population dynamics to evaluate the role of local stream variability in modifying responses of Coastal Cutthroat Trout (Oncorhynchus clarkii clarkii) to scenarios simulating identical changes in temperature and stream flows linked to forest harvest, climate change, and their combined effects over six decades. We parameterized the model for four neighboring streams located in a forested headwater catchment in northwestern Oregon, USA with multi-year, daily measurements of stream temperature, flow, and turbidity (20072011), and field measurements of both instream habitat structure and three years of annual trout population estimates. Model simulations revealed that variability in habitat conditions among streams (depth, available habitat) mediated the effects of forest harvest and climate change. Net effects for most simulated trout responses were different from or less than the sum of their separate scenarios. In some cases, forest harvest countered the effects of climate change through increased summer flow. Climate change most strongly influenced trout (earlier fry emergence, reductions in biomass of older trout, increased biomass of young-of-year), but these changes did not consistently translate into reductions in biomass over time. Forest harvest, in contrast, produced fewer and less consistent responses in trout. Earlier fry emergence driven by climate change was the most consistent simulated response, whereas survival, growth, and biomass were inconsistent. Overall our findings indicate a host of local processes can strongly influence how populations respond to broad scale effects of land use and climate change.	[Penaluna, Brooke E.; Johnson, Sherri L.] US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA; [Penaluna, Brooke E.; Arismendi, Ivan] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Dunham, Jason B.] US Geol Survey, Forest Rangeland Ecosyst Sci Ctr, Corvallis Res Grp, Corvallis, OR 97331 USA; [Railsback, Steve F.] Lang Railsback & Associates, Arcata, CA 95521 USA; [Bilby, Robert E.] Weyerhaeuser Co, Federal Way, WA 98063 USA; [Safeeq, Mohammad] Univ Calif Merced, Sierra Nevada Res Inst, Merced, CA 95343 USA; [Skaugset, Arne E.] Oregon State Univ, Dept Forest Engn, Corvallis, OR 97331 USA	United States Department of Agriculture (USDA); United States Forest Service; Oregon State University; United States Department of the Interior; United States Geological Survey; University of California System; University of California Merced; Oregon State University	Penaluna, BE (corresponding author), US Forest Serv, Pacific NW Res Stn, 3200 SW Jefferson Way, Corvallis, OR 97331 USA.	Brooke.Penaluna@oregonstate.edu	Arismendi, Ivan/B-3144-2010	Arismendi, Ivan/0000-0002-8774-9350; Railsback, Steven/0000-0002-5923-9847	EPA Science to Achieve Results STAR Grant; J Frances Allen Scholarship through American Fisheries Society; Watersheds Research Cooperative at Oregon State University; US Geological Survey Forest and Rangeland Ecosystem Science Center; PNW Research Station; US Forest Service	EPA Science to Achieve Results STAR Grant; J Frances Allen Scholarship through American Fisheries Society; Watersheds Research Cooperative at Oregon State University; US Geological Survey Forest and Rangeland Ecosystem Science Center(United States Geological Survey); PNW Research Station; US Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	BEP was funded by an EPA Science to Achieve Results STAR Grant and J Frances Allen Scholarship through American Fisheries Society. Additional funding support came from the Watersheds Research Cooperative at Oregon State University, US Geological Survey Forest and Rangeland Ecosystem Science Center, and the PNW Research Station with US Forest Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arismendi I, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051448; BAUER DF, 1972, J AM STAT ASSOC, V67, P687, DOI 10.2307/2284469; Berger AM, 2009, CAN J FISH AQUAT SCI, V66, P613, DOI 10.1139/F09-029; BETHKE RW, 1995, ECOL APPL, V5, P588, DOI 10.2307/1941969; Bisson Peter A., 2008, V199, P259; Black BA, 2014, SCIENCE, V345, P1498, DOI 10.1126/science.1253209; Bunnell DB, 2010, OECOLOGIA, V162, P641, DOI 10.1007/s00442-009-1487-6; Clavero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018581; Crozier LG, 2008, GLOBAL CHANGE BIOL, V14, P236, DOI 10.1111/j.1365-2486.2007.01497.x; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Esterby SR, 1996, HYDROL PROCESS, V10, P127; Gaillard JM, 2013, ECOL LETT, V16, P48, DOI 10.1111/ele.12059; Gregory Stanley V., 2008, V199, P237; Groom JD, 2011, FOREST ECOL MANAG, V262, P1618, DOI 10.1016/j.foreco.2011.07.012; Hall J.D., 2004, P365; Hamed KH, 1998, J HYDROL, V204, P182, DOI 10.1016/S0022-1694(97)00125-X; Hartman G. F., 1990, CANADIAN B FISHERIES, V223; Harvey BC, 1998, CAN J FISH AQUAT SCI, V55, P1902, DOI 10.1139/cjfas-55-8-1902; Harvey BC, 2006, T AM FISH SOC, V135, P998, DOI 10.1577/T05-233.1; Harvey BC, 2014, N AM J FISH MANAGE, V34, P247, DOI 10.1080/02755947.2013.860062; Harvey BC, 2014, ENVIRON BIOL FISH, V97, P615, DOI 10.1007/s10641-013-0186-7; HIRSCH RM, 1982, WATER RESOUR RES, V18, P107, DOI 10.1029/WR018i001p00107; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hollander M., 1973, NONPARAMETRIC STAT M; HOLTBY LB, 1989, CAN J FISH AQUAT SCI, V46, P1396, DOI 10.1139/f89-179; Hsieh CH, 2009, GLOBAL CHANGE BIOL, V15, P2137, DOI 10.1111/j.1365-2486.2009.01875.x; Jarema SI, 2009, GLOBAL CHANGE BIOL, V15, P508, DOI 10.1111/j.1365-2486.2008.01732.x; Jeffress MR, 2013, ECOL APPL, V23, P864, DOI 10.1890/12-0979.1; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Johnson SL, 2000, CAN J FISH AQUAT SCI, V57, P30, DOI 10.1139/cjfas-57-S2-30; Jones JA, 2004, WATER RESOUR RES, V40, P1; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Kendall M, 1975, MULTIVARIATE ANAL; Lande R., 2003, OXFORD SERIES ECOLOG; Leach JA, 2012, AQUAT SCI, V74, P427, DOI 10.1007/s00027-011-0238-z; Lemoine N, 2007, CONSERV BIOL, V21, P495, DOI 10.1111/j.1523-1739.2006.00633.x; Livneh B, 2013, J CLIMATE, V26, P9384, DOI 10.1175/JCLI-D-12-00508.1; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Meyers EM, 2010, T AM FISH SOC, V139, P1657, DOI 10.1577/T09-192.1; Moore RD, 2005, J AM WATER RESOUR AS, V41, P763, DOI 10.1111/j.1752-1688.2005.tb04463.x; Overland JE, 2010, J MARINE SYST, V79, P305, DOI 10.1016/j.jmarsys.2008.12.009; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Penaluna BE, 2015, CAN J FISH AQUAT SCI, V72, P893, DOI 10.1139/cjfas-2014-0377; Pollock MM, 2009, J AM WATER RESOUR AS, V45, P141, DOI 10.1111/j.1752-1688.2008.00266.x; Potter KA, 2013, GLOBAL CHANGE BIOL, V19, P2932, DOI [10.1111/, 10.1111/gcb.12257]; R Development Core Team, 2012, R LANG ENV STAT COMP; Railsback S.F., 2009, PSWGTR218 USDA FOR S; Railsback S.F., 2011, INSTREAM INDIVIDUAL; Railsback S.F., 2001, GEN TECHNICAL REPORT; Railsback SF, 2002, ECOLOGY, V83, P1817, DOI 10.2307/3071767; Railsback SF, 2014, P NATL ACAD SCI USA, V111, P6109, DOI 10.1073/pnas.1320957111; Railsback Steven F., 2002, Natural Resource Modeling, V15, P83; Renwick AR, 2012, DIVERS DISTRIB, V18, P121, DOI 10.1111/j.1472-4642.2011.00827.x; Roni P, 2015, CAN J FISH AQUAT SCI, V72, P466, DOI 10.1139/cjfas-2014-0344; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Safeeq M, 2013, HYDROL PROCESS, V27, P655, DOI 10.1002/hyp.9628; Santander Meteorology Group, 2013, FUME PACK SET FUNCT; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Steel EA, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00255.1; Surfleet CG, 2013, WEST J APPL FOR, V28, P13, DOI 10.5849/wjaf.11-038; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren DR, 2012, GLOBAL CHANGE BIOL, V18, P1804, DOI 10.1111/j.1365-2486.2012.02670.x; Wenger SJ, 2013, GLOBAL CHANGE BIOL, V19, P3343, DOI 10.1111/gcb.12294; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Wigington PJ, 2013, J AM WATER RESOUR AS, V49, P163, DOI 10.1111/jawr.12009; Winkel W, 1997, J AVIAN BIOL, V28, P187, DOI 10.2307/3677313; Wu H, 2012, WATER RESOUR RES; Yue S, 2004, WATER RESOUR MANAG, V18, P201, DOI 10.1023/B:WARM.0000043140.61082.60	74	27	28	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135334	10.1371/journal.pone.0135334	http://dx.doi.org/10.1371/journal.pone.0135334			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295478	Green Published, gold			2022-12-27	WOS:000359926900027
J	Harada, AE; Lindgren, EA; Hermsmeier, MC; Rogowski, PA; Terrill, E; Burton, RS				Harada, Alice E.; Lindgren, Elise A.; Hermsmeier, Maiko C.; Rogowski, Peter A.; Terrill, Eric; Burton, Ronald S.			Monitoring Spawning Activity in a Southern California Marine Protected Area Using Molecular Identification of Fish Eggs	PLOS ONE			English	Article							TEMPORAL PATTERNS; ASSEMBLAGES	In order to protect the diverse ecosystems of coastal California, a series of marine protected areas (MPAs) have been established. The ability of these MPAs to preserve and potentially enhance marine resources can only be assessed if these habitats are monitored through time. This study establishes a baseline for monitoring the spawning activity of fish in the MPAs adjacent to Scripps Institution of Oceanography (La Jolla, CA, USA) by sampling fish eggs from the plankton. Using vertical plankton net tows, 266 collections were made from the Scripps Pier between 23 August 2012 and 28 August 2014; a total of 21,269 eggs were obtained. Eggs were identified using DNA barcoding: the COI or 16S rRNA gene was amplified from individual eggs and sequenced. All eggs that were successfully sequenced could be identified from a database of molecular barcodes of California fish species, resulting in species-level identification of 13,249 eggs. Additionally, a surface transport model of coastal circulation driven by current maps from high frequency radar was used to construct probability maps that estimate spawning locations that gave rise to the collected eggs. These maps indicated that currents usually come from the north but water parcels tend to be retained within the MPA; eggs sampled at the Scripps Pier have a high probability of having been spawned within the MPA. The surface transport model also suggests that although larvae have a high probability of being retained within the MPA, there is also significant spill-over into nearby areas outside the MPA. This study provides an important baseline for addressing the extent to which spawning patterns of coastal California species may be affected by future changes in the ocean environment.	[Harada, Alice E.; Lindgren, Elise A.; Hermsmeier, Maiko C.; Burton, Ronald S.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; [Rogowski, Peter A.; Terrill, Eric] Univ Calif San Diego, Scripps Inst Oceanog, CORDC, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography	Harada, AE (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	aharada@ucsd.edu	Terrill, Eric/ABA-4169-2021; Burton, R/F-7694-2010	Burton, R/0000-0002-6995-5329; Harada, Alice/0000-0002-8747-502X	National Oceanic and Atmospheric Administration Grant [NA10OAR4170060]; California Sea Grant Project [2012-R/FISH-216]; Division Of Ocean Sciences [1026607] Funding Source: National Science Foundation	National Oceanic and Atmospheric Administration Grant(National Oceanic Atmospheric Admin (NOAA) - USA); California Sea Grant Project; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This project was supported by National Oceanic and Atmospheric Administration Grant #NA10OAR4170060, California Sea Grant Project No. 2012-R/FISH-216. The statements, findings, conclusions and recommendations are those of the authors and do not necessarily reflect the views of California Sea Grant, state agencies, NOAA or the United States Department of Commerce.	Ahlstrom E. H., 1968, Report California Cooperative Oceanic Fisheries Investigations, V12, P64; Ahlstrom E.H., 1980, California Cooperative Oceanic Fisheries Investigations Reports, V21, P121; Ahlstrom E. H., 1967, Report California Cooperative Oceanic Fisheries Investigations, V11 (1963-1966), P117; AMBROSE RF, 1989, B MAR SCI, V44, P718; Ardura A, 2010, BIOL CONSERV, V143, P1438, DOI 10.1016/j.biocon.2010.03.019; Bacheler NM, 2010, FISH OCEANOGR, V19, P107, DOI 10.1111/j.1365-2419.2009.00531.x; Batchelder HP, 2006, J ATMOS OCEAN TECH, V23, P727, DOI 10.1175/JTECH1874.1; California Department of Fish and Wildlife [Internet], SO CAL MAR PROT AR; Craig MT, 2004, COAST MANAGE, V32, P341, DOI 10.1080/08920750490487188; Duffy-Anderson JT, 2006, FISH OCEANOGR, V15, P80, DOI 10.1111/j.1365-2419.2005.00348.x; Feder HM, 1974, OBSERVATIONS FISHES; Fraker ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120752; Gleason LU, 2012, MOL ECOL RESOUR, V12, P57, DOI 10.1111/j.1755-0998.2011.03059.x; GreenRuiz YA, 1997, J PLANKTON RES, V19, P957, DOI 10.1093/plankt/19.8.957; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hastings P. A., 2014, Bulletin Southern California Academy of Sciences, V113, P200; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hyde JR, 2005, MAR ECOL PROG SER, V286, P269, DOI 10.3354/meps286269; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; JACKSON GA, 1983, CONT SHELF RES, V2, P75, DOI 10.1016/0278-4343(83)90023-7; Kawakami T, 2010, ENVIRON BIOL FISH, V87, P221, DOI 10.1007/s10641-010-9592-2; Kim SY, 2009, ENVIRON SCI TECHNOL, V43, P7450, DOI 10.1021/es900775p; Kim SY, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004244; Lakra WS, 2011, MOL ECOL RESOUR, V11, P60, DOI 10.1111/j.1755-0998.2010.02894.x; Love M. S., 2002, ROCKFISHES NE PACIFI; Matarese A.C., 1984, American Society of Ichthyologists and Herpetologists Special Publication, P27; Matarese AC, 2003, NOAA PROFESSIONAL PA, V1, P281; Miller EF, 2013, ESTUAR COAST SHELF S, V127, P29, DOI 10.1016/j.ecss.2013.04.014; Moser HG, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P269; Ohlmann C, 2007, J ATMOS OCEAN TECH, V24, P666, DOI 10.1175/JTECH1998.1; Paduan J. D., 1997, OCEANOGRAPHY, V10, P36, DOI DOI 10.5670/OCEANOG.1997.18; PAULY D, 1988, ENVIRON BIOL FISH, V22, P261, DOI 10.1007/BF00004892; Planque B, 2007, FISH OCEANOGR, V16, P16, DOI 10.1111/j.1365-2419.2006.00411.x; Rogowski PA, 2015, MAR POLLUT BULL, V90, P135, DOI 10.1016/j.marpolbul.2014.11.004; Schroeder DM, 2002, CAL COOP OCEAN FISH, V43, P182; SIGNELL RP, 1991, J GEOPHYS RES-OCEANS, V96, P2561, DOI 10.1029/90JC02029; Smith PJ, 2008, J FISH BIOL, V72, P464, DOI 10.1111/j.1095-8649.2007.01745.x; Sobel JA, 2004, MARINE RESERVES GUID; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Stephens JS, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P227; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Watson W, 1999, CAL COOP OCEAN FISH, V40, P128	42	35	36	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134647	10.1371/journal.pone.0134647	http://dx.doi.org/10.1371/journal.pone.0134647			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308928	Green Published, gold			2022-12-27	WOS:000360069400028
J	Basset, Y; Barrios, H; Segar, S; Srygley, RB; Aiello, A; Warren, AD; Delgado, F; Coronado, J; Lezcano, J; Arizala, S; Rivera, M; Perez, F; Bobadilla, R; Lopez, Y; Ramirez, JA				Basset, Yves; Barrios, Hector; Segar, Simon; Srygley, Robert B.; Aiello, Annette; Warren, Andrew D.; Delgado, Francisco; Coronado, James; Lezcano, Jorge; Arizala, Stephany; Rivera, Marleny; Perez, Filonila; Bobadilla, Ricardo; Lopez, Yacksecari; Alejandro Ramirez, Jose			The Butterflies of Barro Colorado Island, Panama: Local Extinction since the 1930s	PLOS ONE			English	Article							TROPICAL RAIN-FORESTS; BRITISH BUTTERFLIES; DNA BARCODES; EL-NINO; LEPIDOPTERA; ASSEMBLAGES; ABUNDANCE; ECOLOGY; CONSERVATION; DIVERSITY	Few data are available about the regional or local extinction of tropical butterfly species. When confirmed, local extinction was often due to the loss of host-plant species. We used published lists and recent monitoring programs to evaluate changes in butterfly composition on Barro Colorado Island (BCI, Panama) between an old (1923-1943) and a recent (19932013) period. Although 601 butterfly species have been recorded from BCI during the 1923-2013 period, we estimate that 390 species are currently breeding on the island, including 34 cryptic species, currently only known by their DNA Barcode Index Number. Twenty-three butterfly species that were considered abundant during the old period could not be collected during the recent period, despite a much higher sampling effort in recent times. We consider these species locally extinct from BCI and they conservatively represent 6% of the estimated local pool of resident species. Extinct species represent distant phylogenetic branches and several families. The butterfly traits most likely to influence the probability of extinction were host growth form, wing size and host specificity, independently of the phylogenetic relationships among butterfly species. On BCI, most likely candidates for extinction were small hesperiids feeding on herbs (35% of extinct species). However, contrary to our working hypothesis, extinction of these species on BCI cannot be attributed to loss of host plants. In most cases these host plants remain extant, but they probably subsist at lower or more fragmented densities. Coupled with low dispersal power, this reduced availability of host plants has probably caused the local extinction of some butterfly species. Many more bird than butterfly species have been lost from BCI recently, confirming that small preserves may be far more effective at conserving invertebrates than vertebrates and, therefore, should not necessarily be neglected from a conservation viewpoint.	[Basset, Yves; Srygley, Robert B.; Aiello, Annette; Coronado, James; Lezcano, Jorge; Arizala, Stephany; Perez, Filonila; Bobadilla, Ricardo; Lopez, Yacksecari; Alejandro Ramirez, Jose] Smithsonian Trop Res Inst, Panama City, Panama; [Basset, Yves; Segar, Simon] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Basset, Yves; Segar, Simon] Acad Sci Czech Republ, Inst Entomol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Basset, Yves; Barrios, Hector; Rivera, Marleny] Univ Panama, Maestria Entomol, Panama City 080814, Panama; [Srygley, Robert B.] ARS, Northern Plains Agr Lab, USDA, Sidney, MT 59270 USA; [Warren, Andrew D.] Univ Florida, Florida Museum Nat Hist, McGuire Ctr Lepidoptera & Biodivers, Gainesville, FL 32611 USA; [Delgado, Francisco] Univ Panama, Ctr Reg Univ Veraguas, Santiago, Panama	Smithsonian Institution; Smithsonian Tropical Research Institute; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Universidad de Panama; United States Department of Agriculture (USDA); State University System of Florida; University of Florida; Universidad de Panama	Basset, Y (corresponding author), Smithsonian Trop Res Inst, Apartado 0843-03092, Panama City, Panama.	bassety@si.edu	Segar, Simon/K-6783-2015; Basset, Yves F/B-6642-2014	Basset, Yves F/0000-0002-1942-5717; Arizala Cobo, Stephany/0000-0003-3996-5435; Rivera, Marleny E./0000-0003-1231-4579; Coronado, James/0000-0003-0562-9935	Smithsonian Institution Barcoding Opportunity [FY012, FY013]; Czech Science foundation GACR [41-14-36068G]; USB Postdoc project - EU Education for Competitiveness Operational Programme [CZ.1.07/2.3.00/30.0006]; European Social Fund; Czech State Budget; STRI; NSF Graduate Research Fellowship; OTS-Mellon award; NSF [DEB 9419543, DEB 9119619]	Smithsonian Institution Barcoding Opportunity; Czech Science foundation GACR(Grant Agency of the Czech Republic); USB Postdoc project - EU Education for Competitiveness Operational Programme; European Social Fund(European Social Fund (ESF)); Czech State Budget; STRI(Smithsonian InstitutionSmithsonian Tropical Research Institute); NSF Graduate Research Fellowship(National Science Foundation (NSF)); OTS-Mellon award; NSF(National Science Foundation (NSF))	Grants from the Smithsonian Institution Barcoding Opportunity FY012 and FY013 and in-kind help from the Canadian Centre for DNA Barcoding via Paul Hebert and Alex Borisenko at the Biodiversity Institute of Ontario allowed the sequencing of many of the butterfly specimens collected recently on BCI. YB was supported by Czech Science foundation GACR grant 41-14-36068G and is a member of the Sistema Nacional de Investigacion, SENACYT, Panama. SS was funded by a USB Postdoc project (reg. no. CZ.1.07/2.3.00/30.0006), funded by the EU Education for Competitiveness Operational Programme, the European Social Fund and the Czech State Budget. RBS's sampling was supported by a short-term Fellowship from STRI, an NSF Graduate Research Fellowship, and an OTS-Mellon award. Tom Kursar kindly made available the BCI butterfly data of P.D. Coley and T.A. Kursar, which were supported by NSF grants DEB 9419543 and DEB 9119619.	AIELLO A, 1991, Journal of the Lepidopterists' Society, V45, P181; Aiello A, 2014, AIELLO INSECT REARIN; Aiello A, 2005, ESTUDIOS SOBRE LA BI, P494; Aiello Annette, 1992, P573; Aiello Annette, 1992, P549; [Anonymous], 2014, TRACER V1 6; Basset Y, 1998, J APPL ECOL, V35, P461, DOI 10.1046/j.1365-2664.1998.00311.x; Basset Y, 2013, INSECT CONSERV DIVER, V6, P223, DOI 10.1111/j.1752-4598.2012.00205.x; Basset Yves, 2011, Journal of Research on the Lepidoptera, V44, P17; Bates H.W., 1862, T LINN SOC LOND, V23, P495; BELL E. L., 1937, AMER MUS NOVITATES, V938, P1; Bell EL, 1931, J NY ENT SOC, V39, P81; Bonebrake TC, 2010, BIOL CONSERV, V143, P1831, DOI 10.1016/j.biocon.2010.04.044; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Braak Ter C., 1998, CANOCO REFERENCE MAN; Braby MF, 2012, BIOL J LINN SOC, V106, P699, DOI 10.1111/j.1095-8312.2012.01909.x; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Charrette NA, 2006, ECOLOGY, V87, P2330, DOI 10.1890/0012-9658(2006)87[2330:RSBBAL]2.0.CO;2; Chen IC, 2009, P NATL ACAD SCI USA, V106, P1479, DOI 10.1073/pnas.0809320106; Cleary DFR, 2009, BASIC APPL ECOL, V10, P237, DOI 10.1016/j.baae.2008.03.004; Colwell RK, 2009, ESTIMATES STATISTICA; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Craft KJ, 2010, P NATL ACAD SCI USA, V107, P5041, DOI 10.1073/pnas.0913084107; Croat TB, 1978, FLORA OF BARRO COLOR; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DeVries P.J., 1978, Brenesia, V14-15, P47; Devries Philip J., 1994, P187; DEVRIES PJ, 1991, BIOL J LINN SOC, V43, P179, DOI 10.1111/j.1095-8312.1991.tb00592.x; DeVries PJ, 1987, THE BUTTERFLIES OF C, VI; DeVries PJ, 1997, THE BUTTERFLIES OF C, VII; DUDLEY R, 1994, J EXP BIOL, V191, P125; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Enders R. K., 1935, Bulletin of the Museum of Comparative Zoology, V78, P385; Erhardt A., 1991, Symposia of the Royal Entomological Society of London, P213; Foster RB, 1982, ECOLOGY TROPICAL FOR, P67; Galdamenes C, 2012, RECORDS OF VASCULAR; Ghazoul J, 2002, BIODIVERS CONSERV, V11, P521, DOI 10.1023/A:1014812701423; Hallwachs W, 2014, DYNAMIC DATABASE FOR; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Heikkila M, 2012, P ROY SOC B-BIOL SCI, V279, P1093, DOI 10.1098/rspb.2011.1430; Ho L. S. T., 2015, PACKAGE PHYLOLM; HUNTINGTON E. IRVING, 1932, BULL AMER MUS NAT HIST, V63, P191; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; KARR JR, 1982, AM NAT, V119, P220, DOI 10.1086/283904; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kenoyer LA, 1929, ECOLOGY, V10, P201, DOI 10.2307/1932295; Koh LP, 2004, CONSERV BIOL, V18, P1571, DOI 10.1111/j.1523-1739.2004.00468.x; Koh LP, 2004, ECOL APPL, V14, P1695, DOI 10.1890/03-5269; Koh LP, 2004, BIOTROPICA, V36, P272, DOI 10.1111/j.1744-7429.2004.tb00319.x; Lamas G, 2006, ATLAS OF NEOTROPICAL; Larsen TB, 2008, BIODIVERS CONSERV, V17, P2833, DOI 10.1007/s10531-008-9399-z; Leck CF, 1970, J RES LEPIDOPTERA, V8, P133; Leigh EG, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P451; Leigh EG, 1999, TROPICAL FOREST ECOL; Lewis Owen T., 2007, Symposia of the Royal Entomological Society of London, V23, P34, DOI 10.1079/9781845932541.0034; Linnaeus C., 1758, SYSTEMA NATURE PER R; MALLET J, 1986, HEREDITY, V56, P191, DOI 10.1038/hdy.1986.31; Mavarez J, 2006, NATURE, V441, P868, DOI 10.1038/nature04738; MCZ, 2013, MCZBASE THE DATABASE; Miller, 1985, J RES LEPIDOPTERA, V23, P282; Ollerton J, 2014, SCIENCE, V346, P1360, DOI 10.1126/science.1257259; Orme D, 2013, THE CAPER PACKAGE CO; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; POLLARD E, 1977, BIOL CONSERV, V12, P115, DOI 10.1016/0006-3207(77)90065-9; Purvis A, 2010, PROC ROY SOC B BIOL; Rambaut A., 2014, TREEANNOTATOR V2 1 2; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; ROBBINS RK, 1981, BIOTROPICA, V13, P308, DOI 10.2307/2387810; Robbins RK, 1982, J LEP SOC, V46, P298; Roubik D.W., 1991, MONOGRAPHS SYSTEMATI, V36; Ruckes H, 1965, J LEPID SOC, V19, P190; Salvin O, 1878, BIOLOGIA CENTRALI AM, VI-III; Schulze CH, 2010, ENVIRON SCI ENG, P73, DOI 10.1007/978-3-642-00493-3_3; Sheldon W. G., 1933, Entomologist London, V66, P217; Silberglied R.E., 1979, Psyche (Cambridge), V86, P219, DOI 10.1155/1979/50172; SPARROW HR, 1994, CONSERV BIOL, V8, P800, DOI 10.1046/j.1523-1739.1994.08030800.x; SRYGLEY RB, 1990, AM NAT, V135, P766, DOI 10.1086/285073; SRYGLEY RB, 1990, OECOLOGIA, V84, P491, DOI 10.1007/BF00328165; Srygley RB, 2014, BIOTROPICA, V46, P90, DOI 10.1111/btp.12081; Srygley RB, 2010, GLOBAL CHANGE BIOL, V16, P936, DOI 10.1111/j.1365-2486.2009.01986.x; STRI, 2013, STRI SYNOPTIC DRY CO; Strong DR, 1984, INSECTS ON PLANTS CO; THOMAS CD, 1991, BIOL CONSERV, V55, P269, DOI 10.1016/0006-3207(91)90032-5; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; Vlasanek P, 2013, ECOL ENTOMOL, V38, P560, DOI 10.1111/een.12051; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Wahlberg N, 2006, SYST BIOL, V55, P703, DOI 10.1080/10635150600913235; Warren AD, 2014, ILLUSTRATED LISTS OF; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Wilson John James, 2012, Methods Mol Biol, V858, P17, DOI 10.1007/978-1-61779-591-6_3; Windsor DM, 1990, CLIMATE AND MOISTURE; WOLDA H, 1992, OECOLOGIA, V89, P47, DOI 10.1007/BF00319014; Wright SJ, 2010, ANN NY ACAD SCI, V1195, P1, DOI [10.1111/j.1749-6632.2009.05400.x, 10.1111/j.1749-6632.2010.05455.x]	95	28	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136623	10.1371/journal.pone.0136623	http://dx.doi.org/10.1371/journal.pone.0136623			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305111	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000359995500100
J	Chiroma, H; Abdul-kareem, S; Khan, A; Nawi, NM; Gital, AY; Shuib, L; Abubakar, AI; Rahman, MZ; Herawan, T				Chiroma, Haruna; Abdul-kareem, Sameem; Khan, Abdullah; Nawi, Nazri Mohd; Gital, Abdulsalam Ya'u; Shuib, Liyana; Abubakar, Adamu I.; Rahman, Muhammad Zubair; Herawan, Tutut			Global Warming: Predicting OPEC Carbon Dioxide Emissions from Petroleum Consumption Using Neural Network and Hybrid Cuckoo Search Algorithm	PLOS ONE			English	Article							FORECASTING-MODEL; ENERGY EFFICIENCY; CO2 EMISSIONS; OPTIMIZATION; SYSTEM; COST	Background Global warming is attracting attention from policy makers due to its impacts such as floods, extreme weather, increases in temperature by 0.7 degrees C, heat waves, storms, etc. These disasters result in loss of human life and billions of dollars in property. Global warming is believed to be caused by the emissions of greenhouse gases due to human activities including the emissions of carbon dioxide (CO2) from petroleum consumption. Limitations of the previous methods of predicting CO2 emissions and lack of work on the prediction of the Organization of the Petroleum Exporting Countries (OPEC) CO2 emissions from petroleum consumption have motivated this research. Methods/Findings The OPEC CO2 emissions data were collected from the Energy Information Administration. Artificial Neural Network (ANN) adaptability and performance motivated its choice for this study. To improve effectiveness of the ANN, the cuckoo search algorithm was hybridised with accelerated particle swarm optimisation for training the ANN to build a model for the prediction of OPEC CO2 emissions. The proposed model predicts OPEC CO2 emissions for 3, 6, 9, 12 and 16 years with an improved accuracy and speed over the state-of-the-art methods. Conclusion An accurate prediction of OPEC CO2 emissions can serve as a reference point for propagating the reorganisation of economic development in OPEC member countries with the view of reducing CO2 emissions to Kyoto benchmarks-hence, reducing global warming. The policy implications are discussed in the paper.	[Chiroma, Haruna; Abdul-kareem, Sameem; Shuib, Liyana; Herawan, Tutut] Univ Malaya, Fac Comp Sci & IT, Kuala Lumpur, Malaysia; [Khan, Abdullah; Nawi, Nazri Mohd; Rahman, Muhammad Zubair] Univ Tun Hussein Onn, Software & Multimedia Ctr, Fac Sci & Comp Technol, Johor Baharu, Malaysia; [Gital, Abdulsalam Ya'u] Univ Technol Malaysia, Fac Comp, Johor Baharu, Malaysia; [Abubakar, Adamu I.] Int Islamic Univ Malaysia, Fac Informat & Commun Technol, Kuala Lumpur, Malaysia; [Chiroma, Haruna] Fed Coll Educ Tech, Dept Comp Sci, Sch Sci, Gombe, Nigeria	Universiti Malaya; University of Tun Hussein Onn Malaysia; Universiti Teknologi Malaysia; International Islamic University Malaysia	Chiroma, H (corresponding author), Univ Malaya, Fac Comp Sci & IT, Kuala Lumpur, Malaysia.	hchiroma@acm.org	Haruna, Ph.D Chiroma/O-2934-2013; khan, abdullah/L-5552-2019; Abdul Kareem, Sameem/B-2259-2009; Gillani, Syed Muhammad Zubair Rehman/X-6437-2019; ullah, abd/J-6178-2013; Abubakar, Adamu/Q-8279-2016; Shuib, Nor Liyana Mohd/M-8698-2013; Ibrahim, Adamu Abubakar/AAD-3655-2019; Shuib, Liyana/ABH-6159-2020; Herawan, Tutut/AAB-6534-2021	Haruna, Ph.D Chiroma/0000-0003-3446-4316; khan, abdullah/0000-0003-1718-7038; Abdul Kareem, Sameem/0000-0001-5177-8013; Gillani, Syed Muhammad Zubair Rehman/0000-0003-2589-4189; ullah, abd/0000-0003-1718-7038; Abubakar, Adamu/0000-0001-6471-481X; Shuib, Nor Liyana Mohd/0000-0002-7907-0671; Shuib, Liyana/0000-0002-7907-0671; Herawan, Tutut/0000-0001-9262-9137; Mohd Nawi, Nazri/0000-0003-0685-7892; Ya'u Gital, Abdulsalam/0000-0001-6495-3693	University of Malaya High Impact Research Grant from Ministry of Higher Education Malaysia [UM.C/625/HIR/MOHE/SC/13/2]	University of Malaya High Impact Research Grant from Ministry of Higher Education Malaysia	This work is supported by University of Malaya High Impact Research Grant No vote UM.C/625/HIR/MOHE/SC/13/2 from Ministry of Higher Education Malaysia.	Abu Bakar S.Z., 2014, RECENT ADV SOFT COMP, P239; Adetutu MO, 2014, APPL ENERG, V119, P363, DOI 10.1016/j.apenergy.2014.01.015; [Anonymous], 2002, NEURAL NETWORK DESIG; Bao GL, 2012, ADV MATER RES-SWITZ, V518-523, P1664, DOI 10.4028/www.scientific.net/AMR.518-523.1664; Barnett J, 2004, ENERG POLICY, V32, P2077, DOI 10.1016/S0301-4215(03)00183-6; Beale MH, 2013, NEURAL NETWORK TOOLB; Bhandari AK, 2014, EXPERT SYST APPL, V41, P3538, DOI 10.1016/j.eswa.2013.10.059; Bishop MC, 1995, NEURAL NETWORK PATTE; Bt Abu Bakar S.Z., 2014, LECT NOTES ELECT ENG, P151, DOI DOI 10.1007/978-981-4585-18-7_18; Chen T, 2013, COMPUT IND ENG, V66, P834, DOI 10.1016/j.cie.2013.09.010; Chen T, 2012, INT J INNOV COMPUT I, V8, P7679; Chen T, 2011, INTELL DATA ANAL, V15, P763, DOI 10.3233/IDA-2011-0494; Chiroma H, 2014, LECT NOTES COMPUT SC, V8584, P770, DOI 10.1007/978-3-319-09153-2_57; Chiroma H, 2013, NEURAL NETW WORLD, V23, P523, DOI 10.14311/NNW.2013.23.032; Civicioglu P, 2013, ARTIF INTELL REV, V39, P315, DOI 10.1007/s10462-011-9276-0; Dehuri S, 2010, NEURAL COMPUT APPL, V19, P187, DOI 10.1007/s00521-009-0288-5; Ekonomou L, 2010, ENERGY, V35, P512, DOI 10.1016/j.energy.2009.10.018; Hair F., 2010, MULTIVARIATE DATA AN; Haykin S, 2005, NEURAL NETWORK COMPR; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Kandel A, 2000, NEURO FUZZY PATTERN; Karaboga D, 2007, LECT NOTES ARTIF INT, V4617, P318; Kaynar O, 2011, ENER EDUC SCI TECH-A, V26, P221; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Khosravi A, 2013, IEEE T SUSTAIN ENERG, V4, P602, DOI 10.1109/TSTE.2012.2232944; Kumar S, 2010, COMPUT MATH APPL, V60, P1049, DOI 10.1016/j.camwa.2010.03.061; Kusiak A, 2013, IEEE T SUSTAIN ENERG, V4, P756, DOI 10.1109/TSTE.2013.2246590; Kysely J, 2010, GLOBAL PLANET CHANGE, V72, P55, DOI 10.1016/j.gloplacha.2010.03.006; Lin CS, 2011, APPL ENERG, V88, P3816, DOI 10.1016/j.apenergy.2011.05.013; Lindstad H, 2011, ENERG POLICY, V39, P3456, DOI 10.1016/j.enpol.2011.03.044; Marichelvam MK, 2014, APPL SOFT COMPUT, V19, P93, DOI 10.1016/j.asoc.2014.02.005; Memon J, 2013, INT J GLOBAL WARM, V5, P255, DOI 10.1504/IJGW.2013.055361; Meng M, 2014, ENERGY, V64, P673, DOI 10.1016/j.energy.2013.10.017; Mondor E., 2010, NAT ED KNOWL, V3, P23; Nawi NM, 2014, LECT NOTES COMPUT SC, V8835, P237, DOI 10.1007/978-3-319-12640-1_29; Nguyen KDT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029340; Ouaarab A, 2014, NEURAL COMPUT APPL, V24, P1659, DOI 10.1007/s00521-013-1402-2; Pan TY, 2004, J HYDROL, V297, P34, DOI 10.1016/j.jhydrol.2004.04.010; Payne RB, 2005, THE CUCKOOS; Richardson Katherine, 2009, SYNTHESIS REPORT CLI, P8; Sahab MG, 2013, ELSEV INSIGHT, P25, DOI 10.1016/B978-0-12-398364-0.00002-4; Salimi H., 2012, INT J ARTIFICIAL INT, V3, P343, DOI DOI 10.5121/IJAIA.2012.31011; Sari R, 2009, APPL ENERG, V86, P1887, DOI 10.1016/j.apenergy.2008.12.007; Smith JC, 2013, IEEE POWER ENERGY M, V11, P16, DOI 10.1109/MPE.2013.2276195; Subotic M., 2012, P 5 WSEAS C APPL COM, P151; Tang N, 2011, ENRGY PROCED, V12, DOI 10.1016/j.egypro.2011.10.025; Uddin M, 2011, INT J GLOBAL WARM, V3, P372, DOI 10.1504/IJGW.2011.044400; Uzer MS, 2013, NEURAL COMPUT APPL, V23, P719, DOI 10.1007/s00521-012-0982-6; Valian E., 2011, INT J ARTIFICIAL INT, V2, P36, DOI DOI 10.5121/IJAIA.2011.2304; Venkiteswaran JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101756; Walton S, 2011, CHAOS SOLITON FRACT, V44, P710, DOI 10.1016/j.chaos.2011.06.004; Wang SS, 2011, ENERG POLICY, V39, P4870, DOI 10.1016/j.enpol.2011.06.032; Witten I. H., 2005, DATA MINING PRACTICA; WONG BK, 1995, EXPERT SYST, V12, P253, DOI 10.1111/j.1468-0394.1995.tb00114.x; Xu Y, 2012, NEURAL COMPUT APPL, V21, P1865, DOI 10.1007/s00521-011-0547-0; Yang X., 2008, NATURE INSPIRED META, V2nd; Yang XS, 2009, WOR CONG NAT BIOL, P210, DOI 10.1109/nabic.2009.5393690; Yang XS, 2014, NEURAL COMPUT APPL, V24, P169, DOI 10.1007/s00521-013-1367-1; Yang XS, 2013, COMPUT OPER RES, V40, P1616, DOI 10.1016/j.cor.2011.09.026; Yang XS, 2011, COMM COM INF SC, V136, P53; Yu LA, 2008, IEEE SYS MAN CYBERN, P489, DOI 10.1109/ICSMC.2008.4811324; Zhang GP, 2001, COMPUT OPER RES, V28, P381, DOI 10.1016/S0305-0548(99)00123-9; Zhang GQ, 1998, INT J FORECASTING, V14, P35, DOI 10.1016/S0169-2070(97)00044-7; Zhang QM, 2009, ADV INTEL SOFT COMPU, V62, P1275; Zheng HQ, 2012, J COMPUT INFORM SYST, V8, P4193; Zweiri YH, 2003, NEUROCOMPUTING, V50, P305, DOI 10.1016/S0925-2312(02)00569-6	66	24	24	5	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136140	10.1371/journal.pone.0136140	http://dx.doi.org/10.1371/journal.pone.0136140			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305483	gold, Green Published, Green Submitted			2022-12-27	WOS:000359995500050
J	Marinac, CR; Sears, DD; Natarajan, L; Gallo, LC; Breen, CI; Patterson, RE				Marinac, Catherine R.; Sears, Dorothy D.; Natarajan, Loki; Gallo, Linda C.; Breen, Caitlin I.; Patterson, Ruth E.			Frequency and Circadian Timing of Eating May Influence Biomarkers of Inflammation and Insulin Resistance Associated with Breast Cancer Risk	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MEAL FREQUENCY; CALORIC-INTAKE; BLOOD-GLUCOSE; HEALTHY; TIME; DISEASE; WOMEN; EXPRESSION; PREVENTION	Emerging evidence suggests that there is interplay between the frequency and circadian timing of eating and metabolic health. We examined the associations of eating frequency and timing with metabolic and inflammatory biomarkers putatively associated with breast cancer risk in women participating in the National Health and Nutrition Examination 2009-2010 Survey. Eating frequency and timing variables were calculated from 24-hour food records and included (1) proportion of calories consumed in the evening (5pm-midnight), (2) number of eating episodes per day, and (3) nighttime fasting duration. Linear regression models examined each eating frequency and timing exposure variable with C-reactive protein (CRP) concentrations and the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR). Each 10 percent increase in the proportion of calories consumed in the evening was associated with a 3 percent increase in CRP. Conversely, eating one additional meal or snack per day was associated with an 8 percent reduction in CRP. There was a significant interaction between proportion of calories consumed in the evening and fasting duration with CRP (p = 0.02). A longer nighttime fasting duration was associated with an 8 percent lower CRP only among women who ate less than 30% of their total daily calories in the evening (p = 0.01). None of the eating frequency and timing variables were significantly associated with HOMA-IR. These findings suggest that eating more frequently, reducing evening energy intake, and fasting for longer nightly intervals may lower systemic inflammation and subsequently reduce breast cancer risk. Randomized trials are needed to validate these associations.	[Marinac, Catherine R.; Sears, Dorothy D.; Natarajan, Loki; Breen, Caitlin I.; Patterson, Ruth E.] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Marinac, Catherine R.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Sears, Dorothy D.; Natarajan, Loki; Patterson, Ruth E.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Sears, Dorothy D.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Gallo, Linda C.] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA	University of California System; University of California San Diego; California State University System; San Diego State University; University of California System; University of California San Diego; University of California System; University of California San Diego; California State University System; San Diego State University	Marinac, CR (corresponding author), Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA.	crmarinac@ucsd.edu	Sears, Dorothy D/AHE-5524-2022	Sears, Dorothy D/0000-0002-9260-3540; Gallo, Linda C./0000-0002-3678-5888	NCI [1F31CA183125-01A1]; National Cancer Institute Centers for Transdisciplinary Research on Energetics and Cancer [1U54CA155435-01]; NATIONAL CANCER INSTITUTE [F31CA183125, P30CA023100, U54CA155435] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute Centers for Transdisciplinary Research on Energetics and Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Ms. Marinac is a recipient of an NCI-sponsored Ruth L. Kirschstein National Research Service Award (1F31CA183125-01A1). This work was also supported by the National Cancer Institute Centers for Transdisciplinary Research on Energetics and Cancer (1U54CA155435-01). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almoosawi S, 2012, EUR J CLIN NUTR, V66, P678, DOI 10.1038/ejcn.2011.210; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; BERTELSEN J, 1993, DIABETES CARE, V16, P4, DOI 10.2337/diacare.16.1.4; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Carlson O, 2007, METABOLISM, V56, P1729, DOI 10.1016/j.metabol.2007.07.018; Centers for Disease Control and Prevention, 2009, NAT CTR HLTH STAT NH; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Gunter MJ, 2009, JNCI-J NATL CANCER I, V101, P48, DOI 10.1093/jnci/djn415; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Jakubowicz D, 2013, OBESITY, V21, P2504, DOI 10.1002/oby.20460; JENKINS DJA, 1992, AM J CLIN NUTR, V55, P461, DOI 10.1093/ajcn/55.2.461; Kabat GC, 2009, INT J CANCER, V125, P2704, DOI 10.1002/ijc.24609; Kahleova H, 2014, DIABETOLOGIA, V57, P1552, DOI 10.1007/s00125-014-3253-5; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Marinac CR, 2015, CANCER EPIDEM BIOMAR, V24, P783, DOI 10.1158/1055-9965.EPI-14-1292; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meier-Ewert HK, 2001, CLIN CHEM, V47, P426; Morgan LM, 2012, BRIT J NUTR, V108, P1286, DOI 10.1017/S0007114511006507; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Ockene IS, 2001, CLIN CHEM, V47, P444; Ollberding NJ, 2013, CANCER PREV RES, V6, P188, DOI 10.1158/1940-6207.CAPR-12-0374; Patterson RE, 2015, J ACAD NUTR DIET, V115, P1203, DOI 10.1016/j.jand.2015.02.018; Patterson RE, 2013, J ACAD NUTR DIET, V113, P288, DOI 10.1016/j.jand.2012.08.015; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Rashidi MR, 2003, SAUDI MED J, V24, P945; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Rothschild J, 2014, NUTR REV, V72, P308, DOI 10.1111/nure.12104; Shacter E, 2002, ONCOLOGY-NY, V16, P217; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sofer S, 2015, ADV NUTR, V6, P214, DOI 10.3945/an.114.007518; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Willet W, 1998, NUTR EPIDEMIOLOGY; Wright KP, 2015, BRAIN BEHAV IMMUN, V47, P24, DOI 10.1016/j.bbi.2015.01.004	36	67	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136240	10.1371/journal.pone.0136240	http://dx.doi.org/10.1371/journal.pone.0136240			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305095	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500055
J	Ni, JL; Hu, SF; Zhang, JT; Tang, WX; Lu, WH; Zhang, C				Ni, Jianliang; Hu, Shuangfei; Zhang, Jiangtao; Tang, Wenxin; Lu, Weihong; Zhang, Chen			A Preliminary Genetic Analysis of Complement 3 Gene and Schizophrenia	PLOS ONE			English	Article							CYTOKINE ALTERATIONS; COMMON VARIANTS; ASSOCIATION; C3; SUSCEPTIBILITY; RISK; POLYMORPHISMS; INFLAMMATION; EXPRESSION; PATHWAY	Complement pathway activation was found to occur frequently in schizophrenia, and complement 3 (C3) plays a major role in this process. Previous studies have provided evidence for the possible role of C3 in the development of schizophrenia. In this study, we hypothesized that the gene encoding C3 (C3) may confer susceptibility to schizophrenia in Han Chinese. We analyzed 7 common single nucleotide polymorphisms (SNPs) of C3 in 647 schizophrenia patients and 687 healthy controls. Peripheral C3 mRNA expression level was measured in 23 drug-naive patients with schizophrenia and 24 controls. Two SNPs (rs1047286 and rs2250656) that deviated from Hardy-Weinberg equilibrium were excluded for further analysis. Among the remaining 5 SNPs, there was no significant difference in allele and genotype frequencies between the patient and control groups. Logistic regression analysis showed no significant SNP-gender interaction in either dominant model or recessive model. There was no significant difference in the level of peripheral C3 expression between the drug-naive schizophrenia patients and healthy controls. In conclusion, the results of this study do not support C3 as a major genetic susceptibility factor in schizophrenia. Other factors in AP may have critical roles in schizophrenia and be worthy of further investigation.	[Ni, Jianliang; Zhang, Jiangtao] Tongde Hosp Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Hu, Shuangfei] Zhejiang Prov Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Tang, Wenxin] Hangzhou Seventh Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Lu, Weihong; Zhang, Chen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Schizophrenia Program, Shanghai 200030, Peoples R China	Zhejiang Provincial People's Hospital; Shanghai Jiao Tong University	Zhang, C (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Schizophrenia Program, Shanghai 200030, Peoples R China.	zhangchen645@gmail.com			National Natural Science Foundation of China [81000581, 81471358]; Shanghai Science and Technology Commission [14411969000]; Shanghai Mental Health Center Foundation [2014-FX-03]; Medical Health Technique Project of Zhejiang Province [2010KYA047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Mental Health Center Foundation; Medical Health Technique Project of Zhejiang Province	This work was supported by the National Natural Science Foundation of China (81000581 and 81471358), the Shanghai Science and Technology Commission (14411969000), the Shanghai Mental Health Center Foundation (2014-FX-03), and the Medical Health Technique Project of Zhejiang Province (2010KYA047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avramopoulos D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116696; Benros ME, 2011, AM J PSYCHIAT, V168, P1303, DOI 10.1176/appi.ajp.2011.11030516; Blackwood DHR, 1996, PSYCHIATR GENET, V6, P51, DOI 10.1097/00041444-199622000-00004; Cannon TD, 1998, ARCH GEN PSYCHIAT, V55, P67, DOI 10.1001/archpsyc.55.1.67; Deleidi M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00172; FANANAS L, 1992, HUM HERED, V42, P162, DOI 10.1159/000154060; Fourgeaud L, 2007, CELL, V131, P1034, DOI 10.1016/j.cell.2007.11.031; Francks C, 2010, MOL PSYCHIATR, V15, P319, DOI 10.1038/mp.2008.100; Hakobyan S, 2005, NEUROSCI LETT, V374, P35, DOI 10.1016/j.neulet.2004.10.024; Leza JC, 2015, NEUROSCI BIOBEHAV R, V55, P612, DOI 10.1016/j.neubiorev.2015.05.014; Li Y, 2012, MOL BIOSYST, V8, P2664, DOI 10.1039/c2mb25158b; Liu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep07018; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; Michailidou I, 2015, ANN NEUROL, V77, P1007, DOI 10.1002/ana.24398; Miller BJ, 2011, BIOL PSYCHIAT, V70, P663, DOI 10.1016/j.biopsych.2011.04.013; Miyagawa H, 2008, RHEUMATOLOGY, V47, P158, DOI 10.1093/rheumatology/kem321; Phillips CM, 2009, AM J CLIN NUTR, V90, P1665, DOI 10.3945/ajcn.2009.28101; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Rhodes B, 2009, GENES IMMUN, V10, P525, DOI 10.1038/gene.2009.23; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; RUDDUCK C, 1985, HUM HERED, V35, P255, DOI 10.1159/000153555; Schmitt A, 2014, FRONTIERS NEUROSCIEN, P8; Schmitt A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00019; Severance EG, 2012, NEUROBIOL DIS, V48, P447, DOI 10.1016/j.nbd.2012.07.005; Soria LD, 2012, REV BRAS PSIQUIATR, V34, P119, DOI 10.1590/S1516-44462012000100022; Takabayashi T, 1996, J IMMUNOL, V156, P3455; Tang WX, 2014, HUM PSYCHOPHARM CLIN, V29, P100, DOI 10.1002/hup.2375; Tichaczek-Goska D, 2012, ADV CLIN EXP MED, V21, P105; Wang SH, 2015, NEUROSCI LETT, V590, P189, DOI 10.1016/j.neulet.2015.02.005; Weinberger DR, 1996, NEUROPSYCHOPHARMACOL, V14, pS1, DOI 10.1016/0893-133X(95)00199-N; Wong CT, 1996, SCHIZOPHR RES, V22, P165, DOI 10.1016/S0920-9964(96)00037-0; Yu QQ, 2015, GENE, V561, P249, DOI 10.1016/j.gene.2015.02.039; Zhang C, 2016, MOL NEUROBIOL, V53, P2936, DOI 10.1007/s12035-015-9193-3; Zhang C, 2014, J AFFECT DISORDERS, V155, P288, DOI 10.1016/j.jad.2013.11.010; Zhang C, 2009, NEUROSCI LETT, V462, P308, DOI 10.1016/j.neulet.2009.06.085; Zhang Y, 2014, PSYCHOPHARMACOLOGY, V231, P2211, DOI 10.1007/s00213-013-3410-4; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072652; Zhu YL, 2015, J HUM GENET, V60, P11, DOI 10.1038/jhg.2014.94	38	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136372	10.1371/journal.pone.0136372	http://dx.doi.org/10.1371/journal.pone.0136372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305563	gold, Green Published, Green Submitted			2022-12-27	WOS:000359995500069
J	Pence, MA; Haste, NM; Meharena, HS; Olson, J; Gallo, RL; Nizet, V; Kristian, SA				Pence, Morgan A.; Haste, Nina M.; Meharena, Hiruy S.; Olson, Joshua; Gallo, Richard L.; Nizet, Victor; Kristian, Sascha A.			Beta-Lactamase Repressor BlaI Modulates Staphylococcus aureus Cathelicidin Antimicrobial Peptide Resistance and Virulence	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; DAPTOMYCIN ACTIVITY; OPERON; GENOME; SUSCEPTIBILITY; EXPRESSION; DEFENSINS; EVOLUTION; PATHOGENS; STRAINS	BlaI is a repressor of BlaZ, the beta-lactamase responsible for penicillin resistance in Staphylococcus aureus. Through screening a transposon library in S. aureus Newman for susceptibility to cathelicidin antimicrobial peptide, we discovered BlaI as a novel cathelicidin resistance factor. Additionally, through integrational mutagenesis in S. aureus Newman and MRSA Sanger 252 strains, we confirmed the role of BlaI in resistance to human and murine cathelidicin and showed that it contributes to virulence in human whole blood and murine infection models. We further demonstrated that BlaI could be a target for innate immune-based antimicrobial therapies; by removing BlaI through subinhibitory concentrations of 6-aminopenicillanic acid, we were able to sensitize S. aureus to LL-37 killing.	[Pence, Morgan A.; Haste, Nina M.; Meharena, Hiruy S.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Pence, Morgan A.; Olson, Joshua; Nizet, Victor; Kristian, Sascha A.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Haste, Nina M.; Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Gallo, Richard L.] Univ Calif San Diego, Sch Med, Dept Dermatol, La Jolla, CA 92093 USA; [Gallo, Richard L.] VA San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Nizet, V (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA.	vnizet@ucsd.edu; skristian@ucsd.edu	Pence, Morgan A./N-1620-2019; Nizet, Victor/AAF-3190-2019; Gallo, Richard L/A-8931-2009	Pence, Morgan A./0000-0003-0239-0228; Gallo, Richard L/0000-0002-1401-7861; Nizet, Victor/0000-0003-3847-0422	NIH [HD071600, AI057153, AI052453]; National Institute for General Medical Sciences [T32 GM008666]; Ruth L Kirschstein National Research Service Award (NRSA) from National Institutes of Health [5 F31 GM090658-02]; Network of Antimicrobial Resistance in Staphylococcus aureus (NARSA) program under NIAID/NIH [HHSN272200700055C]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD071600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052453, R01AI116576, R01AI052453, U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM090658, T32GM008666] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ruth L Kirschstein National Research Service Award (NRSA) from National Institutes of Health; Network of Antimicrobial Resistance in Staphylococcus aureus (NARSA) program under NIAID/NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by NIH grants HD071600 (VN), AI057153 (VN) and AI052453 (RG, VN). MAP was supported in part by an institutional training grant to the UCSD Genetics Training Program, T32 GM008666, from the National Institute for General Medical Sciences. NMH was supported by a Ruth L Kirschstein National Research Service Award (NRSA) from National Institutes of Health grants (5 F31 GM090658-02). The isolate MRSA252 (NRS71) was obtained through the Network of Antimicrobial Resistance in Staphylococcus aureus (NARSA) program supported under NIAID/NIH Contract #HHSN272200700055C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Berti AD, 2013, ANTIMICROB AGENTS CH, V57, P5005, DOI 10.1128/AAC.00594-13; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chaffin DO, 1998, GENE, V219, P91, DOI 10.1016/S0378-1119(98)00396-5; Datta V, 2005, MOL MICROBIOL, V56, P681, DOI 10.1111/j.1365-2958.2005.04583.x; Dhand A, 2011, CLIN INFECT DIS, V53, P158, DOI 10.1093/cid/cir340; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Dorschner RA, 2006, FASEB J, V20, P35, DOI 10.1096/fj.05-4406com; Eliopoulos G.M., 2015, M07A10 CLIN LAB STAN, V10th Edn; FAIRWEATHER N, 1983, INFECT IMMUN, V41, P1112, DOI 10.1128/IAI.41.3.1112-1117.1983; Fuda CCS, 2005, CELL MOL LIFE SCI, V62, P2617, DOI 10.1007/s00018-005-5148-6; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Lauth X, 2009, J INNATE IMMUN, V1, P202, DOI 10.1159/000203645; Lewis RA, 2000, J ANTIMICROB CHEMOTH, V45, P139, DOI 10.1093/jac/45.2.139; Llarrull LI, 2012, BIOCHEMISTRY-US, V51, P4642, DOI 10.1021/bi300429p; Llarrull LI, 2011, J BIOL CHEM, V286, P38148, DOI 10.1074/jbc.M111.288985; Llarrull LI, 2010, BIOCHEMISTRY-US, V49, P7975, DOI 10.1021/bi101177a; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Milheirico C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-76; Mukhopadhyay K, 2007, MICROBIOL-SGM, V153, P1187, DOI 10.1099/mic.0.2006/003111-0; Nizet V, 2006, CURR ISSUES MOL BIOL, V8, P11; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; OCALLAGHAN CH, 1972, ANTIMICROB AGENTS CH, V1, P283, DOI 10.1128/AAC.1.4.283; Ouhara K, 2008, J ANTIMICROB CHEMOTH, V61, P1266, DOI 10.1093/jac/dkn106; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; Safo MK, 2005, J BACTERIOL, V187, P1833, DOI 10.1128/JB.187.5.1833-1844.2005; Sala C, 2009, MOL MICROBIOL, V71, P1102, DOI 10.1111/j.1365-2958.2008.06583.x; Weidenmaier C, 2003, CURR DRUG TARGETS, V4, P643, DOI 10.2174/1389450033490731	32	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136605	10.1371/journal.pone.0136605	http://dx.doi.org/10.1371/journal.pone.0136605			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305782	Green Published, gold			2022-12-27	WOS:000359995500098
J	Yang, Q; Lin, HX; Wu, S; Lei, FY; Zhu, X; Song, LB; Hong, MH; Guo, L				Yang, Qi; Lin, Huanxin; Wu, Shu; Lei, Fangyong; Zhu, Xi; Song, Libing; Hong, Minghuang; Guo, Ling			Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes	PLOS ONE			English	Article							IMMUNOHISTOCHEMICAL EXPRESSION; INTRAEPITHELIAL NEOPLASIA; CANCER; PROTEIN	Background Prostate tumor overexpressed 1 (PTOV1) has been reported to contribute to increased cancer proliferation. However, the clinical significance of PTOV1 in the development and progression of nasopharyngeal carcinoma (NPC) is unclear. Our study aimed to investigate the expression pattern of PTOV1 in NPC and its correlation with clinicopathological features of patients. Methods Western blotting and real-time PCR were conducted to examine PTOV1 expression levels in NPC cell lines and biopsy tissues compared with normal controls. Immunohistochemistry (IHC) was performed to analyze PTOV1 protein expression in paraffin-embedded tissues from 123 patients. Statistical analyses were applied to evaluate the clinical significance of PTOV1 expression. Results PTOV1 mRNA and protein levels were upregulated in NPC cell lines and clinical samples. IHC analyses showed that PTOV1 was highly expressed in 68 (55.3%) of 123 NPC specimens. Statistical analysis revealed that PTOV1 expression was significantly correlated with clinical stage (P < 0.001), T classification (P = 0.042) and N classification (P = 0.001). Patients with a higher PTOV1 expression had shorter overall survival compared with those with a lower PTOV1 expression level, especially in lower N stage patients. Multivariate analyses suggested that PTOV1 expression was an independent prognostic marker for survival in NPC patients. Conclusions Our data demonstrated that PTOV1 overexpression is associated with poor survival outcomes of NPC patients, especially in N0-1 patients. Hence, PTOV1 may help to detect early lymph node metastasis of NPC patients and serve as an independent prognostic biomarker for human NPC.	[Yang, Qi; Lin, Huanxin; Wu, Shu; Lei, Fangyong; Zhu, Xi; Song, Libing; Hong, Minghuang; Guo, Ling] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China; [Yang, Qi; Zhu, Xi; Guo, Ling] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510060, Guangdong, Peoples R China; [Lin, Huanxin] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510060, Guangdong, Peoples R China; [Wu, Shu; Lei, Fangyong; Song, Libing] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510060, Guangdong, Peoples R China; [Hong, Minghuang] Sun Yat Sen Univ, Ctr Canc, Dept Clin Trials Ctr, Guangzhou 510060, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Guo, L (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China.	guoling1423@163.com	Song, LB/AAL-1968-2020		National Natural Science Foundation of China [81372814]; Science and Technology Program Fund of Guangdong Province [2012B031800255]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program Fund of Guangdong Province	This study was supported by grants from the National Natural Science Foundation of China (No. 81372814), and the Science and Technology Program Fund of Guangdong Province (No. 2012B031800255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedit P, 2001, ONCOGENE, V20, P1455, DOI 10.1038/sj.onc.1204233; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Cao JY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-237; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Choi HK, 2011, MOL CELL, V43, P203, DOI 10.1016/j.molcel.2011.05.027; Fernandez S, 2011, VIRCHOWS ARCH, V458, P323, DOI 10.1007/s00428-010-1018-1; HSU MM, 1983, CANCER-AM CANCER SOC, V52, P362, DOI 10.1002/1097-0142(19830715)52:2<362::AID-CNCR2820520230>3.0.CO;2-V; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson MI, 1998, PROSTATE, V37, P223, DOI 10.1002/(SICI)1097-0045(19981201)37:4<223::AID-PROS3>3.0.CO;2-O; LEE AWM, 1992, INT J RADIAT ONCOL, V23, P261, DOI 10.1016/0360-3016(92)90740-9; Mazzucchelli R, 2013, CELL ONCOL, V36, P37, DOI 10.1007/s13402-012-0111-7; Mazzucchelli R, 2011, HUM PATHOL, V42, P1931, DOI 10.1016/j.humpath.2011.02.014; Morote J, 2008, CLIN CANCER RES, V14, P2617, DOI 10.1158/1078-0432.CCR-07-4987; NADJI M, 1981, CANCER, V48, P1229, DOI 10.1002/1097-0142(19810901)48:5<1229::AID-CNCR2820480529>3.0.CO;2-L; Nagahara H, 2005, CLIN CANCER RES, V11, P6800, DOI 10.1158/1078-0432.CCR-05-0943; Nakamura Y, 2006, J PATHOL, V209, P522, DOI 10.1002/path.1993; Perri F, 2011, WORLD J CLIN ONCOL, V2, P377, DOI 10.5306/wjco.v2.i12.377; Raissouni S, 2013, Gulf J Oncolog, V1, P35; Santamaria A, 2005, MOL CELL BIOL, V25, P1900, DOI 10.1128/MCB.25.5.1900-1911.2005; Santamaria A, 2003, AM J PATHOL, V162, P897, DOI 10.1016/S0002-9440(10)63885-0; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Tang Ling-Long, 2006, Ai Zheng, V25, P129; Vokes EE, 1997, LANCET, V350, P1087, DOI 10.1016/S0140-6736(97)07269-3; Wang X, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-190; Youn HS, 2011, BIOCHEM BIOPH RES CO, V404, P239, DOI 10.1016/j.bbrc.2010.11.100; Youn H, 2013, CANCER LETT, V331, P192, DOI 10.1016/j.canlet.2012.12.019	26	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136448	10.1371/journal.pone.0136448	http://dx.doi.org/10.1371/journal.pone.0136448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305455	gold, Green Published, Green Submitted			2022-12-27	WOS:000359995500077
J	Boianelli, A; Pettini, E; Prota, G; Medaglini, D; Vicino, A				Boianelli, Alessandro; Pettini, Elena; Prota, Gennaro; Medaglini, Donata; Vicino, Antonio			A Stochastic Model for CD4+T Cell Proliferation and Dissemination Network in Primary Immune Response	PLOS ONE			English	Article							CD8(+) T-CELLS; NAIVE CD4(+); IN-VIVO; CFSE DATA; POPULATION-DYNAMICS; ACTIVATION; DIVISION; DIFFERENTIATION; VACCINATION; TURNOVER	The study of the initial phase of the adaptive immune response after first antigen encounter provides essential information on the magnitude and quality of the immune response. This phase is characterized by proliferation and dissemination of T cells in the lymphoid organs. Modeling and identifying the key features of this phenomenon may provide a useful tool for the analysis and prediction of the effects of immunization. This knowledge can be effectively exploited in vaccinology, where it is of interest to evaluate and compare the responses to different vaccine formulations. The objective of this paper is to construct a stochastic model based on branching process theory, for the dissemination network of antigen-specific CD4+ T cells. The devised model is validated on in vivo animal experimental data. The model presented has been applied to the vaccine immunization context making references to simple proliferation laws that take into account division, death and quiescence, but it can also be applied to any context where it is of interest to study the dynamic evolution of a population.	[Boianelli, Alessandro] Helmholtz Ctr Infect Res, Syst Med Infect Dis Grp, D-38124 Braunschweig, Germany; [Boianelli, Alessandro] Helmholtz Ctr Infect Res, Dept Syst Immunol, Braunschweig Integrated Ctr Syst Biol, D-38124 Braunschweig, Germany; [Pettini, Elena; Prota, Gennaro; Medaglini, Donata] Univ Siena, Dipartimento Biotecnol Med, Lab Microbiol Mol & Biotecnol, I-53100 Siena, Italy; [Vicino, Antonio] Univ Siena, Dipartimento Ingn Informaz & Sci Matemat, I-53100 Siena, Italy	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; University of Siena; University of Siena	Boianelli, A (corresponding author), Helmholtz Ctr Infect Res, Syst Med Infect Dis Grp, Inhoffenstr 7, D-38124 Braunschweig, Germany.	Alessandro.Boianelli@helmholtz-hzi.de	Medaglini, Donata/R-1149-2018; Pettini, Elena/R-4188-2018	Medaglini, Donata/0000-0003-1729-7325; Pettini, Elena/0000-0002-0308-7127; VICINO, Antonio/0000-0002-7969-4054	Commission of the European Communities, Seventh Framework Programme Advanced Immunisation Technologies (ADITEC) [280873]	Commission of the European Communities, Seventh Framework Programme Advanced Immunisation Technologies (ADITEC)	This study has been carried out with the Financial Support from the Commission of the European Communities, Seventh Framework Programme contract 280873 Advanced Immunisation Technologies (ADITEC) url:http://www.aditecproject.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550; Asquith B, 2006, P R SOC B, V273, P1165, DOI 10.1098/rspb.2005.3432; Bains I, 2009, BLOOD, V113, P5480, DOI 10.1182/blood-2008-10-184184; Banks HT, 2012, MATH MODEL NAT PHENO, V7, P24, DOI 10.1051/mmnp/20127504; Banks HT, 2011, B MATH BIOL, V73, P116, DOI 10.1007/s11538-010-9524-5; Boianelli A, 2013, IEEE DECIS CONTR P, P7205, DOI 10.1109/CDC.2013.6761032; Ciabattini A, 2008, INFECT IMMUN, V76, P5817, DOI 10.1128/IAI.00793-08; Ciabattini A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00421; Ciabattini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019346; Ciabattini A, 2010, VACCINE, V28, P1226, DOI 10.1016/j.vaccine.2009.11.021; De Boer RJ, 2005, J COMPUT APPL MATH, V184, P140, DOI 10.1016/j.cam.2004.08.020; De Boer RJ, 2013, J THEOR BIOL, V327, P45, DOI 10.1016/j.jtbi.2012.12.025; Dereuddre-Bosquet N, 2015, VACCINE, V33, P2354, DOI 10.1016/j.vaccine.2015.03.032; Duffy KR, 2012, TRENDS CELL BIOL, V22, P457, DOI 10.1016/j.tcb.2012.05.004; Fiorino F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00128; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Ganusov VV, 2005, J IMMUNOL METHODS, V298, P183, DOI 10.1016/j.jim.2005.01.011; Hasenauer J, 2012, B MATH BIOL, V74, P2692, DOI 10.1007/s11538-012-9774-5; Hawkins ED, 2007, P NATL ACAD SCI USA, V104, P5032, DOI 10.1073/pnas.0700026104; Hyrien O, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-41; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Luzyanina T, 2009, J MATH BIOL, V59, P581, DOI 10.1007/s00285-008-0244-5; Mandl JN, 2012, P NATL ACAD SCI USA, V109, P18036, DOI 10.1073/pnas.1211717109; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; McKay PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084707; Medaglini D, 2006, INFECT IMMUN, V74, P2760, DOI 10.1128/IAI.74.5.2760-2766.2006; Miao HY, 2012, B MATH BIOL, V74, P300, DOI 10.1007/s11538-011-9668-y; Pape KA, 1997, IMMUNOL REV, V156, P67, DOI 10.1111/j.1600-065X.1997.tb00959.x; Pettini E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080545; Pettini E, 2009, METHODS, V49, P340, DOI 10.1016/j.ymeth.2009.03.026; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Schlub TE, 2009, EUR J IMMUNOL, V39, P67, DOI 10.1002/eji.200838554; Six A, 2012, MICROB BIOTECHNOL, V5, P295, DOI 10.1111/j.1751-7915.2011.00321.x; Spensieri F, 2013, P NATL ACAD SCI USA, V110, P14330, DOI 10.1073/pnas.1311998110; Stekel DJ, 1997, IMMUNOL TODAY, V18, P216; Thomas-Vaslin V, 2008, J IMMUNOL, V180, P2240, DOI 10.4049/jimmunol.180.4.2240; Wu HL, 2011, J IMMUNOL, V187, P4474, DOI 10.4049/jimmunol.1101443; Yakovlev AY, 2009, ANN APPL PROBAB, V19, P1, DOI 10.1214/08-AAP539; Yates A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-196	40	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135787	10.1371/journal.pone.0135787	http://dx.doi.org/10.1371/journal.pone.0135787			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301680	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900030
J	Halko, ML; Kaustia, M				Halko, Marja-Liisa; Kaustia, Markku			Risk ON/Risk OFF: Risk-Taking Varies with Subjectively Preferred and Disliked Music	PLOS ONE			English	Article							DECISION-MAKING; PROSPECT-THEORY; UTILITY-THEORY; MOOD; BEHAVIOR; EMOTION; REWARD; PREFERENCES; VIOLATIONS; AVERSION	In this paper we conduct a within-subjects experiment in which teenagers go over 256 gambles with real money gains and losses. For each risky gamble they choose whether to participate in it, or pass. Prior to this main experiment subjects identify specific songs belonging to their favorite musical genre, as well as songs representing a style they dislike. In the main experiment we vary the music playing in the background, so that each subject hears some of their favorite music, and some disliked music, alternating in blocks of 16 gambles. We find that favorite music increases risk-taking ('risk on'), and disliked music suppresses risk-taking ('risk off'), compared to a baseline of no music. Literature in psychology proposes several mechanisms by which mood affects risk-taking, but none of them fully explain the results in our setting. The results are, however, consistent with the economics notion of preference complementarity, extended to the domain of risk preference. The preference structure implied by our results is more complex than previously thought, yet realistic, and consistent with recent theoretical models. More generally, this mechanism offers a potential explanation to why risk-taking is known to change over time and across contexts.	[Halko, Marja-Liisa] Aalto Univ, Sch Business, Dept Econ, Helsinki, Finland; [Kaustia, Markku] Aalto Univ, Sch Business, Dept Finance, Helsinki, Finland	Aalto University; Aalto University	Halko, ML (corresponding author), Univ Helsinki, Dept Polit & Econ Studies, Helsinki, Finland.	marja-liisa.halko@helsinki.fi	Kaustia, Markku/K-3865-2013	Kaustia, Markku/0000-0002-2281-8175; Halko, Marja-Liisa/0000-0001-6295-8917	research project aivoAALTO (Aalto University); Yrjo Jahnsson Foundation [5350]; Research Foundation of Cooperative Banks, Finland [200600002]	research project aivoAALTO (Aalto University); Yrjo Jahnsson Foundation; Research Foundation of Cooperative Banks, Finland	The research is supported by the research project aivoAALTO (Aalto University), the Yrjo Jahnsson Foundation (MH, grant number 5350, http://www.yjs.fi/en/), and the Research Foundation of Cooperative Banks (MH, grant number 200600002, http://www.en.tutkimusapurahat.fi/), Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allais M, 1953, ECONOMETRICA, V21, P503, DOI 10.2307/1907921; Andrade EB, 2015, BUBBLING EXCITEMENT; ANSCOMBE FJ, 1963, ANN MATH STAT, V34, P199, DOI 10.1214/aoms/1177704255; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Barber BM, 2000, J FINANC, V55, P773, DOI 10.1111/0022-1082.00226; Barseghyan L, 2011, AM ECON REV, V101, P591, DOI 10.1257/aer.101.2.591; BECKER GS, 1988, J POLIT ECON, V96, P675, DOI 10.1086/261558; Bernheim BD, 2004, AM ECON REV, V94, P1558, DOI 10.1257/0002828043052222; Berns GS, 2010, NEUROIMAGE, V49, P2687, DOI 10.1016/j.neuroimage.2009.10.070; Birnbaum MH, 1997, ORGAN BEHAV HUM DEC, V71, P161, DOI 10.1006/obhd.1997.2721; BLACK F, 1986, J FINANC, V41, P529, DOI 10.2307/2328481; Brodsky W., 2001, TRANSPORT RES F-TRAF, V4, P219, DOI [10.1016/s1369-8478(01)00025-0, DOI 10.1016/S1369-8478(01)00025-0, 10.1016/S1369-8478(01)00025-0]; CAMERER CF, 1994, J RISK UNCERTAINTY, V8, P167, DOI 10.1007/BF01065371; Chou KL, 2007, PSYCHOL AGING, V22, P310, DOI 10.1037/0882-7974.22.2.310; CHRISTENSON PG, 1988, COMMUN RES, V15, P282, DOI 10.1177/009365088015003004; COOMBS CH, 1976, J MATH PSYCHOL, V13, P323, DOI 10.1016/0022-2496(76)90024-9; Coricelli G, 2007, TRENDS COGN SCI, V11, P258, DOI 10.1016/j.tics.2007.04.003; De Martino B, 2009, J NEUROSCI, V29, P3833, DOI 10.1523/JNEUROSCI.4832-08.2009; Dorn D, 2009, MANAGE SCI, V55, P591, DOI 10.1287/mnsc.1080.0962; Einav Liran, 2012, AM ECON REV, V102, P1; Forgas JP, 1998, J PERS SOC PSYCHOL, V75, P318, DOI 10.1037//0022-3514.75.2.318; FORGAS JP, 1995, PSYCHOL BULL, V117, P39, DOI 10.1037/0033-2909.117.1.39; Fox LS, 1998, PSYCHOL AGING, V13, P519, DOI 10.1037/0882-7974.13.3.519; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Gneezy U, 2003, J FINANC, V58, P821, DOI 10.1111/1540-6261.00547; Guiso L, 2013, 19284 NBER; Halko ML, 2015, J NEUROSCI PSYCHOL E, V8, P100, DOI 10.1037/npe0000036; Hebert S, 2005, LIFE SCI, V76, P2371, DOI 10.1016/j.lfs.2004.11.011; Herrington J. D., 1996, J SERV MARK, V10, P26, DOI DOI 10.1108/08876049610114249; ISEN AM, 1983, ORGAN BEHAV HUM PERF, V31, P194, DOI 10.1016/0030-5073(83)90120-4; ISEN AM, 1978, SOC PSYCHOL, V41, P346, DOI 10.2307/3033588; JOHNSON EJ, 1983, J PERS SOC PSYCHOL, V45, P20, DOI 10.1037/0022-3514.45.1.20; KAHNEMAN D, 1993, MANAGE SCI, V39, P17, DOI 10.1287/mnsc.39.1.17; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Karni E, 1985, DECISION MAKING UNDE; Knutson B, 2008, NEUROREPORT, V19, P509, DOI 10.1097/WNR.0b013e3282f85c01; Kreutz G, 2008, PSYCHOL MUSIC, V36, P101, DOI 10.1177/0305735607082623; Laibson D, 2001, Q J ECON, V116, P81, DOI 10.1162/003355301556356; Laukka P., 2007, J HAPPINESS STUD, V8, P215, DOI [DOI 10.1007/S10902-006-9024-3, 10.1007/s10902-006-9024-3]; Leith KP, 1996, J PERS SOC PSYCHOL, V71, P1250, DOI 10.1037/0022-3514.71.6.1250; Levy DJ, 2012, CURR OPIN NEUROBIOL, V22, P1027, DOI 10.1016/j.conb.2012.06.001; Lo A., 2005, J INVESTMENT CONSULT, V2, P21, DOI DOI 10.2139/SSM.728864; Loewenstein G, 2003, Q J ECON, V118, P1209, DOI 10.1162/003355303322552784; Loewenstein G, 2000, AM ECON REV, V90, P426, DOI 10.1257/aer.90.2.426; Loewenstein G, 1996, ORGAN BEHAV HUM DEC, V65, P272, DOI 10.1006/obhd.1996.0028; LUCE RD, 1990, PSYCHOL SCI, V1, P225, DOI 10.1111/j.1467-9280.1990.tb00205.x; MacDonald R. A. R., 2003, PSYCHOL MUSIC, V31, P187, DOI DOI 10.1177/0305735603031002294; Mattila AS, 2001, J RETAILING, V77, P273, DOI 10.1016/S0022-4359(01)00042-2; MISCHEL W, 1973, PSYCHOL REV, V80, P252, DOI 10.1037/h0035002; Mischel W, 1976, J PERS SOC PSYCHOL, V27, P129; North AC, 1998, J APPL SOC PSYCHOL, V28, P2254, DOI 10.1111/j.1559-1816.1998.tb01370.x; North AC, 1997, NATURE, V390, P132, DOI 10.1038/36484; North AC, 2000, BRIT J EDUC PSYCHOL, V70, P255, DOI 10.1348/000709900158083; North AC, 2004, MUSIC PERCEPT, V22, P41, DOI 10.1525/mp.2004.22.1.41; North AC, 2003, ENVIRON BEHAV, V35, P712, DOI 10.1177/0013916503254749; Pine A, 2009, J NEUROSCI, V29, P9575, DOI 10.1523/JNEUROSCI.1126-09.2009; Porcelli AJ, 2012, FRONTIERS NEUROSCIEN, P6; Rabin M, 2000, ECONOMETRICA, V68, P1281, DOI 10.1111/1468-0262.00158; Rosenboim M, 2012, EXP ECON, V15, P145, DOI 10.1007/s10683-011-9294-4; Schwartz KD, 2003, J YOUTH ADOLESCENCE, V32, P205, DOI 10.1023/A:1022547520656; Schwarz N, 1991, EMOTION SOCIAL JUDGM; Seymour B, 2008, NEURON, V58, P662, DOI 10.1016/j.neuron.2008.05.020; Spangenberg ER, 2005, J BUS RES, V58, P1583, DOI 10.1016/j.jbusres.2004.09.005; Starmer C, 2000, J ECON LIT, V38, P332, DOI 10.1257/jel.38.2.332; THALER RH, 1990, MANAGE SCI, V36, P643, DOI 10.1287/mnsc.36.6.643; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Tymula A, 2012, P NATL ACAD SCI USA, V109, P17135, DOI 10.1073/pnas.1207144109; Unal AB, 2012, ACCIDENT ANAL PREV, V48, P271, DOI 10.1016/j.aap.2012.01.022; WRIGHT WF, 1992, ORGAN BEHAV HUM DEC, V52, P276, DOI 10.1016/0749-5978(92)90039-A; Wu G, 1996, MANAGE SCI, V42, P1676, DOI 10.1287/mnsc.42.12.1676; Yuen KSL, 2003, J AFFECT DISORDERS, V75, P11, DOI 10.1016/S0165-0327(02)00022-8	72	9	10	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135436	10.1371/journal.pone.0135436	http://dx.doi.org/10.1371/journal.pone.0135436			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5VA	26301776	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900018
J	Romey, WL; Lamb, AR				Romey, William L.; Lamb, Alicia R.			Flash Expansion Threshold in Whirligig Swarms	PLOS ONE			English	Article							DECISION-MAKING; INFORMATION-TRANSFER; ANIMAL GROUPS; COLEOPTERA; AVOIDANCE; MOVEMENTS; ATTACK; SEX	In the selfish herd hypothesis, prey animals move toward each other to avoid the likelihood of being selected by a predator. However, many grouped animals move away from each other the moment before a predator attacks. Very little is known about this phenomenon, called flash expansion, such as whether it is triggered by one individual or a threshold and how information is transferred between group members. We performed a controlled experiment with whirligig beetles in which the ratio of sighted to unsighted individuals was systematically varied and emergent flash expansion was measured. Specifically, we examined: the percentage of individuals in a group that startled, the resulting group area, and the longevity of the flash expansion. We found that one or two sighted beetles in a group of 24 was not enough to cause a flash expansion after a predator stimulus, but four sighted beetles usually initiated a flash expansion. Also, the more beetles that were sighted the larger the resulting group area and the longer duration of the flash expansion. We conclude that flash expansion is best described as a threshold event whose adaptive value is to prevent energetically costly false alarms while quickly mobilizing an emergent predator avoidance response. This is one of the first controlled experiments of flash expansion, an important emergent property that has applications to understanding collective motion in swarms, schools, flocks, and human crowds. Also, our study is a convincing demonstration of social contagion, how the actions of one individual can pass through a group.	[Romey, William L.; Lamb, Alicia R.] SUNY Coll Potsdam, Dept Biol, Potsdam, NY 13676 USA	State University of New York (SUNY) System	Romey, WL (corresponding author), SUNY Coll Potsdam, Dept Biol, Potsdam, NY 13676 USA.	romeywl@potsdam.edu			National Science Foundation (US) [1144215]; Division Of Integrative Organismal Systems [1144215] Funding Source: National Science Foundation	National Science Foundation (US)(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation (US) Grant #1144215 to WLR.	Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Cresswell W, 2000, P ROY SOC B-BIOL SCI, V267, P733, DOI 10.1098/rspb.2000.1064; Fernandez-Juricic E, 2004, BEHAV ECOL SOCIOBIOL, V55, P502, DOI 10.1007/s00265-003-0698-9; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Herbert-Read JE, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140355; Janson S, 2005, ANIM BEHAV, V70, P349, DOI 10.1016/j.anbehav.2004.10.018; KOLMES SA, 1983, J NEW YORK ENTOMOL S, V91, P405; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; MAGURRAN AE, 1987, PROC R SOC SER B-BIO, V229, P439, DOI 10.1098/rspb.1987.0004; Mann RP, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0466; Parrish J. K., 1997, BEHAV TELEOST FISHES, P363; PARTRIDGE BL, 1982, SCI AM, V246, P114, DOI 10.1038/scientificamerican0682-114; Pratt SC, 2002, BEHAV ECOL SOCIOBIOL, V52, P117, DOI 10.1007/s00265-002-0487-x; Rasband W., 2004, IMAGE J; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Roberts G, 1997, ANIM BEHAV, V54, P1517, DOI 10.1006/anbe.1997.0544; Romey WL, 2008, BEHAV ECOL, V19, P74, DOI 10.1093/beheco/arm105; Romey WL, 2008, BEHAV ECOL, V19, P338, DOI 10.1093/beheco/arm138; Romey WL, 2007, BEHAV ECOL, V18, P910, DOI 10.1093/beheco/arm057; Romey WL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0812; ROMEY WL, 1995, BEHAV ECOL SOCIOBIOL, V37, P195, DOI 10.1007/s002650050181; Rosenthal SB, 2015, P NATL ACAD SCI USA, V112, P4690, DOI 10.1073/pnas.1420068112; Seeley TD, 1999, BEHAV ECOL SOCIOBIOL, V45, P19, DOI 10.1007/s002650050536; Stienessen SC, 2013, BEHAV ECOL, V24, P1150, DOI 10.1093/beheco/art042; Sumpter D, 2008, THEOR BIOSCI, V127, P177, DOI 10.1007/s12064-008-0040-1; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Thompson J, 2015, TRAFFIC INJ PREV, V16, P147, DOI 10.1080/15389588.2014.914626; VULINEC K, 1989, J NEW YORK ENTOMOL S, V97, P438; Ward AJW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032411	30	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136467	10.1371/journal.pone.0136467	http://dx.doi.org/10.1371/journal.pone.0136467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301958	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900072
J	Wong, TY; Lin, SM; Leung, LK				Wong, Tsz Yan; Lin, Shu-mei; Leung, Lai K.			The Flavone Luteolin Suppresses SREBP-2 Expression and Post-Translational Activation in Hepatic Cells	PLOS ONE			English	Article							ELEMENT-BINDING PROTEINS; FATTY-ACID SYNTHESIS; CHOLESTEROL-BIOSYNTHESIS; LIPID-ACCUMULATION; RAT HEPATOCYTES; GENE-EXPRESSION; HEPG2 CELLS; SOY PROTEIN; IN-VITRO; INHIBITION	High blood cholesterol has been associated with cardiovascular diseases. The enzyme HMG CoA reductase (HMGCR) is responsible for cholesterol synthesis, and inhibitors of this enzyme (statins) have been used clinically to control blood cholesterol. Sterol regulatory element binding protein (SREBP) -2 is a key transcription factor in cholesterol metabolism, and HMGCR is a target gene of SREBP-2. Attenuating SREBP-2 activity could potentially minimize the expression of HMGCR. Luteolin is a flavone that is commonly detected in plant foods. In the present study, Luteolin suppressed the expression of SREBP-2 at concentrations as low as 1 mu M in the hepatic cell lines WRL and HepG2. This flavone also prevented the nuclear translocation of SREBP-2. Post-translational processing of SREBP-2 protein was required for nuclear translocation. Luteolin partially blocked this activation route through increased AMP kinase (AMPK) activation. At the transcriptional level, the mRNA and protein expression of SREBP-2 were reduced through luteolin. A reporter gene assay also verified that the transcription of SREBF2 was weakened in response to this flavone. The reduced expression and protein processing of SREBP-2 resulted in decreased nuclear translocation. Thus, the transcription of HMGCR was also decreased after luteolin treatment. In summary, the results of the present study showed that luteolin modulates HMGCR transcription by decreasing the expression and nuclear translocation of SREBP-2.	[Wong, Tsz Yan; Leung, Lai K.] Chinese Univ Hong Kong, Fac Sci, Sch Life Sci, Food & Nutr Sci Programme, Shatin, Hong Kong, Peoples R China; [Lin, Shu-mei] Natl Chiayi Univ, Dept Food Sci, Chiayi, Taiwan; [Leung, Lai K.] Chinese Univ Hong Kong, Fac Sci, Sch Life Sci, Biochem Programme, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; National Chiayi University; Chinese University of Hong Kong	Leung, LK (corresponding author), Chinese Univ Hong Kong, Fac Sci, Sch Life Sci, Food & Nutr Sci Programme, Shatin, Hong Kong, Peoples R China.	laikleung@cuhk.edu.hk	Leung, Lai K/E-6314-2011	Leung, Lai K/0000-0002-7781-3099	Chinese University of Hong Kong [4053047]	Chinese University of Hong Kong(Chinese University of Hong Kong)	This work was supported by the Chinese University of Hong Kong, Direct Grant no. 4053047.	ANDERSON JW, 1995, NEW ENGL J MED, V333, P276, DOI 10.1056/NEJM199508033330502; Anum EA, 2004, ANN EPIDEMIOL, V14, P705, DOI 10.1016/j.annepidem.2003.10.009; Arai Y, 2000, J NUTR, V130, P2243; Chang JJ, 2013, J AGR FOOD CHEM, V61, P6069, DOI 10.1021/jf401171k; Chen XJ, 2010, BIOMED CHROMATOGR, V24, P826, DOI 10.1002/bmc.1370; Chen ZJ, 2012, DRUG METAB PHARMACOK, V27, P162, DOI 10.2133/dmpk.DMPK-11-RG-081; Edwards PA, 2000, BBA-MOL CELL BIOL L, V1529, P103, DOI 10.1016/S1388-1981(00)00140-2; Ferraz TPL, 2004, J BIOCHEM BIOPH METH, V58, P187, DOI 10.1016/j.jbbm.2003.10.008; GAMBLE W, 1978, J LIPID RES, V19, P1068; Gebhardt R, 2002, PHYTOTHER RES, V16, P368, DOI 10.1002/ptr.960; Gebhardt R, 1998, J PHARMACOL EXP THER, V286, P1122; Guan GM, 1998, J BIOL CHEM, V273, P12526, DOI 10.1074/jbc.273.20.12526; Han LK, 2003, PHYTOTHER RES, V17, P1195, DOI 10.1002/ptr.1405; Hertog MG, 1995, ARCH INTERN MED, V4, P381; Hirano Y, 2001, J BIOL CHEM, V276, P36431, DOI 10.1074/jbc.M105200200; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Ito M, 2013, J LIPID RES, V54, P1531, DOI 10.1194/jlr.M031591; Jeong HJ, 1999, ARCH PHARM RES, V22, P309, DOI 10.1007/BF02976369; Kotzka J, 2000, J LIPID RES, V41, P99; Kotzka J, 2004, J BIOL CHEM, V279, P22404, DOI 10.1074/jbc.M401198200; Lewis CA, 2011, BIOCHEM SOC T, V39, P495, DOI 10.1042/BST0390495; Li FJ, 2014, J PHARMACOL EXP THER, V351, P270, DOI 10.1124/jpet.114.216754; Li FJ, 2011, MOL CELL ENDOCRINOL, V344, P51, DOI 10.1016/j.mce.2011.06.024; Li LP, 2013, PHARMAZIE, V68, P195, DOI 10.1691/ph.2013.2744; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liu JF, 2011, PHYTOTHER RES, V25, P588, DOI 10.1002/ptr.3305; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Paladini AC, 1999, J PHARM PHARMACOL, V51, P519, DOI 10.1211/0022357991772790; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Roth G, 2000, J BIOL CHEM, V275, P33302, DOI 10.1074/jbc.M005425200; Saberi B, 2014, HEPATOLOGY, V59, P1543, DOI 10.1002/hep.26625; Sakakura Y, 2001, BIOCHEM BIOPH RES CO, V286, P176, DOI 10.1006/bbrc.2001.5375; Shih CC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/597067; Singh DK, 2006, J PHARMACOL EXP THER, V318, P1020, DOI 10.1124/jpet.106.107144; Singh DK, 2009, J NUTR BIOCHEM, V20, P816, DOI 10.1016/j.jnutbio.2008.07.011; Sung JH, 2004, BIOSCI BIOTECH BIOCH, V68, P428, DOI 10.1271/bbb.68.428; van Meeuwen JA, 2008, TOXICOL APPL PHARM, V228, P269, DOI 10.1016/j.taap.2007.12.007; Webster CRL, 2014, AM J PHYSIOL-GASTR L, V307, pG1207, DOI 10.1152/ajpgi.00165.2014; Yang NC, 2002, ANAL BIOCHEM, V306, P323, DOI 10.1006/abio.2002.5698; Zhan SY, 2005, AM J CLIN NUTR, V81, P397	42	39	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135637	10.1371/journal.pone.0135637	http://dx.doi.org/10.1371/journal.pone.0135637			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302339	gold, Green Submitted, Green Published			2022-12-27	WOS:000359951900024
J	Newman, PA; Rubincam, C; Slack, C; Essack, Z; Chakrapani, V; Chuang, DM; Tepjan, S; Shunmugam, M; Roungprakhon, S; Logie, C; Koen, J; Lindegger, G				Newman, Peter A.; Rubincam, Clara; Slack, Catherine; Essack, Zaynab; Chakrapani, Venkatesan; Chuang, Deng-Min; Tepjan, Suchon; Shunmugam, Murali; Roungprakhon, Surachet; Logie, Carmen; Koen, Jennifer; Lindegger, Graham			Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study	PLOS ONE			English	Article							CIVIL-SOCIETY PERSPECTIVES; VACCINE TRIALS; CLINICAL-TRIALS; DOUBLE-BLIND; EFFICACY TRIALS; HEALTH RESEARCH; GLOBAL HEALTH; MISCONCEPTION; RISK; INTERVENTION	Objectives Broad international guidelines and studies in the context of individual clinical trials highlight the centrality of community stakeholder engagement in conducting ethically rigorous HIV prevention trials. We explored and identified challenges and facilitators for community stakeholder engagement in biomedical HIV prevention trials in diverse global settings. Our aim was to assess and deepen the empirical foundation for priorities included in the GPP guidelines and to highlight challenges in implementation that may merit further attention in subsequent GPP iterations. Methods From 2008-2012 we conducted an embedded, multiple case study centered in Thailand, India, South Africa and Canada. We conducted in-depth interviews and focus groups with respondents from different trial-related subsystems: civil society organization representatives, community advocates, service providers, clinical trialists/researchers, former trial participants, and key HIV risk populations. Interviews/focus groups were recorded, and coded using thematic content analysis. After intra-case analyses, we conducted cross-case analysis to contrast and synthesize themes and sub-themes across cases. Lastly, we applied the case study findings to explore and assess UNAIDS/AVAC GPP guidelines and the GPP Blueprint for Stakeholder Engagement. Results Across settings, we identified three cross-cutting themes as essential to community stakeholder engagement: trial literacy, including lexicon challenges and misconceptions that imperil sound communication; mistrust due to historical exploitation; and participatory processes: engaging early; considering the breadth of "community"; and, developing appropriate stakeholder roles. Site-specific challenges arose in resource-limited settings and settings where trials were halted. Conclusions This multiple case study revealed common themes underlying community stakeholder engagement across four country settings that largely mirror GPP goals and the GPP Blueprint, as well as highlighting challenges in the implementation of important guidelines. GPP guidance documents could be strengthened through greater focus on: identifying and addressing the community-specific roots of mistrust and its impact on trial literacy activities; achieving and evaluating representativeness in community stakeholder groups; and addressing the impact of power and funding streams on meaningful engagement and independent decision-making.	[Newman, Peter A.; Rubincam, Clara; Chuang, Deng-Min; Tepjan, Suchon; Logie, Carmen] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [Slack, Catherine; Essack, Zaynab; Koen, Jennifer; Lindegger, Graham] Univ KwaZulu Natal, Sch Appl Human Sci, HIV AIDS Vaccines Eth Grp, Pietermaritzburg, South Africa; [Chakrapani, Venkatesan; Shunmugam, Murali] Ctr Sexual & Hlth Res & Policy C SHaRP, Madras, Tamil Nadu, India; [Roungprakhon, Surachet] Rajamangala Univ Technol Phra Nakhon, Fac Sci & Technol, Bangkok, Thailand	University of Toronto; University of Kwazulu Natal; Rajamangala University of Technology Phra Nakhon	Newman, PA (corresponding author), Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada.	p.newman@utoronto.ca	Essack, Zaynab/P-3253-2019; Newman, Peter A/P-7056-2019; Chakrapani, Venkatesan/P-8056-2014; chuang, deng-min/AAP-5207-2020	Essack, Zaynab/0000-0002-8867-3415; Newman, Peter A/0000-0003-0444-5915; Chakrapani, Venkatesan/0000-0001-9998-9135; chuang, deng-min/0000-0001-6824-2792	Canadian Institutes of Health Research [THA-118570, MOP-102512]; Social Sciences and Humanities Research Council [861080042]; Canada Research Chairs Program; Canada Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This research was supported in part by grants from: Canadian Institutes of Health Research (THA-118570; PAN, GL, VC) http://www.cihr-irsc.gc.ca, Canadian Institutes of Health Research (MOP-102512; PAN, VC) http://www.cihr-irsc.gc.ca, Social Sciences and Humanities Research Council (861080042; PAN) http://www.sshrc-crsh.gc.ca, Canada Research Chairs Program (PAN) http://www.chairs-chaires.gc.ca, and Canada Foundation for Innovation (PAN) www.innovation.ca.	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Allen M, 2008, SOC SCI MED, V66, P945, DOI 10.1016/j.socscimed.2007.10.019; Allman D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100058; [Anonymous], 2011, GOOD PART PRACT GUID; AVAC, 2014, GPP BLUEPR STAK ENG; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burnard P, 2008, BR DENT J, V204, P249; Burt RS, 2005, BROKERAGE CLOSURE IN; Chakrapani V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-731; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cooper CJ, 2010, JAMA-J AM MED ASSOC, V304, P275, DOI 10.1001/jama.2010.926; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; Delany-Moretlwe S, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-S1-S8; Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342; Essack Z, 2012, AIDS CARE, V24, P1249, DOI 10.1080/09540121.2012.656566; Fonsart J, 2014, 20 INT AIDS C JUL 20; Francis DP, 2003, AIDS, V17, P147, DOI 10.1097/00002030-200301240-00003; Godfrey C, 2014, JAIDS-J ACQ IMM DEF, V65, pS1, DOI 10.1097/QAI.0000000000000032; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Harriott RE, 1983, ED RES, V12, P14; Henderson GE, 2007, PLOS MED, V4, P1735, DOI 10.1371/journal.pmed.0040324; Horwood J, 2007, LANCET INFECT DIS, V7, P183, DOI 10.1016/S1473-3099(07)70039-7; Jewkes R, 1996, SOC SCI MED, V43, P555, DOI 10.1016/0277-9536(95)00439-4; Kagan JM, 2012, PROG COMM HLTH PARTN, V6, P311, DOI 10.1353/cpr.2012.0034; Kegeles SM, 2006, AIDS EDUC PREV, V18, P560, DOI 10.1521/aeap.2006.18.6.560; King KF, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-84; Koblin BA, 2000, J ACQ IMMUN DEF SYND, V24, P451, DOI 10.1097/00126334-200008150-00010; Koen J, 2013, DEV WORLD BIOETH, V13, P138, DOI 10.1111/j.1471-8847.2012.00338.x; Kolopack PA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003713; Lally M, 2014, J ADOLESCENT HEALTH, V55, P254, DOI 10.1016/j.jadohealth.2014.01.006; Lavery JV, 2010, TRENDS PARASITOL, V26, P279, DOI 10.1016/j.pt.2010.02.009; Mack N, 2013, OPEN ACCESS J CLIN T, V5, P127, DOI 10.2147/OAJCT.S45717; Mack N, 2010, J EMPIR RES HUM RES, V5, P3, DOI 10.1525/jer.2010.5.2.3; MacQueen KM, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0033-9; MacQueen KM, 2012, STAKEHOLDER ENGAGEME; Marsh V, 2008, SOC SCI MED, V67, P721, DOI 10.1016/j.socscimed.2008.02.007; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McGrory E., 2009, RES RASHOMON LESSONS; Merriam S. B., 1998, QUALITATIVE RES GUID; Nakibinge S, 2009, TROP MED INT HEALTH, V14, P190, DOI 10.1111/j.1365-3156.2008.02207.x; Namwat C, 2007, AIDS VACC AUG 20 23; National AIDS Control Organisation, 2012, HIV SENT SURV 2012 1; Newman PA, 2012, GLOB PUBLIC HEALTH, V7, P87, DOI 10.1080/17441692.2010.549139; Newman PA, 2006, LANCET, V367, P302, DOI 10.1016/S0140-6736(06)68067-7; Newman PA, 2008, VACCINE, V26, P1091, DOI 10.1016/j.vaccine.2007.12.016; Newman PA, 2014, EXPERT REV VACCINES, V13, P1553, DOI 10.1586/14760584.2014.953484; Newman PA, 2014, VACCINE, V32, P5854, DOI 10.1016/j.vaccine.2014.08.043; Newman PA, 2012, EXPERT REV VACCINES, V11, P1, DOI [10.1586/erv.11.162, 10.1586/ERV.11.162]; Newman PA, 2011, AM J PUBLIC HEALTH, V101, P1749, DOI 10.2105/AJPH.2011.300208; Participants in the Community Engagement and Consent Workshop  Kilifi Kenya  March 2011, 2013, J Empir Res Hum Res Ethics, V8, P1, DOI 10.1525/jer.2013.8.4.1; Ragin DF, 2008, SOC SCI MED, V66, P1379, DOI 10.1016/j.socscimed.2007.10.022; Rautenbach C, 2015, J EMPIR RES HUM RES, V10, P151, DOI 10.1177/1556264615575509; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Singh JA, 2005, PLOS MED, V2, P824, DOI 10.1371/journal.pmed.0020234; Slevin KW, 2008, COMMUNITY ENGAGEMENT, P14; Strauss A., 1998, BASICS QUALITATIVE R; The Wellcome Trust, 2011, COMM ENG UND MICR IN; Tindana P, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0014-z; Tindana PO, 2007, PLOS MED, V4, P1451, DOI 10.1371/journal.pmed.0040273; Ukpong M., 2009, ORAL TENOFOVIR CONTR; UNAIDS, 2013, THAIL HIV AIDS EST; UNAIDS AVAC, 2007, GOOD PART PRACT GUID; *UNAIDS WHO, 2007, ETH CONS BIOM HIV PR; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Yin R.K., 2009, CASE STUDY RES DESIG, V4th ed., DOI [10.33524/cjar.v14i1.73, DOI 10.33524/CJAR.V14I1.73]; Yin R. K., 2012, APPL CASE STUDY RES, V3rd	68	44	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135937	10.1371/journal.pone.0135937	http://dx.doi.org/10.1371/journal.pone.0135937			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26295159	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900052
J	Vinette, V; Placet, M; Arguin, G; Gendron, FP				Vinette, Valerie; Placet, Morgane; Arguin, Guillaume; Gendron, Fernand-Pierre			Multidrug Resistance-Associated Protein 2 Expression Is Upregulated by Adenosine 5 '-Triphosphate in Colorectal Cancer Cells and Enhances Their Survival to Chemotherapeutic Drugs	PLOS ONE			English	Article							ATP-BINDING CASSETTE; EXTRACELLULAR ATP; COLON-CANCER; PURINERGIC RECEPTORS; SIGNALING PATHWAYS; EPITHELIAL-CELLS; GENE-EXPRESSION; INFLAMMATION; MRP2; TRANSPORT	Extracellular adenosine 5'-triphosphate (ATP) is a signaling molecule that induces a plethora of effects ranging from the regulation of cell proliferation to modulation of cancerous cell behavior. In colorectal cancer, ATP was reported to stimulate epithelial cell proliferation and possibly promote resistance to anti-cancer treatments. However, the exact role of this danger-signaling molecule on cancerous intestinal epithelial cells (IECs) in response to chemotherapeutic agents remains unknown. To address how ATP may influence the response of cancerous IECs to chemotherapeutic agents, we used Caco-2 cells, which display enterocyte-like features, to determine the effect of ATP on the expression of multidrug resistance-associated protein 2 (MRP2). Gene and protein expression were determined by quantitative real-time PCR (qRT-PCR) and Western blotting. Resistance to etoposide, cisplatin and doxorubicin was determined by MTT assays in response to ATP stimulation of Caco-2 cells and in cells for which MRP2 expression was down-regulated by shRNA. ATP increased the expression of MRP2 at both the mRNA and protein levels. MRP2 expression involved an ATP-dependent stimulation of the MEK/ERK signaling pathway that was associated with an increase in relative resistance of Caco-2 cells to etoposide. Abolition of MRP2 expression using shRNA significantly reduced the protective effect of MRP2 toward etoposide as well as to cisplatin and doxorubicin. This study describes the mechanism by which ATP may contribute to the chemoresistance of cancerous IECs in colorectal cancer. Given the heterogeneity of colorectal adenocarcinoma responses to anti-cancer drugs, these findings call for further study to understand the role of P2 receptors in cancer drug therapy and to develop novel therapies aimed at regulating P2 receptor activity.	[Vinette, Valerie; Placet, Morgane; Arguin, Guillaume; Gendron, Fernand-Pierre] Univ Sherbrooke, Dept Anat & Cell Biol, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Gendron, FP (corresponding author), Univ Sherbrooke, Dept Anat & Cell Biol, Fac Med & Sci Sante, Pavillon Rech Appl Canc, Sherbrooke, PQ J1K 2R1, Canada.	Fernand-P.Gendron@USherbrooke.ca	Gendron, Fernand-Pierre/AAN-2965-2021		Canadian Institutes of Health Research [MOP-286567]; FRQS	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); FRQS	This research was supported by a Canadian Institutes of Health Research operating grant (MOP-286567) to F.P.G. F.P.G. is a member of the FRQS-funded "Centre de Recherche du Centre hospitalier universitaire de Sherbrooke".	Agteresch HJ, 2003, ANTI-CANCER DRUG, V14, P639, DOI 10.1097/00001813-200309000-00009; Akhtar R, 2014, WORLD J GASTRO ONCOL, V6, P177, DOI 10.4251/wjgo.v6.i6.177; Amin R, 2013, AM J PHYSIOL-CELL PH, V305, pC78, DOI 10.1152/ajpcell.00339.2012; Amiri F, 2013, EUR J PHARMACOL, V718, P34, DOI 10.1016/j.ejphar.2013.09.020; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bergamin LS, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/959848; Bourzac JF, 2013, J CELL PHYSIOL, V228, P120, DOI 10.1002/jcp.24111; Burnstock G, 2013, PURINERG SIGNAL, V9, P541, DOI 10.1007/s11302-013-9381-4; Buzzi N, 2010, BBA-GEN SUBJECTS, V1800, P946, DOI 10.1016/j.bbagen.2010.05.009; Chang SJ, 2008, CELL SIGNAL, V20, P1248, DOI 10.1016/j.cellsig.2008.02.011; Colombo V, 2011, CANCER CHEMOTH PHARM, V67, P369, DOI 10.1007/s00280-010-1335-8; Coolen EJCM, 2011, BRIT J NUTR, V105, P357, DOI 10.1017/S0007114510003570; Cui YH, 1999, MOL PHARMACOL, V55, P929; Degagne E, 2013, J CELL PHYSIOL, V228, P99, DOI 10.1002/jcp.24109; Degagne E, 2012, FEBS J, V279, P2957, DOI 10.1111/j.1742-4658.2012.08676.x; Degagne E, 2009, J IMMUNOL, V183, P4521, DOI 10.4049/jimmunol.0803977; Deli T, 2008, PATHOL ONCOL RES, V14, P219, DOI 10.1007/s12253-008-9071-7; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Di Virgilio F, 2012, CANCER RES, V72, P5441, DOI 10.1158/0008-5472.CAN-12-1600; Di Virgilio F, 2009, PURINERG SIGNAL, V5, P251, DOI 10.1007/s11302-009-9145-3; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fujita K, 2008, BIOL PHARM BULL, V31, P2137, DOI 10.1248/bpb.31.2137; Galluzzi L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.428; Ghanem E, 2005, BRIT J PHARMACOL, V146, P364, DOI 10.1038/sj.bjp.0706353; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Grbic DM, 2008, J IMMUNOL, V180, P2659, DOI 10.4049/jimmunol.180.4.2659; Grbic DM, 2012, INFLAMM BOWEL DIS, V18, P1456, DOI 10.1002/ibd.21931; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Harden TK, 2010, ACTA PHYSIOL, V199, P149, DOI 10.1111/j.1748-1716.2010.02116.x; Hinoshita E, 2000, CLIN CANCER RES, V6, P2401; Hlavata I, 2012, MUTAGENESIS, V27, P187, DOI 10.1093/mutage/ger075; Hopfner M, 1998, BIOCHEM BIOPH RES CO, V251, P811, DOI 10.1006/bbrc.1998.9555; Huang TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041383; Jacobson KA, 2012, PURINERG SIGNAL, V8, P419, DOI 10.1007/s11302-012-9294-7; Jakubikova J, 2005, BIOCHEM PHARMACOL, V69, P1543, DOI 10.1016/j.bcp.2005.03.015; Jedlitschky G, 2006, EXPERT OPIN DRUG MET, V2, P351, DOI 10.1517/17425255.2.3.351; Jensen NF, 2015, MOL ONCOL; Kim HS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/527534; Kruh GD, 2003, ONCOGENE, V22, P7537, DOI 10.1038/sj.onc.1206953; Kukulski F, 2005, Purinergic Signal, V1, P193, DOI 10.1007/s11302-005-6217-x; Leipziger J, 2003, AM J PHYSIOL-RENAL, V284, pF419, DOI 10.1152/ajprenal.00075.2002; MARKS DC, 1992, LEUKEMIA RES, V16, P1165, DOI 10.1016/0145-2126(92)90114-M; North RA, 2013, MOL PHARMACOL, V83, P759, DOI 10.1124/mol.112.083758; Nussbaum N, 2015, CURR ONCOL REP, V17, DOI 10.1007/s11912-014-0434-9; Nylund G., 2007, Autonomic & Autacoid Pharmacology, V27, P79, DOI 10.1111/j.1474-8673.2007.00389.x; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Schafer R, 2003, AM J PHYSIOL-LUNG C, V285, pL376, DOI 10.1152/ajplung.00447.2002; Shabbir M, 2008, BJU INT, V101, P106, DOI 10.1111/j.1464-410X.2007.07286.x; Swennen ELR, 2010, CHEM-BIOL INTERACT, V184, P338, DOI 10.1016/j.cbi.2010.02.011; Takai E, 2012, J CELL SCI, V125, P5051, DOI 10.1242/jcs.104976; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Tremblay E, 2006, J CELL BIOCHEM, V99, P1175, DOI 10.1002/jcb.21015; von Kugelgen I, 2011, ADV PHARMACOL, V61, P373, DOI 10.1016/B978-0-12-385526-8.00012-6; Wagstaff SC, 2000, CARCINOGENESIS, V21, P2175, DOI 10.1093/carcin/21.12.2175; Watson AJM, 2011, DIGEST DIS, V29, P222, DOI 10.1159/000323926; Wink MR, 2003, CANCER LETT, V198, P211, DOI 10.1016/S0304-3835(03)00308-2; Xiao Z, 2012, ANAT REC, V295, P2122, DOI 10.1002/ar.22552; Xing Y, 2014, J DIGEST DIS, V15, P246, DOI 10.1111/1751-2980.12131; Yaguchi T, 2010, CELL PHYSIOL BIOCHEM, V26, P125, DOI 10.1159/000320518; Yamasaki M, 2011, BRIT J CANCER, V104, P707, DOI 10.1038/sj.bjc.6606071; Yang Youyun, 2011, Int J Biochem Mol Biol, V2, P89; Zhang Y, 2010, CANCER LETT, V293, P189, DOI 10.1016/j.canlet.2010.01.010	62	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136080	10.1371/journal.pone.0136080	http://dx.doi.org/10.1371/journal.pone.0136080			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295158	Green Submitted, Green Published, gold			2022-12-27	WOS:000359926900070
J	Xie, CY; Wu, X; Li, J; Fan, ZY; Long, CM; Liu, HN; Even, PC; Blachier, F; Yin, YL				Xie, Chunyan; Wu, Xin; Li, Jun; Fan, Zhiyong; Long, Cimin; Liu, Hongnan; Even, Patrick Christian; Blachier, Francois; Yin, Yulong			Effects of the Sequence of Isocaloric Meals with Different Protein Contents on Plasma Biochemical Indexes in Pigs	PLOS ONE			English	Article							AMINO-ACIDS; CIRCADIAN CLOCK; ENERGY-INTAKE; DIETARY SUPPLEMENTATION; INSULIN RESPONSES; LOW-CARBOHYDRATE; GLYCEMIC CONTROL; EXPRESSION; GLUCAGON; METABOLISM	Nutrient composition and pattern of food intake may play a significant role in weight gain. The aim of this study was to document the effects of a daily 3-meal pattern with isocaloric diets containing different dietary protein contents on growth performance and different plasma biochemical indexes including amino acid plasma concentration in castrated male pigs. Then, 21 DLY (DurocxLandracexYorkshire) pigs aged 60 days were assigned randomly into 3 groups: a control group (crude protein, CP 18.1%), a group receiving high then basal and then low CP meals (High-Low group) and a group receiving low then basal and then high CP meal (Low-High group) for 40 days with pigs being feed-restricted. On day 40, after 12 h fasting, blood samples were obtained for analysis. The results showed that the insulin/glucagon ratio was lower in the High-Low group (P<0.05) when compared with the control group. Compared with the control group, the average daily gain of pigs from the High-Low group increased by 14.10% (P = 0.046). Compared with the control group, serum gamma-glutamyl transferase (GGT) decreased significantly (P<0.05) in both the High-Low and Low-High groups. Plasma concentrations of branched-chain amino acids (BCAA: valine, isoleucine and leucine) increased in the Low-High group (P<0.05) when compared with the control group; and plasma methionine and serine decreased in both the two experimental groups (P<0.05). Compared with the High-Low group, all the BCAA increased significantly (P<0.05) in the Low-High group. These findings suggest that the sequence and quantity of alimentary protein intake affect the insulin/glucagon ratio, as well as amino acid concentrations including BCAA, methionine and serine. It is proposed that meal pattern with pigs receiving high then basal and then low CP meals daily may help to improve the weight gain of pigs.	[Xie, Chunyan; Wu, Xin; Li, Jun; Long, Cimin; Liu, Hongnan; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr, Hunan Prov Engn Res Ctr Healthy Livestock, Key Lab Agroecol Proc Subtrop Reg, Changsha 410125, Hunan, Peoples R China; [Wu, Xin; Fan, Zhiyong; Long, Cimin] Hunan Agr Univ, Coll Anim Sci & Technol, Changsha 410128, Hunan, Peoples R China; [Yin, Yulong] Hunan Normal Univ, Sch Life Sci, Changsha 41008, Hunan, Peoples R China; [Even, Patrick Christian; Blachier, Francois] INRA, AgroParisTech, Nutr Physiol & Ingest Behav, UMR 914, Paris, France	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Hunan Agricultural University; Hunan Normal University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Wu, X (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, Hunan Prov Engn Res Ctr Healthy Livestock, Key Lab Agroecol Proc Subtrop Reg, Changsha 410125, Hunan, Peoples R China.	wuxin@isa.ac.cn; yinyulong@isa.ac.cn			NSFC [31110103909]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BAD39B00]; Chinese Academy of Sciences and Knowledge Innovation Project [CXJQ120113-1]; Chinese Academy of Sciences President's International Fellowship Initiative Grant [2015VBA009, 2013T2S0014]; China Postdoctoral Science Foundation [2014M552022]	NSFC(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Chinese Academy of Sciences and Knowledge Innovation Project(Knowledge Innovation Program of the Chinese Academy of Sciences); Chinese Academy of Sciences President's International Fellowship Initiative Grant; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This paper was jointly supported by grants from the NSFC (31110103909), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2012BAD39B00), Chinese Academy of Sciences and Knowledge Innovation Project (CXJQ120113-1), Chinese Academy of Sciences President's International Fellowship Initiative Grant (No. 2015VBA009, 2013T2S0014), China Postdoctoral Science Foundation funded project (2014M552022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADIBI SA, 1976, METABOLISM, V25, P1287, DOI 10.1016/S0026-0495(76)80012-1; AHMED M, 1980, AM J CLIN NUTR, V33, P1917, DOI 10.1093/ajcn/33.9.1917; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Blouet C, 2006, J NUTR, V136, P1849, DOI 10.1093/jn/136.7.1849; Bowen J, 2006, J CLIN ENDOCR METAB, V91, P1477, DOI 10.1210/jc.2005-1856; Calbet JAL, 2002, J NUTR, V132, P2174, DOI 10.1093/jn/132.8.2174; Deng J, 2010, J ANIM PHYSIOL AN N, V94, P220, DOI 10.1111/j.1439-0396.2008.00902.x; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; FERNSTROM JD, 1979, AM J CLIN NUTR, V32, P1912, DOI 10.1093/ajcn/32.9.1912; Froy O, 2007, FRONT NEUROENDOCRIN, V28, P61, DOI 10.1016/j.yfrne.2007.03.001; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Huang RL, 2005, POULTRY SCI, V84, P1383, DOI 10.1093/ps/84.9.1383; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lee SY, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/578693; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; MUNRO HN, 1963, NUTR DIETA, V5, P298; NASSET ES, 1979, J NUTR, V109, P621, DOI 10.1093/jn/109.4.621; Nishioka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062929; Oike Hideaki, 2014, Curr Nutr Rep, V3, P204; Oishi K, 2012, CHRONOBIOL INT, V29, P799, DOI 10.3109/07420528.2012.699127; Oosterman JE, 2014, AM J PHYSL REGUL INT; Panda S, 2004, J BIOL RHYTHM, V19, P374, DOI 10.1177/0748730404269008; Pereira M, 2011, J NUTR, V141, P163, DOI 10.3945/jn.109.114405; PERET J, 1981, J NUTR, V111, P1173, DOI 10.1093/jn/111.7.1173; Pomar C, 2014, ANIMAL, V8, P704, DOI 10.1017/S1751731114000408; Raben A, 2003, AM J CLIN NUTR, V77, P91, DOI 10.1093/ajcn/77.1.91; Ranawana V, 2013, ADV FOOD NUTR RES, V70, P1, DOI 10.1016/B978-0-12-416555-7.00001-1; Ren WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088335; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Riggio O, 1989, Recenti Prog Med, V80, P591; ROMON M, 1993, AM J CLIN NUTR, V57, P476, DOI 10.1093/ajcn/57.4.476; Suryawan A, 2008, AM J PHYSIOL-ENDOC M, V295, pE868, DOI 10.1152/ajpendo.90314.2008; Tang ZR, 2005, DOMEST ANIM ENDOCRIN, V28, P430, DOI 10.1016/j.domaniend.2005.02.003; TIEDGEN M, 1980, J NUTR, V110, P876, DOI 10.1093/jn/110.5.876; Tovar AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1016, DOI 10.1152/ajpendo.00398.2001; Tsai PJ, 2000, J FORMOS MED ASSOC, V99, P151; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; van Loon LJC, 2000, AM J CLIN NUTR, V72, P96; Wu X, 2010, AMINO ACIDS, V39, P831, DOI 10.1007/s00726-010-0538-y; Xiao H, 2015, J ANIM SCI, V93, P1114, DOI 10.2527/jas.2014-8229; Yin FG, 2010, BRIT J NUTR, V103, P1404, DOI 10.1017/S0007114509993321; Yin J, 2015, RSC ADV, V5, P15479, DOI 10.1039/c4ra13557a; Yin J, 2014, AMINO ACIDS, V46, P883, DOI 10.1007/s00726-013-1643-5; YIN YL, 1993, ANIM FEED SCI TECH, V42, P297, DOI 10.1016/0377-8401(93)90106-T; Yin YL, 2010, AMINO ACIDS, V39, P1581, DOI 10.1007/s00726-010-0577-4; Yin YL, 2010, AMINO ACIDS, V39, P1477, DOI 10.1007/s00726-010-0612-5; Zhou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056072	48	17	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0125640	10.1371/journal.pone.0125640	http://dx.doi.org/10.1371/journal.pone.0125640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295708	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900002
J	den Besten, G; Gerding, A; van Dijk, TH; Ciapaite, J; Bleeker, A; van Eunen, K; Havinga, R; Groen, AK; Reijngoud, DJ; Bakker, BM				den Besten, Gijs; Gerding, Albert; van Dijk, Theo H.; Ciapaite, Jolita; Bleeker, Aycha; van Eunen, Karen; Havinga, Rick; Groen, Albert K.; Reijngoud, Dirk-Jan; Bakker, Barbara M.			Protection against the Metabolic Syndrome by Guar Gum-Derived Short-Chain Fatty Acids Depends on Peroxisome Proliferator-Activated Receptor. and Glucagon-Like Peptide-1	PLOS ONE			English	Article							INSULIN SENSITIVITY; DIETARY FIBER; BODY-WEIGHT; GLUCOSE; MICROBIOTA; OBESITY; STIMULATION; NUTRITION; GLP-1; TERM	The dietary fiber guar gum has beneficial effects on obesity, hyperglycemia and hypercholesterolemia in both humans and rodents. The major products of colonic fermentation of dietary fiber, the short-chain fatty acids (SCFAs), have been suggested to play an important role. Recently, we showed that SCFAs protect against the metabolic syndrome via a signaling cascade that involves peroxisome proliferator-activated receptor (PPAR). repression and AMP-activated protein kinase (AMPK) activation. In this study we investigated the molecular mechanism via which the dietary fiber guar gum protects against the metabolic syndrome. C57Bl/6J mice were fed a high-fat diet supplemented with 0% or 10% of the fiber guar gum for 12 weeks and effects on lipid and glucose metabolism were studied. We demonstrate that, like SCFAs, also guar gum protects against high-fat diet-induced metabolic abnormalities by PPAR. repression, subsequently increasing mitochondrial uncoupling protein 2 expression and AMP/ATP ratio, leading to the activation of AMPK and culminating in enhanced oxidative metabolism in both liver and adipose tissue. Moreover, guar gum markedly increased peripheral glucose clearance, possibly mediated by the SCFA-induced colonic hormone glucagon-like peptide-1. Overall, this study provides novel molecular insights into the beneficial effects of guar gum on the metabolic syndrome and strengthens the potential role of guar gum as a dietary-fiber intervention.	[den Besten, Gijs; Gerding, Albert; Ciapaite, Jolita; Bleeker, Aycha; van Eunen, Karen; Havinga, Rick; Groen, Albert K.; Reijngoud, Dirk-Jan; Bakker, Barbara M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat & Syst Biol,Ctr Energy Metab & Ageing, Groningen, Netherlands; [van Dijk, Theo H.; Groen, Albert K.; Reijngoud, Dirk-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [den Besten, Gijs; van Eunen, Karen; Groen, Albert K.; Reijngoud, Dirk-Jan; Bakker, Barbara M.] Netherlands Consortium Syst Biol, Amsterdam, Netherlands; [Bleeker, Aycha; van Eunen, Karen; Groen, Albert K.; Reijngoud, Dirk-Jan; Bakker, Barbara M.] Top Inst Food & Nutr, NL-6700 AN Wageningen, Netherlands	University of Groningen; University of Groningen; Top Institute Food & Nutrition	Bakker, BM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat & Syst Biol,Ctr Energy Metab & Ageing, Groningen, Netherlands.	B.M.Bakker01@umcg.nl	van Dijk, Theo/H-6436-2013	Bakker, Barbara/0000-0001-6274-3633; Ciapaite, Jolita/0000-0001-8761-9233; Reijngoud, Dirk-Jan/0000-0003-1157-4491	Netherlands Genomics Initiative via the Netherlands Consortium for Systems Biology from NWO/ZonMw [91108004]; Top Institute Food and Nutrition; Rosalind Franklin fellowship from the University of Groningen	Netherlands Genomics Initiative via the Netherlands Consortium for Systems Biology from NWO/ZonMw; Top Institute Food and Nutrition; Rosalind Franklin fellowship from the University of Groningen	This work was funded by the Netherlands Genomics Initiative via the Netherlands Consortium for Systems Biology (91108004) from NWO/ZonMw. KVE and AB are currently receiving an unrestricted research grant from Top Institute Food and Nutrition. BMB was supported by a Rosalind Franklin fellowship from the University of Groningen.	Barrera JG, 2011, NAT REV ENDOCRINOL, V7, P507, DOI 10.1038/nrendo.2011.77; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bingham SA, 2003, LANCET, V361, P1496, DOI 10.1016/S0140-6736(03)13174-1; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Burcelin R, 2001, DIABETES, V50, P1720, DOI 10.2337/diabetes.50.8.1720; Cannon Barbara, 2008, V456, P109, DOI 10.1007/978-1-59745-245-8_8; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Cicero AFG, 2010, MEDITERR J NUTR META, V3, P47, DOI 10.1007/s12349-009-0056-1; Claus SP, 2011, MBIO, V2, DOI 10.1128/mBio.00271-10; DALESSIO DA, 1994, J CLIN INVEST, V93, P2263, DOI 10.1172/JCI117225; Dall'Alba V, 2013, BRIT J NUTR, V110, P1601, DOI 10.1017/S0007114513001025; den Besten G, 2015, DIABETES, V64, P2398, DOI 10.2337/db14-1213; den Besten G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107392; den Besten G, 2013, AM J PHYSIOL-GASTR L, V305, pG900, DOI 10.1152/ajpgi.00265.2013; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; EBELING P, 1988, AM J CLIN NUTR, V48, P98, DOI 10.1093/ajcn/48.1.98; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Foretz M, 1998, J BIOL CHEM, V273, P14767, DOI 10.1074/jbc.273.24.14767; Freeland KR, 2010, BRIT J NUTR, V103, P460, DOI 10.1017/S0007114509991863; Galisteo M, 2008, J NUTR BIOCHEM, V19, P71, DOI 10.1016/j.jnutbio.2007.02.009; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Gnaiger E, 2000, LIFE IN THE COLD, P431; Grefhorst A, 2005, AM J PHYSIOL-ENDOC M, V289, pE829, DOI 10.1152/ajpendo.00165.2005; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Institute-of-Medicine, 2005, DIET REF INT EN CARB, P339; Ionut V, 2005, DIABETOLOGIA, V48, P967, DOI 10.1007/s00125-005-1709-3; KROTKIEWSKI M, 1984, BRIT J NUTR, V52, P97, DOI 10.1079/BJN19840075; Kuznetsov AV, 1998, OROBOROS BIOENERG NE, V3, P1; LANDIN K, 1992, AM J CLIN NUTR, V56, P1061, DOI 10.1093/ajcn/56.6.1061; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Leclerc I, 1998, FEBS LETT, V431, P180, DOI 10.1016/S0014-5793(98)00745-5; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Mildaziene V, 2002, TOXICOL SCI, V65, P220, DOI 10.1093/toxsci/65.2.220; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Misra A, 2010, J AM COLL NUTR, V29, p289S, DOI 10.1080/07315724.2010.10719844; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Oosterveer MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006066; Papathanasopoulos A, 2010, GASTROENTEROLOGY, V138, P65, DOI 10.1053/j.gastro.2009.11.045; SMITH U, 1982, ATHEROSCLEROSIS, V45, P1, DOI 10.1016/0021-9150(82)90166-6; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; UUSITUPA M, 1989, AM J CLIN NUTR, V49, P345, DOI 10.1093/ajcn/49.2.345; van den Hoek AM, 2004, DIABETES, V53, P1949, DOI 10.2337/diabetes.53.8.1949	47	75	76	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136364	10.1371/journal.pone.0136364	http://dx.doi.org/10.1371/journal.pone.0136364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292284	Green Submitted, Green Published, gold			2022-12-27	WOS:000359919900079
J	Neumann, AJ; Gardner, OFW; Williams, R; Alini, M; Archer, CW; Stoddart, MJ				Neumann, Alexander J.; Gardner, Oliver F. W.; Williams, Rebecca; Alini, Mauro; Archer, Charles W.; Stoddart, Martin J.			Human Articular Cartilage Progenitor Cells Are Responsive to Mechanical Stimulation and Adenoviral-Mediated Overexpression of Bone-Morphogenetic Protein 2	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; FIBRIN-POLYURETHANE COMPOSITES; IN-VITRO CHONDROGENESIS; DYNAMIC COMPRESSION; GENE-EXPRESSION; MARROW; DIFFERENTIATION; CULTURE; REPAIR; TRANSPLANTATION	Articular cartilage progenitor cells (ACPCs) represent a new and potentially powerful alternative cell source to commonly used cell sources for cartilage repair, such as chondrocytes and bone-marrow derived mesenchymal stem cells (MSCs). This is particularly due to the apparent resistance of ACPCs to hypertrophy. The current study opted to investigate whether human ACPCs (hACPCs) are responsive towards mechanical stimulation and/or adenoviral-mediated overexpression of bone morphogenetic protein 2 (BMP-2). hACPCs were cultured in fibrin-polyurethane composite scaffolds. Cells were cultured in a defined chondro-permissive medium, lacking exogenous growth factors. Constructs were cultured, for 7 or 28 days, under free-swelling conditions or with the application of complex mechanical stimulation, using a custom built bioreactor that is able to generate joint-like movements. Outcome parameters were quantification of BMP-2 and transforming growth factor beta 1 (TGF-beta 1) concentration within the cell culture medium, biochemical and gene expression analyses, histology and immunohistochemistry. The application of mechanical stimulation alone resulted in the initiation of chondrogenesis, demonstrating the cells are mechanoresponsive. This was evidenced by increased GAG production, lack of expression of hypertrophic markers and a promising gene expression profile (significant up-regulation of cartilaginous marker genes, specifically collagen type II, accompanied by no increase in the hypertrophic marker collagen type X or the osteogenic marker alkaline phosphatase). To further investigate the resistance of ACPCs to hypertrophy, overexpression of a factor associated with hypertrophic differentiation, BMP-2, was investigated. A novel, three-dimensional, transduction protocol was used to transduce cells with an adenovirus coding for BMP-2. Over-expression of BMP-2, independent of load, led to an increase in markers associated with hypertropy. Taken together ACPCs represent a potential alterative cell source for cartilage tissue engineering applications.	[Neumann, Alexander J.; Gardner, Oliver F. W.; Alini, Mauro; Stoddart, Martin J.] AO Fdn, AO Res Inst Davos, CH-7270 Davos, Switzerland; [Neumann, Alexander J.; Gardner, Oliver F. W.; Williams, Rebecca] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Archer, Charles W.] Swansea Univ, Swansea Sch Med, Swansea SA2 8PP, W Glam, Wales	Cardiff University; Swansea University	Stoddart, MJ (corresponding author), AO Fdn, AO Res Inst Davos, Clavadelerstr 8, CH-7270 Davos, Switzerland.	martin.stoddart@aofoundation.org	Stoddart, Martin J/E-3240-2013; Alini, Mauro/AAG-7961-2020	Stoddart, Martin J/0000-0002-9538-1517; Williams, Rebecca/0000-0003-2168-7369	AO Foundation	AO Foundation	This work was supported by AO Foundation.	Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278; Bosnakovski D, 2006, JPN J VET RES, V53, P127; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Cucchiarini M, 2014, Eur Cell Mater, V27, P12; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Estes BT, 2004, CURR TOP DEV BIOL, V60, P91; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fortier LA, 2011, CLIN ORTHOP RELAT R, V469, P2706, DOI 10.1007/s11999-011-1857-3; Freyria AM, 2012, INJURY, V43, P259, DOI 10.1016/j.injury.2011.05.035; Gaissmaier C, 2008, INJURY, V39, pS88, DOI 10.1016/j.injury.2008.01.035; Gorna K, 2002, J BIOMED MATER RES, V60, P592, DOI 10.1002/jbm.10100; Grad S, 2011, CLIN ORTHOP RELAT R, V469, P2764, DOI 10.1007/s11999-011-1819-9; Hayes AJ, 2008, J HISTOCHEM CYTOCHEM, V56, P125, DOI 10.1369/jhc.7A7320.2007; HOMMINGA GN, 1990, J BONE JOINT SURG BR, V72, P1003, DOI 10.1302/0301-620X.72B6.2246280; Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18; Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173; Khan IM, 2009, OSTEOARTHR CARTILAGE, V17, P518, DOI 10.1016/j.joca.2008.08.002; Kisiday JD, 2008, J ORTHOP RES, V26, P322, DOI 10.1002/jor.20508; Kupcsik L, 2010, TISSUE ENG PT A, V16, P1845, DOI [10.1089/ten.tea.2009.0531, 10.1089/ten.TEA.2009.0531]; Kupcsik L, 2009, TISSUE ENG PT A, V15, P2309, DOI 10.1089/ten.tea.2008.0400; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Leijten J, 2014, P NATL ACAD SCI USA, V111, P13954, DOI 10.1073/pnas.1410977111; Li Z, 2009, J CELL MOL MED; Li Z, 2010, TISSUE ENG PT A, V16, P575, DOI [10.1089/ten.tea.2009.0262, 10.1089/ten.TEA.2009.0262]; Li Z, 2010, J CELL MOL MED, V14, P1338, DOI 10.1111/j.1582-4934.2009.00780.x; Li Z, 2009, TISSUE ENG PT A, V15, P1729, DOI 10.1089/ten.tea.2008.0247; Madry H, 2011, DTSCH ARZTEBL INT, V108, P669, DOI 10.3238/arztebl.2011.0669; Majumdar MK, 2001, J CELL PHYSIOL, V189, P275, DOI 10.1002/jcp.10025; McCarthy HE, 2012, VET J, V192, P345, DOI 10.1016/j.tvjl.2011.08.036; Neumann AJ, 2013, TISSUE ENG PT A, V19, P1285, DOI [10.1089/ten.tea.2012.0411, 10.1089/ten.TEA.2012.0411]; Neumann AJ, 2013, MOL BIOTECHNOL, V53, P207, DOI 10.1007/s12033-012-9522-y; Palmer GD, 2005, MOL THER, V12, P219, DOI 10.1016/j.ymthe.2005.03.024; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Sailor LZ, 1996, J ORTHOPAED RES, V14, P937, DOI 10.1002/jor.1100140614; Salzmann GM, 2009, TISSUE ENG PT A, V15, P2513, DOI 10.1089/ten.tea.2008.0479; Schatti O, 2011, EUR CELLS MATER, V22, P214, DOI 10.22203/eCM.v022a17; Schumann D, 2006, BIO-MED MATER ENG, V16, pS37; Steadman J Richard, 2002, J Knee Surg, V15, P170; Steinert AF, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2822; Szerb I, 2005, BULL HOSP JT DIS, V63, P54; Toh WS, 2007, STEM CELLS, V25, P950, DOI 10.1634/stemcells.2006-0326; Williams R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013246; Wimmer MA, 2004, TISSUE ENG, V10, P1436, DOI 10.1089/1076327042500454; Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004	44	31	35	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136229	10.1371/journal.pone.0136229	http://dx.doi.org/10.1371/journal.pone.0136229			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292283	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900068
J	Corr, SJ; Shamsudeen, S; Vergara, LA; Ho, JCS; Ware, MJ; Keshishian, V; Yokoi, K; Savage, DJ; Meraz, IM; Kaluarachchi, W; Cisneros, BT; Raoof, M; Nguyen, DT; Zhang, YC; Wilson, LJ; Summers, H; Rees, P; Curley, SA; Serda, RE				Corr, Stuart J.; Shamsudeen, Sabeel; Vergara, Leoncio A.; Ho, Jason Chak-Shing; Ware, Matthew J.; Keshishian, Vazrik; Yokoi, Kenji; Savage, David J.; Meraz, Ismail M.; Kaluarachchi, Warna; Cisneros, Brandon T.; Raoof, Mustafa; Nguyen, Duy Trac; Zhang, Yingchun; Wilson, Lon J.; Summers, Huw; Rees, Paul; Curley, Steven A.; Serda, Rita E.			A New Imaging Platform for Visualizing Biological Effects of Non-Invasive Radiofrequency Electric-Field Cancer Hyperthermia	PLOS ONE			English	Article							GOLD NANOPARTICLES; THERAPY; TUMORS; NANOTHERAPEUTICS; CELLS; RF	Herein, we present a novel imaging platform to study the biological effects of non-invasive radiofrequency (RF) electric field cancer hyperthermia. This system allows for real-time in vivo intravital microscopy (IVM) imaging of radiofrequency-induced biological alterations such as changes in vessel structure and drug perfusion. Our results indicate that the IVM system is able to handle exposure to high-power electric-fields without inducing significant hardware damage or imaging artifacts. Furthermore, short durations of low-power (< 200 W) radiofrequency exposure increased transport and perfusion of fluorescent tracers into the tumors at temperatures below 41 degrees C. Vessel deformations and blood coagulation were seen for tumor temperatures around 44 degrees C. These results highlight the use of our integrated IVM-RF imaging platform as a powerful new tool to visualize the dynamics and interplay between radiofrequency energy and biological tissues, organs, and tumors.	[Corr, Stuart J.; Vergara, Leoncio A.; Ho, Jason Chak-Shing; Ware, Matthew J.; Keshishian, Vazrik; Nguyen, Duy Trac; Curley, Steven A.; Serda, Rita E.] Baylor Coll Med, Dept Surg, Div Surg Res, Houston, TX 77030 USA; [Corr, Stuart J.; Cisneros, Brandon T.; Wilson, Lon J.] Rice Univ, Dept Chem, Houston, TX USA; [Corr, Stuart J.; Kaluarachchi, Warna; Cisneros, Brandon T.; Raoof, Mustafa] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Shamsudeen, Sabeel; Yokoi, Kenji; Savage, David J.; Meraz, Ismail M.; Summers, Huw; Rees, Paul; Serda, Rita E.] Houston Methodist Res Inst, Dept Nanomed, Houston, TX USA; [Shamsudeen, Sabeel; Nguyen, Duy Trac; Zhang, Yingchun] Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA; [Summers, Huw] Swansea Univ, Coll Engn, Ctr Nanohlth, Swansea, W Glam, Wales; [Rees, Paul] Broad Inst, Cambridge, MA USA; [Curley, Steven A.] Rice Univ, Dept Mech Engn & Mat Sci, Houston, TX 77251 USA	Baylor College of Medicine; Rice University; University of Texas System; UTMD Anderson Cancer Center; The Methodist Hospital System; The Methodist Hospital - Houston; University of Houston System; University of Houston; Swansea University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rice University	Corr, SJ (corresponding author), Baylor Coll Med, Dept Surg, Div Surg Res, Houston, TX 77030 USA.	stuart.corr@bcm.edu	Savage, David/ABA-5389-2021; Zhang, Yingchun/D-9496-2013; Summers, Huw/Y-7676-2019	Ware, Matthew/0000-0002-1835-9885; Savage, MD, PhD, David/0000-0003-4690-5115; Rees, Paul/0000-0002-7715-6914; Summers, Huw/0000-0002-0898-5612	NIH Physical Science in Oncology Program [U54CA143837]; NIH M.D. Anderson Cancer Center Support Grants [CA016672]; Welch Foundation [C-0627, 616]; Kanzius 617 Research Foundation (Erie, PA); National Center for Advancing Translational Sciences of the National Institutes of Health [TL1TR000369, UL1TR000371]; EPSRC [EP/J00619X/1, EP/H008683/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H008683/1, EP/J00619X/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U54CA143837, T32CA174647, P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371, TL1TR000369] Funding Source: NIH RePORTER	NIH Physical Science in Oncology Program; NIH M.D. Anderson Cancer Center Support Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Kanzius 617 Research Foundation (Erie, PA); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Research reported in this publication was supported by the NIH Physical Science in Oncology Program (U54CA143837), the NIH M.D. Anderson Cancer Center Support Grants (CA016672), The Welch Foundation (C-0627, 616 L.J.W.), an unrestricted research grant from the Kanzius 617 Research Foundation (SAC, Erie, PA), and the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Numbers TL1TR000369 and UL1TR000371. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUDA SP, 1980, CANCER, V46, P1962, DOI 10.1002/1097-0142(19801101)46:9<1962::AID-CNCR2820460911>3.0.CO;2-N; Cheng AY, 1982, BRIT J CANCER, V16, P16; Collins CB, 2014, NANOSCALE, V6, P8459, DOI 10.1039/c4nr00464g; Corr SJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50480; Corr SJ, 2012, J PHYS CHEM C, V116, P24380, DOI 10.1021/jp309053z; Curnis F, 2002, J CLIN INVEST, V110, P475, DOI 10.1172/JCI200215223; Diop-Frimpong B, 2011, P NATL ACAD SCI USA, V108, P2909, DOI 10.1073/pnas.1018892108; Foster K.R JLS, 1981, JOURNAL OF MICROWAVE, V2, P107; Gach HM, 2010, BIOELECTROMAGNETICS, V31, P582, DOI 10.1002/bem.20595; Gannon Christopher J., 2008, Journal of Nanobiotechnology, V6, P2, DOI 10.1186/1477-3155-6-2; Gannon CJ, 2007, CANCER-AM CANCER SOC, V110, P2654, DOI 10.1002/cncr.23155; Glazer ES, 2010, SURGERY, V148, P319, DOI 10.1016/j.surg.2010.04.025; Glazer ES, 2010, CANCER-AM CANCER SOC, V116, P3285, DOI 10.1002/cncr.25135; Hanson GW, 2011, J APPL PHYS, V109, DOI 10.1063/1.3600222; Hanson GW, 2009, J APPL PHYS, V106, DOI 10.1063/1.3204653; Kanzius J, 2007, Enhanced Systems and Methods for RF-Induced Hyperthermia II, Patent No. [WO 2007/027620 A1, 2007027620]; Ketharnath D, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4748285; Koshkina NV, 2014, CANCER-AM CANCER SOC, V120, P480, DOI 10.1002/cncr.28453; Kruse DE, 2011, IEEE T BIO-MED ENG, V58, P2002, DOI 10.1109/TBME.2011.2124460; Letfullin RR, 2015, NANOMED-NANOTECHNOL, V11, P413, DOI 10.1016/j.nano.2014.09.013; Li DX, 2012, IEEE T BIO-MED ENG, V59, P3468, DOI 10.1109/TBME.2012.2219049; Li DX, 2011, J COLLOID INTERF SCI, V358, P47, DOI 10.1016/j.jcis.2011.01.059; Liu XM, 2015, APPL PHYS REV, V2, DOI 10.1063/1.4915002; Pittet Mikael J, CELL, V147, P983, DOI [10.1016/j.cell.2011.11.004, DOI 10.1016/J.CELL.2011.11.004]; Raoof M, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju183; Raoof M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068506; Raoof M, 2012, NANOMED-NANOTECHNOL, V8, P1096, DOI 10.1016/j.nano.2012.02.001; Raoof M, 2012, INT J HYPERTHER, V28, P202, DOI 10.3109/02656736.2012.666318; Ren Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003778; Roussakow S., 2013, C PAPERS MED, DOI [10.1155/2013/428027, DOI 10.1155/2013/428027]; STUCHLY MA, 1982, PHYS MED BIOL, V27, P927, DOI 10.1088/0031-9155/27/7/004; Stylianopoulos T, 2013, P NATL ACAD SCI USA, V110, P18632, DOI 10.1073/pnas.1318415110; Wosik J, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4816668; Yokoi K, 2014, CANCER LETT, V345, P48, DOI 10.1016/j.canlet.2013.11.015; ZIMMER R, 1979, J MICROWAVE POWER EE, V14, P155	35	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136382	10.1371/journal.pone.0136382	http://dx.doi.org/10.1371/journal.pone.0136382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308617	Green Submitted, Green Published, gold			2022-12-27	WOS:000360069400116
J	Dane, SK; Masser, BM; MacDonald, G; Duck, JM				Dane, Sharon K.; Masser, Barbara M.; MacDonald, Geoff; Duck, Julie M.			When "In Your Face" Is Not Out of Place: The Effect of Timing of Disclosure of a Same-Sex Dating Partner under Conditions of Contact	PLOS ONE			English	Article							CROSS-GROUP FRIENDSHIPS; INTERGROUP CONTACT; SELF-DISCLOSURE; GAY MEN; HETEROSEXUALS ATTITUDES; NEGATIVE CONTACT; GROUP MEMBERSHIP; OUT-GROUP; PREJUDICE; ORIENTATION	In a series of experiments we examined heterosexuals' reactions to the timing of disclosure of a gender-matched confederate's same-sex dating partner. Disclosure occurred in a naturalistic context-that is, it occurred when meeting, or expecting to soon meet, a same-sex attracted individual, who voluntarily shared this information with the participant as a natural part of a broader topic of discussion. The confederate, when disclosing early rather than later, was approached more closely (Prestudy) and liked more (Studies 1-2). Those experiencing early disclosure, compared with later, were less drawn to topics of lower intimacy (Study 1), were happier and more excited about meeting the confederate, and more likely to choose to be alone with the confederate for a one-on-one discussion (Study 2). Further, women experiencing early disclosure were more willing to introduce the same-gender confederate to their friends (Study 2). The benefits of knowing sooner, rather than later, continued to apply even when participants were given further time to process the disclosure. To explore the underlying reasons for the more favorable experiences of upfront disclosure, we examined participants' memory of the information shared by the confederate (Study 3). Results revealed that those who experienced delayed disclosure were more likely to incorrectly recall and negatively embellish information related to the confederate's sexual orientation, suggesting that early disclosure resulted in a reduced tendency to focus on the confederate's sexuality as a defining feature. These positive findings for early timing are discussed in light of previous studies that have found benefits for delayed disclosure and those that have failed to investigate the effects of timing of 'coming out' under conditions of contact.	[Dane, Sharon K.; Masser, Barbara M.] Univ Queensland, Sch Psychol, St Lucia, Qld 4072, Australia; [MacDonald, Geoff] Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; [Duck, Julie M.] Univ Queensland, Fac Humanities & Social Sci, St Lucia, Qld 4072, Australia	University of Queensland; University of Toronto; University of Queensland	Dane, SK (corresponding author), Univ Queensland, Sch Psychol, McElwain Bldg, St Lucia, Qld 4072, Australia.	s.dane@psy.uq.edu.au	Masser, Barbara M/A-7900-2018	Masser, Barbara M/0000-0001-9385-6497				Allport G. W., 1954, NATURE PREJUDICE; Altemeyer B, 1988, ENEMIES FREEDOM; Altman L., 1973, SOCIAL PENETRATION T; ARCHER RL, 1980, J PERS SOC PSYCHOL, V38, P120, DOI 10.1037/0022-3514.38.1.120; ASCH SE, 1948, PSYCHOL REV, V55, P250, DOI 10.1037/h0057270; Barlow FK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082228; Barlow FK, 2012, PERS SOC PSYCHOL B, V38, P1629, DOI 10.1177/0146167212457953; Becker HS., 1963, OUTSIDERS STUDIES SO; Blair IV, 2003, GROUP PROCESS INTERG, V6, P151, DOI 10.1177/1368430203006002002; Bogardus ES, 1925, J APPL SOCIOL, V9, P299; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brown R, 1999, EUR J SOC PSYCHOL, V29, P741, DOI 10.1002/(SICI)1099-0992(199908/09)29:5/6<741::AID-EJSP972>3.0.CO;2-8; Brown R, 2005, ADV EXP SOC PSYCHOL, V37, P255, DOI 10.1016/S0065-2601(05)37005-5; Buck DM, 2011, J EXP SOC PSYCHOL, V47, P333, DOI 10.1016/j.jesp.2010.10.016; CARLSTON DE, 1980, J EXP SOC PSYCHOL, V16, P303, DOI 10.1016/0022-1031(80)90025-6; COZBY PC, 1973, PSYCHOL BULL, V79, P73, DOI 10.1037/h0033950; D'Augelli AR, 1998, AM J ORTHOPSYCHIAT, V68, P361, DOI 10.1037/h0080345; Dane SK, 2010, NOT SO PRIVATE LIVES; Davies K, 2011, PERS SOC PSYCHOL REV, V15, P332, DOI 10.1177/1088868311411103; Dennis MJ, 2001, MEM COGNITION, V29, P152, DOI 10.3758/BF03195749; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.1.5; Dovidio JR, 2003, GROUP PROCESS INTERG, V6, P5, DOI 10.1177/1368430203006001009; Ensari N, 2002, J PERS SOC PSYCHOL, V83, P313, DOI 10.1037//0022-3514.83.2.313; Field A., 2013, DISCOVERING STAT USI; Freedom to Marry, FREED MARR INT; Galaxy Research, 2012, REL SAM SEX MARR; Gates GJ, 2012, GALL SPEC REP US AD; GENTRY CS, 1987, J SOC PSYCHOL, V127, P199, DOI 10.1080/00224545.1987.9713680; Goldfried MR, 2001, AM PSYCHOL, V56, P977, DOI 10.1037/0003-066X.56.11.977; Golebiowska EA, 2003, POLIT BEHAV, V25, P313, DOI 10.1023/B:POBE.0000004061.08643.7d; GROSS AE, 1980, PERS SOC PSYCHOL B, V6, P307, DOI 10.1177/014616728062020; HASTIE R, 1986, PSYCHOL REV, V93, P258, DOI 10.1037/0033-295X.93.3.258; Hastie R, 1980, PERSON MEMORY COGNIT; Hebl MR, 2000, SOCIAL PSYCHOLOGY OF STIGMA, P275; Herek G. M., 1994, LESBIAN GAY PSYCHOL, P206, DOI DOI 10.4135/9781483326757.N11; Herek G.M., 2003, PSYCHOL PERSPECTIVES, V2nd, P270; Herek GM, 2000, J SOC ISSUES, V56, P251, DOI 10.1111/0022-4537.00164; Herek GM, 1996, PERS SOC PSYCHOL B, V22, P412, DOI 10.1177/0146167296224007; Hodson G, 2009, EUR J SOC PSYCHOL, V39, P509, DOI 10.1002/ejsp.558; JONES EE, 1972, J PERS SOC PSYCHOL, V24, P358, DOI 10.1037/h0033724; King EB, 2008, GROUP ORGAN MANAGE, V33, P566, DOI 10.1177/1059601108321834; Kite M. E., 2003, PSYCHOL PERSPECTIVES, P165; Kleider HM, 2008, APPL COGNITIVE PSYCH, V22, P1, DOI 10.1002/acp.1361; LaMar L, 1998, J SEX RES, V35, P189, DOI 10.1080/00224499809551932; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Levinson CA, 2011, PERS INDIV DIFFER, V51, P355, DOI 10.1016/j.paid.2011.04.006; Maass A., 2000, SOCIAL IDENTITY PROC, P96, DOI [10.4135/9781446218617.n7, DOI 10.4135/9781446218617.N7]; MacInnis CC, 2014, J SOCIAL PERSONAL RE, P1; MACRAE CN, 1993, EUR J SOC PSYCHOL, V23, P77, DOI 10.1002/ejsp.2420230107; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; Miller N, 2002, J SOC ISSUES, V58, P387, DOI 10.1111/1540-4560.00267; Mohipp C, 2004, CAN J BEHAV SCI, V36, P36, DOI 10.1037/h0087214; Moskowitz GB, 2005, SOICAL COGNITION UND; O'Brien KS, 2013, INT J PSYCHOL, V48, P891, DOI 10.1080/00207594.2012.713107; Pachankis JE, 2007, PSYCHOL BULL, V133, P328, DOI 10.1037/0033-2909.133.2.328; Page-Gould E, 2008, J PERS SOC PSYCHOL, V95, P1080, DOI 10.1037/0022-3514.95.5.1080; Page-Gould E, 2010, J PERS SOC PSYCHOL, V98, P775, DOI 10.1037/a0017880; Pettigrew TF, 1998, ANNU REV PSYCHOL, V49, P65, DOI 10.1146/annurev.psych.49.1.65; Pettigrew TF, 2008, EUR J SOC PSYCHOL, V38, P922, DOI 10.1002/ejsp.504; Pettigrew TF, 2007, INT J INTERCULT REL, V31, P411, DOI 10.1016/j.ijintrel.2006.11.003; Pettigrew TF, 2006, J PERS SOC PSYCHOL, V90, P751, DOI 10.1037/0022-3514.90.5.751; Pettigrew TF, 2011, INT J INTERCULT REL, V35, P271, DOI 10.1016/j.ijintrel.2011.03.001; Pew Research Center, 2013, SURV LGBT AM ATT EXP; Plant EA, 2003, PERS SOC PSYCHOL B, V29, P790, DOI 10.1177/0146167203029006011; Quinn DM, 2009, J PERS SOC PSYCHOL, V97, P634, DOI 10.1037/a0015815; REYES RM, 1980, J PERS SOC PSYCHOL, V39, P2, DOI 10.1037/0022-3514.39.1.2; Rickards T, 2006, HLTH CARE WOMEN INT, V6, P530, DOI DOI 10.1080/07399330600770254; Roediger H.L., 2012, MEMORY LAW, P84, DOI [DOI 10.1093/ACPROF:OSO/9780199920754.003.0004, 10.1093/acprof:oso/9780199920754.003.0004]; Savin-Williams RC, 2001, J ADOLESCENCE, V24, P5, DOI 10.1006/jado.2000.0369; Sedikides C, 1998, J PERS SOC PSYCHOL, V74, P378, DOI 10.1037/0022-3514.74.2.378; Sherman JW, 2000, PERS SOC PSYCHOL B, V26, P26, DOI 10.1177/0146167200261003; SHERMAN SJ, 1983, J PERS SOC PSYCHOL, V44, P1127; Shook NJ, 2008, PSYCHOL SCI, V19, P717, DOI 10.1111/j.1467-9280.2008.02147.x; SKOWRONSKI JJ, 1989, PSYCHOL BULL, V105, P131, DOI 10.1037/0033-2909.105.1.131; STANGOR C, 1992, PSYCHOL BULL, V111, P42, DOI 10.1037/0033-2909.111.1.42; Stones CR, 2006, SOC BEHAV PERSONAL, V34, P1137, DOI 10.2224/sbp.2006.34.9.1137; Tam T, 2006, GROUP PROCESS INTERG, V9, P413, DOI 10.1177/1368430206064642; Techakesari P, 2015, J CROSS CULT PSYCHOL, V46, P454, DOI 10.1177/0022022115570313; Tumer RN, 2007, J PERS SOC PSYCHOL, V93, P369, DOI 10.1037/0022-3514.93.3.369; Turner RN, EUROPEAN REV SOCIAL, P212; Vonofakou C, 2007, J PERS SOC PSYCHOL, V92, P804, DOI 10.1037/0022-3514.92.5.804; Whitley BE, 2000, J APPL SOC PSYCHOL, V30, P144, DOI 10.1111/j.1559-1816.2000.tb02309.x; WORTMAN CB, 1976, J PERS SOC PSYCHOL, V33, P184, DOI 10.1037/0022-3514.33.2.184; Wright SC, 1997, J PERS SOC PSYCHOL, V73, P73, DOI 10.1037/0022-3514.73.1.73	84	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135023	10.1371/journal.pone.0135023	http://dx.doi.org/10.1371/journal.pone.0135023			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LO	26308076	Green Submitted, Green Published, gold			2022-12-27	WOS:000360069400046
J	Ma, LP; Xu, P; Lin, HJ; Ju, LH; Lv, F				Ma Liping; Xu Peng; Lin Haijiang; Ju Lahong; Lv Fan			Quality of Life of People Living with HIV/AIDS: A Cross-Sectional Study in Zhejiang Province, China	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV; HEALTH; OUTCOMES; ADHERENCE; THYMUS	Health-related quality of life (HRQOL) has become a concept commonly used in the related research. Using the World Health Organization Quality of Life Questionnaire for Brief Version (WHOQOL-BREF), this study evaluated the Quality of Life (QOL) of people living with HIV/AIDS (PLWHA) in Zhejiang province, China, and assessed the influences of demographic, laboratory and disease-related variables on QOL. This cross-sectional study was conducted among PLWHA aged >= 18 years in Taizhou municipality, Zhejiang province, China, between August 1 and October 31, 2014. A multiple linear regression model was used to analyze the influential factors. Of 403 subjects, 72.48% were male, 72.46% had received a high-school or above education, 94.79% were of Han ethnicity, and 65.51% were non farmers. The total score of QOL was 15.99 +/- 1.99. The scores of QOL in physiological, psychological, social relation, and environmental domains were 14.99 +/- 2.25, 14.25 +/- 2.12, 13.22 +/- 2.37, and 13.31 +/- 1.99 respectively. Except the total score of QOL and the score of environmental domain (p<0.05), the scores in other domains had no significant difference with the results of the national norm level. The multiple linear regression model identified the physical domain related factors to be age (beta = -0.045), CD4 count (beta = 0.002), and ART adherence(beta = 1.231). And it also showed that psychological domain related factors included CD4 count (beta = 0.002) and WHO clinical stage (beta = -0.437); social domain related factors included WHO clinical stage (beta = -0.704) and ART adherence (beta = 1.177); while environmental domain related factors included WHO clinical stage (beta = -0.538), educational status(beta = 0.549) and ART adherence(beta = 1.078). Those who are young, with higher level of education, higher CD4 count and good access and adherence of ART, are likely to have better QOL among PLWHA in Zhejiang province. This suggests that in addition to ART, many other factors should be taken into consideration to improve the QOL of PLWHA. The relatively lower scores the subjects received in social relation and environmental domains also suggest that social relation and environmental interventions need to be strengthened.	[Ma Liping; Xu Peng; Ju Lahong; Lv Fan] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Lin Haijiang] Taizhou Ctr Dis Control & Prevent, Taizhou, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Lv, F (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	Fanlv@vip.sina.com			National Natural Science Foundation of China [71373008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by National Natural Science Foundation of China (Grant Number: 71373008).	Abboud S, 2010, AIDS CARE, V22, P687, DOI 10.1080/09540120903334658; Akinboro AO, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.234.2816; Cardona-Arias JA, 2014, REV ESP SALUD PUBLIC, V88, P87, DOI [10.4321/S1135-57272014000100006, 10.4321/s1135-57272014000100006]; Beard J, 2009, AIDS CARE, V21, P1343, DOI 10.1080/09540120902889926; Cardona-Arias J, 2011, BIOMEDICA, V31, P532, DOI 10.1590/S0120-41572011000400008; China MoHotPsRo, 2014, 2014 CHIN AIDS RESP; Fang J. -Q., 1999, SB TITLE SBCONTRIBUT, V13, P203; Fu TST, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-37; Handajani Yvonne S, 2012, Acta Med Indones, V44, P310; Hou WL, 2014, AIDS CARE, V26, P996, DOI 10.1080/09540121.2013.873764; Kovacevic SB, 2006, COLLEGIUM ANTROPOL, V30, P79; Ming ZQ, 2014, J ASSOC NURSE AIDS C, V25, P603, DOI 10.1016/j.jana.2014.04.003; Ministry of Health People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2011, 2011 EST HIV AIDS EP; Morgan I, 2015, J HEADACHE PAIN, V16, DOI [10.1186/s10194-016-0601-5, 10.1186/s10194-015-0504-x]; National Health and Family Planning Commission of China, 2014, 2014 CHIN AIDS RESP; Pan Xiaohong, 2014, Zhonghua Yu Fang Yi Xue Za Zhi, V48, P380; Raj R, 2011, SEX TRANSM INFECT, V87, P216, DOI 10.1136/sti.2010.043356; Ribeiro RM, 2008, JAIDS-J ACQ IMM DEF, V49, P1, DOI 10.1097/QAI.0b013e318184fb28; Shaik MM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/523717; Shan D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021839; Stangl AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18734; Sun W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064562; The Ministry of Health The People's Republic of China, 2013, 2012 CHIN AIDS RESP; Tsevat J, 1996, MED CARE, V34, P44, DOI 10.1097/00005650-199601000-00004; UN Joint Programme on HIV/AIDS (UNAIDS), 2014, THE GAP REP; Wang HH, 2010, J CLIN NURS, V19, P380, DOI 10.1111/j.1365-2702.2009.03048.x; Wig Naveet, 2006, Indian J Med Sci, V60, P3; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Xie TS, 2013, CLIN INTERV AGING, V8, P1519, DOI 10.2147/CIA.S53657; Ye P, 2004, CURR HIV RES, V2, P177, DOI 10.2174/1570162043484898; Yt H., 2000, CHIN J TISSUE ENG RE, V4, P1127, DOI DOI 10.3321/J.ISSN:1673-8225.2000.08.002; yuan-tao FJ-q Hao, 2000, MODERN REHABILITATIO, V4, P45; Yuji Feng ZW, 2010, NIH PUBLIC ACC UNPUB, DOI [10.1097/qai, DOI 10.1097/QAI]; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006; Zinman A, 2014, REHABIL RES PRACT, V2014, DOI 10.1155/2014/989025; Zubaran C, 2014, AIDS CARE, V26, P619, DOI 10.1080/09540121.2013.841838	37	28	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135705	10.1371/journal.pone.0135705	http://dx.doi.org/10.1371/journal.pone.0135705			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LO	26308088	Green Submitted, Green Published, gold			2022-12-27	WOS:000360069400072
J	Rich, KJ; Ridealgh, M; West, SE; Cinderby, S; Ashmore, M				Rich, Kevin J.; Ridealgh, Michael; West, Sarah E.; Cinderby, Steve; Ashmore, Mike			Exploring the Links between Post-Industrial Landscape History and Ecology through Participatory Methods	PLOS ONE			English	Article							ECOSYSTEM SERVICES; AIR-QUALITY; RESTORATION; COMMUNITIES; HYMENOPTERA; DYNAMICS; GIS	There is increasing recognition of the importance for local biodiversity of post-mining sites, many of which lie near communities that have suffered significant social and economic deprivation as the result of mine closures. However, no studies to date have actively used the knowledge of local communities to relate the history and treatment of post-mining sites to their current ecological status. We report a study of two post-mining sites in the Yorkshire coalfield of the UK in which the local community were involved in developing site histories and assessing plant and invertebrate species composition. Site histories developed using participatory GIS revealed that the sites had a mixture of areas of spontaneous succession and technical reclamation, and identified that both planned management interventions and informal activities influenced habitat heterogeneity and ecological diversity. Two groups of informal activity were identified as being of particular importance. Firstly, there has been active protection by the community of flower-rich habitats of conservation value (e.g. calcareous grassland) and distinctive plant species (e.g. orchids) which has also provided important foraging resources for butterfly and bumblebee species. Secondly, disturbance by activities such as use of motorbikes, informal camping, and cutting of trees and shrubs for fuel, as well as planned management interventions such as spreading of brick rubble, has provided habitat for plant species of open waste ground and locally uncommon invertebrate species which require patches of bare ground. This study demonstrates the importance of informal, and often unrecorded, activities by the local community in providing diverse habitats and increased biodiversity within a post-mining site, and shows that active engagement with the local community and use of local knowledge can enhance ecological interpretation of such sites and provide a stronger basis for successful future management.	[Rich, Kevin J.; Ridealgh, Michael] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; [West, Sarah E.; Cinderby, Steve; Ashmore, Mike] Univ York, Stockholm Environm Inst, York YO10 5DD, N Yorkshire, England	University of York - UK; University of York - UK	West, SE (corresponding author), Univ York, Stockholm Environm Inst, York YO10 5DD, N Yorkshire, England.	sarah.west@york.ac.uk			National Lottery (UK) through the Big Lottery Fund	National Lottery (UK) through the Big Lottery Fund	This work was conducted under the OPAL (Open Air Laboratories) project, which is funded by The National Lottery (UK) through the Big Lottery Fund (grant holder MA). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2007, ECOL APPL, V17, P1267, DOI 10.1890/06-1116.1; Baasch A, 2012, J APPL ECOL, V49, P251, DOI 10.1111/j.1365-2664.2011.02086.x; Barthel S, 2005, ECOL SOC, V10; Bone J, 2012, ENVIRON SCI TECHNOL, V46, P3687, DOI 10.1021/es203880p; Bryan BA, 2010, LANDSCAPE URBAN PLAN, V97, P111, DOI 10.1016/j.landurbplan.2010.05.002; Buglife, ID OP MOS HAB; Bumblebee Conservation Trust, BEEW GUID; Butterfly Conservation, WOODL BUTT BRIEF GUI; Cinderby S, 2010, AREA, V42, P239, DOI 10.1111/j.1475-4762.2009.00912.x; Cinderby S, 2008, LOCAL ENVIRON, V13, P309, DOI 10.1080/13549830701803265; Cooper CB, 2007, ECOL SOC, V12; Drake C.M., 2007, NERR005; Hobbs SJ, 2012, J NAT CONSERV, V20, P364, DOI 10.1016/j.jnc.2012.08.002; Holec M, 2005, PEDOBIOLOGIA, V49, P345, DOI 10.1016/j.pedobi.2005.03.001; Holl KD, 1996, J APPL ECOL, V33, P225, DOI 10.2307/2404745; Maddock A, 2008, UK BIODIVERSITY ACTI; Millenium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL, P1; Plieninger T, 2013, LAND USE POLICY, V33, P118, DOI 10.1016/j.landusepol.2012.12.013; POLLARD E, 1994, MONITORING BUTTERFLI; Prach K, 2001, ECOL ENG, V17, P55, DOI 10.1016/S0925-8574(00)00132-4; Rae A., 2011, UNDER THE RADAR BLOG; Raine NE, 2007, ENTOMOL GEN, V29, P179; Rodwell JS, 2006, NATL VEGETATION CLAS; Rotherham I., 2003, POSTCOAL MINING LAND; Schadek Ute, 2009, Urban Ecosystems, V12, P115, DOI 10.1007/s11252-008-0072-9; Schofield M., 2009, LIFE VERGE WILD FLOW; Seed L, 2013, ENVIRON POLLUT, V182, P437, DOI 10.1016/j.envpol.2013.07.045; Tropek R, 2013, ECOL ENG, V57, P252, DOI 10.1016/j.ecoleng.2013.04.024; Tsuchiya K, 2014, ECOL SOC, V19, DOI 10.5751/ES-06369-190225; Wiegleb G, 2013, BIODIVERS CONSERV, V22, P1931, DOI 10.1007/s10531-013-0518-0	30	8	9	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136522	10.1371/journal.pone.0136522	http://dx.doi.org/10.1371/journal.pone.0136522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309041	Green Submitted, Green Published, gold			2022-12-27	WOS:000360069400133
J	Serdjebi, C; Gagniere, J; Desrame, J; Fein, F; Guimbaud, R; Francois, E; Andre, T; Seitz, JF; Monterymard, C; Arsene, D; Volet, J; Abakar-Mahamat, A; Lecomte, T; Guerin-Meyer, V; Legoux, JL; Deplanque, G; Guillet, P; Ciccolini, J; Lepage, C; Dahan, L				Serdjebi, Cindy; Gagniere, Johan; Desrame, Jerome; Fein, Francine; Guimbaud, Rosine; Francois, Eric; Andre, Thierry; Seitz, Jean-Francois; Monterymard, Carole; Arsene, Dominique; Volet, Julien; Abakar-Mahamat, Abakar; Lecomte, Thierry; Guerin-Meyer, Veronique; Legoux, Jean-Louis; Deplanque, Gael; Guillet, Pierre; Ciccolini, Joseph; Lepage, Come; Dahan, Laetitia			FFCD-1004 Clinical Trial: Impact of Cytidine Deaminase Activity on Clinical Outcome in Gemcitabine-Monotherapy Treated Patients	PLOS ONE			English	Article							LUNG-CANCER PATIENTS; POPULATION PHARMACOKINETICS; DEOXYCYTIDINE KINASE; PANCREATIC-CANCER; POLYMORPHISMS; METABOLISM; SURVIVAL; VARIANTS; THERAPY	Purpose Because cytidine deaminase (CDA) is the key enzyme in gemcitabine metabolism, numerous studies have attempted to investigate impact of CDA status (i.e. genotype or phenotype) on clinical outcome. To date, data are still controversial because none of these studies has fully investigated genotype-phenotype CDA status, pharmacokinetics and clinical outcome relationships in gemcitabine-treated patients. Besides, most patients were treated with gemcitabine associated with other drugs, thus adding a confounding factor. We performed a multicenter prospective clinical trial in gemcitabine-treated patients which aimed at investigating the link between CDA deficiency on the occurrence of severe toxicities and on pharmacokinetics, and studying CDA genotype-phenotype relationships. Experimental design One hundred twenty patients with resected pancreatic adenocarcinoma eligible for adjuvant gemcitabine monotherapy were enrolled in this study promoted and managed by the Federation Francophone de Cancerologie Digestive. Toxicities were graded according to National Cancer Institute's Common Terminology Criteria for Adverse Events Version 4. They were considered severe for grade >= 3, and early when occurring during the first eight weeks of treatment. CDA status was evaluated using a double approach: genotyping for 79A>C and functional testing. Therapeutic drug monitoring of gemcitabine and its metabolite were performed on the first course of gemcitabine. Results Five patients out of 120 (i.e., 4.6%) were found to be CDA deficient (i.e., CDA activity < 1.3 U/mg), and only one among them experienced early severe hematological toxicity. There was no statistically significant difference in CDA activity between patients experiencing hematological severe toxicities (28.44%) and patients who tolerated the treatment (71.56%). CDA genetic analysis failed in evidencing an impact in terms of toxicities or in CDA activity. Regarding pharmacokinetics, a wide inter-individual variability has been observed in patients. Conclusion This study, which included only 4.6% of CDA-deficient patients, failed in identifying CDA status as a predictive marker of toxicities with gemcitabine. A lack of statistical power because of smoothing effect of CDA variability as compared with real life conditions could explain this absence of impact.	[Serdjebi, Cindy; Ciccolini, Joseph] SMARTc, INSERM UMR S CRO2 911, Marseille, France; [Gagniere, Johan] Univ Hosp Clermont Ferrand, Clermont Ferrand, France; [Desrame, Jerome] Ctr Jean Mermoz, Lyon, France; [Fein, Francine] Univ Hosp Besancon, Besancon, France; [Guimbaud, Rosine] Univ Hosp Toulouse, Toulouse, France; [Francois, Eric] Ctr Antoine Lacassagne, F-06054 Nice, France; [Andre, Thierry] Univ Hosp St Antoine & Pierre & Marie Curie, AP HP, Paris, France; [Seitz, Jean-Francois; Dahan, Laetitia] Univ Hosp La Timone, AP HM, Marseille, France; [Monterymard, Carole] FFCD, Dijon, France; [Arsene, Dominique] Univ Hosp Caen, Caen, France; [Volet, Julien] Univ Hosp Reims, Reims, France; [Abakar-Mahamat, Abakar] Univ Hosp Nice, Nice, France; [Lecomte, Thierry] Univ Hosp Tours, Tours, France; [Guerin-Meyer, Veronique] Univ Hosp Angers, Angers, France; [Legoux, Jean-Louis] Reg Hosp Orleans, Orleans, France; [Deplanque, Gael] St Joseph Hosp, Paris, France; [Guillet, Pierre] Hosp Toulon, Toulon, France; [Lepage, Come] Univ Hosp Dijon, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand; Universite de Franche-Comte; CHU Besancon; CHU de Toulouse; UNICANCER; Centre Antoine Lacassagne; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Bourgogne; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Reims; CHU Nice; CHU Tours; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre Hospitalier Regional d'Orleans; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; CHU Dijon Bourgogne	Serdjebi, C (corresponding author), SMARTc, INSERM UMR S CRO2 911, Marseille, France.	cindy.serdjebi@univ-amu.fr	Dahan, Laetitia LD/M-3441-2016; Ciccolini, Joseph/AAP-7193-2021; André, Thierry P/N-8830-2017	André, Thierry P/0000-0002-5103-7095; Ciccolini, Joseph/0000-0003-1733-3410; LECOMTE, Thierry/0000-0001-5093-0212	Fondation pour la Recherche Medicale [FDM20140629931, FDM20120624035]; Federation Francophone de Cancerologie Digestive	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Federation Francophone de Cancerologie Digestive	Cindy SERDJEBI received two grants from the Fondation pour la Recherche Medicale: FDM20140629931 and FDM20120624035. Furthermore, the clinical study was supported by the Federation Francophone de Cancerologie Digestive (www.ffcd.fr/). The organization participated in study design, data collection and analysis, and preparation of the manuscript.	Baker JAR, 2013, DRUG METAB DISPOS, V41, P541, DOI 10.1124/dmd.112.048769; BOUFFARD DY, 1993, BIOCHEM PHARMACOL, V45, P1857, DOI 10.1016/0006-2952(93)90444-2; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Ciccolini J, 2010, J CLIN ONCOL, V28, P160, DOI 10.1200/JCO.2009.24.4491; Collins Andrew R., 1998, Molecular Aspects of Medicine, V19, P359, DOI 10.1016/S0098-2997(99)00003-5; Deenen MJ, 2011, ONCOLOGIST, V16, P820, DOI 10.1634/theoncologist.2010-0259; Fitzgerald SM, 2006, HUM GENET, V119, P276, DOI 10.1007/s00439-006-0142-0; Giovannetti E, 2008, NUCLEOS NUCLEOT NUCL, V27, P720, DOI 10.1080/15257770802145447; Goldstein D, 2015, J NATL CANC I, V107; Jiang XM, 2008, BRIT J CLIN PHARMACO, V65, P326, DOI 10.1111/j.1365-2125.2007.03040.x; Jones OP, 2014, WORLD J GASTROENTERO, V20, P14733, DOI 10.3748/wjg.v20.i40.14733; Kroep JR, 2000, BRIT J CANCER, V83, P1069, DOI 10.1054/bjoc.2000.1399; Li H, 2014, INT J BIOL MARKER, V29, pE224, DOI 10.5301/jbm.5000076; Ludovini V, 2011, J THORAC ONCOL, V6, P2018, DOI 10.1097/JTO.0b013e3182307e1f; Maring JG, 2010, EUR J CLIN PHARMACOL, V66, P611, DOI 10.1007/s00228-010-0799-0; Micozzi D, 2014, INT J BIOL MACROMOL, V63, P64, DOI 10.1016/j.ijbiomac.2013.10.029; Serdjebi C, 2014, EXPERT OPIN IN PRESS; Serdjebi C, 2013, PHARMACOGENOMICS, V14, P1047, DOI [10.2217/PGS.13.93, 10.2217/pgs.13.93]; Sugiyama E, 2007, J CLIN ONCOL, V25, P32, DOI 10.1200/JCO.2006.06.7405; Sugiyama E, 2010, CLIN PHARMACOKINET, V49, P549, DOI 10.2165/11532970-000000000-00000; Thota R, 2014, ONCOLOGY-NY, V28, P70; Tibaldi C, 2008, CLIN CANCER RES, V14, P1797, DOI 10.1158/1078-0432.CCR-07-1364; Zhou JY, 2012, J CHROMATOGR B, V906, P1, DOI 10.1016/j.jchromb.2012.07.033	23	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135907	10.1371/journal.pone.0135907	http://dx.doi.org/10.1371/journal.pone.0135907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308942	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400080
J	Cho, EB; Joo, EY; Seo, DW; Hong, SC; Hong, SB				Cho, Eun Bin; Joo, Eun Yeon; Seo, Dae-Won; Hong, Seung-Chyul; Hong, Seung Bong			Prognostic Role of Functional Neuroimaging after Multilobar Resection in Patients with Localization-Related Epilepsy	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; FOCAL CORTICAL DYSPLASIA; INTRACRANIAL EEG; FDG-PET; NORMAL MRI; SURGERY; OUTCOMES; PREDICTORS; CHILDREN; ADULTS	To investigate the usage of functional neuroimaging as a prognostic tool for seizure recurrence and long-term outcomes in patients with multilobar resection, we recruited 90 patients who received multilobar resections between 1995 and 2013 with at least 1-year follow-up (mean 8.0 years). All patients were monitored using intracranial electroencephalography (EEG) after pre-surgical evaluation. Clinical data (demographics, electrophysiology, and neuroimaging) were reviewed retrospectively. Surgical outcomes were evaluated at 1, 2, 5 years after surgery, and at the end of the study. After 1 year, 56 patients (62.2%) became Engel class I and at the last follow-up, 47 patients (52.2%) remained seizure-free. Furthermore, non-localized F-18-fluorodeoxyglucose positron emission tomography (PET), identifying hypometabolic areas not concordant with ictal onset zones, significantly correlated with seizure recurrence after 1 year. Non-lesional magnetic resonance imaging (MRI) and left-sided resection correlated with poor outcomes. In the last follow-up, non-localized PET and left-sided resection significantly correlated with seizure recurrence. Both localized PET and ictal-interictal SPECT subtraction co-registered to MR (SISCOM) predicted good surgical outcomes in the last follow-up (69.2%, Engel I). This study suggests that PET and SISCOM may predict postoperative outcomes for patients after multilobar epilepsy and shows comparable long-term surgical outcomes after multilobar resection.	[Cho, Eun Bin; Joo, Eun Yeon; Seo, Dae-Won; Hong, Seung Bong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol,Samsung Biomed Res Inst, Seoul, South Korea; [Hong, Seung-Chyul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg,Samsung Biomed Res Inst, Seoul, South Korea; [Cho, Eun Bin; Joo, Eun Yeon; Seo, Dae-Won; Hong, Seung Bong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Joo, EY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol,Samsung Biomed Res Inst, Seoul, South Korea.	ejoo@skku.edu; sbhong@skku.edu			Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea [2014R1A1A3049510]	Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Science, ICT & Future Planning, Republic of Korea (No. 2014R1A1A3049510).	Aboian MS, 2011, PEDIATR NEUROL, V45, P83, DOI 10.1016/j.pediatrneurol.2011.05.001; Bell ML, 2009, EPILEPSIA, V50, P2053, DOI 10.1111/j.1528-1167.2009.02079.x; Bien CG, 2009, ARCH NEUROL-CHICAGO, V66, P1491, DOI 10.1001/archneurol.2009.283; Bulacio JC, 2012, EPILEPSIA, V53, P1722, DOI 10.1111/j.1528-1167.2012.03633.x; Chassoux F, 2010, NEUROLOGY, V75, P2168, DOI 10.1212/WNL.0b013e31820203a9; Elsharkawy AE, 2009, J NEUROL NEUROSUR PS, V80, P773, DOI 10.1136/jnnp.2008.164145; Elsharkawy AE, 2008, LONG TERM OUTCOME EX; Englot DJ, 2012, J NEUROSURG, V116, P1042, DOI 10.3171/2012.1.JNS111620; Fauser S, 2008, J NEUROL NEUROSUR PS, V79, P103, DOI 10.1136/jnnp.2007.116038; Holtkamp M, 2012, EPILEPSIA, V53, P1739, DOI 10.1111/j.1528-1167.2012.03600.x; Joo EY, 2004, EPILEPSIA, V45, P686, DOI 10.1111/j.0013-9580.2004.35003.x; Joo EY, 2004, ARCH NEUROL-CHICAGO, V61, P1074, DOI 10.1001/archneur.61.7.1074; Kim DW, 2009, NEUROLOGY, V72, P211, DOI 10.1212/01.wnl.0000327825.48731.c3; Kudr M, 2013, EPILEPTIC DISORD, V15, P3, DOI 10.1684/epd.2013.0560; Lazow SP, 2012, EPILEPSIA, V53, P1746, DOI 10.1111/j.1528-1167.2012.03582.x; Noe K, 2013, JAMA NEUROL, V70, P1003, DOI 10.1001/jamaneurol.2013.209; Rathore C, 2014, EPILEPSY RES, V108, P1306, DOI 10.1016/j.eplepsyres.2014.06.012; Ryvlin P, 2014, LANCET NEUROL, V13, P1114, DOI 10.1016/S1474-4422(14)70156-5; Sarkis RA, 2012, EPILEPSIA, V53, P44, DOI 10.1111/j.1528-1167.2011.03274.x; Simasathien T, 2013, ANN NEUROL, V73, P646, DOI 10.1002/ana.23862; Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1; Sulc V, 2014, NEUROLOGY, V82, P932, DOI 10.1212/WNL.0000000000000209; Sylaja PN, 2004, EPILEPSIA, V45, P803, DOI 10.1111/j.0013-9580.2004.48503.x; Tellez-Zenteno JF, 2005, BRAIN, V128, P1188, DOI 10.1093/brain/awh449; Tellez-Zenteno JF, 2010, EPILEPSY RES, V89, P310, DOI 10.1016/j.eplepsyres.2010.02.007; von Oertzen TJ, 2011, EPILEPSIA, V52, P2239, DOI 10.1111/j.1528-1167.2011.03219.x; Vossler DG, 2004, EPILEPSIA, V45, P497, DOI 10.1111/j.0013-9580.2004.47103.x; Widdess-Walsh P, 2007, NEUROLOGY, V69, P660, DOI 10.1212/01.wnl.0000267427.91987.21; Yu SK, 2014, EPILEPSY RES, V108, P555, DOI 10.1016/j.eplepsyres.2013.12.004; Yun CH, 2006, EPILEPSIA, V47, P574, DOI 10.1111/j.1528-1167.2006.00470.x	30	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136565	10.1371/journal.pone.0136565	http://dx.doi.org/10.1371/journal.pone.0136565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305092	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500091
J	Milenkaya, O; Catlin, DH; Legge, S; Walters, JR				Milenkaya, Olga; Catlin, Daniel H.; Legge, Sarah; Walters, Jeffrey R.			Body Condition Indices Predict Reproductive Success but Not Survival in a Sedentary, Tropical Bird	PLOS ONE			English	Article							FLORIDA SCRUB-JAYS; INDIVIDUAL QUALITY; SELECTION; CAPTURE; HABITAT; TRAITS; HEALTH; RIVER; COST; LONG	Body condition may predict individual fitness because those in better condition have more resources to allocate towards improving their fitness. However, the hypothesis that condition indices are meaningful proxies for fitness has been questioned. Here, we ask if intraspecific variation in condition indices predicts annual reproductive success and survival. We monitored a population of Neochmia phaeton (crimson finch), a sedentary, tropical passerine, for reproductive success and survival over four breeding seasons, and sampled them for commonly used condition indices: mass adjusted for body size, muscle and fat scores, packed cell volume, hemoglobin concentration, total plasma protein, and heterophil to lymphocyte ratio. Our study population is well suited for this research because individuals forage in common areas and do not hold territories such that variation in condition between individuals is not confounded by differences in habitat quality. Furthermore, we controlled for factors that are known to impact condition indices in our study population (e.g., breeding stage) such that we assessed individual condition relative to others in the same context. Condition indices that reflect energy reserves predicted both the probability of an individual fledging young and the number of young produced that survived to independence, but only during some years. Those that were relatively heavy for their body size produced about three times more independent young compared to light individuals. That energy reserves are a meaningful predictor of reproductive success in a sedentary passerine supports the idea that energy reserves are at least sometimes predictors of fitness. However, hematological indices failed to predict reproductive success and none of the indices predicted survival. Therefore, some but not all condition indices may be informative, but because we found that most indices did not predict any component of fitness, we question the ubiquitous interpretation of condition indices as surrogates for individual quality and fitness.	[Milenkaya, Olga; Walters, Jeffrey R.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Catlin, Daniel H.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA; [Legge, Sarah] Australian Wildlife Conservancy, Mornington Wildlife Sanctuary, Derby, WA, Australia; [Legge, Sarah] Charles Darwin Univ, Res Inst Environm & Livelihoods, Casuarina, NT, Australia	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Charles Darwin University	Milenkaya, O (corresponding author), Young Harris Coll, Dept Biol, Young Harris, GA 30582 USA.	olm@vt.edu	Legge, Sarah/GYE-1554-2022; Legge, Sarah/AAB-7229-2019	Legge, Sarah/0000-0001-6968-2781; Catlin, Daniel/0000-0003-4637-0384; Chiaradia, Andre/0000-0002-6178-4211	Australian Wildlife Conservancy; Graduate Teaching Assistantship at Virginia Polytechnic Institute and State University (Virginia Tech).	Australian Wildlife Conservancy; Graduate Teaching Assistantship at Virginia Polytechnic Institute and State University (Virginia Tech).	This research was funded by the Australian Wildlife Conservancy. A stipend for OM was funded through a Graduate Teaching Assistantship at Virginia Polytechnic Institute and State University (Virginia Tech). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1982, BIOL J LINN SOC, V17, P375, DOI 10.1111/j.1095-8312.1982.tb02028.x; ANKNEY CD, 1978, AUK, V95, P459; Bates D., 2013, LME4 LINEAR MIXED EF; Bearhop S, 1999, ECOL LETT, V2, P352; Ben-David M, 2002, J WILDLIFE MANAGE, V66, P1208, DOI 10.2307/3802954; Bustnes JO, 1991, CAN J ZOOL, V69, P1577; Catlin DH, 2014, BIOL CONSERV, V180, P196, DOI 10.1016/j.biocon.2014.10.004; Cotton S, 2004, P ROY SOC B-BIOL SCI, V271, P771, DOI 10.1098/rspb.2004.2688; Ellis RD, 2012, LANDSCAPE ECOL, V27, P1, DOI 10.1007/s10980-011-9671-6; Gosler AG, 1996, J ANIM ECOL, V65, P1, DOI 10.2307/5695; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Gregg MA, 2006, J WILDLIFE MANAGE, V70, P472, DOI 10.2193/0022-541X(2006)70[472:TPPARB]2.0.CO;2; GUSTAFSSON L, 1994, PHILOS T R SOC B, V346, P323, DOI 10.1098/rstb.1994.0149; Hanssen SA, 2003, P ROY SOC B-BIOL SCI, V270, P531, DOI 10.1098/rspb.2002.2262; Hanssen SA, 2003, OECOLOGIA, V136, P457, DOI 10.1007/s00442-003-1282-8; Harrison XA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077783; Higgins PJ, 2006, HDB AUSTR NZ ANTAR B; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Hunt J, 2004, TRENDS ECOL EVOL, V19, P329, DOI 10.1016/j.tree.2004.03.035; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Kilgas P, 2006, PHYSIOL BIOCHEM ZOOL, V79, P565, DOI 10.1086/502817; Kilgas P, 2006, COMP BIOCHEM PHYS A, V144, P224, DOI 10.1016/j.cbpa.2006.02.038; Lailvaux SP, 2011, P ROY SOC B-BIOL SCI, V278, P321, DOI 10.1098/rspb.2010.1591; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lewis M, 2007, TEMPORAL DIMENSIONS; Mazerolle M. C., 2013, AICCMODAVG MODEL SEL; Meijer T, 1999, IBIS, V141, P399, DOI 10.1111/j.1474-919X.1999.tb04409.x; Milenkaya O, 2014, PHYSIOL BIOCHEM ZOOL, V87, P550, DOI 10.1086/676651; Milenkaya O, 2013, CONSERV PHYSIOL, V1, DOI [10.1093/conphys/cot1020, DOI 10.1093/CONPHYS/COT1020]; Milenkaya O, 2013, VALIDATING BODY COND; Milenkaya O, 2011, EMU, V111, P312, DOI 10.1071/MU10088; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Romero LM, 2010, P ROY SOC B-BIOL SCI, V277, P3157, DOI 10.1098/rspb.2010.0678; Romero LM, 2001, P NATL ACAD SCI USA, V98, P7366, DOI 10.1073/pnas.131091498; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Sheridan JA, 2004, AUK, V121, P717, DOI 10.1642/0004-8038(2004)121[0717:WABMOH]2.0.CO;2; Svensson E, 2001, EVOLUTION, V55, P2053; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; Verhulst S, 2004, ECOL SOC, V9; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilcoxen TE, 2011, IBIS, V153, P70, DOI 10.1111/j.1474-919X.2010.01078.x; Wilcoxen TE, 2010, BIOL LETTERS, V6, P552, DOI 10.1098/rsbl.2009.1078; Williams T., 2012, PHYSL ADAPTATIONS BR; Williams TD, 2008, PHILOS T R SOC B, V363, P1687, DOI 10.1098/rstb.2007.0003; Wilson AJ, 2010, TRENDS ECOL EVOL, V25, P207, DOI 10.1016/j.tree.2009.10.002; Winkler D.W., 1983, Current Ornithology, V1, P33	47	35	36	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136582	10.1371/journal.pone.0136582	http://dx.doi.org/10.1371/journal.pone.0136582			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305457	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500095
J	Pereira, MP; Donahue, RR; Dahl, JB; Werner, M; Taylor, BK; Werner, MU				Pereira, Manuel P.; Donahue, Renee R.; Dahl, Jorgen B.; Werner, Marianne; Taylor, Bradley K.; Werner, Mads U.			Endogenous Opioid-Masked Latent Pain Sensitization: Studies from Mouse to Human	PLOS ONE			English	Article							HIGH-DOSE NALOXONE; POSTSURGICAL PAIN; HERITABILITY; HYPERALGESIA; NOCICEPTION; MODEL	Following the resolution of a severe inflammatory injury in rodents, administration of muopioid receptor inverse agonists leads to reinstatement of pain hypersensitivity. The mechanisms underlying this form of latent pain sensitization (LS) likely contribute to the development of chronic pain, but LS has not yet been demonstrated in humans. Using a C57BL/6 mouse model of cutaneous mild heat injury (MHI) we demonstrated a dose-dependent reinstatement of pain sensitization, assessed as primary (P < 0.001) and secondary hyperalgesia (P < 0.001) by naloxone (0.3-10 mg/kg), 168 hrs after the induction of MHI. Forward-translating the dose data to a human MHI model (n = 12) we could show that LS does indeed occur after naloxone 2 mg/kg, 168 hrs after a MHI. Our previous unsuccessful efforts to demonstrate unmasking of LS in humans are thus likely explained by an insufficient naloxone dose (0.021 mg/kg). However, while LS was consistently demonstrated in 21/24 mice, LS was only seen in 4/12 subjects. This difference is likely due to selection bias since the C57BL/6 mouse strain exhibits markedly enhanced pain sensitivity in assays of acute thermal nociception. Future exploratory studies in humans should prioritize inclusion of "high-sensitizers" prone to develop LS and use post-surgical models to elucidate markers of vulnerability to chronic postsurgical pain.	[Pereira, Manuel P.; Dahl, Jorgen B.] Rigshosp, Dept Anaesthesia, Ctr Head & Orthopaed, DK-2100 Copenhagen, Denmark; [Donahue, Renee R.] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Werner, Marianne] Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; [Taylor, Bradley K.; Werner, Mads U.] Rigshosp, Neurosci Ctr, Ctr Multidisciplinary Pain, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Kentucky; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Werner, MU (corresponding author), Rigshosp, Neurosci Ctr, Ctr Multidisciplinary Pain, DK-2100 Copenhagen, Denmark.	mads.u.werner@gmail.com	Pereira, Manuel Pedro/AAP-8484-2020; Donahue, Renee/AAI-3512-2020	Donahue, Renee/0000-0002-3344-5650; Werner, Mads/0000-0003-1540-8845	NIH [R01NS45954]; NCRR [UL1RR033173]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062306, R01NS045954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037621] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	B.K.T. was supported by NIH R01NS45954. We thank Tony Yaksh for advice in adapting the MHI-model to mice, Dr. Richard Charnigo and the Center for Clinical and Translational Sciences (CCTS) at the University of Kentucky for assistance with the statistics, Michael C. Rowbotham for comments on the protocol, and Karen-Lisa Hilsted for practical assistance with the protocol and the subjects for their valuable help. The CCTS is supported by NCRR UL1RR033173.	Bryant CD, 2008, J NEUROGENET, V22, P315, DOI 10.1080/01677060802357388; Campillo A, 2011, EUR J PHARMACOL, V657, P89, DOI 10.1016/j.ejphar.2011.01.059; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; COHEN MR, 1982, LIFE SCI, V30, P2025, DOI 10.1016/0024-3205(82)90443-X; COHEN MR, 1984, BIOL PSYCHIAT, V19, P825; COHEN MR, 1985, BIOL PSYCHIAT, V20, P570, DOI 10.1016/0006-3223(85)90030-7; Corder G, 2013, SCIENCE, V341, P1394, DOI 10.1126/science.1239403; DIXON WJ, 1991, NEUROSCI BIOBEHAV R, V15, P47, DOI 10.1016/S0149-7634(05)80090-9; Edwards RR, 2004, PERCEPT MOTOR SKILL, V99, P679, DOI 10.2466/pms.99.2.679-687; FROST JJ, 1989, J CEREBR BLOOD F MET, V9, P398, DOI 10.1038/jcbfm.1989.59; Johansen A, 2014, PAIN, V155, P341, DOI 10.1016/j.pain.2013.10.013; Katz J, 2009, EXPERT REV NEUROTHER, V9, P723, DOI 10.1586/ERN.09.20; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Le Roy C, 2011, J PAIN, V12, P1069, DOI 10.1016/j.jpain.2011.04.011; Mogil JS, 1999, PAIN, V80, P83, DOI 10.1016/S0304-3959(98)00196-1; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nozaki-Taguchi N, 1998, NEUROSCI LETT, V254, P25, DOI 10.1016/S0304-3940(98)00648-X; Pereira MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064608; Ravn P, 2013, J PAIN RES, V6, P23, DOI 10.2147/JPR.S36827; Schweinhardt P, 2008, NEUROSCIENTIST, V14, P415, DOI 10.1177/1073858407312521; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Staud R, 2012, J PAIN, V13, P725, DOI 10.1016/j.jpain.2012.04.006; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Turk DC, 2011, LANCET, V377, P2226, DOI 10.1016/S0140-6736(11)60402-9; Watson M, 2005, OXFORD HDB PALLIATIV, P35; Werner MU, 2013, CLIN J PAIN, V29, P775, DOI 10.1097/AJP.0b013e318277b646; Werner MU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062733; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	30	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0134441	10.1371/journal.pone.0134441	http://dx.doi.org/10.1371/journal.pone.0134441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305798	gold, Green Submitted, Green Published			2022-12-27	WOS:000359995500008
J	Wu, Y; Dabhoiwala, NF; Hagoort, J; Shan, JL; Tan, LW; Fang, BJ; Zhang, SX; Lamers, WH				Wu, Yi; Dabhoiwala, Noshir F.; Hagoort, Jaco; Shan, Jin-Lu; Tan, Li-Wen; Fang, Bin-Ji; Zhang, Shao-Xiang; Lamers, Wouter H.			3D Topography of the Young Adult Anal Sphincter Complex Reconstructed from Undeformed Serial Anatomical Sections	PLOS ONE			English	Article							TOTAL MESORECTAL EXCISION; LEVATOR ANI MUSCLE; PELVIC FLOOR; DENONVILLIERS FASCIA; CLINICAL-RELEVANCE; SURGICAL ANATOMY; PERINEAL BODY; VISIBLE HUMAN; MORPHOLOGY; DEFINITION	Background Pelvic-floor anatomy is usually studied by artifact-prone dissection or imaging, which requires prior anatomical knowledge. We used the serial-section approach to settle contentious issues and an interactive 3D-pdf to make the results widely accessible. Method 3D reconstructions of undeformed thin serial anatomical sections of 4 females and 2 males (21-35y) of the Chinese Visible Human database. Findings Based on tendinous septa and muscle-fiber orientation as segmentation guides, the analsphincter complex (ASC) comprised the subcutaneous external anal sphincter (EAS) and the U-shaped puborectal muscle, a part of the levator ani muscle (LAM). The anococcygeal ligament fixed the EAS to the coccygeal bone. The puborectal-muscle loops, which define the levator hiatus, passed around the anorectal junction and inserted anteriorly on the perineal body and pubic bone. The LAM had a common anterior attachment to the pubic bone, but separated posteriorly into puborectal and "pubovisceral" muscles. This pubovisceral muscle was bilayered: its internal layer attached to the conjoint longitudinal muscle of the rectum and the rectococcygeal fascia, while its outer, patchy layer reinforced the inner layer. ASC contraction makes the ano-rectal bend more acute and lifts the pelvic floor. Extensions of the rectal longitudinal smooth muscle to the coccygeal bone (rectococcygeal muscle), perineal body (rectoperineal muscle), and endopelvic fascia (conjoint longitudinal and pubovisceral muscles) formed a "diaphragm" at the inferior boundary of the mesorectum that suspended the anorectal junction. Its contraction should straighten the anorectal bend. Conclusion The serial-section approach settled contentious topographic issues of the pelvic floor. We propose that the ASC is involved in continence and the rectal diaphragm in defecation.	[Wu, Yi; Dabhoiwala, Noshir F.; Lamers, Wouter H.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Hagoort, Jaco] Univ Amsterdam, Acad Med Ctr, Dept Anat & Embryol, NL-1105 AZ Amsterdam, Netherlands; [Wu, Yi; Shan, Jin-Lu; Tan, Li-Wen; Fang, Bin-Ji; Zhang, Shao-Xiang] Third Mil Med Univ, Inst Comp Med, Chongqing 400038, Peoples R China	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Army Medical University	Zhang, SX (corresponding author), Third Mil Med Univ, Inst Comp Med, Chongqing 400038, Peoples R China.	zhangsx1021@yahoo.com; w.h.lamers@amc.uva.nl	Lamers, Wouter H./D-2965-2012		Emmett Foundation for Urology; National Science Foundation of China [81100480]	Emmett Foundation for Urology; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	WHL NFD were supported by Emmett Foundation for Urology. YW S-XZ were supported by National Science Foundation of China (No. 81100480; http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner F, 2004, DIS COLON RECTUM, V47, P131, DOI 10.1007/s10350-003-0031-8; AYOUB SF, 1979, J ANAT, V128, P571; Bharucha AE, 2007, GASTROENTEROLOGY, V133, P1069, DOI 10.1053/j.gastro.2007.08.051; Bogduk N, 1996, AUST NZ J SURG, V66, P626, DOI 10.1111/j.1445-2197.1996.tb00834.x; Burnett AL, 1998, J UROLOGY, V160, P1301, DOI 10.1016/S0022-5347(01)62521-7; BUSTAMI FM, 1989, ACTA MORPHOL NEER SC, V26, P255; Cai XR, 2013, INT J GYNECOL OBSTET, V121, P233, DOI 10.1016/j.ijgo.2013.01.022; Constantinou CE, 2009, EUR J OBSTET GYN R B, V144, pS159, DOI 10.1016/j.ejogrb.2009.02.021; Curtis A. H., 1942, SURG GYNECOL AND OBSTET, V74, P709; de Boer BA, 2011, DEVELOPMENT, V138, P159, DOI 10.1242/dev.051086; DeLancey J. O., 1990, CIBA FDN S, V151, P57; Fielding JR, 2002, RADIOGRAPHICS, V22, P295, DOI 10.1148/radiographics.22.2.g02mr25295; Fritsch H, 2002, DIS COLON RECTUM, V45, P188, DOI 10.1007/s10350-004-6144-x; Frohlich B, 1997, CLIN ANAT, V10, P223; GOLIGHER JC, 1955, BRIT J SURG, V43, P51, DOI 10.1002/bjs.18004317707; Guo ML, 2007, DIS COLON RECTUM, V50, P1647, DOI 10.1007/s10350-007-0262-1; Havenga K, 2007, DIGEST DIS, V25, P44, DOI 10.1159/000099169; HEALD RJ, 1986, LANCET, V1, P1479; Hsu Y, 2005, OBSTET GYNECOL, V106, P1259, DOI 10.1097/01.AOG.0000189084.82449.fc; HUSSAIN SM, 1995, RADIOLOGY, V197, P671, DOI 10.1148/radiology.197.3.7480737; Kathrein A, 1996, Clin Anat, V9, P227, DOI 10.1002/(SICI)1098-2353(1996)9:4<227::AID-CA2>3.3.CO;2-5; Kearney R, 2004, OBSTET GYNECOL, V104, P168, DOI 10.1097/01.AOG.0000128906.61529.6b; Kinugasa Y, 2007, BRIT J SURG, V94, P620, DOI 10.1002/bjs.5540; Kinugasa Y, 2012, YONSEI MED J, V53, P849, DOI 10.3349/ymj.2012.53.4.849; Kinugasa Y, 2011, DIS COLON RECTUM, V54, P232, DOI 10.1007/DCR.0b013e318202388f; Kurzer M, 2002, BRIT J SURG, V89, P90, DOI 10.1046/j.0007-1323.2001.01956.x; Larson K.A., 2010, AM J OBSTET GYNECOL, V203, P494; LAWSON JON, 1974, ANN ROY COLL SURG, V54, P288; Lindsey I, 2005, DIS COLON RECTUM, V48, P37, DOI 10.1007/s10350-004-0627-7; OH C, 1972, BRIT J SURG, V59, P717, DOI 10.1002/bjs.1800590909; Qiu MG, 2004, SURG RADIOL ANAT, V26, P149, DOI 10.1007/s00276-003-0188-9; Raizada V, 2011, NEUROGASTROENT MOTIL, V23, P1013, DOI 10.1111/j.1365-2982.2011.01782.x; SHAFIK A, 1975, INVEST UROL, V12, P412; Shafik A, 2007, DIS COLON RECTUM, V50, P2120, DOI 10.1007/s10350-007-9064-8; Smith GE, 1908, J ANAT PHYSIOL, V42, P252; Spitzer V, 1996, J AM MED INFORM ASSN, V3, P118, DOI 10.1136/jamia.1996.96236280; Standring S, 2021, GRAYS ANATOMY E BOOK, V42; Stein TA, 2008, OBSTET GYNECOL, V111, P686, DOI 10.1097/AOG.0b013e318163a9a5; Tansatit T, 2013, EUR J OBSTET GYN R B, V166, P221, DOI 10.1016/j.ejogrb.2012.10.038; Thompson P, 1899, J Anat Physiol, V33, P423; Woodman PJ, 2002, CLIN ANAT, V15, P321, DOI 10.1002/ca.10034; Yucel S, 2004, J UROLOGY, V171, P1890, DOI 10.1097/01.ju.0000124106.16505.df; Zhai LD, 2009, DIS COLON RECTUM, V52, P1564, DOI 10.1007/DCR.0b013e3181a8f75c; Zhang Shao-Xiang, 2003, Anatomical Record, V275B, P190, DOI 10.1002/ar.b.10035	44	23	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0132226	10.1371/journal.pone.0132226	http://dx.doi.org/10.1371/journal.pone.0132226			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305117	Green Published, gold			2022-12-27	WOS:000359995500001
J	Xie, C; Zhang, Y; Tran, TDN; Wang, H; Li, SW; George, EV; Zhuang, HY; Zhang, PL; Kandel, A; Lai, YM; Tang, DQ; Reeves, WH; Cheng, H; Ding, YS; Yang, LJ				Xie, Chao; Zhang, Yuan; Tran, Tran D. N.; Wang, Hai; Li, Shiwu; George, Eva Vertes; Zhuang, Haoyang; Zhang, Peilan; Kandel, Avi; Lai, Yimu; Tang, Dongqi; Reeves, Westley H.; Cheng, Henrique; Ding, Yousong; Yang, Li-Jun			Irisin Controls Growth, Intracellular Ca2+ Signals, and Mitochondrial Thermogenesis in Cardiomyoblasts	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; SKELETAL-MUSCLE; KEY REGULATOR; EXERCISE; SERUM; EXPRESSION; MYOCARDIN; KINASE; TRANSCRIPTION; HYPERTROPHY	Exercise offers short-term and long-term health benefits, including an increased metabolic rate and energy expenditure in myocardium. The newly-discovered exercise-induced myokine, irisin, stimulates conversion of white into brown adipocytes as well as increased mitochondrial biogenesis and energy expenditure. Remarkably, irisin is highly expressed in myocardium, but its physiological effects in the heart are unknown. The objective of this work is to investigate irisin's potential multifaceted effects on cardiomyoblasts and myocardium. For this purpose, H9C2 cells were treated with recombinant irisin produced in yeast cells (r-irisin) and in HEK293 cells (hr-irisin) for examining its effects on cell proliferation by MTT [3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay and on gene transcription profiles by qRT-PCR. R-irisin and hr-irisin both inhibited cell proliferation and activated genes related to cardiomyocyte metabolic function and differentiation, including myocardin, follistatin, smooth muscle actin, and nuclear respiratory factor-1. Signal transduction pathways affected by r-irisin in H9C2 cells and C57BL/6 mice were examined by detecting phosphorylation of PI3K-AKT, p38, ERK or STAT3. We also measured intracellular Ca2+ signaling and mitochondrial thermogenesis and energy expenditure in r-irisin-treated H9C2 cells. The results showed that r-irisin, in a certain concentration rage, could activate PI3K-AKT and intracellular Ca2+ signaling and increase cellular oxygen consumption in H9C2 cells. Our study also suggests the existence of irisin-specific receptor on the membrane of H9C2 cells. In conclusion, irisin in a certain concentration rage increased myocardial cell metabolism, inhibited cell proliferation and promoted cell differentiation. These effects might be mediated through PI3K-AKT and Ca2+ signaling, which are known to activate expression of exercise-related genes such as follistatin and myocardin. This work supports the value of exercise, which promotes irisin release.	[Xie, Chao; Zhang, Yuan; Wang, Hai; Li, Shiwu; George, Eva Vertes; Kandel, Avi; Yang, Li-Jun] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; [Zhang, Yuan; Tang, Dongqi] Shandong Univ, Hosp 2, Ctr Stem Cell & Regenerat Med, Jinan 250012, Peoples R China; [Tran, Tran D. N.; Cheng, Henrique] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA; [Lai, Yimu] Med Univ S Carolina, Dept Cell Biol & Anat, Columbia, SC 29209 USA; [Zhuang, Haoyang; Reeves, Westley H.] Univ Florida, Coll Med, Dept Med, Gainesville, FL 32610 USA; [Zhang, Peilan; Ding, Yousong] Univ Florida, Coll Pharm, Ctr Nat Prod Drug Discovery & Dev, Dept Med Chem, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; Shandong University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Medical University of South Carolina; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ding, YS (corresponding author), Univ Florida, Coll Pharm, Ctr Nat Prod Drug Discovery & Dev, Dept Med Chem, Gainesville, FL 32610 USA.	yding@cop.ufl.edu; yanglj@pathology.ufl.edu	Xie, Chao/ABA-7345-2021; Zhuang, Haoyang/P-2591-2015; Zhang, Yuan/B-3806-2019	Xie, Chao/0000-0001-7645-1922; 	Lupus Research Institute; UF Startup funds	Lupus Research Institute; UF Startup funds	This work was supported in part by Lupus Research Institute (to L.Y.), and the UF Startup funds (to Y.D.).	Abdalla M, 2013, J BIOL CHEM, V288, P33483, DOI 10.1074/jbc.M113.504290; Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889; Aronis KN, 2015, INT J OBESITY, V39, P156, DOI 10.1038/ijo.2014.101; Aydin S, 2014, PEPTIDES, V52, P68, DOI 10.1016/j.peptides.2013.11.024; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brenmoehl J, 2014, INT J BIOL SCI, V10, P338, DOI 10.7150/ijbs.7972; Brooks SA, 2006, EXPERT REV PROTEOMIC, V3, P345, DOI 10.1586/14789450.3.3.345; Catalucci D, 2009, J CELL BIOL, V184, P923, DOI 10.1083/jcb.200805063; Chaanine AH, 2011, EUR J HEART FAIL, V13, P825, DOI 10.1093/eurjhf/hfr080; Choi HY, 2014, J CLIN ENDOCR METAB, V99, P2778, DOI 10.1210/jc.2014-1195; Clement S, 2007, J CELL SCI, V120, P229, DOI 10.1242/jcs.03340; DiversePierluissi M, 1996, NEURON, V16, P579, DOI 10.1016/S0896-6273(00)80077-X; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Emanuele E, 2014, AM J MED, V127, P888, DOI 10.1016/j.amjmed.2014.04.025; Gellissen G, 2000, APPL MICROBIOL BIOT, V54, P741, DOI 10.1007/s002530000464; Harleton E, 2015, AM J PHYSIOL-HEART C, V308, pH126, DOI 10.1152/ajpheart.00614.2014; Hofmann T, 2014, PEPTIDES, V54, P89, DOI 10.1016/j.peptides.2014.01.016; Huh JY, 2015, J CLIN ENDOCR METAB, V100, pE453, DOI 10.1210/jc.2014-2416; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/BSE0470053, 10.1042/bse0470053]; Kerstholt N, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0035-x; Koval OM, 2010, P NATL ACAD SCI USA, V107, P4996, DOI 10.1073/pnas.0913760107; Koya V, 2008, DIABETES, V57, P757, DOI 10.2337/db07-1441; Kuloglu T, 2014, PEPTIDES, V55, P85, DOI 10.1016/j.peptides.2014.02.008; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Li MY, 2015, GENE, V555, P403, DOI 10.1016/j.gene.2014.11.039; Li SW, 2010, PROTEIN EXPRES PURIF, V72, P157, DOI 10.1016/j.pep.2010.04.004; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Milde M, 2013, BIOCHEM J, V454, P515, DOI 10.1042/BJ20130554; Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Rimbaud S, 2009, J MOL CELL CARDIOL, V46, P952, DOI 10.1016/j.yjmcc.2009.01.013; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Sardao VA, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-11; Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5; Schumacher MA, 2013, J BIOL CHEM, V288, P33738, DOI 10.1074/jbc.M113.516641; Sesti G, 2014, ACTA DIABETOL, V51, P705, DOI 10.1007/s00592-014-0576-0; Singhal V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100218; Sun H, 2006, CIRC RES, V98, P1390, DOI 10.1161/01.RES.0000223321.34482.8c; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Walsh K, 2006, CIRCULATION, V113, P2032, DOI 10.1161/CIRCULATIONAHA.106.615138; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; Winbanks CE, 2012, J CELL BIOL, V197, P997, DOI 10.1083/jcb.201109091; Wu C, 2007, PROTEIN EXPRES PURIF, V56, P1, DOI 10.1016/j.pep.2007.04.027; Xiang L, 2014, ATHEROSCLEROSIS, V235, P328, DOI 10.1016/j.atherosclerosis.2014.04.036; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	51	62	68	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136816	10.1371/journal.pone.0136816	http://dx.doi.org/10.1371/journal.pone.0136816			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305684	Green Submitted, Green Published, gold			2022-12-27	WOS:000359995500115
J	Xie, WY; Wen, HL; Chu, FL; Yan, SF; Lin, B; Xie, WL; Liu, Y; Ren, GJ; Zhao, L; Song, YY; Sun, CX; Wang, ZY				Xie, Wenyan; Wen, Hongling; Chu, Fulu; Yan, Shaofeng; Lin, Bin; Xie, Wenli; Liu, Ying; Ren, Guijie; Zhao, Li; Song, Yanyan; Sun, Chengxi; Wang, Zhiyu			Mutations in the DI-DII Linker of Human Parainfluenza Virus Type 3 Fusion Protein Result in Diminished Fusion Activity	PLOS ONE			English	Article							NEWCASTLE-DISEASE-VIRUS; RESPIRATORY SYNCYTIAL VIRUS; VIRAL MEMBRANE-FUSION; HEPTAD REPEAT REGIONS; HEMAGGLUTININ-NEURAMINIDASE; F-PROTEIN; PARAMYXOVIRUS FUSION; CELL-FUSION; RECEPTOR-BINDING; INFLUENZA-VIRUS	Human parainfluenza virus type 3 (HPIV3) can cause severe respiratory tract diseases in infants and young children, but no licensed vaccines or antiviral agents are currently available for treatment. Fusing the viral and target cell membranes is a prerequisite for its entry into host cells and is directly mediated by the fusion (F) protein. Although several domains of F are known to have important effects on regulating the membrane fusion activity, the roles of the DI-DII linker (residues 369-374) of the HPIV3 F protein in the fusogenicity still remains ill-defined. To facilitate our understanding of the role of this domain might play in F-induced cell-cell fusion, nine single mutations were engineered into this domain by site-directed mutagenesis. A vaccinia virus-T7 RNA polymerase transient expression system was employed to express the wild-type or mutated F proteins. These mutants were analyzed for membrane fusion activity, cell surface expression, and interaction between F and HN protein. Each of the mutated F proteins in this domain has a cell surface expression level similar to that of wild-type F. All of them resulted in a significant reduction in fusogenic activity in all steps of membrane fusion. Furthermore, all these fusion-deficient mutants reduced the amount of the HN-F complexes at the cell surface. Together, the results of our work suggest that this region has an important effect on the fusogenic activity of F.	[Xie, Wenyan; Wen, Hongling; Liu, Ying; Zhao, Li; Song, Yanyan; Sun, Chengxi; Wang, Zhiyu] Shandong Univ, Sch Publ Hlth, Dept Virol, Jinan 250100, Peoples R China; [Chu, Fulu] Shandong Univ, Prov Hosp, Dept Lab Med, Jinan 250100, Peoples R China; [Yan, Shaofeng] Shandong Univ, Qilu Hosp, Dept Neurosurg, Jinan 250100, Peoples R China; [Lin, Bin] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China; [Xie, Wenli] Shandong Tumor Hosp & Inst, Dept Lab Med, Jinan, Peoples R China; [Ren, Guijie] Shandong Univ, Sch Med, Inst Biochem & Mol Biol, Jinan 250100, Peoples R China; [Wang, Zhiyu] Shandong Univ, Minist Educ, Key Lab Expt Teratol, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University	Wang, ZY (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Virol, Jinan 250100, Peoples R China.	zhiyu.wang@sdu.edu.cn			National Natural Science Foundation of China [81271806]; Natural Science Foundation of Shandong Province [2009ZRB019VW]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by the National Natural Science Foundation of China (No. 81271806) and the Natural Science Foundation of Shandong Province (No. 2009ZRB019VW).	Apte-Sengupta S, 2012, J BIOL CHEM, V287, P33026, DOI 10.1074/jbc.M112.373308; Armstrong RT, 2000, J CELL BIOL, V151, P425, DOI 10.1083/jcb.151.2.425; Ayllon J, 2010, J VIROL, V84, P1066, DOI 10.1128/JVI.01473-09; BAGAI S, 1995, J VIROL, V69, P6712, DOI 10.1128/JVI.69.11.6712-6719.1995; Baker KA, 1999, MOL CELL, V3, P309, DOI 10.1016/S1097-2765(00)80458-X; Bose S, 2013, J VIROL, V87, P13520, DOI 10.1128/JVI.02123-13; Chu FL, 2013, VIRUS RES, V174, P137, DOI 10.1016/j.virusres.2013.03.012; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Corey EA, 2003, J VIROL, V77, P6913, DOI 10.1128/JVI.77.12.6913-6922.2003; Counihan ME, 2001, PEDIATR INFECT DIS J, V20, P646, DOI 10.1097/00006454-200107000-00003; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; DOMS RW, 1993, VIROLOGY, V193, P545, DOI 10.1006/viro.1993.1164; Durbin AP, 2003, CLIN INFECT DIS, V37, P1668, DOI 10.1086/379775; Dutch RE, 1998, J VIROL, V72, P7745, DOI 10.1128/JVI.72.10.7745-7753.1998; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gravel KA, 2011, J VIROL, V85, P3486, DOI 10.1128/JVI.02308-10; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; HORVATH CM, 1992, J VIROL, V66, P2443, DOI 10.1128/JVI.66.4.2443-2455.1992; HU XL, 1992, J VIROL, V66, P1528, DOI 10.1128/JVI.66.3.1528-1534.1992; Ito M, 2000, J GEN VIROL, V81, P719, DOI 10.1099/0022-1317-81-3-719; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Jain S, 2007, J VIROL, V81, P2328, DOI 10.1128/JVI.01940-06; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; Lamb RA, 2006, VIROLOGY, V344, P30, DOI 10.1016/j.virol.2005.09.007; LAMB RA, 1993, VIROLOGY, V197, P1, DOI 10.1006/viro.1993.1561; Lawrence MC, 2004, J MOL BIOL, V335, P1343, DOI 10.1016/j.jmb.2003.11.032; Liu WK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-28; McGinnes L, 2001, VIROLOGY, V283, P332, DOI 10.1006/viro.2001.0899; McGinnes LW, 2006, J VIROL, V80, P2894, DOI 10.1128/JVI.80.6.2894-2903.2006; McGinnes LW, 2001, VIROLOGY, V289, P343, DOI 10.1006/viro.2001.1123; Melanson VR, 2004, J VIROL, V78, P13053, DOI 10.1128/JVI.78.23.13053-13061.2004; Morrison TG, 2003, BBA-BIOMEMBRANES, V1614, P73, DOI 10.1016/S0005-2736(03)00164-0; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Reed G, 1997, J INFECT DIS, V175, P807, DOI 10.1086/513975; Ren GJ, 2007, INTERVIROLOGY, V50, P115, DOI 10.1159/000098237; Ren GJ, 2006, INTERVIROLOGY, V49, P299, DOI 10.1159/000094246; Russell CJ, 2004, J VIROL, V78, P13727, DOI 10.1128/JVI.78.24.13727-13742.2004; Russell CJ, 2003, J CELL BIOL, V163, P363, DOI 10.1083/jcb.200305130; Sanchez-Felipe L, 2014, BBA-BIOMEMBRANES, V1838, P300, DOI 10.1016/j.bbamem.2013.08.008; SCHEID A, 1977, VIROLOGY, V80, P54, DOI 10.1016/0042-6822(77)90380-4; SERGELGERMANO T, 1994, J VIROL, V68, P7654, DOI 10.1128/JVI.68.11.7654-7658.1994; Smith EC, 2009, FEBS J, V276, P7217, DOI 10.1111/j.1742-4658.2009.07401.x; Tsurudome M, 1998, J GEN VIROL, V79, P279, DOI 10.1099/0022-1317-79-2-279; Wang Z, 2001, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V15, P179; West DS, 2005, J VIROL, V79, P1543, DOI 10.1128/JVI.79.3.1543-1551.2005; WHITE JM, 1990, ANNU REV PHYSIOL, V52, P675, DOI 10.1146/annurev.ph.52.030190.003331; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102	51	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136474	10.1371/journal.pone.0136474	http://dx.doi.org/10.1371/journal.pone.0136474			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305905	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500081
J	Dawes, P; Cruickshanks, KJ; Moore, DR; Fortnum, H; Edmondson-Jones, M; McCormack, A; Munro, KJ				Dawes, Piers; Cruickshanks, Karen J.; Moore, David R.; Fortnum, Heather; Edmondson-Jones, Mark; McCormack, Abby; Munro, Kevin J.			The Effect of Prenatal and Childhood Development on Hearing, Vision and Cognition in Adulthood	PLOS ONE			English	Article							THRIFTY PHENOTYPE HYPOTHESIS; BIRTH-WEIGHT; POSTNATAL-GROWTH; LIFE-COURSE; CRITICAL PERIODS; RISK-FACTORS; HEAD GROWTH; AGE; ORIGINS; DISEASE	It is unclear what the contribution of prenatal versus childhood development is for adult cognitive and sensory function and age-related decline in function. We examined hearing, vision and cognitive function in adulthood according to self-reported birth weight (an index of prenatal development) and adult height (an index of early childhood development). Subsets (N = 37,505 to 433,390) of the UK Biobank resource were analysed according to visual and hearing acuity, reaction time and fluid IQ. Sensory and cognitive performance was reassessed after similar to 4 years (N = 2,438 to 17,659). In statistical modelling including age, sex, socioeconomic status, educational level, smoking, maternal smoking and comorbid disease, adult height was positively associated with sensory and cognitive function (partial correlations; pr 0.05 to 0.12, p < 0.001). Within the normal range of birth weight (10th to 90th percentile), there was a positive association between birth weight and sensory and cognitive function (pr 0.06 to 0.14, p < 0.001). Neither adult height nor birth weight was associated with change in sensory or cognitive function. These results suggest that adverse prenatal and childhood experiences are a risk for poorer sensory and cognitive function and earlier development of sensory and cognitive impairment in adulthood. This finding could have significant implications for preventing sensory and cognitive impairment in older age.	[Dawes, Piers; Munro, Kevin J.] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Cruickshanks, Karen J.] Univ Wisconsin, Sch Med & Publ Hlth, Populat Hlth Sci & Ophthalmol & Visual Sci, Madison, WI USA; [Moore, David R.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Moore, David R.] Univ Cincinnati, Coll Med, Dept Otolaryngol, Cincinnati, OH USA; [Moore, David R.; Fortnum, Heather; Edmondson-Jones, Mark; McCormack, Abby] NIHR Nottingham Hearing Biomed Res Unit, Nottingham, England; [Moore, David R.; McCormack, Abby] MRC Inst Hearing Res, Nottingham, England; [Fortnum, Heather; Edmondson-Jones, Mark; McCormack, Abby] Univ Nottingham, Sch Med, Div Clin Neurosci, Otol & Hearing Grp, Nottingham, England; [Munro, Kevin J.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester, Lancs, England	University of Manchester; University of Wisconsin System; University of Wisconsin Madison; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Nottingham; University of Manchester	Dawes, P (corresponding author), Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England.	piers.dawes@manchester.ac.uk	; munro, kevin/A-2899-2015	Dawes, Piers/0000-0003-3180-9884; Hunter, Abby/0000-0002-6533-6918; munro, kevin/0000-0001-6543-9098	MRC [MC_U135097130] Funding Source: UKRI; Medical Research Council [MC_qA137853] Funding Source: researchfish; Medical Research Council [MC_QA137853, MC_U135097130] Funding Source: Medline; Wellcome Trust [093707] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Barker DJP, 2004, PHILOS T R SOC B, V359, P1359, DOI 10.1098/rstb.2004.1518; Barrenas ML, 2005, HEARING RES, V205, P123, DOI 10.1016/j.heares.2005.03.019; Barrenas ML, 2003, BRIT MED J, V327, P1199, DOI 10.1136/bmj.327.7425.1199; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Burr H, 2005, INT J AUDIOL, V44, P531, DOI 10.1080/14992020500190045; Camarero G, 2001, J NEUROSCI, V21, P7630, DOI 10.1523/JNEUROSCI.21-19-07630.2001; Canlon B, 2003, EUR J NEUROSCI, V17, P2035, DOI 10.1046/j.1460-9568.2003.02641.x; Cesur R, 2008, HIGH BIRTH WEIGHT CO, P1; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Dawes P, 2014, EAR HEARING, V35, pE44, DOI 10.1097/AUD.0000000000000010; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Ecob R, 2011, LONGITUD LIFE COURSE, V2, P242; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Erickson K, 2010, ARCH WOMEN MENT HLTH, V13, P141, DOI 10.1007/s00737-009-0102-5; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; European Parliament, 2011, FUT ROADM EUR AG RES; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gale CR, 2006, PEDIATRICS, V118, P1486, DOI 10.1542/peds.2005-2629; Gale CR, 2004, BRAIN, V127, P321, DOI 10.1093/brain/awh034; Gale CR, 2003, BRAIN, V126, P2273, DOI 10.1093/brain/awg225; Hanson M, 2011, AM J CLIN NUTR, V94, p1754S, DOI 10.3945/ajcn.110.001206; Heinonen K, 2008, PEDIATRICS, V121, pE1325, DOI 10.1542/peds.2007-1172; Helzner EP, 2011, J AM GERIATR SOC, V59, P972, DOI 10.1111/j.1532-5415.2011.03444.x; Hendrie Hugh C, 2006, Alzheimers Dement, V2, P12, DOI 10.1016/j.jalz.2005.11.004; Horikawa C, 2013, J CLIN ENDOCR METAB, V98, P51, DOI 10.1210/jc.2012-2119; Kline J.S., 1989, CONCEPTION BIRTH EPI; LANGER O, 1988, AM J OBSTET GYNECOL, V159, P1478, DOI 10.1016/0002-9378(88)90578-9; LAWLERHEAVNER J, 1994, DIABETES RES CLIN PR, V24, P153, DOI 10.1016/0168-8227(94)90110-4; Costa AJL, 2011, ANN EPIDEMIOL, V21, P851, DOI 10.1016/j.annepidem.2011.06.004; Martyn CN, 1996, BRIT MED J, V312, P1393; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Montgomery SM, 2006, ARCH DIS CHILD, V91, P61, DOI 10.1136/adc.2005.077602; Nafstad P, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.3.e30; Norman P., 2010, APPL SPAT ANAL POLIC, V3, P107, DOI [10.1007/s12061-009-9036-6, DOI 10.1007/S12061-009-9036-6]; Olsen J, 2001, EPIDEMIOLOGY, V12, P235, DOI 10.1097/00001648-200103000-00017; Pearce MS, 2005, INT J EPIDEMIOL, V34, P673, DOI 10.1093/ije/dyi038; Plassman BL, 2010, ANN INTERN MED, V153, P182, DOI 10.7326/0003-4819-153-3-201008030-00258; Power C, 2013, ANNU REV PUBL HEALTH, V34, P7, DOI 10.1146/annurev-publhealth-031912-114423; Provenzano MJ, 2007, HEARING RES, V233, P1, DOI 10.1016/j.heares.2007.07.002; Pyhala R, 2011, NEUROLOGY, V77, P2052, DOI 10.1212/WNL.0b013e31823b473e; Rabbitt PMA, 2004, AGING NEUROPSYCHOL C, V11, P245, DOI 10.1080/13825580490511116; Raikkonen Katri, 2013, PLoS One, V8, pe54707, DOI 10.1371/journal.pone.0054707; Raikkonen K, 2009, AM J EPIDEMIOL, V170, P447, DOI 10.1093/aje/kwp132; Rasmussen KM, 2001, ANNU REV NUTR, V21, P73, DOI 10.1146/annurev.nutr.21.1.73; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Richards M, 2005, ANN NEUROL, V58, P617, DOI 10.1002/ana.20637; Richards M, 2001, BRIT MED J, V322, P199, DOI 10.1136/bmj.322.7280.199; Richards M, 2002, INT J EPIDEMIOL, V31, P342, DOI 10.1093/ije/31.2.342; Robinson JS, 2000, EUR J OBSTET GYN R B, V92, P13, DOI 10.1016/S0301-2115(00)00421-8; Sayer AA, 1998, AGE AGEING, V27, P579, DOI 10.1093/ageing/27.5.579; Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049; Shenkin SD, 2004, PSYCHOL BULL, V130, P989, DOI 10.1037/0033-2909.130.6.989; Shenkin SD, 2009, GERONTOLOGY, V55, P92, DOI 10.1159/000163444; Silva A, 2006, ANN EPIDEMIOL, V16, P469, DOI 10.1016/j.annepidem.2005.06.056; Smits C, 2004, INT J AUDIOL, V43, P15, DOI 10.1080/14992020400050004; Surkan PJ, 2004, OBSTET GYNECOL, V104, P720, DOI 10.1097/01.AOG.0000141442.59573.cd; Tyrrell JS, 2013, INT J EPIDEMIOL, V42, P1714, DOI 10.1093/ije/dyt220; Vaag AA, 2012, DIABETOLOGIA, V55, P2085, DOI 10.1007/s00125-012-2589-y; Vickland V, 2012, MODELLING IMPACT INT; Wadsworth MEJ, 2002, INT J EPIDEMIOL, V31, P383, DOI 10.1093/ije/31.2.383; Xu H, 2010, ACTA PAEDIATR, V99, P550, DOI 10.1111/j.1651-2227.2009.01674.x; Zhang ZX, 2009, NEUROLOGY, V73, P186, DOI 10.1212/WNL.0b013e3181ae7c90	65	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136590	10.1371/journal.pone.0136590	http://dx.doi.org/10.1371/journal.pone.0136590			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5VA	26302374	Green Published, gold, Green Submitted			2022-12-27	WOS:000359951900076
J	de Vasconcellos, JF; Laranjeira, ABA; Leal, PC; Bhasin, MK; Zenatti, PP; Nunes, RJ; Yunes, RA; Nowill, AE; Libermann, TA; Zerbini, LF; Yunes, JA				de Vasconcellos, Jaira Ferreira; Albertoni Laranjeira, Angelo Brunelli; Leal, Paulo C.; Bhasin, Manoj K.; Zenatti, Priscila Pini; Nunes, Ricardo J.; Yunes, Rosendo A.; Nowill, Alexandre E.; Libermann, Towia A.; Zerbini, Luiz Fernando; Yunes, Jose Andres			SB225002 Induces Cell Death and Cell Cycle Arrest in Acute Lymphoblastic Leukemia Cells through the Activation of GLIPR1	PLOS ONE			English	Article							NONPEPTIDE CXCR2 ANTAGONIST; KINASE-MEDIATED APOPTOSIS; BREAST-CANCER CELLS; P53 TARGET GENE; PROSTATE-CANCER; REPERFUSION INJURY; STROMAL CELLS; TUMOR-CELLS; NF-KB; EXPRESSION	Acute Lymphoblastic Leukemia (ALL) is the most frequent childhood malignancy. In the effort to find new anti-leukemic agents, we evaluated the small drug SB225002 (N-(2-hydroxy-4-nitrophenyl)-N'-(2-bromophenyl)urea). Although initially described as a selective antagonist of CXCR2, later studies have identified other cellular targets for SB225002, with potential medicinal use in cancer. We found that SB225002 has a significant pro-apoptotic effect against both B-and T-ALL cell lines. Cell cycle analysis demonstrated that treatment with SB225002 induces G2-M cell cycle arrest. Transcriptional profiling revealed that SB225002-mediated apoptosis triggered a transcriptional program typical of tubulin binding agents. Network analysis revealed the activation of genes linked to the JUN and p53 pathways and inhibition of genes linked to the TNF pathway. Early cellular effects activated by SB225002 included the up-regulation of GLIPR1, a p53-target gene shown to have pro-apoptotic activities in prostate and bladder cancer. Silencing of GLIPR1 in B-and T-ALL cell lines resulted in increased resistance to SB225002. Although SB225002 promoted ROS increase in ALL cells, antioxidant N-Acetyl Cysteine pre-treatment only modestly attenuated cell death, implying that the pro-apoptotic effects of SB225002 are not exclusively mediated by ROS. Moreover, GLIPR1 silencing resulted in increased ROS levels both in untreated and SB225002-treated cells. In conclusion, SB225002 induces cell cycle arrest and apoptosis in different B- and T-ALL cell lines. Inhibition of tubulin function with concurrent activation of the p53 pathway, in particular, its downstream target GLIPR1, seems to underlie the anti-leukemic effect of SB225002.	[de Vasconcellos, Jaira Ferreira; Albertoni Laranjeira, Angelo Brunelli; Zenatti, Priscila Pini; Yunes, Jose Andres] Ctr Infantil Boldrini, Campinas, SP, Brazil; [de Vasconcellos, Jaira Ferreira; Yunes, Jose Andres] Univ Estadual Campinas, Fac Med Sci, Dept Med Genet, Campinas, SP, Brazil; [de Vasconcellos, Jaira Ferreira; Bhasin, Manoj K.; Libermann, Towia A.; Zerbini, Luiz Fernando] Beth Israel Deaconess Med Ctr, BIDMC Genom Prote Bioinformat & Syst Biol Ctr, Boston, MA 02215 USA; [de Vasconcellos, Jaira Ferreira; Bhasin, Manoj K.; Libermann, Towia A.; Zerbini, Luiz Fernando] Harvard Univ, Sch Med, Boston, MA USA; [Leal, Paulo C.; Nunes, Ricardo J.; Yunes, Rosendo A.] Univ Fed Santa Catarina, Dept Chem, Florianopolis, SC, Brazil; [Nowill, Alexandre E.] Univ Estadual Campinas, Ctr Integrado Pesquisas Oncohematol Infancia, Campinas, SP, Brazil; [Zerbini, Luiz Fernando] Univ Cape Town, Canc Genom Grp, Int Ctr Genet Engn, ZA-7925 Cape Town, South Africa; [Zerbini, Luiz Fernando] Univ Cape Town, Biotechnol & Med Biochem Div, ZA-7925 Cape Town, South Africa	Universidade Estadual de Campinas; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Universidade Federal de Santa Catarina (UFSC); Universidade Estadual de Campinas; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; University of Cape Town	Yunes, JA (corresponding author), Ctr Infantil Boldrini, Campinas, SP, Brazil.	andres@boldrini.org.br	Zerbini, Luiz/B-7720-2015; Brunelli Albertoni Laranjeira, Angelo/H-3601-2016; Nowill, Alexandre Eduardo/I-9038-2012	Zerbini, Luiz/0000-0003-0736-9508; Nowill, Alexandre Eduardo/0000-0003-0648-6913; Bhasin, Manoj/0000-0001-5172-420X; Brunelli Albertoni Laranjeira, Angelo/0000-0002-6772-0956; Yunes, Jose Andres/0000-0002-1316-3525; Pini Zenatti, Priscila/0000-0002-8662-7458; Ferreira de Vasconcellos, Jaira/0000-0001-5011-4493	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [05/02390-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [401122/05, PC051217]; ICGEB; FAPESP [06/01158-3, 08/02106-2]; CAPES [1102-08-7]; ABAL	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ICGEB(Department of Biotechnology (DBT) India); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); ABAL	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) 05/02390-4 and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) 401122/05 to JAY, and PC051217 and ICGEB to LFZ. JFV was supported by FAPESP 06/01158-3 and CAPES international fellowship 1102-08-7, and ABAL by FAPESP 08/02106-2.	Bakshi P, 2009, BIOORGAN MED CHEM, V17, P8102, DOI 10.1016/j.bmc.2009.09.051; Baraz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102494; Bento AF, 2008, J LEUKOCYTE BIOL, V84, P1213, DOI 10.1189/jlb.0408231; Capalbo G, 2013, ONCOL REP, V30, P2254, DOI 10.3892/or.2013.2716; CHENG J, 1990, MOL CELL BIOL, V10, P5502, DOI 10.1128/MCB.10.10.5502; Coldwell MJ, 2013, CELL CYCLE, V12, P3615, DOI 10.4161/cc.26588; D'Antonio M, 2013, J EXP MED, V210, P821, DOI 10.1084/jem.20122005; de Vasconcellos JF, 2011, PEDIATR BLOOD CANCER, V56, P568, DOI 10.1002/pbc.22941; Du MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054572; Erin N, 2015, BREAST CANCER RES TR, V150, P57, DOI 10.1007/s10549-015-3297-3; Ferretti E, 2011, LEUKEMIA, V25, P1268, DOI 10.1038/leu.2011.88; Fujita T, 2014, UROL ONCOL-SEMIN ORI, V32, P92, DOI 10.1016/j.urolonc.2012.10.007; Goda AE, 2013, BIOCHEM PHARMACOL, V85, P1741, DOI 10.1016/j.bcp.2013.04.011; Grepin R, 2014, CANCER RES, V74, P873, DOI 10.1158/0008-5472.CAN-13-1267; Gu XS, 2007, CANCER RES, V67, P4219, DOI 10.1158/0008-5472.CAN-06-3689; HIGHTOWER LE, 1980, J CELL PHYSIOL, V102, P407, DOI 10.1002/jcp.1041020315; Honczarenko M, 2005, J IMMUNOL, V175, P3698, DOI 10.4049/jimmunol.175.6.3698; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; Kubota H, 2003, J BIOL CHEM, V278, P20457, DOI 10.1074/jbc.C300133200; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Laranjeira ABA, 2012, LEUKEMIA, V26, P1001, DOI 10.1038/leu.2011.289; Lawson B, 1998, J CELL PHYSIOL, V174, P170, DOI 10.1002/(SICI)1097-4652(199802)174:2<170::AID-JCP4>3.3.CO;2-A; Li L, 2008, CANCER RES, V68, P434, DOI 10.1158/0008-5472.CAN-07-2931; Li LK, 2011, CANCER RES, V71, P7694, DOI 10.1158/0008-5472.CAN-11-1714; Li YC, 2010, ANTI-CANCER DRUG, V21, P389, DOI 10.1097/CAD.0b013e328336b383; Lo MC, 2013, CANCER LETT, V335, P81, DOI 10.1016/j.canlet.2013.01.052; Lock RB, 2002, BLOOD, V99, P4100, DOI 10.1182/blood.V99.11.4100; MANABE A, 1992, BLOOD, V79, P2370; Manjavachi MN, 2010, EUR J PAIN, V14, P23, DOI 10.1016/j.ejpain.2009.01.007; Mansilla S, 2006, EUR J PHARMACOL, V540, P34, DOI 10.1016/j.ejphar.2006.04.035; Matsuo Y, 2009, MOL CANCER RES, V7, P799, DOI 10.1158/1541-7786.MCR-08-0577; Moulton VR, 2008, J BIOL CHEM, V283, P20037, DOI 10.1074/jbc.M710434200; Neznanov N, 2011, ONCOTARGET, V2, P209, DOI 10.18632/oncotarget.246; Ogburn KD, 2006, J BIOL CHEM, V281, P23274, DOI 10.1074/jbc.M600635200; OKUDA T, 1995, GENOMICS, V29, P623, DOI 10.1006/geno.1995.9957; Parker AL, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00153; Qu Yi, 2009, Zhonghua Yan Ke Za Zhi, V45, P742; Ren CH, 2002, MOL CELL BIOL, V22, P3345, DOI 10.1128/MCB.22.10.3345-3357.2002; Ren CZ, 2006, GENOMICS, V88, P163, DOI 10.1016/j.ygeno.2006.03.021; Ren CZ, 2004, CANCER RES, V64, P969, DOI 10.1158/0008-5472.CAN-03-2592; Romanini J, 2012, INVEST NEW DRUG, V30, P1371, DOI 10.1007/s10637-011-9701-x; Rosenzweig T, 2006, CANCER RES, V66, P4139, DOI 10.1158/0008-5472.CAN-05-2851; Rushing GD, 2007, J AM COLL SURGEONS, V204, P964, DOI 10.1016/j.jamcollsurg.2007.01.029; Saintigny P, 2013, CANCER RES, V73, P571, DOI 10.1158/0008-5472.CAN-12-0263; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Silva A, 2010, HAEMATOL-HEMATOL J, V95, P674, DOI 10.3324/haematol.2009.011999; Silveira AB, 2015, ONCOTARGET, V6, P13105, DOI 10.18632/oncotarget.3524; Sueoka H, 2014, SURGERY, V155, P640, DOI 10.1016/j.surg.2013.12.037; Wang B, 2006, CANCER RES, V66, P3071, DOI 10.1158/0008-5472.CAN-05-2871; Wang J, 2009, J CELL MOL MED, V13, P3888, DOI 10.1111/j.1582-4934.2009.00873.x; Weis F, 2010, J BIOL CHEM, V285, P9525, DOI 10.1074/jbc.M109.096586; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095; Yu MH, 2010, J ONCOL, V2010, DOI 10.1155/2010/939407	55	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0134783	10.1371/journal.pone.0134783	http://dx.doi.org/10.1371/journal.pone.0134783			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302043	gold, Green Published, Green Submitted			2022-12-27	WOS:000359951900008
J	Carroll, JB; Deik, A; Fossale, E; Weston, RM; Guide, JR; Arjomand, J; Kwak, S; Clish, CB; MacDonald, ME				Carroll, Jeffrey B.; Deik, Amy; Fossale, Elisa; Weston, Rory M.; Guide, Jolene R.; Arjomand, Jamshid; Kwak, Seung; Clish, Clary B.; MacDonald, Marcy E.			Hdh(Q111) Mice Exhibit Tissue Specific Metabolite Profiles that Include Striatal Lipid Accumulation	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HEPATIC MITOCHONDRIAL DYSFUNCTION; HUNTINGTONS-DISEASE; ENERGY HOMEOSTASIS; WEIGHT-LOSS; EXPRESSION; PATHWAY; PHOSPHOETHANOLAMINE; RESPIRATION; IMPAIRMENT	The HTT CAG expansion mutation causes Huntington's Disease and is associated with a wide range of cellular consequences, including altered metabolism. The mutant allele is expressed widely, in all tissues, but the striatum and cortex are especially vulnerable to its effects. To more fully understand this tissue-specificity, early in the disease process, we asked whether the metabolic impact of the mutant CAG expanded allele in heterozygous B6.HdhQ(111/+) mice would be common across tissues, or whether tissues would have tissue-specific responses and whether such changes may be affected by diet. Specifically, we cross-sectionally examined steady state metabolite concentrations from a range of tissues (plasma, brown adipose tissue, cerebellum, striatum, liver, white adipose tissue), using an established liquid chromatography-mass spectrometry pipeline, from cohorts of 8 month old mutant and wild-type littermate mice that were fed one of two different high-fat diets. The differential response to diet highlighted a proportion of metabolites in all tissues, ranging from 3% (7/219) in the striatum to 12% (25/212) in white adipose tissue. By contrast, the mutant CAG-expanded allele primarily affected brain metabolites, with 14% (30/219) of metabolites significantly altered, compared to wild-type, in striatum and 11% (25/224) in the cerebellum. In general, diet and the CAG-expanded allele both elicited metabolite changes that were predominantly tissue-specific and non-overlapping, with evidence for mutation-by-diet interaction in peripheral tissues most affected by diet. Machine-learning approaches highlighted the accumulation of diverse lipid species as the most genotype-predictive metabolite changes in the striatum. Validation experiments in cell culture demonstrated that lipid accumulation was also a defining feature of mutant Hdh(Q111) striatal progenitor cells. Thus, metabolite-level responses to the CAG expansion mutation in vivo were tissue specific and most evident in brain, where the striatum featured signature accumulation of a set of lipids including sphingomyelin, phosphatidylcholine, cholesterol ester and triglyceride species. Importantly, in the presence of the CAG mutation, metabolite changes were unmasked in peripheral tissues by an interaction with dietary fat, implying that the design of studies to discover metabolic changes in HD mutation carriers should include metabolic perturbations.	[Carroll, Jeffrey B.; Fossale, Elisa; Guide, Jolene R.; MacDonald, Marcy E.] Harvard Univ, Sch Med, Dept Neurol, Ctr Human Genet Res,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Carroll, Jeffrey B.; Weston, Rory M.] Western Washington Univ, Dept Psychol, Behav Neurosci Program, Bellingham, WA 98225 USA; [Deik, Amy; Fossale, Elisa; Clish, Clary B.; MacDonald, Marcy E.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Arjomand, Jamshid; Kwak, Seung] CHDI Fdn Inc, Princeton, NJ USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Western Washington University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Carroll, JB (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Ctr Human Genet Res,Massachusetts Gen Hosp, Boston, MA 02115 USA.	jeff.carroll@wwu.edu	Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019	Clish, Clary B/0000-0001-8259-9245; Weston, Rory/0000-0001-6117-0204	National Institute of Health [MEM: NS32765]; CHDI Foundation Inc. (MEM); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032765] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI Foundation Inc. (MEM); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this work was provided by the National Institute of Health (MEM: NS32765); CHDI Foundation Inc. (MEM). CHDI Foundation is also the employer of two authors (JA and SK). Beyond their intellectual contributions to the design of the study, foundation staff did not play a role in the data analysis, primary figure or manuscript drafting, or the decision to publish this manuscript.	ALAVI A, 1986, SEMIN NUCL MED, V16, P2, DOI 10.1016/S0001-2998(86)80002-2; Aziz NA, 2008, NEUROLOGY, V71, P1506, DOI 10.1212/01.wnl.0000334276.09729.0e; Aziz NA, 2010, J NEUROL NEUROSUR PS, V81, P1233, DOI 10.1136/jnnp.2009.191833; Aziz NA, 2008, J NEUROL, V255, P1872, DOI 10.1007/s00415-009-0062-8; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Chaturvedi RK, 2010, HUM MOL GENET, V19, P3190, DOI 10.1093/hmg/ddq229; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; de Graaf RA, 2009, J NEUROCHEM, V109, P494, DOI 10.1111/j.1471-4159.2009.05967.x; ELLISON DW, 1987, BRAIN RES, V417, P389, DOI 10.1016/0006-8993(87)90471-9; Giralt A, 2012, HUM MOL GENET, V21, P1203, DOI 10.1093/hmg/ddr552; Gohil VM, 2013, J BIOL CHEM, V288, P35387, DOI 10.1074/jbc.M113.489237; Gohil VM, 2011, HUM MOL GENET, V20, P294, DOI 10.1093/hmg/ddq464; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911; HAYDEN MR, 1986, NEUROLOGY, V36, P888, DOI 10.1212/WNL.36.7.888; He FS, 1995, NEUROLOGY, V45, P2178, DOI 10.1212/WNL.45.12.2178; HEISS WD, 1986, NEUROPSYCHOLOGIA, V24, P141, DOI 10.1016/0028-3932(86)90048-5; Holter SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080923; Hoffmann R, 2014, MOVEMENT DISORD, V29, P831, DOI 10.1002/mds.25862; Jacobsen JC, 2011, HUM MOL GENET, V20, P2846, DOI 10.1093/hmg/ddr195; Ji JG, 2012, LANCET ONCOL, V13, P642, DOI 10.1016/S1470-2045(12)70132-8; Jin YH, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-10; KUWERT T, 1990, BRAIN, V113, P1405, DOI 10.1093/brain/113.5.1405; Lee JM, 2007, PLOS GENET, V3, P1397, DOI 10.1371/journal.pgen.0030135; Lloret A, 2006, HUM MOL GENET, V15, P2015, DOI 10.1093/hmg/ddl125; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marder K, 2009, NEUROLOGY, V73, P385, DOI 10.1212/WNL.0b013e3181b04aa2; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Menzies FM, 2011, CURR OPIN CELL BIOL, V23, P190, DOI 10.1016/j.ceb.2010.10.010; Mochel F, 2012, J BIOL CHEM, V287, P1361, DOI 10.1074/jbc.M111.309849; Powers WJ, 2007, P NATL ACAD SCI USA, V104, P2945, DOI 10.1073/pnas.0609833104; Ramos EM, 2015, MAMM GENOME, V26, P119, DOI 10.1007/s00335-014-9552-9; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Rosas HD, 2003, NEUROLOGY, V60, P1615, DOI 10.1212/01.WNL.0000065888.88988.6E; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Seong IS, 2005, HUM MOL GENET, V14, P2871, DOI 10.1093/hmg/ddi319; Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107; Shirendeb UP, 2012, HUM MOL GENET, V21, P406, DOI 10.1093/hmg/ddr475; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Stuwe SH, 2013, NEUROLOGY, V80, P743, DOI 10.1212/WNL.0b013e318282514e; Tang CC, 2013, J CLIN INVEST, V123, P4076, DOI 10.1172/JCI69411; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tkac I, 2007, J NEUROCHEM, V100, P1397, DOI 10.1111/j.1471-4159.2006.04323.x; Trager U, 2014, BRAIN, V137, P819, DOI 10.1093/brain/awt355; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Trushina E, 2006, HUM MOL GENET, V15, P3578, DOI 10.1093/hmg/ddl434; Valenza M, 2005, J NEUROSCI, V25, P9932, DOI 10.1523/JNEUROSCI.3355-05.2005; Van Raamsdonk JM, 2006, HUM MOL GENET, V15, P1513, DOI 10.1093/hmg/ddl072; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; YOUNG AB, 1986, ANN NEUROL, V20, P296, DOI 10.1002/ana.410200305; Zheng SQ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000838; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	58	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0134465	10.1371/journal.pone.0134465	http://dx.doi.org/10.1371/journal.pone.0134465			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295712	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900011
J	Farhan, MA; Carmine-Simmen, K; Lewis, JD; Moore, RB; Murray, AG				Farhan, Maikel A.; Carmine-Simmen, Katia; Lewis, John D.; Moore, Ronald B.; Murray, Allan G.			Endothelial Cell mTOR Complex-2 Regulates Sprouting Angiogenesis	PLOS ONE			English	Article							FOCAL ADHESION KINASE; MAMMALIAN TARGET; IN-VITRO; TUMOR-GROWTH; RAPAMYCIN; INHIBITOR; PHOSPHORYLATION; CANCER; VEGF; RICTOR	Tumor neovascularization is targeted by inhibition of vascular endothelial growth factor (VEGF) or the receptor to prevent tumor growth, but drug resistance to angiogenesis inhibition limits clinical efficacy. Inhibition of the phosphoinositide 3 kinase pathway intermediate, mammalian target of rapamycin (mTOR), also inhibits tumor growth and may prevent escape from VEGF receptor inhibitors. mTOR is assembled into two separate multi-molecular complexes, mTORC1 and mTORC2. The direct effect of mTORC2 inhibition on the endothelium and tumor angiogenesis is poorly defined. We used pharmacological inhibitors and RNA interference to determine the function of mTORC2 versus Akt1 and mTORC1 in human endothelial cells (EC). Angiogenic sprouting, EC migration, cytoskeleton re-organization, and signaling events regulating matrix adhesion were studied. Sustained inactivation of mTORC1 activity up-regulated mTORC2-dependent Akt1 activation. In turn, ECs exposed to mTORC1-inhibition were resistant to apoptosis and hyper-responsive to renal cell carcinoma (RCC)-stimulated angiogenesis after relief of the inhibition. Conversely, mTORC1/2 dual inhibition or selective mTORC2 inactivation inhibited angiogenesis in response to RCC cells and VEGF. mTORC2-inactivation decreased EC migration more than Akt1- or mTORC1-inactivation. Mechanistically, mTORC2 inactivation robustly suppressed VEGF-stimulated EC actin polymerization, and inhibited focal adhesion formation and activation of focal adhesion kinase, independent of Akt1. Endothelial mTORC2 regulates angiogenesis, in part by regulation of EC focal adhesion kinase activity, matrix adhesion, and cytoskeletal remodeling, independent of Akt/mTORC1.	[Farhan, Maikel A.; Murray, Allan G.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Carmine-Simmen, Katia; Lewis, John D.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Moore, Ronald B.] Univ Alberta, Dept Surg, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Murray, AG (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	allan.murray@ualberta.ca	Moore, Ronald Brian/AET-3015-2022	Moore, Ronald/0000-0003-2027-2428	Canadian Institutes of Health Research; Alberta Innovates Health Solutions; Alberta Innovates [201201250] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; Alberta Innovates	The work was supported by a grant from the Canadian Institutes of Health Research, and Alberta Innovates Health Solutions to AGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Cacheux W, 2008, ANN ONCOL, V19, P1659, DOI 10.1093/annonc/mdn540; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Del Bufalo D, 2006, CANCER RES, V66, P5549, DOI 10.1158/0008-5472.CAN-05-2825; Duval M, 2007, MOL BIOL CELL, V18, P4659, DOI 10.1091/mbc.E07-05-0467; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Falcon BL, 2011, CANCER RES, V71, P1573, DOI 10.1158/0008-5472.CAN-10-3126; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Giubellino A, 2013, ENDOCRINOLOGY, V154, P646, DOI 10.1210/en.2012-1854; Gokmen-Polar Y, 2012, BREAST CANCER RES TR, V136, P673, DOI 10.1007/s10549-012-2298-8; Griffioen AW, 2012, CLIN CANCER RES, V18, P3961, DOI 10.1158/1078-0432.CCR-12-0002; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Hutson TE, 2014, J CLIN ONCOL, V32, P760, DOI 10.1200/JCO.2013.50.3961; Hutson TE, 2011, CRIT REV ONCOL HEMAT, V77, P49, DOI 10.1016/j.critrevonc.2010.07.018; ILLC D, 1995, NATURE, V377, P539; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kapoor A, 2009, CANCER-AM CANCER SOC, V115, P3618, DOI 10.1002/cncr.24409; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lane HA, 2009, CLIN CANCER RES, V15, P1612, DOI 10.1158/1078-0432.CCR-08-2057; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Le Boeuf F, 2004, J BIOL CHEM, V279, P39175, DOI 10.1074/jbc.M405493200; Luchman HA, 2014, CLIN CANCER RES, V20, P5756, DOI 10.1158/1078-0432.CCR-13-3389; Masson-Gadais B, 2003, CELL STRESS CHAPERON, V8, P37, DOI 10.1379/1466-1268(2003)8<37:IVRFVA>2.0.CO;2; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Nakatsu MN, 2008, METHOD ENZYMOL, V443, P65, DOI 10.1016/S0076-6879(08)02004-1; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; Powles T, 2013, ANN ONCOL, V24, P2098, DOI 10.1093/annonc/mdt130; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Ruan GX, 2012, EMBO J, V31, P1692, DOI 10.1038/emboj.2012.21; Saito K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049456; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schaller MD, 1999, MOL BIOL CELL, V10, P3489, DOI 10.1091/mbc.10.10.3489; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Takahara T, 2013, J BIOCHEM, V154, P1, DOI 10.1093/jb/mvt047; Wary KK, 2012, MICROVASC RES, V83, P64, DOI 10.1016/j.mvr.2011.05.002; Xue Q, 2009, ARTERIOSCL THROM VAS, V29, P1172, DOI 10.1161/ATVBAHA.109.185918; Zhang HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065277, 10.1371/journal.pone.0054510, 10.1371/journal.pone.0068634, 10.1371/journal.pone.0079454]; Zhang QX, 2011, AM J PHYSIOL-RENAL, V301, pF1242, DOI 10.1152/ajprenal.00662.2010; Zijlstra A., 2012, TXB ANGIOGENESIS LYM, P217	49	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135245	10.1371/journal.pone.0135245	http://dx.doi.org/10.1371/journal.pone.0135245			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295809	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900021
J	Mayo, JP; Cohen, MR; Maunsell, JHR				Mayo, J. Patrick; Cohen, Marlene R.; Maunsell, John H. R.			A Refined Neuronal Population Measure of Visual Attention	PLOS ONE			English	Article							PERFORMANCE; COMPUTATION; DYNAMICS	Neurophysiological studies of cognitive mechanisms such as visual attention typically ignore trial-by-trial variability and instead report mean differences averaged across many trials. Advances in electrophysiology allow for the simultaneous recording of small populations of neurons, which may obviate the need for averaging activity over trials. We recently introduced a method called the attention axis that uses multi-electrode recordings to provide estimates of attentional state of behaving monkeys on individual trials. Here, we refine this method to eliminate problems that can cause bias in estimates of attentional state in certain scenarios. We demonstrate the sources of these problems using simulations and propose an amendment to the previous formulation that provides superior performance in trial-by-trial assessments of attentional state.	[Mayo, J. Patrick] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Cohen, Marlene R.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Cohen, Marlene R.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Maunsell, John H. R.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Chicago	Mayo, JP (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	mayo@neuro.duke.edu	Maunsell, John/G-5702-2010; Mayo, J. Patrick/R-4998-2019	Maunsell, John/0000-0003-0018-4439; Mayo, J. Patrick/0000-0001-5696-4667	National Institutes of Health (NIH) [F32EY022529]; NIH [R00EY020844, R01EY022930, P30EY08098, R01EY005911]; Whitehall Foundation; Klingenstein Fellowship; Simons Foundation; Sloan Research Fellowship; NATIONAL EYE INSTITUTE [R00EY020844, R01EY005911, R01EY022930, F32EY022529, P30EY008098] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; Klingenstein Fellowship(Klingenstein Philanthropies); Simons Foundation; Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	JPM's work was supported by National Institutes of Health (NIH; www.nih.gov) grant F32EY022529; MRC's work was supported by NIH grants R00EY020844, R01EY022930, and core grant P30EY08098, a Whitehall Foundation (www.whitehall.org) grant, a Klingenstein Fellowship (www.klingfund.org), a grant from the Simons Foundation (www.simonsfoundation.org), a Sloan Research Fellowship (www.sloan.org); JHRM's work was supported by NIH grant R01EY005911. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Cohen MR, 2011, J NEUROSCI, V31, P15802, DOI 10.1523/JNEUROSCI.3063-11.2011; Cohen MR, 2011, NEURON, V70, P1192, DOI 10.1016/j.neuron.2011.04.029; Cohen MR, 2010, J NEUROSCI, V30, P15241, DOI 10.1523/JNEUROSCI.2171-10.2010; Cunningham JP, 2014, NAT NEUROSCI, V17, P1500, DOI 10.1038/nn.3776; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Hohl SS, 2013, NEURON, V79, P167, DOI 10.1016/j.neuron.2013.05.026; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Morrow MM, 2009, ADV EXP MED BIOL, V629, P179, DOI 10.1007/978-0-387-77064-2_9; Pagan M, 2014, J NEUROPHYSIOL, V112, P1584, DOI 10.1152/jn.00260.2014; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112	11	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136570	10.1371/journal.pone.0136570	http://dx.doi.org/10.1371/journal.pone.0136570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296083	Green Published, gold, Green Accepted			2022-12-27	WOS:000359926900122
J	Ronkina, N; Johansen, C; Bohlmann, L; Lafera, J; Menon, MB; Tiedje, C; Laass, K; Turk, BE; Iversen, L; Kotlyarov, A; Gaestel, M				Ronkina, Natalia; Johansen, Claus; Bohlmann, Lisa; Lafera, Juri; Menon, Manoj B.; Tiedje, Christopher; Laass, Kathrin; Turk, Benjamin E.; Iversen, Lars; Kotlyarov, Alexey; Gaestel, Matthias			Comparative Analysis of Two Gene-Targeting Approaches Challenges the Tumor-Suppressive Role of the Protein Kinase MK5/PRAK	PLOS ONE			English	Article							MAPK-ACTIVATED PROTEIN-KINASE-5; ONCOGENE-INDUCED SENESCENCE; PHOSPHORYLATION; PRAK; P38; MK5; ERK3; P53; TUMORIGENESIS; BIOSYNTHESIS	MK5 (MAPK-activated protein kinase 5) or PRAK (p38-regulated and -activated kinase) are alternative names for a serine/threonine protein kinase downstream to ERK3/4 and p38 MAPK. A previous gene targeting approach for MK5/PRAK (termed here MK5/PRAK-Delta ex8) revealed a seemingly tumor-suppressive role of MK5/PRAK in DMBA-induced one step skin carcinogenesis and Ras-induced transformation. Here we demonstrate that an alternative targeting strategy of MK5/PRAK (termed MK5/PRAK-Delta ex6) increased neither tumor incidence in the one step skin carcinogenesis model, nor Ras-induced transformation in primary cells. Interestingly, due to the targeting strategies and exon skipping both knockouts do not completely abolish the generation of MK5/PRAK protein, but express MK5/PRAK deletion mutants with different biochemical properties depending on the exon targeted: Targeting of exon 6 leads to expression of an unstable cytoplasmic catalytically inactive MK5/PRAK-Delta ex6 mutant while targeting of exon 8 results in a more stable nuclear MK5/PRAK Delta ex8 mutant with residual catalytic activity. The different properties of the MK5/PRAK deletion mutants could be responsible for the observed discrepancy between the knockout strains and challenge the role of MK5/PRAK in p53-dependent tumor suppression. Further MK5/PRAK knockout and knock-in mouse strains will be necessary to assign a physiological function to MK5/PRAK in this model organism.	[Ronkina, Natalia; Bohlmann, Lisa; Lafera, Juri; Menon, Manoj B.; Tiedje, Christopher; Laass, Kathrin; Kotlyarov, Alexey; Gaestel, Matthias] Hannover Med Sch, Dept Biochem, Hannover, Germany; [Johansen, Claus; Iversen, Lars] Aarhus Univ Hosp, Dept Dermatol, DK-8000 Aarhus C, Denmark; [Turk, Benjamin E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Hannover Medical School; Aarhus University; Yale University	Gaestel, M (corresponding author), Hannover Med Sch, Dept Biochem, Hannover, Germany.	gaestel.matthias@mh-hannover.de	Gaestel, Matthias/A-6560-2013; Menon, Manoj B./P-1543-2015	Gaestel, Matthias/0000-0002-4944-4652; Menon, Manoj B./0000-0001-5859-0347; Tiedje, Christopher/0000-0002-3013-6967; Johansen, Claus/0000-0002-5665-5212; Iversen, Lars/0000-0003-1816-4508; Johansen, Claus/0000-0003-0240-5127	Deutsche Forschungsgemeinschaft [Ko2091/1-3]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104047] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Deutsche Forschungsgemeinschaft grant Ko2091/1-3 to AK and MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Aberg E, 2006, J BIOL CHEM, V281, P35499, DOI 10.1074/jbc.M606225200; Aberg E, 2009, J BIOL CHEM, V284, P19392, DOI 10.1074/jbc.M109.023283; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chow KT, 2013, J EXP MED, V210, P1621, DOI 10.1084/jem.20130498; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dingar D, 2010, CELL SIGNAL, V22, P1063, DOI 10.1016/j.cellsig.2010.02.009; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; ENGEL K, 1995, J BIOL CHEM, V270, P27213, DOI 10.1074/jbc.270.45.27213; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kant S, 2006, J BIOL CHEM, V281, P35511, DOI 10.1074/jbc.M606693200; Kostenko Sergiy, 2012, J Mol Signal, V7, P9, DOI 10.1186/1750-2187-7-9; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kress TR, 2011, MOL CELL, V41, P445, DOI 10.1016/j.molcel.2011.01.023; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Moens U, 2013, BIOL CHEM, V394, P1115, DOI 10.1515/hsz-2013-0149; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Muller U, 1999, MECH DEVELOP, V82, P3, DOI 10.1016/S0925-4773(99)00021-0; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Schumacher S, 2004, EMBO J, V23, P4770, DOI 10.1038/sj.emboj.7600467; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Seternes OM, 2002, MOL CELL BIOL, V22, P6931, DOI 10.1128/MCB.22.20.6931-6945.2002; Shi Y, 2003, MOL CELL BIOL, V23, P7732, DOI 10.1128/MCB.23.21.7732-7741.2003; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005; Yoshizuka N, 2012, MOL CANCER RES, V10, P810, DOI 10.1158/1541-7786.MCR-11-0576; Yoshizuka N, 2012, MOL CELL BIOL, V32, P606, DOI 10.1128/MCB.06301-11; Zheng H, 2013, MOL CELL, V50, P699, DOI 10.1016/j.molcel.2013.04.013; Zheng M, 2011, NAT CELL BIOL, V13, P263, DOI 10.1038/ncb2168	39	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136138	10.1371/journal.pone.0136138	http://dx.doi.org/10.1371/journal.pone.0136138			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295581	gold, Green Published, Green Submitted			2022-12-27	WOS:000359926900073
J	Sadr, K				Sadr, Karim			Livestock First Reached Southern Africa in Two Separate Events	PLOS ONE			English	Article							LIMPOPO CONFLUENCE AREA; ROCK-SHELTER; ARTIFACT ASSEMBLAGES; BACKED ARTIFACTS; AGE; CAPE; CHRONOLOGY; PREHISTORY; ART; PASTORALISM	After several decades of research on the subject, we now know when the first livestock reached southern Africa but the question of how they got there remains a contentious topic. Debate centres on whether they were brought with a large migration of Khoe-speakers who originated from East Africa; or whether the livestock were traded down-the-line among hunter-gatherer communities; or indeed whether there was a long history of diverse small scale population movements in this part of the world, one or more of which 'infiltrated' livestock into southern Africa. A new analysis of the distribution of stone toolkits from a sizeable sample of sub-equatorial African Later Stone Age sites, coupled with existing knowledge of the distribution of the earliest livestock remains and ceramics vessels, has allowed us to isolate two separate infiltration events that brought the first livestock into southern Africa just over 2000 years ago; one infiltration was along the Atlantic seaboard and another entered the middle reaches of the Limpopo River Basin. These findings agree well with the latest results of genetic research which together indicate that multiple, small-scale infiltrations probably were responsible for bringing the first livestock into southern Africa.	Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa	University of Witwatersrand	Sadr, K (corresponding author), Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa.	karim.sadr@wits.ac.za		Sadr, Karim/0000-0002-9290-4431				[Anonymous], 1993, SO AFRICAN FIELD ARC; [Anonymous], 1989, IRON AGE MIGRATIONS; Attenbrow V, 2009, J ARCHAEOL SCI, V36, P2765, DOI 10.1016/j.jas.2009.08.018; Barbieri C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099117; Barbieri C, 2014, AM J PHYS ANTHROPOL, V153, P435, DOI 10.1002/ajpa.22441; Barnett W. K, 2000, EUROPES 1 FARMERS, DOI DOI 10.1017/CBO9780511607851.005; Binneman JNF, 1997, S AFR FLD ARCHAEOL, V6, P93; Binneman JNF, 2007, S AFR FLD ARCHAEOL, V13, P49; Blench R. M., 2006, ARCHAEOLOGY LANGUAGE; Bousman C.B., 1998, AFR ARCHAEOL REV, V15, P133; Bousman CB, 2005, J ANTHROPOL ARCHAEOL, V24, P193, DOI 10.1016/j.jaa.2005.05.001; Bowdler S., 1981, ARCHAEOL OCEAN, V16, P99; Breton G, 2014, CURR BIOL, V24, P852, DOI 10.1016/j.cub.2014.02.041; Brooks A.S., 1977, BOTSW NOTES REC, V9, P21; Cable C, 1984, BRIT ARCHAEOLOGICAL; Campbell A. C, 1992, SO OKAVANGO INTEGRAT; Clarkson C, 2007, TERRA AUSTRALIS, V25, P1; Coelho M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-80; Conard NJ., 2006, GRUNDLEGUNGEN BEITRA, P329; COOKE CK, 1965, AFRICA, V35, P263, DOI 10.2307/1157174; Cunliffe B., 2008, EUROPE OCEANS 9000 B; Curtin P, 1995, AFRICAN HIST EARLIES; David B, 1998, WORLD ARCHAEOL, V30, P193, DOI 10.1080/00438243.1998.9980407; Deacon H. J., 1978, S AFRICAN ARCHAEOLOG, V33, P39, DOI DOI 10.2307/3888251; Deacon H.J., 1976, HUNTERS GATHERED STU; DEACON HJ, 1992, PHILOS T ROY SOC B, V337, P177, DOI 10.1098/rstb.1992.0095; Deacon HJ., 1980, S AFR ARCHAEOL BULL, V35, P31, DOI [10.2307/3888722, DOI 10.2307/3888722]; Deacon J., 1984, P221; Deacon J., 1984, LATER STONE AGE SOUT; Deacon J., 1972, S AFR ARCHAEOL BULL, V27, P10, DOI [10.2307/3888813, DOI 10.2307/3888813]; Delre SA, 2010, J PROD INNOVAT MANAG, V27, P267, DOI 10.1111/j.1540-5885.2010.00714.x; DENBOW J, 1986, J AFR HIST, V27, P3, DOI 10.1017/S0021853700029170; Dewar G, 2008, ARCHAEOLOGY COASTAL, V1761; Dewar G.I., 2013, ARCHAEOLOGY W COAST, P109; Ehret Chris, 1982, ARCHAEOLOGICAL LINGU, P158, DOI [10.1525/9780520314757-010, DOI 10.1525/9780520314757-010]; Ehret C, 2008, SOUTH AFR HUMANIT, V20, P7; Ehret Christopher, 1998, AFRICAN CLASSICAL AG; Elphick R, 1985, KHOIKHOI FOUNDING WH; Elphick R, 1977, KRAAL AND CASTLE; Evans N., 1997, ARCHAEOLOGY LINGUIST, P385; Fauvelle-Aymar FX, 2008, SOUTH AFR HUMANIT, V20, P77; Forssman T, 2013, THESIS U OXFORD; Guldemann T, 2008, SOUTH AFR HUMANIT, V20, P93; Henn BM, 2008, P NATL ACAD SCI USA, V105, P10693, DOI 10.1073/pnas.0801184105; Henshilwood C, 1996, ANTIQUITY, V70, P945, DOI 10.1017/S0003598X00084210; Henshilwood C.S., 2008, HOLOCENE PREHISTORY; Hiscock P., 2002, ARCHEOLOGICAL PAPERS, V12, P163, DOI DOI 10.1525/AP3A.2002.12.1.163; Huffman TN., 2005, SO AFRICAN FIELD ARC, V17, P57; Humphreys A.J.B., 1983, S AFRICAN ARCHAEOLOG; Jerardino A, 1998, S AFR ARCHAEOL BULL, V53, P16, DOI 10.2307/3889258; Jerardino A., 1996, THESIS U CAPE TOWN; Jerardino A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113672; Kaplan J., 1987, BAR International Series, P350; KATZ E, 1963, AM SOCIOL REV, V28, P237, DOI 10.2307/2090611; Kinahan J., 2001, PASTORAL NOMADS NAMI; Kinahan J., 1996, S AFR ARCHAEOL BULL, V51, P106, DOI [10.2307/3888846, DOI 10.2307/3888846]; Klein RG, 1986, S AFRICAN ARCHAEOLOG, V5, P5, DOI DOI 10.2307/3858140; Law-de-Lauriston PBM, 2014, THESIS U WITWATERSRA; Lombard M, 2005, S AFR ARCHAEOL BULL, V60, P115; Lombard M, 2012, S AFR ARCHAEOL BULL, V67, P123; Macholdt E, 2014, CURR BIOL, V24, P875, DOI 10.1016/j.cub.2014.03.027; Maggs T.M.Oc., 1980, ANN NAT MUS, V24, P35; Manhire A. H., 1987, LATER STONE AGE SETT; MAZEL A, 1981, WORLD ARCHAEOL, V13, P16, DOI 10.1080/00438243.1981.9979811; Mazel A., 1997, SOUTH AFR HUMANIT, V9, P1; Mazel A, 1989, SOUTH AFR HUMANIT, V1, P1; Mazel A.D., 1986, Annals of the Natal Museum, V27, P389; MAZEL A D, 1984, Annals of the Natal Museum, V26, P25; Mazel A.D., 1988, Annals of the Natal Museum, V29, P379; Mazel A.D., 1990, NATAL MUSEUM J HUMAN, V2, P95; Mazel A. D., 1988, ANN NAT MUS, V29, P321; Mazel A.D., 1996, NATAL MUSEUM J HUMAN, V8, P1; Mazel A.D., 1992, NATAL MUSEUM J HUMAN, V4, P1; Mazel AD, 1993, NATAL MUS J HUMANIT, V5, P1; Mazel AD, 1986, SOUTH AFR HUMANIT, V27, P357; Mazel AD, 1984, SOUTH AFR HUMANIT, V26, P1; Mazel AD, 1999, NATAL MUSEUM J HUMAN, V11, P1; McConvell P., 1996, ARCHAEOL OCEAN, V31, P125, DOI [DOI 10.2307/40387040, DOI 10.1002/J.1834-4453.1996.TB00356.X]; McCormac FG, 2004, RADIOCARBON, V46, P1087, DOI 10.1017/S0033822200033014; Miller S. E. F., 1969, THESIS U CALIFORNIA; Miller SF, 1980, P 8 PANAFRICAN C PRE, P235; Mitchell P, 2002, ARCHAEOLOGY SO AFRIC; Mitchell P.J., 1994, South African Archaeological Bulletin, V49, P33, DOI 10.2307/3889171; Mitchell P.J., 1996, S AFR ARCHAEOL BULL, V51, P17, DOI [10.2307/3888928, DOI 10.2307/3888928]; Mitchell P, 2009, SOUTH AFR HUMANIT, V21, P117; Musonda FB, 1984, S AFR ARCHAEOL B, V39, P24; Newman JL, 1997, PEOPLING AFRICA GEOG; Opperman H., 1987, LATER STONE AGE DRAK; Orton J., 2009, FARMING, V2009, P1, DOI [10.3828/bfarm.2009.4.1, DOI 10.3828/BFARM.2009.4.1]; Orton J, 2012, THESIS U OXFORD; Orton J, 2011, SOUTH AFR HUMANIT, V23, P109; Parsons I, 2000, S AFR FID ARCHAEOL, V9, P55; Parsons I, 2008, S AFR ARCHAEOL BULL, V63, P51, DOI 10.2307/20474992; Phillipson D.W., 1977, LATER PREHISTORY E S; Phillipson D. W., 1976, PREHISTORY E ZAMBIA; Phillipson DW, 1970, P PREHIST SOC, V35, P172; Phillipson L, 1978, STONE AGE ARCHAEOLOG; Pickrell JK, 2014, P NATL ACAD SCI USA, V111, P2632, DOI 10.1073/pnas.1313787111; Pickrell JK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2140; Pleurdeau D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040340; Price TD., 2000, EUROPES 1 FARMERS, P301, DOI DOI 10.1017/CBO9780511607851.012; QGIS Development Team, 2015, QGIS GEOGR INF SYST; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rexova K, 2006, NATURWISSENSCHAFTEN, V93, P189, DOI 10.1007/s00114-006-0088-z; Richter J, 1991, STUDIEN URGESCHICHTE; Robbins L.H., 1986, Botswana Notes and Records, V18, P1; Robbins L.H., 1996, BOTSW NOTES REC, V28, P23; Robbins L.H., 2000, SO AFRICAN FIELD ARC, V9, P17; Robbins L.H., 1989, BOTSW NOTES REC, V20, P1; Robbins LH, 2005, CURR ANTHROPOL, V46, P671, DOI 10.1086/432748; Robbins LH, 2000, J ARCHAEOL SCI, V27, P1085, DOI 10.1006/jasc.2000.0597; Robbins LH., 1985, BOTSWANA NOTES RECOR, V17, P1; Robertson G, 2009, ANTIQUITY, V83, P296, DOI 10.1017/S0003598X00098446; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; RUSSELL T. M., 2004, SPATIAL ANAL RADIOCA; Russell T, 2012, ROCK ART RES INST MO, P37; Sadr K, 2003, J AFR HIST, V44, P195, DOI 10.1017/S0021853702008393; Sadr K., 2014, RADIOCARBON DATES ST; Sadr K., 2013, OXFORD HDB AFRICAN A, P641; Sadr K, 1998, AFR ARCHAEOL REV, V15, P101, DOI [10.1023/A:1022158701778, DOI 10.1023/A:1022158701778]; Sadr K., 2006, S AFRICAN ARCHAEOLOG, V4, P235, DOI [10.3213/1612-1651-10074, DOI 10.3213/1612-1651-10074]; Sadr K, 2010, SOUTH AFR HUMANIT, V22, P19; Sadr K, 2008, SOUTH AFR HUMANIT, V20, P179; Sadr K, 2008, J AFR ARCHAEOL, V6, P103, DOI 10.3213/1612-1651-10105; Sampson C.G., 1974, STONE AGE ARCHAEOLOG; Sampson C.G., 1970, SMITHFIELD IND COMPL; Sampson C.G., 1999, SO AFRICAN FIELD ARC, V8, P3; Sampson G, 1967, RIVERSMEAD SHELTER E; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Schweitzer F., 1979, ANN S AFR MUS, V78, P102; Schweitzer F.R., 1982, Annals of the South African Museum, V88, P1; SEALY J, 1994, ANTIQUITY, V68, P58, DOI 10.1017/S0003598X00046196; Smith A., 2006, EXCAVATIONS KASTEELB; Smith A.B., 1995, S AFRICAN ARCHAEOLOG, V50, P3, DOI [10.2307/3889270, DOI 10.2307/3889270]; Smith A.B., 1991, S AFRICAN ARCHAEOLOG, V46, P71, DOI [10.2307/3889087, DOI 10.2307/3889087]; SMITH AB, 1990, AFR STUD, V49, P51, DOI 10.1080/00020189008707727; Smith AB, 2014, ORIGINS HERDING SO A; Smith AB, 2008, SOUTH AFR HUMANIT, V20, P49; Stow George W., 1905, NATIVE RACES S AFRIC; van der Ryst M. M., 2006, THESIS U WITWATERSRA; van Doornum B, 2007, SOUTH AFR HUMANIT, V19, P17; van Doornum B, 2008, SOUTH AFR HUMANIT, V20, P249; Vogelsang R., 2011, MOPANE TREE HOLOCENE; Wadley L, 1996, J ANTHROPOL ARCHAEOL, V15, P205, DOI 10.1006/jaar.1996.0008; Wadley L, 2000, S AFR ARCHAEOL BULL, V55, P90, DOI 10.2307/3888959; Wadley L., 1979, CIMBEBASIA, V3, P1; Wadley L., 1978, BAR INT SERIES, V25; Wadley L, 2014, S AFR ARCHAEOL BULL, V69, P19; Walker N., 1994, BOTSW NOTES REC, V26, P1; Walker N. J., 1983, S AFRICAN ARCHAEOLOG, V38, P88, DOI DOI 10.2307/3888641; Walker NJ, 1995, STUDIES AFRICAN ARCH; Webley L.E., 1992, SO AFRICAN FIELD ARC, V1, P3; Webley Lita, 2001, Annals of the Eastern Cape Museums, V2, P19; WESTPHAL EOJ, 1963, AFRICA, V33, P237, DOI 10.2307/1157418; White J.P., 1972, MODELS ARCHAEOLOGY P, P275; Wiessner P., 1977, THESIS U MICHIGAN; Wurz S, 1999, S AFR ARCHAEOL BULL, V54, P38, DOI 10.2307/3889138; Yates, 1996, S AFRICAN ARCHAEOLOG, V51, DOI [10.2307/3888927, DOI 10.2307/3888927]; Yellen J.E., 1989, BOTSW NOTES REC, V20, P5; Zvelebil M., 2000, EUROPES 1 FARMERS, P57, DOI DOI 10.1017/CBO9780511607851.004	160	58	59	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0134215	10.1371/journal.pone.0134215	http://dx.doi.org/10.1371/journal.pone.0134215			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CP5MR	26295347	gold, Green Published, Green Submitted			2022-12-27	WOS:000359926900008
J	Sugano, K; Okuyama, T; Iida, S; Komatsu, H; Ishida, T; Kusumoto, S; Uchida, M; Nakaguchi, T; Kubota, Y; Ito, Y; Takahashi, K; Akechi, T				Sugano, Koji; Okuyama, Toru; Iida, Shinsuke; Komatsu, Hirokazu; Ishida, Takashi; Kusumoto, Shigeru; Uchida, Megumi; Nakaguchi, Tomohiro; Kubota, Yosuke; Ito, Yoshinori; Takahashi, Kazuhisa; Akechi, Tatsuo			Medical Decision-Making Incapacity among Newly Diagnosed Older Patients with Hematological Malignancy Receiving First Line Chemotherapy: A Cross-Sectional Study of Patients and Physicians	PLOS ONE			English	Article							MINI-MENTAL-STATE; CANCER-PATIENTS; COGNITIVE IMPAIRMENT; GERIATRIC ASSESSMENT; JAPANESE VERSION; ELDERLY-PATIENTS; DEPRESSION; CAPACITY; COMPETENCE; VALIDITY	Background Decision-making capacity to provide informed consent regarding treatment is essential among cancer patients. The purpose of this study was to identify the frequency of decision-making incapacity among newly diagnosed older patients with hematological malignancy receiving first-line chemotherapy, to examine factors associated with incapacity and assess physicians' perceptions of patients' decision-making incapacity. Methods Consecutive patients aged 65 years or over with a primary diagnosis of malignant lymphoma or multiple myeloma were recruited. Decision-making capacity was assessed using the Structured Interview for Competency and Incompetency Assessment Testing and Ranking Inventory-Revised (SICIATRI-R). Cognitive impairment, depressive condition and other possible associated factors were also evaluated. Results Among 139 eligible patients registered for this study, 114 completed the survey. Of these, 28 (25%, 95% confidence interval [CI]: 17%-32%) were judged as having some extent of decision- making incompetency according to SICIATRI-R. Higher levels of cognitive impairment and increasing age were significantly associated with decision-making incapacity. Physicians experienced difficulty performing competency assessment (Cohen's kappa -0.54). Conclusions Decision-making incapacity was found to be a common and under-recognized problem in older patients with cancer. Age and assessment of cognitive impairment may provide the opportunity to find patients that are at a high risk of showing decision-making incapacity.	[Sugano, Koji; Okuyama, Toru; Uchida, Megumi; Nakaguchi, Tomohiro; Kubota, Yosuke; Ito, Yoshinori; Akechi, Tatsuo] Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Nagoya, Aichi, Japan; [Sugano, Koji; Okuyama, Toru; Uchida, Megumi; Nakaguchi, Tomohiro; Ito, Yoshinori; Akechi, Tatsuo] Nagoya City Univ Hosp, Div Psychooncol & Palliat Care, Nagoya, Aichi, Japan; [Sugano, Koji; Takahashi, Kazuhisa] Juntendo Univ, Fac Med, Div Resp Med, Tokyo, Japan; [Sugano, Koji; Takahashi, Kazuhisa] Grad Sch Med, Tokyo, Japan; [Iida, Shinsuke; Komatsu, Hirokazu; Ishida, Takashi; Kusumoto, Shigeru] Nagoya City Univ, Grad Sch Med Sci, Dept Hematol & Oncol, Nagoya, Aichi, Japan	Nagoya City University; Nagoya City University; Juntendo University	Okuyama, T (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Nagoya, Aichi, Japan.	okuyama@med.nagoya-cu.ac.jp	石田, 高司/GRS-3184-2022	石田, 高司/0000-0002-1060-0777; Okuyama, Toru/0000-0003-0504-6406	Japanese Ministry of Health, Labor and Welfare [H22-009]; Japanese Ministry of Education, Culture, Sports, Science and Technology [23659264]	Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported, in part, by a Grant-in-Aid for Cancer Research [grant number H22-009 to T.A.] from the Japanese Ministry of Health, Labor and Welfare, and a Grant-in Aid for Challenging Exploratory Research [grant number 23659264 to T.A.] from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akechi T, 2015, PALLIAT SUPPORT CARE, V13, P1529, DOI 10.1017/S1478951513000588; Amalraj S, 2009, ONCOLOGY-NY, V23, P369; Appelbaum PS, 2007, NEW ENGL J MED, V357, P1834, DOI 10.1056/NEJMcp074045; Colleoni M, 2000, LANCET, V356, P1326, DOI 10.1016/S0140-6736(00)02821-X; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hindmarch T, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-54; Ideno Y, 2012, GERIATR GERONTOL INT, V12, P310, DOI 10.1111/j.1447-0594.2011.00772.x; Kitamura F, 1998, INT J LAW PSYCHIAT, V21, P223, DOI 10.1016/S0160-2527(98)00016-8; Kitamura T, 2011, STRUCTURED INTERVIEW; Klepin HD, 2006, BONE MARROW TRANSPL, V38, P585, DOI 10.1038/sj.bmt.1705486; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lepping P, 2011, BRIT J PSYCHIAT, V199, P355, DOI 10.1192/bjp.bp.111.094938; Mitchell AJ, 2011, LANCET ONCOL, V12, P160, DOI 10.1016/S1470-2045(11)70002-X; Muramatsu K, 2007, PSYCHOL REP, V101, P952, DOI 10.2466/pr0.101.3.952-960; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Okonkwo O, 2007, NEUROLOGY, V69, P1528, DOI 10.1212/01.wnl.0000277639.90611.d9; Page K, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-10; Pal SK, 2010, CA-CANCER J CLIN, V60, P120, DOI 10.3322/caac.20059; Plassman BL, 2008, ANN INTERN MED, V148, P427, DOI 10.7326/0003-4819-148-6-200803180-00005; Puts MTE, 2012, JNCI-J NATL CANCER I, V104, P1133, DOI 10.1093/jnci/djs285; Repetto L, 1998, CANCER, V82, P760, DOI 10.1002/(SICI)1097-0142(19980215)82:4<760::AID-CNCR20>3.0.CO;2-V; Repetto L, 2003, EUR J CANCER, V39, P870, DOI 10.1016/S0959-8049(03)00062-5; Sessums LL, 2011, JAMA-J AM MED ASSOC, V306, P420, DOI 10.1001/jama.2011.1023; Tomoda A, 1997, J CLIN PSYCHOL, V53, P443, DOI 10.1002/(SICI)1097-4679(199708)53:5<443::AID-JCLP4>3.0.CO;2-O; Weinberger MI, 2011, INT J GERIATR PSYCH, V26, P21, DOI 10.1002/gps.2497; Zachariae R, 2003, BRIT J CANCER, V88, P658, DOI 10.1038/sj.bjc.6600798	28	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136163	10.1371/journal.pone.0136163	http://dx.doi.org/10.1371/journal.pone.0136163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26296202	Green Submitted, Green Published, gold			2022-12-27	WOS:000359926900078
J	Sutton, J; Ben Gibson, C; Spiro, ES; League, C; Fitzhugh, SM; Butts, CT				Sutton, Jeannette; Ben Gibson, C.; Spiro, Emma S.; League, Cedar; Fitzhugh, Sean M.; Butts, Carter T.			What it Takes to Get Passed On: Message Content, Style, and Structure as Predictors of Retransmission in the Boston Marathon Bombing Response	PLOS ONE			English	Article							TERRORISM; COMMUNICATION; INFORMATION; DIFFUSION; EVENTS; TWEETS; RUMOR; NEWS	Message retransmission is a central aspect of information diffusion. In a disaster context, the passing on of official warning messages by members of the public also serves as a behavioral indicator of message salience, suggesting that particular messages are (or are not) perceived by the public to be both noteworthy and valuable enough to share with others. This study provides the first examination of terse message retransmission of official warning messages in response to a domestic terrorist attack, the Boston Marathon Bombing in 2013. Using messages posted from public officials' Twitter accounts that were active during the period of the Boston Marathon bombing and manhunt, we examine the features of messages that are associated with their retransmission. We focus on message content, style, and structure, as well as the networked relationships of message senders to answer the question: what characteristics of a terse message sent under conditions of imminent threat predict its retransmission among members of the public? We employ a negative binomial model to examine how message characteristics affect message retransmission. We find that, rather than any single effect dominating the process, retransmission of official Tweets during the Boston bombing response was jointly influenced by various message content, style, and sender characteristics. These findings suggest the need for more work that investigates impact of multiple factors on the allocation of attention and on message retransmission during hazard events.	[Sutton, Jeannette] Univ Kentucky, Dept Commun, Lexington, KY USA; [Ben Gibson, C.; Fitzhugh, Sean M.; Butts, Carter T.] Univ Calif Irvine, Dept Sociol, Irvine, CA 92697 USA; [Spiro, Emma S.] Univ Washington, Informat Sch, Seattle, WA 98195 USA; [League, Cedar] Univ Colorado, Trauma Hlth & Hazards Ctr, Colorado Springs, CO 80907 USA; [Butts, Carter T.] Univ Calif Irvine, Dept Stat, Irvine, CA USA; [Butts, Carter T.] Univ Calif Irvine, Dept Elect Engn & Comp Sci, Irvine, CA USA; [Butts, Carter T.] Univ Calif Irvine, Inst Math Behav Sci, Irvine, CA USA	University of Kentucky; University of California System; University of California Irvine; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado at Colorado Springs; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Butts, CT (corresponding author), Univ Calif Irvine, Dept Sociol, Irvine, CA 92697 USA.	buttsc@uci.edu			National Science Foundation [CMMI-1031853, CMMI-1031779, IIS-1251267]; Office of Naval Research [N00014-08-1-1015]	National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research)	This work was supported by National Science Foundation awards CMMI-1031853 (CTB) and CMMI-1031779 (JS), and IIS-1251267 and by Office of Naval Research award N00014-08-1-1015 (CTB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel F, 2011, LECT NOTES COMPUT SC, V6787, P1, DOI 10.1007/978-3-642-22362-4_1; [Anonymous], 1991, STRESS COPING ANTHOL; Arkes H. R., 1989, J BEHAVIORAL DECISIO, V2, P81, DOI [10.1002/bdm.3960020203, DOI 10.1002/BDM.3960020203]; Banks WC, 2007, COMBATING TERRORISM; BANTZ CR, 1983, Q J SPEECH, V69, P317, DOI 10.1080/00335638309383658; Blumer Herbert, 1951, NEW OUTLINE PRINCIPL, P166; Boyd D., 2010, 43 HAW INT C SYST SC, V2010, P1, DOI DOI 10.1109/HICSS.2010.412; Bruns A., 2011, 6 EUR CONS POL RES G; CAMERON AC, 1990, J ECONOMETRICS, V46, P347, DOI 10.1016/0304-4076(90)90014-K; Centola D, 2007, AM J SOCIOL, V113, P702, DOI 10.1086/521848; Cheong M, 2011, INFORM SYST FRONT, V13, P45, DOI 10.1007/s10796-010-9273-x; Covello V, 2010, EFFECTIVE RISK COMMU; Danzig ER, 1958, NATL ACAD SCI PUBLIC, V517; Drabek TE, 1999, SOC SCI J, V36, P515, DOI 10.1016/S0362-3319(99)00021-X; Duggan M., 2013, CELL PHONE ACTIVITIE; Duggan M SA, 2013, SOCIAL MEDIA UPDATE; ERICKSON BH, 1978, CAN J SOCIOL, V3, P71, DOI 10.2307/3339794; Federation NA, 2014, CLIN VIOLENCE; GREENBERG BS, 1964, PUBLIC OPIN QUART, V28, P225, DOI 10.1086/267239; Griffin-Padgett DR, 2010, COMMUN MONOGR, V77, P376, DOI 10.1080/03637751.2010.502536; Hawkins SA, 2001, J CONSUM PSYCHOL, V11, P1, DOI 10.1207/S15327663JCP1101_1; Huan-Kai Peng, 2011, 2011 IEEE International Conference on Data Mining Workshops, P336, DOI 10.1109/ICDMW.2011.146; Jiang Zhu, 2011, 2011 IEEE Global Humanitarian Technology Conference, P431, DOI 10.1109/GHTC.2011.48; Junior JPS, 2012, LECT NOTES COMPUTER, P719; Kaniasty K., 2004, BIOTERRORISM PSYCHOL, V3, P200; Kwon K., 2012, AIS T HUMAN COMPUTER, V4, P212; Lee J, 2015, INFORM SYST FRONT, V17, P997, DOI 10.1007/s10796-015-9568-z; Lindell M.K., 1987, INT J MASS EMERGENCI, V5, P137; Mayhorn CB, 2014, SAFETY SCI, V61, P43, DOI 10.1016/j.ssci.2012.04.014; Mileti D, 2012, FEMA NATL CONSORTIUM; Mileti D. S., 1991, SOCIOL PRACT REV, V2, P20; Mileti D. S., 1990, LANDSLIDES, V1, P6; MILETI DS, 1995, INT J MASS EMERGENCI, V0013; Naveed N., 2011, P 3 INT WEB SCI C; News C, 2013, BOST MAR NO PHON TEX; News C, 2013, SOCIAL MEDIA PLAYED; News NG, 2013, SOC MED SHAP BOST BO; Oh O, 2013, MIS QUART, V37, P407, DOI 10.25300/MISQ/2013/37.2.05; Oh O, 2011, INFORM SYST FRONT, V13, P33, DOI 10.1007/s10796-010-9275-8; RICHARDSON RJ, 1979, CAN J SOCIOL, V4, P379, DOI 10.2307/3340260; ROSNOW RL, 1986, LANG COMMUN, V6, P189, DOI 10.1016/0271-5309(86)90022-4; Ruggiero A, 2013, J CONTING CRISIS MAN, V21, P153, DOI 10.1111/1468-5973.12022; Sattler D, 2003, SPECIAL PUBLICATION, P315; SCANLON TJ, 1977, MASS EMERGENCIES, V2, P121; Science N, 2008, RES CHALLENGES COMBA; Sellnow T., 2010, REV COMMUNICATION, V10, P112, DOI [10.1080/15358590903402200, DOI 10.1080/15358590903402200]; Sellnow TL, 2012, RISK ANAL, V32, P633, DOI 10.1111/j.1539-6924.2011.01634.x; Sellnow TL, 2009, FOOD MICROBIOL FOOD, P3, DOI 10.1007/978-0-387-79727-4_1; Sheppard B, 2011, J HOMEL SECUR EMERG, V8, DOI 10.2202/1547-7355.1840; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Slovic P, 2002, RISK ANAL, V22, P425, DOI 10.1111/0272-4332.00053; Sorensen J. H., 2000, NAT HAZARDS REV, V1, P119, DOI [10.1061/(ASCE)1527-6988(2000)1:2(119)., 10.1061/(ASCE)1527-6988(2000)1:2(119), DOI 10.1061/(ASCE)1527-6988(2000)1:2(119)]; Spiro E, 2013, FOLLOWING BOMBING; St Denis LA, 2013, P 11 INT C INF SYST; Starbird K, 2010, P 7 INT COMM INF SYS; Stephens KK, 2013, HUM COMMUN RES, V39, P230, DOI 10.1111/hcre.12002; Stephens KK, 2014, P 11 INT C INF SYST; Suh B, 2010, 2010 IEEE 2 INT C SO, V2, P177, DOI [10.1109/SocialCom.2010.33, DOI 10.1109/SOCIALCOM.2010.33]; Sutton Jeannette, 2013, International Journal of Information Systems for Crisis Response and Management, V5, P58, DOI 10.4018/jiscrm.2013010104; Sutton J, 2014, P 11 INT C INF SYST; Sutton J, 2014, INFORM COMMUN SOC, V17, P765, DOI 10.1080/1369118X.2013.862561; Team RC, 2014, R LANG ENV STAT COMP; Tepper M., 2012, P 21 ACM INT C INF K, P1602, DOI DOI 10.1145/2396761.2398481; Turner R.H., 1987, COLLECTIVE BEHAV, V3rd ed.; Updegraff JA, 2000, LOSS TRAUMA GEN CLOS, P3, DOI DOI 10.4324/9781315783345-2; Vogt BM, 1992, PREPARING EBS MESSAG; Xie S, 2014, COGN COMPUT, P1; Yin R.K., 2009, CASE STUDY RES DESIG, V4th ed., DOI [10.33524/cjar.v14i1.73, DOI 10.33524/CJAR.V14I1.73]; Zaman T, 2014, ANN APPL STAT, V8, P1583, DOI 10.1214/14-AOAS741	69	48	48	7	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0134452	10.1371/journal.pone.0134452	http://dx.doi.org/10.1371/journal.pone.0134452			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26295584	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900010
J	Zhuo, Z; Lamont, SJ; Lee, WR; Abasht, B				Zhuo, Zhu; Lamont, Susan J.; Lee, William R.; Abasht, Behnam			RNA-Seq Analysis of Abdominal Fat Reveals Differences between Modern Commercial Broiler Chickens with High and Low Feed Efficiencies	PLOS ONE			English	Article							STEAROYL-COA DESATURASE; ADIPOSE-TISSUE; GENE-EXPRESSION; IN-VIVO; CHOLESTEROL-METABOLISM; GALLUS-DOMESTICUS; BODY-COMPOSITION; WEIGHT-GAIN; LIPOGENESIS; DIFFERENTIATION	For economic and environmental reasons, chickens with superior feed efficiency (FE) are preferred in the broiler chicken industry. High FE (HFE) chickens typically have reduced abdominal fat, the major adipose tissue in chickens. In addition to its function of energy storage, adipose tissue is a metabolically active organ that also possesses endocrine and immune regulatory functions. It plays a central role in maintaining energy homeostasis. Comprehensive understanding of the gene expression in the adipose tissue and the biological basis of FE are of significance to optimize selection and breeding strategies. Through gene expression profiling of abdominal fat from high and low FE (LFE) commercial broiler chickens, the present study aimed to characterize the differences of gene expression between HFE and LFE chickens. mRNA-seq analysis was carried out on the total RNA of abdominal fat from 10 HFE and 12 LFE commercial broiler chickens, and 1.48 billion of 75-base sequence reads were generated in total. On average, 11,565 genes were expressed (> 5 reads/gene/sample) in the abdominal fat tissue, of which 286 genes were differentially expressed (DE) at q (False Discover Rate) < 0.05 and fold change > 1.3 between HFE and LFE chickens. Expression levels from RNA-seq were confirmed with the NanoString nCounter analysis system. Functional analysis showed that the DE genes were significantly (p < 0.01) enriched in lipid metabolism, coagulation, and immune regulation pathways. Specifically, the LFE chickens had higher expression of lipid synthesis genes and lower expression of triglyceride hydrolysis and cholesterol transport genes. In conclusion, our study reveals the overall differences of gene expression in the abdominal fat from HFE and LFE chickens, and the results suggest that the divergent expression of lipid metabolism genes represents the major differences.	[Zhuo, Zhu; Abasht, Behnam] Univ Delaware, Dept Anim & Food Sci, Newark, DE 19711 USA; [Lamont, Susan J.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Lee, William R.] Maple Leaf Farms Inc, Leesburg, IN USA	University of Delaware; Iowa State University	Abasht, B (corresponding author), Univ Delaware, Dept Anim & Food Sci, Newark, DE 19711 USA.	abasht@udel.edu	z, z/GXZ-4805-2022; Z, Z/AEN-2153-2022; z, z/HHN-3970-2022		Delaware Bioscience Center for Advanced Technology; Heritage Breeders, LLC; Maple Leaf Farms, Inc.	Delaware Bioscience Center for Advanced Technology; Heritage Breeders, LLC; Maple Leaf Farms, Inc.	This work was funded by Delaware Bioscience Center for Advanced Technology and Heritage Breeders, LLC. Phenotypic data were collected at Heritage Breeders, LLC. Maple Leaf Farms, Inc. provided support in the form of salaries for author William R. Lee, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Birsoy K, 2008, P NATL ACAD SCI USA, V105, P12985, DOI 10.1073/pnas.0805621105; Bottje W, 2013, J ANIM SCI, V91, P1582, DOI 10.2527/jas.2012-5787; Bottje WG, 2012, POULTRY SCI, V91, P2576, DOI 10.3382/ps.2012-02204; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CARTWRIGHT AL, 1991, J NUTR, V121, P1486, DOI 10.1093/jn/121.9.1486; Daval S, 2000, GENET SEL EVOL, V32, P521, DOI 10.1051/gse:2000134; De Verdal H, 2010, 9 WORLD C GEN APPL L, P1; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; DOUAIRE M, 1992, POULTRY SCI, V71, P1911, DOI 10.3382/ps.0711911; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; GRIFFIN HD, 1992, J NUTR, V122, P363, DOI 10.1093/jn/122.2.363; Hausman GJ, 2014, ADIPOCYTE, V3, P297, DOI 10.4161/adip.29252; Heinemann FS, 2003, PROSTAG LEUKOTR ESS, V68, P123, DOI 10.1016/S0952-3278(02)00262-4; HOOD RL, 1982, POULTRY SCI, V61, P117, DOI 10.3382/ps.0610117; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Ji B, 2014, PHYSIOL GENOMICS, V46, P315, DOI 10.1152/physiolgenomics.00163.2013; Ji B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-441; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kong BW, 2011, POULTRY SCI, V90, P2535, DOI 10.3382/ps.2011-01435; KOVANEN PT, 1975, J LIPID RES, V16, P211; KRAUSE BR, 1984, J LIPID RES, V25, P97; LEVEILLE GA, 1968, P SOC EXP BIOL MED, V128, P398; Li JH, 2014, J BIOL CHEM, V289, P747, DOI 10.1074/jbc.M113.534172; Li JP, 2003, P NATL ACAD SCI USA, V100, P9476, DOI 10.1073/pnas.1133426100; MacLaren RE, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-3; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; Mathews ST, 2002, DIABETES, V51, P2450, DOI 10.2337/diabetes.51.8.2450; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Mutryn MF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1623-0; OHEA EK, 1968, COMP BIOCHEM PHYSIOL, V26, P111, DOI 10.1016/0010-406X(68)90317-4; PYM RAE, 1979, BRIT POULTRY SCI, V20, P87, DOI 10.1080/00071667908416552; Resnyk CW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-557; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Sato K, 2009, ANIM SCI J, V80, P322, DOI 10.1111/j.1740-0929.2009.00639.x; SHRAGO E, 1976, AM J CLIN NUTR, V29, P540, DOI 10.1093/ajcn/29.5.540; Simon J., 1988, Leanness in domestic birds: genetic, metabolic and hormonal aspects., P258; SIMON J, 1989, Critical Reviews in Poultry Biology, V2, P121; THOMAS CH, 1958, POULTRY SCI, V37, P862, DOI 10.3382/ps.0370862; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Wang HB, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-193; WASHBURN KW, 1975, J NUTR, V105, P1311, DOI 10.1093/jn/105.10.1311; Wu Y, 2010, MECH DEVELOP, V127, P183, DOI 10.1016/j.mod.2009.12.003; Yoo W, 2010, BIOCHEM BIOPH RES CO, V397, P170, DOI 10.1016/j.bbrc.2010.05.067; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4; Zhou N, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1364-0	50	41	41	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135810	10.1371/journal.pone.0135810	http://dx.doi.org/10.1371/journal.pone.0135810			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295149	gold, Green Submitted, Green Published			2022-12-27	WOS:000359926900043
J	McCormick, N; Bhole, V; Lacaille, D; Avina-Zubieta, JA				McCormick, Natalie; Bhole, Vidula; Lacaille, Diane; Avina-Zubieta, J. Antonio			Validity of Diagnostic Codes for Acute Stroke in Administrative Databases: A Systematic Review	PLOS ONE			English	Review							ACUTE ISCHEMIC-STROKE; HOSPITAL DISCHARGE REGISTER; BRAIN ATTACK SURVEILLANCE; ACUTE TREATMENT COSTS; CASE-FATALITY; ICD-9 CODES; INTERNATIONAL-CLASSIFICATION; INTRACEREBRAL HEMORRHAGE; INTRACRANIAL HEMORRHAGE; CEREBROVASCULAR EVENTS	Objective To conduct a systematic review of studies reporting on the validity of International Classification of Diseases (ICD) codes for identifying stroke in administrative data. Methods MEDLINE and EMBASE were searched (inception to February 2015) for studies: (a) Using administrative data to identify stroke; or (b) Evaluating the validity of stroke codes in administrative data; and (c) Reporting validation statistics (sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), or Kappa scores) for stroke, or data sufficient for their calculation. Additional articles were located by hand search (up to February 2015) of original papers. Studies solely evaluating codes for transient ischaemic attack were excluded. Data were extracted by two independent reviewers; article quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies tool. Results Seventy-seven studies published from 1976-2015 were included. The sensitivity of ICD-9 430-438/ICD-10 I60-I69 for any cerebrovascular disease was >= 82% in most [>= 50%] studies, and specificity and NPV were both >= 95%. The PPV of these codes for any cerebrovascular disease was >= 81% in most studies, while the PPV specifically for acute stroke was >= 68%. In at least 50% of studies, PPVs were >= 93% for subarachnoid haemorrhage (ICD-9 430/ICD-10 I60), 89% for intracerebral haemorrhage (ICD-9 431/ICD-10 I61), and 82% for ischaemic stroke (ICD-9 434/ICD-10 I63 or ICD-9 434&436). For in-hospital deaths, sensitivity was 55%. For cerebrovascular disease or acute stroke as a cause-of-death on death certificates, sensitivity was >= 71% in most studies while PPV was >= 87%. Conclusions While most cases of prevalent cerebrovascular disease can be detected using 430-438/I60-I69 collectively, acute stroke must be defined using more specific codes. Most in-hospital deaths and death certificates with stroke as a cause-of-death correspond to true stroke deaths. Linking vital statistics and hospitalization data may improve the ascertainment of fatal stroke.	[McCormick, Natalie] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [McCormick, Natalie; Bhole, Vidula; Lacaille, Diane; Avina-Zubieta, J. Antonio] Arthrit Res Canada, Richmond, BC, Canada; [Lacaille, Diane; Avina-Zubieta, J. Antonio] Univ British Columbia, Dept Med, Div Rheumatol, Vancouver, BC, Canada; [Lacaille, Diane; Avina-Zubieta, J. Antonio] CANRAD Network, Cardiovasc Comm, Richmond, BC, Canada	University of British Columbia; Arthritis Research Canada; University of British Columbia	Avina-Zubieta, JA (corresponding author), Arthrit Res Canada, Richmond, BC, Canada.	azubieta@arthritisresearch.ca		McCormick, Natalie/0000-0002-4147-8348	Canadian Arthritis Network; Canadian Institutes of Health Research; Arthritis Society of Canada; Michael Smith Foundation for Health Research	Canadian Arthritis Network; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Arthritis Society of Canada; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This study was funded by the Canadian Arthritis Network (http://www.canradnetwork.ca). Natalie McCormick is supported by a Doctoral Research Award from the Canadian Institutes of Health Research. J. Antonio Avina-Zubieta held a salary award from the Canadian Arthritis Network and The Arthritis Society of Canada. He is currently the British Columbia Lupus Society Scholar and holds a Scholar Award from the Michael Smith Foundation for Health Research. Diane Lacaille holds the Mary Pack Chair in Arthritis Research from UBC and The Arthritis Society of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboa-Eboule C, 2013, J NEUROL, V260, P605, DOI 10.1007/s00415-012-6686-0; Agrawal N, 2009, STROKE, V40, P3415, DOI 10.1161/STROKEAHA.109.564633; Andrade SE, 2012, PHARMACOEPIDEM DR S, V21, P100, DOI 10.1002/pds.2312; Appelros P, 2011, ACTA NEUROL SCAND, V123, P289, DOI 10.1111/j.1600-0404.2010.01402.x; Appelros P, 2014, CEREBROVASC DIS, V37, P22, DOI 10.1159/000356346; Arnason T, 2006, THROMB RES, V118, P253, DOI 10.1016/j.thromres.2005.06.015; Asi T, 2011, CLIN NEUROL NEUROSUR, V113, P111, DOI 10.1016/j.clineuro.2010.09.014; Barber C, 2013, ARTHRIT CARE RES, V65, P1343, DOI 10.1002/acr.21959; Benesch C, 1997, NEUROLOGY, V49, P660, DOI 10.1212/WNL.49.3.660; Bernatsky S, 2013, J RHEUMATOL, V40, P66, DOI 10.3899/jrheum.120835; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; BLOTH B, 1976, ACTA MED SCAND, V200, P281; Borzecki AM, 2004, AM J MED QUAL, V19, P201, DOI 10.1177/106286060401900504; Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415; Brown DL, 2007, AM J EPIDEMIOL, V165, P591, DOI 10.1093/aje/kwk042; Chen GM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-5; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Christensen MC, 2009, ACTA NEUROL SCAND, V119, P246, DOI 10.1111/j.1600-0404.2008.01094.x; Christensen MC, 2008, NEUROEPIDEMIOLOGY, V30, P239, DOI 10.1159/000128323; Christensen MC, 2009, NEUROEPIDEMIOLOGY, V32, P142, DOI 10.1159/000184747; Davenport R J, 1996, Health Bull (Edinb), V54, P402; Demant MN, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-156; Derby CA, 2000, STROKE, V31, P875, DOI 10.1161/01.STR.31.4.875; Derby CA, 2001, STROKE, V32, P1487, DOI 10.1161/01.STR.32.7.1487; Dodel RC, 2004, VALUE HEALTH, V7, P144, DOI 10.1111/j.1524-4733.2004.72314.x; Ellekjaer H, 1999, STROKE, V30, P56, DOI 10.1161/01.STR.30.1.56; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Gaist D, 2000, BRIT MED J, V320, P141, DOI 10.1136/bmj.320.7228.141; Ghia D, 2010, NEUROEPIDEMIOLOGY, V35, P53, DOI 10.1159/000310338; Gioldasis G, 2008, ACTA NEUROL SCAND, V118, P268, DOI 10.1111/j.1600-0404.2008.01014.x; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; Golomb MR, 2006, NEUROLOGY, V67, P2053, DOI 10.1212/01.wnl.0000247281.98094.e2; Goulart AC, 2012, J STROKE CEREBROVASC, V21, P832, DOI 10.1016/j.jstrokecerebrovasdis.2011.04.017; Haesebaert J, 2013, STROKE, V44, P1770, DOI 10.1161/STROKEAHA.113.001300; Hasan M, 1995, INT J QUAL HEALTH C, V7, P407, DOI 10.1093/intqhc/7.4.407; Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314; Henderson T, 2006, MED CARE, V44, P1011, DOI 10.1097/01.mlr.0000228018.48783.34; Hennessy DA, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-99; Holick CN, 2009, J CLIN PSYCHOPHARM, V29, P453, DOI 10.1097/JCP.0b013e3181b2b828; Holloway RG, 1996, NEUROLOGY, V46, P854; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; Hudson M, 2013, J CLIN EPIDEMIOL, V66, P278, DOI 10.1016/j.jclinepi.2012.10.004; Humphries KH, 2000, J CLIN EPIDEMIOL, V53, P343, DOI 10.1016/S0895-4356(99)00188-2; ISO H, 1990, AM J EPIDEMIOL, V132, P993, DOI 10.1093/oxfordjournals.aje.a115742; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Johnsen SP, 2002, J CLIN EPIDEMIOL, V55, P602, DOI 10.1016/S0895-4356(02)00391-8; Jones SA, 2014, STROKE, V45, P3219, DOI 10.1161/STROKEAHA.114.006316; Kirkman MA, 2009, ACTA NEUROL BELG, V109, P114; Klatsky AL, 2005, NEUROEPIDEMIOLOGY, V25, P26, DOI 10.1159/000085310; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Koster M, 2013, NEUROEPIDEMIOLOGY, V40, P240, DOI 10.1159/000345953; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Kumamaru H, 2014, CIRC-CARDIOVASC QUAL, V7, P611, DOI 10.1161/CIRCOUTCOMES.113.000743; Lakshminarayan K, 2014, STROKE, V45, P815, DOI 10.1161/STROKEAHA.113.003408; Lakshminarayan K, 2009, AM J EPIDEMIOL, V169, P1070, DOI 10.1093/aje/kwp029; Lambert L, 2012, CAN J CARDIOL, V28, P162, DOI 10.1016/j.cjca.2011.10.005; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Lee WC, 2007, ADV THER, V24, P258, DOI 10.1007/BF02849893; Lee WC, 2007, CEREBROVASC DIS, V23, P57, DOI 10.1159/000096542; LEIBSON CL, 1994, STROKE, V25, P2348, DOI 10.1161/01.STR.25.12.2348; Lentine KL, 2009, CLIN J AM SOC NEPHRO, V4, P1213, DOI 10.2215/CJN.00670109; Leone MA, 2004, NEUROL SCI, V25, P281, DOI 10.1007/s10072-004-0355-8; Leong A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075256; Leppala JM, 1999, EUR J EPIDEMIOL, V15, P155, DOI 10.1023/A:1007504310431; Levy AR, 1999, CAN J CARDIOL, V15, P1277; LINDBLAD U, 1993, SCAND J SOC MED, V21, P3, DOI 10.1177/140349489302100102; Liu LY, 1999, CEREBROVASC DIS, V9, P224, DOI 10.1159/000015960; Mayo N, 1993, CAN J CARDIOL SD, V9, p121D; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104519; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092286; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Newton KM, 1999, J CLIN EPIDEMIOL, V52, P199, DOI 10.1016/S0895-4356(98)00161-9; Olson KL, 2014, AM J MANAG CARE, V20, pE27; Palmieri L, 2007, CEREBROVASC DIS, V24, P530, DOI 10.1159/000110423; Phillips S, 1993, CAN J CARDIOL SD, V9, p124D; Piriyawat P, 2002, AM J EPIDEMIOL, V156, P1062, DOI 10.1093/aje/kwf152; Ramalle-Gomara E, 2013, NEUROEPIDEMIOLOGY, V41, P185, DOI 10.1159/000354626; Rampatige R, 2013, HEALTH INF MANAG J, V42, P20, DOI 10.1177/183335831304200302; Rao C, 2007, INT J EPIDEMIOL, V36, P642, DOI 10.1093/ije/dym003; Reed SD, 2001, NEUROLOGY, V57, P305, DOI 10.1212/WNL.57.2.305; REGGIO A, 1995, ITAL J NEUROL SCI, V16, P567, DOI 10.1007/BF02282916; Reker DM, 2001, J REHABIL RES DEV, V38, P281; Rinaldi R, 2003, NEUROL SCI, V24, P65, DOI 10.1007/s100720300074; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Rossnagel K, 2005, EUR J NEUROL, V12, P862, DOI 10.1111/j.1468-1331.2005.01091.x; Rournie CL, 2008, PHARMACOEPIDEM DR S, V17, P20, DOI 10.1002/pds.1518; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Saka O, 2009, AGE AGEING, V38, P27, DOI 10.1093/ageing/afn281; SARTI C, 1994, J CLIN EPIDEMIOL, V47, P1259, DOI 10.1016/0895-4356(94)90131-7; SHAHAR E, 1995, STROKE, V26, P1; Singh B, 2012, MAYO CLIN PROC, V87, P817, DOI 10.1016/j.mayocp.2012.04.015; Sinha S, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-74; Skolarus LE, 2014, STROKE, V45, P224, DOI 10.1161/STROKEAHA.113.002874; So L, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-161; Soo Martin, 2014, BMC Res Notes, V7, P253, DOI 10.1186/1756-0500-7-253; Spolaore P, 2005, STROKE, V36, P1031, DOI 10.1161/01.STR.0000160755.94884.4a; Sprigg N, 2013, STROKE, V44, P3458, DOI 10.1161/STROKEAHA.113.002201; STEGMAYR B, 1992, NEUROEPIDEMIOLOGY, V11, P204, DOI 10.1159/000110933; Sun Y, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-133; SZCZESNIEWSKA D, 1990, REV EPIDEMIOL SANTE, V38, P435; Thigpen JL, 2015, CIRC-CARDIOVASC QUAL, V8, P8, DOI 10.1161/CIRCOUTCOMES.113.000371; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Tolonen H, 2007, EUR J CARDIOV PREV R, V14, P380, DOI 10.1097/01.hjr.0000239466.26132.f2; Tu K, 2013, CAN J CARDIOL, V29, P1388, DOI 10.1016/j.cjca.2013.07.676; Vagal A, 2014, STROKE, V45, P1029, DOI 10.1161/STROKEAHA.113.004332; Wahl PM, 2010, PHARMACOEPIDEM DR S, V19, P596, DOI 10.1002/pds.1924; Wang GJ, 2014, J STROKE CEREBROVASC, V23, P861, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.017; Wei JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013041; Weinfeld, 1981, STROKE S1, V12, pI13; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Widdifield J, 2013, ARTHRIT CARE RES, V65, P1490, DOI 10.1002/acr.21993; Wildenschild C, 2014, CLIN EPIDEMIOL, V6, P27, DOI 10.2147/CLEP.S50449; Wu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112257; Yoneda Y, 2005, HEALTH POLICY, V73, P202, DOI 10.1016/j.healthpol.2004.11.016	116	230	230	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135834	10.1371/journal.pone.0135834	http://dx.doi.org/10.1371/journal.pone.0135834			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5KH	26292280	gold, Green Submitted, Green Published			2022-12-27	WOS:000359919900035
J	He, XY; Zhao, MF; Chen, JY; Wu, RM; Zhang, JL; Cui, R; Jiang, YY; Chen, J; Cao, XL; Xing, Y; Zhang, YC; Meng, JX; Deng, Q; Sui, T				He, Xiaoyuan; Zhao, Mingfeng; Chen, Jinyan; Wu, Rimao; Zhang, Jianlei; Cui, Rui; Jiang, Yanyu; Chen, Jie; Cao, Xiaoli; Xing, Yi; Zhang, Yuchen; Meng, Juanxia; Deng, Qi; Sui, Tao			Overexpression of Both ERG11 and ABC2 Genes Might Be Responsible for Itraconazole Resistance in Clinical Isolates of Candida krusei	PLOS ONE			English	Article							AZOLE RESISTANCE; FLUCONAZOLE RESISTANCE; ANTIFUNGAL AGENTS; MECHANISMS; EPIDEMIOLOGY; ALBICANS; SUBSTITUTIONS; VORICONAZOLE; TRANSPORTER; TROPICALIS	Objective To study the main molecular mechanisms responsible for itraconazole resistance in clinical isolates of Candida krusei. Methods The 14 alpha-demethylases encoded by ERG11 gene in the 16 C. krusei clinical isolates were amplified by polymerase chain reaction (PCR), and their nucleotide sequences were determined to detect point mutations. Meanwhile, ERG11 and efflux transporters (ABC1 and ABC2) genes were determined by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) for their expression in itraconazole-resistant (R), itraconazole-susceptible dose dependent (SDD) and itraconazole-susceptible (S) C. krusei at the mRNA level. Results We found 7-point mutations in ERG11 gene of all the C. krusei clinical isolates, including 6 synonymous mutations and 1 missense mutation (C44T). However, the missense mutation was found in the three groups. The mRNA levels of ERG11 gene in itraconazole-resistant isolates showed higher expression compared with itraconazole-susceptible dose dependent and itraconazole-susceptible ones (P = 0.015 and P = 0.002 respectively). ABC2 gene mRNA levels in itraconazole-resistant group was significantly higher than the other two groups, and the levels of their expression in the isolates appeared to increase with the decrease of susceptibility to itraconazole (P = 0.007 in SDD compared with S, P = 0.016 in SDD with R, and P<0.001 in S with R respectively). While ABC1 gene presented lower expression in itraconazole resistant strains. However, the mRNA levels of ERG11, ABC1 and ABC2 in a C. krusei (CK10) resistant to both itraconazole and voriconazole were expressed highest in all the itraconazole-resistant isolates. Conclusions There are ERG11 gene polymorphisms in clinical isolates of C. krusei. ERG11 gene mutations may not be involved in the development of itraconazole resistance in C. krusei. ERG11 and ABC2 overexpression might be responsible for the acquired itraconazole resistance of these clinical isolates.	[He, Xiaoyuan; Zhao, Mingfeng; Wu, Rimao; Cui, Rui; Jiang, Yanyu; Chen, Jie; Cao, Xiaoli; Xing, Yi; Zhang, Yuchen; Meng, Juanxia; Deng, Qi; Sui, Tao] Tianjin Med Univ, Cent Clin Coll 1, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R China; [Chen, Jinyan; Zhang, Jianlei] Tianjin First Cent Hosp, Dept Clin Lab, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Zhao, MF (corresponding author), Tianjin Med Univ, Cent Clin Coll 1, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R China.	zmfzmf@hotmail.com	Zhang, Yuchen/GYI-8858-2022		National Natural Sciences Foundation of China [81041043, 81400092]; National Natural Science Foundation of Tianjin [13JCYBJC23400]; Science and Technique Foundation of Tianjin [13KG106]; Tianjin Medical University and Tianjin First Central Hospital	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Tianjin; Science and Technique Foundation of Tianjin; Tianjin Medical University and Tianjin First Central Hospital	This study was supported by the National Natural Sciences Foundation of China (81041043, 81400092), the National Natural Science Foundation of Tianjin (13JCYBJC23400), and Science and Technique Foundation of Tianjin (13KG106), as well as Tianjin Medical University and Tianjin First Central Hospital.	Barry AL, 2000, J CLIN MICROBIOL, V38, P3457, DOI 10.1128/JCM.38.9.3457-3459.2000; Bondaryk M, 2013, POSTEP DERM ALERGOL, V30, P293, DOI 10.5114/pdia.2013.38358; Chen LM, 2010, J INT MED RES, V38, P536, DOI 10.1177/147323001003800216; CLSI, 2008, M27A3 CLSI; Cornistein W, 2013, ENFERM INFEC MICR CL, V31, P380, DOI 10.1016/j.eimc.2012.09.011; Costa E, 2010, J HOSP INFECT, V75, P240, DOI 10.1016/j.jhin.2010.03.001; Guinea J, 2006, MED MYCOL, V44, P575, DOI 10.1080/13693780600561544; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Jiang C, 2013, J ANTIMICROB CHEMOTH, V68, P778, DOI 10.1093/jac/dks481; Katiyar SK, 2001, MED MYCOL, V39, P109, DOI 10.1080/mmy.39.1.109.116; Lamping E, 2009, ANTIMICROB AGENTS CH, V53, P354, DOI 10.1128/AAC.01095-08; Morio F, 2010, DIAGN MICR INFEC DIS, V66, P373, DOI 10.1016/j.diagmicrobio.2009.11.006; Orozco AS, 1998, ANTIMICROB AGENTS CH, V42, P2645, DOI 10.1128/AAC.42.10.2645; Pfaller MA, 2007, J CLIN MICROBIOL, V45, P3522, DOI 10.1128/JCM.00403-07; Ricardo E, 2014, ANTIMICROB AGENTS CH, V58, P4604, DOI 10.1128/AAC.02603-14; Sanguinetti M, 2005, ANTIMICROB AGENTS CH, V49, P668, DOI 10.1128/AAC.49.2.668-679.2005; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; Silva NC, 2014, MYCOSES, V57, P1, DOI 10.1111/myc.12095; Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x; Strzelczyk JK, 2013, ACTA BIOCHIM POL, V60, P547; Tavakoli M, 2010, DARU, V18, P276; Vandeputte P, 2005, ANTIMICROB AGENTS CH, V49, P4608, DOI 10.1128/AAC.49.11.4608-4615.2005; Venkateswarlu K, 1996, ANTIMICROB AGENTS CH, V40, P2443, DOI 10.1128/AAC.40.11.2443; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114004	24	9	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136185	10.1371/journal.pone.0136185	http://dx.doi.org/10.1371/journal.pone.0136185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308936	gold, Green Submitted, Green Published			2022-12-27	WOS:000360069400093
J	Rangsin, R; Kana, K; Chuenchitra, T; Sunantarod, A; Mungthin, M; Meesiri, S; Areekul, W; Nelson, KE				Rangsin, Ram; Kana, Khunakorn; Chuenchitra, Thippawan; Sunantarod, Akachai; Mungthin, Mathirut; Meesiri, Supanee; Areekul, Wirote; Nelson, Kenrad E.			Risk Factors for HIV Infection among Young Thai Men during 2005-2009	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; NORTHERN THAILAND; PREVALENCE; SEX; BEHAVIOR; EPIDEMIC; SUBTYPE	Background Thailand is one of several countries with a continuing generalized HIV epidemic. We evaluated the risk factors for HIV prevalence among 17-29 year old men conscripted by a random process into the Royal Thai Army (RTA) in 8 cohorts from 2005-2009. Methods A series of case-cohort studies were conducted among the male RTA conscripts who had been tested for HIV seroprevalence after they were inducted. Men who were HIV positive were compared with a systematic random sample (1 in 30-40) of men from the total population of new conscripts. Each subject completed a detailed risk factor questionnaire. Results A total of 240,039 young Thai men were conscripted into the RTA and were screened for HIV seroprevalence between November 2005 and May 2009. Of 1,208 (0.5%) HIV positive cases, 584 (48.3%) men were enrolled into the study. There were 7,396 men who were enrolled as a comparison group. Among conscripts who had an education lower than a college-level, the independent risk factors for HIV infection were age in years (AOR 1.38, 95% CI 1.28-1.48), a history of sex with another man (AOR 3.73, 95% CI 2.70-5.13), HCV infection (AOR 3.89, 95% CI 2.56-5.90), and a history of sex with a female sex worker (FSW) (AOR 1.35, 95% CI 1.10-1.66). Among conscripts who had a college degree, the independent risk factor for HIV infection was a history of sex with another man (AOR 23.04, 95% CI 10.23-51.90). Numbers of sexual partners increased and the age at first sex, as well as the use of condoms for sex with a FSW decreased in successive cohorts. Conclusion The HIV seroprevalence among cohorts of 17-29 years old men has remained at about 0.5% overall during 2005-2009. The most significant behavior associated with HIV prevalence was a history of sex with another man. Our data indicate continuing acquisition of HIV among young men in Thailand in recent years, especially among men with a history of same sex behavior.	[Rangsin, Ram; Areekul, Wirote] Phramongkutklao Coll Med, Dept Mil & Community Med, Bangkok, Thailand; [Kana, Khunakorn; Chuenchitra, Thippawan; Meesiri, Supanee] AFRIMS, Bangkok, Thailand; [Sunantarod, Akachai] Royal Thai Army Inst Pathol AIP, Bangkok, Thailand; [Mungthin, Mathirut] Phramongkutklao Coll Med, Dept Parasitol, Bangkok, Thailand; [Nelson, Kenrad E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Phramongkutklao College of Medicine; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Phramongkutklao College of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Rangsin, R (corresponding author), Phramongkutklao Coll Med, Dept Mil & Community Med, Bangkok, Thailand.	r_rangsin@yahoo.com	Rangsin, Ram/AAR-9082-2021; Rangsin, Ram/AAW-9527-2020	Rangsin, Ram/0000-0002-7175-0963; Mungthin, Mathirut/0000-0002-6372-9857	Fogarty International Center of the U.S. National Institutes of Health [1 R01 TW006972-01A1, 5 R01 TW006972-02, 5 R01 TW006972-03, 5 R01 TW006972-04, 5 R01 TW006972-05]; National Research Council of Thailand; FOGARTY INTERNATIONAL CENTER [R01TW006972] Funding Source: NIH RePORTER	Fogarty International Center of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Research Council of Thailand(National Research Council of Thailand (NRCT)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Financial assistance was provided by Fogarty International Center of the U.S. National Institutes of Health (Grants 1 R01 TW006972-01A1, 5 R01 TW006972-02, 5 R01 TW006972-03, 5 R01 TW006972-04, and 5 R01 TW006972-05), and the National Research Council of Thailand. The funders did not have a role in study design, data collection and analysis, and the decision to publish the manuscript.	[Anonymous], 1998, MMWR RECOMMENDATIONS, V47, P1; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; CARR JK, 1994, J ACQ IMMUN DEF SYND, V7, P1270; Celentano DD, 1998, AIDS, V12, pF29, DOI 10.1097/00002030-199805000-00004; Celentano DD, 1996, JAMA-J AM MED ASSOC, V275, P122, DOI 10.1001/jama.275.2.122; CELENTANO DD, 1993, AIDS, V7, P1647, DOI 10.1097/00002030-199312000-00016; Jatapai A, 2013, SEX TRANSM DIS, V40, P241, DOI 10.1097/OLQ.0b013e31827e8de4; Jatapai A, 2010, AM J TROP MED HYG, V83, P433, DOI 10.4269/ajtmh.2010.09-0749; Mason CJ, 1998, J ACQ IMMUN DEF SYND, V19, P165, DOI 10.1097/00042560-199810010-00010; MASON CJ, 1995, AIDS, V9, P1061, DOI 10.1097/00002030-199509000-00012; National AIDS Prevention and Alleviation Committee, 2012, UNGASS COUNTRY PROGR; Nelson KE, 1996, NEW ENGL J MED, V335, P297, DOI 10.1056/NEJM199608013350501; NELSON KE, 1993, JAMA-J AM MED ASSOC, V270, P955, DOI 10.1001/jama.270.8.955; Nopkesorn T, 1998, J ACQ IMMUN DEF SYND, V18, P372, DOI 10.1097/00042560-199808010-00009; Rangsin R, 2000, 13 INT C AIDS DURB S; Torugsa K, 2003, EMERG INFECT DIS, V9, P881; UNAIDS, 2014, THE GAP REP; UNGPHAKORN J, 1994, AIDS, V8, pS155; van Griensven F, 2010, 18 INT AIDS C VIENN; van Griensven F, 2010, JAIDS-J ACQ IMM DEF, V53, P234, DOI 10.1097/QAI.0b013e3181c2fc86; Weniger B G, 1991, AIDS, V5 Suppl 2, pS71, DOI 10.1097/00002030-199101001-00011	22	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136555	10.1371/journal.pone.0136555	http://dx.doi.org/10.1371/journal.pone.0136555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308085	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400137
J	Ryu, S; Johnson, A; Park, Y; Kim, B; Norris, D; Armstrong, CA; Song, PI				Ryu, Sunhyo; Johnson, Andrew; Park, Yoonkyung; Kim, Beomjoon; Norris, David; Armstrong, Cheryl A.; Song, Peter I.			The Alpha-Melanocyte-Stimulating Hormone Suppresses TLR2-Mediated Functional Responses through IRAK-M in Normal Human Keratinocytes	PLOS ONE			English	Article							TOLL-LIKE-RECEPTORS; STAPHYLOCOCCUS-AUREUS; EXPRESSION; MSH; KINASE; ACTIVATION; PROTEIN; TOLL-LIKE-RECEPTOR-4; PEPTIDOGLYCAN; MODULATION	Alpha-melanocyte stimulating hormone (alpha-MSH) is a highly conserved 13-aa neuropeptide derived from pro-opiomelanocortin by post-translational processing, which has been reported to exhibit potent anti-inflammatory activity and a wide range of immunosuppressive activities in the skin. However, the regulatory effect of alpha-MSH is not completely clear in cutaneous innate immunity. In this study, we investigate the functional regulation of alpha-MSH in TLR2-mediated inflammatory responses in normal human keratinocytes (HKs). alpha-MSH pretreatment down-regulated the Staphylococcus aureus LTA-induced expression of both TLR2 and IL-8 as well as NF-kappa B nuclear translocation in HK cells. The inhibitory effect of alpha-MSH was blocked by agouti signaling protein (ASP), an alpha-MSH receptor-1 antagonist. To investigate the mechanism of this response in more detail, siRNA of IRAK-M, a negative regulator of TLR signaling, was utilized in these studies. The alpha-MSH suppressive effect on IL-8 production and NF-kappa B transactivation was inhibited by IRAK-M siRNA transfection in HK cells. These results indicate that alpha-MSH is capable of suppressing keratinocyte TLR2-mediated inflammatory responses induced by S. aureus-LTA, thus demonstrating another novel immunomodulatory activity of alpha-MSH in normal human keratinocytes.	[Ryu, Sunhyo; Norris, David; Armstrong, Cheryl A.; Song, Peter I.] Univ Colorado Denver Anschutz Med Campus, Dept Dermatol, Aurora, CO USA; [Ryu, Sunhyo; Park, Yoonkyung] Chosun Univ, Sch Med, Dept Biotechnol, Gwangju, South Korea; [Johnson, Andrew] Univ Arkansas Med Sci, Dept Dermatol, Little Rock, AR 72205 USA; [Kim, Beomjoon] Chung Ang Univ, Sch Med, Dept Dermatol, Seoul 156756, South Korea; [Armstrong, Cheryl A.] Denver Hlth Med Ctr, Div Dermatol, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Chosun University; University of Arkansas System; University of Arkansas Medical Sciences; Chung Ang University; Chung Ang University Hospital; Denver Health Medical Center	Armstrong, CA (corresponding author), Univ Colorado Denver Anschutz Med Campus, Dept Dermatol, Aurora, CO USA.	Cheryl.armstrong@dhha.org; peter.song@ucdenver.edu		Kim, Beom Joon/0000-0003-2320-7621	National Research Foundation of Korea (NRF) - Korean Government (MEST) [2011-0017532]; Global Research Laboratory (GRL) grant [NRF-2014K1A1A2064460];  [NIHRO1 AR052643]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052643] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) - Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); Global Research Laboratory (GRL) grant; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIHRO1 AR052643, the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MEST; No. 2011-0017532), and Global Research Laboratory (GRL) grant (NRF-2014K1A1A2064460).	BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Baker BS, 2003, BRIT J DERMATOL, V148, P670, DOI 10.1046/j.1365-2133.2003.05287.x; Begon E, 2007, EUR J DERMATOL, V17, P497; Bohm M, 1999, EXP DERMATOL, V8, P453, DOI 10.1111/j.1600-0625.1999.tb00303.x; Catania A, 2006, THESCIENTIFICWORLDJO, V6, P1241, DOI 10.1100/tsw.2006.227; Deng JP, 2004, AM J RESP CRIT CARE, V169, P749, DOI 10.1164/rccm.200303-372OC; Donnarumma G, 2004, EXP DERMATOL, V13, P748, DOI 10.1111/j.0906-6705.2004.00218.x; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Frazao JB, 2013, ARCH IMMUNOL THER EX, V61, P427, DOI 10.1007/s00005-013-0243-0; Hill RP, 2006, PEPTIDES, V27, P421, DOI 10.1016/j.peptides.2005.03.061; Hubbard LLN, 2010, INFECT DIS REP, V2, P22, DOI 10.4081/idr.2010.e9; Iwaki D, 2002, J BIOL CHEM, V277, P24315, DOI 10.1074/jbc.M107057200; Jarrousse V, 2006, EUR J DERMATOL, V16, P636, DOI 10.1684/ejd.2006.0088; Jugeau S, 2005, BRIT J DERMATOL, V153, P1105, DOI 10.1111/j.1365-2133.2005.06933.x; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kielian T, 2002, J NEUROIMMUNOL, V130, P86, DOI 10.1016/S0165-5728(02)00216-3; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; Krutzik SR, 2003, NAT MED, V9, P525, DOI 10.1038/nm864; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Lipton JM, 1997, IMMUNOL TODAY, V18, P140, DOI 10.1016/S0167-5699(97)01009-8; Luger TA, 2003, ANN NY ACAD SCI, V994, P133, DOI 10.1111/j.1749-6632.2003.tb03172.x; Luger TA, 2000, ANN NY ACAD SCI, V917, P232; Maheaswari Rajendran, 2014, J Indian Soc Periodontol, V18, P686, DOI 10.4103/0972-124X.147398; Peters EMJ, 2006, J INVEST DERMATOL, V126, P1937, DOI 10.1038/sj.jid.5700429; Pietrocola G, 2011, INT J ARTIF ORGANS, V34, P799, DOI 10.5301/ijao.5000030; Rhyasen GW, 2015, BRIT J CANCER, V112, P232, DOI 10.1038/bjc.2014.513; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Roosterman D, 2006, PHYSIOL REV, V86, P1309, DOI 10.1152/physrev.00026.2005; Ryu S, 2014, BRIT J DERMATOL, V171, P1358, DOI 10.1111/bjd.13480; Sadik CD, 2008, INT J BIOCHEM CELL B, V40, P2508, DOI 10.1016/j.biocel.2008.04.014; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Song P, 2001, J INVEST DERMATOL, V117, P438; Song PI, 2002, J INVEST DERMATOL, V119, P424, DOI 10.1046/j.1523-1747.2002.01847.x; Su JM, 2007, CELL SIGNAL, V19, P1596, DOI 10.1016/j.cellsig.2007.02.009; Suzuki N, 2003, J IMMUNOL, V171, P6065, DOI 10.4049/jimmunol.171.11.6065; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Taylor AW, 2005, J NEUROIMMUNOL, V162, P43, DOI 10.1016/j.jneuroim.2005.01.008; Thirumoorthy R, 2001, J MED CHEM, V44, P4114, DOI 10.1021/jm010215z; TORCZYNSKI RM, 1985, DNA-J MOLEC CELL BIO, V4, P283, DOI 10.1089/dna.1985.4.283; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Yoon SW, 2003, J BIOL CHEM, V278, P32914, DOI 10.1074/jbc.M302444200	43	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136887	10.1371/journal.pone.0136887	http://dx.doi.org/10.1371/journal.pone.0136887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309029	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400159
J	van der Leeuw, C; Peeters, S; Domen, P; van Kroonenburgh, M; van Os, J; Marcelis, M				van der Leeuw, Christine; Peeters, Sanne; Domen, Patrick; van Kroonenburgh, Marinus; van Os, Jim; Marcelis, Machteld		Genetic Risk Outcome Psychosis	Bone Mineral Density as a Marker of Cumulative Estrogen Exposure in Psychotic Disorder: A 3 Year Follow-Up Study	PLOS ONE			English	Article							GENETIC RISK; SCHIZOPHRENIA; PROLACTIN; ANTIPSYCHOTICS; OSTEOPOROSIS; MEDICATION; MECHANISMS; FRACTURE; HISTORY; PEOPLE	Altered estrogen-induced neuroprotection has been implicated in the etiology of psychotic disorders. Using bone mineral density as a marker of lifetime estrogen exposure, a longitudinal family study was conducted to discriminate between etiological mechanisms and secondary effects of disease and treatment. Dual X-ray absorptiometry scans were acquired twice, with an interval of 3 years, in 30 patients with psychotic disorder (male (M)/female (F): 24/6, mean age of 32 years at second measurement), 44 non-psychotic siblings of patients with a psychotic disorder (M/F: 26/18, mean age 32) and 27 controls (M/F: 7/20, mean age 35). Total bone mineral density, Z-scores and T-scores were measured in the lumbar spine and proximal femur. Associations between group and bone mineral density changes were investigated with multilevel random regression analyses. The effect of prolactin-raising antipsychotic medication was evaluated. (Increased risk of) psychotic disorder was not associated with disproportionate bone mineral density loss over a three year period. Instead, femoral bone mineral density measures appeared to decrease less in the patient versus control comparison (total BMD: B = 0.026, 95% CI 0.002 to 0.050, p = 0.037; Z-score: B = 0.224, 95% CI 0.035 to 0.412, p = 0.020; and T-score: B = 0.193, 95% CI 0.003 to 0.382, p = 0.046). Current or past use of a prolactin-raising antipsychotic medication was not associated with bone mineral density changes. In this small longitudinal study, there was no evidence of ongoing estrogen deficiency in psychotic disorder as there was no excessive loss of bone mineral density over a 3-year period in patients using antipsychotic medication.	[van der Leeuw, Christine; Peeters, Sanne; Domen, Patrick; van Os, Jim; Marcelis, Machteld] Maastricht Univ Med Ctr, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, EURON, Maastricht, Netherlands; [van Kroonenburgh, Marinus] Maastricht Univ Med Ctr, Dept Radiol & Nucl Med, Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London WC2R 2LS, England; [Marcelis, Machteld] Inst Mental Hlth Care Eindhoven GGzE, Eindhoven, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); University of London; King's College London	van der Leeuw, C (corresponding author), Maastricht Univ Med Ctr, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, EURON, Maastricht, Netherlands.	c.vanderleeuw@maastrichtuniversity.nl	Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/C-2113-2014; Peeters, Sanne/AAA-9523-2021; Myin-Germeys, Inez/L-5106-2014; van Os, Jim/V-8884-2019	van Os, Jim/0000-0002-7245-1586; Marcelis, Machteld/0000-0003-0045-9244; Bruggeman, Richard/0000-0002-3238-8471; Myin-Germeys, Inez/0000-0002-3731-4930; Peeters, Sanne/0000-0002-3004-4261	Geestkracht program of the Dutch Health Research Council (ZON-MW) [10-000-1002]; European Community [HEALTH-F2-2009-241909]	Geestkracht program of the Dutch Health Research Council (ZON-MW); European Community(European Commission)	This work was supported by the Geestkracht program of the Dutch Health Research Council (ZON-MW, grant number 10-000-1002), and the European Community's Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI). The sponsors had no further role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Abraham G, 2003, AM J PSYCHIAT, V160, P1618, DOI 10.1176/appi.ajp.160.9.1618; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; APA, 2000, DIAGN STAT MAN MENT; Bilici M, 2002, INT J NEUROSCI, V112, P817, DOI 10.1080/00207450290025833; Boerma M A M, 2010, Tijdschr Psychiatr, V52, P235; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Crews MPK, 2012, HUM PSYCHOPHARM CLIN, V27, P15, DOI 10.1002/hup.1265; Goldstein H., 1987, MULTILEVEL MODELS ED; Haddad PM, 2004, DRUGS, V64, P2291, DOI 10.2165/00003495-200464200-00003; Halbreich U, 2007, CNS DRUGS, V21, P641, DOI 10.2165/00023210-200721080-00003; Howard L, 2007, BRIT J PSYCHIAT, V190, P129, DOI 10.1192/bjp.bp.106.023671; Kishimoto T, 2012, CURR OPIN PSYCHIATR, V25, P415, DOI 10.1097/YCO.0b013e328355e1ac; Korver N, 2012, INT J METH PSYCH RES, V21, P205, DOI 10.1002/mpr.1352; Lee TY, 2010, PSYCHIAT INVEST, V7, P278, DOI 10.4306/pi.2010.7.4.278; Maric N, 2005, SCHIZOPHR RES, V73, P351, DOI 10.1016/j.schres.2004.07.016; Markham JA, 2012, REV ENDOCR METAB DIS, V13, P187, DOI 10.1007/s11154-011-9184-2; Meaney AM, 2007, SCHIZOPHR RES, V93, P136, DOI 10.1016/j.schres.2007.01.013; Meaney AM, 2004, BRIT J PSYCHIAT, V184, P503, DOI 10.1192/bjp.184.6.503; Partti K, 2010, PSYCHOSOM MED, V72, P933, DOI 10.1097/PSY.0b013e3181f7abd3; Soundy A, 2014, ARCH PSYCHIAT NURS, V28, P135, DOI 10.1016/j.apnu.2013.12.002; Stubbs B, 2014, ACTA PSYCHIAT SCAND, V130, P470, DOI 10.1111/acps.12313; Takahashi T, 2013, SCHIZOPHR RES, V147, P383, DOI 10.1016/j.schres.2013.04.015; van der Leeuw C, 2013, SCHIZOPHR RES, V150, P114, DOI 10.1016/j.schres.2013.07.033; van der Leeuw C, 2013, SCHIZOPHR RES, V143, P25, DOI 10.1016/j.schres.2012.10.031; Wang MX, 2014, HUM PSYCHOPHARM CLIN, V29, P183, DOI 10.1002/hup.2387; World Health Organization, 1990, COMP INT DIAGN INT C; Wu Q, 2010, OSTEOPOROSIS INT, V21, P1627, DOI 10.1007/s00198-010-1181-x	27	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136320	10.1371/journal.pone.0136320	http://dx.doi.org/10.1371/journal.pone.0136320			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309037	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400107
J	Chen, YY; Chen, F; Chang, SS; Wong, J; Yip, PSF				Chen, Ying-Yeh; Chen, Feng; Chang, Shu-Sen; Wong, Jacky; Yip, Paul S. F.			Assessing the Efficacy of Restricting Access to Barbecue Charcoal for Suicide Prevention in Taiwan: A Community-Based Intervention Trial	PLOS ONE			English	Article							PROCESS INTENSITY FUNCTION; HONG-KONG; BURNING SUICIDES; DERIVATIVES; STRATEGIES; ESTIMATORS	Objective Charcoal-burning suicide has recently been spreading to many Asian countries. There have also been several cases involving this new method of suicide in Western countries. Restricting access to suicide means is one of the few suicide-prevention measures that have been supported by empirical evidence. The current study aims to assess the effectiveness of a community intervention program that restricts access to charcoal to prevent suicide in Taiwan. Methods and Findings A quasi-experimental design is used to compare method-specific (charcoal-burning suicide, non-charcoal-burning suicide) and overall suicide rates in New Taipei City (the intervention site, with a population of 3.9 million) with two other cities (Taipei City and Kaohsiung City, the control sites, each with 2.7 million residents) before (Jan 1st 2009-April 30th 2012) and after (May 1st 2012-Dec. 31st 2013) the initiation of a charcoal-restriction program on May 1st 2012. The program mandates the removal of barbecue charcoal from open shelves to locked storage in major retail stores in New Taipei City. No such restriction measure was implemented in the two control sites. Generalized linear regression models incorporating secular trends were used to compare the changes in method- specific and overall suicide rates before and after the initiation of the restriction measure. A simulation approach was used to estimate the number of lives saved by the intervention. Compared with the pre-intervention period, the estimated rate reduction of charcoal-burning suicide in New Taipei City was 37% (95% CI: 17%, 50%) after the intervention. Taking secular trends into account, the reduction was 30% (95% CI: 14%, 44%). No compensatory rise in non-charcoal-burning suicide was observed in New Taipei City. No significant reduction in charcoal- burning suicide was observed in the other two control sites. The simulation approach estimated that 91 (95%CI [ 55, 128]) lives in New Taipei City were saved during the 20 months of the intervention. Conclusion Our results demonstrate that the charcoal- restriction program reduced method-specific and overall suicides. This study provides strong empirical evidence that restricting the accessibility of common lethal methods of suicide can effectively reduce suicide rates.	[Chen, Ying-Yeh] Taipei City Hosp, Taipei City Psychiat Ctr, Taipei, Taiwan; [Chen, Ying-Yeh] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Chen, Ying-Yeh] Natl Yang Ming Univ, Dept Publ Hlth, Taipei 112, Taiwan; [Chen, Feng] Univ New S Wales, Dept Stat, Sydney, NSW, Australia; [Chang, Shu-Sen] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Policy & Management, Taipei 10764, Taiwan; [Chang, Shu-Sen] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Wong, Jacky; Yip, Paul S. F.] Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China; [Wong, Jacky; Yip, Paul S. F.] Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Hong Kong, Peoples R China	Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; University of New South Wales Sydney; National Taiwan University; National Taiwan University; University of Hong Kong; University of Hong Kong	Yip, PSF (corresponding author), Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China.	sfpyip@hku.hk	Chang, Shu-Sen/AAH-6733-2021; Chang, Shu-Sen/B-3518-2012; Chen, Feng/B-5366-2009; Chen, Ying-Yeh/AAY-1478-2021	Chang, Shu-Sen/0000-0001-5012-1132; Chang, Shu-Sen/0000-0001-5012-1132; Chen, Feng/0000-0002-9646-3338; Chen, Ying-Yeh/0000-0001-5543-5704	Ministry of Science and Technology [MOST 103-2314-B-532 -003-MY2]; Department of Health, Taipei City Government [10401-62-011]; UNSW Australia SFRG grant; General Research Fund from University of Hong Kong	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Department of Health, Taipei City Government; UNSW Australia SFRG grant; General Research Fund from University of Hong Kong	YYC was supported by the Ministry of Science and Technology (MOST 103-2314-B-532 -003-MY2) and the Department of Health, Taipei City Government (10401-62-011). FC was supported by a UNSW Australia SFRG grant. PSFY was supported by a General Research Fund from the University of Hong Kong. The funders had no role in the study design; the collection, analysis, and interpretation of the data; the writing of the article; or the decision to submit the article.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], MODERN APPL STAT S; [Anonymous], 2014, R LANG ENV STAT COMP; Chan KPM, 2005, BRIT J PSYCHIAT, V186, P67, DOI 10.1192/bjp.186.1.67; Chang SS, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001622; Chang SS, 2010, SOC PSYCH PSYCH EPID, V45, P143, DOI 10.1007/s00127-009-0049-x; Chen F, 2014, LPINT LOCAL POLYNOMI; Chen F, 2008, COMMUN STAT-THEOR M, V37, P294, DOI 10.1080/03610920701649035; Chen F, 2011, SCAND J STAT, V38, P631, DOI 10.1111/j.1467-9469.2011.00733.x; Chen F, 2011, STAT SINICA, V21, P107; Chen YY, 2015, SOC PSYCH PSYCH EPID, V50, P227, DOI 10.1007/s00127-014-0910-4; Chen YY, 2012, EPIDEMIOL REV, V34, P129, DOI 10.1093/epirev/mxr025; Chen YY, 2009, J AFFECT DISORDERS, V118, P196, DOI 10.1016/j.jad.2009.05.020; Czado C, 2009, BIOMETRICS, V65, P1254, DOI 10.1111/j.1541-0420.2009.01191.x; Daigle MS, 2005, ACCIDENT ANAL PREV, V37, P625, DOI 10.1016/j.aap.2005.03.004; Department of Household Registration M.O.I., 2014, STATISTICS; HAWTON K, 2005, PREVENTION TREATMENT, P279; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hitosugi M, 2009, J EPIDEMIOL COMMUN H, V63, P862, DOI 10.1136/jech.2008.086025; HUANG S, 1991, J POP CULT, V25, P163, DOI 10.1111/j.0022-3840.1991.1633111.x; Kleiber C, 2008, USE R, P1, DOI 10.1007/978-0-387-77318-6_1; Lester D, 1989, EXPLAINING CHOICE ME; Lin JJ, 2008, J EPIDEMIOL COMMUN H, V62, P566, DOI 10.1136/jech.2007.065771; Lin JJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-480; Liu KY, 2007, J EPIDEMIOL COMMUN H, V61, P248, DOI 10.1136/jech.2006.048553; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; McCullagh P, 1989, GEN LINEAR MODELS; Tsai CW, 2011, J AFFECT DISORDERS, V131, P402, DOI 10.1016/j.jad.2010.12.013; Yip P., 2009, OXFORD TXB SUICIDOLO, P595; Yip PSF, 2007, CRISIS, V28, P21, DOI 10.1027/0227-5910.28.S1.21; Yip PSF, 2012, LANCET, V379, P2393, DOI 10.1016/S0140-6736(12)60521-2; Yip PSF, 2012, INJURY PREV, V18, P187, DOI 10.1136/injuryprev-2011-040177; Yip PSF, 2010, BRIT J PSYCHIAT, V196, P241, DOI 10.1192/bjp.bp.109.065185	33	155	156	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0133809	10.1371/journal.pone.0133809	http://dx.doi.org/10.1371/journal.pone.0133809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6KK	26305374	Green Submitted, gold, Green Published			2022-12-27	WOS:000359995500004
J	Idris, M; Hussain, S; Siddiqi, MH; Hassan, W; Bilal, HSM; Lee, S				Idris, Muhammad; Hussain, Shujaat; Siddiqi, Muhammad Hameed; Hassan, Waseem; Bilal, Hafiz Syed Muhammad; Lee, Sungyoung			MRPack: Multi-Algorithm Execution Using Compute-Intensive Approach in MapReduce	PLOS ONE			English	Article								Large quantities of data have been generated from multiple sources at exponential rates in the last few years. These data are generated at high velocity as real time and streaming data in variety of formats. These characteristics give rise to challenges in its modeling, computation, and processing. Hadoop MapReduce (MR) is a well known data-intensive distributed processing framework using the distributed file system (DFS) for Big Data. Current implementations of MR only support execution of a single algorithm in the entire Hadoop cluster. In this paper, we propose MapReducePack (MRPack), a variation of MR that supports execution of a set of related algorithms in a single MR job. We exploit the computational capability of a cluster by increasing the compute-intensiveness of MapReduce while maintaining its data-intensive approach. It uses the available computing resources by dynamically managing the task assignment and intermediate data. Intermediate data from multiple algorithms are managed using multi-key and skew mitigation strategies. The performance study of the proposed system shows that it is time, I/O, and memory efficient compared to the default MapReduce. The proposed approach reduces the execution time by 200% with an approximate 50% decrease in I/O cost. Complexity and qualitative results analysis shows significant performance improvement.	[Idris, Muhammad; Hussain, Shujaat; Siddiqi, Muhammad Hameed; Bilal, Hafiz Syed Muhammad; Lee, Sungyoung] Kyung Hee Univ, Dept Comp Engn, Ubiquitous Comp Lab, Yongin, Gyeonggi Do, South Korea; [Hassan, Waseem] Kyung Hee Univ, Dept Comp Engn, Hapt Lab, Yongin, Gyeonggi Do, South Korea	Kyung Hee University; Kyung Hee University	Lee, S (corresponding author), Kyung Hee Univ, Dept Comp Engn, Ubiquitous Comp Lab, Yongin, Gyeonggi Do, South Korea.	sylee@oslab.khu.ac.kr	Siddiqi, Muhammad Hameed/ADU-4375-2022; Lee, Sungyoung/AAK-7257-2020	Siddiqi, Muhammad Hameed/0000-0002-4370-8012; Idris, Muhammad/0000-0001-9764-2322; Hassan, Waseem/0000-0003-3922-5648	National Research Foundation of Korea (NRF) - Korea government (MEST) [2011-0030823]; Kyung Hee University [KHU-20130438]; Industrial Core Technology Development Program - Ministry of Trade, Industry and Energy (MOTIE, Korea) [10049079]	National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); Kyung Hee University; Industrial Core Technology Development Program - Ministry of Trade, Industry and Energy (MOTIE, Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2011-0030823) and a grant from Kyung Hee University 2013 (KHU-20130438). This work was also supported by the Industrial Core Technology Development Program (10049079, Development of Mining core technology exploiting personal big data) funded by the Ministry of Trade, Industry and Energy (MOTIE, Korea).	[Anonymous], AM EL COMP CLOUD; Baldeschwieler E, 2012, HORTONWORKS MANIFEST; Buhl HU, 2013, WIRTSCHAFTSINF, V55, P63, DOI DOI 10.1007/S11576-013-0350-X; GHEMAWAT S, 2003, ACM SIGOPS OPERATING, V37, P29, DOI [10.1145/1165389.945450, DOI 10.1145/1165389.945450, 10.1145/945445.945450]; government C, CAN OP DAT; Howe D, 2008, NATURE, V455, P47, DOI 10.1038/455047a; Hu W.C., 2013, BIG DATA MANAGEMENT; Idris Muhammad, 2014, TRUST SEC PRIV COMP, P763; Jung Hyungjae, DYNAMIC SCHEDULING S; Kaushik Rini T., 2010, P USENIX ANN TECHN C; Kornacker Marcel, 2012, CLOUDERA IMPALA REAL; Kumar V., 2013, P 4 ANN S CLOUD COMP; Lee KH, 2011, SIGMOD REC, V40, P11, DOI 10.1145/2094114.2094118; Lewis D. D., 2015, REUTORS DATASET; Matei Zaharia, 2008, OSDI, V8; McAfee A, 2012, HARVARD BUS REV, V90, P60; Michele Tolle Kristin, 2009, 4 PARADIGM DATA INTE, V1; Nykiel T, 2010, PROC VLDB ENDOW, V3, P494, DOI 10.14778/1920841.1920906; Prabhu S, 2015, IJRCCT, V4, P229; Quan Chen, 2010, Proceedings of the 2010 IEEE 10th International Conference on Computer and Information Technology (CIT 2010), P2736, DOI 10.1109/CIT.2010.458; Soeren Sonnenburg, 2015, MACHINE LEARNING DAT; Soumendra Mohanty, 2013, BIG DATA ENTERPRISE, P1; Valvag Steffen Viken, 2008, HIGH PERF COMP COMM, P113; Valvag Steffen Viken, 2009, NETW PAR COMP 2009 N, P174; Vernica R, 2012, P 15 INT C EXT DAT T, P420; White T., 2012, HADOOP DEFINITIVE GU; Wille R, 2011, IEEE COMP SOC ANN, P120, DOI 10.1109/ISVLSI.2011.77; Xiaohong Zhang, 2011, Proceedings of the 2011 International Conference on Cloud and Service Computing (CSC 2011), P235, DOI 10.1109/CSC.2011.6138527	28	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136259	10.1371/journal.pone.0136259	http://dx.doi.org/10.1371/journal.pone.0136259			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305223	Green Published, gold			2022-12-27	WOS:000359995500056
J	Ventura, K; O'Brien, PCM; Moreira, CD; Yonenaga-Yassuda, Y; Ferguson-Smith, MA				Ventura, Karen; O'Brien, Patricia Caroline Mary; Moreira, Camila do Nascimento; Yonenaga-Yassuda, Yatiyo; Ferguson-Smith, Malcolm Andrew			On the Origin and Evolution of the Extant System of B Chromosomes in Oryzomyini Radiation (Rodentia, Sigmodontinae)	PLOS ONE			English	Article							APODEMUS-PENINSULAE RODENTIA; NEW-ZEALAND FROG; SUPERNUMERARY CHROMOSOMES; DNA-SEQUENCES; NYCTEREUTES-PROCYONOIDES; LEIOPELMA-HOCHSTETTERI; (TTAGGG)(N) SEQUENCES; MEIOTIC BEHAVIOR; CRICETIDAE; SEX	Heterogeneous supernumerary chromosomes (Bs) are recognized in the oryzomyines Holochilus brasiliensis, Nectomys rattus, N. squamipes, Oligoryzomys flavescens and Sooretamys angouya, representing about 10% of all known B-containing rodent species. They provide an outstanding model for understanding the origin, evolution and diversity of Bs in a phylogenetic context. Therefore, whole chromosome-specific probes were generated from flow-sorted Holochilus brasiliensis (HBR) autosomes 11 and 25+26 and chromosomes X, Y and Bs. Hybridizations were performed on male metaphases of 15 Oryzomyini species of which 3 are B-containing species. The results reveal that among the species sampled, 12 of them, belonging to a monophyletic Oryzomiyini subclade, are positive for an anonymous Oryzomyini shared heterochromatic region (OSHR) on both sex chromosomes. The OSHR is also present on Bs of Holochilus brasiliensis, Nectomys rattus and N. squamipes but not on Bs of O. flavescens and S. angouya. Two distinct additional OSHR/autosome associations are observed on S. angouya. The three species that are OSHR negative belong to an outgroup. Molecular dating suggests that the OSHR originated between 7.8 and 3 Mya on ancestral sex chromosomes. A tentative explanation for the OSHR-positive nature of B regions in three species could be that transposable elements (TEs) from this specific sex chromosome region may have invaded existing B chromosomes. The presence of the OSHR on entire Xp and Yp adjacent to interstitial telomeric sequences at pericentromeric positions, as observed in Drymoreomys albimaculatus, show a similar organization as on B chromosomes in Nectomys squamipes. The diversity of the Oryzomyini Bs in number, size, morphology and genetic content may be explained by the independent origin of B chromosomes in different subgroups of species, with Bs in Holochilus brasiliensis, Nectomys squamipes and N. rattus sharing the OSHR with sex chromosomes, and those in Oligoryzomys flavescens and Sooretamys angouya lacking OSHR in Bs. The species-specific pattern of Bs is probably a consequence of their independent evolutionary origin.	[Ventura, Karen; Moreira, Camila do Nascimento; Yonenaga-Yassuda, Yatiyo] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil; [Ventura, Karen; O'Brien, Patricia Caroline Mary; Ferguson-Smith, Malcolm Andrew] Univ Cambridge, Dept Vet Med, Cambridge Resource Ctr Comparat Genom, Cambridge, England; [Ventura, Karen] Univ Fed Itajuba, Inst Recursos Nat, Itajuba, MG, Brazil	Universidade de Sao Paulo; University of Cambridge; Universidade Federal de Itajuba	Ventura, K (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil.	kabiousp@yahoo.com.br	Ventura, Karen/G-2566-2012; Nascimento Moreira, Camila/AAA-9464-2022	Nascimento Moreira, Camila/0000-0001-9490-5457	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [Fapesp 2009/54300-0]; Coordenacao de Aperfeicoamento de nivel superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Wellcome Trust	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de nivel superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Wellcome Trust(Wellcome TrustEuropean Commission)	The authors are grateful to Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp 2009/54300-0 for KV), Coordenacao de Aperfeicoamento de nivel superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Wellcome Trust (for MAF-S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrades-Miranda J, 2001, J MAMMAL, V82, P1080, DOI 10.1644/1545-1542(2001)082<1080:CSOSSO>2.0.CO;2; Avaria-Llautureo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034654; Berend SA, 2001, CYTOGENET CELL GENET, V95, P85, DOI 10.1159/000057023; Bueno D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066532; Camacho JPM, 2011, SEX DEV, V5, P155, DOI 10.1159/000324930; Camacho JPM, 2000, PHILOS T R SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; D'Elía Guillermo, 2007, Gayana (Concepc.), V71, P187; DEALMEIDA EJC, 1991, CARYOLOGIA, V44, P63, DOI 10.1080/00087114.1991.10797020; Fantinatti BEA, 2011, GENETICA, V139, P1273, DOI 10.1007/s10709-012-9629-x; Graphodatsky AS, 2005, CHROMOSOME RES, V13, P113, DOI 10.1007/s10577-005-7474-9; GREEN DM, 1990, GENOME, V33, P818, DOI 10.1139/g90-123; GREEN DM, 1993, J EVOLUTION BIOL, V6, P417, DOI 10.1046/j.1420-9101.1993.6030417.x; GUTKNECHT J, 1995, CHROMOSOMA, V103, P539, DOI 10.1007/BF00355318; Houben A, 2014, CELL MOL LIFE SCI, V71, P467, DOI 10.1007/s00018-013-1437-7; JAMILENA M, 1995, CHROMOSOMA, V104, P113, DOI 10.1007/BF00347693; Jones RN, 1982, B CHROMOSOMES; Martis MM, 2012, P NATL ACAD SCI USA, V109, P13343, DOI 10.1073/pnas.1204237109; Matsubara K, 2008, CHROMOSOME RES, V16, P1013, DOI 10.1007/s10577-008-1259-x; MCQUADE LR, 1994, CYTOGENET CELL GENET, V66, P155, DOI 10.1159/000133689; Parada A, 2013, MOL PHYLOGENET EVOL, V66, P960, DOI 10.1016/j.ympev.2012.12.001; Patton JL, 1976, OCCASIONAL PAPERS MU, V49, P1; Percequillo AR, 2011, ZOOL J LINN SOC-LOND, V161, P357, DOI 10.1111/j.1096-3642.2010.00643.x; Perfectti F, 2001, EVOLUTION, V55, P1069, DOI 10.1554/0014-3820(2001)055[1069:TIOOBC]2.0.CO;2; Pine RH, 2012, J MAMMAL, V93, P851, DOI 10.1644/11-MAMM-A-012.1; Rubtsov NB, 2004, CYTOGENET GENOME RES, V106, P289, DOI 10.1159/000079301; SBALQUEIRO IJ, 1991, ACTA THERIOL, V36, P193, DOI 10.4098/AT.arch.91-18; SCHARTL M, 1995, NATURE, V373, P68, DOI 10.1038/373068a0; Sharbel TF, 1998, GENOME, V41, P14, DOI 10.1139/gen-41-1-14; Silva MJD, 1998, CHROMOSOME RES, V6, P455; Silva MJD, 1997, HEREDITAS, V127, P217, DOI 10.1111/j.1601-5223.1997.00217.x; Silva MJJ, 2004, CYTOGENET GENOME RES, V106, P257, DOI 10.1159/000079296; Smith Margaret F., 1999, Journal of Mammalian Evolution, V6, P89, DOI 10.1023/A:1020668004578; Stitou S, 2000, CHROMOSOME RES, V8, P305, DOI 10.1023/A:1009227427575; TELENIUS H, 1992, GENE CHROMOSOME CANC, V4, P257, DOI 10.1002/gcc.2870040311; Trifonov VA, 2010, RUSS J GENET+, V46, P1094, DOI 10.1134/S1022795410090206; Trifonov VA, 2002, CHROMOSOME RES, V10, P109, DOI 10.1023/A:1014940800901; Trifonov VA, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-90; Ventura K, 2012, CYTOGENET GENOME RES, V138, P19, DOI 10.1159/000341887; Weksler M, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3537[1:TNGOOR]2.0.CO;2; WURSTERHILL DH, 1988, CYTOGENET CELL GENET, V49, P278, DOI 10.1159/000132677; YANG F, 1995, CHROMOSOMA, V103, P642, DOI 10.1007/BF00357691	41	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136663	10.1371/journal.pone.0136663	http://dx.doi.org/10.1371/journal.pone.0136663			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305702	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500106
J	Zhou, QM; Ye, MN; Lu, YY; Zhang, H; Chen, QL; Huang, S; Su, SB				Zhou, Qianmei; Ye, Meina; Lu, Yiyu; Zhang, Hui; Chen, Qilong; Huang, Shuang; Su, Shibing			Curcumin Improves the Tumoricidal Effect of Mitomycin C by Suppressing ABCG2 Expression in Stem Cell-Like Breast Cancer Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; IN-VITRO PROPAGATION; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; TRANSPORTER; CHEMOTHERAPY; APOPTOSIS; IDENTIFICATION; DOCETAXEL	Cancer cells with stem cell-like properties contribute to the development of resistance to chemotherapy and eventually to tumor relapses. The current study investigated the potential of curcumin to reduce breast cancer stem cell (BCSC) population for sensitizing breast cancer cells to mitomycin C (MMC) both in vitro and in vivo. Curcumin improved the sensitivity of paclitaxel, cisplatin, and doxorubicin in breast cancer cell lines MCF-7 and MDA-MB-231, as shown by the more than 2-fold decrease in the half-maximal inhibitory concentration of these chemotherapeutic agents. In addition, curcumin sensitized the BCSCs of MCF-7 and MDA-MB-231 to MMC by 5- and 15-fold, respectively. The BCSCs could not grow to the fifth generation in the presence of curcumin and MMC. MMC or curcumin alone only marginally reduced the BCSC population in the mammospheres; however, together, they reduced the BCSC population in CD44(+) CD24(-/low) cells by more than 75% (29.34% to 6.86%). Curcumin sensitized BCSCs through a reduction in the expression of ATP-binding cassette (ABC) transporters ABCG2 and ABCC1. We demonstrated that fumitremorgin C, a selective ABCG2 inhibitor, reduced BCSC survival to a similar degree as curcumin did. Curcumin sensitized breast cancer cells to chemotherapeutic drugs by reducing the BCSC population mainly through a reduction in the expression of ABCG2.	[Zhou, Qianmei; Lu, Yiyu; Zhang, Hui; Chen, Qilong; Su, Shibing] Shanghai Univ Tradit Chinese Med, Res Ctr Tradit Chinese Med Complex Syst, Shanghai, Peoples R China; [Ye, Meina] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Shanghai, Peoples R China; [Huang, Shuang] Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; University System of Georgia; Augusta University	Su, SB (corresponding author), Shanghai Univ Tradit Chinese Med, Res Ctr Tradit Chinese Med Complex Syst, Shanghai, Peoples R China.	shibingsu07@163.com	, 陈启龙_SHUTCM/AAR-5098-2020					Abdullah LN, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-3; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anto RJ, 2002, CARCINOGENESIS, V23, P143, DOI 10.1093/carcin/23.1.143; Behbod F, 2005, CARCINOGENESIS, V26, P703, DOI 10.1093/carcin/bgh293; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Borst P, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120066; Brevig T, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-10; Chen YL, 2012, J CELL BIOCHEM, V113, P3643, DOI 10.1002/jcb.24228; Colak S, 2014, CELL DEATH DIFFER, V21, P1170, DOI 10.1038/cdd.2014.37; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Fong D, 2010, CANCER LETT, V293, P65, DOI 10.1016/j.canlet.2009.12.018; Gatti L, 2009, MINI-REV MED CHEM, V9, P1102, DOI 10.2174/138955709788922656; Hu YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125625; Kim SH, 2013, CANCER PREV RES, V6, P782, DOI 10.1158/1940-6207.CAPR-13-0100; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lu WD, 2013, CLINICS, V68, P694, DOI 10.6061/clinics/2013(05)18; Masuelli L, 2013, J BIOL REG HOMEOS AG, V27, P105; Nobuto H, 2004, INT J CANCER, V109, P627, DOI 10.1002/ijc.20035; Norris L, 2013, MOL NUTR FOOD RES, V57, P1630, DOI 10.1002/mnfr.201300120; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Shukla S, 2009, PHARM RES-DORDR, V26, P480, DOI 10.1007/s11095-008-9735-8; Siddiqui RA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-418; Sreenivasan S, 2012, BIOINFORMATION, V8, P13; Sun YL, 2012, CHIN J CANCER, V31, P51, DOI 10.5732/cjc.011.10466; Tan KW, 2013, FOOD CHEM, V138, P2267, DOI 10.1016/j.foodchem.2012.12.021; Tanaka T, 2012, MOLECULES, V17, P3202, DOI 10.3390/molecules17033202; Vazquez-Martin A, 2011, BREAST CANCER RES TR, V126, P355, DOI 10.1007/s10549-010-0924-x; Vidal SJ, 2014, ONCOGENE, V33, P4451, DOI 10.1038/onc.2013.411; Vulsteke C, 2013, ANN ONCOL, V24, P1513, DOI 10.1093/annonc/mdt008; Wang XH, 2015, CURR PROTEIN PEPT SC, V16, P270, DOI 10.2174/138920371604150429151457; Wang XY, 2012, J BIOMED RES, V26, P325, DOI 10.7555/JBR.26.20110050; Wu KM, 2011, J BIOL CHEM, V286, P2132, DOI 10.1074/jbc.M110.148395; Yang L, 2011, PHYTOMEDICINE, V18, P710, DOI 10.1016/j.phymed.2010.11.017; Ye MX, 2012, PHYTOMEDICINE, V19, P779, DOI 10.1016/j.phymed.2012.03.005; Yu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087129; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu Yang, 2012, Front Biosci (Elite Ed), V4, P1528; Zhang XB, 2012, EUR J CANCER, V48, P1581, DOI 10.1016/j.ejca.2012.02.053; Zhou QM, 2011, EUR J CANCER, V47, P2240, DOI 10.1016/j.ejca.2011.04.032; Zhu YZ, 2013, MOL CANCER THER, V12, P1829, DOI 10.1158/1535-7163.MCT-13-0208	47	54	58	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136694	10.1371/journal.pone.0136694	http://dx.doi.org/10.1371/journal.pone.0136694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305906	gold, Green Submitted, Green Published			2022-12-27	WOS:000359995500108
J	Deshmukh, RD; Dhande, DJ; Sachdeva, KS; Sreenivas, A; Kumar, AMV; Satyanarayana, S; Parmar, M; Moonan, PK; Lo, TQ				Deshmukh, Rajesh D.; Dhande, D. J.; Sachdeva, Kuldeep Singh; Sreenivas, Achuthan; Kumar, A. M. V.; Satyanarayana, Srinath; Parmar, Malik; Moonan, Patrick K.; Lo, Terrence Q.			Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in India	PLOS ONE			English	Article							TUBERCULOSIS TREATMENT; RUSSIAN-FEDERATION; PROGRAM; DEFAULT; TOMSK	Introduction Multidrug-resistant Tuberculosis (MDR TB) is emerging public health concern globally. Lost to follow-up (LTFU) is one of the key challenge in MDRTB treatment. In 2013, 18% of MDR TB patients were reported LTFU in India. A qualitative study was conducted to obtain better understanding of both patient and provider related factors for LTFU among MDR TB treatment. Methods Qualitative semi-structured personal interviews were conducted with 20 MDRTB patients reported as LTFU and 10 treatment providers in seven districts linked to Nagpur Drug resistant TB Centre (DRTBC) during August 2012-February 2013. Interviews were transcribed and inductive content analysis was performed to derive emergent themes. Results We found multiple factors influencing MDR TB treatment adherence. Barriers to treatment adherence included drug side effects, a perceived lack of provider support, patient financial constraints, conflicts with the timing of treatment services, alcoholism and social stigma. Conclusions Patient adherence to treatment is multi-factorial and involves individual patient factors, provider factors, and community factors. Addressing issue of LTFU during MDRTB treatment requires enhanced efforts towards resolving medical problems like adverse drug effects, developing short duration treatment regimens, reducing pill burden, motivational counselling, flexible timings for DOT services, social, family support for patients & improving awareness about disease.	[Deshmukh, Rajesh D.; Sreenivas, Achuthan; Parmar, Malik] World Hlth Org, Country Off India, New Delhi, India; [Dhande, D. J.] Lata Mangeshkar Hosp, Drug Resistant TB Ctr, Dept Pulm Med, Nagpur, Maharashtra, India; [Sachdeva, Kuldeep Singh] Minist Hlth & Family Welf, Cent TB Div, New Delhi, India; [Kumar, A. M. V.] South East Asia Off, Int Union TB & Lung Dis, New Delhi, India; [Moonan, Patrick K.; Lo, Terrence Q.] US Ctr Dis Control & Prevent, Div TB Eliminat, Int Res Programs Branch, Atlanta, GA USA; [Satyanarayana, Srinath] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada	World Health Organization; Centers for Disease Control & Prevention - USA; McGill University	Deshmukh, RD (corresponding author), Minist Hlth & Family Welf, Dept AIDS Control NACO, New Delhi, India.	pohivtb.naco@gmail.com	Moonan, Patrick/AAD-2169-2021	Moonan, Patrick/0000-0002-3550-2065; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Satyanarayana, Srinath/0000-0002-5420-2551; Nair, Sreenivas/0000-0002-2586-6797	Central TB division New Delhi; National TB institute Bangalore; State TB cell Maharashtra; State TB demonstration centre Nagpur	Central TB division New Delhi; National TB institute Bangalore; State TB cell Maharashtra; State TB demonstration centre Nagpur	This training project was conceived and implemented jointly by Central TB Division (Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India), The National TB Institute (Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India Bangalore, India), World Health Organization (India Country Office), The International Union Against Tuberculosis and Lung Diseases (The Union, South-East Asia Regional Office, New Delhi, India) and U.S. Centers for Disease Control and Prevention (Division of TB Elimination, Atlanta, USA). We acknowledge support of the Central TB division New Delhi, National TB institute Bangalore, State TB cell Maharashtra, State TB demonstration centre Nagpur. We also appreciate the help of Gaikwad P, Chavan. H, Kamble.M and Khan.N.	Ahmad S, 2009, RESP MED, V103, P1777, DOI 10.1016/j.rmed.2009.07.010; BARNHOORN F, 1992, SOC SCI MED, V34, P291, DOI 10.1016/0277-9536(92)90271-Q; Central Tuberculosis Division, 2014, TB IND 2014 REV NAT; Central Tuberculosis Division Directorate General of Health Services Ministry of Health and Family Welfare, 2012, GUID PROGR MAN DRUG; Cox H, DEFAULT DRUG RESISTA; Gelmanova IY, 2007, B WORLD HEALTH ORGAN, V85, P703, DOI 10.2471/BLT.06.038331; Gler MT, 2012, INT J TUBERC LUNG D, V16, P955, DOI 10.5588/ijtld.11.0502; Isaakidis P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040781; Jaiswal A, 2003, TROP MED INT HEALTH, V8, P625, DOI 10.1046/j.1365-3156.2003.01061.x; Jakubowiak WM, 2007, INT J TUBERC LUNG D, V11, P1210; Kurbatova EV, 2012, TUBERCULOSIS, V92, P397, DOI 10.1016/j.tube.2012.06.003; Shean K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063057; Shin S, 2013, ADDICTION; Shin SS, 2007, INT J TUBERC LUNG D, V11, P1314; Vega F, 2004, INT J TUBERC LUNG D, V8, P749; World Health Organization, 2013, DEFINITIONS REPORTIN; World Health Organization, 2014, WHOHTMTB201408	17	44	44	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135802	10.1371/journal.pone.0135802	http://dx.doi.org/10.1371/journal.pone.0135802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301748	gold, Green Published, Green Submitted			2022-12-27	WOS:000359951900031
J	Holzmeyer, L; Duretto, M; Crayn, D; Horandl, E; Heslewood, M; Jayanthan, J; Appelhans, MS				Holzmeyer, Laura; Duretto, Marco; Crayn, Darren; Hoerandl, Elvira; Heslewood, Margaret; Jayanthan, Janani; Appelhans, Marc S.			Phylogeny of Acronychia (Rutaceae) and First Insights into Its Historical Biogeography and the Evolution of Fruit Characters	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; CLADISTIC-ANALYSIS; NONCODING REGIONS; GEOGRAPHIC RANGE; REVISION; SUBFAMILIES; DISPERSAL; INFERENCE; MELICOPE; CLASSIFICATION	Background The genus Acronychia (Citrus family, Rutaceae) contains 49 species of trees and shrubs that are found mainly in rain forest. The genus has a large distributional range from mainland southern Asia to Australia and New Caledonia, but most species are endemic to either New Guinea or Australia. This study aimed to provide the first detailed molecular phylogeny of Acronychia and use it to test the taxonomic value of fruit morphological characters, and infer the historical biogeography of the genus. Methodology Phylogenetic analyses (Bayesian Inference, Maximum Likelihood) were undertaken on nucleotide sequence data from two plastid (psbA-trnH, trnL-trnF) and three nuclear markers (ETS, ITS, NIAi3) from 29 Acronychia species (59% of the genus) and representatives of related genera. Results and Conclusions The results indicate that the South-East Asian genus Maclurodendron is nested phylogenetically within Acronychia and must be synonymized to render Acronychia monophyletic. Fruit morphological characters have been used previously to infer relationships within Acronychia and our analyses show that these characters are informative for some subclades but are homoplasious for the group as a whole. Apocarpous fruits are the ancestral state in Acronychia and subapocarpous and fully syncarpous fruits are derived. The unisexual flowers of Maclurodendron are derived from bisexual flowers, which are found in all species of Acronychia as well as its relatives. Acronychia probably first evolved on Australia with range expansion to New Guinea via stepping-stone dispersal or direct land connections within the Sahul Shelf, followed by two independent dispersals to areas west of New Guinea. Most species of Acronychia occur in either Australia or New Guinea, but no species occurs in both regions. This is surprising given the close proximity of the landmasses, but might be explained by ecological factors.	[Holzmeyer, Laura; Hoerandl, Elvira; Appelhans, Marc S.] Univ Gottingen, Dept Systemat Biodivers & Evolut Plants, D-37073 Gottingen, Germany; [Duretto, Marco; Heslewood, Margaret] Royal Bot Gardens & Domain Trust, Natl Herbarium New South Wales, Sydney, NSW, Australia; [Crayn, Darren; Jayanthan, Janani] James Cook Univ, Australian Trop Herbarium, Cairns, Australia; [Appelhans, Marc S.] Smithsonian Inst, Dept Bot, Washington, DC 20560 USA	University of Gottingen; James Cook University; Smithsonian Institution; Smithsonian National Museum of Natural History	Appelhans, MS (corresponding author), Univ Gottingen, Dept Systemat Biodivers & Evolut Plants, Untere Karspule 2, D-37073 Gottingen, Germany.	marc.appelhans@biologie.uni-goettingen.de	Horandl, Elvira/AAQ-9588-2021; Crayn, Darren M/A-7386-2011	Crayn, Darren M/0000-0001-6614-4216; Holzmeyer, Laura/0000-0001-5789-8673	Open Access Publication Funds of Gottingen University	Open Access Publication Funds of Gottingen University	The authors acknowledge support by the Open Access Publication Funds of Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelhans MS, 2011, ANN BOT-LONDON, V107, P1259, DOI 10.1093/aob/mcr076; Appelhans MS, 2014, MOL PHYLOGENET EVOL, V79, P54, DOI 10.1016/j.ympev.2014.06.014; Appelhans MS, 2014, BOT J LINN SOC, V174, P425, DOI 10.1111/boj.12123; Baldwin BG, 1998, MOL PHYLOGENET EVOL, V10, P449, DOI 10.1006/mpev.1998.0545; Barlow BA, 1981, FLORA AUSTR, V1, P25; Bayer RJ, 2009, AM J BOT, V96, P668, DOI 10.3732/ajb.0800341; Bayly MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072493; Becerra JX, 2003, MOL PHYLOGENET EVOL, V26, P300, DOI 10.1016/S1055-7903(02)00256-7; Chase MW, 1999, AM J BOT, V86, P1191, DOI 10.2307/2656983; Crayn DM, 2015, J BIOGEOGR, V42, P11, DOI 10.1111/jbi.12405; CRONQUIST A, 1978, EVOLUTION CLASSIFICA; DA SILVA MFGF, 1988, PLANT SYST EVOL, V161, P97; Dahlgren G., 1989, PLANT TAXONOMY PHYTO, P249; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dianxiang Z, 2008, FLORA CHINA, P51; Engler H.G.A., 1931, NATURLICHEN PFLANZEN, P187; Floyd A.G., 1989, RAINFOREST TREES MAI; FRITH H J, 1976, Emu, V76, P49; Gadek PA, 1996, AM J BOT, V83, P802, DOI 10.2307/2445857; Green PS, 1993, KEW B, V48, P308; Groppo M, 2008, AM J BOT, V95, P985, DOI 10.3732/ajb.2007313; Hartley T, 1984, B MUSEE HIST NAT 6 B, V6, P29; HARTLEY T G, 1991, Australian Systematic Botany, V4, P445, DOI 10.1071/SB9910445; HARTLEY T G, 1982, Reinwardtia, V10, P93; Hartley T. G., 1982, Gardens' Bulletin, V35, P1; HARTLEY T G, 1983, Bulletin du Museum National d'Histoire Naturelle Section B Adansonia Botanique Phytochimie, V5, P391; Hartley T. G., 2001, Allertonia, V8, P1; Hartley T.G., 2013, FLORA AUSTR MELIACEA, V26, P104; HARTLEY TG, 1979, J ARNOLD ARBORETUM, V60, P127, DOI 10.5962/bhl.part.12825; HARTLEY TG, 1985, AUST J BOT, V33, P27, DOI 10.1071/BT9850027; HARTLEY TG, 1982, AUST J BOT, V30, P359, DOI 10.1071/BT9820359; HARTLEY TG, 1974, J ARNOLD ARBORETUM, V55, P469; Hartley Thomas G., 1997, Adansonia (Paris), V19, P189; Hartley Thomas G., 2003, Adansonia (Paris), V25, P251; Hoogland RD, 1975, BRIDGE BARRIER NATUR, P131; INNIS GJ, 1989, AUST WILDLIFE RES, V16, P365; Kubitzki K., 2011, V10, P276; Lucas EJ, 2007, TAXON, V56, P1105, DOI 10.2307/25065906; Maddison WP., 2021, MESQUITE MODULAR SYS; Matzke N.J., 2013, FRONT BIOGEOGR, V5, P242, DOI [DOI 10.21425/F5FBG19694, 10.21425/F5FBG19694]; Morton CM, 2014, ANN MO BOT GARD, V99, P620, DOI 10.3417/2010034; NG KM, 1987, BIOCHEM SYST ECOL, V15, P587, DOI 10.1016/0305-1978(87)90110-4; Poon WS, 2007, SYST BOT, V32, P837, DOI 10.1600/036364407783390692; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pratt T.K., 2015, BIRDS NEW GUINEA, DOI 10.1515/9781400865116; Rambaut A, 2013, TRACER V1 6; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rossetto M, 2005, BIOL CONSERV, V121, P35, DOI 10.1016/j.biocon.2004.04.007; Rowe C, 2007, PALAEOGEOGR PALAEOCL, V251, P83, DOI 10.1016/j.palaeo.2007.02.019; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Scott KD, 2000, PLANT SYST EVOL, V223, P15, DOI 10.1007/BF00985324; Simpson K, 1996, PRINCETON FIELD GUID; Stanford AM, 2000, AM J BOT, V87, P872, DOI 10.2307/2656895; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Takeuchi W., 2007, Harvard Papers in Botany, V11, P203, DOI 10.3100/1043-4534(2007)11[203:NOARFT]2.0.CO;2; Takhtajan A, 1997, DIVERSITY CLASSIFICA; Tate JA, 2003, SYST BOT, V28, P723; Van Steenis C. G. G. J., 1950, FLORA MALESIANA, V1, pXX, DOI DOI 10.1111/J.1365-2699.2011.02519.X; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wace NM., 1975, BRIDGE BARRIER NATUR, P197; Waterman PG, 2007, PHYTOCHEMISTRY, V68, P2896, DOI 10.1016/j.phytochem.2007.06.029; Waterman PG, 1975, BIOCHEM SYST ECOL, V3, P149, DOI DOI 10.1016/0305-1978(75)90019-8; Webb LJ, 1975, BRIDGE BARRIER NATUR, P109; Weeks A, 2009, GENET RESOUR CROP EV, V56, P765, DOI 10.1007/s10722-008-9400-4; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wright SD, 2001, J BIOGEOGR, V28, P769, DOI 10.1046/j.1365-2699.2001.00605.x; Yu J, 2012, SATEE VERSION 2 2 2; Zwickl DJ., 2006, THESIS	72	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136296	10.1371/journal.pone.0136296	http://dx.doi.org/10.1371/journal.pone.0136296			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301574	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000359951900055
J	Newe, A; Wimmer, S; Neubert, A; Becker, L; Prokosch, HU; Beckmann, MW; Fietkau, R; Forster, C; Neurath, MF; Schett, G; Ganslandt, T				Newe, Axel; Wimmer, Stefan; Neubert, Antje; Becker, Linda; Prokosch, Hans-Ulrich; Beckmann, Matthias W.; Fietkau, Rainer; Forster, Christian; Neurath, Markus Friedrich; Schett, Georg; Ganslandt, Thomas			Towards a Computable Data Corpus of Temporal Correlations between Drug Administration and Lab Value Changes	PLOS ONE			English	Article							CLINICAL LABORATORY TESTS; RELIABILITY; HOSPITALS; EVENTS	Background The analysis of electronic health records for an automated detection of adverse drug reactions is an approach to solve the problems that arise from traditional methods like spontaneous reporting or manual chart review. Algorithms addressing this task should be modeled on the criteria for a standardized case causality assessment defined by the World Health Organization. One of these criteria is the temporal relationship between drug intake and the occurrence of a reaction or a laboratory test abnormality. Appropriate data that would allow for developing or validating related algorithms is not publicly available, though. Methods In order to provide such data, retrospective routine data of drug administrations and temporally corresponding laboratory observations from a university clinic were extracted, transformed and evaluated by experts in terms of a reasonable time relationship between drug administration and lab value alteration. Result The result is a data corpus of 400 episodes of normalized laboratory parameter values in temporal context with drug administrations. Each episode has been manually classified whether it contains data that might indicate a temporal correlation between the drug administration and the change of the lab value course, whether such a change is not observable or whether a decision between those two options is not possible due to the data. In addition, each episode has been assigned a concordance value which indicates how difficult it is to assess. This is the first open data corpus of a computable ground truth of temporal correlations between drug administration and lab value alterations. Discussion The main purpose of this data corpus is the provision of data for further research and the provision of a ground truth which allows for comparing the outcome of other assessments of this data with the outcome of assessments made by human experts. It can serve as a contribution towards systematic, computerized ADR detection in retrospective data. With this lab value curve data as a basis, algorithms for detecting temporal relationships can be developed, and with the classification made by human experts, these algorithms can immediately be validated. Due to the normalization of the lab value data, it allows for a generic approach rather than for specific or solitary drug/lab value combinations.	[Newe, Axel; Prokosch, Hans-Ulrich] Univ Erlangen Nurnberg, Chair Med Informat, D-91054 Erlangen, Germany; [Wimmer, Stefan; Neubert, Antje] Univ Hosp Erlangen, Dept Paediat & Adolescent Med, Erlangen, Germany; [Becker, Linda] Univ Erlangen Nurnberg, Inst Psychol, D-91054 Erlangen, Germany; [Beckmann, Matthias W.] Univ Hosp Erlangen, Dept Gynecol & Obstet, Erlangen, Germany; [Fietkau, Rainer] Univ Hosp Erlangen, Dept Radiat Therapy, Erlangen, Germany; [Forster, Christian] Univ Hosp Erlangen, Dept Internal Med 4, Erlangen, Germany; [Neurath, Markus Friedrich] Univ Hosp Erlangen, Dept Internal Med 1, Erlangen, Germany; [Schett, Georg] Univ Hosp Erlangen, Dept Internal Med 3, Erlangen, Germany; [Ganslandt, Thomas] Univ Hosp Erlangen, Med Ctr Informat & Commun Technol, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Newe, A (corresponding author), Univ Erlangen Nurnberg, Chair Med Informat, D-91054 Erlangen, Germany.	axel.newe@fau.de	Newe, Axel/J-8580-2015; Fietkau, Rainer/A-9632-2017; rzhetsky, andrey/B-6118-2012; Ganslandt, Thomas/AAC-6690-2019	Newe, Axel/0000-0003-0843-2900; rzhetsky, andrey/0000-0001-6959-7405; Ganslandt, Thomas/0000-0001-6864-8936; Wimmer, Stefan/0000-0002-7195-7155; Becker, Linda/0000-0002-9950-6882	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation); Friedrich-Alexander-University Erlangen-Nuremberg	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Friedrich-Alexander-University Erlangen-Nuremberg	The authors acknowledge support by Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) and Friedrich-Alexander-University Erlangen-Nuremberg within the funding program Open Access Publishing.	[Anonymous], US WHO UMC SYST STAN; Classen DC, 2011, HEALTH AFFAIR, V30, P581, DOI 10.1377/hlthaff.2011.0190; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Council for International Organizations of Medical Sciences, 1999, GUID PREP COR CLIN S; CURRAN WJ, 1971, NEW ENGL J MED, V284, P481, DOI 10.1056/NEJM197103042840906; GRONROOS P, 1995, SCAND J CLIN LAB INV, V55, P31, DOI 10.3109/00365519509088448; Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664; Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592; KRIPPEND.K, 1970, EDUC PSYCHOL MEAS, V30, P61, DOI 10.1177/001316447003000105; Krippendorff K., 2011, COMPUTING KRIPPENDOR; Krippendorff K., 2012, CONTENT ANAL INTRO I; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Liu Yi, 2012, AMIA Jt Summits Transl Sci Proc, V2012, P47; Meier F, 2015, PHARMACOEPIDEM DR S, V24, P176, DOI 10.1002/pds.3663; Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893; Neubert A, 2013, BRIT J CLIN PHARMACO, V76, P69, DOI 10.1111/bcp.12127; Ramirez E, 2010, CLIN PHARMACOL THER, V87, P74, DOI 10.1038/clpt.2009.185; Scott WA, 1955, PUBLIC OPIN QUART, V19, P321, DOI 10.1086/266577; Siest G., 1980, DRUG EFFECTS LAB TES; Tatonetti NP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003377; Torsvik T, 2013, J AM MED INFORM ASSN, V20, P325, DOI 10.1136/amiajnl-2012-001147; YOUNG DS, 1972, CLIN CHEM, V18, P1041; Young DS., 2000, EFFECTS DRUGS CLIN L, V2	24	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136131	10.1371/journal.pone.0136131	http://dx.doi.org/10.1371/journal.pone.0136131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301507	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900041
J	Ryder, DJ; Judge, SM; Beharry, AW; Farnsworth, CL; Silva, JC; Judge, AR				Ryder, Daniel J.; Judge, Sarah M.; Beharry, Adam W.; Farnsworth, Charles L.; Silva, Jeffrey C.; Judge, Andrew R.			Identification of the Acetylation and Ubiquitin-Modified Proteome during the Progression of Skeletal Muscle Atrophy	PLOS ONE			English	Article							IN-VIVO PHOSPHORYLATION; LARGE GENE LISTS; LYSINE ACETYLATION; HISTONE ACETYLATION; POSTTRANSLATIONAL MODIFICATIONS; IMMUNOAFFINITY ENRICHMENT; LIMB IMMOBILIZATION; SIGNALING PATHWAYS; PASSIVE STIFFNESS; MASS-SPECTROMETRY	Skeletal muscle atrophy is a consequence of several physiological and pathophysiological conditions including muscle disuse, aging and diseases such as cancer and heart failure. In each of these conditions, the predominant mechanism contributing to the loss of skeletal muscle mass is increased protein turnover. Two important mechanisms which regulate protein stability and degradation are lysine acetylation and ubiquitination, respectively. However our understanding of the skeletal muscle proteins regulated through acetylation and ubiquitination during muscle atrophy is limited. Therefore, the purpose of the current study was to conduct an unbiased assessment of the acetylation and ubiquitin-modified proteome in skeletal muscle during a physiological condition of muscle atrophy. To induce progressive, physiologically relevant, muscle atrophy, rats were cast immobilized for 0, 2, 4 or 6 days and muscles harvested. Acetylated and ubiquitinated peptides were identified via a peptide IP proteomic approach using an anti-acetyl lysine antibody or a ubiquitin remnant motif antibody followed by mass spectrometry. In control skeletal muscle we identified and mapped the acetylation of 1,326 lysine residues to 425 different proteins and the ubiquitination of 4,948 lysine residues to 1,131 different proteins. Of these proteins 43, 47 and 50 proteins were differentially acetylated and 183, 227 and 172 were differentially ubiquitinated following 2, 4 and 6 days of disuse, respectively. Bioinformatics analysis identified contractile proteins as being enriched among proteins decreased in acetylation and increased in ubiquitination, whereas histone proteins were enriched among proteins increased in acetylation and decreased in ubiquitination. These findings provide the first proteome-wide identification of skeletal muscle proteins exhibiting changes in lysine acetylation and ubiquitination during any atrophy condition, and provide a basis for future mechanistic studies into how the acetylation and ubiquitination status of these identified proteins regulates the muscle atrophy phenotype.	[Ryder, Daniel J.; Judge, Sarah M.; Beharry, Adam W.; Judge, Andrew R.] Univ Florida, Dept Phys Therapy, Gainesville, FL 32611 USA; [Farnsworth, Charles L.; Silva, Jeffrey C.] Cell Signaling Technol, Danvers, MA USA	State University System of Florida; University of Florida	Judge, AR (corresponding author), Univ Florida, Dept Phys Therapy, Gainesville, FL 32611 USA.	arjudge@phhp.ufl.edu		Judge, Sarah/0000-0002-3974-0247	U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR060209]; National Institute of Child Health and Human Development [T32-HD-043730]; Cell Signaling Technology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD043730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060209] Funding Source: NIH RePORTER	U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Cell Signaling Technology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases grant R01AR060209 (to A.R.J.). A.W.B. is supported by a T32 from the National Institute of Child Health and Human Development Grant T32-HD-043730. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Cell Signaling Technology provided support in the form of salaries for authors C.L.F. and J.C.S., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahtikoski AM, 2003, ACTA PHYSIOL SCAND, V177, P473, DOI 10.1046/j.1365-201X.2003.01061.x; Appella E, 2000, PATHOL BIOL, V48, P227; Argiles Josep M, 2009, Curr Opin Support Palliat Care, V3, P263, DOI 10.1097/SPC.0b013e3283311d09; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Beharry AW, 2014, J CELL SCI, V127, P1441, DOI 10.1242/jcs.136390; Bicer S, 2004, INVEST OPHTH VIS SCI, V45, P138, DOI 10.1167/iovs.03-0716; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bongers KS, 2013, AM J PHYSIOL-ENDOC M, V305, pE907, DOI 10.1152/ajpendo.00380.2013; Bonnette PC, 2010, J PROTEOMICS, V73, P1306, DOI 10.1016/j.jprot.2010.01.011; BOOTH FW, 1973, PFLUG ARCH EUR J PHY, V342, P231, DOI 10.1007/BF00591371; BOOTH FW, 1982, J APPL PHYSIOL, V52, P1113; BOOTH FW, 1973, J APPL PHYSIOL, V34, P404, DOI 10.1152/jappl.1973.34.3.404; Brave SR, 2011, MOL CANCER THER, V10, P861, DOI 10.1158/1535-7163.MCT-10-0976; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Cao J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00026; CARLSON N, 1987, J CELL BIOL, V104, P547, DOI 10.1083/jcb.104.3.547; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Coats AJS, 2002, INT J CARDIOL, V85, P133, DOI 10.1016/S0167-5273(02)00242-5; Cosper PF, 2012, INT J CANCER, V130, P2722, DOI 10.1002/ijc.26298; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Demos-Davies KM, 2014, AM J PHYSIOL-HEART C, V307, pH252, DOI 10.1152/ajpheart.00149.2014; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; Dodd SL, 2009, FASEB J, V23, P3415, DOI 10.1096/fj.08-124602; Dudgeon WD, 2006, HIV MED, V7, P299, DOI 10.1111/j.1468-1293.2006.00380.x; EDES I, 1980, ACTA BIOCHIM BIOPHYS, V15, P305; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Fukuda N, 2005, J GEN PHYSIOL, V125, P257, DOI 10.1085/jgp.200409177; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; GRABAREK Z, 1995, BIOCHEMISTRY-US, V34, P11872, DOI 10.1021/bi00037a027; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Gupta MP, 2008, J BIOL CHEM, V283, P10135, DOI 10.1074/jbc.M710277200; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hasselgren PO, 2000, WORLD J SURG, V24, P1452, DOI 10.1007/s002680010262; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hidalgo C, 2013, TRENDS CARDIOVAS MED, V23, P165, DOI 10.1016/j.tcm.2012.10.005; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jacobson AD, 2014, MOL BIOL CELL, V25, P1824, DOI 10.1091/mbc.E13-10-0585; Jeffers V, 2012, EUKARYOT CELL, V11, P735, DOI 10.1128/EC.00088-12; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Klaude M, 2007, CLIN SCI, V112, P499, DOI 10.1042/CS20060265; Kruger M, 2011, J BIOL CHEM, V286, P9905, DOI 10.1074/jbc.R110.173260; Kruger M, 2009, CIRC RES, V104, P87, DOI 10.1161/CIRCRESAHA.108.184408; Kurash JK, 2008, MOL CELL, V29, P392, DOI 10.1016/j.molcel.2007.12.025; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Lundgren DH, 2009, ANDREAS D BAXEVANIS, DOI [10.1002/0471250953.bi1303s28, DOI 10.1002/0471250953.BI1303S28]; Marx J, 2002, SCIENCE, V297, P1792, DOI 10.1126/science.297.5588.1792; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; MUNOZ KA, 1993, METABOLISM, V42, P1006, DOI 10.1016/0026-0495(93)90014-F; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Ratti F, 2015, J BIOL CHEM, V290, P4215, DOI 10.1074/jbc.M114.600916; Roberts BM, 2013, FASEB J, V27, P2600, DOI 10.1096/fj.12-222844; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Samant SA, 2011, J BIOL CHEM, V286, P5567, DOI 10.1074/jbc.M110.163865; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Senf SM, 2011, AM J PHYSIOL-CELL PH, V300, pC1490, DOI 10.1152/ajpcell.00255.2010; SOMERVILLE LL, 1987, BIOCHEM BIOPH RES CO, V147, P986, DOI 10.1016/S0006-291X(87)80167-5; SOMERVILLE LL, 1988, ARCH BIOCHEM BIOPHYS, V262, P118, DOI 10.1016/0003-9861(88)90174-9; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Stokes MP, 2012, MOL CELL PROTEOMICS, V11, P187, DOI 10.1074/mcp.M111.015883; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Timson DJ, 1998, EUR J BIOCHEM, V255, P654, DOI 10.1046/j.1432-1327.1998.2550654.x; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; TRAYER IP, 1987, EUR J BIOCHEM, V164, P259, DOI 10.1111/j.1432-1033.1987.tb11019.x; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Walter W, 2008, MOL CELL BIOL, V28, P2840, DOI 10.1128/MCB.01457-07; WANG K, 1984, P NATL ACAD SCI-BIOL, V81, P3685, DOI 10.1073/pnas.81.12.3685; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Witt SH, 2005, J MOL BIOL, V350, P713, DOI 10.1016/j.jmb.2005.05.021; WITZMANN FA, 1982, J APPL PHYSIOL, V53, P335, DOI 10.1152/jappl.1982.53.2.335; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yuan C, 2005, CURR OPIN MOL THER, V7, P234	95	26	27	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136247	10.1371/journal.pone.0136247	http://dx.doi.org/10.1371/journal.pone.0136247			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302492	Green Submitted, Green Published, gold			2022-12-27	WOS:000359951900052
J	Harrison, LA; Ahn, C; Adolphs, R				Harrison, Laura A.; Ahn, Curie; Adolphs, Ralph			Exploring the Structure of Human Defensive Responses from Judgments of Threat Scenarios	PLOS ONE			English	Article							SOCIAL STRESS; KNOCKOUT MICE; ANXIETY; FEAR; AMYGDALA; EMOTION; PERSONALITY; MECHANISMS; REACTIVITY; MOTIVATION	How humans react to threats is a topic of broad theoretical importance, and also relevant for understanding anxiety disorders. Many animal threat reactions exhibit a common structure, a finding supported by human evaluations of written threat scenarios that parallel patterns of rodent defensive behavior to actual threats. Yet the factors that underlie these shared behavioral patterns remain unclear. Dimensional accounts rooted in Darwin's conception of antithesis explain many defensive behaviors. Across species, it is also clear that defensive reactions depend on specific situational factors, a feature long emphasized by psychological appraisal theories. Our study sought to extend prior investigations of human judgments of threat to a broader set of threats, including natural disasters, threats from animals, and psychological (as opposed to physical) threats. Our goal was to test whether dimensional and specific patterns of threat evaluation replicate across different threat classes. 85 healthy adult subjects selected descriptions of defensive behaviors that indicated how they would react to 29 threatening scenarios. Scenarios differed with respect to ten factors, e.g., perceived dangerousness or escapability. Across scenarios, we correlated these factor ratings with the pattern of defensive behaviors subjects endorsed. A decision tree hierarchically organized these correlation patterns to successfully predict each scenario's most common reaction, both for the original sample of subjects and a separate replication group (n = 22). At the top of the decision tree, degree of dangerousness interacted with threat type (physical or psychological) to predict dimensional approach/avoidance behavior. Subordinate nodes represented specific defensive responses evoked by particular contexts. Our ecological approach emphasizes the interplay of situational factors in evoking a broad range of threat reactions. Future studies could test predictions made by our results to help understand pathological threat processing, such as seen in anxiety disorders, and could begin to test underlying neural mechanisms.	[Harrison, Laura A.] CALTECH, Computat & Neural Syst, Pasadena, CA 91125 USA; [Ahn, Curie; Adolphs, Ralph] CALTECH, Biol, Pasadena, CA 91125 USA; [Adolphs, Ralph] CALTECH, Humanities & Social Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Harrison, LA (corresponding author), CALTECH, Computat & Neural Syst, Pasadena, CA 91125 USA.	lauraharrison@caltech.edu			National Institute of Mental Health [R01MH080721, P50MH094258]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080721, P50MH094258] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	RA received funding from the National Institute of Mental Health (http://www.nimh.nih.gov) for grants numbered R01MH080721 and P50MH094258, which funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; Anderson DJ, 2014, CELL, V157, P187, DOI 10.1016/j.cell.2014.03.003; Arnold M.B., 1960, EMOTION PERSONALITY; ASMUNDSON GJG, 1992, J ANXIETY DISORD, V6, P295, DOI 10.1016/0887-6185(92)90001-N; ASMUNDSON GJG, 1994, J ANXIETY DISORD, V8, P107, DOI 10.1016/0887-6185(94)90009-4; Bach DR, 2012, NAT REV NEUROSCI, V13, P572, DOI 10.1038/nrn3289; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Bjorkqvist K, 2001, PHYSIOL BEHAV, V73, P435, DOI 10.1016/S0031-9384(01)00490-5; Blanchard DC, 2011, NEUROSCI BIOBEHAV R, V35, P991, DOI 10.1016/j.neubiorev.2010.10.016; Blanchard DC, 2001, NEUROSCI BIOBEHAV R, V25, P761; BLANCHARD RJ, 1990, NEUROSCI BIOBEHAV R, V14, P463, DOI 10.1016/S0149-7634(05)80069-7; BLANCHARD RJ, 1989, NATO ADV SCI I D-BEH, V48, P114; BLANCHARD RJ, 1986, J COMP PSYCHOL, V100, P101, DOI 10.1037/0735-7036.100.2.101; BLANCHARD RJ, 1989, PROG NEURO-PSYCHOPH, V13, pS3, DOI 10.1016/0278-5846(89)90105-X; Brosnan SF, 2005, P ROY SOC B-BIOL SCI, V272, P253, DOI 10.1098/rspb.2004.2947; Chang SWC, 2013, P NATL ACAD SCI USA, V110, P10387, DOI 10.1073/pnas.1301213110; Coleman K, 2014, ILAR J, V55, P333, DOI 10.1093/ilar/ilu019; Cottrell CA, 2005, J PERS SOC PSYCHOL, V88, P770, DOI 10.1037/0022-3514.88.5.770; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Crawley JN, 2003, COMPARATIVE MED, V53, P140; Dahl CD, 2013, ELIFE, V2, DOI 10.7554/eLife.00932; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; DEWAAL FBM, 1986, Q REV BIOL, V61, P459, DOI 10.1086/415144; Ebitz RB, 2013, P NATL ACAD SCI USA, V110, P11630, DOI 10.1073/pnas.1305230110; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fanselow M.S., 1988, P185; Fernald RD, 2012, ANNU REV NEUROSCI, V35, P133, DOI 10.1146/annurev-neuro-062111-150520; Gawronski B, 2013, PERS SOC PSYCHOL REV, V17, P187, DOI 10.1177/1088868313480096; Goldin PR, 2009, ARCH GEN PSYCHIAT, V66, P170, DOI 10.1001/archgenpsychiatry.2008.525; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; Gross CT, 2012, NAT REV NEUROSCI, V13, P651, DOI 10.1038/nrn3301; Gudehus C., 1978, OBEDIENCE AUTHORITY; Hagenaars MA, 2014, NEUROSCI BIOBEHAV R, V47, P165, DOI 10.1016/j.neubiorev.2014.07.021; Holmes A, 2003, BIOL PSYCHIAT, V54, P953, DOI 10.1016/j.biopsych.2003.09.003; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Kim EJ, 2013, P NATL ACAD SCI USA, V110, P14795, DOI 10.1073/pnas.1310845110; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Lang PJ, 1998, BIOL PSYCHIAT, V44, P1248, DOI 10.1016/S0006-3223(98)00275-3; LAZARUS RS, 1991, AM PSYCHOL, V46, P352, DOI 10.1037/0003-066X.46.4.352; LeDoux JE., PROGR BRAIN RES, P431; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; MacDonald G, 2005, PSYCHOL BULL, V131, P202, DOI 10.1037/0033-2909.131.2.202; Mandalaywala TM, 2014, PSYCHOL SCI, V25, P1893, DOI 10.1177/0956797614544175; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; MCNAUGHTON NEIL, 2009, HDB NEUROSCIENCE BEH, P710; Mobbs D, 2007, SCIENCE, V317, P1079, DOI 10.1126/science.1144298; Mobbs D, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00055; Mobbs D, 2010, P NATL ACAD SCI USA, V107, P20582, DOI 10.1073/pnas.1009076107; Papworth S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062000; Perkins AM, 2010, J PERS, V78, P1071, DOI 10.1111/j.1467-6494.2010.00643.x; Perkins AM, 2006, BEHAV BRAIN RES, V169, P21, DOI 10.1016/j.bbr.2005.11.027; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Raper J, 2013, HORM BEHAV, V63, P646, DOI 10.1016/j.yhbeh.2013.01.010; Roelofs K, 2010, PSYCHOL SCI, V21, P1575, DOI 10.1177/0956797610384746; Sambo CF, 2013, J NEUROSCI, V33, P14225, DOI 10.1523/JNEUROSCI.0706-13.2013; Sander D, 2005, NEURAL NETWORKS, V18, P317, DOI 10.1016/j.neunet.2005.03.001; Scheibler E, 2004, PHYSIOL BEHAV, V81, P455, DOI 10.1016/j.physbeh.2004.02.011; Scherer K.R., 2001, APPRAISAL PROCESSES, DOI DOI 10.1016/S0166-4115(08)62387-0; Scherer K.R., 1984, APPROACHES EMOTION, P293; Scherer KR, 2009, COGNITION EMOTION, V23, P1307, DOI 10.1080/02699930902928969; Schwandt ML, 2010, BIOL PSYCHIAT, V67, P323, DOI 10.1016/j.biopsych.2009.10.016; Shuhama R, 2008, BRAZ J MED BIOL RES, V41, P324, DOI 10.1590/S0100-879X2008000400011; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Silva BA, 2013, NAT NEUROSCI, V16, P1731, DOI 10.1038/nn.3573; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; Tamashiro KLK, 2005, FRONT NEUROENDOCRIN, V26, P27, DOI 10.1016/j.yfrne.2005.03.001; Tinbergen, 1951, STUDY INSTINCT; Williams KD, ANN REV PSYCHOL, P425; Williams KD, 2006, BEHAV RES METHODS, V38, P174, DOI 10.3758/BF03192765; Yilmaz M, 2013, CURR BIOL, V23, P2011, DOI 10.1016/j.cub.2013.08.015	72	16	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0133682	10.1371/journal.pone.0133682	http://dx.doi.org/10.1371/journal.pone.0133682			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26296201	Green Published, gold, Green Accepted			2022-12-27	WOS:000359926900006
J	Moore, SE; Decker, A; Hubbard, A; Callcut, RA; Fox, EE; del Junco, DJ; Holcomb, JB; Rahbar, MH; Wade, CE; Schreiber, MA; Alarcon, LH; Brasel, KJ; Bulger, EM; Cotton, BA; Muskat, P; Myers, JG; Phelan, HA; Cohen, MJ				Moore, Sara E.; Decker, Anna; Hubbard, Alan; Callcut, Rachael A.; Fox, Erin E.; del Junco, Deborah J.; Holcomb, John B.; Rahbar, Mohammad H.; Wade, Charles E.; Schreiber, Martin A.; Alarcon, Louis H.; Brasel, Karen J.; Bulger, Eileen M.; Cotton, Bryan A.; Muskat, Peter; Myers, John G.; Phelan, Herb A.; Cohen, Mitchell J.		PROMMTT Study Grp	Statistical Machines for Trauma Hospital Outcomes Research: Application to the PRospective, Observational, Multi-Center Major Trauma Transfusion (PROMMTT) Study	PLOS ONE			English	Article							MASSIVE TRANSFUSION; PROPENSITY SCORE; MORTALITY; BENEFITS; TRIGGERS	Improving the treatment of trauma, a leading cause of death worldwide, is of great clinical and public health interest. This analysis introduces flexible statistical methods for estimating center-level effects on individual outcomes in the context of highly variable patient populations, such as those of the PRospective, Observational, Multi-center Major Trauma Transfusion study. Ten US level I trauma centers enrolled a total of 1,245 trauma patients who survived at least 30 minutes after admission and received at least one unit of red blood cells. Outcomes included death, multiple organ failure, substantial bleeding, and transfusion of blood products. The centers involved were classified as either large or small-volume based on the number of massive transfusion patients enrolled during the study period. We focused on estimation of parameters inspired by causal inference, specifically estimated impacts on patient outcomes related to the volume of the trauma hospital that treated them. We defined this association as the change in mean outcomes of interest that would be observed if, contrary to fact, subjects from large-volume sites were treated at small-volume sites (the effect of treatment among the treated). We estimated this parameter using three different methods, some of which use data-adaptive machine learning tools to derive the outcome models, minimizing residual confounding by reducing model misspecification. Differences between unadjusted and adjusted estimators sometimes differed dramatically, demonstrating the need to account for differences in patient characteristics in clinic comparisons. In addition, the estimators based on robust adjustment methods showed potential impacts of hospital volume. For instance, we estimated a survival benefit for patients who were treated at large-volume sites, which was not apparent in simpler, unadjusted comparisons. By removing arbitrary modeling decisions from the estimation process and concentrating on parameters that have more direct policy implications, these potentially automated approaches allow methodological standardization across similar comparativeness effectiveness studies.	[Moore, Sara E.; Decker, Anna; Hubbard, Alan] Univ Calif Berkeley, Div Biostat, Berkeley, CA 94720 USA; [Callcut, Rachael A.; Cohen, Mitchell J.] Univ Calif San Francisco, Sch Med, Dept Surg, Div Gen Surg, San Francisco, CA 94143 USA; [Fox, Erin E.; del Junco, Deborah J.; Holcomb, John B.; Wade, Charles E.; Cotton, Bryan A.] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, Div Acute Care Surg, Dept Surg,Med Sch, Houston, TX 77030 USA; [Rahbar, Mohammad H.] Univ Texas Hlth Sci Ctr Houston, Div Clin & Translat Sci, Dept Internal Med, Sch Med, Houston, TX 77030 USA; [Schreiber, Martin A.] Oregon Hlth & Sci Univ, Sch Med, Div Trauma Crit Care & Acute Care Surg, Portland, OR 97201 USA; [Alarcon, Louis H.] Univ Pittsburgh, Sch Med, Dept Surg, Div Trauma & Gen Surg, Pittsburgh, PA USA; [Brasel, Karen J.] Med Coll Wisconsin, Dept Surg, Div Trauma & Crit Care, Milwaukee, WI 53226 USA; [Bulger, Eileen M.] Univ Washington, Sch Med, Dept Surg, Div Trauma & Crit Care, Seattle, WA 98195 USA; [Muskat, Peter] Univ Cincinnati, Coll Med, Dept Surg, Div Trauma Crit Care, Cincinnati, OH USA; [Myers, John G.] Univ Texas Hlth Sci Ctr San Antonio, Sch Med, Dept Surg, Div Trauma, San Antonio, TX 78229 USA; [Phelan, Herb A.] Univ Texas SW Med Ctr Dallas, Div Burn Trauma Crit Care, Dept Surg, Sch Med, Dallas, TX 75390 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical College of Wisconsin; University of Washington; University of Washington Seattle; University System of Ohio; University of Cincinnati; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hubbard, A (corresponding author), Univ Calif Berkeley, Div Biostat, Berkeley, CA 94720 USA.	hubbard@berkeley.edu; Mohammad.H.Rahbar@uth.tmc.edu	Callcut, Rachael/ABE-1484-2021	holcomb, john/0000-0001-8312-9157	United States Army Medical Research and Materiel Command [W81XWH-08-C-0712]; National Institutes of Health [UL1 RR024148]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	MHR obtained an United States Army Medical Research and Materiel Command (http://mrmc.amedd.army.mil/) subcontract W81XWH-08-C-0712. Infrastructure for the Data Coordinating Center was supported by Clinical and Translational Science Award (https://www.ctsacentral.org/) funds from National Institutes of Health (http://www.nih.gov/) grant UL1 RR024148. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Callcut RA, 2013, J TRAUMA ACUTE CARE, V74, P59, DOI 10.1097/TA.0b013e3182788b34; Callcut RA, 2011, J TRAUMA, V70, P794, DOI 10.1097/TA.0b013e3182127e40; Centers for Disease Control and Prevention, 2010, LEAD CAUS DEATH; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; Freedman DA, 2006, AM STAT, V60, P299, DOI 10.1198/000313006X152207; Gruber S, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1260; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Hurtuk M, 2006, J TRAUMA, V61, P243, DOI 10.1097/01.ta.0000231353.06095.8d; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Malone DL, 2006, J TRAUMA, V60, pS91, DOI 10.1097/01.ta.0000199549.80731.e6; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Nunez TC, 2009, J TRAUMA, V66, P346, DOI 10.1097/TA.0b013e3181961c35; PHILLIPS GR, 1994, POSTGRAD MED, V95, P61; Polley E, 2012, SUPERLEARNER SUPER L; ROBINS J, 1986, MATH MODELLING, V7, P1393, DOI 10.1016/0270-0255(86)90088-6; Rogers FB, 1997, ARCH SURG-CHICAGO, V132, P376; Rose S, 2011, SPRINGER SER STAT, P3, DOI 10.1007/978-1-4419-9782-1; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; RUBIN DB, 1974, J EDUC PSYCHOL, V66, P688, DOI 10.1037/h0037350; Sekhon JS, 2011, J STAT SOFTW, V42, P1; van der Laan MJ, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1309	22	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136438	10.1371/journal.pone.0136438	http://dx.doi.org/10.1371/journal.pone.0136438			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296088	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900113
J	Sunaguchi, N; Yuasa, T; Hirano, S; Gupta, R; Ando, M				Sunaguchi, Naoki; Yuasa, Tetsuya; Hirano, Shin-ichi; Gupta, Rajiv; Ando, Masami			In Vitro Validation of an Artefact Suppression Algorithm in X-Ray Phase-Contrast Computed Tomography	PLOS ONE			English	Article							DARK-FIELD; RECONSTRUCTION	X-ray phase-contrast tomography can significantly increase the contrast-resolution of conventional attenuation-contrast imaging, especially for soft-tissue structures that have very similar attenuation. Just as in attenuation-based tomography, phase contrast tomography requires a linear dependence of aggregate beam direction on the incremental direction alteration caused by individual voxels along the path of the X-ray beam. Dense objects such as calcifications in biological specimens violate this condition. There are extensive beam deflection artefacts in the vicinity of such structures because they result in large distortion of wave front due to the large difference of refractive index; for such large changes in beam direction, the transmittance of the silicon analyzer crystal saturates and is no longer linearly dependent on the angle of refraction. This paper describes a method by which these effects can be overcome and excellent soft-tissue contrast of phase tomography can be preserved in the vicinity of such artefact-producing structures.	[Sunaguchi, Naoki] Gunma Univ, Grad Sch Engn, Kiryu, Gunma, Japan; [Yuasa, Tetsuya] Yamagata Univ, Grad Sch Engn & Sci, Yonezawa, Yamagata, Japan; [Hirano, Shin-ichi] Mercian Cleantec Corp, Fujisawa, Kanagawa, Japan; [Hirano, Shin-ichi] MiZ Corp, Kamakura, Kanagawa, Japan; [Gupta, Rajiv] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Gupta, Rajiv] Harvard Univ, Sch Med, Boston, MA USA; [Ando, Masami] Tokyo Univ Sci, Res Inst Sci & Technol, Noda, Chiba 278, Japan	Gunma University; Yamagata University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Tokyo University of Science	Sunaguchi, N (corresponding author), Gunma Univ, Grad Sch Engn, Kiryu, Gunma, Japan.				KEK [2008S2-002, 2014G-002]; Japanese Ministry of Education Science and Culture [23602002, 26350494, 26750142]; Mercian Cleantec Corporation; MiZ Corporation	KEK(High Energy Accelerator Research Organization (KEK)); Japanese Ministry of Education Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mercian Cleantec Corporation; MiZ Corporation	The experiment was performed under the auspices of KEK (2008S2-002, 2014G-002). This work was funded by the Japanese Ministry of Education Science and Culture (TY #23602002, TY #26350494, NS #26750142)https://www.jsps.go.jp/j-grantsinaid/. At the time of the study Mercian Cleantec Corporation and MiZ Corporation provided support in the form of a salary for author SH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ando M, 2002, JPN J APPL PHYS 2, V41, pL1016, DOI 10.1143/JJAP.41.L1016; Ando M, 2014, EUR RADIOL, V24, P423, DOI 10.1007/s00330-013-3021-9; BONSE U, 1965, APPL PHYS LETT, V6, P155, DOI 10.1063/1.1754212; Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001; FIENUP JR, 1978, OPT LETT, V3, P27, DOI 10.1364/OL.3.000027; Ge YS, 2014, OPT EXPRESS, V22, P14246, DOI 10.1364/OE.22.014246; Intl Commission on Radiation, 1992, 46 ICRU; Kak A.V., 1988, PRINCIPLES COMPUTERI, DOI DOI 10.1137/1.9780898719277.CH7; Kashyap YS, 2008, APPL RADIAT ISOTOPES, V66, P1083, DOI 10.1016/j.apradiso.2007.12.008; Keyrilainen J, 2010, ACTA RADIOL, V51, P866, DOI 10.3109/02841851.2010.504742; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; Paganin D., 2006, COHERENT XRAY OPTICS, DOI 10.1093/acprof:oso/9780198567288.001.0001; PAPOULIS A, 1975, IEEE T CIRCUITS SYST, V22, P735, DOI 10.1109/TCS.1975.1084118; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; Sunaguchi N, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824075; Sunaguchi N, 2011, OPT LETT, V36, P391, DOI 10.1364/OL.36.000391; Tapfer A, 2012, P NATL ACAD SCI USA, V109, P15691, DOI 10.1073/pnas.1207503109; Wen H, 2008, IEEE T MED IMAGING, V27, P997, DOI 10.1109/TMI.2007.912393; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Zhou W, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4890281	21	5	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135654	10.1371/journal.pone.0135654	http://dx.doi.org/10.1371/journal.pone.0135654			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295713	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900038
J	Vogt, F; Van den Bergh, R; Bernasconi, A; Moyo, B; Havazvidi, L; Bastard, M; Flevaud, L; Taziwa, F; Makondo, E; Mtapuri-Zinyowera, S				Vogt, Florian; Van den Bergh, Rafael; Bernasconi, Andrea; Moyo, Buhlebenkosi; Havazvidi, Liberty; Bastard, Mathieu; Flevaud, Laurence; Taziwa, Fabian; Makondo, Eliphas; Mtapuri-Zinyowera, Sekesai			Using BD Vacutainer CD4 Stabilization Tubes for Absolute Cluster of Differentiation Type 4 Cell Count Measurement on BD FacsCount and Partec Cyflow Cytometers: A Method Comparison Study from Zimbabwe	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; AGREEMENT; TRANSFORMATION; ENUMERATION; VARIABLES; HIV/AIDS; SYSTEMS; ADULTS	Background Blood collected in conventional EDTA tubes requires laboratory analysis within 48 hours to provide valid CD4 cell count results. This restricts access to HIV care for patients from rural areas in resource-constraint settings due to sample transportation problems. Stabilization Tubes with extended storage duration have been developed but not yet evaluated comprehensively. Objective To investigate stability of absolute CD4 cell count measurement of samples in BD Vacutainer CD4 Stabilization Tubes over the course of 30 days. Methods This was a laboratory-based method comparison study conducted at a rural district hospital in Beitbridge, Zimbabwe. Whole peripheral blood from 88 HIV positive adults was drawn into BD Vacutainer CD4 Stabilization Tubes and re-tested 1, 2, 3, 5, 7, 14 and 30 days after collection on BD FacsCount and Partec Cyflow cytometers in parallel. Absolute CD4 cell levels were compared to results from paired samples in EDTA tubes analysed on BD FacsCount at the day of sample collection (references methodology). Bland-Altman analysis based on ratios of the median CD4 counts was used, with acceptable variation ranges for Limits of Agreements of +/-20%. Results Differences in ratios of the medians remained below 10% until day 21 on BD FacsCount and until day 5 on Partec Cyflow. Variations of Limits of Agreement were beyond 20% after day 1 on both cytometers. Specimen quality decreased steadily after day 5, with only 68% and 40% of samples yielding results on BD FacsCount and Partec Cyflow at day 21, respectively. Conclusions We do not recommend the use of BD Vacutainer CD4 Stabilization Tubes for absolute CD4 cell count measurement on BD FacsCount or Partec Cyflow due to large variation of results and decay of specimen quality. Alternative technologies for enhanced CD4 testing in settings with limited laboratory and sample transportation capacity still need to be developed.	[Vogt, Florian; Bernasconi, Andrea; Flevaud, Laurence] Operat Ctr Barcelona, Med Sans Frontieres Doctors Borders, Barcelona, Spain; [Van den Bergh, Rafael] Operat Res Unit Luxembourg, Med Sans Frontieres Doctors Borders, Luxembourg, Luxembourg; [Bernasconi, Andrea] Epicentre, Dept Field Epidemiol & Training, Paris, France; [Moyo, Buhlebenkosi] Beitbridge Project, Med Sans Frontieres Doctors Borders, Beitbridge, Zimbabwe; [Havazvidi, Liberty; Taziwa, Fabian] Zimbabwe Mission, Med Sans Frontieres Doctors Borders, Harare, Zimbabwe; [Bastard, Mathieu] Epicentre, Dept Clin Res, Paris, France; [Makondo, Eliphas] Minist Hlth & Child Welf, Beitbridge Dist Hosp, Dept Lab, Beitbridge, Zimbabwe; [Mtapuri-Zinyowera, Sekesai] Minist Hlth & Child Welf, Natl Microbiol Reference Lab, Harare, Zimbabwe		Vogt, F (corresponding author), Operat Ctr Barcelona, Med Sans Frontieres Doctors Borders, Barcelona, Spain.	florianvogt@hotmail.com		Vogt, Florian/0000-0003-2686-3149; Mtapuri-Zinyowera, Sekesai/0000-0002-0775-3430; Van den Bergh, Rafael/0000-0001-6277-8713	Operational Centre Barcelona of Medecins sans Frontieres / Doctors without Borders, Barcelona, Spain	Operational Centre Barcelona of Medecins sans Frontieres / Doctors without Borders, Barcelona, Spain	This research was entirely funded by the Operational Centre Barcelona of Medecins sans Frontieres / Doctors without Borders, Barcelona, Spain (http://www.msf.es). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemnji G, 2011, INDIAN J MED RES, V134, P779, DOI 10.4103/0971-5916.92625; Altman DG, 2002, CLIN CHEM, V48, P801; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; Balakrishnan P, 2011, INDIAN J MED RES, V134, P823, DOI 10.4103/0971-5916.92628; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Baum LL, 2007, CURR OPIN HIV AIDS, V2, P234, DOI 10.1097/COH.0b013e3280ef6909; Becton Dickinson, 2006, BD DIAGNOSTICS ANNOU; Bland JM, 1996, BRIT MED J, V312, P1079; Bland JM, 1996, BMJ-BRIT MED J, V312, P1153; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bui N, 2009, USE OF CD4 STABILIZA; Bunce C, 2009, AM J OPHTHALMOL, V148, P4, DOI 10.1016/j.ajo.2008.09.032; Cohen GM, 2007, AIDS, V21, pS81, DOI 10.1097/01.aids.0000279710.47298.5c; Daly L, 2008, INTERPRETATION AND U; Dewitte K, 2002, CLIN CHEM, V48, P799; Dickinson Becton, 2004, BD FACSCOUNT INSTRUM; Euser AM, 2008, J CLIN EPIDEMIOL, V61, P978, DOI 10.1016/j.jclinepi.2007.11.003; Fajardo E, 2014, HIGH FREQUENCY OF IN; Galiwango RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088928; Hand D, 1993, HDB SMALL DATA SETS, V1; Hanneman SK, 2008, AACN ADV CRIT CARE, V19, P223, DOI 10.1097/01.AACN.0000318125.41512.a3; Justman JE, 2009, JAIDS-J ACQ IMM DEF, V52, pS30, DOI 10.1097/QAI.0b013e3181bbc9f5; LEVEY S, 1992, ARCH PATHOL LAB MED, V116, P791; Luiz RR, 2005, J CLIN EPIDEMIOL, V58, P215, DOI 10.1016/j.jclinepi.2004.07.007; Marinucci F, 2011, CYTOM PART A, V79A, P368, DOI 10.1002/cyto.a.21064; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Ministry of Health and Child Care Zimbabwe, 2013, GUIDELINES FOR ANTIR; National Statistics Agency Zimbabwe, 2012, ZIMBABWE NATIONAL PO; National Statistics Agency Zimbabwe ICF International, 2012, ZIMBABWE DEMOGRAPHIC; Olivier J, 2008, ANN ALLERG ASTHMA IM, V100, P333, DOI 10.1016/S1081-1206(10)60595-9; Ormerod MG., 2000, FLOW CYTOMETRY A PRA; Partec, 2006, CYFLOW SL 3 PORTABLE; Pattanapanyasat K, 2012, ASIAN PAC J ALLERGY, V30, P11; Peter T, 2008, CYTOM PART B-CLIN CY, V74B, pS123, DOI 10.1002/cyto.b.20416; Robinson JP., 1993, HANDBOOK OF FLOW CYT; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Scott LE, 2003, CYTOM PART B-CLIN CY, V54B, P46, DOI 10.1002/cyto.b.10016; Setty MKHG, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/497046; Shott JP, 2008, CLIN VACCINE IMMUNOL, V15, P1623, DOI 10.1128/CVI.00176-08; Stevens W, 2008, NAT REV MICROBIOL, V6, pS29, DOI 10.1038/nrmicro2000; Uldall A, 1991, Ann Ist Super Sanita, V27, P411; UNITAID, 2012, HIV AIDS DIAGNOSTICS; WHO, 2006, GUIDELINES ON CO TRI; WHO, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2014, MARCH 2014 SUPPLEMEN; World Health Organization, 2011, RAPID ADVICE DIAGNOS; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809; Zijenah LS, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-33	49	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136537	10.1371/journal.pone.0136537	http://dx.doi.org/10.1371/journal.pone.0136537			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295802	Green Submitted, gold, Green Published			2022-12-27	WOS:000359926900120
J	Xu, D; Zhang, MZ; Zhao, TW; Ge, C; Gao, WG; Wei, J; Zhu, KQ				Xu, Dong; Zhang, Meizhuo; Zhao, Tianwan; Ge, Chen; Gao, Weiguo; Wei, Jia; Zhu, Kenny Q.			Data-Driven Information Extraction from Chinese Electronic Medical Records	PLOS ONE			English	Article							NAMED ENTITY RECOGNITION	Objective This study aims to propose a data-driven framework that takes unstructured free text narratives in Chinese Electronic Medical Records (EMRs) as input and converts them into structured time-event-description triples, where the description is either an elaboration or an outcome of the medical event. Materials and Methods Our framework uses a hybrid approach. It consists of constructing cross-domain core medical lexica, an unsupervised, iterative algorithm to accrue more accurate terms into the lexica, rules to address Chinese writing conventions and temporal descriptors, and a Support Vector Machine (SVM) algorithm that innovatively utilizes Normalized Google Distance (NGD) to estimate the correlation between medical events and their descriptions. Results The effectiveness of the framework was demonstrated with a dataset of 24,817 de-identified Chinese EMRs. The cross-domain medical lexica were capable of recognizing terms with an F1-score of 0.896. 98.5% of recorded medical events were linked to temporal descriptors. The NGD SVM description-event matching achieved an F1-score of 0.874. The end-to-end time-event-description extraction of our framework achieved an F1-score of 0.846. Discussion In terms of named entity recognition, the proposed framework outperforms state-of-the-art supervised learning algorithms (F1-score: 0.896 vs. 0.886). In event-description association, the NGD SVM is superior to SVM using only local context and semantic features (F1-score: 0.874 vs. 0.838). Conclusions The framework is data-driven, weakly supervised, and robust against the variations and noises that tend to occur in a large corpus. It addresses Chinese medical writing conventions and variations in writing styles through patterns used for discovering new terms and rules for updating the lexica.	[Xu, Dong; Zhao, Tianwan; Ge, Chen; Zhu, Kenny Q.] Shanghai Jiao Tong Univ, Dept Comp Sci & Engn, Shanghai 200240, Peoples R China; [Zhang, Meizhuo; Gao, Weiguo; Wei, Jia] AstraZeneca, R&D Informat China, Shanghai 201203, Peoples R China	Shanghai Jiao Tong University; AstraZeneca	Wei, J (corresponding author), AstraZeneca, R&D Informat China, 199 Liangjing Rd, Shanghai 201203, Peoples R China.	Jenny.Wei@astrazeneca.com; kzhu@cs.sjtu.edu.cn			AstraZeneca	AstraZeneca(AstraZeneca)	The authors received no specific funding for this work. AstraZeneca provided support in the form of salaries for authors (JW, MZ, WG), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aramaki E, 2010, STUD HEALTH TECHNOL, V160, P739, DOI 10.3233/978-1-60750-588-4-739; Banko M, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2670; Borthwick A, 1998, 7 MESS UND C MUC 7 P; Brin S, 1999, LECT NOTES COMPUT SC, V1590, P172; Carlson A, 2010, AAAI CONF ARTIF INTE, P1306; Chang Pi-Chuan, 2009, P 3 WORKSH SYNT STRU, P51; Chinese Pharmacopoeia commission, 2012, CHINESE PHARMACOPOEI; Cilibrasi RL, 2007, IEEE T KNOWL DATA EN, V19, P370, DOI 10.1109/TKDE.2007.48; Collins Michael, 1999, 1999 JOINT SIGDAT C; Cote R, 1997, SNOMED INT MICROGLOS; Cucchiarelli A, 2001, COMPUT LINGUIST, V27, P123, DOI 10.1162/089120101300346822; Etzioni O, 2004, P 13 INT C WORLD WID, P100, DOI DOI 10.1145/988672.988687; Evans R, 2003, RECENT ADV NATURAL L, V260, P267; Feng Y, 2006, ARTIF INTELL MED, V38, P219, DOI 10.1016/j.artmed.2006.07.005; Galescu L, 2012, P 2 ACM SIGHIT INT H, P715; Hoosain R, 1991, PSYCHOLINGUISTIC IMP; Jiang Min, 2011, J AM MED INFORM ASS; Lei JB, 2014, J AM MED INFORM ASSN, V21, P808, DOI 10.1136/amiajnl-2013-002381; Liu BY, 2012, STAT MED, V31, P653, DOI 10.1002/sim.4417; McCallum Andrew, 2003, P 7 C NATURAL LANGUA, P188; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Patrick J, 2010, J AM MED INFORM ASSN, V17, P524, DOI 10.1136/jamia.2010.003939; Reeves RM, 2013, INT J MED INFORM, V82, P118, DOI 10.1016/j.ijmedinf.2012.04.006; Sirohi E, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P308; Sohn S, 2014, J AM MED INFORM ASSN, V21, P858, DOI 10.1136/amiajnl-2013-002190; Srihari R, 2000, 6TH APPLIED NATURAL LANGUAGE PROCESSING CONFERENCE/1ST MEETING OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE AND PROCEEDINGS OF THE ANLP-NAACL 2000 STUDENT RESEARCH WORKSHOP, P247; Tang BZ, 2012, PROCEEDINGS OF THE ACM SIXTH INTERNATIONAL WORKSHOP ON DATA AND TEXT MINING IN BIOMEDICAL INFORMATICS, P13; Tseng Huihsin, 2005, P 4 SIGHAN WORKSH CH, V171; Uzuner O, 2010, J AM MED INFORM ASSN, V17, P514, DOI 10.1136/jamia.2010.003947; Voorham J, 2007, J AM MED INFORM ASSN, V14, P349, DOI 10.1197/jamia.M2128; Wang H, 2014, J BIOMED INFORM, V48, P130, DOI 10.1016/j.jbi.2013.12.017; Wang ZR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030412; Wu W., 2012, P 2012 ACM SIGMOD IN, DOI DOI 10.1145/2213836.2213891; Xiaohua Zhou, 2006, Applied Computing 2006. 21st Annual ACM Symposium on Applied Computing, P235, DOI 10.1145/1141277.1141330; Yang YM, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P42, DOI 10.1145/312624.312647; Zhou L, 2006, J BIOMED INFORM, V39, P424, DOI 10.1016/j.jbi.2005.07.002; Zhou XZ, 2010, ARTIF INTELL MED, V48, P139, DOI 10.1016/j.artmed.2009.07.012	37	10	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136270	10.1371/journal.pone.0136270	http://dx.doi.org/10.1371/journal.pone.0136270			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26295801	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900093
J	Chen, XG; Wang, Y; Li, F; Gong, J; Yan, YQ				Chen, Xinguang; Wang, Yan; Li, Fang; Gong, Jie; Yan, Yaqiong			Development and Evaluation of the Brief Sexual Openness Scale-A Construal Level Theory Based Approach	PLOS ONE			English	Article							ITEM BIFACTOR ANALYSIS; SOCIAL DISTANCE; BIAS; RELIABILITY; PERCEPTION; VALIDITY	Obtaining reliable and valid data on sensitive questions represents a longstanding challenge for public health, particularly HIV research. To overcome the challenge, we assessed a construal level theory (CLT)-based novel method. The method was previously established and pilot-tested using the Brief Sexual Openness Scale (BSOS). This scale consists of five items assessing attitudes toward premarital sex, multiple sexual partners, homosexuality, extramarital sex, and commercial sex, all rated on a standard 5-point Likert scale. In addition to self-assessment, the participants were asked to assess rural residents, urban residents, and foreigners. The self-assessment plus the assessment of the three other groups were all used as subconstructs of one latent construct: sexual openness. The method was validated with data from 1,132 rural-to-urban migrants (mean age = 32.5, SD = 7.9; 49.6% female) recruited in China. Consistent with CLT, the Cronbach alpha of the BSOS as a conventional tool increased with social distance, from .81 for self-assessment to .97 for assessing foreigners. In addition to a satisfactory fit of the data to a one-factor model (CFI = .94, TLI = .93, RMSEA = .08), a common factor was separated from the four perspective factors (i.e., migrants' self-perspective and their perspectives of rural residents, urban residents and foreigners) through a trifactor modeling analysis (CFI = .95, TLI = .94, RMSEA = .08). Relative to its conventional form, CTL-based BSOS was more reliable (alpha: .96 vs .81) and valid in predicting sexual desire, frequency of dating, age of first sex, multiple sexual partners and STD history. This novel technique can be used to assess sexual openness, and possibly other sensitive questions among Chinese domestic migrants.	[Chen, Xinguang; Wang, Yan] Univ Florida, Gainesville, FL 32611 USA; [Chen, Xinguang; Li, Fang; Gong, Jie; Yan, Yaqiong] Wuhan Ctr Dis Prevent & Control, Wuhan, Hubei, Peoples R China	State University System of Florida; University of Florida	Chen, XG (corresponding author), Univ Florida, Gainesville, FL 32611 USA.	jimax.chen@phhp.ufl.edu; ywang48@phhp.ufl.edu; gongjie@whcdc.org			National Institute of Health [R01 MH086322]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086322] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant awarded to XC from the National Institute of Health, R01 MH086322, http://www.nih.gov/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaum Gerald, 2012, J MARKETING DEV COMP, V6, P71; Bauer DJ, 2013, PSYCHOL METHODS, V18, P475, DOI 10.1037/a0032475; Borsboom D, 2003, PSYCHOL REV, V110, P203, DOI 10.1037/0033-295X.110.2.203; Byrne B., 2009, STRUCTURAL EQUATION, V2nd ed.; Byrne BM, 2004, STRUCT EQU MODELING, V11, P272, DOI 10.1207/s15328007sem1102_8; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Chen X, 2009, HEALTH EDUC RES, V24, P306, DOI 10.1093/her/cyn020; FISHER RJ, 1993, J CONSUM RES, V20, P303, DOI 10.1086/209351; Fujita K, 2012, CURR DIR PSYCHOL SCI, V21, P248, DOI 10.1177/0963721412449169; Gibbons RD, 2007, APPL PSYCH MEAS, V31, P4, DOI 10.1177/0146621606289485; Han Y, COMMENTARY HAN POETR; Holtz R, 2004, GROUP DYN-THEOR RES, V8, P112, DOI 10.1037/1089-2699.8.2.112; Holzinger KJ, 1937, PSYCHOMETRIKA, V2, P41, DOI 10.1007/BF02287965; Kim M, 2002, NONWESTERN PERSPECTI; Kline R.B., 2011, PRINCIPLES PRACTICE; Krumpal I, 2013, QUAL QUANT, V47, P2025, DOI 10.1007/s11135-011-9640-9; Liberman N., 2007, SOCIAL PSYCHOL HDB B, Vsecond; Liviatan I, 2008, J EXP SOC PSYCHOL, V44, P1256, DOI 10.1016/j.jesp.2008.04.007; Raykov T, 2002, STRUCT EQU MODELING, V9, P195, DOI 10.1207/S15328007SEM0902_3; Raykov T, 2012, STRUCT EQU MODELING, V19, P495, DOI 10.1080/10705511.2012.687675; ROESE NJ, 1993, PSYCHOL BULL, V114, P363, DOI 10.1037/0033-2909.114.2.363; ROSS L, 1977, J EXP SOC PSYCHOL, V13, P279, DOI 10.1016/0022-1031(77)90049-X; SIRKEN MG, 1970, J AM STAT ASSOC, V65, P257, DOI 10.2307/2283590; Smith JA, 2014, AM SOCIOL REV, V79, P432, DOI 10.1177/0003122414531776; Spector PE, 2006, ORGAN RES METHODS, V9, P221, DOI 10.1177/1094428105284955; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; van Houwelingen G, SOMETHING RELY INFLU; WARNER SL, 1965, J AM STAT ASSOC, V60, P63, DOI 10.2307/2283137; Wright SA, 2013, USING CONSTRUAL LEVE; Yip PSF, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-691; Zhen W. T. O., 2013, ARCH SEX BEHAV, P1; Zheng WJ, 2011, CULT HEALTH SEX, V13, P497, DOI 10.1080/13691058.2011.563866	35	2	3	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136683	10.1371/journal.pone.0136683	http://dx.doi.org/10.1371/journal.pone.0136683			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LO	26308336	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400152
J	Dutkiewicz, M; Ojdowska, A; Kuczynski, J; Lindig, V; Zeichhardt, H; Kurreck, J; Ciesiolka, J				Dutkiewicz, Mariola; Ojdowska, Agata; Kuczynski, Jakub; Lindig, Vanessa; Zeichhardt, Heinz; Kurreck, Jens; Ciesiolka, Jerzy			Targeting Highly Structured RNA by Cooperative Action of siRNAs and Helper Antisense Oligomers in Living Cells	PLOS ONE			English	Article							COXSACKIEVIRUS B3; IN-VIVO; SYSTEMATIC ANALYSIS; ACCESSIBLE SITES; MESSENGER-RNA; INTERFERENCE; RIBOZYMES; DESIGN; STRAND; EFFICIENCY	RNA target accessibility is one of the most important factors limiting the efficiency of RNA interference-mediated RNA degradation. However, targeting RNA viruses in their poorly accessible, highly structured regions can be advantageous because these regions are often conserved in sequence and thus less prone to viral escape. We developed an experimental strategy to attack highly structured RNA by means of pairs of specifically designed small interfering RNAs and helper antisense oligonucleotides using the 5' untranslated region (5'UTR) of coxsackievirus B3 as a model target. In the first step, sites accessible to hybridization of complementary oligonucleotides were identified using two mapping methods with random libraries of short DNA oligomers. Subsequently, the accessibility of the mapped regions for hybridization of longer DNA 16-mers was confirmed by an RNase H assay. Using criteria for the design of efficient small interfering RNAs ( siRNA) and a secondary structure model of the viral 5'UTR, several DNA 19-mers were designed against partly double-stranded RNA regions. Target sites for DNA 19-mers were located opposite the sites which had been confirmed as accessible for hybridization. Three pairs of DNA 19-mers and the helper 2'-O-methyl-16-mers were able to effectively induce RNase H cleavage in vitro. For cellular assays, the DNA 19-mers were replaced by siRNAs, and the corresponding three pairs of siRNA-helper oligomer tools were found to target 5'UTR efficiently in a reporter construct in HeLa cells. Addition of the helper oligomer improved silencing capacity of the respective siRNA. We assume that the described procedure will generally be useful for designing of nucleic acid-based tools to silence highly structured RNA targets.	[Dutkiewicz, Mariola; Ojdowska, Agata; Kuczynski, Jakub; Ciesiolka, Jerzy] Polish Acad Sci, Inst Bioorgan Chem, Dept RNA Biochem, Poznan, Poland; [Lindig, Vanessa; Zeichhardt, Heinz] Charite, Inst Virol, D-13353 Berlin, Germany; [Kurreck, Jens] Berlin Univ Technol, Dept Appl Biochem, Inst Biotechnol, Berlin, Germany	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Berlin	Dutkiewicz, M (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Dept RNA Biochem, Poznan, Poland.	mariolad@ibch.poznan.pl	Dutkiewicz, Mariola/AAG-5242-2021; Kurreck, Jens/B-7785-2008; Dutkiewicz, Mariola/M-5588-2016	Dutkiewicz, Mariola/0000-0003-1098-0308; Kurreck, Jens/0000-0002-1469-0052; Dutkiewicz, Mariola/0000-0003-1098-0308; Kuczynski, Jakub/0000-0001-6682-2398	National Center of Science [N N302 385537]; PARENT-BRIDGE program of the Foundation for Polish Science; European Union Regional Development Fund [POMOST C/50, POMOST/2013-8/5]; Polish Ministry of Science and Higher Education	National Center of Science(National Science Centre, Poland); PARENT-BRIDGE program of the Foundation for Polish Science; European Union Regional Development Fund(European Commission); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the National Center of Science (www.ncn.gov.pl) grant No. N N302 385537 to M.D. and grants within the PARENT-BRIDGE program of the Foundation for Polish Science (www.fnp.org.pl), co-financed from the European Union Regional Development Fund, Nos. POMOST C/50 and POMOST/2013-8/5, both to M. D. This publication was also supported by the Polish Ministry of Science and Higher Education (www.nauka.gov.pl), under the KNOW program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allawi HT, 2001, RNA, V7, P314, DOI 10.1017/S1355838201001698; Bailey JM, 2007, J VIROL, V81, P650, DOI 10.1128/JVI.01327-06; Brown KM, 2005, NAT STRUCT MOL BIOL, V12, P469, DOI 10.1038/nsmb931; Chen JW, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4769821; Childs JL, 2002, P NATL ACAD SCI USA, V99, P11091, DOI 10.1073/pnas.172391199; Dutkiewicz M, 2008, FEBS LETT, V582, P3061, DOI 10.1016/j.febslet.2008.07.051; Dutkiewicz M, 2014, VIRUS RES, V188, P81, DOI 10.1016/j.virusres.2014.03.020; Fan MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108253; Fernandez-Miragall O, 2007, J GEN VIROL, V88, P3053, DOI 10.1099/vir.0.83218-0; Gorska A, 2013, RNA BIOL, V10, P1726, DOI 10.4161/rna.26562; Gorska A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078863; Haasnoot J, 2007, NAT BIOTECHNOL, V25, P1435, DOI 10.1038/nbt1369; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kruger U, 2007, OLIGONUCLEOTIDES, V17, P237, DOI 10.1089/oli.2006.0065; Kurreck J, 2002, J BIOL CHEM, V277, P7099, DOI 10.1074/jbc.M107206200; Kurreck J, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/83757; Lares MR, 2010, TRENDS BIOTECHNOL, V28, P570, DOI 10.1016/j.tibtech.2010.07.009; Liu Y, 2009, BBA-GENE REGUL MECH, V1789, P495, DOI 10.1016/j.bbagrm.2009.09.007; Merl S, 2005, CIRCULATION, V111, P1583, DOI 10.1161/01.CIR.0000160360.02040.AB; Obernosterer G, 2008, BIOCHEM SOC T, V36, P1216, DOI 10.1042/BST0361216; Oberste MS, 2008, CURR TOP MICROBIOL, V323, P33; Racaniello VR, 2007, FIELDS VIROLOGY, P795; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Schubert S, 2005, J MOL BIOL, V348, P883, DOI 10.1016/j.jmb.2005.03.011; Swiatkowska A, 2007, BIOCHEMISTRY-US, V46, P5523, DOI 10.1021/bi6024287; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Tijerina P, 2007, NAT PROTOC, V2, P2608, DOI 10.1038/nprot.2007.380; Wang DY, 2002, NUCLEIC ACIDS RES, V30, P1735, DOI 10.1093/nar/30.8.1735; Watts JK, 2012, J PATHOL, V226, P365, DOI 10.1002/path.2993; Wells SE, 2000, METHOD ENZYMOL, V318, P479; Werk D, 2005, BIOL CHEM, V386, P857, DOI 10.1515/BC.2005.100; Westerhout EM, 2007, NUCLEIC ACIDS RES, V35, P4322, DOI 10.1093/nar/gkm437; Wrzesinski J, 2007, NUCLEIC ACIDS RES, V28, P1785; Yuan J, 2005, J VIROL, V79, P2151, DOI 10.1128/JVI.79.4.2151-2159.2005; ZAUG AJ, 1995, RNA, V1, P363	37	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136395	10.1371/journal.pone.0136395	http://dx.doi.org/10.1371/journal.pone.0136395			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308932	Green Submitted, gold, Green Published			2022-12-27	WOS:000360069400119
J	Castello, MVD; Gobbini, MI				Castello, Matteo Visconti di Oleggio; Gobbini, M. Ida			Familiar Face Detection in 180ms	PLOS ONE			English	Article							FACIAL EXPRESSIONS; HUMAN BRAIN; PERCEPTION; RECOGNITION; DYNAMICS; ERP; REPRESENTATIONS; EMOTION; SYSTEMS; SPACE	The visual system is tuned for rapid detection of faces, with the fastest choice saccade to a face at 100ms. Familiar faces have a more robust representation than do unfamiliar faces, and are detected faster in the absence of awareness and with reduced attentional resources. Faces of family and close friends become familiar over a protracted period involving learning the unique visual appearance, including a view-invariant representation, as well as person knowledge. We investigated the effect of personal familiarity on the earliest stages of face processing by using a saccadic-choice task to measure how fast familiar face detection can happen. Subjects made correct and reliable saccades to familiar faces when unfamiliar faces were distractors at 180ms-very rapid saccades that are 30 to 70ms earlier than the earliest evoked potential modulated by familiarity. By contrast, accuracy of saccades to unfamiliar faces with familiar faces as distractors did not exceed chance. Saccades to faces with object distractors were even faster (110 to 120 ms) and equivalent for familiar and unfamiliar faces, indicating that familiarity does not affect ultra-rapid saccades. We propose that detectors of diagnostic facial features for familiar faces develop in visual cortices through learning and allow rapid detection that precedes explicit recognition of identity.	[Castello, Matteo Visconti di Oleggio; Gobbini, M. Ida] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; [Gobbini, M. Ida] Univ Bologna, Sch Med, Dipartimento Med Specialist Diagnost & Sperimenta, Bologna, Italy	Dartmouth College; University of Bologna	Gobbini, MI (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	mariaida.gobbini@unibo.it		Visconti di Oleggio Castello, Matteo/0000-0001-7931-5272				Anaki D, 2007, NEUROIMAGE, V37, P1407, DOI 10.1016/j.neuroimage.2007.05.054; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barbeau EJ, 2008, CEREB CORTEX, V18, P997, DOI 10.1093/cercor/bhm140; Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bobes MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076100; Brothers L, 1990, SOCIAL BRAIN PROJECT, P1; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Burton AM, 1999, PSYCHOL SCI, V10, P243, DOI 10.1111/1467-9280.00144; Caharel S, 2002, INT J NEUROSCI, V112, P1499, DOI 10.1080/00207450290158368; Caharel S, 2005, BRAIN COGNITION, V59, P96, DOI 10.1016/j.bandc.2005.05.005; Caharel S, 2014, J COGNITIVE NEUROSCI, V26, P81, DOI 10.1162/jocn_a_00451; Canty A., 2014, BOOT BOOTSTRAP R S P, P3; Carlson TA, 2011, J VISION, V11, DOI 10.1167/11.10.9; Cauchoix M, 2014, J NEUROSCI, V34, P846, DOI 10.1523/JNEUROSCI.3030-13.2014; Cichy RM, 2014, NAT NEUROSCI, V17, P455, DOI 10.1038/nn.3635; Cloutier J, 2011, SOC NEUROSCI-UK, V6, P63, DOI 10.1080/17470911003693622; Crouzet SM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00342; Crouzet SM, 2010, J VISION, V10, DOI 10.1167/10.4.16; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Dunbar RI, 1998, EVOLUTIONARY ANTHR, P1; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Fox J., 2014, R COMPANION APPL REG; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; Freiwald WA, 2009, NAT NEUROSCI, V12, P1187, DOI 10.1038/nn.2363; Furey ML, 2006, P NATL ACAD SCI USA, V103, P1065, DOI 10.1073/pnas.0510124103; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Gobbini MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066620; Gobbini MI, 2004, NEUROIMAGE, V22, P1628, DOI 10.1016/j.neuroimage.2004.03.049; Gosling A, 2011, NEUROPSYCHOLOGIA, V49, P2736, DOI 10.1016/j.neuropsychologia.2011.05.025; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Hancock P, 2000, TRENDS COGNITIVE SCI; Haxby J.V., 2011, OXFORD HDB FACE PERC, P93, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0006; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Henson RNA, 2003, HIPPOCAMPUS, V13, P301, DOI 10.1002/hipo.10117; Herrmann MJ, 2005, J NEURAL TRANSM, V112, P1073, DOI 10.1007/s00702-004-0250-8; Honey C, 2008, J VISION, V8, DOI 10.1167/8.12.9; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jemel B, 2003, COGNITIVE BRAIN RES, V17, P431, DOI 10.1016/S0926-6410(03)00145-9; Kaufmann JM, 2009, J COGNITIVE NEUROSCI, V21, P625, DOI 10.1162/jocn.2009.21080; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Kleiner M, 2007, PERCEPTION; Marzi T, 2007, INT J PSYCHOPHYSIOL, V65, P182, DOI 10.1016/j.ijpsycho.2007.04.003; Matsumoto D, 2009, J PERS SOC PSYCHOL, V96, P1, DOI 10.1037/a0014037; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Natu V, 2011, BRIT J PSYCHOL, V102, P726, DOI 10.1111/j.2044-8295.2011.02053.x; Paller KA, 2000, NEUROIMAGE, V11, P98, DOI 10.1006/nimg.1999.0521; Pinheiro J, 2010, MIXED EFFECTS MODELS; Puce A, 1999, CEREB CORTEX, V9, P445, DOI 10.1093/cercor/9.5.445; R Core Team, 2021, R LANGUAGE ENV STAT; Ramon M, 2015, PEERJ, V3, DOI 10.7717/peerj.850; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schweinberger SR, 2004, NEUROREPORT, V15, P1501, DOI 10.1097/01.wnr.0000131675.00319.42; Schweinberger SR, 2002, COGNITIVE BRAIN RES, V14, P398, DOI 10.1016/S0926-6410(02)00142-8; Schyns PG, 2007, CURR BIOL, V17, P1580, DOI 10.1016/j.cub.2007.08.048; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Tanaka JW, 2006, J COGNITIVE NEUROSCI, V18, P1488, DOI 10.1162/jocn.2006.18.9.1488; Taylor MJ, 2009, HUM BRAIN MAPP, V30, P2008, DOI 10.1002/hbm.20646; Tsao DY, 2008, P NATL ACAD SCI USA, V105, P19514, DOI 10.1073/pnas.0809662105; Visconti di Oleggio Castello M, 2014, FACILITATED DETECTIO, P1; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willenbockel V, 2010, BEHAV RES METHODS, V42, P671, DOI 10.3758/BRM.42.3.671	71	39	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136548	10.1371/journal.pone.0136548	http://dx.doi.org/10.1371/journal.pone.0136548			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6KK	26305788	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500089
J	Harrington, KH; Gudgeon, CJ; Laszlo, GS; Newhall, KJ; Sinclair, AM; Frankel, SR; Kischel, R; Chen, G; Walter, RB				Harrington, Kimberly H.; Gudgeon, Chelsea J.; Laszlo, George S.; Newhall, Kathryn J.; Sinclair, Angus M.; Frankel, Stanley R.; Kischel, Roman; Chen, Guang; Walter, Roland B.			The Broad Anti-AML Activity of the CD33/CD3 BiTE Antibody Construct, AMG 330, Is Impacted by Disease Stage and Risk	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; CELL-ENGAGING ANTIBODY; ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; GEMTUZUMAB OZOGAMICIN; ADULT PATIENTS; FREE SURVIVAL; BLINATUMOMAB; EXPRESSION; TARGET	The CD33/CD3-bispecific T-cell engaging (BiTE) antibody construct, AMG 330, potently lyses CD33+ leukemic cells in vitro. Using specimens from 41 patients with acute myeloid leukemia (AML), we studied the factors that might contribute to clinical response or resistance. For this purpose, thawed aliquots of primary AML samples were immunophenotypically characterized and subjected to various doses of AMG 330 in the presence or absence of healthy donor T-cells. After 48 hours, drug-specific cytotoxicity was quantified and correlated with CD33 expression levels, amounts of T-cells present, and other disease characteristics. AMG 330 caused modest cytotoxicity that was correlated with the amount of autologous T-cells (P = 0.0001) but not CD33 expression, as AMG 330 exerted marked cytotoxic effects in several specimens with minimal CD33 expression. With healthy donor T-cells added, AMG 330 cytotoxicity depended on the drug dose and effector: target (E:T) cell ratio. High cytotoxic activity was observed even with minimal CD33 expression, and AMG 330 cytotoxicity and CD33 expression correlated only at high E: T cell ratio and high AMG 330 doses (P<0.003). AMG 330 resulted in significantly higher cytotoxicity in specimens from patients with newly diagnosed AML than those with relapsed/refractory disease despite similar levels of CD33 on myeloblasts. AMG 330 cytotoxicity also appeared greater in specimens from patients with favorable-risk disease as compared to other specimens. Together, our data demonstrate that AMG 330 is highly active in primary AML specimens across the entire disease spectrum, while suggesting the presence of yet undefined, CD33-independent, relative resistance mechanisms in specific patient subsets.	[Harrington, Kimberly H.; Gudgeon, Chelsea J.; Laszlo, George S.; Walter, Roland B.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Newhall, Kathryn J.; Chen, Guang] Amgen Inc, Seattle, WA USA; [Sinclair, Angus M.] Amgen Inc, Thousand Oaks, CA 91320 USA; [Frankel, Stanley R.] Amgen Inc, Rockville, MD USA; [Kischel, Roman] Amgen Res Munich GmbH, Munich, Germany; [Walter, Roland B.] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Walter, Roland B.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Amgen; Amgen; Amgen; Amgen; Amgen Research Munich GmbH; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Walter, RB (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	rwalter@fredhutch.org	Walter, Roland/C-1064-2008	Walter, Roland/0000-0002-9268-3341	Amgen, Inc.; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER	Amgen, Inc.(Amgen); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a research contract from Amgen, Inc. (to RBW). KJN, AMS, SRF, RK, and GC are employees of Amgen, Inc. Amgen, Inc. provided support in the form of salaries for authors KJN, AMS, SRF, RK, and GC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aigner M, 2013, LEUKEMIA, V27, P1107, DOI 10.1038/leu.2012.341; Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Carter P, 2001, NAT REV CANCER, V1, P118, DOI 10.1038/35101072; Choi BD, 2011, EXPERT OPIN BIOL TH, V11, P843, DOI 10.1517/14712598.2011.572874; De Propris MS, 2011, HAEMATOL-HEMATOL J, V96, P1548, DOI 10.3324/haematol.2011.043786; Ferrara F, 2013, LANCET, V381, P484, DOI 10.1016/S0140-6736(12)61727-9; Friedrich M, 2014, MOL CANCER THER, V13, P1549, DOI 10.1158/1535-7163.MCT-13-0956; Gamis AS, 2014, J CLIN ONCOL, V32, P3021, DOI 10.1200/JCO.2014.55.3628; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Hauswirth AW, 2007, EUR J CLIN INVEST, V37, P73, DOI 10.1111/j.1365-2362.2007.01746.x; Hills RK, 2014, LANCET ONCOL, V15, P986, DOI 10.1016/S1470-2045(14)70281-5; Jilani I, 2002, AM J CLIN PATHOL, V118, P560, DOI 10.1309/1WMW-CMXX-4WN4-T55U; Krupka C, 2014, BLOOD, V123, P356, DOI 10.1182/blood-2013-08-523548; Laszlo GS, 2014, BLOOD REV, V28, P143, DOI 10.1016/j.blre.2014.04.001; Laszlo GS, 2014, BLOOD, V123, P554, DOI 10.1182/blood-2013-09-527044; Mahadevan D, 2004, BLOOD, V104, P1940, DOI 10.1182/blood-2003-07-2490; Othus M, 2014, LEUKEMIA, V28, P289, DOI 10.1038/leu.2013.176; Pollard JA, 2012, BLOOD, V119, P3705, DOI 10.1182/blood-2011-12-398370; Riethmuller Gert, 2012, Cancer Immun, V12, P12; SCHEINBERG DA, 1989, LEUKEMIA, V3, P440; Steinbach D, 2007, LEUKEMIA, V21, P1172, DOI 10.1038/sj.leu.2404692; Sutherland MSK, 2013, BLOOD, V122, P1455, DOI 10.1182/blood-2013-03-491506; Topp MS, 2015, LANCET ONCOL, V16, P57, DOI 10.1016/S1470-2045(14)71170-2; Topp MS, 2014, J CLIN ONCOL, V32, P4134, DOI 10.1200/JCO.2014.56.3247; Topp MS, 2012, BLOOD, V120, P5185, DOI 10.1182/blood-2012-07-441030; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Walter RB, 2014, LEUKEMIA, V28, P1969, DOI 10.1038/leu.2014.107; Walter RB, 2014, EXPERT REV HEMATOL, V7, P317, DOI 10.1586/17474086.2014.896190; Walter RB, 2012, BLOOD, V119, P6198, DOI 10.1182/blood-2011-11-325050; Wickramasinghe D, 2013, DISCOV MED, V16, P149; Wolf E, 2005, DRUG DISCOV TODAY, V10, P1237, DOI 10.1016/S1359-6446(05)03554-3	33	31	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135945	10.1371/journal.pone.0135945	http://dx.doi.org/10.1371/journal.pone.0135945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305211	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500038
J	Luk, B; Mohammed, M; Liu, F; Lee, FJS				Luk, Beryl; Mohammed, Mohinuddin; Liu, Fang; Lee, Frank J. S.			A Physical Interaction between the Dopamine Transporter and DJ-1 Facilitates Increased Dopamine Reuptake	PLOS ONE			English	Article							PARKINSONISM-INDUCING NEUROTOXIN; PROTEIN-KINASE-C; TYROSINE-HYDROXYLASE GENE; OXIDATIVE STRESS; ALPHA-SYNUCLEIN; CELL-DEATH; ANDROGEN RECEPTOR; SUBCELLULAR-LOCALIZATION; FUNCTIONAL INTERACTION; TRANSCRIPTION ACTIVITY	The regulation of the dopamine transporter (DAT) impacts extracellular dopamine levels after release from dopaminergic neurons. Furthermore, a variety of protein partners have been identified that can interact with and modulate DAT function. In this study we show that DJ-1 can potentially modulate DAT function. Co-expression of DAT and DJ-1 in HEK-293T cells leads to an increase in [H-3] dopamine uptake that does not appear to be mediated by increased total DAT expression but rather through an increase in DAT cell surface localization. In addition, through a series of GST affinity purifications and co-immunoprecipitations, we provide evidence that the DAT can be found in a complex with DJ-1, which involve distinct regions within both DAT and DJ-1. Using in vitro binding experiments we also show that this complex can be formed in part by a direct interaction between DAT and DJ-1. Co-expression of a mini-gene that can disrupt the DAT/DJ-1 complex appears to block the increase in [H-3] dopamine uptake by DJ-1. Mutations in DJ-1 have been linked to familial forms of Parkinson's disease, yet the normal physiological function of DJ-1 remains unclear. Our study suggests that DJ-1 may also play a role in regulating dopamine levels by modifying DAT activity.	[Luk, Beryl; Lee, Frank J. S.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Mohammed, Mohinuddin; Liu, Fang] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON, Canada	Simon Fraser University; University of Toronto; Centre for Addiction & Mental Health - Canada	Lee, FJS (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	f.lee@sfu.ca	Lee, Frank J.S./D-5899-2017	Lee, Frank J.S./0000-0002-5768-3776	Natural Sciences and Engineering Research Council of Canada Discovery Grant [371631-2009]; New Investigator Award from Parkinson Society Canada [2010-21]	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); New Investigator Award from Parkinson Society Canada	This study was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant (http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp) to FJSL (#371631-2009) and a New Investigator Award from Parkinson Society Canada (http://www.parkinson.ca/site/c.kgLNIWODKpF/b.3536149/k.6AC9/National_Research_Program.htm) to FJSL (#2010-21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleiman PM, 2003, ANN NEUROL, V54, P283, DOI 10.1002/ana.10675; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Batchelor M, 1998, J NEUROSCI, V18, P10304; Batelli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001884; Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; Blackinton J, 2005, MOL BRAIN RES, V134, P76, DOI 10.1016/j.molbrainres.2004.09.004; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; Carlsson ML, 2004, CURR MED CHEM, V11, P267, DOI 10.2174/0929867043456034; Carneiro AM, 2002, J NEUROSCI, V22, P7045; Carvelli L, 2008, P NATL ACAD SCI USA, V105, P14192, DOI 10.1073/pnas.0802214105; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Cen X, 2008, MOL PSYCHIATR, V13, P451, DOI 10.1038/sj.mp.4002132; Chen LN, 2008, J NEUROSCI, V28, P425, DOI 10.1523/JNEUROSCI.3602-07.2008; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cookson MR, 2010, MOVEMENT DISORD, V25, pS44, DOI 10.1002/mds.22713; Descarries L, 1996, J COMP NEUROL, V375, P167; Doolen S, 2001, J PHARMACOL EXP THER, V296, P931; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Fuxe K, 2010, PROG NEUROBIOL, V90, P82, DOI 10.1016/j.pneurobio.2009.10.012; Garcia-Olivares J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059788; Girotto S, 2012, J BIOL CHEM, V287, P18738, DOI 10.1074/jbc.M111.311589; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Gorentla BK, 2009, BIOCHEMISTRY-US, V48, P1067, DOI 10.1021/bi801696n; GRAHAM DG, 1978, MOL PHARMACOL, V14, P633; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; Hansen FH, 2014, J CLIN INVEST, V124, P3107, DOI 10.1172/JCI73778; Herrera FE, 2007, J BIOL CHEM, V282, P24905, DOI 10.1074/jbc.M701013200; Hersch SM, 1997, J COMP NEUROL, V388, P211; Hoover BR, 2007, J NEUROCHEM, V101, P1258, DOI 10.1111/j.1471-4159.2007.04522.x; HORN AS, 1990, PROG NEUROBIOL, V34, P387, DOI 10.1016/0301-0082(90)90033-D; Huff RA, 1997, J NEUROCHEM, V68, P225; Hulleman JD, 2007, BIOCHEMISTRY-US, V46, P5776, DOI 10.1021/bi7001778; Im JY, 2012, HUM MOL GENET, V21, P3013, DOI 10.1093/hmg/dds131; Ishikawa S, 2010, J BIOL CHEM, V285, P39718, DOI 10.1074/jbc.M110.137034; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Karpowicz RJ, 2013, ACS CHEM NEUROSCI, V4, P858, DOI 10.1021/cn400038u; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; KITAYAMA S, 1992, ANN NEUROL, V32, P109, DOI 10.1002/ana.410320120; KITAYAMA S, 1994, EUR J PHARM-MOLEC PH, V268, P115, DOI 10.1016/0922-4106(94)90180-5; Koide-Yoshida S, 2007, INT J MOL MED, V19, P885; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Lakshminarasimhan M, 2008, BIOCHEMISTRY-US, V47, P1381, DOI 10.1021/bi701189c; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lee FJS, 2007, EMBO J, V26, P2127, DOI 10.1038/sj.emboj.7601656; Lee KH, 2004, NEUROCHEM RES, V29, P1405, DOI 10.1023/B:NERE.0000026404.08779.43; Lev N, 2006, J MOL NEUROSCI, V29, P215, DOI 10.1385/JMN:29:3:215; Li HM, 2005, FREE RADICAL RES, V39, P1091, DOI 10.1080/10715760500260348; Li L, 2006, NEUROSCIENCE, V142, P391, DOI 10.1016/j.neuroscience.2006.06.018; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Lotharius J, 2005, J NEUROSCI, V25, P6329, DOI 10.1523/JNEUROSCI.1746-05.2005; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Lu LL, 2012, INT J BIOCHEM CELL B, V44, P65, DOI 10.1016/j.biocel.2011.09.007; Malgieri G, 2008, PROTEIN SCI, V17, P855, DOI 10.1110/ps.073411608; Manning-Bog AB, 2007, NEUROBIOL DIS, V27, P141, DOI 10.1016/j.nbd.2007.03.014; Marazziti D, 2007, P NATL ACAD SCI USA, V104, P9846, DOI 10.1073/pnas.0703368104; Meisenzahl EM, 2007, INT REV PSYCHIATR, V19, P337, DOI 10.1080/09540260701502468; Meulener MC, 2005, J NEUROCHEM, V93, P1524, DOI 10.1111/j.1471-4159.2005.03145.x; Mo JS, 2008, CELL DEATH DIFFER, V15, P1030, DOI 10.1038/cdd.2008.26; Moore DJ, 2003, J NEUROCHEM, V87, P1558, DOI 10.1111/j.1471-4159.2003.02265.x; Moron JA, 2003, J NEUROSCI, V23, P8480; Moszczynska A, 2007, J MOL NEUROSCI, V32, P217, DOI 10.1007/s12031-007-0037-0; NAPOLITANO A, 1995, J MED CHEM, V38, P917, DOI 10.1021/jm00006a010; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Niki T, 2003, MOL CANCER RES, V1, P247; Nishinaga H, 2005, NEUROSCI LETT, V390, P54, DOI 10.1016/j.neulet.2005.07.053; OLANOW CW, 1994, CURR OPIN NEUROL, V7, P548, DOI 10.1097/00019052-199412000-00013; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Olzmann JA, 2007, J COMP NEUROL, V500, P585, DOI 10.1002/cne.21191; Page G, 2004, NEUROCHEM INT, V45, P627, DOI 10.1016/j.neuint.2004.04.002; PATEL AP, 1994, DEV BRAIN RES, V83, P53, DOI 10.1016/0165-3806(94)90178-3; PIFL C, 1993, J NEUROSCI, V13, P4246, DOI 10.1523/jneurosci.13-10-04246.1993; Pizzo AB, 2014, MOL PSYCHIATR, V19, P279, DOI 10.1038/mp.2013.29; Pristupa ZB, 1998, SYNAPSE, V30, P79, DOI 10.1002/(SICI)1098-2396(199809)30:1<79::AID-SYN10>3.3.CO;2-I; Rice ME, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0185; Sekito A, 2006, FREE RADICAL RES, V40, P155, DOI 10.1080/10715760500456847; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Shinbo YM, 2005, INT J ONCOL, V26, P641; Simon JR, 1997, NEUROSCI LETT, V224, P201, DOI 10.1016/S0304-3940(97)13479-6; SMILEY JF, 1994, P NATL ACAD SCI USA, V91, P5720, DOI 10.1073/pnas.91.12.5720; Solis E, 2012, J BIOL CHEM, V287, P8852, DOI 10.1074/jbc.M111.267757; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Steinkellner T, 2012, J BIOL CHEM, V287, P29627, DOI 10.1074/jbc.M112.367219; Taira T, 2004, BIOL PHARM BULL, V27, P574, DOI 10.1248/bpb.27.574; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Thompson AC, 2000, J NEUROSCI, V20, P9333; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Vaughan RA, 1996, J NEUROCHEM, V66, P2146; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; Volkow ND, 2007, ARCH NEUROL-CHICAGO, V64, P1575, DOI 10.1001/archneur.64.11.1575; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; Wang Y, 2008, NEUROMOL MED, V10, P40, DOI 10.1007/s12017-008-8023-4; Wersinger C, 2003, NEUROSCI LETT, V340, P189, DOI 10.1016/S0304-3940(03)00097-1; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yamaguchi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038144; Yamane T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078374; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; Zapata A, 2007, J BIOL CHEM, V282, P35842, DOI 10.1074/jbc.M611758200; Zhang L, 1997, BIOCHEM PHARMACOL, V53, P677, DOI 10.1016/S0006-2952(96)00898-2; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200; Zhu SJ, 1997, J PHARMACOL EXP THER, V282, P1358; Zoli M, 1998, BRAIN RES REV, V26, P136, DOI 10.1016/S0165-0173(97)00048-9; Zucchelli S, 2009, CELL DEATH DIFFER, V16, P428, DOI 10.1038/cdd.2008.169	114	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136641	10.1371/journal.pone.0136641	http://dx.doi.org/10.1371/journal.pone.0136641			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305376	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500103
J	Danowitz, M; Solounias, N				Danowitz, Melinda; Solounias, Nikos			The Cervical Osteology of Okapia johnstoni and Giraffa camelopardalis	PLOS ONE			English	Article							DEVELOPMENTAL CONSTRAINTS; VERTEBRAL COLUMN; NECK; EVOLUTION; BROWSERS; MAMMALS	Giraffidae is the only family of ruminants that is represented by two extant species; Okapia johnstoni and Giraffa camelopardalis. Of these taxa, O. johnstoni represents a typical short-necked ungulate, and G. camelopardalis exemplifies the most extreme cervical elongation seen in any ruminant. We utilize these two species to provide a comprehensive anatomic description of the cervical vertebrae. In addition, we compare the serial morphologic characteristics of the okapi and giraffe cervical vertebrae, and report on several osteologic differences seen between the two taxa. The giraffe neck appears to exhibit homogenization of C3-C7; the position of the dorsal tubercle, thickness of the cranial articular process, shape of the ventral vertebral body, and orientation of the ventral tubercle are constant throughout these vertebrae, whereas these features are serially variable in the okapi. We also report on several specializations of the giraffe C7, which we believe relates to an atypical cervico-thoracic junction, corresponding to the substantial neck lengthening. The morphologic differences exhibited between the okapi and giraffe cervical vertebrae have implications on the function of the necks relating to both fighting and feeding.	[Danowitz, Melinda; Solounias, Nikos] New York Inst Technol, New York Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA	New York Institute Technology	Danowitz, M (corresponding author), New York Inst Technol, New York Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA.	mdanowit@nyit.edu						Badlangana NL, 2009, ZOOL J LINN SOC-LOND, V155, P736, DOI 10.1111/j.1096-3642.2008.00458.x; Cameron EZ, 2007, AM NAT, V169, P130, DOI 10.1086/509940; Dagg A. I., 1962, Journal of Mammalogy, V43, P88, DOI 10.2307/1376883; Darwin C, 1872, ORIGIN SPECIES; Endo H, 2009, MAMM STUDY, V34, P209, DOI 10.3106/041.034.0405; Galis F, 1999, J EXP ZOOL, V285, P19, DOI 10.1002/(SICI)1097-010X(19990415)285:1<19::AID-JEZ3>3.0.CO;2-Z; Kodric-Brown A, 1984, AM NAT, V124, P209; Lankester R, 1908, P ZOOL SOC LOND, V1908, P320; Mitchell G, 2013, J ZOOL, V290, P49, DOI 10.1111/jzo.12013; Narita Y, 2005, J EXP ZOOL PART B, V304B, P91, DOI 10.1002/jez.b.21029; Nickel R., 1986, ANATOMY DOMESTIC ANI; PRATT DM, 1985, J NAT HIST, V19, P771, DOI 10.1080/00222938500770471; Shorrocks B, 2009, GIRAFFA, V3, P22; Simmons RE, 2010, J ZOOL, V282, P6, DOI 10.1111/j.1469-7998.2010.00711.x; Simmons RE, 1996, AM NAT, V148, P771, DOI 10.1086/285955; Solounias N, 1999, J ZOOL, V247, P257, DOI 10.1111/j.1469-7998.1999.tb00989.x; Solounias Nikos, 2007, P257; Van Sittert SJ, 2010, J EXP ZOOL PART B, V314B, P469, DOI 10.1002/jez.b.21353	18	16	16	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136552	10.1371/journal.pone.0136552	http://dx.doi.org/10.1371/journal.pone.0136552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302156	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900074
J	Lin, HY; Weng, SF; Lin, HJ; Hsu, CC; Wang, JJ; Su, SB; Guo, HR; Huang, CC				Lin, Hong-Yue; Weng, Shih-Feng; Lin, Hung-Jung; Hsu, Chien-Chin; Wang, Jhi-Joung; Su, Shih-Bin; Guo, How-Ran; Huang, Chien-Cheng			Peptic Ulcer Disease in Healthcare Workers: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							BURNOUT	Health care workers (HCWs) in Taiwan have heavy, stressful workloads, are on-call, and have rotating nightshifts, all of which might contribute to peptic ulcer disease (PUD). We wanted to evaluate the PUD risk in HCWs, which is not clear. Using Taiwan's National Health Insurance Research Database, we identified 50,226 physicians, 122,357 nurses, 20,677 pharmacists, and 25,059 other HCWs (dieticians, technicians, rehabilitation therapists, and social workers) as the study cohort, and randomly selected an identical number of non-HCWpatients (i.e., general population) as the comparison cohort. Conditional logistical regression analysis was used to compare the PUD risk between them. Subgroup analysis for physician specialties was also done. Nurses and other HCWs had a significantly higher PUD risk than did the general population (odds ratio [OR]: 1.477; 95% confidence interval [CI]: 1.433-1.521 and OR: 1.328; 95% CI: 1.245-1.418, respectively); pharmacists had a lower risk (OR: 0.884; 95% CI: 0.828-0.945); physicians had a nonsignificantly different risk (OR: 1.029; 95% CI: 0.987-1.072). In the physician specialty subgroup analysis, internal medicine, surgery, Ob/Gyn, and family medicine specialists had a higher PUD risk than other physicians (OR: 1.579; 95% CI: 1.441-1.731, OR: 1.734; 95% CI: 1.565-1.922, OR: 1.336; 95% CI: 1.151-1.550, and OR: 1.615; 95% CI: 1.425-1.831, respectively). In contrast, emergency physicians had a lower risk (OR: 0.544; 95% CI: 0.359-0.822). Heavy workloads, long working hours, workplace stress, rotating nightshifts, and coping skills may explain our epidemiological findings of higher risks for PUD in some HCWs, which might help us improve our health policies for HCWs.	[Lin, Hong-Yue; Lin, Hung-Jung; Hsu, Chien-Chin; Huang, Chien-Cheng] Chi Mei Med Ctr, Dept Emergency Med, Tainan, Taiwan; [Weng, Shih-Feng; Wang, Jhi-Joung; Su, Shih-Bin] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Weng, Shih-Feng] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Lin, Hung-Jung; Hsu, Chien-Chin] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Lin, Hung-Jung] Taipei Med Univ, Dept Emergency Med, Taipei, Taiwan; [Su, Shih-Bin] Southern Taiwan Univ Sci & Technol, Dept Leisure Recreat & Tourism Management, Tainan, Taiwan; [Su, Shih-Bin; Huang, Chien-Cheng] Chi Mei Med Ctr, Dept Occupat Med, Tainan, Taiwan; [Guo, How-Ran; Huang, Chien-Cheng] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Guo, How-Ran] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan; [Huang, Chien-Cheng] Southern Taiwan Univ Sci & Technol, Dept Child Care & Educ, Tainan, Taiwan; [Huang, Chien-Cheng] Chi Mei Med Ctr, Dept Geriatr & Gerontol, Tainan, Taiwan	Chi Mei Hospital; Chi Mei Hospital; Kaohsiung Medical University; Southern Taiwan University of Science & Technology; Taipei Medical University; Southern Taiwan University of Science & Technology; Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; Southern Taiwan University of Science & Technology; Chi Mei Hospital	Guo, HR (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	hrguo@mail.ncku.edu.tw; chienchenghuang@yahoo.com.tw	Guo, How-Ran/AAK-9063-2020	Guo, How-Ran/0000-0003-3343-3446; Weng, Shih-Feng/0000-0001-8684-3487	Chi-Mei Medical Center [CMFHR10496]	Chi-Mei Medical Center	This study was supported by the Chi-Mei Medical Center (grant number "CMFHR10496").	[Anonymous], STAT SURVEYS; Campbell DA, 2001, SURGERY, V130, P696, DOI 10.1067/msy.2001.116676; Chen KY, 2013, INT J MED SCI, V10, P1471, DOI 10.7150/ijms.6743; Chen YT, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/904328; Cho KS, ILO ENCY OCCUPATIONA; Chou LP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004185; Knutson A, 2010, SCAND J WORK ENV HEA, V36, P85, DOI 10.5271/sjweh.2897; Lee F Joseph, 2008, Can Fam Physician, V54, P234; Lin Y.-W., 2004, TAIWAN J PUBLIC HLTH, V23, P108; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; National Health Insurance Administration, ABOUT NHI; National Health Insurance Administration Ministry of Health and Welfare, NAT HLTH INS ANN REP; Pietroiusti A, 2006, OCCUP ENVIRON MED, V63, P773, DOI 10.1136/oem.2006.027367; Sharma A, 2008, PSYCHO-ONCOLOGY, V17, P570, DOI 10.1002/pon.1269; Soler JK, 2008, FAM PRACT, V25, P245, DOI 10.1093/fampra/cmn038; Taiwan Medical Association, STAT DESCR; Yates PJ, 2012, EMERG MED J, V29, P533, DOI 10.1136/emj.2010.099630; Zober A, 1998, J OCCUP ENVIRON MED, V40, P586, DOI 10.1097/00043764-199807000-00002	18	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135456	10.1371/journal.pone.0135456	http://dx.doi.org/10.1371/journal.pone.0135456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301861	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900019
J	Probst, BL; McCauley, L; Trevino, I; Wigley, WC; Ferguson, DA				Probst, Brandon L.; McCauley, Lyndsey; Trevino, Isaac; Wigley, W. Christian; Ferguson, Deborah A.			Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405	PLOS ONE			English	Article							CDDO-METHYL ESTER; TRANSGENIC MOUSE MODEL; LUNG-CANCER; DIRECT INHIBITION; GENE-EXPRESSION; TUMOR-GROWTH; ETHYL AMIDE; BARDOXOLONE METHYL; IKK-BETA; APOPTOSIS	Synthetic triterpenoids are antioxidant inflammation modulators (AIMs) that exhibit broad anticancer activity. AIMs bind to KEAP1 and inhibit its ability to promote NRF2 degradation. As a result, NRF2 increases transcription of genes that restore redox balance and reduce inflammation. AIMs inhibit tumor growth and metastasis by increasing NRF2 activity in the tumor microenvironment and by modulating the activity of oncogenic signaling pathways, including NF-kB, in tumor cells. Accumulating evidence suggests that KEAP1 loss or mutation-which results in high levels of sustained NRF2 activity-may promote cancer growth and increase chemoresistance. Loss of KEAP1 also increases the levels of other oncogenic proteins, including IKK beta and BCL2. The apparent survival advantage provided to some tumor cells by loss of functional KEAP1 raises the question of whether pharmacological inhibition of KEAP1 could promote tumor growth. To address this issue, we characterized the basal levels of KEAP1 and NRF2 in a panel of human tumor cell lines and profiled the activity of an AIM, RTA 405. We found that in tumor cell lines with low or mutant KEAP1, and in Keap1(-/-) murine embryonic fibroblasts, multiple KEAP1 targets including NRF2, IKK beta, and BCL2 were elevated. Keap1(-/-) murine embryonic fibroblasts also had higher rates of proliferation and colony formation than their wild-type counterparts. In cells with functional KEAP1, RTA 405 increased NRF2 levels, but not IKK beta or BCL2 levels, and did not increase cell proliferation or survival. Moreover, RTA 405 inhibited growth at similar concentrations in cells with different basal NRF2 activity levels and in cells with wild-type or mutant KRAS. Finally, pre-treatment with RTA 405 did not protect tumor cells from doxorubicin-or cis-platin-mediated growth inhibition. Collectively, these data demonstrate that pharmacological activation of NRF2 by AIMs is distinct from genetic activation and does not provide a growth or survival advantage to tumor cells.	[Probst, Brandon L.; McCauley, Lyndsey; Trevino, Isaac; Wigley, W. Christian; Ferguson, Deborah A.] Reata Pharmaceut Inc, Dept Res, Irving, TX 75063 USA		Ferguson, DA (corresponding author), Reata Pharmaceut Inc, Dept Res, Irving, TX 75063 USA.	deborah.ferguson@reatapharma.com			Reata Pharmaceuticals	Reata Pharmaceuticals	This work was funded by Reata Pharmaceuticals who had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ahmad R, 2006, J BIOL CHEM, V281, P35764; Ahmad R, 2008, CANCER RES, V68, P2920, DOI 10.1158/0008-5472.CAN-07-3036; Alabran JL, 2008, CELL CYCLE, V7; Baird L, 2013, P NATL ACAD SCI USA, V110, P15259, DOI 10.1073/pnas.1305687110; Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Carrasco RA, 2003, BIOTECHNIQUES, V34, P1064, DOI 10.2144/03345dd02; Chan JY, 2000, BIOCH BIOPHYS ACTA, V1517, P19; Chauhan D, 2004, BLOOD, V103, P3158, DOI 10.1182/blood-2003-08-2873; Chin M, 2013, AM J PHYSIOL-RENAL, V304, pF1438, DOI 10.1152/ajprenal.00387.2012; Choi BH, 2014, MOLECULES, V19, P12727, DOI 10.3390/molecules190812727; Cleasby A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098896; Couch RD, 2005, BIOORG MED CHEM LETT, V15, P2215, DOI 10.1016/j.bmcl.2005.03.031; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Ding YF, 2013, KIDNEY INT, V83, P845, DOI 10.1038/ki.2012.393; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Eades G, 2011, J BIOL CHEM; Fox RJ, 2014, CURR MED RES OPIN, V30, P251, DOI 10.1185/03007995.2013.849236; Hast BE, 2014, CANCER RES, V74, P808, DOI 10.1158/0008-5472.CAN-13-1655; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hiramoto K, 2014, CANCER PREV RES, V7, P835, DOI 10.1158/1940-6207.CAPR-14-0094; Hong DS, CLIN CANC RES; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Jiang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075076; Kensler TW, 2013, TOP CURR CHEM, V329, P163, DOI 10.1007/128_2012_339; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Kim KB, 2002, MOL CANCER THER, V1, P177; Kombairaju Ponvijay, 2012, J Carcinog, V11, P8, DOI 10.4103/1477-3163.98459; Konopleva M, 2006, MOL CANCER THER, V5, P317, DOI 10.1158/1535-7163.MCT-05-0350; Konopleva M, 2002, BLOOD, V99, P326, DOI 10.1182/blood.V99.1.326; Lapillonne H, 2003, CANCER RES, V63, P5926; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Lee OH, 2007, J BIOL CHEM, V282, P36412, DOI 10.1074/jbc.M706517200; Liby K, 2007, CANCER RES, V67, P2414, DOI 10.1158/0008-5472.CAN-06-4534; Liby K, 2006, CLIN CANCER RES, V12, P4288, DOI 10.1158/1078-0432.CCR-06-0215; Liby K, 2009, CANCER PREV RES, V2, P1050, DOI 10.1158/1940-6207.CAPR-09-0085; Liby KT, 2014, DOSE-RESPONSE, V12, P136, DOI 10.2203/dose-response.13-018.Liby; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Liby KT, 2010, CANCER PREV RES, V3, P1427, DOI 10.1158/1940-6207.CAPR-10-0197; Ling X, 2007, CANC RES, V67, P4210; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nagaraj S, 2010, CLIN CANCER RES, V16, P1812, DOI 10.1158/1078-0432.CCR-09-3272; Neymotin A, 2011, FREE RADICAL BIO MED, V51, P88, DOI 10.1016/j.freeradbiomed.2011.03.027; Niture SK, 2011, CELL DEATH DIFFER, V18, P439, DOI 10.1038/cdd.2010.114; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Probst BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122942; Reata Pharmaceuticals I AbbVie, 2000, RTA 408 TREATM ADV S; Satoh H, 2010, CARCINOGENESIS; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Shishodia S, 2006, CLIN CANCER RES, V12, P1828, DOI 10.1158/1078-0432.CCR-05-2044; Singh A, 2008, CANCER RES, V68, P7975, DOI 10.1158/0008-5472.CAN-08-1401; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Singh A, 2010, ANTIOXID REDOX SIGN, V13, P1627, DOI 10.1089/ars.2010.3219; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; So JY, 2013, CANCER PREV RES, V6, P959, DOI 10.1158/1940-6207.CAPR-13-0087; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Sporn MB, 2011, J NAT PROD, V74, P537, DOI 10.1021/np100826q; Stack C, 2010, FREE RADICAL BIO MED, V49, P147, DOI 10.1016/j.freeradbiomed.2010.03.017; Suh NJ, 1999, CANCER RES, V59, P336; Tao S, 2014, CANC RES; Thu KL, 2011, J THORAC ONCOL, V6, P1521, DOI 10.1097/JTO.0b013e3182289479; Tian H, 2012, CANCER LETT, V325, P26, DOI 10.1016/j.canlet.2012.06.007; Townson JL, 2011, CLIN EXP METASTASIS; Tran K, 2012, CANCER PREV RES, V5, P726, DOI 10.1158/1940-6207.CAPR-11-0404; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vannini N, 2007, MOL CANCER THER, V6, P3139, DOI 10.1158/1535-7163.MCT-07-0451; Wang R, 2008, BIOCHEM BIOPH RES CO, V373, P151, DOI 10.1016/j.bbrc.2008.06.004; Wang YY, 2014, MOL CANCER, V13, DOI [10.1186/1476-4598-13-30, 10.1186/s12934-014-0151-y]; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yates MS, 2009, CARCINOGENESIS, V30, P1024, DOI 10.1093/carcin/bgp100; Yates MS, 2006, CANCER RES, V66, P2488, DOI 10.1158/0008-5472.CAN-05-3823; Yore MM, 2006, MOL CANCER THER, V5, P3232, DOI 10.1158/1535-7163.MCT-06-0444; Zhang P, 2010, MOL CANCER THER, V9, P336, DOI 10.1158/1535-7163.MCT-09-0589	74	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135257	10.1371/journal.pone.0135257	http://dx.doi.org/10.1371/journal.pone.0135257			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301506	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900015
J	Wang, XL; Yin, DQ; Li, P; Yin, SW; Wang, L; Jia, YH; Shu, XH				Wang, Xiaolu; Yin, Danqing; Li, Peng; Yin, Shaowu; Wang, Li; Jia, Yihe; Shu, Xinhua			MicroRNA-Sequence Profiling Reveals Novel Osmoregulatory MicroRNA Expression Patterns in Catadromous Eel Anguilla marmorata	PLOS ONE			English	Article							STRESS TRANSCRIPTION FACTOR; FOCAL ADHESION KINASE; OSMOTIC-STRESS; GROWTH-HORMONE; FRESH-WATER; CELLS; GILL; IDENTIFICATION; TILAPIA; FISH	MicroRNAs (miRNAs) are a class of endogenous small non-coding RNAs that regulate gene expression by post-transcriptional repression of mRNAs. Recently, several miRNAs have been confirmed to execute directly or indirectly osmoregulatory functions in fish via translational control. In order to clarify whether miRNAs play relevant roles in the osmoregulation of Anguilla marmorata, three sRNA libraries of A. marmorata during adjusting to three various salinities were sequenced by Illumina sRNA deep sequencing methods. Totally 11,339,168, 11,958,406 and 12,568,964 clear reads were obtained from 3 different libraries, respectively. Meanwhile, 34 conserved miRNAs and 613 novel miRNAs were identified using the sequence data. MiR-10b-5p, miR-181a, miR-26a-5p, miR-30d and miR-99a-5p were dominantly expressed in eels at three salinities. Totally 29 mature miRNAs were significantly up-regulated, while 72 mature miRNAs were significantly down-regulated in brackish water (10 parts per thousand salinity) compared with fresh water (0 parts per thousand salinity); 24 mature miRNAs were significantly up-regulated, while 54 mature miRNAs were significantly down-regulated in sea water (25 parts per thousand salinity) compared with fresh water. Similarly, 24 mature miRNAs were significantly up-regulated, while 45 mature miRNAs were significantly down-regulated in sea water compared with brackish water. The expression patterns of 12 dominantly expressed miRNAs were analyzed at different time points when the eels transferred from fresh water to brackish water or to sea water. These miRNAs showed differential expression patterns in eels at distinct salinities. Interestingly, miR-122, miR-140-3p and miR-10b-5p demonstrated osmoregulatory effects in certain salinities. In addition, the identification and characterization of differentially expressed miRNAs at different salinities can clarify the osmoregulatory roles of miRNAs, which will shed lights for future studies on osmoregulation in fish.	[Wang, Xiaolu; Li, Peng; Yin, Shaowu; Wang, Li; Jia, Yihe] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Yin, Danqing] Univ Melbourne, Fac Med Dent & Hlth Sci, Parkville, Vic 3010, Australia; [Shu, Xinhua] Glasgow Caledonian Univ, Dept Life Sci, Glasgow G4 0BA, Lanark, Scotland; [Wang, Xiaolu; Li, Peng; Yin, Shaowu; Wang, Li; Jia, Yihe] Coinnovat Ctr Marine Bioind Technol Jiangsu Prov, Lian Yungang, Peoples R China	Nanjing Normal University; University of Melbourne; Glasgow Caledonian University	Yin, SW (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China.	yinshaowu@hotmail.com	Li, Peng/GYD-6748-2022		Natural science of Jiangsu Province [BK20141450]; National Natural Science Foundation of China [30770283]; Project Foundation of the Academic Program Development of Jiangsu Higher Education Institution (PAPD); Innovation of Graduate Student Training Project of Jiangsu Province [CXLX13-381]	Natural science of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project Foundation of the Academic Program Development of Jiangsu Higher Education Institution (PAPD); Innovation of Graduate Student Training Project of Jiangsu Province	This study was supported by the Natural science of Jiangsu Province (BK20141450), the National Natural Science Foundation of China (30770283), Project Foundation of the Academic Program Development of Jiangsu Higher Education Institution (PAPD), and the Innovation of Graduate Student Training Project of Jiangsu Province (CXLX13-381).	Ai L, 2012, PARASITOL RES, V110, P2373, DOI 10.1007/s00436-011-2773-x; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Arai T, 2012, J FISH BIOL, V81, P442, DOI 10.1111/j.1095-8649.2012.03353.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chara O, 2011, J EXP ZOOL PART A, V315A, P175, DOI 10.1002/jez.662; Chi W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023549; Chow SC, 2009, J EXP BIOL, V212, P3205, DOI 10.1242/jeb.031302; Cimino S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/632959; Cruz SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077997; D'Onofrio G, 2007, FEBS LETT, V581, P5819, DOI 10.1016/j.febslet.2007.11.052; Dey BK, 2012, GENE DEV, V26, P2180, DOI 10.1101/gad.198085.112; Ellwanger DC, 2011, BIOINFORMATICS, V27, P1346, DOI 10.1093/bioinformatics/btr149; Enright AJ, 2004, GENOME BIOL, V5; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Evans DH, 2008, AM J PHYSIOL-REG I, V295, pR704, DOI 10.1152/ajpregu.90337.2008; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fiol DF, 2005, P NATL ACAD SCI USA, V102, P927, DOI 10.1073/pnas.0408956102; Flynt AS, 2009, J CELL BIOL, V185, P115, DOI 10.1083/jcb.200807026; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Fu YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022957; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; Henkel CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032231; Ho J, 2008, J AM SOC NEPHROL, V19, P2069, DOI 10.1681/ASN.2008020162; Holt MEV, 2006, CELL BIOCHEM BIOPHYS, V45, P1, DOI 10.1385/CBB:45:1:1; Huang H, 2009, GEN COMP ENDOCR, V162, P192, DOI 10.1016/j.ygcen.2009.02.012; Hung TM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0089446, 10.1371/journal.pone.0108284]; Ji ZB, 2012, MOL BIOL REP, V39, P9361, DOI 10.1007/s11033-012-1779-5; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Kultz D, 2012, PHYSIOLOGY, V27, P259, DOI 10.1152/physiol.00014.2012; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YY, 2003, J MOL ENDOCRINOL, V31, P327, DOI 10.1677/jme.0.0310327; Lian CJ, 2012, FEBS J, V279, P964, DOI 10.1111/j.1742-4658.2012.08480.x; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin CH, 2014, ENDOCRINOLOGY, V155, P56, DOI 10.1210/en.2013-1608; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lock EJ, 2010, AQUACULT NUTR, V16, P100, DOI 10.1111/j.1365-2095.2009.00722.x; Marshall WS, 2008, COMP BIOCHEM PHYS A, V150, P288, DOI 10.1016/j.cbpa.2008.03.013; Marshall WS, 2009, J EXP BIOL, V212, P2365, DOI 10.1242/jeb.030015; Marshall WS, 2005, J EXP BIOL, V208, P1063, DOI 10.1242/jeb.01491; McCormick SD, 2001, AM ZOOL, V41, P781, DOI 10.1668/0003-1569(2001)041[0781:ECOOIT]2.0.CO;2; Milenkovic D, 2013, FREE RADICAL BIO MED, V64, P40, DOI 10.1016/j.freeradbiomed.2013.05.046; Ogoshi M, 2003, BIOCHEM BIOPH RES CO, V311, P1072, DOI 10.1016/j.bbrc.2003.10.111; Pelis RM, 2001, GEN COMP ENDOCR, V124, P134, DOI 10.1006/gcen.2001.7703; Persson P, 1998, J FISH BIOL, V52, P334, DOI 10.1111/j.1095-8649.1998.tb00801.x; Qi PZ, 2014, FISH SHELLFISH IMMUN, V39, P483, DOI 10.1016/j.fsi.2014.06.009; Sakamoto T, 2006, J EXP ZOOL PART A, V305A, P173; Sha ZX, 2014, DEV COMP IMMUNOL, V44, P59, DOI 10.1016/j.dci.2013.11.014; Shepotitiovskaya IV, 2008, BIOCHEMISTRY-US, V47, P7034, DOI 10.1021/bi7025358; Sober S, 2010, BIOCHEM BIOPH RES CO, V391, P727, DOI 10.1016/j.bbrc.2009.11.128; Tse WKF, 2008, J EXP BIOL, V211, P1964, DOI 10.1242/jeb.017368; Tse WKF, 2006, BIOCHEM BIOPH RES CO, V346, P1181, DOI 10.1016/j.bbrc.2006.06.028; Tse WKF, 2011, INT J BIOCHEM CELL B, V43, P1764, DOI 10.1016/j.biocel.2011.08.013; Tse WKF, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0086-5; Wang XL, 2014, CONSERV GENET RESOUR, V6, P865, DOI 10.1007/s12686-014-0227-3; Welling PA, 2010, PHYSIOLOGY, V25, P280, DOI 10.1152/physiol.00022.2010; Williams AE, 2008, CELL MOL LIFE SCI, V65, P545, DOI 10.1007/s00018-007-7355-9; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Yan B, 2014, MOL BIOL REP, V41, P4953, DOI 10.1007/s11033-014-3361-9; Yan BA, 2013, J EXP BIOL, V216, P1265, DOI 10.1242/jeb.079590; Yan B, 2012, BIOCHEM BIOPH RES CO, V426, P294, DOI 10.1016/j.bbrc.2012.08.029; Yan B, 2012, BIOCHEM BIOPH RES CO, V425, P315, DOI 10.1016/j.bbrc.2012.07.088; Yi SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-754	68	10	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136383	10.1371/journal.pone.0136383	http://dx.doi.org/10.1371/journal.pone.0136383			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301415	Green Submitted, Green Published, gold			2022-12-27	WOS:000359951900066
J	Zhuo, JC; Keledjian, K; Xu, S; Pampori, A; Gerzanich, V; Simard, JM; Gullapalli, RP				Zhuo, Jiachen; Keledjian, Kaspar; Xu, Su; Pampori, Adam; Gerzanich, Volodymyr; Simard, J. Marc; Gullapalli, Rao P.			Changes in Diffusion Kurtosis Imaging and Magnetic Resonance Spectroscopy in a Direct Cranial Blast Traumatic Brain Injury (dc-bTBI) Model	PLOS ONE			English	Article							TRANSIENT FOCAL ISCHEMIA; PATTERN SEPARATION; HIGH-RESOLUTION; DENTATE GYRUS; PROTON MRS; MODERATE; RATS; CA3; NEUROPATHOLOGY; SENSORIMOTOR	Explosive blast-related injuries are one of the hallmark injuries of veterans returning from recent wars, but the effects of a blast overpressure on the brain are poorly understood. In this study, we used in vivo diffusion kurtosis imaging (DKI) and proton magnetic resonance spectroscopy (MRS) to investigate tissue microstructure and metabolic changes in a novel, direct cranial blast traumatic brain injury (dc-bTBI) rat model. Imaging was performed on rats before injury and 1, 7, 14 and 28 days after blast exposure (similar to 517 kPa peak overpressure to the dorsum of the head). No brain parenchyma abnormalities were visible on conventional T2-weighted MRI, but microstructural and metabolic changes were observed with DKI and proton MRS, respectively. Increased mean kurtosis, which peaked at 21 days post injury, was observed in the hippocampus and the internal capsule. Concomitant increases in myo-Inositol (Ins) and Taurine (Tau) were also observed in the hippocampus, while early changes at 1 day in the Glutamine (Gln) were observed in the internal capsule, all indicating glial abnormality in these regions. Neurofunctional testing on a separate but similarly treated group of rats showed early disturbances in vestibulomotor functions (days 1-14), which were associated with imaging changes in the internal capsule. Delayed impairments in spatial memory and in rapid learning, as assessed by Morris Water Maze paradigms (days 14-19), were associated with delayed changes in the hippocampus. Significant microglial activation and neurodegeneration were observed at 28 days in the hippocampus. Overall, our findings indicate delayed neurofunctional and pathological abnormalities following dc-bTBI that are silent on conventional T2-weighted imaging, but are detectable using DKI and proton MRS.	[Zhuo, Jiachen; Xu, Su; Gullapalli, Rao P.] Univ Maryland, Sch Med, Dept Diagnost Radiol, Baltimore, MD 21201 USA; [Zhuo, Jiachen; Xu, Su; Gullapalli, Rao P.] Univ Maryland, Sch Med, Dept Nucl Med, Baltimore, MD 21201 USA; [Keledjian, Kaspar; Pampori, Adam; Gerzanich, Volodymyr; Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Gullapalli, RP (corresponding author), Univ Maryland, Sch Med, Dept Diagnost Radiol, Baltimore, MD 21201 USA.	msimard@smail.umaryland.edu; rgullapalli@umm.edu			Department of the Army [W81XWH-12-1-0098, W81XWH-08-1-0725, W81XWH 10-1-0898]; Baltimore Veterans Affairs Medical Center [1I01BX001629]; Veterans Affairs [I01BX001629] Funding Source: NIH RePORTER	Department of the Army; Baltimore Veterans Affairs Medical Center; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Department of the Army (W81XWH-12-1-0098 and W81XWH-08-1-0725 to RPG, W81XWH 10-1-0898 to JMS, http://cdmrp.army.mil/funding/), and the Baltimore Veterans Affairs Medical Center (1I01BX001629 to JMS, http://www.maryland.va.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2006, HEPATOLOGY, V44, P788, DOI 10.1002/hep.21357; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bland ST, 2000, STROKE, V31, P1144, DOI 10.1161/01.STR.31.5.1144; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Cheung JS, 2012, STROKE, V43, P2252, DOI 10.1161/STROKEAHA.112.661926; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Gerzanich V, 2003, CIRC RES, V93, P805, DOI 10.1161/01.RES.0000097872.69043.A0; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Helpern JA, 2011, J MAGN RESON IMAGING, V33, P17, DOI 10.1002/jmri.22397; Holshouser BA, 2006, J MAGN RESON IMAGING, V24, P33, DOI 10.1002/jmri.20607; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Lee I, 2004, NEURON, V42, P803, DOI 10.1016/j.neuron.2004.05.010; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Marino S, 2011, NEUROCRIT CARE, V14, P127, DOI 10.1007/s12028-010-9406-6; MARKGRAF CG, 1992, BRAIN RES, V575, P238, DOI 10.1016/0006-8993(92)90085-N; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Mellor S G, 1988, Br J Hosp Med, V39, P536; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Petullo D, 1999, LIFE SCI, V64, P1099, DOI 10.1016/S0024-3205(99)00038-7; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Salzman SK, 1994, NEUROBIOLOGY CENTRAL; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schiemanck SK, 2008, J REHABIL MED, V40, P96, DOI 10.2340/16501977-0130; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Tosun C, 2013, BRAIN SCI, V3, P215, DOI 10.3390/brainsci3010215; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Van Cauter S, 2012, RADIOLOGY, V263, P492, DOI 10.1148/radiol.12110927; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Xu S, 2006, J MAGN RESON, V182, P221, DOI 10.1016/j.jmr.2006.07.003; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050; Zwingmann C, 2000, DEV NEUROSCI-BASEL, V22, P463, DOI 10.1159/000017476	61	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136151	10.1371/journal.pone.0136151	http://dx.doi.org/10.1371/journal.pone.0136151			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301778	Green Submitted, gold, Green Published			2022-12-27	WOS:000359951900044
J	Echevarria, D; Gutfraind, A; Boodram, B; Major, M; Del Valle, S; Cotler, SJ; Dahari, H				Echevarria, Desarae; Gutfraind, Alexander; Boodram, Basmattee; Major, Marian; Del Valle, Sara; Cotler, Scott J.; Dahari, Harel			Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago	PLOS ONE			English	Article							VIRUS-INFECTION; UNITED-STATES; YOUNG-ADULTS; USERS; RISK; HIV; PEOPLE; MASSACHUSETTS; TRANSMISSION; RESTORATION	Background/Aim New direct-acting antivirals (DAAs) provide an opportunity to combat hepatitis C virus (HCV) infection in persons who inject drugs (PWID). Here we use a mathematical model to predict the impact of a DAA-treatment scale-up on HCV prevalence among PWID and the estimated cost in metropolitan Chicago. Methods To estimate the HCV antibody and HCV-RNA (chronic infection) prevalence among the metropolitan Chicago PWID population, we used empirical data from three large epidemiological studies. Cost of DAAs is assumed $50,000 per person. Results Approximately 32,000 PWID reside in metropolitan Chicago with an estimated HCV-RNA prevalence of 47% or 15,040 cases. Approximately 22,000 PWID (69% of the total PWID population) attend harm reduction (HR) programs, such as syringe exchange programs, and have an estimated HCV-RNA prevalence of 30%. There are about 11,000 young PWID (<30 years old) with an estimated HCV-RNA prevalence of 10% (PWID in these two subpopulations overlap). The model suggests that the following treatment scale-up is needed to reduce the baseline HCV-RNA prevalence by one-half over 10 years of treatment [cost per year, min-max in millions]: 35 per 1,000 [$50-$77] in the overall PWID population, 19 per 1,000 [$20-$26] for persons in HR programs, and 5 per 1,000 [$3-$4] for young PWID. Conclusions Treatment scale-up could dramatically reduce the prevalence of chronic HCV infection among PWID in Chicago, who are the main reservoir for on-going HCV transmission. Focusing treatment on PWID attending HR programs and/or young PWID could have a significant impact on HCV prevalence in these subpopulations at an attainable cost.	[Echevarria, Desarae; Gutfraind, Alexander; Cotler, Scott J.; Dahari, Harel] Loyola Univ Chicago, Med Ctr, Program Expt & Theoret Modeling, Div Hepatol,Dept Med, Maywood, IL 60526 USA; [Gutfraind, Alexander; Boodram, Basmattee] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA; [Major, Marian] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Del Valle, Sara] Los Alamos Natl Lab, Energy & Infrastruct Anal Grp, Los Alamos, NM USA; [Dahari, Harel] Los Alamos Natl Lab, Theoret & Biophys Grp, Los Alamos, NM USA	Loyola University Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Food & Drug Administration (FDA); United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Dahari, H (corresponding author), Loyola Univ Chicago, Med Ctr, Program Expt & Theoret Modeling, Div Hepatol,Dept Med, Maywood, IL 60526 USA.	hdahari@lumc.edu	Del Valle, Sara/AAG-5148-2021	Del Valle, Sara/0000-0002-0159-1952	NIH [P20-GM103452, R01-AI078881]; U.S. Department of Energy [DE-AC52-06NA25396]; UIC Award of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103452, P30GM110907] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); UIC Award of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH grants P20-GM103452 and R01-AI078881, the U.S. Department of Energy contract DE-AC52-06NA25396 and UIC Award of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hakeem MS, 2010, J VIROL, V84, P10429, DOI 10.1128/JVI.01094-10; Amon JJ, 2008, CLIN INFECT DIS, V46, P1852, DOI 10.1086/588297; [Anonymous], 2014, PRIOR AUTH SOV OTH M; Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Aspinall EJ, 2013, CLIN INFECT DIS, V57, pS80, DOI 10.1093/cid/cit306; Boodram B, 2010, DRUG ALCOHOL DEPEN, V111, P136, DOI 10.1016/j.drugalcdep.2010.04.003; Boodram B, 2011, DRUG ALCOHOL DEPEN, V119, P166, DOI 10.1016/j.drugalcdep.2011.06.005; Booth RE, 2006, DRUG ALCOHOL DEPEN, V82, pS49, DOI 10.1016/S0376-8716(06)80009-8; Broz D, 2008, DRUG ALCOHOL DEPEN, V94, P221, DOI 10.1016/j.drugalcdep.2007.11.020; Broz D, 2014, MMWR SURVEILL SUMM, V63, P1; Bruggmann P, 2013, HEPATOLOGY, V58, P1523, DOI 10.1002/hep.26539; CDC. Centers for Disease Control and Prevention, 2012, VIR HEP DRUG US; Centers for Disease Control and Prevention, 2010, MMWR MORBIDITY AND M, V60, P1457; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P133; Church D., 2011, Morbidity and Mortality Weekly Report, V60, P1457; Cousien A, 2015, J VIRAL HEPATITIS, V22, P213, DOI 10.1111/jvh.12337; Dahari H, 2010, GASTROENTEROLOGY, V139, P965, DOI 10.1053/j.gastro.2010.05.077; Delwart E, 2012, J INFECT DIS, V205, P875, DOI 10.1093/infdis/jir862; Dimova RB, 2013, CLIN INFECT DIS, V56, P806, DOI 10.1093/cid/cis1007; Feinstone SM, 2012, CLIN INFECT DIS, V55, pS25, DOI 10.1093/cid/cis362; Garfein RS, 2007, DRUG ALCOHOL DEPEN, V91, pS4, DOI 10.1016/j.drugalcdep.2007.05.007; Golub ET, 2007, DRUG ALCOHOL DEPEN, V91, pS30, DOI 10.1016/j.drugalcdep.2007.02.013; Grebely J, 2008, DRUG ALCOHOL DEPEN, V93, P141, DOI 10.1016/j.drugalcdep.2007.09.008; Hahn JA, 2010, ADDICTION, V105, P1254, DOI 10.1111/j.1360-0443.2010.02949.x; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Heckathorn DD, 1997, SOC PROBL, V44, P25; Hellard M, 2014, HEPATOLOGY, V60, P1861, DOI 10.1002/hep.27403; Hill A, 2014, SCIENCE, V345, P141, DOI 10.1126/science.1257737; Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012; Kohli A, 2015, LANCET, V385, P1107, DOI 10.1016/S0140-6736(14)61228-9; Leuchner L., 2008, Morbidity and Mortality Weekly Report, V57, P517; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lum PJ, 2005, SUBST USE MISUSE, V40, P1681, DOI 10.1080/10826080500222834; Major ME, 2004, HEPATOLOGY, V39, P1709, DOI 10.1002/hep.20239; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656; Martin NK, 2011, J HEPATOL, V54, P1137, DOI 10.1016/j.jhep.2010.08.029; Mehta SH, 2002, LANCET, V359, P1478, DOI 10.1016/S0140-6736(02)08435-0; Mehta SH, 2008, J COMMUN HEALTH, V33, P126, DOI 10.1007/s10900-007-9083-3; Missale G, 2012, GUT, V61, P1076, DOI 10.1136/gutjnl-2011-300515; Netski DM, 2005, CLIN INFECT DIS, V41, P667, DOI 10.1086/432478; Onofrey Shauna, 2011, Morbidity and Mortality Weekly Report, V60, P537; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Page K, 2013, CLIN INFECT DIS, V56, P405, DOI 10.1093/cid/cis921; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Rondinelli AJ, 2009, DRUG ALCOHOL DEPEN, V104, P167, DOI 10.1016/j.drugalcdep.2009.05.013; Sacks-Davis R, 2015, J INFECT DIS, V212, P1407, DOI 10.1093/infdis/jiv220; Shiffman ML, 2014, CURR OPIN GASTROEN, V30, P217, DOI 10.1097/MOG.0000000000000062; Sidharthan S, 2014, HEPATOL INT, V8, pS452, DOI 10.1007/s12072-013-9494-4; Spiller MW, 2015, MMWR-MORBID MORTAL W, V64, P270; Tempalski B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064789; Thorpe LE, 2002, AM J EPIDEMIOL, V155, P645, DOI 10.1093/aje/155.7.645; Williams IT, 2011, ARCH INTERN MED, V171, P242, DOI 10.1001/archinternmed.2010.511	54	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135901	10.1371/journal.pone.0135901	http://dx.doi.org/10.1371/journal.pone.0135901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295805	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900048
J	Ghosh, A; Ratha, BN; Gayen, N; Mroue, KH; Kar, RK; Mandal, AK; Bhunia, A				Ghosh, Anirban; Ratha, Bhisma Narayan; Gayen, Nilanjan; Mroue, Kamal H.; Kar, Rajiv K.; Mandal, Atin K.; Bhunia, Anirban			Biophysical Characterization of Essential Phosphorylation at the Flexible C-Terminal Region of C-Raf with 14-3-3 zeta Protein	PLOS ONE			English	Article							TRANSFER DIFFERENCE NMR; STRUCTURAL BASIS; TARGETING RAF; CAUSE NOONAN; MEK KINASE; ACTIVATION; BINDING; 14-3-3-PROTEINS; MUTATIONS; LIGAND	Phosphorylation at the C-terminal flexible region of the C-Raf protein plays an important role in regulating its biological activity. Auto-phosphorylation at serine 621 (S621) in this region maintains C-Raf stability and activity. This phosphorylation mediates the interaction between C-Raf and scaffold protein 14-3-3 zeta to activate the downstream MEK kinase pathway. In this study, we have defined the interaction of C-terminal peptide sequence of C-Raf with 14-3-3 zeta protein and determined the possible structural adaptation of this region. Biophysical elucidation of the interaction was carried out using phosphopeptide (residue number 615-630) in the presence of 14-3-3 zeta protein. Using isothermal titration calorimetry (ITC), a high binding affinity with micro-molar range was found to exist between the peptide and 14-3-3 zeta protein, whereas the non-phosphorylated peptide did not show any appreciable binding affinity. Further interaction details were investigated using several biophysical techniques such as circular dichroism (CD), fluorescence, and nuclear magnetic resonance (NMR) spectroscopy, in addition to molecular modeling. This study provides the molecular basis for C-Raf C-terminal-derived phosphopeptide interaction with 14-3-3 zeta protein as well as structural insights responsible for phosphorylated S621-mediated 14-3-3 zeta binding at an atomic resolution.	[Ghosh, Anirban; Ratha, Bhisma Narayan; Kar, Rajiv K.; Bhunia, Anirban] Bose Inst, Dept Biophys, Kolkata 700054, India; [Gayen, Nilanjan; Mandal, Atin K.] Bose Inst, Dept Mol Med, Kolkata 700054, India; [Mroue, Kamal H.] Univ Michigan, Biophys, Ann Arbor, MI 48109 USA; [Mroue, Kamal H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Mandal, AK (corresponding author), Bose Inst, Dept Mol Med, P-1-12 CIT Scheme VII M, Kolkata 700054, India.	mandalak@jcbose.ac.in; bhunia@jcbose.ac.in	RATHA, BHISMA NARAYAN/ABF-1767-2020; Ghosh, Anirban/S-9315-2017; Kar, Rajiv Kumar/O-5939-2018	RATHA, BHISMA NARAYAN/0000-0002-0829-1637; Ghosh, Anirban/0000-0001-9837-3339; Bhunia, Anirban/0000-0002-8752-2842; Kar, Rajiv Kumar/0000-0003-4629-5863; Mroue, Kamal/0000-0002-4737-6529	Bose Institute, Kolkata, India	Bose Institute, Kolkata, India(Department of Science & Technology (India))	This research was supported by Bose Institute, Kolkata, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; ALTER GM, 1983, J BIOL CHEM, V258, P4966; Banerjee V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072318; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Bera S, 2015, J COLLOID INTERF SCI, V452, P148, DOI 10.1016/j.jcis.2015.04.031; Bhattacharjya S, 1997, BIOPOLYMERS, V41, P251, DOI 10.1002/(SICI)1097-0282(199703)41:3<251::AID-BIP2>3.0.CO;2-R; Bhunia A, 2012, DRUG DISCOV TODAY, V17, P505, DOI 10.1016/j.drudis.2011.12.016; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; CONKLIN DS, 1995, P NATL ACAD SCI USA, V92, P7892, DOI 10.1073/pnas.92.17.7892; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhandapany PS, 2014, NAT GENET, V46, P635, DOI 10.1038/ng.2963; Dhillon AS, 2009, CELL SIGNAL, V21, P1645, DOI 10.1016/j.cellsig.2009.07.001; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; DiMauro MA, 2014, BIOCHEMISTRY-US, V53, P7269, DOI 10.1021/bi501004y; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Fanger GR, 1998, J BIOL CHEM, V273, P3476, DOI 10.1074/jbc.273.6.3476; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; Fischer A, 2009, J BIOL CHEM, V284, P3183, DOI 10.1074/jbc.M804795200; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; FU H, 1994, SCIENCE, V266, P126, DOI 10.1126/science.7939632; Gardino AK, 2006, SEMINARS CANC BIOL; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; GARDNER AM, 1994, MOL BIOL CELL, V5, P193, DOI 10.1091/mbc.5.2.193; Ghosh A, 2014, CHEMMEDCHEM, V9, P2059, DOI 10.1002/cmdc.201402238; Ghosh A, 2014, CHEMMEDCHEM, V9, P2052, DOI 10.1002/cmdc.201402215; Ghosh A, 2014, MOL BIOSYST, V10, P1596, DOI 10.1039/c4mb00111g; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Hekman M, 2004, J BIOL CHEM, V279, P14074, DOI 10.1074/jbc.M309620200; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Honda R, 1997, BIOCHEM BIOPH RES CO, V230, P262, DOI 10.1006/bbrc.1996.5933; JELINEK T, 1994, MOL CELL BIOL, V14, P8212, DOI 10.1128/MCB.14.12.8212; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kar RK, 2013, SAR QSAR ENVIRON RES, V24, P215, DOI 10.1080/1062936X.2013.765912; Killoran RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123934; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Liu YC, 1996, J BIOL CHEM, V271, P14591, DOI 10.1074/jbc.271.24.14591; Mashiach E, 2010, PROTEINS, V78, P3197, DOI 10.1002/prot.22790; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; MICHAUD NR, 1995, MOL CELL BIOL, V15, P3390; Mischak H, 1996, MOL CELL BIOL, V16, P5409; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Molzan M, 2013, ACS CHEM BIOL, V8, P1869, DOI 10.1021/cb4003464; Molzan M, 2010, MOL CELL BIOL, V30, P4698, DOI 10.1128/MCB.01636-09; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; NI F, 1994, ACCOUNTS CHEM RES, V27, P257, DOI 10.1021/ar00045a001; Noble C, 2008, MOL CELL, V31, P862, DOI 10.1016/j.molcel.2008.08.026; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Rajagopalan S, 2010, NUCLEIC ACIDS RES, V38, P893, DOI 10.1093/nar/gkp1041; Rapp UR, 2006, CANCER CELL, V9, P9, DOI 10.1016/j.ccr.2005.12.022; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Reyniers L, 2014, J NEUROCHEM, V131, P239, DOI 10.1111/jnc.12798; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Roy S, 1998, MOL CELL BIOL, V18, P3947, DOI 10.1128/MCB.18.7.3947; Saravanan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072718; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; WARTMANN M, 1994, J BIOL CHEM, V269, P6695; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yip-Schneider MT, 2000, BIOCHEM J, V351, P151, DOI 10.1042/0264-6021:3510151; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	77	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135976	10.1371/journal.pone.0135976	http://dx.doi.org/10.1371/journal.pone.0135976			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295714	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900056
J	Kulminski, AM; Culminskaya, I; Arbeev, KG; Arbeeva, L; Ukraintseva, SV; Stallard, E; Wu, DQ; Yashin, AI				Kulminski, Alexander M.; Culminskaya, Irina; Arbeev, Konstantin G.; Arbeeva, Liubov; Ukraintseva, Svetlana V.; Stallard, Eric; Wu, Deqing; Yashin, Anatoliy I.			Birth Cohort, Age, and Sex Strongly Modulate Effects of Lipid Risk Alleles Identified in Genome-Wide Association Studies	PLOS ONE			English	Article							APOLIPOPROTEIN-E GENOTYPE; DENSITY-LIPOPROTEIN-CHOLESTEROL; LIFE-SPAN; PLASMA PCSK9; GENES; LONGEVITY; HEART; HEALTH; HETEROGENEITY; ENVIRONMENT	Insights into genetic origin of diseases and related traits could substantially impact strategies for improving human health. The results of genome-wide association studies (GWAS) are often positioned as discoveries of unconditional risk alleles of complex health traits. We re-analyzed the associations of single nucleotide polymorphisms (SNPs) associated with total cholesterol (TC) in a large-scale GWAS meta-analysis. We focused on three generations of genotyped participants of the Framingham Heart Study (FHS). We show that the effects of all ten directly-genotyped SNPs were clustered in different FHS generations and/or birth cohorts in a sex-specific or sex-unspecific manner. The sample size and procedure-therapeutic issues play, at most, a minor role in this clustering. An important result was clustering of significant associations with the strongest effects in the youngest, or 3rd Generation, cohort. These results imply that an assumption of unconditional connections of these SNPs with TC is generally implausible and that a demographic perspective can substantially improve GWAS efficiency. The analyses of genetic effects in age-matched samples suggest a role of environmental and age-related mechanisms in the associations of different SNPs with TC. Analysis of the literature supports systemic roles for genes for these SNPs beyond those related to lipid metabolism. Our analyses reveal strong antagonistic effects of rs2479409 (the PCSK9 gene) that cautions strategies aimed at targeting this gene in the next generation of lipid drugs. Our results suggest that standard GWAS strategies need to be advanced in order to appropriately address the problem of genetic susceptibility to complex traits that is imperative for translation to health care.	[Kulminski, Alexander M.; Culminskaya, Irina; Arbeev, Konstantin G.; Arbeeva, Liubov; Ukraintseva, Svetlana V.; Stallard, Eric; Wu, Deqing; Yashin, Anatoliy I.] Duke Univ, Biodemog Aging Res Unit, Social Sci Res Inst, Durham, NC 27708 USA	Duke University	Kulminski, AM (corresponding author), Duke Univ, Biodemog Aging Res Unit, Social Sci Res Inst, Durham, NC 27708 USA.	Alexander.Kulminski@duke.edu	Kulminski, Alexander/T-1290-2019; Arbeev, Konstantin/AAJ-4425-2020	Arbeev, Konstantin/0000-0002-4195-7832	National Institute on Aging [1P01 AG043352-01, 1R01 AG047310, 1R01 AG046860]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047310, P30AG034424, R01AG046860, P01AG043352, RF1AG046860] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The research reported in this paper was supported by Grants No 1P01 AG043352-01 (AIY, AMK, KGA, SVU), 1R01 AG047310 (AMK) and 1R01 AG046860 (AIY) from the National Institute on Aging. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aging NIo, 2010, LIVING LONG WELL IN; Akushevich I, 2012, J AM GERIATR SOC, V60, P323, DOI 10.1111/j.1532-5415.2011.03786.x; Atzmon G, 2008, J GERONTOL A-BIOL, V63, P447, DOI 10.1093/gerona/63.5.447; Baass A, 2009, CLIN CHEM, V55, P1637, DOI 10.1373/clinchem.2009.126987; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Bonde Y, 2014, J LIPID RES, V55, P2408, DOI 10.1194/jlr.M051664; Boomsma DI, 1996, GENET EPIDEMIOL, V13, P49, DOI 10.1002/(SICI)1098-2272(1996)13:1<49::AID-GEPI5>3.0.CO;2-1; Broxmeyer HE, 2006, EXP HEMATOL, V34, P1078, DOI 10.1016/j.exphem.2006.04.008; Chandrasekharan S, 2002, MOL CELL BIOL, V22, P5235, DOI 10.1128/MCB.22.14.5235-5247.2002; CHELLADURAI M, 1991, BIOCHEM BIOPH RES CO, V178, P467, DOI 10.1016/0006-291X(91)90130-Y; Corella D, 2014, AGEING RES REV, V18, P53, DOI 10.1016/j.arr.2014.08.002; Corella D, 2009, ARCH INTERN MED, V169, P1897, DOI 10.1001/archinternmed.2009.343; Cupples L Adrienne, 2009, BMC Proc, V3 Suppl 7, pS3; Daigo K, 2011, J BIOL CHEM, V286, P674, DOI 10.1074/jbc.M110.154732; Day-Williams AG, 2011, EUR J CLIN INVEST, V41, P561, DOI 10.1111/j.1365-2362.2010.02437.x; De Benedictis G, 1998, ANN HUM GENET, V62, P115, DOI 10.1017/S0003480098006757; Deguchi H, 2007, THROMB HAEMOSTASIS, V98, P1160, DOI 10.1160/TH07-07-0451; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; Ganz T, 2007, J AM SOC NEPHROL, V18, P394, DOI 10.1681/ASN.2006070802; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Govindaraju DR, 2008, ADV GENET, V62, P33, DOI 10.1016/S0065-2660(08)00602-0; HERSHCOPF RJ, 1982, J CHRON DIS, V35, P101, DOI 10.1016/0021-9681(82)90111-4; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Ikram MA, 2009, NEW ENGL J MED, V360, P1718, DOI 10.1056/NEJMoa0900094; Ilveskoski E, 1999, CIRCULATION, V100, P608, DOI 10.1161/01.CIR.100.6.608; Jarvik GP, 1997, AM J HUM GENET, V61, P171, DOI 10.1086/513902; JARVIK GP, 1994, GENET EPIDEMIOL, V11, P375, DOI 10.1002/gepi.1370110407; Jiang KY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4280; Kolovou G, 2009, ANN CLIN LAB SCI, V39, P120; Kulminski AM, 2013, REJUV RES, V16, P304, DOI 10.1089/rej.2013.1441; Kulminski AM, 2013, AGING CELL, V12, P237, DOI 10.1111/acel.12046; Kumar R, 2008, EXPERT REV VACCINES, V7, P467, DOI 10.1586/14760584.7.4.467; Kuningas M, 2008, AGING CELL, V7, P270, DOI 10.1111/j.1474-9726.2008.00366.x; Lahoz C, 2001, ATHEROSCLEROSIS, V154, P529, DOI 10.1016/S0021-9150(00)00570-0; Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141; Lambert G, 2009, ATHEROSCLEROSIS, V203, P1, DOI 10.1016/j.atherosclerosis.2008.06.010; Lebel M., 2011, CURR GERONTOL GERIAT, V2011; MacRae CA, 2011, CIRC-CARDIOVASC GENE, V4, P334, DOI 10.1161/CIRCGENETICS.111.960765; MARI D, 1995, BLOOD, V85, P3144, DOI 10.1182/blood.V85.11.3144.bloodjournal85113144; Matsumoto C, 2013, EUR J ENDOCRINOL, V168, P137, DOI 10.1530/EJE-12-0507; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Migeon BR, 2006, JAMA-J AM MED ASSOC, V295, P1428, DOI 10.1001/jama.295.12.1428; Milman S, 2014, CURR VASC PHARMACOL, V12, P690; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; Myers RH, 1996, NEUROLOGY, V46, P673, DOI 10.1212/WNL.46.3.673; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Neel JV, 1998, PERSPECT BIOL MED, V42, P44; Olshansky SJ, 2007, ANN NY ACAD SCI, V1114, P11, DOI 10.1196/annals.1396.050; Ordovas JM, 2004, ANNU REV GENOM HUM G, V5, P71, DOI 10.1146/annurev.genom.5.061903.180008; Ordovas JM, 2007, GENDER MED, V4, pS111, DOI 10.1016/S1550-8579(07)80052-0; Osakabe A, 2013, J CELL SCI, V126, P1323, DOI 10.1242/jcs.112623; Peeters RP, 2008, HORM-INT J ENDOCRINO, V7, P28, DOI 10.14310/horm.2002.1111035; Pibiri M, 2001, FASEB J, V15, P1006, DOI 10.1096/fj.00-0416com; Port SC, 2006, AM J EPIDEMIOL, V163, P342, DOI 10.1093/aje/kwj027; Rezen T, 2011, BBA-PROTEINS PROTEOM, V1814, P146, DOI 10.1016/j.bbapap.2010.05.014; Rieker PP, 2005, J GERONTOL B-PSYCHOL, V60, P40; Rohrlich PS, 2005, P NATL ACAD SCI USA, V102, P12855, DOI 10.1073/pnas.0502309102; Sage AP, 2014, CIRC RES, V114, P935, DOI 10.1161/CIRCRESAHA.114.303480; Scheen AJ, 2005, DIABETES METAB, V31, pS27; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shi Gang, 2009, BMC Proc, V3 Suppl 7, pS89; Sidhu D, 2012, ARCH INTERN MED, V172, P1707, DOI 10.1001/archinternmed.2012.3708; Sierra F, 2009, ANNU REV MED, V60, P457, DOI 10.1146/annurev.med.60.061607.220533; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Takami T, 2011, J CLIN BIOCHEM NUTR, V48, P103, DOI 10.3164/jcbn.10-76; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005; Truksa J, 2009, BLOOD, V113, P688, DOI 10.1182/blood-2008-05-160184; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Verbrugge L M, 1987, Health Matrix, V5, P3; Vijg J, 2005, ANNU REV MED, V56, P193, DOI 10.1146/annurev.med.56.082103.104617; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Yashin AI, 2001, J GERONTOL A-BIOL, V56, pB432, DOI 10.1093/gerona/56.10.B432; Yashin AI, 2006, AGE, V28, P363, DOI 10.1007/s11357-006-9023-7; Yashin Anatoliy I., 2013, Frontiers in Genetics, V4, P125, DOI 10.3389/fgene.2013.00125; Yashin AI, 2012, REJUV RES, V15, P381, DOI 10.1089/rej.2011.1257; Zacharski LR, 2000, AM HEART J, V140, P98, DOI 10.1067/mhj.2000.106646; Zhang QH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084925	82	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136319	10.1371/journal.pone.0136319	http://dx.doi.org/10.1371/journal.pone.0136319			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295473	gold, Green Published, Green Submitted			2022-12-27	WOS:000359926900099
J	Lai, JY; Cheng, HY; Ma, DHK				Lai, Jui-Yang; Cheng, Hsiao-Yun; Ma, David Hui-Kang			Investigation of Overrun-Processed Porous Hyaluronic Acid Carriers in Corneal Endothelial Tissue Engineering	PLOS ONE			English	Article							COMPRISING 2-HYDROXYETHYL METHACRYLATE; CELL SHEET; GELATIN SCAFFOLDS; CHEMICAL-COMPOSITION; DELIVERY CARRIERS; ANTERIOR-CHAMBER; CROSS-LINKING; ACRYLIC-ACID; HYDROGELS; BIOCOMPATIBILITY	Hyaluronic acid (HA) is a linear polysaccharide naturally found in the eye and therefore is one of the most promising biomaterials for corneal endothelial regenerative medicine. This study reports, for the first time, the development of overrun-processed porous HA hydrogels for corneal endothelial cell (CEC) sheet transplantation and tissue engineering applications. The hydrogel carriers were characterized to examine their structures and functions. Evaluations of carbodiimide cross-linked air-dried and freeze-dried HA samples were conducted simultaneously for comparison. The results indicated that during the fabrication of freeze-dried HA discs, a technique of introducing gas bubbles in the aqueous biopolymer solutions can be used to enlarge pore structure and prevent dense surface skin formation. Among all the groups studied, the overrun-processed porous HA carriers show the greatest biological stability, the highest freezable water content and glucose permeability, and the minimized adverse effects on ionic pump function of rabbit CECs. After transfer and attachment of bioengineered CEC sheets to the overrun-processed HA hydrogel carriers, the therapeutic efficacy of cell/biopolymer constructs was tested using a rabbit model with corneal endothelial dysfunction. Clinical observations including slit-lamp biomicroscopy, specular microscopy, and corneal thickness measurements showed that the construct implants can regenerate corneal endothelium and restore corneal transparency at 4 weeks postoperatively. Our findings suggest that cell sheet transplantation using overrun-processed porous HA hydrogels offers a new way to reconstruct the posterior corneal surface and improve endothelial tissue function.	[Lai, Jui-Yang] Chang Gung Univ, Inst Biochem & Biomed Engn, Taoyuan 33302, Taiwan; [Lai, Jui-Yang] Chang Gung Univ, Biomed Engn Res Ctr, Taoyuan 33302, Taiwan; [Lai, Jui-Yang; Cheng, Hsiao-Yun] Chang Gung Univ, Mol Med Res Ctr, Taoyuan 33302, Taiwan; [Ma, David Hui-Kang] Chang Gung Mem Hosp, Dept Ophthalmol, Limbal Stem Cell Lab, Taoyuan 33305, Taiwan; [Ma, David Hui-Kang] Chang Gung Univ, Dept Chinese Med, Taoyuan 33302, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Lai, JY (corresponding author), Chang Gung Univ, Inst Biochem & Biomed Engn, Taoyuan 33302, Taiwan.	jylai@mail.cgu.edu.tw	Lai, Jui-Yang/I-1166-2017	Lai, Jui-Yang/0000-0002-9227-8549	Chang Gung Memorial Hospital [CMRPD2A0111]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by grant CMRPD2A0111 from the Chang Gung Memorial Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CRAWFORD KM, 1995, INVEST OPHTH VIS SCI, V36, P1317; Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937; Fini ME, 1999, PROG RETIN EYE RES, V18, P529, DOI 10.1016/S1350-9462(98)00033-0; Hsiue GH, 2006, TRANSPLANTATION, V81, P473, DOI 10.1097/01.tp.0000194864.13539.2c; Ide T, 2006, BIOMATERIALS, V27, P607, DOI 10.1016/j.biomaterials.2005.06.005; INSLER MS, 1990, CURR EYE RES, V9, P23, DOI 10.3109/02713689009000051; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Kang HG, 2005, POLYM INT, V54, P537, DOI 10.1002/pi.1719; Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8; Kang HG, 2006, J BIOMED MATER RES B, V79B, P388, DOI 10.1002/jbm.b.30553; KHARE AR, 1993, POLYMER, V34, P4736, DOI 10.1016/0032-3861(93)90710-R; Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009; Lai JY, 2007, REACT FUNCT POLYM, V67, P1284, DOI 10.1016/j.reactfunctpolym.2007.07.060; Lai JY, 2006, ARCH OPHTHALMOL-CHIC, V124, P1441, DOI 10.1001/archopht.124.10.1441; Lai JY, 2006, BIOMACROMOLECULES, V7, P1836, DOI 10.1021/bm0601575; Lai JY, 2014, COLLOID SURFACE B, V122, P277, DOI 10.1016/j.colsurfb.2014.07.009; Lai JY, 2014, CARBOHYD POLYM, V101, P203, DOI 10.1016/j.carbpol.2013.09.060; Lai JY, 2014, MAT SCI ENG C-MATER, V34, P334, DOI 10.1016/j.msec.2013.09.026; Lai JY, 2013, DRUG DES DEV THER, V7, P1273, DOI 10.2147/DDDT.S53759; Lai JY, 2013, MAT SCI ENG C-MATER, V33, P3704, DOI 10.1016/j.msec.2013.04.059; Lai JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054058; Lai JY, 2012, MATERIALS, V5, P1986, DOI 10.3390/ma5101986; Lai JY, 2012, INT J MOL SCI, V13, P10970, DOI 10.3390/ijms130910970; Lai JY, 2012, INT J NANOMED, V7, P1101, DOI 10.2147/IJN.S28753; Lai JY, 2012, ACTA BIOMATER, V8, P1068, DOI 10.1016/j.actbio.2011.11.012; Lai JY, 2011, J MECH MED BIOL, V11, P967, DOI 10.1142/S0219519411004873; Lai JY, 2012, J MATER CHEM, V22, P1812, DOI 10.1039/c1jm14211a; Lai JY, 2012, BIOMATERIALS, V33, P2372, DOI 10.1016/j.biomaterials.2011.11.085; Lai JY, 2010, MAT SCI ENG C-MATER, V30, P677, DOI 10.1016/j.msec.2010.02.024; Lai JY, 2010, BIOMACROMOLECULES, V11, P1387, DOI 10.1021/bm100213f; Lai JY, 2010, J BIOMAT SCI-POLYM E, V21, P359, DOI 10.1163/156856209X416980; Lai JY, 2009, BIOMACROMOLECULES, V10, P310, DOI 10.1021/bm801039n; Lai JY, 2007, TRANSPLANTATION, V84, P1222, DOI 10.1097/01.tp.0000287336.09848.39; Lai JY, 2005, AM J OPHTHALMOL, V139, P1123, DOI 10.1016/j.ajo.2004.11.052; Levis HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050993; Liang Y, 2011, J MATER SCI-MATER M, V22, P175, DOI 10.1007/s10856-010-4190-6; Lu PL, 2008, J BIOMED MATER RES A, V86A, P108, DOI 10.1002/jbm.a.31619; Lu PL, 2008, J BIOMAT SCI-POLYM E, V19, P1, DOI 10.1163/156856208783227695; Ma DHK, 2010, BIOMATERIALS, V31, P6647, DOI 10.1016/j.biomaterials.2010.05.034; Ozcelik B, 2013, ACTA BIOMATER, V9, P6594, DOI 10.1016/j.actbio.2013.01.020; Sato M, 2008, ACTA OPHTHALMOL, V86, P65, DOI 10.1111/j.1600-0420.2007.01018.x; Teichmann J, 2013, ACTA BIOMATER, V9, P5031, DOI 10.1016/j.actbio.2012.10.023; Van Vlierberghe S, 2007, BIOMACROMOLECULES, V8, P331, DOI 10.1021/bm060684o; Yoshida J, 2014, INVEST OPHTH VIS SCI, V55, P4975, DOI 10.1167/iovs.14-14211	44	21	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136067	10.1371/journal.pone.0136067	http://dx.doi.org/10.1371/journal.pone.0136067			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296087	gold, Green Published, Green Submitted			2022-12-27	WOS:000359926900068
J	Schall, M; Goetz, T; Martiny, SE; Maymon, R				Schall, Marina; Goetz, Thomas; Martiny, Sarah E.; Maymon, Rebecca			Responses to Success: Seeking Pleasant Experiences before a Task Is Complete?	PLOS ONE			English	Article							SELF-ESTEEM DIFFERENCES; POSITIVE EMOTIONS; MOOD; PLEASURE; BROADEN; PEOPLE; FEEL; WANT	Although engaging in pleasant experiences following successful performance may be hedonically rewarding, in the present research we proposed that individuals might forego pleasant experiences when they have not yet completed a task. In Study 1 (N = 100), participants reported the extent to which they would like to engage in pleasant experiences in a hypothetical situation where their performance outcome on a task (successful vs. average) and task completion (task in progress vs. completed) were manipulated. In Study 2 (N = 115), participants were in a real situation in which they achieved either a successful or average performance outcome. Task completion was manipulated (task in progress vs. completed) and motivation to engage in a pleasant experience was assessed by a behavioral measure. Results of both studies provided support for our prediction by showing individuals to have a lower desire to engage in pleasant experiences following successful, but not average, performance when the task was in progress than when it was complete. These findings are discussed in light of the underlying mechanisms and consequences of the tendency to forego pleasant experiences.	[Schall, Marina; Goetz, Thomas] Univ Konstanz, Dept Empir Educ Res, Constance, Germany; [Schall, Marina; Goetz, Thomas] Thurgau Univ Teacher Educ, Kreuzlingen, Switzerland; [Martiny, Sarah E.] UiT Arctic Univ Norway, Dept Psychol, Tromso, Norway; [Maymon, Rebecca] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada	University of Konstanz; UiT The Arctic University of Tromso; McGill University	Schall, M (corresponding author), Univ Konstanz, Dept Empir Educ Res, Constance, Germany.	marina.schall@uni-konstanz.de		Goetz, Thomas/0000-0002-8908-2166				Andrews F. M., 1976, SOCIAL INDICATORS WE; [Anonymous], 2002, AM PSYCHOL, V57, P1060, DOI DOI 10.1037/0003-066X.57.12.1060; BERGLAS S, 1978, J PERS SOC PSYCHOL, V36, P405, DOI 10.1037/0022-3514.36.4.405; Borkenau P., 2008, NEO FFI NEO FUNF FAK, V2.; Bryant F. B., 2007, SAVORING NEW MODEL P; Bryant F.B., 2003, J MENTAL HLTH, V12, P175, DOI [10.1080/0963823031000103489, DOI 10.1080/0963823031000103489]; Carver CS, 2003, COGNITION EMOTION, V17, P241, DOI 10.1080/02699930302294; Costa PT, 2007, REVISED NEO PERSONAL; Dan-Glauser ES, 2011, BEHAV RES METHODS, V43, P468, DOI 10.3758/s13428-011-0064-1; Erber R, 1996, J PERS SOC PSYCHOL, V70, P757, DOI 10.1037/0022-3514.70.4.757; Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Gable PA, 2008, PSYCHOL SCI, V19, P476, DOI 10.1111/j.1467-9280.2008.02112.x; Gable SL, 2004, J PERS SOC PSYCHOL, V87, P228, DOI 10.1037/0022-3514.87.2.228; Gendolla GHE, 2012, SWISS J PSYCHOL, V71, P59, DOI 10.1024/1421-0185/a000071; Greiner B., 2003, FORSCHUNG WISSENSCHA, V63, P79; Handley IM, 2004, J EXP SOC PSYCHOL, V40, P106, DOI 10.1016/S0022-1031(03)00086-6; Heimpel SA, 2002, J PERS SOC PSYCHOL, V82, P128, DOI 10.1037//0022-3514.82.1.128; ISEN AM, 1978, SOC PSYCHOL, V41, P346, DOI 10.2307/3033588; Katzir M, 2010, J EXP PSYCHOL LEARN, V36, P1314, DOI 10.1037/a0020120; LANGSTON CA, 1994, J PERS SOC PSYCHOL, V67, P1112, DOI 10.1037/0022-3514.67.6.1112; Larsen R.J., 2004, HDB SELF REGULATION, P40; MASTERS JC, 1972, DEV PSYCHOL, V7, P110, DOI 10.1037/h0033015; MILLIGAN GW, 1987, PSYCHOL BULL, V101, P464, DOI 10.1037/0033-2909.101.3.464; MISCHEL HN, 1983, CHILD DEV, V54, P603, DOI 10.2307/1130047; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Rozin P., 1999, WELL BEING FDN HEDON, P109; Scherer K.R., 2013, COMPONENTS EMOTIONAL, P281; Scherer KR, 2005, SOC SCI INFORM, V44, P695, DOI 10.1177/0539018405058216; Tamir M, 2007, EMOTION, V7, P546, DOI 10.1037/1528-3542.7.3.546; Tamir M, 2009, CURR DIR PSYCHOL SCI, V18, P101, DOI 10.1111/j.1467-8721.2009.01617.x; Thompson T, 2004, BRIT J EDUC PSYCHOL, V74, P239, DOI 10.1348/000709904773839860; Tugade M., 2007, J HAPPINESS STUD, V8, P311, DOI [DOI 10.1007/S10902-006-9015-4, 10.1007/s10902-006-9015-4]; WEGENER DT, 1994, J PERS SOC PSYCHOL, V66, P1034, DOI 10.1037/0022-3514.66.6.1034; Wood JV, 2003, J PERS SOC PSYCHOL, V85, P566, DOI 10.1037/0022-3514.85.3.566	35	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135952	10.1371/journal.pone.0135952	http://dx.doi.org/10.1371/journal.pone.0135952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26295350	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900053
J	Sun, HL; Qi, C; Niu, Y; Kang, TF; Wei, YX; Jin, G; Dong, XZ; Wang, CH; Zhu, W				Sun, Hongliu; Qi, Cai; Niu, Yu; Kang, Tengfei; Wei, Yongxin; Jin, Gang; Dong, Xianzhi; Wang, Chunhua; Zhu, Wei			Detection of Cytomegalovirus Antibodies Using a Biosensor Based on Imaging Ellipsometry	PLOS ONE			English	Article							OFF-NULL ELLIPSOMETRY; IGG AVIDITY; INFECTION; DIAGNOSIS; IMMUNOGLOBULIN; VISUALIZATION; IMMUNOASSAY; SURFACE; ASSAYS	Background Cytomegalovirus (CMV) is the most common infectious cause of mental disability in new-borns in developed countries. There is an urgent need to establish an early detection and high-throughput screening method for CMV infection using portable detection devices. Methods An antibody analysis method is reported for the detection and identification of CMV antibodies in serum using a biosensor based on high spatial resolution imaging ellipsometry (BIE). CMV antigen (CMV-3A) was immobilized on silicon wafers and used to capture CMV antibodies in serum. An antibody against human immunoglobulin G (anti-IgG) was used to confirm the IgG antibody against CMV captured by the CMV-3A. Results Our results show that this assay is rapid and specific for the identification of IgG antibody against CMV. Further, patient serum was quantitatively assessed using the standard curve method, and the quantitative results were in agreement with the enzyme-linked immunosorbent assay. The CMV antibody detection sensitivity of BIE reached 0.01 IU/mL. Conclusions This novel biosensor may be a valuable diagnostic tool for analysis of IgG antibody against CMV during CMV infection screening.	[Sun, Hongliu; Wang, Chunhua] Binzhou Med Univ, Sch Pharmaceut Sci, Yantai, Peoples R China; [Qi, Cai] Chinese Acad Inspect & Quarantine, Inst Equipment Technol, Beijing 3, Peoples R China; [Niu, Yu; Kang, Tengfei; Jin, Gang] Chinese Acad Sci, Inst Mech, Beijing 100080 15, Peoples R China; [Wei, Yongxin] Beijing Inspect & Quarantine Testing Ctr, Food Lab, Beijing 6, Peoples R China; [Dong, Xianzhi] Chinese Acad Sci, Inst Biophys, Beijing 100080 15, Peoples R China; [Zhu, Wei] Shandong Acad Med Sci, Inst Radiat Med, Jinan 18877, Peoples R China	Binzhou Medical University; Chinese Academy of Inspection & Quarantine; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Biophysics, CAS; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Zhu, W (corresponding author), Shandong Acad Med Sci, Inst Radiat Med, Jinan 18877, Peoples R China.	fsszw@163.com	Niu, Yu/C-2876-2012	Niu, Yu/0000-0003-2380-1006	Yantai Science and Technology Development Fund [2012128]; Youth Backbone Teacher Fund of Binzhou Medical University; National Natural Science Fund [81202516]; Shandong Province Natural Science Fund [ZR2013HL039]; Science and technology development plan of Shandong Academy of Medical Sciences [2014-08]; Special Fund for Agro-scientific Research in the Public Interest [201303045]; National Key Scientific Instrument and Equipment Development Project of China [2012YQ090197]; National Basic Research Program (Project 973) of China [2009CB320300]; National Basic Research Program of China [2009CB320302]; National High Technology Research Development Program of China [2008AA02Z419]; International Science & Technology Cooperation Program of China [2012DFG31880]; Projects of Sino-Portugal ST Cooperation; National Natural Science Foundation of China [21305147]; Instrument Developing Project of the Chinese Academy of Sciences [KJCX2-YW-M04, KJCX2-YW-M03]	Yantai Science and Technology Development Fund; Youth Backbone Teacher Fund of Binzhou Medical University; National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Fund; Science and technology development plan of Shandong Academy of Medical Sciences; Special Fund for Agro-scientific Research in the Public Interest; National Key Scientific Instrument and Equipment Development Project of China; National Basic Research Program (Project 973) of China(National Basic Research Program of China); National Basic Research Program of China(National Basic Research Program of China); National High Technology Research Development Program of China(National High Technology Research and Development Program of China); International Science & Technology Cooperation Program of China; Projects of Sino-Portugal ST Cooperation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Instrument Developing Project of the Chinese Academy of Sciences	The authors' laboratory work is supported by grants from the Yantai Science and Technology Development Fund (2012128), the Youth Backbone Teacher Fund of Binzhou Medical University, the National Natural Science Fund (81202516), the Shandong Province Natural Science Fund (ZR2013HL039), Science and technology development plan of Shandong Academy of Medical Sciences (2014-08), the Special Fund for Agro-scientific Research in the Public Interest (201303045), the National Key Scientific Instrument and Equipment Development Project of China (2012YQ090197), the National Basic Research Program (Project 973) of China (2009CB320300), the National Basic Research Program of China (2009CB320302), the National High Technology Research Development Program of China (2008AA02Z419), the International Science & Technology Cooperation Program of China (2012DFG31880), the Projects of Sino-Portugal S&T Cooperation 2010-2015, the National Natural Science Foundation of China (21305147) and the Instrument Developing Project of the Chinese Academy of Sciences (KJCX2-YW-M04, KJCX2-YW-M03).	Aabye MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039228; Adler SP, 2013, CLIN INFECT DIS, V57, pS189, DOI 10.1093/cid/cit585; ARWIN H, 1993, J COLLOID INTERF SCI, V156, P377, DOI 10.1006/jcis.1993.1125; Baalawi F, 2010, PATHOLOGY, V42, P578, DOI 10.3109/00313025.2010.508778; Breda G, 2013, PATHOG GLOB HEALTH, V107, P312, DOI 10.1179/2047773213Y.0000000114; Chen YY, 2007, APPL OPTICS, V46, P8475, DOI 10.1364/AO.46.008475; Essa S, 2000, CLIN TRANSPLANT, V14, P147, DOI 10.1034/j.1399-0012.2000.140208.x; Feron D, 2013, ANAL BIOCHEM, V433, P202, DOI 10.1016/j.ab.2012.10.012; FREEDMAN D, 1991, STATISTICS; GrangeotKeros L, 1997, J INFECT DIS, V175, P944, DOI 10.1086/513996; Han Feng, 2013, Maternal and Child Health Care of China, V28, P4738; Jin G, 2011, THIN SOLID FILMS, V519, P2750, DOI 10.1016/j.tsf.2010.12.175; Jin G, 1996, REV SCI INSTRUM, V67, P2930, DOI 10.1063/1.1147074; JIN G, 1995, ANAL BIOCHEM, V232, P69, DOI 10.1006/abio.1995.9959; Kaneko M, 2013, J PERINATOL, V33, P831, DOI 10.1038/jp.2013.87; Lazzarotto T, 1997, CLIN DIAGN LAB IMMUN, V4, P469, DOI 10.1128/CDLI.4.4.469-473.1997; Lazzarotto T, 2008, J CLIN VIROL, V41, P192, DOI 10.1016/j.jcv.2007.10.015; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073842; Novak Z, 2008, J CLIN MICROBIOL, V46, P882, DOI 10.1128/JCM.01079-07; Ogawa-Goto K, 2003, J VIROL, V77, P8541, DOI 10.1128/JVI.77.15.8541-8547.2003; Qi C, 2009, J VIRAL HEPATITIS, V16, P822, DOI 10.1111/j.1365-2893.2009.01123.x; Qi C, 2011, BIOSENSORS FOR HEALT; Qi C, 2006, BIOMED MICRODEVICES, V8, P247, DOI 10.1007/s10544-006-8305-2; Qi C, 2014, SCI REP-UK, V4, DOI 10.1038/srep05341; Qi C, 2010, BIOSENS BIOELECTRON, V25, P1530, DOI 10.1016/j.bios.2009.10.030; Rajasekariah H, 2013, J MED VIROL, V85, P315, DOI 10.1002/jmv.23471; Revello MG, 2012, EUR J CLIN MICROBIOL, V31, P3331, DOI 10.1007/s10096-012-1700-0; Revello Maria Grazia, 2008, Expert Opin Med Diagn, V2, P547, DOI 10.1517/17530059.2.5.547; Revello MG, 2002, CLIN MICROBIOL REV, V15, P680, DOI 10.1128/CMR.15.4.680-715.2002; Ross SA, 2010, J INFECT DIS, V201, P386, DOI 10.1086/649903; Stenberg M., 1983, Journal de Physique Colloque, V44, P83, DOI 10.1051/jphyscol:19831017; Wang W, 2013, ANAL CHEM, V85, P4446, DOI 10.1021/ac303783j; Wang ZH, 2003, J BIOCHEM BIOPH METH, V57, P203, DOI 10.1016/S0165-022X(03)00109-X; Wang ZH, 2006, ELECTROPHORESIS, V27, P4078, DOI 10.1002/elps.200500956; Zhang HG, 2005, CLIN CHEM, V51, P1038, DOI 10.1373/clinchem.2004.043240	35	7	7	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136253	10.1371/journal.pone.0136253	http://dx.doi.org/10.1371/journal.pone.0136253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295458	Green Submitted, gold, Green Published			2022-12-27	WOS:000359926900090
J	Collett, JA; Paulose, JK; Cassone, VM; Osborn, JL				Collett, Jason A.; Paulose, Jiffin K.; Cassone, Vincent M.; Osborn, Jeffrey L.			Kidney-Specific Reduction of Oxidative Phosphorylation Genes Derived from Spontaneously Hypertensive Rat	PLOS ONE			English	Article							CONTROLLING MITOCHONDRIAL BIOGENESIS; PRESSURE REGULATION; DYSFUNCTION; MUTATION; DEFECTS; MECHANISMS; EXPRESSION; COMPLEXES; DISEASES; BRAIN	Mitochondrial (Mt) dysfunction contributes to the pathophysiology of renal function and promotes cardiovascular disease such as hypertension. We hypothesize that renal Mt-genes derived from female spontaneously hypertensive rats (SHR) that exhibit hypertension have reduced expression specific to kidney cortex. After breeding a female Okamoto-Aoki SHR (SAP = 188mmHg) with Brown Norway (BN) males (SAP = 100 and 104 mmHg), hypertensive female progeny were backcrossed with founder BN for 5 consecutive generations in order to maintain the SHR mitochondrial genome in offspring that contain over increasing BN nuclear genome. Mt-protein coding genes (13 total) and nuclear transcription factors mediating Mt-gene transcription were evaluated in kidney, heart and liver of normotensive (NT: n = 20) vs. hypertensive (HT: n = 20) BN/SHR-mt(SHR) using quantitative real-time PCR. Kidney cortex, but not liver or heart Mt-gene expression was decreased similar to 2-5 fold in 12 of 13 protein encoding genes of HT BN/SHR-mt(SHR). Kidney cortex but not liver mRNA expression of the nuclear transcription factors Tfam, NRF1, NRF2 and Pgc1a were also decreased in HT BN/SHR-mt(SHR). Kidney cortical tissue of HT BN/SHR-mt(SHR) exhibited lower cytochrome oxidase histochemical staining, indicating a reduction in renal oxidative phosphorylation but not in liver or heart. These results support the hypothesis that renal cortex of rats with SHR mitochondrial genome has specifically altered renal expression of genes encoding mitochondrial proteins. This kidney-specific coordinated reduction of mitochondrial and nuclear oxidative metabolism genes may be associated with heritable hypertension in SHR.	[Collett, Jason A.; Paulose, Jiffin K.; Cassone, Vincent M.; Osborn, Jeffrey L.] Univ Kentucky, Dept Biol, Lexington, KY 40506 USA	University of Kentucky	Collett, JA (corresponding author), Univ Kentucky, Dept Biol, Lexington, KY 40506 USA.	jacollet@gmail.com	Paulose, Jiffin/AAA-9296-2020; Cassone, Vincent/AAD-5191-2022	Paulose, Jiffin/0000-0002-0061-7786; 	National Science Foundation (NSF) [437768]; American Heart Association Predoctoral Fellowship AHA [1PRE7100000]; Gertrude Flora Ribble Research Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); American Heart Association Predoctoral Fellowship AHA(American Heart Association); Gertrude Flora Ribble Research Foundation	This study was supported by the National Science Foundation (NSF) # 437768, the American Heart Association Predoctoral Fellowship awarded to J.A. Collett AHA# 1PRE7100000 and the Gertrude Flora Ribble Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addabbo F, 2009, HYPERTENSION, V53, P885, DOI 10.1161/HYPERTENSIONAHA.109.130054; Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960; Barlassina C, 2002, J AM SOC NEPHROL, V13, pS155, DOI 10.1097/01.ASN.0000032524.13069.88; Benigni A, 2009, J CLIN INVEST, V119, P524, DOI 10.1172/JCI36703; BIANCHI G, 1974, CLIN SCI MOL MED, V47, P435, DOI 10.1042/cs0470435; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cannino G, 2007, MITOCHONDRION, V7, P359, DOI 10.1016/j.mito.2007.07.001; Chan SHH, 2009, HYPERTENSION, V53, P217, DOI 10.1161/HYPERTENSIONAHA.108.116905; Collett JA, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.104; Cowley AW, 1996, JAMA-J AM MED ASSOC, V275, P1581, DOI 10.1001/jama.275.20.1581; CURTIS JJ, 1983, NEW ENGL J MED, V309, P1009, DOI 10.1056/NEJM198310273091702; DAS AM, 1990, AM J PHYSIOL, V259, pH1264, DOI 10.1152/ajpheart.1990.259.4.H1264; de Cavanagh EMV, 2006, AM J PHYSIOL-REG I, V290, pR1616, DOI 10.1152/ajpregu.00615.2005; DILLEY JR, 1984, AM J PHYSIOL, V246, pF12, DOI 10.1152/ajprenal.1984.246.1.F12; Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5; GUYTON AC, 1972, AM J MED, V52, P584, DOI 10.1016/0002-9343(72)90050-2; GUYTON AC, 1987, HYPERTENSION, V10, P1, DOI 10.1161/01.HYP.10.1.1; GUYTON AC, 1974, CIRC RES, V35, P159, DOI 10.1161/01.RES.35.2.159; GUYTON AC, 1990, ACTA PHYSIOL SCAND, V139, P107; GUYTON AC, 1968, ANN NY ACAD SCI, V150, P537, DOI 10.1111/j.1749-6632.1968.tb14705.x; Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kristal BS, 1997, FREE RADICAL BIO MED, V22, P823, DOI 10.1016/S0891-5849(96)00428-5; Kumarasamy S, 2010, MAMM GENOME, V21, P299, DOI 10.1007/s00335-010-9259-5; Kurtz TW, 2005, ARTERIOSCL THROM VAS, V25, P478, DOI 10.1161/01.ATV.0000153088.15433.8f; Lee H, 2014, KIDNEY INT, V85, P561, DOI 10.1038/ki.2013.397; Li RH, 2009, HYPERTENSION, V54, P329, DOI 10.1161/HYPERTENSIONAHA.109.129270; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Liu YQ, 2009, HYPERTENSION, V53, P1083, DOI 10.1161/HYPERTENSIONAHA.109.128702; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Campistrous A, 2008, HYPERTENSION, V51, P412, DOI 10.1161/HYPERTENSIONAHA.107.102285; Navar LG, 1997, MED CLIN N AM, V81, P1165, DOI 10.1016/S0025-7125(05)70573-3; Park JB, 2002, AM J HYPERTENS, V15, P78, DOI 10.1016/S0895-7061(01)02233-6; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Rodriguez-Iturbe B, 2003, HYPERTENSION, V41, P341, DOI 10.1161/01.HYP.0000052833.20759.64; Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5; Schwartz F, 2004, AM J HYPERTENS, V17, P629, DOI 10.1016/j.amjhyper.2004.02.020; SRERE PA, 1962, METHOD ENZYMOL, V5, P641, DOI 10.1016/S0076-6879(62)05289-1; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; VANDENOUWELAND JMW, 1995, MUSCLE NERVE, pS124; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WhitfieldRucker MG, 1996, HORM BEHAV, V30, P528, DOI 10.1006/hbeh.1996.0056; Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	49	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136441	10.1371/journal.pone.0136441	http://dx.doi.org/10.1371/journal.pone.0136441			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308211	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400125
J	El-Jardali, F; Karroum, LB; Bawab, L; Kdouh, O; El-Sayed, F; Rachidi, H; Makki, M				El-Jardali, Fadi; Karroum, Lama Bou; Bawab, Lamya; Kdouh, Ola; El-Sayed, Farah; Rachidi, Hala; Makki, Malak			Health Reporting in Print Media in Lebanon: Evidence, Quality and Role in Informing Policymaking	PLOS ONE			English	Article							ATTENTION; STORIES	Background Media plays a vital role in shaping public policies and opinions through disseminating health-related information. This study aims at exploring the role of media in informing health policies in Lebanon, identifying the factors influencing health reporting and investigating the role of evidence in health journalism and the quality of health reporting. It also identifies strategies to enhance the use of evidence in health journalism and improve the quality of health reporting. Methods Media analysis was conducted to assess the way media reports on health-related issues and the quality of reporting using a quality assessment tool. Semi-structured interviews were also conducted with 27 journalists, researchers and policymakers to explore their perception on the role of media in health policymaking and the factors influencing health reporting. In addition, a validation workshop was conducted. Results Out of 1,279 health-related news articles identified, 318 articles used certain type of evidence to report health issues 39.8% of which relied on experts' opinions as their source of evidence while only 5.9% referenced peer-reviewed research studies. The quality of health reporting was judged to be low based on a quality assessment tool consisting of a set of ten criteria. Journalists raised concerns about issues impeding them from referring to evidence. Journalists also reported difficulties with the investigative health journalism. Policymakers and researchers viewed media as an important tool for evidence-informed health policies, however, serious concerns were voiced in terms of the current practice and capacities. Conclusion Our study provides a structured reflection on the role of media and the factors that influence health reporting including context-specific strategies that would enhance the quality and promote the use of evidence in health reporting. In the light of the political changes in many Middle Eastern countries, findings from this study can contribute to redefining the role of media in strengthening health systems.	[El-Jardali, Fadi; Karroum, Lama Bou; Bawab, Lamya; Kdouh, Ola; El-Sayed, Farah; Rachidi, Hala] Amer Univ Beirut, Dept Hlth Management & Policy, Beirut, Lebanon; [El-Jardali, Fadi] Amer Univ Beirut, Fac Hlth Sci, Knowledge Policy K2P Ctr, Beirut, Lebanon; [El-Jardali, Fadi] Amer Univ Beirut, Ctr Systemat Reviews Hlth Policy & Syst Res SPARK, Beirut, Lebanon; [El-Jardali, Fadi] Amer Univ Beirut, Issam Fares Inst Publ Policy & Int Affairs, Res Advocacy & Publ Policy Making Program, Beirut, Lebanon; [El-Jardali, Fadi] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Makki, Malak] Assafir Newspaper, Beirut, Lebanon	American University of Beirut; American University of Beirut; American University of Beirut; American University of Beirut; McMaster University	El-Jardali, F (corresponding author), Amer Univ Beirut, Dept Hlth Management & Policy, Beirut, Lebanon.	fe08@aub.edu.lb			Assafir newspaper	Assafir newspaper	Assafir newspaper provided support in the form of salaries for MM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Abeslon J, 2009, HEALTHCARE POLICY, V4; Adami Maria Fenech, 2005, Nurse Res, V12, P19; Albaek E, 2011, JOURNALISM, V12, P335, DOI 10.1177/1464884910392851; Ammar W., 2009, HLTH POLITICS; [Anonymous], 2002, BRIDGING RES POLICY; Ashorkhani M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-627; Bartlett C, 2002, BRIT MED J, V325, P81, DOI 10.1136/bmj.325.7355.81; Baum MA, 2008, ANNU REV POLIT SCI, V11, P39, DOI 10.1146/annurev.polisci.11.060406.214132; Besley JC, 2013, PUBLIC UNDERST SCI, V22, P644, DOI 10.1177/0963662511418743; Bubela TM, 2004, CAN MED ASSOC J, V170, P1399, DOI 10.1503/cmaj.1030762; Buse K., 2005, MAKING HLTH POLICY; Cassels A., 2008, OPEN MED, V2; Cheung A, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-7; COOK FL, 1983, PUBLIC OPIN QUART, V47, P16, DOI 10.1086/268764; Dorfman L, 2003, AM J HEALTH BEHAV, V27, pS217; el Khazen F, 2003, MIDDLE EAST J, V57, P605; El-Jardali F, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-200; El-Jardali F, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-15; El-Jardali F, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-2; Gascoigne T, 1997, SCI COMMUN, V18, P265, DOI 10.1177/1075547097018003005; Grilli R., 2002, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD000389; Innvaer Simon, 2002, J Health Serv Res Policy, V7, P239, DOI 10.1258/135581902320432778; Jones H., 2009, KNOWLEDGE POLICY POW; Kingdon J., 2003, AGENDAS ALTERNATIVES, V2nd; Korownyk C, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7346; Larsson Anna, 2003, Health Expect, V6, P323, DOI 10.1046/j.1369-7625.2003.00228.x; Lavis JN, 2006, B WORLD HEALTH ORGAN, V84, P620, DOI 10.2471/BLT.06.030312; Lavis JN, 2009, HEALTH RES POLICY SY, V7, DOI [10.1186/1478-4505-7-S1-S1, 10.1186/1478-4505-7-S1-11, 10.1186/1478-4505-7-S1-S15, 10.1186/1478-4505-7-S1-I1]; Leask J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-535; Mitton C, 2007, MILBANK Q, V85, P729, DOI 10.1111/j.1468-0009.2007.00506.x; Peters HP, 2008, SCIENCE, V321, P204, DOI 10.1126/science.1157780; Phillips DP, 1991, N ENGL J MED, P325; Reporters Without Borders, 2014, WORLD PRESS FREED IN; Robinson A, 2013, PUBLIC HEALTH, V127, P39, DOI 10.1016/j.puhe.2012.10.001; Schwitzer G, 2005, PLOS MED, V2; Soroka S, 2012, ROUTLEDGE HDB POLICY; Teixeira RA, 2012, CLINICS, V67, P261, DOI 10.6061/clinics/2012(03)10; Voss M, 2002, AM J PUBLIC HEALTH, V92, P1158, DOI 10.2105/AJPH.92.7.1158; Waddell Charlotte, 2005, Healthc Policy, V1, P123; Wilson A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000323; Wilson A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004831; Wolfe M, 2012, POLICY STUD J, V40, P109, DOI 10.1111/j.1541-0072.2011.00436.x; Woloshin S, 2002, JAMA-J AM MED ASSOC, V287, P2856, DOI 10.1001/jama.287.21.2856; Yanovitzky I, 1999, COMMUN RES, V26, P429, DOI 10.1177/009365099026004004	44	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136435	10.1371/journal.pone.0136435	http://dx.doi.org/10.1371/journal.pone.0136435			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LO	26308077	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400124
J	Ludwig, SKJ; Tokarski, C; Lang, SN; van Ginkel, LA; Zhu, HY; Ozcan, A; Nielen, MWF				Ludwig, Susann K. J.; Tokarski, Christian; Lang, Stefan N.; van Ginkel, Leendert A.; Zhu, Hongying; Ozcan, Aydogan; Nielen, Michel W. F.			Calling Biomarkers in Milk Using a Protein Microarray on Your Smartphone	PLOS ONE			English	Article							RECOMBINANT BOVINE SOMATOTROPIN; CARE DIAGNOSTICS; GROWTH-HORMONE; PLATFORM; IMMUNOASSAY; BIOSENSOR; CELLPHONE; POINT; ABUSE; IGF-1	Here we present the concept of a protein microarray-based fluorescence immunoassay for multiple biomarker detection in milk extracts by an ordinary smartphone. A multiplex immunoassay was designed on a microarray chip, having built-in positive and negative quality controls. After the immunoassay procedure, the 48 microspots were labelled with Quantum Dots (QD) depending on the protein biomarker levels in the sample. QD-fluorescence was subsequently detected by the smartphone camera under UV light excitation from LEDs embedded in a simple 3D-printed opto-mechanical smartphone attachment. The somewhat aberrant images obtained under such conditions, were corrected by newly developed Android-based software on the same smartphone, and protein biomarker profiles were calculated. The indirect detection of recombinant bovine somatotropin (rbST) in milk extracts based on altered biomarker profile of anti-rbST antibodies was selected as a real-life challenge. RbST-treated and untreated cows clearly showed reproducible treatment-dependent biomarker profiles in milk, in excellent agreement with results from a flow cytometer reference method. In a pilot experiment, anti-rbST antibody detection was multiplexed with the detection of another rbST-dependent biomarker, insulin-like growth factor 1 (IGF-1). Milk extract IGF-1 levels were found to be increased after rbST treatment and correlated with the results obtained from the reference method. These data clearly demonstrate the potential of the portable protein microarray concept towards simultaneous detection of multiple biomarkers. We envisage broad application of this 'protein microarray on a smartphone'-concept for on-site testing, e.g., in food safety, environment and health monitoring.	[Ludwig, Susann K. J.; van Ginkel, Leendert A.; Nielen, Michel W. F.] RIKILT Wageningen UR, Wageningen, Netherlands; [Tokarski, Christian; Lang, Stefan N.] Univ Jena, Biol Pharmazeut Fak, Jena, Germany; [Zhu, Hongying; Ozcan, Aydogan] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA; [Ozcan, Aydogan] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90024 USA; [Ozcan, Aydogan] Univ Calif Los Angeles, Calif NanoSyst Inst CNSI, Los Angeles, CA 90024 USA; [Nielen, Michel W. F.] Wageningen Univ, Organ Chem Lab, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Friedrich Schiller University of Jena; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Wageningen University & Research	Ludwig, SKJ (corresponding author), RIKILT Wageningen UR, Wageningen, Netherlands.	s.k.j.ludwig@tue.nl	Ozcan, Aydogan/I-2608-2013; Ludwig, Susann KJ/I-5844-2014	Ozcan, Aydogan/0000-0002-0717-683X; Ludwig, Susann KJ/0000-0002-7614-0558	Dutch Ministry of Economic Affairs [1227202901]; National Science Foundation (NSF Career Award); National Institutes of Health (Director's New Innovator Award, DP2); Office of Naval Research (ONR - PECASE); Army Research Office (ARO)	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); National Science Foundation (NSF Career Award)(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Institutes of Health (Director's New Innovator Award, DP2); Office of Naval Research (ONR - PECASE); Army Research Office (ARO)	Funding for the work came from the Dutch Ministry of Economic Affairs project 1227202901, http://www.rijksoverheid.nl/ministeries/ez. AO received the following: Office of Naval Research (ONR - PECASE), Army Research Office (ARO), National Science Foundation (NSF Career Award), and National Institutes of Health (Director's New Innovator Award, DP2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, OFF J EUR COMMUN L, VL331, P71; BICK P H, 1990, Animal Biotechnology, V1, P61, DOI 10.1080/10495399009525729; Coskun AF, 2014, CURR OPIN BIOTECH, V25, P8, DOI 10.1016/j.copbio.2013.08.008; Coskun AF, 2013, LAB CHIP, V13, P636, DOI 10.1039/c2lc41152k; Dai JH, 2006, ANAL CHEM, V78, P135, DOI 10.1021/ac0513966; Daxenberger A, 1998, ANALYST, V123, P2429, DOI 10.1039/a804923h; Faulkner A, 1999, J DAIRY RES, V66, P207, DOI 10.1017/S0022029999003441; Gubala V, 2012, ANAL CHEM, V84, P487, DOI 10.1021/ac2030199; Holt RIG, 2011, ANAL BIOANAL CHEM, V401, P449, DOI 10.1007/s00216-011-5068-2; Marzo AML, 2013, ANAL CHEM, V85, P3532, DOI 10.1021/ac3034536; Ludwig SKJ, 2014, ANAL BIOANAL CHEM, V406, P6857, DOI 10.1007/s00216-014-7984-4; Ludwig SKJ, 2014, TRAC-TREND ANAL CHEM, V57, P47, DOI 10.1016/j.trac.2014.01.005; Ludwig SKJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052917; Ludwig SKJ, 2012, FOOD CONTROL, V26, P68, DOI 10.1016/j.foodcont.2011.12.011; Ludwig SKJ, 2013, J AGR FOOD CHEM, V61, P4514, DOI 10.1021/jf4004972; Matthews J, 2012, MOBILE NETW APPL, V17, P178, DOI 10.1007/s11036-011-0295-5; Petryayeva E, 2014, ANAL CHEM, V86, P3195, DOI 10.1021/ac500131r; Rasband W., 2006, IMAGEJ; Robinson T, 2013, ADV BIOCHEM ENG BIOT, V133, P89, DOI 10.1007/10_2012_139; Shriver-Lake LC, 2004, J AOAC INT, V87, P1498; Smith ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017150; Spier CR, 2011, ENVIRON TOXICOL CHEM, V30, P1557, DOI 10.1002/etc.546; Topol EJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000484; Vashist SK, 2014, ANAL BIOANAL CHEM, V406, P3263, DOI 10.1007/s00216-013-7473-1; Webster M, 2012, CLIN CHEM, V58, P1607, DOI 10.1373/clinchem.2012.194555; Wei QS, 2014, ACS NANO, V8, P1121, DOI 10.1021/nn406571t; Wen HW, 2005, ANAL BIOANAL CHEM, V382, P1217, DOI 10.1007/s00216-005-3292-3; Zhu HY, 2013, LAB CHIP, V13, P51, DOI [10.1039/c2lc40864c, 10.1039/c21c40864c]; Zhu HY, 2011, LAB CHIP, V11, P315, DOI [10.1039/c0lc00358a, 10.1039/c01c00358a]; ZWICKL CM, 1990, J DAIRY SCI, V73, P2888, DOI 10.3168/jds.S0022-0302(90)78976-X	31	52	53	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134360	10.1371/journal.pone.0134360	http://dx.doi.org/10.1371/journal.pone.0134360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308444	Green Submitted, Green Published, gold			2022-12-27	WOS:000360069400023
J	Pluchino, KM; Esposito, D; Moen, JK; Hall, MD; Madigan, JP; Shukla, S; Procter, LV; Wall, VE; Schneider, TD; Pringle, I; Ambudkar, SV; Gill, DR; Hyde, SC; Gottesman, MM				Pluchino, Kristen M.; Esposito, Dominic; Moen, Janna K.; Hall, Matthew D.; Madigan, James P.; Shukla, Suneet; Procter, Lauren V.; Wall, Vanessa E.; Schneider, Thomas D.; Pringle, Ian; Ambudkar, Suresh V.; Gill, Deborah R.; Hyde, Steven C.; Gottesman, Michael M.			Identification of a Cryptic Bacterial Promoter in Mouse (mdr1a) P-Glycoprotein cDNA	PLOS ONE			English	Article							DRUG-RESISTANCE PROFILES; ESCHERICHIA-COLI; CYSTIC-FIBROSIS; FUNCTIONAL EXPRESSION; MULTIDRUG TRANSPORTER; MOLECULAR-BASIS; ATPASE ACTIVITY; BINDING-SITES; GENE; PHARMACOKINETICS	The efflux transporter P-glycoprotein (P-gp) is an important mediator of various pharmacokinetic parameters, being expressed at numerous physiological barriers and also in multi-drug-resistant cancer cells. Molecular cloning of homologous cDNAs is an important tool for the characterization of functional differences in P-gp between species. However, plasmids containing mouse mdr1a cDNA display significant genetic instability during cloning in bacteria, indicating that mdr1a cDNA may be somehow toxic to bacteria, allowing only clones containing mutations that abrogate this toxicity to survive transformation. We demonstrate here the presence of a cryptic promoter in mouse mdr1a cDNA that causes mouse P-gp expression in bacteria. This expression may account for the observed toxicity of mdr1a DNA to bacteria. Sigma 70 binding site analysis and GFP reporter plasmids were used to identify sequences in the first 321 bps of mdr1a cDNA capable of initiating bacterial protein expression. An mdr1a M107L cDNA containing a single residue mutation at the proposed translational start site was shown to allow sub-cloning of mdr1a in E. coli while retaining transport properties similar to wild-type P-gp. This mutant mdr1a cDNA may prove useful for efficient cloning of mdr1a in E. coli.	[Pluchino, Kristen M.; Moen, Janna K.; Hall, Matthew D.; Madigan, James P.; Shukla, Suneet; Ambudkar, Suresh V.; Gottesman, Michael M.] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Esposito, Dominic; Procter, Lauren V.; Wall, Vanessa E.] Leidos Biomed Res Inc, Prot Express Lab, Frederick Natl Lab Canc Res, Frederick, MD USA; [Schneider, Thomas D.] NCI, Gene Regulat & Chromosome Biol Lab, Mol Informat Theory Grp, Frederick, MD 21701 USA; [Pringle, Ian; Gill, Deborah R.; Hyde, Steven C.] Univ Oxford, Radcliffe Dept Med, NDCLS, Gene Med Res Grp, Oxford, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oxford	Gottesman, MM (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.	mgottesman@nih.gov	Ambudkar, Suresh V/L-1317-2016	Moen, Janna/0000-0001-6167-5472; Hyde, Stephen/0000-0002-8877-4005; Gill, Deborah/0000-0002-5264-054X; Schneider, Thomas/0000-0002-9841-1531; Esposito, Dominic/0000-0002-9987-1687	National Institutes of Health [HHSN261200800001E]; NIH, National Cancer Institute, Center for Cancer Research; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC005598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract number HHSN261200800001E and the by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	AKIYAMA SI, 1985, SOMAT CELL MOLEC GEN, V11, P117, DOI 10.1007/BF01534700; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504; Bai JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022577; Beja O, 1996, P NATL ACAD SCI USA, V93, P5969, DOI 10.1073/pnas.93.12.5969; Bernaudat F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029191; BIBI E, 1993, P NATL ACAD SCI USA, V90, P9209, DOI 10.1073/pnas.90.19.9209; Bibi E, 1998, METHOD ENZYMOL, V292, P370; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boyd AC, 1999, J GENE MED, V1, P312; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CURRIER SJ, 1989, J BIOL CHEM, V264, P14376; DEVAULT A, 1990, MOL CELL BIOL, V10, P1652, DOI 10.1128/MCB.10.4.1652; DHIR R, 1992, BIOCHEMISTRY-US, V31, P6103, DOI 10.1021/bi00141a021; EVANS GL, 1995, J BIOENERG BIOMEMBR, V27, P43, DOI 10.1007/BF02110330; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kannan P, 2009, CLIN PHARMACOL THER, V86, P368, DOI 10.1038/clpt.2009.138; Kim IW, 2008, MINI-REV MED CHEM, V8, P193; Li DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018197; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Lin JH, 2003, CLIN PHARMACOKINET, V42, P59, DOI 10.2165/00003088-200342010-00003; Miroslavova NS, 2006, BIOCHEM SOC SYMP, V73, P1; MISSIAKAS D, 1993, J BACTERIOL, V175, P2613, DOI 10.1128/JB.175.9.2613-2624.1993; Montigny C, 2004, BBA-BIOMEMBRANES, V1660, P53, DOI 10.1016/j.bbamem.2003.10.013; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schinkel AH, 1999, ADV DRUG DELIVER REV, V36, P179, DOI 10.1016/S0169-409X(98)00085-4; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Schlegel S, 2010, MICROB BIOTECHNOL, V3, P403, DOI 10.1111/j.1751-7915.2009.00148.x; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Shultzaberger RK, 2001, J MOL BIOL, V313, P215, DOI 10.1006/jmbi.2001.5040; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P771, DOI 10.1093/nar/gkl956; Singh SS, 2014, GENE DEV, V28, P214, DOI 10.1101/gad.234336.113; Syvanen S, 2009, DRUG METAB DISPOS, V37, P635, DOI 10.1124/dmd.108.024745; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Szewczyk P, 2015, ACTA CRYSTALLOGR D, V71, P732, DOI 10.1107/S1399004715000978; Takeuchi T, 2006, PHARM RES, V23, P1460, DOI 10.1007/s11095-006-0285-7; TANGWAI DF, 1995, BIOCHEMISTRY-US, V34, P32, DOI 10.1021/bi00001a005; van den Elsen JMH, 1999, P NATL ACAD SCI USA, V96, P13679, DOI 10.1073/pnas.96.24.13679; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Wei L, 2000, FEBS LETT, V473, P149, DOI 10.1016/S0014-5793(00)01519-2; Xia CQ, 2006, MOL PHARMACEUT, V3, P78, DOI 10.1021/mp050034j	48	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136396	10.1371/journal.pone.0136396	http://dx.doi.org/10.1371/journal.pone.0136396			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309032	Green Published, gold			2022-12-27	WOS:000360069400120
J	Vardanjani, HM; Baneshi, MR; Haghdoost, A				Vardanjani, Hossein Molavi; Baneshi, Mohammad Reza; Haghdoost, AliAkbar			Cancer Visibility among Iranian Familial Networks: To What Extent Can We Rely on Family History Reports?	PLOS ONE			English	Article							ONCOLOGY PRACTICES; PROSPECTIVE COHORT; COLORECTAL-CANCER; AWARENESS; ACCURACY; DIAGNOSIS; INFORMATION; RISK; DISCLOSURE; SURVIVAL	Objective Patients' unawareness of their cancer diagnosis (PUAW) and their tendency for non-disclosure (TTND) to relatives leads to a lack of cancer visibility among familial networks. Lack of familial cancer visibility could affect the accuracy of family cancer history (FCH) reports. In this study, we investigated familial cancer visibility and its potential determinants. Patients and Methods A sample of patients with a confirmed cancer diagnosis was interviewed. Participants were asked about their number of relatives, number of their relatives who are aware about the cancer diagnosis, and the number of relatives from whom they intended to conceal their diagnosis. PUAW was also assessed. Point estimates and 95% confidence intervals were calculated using the bootstrap technique. Multivariate analyses were conducted using mixed Poisson and logistic regression analyses. Results A total of 415 participants with a mean age of 53 +/- 15 years and a male to female ratio of 0.53 were enrolled in this study. The rates of PUAW, TTND, and familial cancer visibility in the total sample were 0.20 (95% confidence interval (CI): 0.16, 0.24), 0.16 (95% CI: 0.12, 0.19), and 0.86 (95% CI: 0.83, 0.89), respectively. PUAW (adjusted rate ratio (RR) = 1.32, 95% CI: 1.27, 1.38), TTND (RR = 0.92, 95% CI: 0.91, 0.93), and the patients' gender (RR = 0.92, 95% CI: 0.82, 0.95) were the most important determinants of familial cancer visibility. Conclusion Familial cancer visibility may be a point of concern among the Iranian population. Self-reported cancer histories and FCHs may have low sensitivities (not exceeding 80% and 86%, respectively) in this population. However, these estimates may vary across different societies, because of societal and cultural contexts.	[Vardanjani, Hossein Molavi; Baneshi, Mohammad Reza] Kerman Univ Med Sci, Inst Futures Studies Hlth, Res Ctr Modeling Hlth, Kerman, Iran; [Haghdoost, AliAkbar] Kerman Univ Med Sci, Inst Futures Studies Hlth, Reg Knowledge Hub, Kerman, Iran; [Haghdoost, AliAkbar] Kerman Univ Med Sci, Inst Futures Studies Hlth, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran	Kerman University of Medical Sciences; Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization	Haghdoost, A (corresponding author), Kerman Univ Med Sci, Inst Futures Studies Hlth, Reg Knowledge Hub, Kerman, Iran.	Ahaghdoost@kmu.ac.ir	Baneshi, Mohammad Reza/C-2586-2017; Vardanjani, Hossein Molavi/U-2659-2017; Haghdoost, Ali Akbar/C-2823-2009	Baneshi, Mohammad Reza/0000-0002-6405-8688; Vardanjani, Hossein Molavi/0000-0001-7024-8894; Haghdoost, Ali Akbar/0000-0003-4628-4849	Kerman University of Medical Sciences [9350]	Kerman University of Medical Sciences	The parent study for this work was funded by Kerman University of Medical Sciences. Grant no: 9350 (www.kmu.ac.ir).	AITKEN J, 1995, AM J EPIDEMIOL, V141, P863, DOI 10.1093/oxfordjournals.aje.a117522; Berry DA, 2002, J CLIN ONCOL, V20, P2701, DOI 10.1200/JCO.2002.05.121; Bolland MJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002334; BONDY ML, 1994, J CLIN EPIDEMIOL, V47, P89, DOI 10.1016/0895-4356(94)90037-X; Braun D, 2014, J CLIN ONCOL, V32, P3682, DOI 10.1200/JCO.2014.57.4848; Brokalaki EI, 2005, SUPPORT CARE CANCER, V13, P938, DOI 10.1007/s00520-005-0794-7; Caruso A, 2000, TUMORI, V86, P199, DOI 10.1177/030089160008600304; Chan JA, 2008, JAMA-J AM MED ASSOC, V299, P2515, DOI 10.1001/jama.299.21.2515; Daniels MS, 2014, J CLIN ONCOL, V32, P1249, DOI 10.1200/JCO.2013.50.6055; Hampel H, 2004, J MED GENET, V41, P81, DOI 10.1136/jmg.2003.010918; Han MA, 2012, J CLIN ONCOL, V30, P701, DOI 10.1200/JCO.2011.35.3078; HARLOW SD, 1989, AM J EPIDEMIOL, V129, P233, DOI 10.1093/oxfordjournals.aje.a115129; Hemminki K, 2014, J CLIN ONCOL, V32, P3344, DOI 10.1200/JCO.2014.56.4336; Hilton S, 2009, QUAL HEALTH RES, V19, P744, DOI 10.1177/1049732309334737; Inoue M, 2011, CANCER EPIDEMIOL, V35, P250, DOI 10.1016/j.canep.2010.12.002; Janssens ACJW, 2012, J CLIN EPIDEMIOL, V65, P82, DOI 10.1016/j.jclinepi.2011.05.003; Kerber RA, 1997, AM J EPIDEMIOL, V146, P244; Killworth PD, 2003, SOC NETWORKS, V25, P141, DOI 10.1016/S0378-8733(02)00040-0; Kim SY, 2013, PSYCHO-ONCOLOGY, V22, P2206, DOI 10.1002/pon.3275; Kim S, 2014, PSYCHO-ONCOLOGY, V23, P1300, DOI 10.1002/pon.3565; Kleinerman RA, 2012, J CLIN ONCOL, V30, P950, DOI 10.1200/JCO.2011.37.0239; Maghsoudi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110917; Mitchell Jamie A, 2013, J Mens Stud, V21, P97, DOI 10.3149/jms.2102.97; Mitchell RJ, 2004, GUT, V53, P291, DOI 10.1136/gut.2003.027896; Motlagh A, 2014, ARCH IRAN MED, V17, P232, DOI 014174/AIM.004; Murff HJ, 2004, JAMA-J AM MED ASSOC, V292, P1480, DOI 10.1001/jama.292.12.1480; Mystakidou K, 2004, SUPPORT CARE CANCER, V12, P147, DOI 10.1007/s00520-003-0552-7; Navarro C, 2006, J EPIDEMIOL COMMUN H, V60, P593, DOI 10.1136/jech.2005.039131; Nord C, 2003, J PUBLIC HEALTH MED, V25, P313, DOI 10.1093/pubmed/fdg076; Offit K, 2004, JAMA-J AM MED ASSOC, V292, P1469, DOI 10.1001/jama.292.12.1469; Ozanne EM, 2012, J GENET COUNS, V21, P547, DOI 10.1007/s10897-011-9470-x; Papadopoulos A, 2011, PSYCHO-ONCOLOGY, V20, P294, DOI 10.1002/pon.1731; Qureshi Nadeem, 2009, Evid Rep Technol Assess (Full Rep), P1; Salganik MJ, 2011, SOC NETWORKS, V33, P70, DOI 10.1016/j.socnet.2010.10.006; Sie AS, 2014, J CLIN ONCOL, V32, P3343, DOI 10.1200/JCO.2014.56.2942; Sijmons RH, 2000, EUR J HUM GENET, V8, P181, DOI 10.1038/sj.ejhg.5200441; Tolonen H, 2014, EUR J PUBLIC HEALTH, V24, P941, DOI 10.1093/eurpub/cku074; Weissman SM, 2011, J GENET COUNS, V20, P5, DOI 10.1007/s10897-010-9325-x; Wood ME, 2014, J CLIN ONCOL, V32, P824, DOI 10.1200/JCO.2013.51.4661; Yoshinaga A, 2001, J CLIN EPIDEMIOL, V54, P741, DOI 10.1016/S0895-4356(00)00356-5; Yun YH, 2011, J CLIN ONCOL, V29, P2474, DOI 10.1200/JCO.2010.30.1184; Ziogas A, 2003, AM J PREV MED, V24, P190, DOI 10.1016/S0749-3797(02)00593-7	42	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136038	10.1371/journal.pone.0136038	http://dx.doi.org/10.1371/journal.pone.0136038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LO	26308087	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400085
J	Ahmed, A; Nawaz, SJ; Gulfam, SM				Ahmed, Abrar; Nawaz, Syed Junaid; Gulfam, Sardar Muhammad			A 3-D Propagation Model for Emerging Land Mobile Radio Cellular Environments	PLOS ONE			English	Article							OF-ARRIVAL STATISTICS; SCATTERING MODEL; DIRECTIONAL ANTENNA; CHANNEL MODEL; MASSIVE MIMO; HOLLOW-DISC; OUTDOOR; ANGLE; DISPERSION; ARISEN	A tunable stochastic geometry based Three-Dimensional (3-D) scattering model for emerging land mobile radio cellular systems is proposed. Uniformly distributed scattering objects are assumed around the Mobile Station (MS) bounded within an ellipsoidal shaped Scattering Region (SR) hollowed with an elliptically-cylindric scattering free region in immediate vicinity of MS. To ensure the degree of expected accuracy, the proposed model is designed to be tunable (as required) with nine degrees of freedom, unlike its counterparts in the existing literature. The outer and inner boundaries of SR are designed as independently scalable along all the axes and rotatable in horizontal plane around their origin centered at MS. The elevated Base Station (BS) is considered outside the SR at a certain adjustable distance and height w.r.t. position of MS. Closed-form analytical expressions for joint and marginal Probability Density Functions (PDFs) of Angle-of-Arrival (AoA) and Time-of-Arrival (ToA) are derived for both up-and down-links. The obtained analytical results for angular and temporal statistics of the channel are presented along with a thorough analysis. The impact of various physical model parameters on angular and temporal characteristics of the channel is presented, which reveals the comprehensive insight on the proposed results. To evaluate the robustness of the proposed analytical model, a comparison with experimental datasets and simulation results is also presented. The obtained analytical results for PDF of AoA observed at BS are seen to fit a vast range of empirical datasets in the literature taken for various outdoor propagation environments. In order to establish the validity of the obtained analytical results for spatial and temporal characteristics of the channel, a comparison of the proposed analytical results with the simulation results is shown, which illustrates a good fit for 107 scattering points. Moreover, the proposed model is shown to degenerate to various notable geometric models in the literature by an appropriate choice of a few parameters.	[Ahmed, Abrar; Nawaz, Syed Junaid; Gulfam, Sardar Muhammad] COMSATS Inst Informat Technol, Dept Elect Engn, Islamabad, Pakistan	COMSATS University Islamabad (CUI)	Ahmed, A (corresponding author), COMSATS Inst Informat Technol, Dept Elect Engn, Islamabad, Pakistan.	abrar_ahmed@comsats.edu.pk	Ahmed, Abrar/AAQ-2790-2021; Syed, Junaid Nawaz/AAA-7035-2020	Syed, Junaid Nawaz/0000-0001-5448-2170				Alsehaili M., 2006, ANTEM/URSI 2006. 12th International Symposium on Antenna Technology and Applied Electromagnetics [ANTEM] and Canadian Radio Sciences Conference [URSI/CNC], P407; Baltzis KB, 2012, WIRELESS PERS COMMUN, V67, P971, DOI 10.1007/s11277-011-0434-0; Baltzis KB, 2009, WIRELESS PERS COMMUN, V51, P329, DOI 10.1007/s11277-008-9646-3; Biswas S, 2006, IEEE COMMUN MAG, V44, P74, DOI 10.1109/MCOM.2006.1580935; Clarke RH, 1997, IEEE T VEH TECHNOL, V46, P798, DOI 10.1109/25.618205; GRM Jr, 2013, PATH LOSS MODELS 5G, P3948; Jaafar I., 2008, P 2 INT C SIGN CIRC, P1; Janaswamy R, 2002, IEEE T VEH TECHNOL, V51, P1242, DOI 10.1109/TVT.2002.801756; Jungnickel V, 2014, IEEE COMMUN MAG, V52, P44, DOI 10.1109/MCOM.2014.6815892; Kloch C, 2001, IEEE T ANTENN PROPAG, V49, P1254, DOI 10.1109/8.947016; Larsson EG, 2014, IEEE COMMUN MAG, V52, P186, DOI 10.1109/MCOM.2014.6736761; Nawaz SJ, 2015, WIRELESS PERS COMMUN, V82, P1337, DOI 10.1007/s11277-015-2286-5; Nawaz SJ, 2011, IEEE T VEH TECHNOL, V60, P2895, DOI 10.1109/TVT.2011.2161788; Nawaz SJ, 2010, ADV SAT MULTMED SYS, P395, DOI 10.1109/ASMS-SPSC.2010.5586870; Nawaz SJ, 2010, IEEE T VEH TECHNOL, V59, P3193, DOI 10.1109/TVT.2010.2050015; Olenko AY, 2003, IEEE ANTENN WIREL PR, V2, P345, DOI 10.1109/LAWP.2004.824174; Olenko AY, 2006, IEEE T ANTENN PROPAG, V54, P2446, DOI 10.1109/TAP.2006.880661; Olenko AY, 2013, T EMERG TELECOMMUN T, V24, P113, DOI 10.1002/ett.2530; Olenko AY, 2007, P TENCON 2007 2007 I, P1; Paul BS, 2010, IETE J RES, V56, P327, DOI 10.1080/03772063.2010.10876321; Pedersen KI, 2000, IEEE T VEH TECHNOL, V49, P437, DOI 10.1109/25.832975; Pedersen KI, 1998, IEEE VTC P, P719, DOI 10.1109/VETEC.1998.683676; Qu SX, 1999, IEEE T VEH TECHNOL, V48, P765, DOI 10.1109/25.764993; Riaz M, 2015, IEEE T VEH TECHNOL, V64, P4399, DOI 10.1109/TVT.2014.2371531; Riaz M, 2013, WIRELESS PERS COMMUN, V72, P2465, DOI 10.1007/s11277-013-1158-0; Sun C, 2015, IEEE T CONTR SYST T, V23, P1075, DOI 10.1109/TCST.2014.2361294; Wang C.X., IEEE WIRELE IN PRESS; Wang CX, 2014, IEEE COMMUN MAG, V52, P122, DOI 10.1109/MCOM.2014.6736752; Zhou J, 2012, IET COMMUN, V6, P2775, DOI 10.1049/iet-com.2011.0906	29	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0132555	10.1371/journal.pone.0132555	http://dx.doi.org/10.1371/journal.pone.0132555			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305328	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500003
J	Carvalho, A; Nabais, C; Vieira, J; Rossi, S; Campelo, F				Carvalho, Ana; Nabais, Cristina; Vieira, Joana; Rossi, Sergio; Campelo, Filipe			Plastic Response of Tracheids in Pinus pinaster in a Water-Limited Environment: Adjusting Lumen Size instead of Wall Thickness	PLOS ONE			English	Article							INTRAANNUAL DENSITY-FLUCTUATIONS; TREE-RING GROWTH; CLIMATIC SIGNALS; WOOD STRUCTURE; XYLOGENESIS; DROUGHT; WIDTH; AGE; HALEPENSIS; CONIFERS	The formation of wood results from cambial activity and its anatomical properties reflect the variability of environmental conditions during the growing season. Recently, it was found that wood density variations in conifers growing under cold-limited environment result from the adjustment of cell wall thickness (CWT) to temperature. Additionally, it is known that intra-annual density fluctuations (IADFs) are formed in response to precipitation after the summer drought. Although IADFs are frequent in Mediterranean conifers no study has yet been conducted to determine if these structures result from the adjustment of lumen diameter (LD) or CWT to soil water availability. Our main objective is to investigate the intra-ring variation of wood anatomical features (LD and CWT) in Pinus pinaster Ait. growing under a water-limited environment. We compared the tracheidograms of LD and CWT for the years 2010-2013 in P. pinaster growing in the west coast of Portugal. Our results suggest a close association between LD and soil moisture content along the growing season, reinforcing the role of water availability in determining tracheid size. Compared with CWT, LD showed a higher intra-and inter-annual variability suggesting its strong adjustment value to variations in water availability. The formation of a latewood IADF appears to be predisposed by higher rates of cell production in spring and triggered by early autumn precipitation. Our findings reinforce the crucial role of water availability on cambial activity and wood formation in Mediterranean conifers, and emphasize the high plasticity of wood anatomical features under Mediterranean climate.	[Carvalho, Ana; Nabais, Cristina; Vieira, Joana; Campelo, Filipe] Univ Coimbra, Dept Life Sci, CFE Ctr Funct Ecol, P-3000456 Coimbra, Portugal; [Rossi, Sergio] Univ Quebec Chicoutimi, Dept Sci Fondament, Chicoutimi, PQ, Canada; [Rossi, Sergio] Chinese Acad Sci, Prov Key Lab Appl Bot South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China	Universidade de Coimbra; University of Quebec; University of Quebec Chicoutimi; Chinese Academy of Sciences; South China Botanical Garden, CAS	Campelo, F (corresponding author), Univ Coimbra, Dept Life Sci, CFE Ctr Funct Ecol, P-3000456 Coimbra, Portugal.	fcampelo@uc.pt	Carvalho, Ana/AAF-3487-2021; Carvalho, Ana L P/L-2564-2016; Campelo, Filipe/D-6931-2011; Vieira, Joana/M-6152-2013	Carvalho, Ana/0000-0002-9316-9571; Carvalho, Ana L P/0000-0002-9316-9571; Campelo, Filipe/0000-0001-6022-9948; Vieira, Joana/0000-0003-1021-4101; Nabais, Cristina/0000-0001-6901-8776	Fundacao para a Ciencia e a Tecnologia, Ministerio da Educacao e Ciencia (FCT); Compete [PTDC/AAC-AMB/111675/2009, EXPL/AAG-GLO/1885/2013]; CFE strategic program [UI0134-UID/BIA/04004/2013]; FCT [SFRH/BPD/47822/2008]; POPH (Portuguese Operational Human Potential Program); QREN Portugal (Portuguese National Strategic Reference Framework)	Fundacao para a Ciencia e a Tecnologia, Ministerio da Educacao e Ciencia (FCT); Compete; CFE strategic program; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); POPH (Portuguese Operational Human Potential Program); QREN Portugal (Portuguese National Strategic Reference Framework)	This study was supported by the Fundacao para a Ciencia e a Tecnologia, Ministerio da Educacao e Ciencia (FCT) co-financed by Compete, through the projects PTDC/AAC-AMB/111675/2009 and EXPL/AAG-GLO/1885/2013, and CFE strategic program UI0134-UID/BIA/04004/2013. Filipe Campelo was supported by a postdoctoral research grant (SFRH/BPD/47822/2008) from FCT with funds from POPH (Portuguese Operational Human Potential Program) and QREN Portugal (Portuguese National Strategic Reference Framework).	Abe H, 2003, TREE PHYSIOL, V23, P859, DOI 10.1093/treephys/23.12.859; Abrantes J, 2013, TREES-STRUCT FUNCT, V27, P655, DOI 10.1007/s00468-012-0820-6; Campelo F, 2007, ANN FOREST SCI, V64, P229, DOI 10.1051/forest:2006107; Campelo F, 2015, TREES-STRUCT FUNCT, V29, P237, DOI 10.1007/s00468-014-1108-9; Campelo F, 2013, TREES-STRUCT FUNCT, V27, P763, DOI 10.1007/s00468-012-0831-3; Campelo F, 2010, TREES-STRUCT FUNCT, V24, P463, DOI 10.1007/s00468-010-0414-0; Linares JC, 2009, TREE PHYSIOL, V29, P1525, DOI 10.1093/treephys/tpp084; Cherubini P, 2003, BIOL REV, V78, P119, DOI 10.1017/S1464793102006000; Cuny HE, 2014, NEW PHYTOL, V203, P1231, DOI 10.1111/nph.12871; de Luis M, 2011, FOREST ECOL MANAG, V262, P1630, DOI 10.1016/j.foreco.2011.07.013; de Luis M, 2011, DENDROCHRONOLOGIA, V29, P163, DOI 10.1016/j.dendro.2011.01.005; DENNE MP, 1989, IAWA BULL, V10, P59, DOI 10.1163/22941932-90001112; Deslauriers A, 2005, TREES-STRUCT FUNCT, V19, P402, DOI 10.1007/s00468-004-0398-8; DeSoto L, 2011, CAN J FOREST RES, V41, P1280, DOI [10.1139/x11-045, 10.1139/X11-045]; Domec JC, 2002, J EXP BOT, V53, P2369, DOI 10.1093/jxb/erf100; Fonti P, 2013, AM J BOT, V100, P1332, DOI 10.3732/ajb.1200484; Fonti P, 2010, NEW PHYTOL, V185, P42, DOI 10.1111/j.1469-8137.2009.03030.x; Franceschini T, 2013, TREES-STRUCT FUNCT, V27, P913, DOI 10.1007/s00468-013-0844-6; Gricar J, 2005, ANN BOT-LONDON, V95, P959, DOI 10.1093/aob/mci112; Gutierrez E, 2011, TREES-STRUCT FUNCT, V25, P637, DOI 10.1007/s00468-011-0540-3; Hacke UG, 2001, PERSPECT PLANT ECOL, V4, P97, DOI 10.1078/1433-8319-00017; Huang J, 1996, J CLIMATE, V9, P1350, DOI 10.1175/1520-0442(1996)009<1350:AOMCSM>2.0.CO;2; Camarero JJ, 2010, NEW PHYTOL, V185, P471, DOI 10.1111/j.1469-8137.2009.03073.x; Kirdyanov AV, 2007, TREES-STRUCT FUNCT, V21, P37, DOI 10.1007/s00468-006-0094-y; Liang EY, 2006, NEW PHYTOL, V171, P783, DOI 10.1111/j.1469-8137.2006.01775.x; Lugo JB, 2012, ANN BOT-LONDON, V110, P1099, DOI 10.1093/aob/mcs175; Martin-Benito D, 2013, EUR J FOREST RES, V132, P33, DOI 10.1007/s10342-012-0652-3; MITRAKOS K, 1980, ACTA OECOL-OEC PLANT, V1, P245; Nabais C, 2014, FORESTRY, V87, P598, DOI 10.1093/forestry/cpu021; Novak K, 2013, TREES-STRUCT FUNCT, V27, P927, DOI 10.1007/s00468-013-0845-5; Olano JM, 2012, INT J PLANT SCI, V173, P137, DOI 10.1086/663165; Pasho E, 2012, TREES-STRUCT FUNCT, V26, P1875, DOI 10.1007/s00468-012-0756-x; Perrot-Rechenmann C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001446; Rigling A, 2002, PLANT ECOL, V163, P105, DOI 10.1023/A:1020355407821; Rossi S, 2006, IAWA J, V27, P89, DOI 10.1163/22941932-90000139; Rossi S, 2008, GLOBAL ECOL BIOGEOGR, V17, P696, DOI 10.1111/j.1466-8238.2008.00417.x; Rossi S, 2015, ANN FOREST SCI, V72, P77, DOI [10.1007/s13595-014-0399-8, 10.1007/s13595-013-0341-5]; Rozas V, 2011, TREES-STRUCT FUNCT, V25, P443, DOI 10.1007/s00468-010-0519-5; Sundberg B, 2000, EXPTL BIOL REV, P169; Tessier L, 1997, CLIMATIC CHANGE, V36, P499, DOI 10.1023/A:1005362231199; Uggla C, 1996, P NATL ACAD SCI USA, V93, P9282, DOI 10.1073/pnas.93.17.9282; Vaganov EA, 1990, METHODS DENDROCHRONO, P63, DOI DOI 10.1007/978-94-015-7879-0; Vieira J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126223; Vieira J, 2014, EUR J FOREST RES, V133, P41, DOI 10.1007/s10342-013-0734-x; Vieira J, 2013, AGR FOREST METEOROL, V180, P173, DOI 10.1016/j.agrformet.2013.06.009; Vieira J, 2010, CAN J FOREST RES, V40, P1567, DOI 10.1139/X10-096; Vieira J, 2009, TREES-STRUCT FUNCT, V23, P257, DOI 10.1007/s00468-008-0273-0; Willson CJ, 2006, PHYSIOL PLANTARUM, V127, P374, DOI 10.1111/j.1399-3054.2006.00644.x; Wood SN, 2006, BIOMETRICS, V62, P1025, DOI 10.1111/j.1541-0420.2006.00574.x; Zweifel R, 2006, J EXP BOT, V57, P1445, DOI 10.1093/jxb/erj125	50	37	38	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136305	10.1371/journal.pone.0136305	http://dx.doi.org/10.1371/journal.pone.0136305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305893	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000359995500063
J	He, L; Li, Q; Liu, LH; Wang, YL; Xie, J; Yang, HD; Wang, Q				He, Lin; Li, Qing; Liu, Lihua; Wang, Yuanli; Xie, Jing; Yang, Hongdan; Wang, Qun			A Catalog of Proteins Expressed in the AG Secreted Fluid during the Mature Phase of the Chinese Mitten Crabs (Eriocheir sinensis)	PLOS ONE			English	Article							MALE REPRODUCTIVE-TRACT; DROSOPHILA-MELANOGASTER; PEPTIDASE INHIBITORS; ACROSOME REACTION; ADP-RIBOSYLATION; CANCER-MAGISTER; GLAND PROTEINS; CDNA CLONING; SPERM; FAMILY	The accessory gland (AG) is an important component of the male reproductive system of arthropods, its secretions enhance fertility, some AG proteins bind to the spermatozoa and affect its function and properties. Here we report the first comprehensive catalog of the AG secreted fluid during the mature phase of the Chinese mitten crab (Eriocheir sinensis). AG proteins were separated by one-dimensional gel electrophoresis and analyzed by reverse phase high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS). Altogether, the mass spectra of 1173 peptides were detected (1067 without decoy and contaminants) which allowed for the identification of 486 different proteins annotated upon the NCBI database (http://www.ncbi.nlm.nih.gov/) and our transcritptome dataset. The mass spectrometry proteomics data have been deposited at the ProteomeXchange with identifier PXD000700. An extensive description of the AG proteome will help provide the basis for a better understanding of a number of reproductive mechanisms, including potentially spermatophore breakdown, dynamic functional and morphological changes in sperm cells and sperm acrosin enzyme vitality. Thus, the comprehensive catalog of proteins presented here can serve as a valuable reference for future studies of sperm maturation and regulatory mechanisms involved in crustacean reproduction.	[He, Lin; Li, Qing; Liu, Lihua; Wang, Yuanli; Xie, Jing; Yang, Hongdan; Wang, Qun] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China	East China Normal University	Wang, Q (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China.	qwang@bio.ecnu.edu.cn	Wang, Qun/I-7778-2013	Wang, Qun/0000-0001-7929-7692	National Natural Science Foundation of China [41376157, 31201974, 31172393]; Shanghai Natural Science Fund Committee [12ZR1408900]; Ministry of education [20120076120011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Fund Committee; Ministry of education	This work was supported by grants from the National Natural Science Foundation of China (No. 41376157, No. 31201974 and No. 31172393), Shanghai Natural Science Fund Committee (No. 12ZR1408900) and the Doctoral Fund of Ministry of education (No. 20120076120011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asquith KL, 2005, BIOL REPROD, V72, P328, DOI 10.1095/biolreprod.104.034470; Avila V, 2011, HEREDITY, V106, P765, DOI 10.1038/hdy.2010.117; Baek K, 2008, P NATL ACAD SCI USA, V105, P11748, DOI 10.1073/pnas.0805852105; Bi Y, 2009, ASIAN J ANDROL, V11, P229, DOI 10.1038/aja.2009.6; Breugelmans B, 2009, PEPTIDES, V30, P622, DOI 10.1016/j.peptides.2008.07.026; CERENIUS L, 1994, J BIOL CHEM, V269, P29462; Chang YJ, 2011, ANN SURG ONCOL, V18, P2395, DOI 10.1245/s10434-011-1597-3; Cheng C Yan, 2011, Spermatogenesis, V1, P174; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; Dacheux JL, 2003, MICROSC RES TECHNIQ, V61, P7, DOI 10.1002/jemt.10312; DUVIC B, 1990, J BIOL CHEM, V265, P9327; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Faini M, 2012, SCIENCE, V336, P1451, DOI 10.1126/science.1221443; de Godoy LMF, 2012, PROTEOMICS, V12, P2694, DOI 10.1002/pmic.201200078; Gadella BM, 2008, ANIM REPROD SCI, V107, P229, DOI 10.1016/j.anireprosci.2008.05.006; Gai YC, 2008, FISH SHELLFISH IMMUN, V25, P657, DOI 10.1016/j.fsi.2008.08.013; GALAT A, 1993, EUR J BIOCHEM, V216, P689, DOI 10.1111/j.1432-1033.1993.tb18189.x; Girouard J, 2011, INT J ANDROL, V34, pE475, DOI 10.1111/j.1365-2605.2011.01203.x; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053915; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Hou XL, 2010, J CRUSTACEAN BIOL, V30, P435, DOI 10.1651/09-3177.1; Huang QY, 2011, PROTEOMICS, V11, P3743, DOI 10.1002/pmic.201100084; Hubbard MJ, 2000, ELECTROPHORESIS, V21, P3785, DOI 10.1002/1522-2683(200011)21:17<3785::AID-ELPS3785>3.0.CO;2-2; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawabe S, 2009, COMP BIOCHEM PHYS B, V154, P290, DOI 10.1016/j.cbpb.2009.07.001; KIRKPATRICK RB, 1995, J BIOL CHEM, V270, P19800, DOI 10.1074/jbc.270.34.19800; Kitazawa D, 2012, J CELL SCI, V125, P3649, DOI 10.1242/jcs.103317; LaFlamme BA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002435; Li XY, 2010, DEVELOPMENT, V137, P151, DOI 10.1242/dev.040659; MCCARTHY KJ, 1994, J HISTOCHEM CYTOCHEM, V42, P473, DOI 10.1177/42.4.8126374; Moura AA, 2010, J PROTEOMICS, V73, P2006, DOI 10.1016/j.jprot.2010.06.005; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Nakamura A, 2007, ACTA TROP, V103, P222, DOI 10.1016/j.actatropica.2007.06.009; Ni Y, 2009, MOL REPROD DEV, V76, P984, DOI 10.1002/mrd.21063; Nicol SM, 2000, EXP CELL RES, V257, P272, DOI 10.1006/excr.2000.4886; Olswang-Kutz Y, 2009, J CELL SCI, V122, P471, DOI 10.1242/jcs.038521; Pan D, 2005, DEV COMP IMMUNOL, V29, P103, DOI 10.1016/j.dci.2004.07.001; Peralta I, 2009, POULTRY SCI, V88, P380, DOI 10.3382/ps.2007-00402; Peterson TA, 2013, BBA-MOL CELL RES, V1833, P487, DOI 10.1016/j.bbamcr.2012.11.011; Ram KR, 2007, INTEGR COMP BIOL, V47, P427, DOI 10.1093/icb/icm046; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Ren FF, 2010, DEV BIOL, V337, P303, DOI 10.1016/j.ydbio.2009.10.046; Sawada H, 2002, P NATL ACAD SCI USA, V99, P1223, DOI 10.1073/pnas.032389499; Seman M, 2004, CURR MED CHEM, V11, P857, DOI 10.2174/0929867043455611; Simonet G, 2002, COMP BIOCHEM PHYS B, V132, P247, DOI 10.1016/S1096-4959(01)00530-9; Simonet G, 2002, INSECT MOL BIOL, V11, P249, DOI 10.1046/j.1365-2583.2002.00331.x; Smith CA, 2004, MOL BIOL CELL, V15, P3698, DOI 10.1091/mbc.E04-01-0026; Song XQ, 2007, DEVELOPMENT, V134, P1071, DOI 10.1242/dev.003392; Sullivan R, 2007, ASIAN J ANDROL, V9, P483, DOI 10.1111/j.1745-7262.2007.00281.x; Sun X, 2012, GENE, V508, P78, DOI 10.1016/j.gene.2012.07.035; Sutovsky P, 2011, REPRODUCTION, V142, P1, DOI 10.1530/REP-11-0041; Takemori N, 2009, PROTEOMICS, V9, P2484, DOI 10.1002/pmic.200800795; TAKEUCHI A, 1995, CANCER RES, V55, P1586; Terwilliger NB, 1999, P NATL ACAD SCI USA, V96, P2013, DOI 10.1073/pnas.96.5.2013; Terwilliger NB, 2006, BIOL BULL-US, V210, P38, DOI 10.2307/4134535; Terwilliger NB, 2005, J EXP BIOL, V208, P2467, DOI 10.1242/jeb.01667; Terwilliger NB, 2006, INTEGR COMP BIOL, V46, P991, DOI 10.1093/icb/icl012; Tomes CN, 2002, DEV BIOL, V243, P326, DOI 10.1006/dbio.2002.0567; Tulsiani DRP, 1998, J REPROD FERTIL, P85; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Walker MJ, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-9; Wasbrough ER, 2010, J PROTEOMICS, V73, P2171, DOI 10.1016/j.jprot.2010.09.002; Xu JJ, 2013, J PROTEOMICS, V78, P83, DOI 10.1016/j.jprot.2012.11.011; Yoshikawa H, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006148; Zhang X, 2012, P NATL ACAD SCI USA, V109, P12485, DOI 10.1073/pnas.1207821109; Zhou YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004106; Zhu M, 2015, GENE, V559, P103, DOI 10.1016/j.gene.2014.11.050	70	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136266	10.1371/journal.pone.0136266	http://dx.doi.org/10.1371/journal.pone.0136266			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305468	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500059
J	Herrera, D; Trevino, M				Herrera, David; Trevino, Mario			Undesirable Choice Biases with Small Differences in the Spatial Structure of Chance Stimulus Sequences	PLOS ONE			English	Article							VISUAL-DISCRIMINATION; MATCHING BEHAVIOR; REINFORCEMENT; SCHEDULES; MODELS; RATS	In two-alternative discrimination tasks, experimenters usually randomize the location of the rewarded stimulus so that systematic behavior with respect to irrelevant stimuli can only produce chance performance on the learning curves. One way to achieve this is to use random numbers derived from a discrete binomial distribution to create a 'full random training schedule' (FRS). When using FRS, however, sporadic but long laterally-biased training sequences occur by chance and such 'input biases' are thought to promote the generation of laterally-biased choices (i.e., 'output biases'). As an alternative, a 'Gellerman-like training schedule' (GLS) can be used. It removes most input biases by prohibiting the reward from appearing on the same location for more than three consecutive trials. The sequence of past rewards obtained from choosing a particular discriminative stimulus influences the probability of choosing that same stimulus on subsequent trials. Assuming that the long-term average ratio of choices matches the long-term average ratio of reinforcers, we hypothesized that a reduced amount of input biases in GLS compared to FRS should lead to a reduced production of output biases. We compared the choice patterns produced by a 'Rational Decision Maker' (RDM) in response to computer-generated FRS and GLS training sequences. To create a virtual RDM, we implemented an algorithm that generated choices based on past rewards. Our simulations revealed that, although the GLS presented fewer input biases than the FRS, the virtual RDM produced more output biases with GLS than with FRS under a variety of test conditions. Our results reveal that the statistical and temporal properties of training sequences interacted with the RDM to influence the production of output biases. Thus, discrete changes in the training paradigms did not translate linearly into modifications in the pattern of choices generated by a RDM. Virtual RDMs could be further employed to guide the selection of proper training schedules for perceptual decision making studies.	[Herrera, David; Trevino, Mario] Univ Guadalajara, Inst Neurociencias, Guadalajara 44430, Jalisco, Mexico	Universidad de Guadalajara	Trevino, M (corresponding author), Univ Guadalajara, Inst Neurociencias, Guadalajara 44430, Jalisco, Mexico.	mariomtv@hotmail.com			Consejo Nacional de Ciencia y Tecnologia (CONACYT) [220862, 07384, 251406]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants from the Consejo Nacional de Ciencia y Tecnologia (CONACYT) to MT (220862, 07384, 251406). MT was sponsored by CONACyT's 'Repatriation Program'.	BAUM WM, 1974, J EXP ANAL BEHAV, V22, P231, DOI 10.1901/jeab.1974.22-231; Bhagavatula PS, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003473; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Busse L, 2011, J NEUROSCI, V31, P11351, DOI 10.1523/JNEUROSCI.6689-10.2011; Carvalho TP, 2009, NEURON, V61, P774, DOI 10.1016/j.neuron.2009.01.013; CATANIA AC, 1971, J EXP ANAL BEHAV, V15, P271, DOI 10.1901/jeab.1971.15-271; Corrado GS, 2005, J EXP ANAL BEHAV, V84, P581, DOI 10.1901/jeab.2005.23-05; Davison M, 2000, J EXP ANAL BEHAV, V74, P1, DOI 10.1901/jeab.2000.74-1; FELLOWS BJ, 1967, PSYCHOL BULL, V67, P87, DOI 10.1037/h0024098; Gellermann LW, 1933, PEDAGOG SEMIN J GEN, V42, P206; Grunow A, 2002, PSYCHON B REV, V9, P250, DOI 10.3758/BF03196279; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Huh N, 2009, LEARN MEMORY, V16, P315, DOI 10.1101/lm.1295509; Iversen IH, 1997, J EXP ANAL BEHAV, V68, P27, DOI 10.1901/jeab.1997.68-27; KILLEEN PR, 1994, BEHAV BRAIN SCI, V17, P105, DOI 10.1017/S0140525X00033628; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Priddy K L, 2005, SPIE TUTORIAL TEXTS, VTT68; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; RACHLIN H, 1991, J EXP ANAL BEHAV, V55, P233, DOI 10.1901/jeab.1991.55-233; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Sanabria F, 2009, J EXP ANAL BEHAV, V91, P169, DOI 10.1901/jeab.2009.91-169; SCHWARTZ B, 1980, J EXP ANAL BEHAV, V33, P153, DOI 10.1901/jeab.1980.33-153; Shadlen MN, 2013, NEURON, V80, P791, DOI 10.1016/j.neuron.2013.10.047; Stuttgen MC, 2011, J EXP ANAL BEHAV, V96, P155, DOI 10.1901/jeab.2011.96-155; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; SUTHERLAND NS, 1964, BRIT MED BULL, V20, P54, DOI 10.1093/oxfordjournals.bmb.a070283; Trevino M, 2014, SCI REP-UK, V4, DOI 10.1038/srep07569; Trevino M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01048; Trevino M, 2012, CEREB CORTEX, V22, P2529, DOI 10.1093/cercor/bhr333; Trevino Mario, 2011, Int Arch Med, V4, P26, DOI 10.1186/1755-7682-4-26; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Wolfart J, 2005, NAT NEUROSCI, V8, P1760, DOI 10.1038/nn1591	32	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136084	10.1371/journal.pone.0136084	http://dx.doi.org/10.1371/journal.pone.0136084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6KK	26305097	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500046
J	Liu, R; Li, X; Zhang, W; Zhou, HH				Liu, Rong; Li, Xi; Zhang, Wei; Zhou, Hong-Hao			Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database	PLOS ONE			English	Article							HEART-VALVE REPLACEMENT; CHINESE PATIENTS; CYP2C9 GENOTYPES; PATIENT CHARACTERISTICS; ANTICOAGULANT RESPONSE; VKORC1 GENOTYPES; DOSE REQUIREMENT; KOREAN PATIENTS; PHENPROCOUMON; PREDICTION	Objective Multiple linear regression (MLR) and machine learning techniques in pharmacogenetic algorithm-based warfarin dosing have been reported. However, performances of these algorithms in racially diverse group have never been objectively evaluated and compared. In this literature-based study, we compared the performances of eight machine learning techniques with those of MLR in a large, racially-diverse cohort. Methods MLR, artificial neural network (ANN), regression tree (RT), multivariate adaptive regression splines (MARS), boosted regression tree (BRT), support vector regression (SVR), random forest regression (RFR), lasso regression (LAR) and Bayesian additive regression trees (BART) were applied in warfarin dose algorithms in a cohort from the International Warfarin Pharmacogenetics Consortium database. Covariates obtained by stepwise regression from 80% of randomly selected patients were used to develop algorithms. To compare the performances of these algorithms, the mean percentage of patients whose predicted dose fell within 20% of the actual dose (mean percentage within 20%) and the mean absolute error (MAE) were calculated in the remaining 20% of patients. The performances of these techniques in different races, as well as the dose ranges of therapeutic warfarin were compared. Robust results were obtained after 100 rounds of resampling. Results BART, MARS and SVR were statistically indistinguishable and significantly out performed all the other approaches in the whole cohort (MAE: 8.84-8.96 mg/week, mean percentage within 20%: 45.88%-46.35%). In the White population, MARS and BART showed higher mean percentage within 20% and lower mean MAE than those of MLR (all p values < 0.05). In the Asian population, SVR, BART, MARS and LAR performed the same as MLR. MLR and LAR optimally performed among the Black population. When patients were grouped in terms of warfarin dose range, all machine learning techniques except ANN and LAR showed significantly higher mean percentage within 20%, and lower MAE (all p values < 0.05) than MLR in the low- and high-dose ranges. Conclusion Overall, machine learning-based techniques, BART, MARS and SVR performed superior than MLR in warfarin pharmacogenetic dosing. Differences of algorithms' performances exist among the races. Moreover, machine learning-based algorithms tended to perform better in the low- and high-dose ranges than MLR.	[Liu, Rong; Li, Xi; Zhang, Wei; Zhou, Hong-Hao] Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha, Hunan, Peoples R China; [Liu, Rong; Li, Xi; Zhang, Wei; Zhou, Hong-Hao] Cent S Univ, Inst Clin Pharmacol, Hunan Key Lab Pharmacogenet, Changsha, Hunan, Peoples R China	Central South University; Central South University	Li, X (corresponding author), Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha, Hunan, Peoples R China.	lixi6931430@126.com; HHZhou2003@163.com			863 Plan [2012AA02A518]; National Scientific Foundation of China [81273595, 81403017]; Fundamental Research Funds for the Central Universities [2012QNZT086]; China Postdoctoral Science Foundation [2013M531818]; Specialized Research Fund for the Doctoral Program of Higher Education [20120162120078]	863 Plan(National High Technology Research and Development Program of China); National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was partially supported by the major project of 863 Plan (No. 2012AA02A518), National Scientific Foundation of China (No. 81273595, 81403017), the Fundamental Research Funds for the Central Universities (2012QNZT086), China Postdoctoral Science Foundation (2013M531818), and Specialized Research Fund for the Doctoral Program of Higher Education (20120162120078).	Alpaydin E., 2004, INTRO MACHINE LEARNI; Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Biss TT, 2012, BLOOD, V119, P868, DOI 10.1182/blood-2011-08-372722; Budnitz DS, 2007, ANN INTERN MED, V147, P755, DOI 10.7326/0003-4819-147-11-200712040-00006; Cho HJ, 2011, CLIN THER, V33, P1371, DOI 10.1016/j.clinthera.2011.09.004; Cosgun E, 2011, BIOINFORMATICS, V27, P1384, DOI 10.1093/bioinformatics/btr159; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Grossi E, 2014, PHARMACOGENOMICS, V15, P29, DOI 10.2217/pgs.13.212; Huang SW, 2009, PHARMACOGENET GENOM, V19, P226, DOI 10.1097/FPC.0b013e328326e0c7; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Ie HA, 2014, EUR J CLIN PHARMACOL, V70, P265, DOI [10.1007/s00228-013-1617-2, DOI 10.1007/S00228-013-1617-2]; Kamali F, 2004, CLIN PHARMACOL THER, V75, P204, DOI 10.1016/j.clpt.2003.10.001; Kim HS, 2009, PHARMACOGENET GENOM, V19, P103, DOI 10.1097/FPC.0b013e32831a9ae3; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Li X, 2014, J CLIN PHARMACOL, V4, P392; Li X, 2015, PHARMACOGENOMICS, V16, P583, DOI [10.2217/PGS.15.26, 10.2217/pgs.15.26]; Limdi NA, 2010, BLOOD, V115, P3827, DOI 10.1182/blood-2009-12-255992; Liu KE, 2014, METHOD INFORM MED, V53, P47, DOI 10.3414/ME13-01-0027; MacKay D. J. C., 2003, INFORM THEORY INFERE; Miao LY, 2007, EUR J CLIN PHARMACOL, V63, P1135, DOI 10.1007/s00228-007-0381-6; Mohri M., 2018, FDN MACHINE LEARNING; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Schalekamp T, 2007, CLIN PHARMACOL THER, V81, P185, DOI 10.1038/sj.clpt.6100036; Tan SL, 2012, PHARMAZIE, V67, P930, DOI 10.1691/ph.2012.2633; Tham LS, 2006, CLIN PHARMACOL THER, V80, P346, DOI 10.1016/j.clpt.2006.06.009; Ugrinowitsch C, 2004, MED SCI SPORT EXER, V36, P2144, DOI 10.1249/01.MSS.0000147580.40591.75; van Schie RMF, 2011, EUR HEART J, V32, P1909, DOI 10.1093/eurheartj/ehr116; Wadelius M, 2007, HUM GENET, V121, P23, DOI 10.1007/s00439-006-0260-8; Wadelius M, 2009, BLOOD, V113, P784, DOI 10.1182/blood-2008-04-149070; WELLS PS, 1994, ANN INTERN MED, V121, P676, DOI 10.7326/0003-4819-121-9-199411010-00009; Wen MS, 2008, CLIN PHARMACOL THER, V84, P83, DOI 10.1038/sj.clpt.6100453; You JHS, 2011, J THROMB THROMBOLYS, V31, P113, DOI 10.1007/s11239-010-0497-x; Zhu Y, 2007, CLIN CHEM, V53, P1199, DOI 10.1373/clinchem.2006.078139	33	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135784	10.1371/journal.pone.0135784	http://dx.doi.org/10.1371/journal.pone.0135784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305568	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500033
J	Malassis, R; Del Cul, A; Collins, T				Malassis, Raphaelle; Del Cul, Antoine; Collins, Therese			Corollary Discharge Failure in an Oculomotor Task Is Related to Delusional Ideation in Healthy Individuals	PLOS ONE			English	Article							FRONTAL EYE FIELD; SENSORY PREDICTION; AUDITORY HALLUCINATIONS; EFFERENCE COPY; SCHIZOPHRENIA; DYSFUNCTION; MOVEMENTS; DEFICITS; SIGNALS; CONSEQUENCES	Predicting the sensory consequences of saccadic eye movements likely plays a crucial role in planning sequences of saccades and in maintaining visual stability despite saccade-caused retinal displacements. Deficits in predictive activity, such as that afforded by a corollary discharge signal, have been reported in patients with schizophrenia, and may lead to the emergence of positive symptoms, in particular delusions of control and auditory hallucinations. We examined whether a measure of delusional thinking in the general, non-clinical population correlated with measures of predictive activity in two oculomotor tasks. The double-step task measured predictive activity in motor control, and the in-flight displacement task measured predictive activity in trans-saccadic visual perception. Forty-one healthy adults performed both tasks and completed a questionnaire to assess delusional thinking. The quantitative measure of predictive activity we obtained correlated with the tendency towards delusional ideation, but only for the motor task, and not the perceptual task: Individuals with higher levels of delusional thinking showed less self-movement information use in the motor task. Variation of the degree of self-generated movement knowledge as a function of the prevalence of delusional ideation in the normal population strongly supports the idea that corollary discharge deficits measured in schizophrenic patients in previous researches are not due to neuroleptic medication. We also propose that this difference in results between the perceptual and the motor tasks may point to a dissociation between corollary discharge for perception and corollary discharge for action.	[Malassis, Raphaelle; Collins, Therese] Univ Paris 05, Lab Psychol Percept, Paris, France; [Malassis, Raphaelle; Collins, Therese] CNRS, Paris, France; [Del Cul, Antoine] Univ Paris 06, ICM SAN TEAM, Grp Hosp Pitie Salpetriere, Serv Psychiat Adultes, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Collins, T (corresponding author), Univ Paris 05, Lab Psychol Percept, Paris, France.	therese.collins@parisdescartes.fr			ANR	ANR(French National Research Agency (ANR))	This work was supported by an ANR grant to TC (ANR Jeunes Chercheurs - EPA).	Aichert DS, 2012, PSYCHOPHYSIOLOGY, V49, P345, DOI 10.1111/j.1469-8986.2011.01306.x; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 2000, PSYCHOL MED, V30, P1131, DOI 10.1017/S0033291799002676; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; Collins T, J VISION IN PRESS; Collins T, 2010, J VISION, V10, DOI 10.1167/10.14.7; Collins T, 2009, J VISION, V9, DOI 10.1167/9.5.29; Crapse TB, 2012, J NEUROSCI, V32, P2835, DOI 10.1523/JNEUROSCI.1320-11.2012; Daprati E, 1997, COGNITION, V65, P71, DOI 10.1016/S0010-0277(97)00039-5; Dore-Mazars K, 2006, BRAIN RES, V1113, P153, DOI 10.1016/j.brainres.2006.07.011; Ettinger U, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00018; FEINBERG I, 1978, SCHIZOPHRENIA BULL, V4, P636, DOI 10.1093/schbul/4.4.636; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Ford JM, 2005, INT J PSYCHOPHYSIOL, V58, P179, DOI 10.1016/j.ijpsycho.2005.01.014; Ford JM, 2001, AM J PSYCHIAT, V158, P2069, DOI 10.1176/appi.ajp.158.12.2069; Ford JM, 2007, PSYCHOPHYSIOLOGY, V44, P522, DOI 10.1111/j.1469-8986.2007.00533.x; Ford JM, 2007, AM J PSYCHIAT, V164, P458, DOI 10.1176/appi.ajp.164.3.458; Fourneret Pierre, 2002, Cogn Neuropsychiatry, V7, P139, DOI 10.1080/13546800143000212; Frith CD, 2000, BRAIN RES REV, V31, P357, DOI 10.1016/S0165-0173(99)00052-1; HALLETT PE, 1976, VISION RES, V16, P107, DOI 10.1016/0042-6989(76)90084-5; Heide W, 1998, EXP BRAIN RES, V123, P164, DOI 10.1007/s002210050558; HEIDE W, 1995, ANN NEUROL, V38, P739, DOI 10.1002/ana.410380508; Joiner WM, 2013, J NEUROPHYSIOL, V110, P2402, DOI 10.1152/jn.00362.2013; Joiner WM, 2010, J VISION, V10, DOI 10.1167/10.2.22; Kleiner M, 2007, PERCEPTION, V36, P14; Koch Carmen, 2007, P193, DOI 10.1016/B978-008044980-7/50011-2; Lindner A, 2005, CURR BIOL, V15, P1119, DOI 10.1016/j.cub.2005.05.049; Meyhofer I, 2015, HUM BRAIN MAPP, V36, P340, DOI 10.1002/hbm.22632; Ostendorf F, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00010; Ostendorf F, 2010, P NATL ACAD SCI USA, V107, P1229, DOI 10.1073/pnas.0910742107; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peters E, 2004, SCHIZOPHRENIA BULL, V30, P1005, DOI 10.1093/oxfordjournals.schbul.a007116; Peters ER, 1999, SCHIZOPHRENIA BULL, V25, P553, DOI 10.1093/oxfordjournals.schbul.a033401; Picard F, 2014, NEUROLOGY, V83, P1112, DOI 10.1212/WNL.0000000000000798; Richard A, 2014, J NEUROSCI, V34, P4760, DOI 10.1523/JNEUROSCI.4744-13.2014; RIVAUD S, 1994, EXP BRAIN RES, V102, P110; Schneider K., 1959, CLIN PSYCHOPATHOLOGY; Shergill SS, 2005, AM J PSYCHIAT, V162, P2384, DOI 10.1176/appi.ajp.162.12.2384; Shergill SS, 2014, JAMA PSYCHIAT, V71, P28, DOI 10.1001/jamapsychiatry.2013.2974; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1381, DOI 10.1152/jn.00738.2003; Spering M, 2013, J NEUROSCI, V33, P11779, DOI 10.1523/JNEUROSCI.0578-13.2013; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Synofzik M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00127; Synofzik M, 2010, BRAIN, V133, P262, DOI 10.1093/brain/awp291; Tanaka M, 2003, J NEUROPHYSIOL, V90, P2080, DOI 10.1152/jn.00207.2003; Terenius L, 2000, BRAIN RES REV, V31, P401, DOI 10.1016/S0165-0173(99)00057-0; Teufel C, 2010, NEUROPSYCHOLOGIA, V48, P4169, DOI 10.1016/j.neuropsychologia.2010.10.024; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Woodward ND, 2016, NEUROSCI RES, V102, P39, DOI 10.1016/j.neures.2014.08.006; Wurtz RH, 2003, PROG BRAIN RES, V144, P47, DOI 10.1016/S0079-6123(03)14400-3	52	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0134483	10.1371/journal.pone.0134483	http://dx.doi.org/10.1371/journal.pone.0134483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6KK	26305115	Green Submitted, Green Published, gold			2022-12-27	WOS:000359995500010
J	Mirelman, A; Bernad-Elazari, H; Nobel, T; Thaler, A; Peruzzi, A; Plotnik, M; Giladi, N; Hausdorff, JM				Mirelman, Anat; Bernad-Elazari, Hagar; Nobel, Tomer; Thaler, Avner; Peruzzi, Agnese; Plotnik, Meir; Giladi, Nir; Hausdorff, Jeffrey M.			Effects of Aging on Arm Swing during Gait: The Role of Gait Speed and Dual Tasking	PLOS ONE			English	Article							WALKING SPEED; BILATERAL COORDINATION; STABILITY; AGE; VARIABILITY; KINEMATICS; ASYMMETRY; LENGTH; YOUNG; STEP	Healthy walking is characterized by pronounced arm swing and axial rotation. Aging effects on gait speed, stride length and stride time variability have been previously reported, however, less is known about aging effects on arm swing and axial rotation and their relationship to age-associated gait changes during usual walking and during more challenging conditions like dual tasking. Sixty healthy adults between the ages of 30-77 were included in this study designed to address this gap. Lightweight body fixed sensors were placed on each wrist and lower back. Participants walked under 3 walking conditions each of 1 minute: 1) comfortable speed, 2) walking while serially subtracting 3's (Dual Task), 3) walking at fast speed. Aging effects on arm swing amplitude, range, symmetry, jerk and axial rotation amplitude and jerk were compared between decades of age (30-40; 41-50; 51-60; 61-77 years). As expected, older adults walked slower (p = 0.03) and with increased stride variability (p = 0.02). Arm swing amplitude decreased with age under all conditions (p = 0.04). In the oldest group, arm swing decreased during dual task and increased during the fast walking condition (p<0.0001). Similarly, arm swing asymmetry increased during the dual task in the older groups (p<0.004), but not in the younger groups (p = 0.67). Significant differences between groups and within conditions were observed in arm swing jerk (p<0.02), axial rotation amplitude (p<0.02) and axial jerk (p<0.001). Gait speed, arm swing amplitude of the dominant arm, arm swing asymmetry and axial rotation jerk were all independent predictors of age in a multivariate model. These findings suggest that the effects of gait speed and dual tasking on arm swing and axial rotation during walking are altered among healthy older adults. Follow-up work is needed to examine if these effects contribute to reduced stability in aging.	[Mirelman, Anat; Bernad-Elazari, Hagar; Hausdorff, Jeffrey M.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, Ctr Study Movement Cognit & Mobil, IL-69978 Tel Aviv, Israel; [Nobel, Tomer] Ben Gurion Univ Negev, Sch Hlth Related Profess, Beer Sheva, Israel; [Thaler, Avner; Giladi, Nir] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, IL-69978 Tel Aviv, Israel; [Peruzzi, Agnese] Univ Sassari, POLCOMING Dept, Informat Engn Unit, I-07100 Sassari, Italy; [Plotnik, Meir] Chaim Sheba Med Ctr, Ctr Adv Technol Rehabil, Ramat Gan, Israel; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, IL-69978 Tel Aviv, Israel; [Giladi, Nir] Tel Aviv Univ, Sackler Fac Med, Sieratzki Chair Neurol, IL-69978 Tel Aviv, Israel; [Mirelman, Anat; Giladi, Nir] Tel Aviv Univ, Sackler Fac Med, Dept Neurol, IL-69978 Tel Aviv, Israel; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Ben Gurion University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of Sassari; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Mirelman, A (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, Ctr Study Movement Cognit & Mobil, IL-69978 Tel Aviv, Israel.	anatmi@tasmc.health.gov.il	Giladi, Nir/AAU-8660-2020	Giladi, Nir/0000-0003-1482-8522				Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Amboni M, 2013, MOVEMENT DISORD, V28, P1520, DOI 10.1002/mds.25674; Bruijn SM, 2008, GAIT POSTURE, V27, P455, DOI 10.1016/j.gaitpost.2007.05.017; Bruijn SM, 2010, J EXP BIOL, V213, P3945, DOI 10.1242/jeb.045112; BUCHTAHL F, 1965, BRAIN, V88, P875, DOI 10.1093/brain/88.5.875; Carpinella I, 2010, EUR J APPL PHYSIOL, V108, P71, DOI 10.1007/s00421-009-1168-5; Collins SH, 2009, P ROY SOC B-BIOL SCI, V276, P3679, DOI 10.1098/rspb.2009.0664; Crosbie J, 2013, SPINE, V38, pE286, DOI 10.1097/BRS.0b013e318281de28; Davids K., 2006, MOVEMENT SYSTEM VARI; Goudriaan M, 2014, GAIT POSTURE, V40, P321, DOI 10.1016/j.gaitpost.2014.04.204; Hausdorff JM, 2008, J GERONTOL A-BIOL, V63, P1335, DOI 10.1093/gerona/63.12.1335; Hausdorff JM, 2005, EXP BRAIN RES, V164, P541, DOI 10.1007/s00221-005-2280-3; Hausdorff JM, 2004, GAIT POSTURE, V20, P304, DOI 10.1016/j.gaitpost.2003.08.002; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; Hogan N, 2009, J MOTOR BEHAV, V41, P529, DOI 10.3200/35-09-004-RC; Huang XM, 2012, GAIT POSTURE, V35, P373, DOI 10.1016/j.gaitpost.2011.10.180; Huang YP, 2011, EUR SPINE J, V20, P491, DOI 10.1007/s00586-010-1639-8; JACKSON KM, 1983, J THEOR BIOL, V105, P311, DOI 10.1016/S0022-5193(83)80010-1; Kang HG, 2008, GAIT POSTURE, V27, P572, DOI 10.1016/j.gaitpost.2007.07.009; Krasovsky T, 2014, GAIT POSTURE, V39, P378, DOI 10.1016/j.gaitpost.2013.08.011; Kuhtz-Buschbeck JP, 2008, GAIT POSTURE, V27, P447, DOI 10.1016/j.gaitpost.2007.05.011; Lewek MD, 2010, GAIT POSTURE, V31, P256, DOI 10.1016/j.gaitpost.2009.10.013; Liang BW, 2014, GAIT POSTURE, V39, P105, DOI 10.1016/j.gaitpost.2013.06.006; Liu D, 2007, J NEUROSCI, V27, P9354, DOI 10.1523/JNEUROSCI.1110-06.2007; Menz HB, 2003, AGE AGEING, V32, P137, DOI 10.1093/ageing/32.2.137; Meyns P, 2013, GAIT POSTURE, V38, P555, DOI 10.1016/j.gaitpost.2013.02.006; Muir BC, 2014, GAIT POSTURE, V39, P490, DOI 10.1016/j.gaitpost.2013.08.037; Nakakubo S, 2014, GAIT POSTURE, V40, P516, DOI 10.1016/j.gaitpost.2014.06.005; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Newell K.M, 1993, VARIABILITY MOTOR CO; Ortega JD, 2008, J BIOMECH, V41, P3303, DOI 10.1016/j.jbiomech.2008.06.039; Owings TM, 2004, GAIT POSTURE, V20, P26, DOI 10.1016/S0966-6362(03)00088-2; Pijnappels M, 2010, EXP BRAIN RES, V201, P689, DOI 10.1007/s00221-009-2088-7; Plate A, 2014, GAIT POSTURE, DOI [10.1016/j.gaitpost.2014.07, DOI 10.1016/J.GAITP0ST.2014.07.011]; Plotnik M, 2007, EXP BRAIN RES, V181, P561, DOI 10.1007/s00221-007-0955-7; Plotnik M, 2013, GAIT POSTURE, V38, P864, DOI 10.1016/j.gaitpost.2013.04.011; Plummer-D'Amato Prudence, 2012, J Aging Res, V2012, P583894, DOI 10.1155/2012/583894; Pontzer H, 2009, J EXP BIOL, V212, P523, DOI 10.1242/jeb.024927; Punt M, 2015, GAIT POSTURE, V41, P504, DOI 10.1016/j.gaitpost.2014.12.002; Qu XD, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-149; Sainburg RL, 2000, J NEUROPHYSIOL, V83, P2661, DOI 10.1152/jn.2000.83.5.2661; Stathokostas Liza, 2013, J Aging Res, V2013, P743843, DOI 10.1155/2013/743843; Umberger BR, 2008, J BIOMECH, V41, P2575, DOI 10.1016/j.jbiomech.2008.05.024; Zivotofsky AZ, 2012, HUM MOVEMENT SCI, V31, P1268, DOI 10.1016/j.humov.2012.01.003	44	40	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136043	10.1371/journal.pone.0136043	http://dx.doi.org/10.1371/journal.pone.0136043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305896	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500045
J	Cao, LY; Gross, J				Cao, Liyu; Gross, Joachim			Attention Wins over Sensory Attenuation in a Sound Detection Task	PLOS ONE			English	Article							PRIMATE AUDITORY-CORTEX; SELF-INITIATED SOUNDS; COROLLARY DISCHARGE; PREDICTION; SENSITIVITY; SUPPRESSION; PERCEPTION; FREQUENCY; RESPONSES; SPEECH	'Sensory attenuation', i.e., reduced neural responses to self-induced compared to externally generated stimuli, is a well-established phenomenon. However, very few studies directly compared sensory attenuation with attention effect, which leads to increased neural responses. In this study, we brought sensory attenuation and attention together in a behavioural auditory detection task, where both effects were quantitatively measured and compared. The classic auditory attention effect of facilitating detection performance was replicated. When attention and sensory attenuation were both present, attentional facilitation decreased but remained significant. The results are discussed in the light of current theories of sensory attenuation.	[Cao, Liyu; Gross, Joachim] Univ Glasgow, Glasgow, Lanark, Scotland	University of Glasgow	Cao, LY (corresponding author), Univ Glasgow, Glasgow, Lanark, Scotland.	liyuc@psy.gla.ac.uk	Gross, Joachim/C-5886-2009	Gross, Joachim/0000-0002-3994-1006; Cao, Liyu/0000-0002-1124-9579	German Research Foundation DFG [SFB 991]; Wellcome Trust [098433]	German Research Foundation DFG(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was partly funded by the German Research Foundation DFG as part of the SFB 991 and JG is supported by Wellcome Trust (098433).	Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; Borra T, 2013, P NATL ACAD SCI USA, V110, P15225, DOI 10.1073/pnas.1213756110; Cardoso-Leite P, 2010, PSYCHOL SCI, V21, P1740, DOI 10.1177/0956797610389187; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; GREEN DM, 1959, J ACOUST SOC AM, V31, P1446, DOI 10.1121/1.1907648; GREENBERG GZ, 1968, J ACOUST SOC AM, V44, P1513, DOI 10.1121/1.1911290; HAUTUS MJ, 1995, BEHAV RES METH INS C, V27, P46, DOI 10.3758/BF03203619; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Horvath J, 2012, J COGNITIVE NEUROSCI, V24, P1919, DOI 10.1162/jocn_a_00215; Houde JF, 2002, J COGNITIVE NEUROSCI, V14, P1125, DOI 10.1162/089892902760807140; Hughes G, 2013, PSYCHOL BULL, V139, P133, DOI 10.1037/a0028566; Kok P., 2011, CEREB CORTEX; Martikainen MH, 2005, CEREB CORTEX, V15, P299, DOI 10.1093/cercor/bhh131; Poulet JFA, 2002, NATURE, V418, P872, DOI 10.1038/nature00919; Sanmiguel I, 2013, PSYCHOPHYSIOLOGY, V50, P334, DOI 10.1111/psyp.12024; Sato A, 2005, COGNITION, V94, P241, DOI 10.1016/j.cognition.2004.04.003; Sato A, 2008, CONSCIOUS COGN, V17, P1219, DOI 10.1016/j.concog.2008.01.003; Schneider DM, 2014, NATURE, V513, P189, DOI 10.1038/nature13724; Schroger E, 2015, EUR J NEUROSCI, V41, P641, DOI 10.1111/ejn.12816; Scott M, 2013, PSYCHOL SCI, V24, P1824, DOI 10.1177/0956797613478614; Shergill SS, 2003, SCIENCE, V301, P187, DOI 10.1126/science.1085327; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Timm J, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-2; Van Hulle L, 2013, CONSCIOUS COGN, V22, P420, DOI 10.1016/j.concog.2013.01.011; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Walsh E, 2007, EXP BRAIN RES, V183, P405, DOI 10.1007/s00221-007-1128-4; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2	30	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136585	10.1371/journal.pone.0136585	http://dx.doi.org/10.1371/journal.pone.0136585			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5VA	26302246	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000359951900075
J	O'Keefe, LV; Lee, CS; Choo, A; Richards, RI				O'Keefe, Louise V.; Lee, Cheng Shoou; Choo, Amanda; Richards, Robert I.			Tumor Suppressor WWOX Contributes to the Elimination of Tumorigenic Cells in Drosophila melanogaster	PLOS ONE			English	Article							FRAGILE SITE FRA16D; DOMAIN-CONTAINING OXIDOREDUCTASE; COPY NUMBER VARIATION; GROWTH IN-VITRO; INHIBITS PROLIFERATION; GENE-EXPRESSION; DOWN-REGULATION; CANCER; APOPTOSIS; EIGER	WWOX is a > 1Mb gene spanning FRA16D Common Chromosomal Fragile Site, a region of DNA instability in cancer. Consequently, altered WWOX levels have been observed in a wide variety of cancers. In vitro studies have identified a large number and variety of potential roles for WWOX. Although its normal role in vivo and functional contribution to cancer have not been fully defined, WWOX does have an integral role in metabolism and can suppress tumor growth. Using Drosophila melanogaster as an in vivo model system, we find that WWOX is a modulator of TNF alpha/Egr-mediated cell death. We found that altered levels of WWOX can modify phenotypes generated by low level ectopic expression of TNF alpha/Egr and this corresponds to altered levels of Caspase 3 activity. These results demonstrate an in vivo role for WWOX in promoting cell death. This form of cell death is accompanied by an increase in levels of reactive oxygen species, the regulation of which we have previously shown can also be modified by altered WWOX activity. We now hypothesise that, through regulation of reactive oxygen species, WWOX constitutes a link between alterations in cellular metabolism observed in cancer cells and their ability to evade normal cell death pathways. We have further shown that WWOX activity is required for the efficient removal of tumorigenic cells from a developing epithelial tissue. Together these results provide a molecular basis for the tumor suppressor functions of WWOX and the better prognosis observed in cancer patients with higher levels of WWOX activity. Understanding the conserved cellular pathways to which WWOX contributes provides novel possibilities for the development of therapeutic approaches to restore WWOX function in cancer.	[O'Keefe, Louise V.; Lee, Cheng Shoou; Choo, Amanda; Richards, Robert I.] Univ Adelaide, Dept Genet & Evolut, Ctr Mol Pathol, Sch Biol Sci, Adelaide, SA, Australia	University of Adelaide	Richards, RI (corresponding author), Univ Adelaide, Dept Genet & Evolut, Ctr Mol Pathol, Sch Biol Sci, Adelaide, SA, Australia.	robert.richards@adelaide.edu.au	Richards, Robert/ABE-6423-2020; O'Keefe, Louise V/B-9856-2008; Choo, Amanda/ABA-9721-2021	Choo, Amanda/0000-0002-4510-3615; Richards, Robert Ian/0000-0002-5978-6453	National Health and Medical Research Council of Australia [519125, 207830]; Cancer Council South Australia; Australian Research Council (ARC)-NHMRC Research Network Grant [RN0457079]; Australian Research Council Special Research Centre for the Molecular Genetics of Development (CMGD) Grant [S0001531]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council South Australia(Cancer Council South Australia); Australian Research Council (ARC)-NHMRC Research Network Grant(Australian Research Council); Australian Research Council Special Research Centre for the Molecular Genetics of Development (CMGD) Grant(Australian Research Council)	This work was supported by the National Health and Medical Research Council of Australia (519125 to LVO and RIR 207830 to LVO), the Cancer Council South Australia (to RIR), an Australian Research Council (ARC)-NHMRC Research Network Grant (RN0457079 to RIR) and an Australian Research Council Special Research Centre for the Molecular Genetics of Development (CMGD) Grant (S0001531 to RIR).	Abu-Odeh M, 2014, P NATL ACAD SCI USA, V111, pE4716, DOI 10.1073/pnas.1409252111; Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Aqeilan RI, 2007, CANCER RES, V67, P5606, DOI 10.1158/0008-5472.CAN-07-1081; Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104; Baryla I, 2015, EXP BIOL MED, V240, P305, DOI 10.1177/1535370214561953; Bednarek AK, 2001, CANCER RES, V61, P8068; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Chang JY, 2010, EXP BIOL MED, V235, P796, DOI 10.1258/ebm.2010.009351; Chang NS, 2001, J BIOL CHEM, V276, P3361, DOI 10.1074/jbc.M007140200; Chiang MF, 2012, BIOMED PHARMACOTHER, V66, P433, DOI 10.1016/j.biopha.2012.03.003; Choo A, CHROMOSOMES AND CANC; Cui ZL, 2013, ONCOL REP, V29, P2154, DOI 10.3892/or.2013.2361; Dayan S, 2013, GENE CHROMOSOME CANC, V52, P823, DOI 10.1002/gcc.22078; Denton Donna, 2015, Cold Spring Harb Protoc, V2015, P576, DOI 10.1101/pdb.prot086215; Evans CJ, 2009, NAT METHODS, V6, P603, DOI 10.1038/nmeth.1356; Fabbri M, 2005, P NATL ACAD SCI USA, V102, P15611, DOI 10.1073/pnas.0505485102; Fernandez BG, 2014, ONCOGENE, V33, P2027, DOI 10.1038/onc.2013.155; Gao G, 2014, CELL MOL LIFE SCI, V71, P4601, DOI 10.1007/s00018-014-1753-6; Gardenswartz A, 2014, EXP BIOL MED, V239, P253, DOI 10.1177/1535370213519213; Glover TW, 2005, HUM MOL GENET, V14, pR197, DOI 10.1093/hmg/ddi265; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu BS, 2012, WORLD J GASTROENTERO, V18, P3020, DOI 10.3748/wjg.v18.i23.3020; Ibrahim DM, 2013, G3-GENES GENOM GENET, V3, P1353, DOI 10.1534/g3.113.006569; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Iliopoulos D, 2007, CLIN CANCER RES, V13, P268, DOI 10.1158/1078-0432.CCR-06-2038; Kanda H, 2002, J BIOL CHEM, V277, P28372, DOI 10.1074/jbc.C200324200; Kanda H, 2011, P NATL ACAD SCI USA, V108, P18977, DOI 10.1073/pnas.1103242108; Karras JR, 2014, CANCERS, V6, P1208, DOI 10.3390/cancers6021208; Kauppila S, 2003, ONCOGENE, V22, P4860, DOI 10.1038/sj.onc.1206715; Kosla K, 2011, J NEURO-ONCOL, V101, P207, DOI 10.1007/s11060-010-0254-1; Lai FJ, 2005, CLIN CANCER RES, V11, P5769, DOI 10.1158/1078-0432.CCR-04-2274; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lin JT, 2013, ANN SURG ONCOL, V20, P193, DOI 10.1245/s10434-012-2371-x; Lo JY, 2015, EXP BIOL MED; Ludes-Meyers JH, 2007, GENE CHROMOSOME CANC, V46, P1129, DOI 10.1002/gcc.20497; Ludes-Meyers JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007775; Mangelsdorf M, 2000, CANCER RES, V60, P1683; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Nakayama S, 2008, CANCER SCI, V99, P1370, DOI 10.1111/j.1349-7006.2008.00841.x; Nowakowska M, 2014, TUMOR BIOL, V35, P9291, DOI 10.1007/s13277-014-2196-2; O'Keefe LV, 2011, HUM MOL GENET, V20, P497, DOI 10.1093/hmg/ddq495; O'Keefe LV, 2006, CANCER LETT, V232, P37, DOI 10.1016/j.canlet.2005.07.041; O'Keefe LV, 2005, ONCOGENE, V24, P6590, DOI 10.1038/sj.onc.1208806; Ohsawa S, 2011, DEV CELL, V20, P315, DOI 10.1016/j.devcel.2011.02.007; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Park SW, 2004, BRIT J CANCER, V91, P753, DOI 10.1038/sj.bjc.6602023; Perez-Garijo A, 2013, ELIFE, V2, DOI 10.7554/eLife.01004; Pluciennik E, 2006, EJSO-EUR J SURG ONC, V32, P153, DOI 10.1016/j.ejso.2005.11.002; Qin HR, 2006, CANCER RES, V66, P6477, DOI 10.1158/0008-5472.CAN-06-0956; Qu JJ, 2013, INT J MOL MED, V31, P1139, DOI 10.3892/ijmm.2013.1314; Richards R, 2015, EXP BIOL MED; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Salah Z, 2010, FUTURE ONCOL, V6, P249, DOI [10.2217/fon.09.152, 10.2217/FON.09.152]; Schoenherr JA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002725; Schrock MS, 2014, EXP BIOL MED; Shaukat Z, 2015, ONCOGENE, V34, P4044, DOI 10.1038/onc.2014.344; Suzuki H, 2009, GENES BRAIN BEHAV, V8, P650, DOI 10.1111/j.1601-183X.2009.00502.x; Trapasso F, 2008, J BIOL CHEM, V283, P13736, DOI 10.1074/jbc.M709062200; Wagstaff L, 2013, TRENDS CELL BIOL, V23, P160, DOI 10.1016/j.tcb.2012.11.002; Wei D, 2014, TUMOR BIOL, V35, P1539, DOI 10.1007/s13277-013-1213-1; Yang L, 2013, HUM MOL GENET, V22, P1886, DOI 10.1093/hmg/ddt019; Yu K, 2014, INT J CANCER, V135, P1687, DOI 10.1002/ijc.28815; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375; Zelazowski MJ, 2011, TUMOR BIOL, V32, P551, DOI 10.1007/s13277-010-0150-5; Zhang HS, 2014, INT J MOL MED, V34, P804, DOI 10.3892/ijmm.2014.1824	70	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136356	10.1371/journal.pone.0136356	http://dx.doi.org/10.1371/journal.pone.0136356			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302329	gold, Green Submitted, Green Published			2022-12-27	WOS:000359951900063
J	Zaragoza, J; Babhadiashar, N; O'Brien, V; Chang, A; Blanco, M; Zabalegui, A; Lee, H; Asuri, P				Zaragoza, Josergio; Babhadiashar, Nasim; O'Brien, Victor; Chang, Andrew; Blanco, Matthew; Zabalegui, Aitor; Lee, Hohyun; Asuri, Prashanth			Experimental Investigation of Mechanical and Thermal Properties of Silica Nanoparticle-Reinforced Poly(acrylamide) Nanocomposite Hydrogels	PLOS ONE			English	Article							POLYMER NANOCOMPOSITES; POLY(ETHYLENE GLYCOL); CONDUCTIVITY; COMPOSITES; RESISTANCE; MELTS	Current studies investigating properties of nanoparticle-reinforced polymers have shown that nanocomposites often exhibit improved properties compared to neat polymers. However, over two decades of research, using both experimental studies and modeling analyses, has not fully elucidated the mechanistic underpinnings behind these enhancements. Moreover, few studies have focused on developing an understanding among two or more polymer properties affected by incorporation of nanomaterials. In our study, we investigated the elastic and thermal properties of poly(acrylamide) hydrogels containing silica nanoparticles. Both nanoparticle concentration and size affected hydrogel properties, with similar trends in enhancements observed for elastic modulus and thermal diffusivity. We also observed significantly lower swellability for hydrogel nanocomposites relative to neat hydrogels, consistent with previous work suggesting that nanoparticles can mediate pseudo crosslinking within polymer networks. Collectively, these results indicate the ability to develop next-generation composite materials with enhanced mechanical and thermal properties by increasing the average crosslinking density using nanoparticles.	[Zaragoza, Josergio; Babhadiashar, Nasim; O'Brien, Victor; Chang, Andrew; Blanco, Matthew; Asuri, Prashanth] Santa Clara Univ, Dept Bioengn, Santa Clara, CA 95053 USA; [Zabalegui, Aitor; Lee, Hohyun] Santa Clara Univ, Dept Mech Engn, Santa Clara, CA 95053 USA	Santa Clara University; Santa Clara University	Lee, H (corresponding author), Santa Clara Univ, Dept Mech Engn, Santa Clara, CA 95053 USA.	hlee@scu.edu; asurip@scu.edu			School of Engineering at Santa Clara University	School of Engineering at Santa Clara University	This project was funded by Sustainable Initiative Program and the School of Engineering at Santa Clara University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashcroft W., 1976, SOLID STATE PHYS; Blumm J, 2002, HIGH TEMP-HIGH PRESS, V34, P515, DOI 10.1068/htjr061; Carlsson L, 2010, SOFT MATTER, V6, P3619, DOI 10.1039/c0sm00009d; Deka BK, 2012, IND ENG CHEM RES, V51, P11881, DOI 10.1021/ie3003123; Fu SY, 2008, COMPOS PART B-ENG, V39, P933, DOI 10.1016/j.compositesb.2008.01.002; Gaharwar AK, 2011, BIOMACROMOLECULES, V12, P1641, DOI 10.1021/bm200027z; Goren K, 2010, J SUPERCRIT FLUID, V51, P420, DOI 10.1016/j.supflu.2009.09.007; Guo ZH, 2006, J MATER CHEM, V16, P2800, DOI 10.1039/b603020c; Huang JC, 2001, POLYMER, V42, P873, DOI 10.1016/S0032-3861(00)00411-0; Jancar J, 2010, POLYMER, V51, P3321, DOI 10.1016/j.polymer.2010.04.074; Jordan J, 2005, MAT SCI ENG A-STRUCT, V393, P1, DOI 10.1016/j.msea.2004.09.044; Ju S, 2014, EXPRESS POLYM LETT, V8, P682, DOI 10.3144/expresspolymlett.2014.71; Kutvonen A, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4767517; Lee GW, 2006, COMPOS PART A-APPL S, V37, P727, DOI 10.1016/j.compositesa.2005.07.006; Lu XL, 2005, MACROMOLECULES, V38, P839, DOI 10.1021/ma0486896; Lundstrom M., 2009, FUNDAMENTALS CARRIER; Meera AP, 2012, J ELASTOM PLAST, V44, P369, DOI 10.1177/0095244311432611; Munstedt H, 2011, AIP CONF PROC, V1375, DOI 10.1063/1.3604479; Nan CW, 1997, J APPL PHYS, V81, P6692, DOI 10.1063/1.365209; NIELSEN LE, 1973, J APPL POLYM SCI, V17, P3819, DOI 10.1002/app.1973.070171224; Prado-Gotor R, 2014, J INORG BIOCHEM, V135, P77, DOI 10.1016/j.jinorgbio.2014.03.005; Rittigstein P, 2007, NAT MATER, V6, P278, DOI 10.1038/nmat1870; Rose S, 2014, NATURE, V505, P382, DOI 10.1038/nature12806; Schadler LS, 2007, MRS BULL, V32, P335, DOI 10.1557/mrs2007.232; Sen S, 2007, MACROMOLECULES, V40, P4059, DOI 10.1021/ma070512z; Senses E, 2014, SOFT MATTER, V10, P4464, DOI 10.1039/c4sm00460d; Senses E, 2013, MACROMOLECULES, V46, P1868, DOI 10.1021/ma302275f; Song WL, 2012, J MATER CHEM, V22, P17133, DOI 10.1039/c2jm32469e; Sternstein SS, 2002, MACROMOLECULES, V35, P7262, DOI 10.1021/ma020482u; Tanaka T, 2004, IEEE T DIELECT EL IN, V11, P763, DOI 10.1109/TDEI.2004.1349782; Tjong SC, 2006, MAT SCI ENG R, V53, P73, DOI 10.1016/j.mser.2006.06.001; Wang Q, 2011, J POLYM SCI POL PHYS, V49, P1421, DOI 10.1002/polb.22337; Weidenfeller B, 2004, COMPOS PART A-APPL S, V35, P423, DOI 10.1016/j.compositesa.2003.11.005; Wong CP, 1999, J APPL POLYM SCI, V74, P3396, DOI 10.1002/(SICI)1097-4628(19991227)74:14<3396::AID-APP13>3.0.CO;2-3; Wu CJ, 2013, MACROMOL BIOSCI, V13, P59, DOI 10.1002/mabi.201200362; Wu LL, 2012, POLYM BULL, V68, P309, DOI 10.1007/s00289-011-0536-6; Xia LW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3226; Yang J, 2013, ACS APPL MATER INTER, V5, P3199, DOI 10.1021/am4001997; Ye ZB, 2013, J CHEM NY; Zhang Q, 2002, LANGMUIR, V18, P10435, DOI 10.1021/la026338j; Zhang X, 2005, MACROMOL MATER ENG, V290, P573, DOI 10.1002/mame.200500075	41	23	23	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136293	10.1371/journal.pone.0136293	http://dx.doi.org/10.1371/journal.pone.0136293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301505	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900054
J	Aenishaenslin, C; Gern, L; Michel, P; Ravel, A; Hongoh, V; Waaub, JP; Milord, F; Belanger, D				Aenishaenslin, Cecile; Gern, Lise; Michel, Pascal; Ravel, Andre; Hongoh, Valerie; Waaub, Jean-Philippe; Milord, Francois; Belanger, Denise			Adaptation and Evaluation of a Multi-Criteria Decision Analysis Model for Lyme Disease Prevention	PLOS ONE			English	Article							IXODES-SCAPULARIS ACARI; TICK-BORNE DISEASES; REDUCED ABUNDANCE; PUBLIC-HEALTH; NORTH-AMERICA; IXODIDAE; BORRELIOSIS; RISK; EUROPE; DEER	Designing preventive programs relevant to vector-borne diseases such as Lyme disease (LD) can be complex given the need to include multiple issues and perspectives into prioritizing public health actions. A multi-criteria decision aid (MCDA) model was previously used to rank interventions for LD prevention in Quebec, Canada, where the disease is emerging. The aim of the current study was to adapt and evaluate the decision model constructed in Quebec under a different epidemiological context, in Switzerland, where LD has been endemic for the last thirty years. The model adaptation was undertaken with a group of Swiss stakeholders using a participatory approach. The PROMETHEE method was used for multi-criteria analysis. Key elements and results of the MCDA model are described and contrasted with the Quebec model. All criteria and most interventions of the MCDA model developed for LD prevention in Quebec were directly transferable to the Swiss context. Four new decision criteria were added, and the list of proposed interventions was modified. Based on the overall group ranking, interventions targeting human populations were prioritized in the Swiss model, with the top ranked action being the implementation of a large communication campaign. The addition of criteria did not significantly alter the intervention rankings, but increased the capacity of the model to discriminate between highest and lowest ranked interventions. The current study suggests that beyond the specificity of the MCDA models developed for Quebec and Switzerland, their general structure captures the fundamental and common issues that characterize the complexity of vector-borne disease prevention. These results should encourage public health organizations to adapt, use and share MCDA models as an effective and functional approach to enable the integration of multiple perspectives and considerations in the prevention and control of complex public health issues such as Lyme disease or other vector- borne and zoonotic diseases.	[Aenishaenslin, Cecile; Michel, Pascal; Hongoh, Valerie; Belanger, Denise] Univ Montreal, Fac Med Vet, Res Grp Epidemiol Zoonoses & Publ Hlth, St Hyacinthe, PQ J2S 7C6, Canada; [Michel, Pascal] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, St Hyacinthe, PQ, Canada; [Gern, Lise] Univ Neuchatel, Inst Biol, Lab Ecopidemiol, CH-2000 Neuchatel, Switzerland; [Milord, Francois] Inst Natl Sante Publ Quebec, Longueuil, PQ, Canada; [Waaub, Jean-Philippe] Grp Res Decis Anal GERAD, Montreal, PQ, Canada; [Aenishaenslin, Cecile; Ravel, Andre; Hongoh, Valerie; Belanger, Denise] Univ Montreal, Fac Med Vet, Dept Pathol & Microbiol, St Hyacinthe, PQ J2S 7C6, Canada	Universite de Montreal; Public Health Agency of Canada; University of Neuchatel; Institut national de sante publique du Quebec (INSPQ); Universite de Montreal; Universite de Montreal	Aenishaenslin, C (corresponding author), Univ Montreal, Fac Med Vet, Res Grp Epidemiol Zoonoses & Publ Hlth, St Hyacinthe, PQ J2S 7C6, Canada.	cecile.aenishaenslin@umontreal.ca		Aenishaenslin, Cecile/0000-0002-8594-4945	Fonds de la recherche du Quebec; 4P Training program in health promotion, prevention and public policy; Ministere de l'Education, des Loisirs et des Sports du Quebec	Fonds de la recherche du Quebec; 4P Training program in health promotion, prevention and public policy; Ministere de l'Education, des Loisirs et des Sports du Quebec	This work was supported by Fonds de la recherche du Quebec: Doctoral grant for CA (http://www.frqs.gouv.qc.ca/); the 4P Training program in health promotion, prevention and public policy: Doctoral grant for CA (http://www.santepop.qc.ca/en/4p-training-program); and Ministere de l'Education, des Loisirs et des Sports du Quebec: Mobility grant for CA (http://www.education.gouv.qc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aenishaenslin C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-897; Behzadian M, 2010, EUR J OPER RES, V200, P198, DOI 10.1016/j.ejor.2009.01.021; BRANS JP, 1986, EUR J OPER RES, V24, P228, DOI 10.1016/0377-2217(86)90044-5; Brei B, 2009, VECTOR-BORNE ZOONOT, V9, P423, DOI 10.1089/vbz.2008.0150; Brownstein John S., 2005, EcoHealth, V2, P38, DOI 10.1007/s10393-004-0139-x; Brownstein JS, 2005, OECOLOGIA, V146, P469, DOI 10.1007/s00442-005-0251-9; C, 2013, CDC PROV EST AM DIAG; Daltroy LH, 2007, HEALTH EDUC BEHAV, V34, P531, DOI 10.1177/1090198106294646; DANIELS TJ, 1993, J MED ENTOMOL, V30, P1043, DOI 10.1093/jmedent/30.6.1043; DANIELS TJ, 1991, J MED ENTOMOL, V28, P537, DOI 10.1093/jmedent/28.4.537; DEBLINGER RD, 1993, J MED ENTOMOL, V30, P144, DOI 10.1093/jmedent/30.1.144; Dolan MC, 2004, J MED ENTOMOL, V41, P1043, DOI 10.1603/0022-2585-41.6.1043; Gage KL, 2008, AM J PREV MED, V35, P436, DOI 10.1016/j.amepre.2008.08.030; Guitouni A, 1998, EUR J OPER RES, V109, P501, DOI 10.1016/S0377-2217(98)00073-3; Hayez Q, 2012, IGI GLOBAL, P1; MARESCHAL B, 1988, EUR J OPER RES, V34, P69, DOI 10.1016/0377-2217(88)90456-0; Mareschal P., 1994, INVESTIGATION OPERAT, V4, P107; Marsh K, 2013, J PUBLIC HEALTH-UK, V35, P460, DOI 10.1093/pubmed/fds099; Montibeller G, 2005, OPERATIONAL RES SOC, P17; Mowbray F, 2012, VECTOR-BORNE ZOONOT, V12, P817, DOI 10.1089/vbz.2011.0774; Ogden N H, 2008, Can Commun Dis Rep, V34, P1; Ogden NH, 2008, CAN FAM PHYSICIAN, V54, P1381; Piesman J, 2004, PARASITOLOGY, V129, pS191, DOI 10.1017/S0031182003004694; Piesman J, 2008, ANNU REV ENTOMOL, V53, P323, DOI 10.1146/annurev.ento.53.103106.093429; Piesman J, 2006, INT J MED MICROBIOL, V296, P17, DOI 10.1016/j.ijmm.2005.11.007; Poland GA, 2001, MAYO CLIN PROC, V76, P713, DOI 10.4065/76.7.713; Poland GA, 2001, VACCINE, V19, P2303, DOI 10.1016/S0264-410X(00)00520-X; Randolph SE, 2001, PHILOS T R SOC B, V356, P1045, DOI 10.1098/rstb.2001.0893; Randolph SE, 2004, INT J MED MICROBIOL, V293, P5, DOI 10.1016/S1433-1128(04)80004-4; Roy B., 1985, METHODOLOGIE MULTICR; Schulze TL, 2009, VECTOR-BORNE ZOONOT, V9, P389, DOI 10.1089/vbz.2008.0160; Shen AK, 2011, CLIN INFECT DIS, V52, pS247, DOI 10.1093/cid/ciq115; Solberg VB, 2003, J VECTOR ECOL, V28, P117; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Swiss Federal Public Health Office, 2011, B OFF FED SANT PUBL, P895; Vilas VJD, 2013, PATHOG GLOB HEALTH, V107, P340, DOI 10.1179/2047773213Y.0000000122; WHO, 2006, LYM BORR EUR INFL CL; Zinsstag J, 2005, LANCET, V366, P2142, DOI 10.1016/S0140-6736(05)67731-8	38	9	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135171	10.1371/journal.pone.0135171	http://dx.doi.org/10.1371/journal.pone.0135171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295344	Green Submitted, Green Published, gold			2022-12-27	WOS:000359926900017
J	Duyvejonck, H; Cools, P; Decruyenaere, J; Roelens, K; Noens, L; Vermeulen, S; Claeys, G; Decat, E; Van Mechelen, E; Vaneechoutte, M				Duyvejonck, Hans; Cools, Piet; Decruyenaere, Johan; Roelens, Kristien; Noens, Lucien; Vermeulen, Stefan; Claeys, Geert; Decat, Ellen; Van Mechelen, Els; Vaneechoutte, Mario			Validation of High Resolution Melting Analysis (HRM) of the Amplified ITS2 Region for the Detection and Identification of Yeasts from Clinical Samples: Comparison with Culture and MALDI-TOF Based Identification	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CANDIDA; RESISTANCE; INFECTIONS; PREVALENCE; DIAGNOSIS; TIME	Aim Candida species are known as opportunistic pathogens, and a possible cause of invasive infections. Because of their species-specific antimycotic resistance patterns, reliable techniques for their detection, quantification and identification are needed. We validated a DNA amplification method for direct detection of Candida spp. from clinical samples, namely the ITS2-High Resolution Melting Analysis (direct method), by comparing it with a culture and MALDI-TOF Mass Spectrometry based method (indirect method) to establish the presence of Candida species in three different types of clinical samples. Materials and Methods A total of 347 clinical samples, i.e. throat swabs, rectal swabs and vaginal swabs, were collected from the gynaecology/obstetrics, intensive care and haematology wards at the Ghent University Hospital, Belgium. For the direct method, ITS2-HRM was preceded by Nucli-SENS easyMAG DNA extraction, directly on the clinical samples. For the indirect method, clinical samples were cultured on Candida ID and individual colonies were identified by MALDI-TOF. Results For 83.9% of the samples there was complete concordance between both techniques, i.e. the same Candida species were detected in 31.1% of the samples or no Candida species were detected in 52.8% of the samples. In 16.1% of the clinical samples, discrepant results were obtained, of which only 6.01% were considered as major discrepancies. Discrepancies occurred mostly when overall numbers of Candida cells in the samples were low and/or when multiple species were present in the sample. Discussion Most of the discrepancies could be decided in the advantage of the direct method. This is due to samples in which no yeast could be cultured whereas low amounts could be detected by the direct method and to samples in which high quantities of Candida robusta according to ITS2-HRM were missed by culture on Candida ID agar. It remains to be decided whether the diagnostic advantages of the direct method compensate for its disadvantages.	[Duyvejonck, Hans; Cools, Piet; Decat, Ellen; Vaneechoutte, Mario] Univ Ghent, Dept Clin Chem Microbiol & Immunol, Lab Bacteriol Res, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Decruyenaere, Johan] Ghent Univ Hosp, Dept Intens Care Med, B-9000 Ghent, Belgium; [Roelens, Kristien] Ghent Univ Hosp, Fac Med & Hlth Sci, Dept Obstet & Gynaecol, B-9000 Ghent, Belgium; [Noens, Lucien] Ghent Univ Hosp, Dept Haematol, B-9000 Ghent, Belgium; [Noens, Lucien] Ghent Univ Hosp, Blood Bank, B-9000 Ghent, Belgium; [Duyvejonck, Hans; Vermeulen, Stefan; Van Mechelen, Els] Univ Coll Ghent, Fac Educ Hlth & Social Work, Dept Biomed Sci, B-9000 Ghent, Belgium; [Claeys, Geert] Ghent Univ Hosp, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; HOGENT University College of Applied Sciences & Arts; Ghent University; Ghent University Hospital	Vaneechoutte, M (corresponding author), Univ Ghent, Dept Clin Chem Microbiol & Immunol, Lab Bacteriol Res, Fac Med & Hlth Sci, De Pintelaan 185, B-9000 Ghent, Belgium.	Mario.Vaneechoutte@UGent.be	Vaneechoutte, Mario/A-6189-2009	Vaneechoutte, Mario/0000-0002-4586-203X; Van Mechelen, Els/0000-0001-8446-6227; Cools, Piet/0000-0003-2980-5307; Vermeulen, Stefan/0000-0003-3710-800X	PWO (Projectmatig Wetenschappelijk Onderzoek) project, entitled "Study of the Microbiological Application for Real Time PCR (SMART)" of the University College Ghent; Ghent University Hospital	PWO (Projectmatig Wetenschappelijk Onderzoek) project, entitled "Study of the Microbiological Application for Real Time PCR (SMART)" of the University College Ghent; Ghent University Hospital(Ghent University)	This study has been funded by the PWO (Projectmatig Wetenschappelijk Onderzoek) project, entitled "Study of the Microbiological Application for Real Time PCR (SMART)" of the University College Ghent as well as Ghent University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BD, 2013, CLIN INFECT DIS, V56, P1724, DOI 10.1093/cid/cit136; Arabatzis M, 2007, BRIT J DERMATOL, V157, P681, DOI 10.1111/j.1365-2133.2007.08100.x; Arabatzis M, 2006, VET DERMATOL, V17, P322, DOI 10.1111/j.1365-3164.2006.00535.x; Arancia S, 2011, DIAGN MICR INFEC DIS, V69, P283, DOI 10.1016/j.diagmicrobio.2010.10.003; Bondaryk M, 2013, POSTEP DERM ALERGOL, V30, P293, DOI 10.5114/pdia.2013.38358; De Baere T, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-21; de Llanos R, 2006, INT J FOOD MICROBIOL, V110, P286, DOI 10.1016/j.ijfoodmicro.2006.04.023; Decat E, 2013, RES MICROBIOL, V164, P110, DOI 10.1016/j.resmic.2012.10.017; Kautzky S, 2015, WIEN KLIN WOCHENSCHR, V127, P132, DOI 10.1007/s00508-014-0644-z; Kett DH, 2011, CRIT CARE MED, V39, P665, DOI 10.1097/CCM.0b013e318206c1ca; Kothavade RJ, 2010, J MED MICROBIOL, V59, P873, DOI 10.1099/jmm.0.013227-0; LEMIEUX C, 1990, J CLIN MICROBIOL, V28, P249, DOI 10.1128/JCM.28.2.249-253.1990; Mandviwala T, 2010, J MOL DIAGN, V12, P91, DOI 10.2353/jmoldx.2010.090085; Marklein G, 2009, J CLIN MICROBIOL, V47, P2912, DOI 10.1128/JCM.00389-09; Massonet C, 2004, J CLIN MICROBIOL, V42, P2209, DOI 10.1128/JCM.42.5.2209-2211.2004; Meurman JH, 2011, GERODONTOLOGY, V28, P246, DOI 10.1111/j.1741-2358.2010.00407.x; Morace G, 2010, MINERVA ANESTESIOL, V76, P950; Munoz P, 2005, CLIN INFECT DIS, V40, P1625, DOI 10.1086/429916; Murphy A, 1999, ENZYME MICROB TECH, V25, P551, DOI 10.1016/S0141-0229(99)00086-1; Nejad BS, 2011, AFR J BIOTECHNOL, V10, P2987; Noumi E, 2010, J YEAST FUNGAL RES, V1, P170; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pavlovic Melanie, 2013, Open Microbiol J, V7, P135, DOI 10.2174/1874285801307010135; Perea S, 2002, CLIN INFECT DIS, V35, P1073, DOI 10.1086/344058; Pfaller MA, 1999, DIAGN MICR INFEC DIS, V33, P217, DOI 10.1016/S0732-8893(98)00160-6; Toscano, 1999, Curr Infect Dis Rep, V1, P347, DOI 10.1007/s11908-999-0041-3; Turenne CY, 1999, J CLIN MICROBIOL, V37, P1846, DOI 10.1128/JCM.37.6.1846-1851.1999; Van Herendael BH, 2012, EUR J CLIN MICROBIOL, V31, P841, DOI 10.1007/s10096-011-1383-y	28	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0132149	10.1371/journal.pone.0132149	http://dx.doi.org/10.1371/journal.pone.0132149			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295947	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900004
J	Luthuli, BB; Purdy, GE; Balagadde, FK				Luthuli, Brilliant B.; Purdy, Georgiana E.; Balagadde, Frederick K.			Confinement-Induced Drug-Tolerance in Mycobacteria Mediated by an Efflux Mechanism	PLOS ONE			English	Article							BIOFILM FORMATION; MULTIDRUG-RESISTANT; STATIONARY-PHASE; GENE-EXPRESSION; VIBRIO-CHOLERAE; TUBERCULOSIS; SUSCEPTIBILITY; BACTERIA; GROWTH; TRANSPORTERS	Tuberculosis (TB) is the world's deadliest curable disease, responsible for an estimated 1.5 million deaths annually. A considerable challenge in controlling this disease is the prolonged multidrug chemotherapy (6 to 9 months) required to overcome drug-tolerant mycobacteria that persist in human tissues, although the same drugs can sterilize genetically identical mycobacteria growing in axenic culture within days. An essential component of TB infection involves intracellular Mycobacterium tuberculosis bacteria that multiply within macrophages and are significantly more tolerant to antibiotics compared to extracellular mycobacteria. To investigate this aspect of human TB, we created a physical cell culture system that mimics confinement of replicating mycobacteria, such as in a macrophage during infection. Using this system, we uncovered an epigenetic drug-tolerance phenotype that appears when mycobacteria are cultured in space-confined bioreactors and disappears in larger volume growth contexts. Efflux mechanisms that are induced in space-confined growth environments contribute to this drug-tolerance phenotype. Therefore, macrophage-induced drug tolerance by mycobacteria may be an effect of confined growth among other macrophage-specific mechanisms.	[Luthuli, Brilliant B.; Balagadde, Frederick K.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, KwaZulu Natal Res Inst TB & HIV, ZA-4001 Durban, South Africa; [Purdy, Georgiana E.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA	University of Kwazulu Natal; Oregon Health & Science University	Balagadde, FK (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, KwaZulu Natal Res Inst TB & HIV, ZA-4001 Durban, South Africa.	frederick.balagadde@k-rith.org			Howard Hughes Medical Institute; University of KwaZulu-Natal College of Health Sciences	Howard Hughes Medical Institute(Howard Hughes Medical Institute); University of KwaZulu-Natal College of Health Sciences	This work was supported by the Howard Hughes Medical Institute (http://www.hhmi.org/) and the University of KwaZulu-Natal College of Health Sciences.	Adams KN, 2014, J INFECT DIS, V210, P456, DOI 10.1093/infdis/jiu095; Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Aldridge BB, 2012, SCIENCE, V335, P100, DOI 10.1126/science.1216166; Balganesh M, 2012, ANTIMICROB AGENTS CH, V56, P2643, DOI 10.1128/AAC.06003-11; Barbassa L, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-40; Boedicker JQ, 2009, ANGEW CHEM INT EDIT, V48, P5908, DOI 10.1002/anie.200901550; Bottger EC, 2011, CLIN MICROBIOL INFEC, V17, P1128, DOI 10.1111/j.1469-0691.2011.03551.x; Carnes EC, 2010, NAT CHEM BIOL, V6, P41, DOI [10.1038/NCHEMBIO.264, 10.1038/nchembio.264]; Chaturvedi V, 2007, J GEN APPL MICROBIOL, V53, P333, DOI 10.2323/jgam.53.333; Connell JL, 2010, MBIO, V1, DOI 10.1128/mBio.00202-10; Connolly LE, 2007, PLOS MED, V4, P435, DOI 10.1371/journal.pmed.0040120; De Kievit TR, 2001, APPL ENVIRON MICROB, V67, P1865, DOI 10.1128/AEM.67.4.1865-1873.2001; De Rossi E, 2006, FEMS MICROBIOL REV, V30, P36, DOI 10.1111/j.1574-6976.2005.00000.x; De Rossi Edda, 2002, Molecular Medicine (Baltimore), V8, P714; de Steenwinkel JE, 2010, J ANTIMICROB CHEMOTH; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Golchin SA, 2012, TUBERCULOSIS, V92, P489, DOI 10.1016/j.tube.2012.06.006; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Gospodarevskaya E, 2014, INT J TUBERC LUNG D, V18, P810, DOI 10.5588/ijtld.13.0391; Gunther G, 2014, CLIN MED, V14, P279, DOI 10.7861/clinmedicine.14-3-279; Gupta S, 2014, ANTIMICROB AGENTS CH, V58, P574, DOI 10.1128/AAC.01462-13; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Hartkoorn RC, 2007, TUBERCULOSIS, V87, P248, DOI 10.1016/j.tube.2006.12.001; Heginbothom ML, 2001, INT J TUBERC LUNG D, V5, P539; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hingley-Wilson SM, 2003, NAT IMMUNOL, V4, P949, DOI 10.1038/ni981; Horswill AR, 2007, ANAL BIOANAL CHEM, V387, P371, DOI 10.1007/s00216-006-0720-y; Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC; Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042; Krombach F, 1997, ENVIRON HEALTH PERSP, V105, P1261, DOI 10.2307/3433544; Lazazzera BA, 2000, CURR OPIN MICROBIOL, V3, P177, DOI 10.1016/S1369-5274(00)00072-2; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Li XJ, 2014, PROTEIN CELL, V5, P182, DOI 10.1007/s13238-014-0024-5; Louw GE, 2009, ANTIMICROB AGENTS CH, V53, P3181, DOI 10.1128/AAC.01577-08; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Matteelli A, 2014, CLIN EPIDEMIOL, V6, P111, DOI 10.2147/CLEP.S35839; Mavrici D, 2014, P NATL ACAD SCI USA, V111, P8037, DOI 10.1073/pnas.1321812111; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Mitchison D, 2012, INT J TUBERC LUNG D, V16, P724, DOI 10.5588/ijtld.12.0083; Pacheco SA, 2013, J BIOL CHEM, V288, P24213, DOI 10.1074/jbc.M113.473371; Purdy GE, 2009, MOL MICROBIOL, V73, P844, DOI 10.1111/j.1365-2958.2009.06801.x; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Ren DC, 2004, APPL ENVIRON MICROB, V70, P2038, DOI 10.1128/AEM.70.4.2038-2043.2004; Schlesinger L., 1997, LUNG MACROPHAGES AND; Stratton CW, 2003, EMERG INFECT DIS, V9, P10; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Viveiros M, 2010, EXPERT REVIEW OF ANT; Vivino M., NIH IMAGE ENGINEERIN; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; WHO, 2014, GLOBAL TUBERCULOSIS; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	54	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136231	10.1371/journal.pone.0136231	http://dx.doi.org/10.1371/journal.pone.0136231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295942	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900085
J	Park, CS; Chung, WB; Choi, YS; Kim, PJ; Lee, JM; Baek, KH; Kim, HY; Yoo, KD; Song, KH; Chung, WS; Seung, KB; Lee, MY; Kwon, HS				Park, Chul Soo; Chung, Woo Baek; Choi, Yun Seok; Kim, Pum Joon; Lee, Jong Min; Baek, Ki-Hyun; Kim, Hee Yeol; Yoo, Ki Dong; Song, Ki-Ho; Chung, Wook Sung; Seung, Ki Bae; Lee, Man Young; Kwon, Hyuk-Sang			Acute Myocardial Infarction Is a Risk Factor for New Onset Diabetes in Patients with Coronary Artery Disease	PLOS ONE			English	Article							3-VESSEL INTRAVASCULAR ULTRASOUND; C-REACTIVE PROTEIN; PLAQUE RUPTURE; BETA-BLOCKERS; MELLITUS; INFLAMMATION; PREDICTOR; MARKERS; BYPASS	Objective To test the hypothesis that acute myocardial infarction (AMI) might accelerate development of new onset diabetes in patients with coronary artery disease independent of known risk factors. Methods We conducted a retrospective cohort study within COACT (CathOlic medical center percutAneous Coronary in Tervention) registry. From a total of 9,127 subjects, 2,036 subjects were diabetes naive and followed up for at least one year with both index and follow-up laboratory data about diabetes. Cox proportional hazard model was used to derive hazard ratios (HRs) and 95% confidence interval (CI) for new onset diabetes associated with AMI in univariate and multivariate analysis after adjusting several covariates. Results The overall hazard for diabetes was higher in AMI compared to non-AMI patients (p by log rank <0.01) with HR of 1.78 and 95% CI of 1.37-2.32 in univariate analysis. This association remained significant after adjusting covariates (HR, 1.54; 95% CI, 1.14-2.07; p<0.01). AMI was an independent predictor for higher quartile of WBC count in multivariate ordinal logistic regression analysis (OR, 6.75; 95% CI, 5.53-8.22, p<0.01). In subgroup analysis, the diabetogenic effect of AMI was more prominent in the subgroup without MetS compared to MetS patients (p for interaction<0.05). Compared to the reference group of non-AMI+nonMetS, the group of AMI+non-MetS (HR, 2.44; 95% CI, 1.58-3.76), non-AMI+MetS (HR, 3.42; 95% CI, 2.34-4.98) and AMI+MetS (HR, 4.12; 95% CI, 2.67-6.36) showed higher HR after adjusting covariates. However, the hazard was not different between the non-AMI+MetS and AMI+non-MetS groups. Conclusions AMI patients have a greater risk of new-onset diabetes when compared to non AMI patients, especially those with mild metabolic abnormalities.	[Park, Chul Soo; Chung, Woo Baek; Choi, Yun Seok; Kim, Pum Joon; Lee, Jong Min; Baek, Ki-Hyun; Kim, Hee Yeol; Yoo, Ki Dong; Song, Ki-Ho; Chung, Wook Sung; Seung, Ki Bae; Lee, Man Young; Kwon, Hyuk-Sang] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Park, Chul Soo; Chung, Woo Baek; Choi, Yun Seok; Lee, Man Young] Catholic Univ Korea, Yeouido St Marys Hosp, Ctr Cardiovasc, Seoul, South Korea; [Park, Chul Soo; Chung, Woo Baek; Choi, Yun Seok; Lee, Man Young] Catholic Univ Korea, Yeouido St Marys Hosp, Div Cardiol, Seoul, South Korea; [Kim, Pum Joon; Chung, Wook Sung; Seung, Ki Bae] Catholic Univ Korea, Seoul St Marys Hosp, Ctr Cardiovasc, Seoul, South Korea; [Kim, Pum Joon; Chung, Wook Sung; Seung, Ki Bae] Catholic Univ Korea, Seoul St Marys Hosp, Div Cardiol, Seoul, South Korea; [Lee, Jong Min] Catholic Univ Korea, Uijeongbu St Marys Hosp, Ctr Cardiovasc, Seoul, South Korea; [Lee, Jong Min] Catholic Univ Korea, Uijeongbu St Marys Hosp, Div Cardiol, Uijongbu, South Korea; [Kim, Hee Yeol] Catholic Univ Korea, Bucheon St Marys Hosp, Ctr Cardiovasc, Bucheon, South Korea; [Kim, Hee Yeol] Catholic Univ Korea, Bucheon St Marys Hosp, Div Cardiol, Bucheon, South Korea; [Yoo, Ki Dong] Catholic Univ Korea, St Vincent Hosp, Ctr Cardiovasc, Suwon, South Korea; [Yoo, Ki Dong] Catholic Univ Korea, St Vincent Hosp, Div Cardiol, Suwon, South Korea; [Baek, Ki-Hyun; Song, Ki-Ho; Kwon, Hyuk-Sang] Catholic Univ Korea, Yeouido St Marys Hosp, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Kwon, HS (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea.	drkwon@catholic.ac.kr	Chung, Woo-Baek/AAE-4587-2020					Alderman E, 1997, CIRCULATION, V96, P1761, DOI 10.1161/01.CIR.96.6.1761; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Asakura M, 2001, J AM COLL CARDIOL, V37, P1284, DOI 10.1016/S0735-1097(01)01135-4; Bangalore S, 2007, AM J CARDIOL, V100, P1254, DOI 10.1016/j.amjcard.2007.05.057; Barsness GW, 1997, CIRCULATION, V96, P2551, DOI 10.1161/01.CIR.96.8.2551; Barzilay JI, 2001, DIABETES, V50, P2384, DOI 10.2337/diabetes.50.10.2384; Corrao G, 2014, DIABETES CARE, V37, P2225, DOI 10.2337/dc13-2215; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Einhorn Daniel, 2003, Endocr Pract, V9, P237; Elezi S, 1998, J AM COLL CARDIOL, V32, P1866, DOI 10.1016/S0735-1097(98)00467-7; Ford ES, 2002, AM J EPIDEMIOL, V155, P57, DOI 10.1093/aje/155.1.57; Freeman DJ, 2002, DIABETES, V51, P1596, DOI 10.2337/diabetes.51.5.1596; Goldstein JA, 2000, NEW ENGL J MED, V343, P915, DOI 10.1056/NEJM200009283431303; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Han YF, 2014, INT J CARDIOVAS IMAG, V30, P253, DOI 10.1007/s10554-013-0354-z; Hong MK, 2004, CIRCULATION, V110, P928, DOI 10.1161/01.CIR.0000139858.69915.2E; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kim EJ, 2014, CIRC-CARDIOVASC IMAG, V7, P455, DOI 10.1161/CIRCIMAGING.113.001093; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Milonas C, 2010, AM J CARDIOL, V105, P1229, DOI 10.1016/j.amjcard.2009.12.032; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Rioufol G, 2002, CIRCULATION, V106, P804, DOI 10.1161/01.CIR.0000025609.13806.31; Saleh N, 2012, DIABETOLOGIA, V55, P2109, DOI 10.1007/s00125-012-2565-6; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Sell H, 2010, CURR OPIN CLIN NUTR, V13, P366, DOI 10.1097/MCO.0b013e32833aab7f; Silbernagel G, 2012, ATHEROSCLEROSIS, V221, P551, DOI 10.1016/j.atherosclerosis.2012.01.011; Thorand B, 2003, ARCH INTERN MED, V163, P93, DOI 10.1001/archinte.163.1.93; Vardeny O, 2011, AM J CARDIOL, V107, P1705, DOI 10.1016/j.amjcard.2011.01.064; Waters DD, 2011, J AM COLL CARDIOL, V57, P1535, DOI 10.1016/j.jacc.2010.10.047; Weintraub WS, 1998, J AM COLL CARDIOL, V31, P10, DOI 10.1016/S0735-1097(97)00441-5; Wollenweber T, 2014, CIRC-CARDIOVASC IMAG, V7, P811, DOI 10.1161/CIRCIMAGING.114.001689	33	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136354	10.1371/journal.pone.0136354	http://dx.doi.org/10.1371/journal.pone.0136354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295946	gold, Green Submitted, Green Published			2022-12-27	WOS:000359926900103
J	Rocha, MC; de Godoy, KF; de Castro, PA; Hori, JI; Bom, VLP; Brown, NA; da Cunha, AF; Goldman, GH; Malavazi, I				Rocha, Marina Campos; de Godoy, Krissia Franco; de Castro, Patrcia Alves; Hori, Juliana Issa; Pedro Bom, Vinicius Leite; Brown, Neil Andrew; da Cunha, Anderson Ferreira; Goldman, Gustavo Henrique; Malavazi, Iran			The Aspergillus fumigatus pkcA(G579R) Mutant Is Defective in the Activation of the Cell Wall Integrity Pathway but Is Dispensable for Virulence in a Neutropenic Mouse Infection Model	PLOS ONE			English	Article							PROTEIN-KINASE-C; YEAST SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS-RESPONSE; CRYPTOCOCCUS-NEOFORMANS; SIGNALING PATHWAY; POLARIZED GROWTH; INVASIVE ASPERGILLOSIS; CALCOFLUOR WHITE; CANDIDA-ALBICANS; NIKKOMYCIN-Z	Aspergillus fumigatus is an opportunistic human pathogen, which causes the life-threatening disease, invasive pulmonary aspergillosis. In fungi, cell wall homeostasis is controlled by the conserved Cell Wall Integrity (CWI) pathway. In A. fumigatus this signaling cascade is partially characterized, but the mechanisms by which it is activated are not fully elucidated. In this study we investigated the role of protein kinase C (PkcA) in this signaling cascade. Our results suggest that pkcA is an essential gene and is activated in response to cell wall stress. Subsequently, we constructed and analyzed a non-essential A. fumigatus pkcA(G579R) mutant, carrying a Gly579Arg substitution in the PkcA C1B regulatory domain. The pkcAG579R mutation has a reduced activation of the downstream Mitogen-Activated Protein Kinase, MpkA, resulting in the altered expression of genes encoding cell wall-related proteins, markers of endoplasmic reticulum stress and the unfolded protein response. Furthermore, PkcA(G579R) is involved in the formation of proper conidial architecture and protection to oxidative damage. The pkcA(G579R) mutant elicits increased production of TNF-alpha and phagocytosis but it has no impact on virulence in a murine model of invasive pulmonary aspergillosis. These results highlight the importance of PkcA to the CWI pathway but also indicated that additional regulatory circuits may be involved in the biosynthesis and/or reinforcement of the A. fumigatus cell wall during infection.	[Rocha, Marina Campos; de Godoy, Krissia Franco; da Cunha, Anderson Ferreira; Malavazi, Iran] Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet Evolucao, Sao Paulo, Brazil; [de Castro, Patrcia Alves; Pedro Bom, Vinicius Leite; Goldman, Gustavo Henrique] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Ciencias Farmaceut, Sao Paulo, Brazil; [Hori, Juliana Issa] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Farmacol, Sao Paulo, Brazil; [Brown, Neil Andrew] Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden, Herts, England; [Goldman, Gustavo Henrique] Lab Nacl Ciencia & Tecnol Bioetanol, Sao Paulo, Brazil	Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universidade de Sao Paulo; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Malavazi, I (corresponding author), Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet Evolucao, Sao Paulo, Brazil.	imalavazi@ufscar.br	da Cunha, Anderson Ferreira/M-9038-2019; Hori, Juliana I/L-2302-2016; da Cunha, Anderson Ferreira/B-7931-2012; Malavazi, Iran/E-4132-2013; Goldman, Gustavo Henrique/F-1848-2013; Campos Rocha, Marina/P-7337-2015; Hori, Juliana Issa/D-3486-2014	da Cunha, Anderson Ferreira/0000-0003-3485-5659; Malavazi, Iran/0000-0002-4526-4961; Goldman, Gustavo Henrique/0000-0002-2986-350X; Brown, Neil/0000-0002-3555-5765; Campos Rocha, Marina/0000-0003-4988-7629; Hori, Juliana Issa/0000-0002-5421-3728; Leite Pedro Bom, Vinicius/0000-0002-3083-2524	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2009/53546-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [485478/2011-0]; BBSRC [BBS/E/C/00005192] Funding Source: UKRI	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (http://www.fapesp.br/en/), grant number: 2009/53546-5 to IM; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (http://www.cnpq.br), grant number 485478/2011-0) to IM.	Abad A, 2010, REV IBEROAM MICOL, V27, P155, DOI 10.1016/j.riam.2010.10.003; Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Aquino-Pinero E, 2002, MED MYCOL, V40, P185, DOI 10.1080/714031095; Arellano M, 1999, J CELL SCI, V112, P3569; Beauvais A, 2005, APPL ENVIRON MICROB, V71, P1531, DOI 10.1128/AEM.71.3.1531-1538.2005; Beauvais A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003716; BELL RM, 1991, J BIOL CHEM, V266, P4661; Brown NA, 2014, MOL MICROBIOL, V94, P1103, DOI 10.1111/mmi.12820; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Cheon SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002177; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Colabardini AC, 2010, MOL MICROBIOL, V78, P1259, DOI 10.1111/j.1365-2958.2010.07403.x; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Corbalan-Garcia S, 2006, BBA-MOL CELL BIOL L, V1761, P633, DOI 10.1016/j.bbalip.2006.04.015; Damveld RA, 2005, MOL MICROBIOL, V58, P305, DOI 10.1111/j.1365-2958.2005.04827.x; Damveld RA, 2005, FUNGAL GENET BIOL, V42, P165, DOI 10.1016/j.fgb.2004.11.006; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; Dichtl K, 2015, MOL MICROBIOL, V95, P458, DOI 10.1111/mmi.12877; Dichtl K, 2012, MOL MICROBIOL, V83, P506, DOI 10.1111/j.1365-2958.2011.07946.x; Dinamarco TM, 2012, EUKARYOT CELL, V11, P518, DOI 10.1128/EC.00016-12; Dirr F, 2010, INT J MED MICROBIOL, V300, P496, DOI 10.1016/j.ijmm.2010.03.001; Do JH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-306; Feng XZ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002330; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Fujioka T, 2007, EUKARYOT CELL, V6, P1497, DOI 10.1128/EC.00281-06; Gastebois A, 2009, FUTURE MICROBIOL, V4, P583, DOI 10.2217/FMB.09.29; GAUGHRAN JP, 1994, J BACTERIOL, V176, P5857, DOI 10.1128/JB.176.18.5857-5860.1994; Gerik KJ, 2008, EUKARYOT CELL, V7, P1685, DOI 10.1128/EC.00146-08; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Graham LM, 2006, J IMMUNOL METHODS, V314, P164, DOI 10.1016/j.jim.2006.05.013; Gravelat FN, 2010, CELL MICROBIOL, V12, P473, DOI 10.1111/j.1462-5822.2009.01408.x; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Henry C, 2012, EUKARYOT CELL, V11, P26, DOI 10.1128/EC.05270-11; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Herrmann M, 2006, APPL ENVIRON MICROB, V72, P2957, DOI 10.1128/AEM.72.4.2957-2970.2006; Heung LJ, 2005, J BIOL CHEM, V280, P28547, DOI 10.1074/jbc.M503404200; Heung LJ, 2004, J BIOL CHEM, V279, P21144, DOI 10.1074/jbc.M312995200; Hill TW, 2006, MYCOLOGIA, V98, P399, DOI 10.3852/mycologia.98.3.399; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Hurley JH, 1997, PROTEIN SCI, V6, P477; Ichinomiya M, 2007, BIOSCI BIOTECH BIOCH, V71, P2787, DOI 10.1271/bbb.70409; Ingham CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035478; IRIE K, 1993, MOL CELL BIOL, V13, P3076, DOI 10.1128/MCB.13.5.3076; Jacoby JJ, 1997, FEBS LETT, V417, P219, DOI 10.1016/S0014-5793(97)01287-8; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Ketela T, 1999, J BACTERIOL, V181, P3330, DOI 10.1128/JB.181.11.3330-3340.1999; Khatun R, 2011, FUNGAL GENET BIOL, V48, P465, DOI 10.1016/j.fgb.2010.11.002; Krishnan K, 2014, VIRULENCE, V5, P334, DOI 10.4161/viru.26571; KRIVJANSKY V, 1994, FEMS MICROBIOL LETT, V120, P87; Kuranda K, 2006, MOL MICROBIOL, V61, P1147, DOI 10.1111/j.1365-2958.2006.05300.x; Kwon-Chung KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003743; LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069; Latge JP, 2010, CELL MICROBIOL, V12, P863, DOI 10.1111/j.1462-5822.2010.01474.x; LEE KS, 1992, MOL CELL BIOL, V12, P172, DOI 10.1128/MCB.12.1.172; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malavazi I, 2014, BRIEF FUNCT GENOMICS, V13, P456, DOI 10.1093/bfgp/elu027; Malavazi Iran, 2012, Methods Mol Biol, V845, P99, DOI 10.1007/978-1-61779-539-8_7; Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Maubon D, 2006, FUNGAL GENET BIOL, V43, P366, DOI 10.1016/j.fgb.2006.01.006; Mech F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019591; Mehrad B, 1999, J IMMUNOL, V162, P1633; Mellado E, 2003, FUNGAL GENET BIOL, V38, P98, DOI 10.1016/S1087-1845(02)00516-9; Miyazaki T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003160; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; Pakula TM, 2003, J BIOL CHEM, V278, P45011, DOI 10.1074/jbc.M302372200; Paravicini G, 1996, YEAST, V12, P741, DOI 10.1002/(SICI)1097-0061(19960630)12:8<741::AID-YEA967>3.0.CO;2-G; Bom VLP, 2015, EUKARYOT CELL, V14, P728, DOI 10.1128/EC.00008-15; Perlin DS, 2011, FUTURE MICROBIOL, V6, P441, DOI [10.2217/fmb.11.19, 10.2217/FMB.11.19]; Rajavel M, 1999, MOL CELL BIOL, V19, P3969; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; Ronen R, 2007, CURR GENET, V51, P321, DOI 10.1007/s00294-007-0129-y; Sambrook J., 2001, MOL CLONING LAB MANU; Schmitz HP, 2003, CURR GENET, V43, P245, DOI 10.1007/s00294-003-0403-6; Schmitz HP, 2001, J MOL BIOL, V311, P1, DOI 10.1006/jmbi.2001.4848; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Taramelli D, 1996, J MED VET MYCOL, V34, P49; Teepe AG, 2007, FUNGAL GENET BIOL, V44, P554, DOI 10.1016/j.fgb.2006.10.001; Thon M, 2007, J BIOL CHEM, V282, P27259, DOI 10.1074/jbc.M704298200; Valiante V, 2008, FUNGAL GENET BIOL, V45, P618, DOI 10.1016/j.fgb.2007.09.006; Valiante V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00325; Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; Verwer PEB, 2012, ANTIMICROB AGENTS CH, V56, P1595, DOI 10.1128/AAC.05323-11; Castro FAV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003999; Walker LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000040; Wallace MA, 2005, CHEM RES TOXICOL, V18, P1279, DOI 10.1021/tx050050n; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; WATANABE Y, 1995, MOL CELL BIOL, V15, P5740; Watanabe Y, 1997, MOL CELL BIOL, V17, P2615, DOI 10.1128/MCB.17.5.2615; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Wimalasena TT, 2008, FUNGAL GENET BIOL, V45, P1235, DOI 10.1016/j.fgb.2008.06.001; Winkelstroter LK, 2015, MOL MICROBIOL, V96, P42, DOI 10.1111/mmi.12919; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003	102	38	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135195	10.1371/journal.pone.0135195	http://dx.doi.org/10.1371/journal.pone.0135195			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295576	gold, Green Submitted, Green Published			2022-12-27	WOS:000359926900019
J	Ekdale, EG				Ekdale, Eric G.			Comparative Anatomy of the Bony Labyrinth (Inner Ear) of Placental Mammals (vol 8, e66624, 2013)	PLOS ONE			English	Correction																		Ekdale EG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066624	1	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0137149	10.1371/journal.pone.0137149	http://dx.doi.org/10.1371/journal.pone.0137149			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308338	Green Submitted, Green Published, gold			2022-12-27	WOS:000360069400165
J	Morgan, TJ; Turn, SQ; George, A				Morgan, Trevor James; Turn, Scott Q.; George, Anthe			Fast Pyrolysis Behavior of Banagrass as a Function of Temperature and Volatiles Residence Time in a Fluidized Bed Reactor	PLOS ONE			English	Article							FLASH PYROLYSIS; ELEPHANT GRASS; BIO-OIL; BIOMASS; QUALITY; LIGNIN; COALS; STRAW; WOOD; GAS	A reactor was designed and commissioned to study the fast pyrolysis behavior of banagrass as a function of temperature and volatiles residence time. Four temperatures between 400 and 600 degrees C were examined as well as four residence times between similar to 1.0 and 10 seconds. Pyrolysis product distributions of bio-oil, char and permanent gases were determined at each reaction condition. The elemental composition of the bio-oils and chars was also assessed. The greatest bio-oil yield was recorded when working at 450 degrees C with a volatiles residence time of 1.4 s, similar to 37 wt% relative to the dry ash free feedstock (excluding pyrolysis water). The amounts of char (organic fraction) and permanent gases under these conditions are similar to 4 wt% and 8 wt% respectively. The bio-oil yield stated above is for 'dry' bio-oil after rotary evaporation to remove solvent, which results in volatiles and pyrolysis water being removed from the bio-oil. The material removed during drying accounts for the remainder of the pyrolysis products. The 'dry' bio-oil produced under these conditions contains similar to 56 wt% carbon which is similar to 40 wt% of the carbon present in the feedstock. The oxygen content of the 450 degrees C, 1.4 s 'dry' bio-oil is similar to 38 wt%, which accounts for similar to 33 wt% of the oxygen in the feedstock. At higher temperature or longer residence time less bio-oil and char is recovered and more gas and light volatiles are produced. Increasing the temperature has a more significant effect on product yields and composition than increasing the volatiles residence time. At 600 degrees C and a volatiles residence time of 1.2 seconds the bio-oil yield is similar to 21 wt% of the daf feedstock, with a carbon content of 64 wt% of the bio-oil. The bio-oil yield from banagrass is significantly lower than from woody biomass or grasses such as switchgrass or miscanthus, but is similar to barley straw. The reason for the low bio-oil yield from banagrass is thought to be related to its high ash content (8.5 wt% dry basis) and high concentration of alkali and alkali earth metals (totaling similar to 2.8 wt% relative to the dry feedstock) which are catalytic and increase cracking reactions during pyrolysis.	[Morgan, Trevor James; Turn, Scott Q.] Univ Hawaii Manoa, Hawaii Nat Energy Inst, Honolulu, HI 96822 USA; [George, Anthe] Sandia Natl Labs, Combust Res Facil, Livermore, CA 94550 USA	University of Hawaii System; University of Hawaii Manoa; United States Department of Energy (DOE); Sandia National Laboratories	Morgan, TJ (corresponding author), Univ Hawaii Manoa, Hawaii Nat Energy Inst, Honolulu, HI 96822 USA.	morgatr@gmail.com	Aburto, Jorge/B-4600-2009	Aburto, Jorge/0000-0002-8282-6046	U.S. Department of Energy (Cooperative Agreement) [DE-EE0003507]	U.S. Department of Energy (Cooperative Agreement)(United States Department of Energy (DOE))	This work was conducted under the Hawai'i Energy Sustainability Program with funding from the U.S. Department of Energy (Cooperative Agreement #DE-EE0003507). The funding was received by SQT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal JMJ, 2014, J JPN I ENERGY, V93, P684, DOI 10.3775/jie.93.684; Antal MJ, 1985, ADV SOLAR ENERGY ANN, V1, P61, DOI [DOI 10.1007/978-1-4684-8992-7_3, 10.1007/978-1-4684-8992-7_3]; Boateng AA, 2007, IND ENG CHEM RES, V46, P1891, DOI 10.1021/ie0614529; Braga RM, 2014, J THERM ANAL CALORIM, V117, P1341, DOI 10.1007/s10973-014-3884-2; Bridgwater AV, 2012, BIOMASS BIOENERG, V38, P68, DOI 10.1016/j.biombioe.2011.01.048; Cetinkol OP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052820; Cui H, 2010, ENERG FUEL, V24, P1222, DOI 10.1021/ef9010109; Diebold J. P., 1999, NRELSR57027613, DOI [10.2172/753818, DOI 10.2172/753818]; Diebold JP, 1997, ENERG FUEL, V11, P1081, DOI 10.1021/ef9700339; EKWENCHI MM, 1988, IND ENG CHEM RES, V27, P2169, DOI 10.1021/ie00083a036; ELLIOTT DC, 1991, ENERG FUEL, V5, P399, DOI 10.1021/ef00027a008; Eom IY, 2013, BIORESOURCE TECHNOL, V128, P664, DOI 10.1016/j.biortech.2012.09.082; Fahmi R, 2008, FUEL, V87, P1230, DOI 10.1016/j.fuel.2007.07.026; FRAGA AR, 1991, FUEL, V70, P803, DOI 10.1016/0016-2361(91)90186-E; George A, 2014, ENERG FUEL, V28, P6918, DOI 10.1021/ef501459c; Greenhalf CE, 2013, FUEL, V108, P216, DOI 10.1016/j.fuel.2013.01.075; Huber GW, 2006, CHEM REV, V106, P4044, DOI 10.1021/cr068360d; Joubert JE, 2015, FUEL PROCESS TECHNOL, V131, P389, DOI 10.1016/j.fuproc.2014.12.012; Kim KH, 2013, RENEW ENERG, V50, P188, DOI 10.1016/j.renene.2012.06.030; Lee MK, 2010, J ANAL APPL PYROL, V88, P110, DOI 10.1016/j.jaap.2010.03.003; LIDEN AG, 1988, CHEM ENG COMMUN, V65, P207, DOI 10.1080/00986448808940254; Mesa-Perez JM, 2014, APPL THERM ENG, V65, P322, DOI 10.1016/j.applthermaleng.2013.12.072; Miles TR, 1995, NRELTP4338142, V1, DOI 10.2172/251288Other:ON:DE96007897; Mohan D, 2006, ENERG FUEL, V20, P848, DOI 10.1021/ef0502397; Morgan TJ, 2014, CHEM REV, V114, P1547, DOI 10.1021/cr400194p; Mourant D, 2011, FUEL, V90, P2915, DOI 10.1016/j.fuel.2011.04.033; Mythili R, 2013, BIORESOURCE TECHNOL, V138, P71, DOI 10.1016/j.biortech.2013.03.161; Oasmaa A, 1999, ENERG FUEL, V13, P914, DOI 10.1021/ef980272b; Oasmaa A., 2001, VTT Publications; Oasmaa A., 1997, PHYS CHARACTERISATIO; Oasmaa A, 2010, ENERG FUEL, V24, P1380, DOI 10.1021/ef901107f; Ogoshi R., 2010, CROP ASSESSMEN UNPUB; SCOTT DS, 1982, CAN J CHEM ENG, V60, P666, DOI 10.1002/cjce.5450600514; SHAFIZADEH F, 1982, J ANAL APPL PYROL, V3, P283, DOI 10.1016/0165-2370(82)80017-X; Shafizedeh F, 1985, FUNDAMENTALS THERMOC, P183, DOI DOI 10.1007/978-94-009-4932-4_11; Sluiter A., 2008, NRELTP510060223; STILES HN, 1989, FUEL, V68, P275, DOI 10.1016/0016-2361(89)90087-2; Strezov V, 2008, BIORESOURCE TECHNOL, V99, P8394, DOI 10.1016/j.biortech.2008.02.039; Tran N, 2011, BIOMASS BIOENERG, V35, P1756, DOI 10.1016/j.biombioe.2011.01.012; Turn SQ, 1998, FUEL, V77, P135, DOI 10.1016/S0016-2361(97)00190-7; TYLER RJ, 1979, FUEL, V58, P680, DOI 10.1016/0016-2361(79)90223-0; Vassilev SV, 2013, FUEL, V105, P40, DOI 10.1016/j.fuel.2012.09.041; Vassilev SV, 2012, FUEL, V94, P1, DOI 10.1016/j.fuel.2011.09.030; Xu R, 2011, J ANAL APPL PYROL, V91, P263, DOI 10.1016/j.jaap.2011.03.001; Yoshida T, 2008, IND ENG CHEM RES, V47, P9882, DOI 10.1021/ie801123a	45	20	20	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136511	10.1371/journal.pone.0136511	http://dx.doi.org/10.1371/journal.pone.0136511			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308860	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400131
J	Tripathi, S; Wang, GS; White, M; Rynkiewicz, M; Seaton, B; Hartshorn, K				Tripathi, Shweta; Wang, Guangshun; White, Mitchell; Rynkiewicz, Michael; Seaton, Barbara; Hartshorn, Kevan			Identifying the Critical Domain of LL-37 Involved in Mediating Neutrophil Activation in the Presence of Influenza Virus: Functional and Structural Analysis	PLOS ONE			English	Article							HUMAN CATHELICIDIN LL-37; SURFACTANT PROTEIN-D; ANTIMICROBIAL PEPTIDE LL-37; A VIRUS; RECEPTOR; DEFENSE; RESPONSES; BINDING; MECHANISMS; COLLECTINS	The human cathelicidin LL-37 has been shown to play a role in host defense against influenza A viruses (IAV) through direct antiviral effects and through modulating inflammatory responses to infection. We recently showed that LL-37 increases neutrophil respiratory burst and neutrophil extracellular trap (NET) responses to IAV through engaging formyl peptide receptor 2 (FPR-2). In this paper we show that a fragment of LL-37, GI-20, which is composed of the central helical segment of the peptide, has similar effects as LL-37 on neutrophil activation. In addition to increasing respiratory burst and NET responses of the cells to IAV through an FPR-2 dependent mechanism, it reduces neutrophil IL-8 production to IAV (also like LL-37). The N-terminal fragment, LL-23, did not have similar effects. Both GI-20 and LL-37 increase neutrophil intracellular calcium levels and their ability to increase neutrophil activation responses was calcium dependent and partially inhibited by pertussis toxin. These studies show that the central helix of LL-37 retains the ability of LL-37 to modulate neutrophil responses through FPR-2. Based on our findings we developed a homology model of FPR-2 and performed docking experiments of LL-37 and GI-20 with the receptor.	[Tripathi, Shweta; White, Mitchell; Hartshorn, Kevan] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Wang, Guangshun] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Rynkiewicz, Michael; Seaton, Barbara] Boston Univ, Sch Med, Dept Biophys, Boston, MA 02118 USA	Boston University; University of Nebraska System; University of Nebraska Medical Center; Boston University	Hartshorn, K (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	khartsho@bu.edu		Rynkiewicz, Michael/0000-0002-4717-5700	NIH [HL069031, AI105147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI105147, R01AI105147] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIH Grant HL069031 (KH) and NIH Grant AI105147 (GW).	Barlow PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025333; Buss NAPS, 2015, FASEB J, V29, P2930, DOI 10.1096/fj.14-268375; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Comeau SR, 2007, PROTEINS, V69, P781, DOI 10.1002/prot.21795; DAIGNEAULT DE, 1992, BLOOD, V80, P3227; Dannehl C, 2013, COLLOID SURFACE B, V109, P129, DOI 10.1016/j.colsurfb.2013.03.030; Doss M, 2010, J LEUKOCYTE BIOL, V87, P79, DOI 10.1189/jlb.0609382; Doss M, 2009, J IMMUNOL, V182, P7878, DOI 10.4049/jimmunol.0804049; Douda DN, 2015, P NATL ACAD SCI USA, V112, P2817, DOI 10.1073/pnas.1414055112; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Gaudreault E, 2008, J IMMUNOL, V180, P6211, DOI 10.4049/jimmunol.180.9.6211; Gong TX, 2010, ARCH VIROL, V155, P491, DOI 10.1007/s00705-010-0608-1; Gwyer Findlay E, 2013, BIODRUGS; Hartshorn KL, 2006, J IMMUNOL, V176, P6962, DOI 10.4049/jimmunol.176.11.6962; Hartshorn KL, 2000, BIOCHEM J, V351, P449, DOI 10.1042/0264-6021:3510449; HARTSHORN KL, 1988, J IMMUNOL, V141, P1295; Hartshorn KL, 1996, BLOOD, V87, P3450, DOI 10.1182/blood.V87.8.3450.bloodjournal8783450; Hartshorn KL, 1997, AM J PHYSIOL-LUNG C, V273, pL1156, DOI 10.1152/ajplung.1997.273.6.L1156; HARTSHORN KL, 1990, BLOOD, V75, P218; HARTSHORN KL, 1990, AM J PHYSIOL, V258, pC1070, DOI 10.1152/ajpcell.1990.258.6.C1070; Jacob B, 2013, J PEPT SCI, V19, P700, DOI 10.1002/psc.2552; Jiang Y, 2009, ARCH VIROL, V154, P639, DOI 10.1007/s00705-009-0352-6; Le YY, 2002, INT IMMUNOPHARMACOL, V2, P1, DOI 10.1016/S1567-5769(01)00150-3; Leikina E, 2005, NAT IMMUNOL, V6, P995, DOI 10.1038/ni1248; Li HN, 2009, J LEUKOCYTE BIOL, V86, P891, DOI 10.1189/jlb.0209050; Mookherjee N, 2006, J LEUKOCYTE BIOL, V80, P1563, DOI 10.1189/jlb.0106048; Mookherjee N, 2009, J IMMUNOL, V183, P2688, DOI 10.4049/jimmunol.0802586; Murakami M, 2004, J IMMUNOL, V172, P3070, DOI 10.4049/jimmunol.172.5.3070; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Rico-Mata R, 2013, EXP PARASITOL, V133, P300, DOI 10.1016/j.exppara.2012.12.009; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Salvatore M, 2007, J INFECT DIS, V196, P835, DOI 10.1086/521027; Singh D, 2013, J BIOL CHEM, V288, P8258, DOI 10.1074/jbc.M112.440883; SWEET C, 1980, MICROBIOL REV, V44, P303, DOI 10.1128/MMBR.44.2.303-330.1980; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Tecle T, 2007, J IMMUNOL, V178, P8046, DOI 10.4049/jimmunol.178.12.8046; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Tripathi S, 2014, LL 37 MODULATES HUMA, V96, P931; Tripathi S, 2015, PLOS ONE; Tripathi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124706; Tripathi S, 2015, INNATE IMMUN-LONDON, V21, P73, DOI 10.1177/1753425913508992; Tripathi S, 2014, J LEUKOCYTE BIOL, V96, P931, DOI 10.1189/jlb.4A1113-604RR; Tripathi S, 2013, J GEN VIROL, V94, P40, DOI 10.1099/vir.0.045013-0; Wan M, 2011, FASEB J, V25, P1697, DOI 10.1096/fj.10-175687; Wang GS, 2008, J BIOL CHEM, V283, P32637, DOI 10.1074/jbc.M805533200; Wang GS, 2014, ACS CHEM BIOL, V9, P1997, DOI 10.1021/cb500475y; Wang GS, 2014, BBA-BIOMEMBRANES, V1838, P2160, DOI 10.1016/j.bbamem.2014.01.016; Wang GS, 2012, BIOCHEMISTRY-US, V51, P653, DOI 10.1021/bi2016266; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Zhang ZF, 2009, EUR J IMMUNOL, V39, P3181, DOI 10.1002/eji.200939496	51	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0133454	10.1371/journal.pone.0133454	http://dx.doi.org/10.1371/journal.pone.0133454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308522	Green Submitted, Green Published, gold			2022-12-27	WOS:000360069400011
J	Ahn, EH; Hirohata, K; Kohrn, BF; Fox, EJ; Chang, CC; Loeb, LA				Ahn, Eun Hyun; Hirohata, Kensen; Kohrn, Brendan F.; Fox, Edward J.; Chang, Chia-Cheng; Loeb, Lawrence A.			Detection of Ultra-Rare Mitochondrial Mutations in Breast Stem Cells by Duplex Sequencing	PLOS ONE			English	Article							DNA-POLYMERASE GAMMA; STRESS DEFENSE; IN-VIVO; CANCER; GENOME; DAMAGE; SUBSTITUTIONS; REPLICATION; MECHANISMS; DISEASE	Long-lived adult stem cells could accumulate non-repaired DNA damage or mutations that increase the risk of tumor formation. To date, studies on mutations in stem cells have concentrated on clonal (homoplasmic) mutations and have not focused on rarely occurring stochastic mutations that may accumulate during stem cell dormancy. A major challenge in investigating these rare mutations is that conventional next generation sequencing (NGS) methods have high error rates. We have established a new method termed Duplex Sequencing (DS), which detects mutations with unprecedented accuracy. We present a comprehensive analysis of mitochondrial DNA mutations in human breast normal stem cells and non-stem cells using DS. The vast majority of mutations occur at low frequency and are not detectable by NGS. The most prevalent point mutation types are the C>T/G>A and A>G/T>C transitions. The mutations exhibit a strand bias with higher prevalence of G>A, T>C, and A>C mutations on the light strand of the mitochondrial genome. The overall rare mutation frequency is significantly lower in stem cells than in the corresponding non-stem cells. We have identified common and unique non-homoplasmic mutations between non-stem and stem cells that include new mutations which have not been reported previously. Four mutations found within the MT-ND5 gene (m.12684G>A, m.12705C>T, m.13095T>C, m.13105A>G) are present in all groups of stem and non-stem cells. Two mutations (m.8567T>C, m.10547C>G) are found only in non-stem cells. This first genome-wide analysis of mitochondrial DNA mutations may aid in characterizing human breast normal epithelial cells and serve as a reference for cancer stem cell mutation profiles.	[Ahn, Eun Hyun; Hirohata, Kensen; Kohrn, Brendan F.; Fox, Edward J.; Loeb, Lawrence A.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Ahn, Eun Hyun] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Hirohata, Kensen; Loeb, Lawrence A.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Chang, Chia-Cheng] Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Michigan State University	Ahn, EH (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	ahneun@uw.edu; laloeb@uw.edu	Fox, Edward/A-4675-2011	Fox, Edward/0000-0002-3740-651X; Kohrn, Brendan/0000-0001-9948-2131	National Institutes of Health [P01 AG001751, R-33 CA 181771]; National Institutes of Environmental Health Sciences (NIEHS); University of Washington Center for Ecogenetics and Environmental Health; ITHS [NIH/NIEHS P30ES007033]; NATIONAL CANCER INSTITUTE [R33CA181771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG001751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); University of Washington Center for Ecogenetics and Environmental Health(University of Washington); ITHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The research was supported by grants from the National Institutes of Health (http://www.nih.gov/) P01 AG001751 and R-33 CA 181771 (to L.A. Loeb) and National Institutes of Environmental Health Sciences (NIEHS, http://www.niehs.nih.gov/) sponsored by the University of Washington Center for Ecogenetics and Environmental Health (https://depts.washington.edu/ceeh/) and ITHS Grant #: NIH/NIEHS P30ES007033 (to E.H. Ahn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn EH, 2006, EXP BIOL MED, V231, P1664; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Belle EMS, 2005, GENE, V355, P58, DOI 10.1016/j.gene.2005.05.019; Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199; Chang CC, 2001, RADIAT RES, V155, P201, DOI 10.1667/0033-7587(2001)155[0201:AHBECT]2.0.CO;2; Chatterjee A, 2011, CANCER PREV RES, V4, P638, DOI 10.1158/1940-6207.CAPR-10-0326; Chen C, 2009, CELL CYCLE, V8, P1158, DOI 10.4161/cc.8.8.8139; CHENG KC, 1992, J BIOL CHEM, V267, P166; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Darvishi K, 2007, CANCER LETT, V249, P249, DOI 10.1016/j.canlet.2006.09.005; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; Fox E.J., 2014, NEXT GENER SEQ APPL, V1, P1; Frosina G, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/845396; Fujimori H, 2012, J BIOL CHEM, V287, P36777, DOI 10.1074/jbc.M112.372557; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Guan JL, 2013, AUTOPHAGY, V9, P830, DOI 10.4161/auto.24132; Itsara LS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003974; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Joshi A, 2013, AUTOPHAGY, V9, P1737, DOI 10.4161/auto.26681; Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935; Kang KS, 1997, CARCINOGENESIS, V18, P251, DOI 10.1093/carcin/18.2.251; KAO CY, 1995, CARCINOGENESIS, V16, P531, DOI 10.1093/carcin/16.3.531; Kennedy SR, 2014, NAT PROTOC, V9, P2586, DOI 10.1038/nprot.2014.170; Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794; Klonisch T, 2008, TRENDS MOL MED, V14, P450, DOI 10.1016/j.molmed.2008.08.003; Kreutzer DA, 1998, P NATL ACAD SCI USA, V95, P3578, DOI 10.1073/pnas.95.7.3578; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200; Lou DI, 2013, P NATL ACAD SCI USA, V110, P19872, DOI 10.1073/pnas.1319590110; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McMahon S, 2014, CARCINOGENESIS, V35, P1046, DOI 10.1093/carcin/bgu012; NORDMANN PL, 1988, MOL GEN GENET, V214, P62, DOI 10.1007/BF00340180; Patra A, 2014, J BIOL CHEM, V289, P16867, DOI 10.1074/jbc.M114.551820; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; Salk JJ, 2010, ANNU REV PATHOL-MECH, V5, P51, DOI 10.1146/annurev-pathol-121808-102113; Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962; Saretzki G, 2008, STEM CELLS, V26, P455, DOI 10.1634/stemcells.2007-0628; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102; Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200; Strachan T RA, 1999, HUM MOL GENET, P255; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; TANAKA M, 1994, GENOMICS, V22, P327, DOI 10.1006/geno.1994.1391; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Venkatesh S, 2010, ARCH GYNECOL OBSTET, V282, P313, DOI 10.1007/s00404-010-1444-y; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Weinberg RA, 2013, BIOL CANC, P526; Williams SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003990; Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012	58	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136216	10.1371/journal.pone.0136216	http://dx.doi.org/10.1371/journal.pone.0136216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305705	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500052
J	Kilvaer, TK; Paulsen, EE; Hald, SM; Wilsgaard, T; Bremnes, RM; Busund, LT; Donnem, T				Kilvaer, Thomas K.; Paulsen, Erna-Elise; Hald, Sigurd M.; Wilsgaard, Tom; Bremnes, Roy M.; Busund, Lill-Tove; Donnem, Tom			Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer - A Structured Review with Meta-Analysis	PLOS ONE			English	Review							ENDOTHELIAL GROWTH-FACTOR; LYMPHATIC MICROVESSEL DENSITY; FACTOR-C LEVEL; VEGF-C; CLINICAL-SIGNIFICANCE; VESSEL DENSITY; FACTOR RECEPTOR-3; TUMOR-CELLS; 7TH EDITION; PROGNOSTIC-SIGNIFICANCE	Background In non-small cell lung cancer (NSCLC), nodal metastasis is an adverse prognostic factor. Several mediating factors have been implied in the development of nodal metastases and investigated for predictive and prognostic properties in NSCLC. However, study results differ. In this structured review and meta-analysis we explore the published literature on commonly recognized pathways for molecular regulation of lymphatic metastasis in NSCLC. Methods A structured PubMed search was conducted for papers reporting on the expression of known markers of lymhangiogenesis in NSCLC patients. Papers of sufficient quality, presenting survival and/or correlation data were included. Results High levels of vascular endothelial growth factor C (VEGF-C, HR 1.57 95% CI 1.34-1.84) and high lymphatic vascular density (LVD, HR 1.84 95% CI 1.18-2.87) were significant prognostic markers of poor survival and high expression of VEGF-C, vascular endothelial growth factor receptor 3 (VEGFR3) and LVD was associated with lymph node metastasis in NSCLC. Conclusion Lymphangiogenic markers are prognosticators of survival and correlate with lymph node metastasis in NSCLC. Their exact role and clinical implications should be further elucidated.	[Kilvaer, Thomas K.; Paulsen, Erna-Elise; Bremnes, Roy M.; Donnem, Tom] Univ Hosp North Norway, Dept Oncol, Tromso, Norway; [Kilvaer, Thomas K.; Paulsen, Erna-Elise; Hald, Sigurd M.; Bremnes, Roy M.; Donnem, Tom] UiT Arctic Univ Norway, Inst Clin Med, Tromso, Norway; [Wilsgaard, Tom] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway; [Busund, Lill-Tove] Univ Hosp North Norway, Dept Clin Pathol, Tromso, Norway; [Busund, Lill-Tove] UiT Arctic Univ Norway, Inst Med Biol, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Kilvaer, TK (corresponding author), Univ Hosp North Norway, Dept Oncol, Tromso, Norway.	kilvaer@gmail.com	Kilvaer, Thomas/AAI-7418-2020	Kilvaer, Thomas/0000-0003-1669-0117				Achen MG, 2008, ANN NY ACAD SCI, V1131, P225, DOI 10.1196/annals.1413.020; Adachi Y, 2007, PATHOL INT, V57, P171, DOI 10.1111/j.1440-1827.2007.02077.x; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Alitalo A, 2012, ONCOGENE, V31, P4499, DOI 10.1038/onc.2011.602; Anagnostou VK, 2011, VIRCHOWS ARCH, V458, P331, DOI 10.1007/s00428-010-1015-4; Antonia SJ, 2014, CLIN CANCER RES, V20, P6258, DOI 10.1158/1078-0432.CCR-14-1457; Arinaga M, 2003, CANCER-AM CANCER SOC, V97, P457, DOI 10.1002/cncr.11073; Bolenz C, 2009, BJU INT, V104, P592, DOI 10.1111/j.1464-410X.2009.08704.x; Card CM, 2014, J CLIN INVEST, V124, P943, DOI 10.1172/JCI73316; Chen FS, 2004, CLIN CANCER RES, V10, P8548, DOI 10.1158/1078-0432.CCR-04-0950; Chen G, 2010, EUR J CARDIO-THORAC, V37, P546, DOI 10.1016/j.ejcts.2009.08.005; Chen SC, 2011, ANN ACAD MED SINGAP, V40, P319; Chung MK, 2012, ANN SURG ONCOL, V19, P1595, DOI 10.1245/s10434-011-2154-9; Daly S, 2014, ANN THORAC SURG, V98, P1968, DOI 10.1016/j.athoracsur.2014.06.071; Pau ECD, 2009, CANCER-AM CANCER SOC, V115, P1701, DOI 10.1002/cncr.24193; Detterbeck FC, 2013, CHEST, V143, pE191, DOI 10.1378/chest.12-2354; Donnem T, 2007, CLIN CANCER RES, V13, P6649, DOI 10.1158/1078-0432.CCR-07-0414; Donnem T, 2013, CANCER MED-US, V2, P427, DOI 10.1002/cam4.105; Donnem T, 2009, LUNG CANCER, V63, P277, DOI 10.1016/j.lungcan.2008.05.022; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Enatsu S, 2006, EUR J CARDIO-THORAC, V29, P891, DOI 10.1016/j.ejcts.2006.03.027; Faoro L, 2008, ARCH PATHOL LAB MED, V132, P1882, DOI 10.1043/1543-2165-132.12.1882; Feng YK, 2010, ANAT REC, V293, P802, DOI 10.1002/ar.21096; Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Guerrera F, 2015, EUR J CARDIO-THORAC, V47, P1037, DOI 10.1093/ejcts/ezu410; Guo XF, 2009, ACTA BIOCH BIOPH SIN, V41, P217, DOI 10.1093/abbs/gmp004; He YL, 2005, CANCER RES, V65, P4739, DOI 10.1158/0008-5472.CAN-04-4576; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; Huang C, 2005, BRIT J CANCER, V92, P1231, DOI 10.1038/sj.bjc.6602481; Iwakiri S, 2009, ANN SURG ONCOL, V16, P1678, DOI 10.1245/s10434-009-0432-6; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Ji RC, 2006, CANCER METAST REV, V25, P677, DOI 10.1007/s10555-006-9026-y; Jin SD, 2012, MED ONCOL, V29, P3157, DOI 10.1007/s12032-012-0229-5; Kadota K, 2008, EUR J CANCER, V44, P1057, DOI 10.1016/j.ejca.2008.03.012; Kadota K, 2010, LUNG CANCER, V70, P88, DOI 10.1016/j.lungcan.2009.12.014; Kajita T, 2001, BRIT J CANCER, V85, P255, DOI 10.1054/bjoc.2001.1882; Ko Yoon Ho, 2008, Cancer Res Treat, V40, P133, DOI 10.4143/crt.2008.40.3.133; Kojima H, 2005, CANCER-AM CANCER SOC, V104, P1668, DOI 10.1002/cncr.21366; Li MH, 2010, TUMORI, V96, P734, DOI 10.1177/030089161009600516; Li QC, 2003, CHINESE MED J-PEKING, V116, P727; Liersch R, 2012, INT J ONCOL, V41, P2073, DOI 10.3892/ijo.2012.1665; Maekawa S, 2007, ANTICANCER RES, V27, P3735; Min KH, 2011, LUNG, V189, P57, DOI 10.1007/s00408-010-9268-x; Mollberg NM, 2014, ANN THORAC SURG, V97, P965, DOI 10.1016/j.athoracsur.2013.11.002; Nakashima T, 2004, MED SCI MONITOR, V10, pBR157; Niki T, 2000, CLIN CANCER RES, V6, P2431; Niki T, 2001, J PATHOL, V193, P450, DOI 10.1002/path.828; Nwogu CE, 2013, J THORAC CARDIOV SUR, V145, P702, DOI 10.1016/j.jtcvs.2012.12.023; Ogawa E, 2004, BRIT J CANCER, V91, P498, DOI 10.1038/sj.bjc.6601992; Ohta Y, 2000, J THORAC CARDIOV SUR, V119, P804, DOI 10.1016/S0022-5223(00)70017-1; Palmer T, 2008, STATA J; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Renyi-Vamos F, 2005, CLIN CANCER RES, V11, P7344, DOI 10.1158/1078-0432.CCR-05-1077; Saijo T, 2007, LUNG CANCER, V55, P61, DOI 10.1016/j.lungcan.2006.09.027; Saintigny P, 2007, LUNG CANCER, V58, P205, DOI 10.1016/j.lungcan.2007.06.021; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Steels E, 2001, EUR RESPIR J, V18, P705, DOI 10.1183/09031936.01.00062201; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Strand TE, 2010, EUR RESPIR J, V36, P401, DOI 10.1183/09031936.00171809; Su JL, 2006, CANCER CELL, V9, P209, DOI 10.1016/j.ccr.2006.02.018; Su JL, 2004, CANCER RES, V64, P554, DOI 10.1158/0008-5472.CAN-03-1301; Sun JG, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-21; Takanami I, 2006, ONCOL REP, V15, P437; Takizawa H, 2006, BRIT J CANCER, V95, P75, DOI 10.1038/sj.bjc.6603209; Tamura M, 2003, CANCER, V98, P1217, DOI 10.1002/cncr.11529; Tamura M, 2004, CHEST, V126, P342, DOI 10.1378/chest.126.2.342; Tamura M, 2004, ANN SURG ONCOL, V11, P928, DOI 10.1245/ASO.2004.01.013; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wang J, 2014, J CANCER RES CLIN, V140, P1189, DOI 10.1007/s00432-014-1636-0; Wang J, 2012, MOL BIOL REP, V39, P5331, DOI 10.1007/s11033-011-1332-y; Wang J, 2011, MED ONCOL, V28, pS577, DOI 10.1007/s12032-010-9734-6; Yamashita T, 2010, LUNG CANCER, V70, P320, DOI 10.1016/j.lungcan.2010.02.013; Yoshida Yukihiro, 2013, Asian Cardiovasc Thorac Ann, V21, P693, DOI 10.1177/0218492312470670; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb; Yu M, 2014, HEAD NECK-J SCI SPEC, V36, P596, DOI 10.1002/hed.23301; Zhan P, 2009, J THORAC ONCOL, V4, P1094, DOI 10.1097/JTO.0b013e3181a97e31; Zhang BC, 2011, MED ONCOL, V28, P1447, DOI 10.1007/s12032-010-9638-5; Zhang Y, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-2014-6; Zuo SQ, 2008, J HUAZHONG U SCI-MED, V28, P674, DOI 10.1007/s11596-008-0613-8	84	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0132481	10.1371/journal.pone.0132481	http://dx.doi.org/10.1371/journal.pone.0132481			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305218	gold, Green Submitted, Green Published			2022-12-27	WOS:000359995500002
J	Schmitz-Rohmer, D; Probst, S; Yang, ZZ; Laurent, F; Stadler, MB; Zuniga, A; Zeller, R; Hynx, D; Hemmings, BA; Hergovich, A				Schmitz-Rohmer, Debora; Probst, Simone; Yang, Zhong-Zhou; Laurent, Frederic; Stadler, Michael B.; Zuniga, Aimee; Zeller, Rolf; Hynx, Debby; Hemmings, Brian A.; Hergovich, Alexander			NDR Kinases Are Essential for Somitogenesis and Cardiac Looping during Mouse Embryonic Development	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; TUMOR-SUPPRESSOR GENE; DELTA-HOMOLOG; HEPATOCELLULAR-CARCINOMA; PRESOMITIC MESODERM; SOMITE SEGMENTATION; EXPRESSION PATTERN; VERTEBRATE EMBRYOS; MUTATION DISRUPTS; SONIC-HEDGEHOG	Studies of mammalian tissue culture cells indicate that the conserved and distinct NDR isoforms, NDR1 and NDR2, play essential cell biological roles. However, mice lacking either Ndr1 or Ndr2 alone develop normally. Here, we studied the physiological consequences of inactivating both NDR1 and NDR2 in mice, showing that the lack of both Ndr1/Ndr2 (called Ndr1/2-double null mutants) causes embryonic lethality. In support of compensatory roles for NDR1 and NDR2, total protein and activating phosphorylation levels of the remaining NDR isoform were elevated in mice lacking either Ndr1 or Ndr2. Mice retaining one single wild-type Ndr allele were viable and fertile. Ndr1/2-double null embryos displayed multiple phenotypes causing a developmental delay from embryonic day E8.5 onwards. While NDR kinases are not required for notochord formation, the somites of Ndr1/2-double null embryos were smaller, irregularly shaped and unevenly spaced along the anterior-posterior axis. Genes implicated in somitogenesis were down-regulated and the normally symmetric expression of Lunatic fringe, a component of the Notch pathway, showed a left-right bias in the last forming somite in 50% of all Ndr1/2-double null embryos. In addition, Ndr1/2-double null embryos developed a heart defect that manifests itself as pericardial edemas, obstructed heart tubes and arrest of cardiac looping. The resulting cardiac insufficiency is the likely cause of the lethality of Ndr1/2-double null embryos around E10. Taken together, we show that NDR kinases compensate for each other in vivo in mouse embryos, explaining why mice deficient for either Ndr1 or Ndr2 are viable. Ndr1/2-double null embryos show defects in somitogenesis and cardiac looping, which reveals their essential functions and shows that the NDR kinases are critically required during the early phase of organogenesis.	[Schmitz-Rohmer, Debora; Stadler, Michael B.; Hynx, Debby; Hemmings, Brian A.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Probst, Simone; Laurent, Frederic; Zuniga, Aimee; Zeller, Rolf] Univ Basel, Dept Biomed, Dev Genet, Basel, Switzerland; [Yang, Zhong-Zhou] Nanjing Univ, Model Anim Res Ctr, Nanjing 210008, Jiangsu, Peoples R China; [Stadler, Michael B.] Swiss Inst Bioinformat, Basel, Switzerland; [Hergovich, Alexander] UCL, UCL Canc Inst, London, England	Friedrich Miescher Institute for Biomedical Research; University of Basel; Nanjing University; Swiss Institute of Bioinformatics; University of London; University College London	Schmitz-Rohmer, D (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	Debora.Schmitz@fmi.ch; a.hergovich@ucl.ac.uk	Zuniga, Aimée/AAG-7335-2020; Zuniga, Aimée/Q-2692-2018; Zeller, Rolf/C-2610-2013	Zuniga, Aimée/0000-0002-9953-3637; Zuniga, Aimée/0000-0002-9953-3637; Zeller, Rolf/0000-0002-3186-7403; Laurent, Frederic/0000-0001-7563-9800	Swiss National Science Foundation SNSF [31003A_138287, 31003A_112607, 31003A_127596, 310003A_130803]; University of Basel; Wellcome Trust [090090/Z/09/Z]; Novartis Research Foundation	Swiss National Science Foundation SNSF(Swiss National Science Foundation (SNSF)); University of Basel; Wellcome Trust(Wellcome TrustEuropean Commission); Novartis Research Foundation	D.S-R. received support from the Swiss National Science Foundation SNSF (grant 31003A_138287). The research of S.P. and F.L. was supported by SNSF grants 31003A_112607 and 31003A_127596 (to AZ), SNSF grant 310003A_130803 (to RZ), and the University of Basel. A.H. is a Wellcome Trust Research Career Development fellow (grant 090090/Z/09/Z). The FMI is supported by the Novartis Research Foundation.	Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; Brend T, 2009, SEMIN CELL DEV BIOL, V20, P472, DOI 10.1016/j.semcdb.2008.11.009; Chakraborty A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4445; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chiba S, 2013, EMBO J, V32, P874, DOI 10.1038/emboj.2013.32; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; Cornils H, 2011, CELL CYCLE, V10, P1897, DOI 10.4161/cc.10.12.15826; Cornils H, 2011, MOL CELL BIOL, V31, P1382, DOI 10.1128/MCB.01216-10; Cornils H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000681; Dale JK, 2006, DEV CELL, V10, P355, DOI 10.1016/j.devcel.2006.02.011; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Devroe E, 2004, J BIOL CHEM, V279, P24444, DOI 10.1074/jbc.M401999200; Du ZY, 2013, J BIOL CHEM, V288, P26678, DOI 10.1074/jbc.M113.466433; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Geng W, 2000, GENETICS, V156, P1817; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Haramis AG, 1995, DEVELOPMENT, V121, P4237; Harvey RP, 1998, SEMIN CELL DEV BIOL, V9, P101, DOI 10.1006/scdb.1997.0188; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; HARVEY RP, 1999, HEART DEV, P111; He Y, 2005, MOL BIOL CELL, V16, P689, DOI 10.1091/mbc.E04-09-0828; Hergovich A, 2005, MOL CELL BIOL, V25, P8259, DOI 10.1128/MCB.25.18.8259-8272.2005; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; Hergovich A, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-32; Hergovich A, 2009, CURR BIOL, V19, P1692, DOI 10.1016/j.cub.2009.09.020; HERRMANN BG, 1991, DEVELOPMENT, V113, P913; Kaufman HL, 1992, THE ATLAS OF MOUSE D; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kusumi K, 1998, NAT GENET, V19, P274, DOI 10.1038/961; Linask KK, 2005, DEV DYNAM, V233, P739, DOI 10.1002/dvdy.20377; Lu WG, 2008, DEV DYNAM, V237, P3577, DOI 10.1002/dvdy.21645; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; MANASEK FJ, 1972, DEV BIOL, V29, P349, DOI 10.1016/0012-1606(72)90077-2; Mankoo BS, 2003, DEVELOPMENT, V130, P4655, DOI 10.1242/dev.00687; Mankoo BS, 1999, NATURE, V400, P69, DOI 10.1038/21892; Narla G, 2007, ONCOGENE, V26, P4428, DOI 10.1038/sj.onc.1210223; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Oh HJ, 2010, CURR BIOL, V20, P416, DOI 10.1016/j.cub.2009.12.054; Oh S, 2009, MOL CELL BIOL, V29, P6309, DOI 10.1128/MCB.00551-09; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Pechnick RN, 2008, P NATL ACAD SCI USA, V105, P1358, DOI 10.1073/pnas.0711030105; Rehberg K, 2014, J NEUROSCI, V34, P5342, DOI 10.1523/JNEUROSCI.2728-13.2014; Satoh W, 2006, DEVELOPMENT, V133, P989, DOI 10.1242/dev.02274; Sefton M, 1998, DEVELOPMENT, V125, P3111; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Stegert MR, 2004, J BIOL CHEM, V279, P23806, DOI 10.1074/jbc.M402472200; Stemple DL, 2005, DEVELOPMENT, V132, P2503, DOI 10.1242/dev.01812; Stork O, 2004, J BIOL CHEM, V279, P45773, DOI 10.1074/jbc.M403552200; Tam P.P.L., 1999, HEART DEV, DOI [10.1016/b978-012329860-7/50003-9, DOI 10.1016/B978-012329860-7/50003-9]; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Vermot J, 2005, NATURE, V435, P215, DOI 10.1038/nature03488; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Wang DZ, 1999, DEVELOPMENT, V126, P1281; Watabe-Rudolph M, 2002, MECH DEVELOP, V119, P251, DOI 10.1016/S0925-4773(02)00394-5; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; White PH, 2003, DEVELOPMENT, V130, P1681, DOI 10.1242/dev.00367; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Wittler L, 2007, EMBO REP, V8, P784, DOI 10.1038/sj.embor.7401030; Zhang L, 2015, CURR BIOL, V25, P296, DOI 10.1016/j.cub.2014.11.054; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zhou YP, 2011, MOL CELL BIOL, V31, P3603, DOI 10.1128/MCB.01389-10	74	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136566	10.1371/journal.pone.0136566	http://dx.doi.org/10.1371/journal.pone.0136566			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305214	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500092
J	Terazawa, S; Mori, S; Nakajima, H; Yasuda, M; Imokawa, G				Terazawa, Shuko; Mori, Shingo; Nakajima, Hiroaki; Yasuda, Michitaka; Imokawa, Genji			The UVB-Stimulated Expression of Transglutaminase 1 Is Mediated Predominantly via the NF kappa B Signaling Pathway: New Evidence of Its Significant Attenuation through the Specific Interruption of the p38/MSK1/NF kappa Bp65 Ser276 Axis	PLOS ONE			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; TRANSCRIPTION FACTOR; ENVELOPE FORMATION; CORNIFIED ENVELOPE; RETINOIC ACID; P65 SUBUNIT; ACTIVATION; MSK1; PHOSPHORYLATION; ASTAXANTHIN	The influence of ultraviolet B (UVB) radiation on transglutaminase 1 (TGase 1), a major factor that regulates skin keratinization, has not been sufficiently characterized especially at the gene or protein level. Thus, we determined whether UVB affects the expression of TGase 1 in human keratinocytes and clarified the intracellular stress signaling mechanism (s) involved. Exposure of human keratinocytes to UVB significantly up-regulated the expression of TGase 1 at the gene and protein levels. Treatment with inhibitors of p38, MEK, JNK or NF kappa B significantly abolished the UVB-stimulated protein expression of TGase 1. Treatment with astaxanthin immediately after UVB irradiation did not attenuate the increased phosphorylation of Ser536/Ser468NF kappa Bp65, c-Jun, ATK-2 and CK2, and did not abrogate the increased or diminished protein levels of c-Jun/c-Fos or I-kappa B alpha, respectively. However, the same treatment with astaxanthin significantly abolished the UVB-stimulated expression of TGase 1 protein, which was accompanied by the attenuated phosphorylation of Thr565/Ser376/Ser360MSK1, Ser276NF kappa Bp65 and Ser133CREB. The MSK1 inhibitor H89 significantly down-regulated the increased protein expression of TGase 1 in UVB-exposed human keratinocytes, which was accompanied by an abrogating effect on the increased phosphorylation of Ser276NF kappa Bp65 and Ser133CREB but not Thr565/Ser376/Ser360MSK1. Transfection of human keratinocytes with MSK1 siRNA suppressed the UVB-stimulated protein expression of TGase 1. These findings suggest that the UVB-stimulated expression of TGase 1 is mediated predominantly via the NF kappa B pathway and can be attenuated through a specific interruption of the p38/MSK1/NF kappa Bp65Ser276 axis.	[Terazawa, Shuko; Imokawa, Genji] Chubu Univ, Res Inst Biol Funct, Kasugai, Aichi 487, Japan; [Mori, Shingo; Nakajima, Hiroaki; Yasuda, Michitaka] Tokyo Univ Technol, Sch Biosci & Biotechnol, Tokyo, Japan	Chubu University; Tokyo University of Technology	Imokawa, G (corresponding author), Chubu Univ, Res Inst Biol Funct, Kasugai, Aichi 487, Japan.	imokawag@dream.ocn.ne.jp						Adhami VM, 2003, NEOPLASIA, V5, P74, DOI 10.1016/S1476-5586(03)80019-2; Afaq F, 2003, ONCOGENE, V22, P1035, DOI 10.1038/sj.onc.1206206; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; CANDI E, 1995, J BIOL CHEM, V270, P26382, DOI 10.1074/jbc.270.44.26382; Candi E, 2001, J BIOL CHEM, V276, P35014, DOI 10.1074/jbc.M010157200; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Chrestensen CA, 2002, J BIOL CHEM, V277, P27733, DOI 10.1074/jbc.M202663200; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Del Bino S, 2004, BRIT J DERMATOL, V150, P658, DOI 10.1111/j.0007-0963.2004.05886.x; Funding AT, 2006, J INVEST DERMATOL, V126, P1784, DOI 10.1038/sj.jid.5700252; Gesser B, 2007, J INVEST DERMATOL, V127, P2129, DOI 10.1038/sj.jid.5700859; Gong RJ, 2008, J BIOL CHEM, V283, P7401, DOI 10.1074/jbc.M710396200; Gonzales M, 2002, GENE, V293, P169, DOI 10.1016/S0378-1119(02)00723-0; Grandjean-Laquerriere A, 2005, CYTOKINE, V29, P197, DOI 10.1016/j.cyto.2004.10.012; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Higuchi K, 2001, J LIPID RES, V42, P1562; Hitomi K, 2001, INT J BIOCHEM CELL B, V33, P491, DOI 10.1016/S1357-2725(01)00033-4; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Hur S, 2010, J DERMATOL SCI, V59, P163, DOI 10.1016/j.jdermsci.2010.07.001; Jessen BA, 2001, TOXICOL APPL PHARM, V174, P302, DOI 10.1006/taap.2001.9227; John S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034252; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; KIM HC, 1991, J BIOL CHEM, V266, P536; KIM SY, 1995, J INVEST DERMATOL, V104, P211, DOI 10.1111/1523-1747.ep12612769; Lee SJ, 2003, MOL CELLS, V16, P97; LICHTI U, 1988, CANCER RES, V48, P74; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Mccoy CE, 2007, BIOCHEM J, V402, P491, DOI 10.1042/BJ20061183; Mizutani Y, 2010, ARCH DERMATOL RES, V302, P283, DOI 10.1007/s00403-009-1007-x; Morisaki N, 2010, J BIOL CHEM, V285, P39819, DOI 10.1074/jbc.M110.161547; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakajima H, 2012, ARCH DERMATOL RES, V304, P803, DOI 10.1007/s00403-012-1248-y; Nakajima H, 2011, ARCH DERMATOL RES, V303, P263, DOI 10.1007/s00403-011-1143-y; Nemes Z, 1999, P NATL ACAD SCI USA, V96, P8402, DOI 10.1073/pnas.96.15.8402; Niwano T, 2015, CYTOKINE, V73, P184, DOI 10.1016/j.cyto.2015.02.006; Ockenfels HM, 1998, BRIT J DERMATOL, V139, P390; PARENTEAU NL, 1986, DIFFERENTIATION, V33, P130, DOI 10.1111/j.1432-0436.1986.tb00418.x; Peng HY, 2012, J BIOL CHEM, V287, P28017, DOI 10.1074/jbc.M112.383380; Perl A, 2002, ANTIOXID REDOX SIGN, V4, P427, DOI 10.1089/15230860260196227; Rahman MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028065; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Reichert Uwe, 1993, P107; Rossi A, 1998, J INVEST DERMATOL, V110, P34, DOI 10.1046/j.1523-1747.1998.00071.x; Rossi A, 2000, J INVEST DERMATOL, V115, P731, DOI 10.1046/j.1523-1747.2000.00116.x; RUBIN AL, 1986, CANCER RES, V46, P2356; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; Ryborg AK, 2004, ACTA DERM-VENEREOL, V84, P433, DOI 10.1080/00015550410016930; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sato-Jin K, 2008, FASEB J, V22, P1155, DOI 10.1096/fj.07-9080com; Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x; SPENCER SR, 1990, CANCER RES, V50, P7871; Suzuki Y, 2006, EXP EYE RES, V82, P275, DOI 10.1016/j.exer.2005.06.023; Takagi Y, 2004, J INVEST DERMATOL, V123, P1102, DOI 10.1111/j.0022-202X.2004.23491.x; Takahashi H, 2000, J DERMATOL SCI, V23, P161, DOI 10.1016/S0923-1811(00)00071-2; Terazawa S, 2012, EXP DERMATOL, V21, P11, DOI 10.1111/j.1600-0625.2012.01496.x; THACHER SM, 1985, CELL, V40, P685, DOI 10.1016/0092-8674(85)90217-X; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Vicentini FTMC, 2011, J DERMATOL SCI, V61, P162, DOI 10.1016/j.jdermsci.2011.01.002; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Yano S, 2008, J CELL PHYSIOL, V214, P1, DOI 10.1002/jcp.21300; Yoon JH, 2011, J AGR FOOD CHEM, V59, P222, DOI 10.1021/jf103204x; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	67	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136311	10.1371/journal.pone.0136311	http://dx.doi.org/10.1371/journal.pone.0136311			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305102	Green Submitted, gold, Green Published			2022-12-27	WOS:000359995500064
J	Callaway, JB; Smith, SA; Widman, DG; McKinnon, KP; Scholle, F; Sempowski, GD; Dittmer, DP; Crowe, JE; de Silva, AM; Ting, JPY				Callaway, Justin B.; Smith, Scott A.; Widman, Douglas G.; McKinnon, Karen P.; Scholle, Frank; Sempowski, Gregory D.; Dittmer, Dirk P.; Crowe, James E., Jr.; de Silva, Aravinda M.; Ting, Jenny P. -Y.			Source and Purity of Dengue-Viral Preparations Impact Requirement for Enhancing Antibody to Induce Elevated IL-1 beta Secretion: A Primary Human Monocyte Model	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; INFLAMMASOME ACTIVATION; HEMORRHAGIC-FEVER; VIRUS-INFECTION; IMMUNE-RESPONSE; DENDRITIC CELLS; SHOCK SYNDROME; B-CELLS; DISEASE; GENE	Dengue virus is a major global health threat and can lead to life-threatening hemorrhagic complications due to immune activation and cytokine production. Cross-reactive antibodies to an earlier dengue virus infection are a recognized risk factor for severe disease. These antibodies bind heterologous dengue serotypes and enhance infection into Fc-receptor-bearing cells, a process known as antibody-dependent enhancement of infection. One crucial cytokine seen elevated in severe dengue patients is IL-1 beta, a potent inflammatory cytokine matured by the inflammasome. We used a highly-physiologic system by studying antibody-dependent enhancement of IL-1 beta in primary human monocytes with anti-dengue human monoclonal antibodies isolated from patients. Antibody-enhancement increased viral replication in primary human monocytes inoculated with supernatant harvested from Vero cells infected with dengue virus serotype 2 (DENV-2) 16681. Surprisingly, IL-1 beta secretion induced by infectious supernatant harvested from two independent Vero cell lines was not enhanced by antibody. Secretion of multiple other inflammatory cytokines was also independent of antibody signaling. However, IL-1 beta secretion did require NLRP3 and caspase-1 activity. Immunodepletion of dengue virions from the infectious supernatant confirmed that virus was not the main IL-1 beta-inducing agent, suggesting that a supernatant component(s) not associated with the virion induced IL-1 beta production. We excluded RNA, DNA, contaminating LPS, viral NS1 protein, complement, and cytokines. In contrast, purified Vero-derived DENV-2 16681 exhibited antibody-enhancement of both infection and IL-1 beta induction. Furthermore, C6/36 mosquito cells did not produce such an inflammatory component, as crude supernatant harvested from insect cells infected with DENV-2 16681 induced antibody-dependent IL-1 beta secretion. This study indicates that Vero cells infected with DENV-2 16681 may produce inflammatory components during dengue virus propagation that mask the virus-specific immune response. Thus, the choice of host cell and viral purity should be carefully considered, while insect-derived virus represents a system that elicits antibody-dependent cytokine responses to dengue virus with fewer confounding issues.	[Callaway, Justin B.; Widman, Douglas G.; McKinnon, Karen P.; Dittmer, Dirk P.; de Silva, Aravinda M.; Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27514 USA; [Callaway, Justin B.; McKinnon, Karen P.; Dittmer, Dirk P.; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Smith, Scott A.; Crowe, James E., Jr.] Vanderbilt Univ Sch Med, Vanderbilt Vaccine Ctr, Nashville, TN USA; [Smith, Scott A.] Vanderbilt Univ Sch Med, Dept Med, Nashville, TN USA; [Scholle, Frank] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Sempowski, Gregory D.] Duke Human Vaccine Inst, Durham, NC USA; [Crowe, James E., Jr.] Vanderbilt Univ Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Crowe, James E., Jr.] Vanderbilt Univ Sch Med, Dept Pediat, Nashville, TN USA; [Ting, Jenny P. -Y.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University; Vanderbilt University; University of North Carolina; North Carolina State University; Vanderbilt University; Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill	Ting, JPY (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27514 USA.	jenny_ting@med.unc.edu	desilva, Aravinda/ABE-6260-2020; , UNC Flow Cytometry Core/AGU-9839-2022; Crowe, James/B-5549-2009; Dittmer, Dirk/AAH-3535-2021; Dittmer, Dirk/GPW-7423-2022	desilva, Aravinda/0000-0003-3317-5950; Crowe, James/0000-0002-0049-1079; Dittmer, Dirk/0000-0003-4968-5656; Sempowski, Gregory/0000-0003-0391-6594; Widman, Douglas/0000-0002-3585-6373	National Institute of Allergy and Infectious Diseases [U54-AI057157, U19-AI109965, U19-AI109784, 5T32AI007273-29, 5U19AI107810-02, 1F32AI094941-01]; National Institute of Dental and Craniofacial Research [R01-DE018304]; National Cancer Institute [2P50CA058223-19A1]; Susan G. Komen Breast Cancer Foundation [KG100307]; University Cancer Research Fund; NATIONAL CANCER INSTITUTE [P50CA058223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109965, T32AI007273, U19AI107810, UC6AI058607, F32AI094941, U54AI057157, K08AI103038, U19AI109784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018304] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); University Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx): U54-AI057157 (JBC DGW SAS FS GDS JEC AMD JPT); U19-AI109965 (JPT); U19-AI109784 (GDS AMD JPT); 5T32AI007273-29 (JBC); 5U19AI107810-02 (DPD); 1F32AI094941-01 (DGW). National Institute of Dental and Craniofacial Research (http://www.nidcr.nih.gov/): R01-DE018304 (DPD). National Cancer Institute (http://www.cancer.gov/): 2P50CA058223-19A1 (KPM). Susan G. Komen Breast Cancer Foundation (http://ww5.komen.org/): KG100307 (KPM). Supported in part by the University Cancer Research Fund (http://unclineberger.org/ucrf/): KPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader DB, 2004, VIRAL IMMUNOL, V17, P252, DOI 10.1089/0882824041310496; Antonopoulos C, 2015, J BIOL CHEM, V290, P20167, DOI 10.1074/jbc.M115.652321; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; BHAMARAPRAVATI N, 1989, REV INFECT DIS, V11, pS826; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Brown MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034055; Callaway JB, 2015, J BIOL CHEM, V290, P17306, DOI 10.1074/jbc.M115.664136; CHANG DM, 1994, J INFECT DIS, V170, P811, DOI 10.1093/infdis/170.4.811; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028; Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999; Goto M, 1999, CYTOKINE, V11, P16, DOI 10.1006/cyto.1998.0390; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10; Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024; HOWARD AD, 1991, J IMMUNOL, V147, P2964; Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762; Jaiyen Y, 2009, MICROBIOL IMMUNOL, V53, P442, DOI 10.1111/j.1348-0421.2009.00148.x; Kamau E, 2009, J GEN VIROL, V90, P1827, DOI 10.1099/vir.0.009027-0; Kang S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8515; King CA, 2002, J VIROL, V76, P8408, DOI 10.1128/JVI.76.16.8408-8419.2002; Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051; Marinho CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102014; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Norazizah Shafee, 2011, International Journal of Virology, V7, P24, DOI 10.3923/ijv.2011.24.32; Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008; Poeck H, 2012, EUR J CELL BIOL, V91, P59, DOI 10.1016/j.ejcb.2011.01.013; Priyadarshini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008709; Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Smith SA, 2014, J VIROL, V88, P12233, DOI 10.1128/JVI.00247-14; Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11; Srikiatkhachorn A, 2010, CURR TOP MICROBIOL, V338, P67, DOI 10.1007/978-3-642-02215-9_6; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; TESHIMA T, 1992, BONE MARROW TRANSPL, V10, P215; Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699; Uchino S, 2002, INT J ARTIF ORGANS, V25, P27, DOI 10.1177/039139880202500105; von Sydow FFO, 2000, MEM I OSWALDO CRUZ, V95, P483, DOI 10.1590/S0074-02762000000400007; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; WHO, 2012, DENG SEV DENG WHO ME; Widman DG, 2008, VACCINE, V26, P2762, DOI 10.1016/j.vaccine.2008.03.009; Winkelmann ER, 2012, VACCINE, V30, P1465, DOI 10.1016/j.vaccine.2011.12.103; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090	51	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136708	10.1371/journal.pone.0136708	http://dx.doi.org/10.1371/journal.pone.0136708			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301593	gold, Green Published			2022-12-27	WOS:000359951900081
J	Dienes, L; Kiss, HJ; Perenyl, K; Szepessy, Z; Nagy, ZZ; Barsi, A; Acosta, MC; Gallar, J; Kovacs, I				Dienes, Lorant; Kiss, Huba J.; Perenyl, Kristof; Szepessy, Zsuzsanna; Nagy, Zoltan Z.; Barsi, Arpad; Carmen Acosta, M.; Gallar, Juana; Kovacs, Illes			The Effect of Tear Supplementation on Ocular Surface Sensations during the Interblink Interval in Patients with Dry Eye	PLOS ONE			English	Article							GELLABLE LUBRICANT EYE; HP-GUAR; CORNEAL SENSITIVITY; LIPID LAYER; COLD THERMORECEPTORS; FILM THICKNESS; PRECORNEAL; SYMPTOMS; CONJUNCTIVAL; STIMULATION	Purpose To investigate the characteristics of ocular surface sensations and corneal sensitivity during the interblink interval before and after tear supplementation in dry eye patients. Methods Twenty subjects (41.88 +/- 14.37 years) with dry eye symptoms were included in the dry eye group. Fourteen subjects (39.13 +/- 11.27 years) without any clinical signs and/or symptoms of dry eye were included in the control group. Tear film dynamics was assessed by non-invasive tear film breakup time (NI-BUT) in parallel with continuous recordings of ocular sensations during forced blinking. Corneal sensitivity to selective stimulation of corneal mechano-, cold and chemical receptors was assessed using a gas esthesiometer. All the measurements were made before and 5 min after saline and hydroxypropyl-guar (HP-guar) drops. Results In dry eye patients the intensity of irritation increased rapidly after the last blink during forced blinking, while in controls there was no alteration in the intensity during the first 10 sec followed by an exponential increase. Irritation scores were significantly higher in dry eye patients throughout the entire interblink interval compared to controls (p<0.004). NI-BUT significantly increased after HP-guar (p = 0.003) but not after saline drops (p = 0.14). In both groups, either after saline or HP-guar the shape of symptom intensity curves remained the same with significantly lower irritation scores (p<0.004), however after HP-guar the decrease was significantly more pronounced (p<0.004). Corneal sensitivity to selective mechanical, cold and chemical stimulation decreased significantly in both groups after HP-guar (p<0.05), but not after saline drops (p>0.05). Conclusion Ocular surface irritation responses due to tear film drying are considerably increased in dry eye patients compared to normal subjects. Although tear supplementation improves the protective tear film layer, and thus reduce unpleasant sensory responses, the rapid rise in discomfort is still maintained and might be responsible for the remaining complaints of dry eye patients despite the treatment.	[Dienes, Lorant; Kiss, Huba J.; Perenyl, Kristof; Szepessy, Zsuzsanna; Nagy, Zoltan Z.; Kovacs, Illes] Semmelweis Univ, Dept Ophthalmol, H-1085 Budapest, Hungary; [Barsi, Arpad] Budapest Univ Technol & Econ, Dept Photogrammetry & Geoinformat, Budapest, Hungary; [Carmen Acosta, M.; Gallar, Juana] Univ Miguel Hernandez, Inst Neurociencias, CSIC, Alacant, Spain	Semmelweis University; Budapest University of Technology & Economics; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Kovacs, I (corresponding author), Semmelweis Univ, Dept Ophthalmol, H-1085 Budapest, Hungary.	kovacs.illes@med.semmelweis-univ.hu	Nagy, Zoltan Zsolt/T-6180-2017; Gallar, Juana/B-4563-2011; Barsi, Arpad/A-5030-2008; Acosta, M.Carmen/K-1313-2014	Gallar, Juana/0000-0002-3559-3649; Barsi, Arpad/0000-0002-0298-7502; Acosta, M. Carmen/0000-0002-1759-068X	Hungarian Scientific Research Fund OTKA [NN106649]; Ministerio de Economia y Competitividad, Spain [SAF2014-54518-C3-1-R]; Alcon Hungary Kft	Hungarian Scientific Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Ministerio de Economia y Competitividad, Spain; Alcon Hungary Kft	This work was supported by the Hungarian Scientific Research Fund OTKA NN106649 research grant (IK, LD) and SAF2014-54518-C3-1-R from Ministerio de Economia y Competitividad, Spain (JG, MCA). Publication fees of the manuscript were partially covered by the Spes Futuri Research Grant provided by Alcon Hungary Kft (LD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Acosta MC, 2004, INVEST OPHTH VIS SCI, V45, P2333, DOI 10.1167/iovs.03-1366; Acosta MC, 2001, J PHYSIOL-LONDON, V534, P511, DOI 10.1111/j.1469-7793.2001.t01-1-00511.x; Acosta MC, 2010, INVEST OPHTHALMOL VI; Argueso P, 2001, EXP EYE RES, V73, P281, DOI 10.1006/exer.2001.1045; Begley C, 2013, INVEST OPHTH VIS SCI, V54, P2645, DOI 10.1167/iovs.12-11299; Belmonte C, 1999, INVEST OPHTH VIS SCI, V40, P513; Belmonte C, 2004, EXP EYE RES, V78, P513, DOI 10.1016/j.exer.2003.09.023; Belmonte C, 2011, INVEST OPHTH VIS SCI, V52, P3888, DOI 10.1167/iovs.09-5119; BENEDETTO DA, 1984, ARCH OPHTHALMOL-CHIC, V102, P410; Benelli U, 2010, CONTACT LENS ANTERIO, V33, P61, DOI 10.1016/j.clae.2010.01.003; Blackie CA, 2009, CORNEA, V28, P789, DOI 10.1097/ICO.0b013e318191b870; Bourcier T, 2005, INVEST OPHTH VIS SCI, V46, P2341, DOI 10.1167/iovs.04-1426; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Christensen MT, 2010, INVEST OPHTH VIS SCI, V51; Christensen MT, 2004, CURR EYE RES, V28, P55, DOI 10.1076/ceyr.28.1.55.23495; Craig JP, 1997, OPTOMETRY VISION SCI, V74, P8, DOI 10.1097/00006324-199701000-00014; De Paiva CS, 2004, AM J OPHTHALMOL, V137, P109, DOI 10.1016/S0002-9394(03)00897-3; Foulks GN, 2007, SURV OPHTHALMOL, V52, P369, DOI 10.1016/j.survophthal.2007.04.009; Friedman NJ, 2010, CURR OPIN OPHTHALMOL, V21, P310, DOI 10.1097/ICU.0b013e32833a8c15; Gifford Paul, 2006, Cont Lens Anterior Eye, V29, P31, DOI 10.1016/j.clae.2005.12.003; Gomis A, 2009, OSTEOARTHR CARTILAGE, V17, P798, DOI 10.1016/j.joca.2008.11.013; Hartstein I, 2005, CURR MED RES OPIN, V21, P255, DOI 10.1185/030079905X26252; Jamison RN, 2002, PAIN, V99, P341, DOI 10.1016/S0304-3959(02)00178-1; King-Smith PE, 2008, OPTOMETRY VISION SCI, V85, P623, DOI 10.1097/OPX.0b013e318181ae60; King-Smith PE, 2000, INVEST OPHTH VIS SCI, V41, P3348; Miller KL, 2010, ARCH OPHTHALMOL-CHIC, V128, P94, DOI 10.1001/archophthalmol.2009.356; Montes-Mico R, 2004, INVEST OPHTH VIS SCI, V45, P1752, DOI 10.1167/iovs.03-0839; Murphy PJ, 1998, OPHTHAL PHYSL OPT, V18, P532, DOI 10.1016/S0275-5408(98)00021-0; Nichols JJ, 2005, INVEST OPHTH VIS SCI, V46, P2353, DOI 10.1167/iovs.05-0094; Ousler GW, 2007, CORNEA, V26, P949, DOI 10.1097/ICO.0b013e3180de1c38; Palakuru JR, 2007, INVEST OPHTH VIS SCI, V48, P3032, DOI 10.1167/iovs.06-1507; Parra A, 2014, PAIN, V155, P1481, DOI 10.1016/j.pain.2014.04.025; Parra A, 2010, NAT MED, V16, P1396, DOI 10.1038/nm.2264; Paugh JR, 2008, OPTOMETRY VISION SCI, V85, P873, DOI 10.1097/OPX.0b013e318185279d; Pflugfelder SC, 2007, OCUL SURF, V5, P163; PRYDAL JI, 1992, INVEST OPHTH VIS SCI, V33, P2006; Rolando M, 2009, J OCUL PHARMACOL TH, V25, P271, DOI 10.1089/jop.2008.0026; Sanchez MA, 2010, EYE, V24, P1331, DOI 10.1038/eye.2010.24; Schaumberg DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076121; Schmidl D, 2015, CORNEA, V34, P421, DOI 10.1097/ICO.0000000000000358; SHARMA A, 1993, BIOPHYS CHEM, V47, P87, DOI 10.1016/0301-4622(93)80036-I; Sindt CW, 2013, CLIN OPHTHALMOL, V7, P1713, DOI [10.2147/OPTH.S35833, 10.2147/OPTH.S35833`]; Situ P, 2008, INVEST OPHTH VIS SCI, V49, P2971, DOI 10.1167/iovs.08-1734; Smith JA, 2007, OCUL SURF, V5, P93; SNIBSON GR, 1990, EYE, V4, P594, DOI 10.1038/eye.1990.83; Teson M, 2012, INVEST OPHTH VIS SCI, V53, P3154, DOI 10.1167/iovs.11-9304; Tomlinson A, 2009, OCUL SURF, V7, P186, DOI 10.1016/S1542-0124(12)70186-6; Varikooty J, 2009, INVEST OPHTH VIS SCI, V50, P1087, DOI 10.1167/iovs.08-1843; Vega JA, 1999, CORNEA, V18, P675, DOI 10.1097/00003226-199911000-00009; Versura P, 2008, CLIN OPHTHALMOL, V2, P629; Wang JH, 2006, INVEST OPHTH VIS SCI, V47, P3325, DOI 10.1167/iovs.06-0055	51	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135629	10.1371/journal.pone.0135629	http://dx.doi.org/10.1371/journal.pone.0135629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302222	Green Published, gold, Green Submitted			2022-12-27	WOS:000359951900023
J	Cheng, GY; Li, B; Wang, CX; Zhang, HF; Liang, GX; Weng, ZF; Hao, HH; Wang, X; Liu, ZL; Dai, MH; Wang, YL; Yuan, ZH				Cheng, Guyue; Li, Bei; Wang, Chenxi; Zhang, Hongfei; Liang, Guixia; Weng, Zhifei; Hao, Haihong; Wang, Xu; Liu, Zhenli; Dai, Menghong; Wang, Yulian; Yuan, Zonghui			Systematic and Molecular Basis of the Antibacterial Action of Quinoxaline 1,4-Di-N-Oxides against Escherichia coli	PLOS ONE			English	Article							TUMOR-CELLS; BACTERICIDAL ANTIBIOTICS; TIRAPAZAMINE SR-4233; GEL-ELECTROPHORESIS; SENSITIVITY; 1,4-DIOXIDE; METABOLISM; RESISTANCE; PROTEINS; OXIDES	Quinoxaline 1,4-di-N-oxides (QdNOs) are widely known as potent antibacterial agents, but their antibacterial mechanisms are incompletely understood. In this study, the transcriptomic and proteomic profiles of Escherichia coli exposed to QdNOs were integratively investigated, and the results demonstrated that QdNOs mainly induced an SOS response and oxidative stress. Moreover, genes and proteins involved in the bacterial metabolism, cellular structure maintenance, resistance and virulence were also found to be changed, conferring bacterial survival strategies. Biochemical assays showed that reactive oxygen species were induced in the QdNO-treated bacteria and that free radical scavengers attenuated the antibacterial action of QdNOs and DNA damage, suggesting an oxidative-DNA-damage action of QdNOs. The QdNO radical intermediates, likely carbon-centered and aryl-type radicals, as identified by electron paramagnetic resonance, were the major radicals induced by QdNOs, and xanthine oxidase was one of the QdNO-activating enzymes. This study provides new insights into the action of QdNOs in a systematic manner and increases the current knowledge of bacterial physiology under antibiotic stresses, which may be of great value in the development of new antibiotic-potentiating strategies.	[Cheng, Guyue; Li, Bei; Wang, Chenxi; Zhang, Hongfei; Liang, Guixia; Weng, Zhifei; Hao, Haihong; Wang, Xu; Dai, Menghong; Yuan, Zonghui] Huazhong Agr Univ, MOA Lab Risk Assessment Qual & Safety Livestock &, Wuhan 430070, Hubei, Peoples R China; [Liu, Zhenli; Wang, Yulian; Yuan, Zonghui] Huazhong Agr Univ, Natl Reference Lab Vet Drug Residues HZAU, Wuhan 430070, Hubei, Peoples R China; [Liu, Zhenli; Wang, Yulian; Yuan, Zonghui] Huazhong Agr Univ, MAO Key Lab Detect Vet Drug Residues, Wuhan 430070, Hubei, Peoples R China; [Cheng, Guyue; Hao, Haihong; Wang, Xu; Liu, Zhenli; Dai, Menghong; Wang, Yulian; Yuan, Zonghui] Huazhong Agr Univ, Hubei Collaborat Innovat Ctr Anim Nutr & Feed Saf, Wuhan 430070, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Dai, MH (corresponding author), Huazhong Agr Univ, MOA Lab Risk Assessment Qual & Safety Livestock &, Wuhan 430070, Hubei, Peoples R China.	daimenghong@mail.hzau.edu.cn; wangyulian@mail.hzau.edu.cn; yuan5802@mail.hzau.edu.cn	DAI, M/GPS-8291-2022; yuan, zonghui/A-1158-2017; Hao, Haihong/E-2789-2019	Hao, Haihong/0000-0003-0199-5700	National High Technology Research and Development Program of China [2011AA10A214]; National Program for Risk Assessment of Quality and Safety of Livestock and Poultry Products [GJFP2015008]; National Natural Science Foundation of China [31272614]; Fundamental Research Funds for the Central Universities of China [2013QC002]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Program for Risk Assessment of Quality and Safety of Livestock and Poultry Products; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	The research was supported by the National High Technology Research and Development Program of China (2011AA10A214) (www.most.gov.cn) to MD, the National Program for Risk Assessment of Quality and Safety of Livestock and Poultry Products (GJFP2015008) (www.moa.gov.cn) to ZY, the National Natural Science Foundation of China (31272614) (www.nsfc.gov.cn) to XW and the Fundamental Research Funds for the Central Universities of China (2013QC002) (www.moe.gov.cn) to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard Karine R, 2004, Methods Mol Biol, V250, P263; Carta A, 2005, CURR MED CHEM, V12, P2259, DOI 10.2174/0929867054864831; Chatterji M, 2003, ARCH MICROBIOL, V180, P339, DOI 10.1007/s00203-003-0598-4; Clinical and Laboratory Standards Institute, 2009, METHODS FOR DILUTION; COHEN SP, 1993, J BACTERIOL, V175, P1484, DOI 10.1128/JB.175.5.1484-1492.1993; Delahoussaye YM, 2001, BIOCHEM PHARMACOL, V62, P1201, DOI 10.1016/S0006-2952(01)00784-5; ENGLISH AR, 1970, P SOC EXP BIOL MED, V133, P398; Gorg A, 2009, ELECTROPHORESIS, V30, pS122, DOI 10.1002/elps.200900051; Hao HH, 2013, REGUL TOXICOL PHARM, V67, P335, DOI 10.1016/j.yrtph.2013.08.011; Hassett DJ, 2007, ACS CHEM BIOL, V2, P708, DOI 10.1021/cb700232k; Hayashi M, 2010, FEMS MICROBIOL LETT, V304, P12, DOI 10.1111/j.1574-6968.2009.01879.x; HERA A, 1980, BIOL CHEM ZIVOCISME, V16, P319; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; LADEROUTE K, 1988, BIOCHEM PHARMACOL, V37, P1487, DOI 10.1016/0006-2952(88)90010-X; Lee C, 2008, APPL MICROBIOL BIOT, V78, P371, DOI 10.1007/s00253-007-1300-6; LI CY, 1993, J BACTERIOL, V175, P2229, DOI 10.1128/JB.175.8.2229-2235.1993; Pasquali C, 1996, ELECTROPHORESIS, V17, P547, DOI 10.1002/elps.1150170325; PATTERSON AV, 1995, BRIT J CANCER, V72, P1144, DOI 10.1038/bjc.1995.478; PATTERSON AV, 1994, INT J RADIAT ONCOL, V29, P369, DOI 10.1016/0360-3016(94)90291-7; Peters KB, 2002, CANCER RES, V62, P5248; Shaw KJ, 2003, J MOL MICROB BIOTECH, V5, P105, DOI 10.1159/000069981; Shinde SS, 2010, J AM CHEM SOC, V132, P2591, DOI 10.1021/ja908689f; Shinde SS, 2009, J AM CHEM SOC, V131, P14220, DOI 10.1021/ja906860a; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; SUTER W, 1978, ANTIMICROB AGENTS CH, V13, P770, DOI 10.1128/AAC.13.5.770; Thomassen GOS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015356; WANG J, 1993, BRIT J CANCER, V67, P321, DOI 10.1038/bjc.1993.59; Wang X, 2015, IJITEE, V4, P1, DOI DOI 10.1021/TX5004326; Zhang YL, 2009, J BIOL CHEM, V284, P25522, DOI 10.1074/jbc.M109.036624	29	30	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136450	10.1371/journal.pone.0136450	http://dx.doi.org/10.1371/journal.pone.0136450			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296207	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900114
J	Dong, YD; Liu, DL; Hu, Y; Ma, XL				Dong, Yaodong; Liu, Dongliang; Hu, Yue; Ma, Xiulan			NaHS Protects Cochlear Hair Cells from Gentamicin-Induced Ototoxicity by Inhibiting the Mitochondrial Apoptosis Pathway	PLOS ONE			English	Article							HYDROGEN-SULFIDE ELICITS; SMALL-INTESTINE ROLE; INNER-EAR; ANTIINFLAMMATORY PHENOTYPE; OXIDATIVE STRESS; IN-VITRO; DEATH; CHANNELS; MECHANOTRANSDUCTION; AMINOGLYCOSIDES	Aminoglycoside antibiotics such as gentamicin could cause ototoxicity in mammalians, by inducing oxidative stress and apoptosis in sensory hair cells of the cochlea. Sodium hydrosulfide (NaHS) is reported to alleviate oxidative stress and apoptosis, but its role in protecting aminoglycoside-induced hearing loss is unclear. In this study, we investigated the antioxidant and anti-apoptosis effect of NaHS in in vitro cultured House Ear Institute-Organ of Corti 1 (HEI-OC1) cells and isolated mouse cochlea. Results from cultured HEI-OC1 cells and cochlea consistently indicated that NaHS exhibited protective effects from gentamicin-induced ototoxicity, evident by maintained cell viability, hair cell number and cochlear morphology, reduced reactive oxygen species production and mitochondrial depolarization, as well as apoptosis activation of the intrinsic pathway. Moreover, in the isolated cochlear culture, NaHS was also demonstrated to protect the explant from gentamicin-induced mechanotransduction loss. Our study using multiple in vitro models revealed for the first time, the potential of NaHS as a therapeutic agent in protecting against aminoglycoside-induced hearing loss.	[Dong, Yaodong; Liu, Dongliang; Hu, Yue; Ma, Xiulan] China Med Univ, Shengjing Hosp, Dept Otol, Shenyang 110004, Peoples R China	China Medical University	Ma, XL (corresponding author), China Med Univ, Shengjing Hosp, Dept Otol, Shenyang 110004, Peoples R China.	maxl1@sj-hospital.org			Natural Science foundation of Liaoning province [201402019]	Natural Science foundation of Liaoning province(Natural Science Foundation of Liaoning Province)	This work was supported by Natural Science foundation of Liaoning province (201402019).	Abi-Hachem Ralph N, 2010, Recent Pat CNS Drug Discov, V5, P147; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Avanzato D, 2014, CELL PHYSIOL BIOCHEM, V33, P1205, DOI 10.1159/000358690; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bodmer D, 2008, SWISS MED WKLY, V138, P708, DOI /aop/smw-aop12260; Borg E, 2002, HEARING RES, V172, P10, DOI 10.1016/S0378-5955(02)00284-8; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Chen P, 2002, DEVELOPMENT, V129, P2495; Choung YH, 2009, NEUROSCIENCE, V161, P214, DOI 10.1016/j.neuroscience.2009.02.085; Coffin AB, 2013, JARO-J ASSOC RES OTO, V14, P645, DOI 10.1007/s10162-013-0404-1; Dehne N, 2002, HEARING RES, V169, P47, DOI 10.1016/S0378-5955(02)00338-6; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Durante-Mangoni E, 2009, INT J ANTIMICROB AG, V33, P201, DOI 10.1016/j.ijantimicag.2008.09.001; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hirose K, 1997, HEARING RES, V104, P1, DOI 10.1016/S0378-5955(96)00169-4; Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P20888, DOI 10.1073/pnas.0811258106; Kalinec GM, 2003, AUDIOL NEURO-OTOL, V8, P177, DOI 10.1159/000071059; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Mangiardi DA, 2004, J COMP NEUROL, V475, P1, DOI 10.1002/cne.20129; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Minamishima S, 2009, CIRCULATION, V120, P888, DOI 10.1161/CIRCULATIONAHA.108.833491; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P727, DOI 10.1128/AAC.43.4.727; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Romand R, 1997, EUR J CELL BIOL, V74, P138; Roy S, 2000, J EXP MED, V192, pF21, DOI 10.1084/jem.192.8.F21; Rybak LP, 2007, HEARING RES, V226, P157, DOI 10.1016/j.heares.2006.09.015; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; TABLAN OC, 1984, J INFECT DIS, V149, P257, DOI 10.1093/infdis/149.2.257; Zuidema MY, 2011, AM J PHYSIOL-HEART C, V301, pH888, DOI 10.1152/ajpheart.00432.2010; Zuidema MY, 2010, AM J PHYSIOL-HEART C, V299, pH1554, DOI 10.1152/ajpheart.01229.2009	33	13	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136051	10.1371/journal.pone.0136051	http://dx.doi.org/10.1371/journal.pone.0136051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295804	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900066
J	Liu, JJ; Lou, FL; Lavebratt, C; Forsell, Y				Liu, Jia Jia; Lou, Fenglan; Lavebratt, Catharina; Forsell, Yvonne			Impact of Childhood Adversity and Vasopressin receptor 1a Variation on Social Interaction in Adulthood: A Cross-Sectional Study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ARGININE-VASOPRESSIN; INTERVIEW SCHEDULE; PROMOTER REGION; BEHAVIOR; ASSOCIATION; PSYCHOSIS; GENE; MICROSATELLITE; POLYMORPHISMS	Background Arginine vasopressin (AVP) plays a role in social behavior, through receptor AVPR1A. The promoter polymorphism AVPR1A RS3 has been associated with human social behaviors, and with acute response to stress. Here, the relationships between AVPR1A RS3, early-life stressors, and social interaction in adulthood were explored. Methods Adult individuals from a Swedish population-based cohort (n = 1871) were assessed for self-reported availability of social integration and social attachment and for experience of childhood adversities. Their DNA samples were genotyped for the microsatellite AVPR1A RS3. Results Among males, particularly those homozygous for the long alleles of AVPR1A RS3 were vulnerable to childhood adversity for their social attachment in adulthood. A similar vulnerability to childhood adversity among long allele carriers was found on adulthood social integration, but here both males and females were influenced. Limitation Data were self-reported and childhood adversity data were retrospective. Conclusions Early-life stress influenced the relationship between AVPR1A genetic variants and social interaction. For social attachment, AVPR1A was of importance in males only. The findings add to previous reports on higher acute vulnerability to stress in persons with long AVPR1A RS3 alleles and increased AVP levels.	[Liu, Jia Jia; Lou, Fenglan] Shandong Univ, Sch Nursing, Jinan 250012, Peoples R China; [Liu, Jia Jia; Lavebratt, Catharina] Karolinska Inst, Neurogenet Unit, Dept Mol Med & Surg, Stockholm, Sweden; [Lavebratt, Catharina] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Forsell, Yvonne] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	Shandong University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Lavebratt, C (corresponding author), Karolinska Inst, Neurogenet Unit, Dept Mol Med & Surg, Stockholm, Sweden.	catharina.lavebratt@ki.se	Forsell, Yvonne/ABB-8879-2020		Swedish Research Council [2009-5546, 20103631]; China Scholarship Council; Karolinska Institutet's Faculty Funds; Stockholm County Council [SLL20110560, 20090281]; Karolinska Institutet [SLL20110560, 20090281]	Swedish Research Council(Swedish Research CouncilEuropean Commission); China Scholarship Council(China Scholarship Council); Karolinska Institutet's Faculty Funds; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Research Council (www.vr.se; 2009-5546 YF, 20103631 CL), the China Scholarship Council (www.csc.edu.cn), the Karolinska Institutet's Faculty Funds (https://fonder.ki.se), and the regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet (www.forskningsstod.sll.se; SLL20110560 CL, 20090281 YF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Amaral DG, 2003, ANN NY ACAD SCI, V1000, P337, DOI 10.1196/annals.1280.015; Avinun R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025274; Bachner-Melman R., 2005, J INDIVID DIFFER, V26, P2, DOI DOI 10.1027/1614-0001.26.1.2; Bentall RP, 2014, SOC PSYCH PSYCH EPID, V49, P1011, DOI 10.1007/s00127-014-0914-0; Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924; Carrion VG, 2001, BIOL PSYCHIAT, V50, P943, DOI 10.1016/S0006-3223(01)01218-5; Dvir Y, 2013, CHILD ADOL PSYCH CL, V22, P629, DOI 10.1016/j.chc.2013.04.006; Eklund M, 2007, NORD J PSYCHIAT, V61, P182, DOI 10.1080/08039480701352439; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Ford E, 2011, J AFFECT DISORDERS, V133, P320, DOI 10.1016/j.jad.2011.03.017; Halonen JI, 2014, J EPIDEMIOL COMMUN H, V68, P741, DOI 10.1136/jech-2013-203441; Hammock EAD, 2005, GENES BRAIN BEHAV, V4, P289, DOI 10.1111/j.1601-183X.2005.00119.x; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; Hammock EAD, 2002, EUR J NEUROSCI, V16, P399, DOI 10.1046/j.1460-9568.2002.02083.x; Hammock EAD, 2007, ADV GENET, V59, P107, DOI 10.1016/S0065-2660(07)59004-8; HENDERSON S, 1980, PSYCHOL MED, V10, P723, DOI 10.1017/S003329170005501X; Humphreys K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022547; Insel TR, 2000, CURR OPIN NEUROBIOL, V10, P784, DOI 10.1016/S0959-4388(00)00146-X; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Kim SJ, 2002, MOL PSYCHIATR, V7, P503, DOI 10.1038/sj.mp.4001125; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; Kreek MJ, 2011, BIOL PSYCHIAT, V70, P502, DOI 10.1016/j.biopsych.2011.07.013; Lappalainen T, 2009, ANN HUM GENET, V73, P61, DOI 10.1111/j.1469-1809.2008.00487.x; Levin R, 2009, PSYCHONEUROENDOCRINO, V34, P901, DOI 10.1016/j.psyneuen.2008.12.014; Lundberg I, 2005, SOC PSYCH PSYCH EPID, V40, P475, DOI 10.1007/s00127-005-0911-4; Melas PA, 2010, J MED ETHICS, V36, P93, DOI 10.1136/jme.2009.032367; Meyer-Lindenberg A, 2009, MOL PSYCHIATR, V14, P968, DOI 10.1038/mp.2008.54; Orwelius L, 2011, INTENS CARE MED, V37, P831, DOI 10.1007/s00134-011-2137-0; Schacter DL, 1996, CURR OPIN NEUROBIOL, V6, P207, DOI 10.1016/S0959-4388(96)80074-2; Sjoholm LK, 2009, J AFFECT DISORDERS, V118, P124, DOI 10.1016/j.jad.2009.02.009; Storm EE, 2005, NEURON, V47, P483, DOI 10.1016/j.neuron.2005.08.004; Teicher MH, 2012, P NATL ACAD SCI USA, V109, pE563, DOI 10.1073/pnas.1115396109; Thompson R, 2004, PSYCHONEUROENDOCRINO, V29, P35, DOI 10.1016/S0306-4530(02)00133-6; Thompson RR, 2006, P NATL ACAD SCI USA, V103, P7889, DOI 10.1073/pnas.0600406103; UNDEN AL, 1989, SOC SCI MED, V29, P1387, DOI 10.1016/0277-9536(89)90240-2; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; Yirmiya N, 2006, MOL PSYCHIATR, V11, P488, DOI 10.1038/sj.mp.4001812	39	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136436	10.1371/journal.pone.0136436	http://dx.doi.org/10.1371/journal.pone.0136436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295806	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900111
J	Rosenheinrich, M; Heine, W; Schmuhl, CM; Pisano, F; Dersch, P				Rosenheinrich, Maik; Heine, Wiebke; Schmuehl, Carina M.; Pisano, Fabio; Dersch, Petra			Natural Killer Cells Mediate Protection against Yersinia pseudotuberculosis in the Mesenteric Lymph Nodes	PLOS ONE			English	Article							IFN-GAMMA PRODUCTION; NECROSIS-FACTOR-ALPHA; NK CELLS; IMMUNE-RESPONSES; ENTEROCOLITICA INFECTION; INTERFERON-GAMMA; MACROPHAGES; VIRULENCE; MICE; PROTEIN	Natural killer cells play a crucial role in the initial defense against bacterial pathogens. The crosstalk between host cells infected with intracellular pathogens and NK cells has been studied intensively, but not much attention has been given to characterize the role of NK cells in the response to extracellular bacterial pathogens such as yersiniae. In this study we used antibody-mediated NK cell depletion to address the importance of this immune cell type in controlling a Y. pseudotuberculosis infection. Analysis of the bacterial counts was used to follow the infection and flow cytometry was performed to characterize the composition and dynamic of immune cells. Depletion of NK cells led to higher bacterial loads within the mesenteric lymph nodes. We further show that in particular CD11b(+) CD27(+) NK cells which express higher levels of the activation marker CD69 increase within the mesenteric lymph nodes during a Y. pseudotuberculosis infection. Moreover, in response to the activation NK cells secrete higher levels of IFNy, which in turn triggers the production of the proinflammatory cytokine TNF alpha. These results suggest, that NK cells aid in the clearance of Y. pseudotuberculosis infections mainly by triggering the expression of proinflammatory cytokines manipulating the host immune response.	[Rosenheinrich, Maik; Heine, Wiebke; Schmuehl, Carina M.; Pisano, Fabio; Dersch, Petra] Helmholtz Ctr Infect Res, Dept Mol Infect Biol, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Dersch, P (corresponding author), Helmholtz Ctr Infect Res, Dept Mol Infect Biol, Braunschweig, Germany.	petra.dersch@helmholtz-hzi.de			Deutsche Forschungsgemeinschaft [IRTG1273]; President's Initiative and Networking Fund of the Helmholtz Association of German Research Centres (HGF) [VH-GS-202]; German Center of Infection Research (DZIF)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); President's Initiative and Networking Fund of the Helmholtz Association of German Research Centres (HGF); German Center of Infection Research (DZIF)	This work was supported by a stipend to M. Rosenheinrich of the International Research Training Group IRTG1273 funded by the Deutsche Forschungsgemeinschaft, by a stipend of the President's Initiative and Networking Fund of the Helmholtz Association of German Research Centres (HGF) under contract number VH-GS-202 for W. Heine. P. Dersch is supported by the German Center of Infection Research (DZIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2014, IMMUNOL CELL BIOL, V92, P256, DOI 10.1038/icb.2013.99; Auerbuch V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000686; AUTENRIETH IB, 1994, INFECT IMMUN, V62, P2590, DOI 10.1128/IAI.62.6.2590-2599.1994; AUTENRIETH IB, 1992, MED MICROBIOL IMMUN, V181, P333; Balada-Llasat JM, 2006, PLOS PATHOG, V2, P816, DOI 10.1371/journal.ppat.0020086; Bergman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000573; Bliska JB, 2013, CELL MICROBIOL, V15, P1622, DOI 10.1111/cmi.12164; Bohme K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002518; Bohn E, 1996, J IMMUNOL, V156, P1458; BOLIN I, 1982, INFECT IMMUN, V37, P506; Bottone EJ, 1999, MICROBES INFECT, V1, P323, DOI 10.1016/S1286-4579(99)80028-8; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Clark MA, 1998, INFECT IMMUN, V66, P1237, DOI 10.1128/IAI.66.3.1237-1243.1998; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Ehl S, 1996, J IMMUNOL METHODS, V199, P149, DOI 10.1016/S0022-1759(96)00175-5; Fu BQ, 2011, IMMUNOLOGY, V133, P350, DOI 10.1111/j.1365-2567.2011.03446.x; GIDLUND M, 1981, NATURE, V292, P848, DOI 10.1038/292848a0; Hall LJ, 2013, INFECT IMMUN, V81, P460, DOI 10.1128/IAI.00953-12; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; KAGAYA K, 1989, INFECT IMMUN, V57, P609, DOI 10.1128/IAI.57.2.609-615.1989; Kampik D, 2000, INFECT IMMUN, V68, P2484, DOI 10.1128/IAI.68.5.2484-2492.2000; Karasova D, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-75; Kerschen EJ, 2004, INFECT IMMUN, V72, P4589, DOI 10.1128/IAI.72.8.4589-4602.2004; Koch I, 2013, INT J MED MICROBIOL, V303, P433, DOI 10.1016/j.ijmm.2013.05.004; Koornhof HJ, 1999, EUR J CLIN MICROBIOL, V18, P87, DOI 10.1007/s100960050237; Kubota K, 2010, SCAND J IMMUNOL, V71, P199, DOI 10.1111/j.1365-3083.2009.02366.x; Kupz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097418; Kupz A, 2013, P NATL ACAD SCI USA, V110, P2252, DOI 10.1073/pnas.1222047110; Lapaque N, 2009, J IMMUNOL, V182, P4339, DOI 10.4049/jimmunol.0803329; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Logsdon LK, 2006, INFECT IMMUN, V74, P1516, DOI 10.1128/IAI.74.3.1516-1527.2006; McCoy MW, 2010, INFECT IMMUN, V78, P2584, DOI 10.1128/IAI.00141-10; NAKAJIMA R, 1993, INFECT IMMUN, V61, P23, DOI 10.1128/IAI.61.1.23-31.1993; Naper C, 2011, J INNATE IMMUN, V3, P289, DOI 10.1159/000324143; Nishibori T, 1996, INFECT IMMUN, V64, P3188, DOI 10.1128/IAI.64.8.3188-3195.1996; Nishikado H, 2011, J IMMUNOL, V186, P5766, DOI 10.4049/jimmunol.1100370; Pisano F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103541; Reid-Yu SA, 2013, EUR J IMMUNOL, V43, P2638, DOI 10.1002/eji.201343435; ROBERSON SM, 1988, CELL IMMUNOL, V116, P341, DOI 10.1016/0008-8749(88)90236-5; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schweer J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003746; Souza-Fonseca-Guimaraes F, 2012, MOL MED, V18, P270, DOI 10.2119/molmed.2011.00201; Szaba FM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004142; Viegas N, 2013, EUR J IMMUNOL, V43, P2626, DOI 10.1002/eji.201242937; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wren BW, 2003, NAT REV MICROBIOL, V1, P55, DOI 10.1038/nrmicro730; Zhao YX, 2000, INFECT IMMUN, V68, P1243, DOI 10.1128/IAI.68.3.1243-1251.2000	50	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136290	10.1371/journal.pone.0136290	http://dx.doi.org/10.1371/journal.pone.0136290			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296209	gold, Green Published, Green Submitted			2022-12-27	WOS:000359926900096
J	Sejourne, J; Llaneza, D; Kuti, OJ; Page, DT				Sejourne, Julien; Llaneza, Danielle; Kuti, Orsolya J.; Page, Damon T.			Social Behavioral Deficits Coincide with the Onset of Seizure Susceptibility in Mice Lacking Serotonin Receptor 2c	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; 5-HT2C RECEPTORS; M-CHLOROPHENYLPIPERAZINE; AUDIOGENIC-SEIZURES; COWDEN-SYNDROME; TENSIN HOMOLOG; GENE-MUTATIONS; MOUSE STRAINS; MUTANT MICE; IN-VIVO	The development of social behavior is strongly influenced by the serotonin system. Serotonin 2c receptor (5-HT2cR) is particularly interesting in this context considering that pharmacological modulation of 5-HT2cR activity alters social interaction in adult rodents. However, the role of 5-HT2cR in the development of social behavior is unexplored. Here we address this using Htr2c knockout mice, which lack 5-HT2cR. We found that these animals exhibit social behavior deficits as adults but not as juveniles. Moreover, we found that the age of onset of these deficits displays similar timing as the onset of susceptibility to spontaneous death and audiogenic-seizures, consistent with the hypothesis that imbalanced excitation and inhibition (E/I) may contribute to social behavioral deficits. Given that autism spectrum disorder (ASD) features social behavioral deficits and is often co-morbid with epilepsy, and given that 5-HT2cR physically interacts with Pten, we tested whether a second site mutation in the ASD risk gene Pten can modify these phenotypes. The age of spontaneous death is accelerated in mice double mutant for Pten and Htr2c relative to single mutants. We hypothesized that pharmacological antagonism of 5-HT2cR activity in adult animals, which does not cause seizures, might modify social behavioral deficits in Pten haploinsufficient mice. SB 242084, a 5-HT2cR selective antagonist, can reverse the social behavior deficits observed in Pten haploinsufficient mice. Together, these results elucidate a role of 5-HT2cR in the modulation of social behavior and seizure susceptibility in the context of normal development and Pten haploinsufficiency.	[Sejourne, Julien; Llaneza, Danielle; Page, Damon T.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Kuti, Orsolya J.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Kuti, Orsolya J.] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Scripps Research Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health	Page, DT (corresponding author), Scripps Res Inst, Dept Neurosci, 130 Scripps Way, Jupiter, FL 33458 USA.	paged@scripps.edu			Scripps Research Institute; National Institute of Health (NIH) grant [R01MH105610]; Ms. Nancy Lurie Marks; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105610] Funding Source: NIH RePORTER	Scripps Research Institute; National Institute of Health (NIH) grant; Ms. Nancy Lurie Marks; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by startup funds from The Scripps Research Institute (D. T. P.), gift funds from Ms. Nancy Lurie Marks (D. T. P.), and National Institute of Health (NIH) grant R01MH105610 (D. T. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Saab WM, 1999, NEUROPSYCHOPHARMACOL, V20, P92, DOI 10.1016/S0893-133X(98)00046-3; Allan AM, 2008, HUM MOL GENET, V17, P2047, DOI 10.1093/hmg/ddn102; Anastasio NC, 2013, J NEUROSCI, V33, P1615, DOI 10.1523/JNEUROSCI.2656-12.2013; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Baskerville TA, 2010, CNS NEUROSCI THER, V16, pe92, DOI 10.1111/j.1755-5949.2010.00154.x; Berg KA, 2005, TRENDS PHARMACOL SCI, V26, P625, DOI 10.1016/j.tips.2005.10.008; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Brennan TJ, 1997, NAT GENET, V16, P387, DOI 10.1038/ng0897-387; Brodkin ES, 2004, BRAIN RES, V1002, P151, DOI 10.1016/j.brainres.2003.12.013; BROWNING RA, 1989, EPILEPSY RES, V4, P119, DOI 10.1016/0920-1211(89)90016-8; Bubar MJ, 2007, NEUROSCIENCE, V146, P286, DOI 10.1016/j.neuroscience.2006.12.071; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Choleris E, 2011, NEUROPSYCHOPHARMACOL, V36, P1689, DOI 10.1038/npp.2011.50; Christianson JP, 2010, BIOL PSYCHIAT, V67, P339, DOI 10.1016/j.biopsych.2009.09.011; Clipperton-Allen AE, 2014, HUM MOL GENET, V23, P3490, DOI 10.1093/hmg/ddu057; Conti S, 2012, J CHILD NEUROL, V27, P392, DOI 10.1177/0883073811420296; Cremers TIFH, 2007, NEUROPSYCHOPHARMACOL, V32, P1550, DOI 10.1038/sj.npp.1301287; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Curia G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00046; Dekeyne A, 2000, NEUROPHARMACOLOGY, V39, P1114, DOI 10.1016/S0028-3908(99)00268-3; Di Giovanni G, 2001, NEUROSCIENCE, V103, P111, DOI 10.1016/S0306-4522(00)00561-3; Di Matteo V, 1999, NEUROPHARMACOLOGY, V38, P1195, DOI 10.1016/S0028-3908(99)00047-7; Enter D, 2012, GENES BRAIN BEHAV, V11, P671, DOI 10.1111/j.1601-183X.2012.00791.x; Ernst M, 1997, LANCET, V350, P638, DOI 10.1016/S0140-6736(05)63326-0; FULLER JL, 1967, J HERED, V58, P135, DOI 10.1093/oxfordjournals.jhered.a107565; Goffin A, 2001, AM J MED GENET, V105, P521, DOI 10.1002/ajmg.1477; Hackler EA, 2007, J PHARMACOL EXP THER, V320, P1023, DOI 10.1124/jpet.106.113357; Hay-Schmidt A, 2000, P ROY SOC B-BIOL SCI, V267, P1071, DOI 10.1098/rspb.2000.1111; Herman GE, 2007, GENET MED, V9, P268, DOI 10.1097/GIM.0b013e31804d683b; Herman GE, 2007, AM J MED GENET A, V143A, P589, DOI 10.1002/ajmg.a.31619; Higley JD, 1996, NEUROPSYCHOPHARMACOL, V14, P67, DOI 10.1016/S0893-133X(96)80060-1; Ji SP, 2006, NAT MED, V12, P324, DOI 10.1038/nm1349; KANDEL ER, 1961, EXP NEUROL, V4, P162, DOI 10.1016/0014-4886(61)90038-3; Kennett GA, 1997, NEUROPHARMACOLOGY, V36, P609, DOI 10.1016/S0028-3908(97)00038-5; Kravitz EA, 2003, CURR OPIN NEUROBIOL, V13, P736, DOI 10.1016/j.conb.2003.10.003; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lesch KP, 2012, NEURON, V76, P175, DOI 10.1016/j.neuron.2012.09.013; Liu RJ, 2000, BRAIN RES, V873, P34, DOI 10.1016/S0006-8993(00)02468-9; Luikart BW, 2011, J NEUROSCI, V31, P4345, DOI 10.1523/JNEUROSCI.0061-11.2011; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Markram K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00224; Nakamura K, 2010, ARCH GEN PSYCHIAT, V67, P59, DOI 10.1001/archgenpsychiatry.2009.137; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Nonogaki K, 2003, DIABETES, V52, P315, DOI 10.2337/diabetes.52.2.315; Olivier B, 1998, NEUROSCI BIOBEHAV R, V23, P215, DOI 10.1016/S0149-7634(98)00022-0; Page DT, 2009, P NATL ACAD SCI USA, V106, P1989, DOI 10.1073/pnas.0804428106; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rubenstein JLR, 2010, CURR OPIN NEUROL, V23, P118, DOI 10.1097/WCO.0b013e328336eb13; Stief F, 2007, EUR J NEUROSCI, V25, P519, DOI 10.1111/j.1460-9568.2006.05296.x; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Tuchman R, 2010, BRAIN DEV-JPN, V32, P709, DOI 10.1016/j.braindev.2010.04.008; Vattikuti S, 2010, BIOL PSYCHIAT, V67, P672, DOI 10.1016/j.biopsych.2009.09.008; Xu Y, 2008, NEURON, V60, P582, DOI 10.1016/j.neuron.2008.09.033; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Young SN, 2002, PHARMACOL BIOCHEM BE, V71, P857, DOI 10.1016/S0091-3057(01)00670-0; Yu HJ, 2009, J NEUROPHYSIOL, V102, P752, DOI 10.1152/jn.90469.2008; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009	60	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136494	10.1371/journal.pone.0136494	http://dx.doi.org/10.1371/journal.pone.0136494			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308619	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400129
J	Sepulveda, M; Newsome, SD; Pavez, G; Oliva, D; Costa, DP; Huckstadt, LA				Sepulveda, Maritza; Newsome, Seth D.; Pavez, Guido; Oliva, Doris; Costa, Daniel P.; Hueckstaedt, Luis A.			Using Satellite Tracking and Isotopic Information to Characterize the Impact of South American Sea Lions on Salmonid Aquaculture in Southern Chile	PLOS ONE			English	Article							NORTHERN FUR SEALS; OTARIA-FLAVESCENS; STABLE-ISOTOPES; FORAGING STRATEGIES; FEEDING ECOLOGY; INDIVIDUAL VARIATION; DIET SPECIALIZATION; TEMPORAL VARIATION; FARMED SALMON; MIXING MODELS	Apex marine predators alter their foraging behavior in response to spatial and/or seasonal changes in natural prey distribution and abundance. However, few studies have identified the impacts of aquaculture that represents a spatially and temporally predictable and abundant resource on their foraging behavior. Using satellite telemetry and stable isotope analysis we examined the degree of spatial overlap between the South American sea lion (SASL) and salmon farms, and quantify the amount of native prey versus farmed salmonids in SASL diets. We instrumented eight SASL individuals with SRDL-GPS tags. Vibrissae, hair and skin samples were collected for delta C-13 and delta N-15 analyses from five of the tagged individuals and from four males captured in a haul-out located adjacent to salmon farms. Tracking results showed that almost all the foraging areas of SASL are within close proximity to salmon farms. The most important prey for the individuals analyzed was farmed salmonids, with an estimated median (+/- SD) contribution of 19.7 +/- 13.5% and 15.3 +/- 9.6% for hair and skin, respectively. Using vibrissae as a temporal record of diet for each individual, we observed a remarkable switch in diet composition in two SASL, from farmed salmonids to pelagic fishes, which coincided with the decrease of salmon production due to the infectious salmon anemia virus that affected salmon farms in Chile at the end of 2008. Our study demonstrates the usefulness of integrating stable isotope derived dietary data with movement patterns to characterize the impacts of a non-native prey on the foraging ecology of an apex marine predator, providing important applied implications in situations where interactions between aquaculture and wildlife are common.	[Sepulveda, Maritza; Pavez, Guido; Oliva, Doris] Univ Valparaiso, Fac Ciencias, Inst Biol, Ctr Invest & Gest Recursos Nat CIGREN, Valparaiso, Chile; [Newsome, Seth D.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Costa, Daniel P.; Hueckstaedt, Luis A.] Univ Calif Santa Cruz, Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	Universidad de Valparaiso; University of New Mexico; University of California System; University of California Santa Cruz	Sepulveda, M (corresponding author), Univ Valparaiso, Fac Ciencias, Inst Biol, Ctr Invest & Gest Recursos Nat CIGREN, Valparaiso, Chile.	maritza.sepulveda@uv.cl	OLIVA, DORIS/AAM-8600-2021; Huckstadt, Luis A./J-8532-2019; Huckstadt, Luis/A-5838-2018; Costa, Daniel/E-2616-2013	Huckstadt, Luis A./0000-0002-2453-7350; Huckstadt, Luis/0000-0002-2453-7350; Costa, Daniel/0000-0002-0233-5782	Fondecyt [11110081]; INNOVA-CORFO Grant [07CN13IPM-170]; Office of Naval Research Grant [N00014-08-1-1195]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); INNOVA-CORFO Grant; Office of Naval Research Grant(Office of Naval Research)	This study was supported by funding from Fondecyt Grant number 11110081 to MS, INNOVA-CORFO Grant number 07CN13IPM-170 to MS and DO and Office of Naval Research Grant number N00014-08-1-1195 to DPC.	Aguayo Lobo A., 1973, Biologia Pesq, VNo. 6, P45; Aguayo-Lobo A, 1998, 9651 FIP; Alonso MK, 2000, FISH B-NOAA, V98, P250; Aurioles D, 2006, MAR MAMMAL SCI, V22, P326, DOI 10.1111/j.1748-7692.2006.00023.x; BAILEY KM, 1982, FISH RES, V1, P163; Bailleul F, 2010, ECOGRAPHY, V33, P709, DOI 10.1111/j.1600-0587.2009.06034.x; Barton JR, 2010, GLOBAL ENVIRON CHANG, V20, P739, DOI 10.1016/j.gloenvcha.2010.04.001; Baylis AMM, 2012, MAR MAMMAL SCI, V28, P276, DOI 10.1111/j.1748-7692.2011.00487.x; Bearhop S, 2006, MAR ECOL PROG SER, V311, P157, DOI 10.3354/meps311157; Beyer H., 2012, GEOSP MOD ENV VERS 0; Bradshaw CJA, 2000, J ZOOL, V252, P41, DOI 10.1111/j.1469-7998.2000.tb00818.x; Campagna C, 2001, J ZOOL, V255, P205, DOI 10.1017/S0952836901001285; Carleton SA, 2005, OECOLOGIA, V144, P226, DOI 10.1007/s00442-005-0066-8; Cherel Y, 2009, BIOL LETTERS, V5, P830, DOI 10.1098/rsbl.2009.0552; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Crawford K, 2008, MAMMAL REV, V38, P87, DOI 10.1111/j.1365-2907.2008.00120.x; Cronin MA, 2012, BIOL CONSERV, V150, P136, DOI 10.1016/j.biocon.2012.02.013; Das K, 2003, MAR ECOL PROG SER, V263, P287, DOI 10.3354/meps263287; de la Torriente A, 2010, ICES J MAR SCI, V67, P294, DOI 10.1093/icesjms/fsp235; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Dujon AM, 2014, METHODS ECOL EVOL, V5, P1162, DOI 10.1111/2041-210X.12286; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Fedak MA, 2001, MAR MAMMAL SCI, V17, P94, DOI 10.1111/j.1748-7692.2001.tb00982.x; GEORGENASCIMENTO M, 1985, MAR ECOL PROG SER, V21, P135, DOI 10.3354/meps021135; Giardino Gisela, 2013, Mastozool. neotrop., V20, P393; Harcourt RG, 2002, MAR ECOL PROG SER, V227, P11, DOI 10.3354/meps227011; Hirons AC, 2001, CAN J ZOOL, V79, P1053, DOI 10.1139/z01-055; Hobson KA, 1996, CAN J FISH AQUAT SCI, V53, P528, DOI 10.1139/cjfas-53-3-528; Huckstadt LA, 2007, J EXP MAR BIOL ECOL, V347, P123, DOI 10.1016/j.jembe.2007.03.014; Huckstadt LA, 2012, MAR ECOL PROG SER, V455, P287, DOI 10.3354/meps09601; Huckstadt LA, 2012, OECOLOGIA, V169, P395, DOI 10.1007/s00442-011-2202-y; Huckstadt LA, 2014, MAR MAMMAL SCI, V30, P1175, DOI 10.1111/mms.12085; HUGGARD DJ, 1993, CAN J ZOOL, V71, P130, DOI 10.1139/z93-019; Hume F, 2004, MAR BIOL, V144, P407, DOI 10.1007/s00227-003-1219-0; Iliopoulos Y, 2009, ACTA THERIOL, V54, P11, DOI 10.1007/BF03193133; Jeglinski JWE, 2013, J ANIM ECOL, V82, P694, DOI 10.1111/1365-2656.12019; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kemper Catherine M., 2003, P208; Kurle CM, 2001, OECOLOGIA, V126, P254, DOI 10.1007/s004420000518; Lesage V, 2002, MAR MAMMAL SCI, V18, P182, DOI 10.1111/j.1748-7692.2002.tb01027.x; Lewis R, 2006, P ROY SOC B-BIOL SCI, V273, P2901, DOI 10.1098/rspb.2006.3642; Lillo S, 2012, 201104 FIP; Lowther AD, 2011, MAR ECOL PROG SER, V443, P249, DOI 10.3354/meps09392; Lowther AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074348; Cappozzo HL, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P1076; Matthiopoulos J, 2008, MAMMAL REV, V38, P167, DOI 10.1111/j.1365-2907.2008.00123.x; McCafferty DJ, 1998, MAR ECOL PROG SER, V166, P285, DOI 10.3354/meps166285; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Mote S, 2011, THESIS I POLITECNICO; Munoz L, 2013, REV BIOL MAR OCEANOG, V48, P613, DOI 10.4067/S0718-19572013000300017; Nelson ML, 2006, CAN J FISH AQUAT SCI, V63, P1710, DOI 10.1139/F06-067; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Newsome SD, 2010, ECOL APPL, V20, P1744, DOI 10.1890/09-1502.1; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; OLIVA D, 2012, 472846LP11 FAP; Oliva D., 2003, 200332 FIP; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Phillips DL, 2001, OECOLOGIA, V127, P166, DOI 10.1007/s004420000571; Quick NJ, 2004, AQUACULTURE, V230, P169, DOI 10.1016/S0044-8486(03)00428-9; Ramos R, 2012, FRONT ECOL ENVIRON, V10, P258, DOI 10.1890/110140; Riet-Sapriza FG, 2013, DEEP-SEA RES PT II, V88-89, P106, DOI 10.1016/j.dsr2.2012.09.005; Rodriguez DH, 2013, DEEP-SEA RES PT II, V88-89, P120, DOI 10.1016/j.dsr2.2012.07.012; Sepulveda M, 2005, AQUAC RES, V36, P1062, DOI 10.1111/j.1365-2109.2005.01320.x; Sepulveda M, 2013, AQUACULT ENV INTERAC, V4, P273, DOI 10.3354/aei00089; Sernapesca, AN EST PESC DES ART; Sielfeld W., 1997, 9528 FIP; Sigler MF, 2009, MAR ECOL PROG SER, V388, P243, DOI 10.3354/meps08144; Sinclair EH, 2002, J MAMMAL, V83, P973, DOI 10.1644/1545-1542(2002)083<0973:SASDID>2.0.CO;2; Stahl P, 2001, J APPL ECOL, V38, P674, DOI 10.1046/j.1365-2664.2001.00625.x; Thomas AC, 2011, MAR ECOL PROG SER, V441, P225, DOI 10.3354/meps09370; Thompson D, 1998, J ZOOL, V246, P135, DOI 10.1111/j.1469-7998.1998.tb00142.x; Tinker MT, 2012, ECOL LETT, V15, P475, DOI 10.1111/j.1461-0248.2012.01760.x; Tinker MT, 2008, P NATL ACAD SCI USA, V105, P560, DOI 10.1073/pnas.0709263105; Vilata J, 2010, ICES J MAR SCI, V67, P475, DOI 10.1093/icesjms/fsp250; Waite JN, 2012, J EXP MAR BIOL ECOL, V416, P41, DOI 10.1016/j.jembe.2012.02.009; Weise MJ, 2008, MAR ECOL PROG SER, V373, P157, DOI 10.3354/meps07737; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959	80	19	19	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134926	10.1371/journal.pone.0134926	http://dx.doi.org/10.1371/journal.pone.0134926			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309046	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400042
J	Huang, YH; Tiao, MM; Huang, LT; Chuang, JH; Kuo, KC; Yang, YL; Wang, FS				Huang, Ying-Hsien; Tiao, Mao-Meng; Huang, Li-Tung; Chuang, Jiin-Haur; Kuo, Kuang-Che; Yang, Ya-Ling; Wang, Feng-Sheng			Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; LIVER FIBROSIS; MICRORNA-29A PROTECTS; CYTOKINE EXPRESSION; MOUSE MODEL; RAT-LIVER; DIFFERENTIATION; FIBROGENESIS; BETA; MICE	Background Recent studies have shown that microRNA-29 (miR-29) is significantly decreased in liver fibrosis and that its downregulation influences the activation of hepatic stellate cells (HSCs). In addition, inhibition of the activity of histone deacetylases 4 (HDAC4) has been shown to strongly reduce HSC activation in the context of liver fibrosis. Objectives In this study, we examined whether miR-29a was involved in the regulation of HDAC4 and modulation of the profibrogenic phenotype in HSCs. Methods We employed miR-29a transgenic mice (miR-29aTg mice) and wild-type littermates to clarify the role of miR-29a in cholestatic liver fibrosis, using the bile duct-ligation (BDL) mouse model. Primary HSCs from both mice were treated with a miR-29a mimic and antisense inhibitor in order to analyze changes in profibrogenic gene expression and HSC activation using real-time quantitative RT-PCR, immunofluorescence staining, western blotting, and cell proliferation and migration assays. Results After BDL, overexpression of miR-29a decreased collagen-1a1, HDAC4 and activated HSC markers of glial fibrillary acidic protein expression in miR-29aTg mice compared to wild-type littermates. Overexpression of miR-29a and HDAC4 RNA-interference decreased the expression of fibrotic genes, HDAC4 signaling, and HSC migration and proliferation. In contrast, knockdown of miR-29a with an antisense inhibitor increased HDAC4 function, restored HSC migration, and accelerated HSC proliferation. Conclusions Our results indicate that miR-29a ameliorates cholestatic liver fibrosis after BDL, at least partially, by modulating the profibrogenic phenotype of HSCs through inhibition of HDAC4 function.	[Huang, Ying-Hsien; Tiao, Mao-Meng; Huang, Li-Tung; Kuo, Kuang-Che] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Huang, Ying-Hsien; Tiao, Mao-Meng; Huang, Li-Tung; Chuang, Jiin-Haur; Kuo, Kuang-Che; Yang, Ya-Ling; Wang, Feng-Sheng] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chuang, Jiin-Haur] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Kaohsiung, Taiwan; [Yang, Ya-Ling] Kaohsiung Chang Gung Mem Hosp, Dept Anesthesiol, Kaohsiung, Taiwan; [Wang, Feng-Sheng] Kaohsiung Chang Gung Mem Hosp, Dept Med Res, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Wang, FS (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Med Res, Kaohsiung, Taiwan.	wangfs@ms33.hinet.net		Tiao, Mao-Meng/0000-0002-0338-3495	Ministry of Science and Technology of Taiwan [MOST 104-2314-B-182A-118-MY2]; Chang Gung Memorial Grant [CMRPG 8B0992, 8B0993, 8B0873, 8D0371, 8B1461, 8D0441]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Grant(Chang Gung Memorial Hospital)	This study was supported by grants from the Ministry of Science and Technology of Taiwan (MOST 104-2314-B-182A-118-MY2) and the Chang Gung Memorial Grant CMRPG 8B0992, 8B0993, 8B0873, 8D0371, 8B1461 and 8D0441. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay S, 2011, J INFECT DIS, V203, P1753, DOI 10.1093/infdis/jir186; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Boon RA, 2011, CIRC RES, V109, P1115, DOI 10.1161/CIRCRESAHA.111.255737; Canbay A, 2003, HEPATOLOGY, V38, P1188, DOI 10.1053/jhep.2003.50472; Canbay A, 2003, LAB INVEST, V83, P655, DOI 10.1097/01.LAB.0000069036.63405.5C; Carotti S, 2008, LIVER TRANSPLANT, V14, P806, DOI 10.1002/lt.21436; Chou MH, 2012, BIOCHEM J, V447, P25, DOI 10.1042/BJ20112058; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Guo WC, 2009, AM J PHYSIOL-LUNG C, V297, pL864, DOI 10.1152/ajplung.00128.2009; Harada K, 2011, J CLIN PATHOL, V64, P660, DOI 10.1136/jclinpath-2011-200040; Hillebrandt S, 2005, NAT GENET, V37, P835, DOI 10.1038/ng1599; Hsiao YC, 2004, GENESIS, V39, P122, DOI 10.1002/gene.20038; Khan S, 2015, EXP MOL PATHOL, V98, P230, DOI 10.1016/j.yexmp.2015.01.003; Ko JY, 2013, BONE, V57, P468, DOI 10.1016/j.bone.2013.09.019; Kogure T, 2012, J CELL MOL MED, V16, P2647, DOI 10.1111/j.1582-4934.2012.01578.x; Kwiecinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024568; Lin CL, 2014, J AM SOC NEPHROL, V25, P1698, DOI 10.1681/ASN.2013050527; Liu YQ, 2013, LIVER INT, V33, P504, DOI 10.1111/liv.12034; Mannaerts I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055786; Mannaerts I, 2010, HEPATOLOGY, V51, P603, DOI 10.1002/hep.23334; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Niki T, 1996, HEPATOLOGY, V23, P1538, DOI 10.1053/jhep.1996.v23.pm0008675175; Niki T, 1999, HEPATOLOGY, V29, P858, DOI 10.1002/hep.510290328; Palacios RS, 2008, LAB INVEST, V88, P1192, DOI 10.1038/labinvest.2008.91; Port JD, 2011, PHYSIOL GENOMICS, V43, P1087, DOI 10.1152/physiolgenomics.00074.2011; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Tennakoon AH, 2015, EXP TOXICOL PATHOL, V67, P53, DOI 10.1016/j.etp.2014.09.008; Tiao MM, 2014, APOPTOSIS, V19, P30, DOI 10.1007/s10495-013-0909-4; Van Beneden K, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-1; Wang FS, 2013, ARTHRITIS RHEUM-US, V65, P1530, DOI 10.1002/art.37948; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang ZK, 2014, EPIGENOMICS-UK, V6, P139, DOI 10.2217/epi.13.73; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625	39	36	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136453	10.1371/journal.pone.0136453	http://dx.doi.org/10.1371/journal.pone.0136453			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305546	gold, Green Submitted, Green Published			2022-12-27	WOS:000359995500078
J	Milan, L; Courtand, G; Cardoit, L; Masmejean, F; Barriere, G; Cazalets, JR; Garret, M; Bertrand, SS				Milan, Lea; Courtand, Gilles; Cardoit, Laura; Masmejean, Frederique; Barriere, Gregory; Cazalets, Jean-Rene; Garret, Maurice; Bertrand, Sandrine S.			Age-Related Changes in Pre- and Postsynaptic Partners of the Cholinergic C-Boutons in Wild-Type and SOD1(G93A) Lumbar Motoneurons	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSGENIC MOUSE MODEL; SUPEROXIDE-DISMUTASE 1; SPINAL MOTONEURONS; MOTOR-NEURONS; ALPHA-MOTONEURONS; PARTITION CELLS; NEONATAL-RAT; TERMINALS; INPUTS	Large cholinergic synaptic terminals known as C-boutons densely innervate the soma and proximal dendrites of motoneurons that are prone to neurodegeneration in amyotrophic lateral sclerosis (ALS). Studies using the Cu/Zn-superoxide dismutase (SOD1) mouse model of ALS have generated conflicting data regarding C-bouton alterations exhibited during ALS pathogenesis. In the present work, a longitudinal study combining immunohistochemistry, biochemical approaches and extra- and intra-cellular electrophysiological recordings revealed that the whole spinal cholinergic system is modified in the SOD1 mouse model of ALS compared to wild type (WT) mice as early as the second postnatal week. In WT motoneurons, both C-bouton terminals and associated M2 postsynaptic receptors presented a complex age-related dynamic that appeared completely disrupted in SOD1 motoneurons. Indeed, parallel to C-bouton morphological alterations, analysis of confocal images revealed a clustering process of M2 receptors during WT motoneuron development and maturation that was absent in SOD1 motoneurons. Our data demonstrated for the first time that the lamina X cholinergic interneurons, the neuronal source of C-boutons, are over-abundant in high lumbar segments in SOD1 mice and are subject to neurodegeneration in the SOD1 animal model. Finally, we showed that early C-bouton system alterations have no physiological impact on the cholinergic neuromodulation of newborn motoneurons. Altogether, these data suggest a complete reconfiguration of the spinal cholinergic system in SOD1 spinal networks that could be part of the compensatory mechanisms established during spinal development.	[Milan, Lea; Courtand, Gilles; Cardoit, Laura; Masmejean, Frederique; Barriere, Gregory; Cazalets, Jean-Rene; Garret, Maurice; Bertrand, Sandrine S.] Univ Bordeaux 2, INCIA, CNRS UMR5287, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Bertrand, SS (corresponding author), Univ Bordeaux 2, INCIA, CNRS UMR5287, F-33076 Bordeaux, France.	sandrine.bertrand@u-bordeaux.fr	Cazalets, Jean-René/D-7851-2014; Bertrand, Sandrine/P-9290-2015	Cazalets, Jean-René/0000-0001-9047-3933; Barriere, Gregory/0000-0002-0704-508X; Bertrand, Sandrine S/0000-0002-3020-7980	Association francaise contre les myopathies (AFM) [15435]; Association Francaise contre les Myopathies (AFM); PhD-fellowship from AFM; CNRS; Region Aquitaine;  [LABEX BRAIN ANR-10LABX-43];  [LABEX BRAIN ANR-10-LABX-43]	Association francaise contre les myopathies (AFM)(Association Francaise contre les Myopathies); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); PhD-fellowship from AFM; CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Aquitaine(Region Nouvelle-Aquitaine); ; 	This work was supported by a grant from the Association Francaise contre les Myopathies (AFM). Lea Milan was supported by a PhD-fellowship from AFM. This project was also supported by the grant LABEX BRAIN ANR-10-LABX-43. The authors thank Delphine Gonzales and the genotyping facility from Magendie Neurocenter in Bordeaux for mouse genotyping. This work has benefited from the facilities and expertise of the Bordeaux Imaging Center (BIC: www.bic.u-bordeaux2.fr) and the imagery platform Imag'In (www.incia.u-bordeaux1.fr), which is supported by the CNRS and Region Aquitaine.	Amendola J, 2004, EUR J NEUROSCI, V20, P2822, DOI 10.1111/j.1460-9568.2004.03745.x; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Bertrand SS, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00015; Carp JS, 2008, J NEUROPHYSIOL, V100, P474, DOI 10.1152/jn.90422.2008; Casas C, 2013, BRAIN BEHAV, V3, P145, DOI 10.1002/brb3.104; CAZALETS JR, 1995, J NEUROSCI, V15, P4943; CAZALETS JR, 1992, J PHYSIOL-LONDON, V455, P187, DOI 10.1113/jphysiol.1992.sp019296; Chang Q, 2009, AM J PATHOL, V174, P574, DOI 10.2353/ajpath.2009.080557; Chaumont S, 2013, J BIOL CHEM, V288, P28254, DOI 10.1074/jbc.M113.470807; Choquet D, 2013, NEURON, V80, P691, DOI 10.1016/j.neuron.2013.10.013; CONNAUGHTON M, 1986, NEUROSCIENCE, V17, P205, DOI 10.1016/0306-4522(86)90237-X; CONRADI S, 1979, J COMP NEUROL, V184, P741, DOI 10.1002/cne.901840407; Conradi S, 1969, Acta Physiol Scand Suppl, V333, P5; CONRADI S, 1969, ACTA PHYSIOL SCAND, P49; Deardorff AS, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00106; Deardorff AS, 2013, J PHYSIOL-LONDON, V591, P875, DOI 10.1113/jphysiol.2012.240879; Enjin A, 2010, J COMP NEUROL, V518, P2284, DOI 10.1002/cne.22332; FengChen KC, 1996, P NATL ACAD SCI USA, V93, P9206, DOI 10.1073/pnas.93.17.9206; Filipchuk AA, 2012, NEUROSCIENCE, V209, P144, DOI 10.1016/j.neuroscience.2012.01.046; Frey D, 2000, J NEUROSCI, V20, P2534; Guilmatre A, 2014, DEV NEUROBIOL, V74, P113, DOI 10.1002/dneu.22128; Hadzipasic M, 2014, P NATL ACAD SCI USA, V111, P16883, DOI 10.1073/pnas.1419497111; Hegedus J, 2008, J PHYSIOL-LONDON, V586, P3337, DOI 10.1113/jphysiol.2007.149286; Hellstrom J, 2003, J COMP NEUROL, V460, P476, DOI 10.1002/cne.10648; Herron LR, 2012, NEUROSCIENCE, V226, P313, DOI 10.1016/j.neuroscience.2012.09.031; Jiang ZY, 1999, BRAIN RES, V816, P493, DOI 10.1016/S0006-8993(98)01199-8; Kaplan A, 2014, NEURON, V81, P333, DOI 10.1016/j.neuron.2013.12.009; Kiehn O, 1996, J NEUROPHYSIOL, V75, P1472, DOI 10.1152/jn.1996.75.4.1472; Krysciak K, 2014, MUSCLE NERVE, V50, P577, DOI 10.1002/mus.24196; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; MCLAUGHLIN BJ, 1972, J COMP NEUROL, V144, P429, DOI 10.1002/cne.901440404; Milan L, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00077; Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104; Mitra P, 2012, J NEUROPHYSIOL, V107, P728, DOI 10.1152/jn.00558.2011; Muennich EAL, 2004, J PHYSIOL-LONDON, V554, P673, DOI 10.1113/jphysiol.2003.056192; NAGY JI, 1993, SYNAPSE, V15, P17, DOI 10.1002/syn.890150103; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Proctor DT, 2011, PROG NEUROBIOL, V93, P509, DOI 10.1016/j.pneurobio.2011.02.002; Pullen AH, 2009, EUR J NEUROSCI, V29, P551, DOI 10.1111/j.1460-9568.2008.06602.x; PULLEN AH, 1983, J PHYSIOL-LONDON, V337, P373, DOI 10.1113/jphysiol.1983.sp014629; Romer SH, 2014, BRAIN RES, V1547, P1, DOI 10.1016/j.brainres.2013.12.012; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Saxena S, 2013, NEURON, V80, P80, DOI 10.1016/j.neuron.2013.07.027; Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620; Shin JH, 2005, NEUROCHEM INT, V46, P641, DOI 10.1016/j.neuint.2004.06.017; STARR KA, 1994, J COMP NEUROL, V345, P345, DOI 10.1002/cne.903450303; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Venugopal S, 2015, J NEUROSCI, V35, P707, DOI 10.1523/JNEUROSCI.1682-14.2015; Wetts R, 2001, J COMP NEUROL, V435, P171, DOI 10.1002/cne.1200; Wilson JM, 2004, J COMP NEUROL, V474, P13, DOI 10.1002/cne.20089; Witts EC, 2014, J ANAT, V224, P52, DOI 10.1111/joa.12063; Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017	52	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135525	10.1371/journal.pone.0135525	http://dx.doi.org/10.1371/journal.pone.0135525			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305672	gold, Green Published, Green Submitted			2022-12-27	WOS:000359995500025
J	Amer, AO; Probert, PM; Dunn, M; Knight, M; Vallance, AE; Flecknell, PA; Oakley, F; Cameron, I; White, SA; Blain, PG; Wright, MC				Amer, Aimen O.; Probert, Philip M.; Dunn, Michael; Knight, Margaret; Vallance, Abigail E.; Flecknell, Paul A.; Oakley, Fiona; Cameron, Iain; White, Steven A.; Blain, Peter G.; Wright, Matthew C.			Sustained Isoprostane E2 Elevation, Inflammation and Fibrosis after Acute Ischaemia-Reperfusion Injury Are Reduced by Pregnane X Receptor Activation	PLOS ONE			English	Article							CONSTITUTIVE ANDROSTANE RECEPTOR; LIVER-TRANSPLANTATION; PXR; F-2-ISOPROSTANES; PROTECTS; CHOLANGIOPATHY; RESOLUTION; EXPRESSION; APOPTOSIS; DEFINES	Liver grafts donated after cardiac death are increasingly used to expand the donor pool but are prone to ischaemic-type biliary lesions. The anti-inflammatory effects of the activated pregnane X receptor have previously been shown to be beneficial in a number of inflammatory liver conditions. However, its role in reducing peri-portal inflammation and fibrosis following ischaemia-reperfusion injury has not been investigated. Hepatic injury and its response to pregnane X receptor activation was examined after partial hepatic ischaemia-reperfusion injury induced by surgically clamping the left and middle lobar blood vessels in rats. Molecular and pathological changes in the liver were examined over the following 28 days. Ischaemia-reperfusion injury resulted in transient cholestasis associated with microvillar changes in biliary epithelial cell membranes and hepatocellular injury which resolved within days after reperfusion. However, in contrast to chemically-induced acute liver injuries, this was followed by sustained elevation in isoprostane E2, peri-portal inflammation and fibrosis that remained unresolved in the ischaemic reperfused lobe for at least 28 days after clamping. Administration of pregnenolone-16 alpha-carbonitrile-a rodent-specific pregnane X receptor activator-resulted in significant reductions in cholestasis, hepatic injury, ischaemic lobe isoprostane E2 levels, peri-portal inflammation and fibrosis. Hepatic ischaemia-reperfusion injury therefore results in inflammatory and fibrotic changes that persist well beyond the initial ischaemic insult. Drug-mediated activation of the pregnane X receptor reduced these adverse changes in rats, suggesting that the pregnane X receptor is a viable drug target to reduce ischaemic-type biliary lesions in recipients of liver transplants donated after cardiac death.	[Amer, Aimen O.; Probert, Philip M.; Dunn, Michael; Knight, Margaret; Vallance, Abigail E.; Oakley, Fiona; Cameron, Iain; White, Steven A.; Blain, Peter G.; Wright, Matthew C.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Dunn, Michael; Knight, Margaret; Blain, Peter G.] Newcastle Univ, Med Toxicol Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Flecknell, Paul A.] Newcastle Univ, Comparat Biol Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Cameron, Iain] Altnagelvin Hosp, Dept Pathol, Altnagelvin, Londonderry, North Ireland	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Wright, MC (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	M.C.Wright@ncl.ac.uk		Flecknell, Paul/0000-0002-1075-1129; Wright, Matthew/0000-0003-3167-6743; Amer, Aimen/0000-0003-0596-686X	Libyan Ministry of Higher Education and Scientific Research; Newcastle University; NC3Rs; MRC [MC_PC_13071, G0900535] Funding Source: UKRI; Medical Research Council [MC_PC_13071, G0900535] Funding Source: researchfish; National Institute for Health Research [ACF-2013-02-006] Funding Source: researchfish; National Centre for the Replacement [NC/K500471/1] Funding Source: researchfish	Libyan Ministry of Higher Education and Scientific Research; Newcastle University; NC3Rs(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); National Centre for the Replacement	AOA received a scholarship from the Libyan Ministry of Higher Education and Scientific Research to complete this work. This work was also supported by a PhD studentship (the NC3Rs) to PMP and by Newcastle University.	Andrews E, 2010, HEPATOLOGY, V51, P1656, DOI 10.1002/hep.23549; Arab HA, 2009, WORLD J GASTROENTERO, V15, P1951, DOI 10.3748/wjg.15.1951; Axon A, 2008, TOXICOLOGY, V246, P40, DOI 10.1016/j.tox.2007.12.008; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Bongoni AK, 2013, CYTOM PART A, V83A, P636, DOI 10.1002/cyto.a.22287; Burr P, 2012, J HEPATOL, V56, pS101, DOI 10.1016/S0168-8278(12)60011-7; Cheng J, 2010, J PHARMACOL EXP THER, V335, P32, DOI 10.1124/jpet.110.170225; COLLETTI LM, 1990, J CLIN INVEST, V85, P1936, DOI 10.1172/JCI114656; Cursio R, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/164329; di Masi A, 2009, MOL ASPECTS MED, V30, P297, DOI 10.1016/j.mam.2009.04.002; Dou Wei, 2013, J Pharmacol Exp Ther, V345, P473, DOI 10.1124/jpet.112.201863; Ebrahimkhani MR, 2011, NAT MED, V17, P1668, DOI 10.1038/nm.2490; Farias SE, 2008, J LIPID RES, V49, P1990, DOI 10.1194/jlr.M800200-JLR200; Hardy KD, 2011, J LIPID RES, V52, P113, DOI 10.1194/jlr.M010264; Haughton EL, 2006, GASTROENTEROLOGY, V131, P194, DOI 10.1053/j.gastro.2006.04.012; Iannelli A, 2009, TRANSPL P, V41, P4099, DOI 10.1016/j.transproceed.2009.08.074; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Jay CL, 2011, ANN SURG, V253, P259, DOI 10.1097/SLA.0b013e318204e658; Jonker JW, 2012, J STEROID BIOCHEM, V130, P147, DOI 10.1016/j.jsbmb.2011.06.012; Kaczmarek B, 2007, TRANSPL P, V39, P2793, DOI 10.1016/j.transproceed.2007.08.081; Kanazawa H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019195; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Li HW, 1999, P NATL ACAD SCI USA, V96, P13381, DOI 10.1073/pnas.96.23.13381; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marek Carylyn J, 2009, Comp Hepatol, V8, P1, DOI 10.1186/1476-5926-8-1; Marek CJ, 2005, BIOCHEM J, V387, P601, DOI 10.1042/BJ20041598; Mencarelli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022978; Milne GL, 2015, BBA-MOL CELL BIOL L, V1851, P433, DOI 10.1016/j.bbalip.2014.10.007; Moore JT, 2000, TOXICOLOGY, V153, P1, DOI 10.1016/S0300-483X(00)00300-0; Morrow JD, 1998, ARCH BIOCHEM BIOPHYS, V353, P160, DOI 10.1006/abbi.1998.0645; MORROW JD, 1992, P NATL ACAD SCI USA, V89, P10721, DOI 10.1073/pnas.89.22.10721; MORROW JD, 1990, ANAL BIOCHEM, V184, P1, DOI 10.1016/0003-2697(90)90002-Q; NHSBT, 2011, TRANSPL ACT UK; Ogura J, 2012, J PHARM PHARM SCI, V15, P616, DOI 10.18433/J38C88; op den Dries S, 2011, TRANSPLANTATION, V92, P373, DOI 10.1097/TP.0b013e318223a384; Pratico D, 1998, P NATL ACAD SCI USA, V95, P3449, DOI 10.1073/pnas.95.7.3449; Probert PME, 2014, TOXICOL RES-UK, V3, P98, DOI 10.1039/c3tx50069a; Rosenfeld JM, 2003, MOL ENDOCRINOL, V17, P1268, DOI 10.1210/me.2002-0421; Ross J, 2010, TOXICOL SCI, V116, P452, DOI 10.1093/toxsci/kfq118; Schlegel A, 2013, J HEPATOL, V59, P984, DOI 10.1016/j.jhep.2013.06.022; Sharma S, 2008, LIVER TRANSPLANT, V14, P759, DOI 10.1002/lt.21509; Shizu R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061802; Stafforini DM, 2006, J BIOL CHEM, V281, P4616, DOI 10.1074/jbc.M507340200; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Staudinger JL, 2003, DRUG METAB DISPOS, V31, P523, DOI 10.1124/dmd.31.5.523; Stedman CAM, 2005, P NATL ACAD SCI USA, V102, P2063, DOI 10.1073/pnas.0409794102; Sun MX, 2015, DRUG METAB DISPOS, V43, P335, DOI 10.1124/dmd.114.062307; Teng S, 2007, BRIT J PHARMACOL, V151, P367, DOI 10.1038/sj.bjp.0707235; Teng S, 2005, J PHARMACOL EXP THER, V312, P841, DOI 10.1124/jpet.104.076141; Wallace K, 2008, BIOCHEM J, V411, P1, DOI 10.1042/BJ20071570; Wallace K, 2010, J STEROID BIOCHEM, V120, P137, DOI 10.1016/j.jsbmb.2010.04.012; Wertheim JA, 2011, AM J TRANSPLANT, V11, P1773, DOI 10.1111/j.1600-6143.2011.03587.x; Wright MC, 2001, GASTROENTEROLOGY, V121, P685, DOI 10.1053/gast.2001.27188; Yagi K, 1998, Methods Mol Biol, V108, P101	54	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136173	10.1371/journal.pone.0136173	http://dx.doi.org/10.1371/journal.pone.0136173			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302150	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900048
J	Gomes, ELFD; Carvalho, CRF; Peixoto-Souza, FS; Teixeira-Carvalho, EF; Mendonca, JFB; Stirbulov, R; Sampaio, LMM; Costa, D				Gomes, Evelim L. F. D.; Carvalho, Celso R. F.; Peixoto-Souza, Fabiana Sobral; Teixeira-Carvalho, Etiene Farah; Barreto Mendonca, Juliana Fernandes; Stirbulov, Roberto; Malosa Sampaio, Luciana Maria; Costa, Dirceu			Active Video Game Exercise Training Improves the Clinical Control of Asthma in Children: Randomized Controlled Trial	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ENERGY-EXPENDITURE; INFLAMMATION; KINECT; CYCLE; TIME	Objective The aim of the present study was to determine whether aerobic exercise involving an active video game system improved asthma control, airway inflammation and exercise capacity in children with moderate to severe asthma. Design A randomized, controlled, single-blinded clinical trial was carried out. Thirty-six children with moderate to severe asthma were randomly allocated to either a video game group (VGG; N = 20) or a treadmill group (TG; n = 16). Both groups completed an eight-week supervised program with two weekly 40-minute sessions. Pre-training and post-training evaluations involved the Asthma Control Questionnaire, exhaled nitric oxide levels (FeNO), maximum exercise testing (Bruce protocol) and lung function. Results No differences between the VGG and TG were found at the baseline. Improvements occurred in both groups with regard to asthma control and exercise capacity. Moreover, a significant reduction in FeNO was found in the VGG (p < 0.05). Although the mean energy expenditure at rest and during exercise training was similar for both groups, the maximum energy expenditure was higher in the VGG. Conclusion The present findings strongly suggest that aerobic training promoted by an active video game had a positive impact on children with asthma in terms of clinical control, improvementin their exercise capacity and a reductionin pulmonary inflammation.	[Gomes, Evelim L. F. D.; Peixoto-Souza, Fabiana Sobral; Teixeira-Carvalho, Etiene Farah; Barreto Mendonca, Juliana Fernandes; Malosa Sampaio, Luciana Maria; Costa, Dirceu] Nove de Julho Univ, Postgrad Program Rehabil Sci, Sao Paulo, Brazil; [Carvalho, Celso R. F.] Univ Sao Paulo, Phys Therapy Dept, Sao Paulo, Brazil; [Stirbulov, Roberto] Santa Casa Sch Med Sci, Sao Paulo, Brazil	Universidade Nove de Julho; Universidade de Sao Paulo	Costa, D (corresponding author), Nove de Julho Univ, Postgrad Program Rehabil Sci, Sao Paulo, Brazil.	dcosta@uninove.br	COSTA, DIRCEU/W-8832-2019; Sampaio, Luciana Maria Malosa/H-9429-2016; COSTA, DIRCEU/GZL-8789-2022; de Freitas Dantas Gomes, Evelim Leal/B-5871-2014; de Carvalho, Etiene F Teixeira/G-7356-2018; Carvalho, Celso RF/B-7626-2012	COSTA, DIRCEU/0000-0002-0334-3899; Sampaio, Luciana Maria Malosa/0000-0002-0110-7710; de Freitas Dantas Gomes, Evelim Leal/0000-0002-0636-6041; de Carvalho, Etiene F Teixeira/0000-0002-5765-7228; Carvalho, Celso RF/0000-0003-3046-3412; Mendonca, Juliana/0000-0001-8989-7931				American Association of Cardiovascular & Pulmonary Rehabilitation, 1998, GUID PULM REH PROGR; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Baquet G, 2010, J STRENGTH COND RES, V24, P1381, DOI 10.1519/JSC.0b013e3181d1575a; Baranowski T, 2012, PEDIATRICS, V129, pE636, DOI 10.1542/peds.2011-2050; Barnes PJ, 2010, CHEST, V138, P682, DOI 10.1378/chest.09-2090; Berthoin S, 2006, EUR J APPL PHYSIOL, V98, P132, DOI 10.1007/s00421-006-0253-2; Biddiss E, 2010, ARCH PEDIAT ADOL MED, V164, P664, DOI 10.1001/archpediatrics.2010.104; Biddle SJH, 2004, J R SOC PROMO HEALTH, V124, P29, DOI 10.1177/146642400312400110; Bonsignore MR, 2008, MED SCI SPORT EXER, V40, P405, DOI [10.1249/mss.0b013e31815d9670, 10.1249/MSS.0b013e31815d9670]; Carson KV, 2013, COCHRANE DB SYST REV, V30, P9; Carson V, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-173; CLARK CJ, 1988, THORAX, V43, P745, DOI 10.1136/thx.43.10.745; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Onis Mercedes, 2007, Bull World Health Organ, V85, P660; del Corral T, 2014, J CYST FIBROS, V13, P706, DOI 10.1016/j.jcf.2014.05.004; Disabella V, 1998, PHYSICIAN SPORTSMED, V26, P75, DOI 10.3810/psm.1998.06.1041; Dogra S, 2011, EUR RESPIR J, V37, P318, DOI 10.1183/09031936.00182209; Drenowatz C, 2011, EUR J APPL PHYSIOL, V111, P883, DOI 10.1007/s00421-010-1695-0; Fanelli A, 2007, MED SCI SPORT EXER, V39, P1474, DOI 10.1249/mss.0b013e3180d099ad; Gao Z, 2013, J SPORT HEALTH SCI, V2, P122, DOI 10.1016/j.jshs.2012.07.001; Giugliano Rodolfo, 2004, J. Pediatr. (Rio J.), V80, P129, DOI 10.1590/S0021-75572004000200010; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; GORAN MI, 1993, J APPL PHYSIOL, V75, P1776, DOI 10.1152/jappl.1993.75.4.1776; Graf DL, 2009, PEDIATRICS, V124, P534, DOI 10.1542/peds.2008-2851; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; Ko FWS, 2012, RESPIROLOGY, V17, P370, DOI 10.1111/j.1440-1843.2011.02105.x; Kuys SS, 2011, J PHYSIOTHER, V57, P35, DOI 10.1016/S1836-9553(11)70005-4; Lamb K.L., 1995, PEDIATR EXERC SCI, V7, P407, DOI 10.1123/pes.7.4.407; LeBlanc AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065351; Leite Mylene, 2008, J. bras. pneumol., V34, P756, DOI 10.1590/S1806-37132008001000002; Maddison R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-524; Mellecker RR, 2014, J SCI MED SPORT, V17, P288, DOI 10.1016/j.jsams.2013.05.008; Mendes FAR, 2010, CHEST, V138, P331, DOI 10.1378/chest.09-2389; Moreira A, 2008, EUR RESPIR J, V32, P1570, DOI 10.1183/09031936.00171707; O'Donovan C, 2012, PHYSIOTHERAPY, V98, P224, DOI 10.1016/j.physio.2012.05.010; Silva LOE, 2011, REV BRAS MED ESPORTE, V17, P393, DOI 10.1590/S1517-86922011000600004; Pakhale S, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-38; Paw MJMCA, 2008, J SCI MED SPORT, V11, P163, DOI 10.1016/j.jsams.2007.06.001; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Peyer K, 2011, RES Q EXERCISE SPORT, V82, P685, DOI 10.1080/02701367.2011.10599805; Polgar P, 1971, PULMONARY TESTING CH, P100; Mendes FAR, 2011, MED SCI SPORT EXER, V43, P197, DOI 10.1249/MSS.0b013e3181ed0ea3; Slutsky AS, 1999, AM J RESP CRIT CARE, V160, P2104; Smallwood SR, 2012, ARCH PEDIAT ADOL MED, V166, P1005, DOI 10.1001/archpediatrics.2012.1271; van der Cammen-van Zijp MHM, 2010, EUR J APPL PHYSIOL, V108, P393, DOI 10.1007/s00421-009-1236-x; Villa F, 2011, ARCH DIS CHILD, V96, P554, DOI 10.1136/adc.2011.212431; Wanrooj VHM, 2013, BR J SPORTS MED	49	21	24	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135433	10.1371/journal.pone.0135433	http://dx.doi.org/10.1371/journal.pone.0135433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301706	gold, Green Published, Green Submitted			2022-12-27	WOS:000359951900017
J	Fonseka, RW; Minnis, AM; Gomez, AM				Fonseka, Ruvani W.; Minnis, Alexandra M.; Gomez, Anu Manchikanti			Impact of Adverse Childhood Experiences on Intimate Partner Violence Perpetration among Sri Lankan Men	PLOS ONE			English	Article							DOMESTIC VIOLENCE; RISK-FACTORS; WOMENS HEALTH; ABUSE; MULTICOUNTRY; PREVALENCE; ATTITUDES; ASIA; DEPRESSION; CHILDREN	In Sri Lanka, over one in three women experience intimate partner violence (IPV) victimization in their lifetime, making it a serious public health concern. Adverse childhood experiences (ACEs) such as child abuse and neglect, witnessing domestic violence, parental separation, and bullying are also widespread. Studies in Western settings have shown positive associations between ACEs and IPV perpetration in adulthood, but few have examined this relationship in a non-Western context. In the present study, we examined the association of ACEs with IPV perpetration among Sri Lankan men surveyed for the UN Multi-Country Study on Men and Violence in Asia and the Pacific. We found statistically significant positive associations between the number of ACE categories (ACE score) and emotional, financial, physical, and sexual IPV perpetration among Sri Lankan men. We analyzed the contributions of each ACE category and found that childhood abuse was strongly associated with perpetration of IPV in adulthood, with sexual abuse associated with the greatest increase in odds of perpetration (Adjusted odds ratio 2.36; 95% confidence interval: 1.69, 3.30). Witnessing abuse of one's mother was associated with the greatest increase in the odds of perpetrating physical IPV (AOR 1.82; 95% CI: 1.29, 2.58), while lack of a male parental figure was not associated with physical IPV perpetration (AOR 0.76; 95% CI: 0.53, 1.09). These findings support a social learning theory of IPV perpetration, in which children who are exposed to violence learn to perpetrate IPV in adulthood. They also suggest that in Sri Lanka, being raised in a female-headed household does not increase the risk of IPV perpetration in adulthood compared to being raised in a household with a male parental figure. The relationship between being raised in a female-headed household (the number of which increased dramatically during Sri Lanka's recent civil war) and perpetration of IPV warrants further study. Interventions that aim to decrease childhood abuse in Sri Lanka could both protect children now and reduce IPV in the future, decreasing violence on multiple fronts.	[Fonseka, Ruvani W.; Minnis, Alexandra M.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Fonseka, Ruvani W.; Gomez, Anu Manchikanti] Univ Calif Berkeley, Sch Social Welf, Berkeley, CA 94720 USA; [Minnis, Alexandra M.] RTI Int, Div Global Hlth, San Francisco, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Research Triangle Institute	Fonseka, RW (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	rfonseka@post.harvard.edu	; Dalal, Koustuv/O-6737-2017	Fonseka, Ruvani W./0000-0002-2809-3574; Gomez, Anu Manchikanti/0000-0002-9461-4411; Dalal, Koustuv/0000-0001-7393-796X; Minnis, Alexandra/0000-0002-2943-2005				Abrahams N, 2005, AM J PUBLIC HEALTH, V95, P1811, DOI 10.2105/AJPH.2003.035006; Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; Ackerson LK, 2008, AM J EPIDEMIOL, V167, P1188, DOI 10.1093/aje/kwn049; Ali NS, 2014, HONG KONG MED J, V20, P297, DOI 10.12809/hkmj134074; Anda R. F., 2006, PHYS GUIDE INTIMATE, P77; [Anonymous], 2011, WORKING PAPER; Assembly UG, 2006, IN DEPTH STUDY ALL F; BANDURA A, 1978, J COMMUN, V28, P12, DOI 10.1111/j.1460-2466.1978.tb01621.x; Barker G., 2011, EVOLVING MEN INITIAL; Bernstein D. P., 1994, AM J PSYCHIAT; Boyagoda K, 2014, THESIS U WAIKATO; Coker AL, 2007, TRAUMA VIOLENCE ABUS, V8, P149, DOI 10.1177/1524838007301162; Contreras Urbina J M, 2005, THESIS LONDON SCH HY; Dalal K, 2012, J ADOLESCENT HEALTH, V50, P437, DOI 10.1016/j.jadohealth.2011.09.012; De Mel N., 2013, BROADENING GENDER WH; Decker MR, 2013, LANCET GLOB HEALTH, V1, pE170, DOI 10.1016/S2214-109X(13)70085-8; Department of Census (DCS) Ministry of Healthcare and Nutrition (MOH), 2009, SRI LANK DEM HLTH SU; Dong MX, 2005, ARCH PEDIAT ADOL MED, V159, P1104, DOI 10.1001/archpedi.159.12.1104; Dube Shanta R, 2002, Violence Vict, V17, P3, DOI 10.1891/vivi.17.1.3.33635; Ehrensaft MK, 2003, J CONSULT CLIN PSYCH, V71, P741, DOI 10.1037/0022-006X.71.4.741; El Kady D, 2005, OBSTET GYNECOL, V105, P357, DOI 10.1097/01.AOG.0000151109.46641.03; Emenike E, 2008, INT NURS REV, V55, P97, DOI 10.1111/j.1466-7657.2007.00580.x; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; FINKELHOR D, 1988, CHILD ABUSE NEGLECT, V12, P3, DOI 10.1016/0145-2134(88)90003-8; Finkelhor D, 2013, JAMA PEDIATR, V167, P70, DOI 10.1001/jamapediatrics.2013.420; Flake DF, 2005, VIOLENCE AGAINST WOM, V11, P353, DOI 10.1177/1077801204272129; Fulu E., 2013, WHY DO SOME MEN USE; Fulu E., 2013, TOOLKIT REPLICATING; Fulu E, 2013, LANCET GLOB HEALTH, V1, pE187, DOI 10.1016/S2214-109X(13)70074-3; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gil-Gonzalez D, 2008, J PUBLIC HEALTH-UK, V30, P14, DOI 10.1093/pubmed/fdm071; Gomez AM., 2010, TESTING CYCLE VIOLEN; Gomez AM, 2009, MATERN CHILD HLTH J, V13, P559, DOI 10.1007/s10995-008-0387-4; Haj-Yahia MM, 2007, J INTERPERS VIOLENCE, V22, P26, DOI 10.1177/0886260506294995; Heise L, 2014, WHAT WORKS PREVENT V; Herrenkohl TI, 2007, J FAM VIOLENCE, V22, P553, DOI 10.1007/s10896-007-9107-x; Ireland TO, 2009, J YOUTH ADOLESCENCE, V38, P323, DOI 10.1007/s10964-008-9347-y; Jayasinghe S, 2009, J FAM STUD, V15, P274, DOI 10.5172/jfs.15.3.274; Jayasuriya V, 2011, VIOLENCE AGAINST WOM, V17, P1086, DOI 10.1177/1077801211417151; Jayatilleke A, 2011, J INTERPERS VIOLENCE, V26, P414, DOI 10.1177/0886260510363420; Jayatilleke AC, 2010, BIOSCI TRENDS, V4, P90; Jewell N, 2003, STAT EPIDEMIOLOGY; Jewkes R, 2002, SOC SCI MED, V55, P1603, DOI 10.1016/S0277-9536(01)00294-5; Jewkes R, 2013, LANCET GLOB HEALTH, V1, pE208, DOI 10.1016/S2214-109X(13)70069-X; Jewkes RK, 2010, CHILD ABUSE NEGLECT, V34, P833, DOI 10.1016/j.chiabu.2010.05.002; Jordal M, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-5; Kitzmann KM, 2003, J CONSULT CLIN PSYCH, V71, P339, DOI 10.1037/0022-006X.71.2.339; Magdol L, 1998, J ABNORM PSYCHOL, V107, P375, DOI 10.1037/0021-843X.107.3.375; Martin SL, 2002, INT J EPIDEMIOL, V31, P560, DOI 10.1093/ije/31.3.560; Miller E, 2011, J EPIDEMIOL COMMUN H, V65, P1006, DOI 10.1136/jech.2009.105429; Orcutt HK, 2003, J TRAUMA STRESS, V16, P381, DOI 10.1023/A:1024470103325; Ruwanpura Kanchana N., 2006, MATRILINEAL COMMUNIT; Ruwanpura KN, 2006, ASIAN POPULATION STU, V2, P187, DOI DOI 10.1080/17441730600923125; Schumacher JA, 2001, AGGRESS VIOLENT BEH, V6, P281, DOI 10.1016/S1359-1789(00)00027-6; Silverman JG, 2007, SEX TRANSM INFECT, V83, P211, DOI 10.1136/sti.2006.023366; Solotaroff JL., 2014, VIOLENCE WOMEN GIRLS; Somasundaram D, 2013, INT J MENT HEALTH SY, V7, DOI 10.1186/1752-4458-7-3; Stephenson R, 2006, INT FAM PLAN PERSPEC, V32, P201, DOI 10.1363/3220106; Varma D, 2007, J AFFECT DISORDERS, V102, P227, DOI 10.1016/j.jad.2006.09.026; Verma RK, 2006, REPROD HEALTH MATTER, V14, P135, DOI 10.1016/S0968-8080(06)28261-2; Vizcarra Beatriz, 2004, Inj Control Saf Promot, V11, P125, DOI 10.1080/15660970412331292351; Whitfield CL, 2003, J INTERPERS VIOLENCE, V18, P166, DOI 10.1177/0886260502238733	63	25	25	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136321	10.1371/journal.pone.0136321	http://dx.doi.org/10.1371/journal.pone.0136321			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26295577	Green Published, gold			2022-12-27	WOS:000359926900100
J	Hwang, MH; Li, XJ; Kim, JE; Jeong, SY; Lee, SW; Lee, J; Ahn, BC				Hwang, Mi-Hye; Li, Xiu Juan; Kim, Jung Eun; Jeong, Shin Young; Lee, Sang-Woo; Lee, Jaetae; Ahn, Byeong-Cheol			Potential Therapeutic Effect of Natural Killer Cells on Doxorubicin-Resistant Breast Cancer Cells In Vitro	PLOS ONE			English	Article							NK CELLS; CELLULAR IMMUNOTHERAPY; LINE; LEUKOCYTES; THERAPIES; OVARIAN	Objective The aim of this study was to explore the therapeutic effect of natural killer (NK) cells on human doxorubicin-sensitive and resistant breast adenocarcinoma. Methods Human doxorubicin-sensitive and resistant breast cancer cell lines (MCF-7 and MCF-7/ADR) were tagged with renilla luciferase (Rluc) (MCF-7/RC and MCF-7/ADR/RC). NK cells were tagged with enhanced firefly luciferase (effluc) using a recombinant retrovirus transfection (NKF). Expression of Rluc, effluc, and NK cell surface markers CD16, CD56 as well as death receptors, DR4 and DR5, were assessed by using flow cytometry. In vitro cytotoxic effect of NK to MCF-7 and MCF-7/ADR was measured and in vivo bioluminescence imaging was also performed to visualize MCF-7/RC, MCF-7/ADR, and NKF in an animal model. Results NK92-MI, MCF-7, and MCF-7/ADR cells were successfully labeled with Rluc or effluc. Both the target breast cancer cells (with Rluc) and therapeutic NK cells (with effluc) were noninvasively visualized in nude mice. Doxorubicin-resistant breast cancer cells (MCF-7/ADR) presented a higher expression of DR5 and were more sensitive to NK cells compared with doxorubicin-sensitive breast cancer cells (MCF-7). Conclusion The results of present study suggest that NK cell therapy has a therapeutic effect on doxorubicin-sensitive and resistant breast cancer cells.	[Hwang, Mi-Hye; Li, Xiu Juan; Kim, Jung Eun; Jeong, Shin Young; Lee, Sang-Woo; Lee, Jaetae; Ahn, Byeong-Cheol] Kyungpook Natl Univ, Sch Med, Dept Nucl Med, Daegu, South Korea	Kyungpook National University	Ahn, BC (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Nucl Med, Daegu, South Korea.	abc2000@knu.ac.kr	Lee, Jaetae/ABF-3980-2020; Lee, Jaetae/AAR-3317-2021; li, xiu/GXV-1745-2022		Medical Cluster R & D Support Project through the Daegu-Gyengbuk Medical Innovation Foundation (DGMIF) - Ministry of Health & Welfare, Republic of Korea [HT13C0002]; National Nuclear R&D Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012M2A2A7014020, NRF-2009-0078234]; Korea Healthcare Technology R & D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A111345]	Medical Cluster R & D Support Project through the Daegu-Gyengbuk Medical Innovation Foundation (DGMIF) - Ministry of Health & Welfare, Republic of Korea; National Nuclear R&D Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Korea Healthcare Technology R & D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This research was supported by a grant from the Medical Cluster R & D Support Project through the Daegu-Gyengbuk Medical Innovation Foundation (DGMIF: http://www.dgmif.re.kr/main.htm), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HT13C0002), BCA received the funding. Grants from the National Nuclear R&D Program through the National Research Foundation of Korea (NRF: www.nrf.re.kr) funded by the Ministry of Education, Science and Technology (No. 2012M2A2A7014020, NRF-2009-0078234), JL received the funding. Grants from the Korea Healthcare Technology R & D Project, Ministry for Health, Welfare & Family Affairs (www.mw.go.kr), Republic of Korea (A111345), SWL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachanova V, 2010, CANCER IMMUNOL IMMUN, V59, P1739, DOI 10.1007/s00262-010-0896-z; Cao X., 2014, MOL PHARM; El-Gazzar A, 2010, MOL CANCER THER, V9, P1007, DOI 10.1158/1535-7163.MCT-09-0933; Eun Kim Jung, 2014, NUCL MED MOL IMAGING, DOI [10.1007/s13139-014-0309-x, DOI 10.1007/S13139-014-0309-X]; Gambhir SS, 1999, P NATL ACAD SCI USA, V96, P2333, DOI 10.1073/pnas.96.5.2333; Geller MA, 2011, CYTOTHERAPY, V13, P98, DOI 10.3109/14653249.2010.515582; Germano S, 2009, CURR CANCER DRUG TAR, V9, P398, DOI 10.2174/156800909788166529; Herberman RB, 2012, NATURAL CELL MEDIATE; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Kim HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070194; Kim JA, 2008, CANCER LETT, V268, P225, DOI 10.1016/j.canlet.2008.03.050; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Mitchell MJ, 2015, EXPERT OPIN DRUG DEL, V12, P375, DOI 10.1517/17425247.2015.966684; Mitchell MJ, 2014, P NATL ACAD SCI USA, V111, P930, DOI 10.1073/pnas.1316312111; Pachynski RK, 2012, J EXP MED, V209, P1427, DOI 10.1084/jem.20112124; Rehemtulla A, 2000, NEOPLASIA, V2, P491, DOI 10.1038/sj.neo.7900121; Roberti MP, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00375; Screpanti V, 2005, MOL IMMUNOL, V42, P495, DOI 10.1016/j.molimm.2004.07.033; Takeda K, 2007, ONCOGENE, V26, P3745, DOI 10.1038/sj.onc.1210374; Tam YK, 1999, HUM GENE THER, V10, P1359, DOI 10.1089/10430349950018030; TAYLOR CW, 1991, BRIT J CANCER, V63, P923, DOI 10.1038/bjc.1991.202; Terme M, 2008, NAT IMMUNOL, V9, P486, DOI 10.1038/ni1580; Tonn T, 2001, J HEMATOTH STEM CELL, V10, P535, DOI 10.1089/15258160152509145; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Yan Y, 1998, CLIN CANCER RES, V4, P2859; Yu P, 2014, ACTA BIOMATER; Zamai L, 2007, J IMMUNOL, V178, P4011, DOI 10.4049/jimmunol.178.7.4011	27	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136209	10.1371/journal.pone.0136209	http://dx.doi.org/10.1371/journal.pone.0136209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295571	Green Submitted, Green Published, gold			2022-12-27	WOS:000359926900082
J	Lacraz, G; Rouleau, AJ; Couture, V; Sollrald, T; Drouin, G; Veillette, N; Grandbois, M; Grenier, G				Lacraz, Gregory; Rouleau, Andre-Jean; Couture, Vanessa; Soellrald, Thomas; Drouin, Genevieve; Veillette, Noemie; Grandbois, Michel; Grenier, Guillaume			Increased Stiffness in Aged Skeletal Muscle Impairs Muscle Progenitor Cell Proliferative Activity	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; STEM-CELL; SATELLITE CELL; EXTRACELLULAR-MATRIX; SELF-RENEWAL; REVERSIBLE QUIESCENCE; CONNECTIVE-TISSUE; ADULT MYOGENESIS; NICHE; REGENERATION	Background Skeletal muscle aging is associated with a decreased regenerative potential due to the loss of function of endogenous stem cells or myogenic progenitor cells (MPCs). Aged skeletal muscle is characterized by the deposition of extracellular matrix (ECM), which in turn influences the biomechanical properties of myofibers by increasing their stiffness. Since the stiffness of the MPC microenvironment directly impacts MPC function, we hypothesized that the increase in muscle stiffness that occurs with aging impairs the behavior of MPCs, ultimately leading to a decrease in regenerative potential. Results We showed that freshly isolated individual myofibers from aged mouse muscles contain fewer MPCs overall than myofibers from adult muscles, with fewer quiescent MPCs and more proliferative and differentiating MPCs. We observed alterations in cultured MPC behavior in aged animals, where the proliferation and differentiation of MPCs were lower and higher, respectively. These alterations were not linked to the intrinsic properties of aged myofibers, as shown by the similar values for the cumulative population-doubling values and fusion indexes. However, atomic force microscopy (AFM) indentation experiments revealed a nearly 4-fold increase in the stiffness of the MPC microenvironment. We further showed that the increase in stiffness is associated with alterations to muscle ECM, including the accumulation of collagen, which was correlated with higher hydroxyproline and advanced glycation end-product content. Lastly, we recapitulated the impaired MPC behavior observed in aging using a hydrogel substrate that mimics the stiffness of myofibers. Conclusions These findings provide novel evidence that the low regenerative potential of aged skeletal muscle is independent of intrinsic MPC properties but is related to the increase in the stiffness of the MPC microenvironment.	[Lacraz, Gregory; Rouleau, Andre-Jean; Couture, Vanessa; Drouin, Genevieve; Veillette, Noemie; Grandbois, Michel; Grenier, Guillaume] Univ Sherbrooke, CRCHUS, Sherbrooke, PQ J1K 2R1, Canada; [Soellrald, Thomas] Univ Sherbrooke, Fac Engn, Dept Elect & Comp Engn, Sherbrooke, PQ J1K 2R1, Canada; [Grandbois, Michel] Univ Sherbrooke, Fac Med, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada; [Grenier, Guillaume] Univ Sherbrooke, Fac Med, Dept Orthoped Surg, Sherbrooke, PQ, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Grenier, G (corresponding author), Univ Sherbrooke, CRCHUS, Sherbrooke, PQ J1K 2R1, Canada.	guillaume.grenier@usherbrooke.ca			Canadian Institutes of Health Research (CIHR) [MOP - 110966]; Canada Foundation for Innovation (CFI); Fonds de Recherche Quebec-Sante (FRQS); CIHR; FRQS	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds de Recherche Quebec-Sante (FRQS); CIHR(Canadian Institutes of Health Research (CIHR)); FRQS	This work was supported by grants from the Canadian Institutes of Health Research (CIHR, http://www.cihr-irsc.gc.ca/) (MOP - 110966), the Canada Foundation for Innovation (CFI), and the Fonds de Recherche Quebec-Sante (FRQS). GL received a scholarship from CIHR. GG received a New Investigator Award from FRQS.	ALNAQEEB MA, 1984, J ANAT, V139, P677; Bentzinger CF, 2014, NAT MED, V20, P234, DOI 10.1038/nm.3499; BILODEAU GG, 1992, J APPL MECH-T ASME, V59, P519, DOI 10.1115/1.2893754; Boirie Y, 2009, J NUTR HEALTH AGING, V13, P717, DOI 10.1007/s12603-009-0203-x; Boonen KJM, 2009, AM J PHYSIOL-CELL PH, V296, pC1338, DOI 10.1152/ajpcell.00015.2009; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Cosgrove BD, 2009, DIFFERENTIATION, V78, P185, DOI 10.1016/j.diff.2009.08.004; Cretu Alexandra, 2010, J Vis Exp, DOI 10.3791/2089; Crick SL, 2007, BIOMECH MODEL MECHAN, V6, P199, DOI 10.1007/S10237-006-0046-x; Cuerrier CM, 2009, PFLUG ARCH EUR J PHY, V457, P1361, DOI 10.1007/s00424-008-0596-0; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8; Garcia-Prat L, 2013, FEBS J, V280, P4051, DOI 10.1111/febs.12221; Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gosselin LE, 1998, J APPL PHYSIOL, V85, P1011; Grenier G, 2003, IN VITRO CELL DEV-AN, V39, P131; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Haus JM, 2007, J APPL PHYSIOL, V103, P2068, DOI 10.1152/japplphysiol.00670.2007; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Meregalli M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00048; Meyer GA, 2011, J BIOMECH, V44, P771, DOI 10.1016/j.jbiomech.2010.10.044; Motohashi N, 2014, FRONTIERS CELL DEV B, V2; NEUMAN RE, 1950, J BIOL CHEM, V186, P549; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Pisconti A, 2010, J CELL BIOL, V190, P427, DOI 10.1083/jcb.201003081; Prado LG, 2005, J GEN PHYSIOL, V126, P461, DOI 10.1085/jgp.200509364; ROWE RWD, 1981, TISSUE CELL, V13, P681, DOI 10.1016/S0040-8166(81)80005-5; Scime A, 2010, MECH AGEING DEV, V131, P9, DOI 10.1016/j.mad.2009.11.001; Serrano AL, 2011, CURR TOP DEV BIOL, V96, P167, DOI 10.1016/B978-0-12-385940-2.00007-3; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Trensz F, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0030-1; Trensz F, 2011, STEM CELLS BIOL REG, P197, DOI 10.1007/978-1-61779-322-6_10; Trensz F, 2010, AM J PHYSIOL-CELL PH, V299, pC939, DOI 10.1152/ajpcell.00253.2010; Tse J.R., 2010, CURR PROTOC CELL BIO, V10, pUnit, DOI [DOI 10.1002/0471143030.CB1016S47, 10.1002/0471143030.cb1016s47]; Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]; Wood LK, 2014, J APPL PHYSIOL, V117, P363, DOI 10.1152/japplphysiol.00256.2014; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	47	77	80	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136217	10.1371/journal.pone.0136217	http://dx.doi.org/10.1371/journal.pone.0136217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295702	gold, Green Published			2022-12-27	WOS:000359926900083
J	Liu, XL; Gai, SS; Zhang, SL; Wang, P				Liu, Xue-Li; Gai, Shuang-Shuang; Zhang, Shi-Le; Wang, Pu			An Analysis of Peer-Reviewed Scores and Impact Factors with Different Citation Time Windows: A Case Study of 28 Ophthalmologic Journals	PLOS ONE			English	Article							SCIENCE; FIELDS; PERFORMANCE; INDEX	Background An important attribute of the traditional impact factor was the controversial 2-year citation window. So far, several scholars have proposed using different citation time windows for evaluating journals. However, there is no confirmation whether a longer citation time window would be better. How did the journal evaluation effects of 3IF, 4IF, and 6IF comparing with 2IF and 5IF? In order to understand these questions, we made a comparative study of impact factors with different citation time windows with the peer-reviewed scores of ophthalmologic journals indexed by Science Citation Index Expanded (SCIE) database. Methods The peer-reviewed scores of 28 ophthalmologic journals were obtained through a self-designed survey questionnaire. Impact factors with different citation time windows (including 2IF, 3IF, 4IF, 5IF, and 6IF) of 28 ophthalmologic journals were computed and compared in accordance with each impact factor's definition and formula, using the citation analysis function of the Web of Science (WoS) database. An analysis of the correlation between impact factors with different citation time windows and peer-reviewed scores was carried out. Results Although impact factor values with different citation time windows were different, there was a high level of correlation between them when it came to evaluating journals. In the current study, for ophthalmologic journals' impact factors with different time windows in 2013, 3IF and 4IF seemed the ideal ranges for comparison, when assessed in relation to peer-reviewed scores. In addition, the 3-year and 4-year windows were quite consistent with the cited peak age of documents published by ophthalmologic journals. Research Limitations Our study is based on ophthalmology journals and we only analyze the impact factors with different citation time window in 2013, so it has yet to be ascertained whether other disciplines (especially those with a later cited peak) or other years would follow the same or similar patterns. Originality/Value We designed the survey questionnaire ourselves, specifically to assess the real influence of journals. We used peer-reviewed scores to judge the journal evaluation effect of impact factors with different citation time windows. The main purpose of this study was to help researchers better understand the role of impact factors with different citation time windows in journal evaluation.	[Liu, Xue-Li] Xinxiang Med Univ, Xinxiang, Henan Province, Peoples R China; [Liu, Xue-Li; Gai, Shuang-Shuang; Zhang, Shi-Le] Xinxiang Med Univ, Henan Res Ctr Sci Journals, Xinxiang, Henan Province, Peoples R China; [Wang, Pu] Xiamen Univ, Tan Kan Kee Coll Lib, Zhangzhou, Fujian Province, Peoples R China	Xinxiang Medical University; Xinxiang Medical University; Xiamen University	Liu, XL (corresponding author), Xinxiang Med Univ, Periodicals Publishing House, Xinxiang, Henan Province, Peoples R China.	hrcsj2009@163.com			National Social Science Fund of China [15BTQ061]	National Social Science Fund of China	This work was supported by the National Social Science Fund of China (15BTQ061).	[Anonymous], 2013, NAT MATER, V12, P89, DOI DOI 10.1038/NMAT3566; [Anonymous], [No title captured]; Betz CL, 2014, J PEDIATR NURS, V29, P1, DOI 10.1016/j.pedn.2013.11.004; Della Sala S, 2010, CORTEX, V46, P1069, DOI 10.1016/j.cortex.2010.07.002; Della Sala S, 2009, CORTEX, V45, P911, DOI 10.1016/j.cortex.2009.04.002; Dorta-Gonzalez P, 2013, J INFORMETR, V7, P593, DOI 10.1016/j.joi.2013.03.005; Dorta-Gonzalez P, 2013, SCIENTOMETRICS, V95, P645, DOI 10.1007/s11192-012-0929-9; Dorta-Gonzalez P, 2015, SCIENTOMETRICS, V102, P1467, DOI 10.1007/s11192-014-1459-4; Dorta-Gonzalez P, 2014, J INFORMETR, V8, P406, DOI 10.1016/j.joi.2014.01.013; Finardi U, 2013, J INFORMETR, V7, P357, DOI 10.1016/j.joi.2012.12.004; Gai SS, 2014, CHINESE J SCI TECHNO, V25, P980; GARFIELD E, 1988, SCIENTIST, V2, P11; GARFIELD E, 1955, SCIENCE, V122, P108, DOI 10.1126/science.122.3159.108; GARFIELD E, 1963, AM DOC, V14, P195, DOI 10.1002/asi.5090140304; GARFIELD E, 1972, SCIENCE, V178, P471, DOI 10.1126/science.178.4060.471; Garfield E., 1988, SCIENTIST, V12, P12; Ha TC, 2006, ANN ACAD MED SINGAP, V35, P911; HARNAD S, 2008, ETHICS SCI ENV POLIT, V8, P103; He Yinf, 2012, LIB INFORM SERVICE, V56, P33; Huang MH, 2012, ONLINE INFORM REV, V36, P639, DOI 10.1108/14684521211275957; Jacso P, 2010, ONLINE INFORM REV, V34, P496, DOI 10.1108/14684521011054099; Jacso P, 2009, ONLINE INFORM REV, V33, P603, DOI 10.1108/14684520910969989; Leydesdorff L, 2013, J AM SOC INF SCI TEC, V64, P96, DOI 10.1002/asi.22765; Leydesdorff L, 2011, J AM SOC INF SCI TEC, V62, P2133, DOI 10.1002/asi.21609; Liu XL, 2014, METHOD PREDICTING IM, P87; Martyn J, 1968, EVALUATION BRIT SCI; Campanario JM, 2011, SCIENTOMETRICS, V88, P421, DOI 10.1007/s11192-011-0387-9; Campanario JM, 2011, SCIENTOMETRICS, V87, P189, DOI 10.1007/s11192-010-0334-1; Perez-Hornero P, 2013, J INFORMETR, V7, P1, DOI 10.1016/j.joi.2012.08.004; Ren SL, 2009, CHINESE J SCI TECHNO, V20, P415; Rizkallah J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010204; Seglen PO, 1997, BRIT MED J, V314, P498; Shao PJ, 2005, P 5 AS E BUS WORKSH; Shubert E, 2012, SYST BIODIVERS, V10, P391, DOI 10.1080/14772000.2012.753716; Sombatsompop N, 2004, SCIENTOMETRICS, V60, P217, DOI 10.1023/B:SCIE.0000027794.98854.f6; Tort ABL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053374; van Leeuwen TN, 1999, J INFORM SCI, V25, P489, DOI 10.1177/016555159902500605; van Nierop E, 2010, STAT NEERL, V64, P71, DOI 10.1111/j.1467-9574.2009.00448.x; Vanclay JK, 2008, J INFORMETR, V2, P326, DOI 10.1016/j.joi.2008.07.002; Vanclay JK, 2012, SCIENTOMETRICS, V92, P211, DOI 10.1007/s11192-011-0561-0; Wang P, 2014, CHINESE J SCI TECHNO, V25, P833; Weale AR, 2004, BMC MED RES METHODOL, V4, P1; Yoshikane F, 2014, SCIENTOMETRICS, V98, P1879, DOI 10.1007/s11192-013-1165-7; Yu G, 2008, STUDIES SCI SCI, P183; Zhao Xing, 2010, J LIB SCI CHINA, V36, P120	45	12	14	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135583	10.1371/journal.pone.0135583	http://dx.doi.org/10.1371/journal.pone.0135583			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26295157	gold, Green Published, Green Submitted			2022-12-27	WOS:000359926900034
J	Possner, DDD; Claesson, M; Guy, JE				Possner, Dominik D. D.; Claesson, Magnus; Guy, Jodie E.			Structure of the Glycosyltransferase Ktr4p from Saccharomyces cerevisiae	PLOS ONE			English	Article							MANNOSYLPHOSPHATE TRANSFER; CRYSTAL-STRUCTURE; GENE FAMILY; YEAST; GLYCOSYLATION; KRE2P/MNT1P; MECHANISM; VIRULENCE; PROTEINS; COMPLEX	In the yeast Saccharomyces cerevisiae, members of the Kre2/Mnt1 protein family have been shown to be alpha-1,2-mannosyltransferases or alpha-1,2-mannosylphosphate transferases, utilising an Mn2+-coordinated GDP-mannose as the sugar donor and a variety of mannose derivatives as acceptors. Enzymes in this family are localised to the Golgi apparatus, and have been shown to be involved in both N- and O-linked glycosylation of newly-synthesised proteins, including cell wall glycoproteins. Our knowledge of the nine proteins in this family is however very incomplete at present. Only one family member, Kre2p/Mnt1p, has been studied by structural methods, and three (Ktr4p, Ktr5p, Ktr7p) are completely uncharacterised and remain classified only as putative glycosyltransferases. Here we use in vitro enzyme activity assays to provide experimental confirmation of the predicted glycosyltransferase activity of Ktr4p. Using GDP-mannose as the donor, we observe activity towards the acceptor methyl-alpha-mannoside, but little or no activity towards mannose or alpha-1,2-mannobiose. We also present the structure of the lumenal catalytic domain of S. cerevisiae Ktr4p, determined by X-ray crystallography to a resolution of 2.2 angstrom, and the complex of the enzyme with GDP to 1.9 angstrom resoultion.	[Possner, Dominik D. D.; Guy, Jodie E.] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Claesson, Magnus] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm University	Guy, JE (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Tomtebodavagen 6, S-17177 Stockholm, Sweden.	jodie.guy@ki.se		Guy, Jodie/0000-0003-0331-0699	Ake Wibergs Stiftelse; European Community [283570]	Ake Wibergs Stiftelse; European Community(European Commission)	This work was supported by funding awarded to JEG from the Ake Wibergs Stiftelse (ake-wiberg.se). Access to BESSY was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (grant agreement No283570). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buurman ET, 1998, P NATL ACAD SCI USA, V95, P7670, DOI 10.1073/pnas.95.13.7670; Cho JH, 2014, BIOSCI BIOTECH BIOCH, V65, P2226; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; Empadinhas N, 2011, MOL MICROBIOL, V79, P76, DOI 10.1111/j.1365-2958.2010.07432.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; HAUN RS, 1992, BIOTECHNIQUES, V13, P515; HILL K, 1992, GENETICS, V130, P273; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jigami Y, 1999, BBA-GEN SUBJECTS, V1426, P335, DOI 10.1016/S0304-4165(98)00134-2; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Lobsanov YD, 2004, J BIOL CHEM, V279, P17921, DOI 10.1074/jbc.M312720200; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lussier M, 1997, J BIOL CHEM, V272, P15527, DOI 10.1074/jbc.272.24.15527; Lussier M, 1996, J BIOL CHEM, V271, P11001, DOI 10.1074/jbc.271.18.11001; Lussier M, 1999, BBA-GEN SUBJECTS, V1426, P323, DOI 10.1016/S0304-4165(98)00133-0; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Munro S, 2001, FEBS LETT, V498, P223, DOI 10.1016/S0014-5793(01)02488-7; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Noda Y, 2014, BIOL OPEN, V3, P209, DOI 10.1242/bio.20146312; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Unligil UM, 2000, EMBO J, V19, P5269, DOI 10.1093/emboj/19.20.5269; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; Wang JJ, 2014, FUNGAL GENET BIOL, V70, P1, DOI 10.1016/j.fgb.2014.06.010; Wang XH, 1997, J BIOL CHEM, V272, P18117, DOI 10.1074/jbc.272.29.18117; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	33	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136239	10.1371/journal.pone.0136239	http://dx.doi.org/10.1371/journal.pone.0136239			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296208	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900087
J	Salvadeo, CJ; Gomez-Gallardo, A; Najera-Caballero, M; Urban-Ramirez, J; Lluch-Belda, D				Salvadeo, Christian J.; Gomez-Gallardo U, Alejandro; Najera-Caballero, Mauricio; Urban-Ramirez, Jorge; Lluch-Belda, Daniel			The Effect of Climate Variability on Gray Whales (Eschrichtius robustus) within Their Wintering Areas	PLOS ONE			English	Article							EASTERN NORTH PACIFIC; SEA-ICE; INTERANNUAL VARIABILITY; ENSO VARIABILITY; BERING-SEA; CALIFORNIA; ABUNDANCE; FLUCTUATIONS; OSCILLATION; TRENDS	The environmental conditions of the breeding and feeding grounds of the gray whale (Eschrichtius robustus) fluctuates at inter-annual scales in response to regional and basin climate patterns. Thus, the goals of this study were to assess if there are any relationships between summer sea ice on their feeding ground and counts of gray whale mother-calf (MC) pairs at Ojo de Liebre Lagoon (OLL); and if El Nino Southern Oscillation (ENSO) influences the winter distribution of gray whales MC pairs in the three primary breeding lagoons of OLL, San Ignacio Lagoon (SIL) and Santo Domingo Channel north of Bahia Magdalena (SDCh). Maximum February counts of MC pairs were compared with the length of the open-water season at the Bering Sea during the previous year. Then, an ENSO index and sea surface temperature anomalies outside the primary lagoons was compared with the maximum February counts of MC pairs at these lagoons. Results showed that maximum counts of MC pairs in OLL correlates with sea ice conditions in their feeding grounds from the previous feeding season, and this relationship can be attributed to changes in nutritive condition of females. ENSO-related variability influences distribution of MC pairs in the southern area of SDCh during the warm 1998 El Nino and cold 1999 La Nina. This supports the hypothesis that changes in the whales' distribution related to sea temperature occurs to reduce thermal- stress and optimize energy utilization for newborn whales. Although this last conclusion should be considered in view of the limited data available from all the whales' wintering locations in all the years considered.	[Salvadeo, Christian J.; Gomez-Gallardo U, Alejandro; Najera-Caballero, Mauricio; Urban-Ramirez, Jorge] Univ Autonoma Baja California Sur, La Paz 23081, Mexico; [Salvadeo, Christian J.] Ctr Invest Biol Noroeste SC, Inst Politecn Nacl, La Paz 23096, Mexico; [Lluch-Belda, Daniel] Ctr Interdisciplinario Ciencias Marinas, Inst Politecn Nacl, La Paz 23096, Mexico	Universidad Autonoma de Baja California; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico	Salvadeo, CJ (corresponding author), Univ Autonoma Baja California Sur, Ap Post 19-B, La Paz 23081, Mexico.	chsalvadeo@yahoo.com.mx	R., Jorge Urbán/J-8126-2019	R., Jorge Urbán/0000-0003-1423-8573	Consejo Nacional de Ciencia y Tecnologia (CONACYT); Ocean Foundation; Exportadora de Sal SA de CV; CONACYT; Ecoturismo Kuyima	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ocean Foundation; Exportadora de Sal SA de CV; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ecoturismo Kuyima	Thank you to Consejo Nacional de Ciencia y Tecnologia (CONACYT) for financial support for research projects; the Ocean Foundation for financial support to monitoring programs in the lagoons; and the Exportadora de Sal SA de CV, for financial support to monitoring programs at El Vizcaino Biosphere Reserve. Ecoturismo Kuyima gave the authors great logistic and financial support at their facilities at San Ignacio lagoon. The authors are grateful for the scholarships and support to students given by CONACYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAMISH RJ, 1993, CAN J FISH AQUAT SCI, V50, P1002, DOI 10.1139/f93-116; BERTA A, 2006, MARINE MAMMALS EVOLU; Bradford AL, 2012, J MAMMAL, V93, P251, DOI 10.1644/11-MAMM-A-091.1; Bradford Amanda L., 2008, Endangered Species Research, V6, P1, DOI 10.3354/esr00106; Braithwaite JE, 2015, POLAR BIOL, V38, P1195, DOI 10.1007/s00300-015-1685-0; Brown ZW, 2012, ICES J MAR SCI, V69, P1180, DOI 10.1093/icesjms/fss113; Calambokidis J, 2009, MAR MAMMAL SCI, V25, P816, DOI 10.1111/j.1748-7692.2009.00298.x; Cardenas-Hinojosa G, 2004, THESIS U AUTONOMA BA; Cayan D.R., 1990, P 7 ANN PAC CLIM PAC, P115; Christiansen F, 2014, FUNCT ECOL, V28, P579, DOI 10.1111/1365-2435.12200; Clapham P, 2001, MAR MAMMAL SCI, V17, P432, DOI 10.1111/j.1748-7692.2001.tb01289.x; Cooke JG, 2013, INT WHAL COMM SCI CO; Gardner SC, 2000, MAR MAMMAL SCI, V16, P728, DOI 10.1111/j.1748-7692.2000.tb00968.x; Gilmore R. M., 1960, Spec Sci Rep Fisheries US Fish and Wildlife Serv, VNo.342, P1; Holbrook SJ, 1997, ECOL APPL, V7, P1299; Jones M. L., 1984, GRAY WHALE ESCHRICHT, P309; Kawasaki T, 1983, FAO FISH REP, V291, P1065; Kerosky SM, 2012, DEEP-SEA RES PT I, V65, P125, DOI 10.1016/j.dsr.2012.03.013; Laake J., 2009, NMFSAFSC203 NOAA; Le Boeuf B. J., 2000, Journal of Cetacean Research and Management, V2, P85; Leaper R, 2006, BIOL LETTERS, V2, P289, DOI 10.1098/rsbl.2005.0431; Lluch-Belda D, 2005, FISH OCEANOGR, V14, P458, DOI 10.1111/j.1365-2419.2005.00347.x; Lluch-Belda D, 2003, CAL COOP OCEAN FISH, V44, P76; LLUCHBELDA D, 1989, S AFR J MARINE SCI, V8, P195, DOI 10.2989/02577618909504561; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Medrano-Gonzalez L, 2015, REGISTROS BALLENA GR; Miller CA, 2011, MAR ECOL PROG SER, V438, P267, DOI 10.3354/meps09174; Moore JE, 2011, J APPL ECOL, V48, P1195, DOI 10.1111/j.1365-2664.2011.02018.x; Moore SE, 2008, J MAMMAL, V89, P534, DOI 10.1644/07-MAMM-S-312R1.1; Nerini M., 1984, P423; Perryman WL, 2002, MAR MAMMAL SCI, V18, P121, DOI 10.1111/j.1748-7692.2002.tb01023.x; Punt Andre E., 2012, Journal of Cetacean Research and Management, V12, P15; Rasmussen K, 2007, BIOLOGY LETT, V3, P302, DOI 10.1098/rsbl.2007.0067; Ripa P, 2002, CIENC MAR, V28, P79; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Salvadeo CJ, 2011, CIENC MAR, V37, P215, DOI 10.7773/cm.v37i2.1840; Salvadeo C, 2011, CLIMATE CHANGE - GEOPHYSICAL FOUNDATIONS AND ECOLOGICAL EFFECTS, P217; Sasaki YN, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002486; Schwing FB, 2002, PROG OCEANOGR, V53, P115, DOI 10.1016/S0079-6611(02)00027-7; SHANE SH, 1995, MAR ECOL PROG SER, V123, P5, DOI 10.3354/meps123005; Shelden KEW, 2004, ECOL APPL, V14, P1789, DOI 10.1890/03-5349; Stafford KM, 2007, ARCTIC, V60, P167; Sumich J. L., 1986, THESIS OREGON STATE; TERSHY BR, 1991, MAR ECOL PROG SER, V69, P299, DOI 10.3354/meps069299; Tynan C. T, 1999, PICES SCI REP, V10, P115; Urban R. J., 2003, Journal of Cetacean Research and Management, V5, P281; URBAN RJ, 2003, GEOFIS INT, V42, P439; Wang CZ, 2006, PROG OCEANOGR, V69, P239, DOI 10.1016/j.pocean.2006.03.004; Woodgate RA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026931; Yeates LC, 2008, J EXP BIOL, V211, P3249, DOI 10.1242/jeb.020610	50	18	18	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134655	10.1371/journal.pone.0134655	http://dx.doi.org/10.1371/journal.pone.0134655			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309028	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400029
J	Xia, H; Huang, XJ; Guo, Y; Hu, PZ; He, GX; Deng, X; Xu, HB; Yang, ZJ; Deng, H				Xia, Hong; Huang, Xiangjun; Guo, Yi; Hu, Pengzhi; He, Guangxiang; Deng, Xiong; Xu, Hongbo; Yang, Zhijian; Deng, Hao			Identification of a Novel MYO15A Mutation in a Chinese Family with Autosomal Recessive Nonsyndromic Hearing Loss	PLOS ONE			English	Article							UNCONVENTIONAL MYOSIN; DEAFNESS DFNB3; CELL STEREOCILIA; GENETIC-ANALYSIS; POPULATION; XVA; IMPAIRMENT; SPECTRUM; VARIANTS; SHAKER-2	Autosomal recessive nonsyndromic hearing loss (ARNSHL) is a genetically heterogeneous sensorineural disorder, generally manifested with prelingual hearing loss and absence of other clinical manifestations. The aim of this study is to identify the pathogenic gene in a four-generation consanguineous Chinese family with ARNSHL. A novel homozygous variant, c.9316dupC (p.H3106Pfs*2), in the myoxin XVa gene (MYO15A) was identified by exome sequencing and Sanger sequencing. The homozygous MYO15A c.9316dupC variant co-segregated with the phenotypes in the ARNSHL family and was absent in two hundred normal controls. The variant was predicted to interfere with the formation of the Myosin XVa-whirlin-Eps8 complex at the tip of stereocilia, which is indispensable for stereocilia elongation. Our data suggest that the homozygous MYO15A c.9316dupC variant might be the pathogenic mutation, and exome sequencing is a powerful molecular diagnostic strategy for ARNSHL, an extremely heterogeneous disorder. Our findings extend the mutation spectrum of the MYO15A gene and have important implications for genetic counseling for the family.	[Xia, Hong; Huang, Xiangjun; Guo, Yi; Deng, Xiong; Xu, Hongbo; Yang, Zhijian; Deng, Hao] Cent S Univ, Xiangya Hosp 3, Ctr Med Expt, Changsha, Hunan, Peoples R China; [Xia, Hong; Huang, Xiangjun; Guo, Yi; Deng, Xiong; Xu, Hongbo; Yang, Zhijian; Deng, Hao] Cent S Univ, Xiangya Hosp 3, Dept Neurol, Changsha, Hunan, Peoples R China; [Xia, Hong] Cent S Univ, Xiangya Hosp 3, Dept Emergency, Changsha, Hunan, Peoples R China; [Guo, Yi] Cent S Univ, Xiangya Sch Med, Dept Med Informat, Changsha, Hunan, Peoples R China; [Hu, Pengzhi] Cent S Univ, Xiangya Hosp 3, Dept Radiol, Changsha, Hunan, Peoples R China; [He, Guangxiang] Cent S Univ, Xiangya Hosp 3, Dept Otolaryngol Head & Neck Surg, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University; Central South University; Central South University	Deng, H (corresponding author), Cent S Univ, Xiangya Hosp 3, Ctr Med Expt, Changsha, Hunan, Peoples R China.	hdeng008@yahoo.com	GUO, YI/AAW-2801-2021; Deng, Hao/O-6340-2017	Deng, Hao/0000-0003-3240-4352	National Natural Science Foundation of China [81271921, 81441033]; Hunan Provincial Innovation Foundation for Postgraduate, China [7138000008]; Top-notch Innovative Doctoral Scholarship of Central South University, China [2014bjjxj039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Innovation Foundation for Postgraduate, China; Top-notch Innovative Doctoral Scholarship of Central South University, China	This work was supported by grants from National Natural Science Foundation of China (81271921 and 81441033), Hunan Provincial Innovation Foundation for Postgraduate, China (7138000008), and the Top-notch Innovative Doctoral Scholarship of Central South University, China (2014bjjxj039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SH, 2013, GENE, V522, P65, DOI 10.1016/j.gene.2013.02.057; Bashir R, 2012, EUR J MED GENET, V55, P99, DOI 10.1016/j.ejmg.2011.12.003; Belguith H, 2009, GENET TEST MOL BIOMA, V13, P147, DOI 10.1089/gtmb.2008.0077; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Brownstein Z, 2014, EUR J HUM GENET, V22, P768, DOI 10.1038/ejhg.2013.232; Brownstein Z, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r89; Cengiz FB, 2010, GENET TEST MOL BIOMA, V14, P543, DOI 10.1089/gtmb.2010.0039; Chang Mun Young, 2014, Korean J Audiol, V18, P45, DOI 10.7874/kja.2014.18.2.45; Diaz-Horta O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050628; Dror AA, 2010, NEURON, V68, P293, DOI 10.1016/j.neuron.2010.10.011; Duman D, 2012, FRONT BIOSCI-LANDMRK, V17, P2213, DOI 10.2741/4046; Duman D, 2011, GENET TEST MOL BIOMA, V15, P29, DOI 10.1089/gtmb.2010.0120; Fattahi Z, 2012, AM J MED GENET A, V158A, P1857, DOI 10.1002/ajmg.a.34411; FRIEDMAN TB, 1995, NAT GENET, V9, P86, DOI 10.1038/ng0195-86; Gao X, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-284; Gu X, 2015, CLIN GENET, V87, P588, DOI 10.1111/cge.12431; Guo Y, 2013, NEUROSCI LETT, V555, P134, DOI 10.1016/j.neulet.2013.09.037; Hoefsloot LH, 2014, CLIN GENET, V85, P514, DOI 10.1111/cge.12339; Imtiaz F, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-91; Kalay E, 2007, AM J MED GENET A, V143A, P2382, DOI 10.1002/ajmg.a.31937; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lezirovitz K, 2008, EUR J HUM GENET, V16, P89, DOI 10.1038/sj.ejhg.5201917; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang Y, 1999, GENOMICS, V61, P243, DOI 10.1006/geno.1999.5976; Liang Y, 1998, AM J HUM GENET, V62, P904, DOI 10.1086/301786; Liburd N, 2001, HUM GENET, V109, P535, DOI 10.1007/s004390100604; Mahdieh N, 2012, INT J PEDIATR OTORHI, V76, P1610, DOI 10.1016/j.ijporl.2012.07.030; Manor U, 2011, CURR BIOL, V21, P167, DOI 10.1016/j.cub.2010.12.046; Miyagawa M, 2015, ANN OTO RHINOL LARYN, V124, p158S, DOI 10.1177/0003489415575058; Miyagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075793; Miyagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071381; Nal N, 2007, HUM MUTAT, V28, P1014, DOI 10.1002/humu.20556; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Riahi Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099797; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shafique S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100146; Shahin H, 2010, EUR J HUM GENET, V18, P407, DOI 10.1038/ejhg.2009.190; Shearer AE, 2014, AM J HUM GENET, V95, P445, DOI 10.1016/j.ajhg.2014.09.001; Shearer AE, 2009, LARYNGOSCOPE, V119, P727, DOI 10.1002/lary.20116; Stanton SG, 2014, AM J AUDIOL, V23, P190, DOI 10.1044/2014_AJA-13-0040; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang QJ, 2005, AM J MED GENET A, V133A, P27, DOI 10.1002/ajmg.a.30424; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; Woo HM, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-72; Wu CC, 2011, LARYNGOSCOPE, V121, P1287, DOI 10.1002/lary.21751; Yang T, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-85; Yuan LM, 2015, BIOL CHEM, V396, P27, DOI 10.1515/hsz-2014-0187; Zheng W, 2013, NEUROBIOL AGING, V34, P2073	52	6	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136306	10.1371/journal.pone.0136306	http://dx.doi.org/10.1371/journal.pone.0136306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308726	Green Submitted, Green Published, gold			2022-12-27	WOS:000360069400104
J	Amugsi, DA; Mittelmark, MB; Oduro, A				Amugsi, Dickson Abanimi; Mittelmark, Maurice B.; Oduro, Abraham			Association between Maternal and Child Dietary Diversity: An Analysis of the Ghana Demographic and Health Survey	PLOS ONE			English	Article							QUALITY; HABITS	Objective (s) This study examined the association between maternal and child dietary diversity in a population-based national sample in Ghana. Methods The data for this analysis are from the 2008 Ghana Demographic and Health Survey. We used data obtained from 1187 dyads comprised of mothers' ages 15-49 and their youngest child (ages 6-36 months). Maternal and child dietary diversity scores (DDS) were created based on the mother's recall of her own and her child's consumption of 15 food groups, during the 24 hours prior to the in-home survey. The same food groups were used to compose both maternal and child DDS. Linear regression was used to assess the relationship between the predicted outcome-child DDS-and maternal DDS, taking into account child age and sex, maternal factors (age, education, occupation, literacy, empowerment, number of antenatal visits as an indicator of health care use), household Wealth Index, and urban/ rural place of residence. Results There was a statistically significant positive association between child and maternal DDS, after adjusting for all other variables. A difference of one food group in mother's consumption was associated with a difference of 0.72 food groups in the child's food consumption (95% CI: 0.63, 0.82). Also, statistically significant positive associations were observed such that higher child DDS was associated with older child age, and with greater women's empowerment. Conclusions The results show a significant positive association between child and maternal DD, after accounting for the influence of child, maternal and household level factors. Since the likely path of influence is that maternal DDS impacts child DDS, public health efforts to improve child health may be strengthened by promoting maternal DDS due to its potential for a widened effect on the entire family.	[Amugsi, Dickson Abanimi; Oduro, Abraham] Navrongo Hlth Res Ctr, Navrongo, Upper East Regi, Ghana; [Amugsi, Dickson Abanimi; Mittelmark, Maurice B.] Univ Bergen, Fac Psychol, Dept Hlth Promot & Dev, Bergen, Norway	Navrongo Health Research Center; University of Bergen	Amugsi, DA (corresponding author), Navrongo Hlth Res Ctr, Navrongo, Upper East Regi, Ghana.	damugsi2002@yahoo.com	Amugsi, Dickson A./AAG-3004-2020	ODURO, ABRAHAM/0000-0002-4191-7419; Amugsi, DICKSON A/0000-0002-5261-8481				Ackatia-Armah R, 2011, DIETARY DIVERSITY BR; Ajieroh V, 2009, QUANTITATIVE ANAL DE; Amugsi D. A., 2014, British Journal of Medicine and Medical Research, V4, P4310, DOI 10.9734/BJMMR/2014/10014; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Australasian child and adolescent obesity research network (ACAORN), DIET INT ASS 24 HR R; Bhagowalia P, 2012, WHAT DIMENSIONS WOME; Cincinnati Childrens Hospital Medical Center, 3 4 HEAV BREASTF INF; DETTWYLER K A, 1989, American Journal of Human Biology, V1, P683, DOI 10.1002/ajhb.1310010606; Dewey K, 2003, GUIDING PRINCIPAL CO; Ekesa B.N., 2011, AFRICAN J FOOD AGR N, V11; Fisk CM, 2011, BRIT J NUTR, V105, P287, DOI 10.1017/S0007114510003302; Food and Nutrition Technical Assistance (FANTA), 2006, FANTA PROJ WORK GOUP; Ghana Statistical Service (GSS) Ghana Health Service (GHS), 2009, DEM HLTH SURV 2008; Hanoi Medical University, 2010, TECHN REP FORM RES I; Hart CN, 2010, CHILD CARE HLTH DEV, V36, P396, DOI 10.1111/j.1365-2214.2010.01072.x; Hoerr SL, 2006, J AM DIET ASSOC, V106, P1766, DOI 10.1016/j.jada.2006.08.017; Kennedy GL, 2007, J NUTR, V137, P472, DOI 10.1093/jn/137.2.472; Lee Seung-yeon, 2005, MCN Am J Matern Child Nurs, V30, P60; Liu WH, 2013, FEEDING ATTITUDES PR; Mishra V, 2009, ASIAN ECON J, V23, P225, DOI 10.1111/j.1467-8381.2009.02010.x; Moursi MM, 2008, J NUTR, V138, P2448, DOI 10.3945/jn.108.093971; Nguyen PH, 2013, J NUTR, V143, P1176, DOI 10.3945/jn.112.172247; Nti CA., 2011, ASIAN J MED SCI, V2, P105, DOI [10.3126/ajms.v2i2.4179, DOI 10.3126/AJMS.V2I2.4179]; Ogunba BO, 2010, DIET DIVERSITY COMPL; Oniang'o RK, 1999, APPETITE, V32, P93, DOI 10.1006/appe.1998.0201; Pachon H, 2002, FOOD NUTR B S, V23; PAHO, 2001, GUID PRINC COMPL FEE; Pearson N, 2009, PUBLIC HEALTH NUTR, V12, P267, DOI 10.1017/S1368980008002589; Rah JH, 2010, J CLIN NUTR; Robinson S, 2007, BRIT J NUTR, V98, P1029, DOI 10.1017/S0007114507750936; Savage JS, 2007, J LAW MED ETHICS, V35, P22, DOI 10.1111/j.1748-720X.2007.00111.x; Skafida V, 2013, SOCIOL HEALTH ILL, V35, P906, DOI 10.1111/1467-9566.12007; Steyn NP, 2006, PUBLIC HEALTH NUTR, V9, P644, DOI 10.1079/PHN2005912; Swanson V, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-65; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Thompson F. E., 2013, NUTR PREVENTION TREA; USAID, 2011, INT NUTR ED ETH URB; USAID, 2012, MAT DIET DIV IMPL CH; WHO, 2009, IND ASS INF YOUNG 2; Yohannes Y, 2002, DIETARY DIVERSITY FO; Zeitlin MF, 1995, PARENTS CULTURAL BEL, P558; Zuercher JL, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-131	42	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136748	10.1371/journal.pone.0136748	http://dx.doi.org/10.1371/journal.pone.0136748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6KK	26305458	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500113
J	Bhattacharya, D; Dunaway, EP; Bhattacharya, S; Bloemer, J; Buabeid, M; Escobar, M; Suppiramaniam, V; Dhanasekaran, M				Bhattacharya, D.; Dunaway, E. P.; Bhattacharya, S.; Bloemer, J.; Buabeid, M.; Escobar, M.; Suppiramaniam, V.; Dhanasekaran, M.			Impaired ILK Function Is Associated with Deficits in Hippocampal Based Memory and Synaptic Plasticity in a FASD Rat Model	PLOS ONE			English	Article							PRENATAL ALCOHOL EXPOSURE; AMPA RECEPTOR TRAFFICKING; INTEGRIN-LINKED KINASE; ETHANOL; NEUROGENESIS; EXPRESSION; CHILDREN; CONSUMPTION; MECHANISMS; DORSAL	Fetal Alcohol Spectrum Disorder (FASD) is an umbrella term that encompasses a wide range of anatomical and behavioral problems in children who are exposed to alcohol during the prenatal period. There is no effective treatment for FASD, because of lack of complete characterization of the cellular and molecular mechanisms underlying this condition. Alcohol has been previously characterized to affect integrins and growth factor signaling receptors. Integrin Linked Kinase (ILK) is an effector of integrin and growth-factor signaling which regulates various signaling processes. In FASD, a downstream effector of ILK, Glycogen Synthase Kinase 3 beta (GSK3 beta) remains highly active (reduced Ser(9) phosphorylation). GSK3 beta has been known to modulate glutamate receptor trafficking and channel properties. Therefore, we hypothesize that the cognitive deficits accompanying FASD are associated with impairments in the ILK signaling pathway. Pregnant Sprague Dawley rats consumed a "moderate" amount of alcohol throughout gestation, or a calorie-equivalent sucrose solution. Contextual fear conditioning was used to evaluate memory performance in 32-33-day-old pups. Synaptic plasticity was assessed in the Schaffer Collateral pathway, and hippocampal protein lysates were used to evaluate ILK signaling. Alcohol exposed pups showed impaired contextual fear conditioning, as compared to control pups. This reduced memory performance was consistent with decrease in LTP as compared to controls. Hippocampal ILK activity and GSK3 beta Ser(21/9) phosphorylation were significantly lower in alcohol-exposed pups than controls. Increased synaptic expression of GluR2 AMPA receptors was observed with immunoprecipitation of post-synaptic density protein 95 (PSD95). Furthermore, immunoprecipitation of ILK revealed a decreased interaction with GluR2. The ILK pathway appears to play a significant role in memory and synaptic plasticity impairments in FASD rats. These impairments appear to be mediated by reduced GSK3 beta regulation and increased synaptic stabilization of the calcium-impermeable GluR2 AMPA receptors.	[Bhattacharya, D.; Bhattacharya, S.; Bloemer, J.; Buabeid, M.; Suppiramaniam, V.; Dhanasekaran, M.] Auburn Univ, Dept Drug Discovery & Dev, Auburn, AL 36849 USA; [Dunaway, E. P.; Escobar, M.] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Dhanasekaran, M (corresponding author), Auburn Univ, Dept Drug Discovery & Dev, Auburn, AL 36849 USA.	dhanamu@auburn.edu	Bloemer, Jenna/AAE-3548-2020	Bloemer, Jenna/0000-0002-1090-0286; Escobar, Martha/0000-0002-0110-3525				Aberg E, 2005, INT J NEUROPSYCHOPH, V8, P557, DOI 10.1017/S1461145705005286; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Aronson M, 1997, DEV MED CHILD NEUROL, V39, P583; Bartsch T, 2011, P NATL ACAD SCI USA, V108, P17562, DOI 10.1073/pnas.1110266108; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Benitez-King G, 2004, CNS NEUROL DISORD-DR, V3, P515, DOI 10.2174/1568007043336761; Bird CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118721; Brady ML, 2013, J NEUROSCI, V33, P1062, DOI 10.1523/JNEUROSCI.1217-12.2013; Brady ML, 2012, ALCOHOL CLIN EXP RES, V36, P457, DOI 10.1111/j.1530-0277.2011.01644.x; Brigadski T, 2014, E NEUROFORUM, V20, P1, DOI DOI 10.1007/S13295-014-0053-9; Briones TL, 2013, NEUROSCIENCE, V254, P324, DOI 10.1016/j.neuroscience.2013.09.031; Burd L, 2003, NEUROTOXICOL TERATOL, V25, P697, DOI 10.1016/j.ntt.2003.07.014; Cardenas VA, 2014, NEUROIMAGE-CLIN, V4, P295, DOI 10.1016/j.nicl.2014.01.002; Chen Q, 2010, J MOL NEUROSCI, V40, P284, DOI 10.1007/s12031-009-9218-3; Chung HJ, 2000, J NEUROSCI, V20, P7258; Cullen CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101482; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Feng MJ, 2005, BRAIN RES, V1042, P125, DOI 10.1016/j.brainres.2005.02.017; Ferrer-Donato A, 2013, DEV NEUROSCIENCE, V36, P10; GIANOULAKIS C, 1990, BEHAV BRAIN RES, V36, P217, DOI 10.1016/0166-4328(90)90060-R; Goggin SL, 2014, TOXICOL REP, V1, P544, DOI 10.1016/j.toxrep.2014.08.005; Graham DM, 2013, ALCOHOL CLIN EXP RES, V37, pE338, DOI 10.1111/j.1530-0277.2012.01886.x; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hernandez F, 2009, BRAIN RES BULL, V80, P248, DOI 10.1016/j.brainresbull.2009.05.017; Humphriss R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002718; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; JONES KL, 1973, LANCET, V2, P999; Kalberg WO, 2013, INT J ALCOHOL DRUG R, P2; Klintsova AY, 2007, ALCOHOL CLIN EXP RES, V31, P2073, DOI 10.1111/j.1530-0277.2007.00528.x; Kryukov V. I., 2008, Journal of Integrative Neuroscience, V7, P117, DOI 10.1142/S021963520800171X; Kully-Martens K, 2012, J PEDIATR PSYCHOL, V37, P725, DOI 10.1093/jpepsy/jsr123; Lebel C, 2011, NEUROPSYCHOL REV, V21, P102, DOI 10.1007/s11065-011-9163-0; Li M, 2012, BEHAV BRAIN RES, V231, P146, DOI 10.1016/j.bbr.2012.03.010; Liu SJ, 2012, J PHYSIOL-LONDON, V590, P13, DOI 10.1113/jphysiol.2011.213926; Lupton C, 2004, AM J MED GENETICS C; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mills J, 2003, J NEUROSCI, V23, P1638; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Patten AR, 2014, FRONTIERS PEDIAT, P2; PHILLIPS RG, 1994, LEARN MEMORY, V1, P34; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; samhsa, FET ALC SPECTR DIS T; Shonesy BC, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.002; Smith CC, 2015, ALCOHOL CLIN EXP RES, V39, P36, DOI 10.1111/acer.12606; Tyler CR, 2014, ALCOHOL, V48, P483, DOI 10.1016/j.alcohol.2014.06.001; Wijayawardhane N, 2007, NEUROBIOL DIS, V26, P696, DOI 10.1016/j.nbd.2007.03.009; Xu J, 2003, J BIOL CHEM, V278, P26929, DOI 10.1074/jbc.M300401200; Xu X, 2015, REPROD SCI; Yang JM, 2014, CELL REP, V7, P796, DOI 10.1016/j.celrep.2014.03.040; Yao XH, 2008, AM J PHYSIOL-REG I, V294, pR1797, DOI 10.1152/ajpregu.00804.2007	52	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135700	10.1371/journal.pone.0135700	http://dx.doi.org/10.1371/journal.pone.0135700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305322	gold, Green Published, Green Submitted			2022-12-27	WOS:000359995500030
J	Jia, LH; Liu, W; Guan, LZ; Lu, M; Wang, KW				Jia, Linghan; Liu, Wen; Guan, Lizhao; Lu, Min; Wang, Kewei			Inhibition of Calcium-Activated Chloride Channel ANO1/TMEM16A Suppresses Tumor Growth and Invasion in Human Lung Cancer	PLOS ONE			English	Article							REGULATORY VOLUME DECREASE; CA2+-ACTIVATED CL-CHANNEL; SQUAMOUS-CELL CARCINOMA; BREAST-CANCER; ION CHANNELS; TRANSCRIPTOME ANALYSIS; PROSTATE-CANCER; 11Q13 AMPLICON; ORAL-CANCER; TMEM16A	Lung cancer or pulmonary carcinoma is primarily derived from epithelial cells that are thin and line on the alveolar surfaces of the lung for gas exchange. ANO1/TMEM16A, initially identified from airway epithelial cells, is a member of Ca2(+)-activated Cl- channels (CaCCs) that function to regulate epithelial secretion and cell volume for maintenance of ion and tissue homeostasis. ANO1/TMEM16A has recently been shown to be highly expressed in several epithelium originated carcinomas. However, the role of ANO1 in lung cancer remains unknown. In this study, we show that inhibition of calcium-activated chloride channel ANO1/TMEM16A suppresses tumor growth and invasion in human lung cancer. ANO1 is upregulated in different human lung cancer cell lines. Knocking-down ANO1 by small hairpin RNAs inhibited proliferation, migration and invasion of GLC82 and NCI-H520 cancel cells evaluated by CCK-8, would-healing, transwell and 3D soft agar assays. ANO1 protein is overexpressed in 77.3% cases of human lung adenocarcinoma tissues detected by immunohistochemistry. Furthermore, the tumor growth in nude mice implanted with GLC82 cells was significantly suppressed by ANO1 silencing. Taken together, our findings provide evidence that ANO1 overexpression contributes to tumor growth and invasion of lung cancer; and suppressing ANO1 overexpression may have therapeutic potential in lung cancer therapy.	[Jia, Linghan; Liu, Wen; Guan, Lizhao; Wang, Kewei] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Dept Mol & Cellular Pharmacol, Beijing 100191, Peoples R China; [Lu, Min] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100191, Peoples R China; [Wang, Kewei] Qingdao Univ, Sch Pharm, Dept Pharmacol, Qingdao 266021, Peoples R China	Peking University; Peking University; Qingdao University	Wang, KW (corresponding author), Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Dept Mol & Cellular Pharmacol, Beijing 100191, Peoples R China.	wangkw@bjmu.edu.cn			Ministry of Science and Technology of China [2013CB531302, 2014ZX09507003-006-004]; National Science Foundation of China	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants to KWW from the Ministry of Science and Technology of China (2013CB531302 and 2014ZX09507003-006-004) and the National Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERVALL JA, 1995, CANCER, V76, P853, DOI 10.1002/1097-0142(19950901)76:5<853::AID-CNCR2820760520>3.0.CO;2-6; Aryal P, 2015, J MOL BIOL, V427, P121, DOI 10.1016/j.jmb.2014.07.030; Berglund E, 2014, EXP CELL RES, V326, P315, DOI 10.1016/j.yexcr.2014.05.003; Bill A, 2015, ONCOTARGET, V6, P9173, DOI 10.18632/oncotarget.3277; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Carles A, 2006, ONCOGENE, V25, P1821, DOI 10.1038/sj.onc.1209203; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Diss JKJ, 2005, PROSTATE CANCER P D, V8, P266, DOI 10.1038/sj.pcan.4500796; Duran C, 2010, ANNU REV PHYSIOL, V72, P95, DOI 10.1146/annurev-physiol-021909-135811; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Fan WD, 2012, ASIAN PAC J CANCER P, V13, P1477, DOI 10.7314/APJCP.2012.13.4.1477; Forrest AS, 2012, AM J PHYSIOL-CELL PH, V303, pC1229, DOI 10.1152/ajpcell.00044.2012; Fraser SP, 2005, CLIN CANCER RES, V11, P5381, DOI 10.1158/1078-0432.CCR-05-0327; Furst J, 2002, PFLUG ARCH EUR J PHY, V444, P1, DOI 10.1007/s00424-002-0805-1; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Haussinger D, 1996, BIOCHEM J, V313, P697; Hille B, 2001, ION CHANNELS OF EXCI; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Huang X, 2002, P NATL ACAD SCI USA, V99, P11369, DOI 10.1073/pnas.172285799; Huang X, 2006, GENE CHROMOSOME CANC, V45, P1058, DOI 10.1002/gcc.20371; Katoh M, 2003, INT J ONCOL, V22, P1375; Kerrigan MJP, 2008, OSTEOARTHR CARTILAGE, V16, P312, DOI 10.1016/j.joca.2007.07.006; Kim TH, 2015, J MED FOOD, V18, P332, DOI 10.1089/jmf.2013.3135; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lang F, 2005, J MEMBRANE BIOL, V205, P147, DOI 10.1007/s00232-005-0780-5; Liu W, 2012, CANCER LETT, V326, P41, DOI 10.1016/j.canlet.2012.07.015; Malumbres M, 2006, CANCER CELL, V9, P2, DOI 10.1016/j.ccr.2005.12.026; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Mazzone A, 2012, BIOCHEM BIOPH RES CO, V427, P248, DOI 10.1016/j.bbrc.2012.09.022; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pedersen SF, 2013, CANCER RES, V73, P1658, DOI 10.1158/0008-5472.CAN-12-4188; Perez-Cornejo P, 2012, P NATL ACAD SCI USA, V109, P10376, DOI 10.1073/pnas.1200174109; Razik MA, 2002, BIOL RES, V35, P203, DOI 10.4067/s0716-97602002000200011; Rowell NP, 2001, THORAX, V56, P628, DOI 10.1136/thorax.56.8.628; Ruiz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043265; Santos-Martinez MJ, 2005, ARCH BRONCONEUMOL, V41, P307, DOI 10.1157/13075998; Sauter DRP, 2015, PFLUG ARCH EUR J PHY, V467, P1495, DOI 10.1007/s00424-014-1598-8; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Schwab M, 1998, BIOESSAYS, V20, P473, DOI 10.1002/(SICI)1521-1878(199806)20:6<473::AID-BIES5>3.3.CO;2-N; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sui YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115443; Tsavaler L, 2001, CANCER RES, V61, P3760; Ubby I, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-75; Wang P, 2012, MOL CELL BIOCHEM, V365, P313, DOI 10.1007/s11010-012-1271-5; Wanitchakool P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0096; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; WRIGHT JC, 1985, J NATL MED ASSOC, V77, P815; Xu B, 2014, ONCOTARGET; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhou Zi-Liang, 2014, Shengli Xuebao, V66, P341	54	39	41	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136584	10.1371/journal.pone.0136584	http://dx.doi.org/10.1371/journal.pone.0136584			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305547	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500096
J	Migliore, E; Zugna, D; Galassi, C; Merletti, F; Gagliardi, L; Rasero, L; Trevisan, M; Rusconi, F; Richiardi, L				Migliore, Enrica; Zugna, Daniela; Galassi, Claudia; Merletti, Franco; Gagliardi, Luigi; Rasero, Laura; Trevisan, Morena; Rusconi, Franca; Richiardi, Lorenzo			Prenatal Paracetamol Exposure and Wheezing in Childhood: Causation or Confounding?	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; BIRTH COHORT; ASTHMA; ACETAMINOPHEN; RISK; CHILDREN; PREGNANCY; SYMPTOMS; INFANCY; LIFE	Background Several studies have reported an increased risk of wheezing in the children of mothers who used paracetamol during pregnancy. We evaluated to what extent this association is explained by confounding. Methods We investigated the association between maternal paracetamol use in the first and third trimester of pregnancy and ever wheezing or recurrent wheezing/asthma in infants in the NIN-FEA cohort study. Risks ratios (RR) and 95% confidence intervals (CI) were estimated after adjustment for confounders, including maternal infections and antibiotic use during pregnancy. Results The prevalence of maternal paracetamol use was 30.6% during the first and 36.7% during the third trimester of pregnancy. The prevalence of ever wheezing and recurrent wheezing/asthma was 16.9% and 5.6%, respectively. After full adjustment, the RR for ever wheezing decreased from 1.25 [1.07-1.47] to 1.10 [0.94-1.30] in the first, and from 1.26 [1.08-1.47] to 1.10 [0.93-1.29] in the third trimester. A similar pattern was observed for recurrent wheezing/asthma. Duration of maternal paracetamol use was not associated with either outcome. Further analyses on paracetamol use for three non-infectious disorders (sciatica, migraine, and headache) revealed no increased risk of wheezing in children. Conclusion The association between maternal paracetamol use during pregnancy and infant wheezing is mainly, if not completely explained by confounding.	[Migliore, Enrica; Zugna, Daniela; Galassi, Claudia; Merletti, Franco; Trevisan, Morena; Richiardi, Lorenzo] CERMS, CPO Piemonte, AOU Citta Salute & Sci Torino, Canc Epidemiol Unit,Dept Med Sci, Turin, Italy; [Migliore, Enrica; Zugna, Daniela; Galassi, Claudia; Merletti, Franco; Trevisan, Morena; Richiardi, Lorenzo] Univ Turin, Turin, Italy; [Gagliardi, Luigi] Osped Versilia, Woman & Child Hlth Dept, Pediat & Neonatol Div, Viareggio, Italy; [Rasero, Laura] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Rusconi, Franca] Anna Meyer Childrens Univ Hosp, Epidemiol Unit, Florence, Italy	A.O.U. Citta della Salute e della Scienza di Torino; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; University of Turin; Ospedale Versilia; University of Florence; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER	Migliore, E (corresponding author), CERMS, CPO Piemonte, AOU Citta Salute & Sci Torino, Canc Epidemiol Unit,Dept Med Sci, Turin, Italy.	enrica.migliore@cpo.it	Rusconi, Franca/K-2346-2016; Gagliardi, Luigi/K-2144-2016; Galassi, Claudia/K-3041-2016; Trevisan, Morena/J-9088-2016; richiardi, lorenzo/J-3480-2018	Rusconi, Franca/0000-0002-9544-6472; Gagliardi, Luigi/0000-0001-6074-8975; Galassi, Claudia/0000-0003-1502-4390; Trevisan, Morena/0000-0001-7982-7411; richiardi, lorenzo/0000-0003-0316-9402	Compagnia San Paolo	Compagnia San Paolo(Compagnia di San Paolo)	The study was partly supported by the Compagnia San Paolo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Andersen Ane Birgitte Telen, 2012, Clin Epidemiol, V4, P33, DOI 10.2147/CLEP.S28312; Bakkeheim E, 2011, ACTA PAEDIATR, V100, P90, DOI 10.1111/j.1651-2227.2010.01942.x; Brand PLP, 2008, EUR RESPIR J, V32, P1096, DOI 10.1183/09031936.00002108; Cheelo M, 2015, ARCH DIS CHILD, V100, P81, DOI 10.1136/archdischild-2012-303043; Ducharme FM, 2014, LANCET, V383, P1593, DOI 10.1016/S0140-6736(14)60615-2; Goksor E, 2011, ACTA PAEDIATR, V100, P1567, DOI 10.1111/j.1651-2227.2011.02403.x; Heintze K, 2013, EUR J CLIN PHARMACOL, V69, P1197, DOI 10.1007/s00228-012-1463-7; Hughes CH, 1999, CLIN EXP ALLERGY, V29, P1378; ISAAC, 1993, MAN PHAS ON; Kallen B, 2013, PEDIAT ALLERG IMM-UK, V24, P28, DOI 10.1111/pai.12034; Kang EM, 2009, OBSTET GYNECOL, V114, P1295, DOI 10.1097/AOG.0b013e3181c225c0; Kreiner-Moller E, 2012, J ALLERGY CLIN IMMUN, V130, P1434, DOI 10.1016/j.jaci.2012.09.017; Lowe AJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4616; MICHELI L, 1994, ENVIRON HEALTH PERSP, V102, P63, DOI 10.1289/ehp.94102s963; Persky V, 2008, ANN ALLERG ASTHMA IM, V101, P271, DOI 10.1016/S1081-1206(10)60492-9; Perzanowski MS, 2010, THORAX, V65, P118, DOI 10.1136/thx.2009.121459; Pizzi C, 2012, J EPIDEMIOL COMMUN H, V66, P976, DOI 10.1136/jech-2011-200065; Rebordosa C, 2008, INT J EPIDEMIOL, V37, P583, DOI 10.1093/ije/dyn070; Richiardi L, 2007, EUR J EPIDEMIOL, V22, P831, DOI 10.1007/s10654-007-9194-2; Richiardi L, 2013, INT J EPIDEMIOL, V42, P1018, DOI 10.1093/ije/dyt103; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Schnabel E, 2010, J ALLERGY CLIN IMMUN, V126, P1071, DOI 10.1016/j.jaci.2010.08.023; Scialli AR, 2010, REPROD TOXICOL, V30, P508, DOI 10.1016/j.reprotox.2010.09.005; Shaheen SO, 2005, CLIN EXP ALLERGY, V35, P18, DOI 10.1111/j.1365-2222.2005.02151.x; Shaheen SO, 2002, THORAX, V57, P958, DOI 10.1136/thorax.57.11.958; Sordillo JE, 2015, J ALLERGY CLIN IMMUN, V135, P441, DOI 10.1016/j.jaci.2014.07.065; Varner AE, 1998, ANN ALLERG ASTHMA IM, V81, P347, DOI 10.1016/S1081-1206(10)63127-4; Weatherall M, 2015, CLIN EXP ALLERGY, V45, P108, DOI 10.1111/cea.12410	29	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135775	10.1371/journal.pone.0135775	http://dx.doi.org/10.1371/journal.pone.0135775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305473	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500032
J	Polak, GL; Pasqualino, A; Docherty, JEB; Beck, SJ; DiAngelo, JR				Polak, Grzegorz L.; Pasqualino, Anthony; Docherty, James E. B.; Beck, Stephen J.; DiAngelo, Justin R.			The Regulation of Muscle Structure and Metabolism by Mio/dChREBP in Drosophila	PLOS ONE			English	Article							POLYSACCHARIDE STORAGE MYOPATHY; SKELETAL-MUSCLE; FLIGHT-MUSCLE; MUSCULAR-DYSTROPHY; GENE-EXPRESSION; TRANSCRIPTION FACTORS; ACTIN MUTANTS; PROTEIN; MELANOGASTER; DEFECTS	All cells require energy to perform their specialized functions. Muscle is particularly sensitive to the availability of nutrients due to the high-energy requirement for muscle contraction. Therefore the ability of muscle cells to obtain, store and utilize energy is essential for the function of these cells. Mio, the Drosophila homolog of carbohydrate response element binding protein (ChREBP), has recently been identified as a nutrient responsive transcription factor important for triglyceride storage in the fly fat body. However, the function of Mio in muscle is unknown. In this study, we characterized the role of Mio in controlling muscle function and metabolism. Decreasing Mio levels using RNAi specifically in muscle results in increased thorax glycogen storage. Adult Mio-RNAi flies also have a flight defect due to altered myofibril shape and size in the indirect flight muscles as shown by electron microscopy. Myofibril size is also decreased in flies just before emerging from their pupal cases, suggesting a role for Mio in myofibril development. Together, these data indicate a novel role for Mio in controlling muscle structure and metabolism and may provide a molecular link between nutrient availability and muscle function.	[Polak, Grzegorz L.; Pasqualino, Anthony; Docherty, James E. B.; DiAngelo, Justin R.] Hofstra Univ, Dept Biol, Hempstead, NY 11549 USA; [Beck, Stephen J.] Nassau Community Coll, Dept Biol, Garden City, NY 11530 USA; [DiAngelo, Justin R.] Penn State Berks, Div Sci, Reading, PA 19610 USA	Hofstra University; State University of New York (SUNY) System; SUNY Community College; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	DiAngelo, JR (corresponding author), Hofstra Univ, Dept Biol, Hempstead, NY 11549 USA.	jrd5671@psu.edu			National Institutes of Health [1R15NS080155-01A1]; Hofstra University; NSF [DBI-1337525]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS080155] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hofstra University; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (www.nih.gov) grant 1R15NS080155-01A1 and funds from Hofstra University to JRD and NSF (www.nsf.gov) grant DBI-1337525 to SJB and JRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.36; An HS, 1996, J MOL BIOL, V260, P492, DOI 10.1006/jmbi.1996.0417; Andersen H, 1997, DIABETOLOGIA, V40, P1062, DOI 10.1007/s001250050788; Barrey E, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-29; BERNSTEIN SI, 1993, INT REV CYTOL, V143, P63; Billin AN, 2006, CURR TOP MICROBIOL, V302, P255; Billin AN, 2000, MOL CELL BIOL, V20, P8845, DOI 10.1128/MCB.20.23.8845-8854.2000; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; CRIPPS RM, 1994, GENETICS, V137, P151; DEAK II, 1982, J EMBRYOL EXP MORPH, V69, P61; DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Felice KJ, 1996, MUSCLE NERVE, V19, P1608; Figueroa-Clarevega A, 2015, DEV CELL, V33, P47, DOI 10.1016/j.devcel.2015.03.001; Haigh SE, 2010, NEUROMUSCULAR DISORD, V20, P363, DOI 10.1016/j.nmd.2010.03.008; Han HQ, 2013, INT J BIOCHEM CELL B, V45, P2333, DOI 10.1016/j.biocel.2013.05.019; Hanke N, 2011, BBA-MOL CELL RES, V1813, P377, DOI 10.1016/j.bbamcr.2010.12.021; Havula E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003438; Havula E, 2012, SEMIN CELL DEV BIOL, V23, P640, DOI 10.1016/j.semcdb.2012.02.007; He ZB, 2004, AM J PHYSIOL-ENDOC M, V287, pE424, DOI 10.1152/ajpendo.00568.2003; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; KOANA T, 1978, J EMBRYOL EXP MORPH, V45, P123; KRONERT WA, 1995, J MOL BIOL, V249, P111, DOI 10.1006/jmbi.1995.0283; LAKEY A, 1993, EMBO J, V12, P2863, DOI 10.1002/j.1460-2075.1993.tb05948.x; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; McCue ME, 2009, VET PATHOL, V46, P1281, DOI 10.1354/vp.08-VP-0177-M-FL; MOMMAERTS WFHM, 1959, P NATL ACAD SCI USA, V45, P791, DOI 10.1073/pnas.45.6.791; Musselman LP, 2013, J BIOL CHEM, V288, P8028, DOI 10.1074/jbc.M112.371047; ODONNELL PT, 1988, J CELL BIOL, V107, P2601, DOI 10.1083/jcb.107.6.2601; OWEN OE, 1978, ADV MOD NUTR, V2, P517; Peterson CW, 2010, MOL CELL BIOL, V30, P2887, DOI 10.1128/MCB.01613-09; Peyrefitte S, 2001, MECH DEVELOP, V104, P99, DOI 10.1016/S0925-4773(01)00360-4; Ranganayakulu G, 1998, DEVELOPMENT, V125, P3037; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Ryall JG, 2008, BIOGERONTOLOGY, V9, P213, DOI 10.1007/s10522-008-9131-0; Salvi SS, 2012, J MOL BIOL, V419, P22, DOI 10.1016/j.jmb.2012.02.025; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sans CL, 2006, MOL CELL BIOL, V26, P4863, DOI 10.1128/MCB.00657-05; Sassu ED, 2012, BIOCHEM BIOPH RES CO, V426, P43, DOI 10.1016/j.bbrc.2012.08.028; Sullivan DT, 2003, J EXP BIOL, V206, P2031, DOI 10.1242/jeb.00367; Towle HC, 2005, TRENDS ENDOCRIN MET, V16, P489, DOI 10.1016/j.tem.2005.10.003; VIGOREAUX JO, 1993, J CELL BIOL, V121, P587, DOI 10.1083/jcb.121.3.587; WARMKE J, 1992, J CELL BIOL, V119, P1523, DOI 10.1083/jcb.119.6.1523; Wojtas K, 1997, MOL BIOL CELL, V8, P1665, DOI 10.1091/mbc.8.9.1665; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	49	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136504	10.1371/journal.pone.0136504	http://dx.doi.org/10.1371/journal.pone.0136504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305467	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500086
J	Uhlig, C; Krause, H; Koch, T; de Abreu, MG; Spieth, PM				Uhlig, Christopher; Krause, Hannes; Koch, Thea; de Abreu, Marcelo Gama; Spieth, Peter Markus			Anesthesia and Monitoring in Small Laboratory Mammals Used in Anesthesiology, Respiratory and Critical Care Research: A Systematic Review on the Current Reporting in Top-10 Impact Factor Ranked Journals	PLOS ONE			English	Review							GENERAL-ANESTHESIA; PAIN MANAGEMENT; ANIMAL RESEARCH; CARBON-DIOXIDE; MICE; HYPOTHERMIA; GUIDELINES; AGE; SENSITIVITY; ANALGESIA	Rationale This study aimed to investigate the quality of reporting of anesthesia and euthanasia in experimental studies in small laboratory mammals published in the top ten impact factor journals. Methods A descriptive systematic review was conducted and data was abstracted from the ten highest ranked journals with respect to impact factor in the categories 'Anesthesiology', 'Critical Care Medicine' and 'Respiratory System' as defined by the 2012 Journal Citation Reports. Inclusion criteria according to PICOS criteria were as follows: 1) population: small laboratory mammals; 2) intervention: any form of anesthesia and/or euthanasia; 3) comparison: not specified; 4) primary outcome: type of anesthesia, anesthetic agents and type of euthanasia; secondary outcome: animal characteristics, monitoring, mechanical ventilation, fluid management, postoperative pain therapy, animal care approval, sample size calculation and performed interventions; 5) study: experimental studies. Anesthesia, euthanasia, and monitoring were analyzed per performed intervention in each article. Results The search yielded 845 articles with 1,041 interventions of interest. Throughout the manuscripts we found poor quality and frequency of reporting with respect to completeness of data on animal characteristics as well as euthanasia, while anesthesia (732/1041, 70.3%) and interventions without survival (970/1041, 93.2%) per se were frequently reported. Premedication and neuromuscular blocking agents were reported in 169/732 (23.1%) and 38/732 (5.2%) interventions, respectively. Frequency of reporting of analgesia during (117/610, 19.1%) and after painful procedures (38/364, 10.4%) was low. Euthanasia practice was reported as anesthesia (348/501, 69%), transcardial perfusion (37/501, 8%), carbon dioxide (26/501, 6%), decapitation (22/501, 5%), exsanguination (23/501, 5%), other (25/501, 5%) and not specified (20/501, 4%, respectively. Conclusions The present systematic review revealed insufficient reporting of anesthesia and euthanasia methods throughout experimental studies in small laboratory mammals. Specific guidelines for anesthesia and euthanasia regimens should be considered to achieve comparability, quality of animal experiments and animal welfare. These measures are of special interest when translating experimental findings to future clinical applications.	[Uhlig, Christopher; Krause, Hannes; Koch, Thea; de Abreu, Marcelo Gama; Spieth, Peter Markus] Tech Univ Dresden, Univ Hosp Dresden, Pulm Engn Grp, Dept Anesthesiol & Intens Care Therapy, D-01062 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital	Spieth, PM (corresponding author), Tech Univ Dresden, Univ Hosp Dresden, Pulm Engn Grp, Dept Anesthesiol & Intens Care Therapy, D-01062 Dresden, Germany.	peter.spieth@uniklinikum-dresden.de	Spieth, Peter/C-2928-2011	Spieth, Peter/0000-0003-3953-3253				Al-Hashimi M, 2013, BRIT J ANAESTH, V111, P80, DOI 10.1093/bja/aet153; American Veterinary Medical Association, 2013, AVMA GUIDELINES FOR; Bara M, 2014, CRIT CARE, V18, DOI 10.1186/cc13694; Beckman B, 2013, VET CLIN N AM-SMALL, V43, P669, DOI 10.1016/j.cvsm.2013.02.006; Bednarski R, 2011, J AM ANIM HOSP ASSOC, V47, P377, DOI 10.5326/JAAHA-MS-5846; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; BOLANDER HG, 1984, ARCH INT PHARMACOD T, V267, P213; Bouzom F, 2012, BIOPHARM DRUG DISPOS, V33, P55, DOI 10.1002/bdd.1767; Boyko M, 2013, J NEUROSURG ANESTH, V25, P174, DOI 10.1097/ANA.0b013e31827ee0ac; Cesarovic N, 2012, J AM ASSOC LAB ANIM, V51, P209; Conlee KM, 2005, LAB ANIM-UK, V39, P137, DOI 10.1258/0023677053739747; Coulter CA, 2009, LAB ANIM-UK, V43, P232, DOI 10.1258/la.2008.008021; Coulter CA, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-12; Cove ME, 2012, BEST PRACT RES-CLIN, V26, P453, DOI 10.1016/j.bpa.2012.10.003; Di Ianni ME, 2012, J CHEM INF MODEL, V52, P3325, DOI 10.1021/ci300423q; Festing S, 2005, ATLA-ALTERN LAB ANIM, V33, P654, DOI 10.1177/026119290503300603; FLECKNELL PA, 1993, BRIT J ANAESTH, V71, P885, DOI 10.1093/bja/71.6.885; Flecknell P, 2007, ALTEX-ALTERN TIEREXP, V24, P82; Fuentes JM, 2006, CLIN VACCINE IMMUNOL, V13, P281, DOI 10.1128/CVI.13.2.281-288.2006; Galley HF, 2000, INTENS CARE MED, V26, P267, DOI 10.1007/s001340051149; Gargiulo S, 2012, ILAR J, V53, pE55, DOI 10.1093/ilar.53.1.55; Gorska P, 2000, Med Sci Monit, V6, P171; Gruber Franz P, 2004, ALTEX, V21 Suppl 1, P3; Guillen J, 2012, J AM ASSOC LAB ANIM, V51, P311; Hawkins P, 2002, LAB ANIM-UK, V36, P378, DOI 10.1258/002367702320389044; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Huiku M, 2007, BRIT J ANAESTH, V98, P447, DOI 10.1093/bja/aem004; Kanazawa M, 2010, J NUTR SCI VITAMINOL, V56, P117, DOI 10.3177/jnsv.56.117; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KOBLIN DD, 1983, ANESTHESIOLOGY, V58, P428, DOI 10.1097/00000542-198305000-00006; Kos M, 2006, SURG ENDOSC, V20, P570, DOI 10.1007/s00464-004-2175-6; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Larsson JE, 1998, ACTA ANAESTH SCAND, V42, P987, DOI 10.1111/j.1399-6576.1998.tb05360.x; Lindenblatt N, 2005, AM J PHYSIOL-HEART C, V289, pH2680, DOI 10.1152/ajpheart.00425.2005; Luan F, 2013, BIOORGAN MED CHEM, V21, P1870, DOI 10.1016/j.bmc.2013.01.035; Merchant R, 2013, CAN J ANESTH, V60, P63, DOI 10.1007/s12630-012-9820-7; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Perry P, 2007, ILAR J, V48, P42, DOI 10.1093/ilar.48.1.42; Picha B, 2012, NATURE, V485, P41, DOI 10.1038/485041d; Reinhart K, 2012, INTENS CARE MED, V38, P368, DOI 10.1007/s00134-012-2472-9; Richardson CA, 2005, ATLA-ALTERN LAB ANIM, V33, P119, DOI 10.1177/026119290503300207; Riva John J, 2012, J Can Chiropr Assoc, V56, P167; ROBERTS NJ, 1979, MICROBIOL REV, V43, P241, DOI 10.1128/MMBR.43.2.241-259.1979; Robertson SA, 2002, J AM VET MED ASSOC, V221, P205, DOI 10.2460/javma.2002.221.205; Roughan JV, 2003, EUR J PAIN, V7, P397, DOI 10.1016/S1090-3801(02)00140-4; Roughan JV, 2003, LAB ANIM-UK, V37, P172, DOI 10.1258/00236770360563831; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Urban R, 2011, PAIN, V152, P990, DOI 10.1016/j.pain.2010.12.003; van den Brink I, 2013, LAB ANIMAL, V42, P253, DOI 10.1038/laban.252; Wagner AE, 1997, J AM VET MED ASSOC, V210, P1279; Yatabe T, 2011, J ANESTH, V25, P558, DOI 10.1007/s00540-011-1170-z; Zambricki EA, 2004, COMPARATIVE MED, V54, P49	52	22	22	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0134205	10.1371/journal.pone.0134205	http://dx.doi.org/10.1371/journal.pone.0134205			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305700	Green Submitted, Green Published, gold			2022-12-27	WOS:000359995500007
J	Kabakov, AY; Rosenberg, PA				Kabakov, Anatoli Y.; Rosenberg, Paul A.			GLT-1 Transport Stoichiometry Is Constant at Low and High Glutamate Concentrations when Chloride Is Substituted by Gluconate	PLOS ONE			English	Article							SYNAPTICALLY RELEASED GLUTAMATE; SEROTONIN TRANSPORTER; HIPPOCAMPAL ASTROCYTES; RECEPTOR ACTIVATION; CEREBRAL-CORTEX; SPLICE VARIANT; NEURONS; CHANNEL; BRAIN; RATS	Glutamate is the major excitatory neurotransmitter, but prolonged exposure even at micromolar concentrations causes neuronal death. Extracellular glutamate is maintained at nano-molar level by glutamate transporters, which, however, may reverse transport and release glutamate. If and when the reverse occurs depends on glutamate transport stoichiometry (GTS). Previously we found that in the presence of chloride, the coupled GLT-1 glutamate transporter current and its relationship to radiolabeled glutamate flux significantly decreased when extracellular glutamate concentration increased above 0.2 mM, which implies a change in GTS. Such high concentrations are feasible near GLT-1 expressed close to synaptic release site during excitatory neurotransmission. The aim of this study was to determine GLT-1 GTS at both low (19-75 mu M) and high (300-1200 mu M) glutamate concentration ranges. GTS experiments were conducted in the absence of chloride to avoid contributions by the GLT-1 uncoupled chloride conductance. Mathematical analysis of the transporter thermodynamic equilibrium allowed us to derive equations revealing the number of a particular type of ion transported per elementary charge based on the measurements of the transporter reversal potential. We found that GLT-1a expressed in COS-7 cells co-transports 1.5 Na+, 0.5 Glu(-), 0.5 H+ and counter-transports 0.6 K+ per elementary charge in both glutamate concentration ranges, and at both 37 degrees C and 26 degrees C temperatures. The thermodynamic parameter Q(10) = 2.4 for GLT-1 turnover rate of 19 s(-1) (37 degrees C, -50 mV) remained constant in the 10 mu M-10 mM glutamate concentration range. Importantly, the previously reported decrease in the current/flux ratio at high glutamate concentration was not seen in the absence of chloride in both COS-7 cells and cultured rat neurons. Therefore, only in the absence of chloride, GLT-1 GTS remains constant at all glutamate concentrations. Possible explanations for why apparent GTS might vary in the presence of chloride are discussed.	Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Kabakov, AY (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	kabakov@brandeis.edu; paul.rosenberg@childrens.harvard.edu		Rosenberg, Paul/0000-0002-5185-1118	National Institutes of Health [HD18655, NS066019]; Harvard Center for Neurodegeneration and Repair; Ron Shapiro Charitable Foundation; William Randolph Hearst Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066019] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Center for Neurodegeneration and Repair; Ron Shapiro Charitable Foundation; William Randolph Hearst Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants HD18655 and NS066019 (PR), by grants from the Harvard Center for Neurodegeneration and Repair (PR and AK), the Ron Shapiro Charitable Foundation, and the William Randolph Hearst Fund (AK).	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Adams SV, 2003, BIOPHYS J, V85, P1548, DOI 10.1016/S0006-3495(03)74587-1; Bassan M, 2008, EUR J NEUROSCI, V27, P66, DOI 10.1111/j.1460-9568.2007.05986.x; Beckman ML, 2001, NEUROPHARMACOLOGY, V40, P526, DOI 10.1016/S0028-3908(00)00191-X; Bergles DE, 2002, J NEUROSCI, V22, P10153; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Bergles DE, 1998, J NEUROSCI, V18, P7709; Chen WZ, 2004, J NEUROSCI, V24, P1136, DOI 10.1523/JNEUROSCI.1586-03.2004; Chen WZ, 2002, J NEUROSCI, V22, P2142, DOI 10.1523/JNEUROSCI.22-06-02142.2002; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Danbolt NC, 2006, 62982006 SOC NEUR; DeFelice LJ, 2004, TRENDS NEUROSCI, V27, P352, DOI 10.1016/j.tins.2004.04.007; Diamond JS, 1997, J NEUROSCI, V17, P4672; Diamond JS, 2000, J NEUROPHYSIOL, V83, P2835, DOI 10.1152/jn.2000.83.5.2835; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Follett PL, 2000, J NEUROSCI, V20, P9235; Furness DN, 2008, NEUROSCIENCE, V157, P80, DOI 10.1016/j.neuroscience.2008.08.043; Galli A, 1998, P NATL ACAD SCI USA, V95, P13260, DOI 10.1073/pnas.95.22.13260; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Grunewald M, 2002, J BIOL CHEM, V277, P26074, DOI 10.1074/jbc.M202248200; Herman MA, 2007, J NEUROSCI, V27, P9736, DOI 10.1523/JNEUROSCI.3009-07.2007; Kabakov AY, 2009, EUR J NEUROSCI, V30, P186, DOI 10.1111/j.1460-9568.2009.06809.x; Kabakov AY, 1998, BIOPHYS J, V75, P2858, DOI 10.1016/S0006-3495(98)77728-8; Kang TM, 2004, NATURE, V427, P544, DOI 10.1038/nature02271; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Macnab LT, 2007, NEUROSCIENCE, V150, P705, DOI 10.1016/j.neuroscience.2007.09.049; Melone M, 2009, GLIA, V57, P108, DOI 10.1002/glia.20744; Mercik K, 2002, EUR J NEUROSCI, V16, P2253, DOI 10.1046/j.1460-9568.2002.02307.x; Owe SG, 2006, J PHYSIOL-LONDON, V577, P591, DOI 10.1113/jphysiol.2006.116830; Petersen CI, 1999, NAT NEUROSCI, V2, P605, DOI 10.1038/10158; Potier B, 2010, AGING CELL, V9, P722, DOI 10.1111/j.1474-9726.2010.00593.x; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; Rauen T, 2004, NEUROCHEM INT, V45, P1095, DOI 10.1016/j.neuint.2004.04.006; Reye P, 2002, J COMP NEUROL, V445, P1, DOI 10.1002/cne.10095; ROSENBERG PA, 1992, J NEUROSCI, V12, P56; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; Saftenku EE, 2005, J THEOR BIOL, V234, P363, DOI 10.1016/j.jtbi.2004.11.036; Schmitt A, 2002, NEUROSCIENCE, V109, P45, DOI 10.1016/S0306-4522(01)00451-1; Selkirk JV, 2005, EUR J NEUROSCI, V21, P3217, DOI 10.1111/j.1460-9568.2005.04162.x; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; Sonders MS, 1997, J NEUROSCI, V17, P960; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; Torres-Salazar D, 2006, J NEUROSCI, V26, P7513, DOI 10.1523/JNEUROSCI.4545-05.2006; UtsunomiyaTate N, 1997, FEBS LETT, V416, P312, DOI 10.1016/S0014-5793(97)01232-5; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wadiche JI, 1998, J NEUROSCI, V18, P7650; Wang GJ, 1998, MOL PHARMACOL, V53, P88, DOI 10.1124/mol.53.1.88; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	51	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136111	10.1371/journal.pone.0136111	http://dx.doi.org/10.1371/journal.pone.0136111			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301411	gold, Green Published, Green Submitted			2022-12-27	WOS:000359951900040
J	Andersen, RL; Jensen, KM; Mikkelsen, MJ				Andersen, Rasmus Lund; Jensen, Karen Moller; Mikkelsen, Marie Just			Continuous Ethanol Fermentation of Pretreated Lignocellulosic Biomasses, Waste Biomasses, Molasses and Syrup Using the Anaerobic, Thermophilic Bacterium Thermoanaerobacter italicus Pentocrobe 411	PLOS ONE			English	Article							HYDROLYSATE; INHIBITION; MECHANISMS; BG1L1	Lignocellosic ethanol production is now at a stage where commercial or semi-commercial plants are coming online and, provided cost effective production can be achieved, lignocellulosic ethanol will become an important part of the world bio economy. However, challenges are still to be overcome throughout the process and particularly for the fermentation of the complex sugar mixtures resulting from the hydrolysis of hemicellulose. Here we describe the continuous fermentation of glucose, xylose and arabinose from non-detoxified pretreated wheat straw, birch, corn cob, sugar cane bagasse, cardboard, mixed bio waste, oil palm empty fruit bunch and frond, sugar cane syrup and sugar cane molasses using the anaerobic, thermophilic bacterium Thermoanaerobacter Pentocrobe 411. All fermentations resulted in close to maximum theoretical ethanol yields of 0.47-0.49 g/g (based on glucose, xylose, and arabinose), volumetric ethanol productivities of 1.2-2.7 g/L/h and a total sugar conversion of 90-99% including glucose, xylose and arabinose. The results solidify the potential of Thermoanaerobacter strains as candidates for lignocellulose bioconversion.	[Andersen, Rasmus Lund; Jensen, Karen Moller; Mikkelsen, Marie Just] Estibio ApS, Ballerup, Denmark		Mikkelsen, MJ (corresponding author), Estibio ApS, Ballerup, Denmark.	mjm@estibio.com	Andersen, Rasmus/GWD-0055-2022		European Union [241640]; Fjord Capital Partners, London; Estibio ApS	European Union(European Commission); Fjord Capital Partners, London; Estibio ApS	The study was funded by European Union FP7 grant number 241640, Suprabio, and by Fjord Capital Partners, London. Websites: http://cordis.europa.eu/fp7/home_en.html; http://www.fjordcap.com/Home. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Estibio ApS provided support in the form of salaries for authors [RLA, KMJ, and MJM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANGELIDAKI I, 1990, APPL MICROBIOL BIOT, V33, P469, DOI 10.1007/BF00176668; Clarkson SM, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0165-z; Dien BS, 2003, APPL MICROBIOL BIOT, V63, P258, DOI 10.1007/s00253-003-1444-y; Erbeznik M, 1998, J BACTERIOL, V180, P1103, DOI 10.1128/JB.180.5.1103-1109.1998; Georgieva T, 2007, CENTRAL EUROPEAN J B, V2, P13; Georgieva TI, 2008, APPL BIOCHEM BIOTECH, V145, P99, DOI 10.1007/s12010-007-8014-1; Georgieva TI, 2007, BIOTECHNOL BIOENG, V98, P1161, DOI 10.1002/bit.21536; Georgieva TI, 2007, APPL MICROBIOL BIOT, V77, P61, DOI 10.1007/s00253-007-1149-8; Harner NK, 2015, J IND MICROBIOL BIOT, V42, P1, DOI 10.1007/s10295-014-1535-z; Ho NWY, 1995, PCT patent application, Patent No. [WO9513362, 9513362]; Ibraheem O, 2013, INT J BIOL SCI, V9, P598, DOI 10.7150/ijbs.6091; Jeffries TW, 2004, APPL MICROBIOL BIOT, V63, P495, DOI 10.1007/s00253-003-1450-0; Jones CR, 2002, CURR MICROBIOL, V45, P54, DOI 10.1007/s00284-001-0099-0; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; Kvist T, 2014, PCT patent application, Patent No. [WO2014096436, 2014096436]; Lin L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002318; Mikkelsen MJ, 2007, WIPO publication, Patent No. [WO/2007/134607, 2007134607]; Nogue VS, 2015, BIOTECHNOL LETT, V37, P761, DOI 10.1007/s10529-014-1756-2; Scully SM, 2015, ENERGIES, V8, P1, DOI 10.3390/en8010001	19	19	19	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136060	10.1371/journal.pone.0136060	http://dx.doi.org/10.1371/journal.pone.0136060			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295944	gold, Green Submitted, Green Published			2022-12-27	WOS:000359926900067
J	Laille, E; Shi, T; Garcia-Manero, G; Cogle, CR; Gore, SD; Hetzer, J; Kumar, K; Skikne, B; MacBeth, KJ				Laille, Eric; Shi, Tao; Garcia-Manero, Guillermo; Cogle, Christopher R.; Gore, Steven D.; Hetzer, Joel; Kumar, Keshava; Skikne, Barry; MacBeth, Kyle J.			Pharmacokinetics and Pharmacodynamics with Extended Dosing of CC-486 in Patients with Hematologic Malignancies	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; DNA METHYLTRANSFERASE INHIBITORS; RISK MYELODYSPLASTIC SYNDROMES; INTERNATIONAL WORKING GROUP; CYTIDINE DEAMINASE; RESPONSE CRITERIA; MAMMALIAN-CELLS; AZACITIDINE; 5-AZACYTIDINE; METHYLATION	CC-486 (oral azacitidine) is an epigenetic modifier in development for patients with myelodysplastic syndromes and acute myeloid leukemia. In part 1 of this two-part study, a 7-day CC-486 dosing schedule showed clinical activity, was generally well tolerated, and reduced DNA methylation. Extending dosing of CC-486 beyond 7 days would increase duration of azacitidine exposure. We hypothesized that extended dosing would therefore provide more sustained epigenetic activity. Reported here are the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of CC-486 extended dosing schedules in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) or acute myeloid leukemia (AML) from part 2 of this study. PK and/or PD data were available for 59 patients who were sequentially assigned to 1 of 4 extended CC-486 dosing schedules: 300mg once-daily or 200mg twice-daily for 14 or 21 days per 28-day cycle. Both 300mg once-daily schedules and the 200mg twice-daily 21-day schedule significantly (all P < .05) reduced global DNA methylation in whole blood at all measured time points (days 15, 22, and 28 of the treatment cycle), with sustained hypomethylation at cycle end compared with baseline. CC-486 exposures and reduced DNA methylation were significantly correlated. Patients who had a hematologic response had significantly greater methylation reductions than non-responding patients. These data demonstrate that extended dosing of CC-486 sustains epigenetic effects through the treatment cycle.	[Laille, Eric; Shi, Tao; Hetzer, Joel; Kumar, Keshava; Skikne, Barry; MacBeth, Kyle J.] Celgene Corp, Summit, NJ 07901 USA; [Garcia-Manero, Guillermo] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Cogle, Christopher R.] Univ Florida, Div Hematol Oncol, Gainesville, FL USA; [Gore, Steven D.] Yale Canc Ctr, New Haven, CT USA	Bristol-Myers Squibb; Celgene Corporation; University of Texas System; UTMD Anderson Cancer Center; State University System of Florida; University of Florida; Yale University	Laille, E (corresponding author), Celgene Corp, Summit, NJ 07901 USA.	elaille@celgene.com	Laille, Eric/ABG-6723-2020	Laille, Eric/0000-0002-7823-0004; , Tao/0000-0001-5489-2655	Celgene Corporation; NATIONAL CANCER INSTITUTE [K24CA111717] Funding Source: NIH RePORTER	Celgene Corporation(Bristol-Myers SquibbCelgene Corporation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Celgene Corporation funded this study. The funder provided support in the form of salaries for authors EL, TS, JH, KK, BS, and KM. EL, TS, JH, KK, BS, and KM had additional roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section." We have revised the authorship contributions since the original submission. We confirm that the following is correct: GGM, CRC, SDG designed the study and collected and analyzed the data. EL, KK, BS, and KM designed the study and analyzed data. TS and JH analyzed the data and provided statistical support. All authors participated in manuscript development and revision and the decision to publish the paper. The primary authors (EL and TS) are responsible for manuscript content and approval to submit the manuscript.	Aggerholm A, 2006, EUR J HAEMATOL, V76, P23, DOI 10.1111/j.1600-0609.2005.00559.x; Aimiuwu J, 2012, BLOOD, V119, P5229, DOI 10.1182/blood-2011-11-382226; Bontkes HJ, 2012, LEUKEMIA RES, V36, P921, DOI 10.1016/j.leukres.2012.03.026; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Cheson BD, 2006, BLOOD, V108, P419, DOI 10.1182/blood-2005-10-4149; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fandy TE, 2009, BLOOD, V114, P2764, DOI 10.1182/blood-2009-02-203547; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Figueroa ME, 2009, BLOOD, V114, P3448, DOI 10.1182/blood-2009-01-200519; Flotho C, 2009, LEUKEMIA, V23, P1019, DOI 10.1038/leu.2008.397; Garcia-Manero G, 2011, J CLIN ONCOL, V29, P2521, DOI 10.1200/JCO.2010.34.4226; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; GLOVER AB, 1987, CANCER TREAT REP, V71, P959; Gore SD, 2006, CANCER RES, V66, P6361, DOI 10.1158/0008-5472.CAN-06-0080; Grovdal M, 2007, CLIN CANCER RES, V13, P7107, DOI 10.1158/1078-0432.CCR-07-1193; Harris NL, 1999, ANN ONCOL, V10, P1419, DOI 10.1023/A:1008375931236; Head DR, 2011, BONE MARROW RES, DOI 10.1155/2011/950934; Hollenbach PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009001; JONES PA, 1983, J EXP ZOOL, V228, P287, DOI 10.1002/jez.1402280212; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kaminskas E, 2005, ONCOLOGIST, V10, P176, DOI 10.1634/theoncologist.10-3-176; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Leone G, 2002, HAEMATOLOGICA, V87, P1324; Li HL, 2014, ONCOTARGET, V5, P587, DOI 10.18632/oncotarget.1782; LI LH, 1970, CANCER RES, V30, P2770; LI LH, 1970, CANCER RES, V30, P2760; Mahfouz RZ, 2013, CLIN CANCER RES, V19, P3106, DOI 10.1158/1078-0432.CCR-13-0872; Marcucci G, 2005, J CLIN PHARMACOL, V45, P597, DOI 10.1177/0091270004271947; Micozzi D, 2014, INT J BIOL MACROMOL, V63, P64, DOI 10.1016/j.ijbiomac.2013.10.029; MOMPARLER RL, 1977, CANCER RES, V37, P1636; PLAGEMANN PGW, 1978, CANCER RES, V38, P2458; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; Rudek MA, 2005, J CLIN ONCOL, V23, P3906, DOI 10.1200/JCO.2005.07.450; SANTI DV, 1983, CELL, V33, P9, DOI 10.1016/0092-8674(83)90327-6; Saunthararajah Y, 2013, HEMATOL-AM SOC HEMAT, P511, DOI 10.1182/asheducation-2013.1.511; Silverman LR, 2011, CANCER-AM CANCER SOC, V117, P2697, DOI 10.1002/cncr.25774; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soriano AO, 2007, BLOOD, V110, P2302, DOI 10.1182/blood-2007-03-078576; Sproul D, 2011, P NATL ACAD SCI USA, V108, P4364, DOI 10.1073/pnas.1013224108; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Stresemann C, 2008, MOL CANCER THER, V7, P2998, DOI 10.1158/1535-7163.MCT-08-0411; THOMPSON PW, 1989, ANN RHEUM DIS, V48, P502, DOI 10.1136/ard.48.6.502; Yang H, 2014, LEUKEMIA, V28, P1280, DOI 10.1038/leu.2013.355; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	45	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135520	10.1371/journal.pone.0135520	http://dx.doi.org/10.1371/journal.pone.0135520			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296092	Green Submitted, Green Published, gold			2022-12-27	WOS:000359926900032
J	Yu, H; Meng, J; Xu, J; Liu, TX; Wang, D				Yu, Huan; Meng, Jiao; Xu, Jian; Liu, Tong-xian; Wang, Dun			A Novel Neurotoxin Gene ar1b Recombination Enhances the Efficiency of Helicoverpa armigera Nucleopolyhedrovirus as a Pesticide by Inhibiting the Host Larvae Ability to Feed and Grow	PLOS ONE			English	Article							SINGLE-NUCLEOCAPSID NUCLEOPOLYHEDROVIRUS; BACULOVIRUS-MEDIATED EXPRESSION; UDP-GLUCOSYL TRANSFERASE; INSECTICIDAL EFFICACY; MULTICAPSID NUCLEOPOLYHEDROVIRUS; BACILLUS-THURINGIENSIS; HELIOTHIS-VIRESCENS; SIGNAL SEQUENCE; EGT GENE; TOXIN	A recombinant Helicoverpa armigera nucleopolyhedrovirus (HearNPV), Ar1b-HearNPV, was constructed and identified as an improved bio-control agent of Helicoverpa armigera larvae. The HearNPV polyhedrin promoter was used to express the insect-specific neurotoxin gene, ar1b, which was originally isolated from the Australian funnel-web spider (Atrax robustus). RT-PCR and Western blotting analysis showed that both the ar1b transcript and protein were produced successfully in Ar1b-HearNPV-infected HzAM1 cells. In order to investigate the influence of foreign gene insertion in HearNPV, including the ar1b gene, chloramphenicol resistance gene, lacZ, kanamycin resistance gene, and the gentamicin resistance gene, two virus strains (HZ8-HearNPV and wt-HearNPV) were used as controls in the cell transfection analysis. As expected, foreign gene insertion had no impact on budded virus production and viral DNA replication. Both optical microscopy and electron microscopy observations indicated that the formation of the occlusion bodies of recombinant virus was similar to wild type virus. The Ar1b-HearNPV-infected H. armigera larvae exhibited paralysis and weight loss before dying. This recombinant virus also showed a 32.87% decrease in LT50 assays compared with the wild type virus. Besides, Ar1b-HearNPV also inhibited host larval growth and diet consumption. This inhibition was still significant in the older instar larvae treated with the recombinant virus. All of these positive properties of this novel recombinant HearNPV provide a further opportunity to develop this virus strain into a commercial product to control the cotton bollworm.	[Yu, Huan; Meng, Jiao; Xu, Jian; Liu, Tong-xian; Wang, Dun] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Yu, Huan; Liu, Tong-xian] Northwest A&F Univ, Key Lab Appl Entomol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Wang, D (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	txliu@nwsuaf.edu.cn; wanghande@yahoo.com		Xu, Jian/0000-0002-4463-0413	National Natural Science Foundation of China [31270691, 31170609]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (NO: 31270691, 31170609, which were received by DW).	Black B.C., 1997, BACULOVIRUSES, DOI [10.1007/978-1-4899-1834-5_13, DOI 10.1007/978-1-4899-1834-5_13]; Bonning BC, 1999, J INVERTEBR PATHOL, V73, P234, DOI 10.1006/jipa.1998.4839; CHEJANOVSKY N, 1995, FEBS LETT, V376, P181, DOI 10.1016/0014-5793(95)01263-4; Chen XW, 2002, J GEN VIROL, V83, P673, DOI 10.1099/0022-1317-83-3-673; Chen XW, 2001, J GEN VIROL, V82, P241, DOI 10.1099/0022-1317-82-1-241; Chen XW, 2000, J INVERTEBR PATHOL, V76, P140, DOI 10.1006/jipa.2000.4963; Cross JV, 1999, BIOCONTROL SCI TECHN, V9, P125, DOI 10.1080/09583159929721; El-Sheikh ESA, 2011, BIOL CONTROL, V58, P354, DOI 10.1016/j.biocontrol.2011.06.002; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Gelernter W.D., 1999, Integrated Pest Management Reviews, V4, P301, DOI 10.1023/A:1009645010358; Gershburg E, 1998, FEBS LETT, V422, P132, DOI 10.1016/S0014-5793(97)01614-1; Gould F, 1997, P NATL ACAD SCI USA, V94, P3519, DOI 10.1073/pnas.94.8.3519; Harrison RL, 2000, BIOL CONTROL, V17, P191, DOI 10.1006/bcon.1999.0792; Harrison RL, 2001, BIOL CONTROL, V20, P199, DOI 10.1006/bcon.2000.0899; HOOVER K, 1995, BIOL CONTROL, V5, P419, DOI 10.1006/bcon.1995.1050; Hughes PR, 1997, J INVERTEBR PATHOL, V69, P112, DOI 10.1006/jipa.1996.4643; HUGHES PR, 1986, J INVERTEBR PATHOL, V48, P187, DOI 10.1016/0022-2011(86)90122-9; Jarvis DL, 1996, BIOL CONTROL, V7, P228, DOI 10.1006/bcon.1996.0088; Keszthelyi S, 2013, CENT EUR J BIOL, V8, P756, DOI 10.2478/s11535-013-0195-0; Li XF, 2014, ARCH VIROL, V159, P2011, DOI 10.1007/s00705-014-2034-2; Liu YB, 1999, NATURE, V400, P519, DOI 10.1038/22919; Lu A, 1996, BIOL CONTROL, V7, P320, DOI 10.1006/bcon.1996.0101; MCCAFFERY AR, 1991, PESTIC SCI, V32, P85, DOI 10.1002/ps.2780320109; MCCUTCHEN BF, 1991, BIO-TECHNOL, V9, P848, DOI 10.1038/nbt0991-848; Moscardi F, 1999, ANNU REV ENTOMOL, V44, P257, DOI 10.1146/annurev.ento.44.1.257; Ogembo JG, 2009, VIRUS GENES, V39, P261, DOI 10.1007/s11262-009-0389-3; OREILLY DR, 1995, INSECT BIOCHEM MOLEC, V25, P541, DOI 10.1016/0965-1748(94)00105-Q; OREILLY DR, 1991, BIO-TECHNOL, V9, P1086, DOI 10.1038/nbt1191-1086; OREILLY DR, 1989, SCIENCE, V245, P1110, DOI 10.1126/science.2505387; Popham HJR, 1997, BIOL CONTROL, V10, P83, DOI 10.1006/bcon.1997.0552; Possee RD., 1992, BACULOVIRUS EXPRESSI; Prikhodko GG, 1996, BIOL CONTROL, V7, P236, DOI 10.1006/bcon.1996.0089; Qin Q., 2008, BIOTECHNOL B, V1, P467; Shelton AM, 2000, NAT BIOTECHNOL, V18, P339, DOI 10.1038/73804; Slavicek JM, 1999, BIOL CONTROL, V16, P91, DOI 10.1006/bcon.1999.0734; STEWART LMD, 1991, NATURE, V352, P85, DOI 10.1038/352085a0; Sun XL, 2004, BIOL CONTROL, V29, P124, DOI 10.1016/S1049-9644(03)00117-8; Sun XL, 2002, J INVERTEBR PATHOL, V81, P63, DOI 10.1016/S0022-2011(02)00144-1; Szewczyk B, 2006, BIOTECHNOL ADV, V24, P143, DOI 10.1016/j.biotechadv.2005.09.001; Tang P, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-168; TOMALSKI MD, 1992, BIO-TECHNOL, V10, P545, DOI 10.1038/nbt0592-545; TOMALSKI MD, 1991, NATURE, V352, P82, DOI 10.1038/352082a0; TOMALSKI MD, 1993, ARCH INSECT BIOCHEM, V22, P303, DOI 10.1002/arch.940220302; Treacy MF, 1999, METH BIOTEC, V5, P321; van Beek N, 2003, BIOL CONTROL, V27, P53, DOI 10.1016/S1049-9644(02)00172-X; Wang HZ, 2003, VIRUS RES, V97, P57, DOI 10.1016/j.virusres.2003.07.001; Wang YQ, 2010, AGR SCI CHINA, V9, P1292, DOI 10.1016/S1671-2927(09)60219-4; Wilson KR, 2000, BIOL CONTROL, V19, P57, DOI 10.1006/bcon.2000.0841; Wood H. Alan, 1996, P91; Xia J., 1997, COTTON INT, P95; Zhang CX, 2005, VIROLOGY, V333, P190, DOI 10.1016/j.virol.2004.12.028; Zhang G, 1994, RESOUR ENV YANGTZE V, V3, P36; Zhang Guangyu, 1995, Virologica Sinica, V10, P242; Zhang H, 2014, ARCH VIROL, V159, P595, DOI 10.1007/s00705-013-1823-3	54	4	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135279	10.1371/journal.pone.0135279	http://dx.doi.org/10.1371/journal.pone.0135279			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296090	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900023
J	Zhu, CJ; Hua, F; Zhu, XL; Li, M; Wang, HX; Yu, XM; Li, Y				Zhu, Chuan-jiang; Hua, Fang; Zhu, Xiao-lu; Li, Meng; Wang, Hong-xu; Yu, Xiao-ming; Li, Yan			Stereoselective Regulation of P-gp Activity by Clausenamide Enantiomers in Caco-2, KB/KBv and Brain Microvessel Endothelial Cells	PLOS ONE			English	Article							TISSUE DISTRIBUTION; PROTEIN EXPRESSION; CYTOCHROME-P450 3A; GLYCOPROTEIN; RHODAMINE-123; METABOLISM; MONOLAYERS; SUBSTRATE; TRANSPORT; BINDING	The (-)- and (+)-clausenamide (CLA) enantiomers have different pharmacokinetic effects in animals, but their association with putative stereoselective regulation of P-glycoprotein (P-gp) remains unclear. Using three cells expressing P-gp-Caco-2, KBv and rat brain micro-vessel endothelial cells(RBMEC), this study investigated the association of CLA enantiomers with P-gp. The results showed that the rhodamine 123 (Rh123) accumulation, an indicator of P-gp activity, in Caco-2, KBv and RBMECs was increased by (-) CLA (1 or 5 mu mol/L) at 8.2%-28.5%, but reduced by (+) CLA at 11.7%-25.9%, showing stereoselectivity in their regulation of P-gp activity. Following co-treatment of these cells with each CLA enantiomer and verapamil as a P-gp inhibitor, the (+)-isomer clearly antagonized the inhibitory effects of verapamil on P-gp efflux, whereas the (-)-isomer had slightly synergistic or additive effects. When higher concentrations (5 or 10 mu mol/L) of CLA enantiomers were added, the stimulatory effects of the (+)-isomer were converted into inhibitory ones, leading to an enhanced intracellular uptake of Rh123 by 24.5%-58.2%; but (-)-isomer kept its inhibition to P-gp activity, causing 30.0%-63.0% increase in the Rh123 uptake. The biphasic effects of (+) CLA were confirmed by CLA uptake in the Caco-2 cells. (+) CLA at 1 mu mol/L had significantly lower intracellular uptake than (-) CLA with a ratio[(-)/(+)] of 2.593, which was decreased to 2.167 and 1.893 after CLA concentrations increased to 2.5 and 5 mu mol/L. Besides, in the non-induced KB cells, (+) CLA(5 mu mol/L) upregulated P-gp expression at 54.5% relative to vehicle control, and decreased Rh123 accumulation by 28.2%, while (-) CLA(5 mu mol/L) downregulated P-gp expression at 15.9% and increased Rh123 accumulation by 18.0%. These results suggested that (-) CLA could be a P-gp inhibitor and (+) CLA could be a modulator with concentration-dependent biphasic effects on P-gp activity, which may result in drug-drug interactions when combined with other P-gp substrate drugs.	[Zhu, Chuan-jiang; Hua, Fang; Zhu, Xiao-lu; Li, Meng; Wang, Hong-xu; Yu, Xiao-ming; Li, Yan] Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China; [Zhu, Chuan-jiang; Hua, Fang; Zhu, Xiao-lu; Li, Meng; Wang, Hong-xu; Yu, Xiao-ming; Li, Yan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhu, Chuan-jiang; Li, Yan] Beijing Key Lab Nonclin Drug Metab & PK PD Study, Beijing, Peoples R China; [Zhu, Chuan-jiang] Beijing Key Lab New Drug Mech & Pharmacol Evaluat, Beijing, Peoples R China; [Yu, Xiao-ming] Beijing Key Lab Act Subst Discovery & Druggabil E, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhu, CJ (corresponding author), Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China.	zhucj@imm.ac.cn	meng, li/GVT-2063-2022; Zhu, Xiao/AAV-2637-2021		National Natural Science Foundation of China [30873117]; Major Scientific and Technological Special Project for "Significant New Drugs Creation" [2009ZX09501-018, 2009ZX09301-003-51, 2012ZX09301-002-001-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Scientific and Technological Special Project for "Significant New Drugs Creation"	This work was supported by the grants from the National Natural Science Foundation of China (30873117, http://www.nsfc.gov.cn/, CJZ), and the Major Scientific and Technological Special Project for "Significant New Drugs Creation" (http://www.most.gov.cn/; 2009ZX09501-018, CJZ, XMY; 2009ZX09301-003-51, CJZ, YL; 2012ZX09301-002-001-002, CJZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmeier CJ, 2011, BIOPHARM DRUG DISPOS, V32, P233, DOI 10.1002/bdd.753; Chen Y, 2009, J PHARMACOL EXP THER, V330, P956, DOI 10.1124/jpet.109.154781; Duan Wenzhen, 1998, Yaoxue Xuebao, V33, P259; Duan WZ, 1998, ACTA PHARMACOL SIN, V19, P332; Fontaine M, 1996, LIFE SCI, V59, P1521, DOI 10.1016/0024-3205(96)00483-3; Glaeser H, 2011, HANDB EXP PHARMACOL, V201, P285, DOI 10.1007/978-3-642-14541-4_7; Hochman JH, 2000, J PHARMACOL EXP THER, V292, P310; Iwanaga K, 2011, BIOL PHARM BULL, V34, P1246, DOI 10.1248/bpb.34.1246; Karwatsky J, 2003, BIOCHEMISTRY-US, V42, P12163, DOI 10.1021/bi034149+; Kirby B, 2006, J CLIN PHARMACOL, V46, P1313, DOI 10.1177/0091270006292625; Kondratov RV, 2001, P NATL ACAD SCI USA, V98, P14078, DOI 10.1073/pnas.241314798; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P169, DOI 10.1016/S0925-4439(97)00027-6; Liu Shaolin, 1998, Yaoxue Xuebao, V33, P254; Liu ShaoLin, 1999, Acta Pharmaceutica Sinica, V34, P325; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Meyer RP, 2007, CURR DRUG METAB, V8, P297, DOI 10.2174/138920007780655478; Qian ZY, 1999, CHIN J CELL BIOL, V21, P42; Rao EC, 1994, ACTA PHARMACOL SIN, V29, P502; Sachs-Barrable K, 2007, J PHARM PHARM SCI, V10, P319; Schuetz EG, 1996, MOL PHARMACOL, V49, P311; Shen SJ, 2007, CHIRALITY, V19, P485, DOI 10.1002/chir.20400; Swed A, 2009, MOL PHARMACEUT, V6, P1883, DOI 10.1021/mp900170y; Tang FX, 2004, J PHARM SCI-US, V93, P1185, DOI 10.1002/jps.20046; Tian Y, 2012, ACTA PHARM SIN B, V2, P168, DOI 10.1016/j.apsb.2012.02.005; WACHER VJ, 1995, MOL CARCINOGEN, V13, P129, DOI 10.1002/mc.2940130302; YANG M-H, 1987, Yaoxue Xuebao, V22, P33; YANG MH, 1987, ACTA CHIM SINICA, V45, P1170; Yumoto R, 1999, J PHARMACOL EXP THER, V289, P149; Zhang XH, 1994, ACTA PHARMACOL SINIC, V29, P246; Zhang Y, 2010, CANCER CHEMOTH PHARM, V66, P851, DOI 10.1007/s00280-009-1229-9; Zhu CJ, 2009, CHIRALITY, V21, P402, DOI 10.1002/chir.20623; Zhu CJ, 2013, EUR J PHARM SCI, V49, P761, DOI 10.1016/j.ejps.2013.04.033; Zhu CJ, 2003, CHIRALITY, V15, P668, DOI 10.1002/chir.10278; Zhu CJ, 2003, CHIRALITY, V15, P448, DOI 10.1002/chir.10228	34	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135866	10.1371/journal.pone.0135866	http://dx.doi.org/10.1371/journal.pone.0135866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295572	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900046
J	Yang, XP; Hu, HJ; Yu, DZ; Sun, ZH; He, XJ; Zhang, JG; Chen, QL; Tian, R; Fan, J				Yang, Xiaoping; Hu, Hongju; Yu, Dazhao; Sun, Zhonghai; He, Xiujuan; Zhang, Jingguo; Chen, Qiliang; Tian, Rui; Fan, Jing			Candidate Resistant Genes of Sand Pear (Pyrus pyrifolia Nakai) to Alternaria alternata Revealed by Transcriptome Sequencing	PLOS ONE			English	Article							JAPANESE PEAR; IDENTIFICATION; VARIABILITY; RIN4	Pear black spot (PBS) disease, which is caused by Alternaria alternata (Aa), is one of the most serious diseases affecting sand pear (Pyrus pyrifolia Nakai) cultivation worldwide. To investigate the defense mechanisms of sand pear in response to Aa, the transcriptome of a sand pear germplasm with differential resistance to Aa was analyzed using Illumina paired-end sequencing. Four libraries derived from PBS-resistant and PBS-susceptible sand pear leaves were characterized through inoculation or mock-inoculation. In total, 20.5 Gbp of sequence data and 101,632,565 reads were generated, representing 44717 genes. Approximately 66% of the genes or sequenced reads could be aligned to the pear reference genome. A large number (5213) of differentially expressed genes related to PBS resistance were obtained; 34 microsatellites were detected in these genes, and 28 genes were found to be closely related to PBS resistance. Using a transcriptome analysis in response to PBS inoculation and comparison analysis to the PHI database, 4 genes (Pbr039001, Pbr001627, Pbr025080 and Pbr023112) were considered to be promising candidates for sand pear resistance to PBS. This study provides insight into changes in the transcriptome of sand pear in response to PBS infection, and the findings have improved our understanding of the resistance mechanism of sand pear to PBS and will facilitate future gene discovery and functional genome studies of sand pear.	[Yang, Xiaoping; Yu, Dazhao] Wuhan Univ, Sch Life Sci, Wuhan 430072, Hubei, Peoples R China; [Yang, Xiaoping; Hu, Hongju; Sun, Zhonghai; He, Xiujuan; Zhang, Jingguo; Chen, Qiliang; Tian, Rui; Fan, Jing] Hubei Acad Agr Sci, Res Inst Fruit & Tea, Wuhan 430064, Hubei, Peoples R China; [Yu, Dazhao] Hubei Lab Crop Dis Insect Pests & Weeds Control, Wuhan 430064, Hubei, Peoples R China	Wuhan University; Hubei Academy of Agricultural Sciences	Yu, DZ (corresponding author), Wuhan Univ, Sch Life Sci, Wuhan 430072, Hubei, Peoples R China.	dazhaoyu@china.com; hbfruit@126.com			Ministry of Science and Technology of China [2011AA100206]; Construction of Modern Agricultural Industry Technology System [nycytx-29-23]; Hubei Agricultural Science and Technology Innovation Fund [2011-620-005-003-01]; Young Scientist Foundation of Hubei Academy of Agricultural Sciences [2013NKYJJ14]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Construction of Modern Agricultural Industry Technology System; Hubei Agricultural Science and Technology Innovation Fund; Young Scientist Foundation of Hubei Academy of Agricultural Sciences	This research was financially supported by the Ministry of Science and Technology of China (no. 2011AA100206), The Construction of Modern Agricultural Industry Technology System (no. nycytx-29-23), Hubei Agricultural Science and Technology Innovation Fund (no. 2011-620-005-003-01), and Young Scientist Foundation of Hubei Academy of Agricultural Sciences (no. 2013NKYJJ14).	Bao L, 2008, SCI HORTIC-AMSTERDAM, V116, P374, DOI 10.1016/j.scienta.2008.02.008; Bassil N, 2010, GENET RESOUR CROP EV, V57, P357, DOI 10.1007/s10722-009-9474-7; Demirbas A, 2001, CROP SCI, V41, P1220, DOI 10.2135/cropsci2001.4141220x; Donald TM, 2002, THEOR APPL GENET, V104, P610, DOI 10.1007/s00122-001-0768-1; Dondini L, 2004, MOL BREEDING, V14, P407, DOI 10.1007/s11032-004-0505-y; Faize Mohamed, 2007, Journal of General Plant Pathology, V73, P104, DOI 10.1007/s10327-006-0330-8; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; Hou L, 2013, J INTEGR AGR, V12, P2197, DOI 10.1016/S2095-3119(13)60293-2; Kaneyoshi J, 2001, PLANT CELL REP, V20, P622, DOI 10.1007/s002990100380; Karasov TL, 2014, CURR OPIN PLANT BIOL, V18, P24, DOI 10.1016/j.pbi.2013.12.003; Katula-Debreceni D, 2010, SCI HORTIC-AMSTERDAM, V126, P448, DOI 10.1016/j.scienta.2010.08.012; Ke XW, 2014, FUNGAL GENET BIOL, V68, P31, DOI 10.1016/j.fgb.2014.04.004; Knight SC, 1997, ANNU REV PHYTOPATHOL, V35, P349, DOI 10.1146/annurev.phyto.35.1.349; Krajaejun T, 2014, FUNGAL BIOL, P31; Lei CL, 2013, CROP J, V1, P2, DOI 10.1016/j.cj.2013.07.007; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Liu J, 2011, CELL HOST MICROBE, V9, P137, DOI 10.1016/j.chom.2011.01.010; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Reis RF, 2007, SCI HORTIC-AMSTERDAM, V113, P336, DOI 10.1016/j.scienta.2007.04.005; Sanzani SM, 2010, POSTHARVEST BIOL TEC, V56, P1, DOI 10.1016/j.postharvbio.2009.11.010; Shan JW, 2013, GENOMICS, V102, P388, DOI 10.1016/j.ygeno.2013.07.001; Terakami S, 2006, THEOR APPL GENET, V113, P743, DOI 10.1007/s00122-006-0344-9; Terakami S, 2009, J JPN SOC HORTIC SCI, V78, P417, DOI 10.2503/jjshs1.78.417; Wolko L, 2010, GENET RESOUR CROP EV, V57, P801, DOI 10.1007/s10722-010-9587-z; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Wu Tao, 2012, African Journal of Agricultural Research, V7, P3701; Zhang HL, 2011, SCI HORTIC-AMSTERDAM, V127, P282, DOI 10.1016/j.scienta.2010.10.016; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zou D, 2013, GENOMICS, V102, P57, DOI 10.1016/j.ygeno.2013.02.014	31	17	19	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135046	10.1371/journal.pone.0135046	http://dx.doi.org/10.1371/journal.pone.0135046			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292286	Green Submitted, Green Published, gold			2022-12-27	WOS:000359919900013
J	Andreakis, N; Hoj, L; Kearns, P; Hall, MR; Ericson, G; Cobb, RE; Gordon, BR; Evans-Illidge, E				Andreakis, Nikos; Hoj, Lone; Kearns, Philip; Hall, Michael R.; Ericson, Gavin; Cobb, Rose E.; Gordon, Benjamin R.; Evans-Illidge, Elizabeth			Diversity of Marine-Derived Fungal Cultures Exposed by DNA Barcodes: The Algorithm Matters	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; INTERNAL TRANSCRIBED SPACER; EVOLUTIONARY DISTANCES; MITOCHONDRIAL-DNA; DISCOVERY; ACCURACY; REGION; IDENTIFICATION; SUBSTITUTIONS; RELIABILITY	Marine fungi are an understudied group of eukaryotic microorganisms characterized by unresolved genealogies and unstable classification. Whereas DNA barcoding via the nuclear ribosomal internal transcribed spacer (ITS) provides a robust and rapid tool for fungal species delineation, accurate classification of fungi is often arduous given the large number of partial or unknown barcodes and misidentified isolates deposited in public databases. This situation is perpetuated by a paucity of cultivable fungal strains available for phylogenetic research linked to these data sets. We analyze ITS barcodes produced from a subsample (290) of 1781 cultured isolates of marine-derived fungi in the Bioresources Library located at the Australian Institute of Marine Science (AIMS). Our analysis revealed high levels of under-explored fungal diversity. The majority of isolates were ascomycetes including representatives of the subclasses Eurotiomycetidae, Hypocreomycetidae, Sordariomycetidae, Pleosporomycetidae, Dothideomycetidae, Xylariomycetidae and Saccharomycetidae. The phylum Basidiomycota was represented by isolates affiliated with the genera Tritirachium and Tilletiopsis. BLAST searches revealed 26 unknown OTUs and 50 isolates corresponding to previously uncultured, unidentified fungal clones. This study makes a significant addition to the availability of barcoded, culturable marine-derived fungi for detailed future genomic and physiological studies. We also demonstrate the influence of commonly used alignment algorithms and genetic distance measures on the accuracy and comparability of estimating Operational Taxonomic Units (OTUs) by the automatic barcode gap finder (ABGD) method. Large scale biodiversity screening programs that combine datasets using algorithmic OTU delineation pipelines need to ensure compatible algorithms have been used because the algorithm matters.	[Andreakis, Nikos; Hoj, Lone; Kearns, Philip; Hall, Michael R.; Ericson, Gavin; Cobb, Rose E.; Gordon, Benjamin R.; Evans-Illidge, Elizabeth] Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia	Australian Institute of Marine Science	Andreakis, N (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	n.andreakis@gmail.com	Hoj, Lone/A-1307-2008; Evans-Illidge, Libby/AAK-1521-2021; Andreakis, Nikos/A-4010-2010	Hoj, Lone/0000-0002-7781-8754; Andreakis, Nikos/0000-0001-7120-4279	Commonwealth Research and Environment Facilities (CERF) Marine Biodiversity Hub; Australian Government initiative	Commonwealth Research and Environment Facilities (CERF) Marine Biodiversity Hub; Australian Government initiative(Australian Government)	NA is supported by the Commonwealth Research and Environment Facilities (CERF) Marine Biodiversity Hub. The CERF program is an Australian Government initiative supporting world class, public good research and is a collaborative partnership between the University of Tasmania, CSIRO Wealth from Oceans Flagship, Geoscience Australia, Australian Institute of Marine Science and Museum Victoria.	Abdul Wahab MA, 2014, MOL PHYLOGENET EVOL, V73, P23, DOI 10.1016/j.ympev.2014.01.004; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Amaral-Zettler Linda, 2010, P223; Australia G, 2004, GEODATA COAST 100K 2; Bannister R., 2008, ECOLOGY FEEDING BIOL; Bannister RJ, 2012, CONT SHELF RES, V32, P86, DOI 10.1016/j.csr.2011.10.018; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Blunt JW, 2007, NAT PROD REP, V24, P31, DOI 10.1039/b603047p; Blunt JW, 2014, NAT PROD REP, V31, P160, DOI 10.1039/c3np70117d; Bokulich NA, 2013, APPL ENVIRON MICROB, V79, P2519, DOI 10.1128/AEM.03870-12; Branco S., 2011, FUNGAL DIVERSITY OVE; Bridge PD, 2003, NEW PHYTOL, V160, P43, DOI 10.1046/j.1469-8137.2003.00861.x; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Duarte K, 2012, TRAC-TREND ANAL CHEM, V34, P97, DOI 10.1016/j.trac.2011.10.014; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Escobar D, 2012, MOL PHYLOGENET EVOL, V64, P271, DOI 10.1016/j.ympev.2012.03.021; Evans-Illidge EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073800; Fabricius KE, 2013, ESTUAR COAST SHELF S, V116, P57, DOI 10.1016/j.ecss.2012.03.010; Fan L, 2014, MOL ECOL RESOUR; Geiser DM, 1998, NATURE, V394, P137, DOI 10.1038/28079; Gerwick WH, 2012, CHEM BIOL, V19, P85, DOI 10.1016/j.chembiol.2011.12.014; Goertzen LR, 2003, MOL PHYLOGENET EVOL, V29, P216, DOI 10.1016/S1055-7903(03)00094-0; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; HILLIS DM, 1992, J HERED, V83, P189, DOI 10.1093/oxfordjournals.jhered.a111190; Hyde KD, 1998, BIODIVERS CONSERV, V7, P1147, DOI 10.1023/A:1008823515157; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P454, DOI 10.1073/pnas.78.1.454; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kohlmeyer J., 1979, Marine mycology. The higher fungi.; La Rosa M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S4; Lachance MA, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P1, DOI 10.1007/3-540-30985-3_1; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lu Y, 2009, NUCLEIC ACIDS RES, V37, P463, DOI 10.1093/nar/gkn945; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Morrison-Gardiner S, 2002, FUNGAL DIVERS, V9, P105; Nei M, 2001, EVOLUTIONARY DISTANC; Nei M, 2000, MOL EVOLUTION PHYLOG; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Nilsson RH, 2009, FEMS MICROBIOL LETT, V296, P97, DOI 10.1111/j.1574-6968.2009.01618.x; Notredame C, 2002, PHARMACOGENOMICS, V3, P131, DOI 10.1517/14622416.3.1.131; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pretorius I. S., 1999, South African Journal of Enology and Viticulture, V20, P61; Puckridge M, 2013, MOL ECOL RESOUR, V13, P32, DOI 10.1111/1755-0998.12022; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rama T, 2014, FUNGAL ECOL, V8, P46, DOI 10.1016/j.funeco.2013.12.002; Richards TA, 2012, ANNU REV MAR SCI, V4, P495, DOI 10.1146/annurev-marine-120710-100802; Romo-Sanchez S, 2010, FOOD MICROBIOL, V27, P487, DOI 10.1016/j.fm.2009.12.009; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg MS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-102; Rosenberg MS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-278; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Samuel P, 2011, EUROPEAN J EXPT BIOL, V1, P130; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Shearer CA, 2007, BIODIVERS CONSERV, V16, P49, DOI 10.1007/s10531-006-9120-z; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith ME, 2007, MYCORRHIZA, V18, P15, DOI 10.1007/s00572-007-0148-z; Stern RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013991; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; Thomas TRA, 2010, MAR DRUGS, V8, P1417, DOI 10.3390/md8041417; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wiese J, 2011, MAR DRUGS, V9, P561, DOI 10.3390/md9040561; Zhang Y, 2009, MAR DRUGS, V7, P97, DOI 10.3390/md7020097; ZHARKIKH A, 1994, J MOL EVOL, V39, P315, DOI 10.1007/BF00160155	74	13	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136130	10.1371/journal.pone.0136130	http://dx.doi.org/10.1371/journal.pone.0136130			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308620	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000360069400090
J	Boucher, JA; Abboud, J; Nougarou, F; Normand, MC; Descarreaux, M				Boucher, Jean-Alexandre; Abboud, Jacques; Nougarou, Francois; Normand, Martin C.; Descarreaux, Martin			The Effects of Vibration and Muscle Fatigue on Trunk Sensorimotor Control in Low Back Pain Patients	PLOS ONE			English	Article							POSITION SENSE; TENDON VIBRATION; SPINDLE ENDINGS; VISUAL ANALOG; MOVEMENT; CONTRACTION; AFFERENTS; INDIVIDUALS; RELIABILITY; PERFORMANCE	Introduction Changes in sensorimotor function and increased trunk muscle fatigability have been identified in patients with chronic low back pain (cLBP). This study assessed the control of trunk force production in conditions with and without local erector spinae muscle vibration and evaluated the influence of muscle fatigue on trunk sensorimotor control. Methods Twenty non-specific cLBP patients and 20 healthy participants were asked to perform submaximal isometric trunk extension torque with and without local vibration stimulation, before and after a trunk extensor muscle fatigue protocol. Constant error (CE), variable error (VE) as well as absolute error (AE) in peak torque were computed and compared across conditions. Trunk extensor muscle activation during isometric contractions and during the fatigue protocol was measured using surface electromyography (sEMG). Results Force reproduction accuracy of the trunk was significantly lower in the patient group (CE = 9.81 +/- 2.23 Nm; AE = 18.16 +/- 3.97 Nm) than in healthy participants (CE = 4.44 +/- 1.68 Nm; AE = 12.23 +/- 2.44 Nm). Local erector spinae vibration induced a significant reduction in CE (4.33 +/- 2.14 Nm) and AE (13.71 +/- 3.45 Nm) mean scores in the patient group. Healthy participants conversely showed a significant increase in CE (8.17 +/- 2.10 Nm) and AE (16.29 +/- 2.82 Nm) mean scores under vibration conditions. The fatigue protocol induced erector spinae muscle fatigue as illustrated by a significant decrease in sEMG median time-frequency slopes. Following the fatigue protocol, patients with cLBP showed significant decrease in sEMG root mean square activity at L4-5 level and responded in similar manner with and without vibration stimulation in regard to CE mean scores. Conclusions Patients with cLBP have a less accurate force reproduction sense than healthy participants. Local muscle vibration led to significant trunk neuromuscular control improvements in the cLBP patients before and after a muscle fatigue protocol. Muscle vibration stimulation during motor control exercises is likely to influence motor adaptation and could be considered in the treatment of cLBP. Further work is needed to clearly identify at what levels of the sensorimotor system these gains are achievable.	[Boucher, Jean-Alexandre] Univ Quebec Trois Rivieres, Dept Psychol, Trois Rivieres, PQ GA9 5H7, Canada; [Abboud, Jacques] Univ Quebec Trois Rivieres, Dept Anat, Trois Rivieres, PQ GA9 5H7, Canada; [Nougarou, Francois; Descarreaux, Martin] Univ Quebec Trois Rivieres, Dept Sci Act Phys, Trois Rivieres, PQ GA9 5H7, Canada; [Normand, Martin C.] Univ Quebec Trois Rivieres, Dept Chiroprat, Trois Rivieres, PQ GA9 5H7, Canada	University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Trois Rivieres	Boucher, JA (corresponding author), Univ Quebec Trois Rivieres, Dept Psychol, Trois Rivieres, PQ GA9 5H7, Canada.	charljea@uqtr.ca		Descarreaux, Martin/0000-0002-3545-5860				Anonymous, 2008, Annales de Readaptation et de Medecine Physique, V51, P379, DOI 10.1016/j.annrmp.2008.03.006; BIERINGSORENSEN F, 1984, SPINE, V9, P106, DOI 10.1097/00007632-198403000-00002; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bosco C, 1999, EUR J APPL PHYSIOL O, V79, P306, DOI 10.1007/s004210050512; Boucher JA, 2015, J MANIP PHYSIOL THER, V38, P35, DOI 10.1016/j.jmpt.2014.10.013; Boucher JA, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-89; Boucher JA, 2012, J MANIP PHYSIOL THER, V35, P662, DOI 10.1016/j.jmpt.2012.10.003; Brumagne S, 1999, SPINE, V24, P1328, DOI 10.1097/00007632-199907010-00010; Brumagne S, 2004, NEUROSCI LETT, V366, P63, DOI 10.1016/j.neulet.2004.05.013; Brumagne S, 2000, SPINE, V25, P989, DOI 10.1097/00007632-200004150-00015; Brumagne S, 2008, EUR SPINE J, V17, P1177, DOI 10.1007/s00586-008-0709-7; BURKE D, 1976, J PHYSIOL-LONDON, V261, P695, DOI 10.1113/jphysiol.1976.sp011581; BURKE D, 1976, J PHYSIOL-LONDON, V261, P673, DOI 10.1113/jphysiol.1976.sp011580; CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X; CORDO P, 1995, J NEUROPHYSIOL, V74, P1675, DOI 10.1152/jn.1995.74.4.1675; Demoulin C, 2006, JOINT BONE SPINE, V73, P43, DOI 10.1016/j.jbspin.2004.08.002; Dingwell JB, 2008, IEEE T BIO-MED ENG, V55, P2666, DOI 10.1109/TBME.2008.2001130; Enthoven P, 2003, J REHABIL MED, V35, P168, DOI 10.1080/16501970310013517; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; Gandevia SC, 1998, ACTA PHYSIOL SCAND, V162, P275, DOI 10.1046/j.1365-201X.1998.0299f.x; Gill KP, 1998, SPINE, V23, P371, DOI 10.1097/00007632-199802010-00017; GOODWIN GM, 1972, BRAIN, V95, P705, DOI 10.1093/brain/95.4.705; Granata KP, 2008, ERGONOMICS, V51, P1258, DOI 10.1080/00140130802030722; Griffin L, 2001, J PHYSIOL-LONDON, V535, P929, DOI 10.1111/j.1469-7793.2001.00929.x; Hodges P, 2009, J BIOMECH, V42, P61, DOI 10.1016/j.jbiomech.2008.10.001; Hodges PW, 2011, J ELECTROMYOGR KINES, V21, P220, DOI 10.1016/j.jelekin.2011.01.002; Hollins M, 2003, J PAIN, V4, P381, DOI 10.1016/S1526-5900(03)00714-4; INGLIS JT, 1991, EXP BRAIN RES, V84, P631; Johanson E, 2011, EUR SPINE J, V20, P2152, DOI 10.1007/s00586-011-1825-3; KAKIGI R, 1992, J NEUROL NEUROSUR PS, V55, P282, DOI 10.1136/jnnp.55.4.282; Kori SH, 1990, PAIN MANAG, V3, P35; Lariviere C, 2002, J ELECTROMYOGR KINES, V12, P91, DOI 10.1016/S1050-6411(02)00011-1; Lariviere C, 2011, MED SCI SPORT EXER, V43, P157, DOI 10.1249/MSS.0b013e3181e96388; MACEFIELD G, 1991, J PHYSIOL-LONDON, V440, P497, DOI 10.1113/jphysiol.1991.sp018721; Mannion AF, 1999, J ELECTROMYOGR KINES, V9, P363, DOI 10.1016/S1050-6411(99)00010-3; McCaffery M, 1999, PAIN CLIN MANUAL; Merletti R., 2004, ELECTROMYOGRAPHY; Mischi M, 2009, MED SCI SPORT EXER, V41, P645, DOI 10.1249/MSS.0b013e31818a8a69; Myers JB, 2006, MANUAL THER, V11, P197, DOI 10.1016/j.math.2006.04.002; Nakajima T, 2009, EXP BRAIN RES, V192, P211, DOI 10.1007/s00221-008-1571-x; Newcomer KL, 2000, SPINE, V25, P2488, DOI 10.1097/00007632-200010010-00011; PANJABI MM, 1992, J SPINAL DISORD, V5, P390, DOI 10.1097/00002517-199212000-00002; PARNIANPOUR M, 1988, SPINE, V13, P982, DOI 10.1097/00007632-198809000-00004; Passatore M, 2006, EUR J APPL PHYSIOL, V98, P423, DOI 10.1007/s00421-006-0312-8; ROLL JP, 1982, EXP BRAIN RES, V47, P177; Salvetti MD, 2013, REV LAT-AM ENFERM, V21, P12; Schmidt RA, 2005, MOTOR CONTROL LEARNI, P125; Schmidt RA, 2001, MOTOR LEARNING PERFO, P175; Scrimshaw SV, 2001, J MANIP PHYSIOL THER, V24, P501, DOI 10.1067/mmt.2001.118208; Sharma Leena, 1997, Current Opinion in Rheumatology, V9, P253, DOI 10.1097/00002281-199705000-00013; Sparto PJ, 1997, J SPINAL DISORD, V10, P145; Taimela S, 1999, SPINE, V24, P1322, DOI 10.1097/00007632-199907010-00009; van Dieen JH, 2003, J ELECTROMYOGR KINES, V13, P333, DOI 10.1016/S1050-6411(03)00041-5; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; VONKORFF M, 1994, SPINE, V19, pS2041; Willigenburg NW, 2013, HUM MOVEMENT SCI, V32, P228, DOI 10.1016/j.humov.2012.12.007	56	13	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135838	10.1371/journal.pone.0135838	http://dx.doi.org/10.1371/journal.pone.0135838			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308725	Green Published, gold			2022-12-27	WOS:000360069400078
J	Ziegler, AB; Menage, C; Gregoire, S; Garcia, T; Ferveur, JF; Bretillon, L; Grosjean, Y				Ziegler, Anna B.; Menage, Cindy; Gregoire, Stephane; Garcia, Thibault; Ferveur, Jean-Francois; Bretillon, Lionel; Grosjean, Yael			Lack of Dietary Polyunsaturated Fatty Acids Causes Synapse Dysfunction in the Drosophila Visual System	PLOS ONE			English	Article							DOCOSAHEXAENOIC ACID; TRPL CHANNELS; MACULAR DEGENERATION; INSP(3) RECEPTOR; DESATURASE GENE; COA LIGASE-4; PHOTOTRANSDUCTION; MELANOGASTER; LIGHT; PHOTORECEPTORS	Polyunsaturated fatty acids (PUFAs) are essential nutrients for animals and necessary for the normal functioning of the nervous system. A lack of PUFAs can result from the consumption of a deficient diet or genetic factors, which impact PUFA uptake and metabolism. Both can cause synaptic dysfunction, which is associated with numerous disorders. However, there is a knowledge gap linking these neuronal dysfunctions and their underlying molecular mechanisms. Because of its genetic manipulability and its easy, fast, and cheap breeding, Drosophila melanogaster has emerged as an excellent model organism for genetic screens, helping to identify the genetic bases of such events. As a first step towards the understanding of PUFA implications in Drosophila synaptic physiology we designed a breeding medium containing only very low amounts of PUFAs. We then used the fly's visual system, a well-established model for studying signal transmission and neurological disorders, to measure the effects of a PUFA deficiency on synaptic function. Using both visual performance and eye electrophysiology, we found that PUFA deficiency strongly affected synaptic transmission in the fly's visual system. These defects were rescued by diets containing omega-3 or omega-6 PUFAs alone or in combination. In summary, manipulating PUFA contents in the fly's diet was powerful to investigate the role of these nutrients on the fly's visual synaptic function. This study aims at showing how the first visual synapse of Drosophila can serve as a simple model to study the effects of PUFAs on synapse function. A similar approach could be further used to screen for genetic factors underlying the molecular mechanisms of synaptic dysfunctions associated with altered PUFA levels.	[Ziegler, Anna B.; Menage, Cindy; Gregoire, Stephane; Garcia, Thibault; Ferveur, Jean-Francois; Bretillon, Lionel; Grosjean, Yael] CNRS, CSGA, UMR6265, F-21000 Dijon, France; [Ziegler, Anna B.; Menage, Cindy; Gregoire, Stephane; Garcia, Thibault; Ferveur, Jean-Francois; Bretillon, Lionel; Grosjean, Yael] INRA, UMR1324, CSGA, F-21000 Dijon, France; [Ziegler, Anna B.; Menage, Cindy; Gregoire, Stephane; Garcia, Thibault; Ferveur, Jean-Francois; Bretillon, Lionel; Grosjean, Yael] Univ Bourgogne Franche Comte, UMR, CSGA, F-21000 Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Ziegler, AB (corresponding author), CNRS, CSGA, UMR6265, F-21000 Dijon, France.	anna.ziegler@u-bourgogne.fr; yael.grosjean@u-bourgogne.fr	Grosjean, Yael/E-2634-2017	Grosjean, Yael/0000-0003-0689-8344; Bretillon, Lionel/0000-0002-6957-100X	European Research Council (ERC starting grant GliSFCo) [311403]; Centre National de la Recherche Scientifique; ANR-blanc GUSTAILE; CSGA (Gravugli); Institut National de la Recherche Agronomique	European Research Council (ERC starting grant GliSFCo); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); ANR-blanc GUSTAILE(French National Research Agency (ANR)); CSGA (Gravugli); Institut National de la Recherche Agronomique	This work was supported by the European Research Council (ERC starting grant GliSFCo, 311403 to YG). ABZ, CM, TG, JFF and YG are also supported by the "Centre National de la Recherche Scientifique". JFF was also supported by the ANR-blanc GUSTAILE. ABZ received a complementary financial support from the CSGA (Gravugli). And the "Institut National de la Recherche Agronomique" is supporting SG and LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; AUESTAD N, 1991, J NEUROCHEM, V56, P1376, DOI 10.1111/j.1471-4159.1991.tb11435.x; Avet-Rochex A, 2014, GENE EXPR PATTERNS, V16, P61, DOI 10.1016/j.gep.2014.09.001; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Ben Gedalya T, 2009, TRAFFIC, V10, P218, DOI 10.1111/j.1600-0854.2008.00853.x; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Borycz J, 2002, J NEUROSCI, V22, P10549; BURG MG, 1993, EMBO J, V12, P911, DOI 10.1002/j.1460-2075.1993.tb05732.x; Camargo N, 2009, FEBS J, V276, P628, DOI 10.1111/j.1742-4658.2008.06808.x; Chang CL, 2010, J INSECT PHYSIOL, V56, P356, DOI 10.1016/j.jinsphys.2009.11.014; Chong EWT, 2008, ARCH OPHTHALMOL-CHIC, V126, P826, DOI 10.1001/archopht.126.6.826; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Connell E, 2007, EMBO REP, V8, P414, DOI 10.1038/sj.embor.7400935; Covault J, 2004, AM J MED GENET B, V127B, P42, DOI 10.1002/ajmg.b.20156; Dacks PA, 2013, J NUTR HEALTH AGING, V17, P240, DOI 10.1007/s12603-012-0431-3; Dallerac R, 2000, P NATL ACAD SCI USA, V97, P9449, DOI 10.1073/pnas.150243997; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Delgado R, 2014, J NEUROSCI, V34, P6679, DOI 10.1523/JNEUROSCI.0513-14.2014; Delgado R, 2009, J NEUROPHYSIOL, V101, P2372, DOI 10.1152/jn.90578.2008; DEUTSCH JW, 1981, BIOCHEMISTRY-US, V20, P378, DOI 10.1021/bi00505a024; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fougeron AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026899; Galli C, 2006, EUR J LIPID SCI TECH, V108, P521, DOI 10.1002/ejlt.200600056; Gengs CX, 2002, J BIOL CHEM, V277, P42113, DOI 10.1074/jbc.M207133200; Geraldine M, 2010, NEUROCHEM INT, V56, P94, DOI 10.1016/j.neuint.2009.09.006; Gisselmann G, 2002, NAT NEUROSCI, V5, P11, DOI 10.1038/nn787; Grintal B, 2009, NEUROCHEM INT, V54, P535, DOI 10.1016/j.neuint.2009.02.018; Hardie RC, 1998, CELL CALCIUM, V24, P153, DOI 10.1016/S0143-4160(98)90125-7; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HEISENBERG M, 1971, J EXP BIOL, V55, P85; Hibbeln JR, 2014, MIL MED, V179, P117, DOI 10.7205/MILMED-D-14-00153; Hibbeln Joseph R., 2009, V99, P17, DOI 10.1159/000192992; HOTTA Y, 1969, NATURE, V222, P354, DOI 10.1038/222354a0; Huang JH, 2010, CURR BIOL, V20, P189, DOI 10.1016/j.cub.2009.12.019; Lesa GM, 2003, J CELL SCI, V116, P4965, DOI 10.1242/jcs.00918; Leung HT, 2008, NEURON, V58, P884, DOI 10.1016/j.neuron.2008.05.001; Marza E, 2008, MOL BIOL CELL, V19, P833, DOI 10.1091/mbc.E07-07-0719; Meloni I, 2002, NAT GENET, V30, P436, DOI 10.1038/ng857; Merle BMJ, 2013, J NUTR, V143, P505, DOI 10.3945/jn.112.171033; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; MOORE SA, 1991, J NEUROCHEM, V56, P518, DOI 10.1111/j.1471-4159.1991.tb08180.x; MORRISON WR, 1964, J LIPID RES, V5, P600; Nichols CD, 2012, JOVE-J VIS EXP, DOI 10.3791/3795; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Pae CU, 2004, NEUROPSYCHOBIOLOGY, V49, P185, DOI 10.1159/000077364; Papadimitriou GN, 2003, PSYCHIAT GENET, V13, P211, DOI 10.1097/00041444-200312000-00004; Parvy JP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002925; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Puchkov D, 2013, TRENDS CELL BIOL, V23, P493, DOI 10.1016/j.tcb.2013.05.002; Raghu P, 2000, MOL CELL NEUROSCI, V15, P429, DOI 10.1006/mcne.2000.0846; Richardt A, 2003, J BIOL CHEM, V278, P41160, DOI 10.1074/jbc.M304303200; Richardt A, 2002, J COMP NEUROL, V452, P93, DOI 10.1002/cne.10360; Rickman C, 2005, CHEM BIOL, V12, P545, DOI 10.1016/j.chembiol.2005.03.004; Ross BM, 2007, MED HYPOTHESES, V68, P515, DOI 10.1016/j.mehy.2006.07.054; Savarit F, 1999, P NATL ACAD SCI USA, V96, P9015, DOI 10.1073/pnas.96.16.9015; Schnebelen C, 2009, GRAEF ARCH CLIN EXP, V247, P1191, DOI 10.1007/s00417-009-1094-6; Shen LR, 2010, J LIPID RES, V51, P2985, DOI 10.1194/jlr.M008524; STARK WS, 1993, LIPIDS, V28, P345, DOI 10.1007/BF02536321; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tanaka K, 2012, BIOMOL THER, V20, P152, DOI 10.4062/biomolther.2012.20.2.152; True JR, 2005, PLOS GENET, V1, P551, DOI 10.1371/journal.pgen.0010063; Visioli Francesco, 2006, Nutrition and Health (Bicester), V18, P127; Vrablik TL, 2013, MOL REPROD DEV, V80, P244, DOI 10.1002/mrd.22167; Wang T, 2007, J CELL BIOL, V177, P305, DOI 10.1083/jcb.200610081; Wicker-Thomas C, 1997, INSECT BIOCHEM MOLEC, V27, P963, DOI 10.1016/S0965-1748(97)00077-5; Witte I, 2002, J NEUROCHEM, V83, P504, DOI 10.1046/j.1471-4159.2002.01076.x; Yehuda S, 1999, J NEUROSCI RES, V56, P565, DOI 10.1002/(SICI)1097-4547(19990615)56:6<565::AID-JNR2>3.0.CO;2-H; Ziegler AB, 2013, J COMP NEUROL, V521, P1207, DOI 10.1002/cne.23247	71	21	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135353	10.1371/journal.pone.0135353	http://dx.doi.org/10.1371/journal.pone.0135353			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308084	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400059
J	Christgen, B; Scott, K; Dolfing, J; Head, IM; Curtis, TP				Christgen, Beate; Scott, Keith; Dolfing, Jan; Head, Ian M.; Curtis, Thomas P.			An Evaluation of the Performance and Economics of Membranes and Separators in Single Chamber Microbial Fuel Cells Treating Domestic Wastewater	PLOS ONE			English	Article							ION-EXCHANGE MEMBRANES; POWER-GENERATION; TRANSPORT; OXYGEN; ELECTRODE; NAFION; REDUCTION; CATHODE; CATION; PH	The cost of materials is one of the biggest barriers for wastewater driven microbial fuel cells (MFCs). Many studies use expensive materials with idealistic wastes. Realistically the choice of an ion selective membrane or nonspecific separators must be made in the context of the cost and performance of materials available. Fourteen membranes and separators were characterized for durability, oxygen diffusion and ionic resistance to enable informed membrane selection for reactor tests. Subsequently MFCs were operated in a cost efficient reactor design using Nafion, ethylene tetrafluoroethylene (ETFE) or polyvinylidene fluoride (PVDF) membranes, a nonspecific separator (Rhinohide), and a no-membrane design with a carbon-paper internal gas diffusion cathode. Peak power densities during polarisation, from MFCs using no-membrane, Nafion and ETFE, reached 67, 61 and 59 mWm(-2), and coulombic efficiencies of 68+/-11%, 71+/-12% and 92+/-6%, respectively. Under 1000 Omega, Nafion and ETFE achieved an average power density of 29 mWm-2 compared to 24 mWm(-2) for the membrane-less reactors. Over a hypothetical lifetime of 10 years the generated energy (1 to 2.5 kWhm(-2)) would not be sufficient to offset the costs of any membrane and separator tested.	[Christgen, Beate; Dolfing, Jan; Head, Ian M.; Curtis, Thomas P.] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Scott, Keith] Newcastle Univ, Sch Chem Engn & Adv Mat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Christgen, B (corresponding author), Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Beate.Christgen@ncl.ac.uk	Dolfing, Jan/B-8641-2015	Dolfing, Jan/0000-0002-7220-530X; Curtis, Thomas/0000-0002-9009-1748; Head, Ian/0000-0002-5373-162X	Northumbrian Water; Engineering and Physical Sciences Research Council (EPSRC) [BH052678]; Natural Environment Research Council [NE/K015788/1, NE/L01422X/1] Funding Source: researchfish; NERC [NE/L01422X/1, NE/K015788/1] Funding Source: UKRI	Northumbrian Water; Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by Northumbrian Water and the Engineering and Physical Sciences Research Council (EPSRC Case award reference BH052678 to KS). The funders had no role in the study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora P, 2004, CHEM REV, V104, P4419, DOI 10.1021/cr020738u; BATTINO R, 1966, CHEM REV, V66, P395, DOI 10.1021/cr60242a003; Chae KJ, 2008, ENERG FUEL, V22, P169, DOI 10.1021/ef700308u; Cheng H, 2007, J MEMBRANE SCI, V288, P168, DOI 10.1016/j.memsci.2006.11.014; Cheng S, 2006, ENVIRON SCI TECHNOL, V40, P2426, DOI 10.1021/es051652w; Chu YQ, 2004, CHINESE CHEM LETT, V15, P805; De Paula J, 2010, ATKINS PHYS CHEM, Vxxxii; Di Lorenzo M, 2009, ENERG FUEL, V23, P5707, DOI 10.1021/ef9005934; Du ZW, 2008, CHINESE J CHEM ENG, V16, P772, DOI 10.1016/S1004-9541(08)60154-8; Eaton A., 1998, STANDARD METHODS EXA; Franz JA, 2002, WATER RES, V36, P2243, DOI 10.1016/S0043-1354(01)00443-2; Harnisch F, 2008, ENVIRON SCI TECHNOL, V42, P1740, DOI 10.1021/es702224a; Harnisch F, 2009, BIOELECTROCHEMISTRY, V75, P136, DOI 10.1016/j.bioelechem.2009.03.001; Hays S, 2011, J POWER SOURCES, V196, P8293, DOI 10.1016/j.jpowsour.2011.06.027; Heidrich ES, 2011, ENVIRON SCI TECHNOL, V45, P827, DOI 10.1021/es103058w; Hietala S, 1997, J MATER CHEM, V7, P721, DOI 10.1039/a607675k; Horsfall JA, 2002, EUR POLYM J, V38, P1671, DOI 10.1016/S0014-3057(02)00031-9; Kim JR, 2007, ENVIRON SCI TECHNOL, V41, P1004, DOI 10.1021/es062202m; Kruusenberg I, 2009, CARBON, V47, P651, DOI 10.1016/j.carbon.2008.10.032; Lehmani A, 1997, J ELECTROANAL CHEM, V428, P81, DOI 10.1016/S0022-0728(96)05060-7; Li WW, 2011, BIORESOURCE TECHNOL, V102, P244, DOI 10.1016/j.biortech.2010.03.090; Liu GL, 2011, BIORESOURCE TECHNOL, V102, P7301, DOI 10.1016/j.biortech.2011.04.087; Liu H, 2004, ENVIRON SCI TECHNOL, V38, P4040, DOI 10.1021/es0499344; Logan BE, 1999, ENV TRANSPORT PROCES, Vxiii; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Mauritz KA, 2004, CHEM REV, V104, P4535, DOI 10.1021/cr0207123; Okada T, 1998, J ELECTROANAL CHEM, V442, P137, DOI 10.1016/S0022-0728(97)00499-3; Ritchie AC, 1996, J MEMBRANE SCI, V121, P169, DOI 10.1016/S0376-7388(96)00174-3; Rozendal RA, 2008, TRENDS BIOTECHNOL, V26, P450, DOI 10.1016/j.tibtech.2008.04.008; Rozendal RA, 2006, ENVIRON SCI TECHNOL, V40, P5206, DOI 10.1021/es060387r; Shen M, 2005, J MEMBRANE SCI, V251, P121, DOI 10.1016/j.memsci.2004.11.006; Stenina IA, 2004, DESALINATION, V170, P49, DOI 10.1016/j.desal.2004.02.092; Unnikrishnan EK, 1997, J MEMBRANE SCI, V137, P133, DOI 10.1016/S0376-7388(97)00193-2; Vielstich W, 2003, HDB FUEL CELLS FUNDA; Zhang XY, 2010, BIOSENS BIOELECTRON, V25, P1825, DOI 10.1016/j.bios.2009.11.018; Zhang XY, 2009, ENVIRON SCI TECHNOL, V43, P8456, DOI 10.1021/es901631p; Zhao F, 2006, ENVIRON SCI TECHNOL, V40, P5193, DOI 10.1021/es060332p	37	28	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136108	10.1371/journal.pone.0136108	http://dx.doi.org/10.1371/journal.pone.0136108			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305330	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500048
J	Shoji, K; Lesnierowska, M; Smoktunowicz, E; Bock, J; Luszczynska, A; Benight, CC; Cieslak, R				Shoji, Kotaro; Lesnierowska, Magdalena; Smoktunowicz, Ewelina; Bock, Judith; Luszczynska, Aleksandra; Benight, Charles C.; Cieslak, Roman			What Comes First, Job Burnout or Secondary Traumatic Stress? Findings from Two Longitudinal Studies from the US and Poland	PLOS ONE			English	Article							DEMANDS-RESOURCES MODEL; SOCIAL SUPPORT; SELF-EFFICACY; MISSING DATA; WORKERS; CONSERVATION; CLINICIAN; EXPOSURE; METAANALYSIS; PREVALENCE	This longitudinal research examined the directions of the relationships between job burnout and secondary traumatic stress (STS) among human services workers. In particular, using cross-lagged panel design, we investigated whether job burnout predicts STS at 6-month follow up or whether the level of STS symptoms explains job burnout at 6-month follow-up. Participants in Study 1 were behavioral or mental healthcare providers (N = 135) working with U.S. military personnel suffering from trauma. Participants in Study 2 were healthcare providers, social workers, and other human services professions (N = 194) providing various types of services for civilian trauma survivors in Poland. The cross-lagged analyses showed consistent results for both longitudinal studies; job burnout measured at Time 1 led to STS at Time 2, but STS assessed at Time 1 did not lead to job burnout at Time 2. These results contribute to a discussion on the origins of STS and job burnout among human services personnel working in highly demanding context of work-related secondary exposure to traumatic events and confirm that job burnout contributes to the development of STS.	[Shoji, Kotaro; Bock, Judith; Luszczynska, Aleksandra; Benight, Charles C.; Cieslak, Roman] Univ Colorado, Trauma Hlth & Hazards Ctr, Colorado Springs, CO 80907 USA; [Lesnierowska, Magdalena; Smoktunowicz, Ewelina; Cieslak, Roman] Univ Social Sci & Humanities, Dept Psychol, Warsaw, Poland; [Luszczynska, Aleksandra] Univ Social Sci & Humanities, Dept Psychol, Wroclaw, Poland; [Benight, Charles C.] Univ Colorado, Dept Psychol, Colorado Springs, CO 80933 USA	University of Colorado System; University of Colorado at Colorado Springs; SWPS University of Social Sciences & Humanities; SWPS University of Social Sciences & Humanities; University of Colorado System; University of Colorado at Colorado Springs	Benight, CC (corresponding author), Univ Colorado, Trauma Hlth & Hazards Ctr, Colorado Springs, CO 80907 USA.	cbenight@uccs.edu; rcieslak@uccs.edu	Cieslak, Roman/F-3435-2014; Smoktunowicz, Ewelina/M-7205-2014; Luszczynska, Aleksandra/F-3692-2014	Cieslak, Roman/0000-0002-2413-5343; Luszczynska, Aleksandra/0000-0002-4704-9544; Lesnierowska, Magdalena/0000-0003-4095-8865	U.S. Army Medical Research and Materiel Command and the Telemedicine and Advanced Technology Research Center at Fort Detrick, Maryland [W81XWH-11-2-0153]; National Science Center, Poland [N N106 139537]	U.S. Army Medical Research and Materiel Command and the Telemedicine and Advanced Technology Research Center at Fort Detrick, Maryland; National Science Center, Poland(National Science Centre, Poland)	This research was supported by grant awarded to Charles C. Benight and administered by the U.S. Army Medical Research and Materiel Command and the Telemedicine and Advanced Technology Research Center at Fort Detrick, Maryland, under Contract Number W81XWH-11-2-0153 (http://www.tatrc.org/www/default.html). The study was also supported by the research grant from the National Science Center, Poland (N N106 139537) awarded to Roman Cieslak (https://www.ncn.gov.pl/?language = en). The contribution of Aleksandra Luszczynska is supported by the Foundation for Polish Science, Master program (http://www.fnp.org.pl/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon GM, 2011, J VOCAT BEHAV, V79, P549, DOI 10.1016/j.jvb.2011.03.007; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Baird Stephanie, 2003, Violence Vict, V18, P71, DOI 10.1891/vivi.2003.18.1.71; Benight CC, 2013, MILITARY PSYCHOL DES, P138; Brewer E., 2004, HUMAN RESOURCE DEV R, V3, P102, DOI [10.1177/1534484304263335, DOI 10.1177/1534484304263335]; Bride BE, 2004, RES SOCIAL WORK PRAC, V14, P27, DOI 10.1177/1049731503254106; Bride BE, 2007, SOC WORK, V52, P63, DOI 10.1093/sw/52.1.63; Bride BE, 2007, J EVID-INFORM SOC WO, V4, P69, DOI 10.1300/J394v04n03_05; Browne MW, 1993, TESTING STRUCTURAL E; Cieslak R, 2014, PSYCHOL SERV, V11, P75, DOI 10.1037/a0033798; Cieslak R, 2013, J NERV MENT DIS, V201, P917, DOI 10.1097/NMD.0000000000000034; Cieslak R, 2013, PSYCHOL ASSESSMENT, V25, P917, DOI 10.1037/a0032687; Clarke G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.2.e16; Creamer TL, 2005, J TRAUMA STRESS, V18, P89, DOI 10.1002/jts.20008; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Elwood LS, 2011, CLIN PSYCHOL REV, V31, P25, DOI 10.1016/j.cpr.2010.09.004; Eunha K., 2007, INT J STRESS MANAGE, V14, P111; Figley C.R., 1995, COMPASSION FATIGUE C, DOI 10.1192/bjp.bp.114.150078; Gill A, 2012, INT J MANAG, V29, P190; Hakanen JJ, 2008, WORK STRESS, V22, P224, DOI 10.1080/02678370802379432; Halbesleben JRB, 2006, J APPL PSYCHOL, V91, P1134, DOI 10.1037/0021-9010.91.5.1134; Halbesleben JRB, 2005, WORK STRESS, V19, P208, DOI 10.1080/02678370500340728; HARARI H, 1988, J CROSS CULT PSYCHOL, V19, P243, DOI 10.1177/0022022188192009; HOBFOLL SE, 1989, AM PSYCHOL, V44, P513, DOI 10.1037/0003-066X.44.3.513; Horrell SCV, 2011, PROF PSYCHOL-RES PR, V42, P79, DOI 10.1037/a0022297; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Ito JK, 2003, J VOCAT BEHAV, V63, P490, DOI 10.1016/S0001-8791(02)00033-7; Kehl D, 2014, J AGGRESS MALTREAT T, V23, P842, DOI 10.1080/10926771.2014.938143; Lee RT, 1996, J APPL PSYCHOL, V81, P123, DOI 10.1037/0021-9010.81.2.123; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Lusk M, 2015, HISPANIC J BEHAV SCI, V37, P257, DOI 10.1177/0739986315578842; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; McCann I. L., 1990, J TRAUMA STRESS, V3, P131, DOI DOI 10.1007/BF00975140; McNally RJ, 2010, PSYCHOLOGIST, V23, P386; McNally RJ, 2009, DEPRESS ANXIETY, V26, P597, DOI 10.1002/da.20586; Morse G, 2012, ADM POLICY MENT HLTH, V39, P341, DOI 10.1007/s10488-011-0352-1; Prince M, 2008, EPIDEMIOL PSICHIAT S, V17, P211, DOI 10.1017/S1121189X00001305; Pulido ML, 2012, CLIN SOC WORK J, V40, P307, DOI 10.1007/s10615-012-0384-3; Pyevich CM, 2003, J TRAUMA STRESS, V16, P325, DOI 10.1023/A:1024405716529; Royle Liz, 2009, Int J Emerg Ment Health, V11, P79; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; SCHAUFELI WB, 1994, J CROSS CULT PSYCHOL, V25, P95, DOI 10.1177/0022022194251006; Schroder H, 2011, PSYCHOL BULL, V42, P114; Shoji K, 2015, ANXIETY STRESS COPIN; Shoji K, 2014, J CLIN PSYCHOL, V70, P831, DOI 10.1002/jclp.22070; Skaalvik EM, 2009, TEACH TEACH EDUC, V25, P518, DOI 10.1016/j.tate.2008.12.006; Smith Hatcher Schnavia, 2011, J Correct Health Care, V17, P208, DOI 10.1177/1078345811401509; Streiner DL, 2002, CAN J PSYCHIAT, V47, P68; van der Ploeg E, 2003, OCCUP ENVIRON MED, V60, P40	49	72	72	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136730	10.1371/journal.pone.0136730	http://dx.doi.org/10.1371/journal.pone.0136730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6KK	26305222	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500110
J	Barnabe, C; Sun, Y; Boire, G; Hitchon, CA; Haraoui, B; Thorne, JC; Tin, D; van der Heijde, D; Curtis, JR; Jamal, S; Pope, JE; Keystone, EC; Bartlett, S; Bykerk, VP				Barnabe, Cheryl; Sun, Ye; Boire, Gilles; Hitchon, Carol A.; Haraoui, Boulos; Thorne, J. Carter; Tin, Diane; van der Heijde, Desiree; Curtis, Jeffrey R.; Jamal, Shahin; Pope, Janet E.; Keystone, Edward C.; Bartlett, Susan; Bykerk, Vivian P.		CATCH Investigators	Heterogeneous Disease Trajectories Explain Variable Radiographic, Function and Quality of Life Outcomes in the Canadian Early Arthritis Cohort (CATCH)	PLOS ONE			English	Article							EARLY RHEUMATOID-ARTHRITIS; CLINICALLY IMPORTANT DIFFERENCE; CLASSIFICATION CRITERIA; JOINT DAMAGE; DISABILITY; SHARP/VAN; HEIJDE; MODELS	Our objective was to identify distinct trajectories of disease activity state (DAS) and assess variation in radiographic progression, function and quality of life over the first two years of early rheumatoid arthritis (ERA). The CATCH (Canadian early ArThritis CoHort) is a prospective study recruiting ERA patients from academic and community rheumatology clinics in Canada. Sequential DAS28 scores were used to identify five mutually exclusive groups in the cohort (n = 1,586) using growth-based trajectory modeling. Distinguishing baseline sociodemographic and disease variables, treatment required, and differences in radiographic progression and quality of life measures over two years were assessed. The trajectory groups are characterized as: Group 1 (20%) initial high DAS improving rapidly to remission (REM); Group 2 (21%) initial moderate DAS improving rapidly to REM; Group 3 (30%) initial moderate DAS improving gradually to low DAS; Group 4 (19%) initial high DAS improving continuously to low DAS; and Group 5 (10%) initial high DAS improving gradually only to moderate DAS. Groups differed significantly in age, sex, race, education, employment, income and presence of comorbidities. Group 5 had persistent steroid requirements and the highest biologic therapy use. Group 2 had lower odds (OR 0.22, 95% CI 0.09 to 0.58) and Group 4 higher odds (OR 1.94, 95% CI 0.90 to 4.20) of radiographic progression compared to Group 1. Group 1 had the best improvement in physical function (Health Assessment Questionnaire 1.08 (SD 0.68) units), Physical Component Score (16.4 (SD 10.2) units), Mental Component Score (9.7 (SD 12.5) units) and fatigue (4.1 (SD 3.3) units). In conclusion, distinct disease activity state trajectories explain variable outcomes in ERA. Early prediction of disease course to tailor therapy and addressing social determinants of health could optimize outcomes.	[Barnabe, Cheryl] Univ Calgary, Dept Med, Calgary, AB, Canada; [Barnabe, Cheryl] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Sun, Ye; Keystone, Edward C.; Bykerk, Vivian P.] Univ Toronto, Mt Sinai Hosp, Div Rheumatol, Toronto, ON M5G 1X5, Canada; [Boire, Gilles] Univ Sherbrooke, Dept Med, Sherbrooke, PQ J1K 2R1, Canada; [Hitchon, Carol A.] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Haraoui, Boulos] Inst Rheumatol, Rheumat Dis Unit, Montreal, PQ, Canada; [Thorne, J. Carter; Tin, Diane] Southlake Reg Hlth Ctr, Newmarket, ON, Canada; [van der Heijde, Desiree] Leiden Univ, Med Ctr, Leiden, Netherlands; [Curtis, Jeffrey R.] Univ Alabama Birmingham, Birmingham, AL USA; [Jamal, Shahin] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Pope, Janet E.] Univ Western Ontario, London, ON, Canada; [Bartlett, Susan] McGill Univ, Montreal, PQ, Canada; [Bykerk, Vivian P.] Hosp Special Surg, Weill Cornell Med Coll, New York, NY 10021 USA	University of Calgary; University of Calgary; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Sherbrooke; University of Manitoba; Southlake Regional Health Centre; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Alabama System; University of Alabama Birmingham; University of British Columbia; Western University (University of Western Ontario); McGill University; Cornell University	Bykerk, VP (corresponding author), Univ Toronto, Mt Sinai Hosp, Div Rheumatol, Toronto, ON M5G 1X5, Canada.	bykerkv@hss.edu	Sun, Ye/B-9814-2017; Pope, Janet/G-3342-2011; Bartlett, Susan Joan/AAD-4103-2020; Hazlewood, Glen S/N-2233-2019; Bartlett, Susan J./J-9864-2012; van der Heijde, Désirée/I-6774-2019; Barnabe, Cheryl/C-3577-2011	Pope, Janet/0000-0003-1479-5302; Bartlett, Susan Joan/0000-0001-9755-2490; Hazlewood, Glen S/0000-0001-7709-3741; van der Heijde, Désirée/0000-0002-5781-158X; Bessette, Louis/0000-0002-6834-2731; Hitchon, Carol/0000-0001-5547-3268	Amgen Canada Inc.; Pfizer Canada Inc.; Hoffmann-La Roche Ltd.; United Chemicals of Belgium (UCB) Canada Inc.; Bristol-Myers Squibb Canada Co.; Abbott Laboratories Ltd.; Janssen Biotech Inc.	Amgen Canada Inc.(Amgen); Pfizer Canada Inc.; Hoffmann-La Roche Ltd.(Hoffmann-La Roche); United Chemicals of Belgium (UCB) Canada Inc.; Bristol-Myers Squibb Canada Co.(Bristol-Myers Squibb); Abbott Laboratories Ltd.(Abbott Laboratories); Janssen Biotech Inc.(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	The CATCH study was designed and implemented by the investigators and financially supported initially by Amgen Canada Inc. and Pfizer Canada Inc. via an unrestricted research grant since inception of CATCH. As of 2011, further support was provided by Hoffmann-La Roche Ltd., United Chemicals of Belgium (UCB) Canada Inc., Bristol-Myers Squibb Canada Co., Abbott Laboratories Ltd., and Janssen Biotech Inc. (a wholly owned subsidiary of Johnson & Johnson Inc.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2007, ARTHRITIS RHEUM-US, V56, P3226, DOI 10.1002/art.22943; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ARNETT FC, 1987, ARTHRITIS RHEUM, V31, P315; Baron G, 2008, ARTHRIT RHEUM-ARTHR, V59, P25, DOI 10.1002/art.23253; Berard RA, 2014, J RHEUMATOL, V41, P2466, DOI 10.3899/jrheum.130835; Bombardier C, 2012, ANN RHEUM DIS, V71, P836, DOI 10.1136/annrheumdis-2011-200343; Bruce B, 2005, CLIN EXP RHEUMATOL, V23, pS14; Bruynesteyn K, 2002, ARTHRITIS RHEUM-US, V46, P913, DOI 10.1002/art.10190; Bykerk VP, 2012, J RHEUMATOL, V39, P2071, DOI 10.3899/jrheum.120029; Franklin JM, 2013, MED CARE, V51, P789, DOI 10.1097/MLR.0b013e3182984c1f; Iqbal S. U., 2007, TECHNICAL REPORT; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Lubeck DP, 2004, PHARMACOECONOMICS, V22, P27; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; Nagin DS, 2010, J QUANT CRIMINOL, V26, P445, DOI 10.1007/s10940-010-9113-7; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Norton S, 2014, SEMIN ARTHRITIS RHEU, V44, P131, DOI 10.1016/j.semarthrit.2014.05.003; Norton S, 2013, RHEUMATOLOGY, V52, P2016, DOI 10.1093/rheumatology/ket253; Pouchot J, 2008, J CLIN EPIDEMIOL, V61, P705, DOI 10.1016/j.jclinepi.2007.08.016; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Quinlan Patricia, 2013, HSS J, V9, P42, DOI 10.1007/s11420-012-9308-6; Siemons L, 2014, ARTHRIT CARE RES, V66, P625, DOI 10.1002/acr.22175; van der Heijde D, 1999, J RHEUMATOL, V26, P743; van Riel PLCM, 2000, ANN RHEUM DIS, V59, P28	24	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135327	10.1371/journal.pone.0135327	http://dx.doi.org/10.1371/journal.pone.0135327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301589	Green Published, gold, Green Submitted			2022-12-27	WOS:000359951900016
J	Hao, ZB; Wang, GZ; Li, WB; Zhang, JG; Kan, JM				Hao, Zhibin; Wang, Guozhu; Li, Wenbin; Zhang, Junguo; Kan, Jiangming			Effects of Electrode Material on the Voltage of a Tree-Based Energy Generator	PLOS ONE			English	Article							ELECTRICAL SIGNALS; SAP FLOW; TRUNK; FILMS	The voltage between a standing tree and its surrounding soil is regarded as an innovative renewable energy source. This source is expected to provide a new power generation system for the low-power electrical equipment used in forestry. However, the voltage is weak, which has caused great difficulty in application. Consequently, the development of a method to increase the voltage is a key issue that must be addressed in this area of applied research. As the front-end component for energy harvesting, a metal electrode has a material effect on the level and stability of the voltage obtained. This study aimed to preliminarily ascertain the rules and mechanisms that underlie the effects of electrode material on voltage. Electrodes of different materials were used to measure the tree-source voltage, and the data were employed in a comparative analysis. The results indicate that the conductivity of the metal electrode significantly affects the contact resistance of the electrode-soil and electrode-trunk contact surfaces, thereby influencing the voltage level. The metal reactivity of the electrode has no significant effect on the voltage. However, passivation of the electrode materials markedly reduces the voltage. Suitable electrode materials are demonstrated and recommended.	[Hao, Zhibin; Wang, Guozhu; Li, Wenbin; Zhang, Junguo; Kan, Jiangming] Beijing Forestry Univ, Sch Technol, Beijing, Peoples R China	Beijing Forestry University	Li, WB (corresponding author), Beijing Forestry Univ, Sch Technol, Beijing, Peoples R China.	leewb@bjfu.edu.cn		Hao, Zhibin/0000-0003-0953-6576; Li, wenbin/0000-0001-8821-8992	National Natural Science Foundation of China [31170669]; Fundamental Research Funds for the Central Universities [BLYJ201421]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/), Grant No.: 31170669 to WL and the Fundamental Research Funds for the Central Universities, Project No.: BLYJ201421 to ZH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arutchelvi M, 2007, INT J ENERG RES, V31, P515, DOI 10.1002/er.1262; Bartzsch H, 2003, SURF COAT TECH, V174, P774, DOI 10.1016/S0257-8972(03)00384-0; Dincer I, 2015, INT J ENERG RES, V39, P585, DOI 10.1002/er.3329; Fromm J, 2007, PLANT CELL ENVIRON, V30, P249, DOI 10.1111/j.1365-3040.2006.01614.x; Ghosh S, 2014, IEEE T POWER ELECTR, V29, P4658, DOI 10.1109/TPEL.2013.2273674; Gibert D, 2006, PLANT SCI, V171, P572, DOI 10.1016/j.plantsci.2006.06.012; Gurovich LA, 2009, J PLANT PHYSIOL, V166, P290, DOI 10.1016/j.jplph.2008.06.004; Hao ZB, 2013, TELKOMNIK, V11, P4841; Himes Carlton, 2010, Nanotechnology Perceptions, V6, P29, DOI 10.4024/N01HI10A.ntp.06.01; Himes C, 2010, IEEE T NANOTECHNOL, V9, P2, DOI 10.1109/TNANO.2009.2032293; Koppan A, 2000, CR ACAD SCI III-VIE, V323, P559, DOI 10.1016/S0764-4469(00)00179-7; Koppan A., 1999, ACTA GEOD GEOPHY HU, V34, P169; Koppan Andras, 2002, Acta Biologica Szegediensis, V46, P37; Labady A, 2002, BIOELECTROCHEMISTRY, V57, P47, DOI 10.1016/S1567-5394(01)00175-X; Lautner S, 2005, PLANT PHYSIOL, V138, P2200, DOI 10.1104/pp.105.064196; Li XW, 2013, J INFORM COMPUTATION, V10, P6131; Love CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002963; MORAT P, 1994, CR ACAD SCI III-VIE, V317, P98; Paradiso JA, 2005, IEEE PERVAS COMPUT, V4, P18, DOI 10.1109/MPRV.2005.9; Remeli MF, 2015, ENERG CONVERS MANAGE, V91, P110, DOI 10.1016/j.enconman.2014.12.001; Rodriguez-Barreiro R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056358; Saadon S, 2011, ENERG CONVERS MANAGE, V52, P500, DOI 10.1016/j.enconman.2010.07.024; Sheffer M, 2003, CORROS SCI, V45, P2893, DOI 10.1016/S0010-938X(03)00106-9; Suzuki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106012; Volkov AG, 2013, J PLANT PHYSIOL, V170, P838, DOI 10.1016/j.jplph.2013.01.009; Yamaguchi T, 2012, IEEJ T ELECTR ELECTR, V7, P441, DOI 10.1002/tee.21754	26	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136639	10.1371/journal.pone.0136639	http://dx.doi.org/10.1371/journal.pone.0136639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302491	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900078
J	Liu, TW; Park, YM; Holscher, HD; Padilla, J; Scroggins, RJ; Welly, R; Britton, SL; Koch, LG; Vieira-Potter, VJ; Swanson, KS				Liu, Tzu-Wen; Park, Young-Min; Holscher, Hannah D.; Padilla, Jaume; Scroggins, Rebecca J.; Welly, Rebecca; Britton, Steven L.; Koch, Lauren G.; Vieira-Potter, Victoria J.; Swanson, Kelly S.			Physical Activity Differentially Affects the Cecal Microbiota of Ovariectomized Female Rats Selectively Bred for High and Low Aerobic Capacity	PLOS ONE			English	Article							CORE GUT MICROBIOME; EXERCISE; OBESITY; DIET; SUSCEPTIBILITY; MITOCHONDRIAL; BEHAVIOR; MOUSE	The gut microbiota is considered a relevant factor in obesity and associated metabolic diseases, for which postmenopausal women are particularly at risk. Increasing physical activity has been recognized as an efficacious approach to prevent or treat obesity, yet the impact of physical activity on the microbiota remains under-investigated. We examined the impacts of voluntary exercise on host metabolism and gut microbiota in ovariectomized (OVX) high capacity (HCR) and low capacity running (LCR) rats. HCR and LCR rats (age=27wk) were OVX and fed a high-fat diet (45% kcal fat) ad libitum and housed in cages equipped with (exercise, EX) or without (sedentary, SED) running wheels for 11wk (n=7-8/group). We hypothesized that increased physical activity would hinder weight gain, increase metabolic health and shift the microbiota of LCR rats, resulting in populations more similar to that of HCR rats. Animals were compared for characteristic metabolic parameters including body composition, lipid profile and energy expenditure; whereas cecal digesta were collected for DNA extraction. 16S rRNA gene-based amplicon Illumina MiSeq sequencing was performed, followed by analysis using QIIME 1.8.0 to assess cecal microbiota. Voluntary exercise decreased body and fat mass, and normalized fasting NEFA concentrations of LCR rats, despite only running one-third the distance of HCR rats. Exercise, however, increased food intake, weight gain and fat mass of HCR rats. Exercise clustered the gut microbial community of LCR rats, which separated them from the other groups. Assessments of specific taxa revealed significant (p<0.05) line by exercise interactions including shifts in the abundances of Firmicutes, Proteobacteria, and Cyanobacteria. Relative abundance of Christensenellaceae family was higher (p=0.026) in HCR than LCR rats, and positively correlated (p<0.05) with food intake, body weight and running distance. These findings demonstrate that exercise differentially impacts host metabolism and gut microbial communities of female HCR and LCR rats without ovarian function.	[Liu, Tzu-Wen; Swanson, Kelly S.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Holscher, Hannah D.; Swanson, Kelly S.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Park, Young-Min; Padilla, Jaume; Scroggins, Rebecca J.; Welly, Rebecca; Vieira-Potter, Victoria J.] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO USA; [Padilla, Jaume] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA; [Padilla, Jaume] Univ Missouri, Dept Child Hlth, Columbia, MO 65201 USA; [Britton, Steven L.; Koch, Lauren G.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Britton, Steven L.; Koch, Lauren G.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Swanson, KS (corresponding author), Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA.	ksswanso@illinois.edu	; Holscher, Hannah/N-3636-2013	Swanson, Kelly/0000-0001-5518-3076; Holscher, Hannah/0000-0003-4918-2426; Cross, Tzu-Wen/0000-0002-8856-8578	National Institutes of Health [R01DK099034, K01HL125503]; Office of Research Infrastructure Programs [R24OD010950]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL125503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK099034] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research Infrastructure Programs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the National Institutes of Health (R01DK099034; K01HL125503) and The Office of Research Infrastructure Programs (R24OD010950). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 2006, OFFICIAL METHODS ANA; BOUCHARD C, 1986, MED SCI SPORT EXER, V18, P639; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Casey E, 2005, CLIN SPORT MED, V24, P525, DOI 10.1016/j.csm.2005.05.002; Clarke SF, 2014, GUT, V63, P1913, DOI 10.1136/gutjnl-2013-306541; Dainese R, 2004, AM J MED, V116, P536, DOI 10.1016/j.amjmed.2003.12.018; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Duval K, 2013, EUR J CLIN NUTR, V67, P407, DOI 10.1038/ejcn.2013.33; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gibson CJ, 2013, INT J OBESITY, V37, P809, DOI 10.1038/ijo.2012.164; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Hong J, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-11; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johnson ML, 2010, J NEUROENDOCRINOL, V22, P226, DOI 10.1111/j.1365-2826.2010.01964.x; Koch LG, 2008, OBESITY, V16, pS28, DOI 10.1038/oby.2008.513; Koch LG, 2011, CIRC RES, V109, P1162, DOI 10.1161/CIRCRESAHA.111.253807; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Mclnnes P, 2010, MANUAL PROCEDURES HU, V11, P1; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Naples SP, 2010, APPL PHYSIOL NUTR ME, V35, P151, DOI 10.1139/H09-139; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Nickelson KJ, 2012, EXP DIABETES RES, DOI [10.1155/2012/849540, 10.1155/2012/859395]; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Perseghin G, 2007, DIABETES CARE, V30, P683, DOI 10.2337/dc06-2032; Peters HPF, 2001, GUT, V48, P435, DOI 10.1136/gut.48.3.435; Petriz BA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-511; Potter VJV, 2012, ENDOCRINOLOGY, V153, P4266, DOI 10.1210/en.2011-2006; Ren YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077588; ROWELL LB, 1971, J APPL PHYSIOL, V31, P864, DOI 10.1152/jappl.1971.31.6.864; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Thyfault JP, 2009, J PHYSIOL-LONDON, V587, P1805, DOI 10.1113/jphysiol.2009.169060; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Wijck K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022366; Vieira-Potter VJ, 2015, AM J PHYSIOL-REG I, V308, pR530, DOI 10.1152/ajpregu.00401.2014; Waters RP, 2008, PHYSIOL BEHAV, V93, P1044, DOI 10.1016/j.physbeh.2008.01.013; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Zuhl M, 2014, BRIT J SPORT MED, V48, P980, DOI 10.1136/bjsports-2012-091585	45	48	51	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136150	10.1371/journal.pone.0136150	http://dx.doi.org/10.1371/journal.pone.0136150			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301712	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900043
J	Ahmad, A; Khan, MU; Gogoi, LJ; Kalita, M; Sikdar, AP; Pandey, S; Dhingra, S				Ahmad, Akram; Khan, Muhammad Umair; Gogoi, Lakhya Jyoti; Kalita, Manabendra; Sikdar, Atul Prasad; Pandey, Sureshwar; Dhingra, Sameer			Japanese Encephalitis in Assam, India: Need to Increase Healthcare Workers' Understanding to Improve Health Care	PLOS ONE			English	Article							KNOWLEDGE; ATTITUDE; DISEASE; VIRUS	Introduction Japanese encephalitis (JE) is a major cause of high morbidity and mortality in several states across India. However, in 2014, a sharp rise was observed in the number of cases of JE in north-eastern Assam state, and 51% of the total cases of JE in India were reported from the Assam in the same year. In this regard, a study was conducted to evaluate the knowledge and attitudes of healthcare workers in Darrang, a district of Assam highly affected by JE. Methods A cross sectional study was conducted for 2 months among HCWs in the major district hospital of Darrang, Assam. A pre-tested, self-administered questionnaire was used to collect data from the participants. Convenience sampling approach was used to collect data from different departments of the hospitals. Descriptive and logistic regression analyses were used to express the results. Results The knowledge of HCWs regarding JE was poor with a mean knowledge score of 11.02 +/- 2.39 (out of 17), while their attitudes were positive with a mean attitudes score of 43.16 +/- 2.47 (ranging from 13 to 52). Overall, 40.4% and 74.3% of participants demonstrated good knowledge and positive attitudes respectively. Cut-off score for good knowledge and positive attitudes toward JE was set as >= 12 and >40 respectively. Older participants (40-49 years) and experienced workers (>10 years) were significantly associated with good knowledge as compared to their referent group (p<0.05), while knowledge of nurses and other orderlies were significantly lower than physicians (p<0.01). Similar factors were associatedwith the positive attitudes of the participants with the exception of experience. Television was the major source of information regarding JE reported by HCWs (79%). Conclusion Although the knowledge was not optimized, HCWs exhibited positive attitudes towards JE. Future research is required to design, implement and evaluate interventions to improve the knowledge of JE among HCWs.	[Ahmad, Akram; Khan, Muhammad Umair] Fac Pharmaceut Sci, Dept Clin Pharm, Kuala Lumpur, Malaysia; [Gogoi, Lakhya Jyoti] Mangaldai Coll, Inst Level Biotech Hub, Mangaldai 784125, Assam, India; [Kalita, Manabendra] Dakshin Kamrup Coll, Inst Level Biotech Hub, Mirza 781125, Assam, India; [Sikdar, Atul Prasad] Mangaldai Coll, Dept Chem, Mangaldai 784125, Assam, India; [Pandey, Sureshwar; Dhingra, Sameer] Univ W Indies, Fac Med Sci, Sch Pharm, St Augustine, Trinidad Tobago	University West Indies Mona Jamaica; University West Indies Saint Augustine	Dhingra, S (corresponding author), Univ W Indies, Fac Med Sci, Sch Pharm, Eric Williams Med Sci Complex, St Augustine, Trinidad Tobago.	sameer.dhingra@sta.uwi.edu	Ahmad, PhD, Akram/P-7368-2015; Dhingra, Sameer/AFS-2976-2022; Dhingra, Sameer/AAT-1873-2021	Ahmad, PhD, Akram/0000-0002-9998-5860; Dhingra, Sameer/0000-0003-2537-8889; Gogoi, Lakhya Jyoti/0000-0002-1479-146X; Kalita, Manabendra/0000-0003-1244-8446				[Anonymous], TRANSM JAP ENC VIR; Burke DS, 2001, FIELDS VIROLGY; Dhillon G P S, 2008, J Indian Med Assoc, V106, P660; Dulce B, 2010, ACTA PAUL ENFERM, V23, P8; Fisher WA, HLTH PSYCHOL, V14, P255; Goswami Nimit, 2013, Perspect Clin Res, V4, P130, DOI 10.4103/2229-3485.111797; Halstead Scott B, 2003, Adv Virus Res, V61, P103, DOI 10.1016/S0065-3527(03)61003-1; Ho TS, 2013, J FORMOS MED ASSOC, V112, P18, DOI 10.1016/j.jfma.2012.11.004; Huang HL, 2011, J TRAVEL MED, V18, P34, DOI 10.1111/j.1708-8305.2010.00483.x; Japanese Encephalitis Morbidity Mortality and Disability, THE PATH PROJ; Khan MU, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1281; Kilmarx PH, 2014, MMWR-MORBID MORTAL W, V63, P1168; Mackenzie JS, 2005, J NEUROVIROL, V11, P434, DOI 10.1080/13550280591002487; Munnell A, 2006, EMPLOYER ATTITUDES T; National Guidelines for Rabies Prophylaxis, 2019, NAT RAB CONTR PROGR, P618; Phukan A. C., 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P618; Rahman AGEDA, 2013, ASIAN J MED RES, V2, P10; Rahnavardi M, 2008, J HOSP INFECT, V69, P77, DOI 10.1016/j.jhin.2008.02.007; Raosoft, 2008, ONL SAMPL SIZ CALC; Sharma J, 2015, INNOVARE J HLTH SCI, V3, P11; Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003; Solomon T, 2002, JAPANESE ENCEPHALITI; Suchitra J B, 2007, Indian J Med Microbiol, V25, P181; Tiwari S, 2012, BRAZ J INFECT DIS, V16, P564, DOI 10.1016/j.bjid.2012.10.004; Zhang S, 2011, PUBLIC HEALTH, V125, P79, DOI 10.1016/j.puhe.2010.10.011	25	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135767	10.1371/journal.pone.0135767	http://dx.doi.org/10.1371/journal.pone.0135767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296212	Green Submitted, Green Published, gold			2022-12-27	WOS:000359926900042
J	Noda, A; Suemori, H; Hirai, Y; Hamasaki, K; Kodama, Y; Mitani, H; Landes, RD; Nakamura, N				Noda, Asao; Suemori, Hirofumi; Hirai, Yuko; Hamasaki, Kanya; Kodama, Yoshiaki; Mitani, Hiroshi; Landes, Reid D.; Nakamura, Nori			Creation of Mice Bearing a Partial Duplication of HPRT Gene Marked with a GFP Gene and Detection of Revertant Cells In Situ as GFP-Positive Somatic Cells	PLOS ONE			English	Article							EYED UNSTABLE MUTATION; INTRACHROMOSOMAL HOMOLOGOUS RECOMBINATION; BLOOD T-LYMPHOCYTES; SMALL-INTESTINE; STEM-CELLS; CHROMOSOME TRANSLOCATIONS; GAMMA-RADIATION; DIRECT REPEAT; ANEUPLOIDY; MOSAICISM	It is becoming clear that apparently normal somatic cells accumulate mutations. Such accumulations or propagations of mutant cells are thought to be related to certain diseases such as cancer. To better understand the nature of somatic mutations, we developed a mouse model that enables in vivo detection of rare genetically altered cells via GFP positive cells. The mouse model carries a partial duplication of 3' portion of X-chromosomal HPRT gene and a GFP gene at the end of the last exon. In addition, although HPRT gene expression was thought ubiquitous, the expression level was found insufficient in vivo to make the revertant cells detectable by GFP positivity. To overcome the problem, we replaced the natural HPRT-gene promoter with a CAG promoter. In such animals, termed HPRT-dup-GFP mouse, losing one duplicated segment by crossover between the two sister chromatids or within a single molecule of DNA reactivates gene function, producing hybrid HPRT-GFP proteins which, in turn, cause the revertant cells to be detected as GFP-positive cells in various tissues. Frequencies of green mutant cells were measured using fixed and frozen sections (liver and pancreas), fixed whole mount (small intestine), or by means of flow cytometry (unfixed splenocytes). The results showed that the frequencies varied extensively among individuals as well as among tissues. X-ray exposure (3 Gy) increased the frequency moderately (similar to 2 times) in the liver and small intestine. Further, in two animals out of 278 examined, some solid tissues showed too many GFP-positive cells to score (termed extreme jackpot mutation). Present results illustrated a complex nature of somatic mutations occurring in vivo. While the HPRT-dup-GFP mouse may have a potential for detecting tissue-specific environmental mutagens, large inter-individual variations of mutant cell frequency cause the results unstable and hence have to be reduced. This future challenge will likely involve lowering the background mutation frequency, thus reducing inter-individual variation.	[Noda, Asao; Hirai, Yuko; Hamasaki, Kanya; Kodama, Yoshiaki; Nakamura, Nori] Radiat Effects Res Fdn, Dept Genet, Minami Ku, Hiroshima 7320815, Japan; [Suemori, Hirofumi] Kyoto Univ, Lab Embryon Stem Cell Res, Stem Cell Res Ctr, Inst Frontier Med Sci,Sakyo Ku, Kyoto 6068507, Japan; [Mitani, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; [Landes, Reid D.] Radiat Effects Res Fdn, Dept Stat, Minami Ku, Hiroshima 7320815, Japan	Radiation Effects Research Foundation - Japan; Kyoto University; University of Tokyo; Radiation Effects Research Foundation - Japan	Noda, A (corresponding author), Radiat Effects Res Fdn, Dept Genet, Minami Ku, 5-2 Hijiyama Pk, Hiroshima 7320815, Japan.	asnoda@rerf.or.jp		Noda, Asao/0000-0002-9029-9813	DOE grant (National Academy of Sciences, United States) [DE-HS0000031]; MEXT grant (Japanese Ministry of Health, Labour and Welfare) [s21001003, s25220102]; Central Research Institute of Electronic Industry grant; Japan Chemical Industry Association LRI grant	DOE grant (National Academy of Sciences, United States); MEXT grant (Japanese Ministry of Health, Labour and Welfare); Central Research Institute of Electronic Industry grant; Japan Chemical Industry Association LRI grant	Funding provided by DOE Award DE-HS0000031 (National Academy of Sciences, United States) to AN, YH, KH, YK, RDL, NN, MEXT grant (Japanese Ministry of Health, Labour and Welfare) s21001003, s25220102 to AN, HM, Central Research Institute of Electronic Industry grant to AN and Japan Chemical Industry Association LRI grant to AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views of the authors do not necessarily reflect those of the two governments.	ABRUZZO MA, 1985, CYTOGENET CELL GENET, V39, P275, DOI 10.1159/000132157; Aubrecht J, 1999, CARCINOGENESIS, V20, P2229, DOI 10.1093/carcin/20.12.2229; Baker DJ, 2013, NAT CELL BIOL, V15, P96, DOI 10.1038/ncb2643; Baker DJ, 2010, CELL CYCLE, V9, P1711, DOI 10.4161/cc.9.9.11314; Barber RC, 2006, MUTAT RES-FUND MOL M, V598, P50, DOI 10.1016/j.mrfmmm.2006.01.009; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Bertrand P, 1997, ONCOGENE, V14, P1117, DOI 10.1038/sj.onc.1200931; Bishop AJR, 2000, CANCER RES, V60, P395; Bourdeaut F, 2010, J MED GENET, V47, P859, DOI 10.1136/jmg.2009.075374; Bushman DM, 2013, SEMIN CELL DEV BIOL, V24, P357, DOI 10.1016/j.semcdb.2013.02.003; De S, 2011, TRENDS GENET, V27, P217, DOI 10.1016/j.tig.2011.03.002; Faggioli F, 2012, HUM MOL GENET, V21, P5246, DOI 10.1093/hmg/dds375; Frank SA, 2010, P NATL ACAD SCI USA, V107, P1725, DOI 10.1073/pnas.0909343106; GONDO Y, 1993, P NATL ACAD SCI USA, V90, P297, DOI 10.1073/pnas.90.1.297; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Hendricks CA, 2003, P NATL ACAD SCI USA, V100, P6325, DOI 10.1073/pnas.1232231100; Hinkley DV, 1997, BOOTSTRAP METHODS TH, P582, DOI [10.1017/CBO9780511802843, DOI 10.1017/CBO9780511802843]; HIRAI Y, 1995, MUTAT RES-FUND MOL M, V329, P183, DOI 10.1016/0027-5107(95)00044-J; Hulten MA, 2010, CURR GENOMICS, V11, P409, DOI 10.2174/138920210793176056; IANNACCONE PM, 1987, INT J CANCER, V39, P778, DOI 10.1002/ijc.2910390621; Kass EM, 2013, P NATL ACAD SCI USA, V110, P5564, DOI 10.1073/pnas.1216824110; Knouse KA, 2014, P NATL ACAD SCI USA, V111, P13409, DOI 10.1073/pnas.1415287111; KUSHIRO J, 1992, MUTAT RES, V272, P17, DOI 10.1016/0165-1161(92)90005-7; LI YQ, 1994, J CELL SCI, V107, P3271; Mekeel KL, 1997, ONCOGENE, V14, P1847, DOI 10.1038/sj.onc.1201143; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Nakano M, 2004, RADIAT RES, V161, P273, DOI 10.1667/RR3133; Noda A, 2011, MUTAT RES-GEN TOX EN, V721, P101, DOI 10.1016/j.mrgentox.2010.12.010; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; PARK HS, 1995, AM J PATHOL, V147, P1416; POTTEN CS, 1987, VIRCHOWS ARCH B, V53, P227, DOI 10.1007/BF02890247; Prochazkova K, 2009, AM J MED GENET A, V149A, P206, DOI 10.1002/ajmg.a.32574; Rodriguez-Santiago B, 2010, AM J HUM GENET, V87, P129, DOI 10.1016/j.ajhg.2010.06.002; Schiestl RH, 1997, P NATL ACAD SCI USA, V94, P4576, DOI 10.1073/pnas.94.9.4576; SCHIESTL RH, 1994, SCIENCE, V266, P1573, DOI 10.1126/science.7985029; SCHMIDT GH, 1988, DEVELOPMENT, V103, P785; SCHONBERG S, 1984, AM J HUM GENET, V36, P387; Shao CS, 2001, NAT GENET, V28, P169, DOI 10.1038/88897; Sukup-Jackson MR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004299; Tang JCY, 2013, CELL, V154, P928, DOI 10.1016/j.cell.2013.07.021; Tichy ED, 2010, STEM CELLS DEV, V19, P1699, DOI 10.1089/scd.2010.0058; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Tucker JD, 1998, MUTAT RES-FUND MOL M, V400, P321, DOI 10.1016/S0027-5107(98)00048-7; Wiktor-Brown DM, 2006, P NATL ACAD SCI USA, V103, P11862, DOI 10.1073/pnas.0604943103; Wiktor-Brown DM, 2011, DNA REPAIR, V10, P1294, DOI 10.1016/j.dnarep.2011.09.009; WINTON DJ, 1989, MUTAGENESIS, V4, P404, DOI 10.1093/mutage/4.5.404; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; Yurov YB, 2009, MOL CYTOGENET, V2, DOI 10.1186/1755-8166-2-23	50	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136041	10.1371/journal.pone.0136041	http://dx.doi.org/10.1371/journal.pone.0136041			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295470	Green Submitted, Green Published, gold			2022-12-27	WOS:000359926900063
J	Verhoef, BE; Vogels, R; Janssen, P				Verhoef, Bram-Ernst; Vogels, Rufin; Janssen, Peter			Effects of Microstimulation in the Anterior Intraparietal Area during Three-Dimensional Shape Categorization	PLOS ONE			English	Article							INFERIOR TEMPORAL CORTEX; POSTERIOR PARIETAL CORTEX; FINE DISPARITY DISCRIMINATION; DECISION-RELATED ACTIVITY; FRONTAL EYE FIELD; DEPTH-PERCEPTION; ELECTRICAL MICROSTIMULATION; INFEROTEMPORAL CORTEX; HEADING PERCEPTION; CEREBRAL-CORTEX	The anterior intraparietal area (AIP) of rhesus monkeys is part of the dorsal visual stream and contains neurons whose visual response properties are commensurate with a role in three-dimensional (3D) shape perception. Neuronal responses in AIP signal the depth structure of disparity-defined 3D shapes, reflect the choices of monkeys while they categorize 3D shapes, and mirror the behavioral variability across different stimulus conditions during 3D-shape categorization. However, direct evidence for a role of AIP in 3D-shape perception has been lacking. We trained rhesus monkeys to categorize disparity-defined 3D shapes and examined AIP's contribution to 3D-shape categorization by microstimulating in clusters of 3D-shape selective AIP neurons during task performance. We find that microstimulation effects on choices (monkey M1) and reaction times (monkey M1 and M2) depend on the 3D-shape preference of the stimulated site. Moreover, electrical stimulation of the same cells, during either the 3D-shape-categorization task or a saccade task, could affect behavior differently. Interestingly, in one monkey we observed a strong correlation between the strength of choice-related AIP activity (choice probabilities) and the influence of microstimulation on 3D-shape-categorization behavior (choices and reaction time). These findings propose AIP as part of the network responsible for 3D-shape perception. The results also show that the anterior intraparietal cortex contains cells with different tuning properties, i.e. 3D-shape-or saccade-related, that can be dynamically read out depending on the requirements of the task at hand.	[Verhoef, Bram-Ernst; Vogels, Rufin; Janssen, Peter] Katholieke Univ Leuven, Lab Neuro Psychofysiol, O&N2, Leuven, Belgium; [Verhoef, Bram-Ernst] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	KU Leuven; University of Chicago	Janssen, P (corresponding author), Katholieke Univ Leuven, Lab Neuro Psychofysiol, O&N2, Campus Gasthuisberg, Leuven, Belgium.	Peter.Janssen@med.kuleuven.be		Verhoef, Bram-Ernst/0000-0003-3535-9008	Flemish fund for Scientific Research, Fonds voor Wetenschappelijk Onderzoek Vlaanderen [G.0713.09, G.0A22.13N]; Programmafinanciering [PFV10/008]; Geconcerteerde Onderzoeksacties [GOA 10/19]; Interuniversitaire Attractiepolen [IUAP P6/29]	Flemish fund for Scientific Research, Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); Programmafinanciering; Geconcerteerde Onderzoeksacties; Interuniversitaire Attractiepolen	Flemish fund for Scientific Research, postdoctoral fellowship BEV, Fonds voor Wetenschappelijk Onderzoek Vlaanderen (G.0713.09 and G.0A22.13N) PJ Programmafinanciering PFV10/008 PJ Geconcerteerde Onderzoeksacties GOA 10/19 PJ Interuniversitaire Attractiepolen IUAP P6/29 PJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai A, 2010, CURR OPIN NEUROBIOL, V20, P367, DOI 10.1016/j.conb.2010.04.006; Baumann MA, 2009, J NEUROSCI, V29, P6436, DOI 10.1523/JNEUROSCI.5479-08.2009; Bennur S, 2011, J NEUROSCI, V31, P913, DOI 10.1523/JNEUROSCI.4417-10.2011; Borra E, 2008, CEREB CORTEX, V18, P1094, DOI 10.1093/cercor/bhm146; Bosman CA, 2009, J NEUROSCI, V29, P9471, DOI 10.1523/JNEUROSCI.1193-09.2009; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; Britten KH, VIS NEUROSCI, V13, P87; Chandrasekaran C, 2007, J NEUROPHYSIOL, V97, P1553, DOI 10.1152/jn.01074.2006; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Ferraina S, 2000, J NEUROPHYSIOL, V83, P625, DOI 10.1152/jn.2000.83.1.625; Freedman DJ, 2011, NAT NEUROSCI, V14, P143, DOI 10.1038/nn.2740; Genovesio A, 2004, J NEUROPHYSIOL, V91, P2670, DOI 10.1152/jn.00712.2003; Georgieva S, 2009, J NEUROSCI, V29, P727, DOI 10.1523/JNEUROSCI.4753-08.2009; Gu Y, 2012, J NEUROSCI, V32, P2299, DOI 10.1523/JNEUROSCI.5154-11.2012; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; Janssen P, 2015, ANNU REV NEUROSCI, V38, P69, DOI 10.1146/annurev-neuro-071714-034028; Joly O, 2009, NEUROIMAGE, V47, P262, DOI 10.1016/j.neuroimage.2009.04.043; Mayo JP, 2014, J NEUROSCI, V34, P8385, DOI 10.1523/JNEUROSCI.1493-14.2014; Meister MLR, 2013, J NEUROSCI, V33, P2254, DOI 10.1523/JNEUROSCI.2984-12.2013; Mirpour K, 2010, J NEUROPHYSIOL, V104, P3021, DOI 10.1152/jn.00397.2010; Mushiake H, 1999, J NEUROPHYSIOL, V81, P1443, DOI 10.1152/jn.1999.81.3.1443; Neri P, 2005, J NEUROPHYSIOL, V93, P1823, DOI 10.1152/jn.01068.2004; Nienborg H, 2014, J NEUROSCI, V34, P3579, DOI 10.1523/JNEUROSCI.2340-13.2014; Parker AJ, 2007, NAT REV NEUROSCI, V8, P379, DOI 10.1038/nrn2131; Premereur E, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002072; Price NSC, 2010, J NEUROSCI, V30, P14036, DOI 10.1523/JNEUROSCI.2336-10.2010; Rishel CA, 2013, NEURON, V77, P969, DOI 10.1016/j.neuron.2013.01.007; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Romero MC, 2012, EUR J NEUROSCI, V36, P2324, DOI 10.1111/j.1460-9568.2012.08135.x; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Scherberger H, 2007, J NEUROSCI, V27, P2001, DOI 10.1523/JNEUROSCI.4274-06.2007; Shiozaki HM, 2012, J NEUROSCI, V32, P3830, DOI 10.1523/JNEUROSCI.5083-11.2012; Srivastava S, 2009, J NEUROSCI, V29, P10613, DOI 10.1523/JNEUROSCI.6016-08.2009; Swaminathan SK, 2012, NAT NEUROSCI, V15, P315, DOI 10.1038/nn.3016; Theys T, 2013, J COGNITIVE NEUROSCI, V25, P352, DOI 10.1162/jocn_a_00332; Theys T, 2012, J NEUROSCI, V32, P12038, DOI 10.1523/JNEUROSCI.1790-12.2012; Theys T, 2012, J NEUROPHYSIOL, V107, P995, DOI 10.1152/jn.00248.2011; Thier P, 1996, P NATL ACAD SCI USA, V93, P4962, DOI 10.1073/pnas.93.10.4962; Tsutsui KI, 2001, J NEUROPHYSIOL, V86, P2856, DOI 10.1152/jn.2001.86.6.2856; Uka T, 2005, J NEUROSCI, V25, P10796, DOI 10.1523/JNEUROSCI.1637-05.2005; Uka T, 2006, J NEUROSCI, V26, P6791, DOI 10.1523/JNEUROSCI.5435-05.2006; Verhoef BE, 2015, J COGNITIVE NEUROSCI, V27, P1104, DOI 10.1162/jocn_a_00773; Verhoef BE, 2015, J NEUROSCI, V35, P6952, DOI 10.1523/JNEUROSCI.5079-14.2015; Verhoef BE, 2012, NEURON, V73, P171, DOI 10.1016/j.neuron.2011.10.031; Verhoef BE, 2011, J NEUROPHYSIOL, V105, P2030, DOI 10.1152/jn.00924.2010; Verhoef BE, 2010, CURR BIOL, V20, P909, DOI 10.1016/j.cub.2010.03.058; Yamane Y, 2008, NAT NEUROSCI, V11, P1352, DOI 10.1038/nn.2202	51	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136543	10.1371/journal.pone.0136543	http://dx.doi.org/10.1371/journal.pone.0136543			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295941	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900121
J	Cauvy-Fraunie, S; Espinosa, R; Andino, P; Jacobsen, D; Dangles, O				Cauvy-Fraunie, Sophie; Espinosa, Rodrigo; Andino, Patricio; Jacobsen, Dean; Dangles, Olivier			Invertebrate Metacommunity Structure and Dynamics in an Andean Glacial Stream Network Facing Climate Change	PLOS ONE			English	Article							MACROINVERTEBRATE COMMUNITY STRUCTURE; DISPERSAL LIMITATION; LONGITUDINAL DISTRIBUTION; ENVIRONMENTAL-CONDITIONS; MACRO INVERTEBRATES; HEADWATER STREAMS; SPATIAL PROCESSES; AQUATIC INSECTS; TROPICAL ANDES; BETA DIVERSITY	Under the ongoing climate change, understanding the mechanisms structuring the spatial distribution of aquatic species in glacial stream networks is of critical importance to predict the response of aquatic biodiversity in the face of glacier melting. In this study, we propose to use metacommunity theory as a conceptual framework to better understand how river network structure influences the spatial organization of aquatic communities in glacierized catchments. At 51 stream sites in an Andean glacierized catchment (Ecuador), we sampled benthic macroinvertebrates, measured physico-chemical and food resource conditions, and calculated geographical, altitudinal and glaciality distances among all sites. Using partial redundancy analysis, we partitioned community variation to evaluate the relative strength of environmental conditions (e.g., glaciality, food resource) vs. spatial processes (e.g., overland, watercourse, and downstream directional dispersal) in organizing the aquatic metacommunity. Results revealed that both environmental and spatial variables significantly explained community variation among sites. Among all environmental variables, the glacial influence component best explained community variation. Overland spatial variables based on geographical and altitudinal distances significantly affected community variation. Watercourse spatial variables based on glaciality distances had a unique significant effect on community variation. Within alpine catchment, glacial meltwater affects macroinvertebrate metacommunity structure in many ways. Indeed, the harsh environmental conditions characterizing glacial influence not only constitute the primary environmental filter but also, limit water-borne macroinvertebrate dispersal. Therefore, glacier runoff acts as an aquatic dispersal barrier, isolating species in headwater streams, and preventing non-adapted species to colonize throughout the entire stream network. Under a scenario of glacier runoff decrease, we expect a reduction in both environmental filtering and dispersal limitation, inducing a taxonomic homogenization of the aquatic fauna in glacierized catchments as well as the extinction of specialized species in headwater groundwater and glacier-fed streams, and consequently an irreversible reduction in regional diversity.	[Cauvy-Fraunie, Sophie; Dangles, Olivier] IRD 247 CNRS UP Sud 9191, UMR EGCE, IRD, F-91198 Gif Sur Yvette, France; [Cauvy-Fraunie, Sophie; Espinosa, Rodrigo; Andino, Patricio; Jacobsen, Dean; Dangles, Olivier] Pontificia Univ Catolica Ecuador, Fac Ciencias Exactas & Nat, Quito, Ecuador; [Cauvy-Fraunie, Sophie; Dangles, Olivier] Univ Mayor San Andres, Inst Ecol, La Paz, Bolivia; [Jacobsen, Dean] Univ Copenhagen, Dept Biol, Freshwater Biol Lab, DK-2100 Copenhagen, Denmark	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; Pontificia Universidad Catolica del Ecuador; Universidad Mayor de San Andres; University of Copenhagen	Cauvy-Fraunie, S (corresponding author), IRD 247 CNRS UP Sud 9191, UMR EGCE, IRD, F-91198 Gif Sur Yvette, France.	sophie.cauvy@gmail.com	Dangles, Olivier/C-4924-2009; , Cauvy-Fraunié/S-9450-2019; Espinosa, Rodrigo/AAR-1606-2020; Jacobsen, Dean/K-4920-2014	Dangles, Olivier/0000-0002-1987-8433; Espinosa, Rodrigo/0000-0003-1945-9666; Jacobsen, Dean/0000-0001-5137-297X; Cauvy-Fraunie, sophie/0000-0001-8600-0519	Ecofondo Grant [034-ECO8-inv1]; Fond Francais pour l'Environnement Mondial (FFEM); Fondation pour la Recherche sur la Biodiversite [AAP-SCEN-2011-II]	Ecofondo Grant; Fond Francais pour l'Environnement Mondial (FFEM); Fondation pour la Recherche sur la Biodiversite	Funding was provided by Ecofondo Grant (No. 034-ECO8-inv1) to O.D., Fond Francais pour l'Environnement Mondial (FFEM) and the Fondation pour la Recherche sur la Biodiversite (Modeling BIOdiversity and land use interactions under changing glacial water availability in Tropical High Andean Wetlands"-BIOTHAW, AAP-SCEN-2011-II) to O.D. (data analysis, preparation of the manuscript).	Altermatt F, 2013, J BIOGEOGR, V92, P859; Altermatt F, 2013, AQUAT ECOL, V47, P365, DOI 10.1007/s10452-013-9450-3; Astorga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P365, DOI 10.1111/j.1466-8238.2011.00681.x; Baraer M, 2012, J GLACIOL, V58, P134, DOI 10.3189/2012JoG11J186; Barquin J, 2006, J N AM BENTHOL SOC, V25, P768, DOI 10.1899/0887-3593(2006)025[0768:SPOMDI]2.0.CO;2; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Blanchet FG, 2008, ECOL MODEL, V215, P325, DOI 10.1016/j.ecolmodel.2008.04.001; Blanchet FG, 2011, OECOLOGIA, V166, P357, DOI 10.1007/s00442-010-1867-y; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brown BL, 2010, J ANIM ECOL, V79, P571, DOI 10.1111/j.1365-2656.2010.01668.x; Brown BL, 2011, J N AM BENTHOL SOC, V30, P310, DOI 10.1899/10-129.1; Brown LE, 2003, ARCT ANTARCT ALP RES, V35, P313, DOI 10.1657/1523-0430(2003)035[0313:ASHCAA]2.0.CO;2; Brown LE, 2007, GLOBAL CHANGE BIOL, V13, P958, DOI 10.1111/j.1365-2486.2007.01341.x; Brown LE, 2012, GLOBAL CHANGE BIOL, V18, P2195, DOI 10.1111/j.1365-2486.2012.02675.x; Brown LE, 2010, AQUAT SCI, V72, P325, DOI 10.1007/s00027-010-0138-7; Brown LE, 2009, BIOL CONSERV, V142, P2613, DOI 10.1016/j.biocon.2009.06.009; Brown LE, 2009, FRESHWATER BIOL, V54, P1357, DOI 10.1111/j.1365-2427.2008.02161.x; Canedo-Arguelles M, 2015, J BIOGEOGR, V42, P778, DOI 10.1111/jbi.12457; Casassa G, 2009, HYDROL PROCESS, V23, P31, DOI 10.1002/hyp.7194; Castella E, 2001, FRESHWATER BIOL, V46, P1811, DOI 10.1046/j.1365-2427.2001.00860.x; Cauvy-Fraunie S, 2013, HYDROL EARTH SYST SC, V17, P4803, DOI 10.5194/hess-17-4803-2013; Cauvy-Fraunie S., 2014, THESIS P M CURIE U P; Cauvy-Fraunie S, 2015, LIMNOL OCEANOGR, V60, P1836, DOI 10.1002/lno.10137; Cauvy-Fraunie S, 2014, FRESHWATER BIOL, V59, P1916, DOI 10.1111/fwb.12395; Cauvy-Fraunie S, 2014, HYDROL PROCESS, V28, P3008, DOI 10.1002/hyp.9866; Chase JM, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P335; Clarke A, 2008, FRESHWATER BIOL, V53, P1707, DOI 10.1111/j.1365-2427.2008.02041.x; Clitherow LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060899; Cochrane M., 2011, MACALESTER REV BIOGE, V2, P1; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Effenberger M, 2011, J ANIM ECOL, V80, P603, DOI 10.1111/j.1365-2656.2011.01807.x; Fagan WF, 2002, ECOLOGY, V83, P3243, DOI 10.2307/3072074; Fernandez H., 2001, ENTOMOTROPICA, V16, P219; Finn DS, 2006, MOL ECOL, V15, P3553, DOI 10.1111/j.1365-294X.2006.03034.x; Finn DS, 2013, GLOBAL ECOL BIOGEOGR, V22, P40, DOI 10.1111/j.1466-8238.2012.00766.x; Finn DS, 2010, GLOBAL CHANGE BIOL, V16, P3314, DOI 10.1111/j.1365-2486.2009.02160.x; Francou B, 2000, AMBIO, V29, P416, DOI 10.1639/0044-7447(2000)029[0416:GEITTA]2.0.CO;2; Fureder L, 2012, NAT CLIM CHANGE, V2, P318; Fugere V, 2012, J ANIM ECOL, V81, P1259, DOI 10.1111/j.1365-2656.2012.01994.x; Gotelli Nicholas J., 2011, P39; Gothe E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072237; Gothe E, 2013, J ANIM ECOL, V82, P449, DOI 10.1111/1365-2656.12004; Grant EHC, 2007, ECOL LETT, V10, P165, DOI 10.1111/j.1461-0248.2006.01007.x; Gronroos M, 2013, ECOL EVOL, V3, P4473, DOI 10.1002/ece3.834; Hannah DM, 2007, AQUAT CONSERV, V17, P636, DOI 10.1002/aqc.800; Heino J, 2015, ECOL EVOL, V5, P1235, DOI 10.1002/ece3.1439; Heino J, 2015, FRESHWATER BIOL, V60, P845, DOI 10.1111/fwb.12533; Heino J, 2015, FRESHWATER BIOL, V60, P223, DOI 10.1111/fwb.12502; Heino J, 2012, OIKOS, V121, P537, DOI 10.1111/j.1600-0706.2011.19715.x; Huss M, 2008, HYDROL PROCESS, V22, P3888, DOI 10.1002/hyp.7055; Huss M, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010299; Ilg C, 2006, FRESHWATER BIOL, V51, P840, DOI 10.1111/j.1365-2427.2006.01533.x; Ilg C, 2001, ARCH HYDROBIOL, V151, P335; Jacobsen D, 2008, OECOLOGIA, V154, P795, DOI 10.1007/s00442-007-0877-x; Jacobsen D, 2014, FRESHWATER BIOL, V59, P2038, DOI 10.1111/fwb.12405; Jacobsen D, 2014, FRESHW SCI, V33, P32, DOI 10.1086/674745; Jacobsen D, 2012, NAT CLIM CHANGE, V2, P361, DOI [10.1038/nclimate1435, 10.1038/NCLIMATE1435]; Jacobsen D, 2012, GLOBAL ECOL BIOGEOGR, V21, P647, DOI 10.1111/j.1466-8238.2011.00699.x; Jenkins DG, 2007, GLOBAL ECOL BIOGEOGR, V16, P415, DOI 10.1111/j.1466-8238.2007.00312.x; Jiang XM, 2013, QUATERN INT, V304, P107, DOI 10.1016/j.quaint.2013.02.034; Karna OM, 2015, J ANIM ECOL, DOI [10.1111/1365-2656.12397, DOI 10.1111/1365-2656.123]; Khamis K, 2014, ENVIRON SCI POLICY, V43, P39, DOI 10.1016/j.envsci.2013.10.004; Landeiro VL, 2012, FRESHWATER BIOL, V57, P1554, DOI 10.1111/j.1365-2427.2012.02816.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Liu J, 2013, J BIOGEOGR, V40, P2238, DOI 10.1111/jbi.12160; Lods-Crozet B, 2001, FRESHWATER BIOL, V46, P1641, DOI 10.1046/j.1365-2427.2001.00850.x; Macneale KH, 2005, FRESHWATER BIOL, V50, P1117, DOI 10.1111/j.1365-2427.2005.01387.x; Mark BG, 2005, HYDROLOG SCI J, V50, P975, DOI 10.1623/hysj.2005.50.6.975; Milner AM, 2009, HYDROL PROCESS, V23, P62, DOI 10.1002/hyp.7197; MILNER AM, 1994, FRESHWATER BIOL, V32, P295, DOI 10.1111/j.1365-2427.1994.tb01127.x; Milner AM, 2001, FRESHWATER BIOL, V46, P1833, DOI 10.1046/j.1365-2427.2001.00861.x; Milner AM, 2001, FRESHWATER BIOL, V46, P1765, DOI 10.1046/j.1365-2427.2001.00856.x; Moritz C, 2013, OIKOS, V122, P1401, DOI 10.1111/j.1600-0706.2013.00377.x; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Mykra H, 2011, FRESHWATER BIOL, V56, P1122, DOI 10.1111/j.1365-2427.2010.02555.x; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; Petersen I, 2004, J APPL ECOL, V41, P934, DOI 10.1111/j.0021-8901.2004.00942.x; Petersen I, 1999, FRESHWATER BIOL, V42, P401, DOI 10.1046/j.1365-2427.1999.00466.x; Pfankuch D.J., 1975, STREAM REACH INVENTO, P1; Poff NL, 2006, J N AM BENTHOL SOC, V25, P730, DOI 10.1899/0887-3593(2006)025[0730:FTNONA]2.0.CO;2; Rabatel A, 2013, CRYOSPHERE, V7, P81, DOI 10.5194/tc-7-81-2013; Richardson JS, 2007, FOREST SCI, V53, P131; Rios-Touma B, 2012, ENVIRON ENTOMOL, V41, P1322, DOI 10.1603/EN12037; Robinson CT, 2004, ARCH HYDROBIOL, V160, P447, DOI 10.1127/0003-9136/2004/0160-0447; Robinson CT, 2002, FRESHWATER BIOL, V47, P985, DOI 10.1046/j.1365-2427.2002.00835.x; Rouquette JR, 2013, DIVERS DISTRIB, V19, P1429, DOI 10.1111/ddi.12120; Sakakibara D, 2013, ANN GLACIOL, V54, P131, DOI 10.3189/2013AoG63A236; Saltveit SJ, 2001, FRESHWATER BIOL, V46, P1777, DOI 10.1046/j.1365-2427.2001.00858.x; Shurin JB, 2009, OECOLOGIA, V159, P151, DOI 10.1007/s00442-008-1174-z; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Stahl K, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR005956; Thompson R, 2006, J ANIM ECOL, V75, P476, DOI 10.1111/j.1365-2656.2006.01068.x; Tonkin JD, 2015, PEERJ PREPRINTS, V3, pe1276, DOI DOI 10.7287/PEERJ.PREPRINTS.1040V1; Urban MC, 2004, ECOLOGY, V85, P2971, DOI 10.1890/03-0631; Van De Meutter F, 2007, ECOLOGY, V88, P1687, DOI 10.1890/06-0333.1; Verberk WCEP, 2011, ECOLOGY, V92, P1565, DOI 10.1890/10-2369.1; Verleyen E, 2009, OIKOS, V118, P1239, DOI 10.1111/j.1600-0706.2009.17575.x; Winegardner AK, 2012, TRENDS ECOL EVOL, V27, P253, DOI 10.1016/j.tree.2012.01.007; Zbinden M, 2008, FUND APPL LIMNOL, V171, P75, DOI 10.1127/1863-9135/2008/0171-0075	103	57	57	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136793	10.1371/journal.pone.0136793	http://dx.doi.org/10.1371/journal.pone.0136793			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308853	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400157
J	Cavieres, VA; Gonzalez, A; Munoz, VC; Yefi, CP; Bustamante, HA; Barraza, RR; Tapia-Rojas, C; Otth, C; Barrera, MJ; Gonzalez, C; Mardones, GA; Inestrosa, NC; Burgos, PV				Cavieres, Viviana A.; Gonzalez, Alexis; Munoz, Vanessa C.; Yefi, Claudia P.; Bustamante, Hianara A.; Barraza, Rafael R.; Tapia-Rojas, Cheril; Otth, Carola; Barrera, Maria Jose; Gonzalez, Carlos; Mardones, Gonzalo A.; Inestrosa, Nibaldo C.; Burgos, Patricia V.			Tetrahydrohyperforin Inhibits the Proteolytic Processing of Amyloid Precursor Protein and Enhances Its Degradation by Atg5-Dependent Autophagy	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; SPATIAL MEMORY IMPAIRMENTS; ENDOPLASMIC-RETICULUM; ALZHEIMERS-DISEASE; CELL BIOLOGY; MISFOLDED GLYCOPROTEINS; SECRETED OLIGOMERS; BETA-PROTEIN; HYPERFORIN; GLYCOSYLATION	Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the accumulation of amyloid-beta (A beta) peptide. We have previously shown that the compound tetrahydrohyperforin (IDN5706) prevents accumulation of A beta species in an in vivo model of AD, however the mechanism that explains this reduction is not well understood. We show herein that IDN5706 decreases the levels of ER degradation enhancer, mannosidase alpha-like 1 (EDEM1), a key chaperone related to endoplasmic-reticulum-associated degradation (ERAD). Moreover, we observed that low levels of EDEM1 correlated with a strong activation of autophagy, suggesting a crosstalk between these two pathways. We observed that IDN5706 perturbs the glycosylation and proteolytic processing of the amyloid precursor protein (APP), resulting in the accumulation of immature APP (iAPP) in the endoplasmic reticulum. To investigate the contribution of autophagy, we tested the effect of IDN5706 in Atg5-depleted cells. We found that depletion of Atg5 enhanced the accumulation of iAPP in response to IDN5706 by slowing down its degradation. Our findings reveal that IDN5706 promotes degradation of iAPP via the activation of Atg5-dependent autophagy, shedding light on the mechanism that may contribute to the reduction of A beta production in vivo.	[Cavieres, Viviana A.; Gonzalez, Alexis; Munoz, Vanessa C.; Yefi, Claudia P.; Bustamante, Hianara A.; Barraza, Rafael R.; Gonzalez, Carlos; Mardones, Gonzalo A.; Burgos, Patricia V.] Univ Austral Chile, Fac Med, Inst Fisiol, Valdivia, Chile; [Cavieres, Viviana A.; Gonzalez, Alexis; Munoz, Vanessa C.; Yefi, Claudia P.; Bustamante, Hianara A.; Barraza, Rafael R.; Mardones, Gonzalo A.; Burgos, Patricia V.] Univ Austral Chile, Ctr Interdisciplinario Estudios Sistema Nervioso, Valdivia, Chile; [Tapia-Rojas, Cheril] Pontificia Univ Catolica Chile, Ctr Envejecimiento & Regenerac CARE, Santiago, Chile; [Otth, Carola] Univ Austral Chile, Fac Med, Inst Microbiol Clin, Valdivia, Chile; [Barrera, Maria Jose; Inestrosa, Nibaldo C.] Univ Chile, Fac Med, Inst Ciencias Biomed, Santiago, Chile; [Inestrosa, Nibaldo C.] Univ New S Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Fac Med, Sydney, NSW, Australia; [Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Centro UC Sandrome Down, Santiago, Chile; [Inestrosa, Nibaldo C.] Univ Magallanes, Ctr Excelencia Biomed Magallanes CEBIMA, Punta Arenas, Chile	Universidad Austral de Chile; Universidad Austral de Chile; Pontificia Universidad Catolica de Chile; Universidad Austral de Chile; Universidad de Chile; University of New South Wales Sydney; Pontificia Universidad Catolica de Chile; Universidad de Magallanes	Inestrosa, NC (corresponding author), Univ Chile, Fac Med, Inst Ciencias Biomed, Santiago, Chile.	ninestrosa@bio.puc.cl; patricia.burgos@uach.cl	Gonzalez, Carlos/V-7628-2019	otth, carola/0000-0001-8677-3706; Tapia Rojas, Cheril/0000-0002-7084-0318; Barrera, Maria-Jose/0000-0002-6061-216X	FONDECYT [1130929, 1130710, 1150176, 1120156]; Basal Center of Excellence in Aging and Regeneration [CONICYT-PFB12/2007]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Basal Center of Excellence in Aging and Regeneration(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL)	This work was supported by Grants from FONDECYT (1130929) to PVB, FONDECYT (1130710) to GAM, FONDECYT (1150176) to CG, FONDECYT (1120156) to NCI, and the Basal Center of Excellence in Aging and Regeneration (CONICYT-PFB12/2007) to NCI.	BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Bustamante HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083096; Cali T, 2008, BIOCHEM BIOPH RES CO, V371, P405, DOI 10.1016/j.bbrc.2008.04.098; Cerpa W, 2010, CURR ALZHEIMER RES, V7, P126, DOI 10.2174/156720510790691218; Cortes Constanza J, 2013, Int J Cell Biol, V2013, P560421, DOI 10.1155/2013/560421; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dinamarca MC, 2006, MOL PSYCHIATR, V11, P1032, DOI 10.1038/sj.mp.4001866; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Inestrosa NC, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.19; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kaneko M, 2010, J NEUROSCI, V30, P3924, DOI 10.1523/JNEUROSCI.2422-09.2010; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klusa V, 2001, PHARMACOPSYCHIATRY, V34, pS61, DOI 10.1055/s-2001-15451; Kosmaoglou M, 2009, J CELL SCI, V122, P4465, DOI 10.1242/jcs.055228; Le Fourn V, 2009, CELL MOL LIFE SCI, V66, P1434, DOI 10.1007/s00018-009-9038-1; MANDERS EMM, 1992, J CELL SCI, V103, P857; Mardones GA, 2007, MOL BIOL CELL, V18, P3486, DOI 10.1091/mbc.E07-02-0190; Marin MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042998; Menzies FM, 2011, CURR OPIN CELL BIOL, V23, P190, DOI 10.1016/j.ceb.2010.10.010; Midorikawa R, 2010, J NEUROSCI, V30, P10703, DOI 10.1523/JNEUROSCI.2061-10.2010; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Mufson EJ, 2012, J NEUROPATH EXP NEUR, V71, P1018, DOI 10.1097/NEN.0b013e318272caab; Mohamed NV, 2014, SCI REP-UK, V4, DOI 10.1038/srep05715; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; PAHLSSON P, 1992, BIOCHEM BIOPH RES CO, V189, P1667, DOI 10.1016/0006-291X(92)90269-Q; Pandey UB, 2007, AUTOPHAGY, V3, P643, DOI 10.4161/auto.5050; Prabhu Y, 2012, MOL BIOL CELL, V23, P2339, DOI 10.1091/mbc.E11-11-0944; Purhonen P, 1997, EUR J CELL BIOL, V74, P63; Ross BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088147; ROTHMAN JE, 1980, P NATL ACAD SCI-BIOL, V77, P780, DOI 10.1073/pnas.77.2.780; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Tanida I, 2010, METHODS MOL BIOL, V648, P193, DOI 10.1007/978-1-60761-756-3_13; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Termine DJ, 2009, J CELL SCI, V122, P976, DOI 10.1242/jcs.037291; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; UMEMOTO J, 1977, J BIOL CHEM, V252, P8609; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Villalba M, 2012, MED MICROBIOL IMMUN, V201, P371, DOI 10.1007/s00430-012-0247-0; Walczak M, 2013, AUTOPHAGY, V9, P424, DOI 10.4161/auto.22931; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang Y, 2010, NEURODEGENER DIS, V7, P103, DOI 10.1159/000285516; Wang Y, 2011, NEURAL REGEN RES, V6, P6, DOI 10.3969/j.issn.1673-5374.2011.01.001; Watanabe-Asano T, 2014, BIOCHEM BIOPH RES CO, V445, P334, DOI 10.1016/j.bbrc.2014.01.180; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278	60	25	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136313	10.1371/journal.pone.0136313	http://dx.doi.org/10.1371/journal.pone.0136313			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308941	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400106
J	Chang, TT; Wu, TC; Huang, PH; Lin, CP; Chen, JS; Lin, LY; Lin, SJ; Chen, JW				Chang, Ting-Ting; Wu, Tao-Cheng; Huang, Po-Hsun; Lin, Chih-Pei; Chen, Jia-Shiong; Lin, Liang-Yu; Lin, Shing-Jong; Chen, Jaw-Wen			Direct Renin Inhibition with Aliskiren Improves Ischemia-Induced Neovasculogenesis in Diabetic Animals via the SDF-1 Related Mechanism	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; ANGIOTENSIN-II; NITRIC-OXIDE; MYOCARDIAL-INFARCTION; INDUCED ANGIOGENESIS; (PRO)RENIN RECEPTOR; GROWTH-FACTOR; NEOVASCULARIZATION; MICE; RECRUITMENT	Objective Aliskiren is a direct renin inhibitor which is suggested to modify proangiogenic cells in addition to lower blood pressure. Given that angiogenesis is impaired in the presence of diabetes mellitus, we would like to investigate whether and how aliskiren enhances endothelial progenitor cells (EPCs) and improves ischemic-induced neovasculogenesis by an effect independent of blood pressure reduction in diabetic animals. Methods Streptozotocin-induced diabetic mice were administered with either aliskiren (5 or 25 mg/kg/day) using an osmotic pump or hydralazine (2 or 10 mg/kg/day) given in drinking water for two weeks prior to a hind-limb ischemia surgery. Laser Doppler imaging and flow cytometry were used to evaluate the degree of neovasculogenesis and the circulating levels of EPCs, respectively. Results In streptozotocin-induced diabetic mice, aliskiren enhanced the recovery of limb perfusion and capillary density, increased the number of circulating Sca-1(+)/Flk-1(+) EPC-like cells, and elevated the levels of the plasma vascular endothelial growth factor (VEGF) and stromal cell-derived factor (SDF)-1a in a dose-dependent manner, whereas there were no such effects in hydralazine-treated mice. Intraperitoneal administration of anti-SDF-1 neutralizing monoclonal antibodies abolished the effects of aliskiren. Conclusions Independent of the reduction of blood pressure, aliskiren enhanced ischemia-induced neovasculogenesis in a dose-dependent manner via VEGF/SDF-1 alpha related mechanisms in diabetic mice.	[Chang, Ting-Ting; Chen, Jia-Shiong; Lin, Liang-Yu; Chen, Jaw-Wen] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Wu, Tao-Cheng; Huang, Po-Hsun; Lin, Liang-Yu; Lin, Shing-Jong; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Wu, Tao-Cheng; Huang, Po-Hsun; Chen, Jia-Shiong; Lin, Shing-Jong; Chen, Jaw-Wen] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Huang, Po-Hsun] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Lin, Chih-Pei] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Lin, Shing-Jong; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Chen, JW (corresponding author), Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan.	jwchen@vghtpe.gov.tw	Lin, Liang-Yu/R-8480-2017	Lin, Liang-Yu/0000-0003-0334-790X	Taipei Veterans General Hospital, Taipei, Taiwan [V102C-155, V103E1-005, V103C-151]	Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital)	This study was supported by the funding of V102C-155, V103E1-005, and V103C-151 to JW Chen from Taipei Veterans General Hospital, Taipei, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; Arndt PG, 2006, J IMMUNOL, V177, P7233, DOI 10.4049/jimmunol.177.10.7233; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Bahlmann FH, 2005, HYPERTENSION, V45, P526, DOI 10.1161/01.HYP.0000159191.98140.89; Batenburg WW, 2008, ARTERIOSCL THROM VAS, V28, P1151, DOI 10.1161/ATVBAHA.108.164210; Bento CF, 2011, DIABETOLOGIA, V54, P1946, DOI 10.1007/s00125-011-2191-8; Ceradini DJ, 2008, J BIOL CHEM, V283, P10930, DOI 10.1074/jbc.M707451200; Ceradini DJ, 2005, TRENDS CARDIOVAS MED, V15, P57, DOI 10.1016/j.tcm.2005.02.002; Connelly KA, 2011, J HYPERTENS, V29, P1175, DOI 10.1097/HJH.0b013e3283462674; Dhakarwal P, 2014, RENAL FAILURE, V36, P963, DOI 10.3109/0886022X.2014.900425; Ebrahimian TG, 2005, ARTERIOSCL THROM VAS, V25, P65, DOI 10.1161/01.ATV.0000149377.90852.d8; Feldman DL, 2008, HYPERTENSION, V52, P130, DOI 10.1161/HYPERTENSIONAHA.107.108845; Feldt S, 2008, HYPERTENSION, V51, P682, DOI 10.1161/HYPERTENSIONAHA.107.101444; Flammer AJ, 2013, J HYPERTENS, V31, P632, DOI 10.1097/HJH.0b013e32835c6d2d; Fukuda D, 2008, ARTERIOSCL THROM VAS, V28, P90, DOI 10.1161/ATVBAHA.107.152363; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hiasa K, 2004, CIRCULATION, V109, P2454, DOI 10.1161/01.CIR.0000128213.96779.61; Higashikuni Y, 2012, HYPERTENS RES, V35, P62, DOI 10.1038/hr.2011.136; Ino J, 2009, ARTERIOSCL THROM VAS, V29, P1858, DOI 10.1161/ATVBAHA.108.182519; Jesmin S, 2002, AM J PHYSIOL-HEART C, V283, pH1387, DOI 10.1152/ajpheart.00299.2002; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Jude EB, 2010, DIABETIC MED, V27, P4, DOI 10.1111/j.1464-5491.2009.02866.x; Kawarazaki W, 2012, J AM SOC NEPHROL, V23, P997, DOI 10.1681/ASN.2011070734; Li P, 2008, HYPERTENSION, V51, P252, DOI 10.1161/HYPERTENSIONAHA.107.097394; Lin HH, 2008, J MOL CELL CARDIOL, V45, P44, DOI 10.1016/j.yjmcc.2008.04.011; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Matsuura K, 2011, CURR VASC PHARMACOL, V9, P153, DOI 10.2174/157016111794519345; Mihai G, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004879; Murakami Y, 2003, CARDIOVASC DRUG THER, V17, P249, DOI 10.1023/A:1026128308440; Nussberger J, 2002, HYPERTENSION, V39, pE1, DOI 10.1161/hy0102.102293; Pimenta E, 2009, VASC HEALTH RISK MAN, V5, P453; Poss J, 2010, BASIC RES CARDIOL, V105, P725, DOI 10.1007/s00395-010-0120-5; Raptis AE, 2014, AM J HYPERTENS; Riccioni G, 2013, THER ADV ENDOCRINOL, V4, P139, DOI 10.1177/2042018813490779; Rusai K, 2011, J HYPERTENS, V29, P266, DOI 10.1097/HJH.0b013e328340aa72; Sbaa E, 2006, CIRC RES, V98, P1219, DOI 10.1161/01.RES.0000220648.80170.8b; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tamarat R, 2002, HYPERTENSION, V39, P830, DOI 10.1161/hy0302.104671; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; van Weel V, 2007, ARTERIOSCL THROM VAS, V27, P1426, DOI 10.1161/ATVBAHA.107.139642; Yamagishi SI, 2008, MICROVASC RES, V75, P130, DOI 10.1016/j.mvr.2007.05.001; Yamamoto E, 2008, HYPERTENSION, V52, P573, DOI 10.1161/HYPERTENSIONAHA.108.112292; Yu Y, 2008, AM J HYPERTENS, V21, P72, DOI 10.1038/ajh.2007.5; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873; Zhang W, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000606	46	17	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136627	10.1371/journal.pone.0136627	http://dx.doi.org/10.1371/journal.pone.0136627			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305217	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500101
J	Crispo, M; Mulet, AP; Tesson, L; Barrera, N; Cuadro, F; dos Santos-Neto, PC; Nguyen, TH; Creneguy, A; Brusselle, L; Anegon, I; Menchaca, A				Crispo, M.; Mulet, A. P.; Tesson, L.; Barrera, N.; Cuadro, F.; dos Santos-Neto, P. C.; Nguyen, T. H.; Creneguy, A.; Brusselle, L.; Anegon, I.; Menchaca, A.			Efficient Generation of Myostatin Knock-Out Sheep Using CRISPR/Cas9 Technology and Microinjection into Zygotes	PLOS ONE			English	Article							TRANSGENIC FARM-ANIMALS; CELL NUCLEAR TRANSFER; MUSCLE MASS; GENE; MICE; EMBRYOS; SYSTEM; PIGS; SPECIFICITY; ALLELE	While CRISPR/Cas9 technology has proven to be a valuable system to generate gene-targeted modified animals in several species, this tool has been scarcely reported in farm animals. Myostatin is encoded by MSTN gene involved in the inhibition of muscle differentiation and growth. We determined the efficiency of the CRISPR/Cas9 system to edit MSTN in sheep and generate knock-out (KO) animals with the aim to promote muscle development and body growth. We generated CRISPR/Cas9 mRNAs specific for ovine MSTN and microinjected them into the cytoplasm of ovine zygotes. When embryo development of CRISPR/Cas9 microinjected zygotes (n = 216) was compared with buffer injected embryos (n = 183) and non microinjected embryos (n = 173), cleavage rate was lower for both microinjected groups (P<0.05) and neither was affected by CRISPR/Cas9 content in the injected medium. Embryo development to blastocyst was not affected by microinjection and was similar among the experimental groups. From 20 embryos analyzed by Sanger sequencing, ten were mutant (heterozygous or mosaic; 50% efficiency). To obtain live MSTN KO lambs, 53 blastocysts produced after zygote CRISPR/Cas9 microinjection were transferred to 29 recipient females resulting in 65.5%(19/29) of pregnant ewes and 41.5% (22/53) of newborns. From 22 born lambs analyzed by T7EI and Sanger sequencing, ten showed indel mutations at MSTN gene. Eight showed mutations in both alleles and five of them were homozygous for indels generating out-of frame mutations that resulted in premature stop codons. Western blot analysis of homozygous KO founders confirmed the absence of myostatin, showing heavier body weight than wild type counterparts. In conclusion, our results demonstrate that CRISPR/Cas9 system was a very efficient tool to generate gene KO sheep. This technology is quick and easy to perform and less expensive than previous techniques, and can be applied to obtain genetically modified animal models of interest for biomedicine and livestock.	[Crispo, M.; Mulet, A. P.] Inst Pasteur Montevideo, UATE, Montevideo, Uruguay; [Barrera, N.; Cuadro, F.; dos Santos-Neto, P. C.; Menchaca, A.] Fdn IRAUy, Inst Reprod Anim Uruguay, Montevideo, Uruguay; [Tesson, L.; Nguyen, T. H.; Creneguy, A.; Brusselle, L.; Anegon, I.] INSERM UMR 1064, Ctr Res Transplantat & Immunol ITUN, Nantes, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Institut National de la Sante et de la Recherche Medicale (Inserm)	Crispo, M (corresponding author), Inst Pasteur Montevideo, UATE, Montevideo, Uruguay.	crispo@pasteur.edu.uy; ignacio.anegon@univ-nantes.fr; menchaca.alejo@gmail.com	Anegon, Ignacio/I-7498-2018; Crispo, Martina/R-2591-2019; xu, jianxiang/I-9347-2016; Menchaca, Alejo/S-1835-2017; Anegon, Ignacio/I-7760-2018; Mulet, Ana/AAW-5713-2021	Menchaca, Alejo/0000-0002-2494-9574; Cuadro, Federico/0000-0002-5764-5155; Crispo, Martina/0000-0002-9852-5563	IHU-CESTI; Region Pays de la Loire through Biogenouest; IBiSA program; Fondation Progreffe; TEFOR (Infrastructures d'Avenir of the French government); FOCEM (MERCOSUR Structural Convergence Fund) (Uruguay) [COF 03/11]; PEDECIBA (UdelaR, Uruguay)	IHU-CESTI(Region Pays de la Loire); Region Pays de la Loire through Biogenouest(Region Pays de la Loire); IBiSA program; Fondation Progreffe; TEFOR (Infrastructures d'Avenir of the French government); FOCEM (MERCOSUR Structural Convergence Fund) (Uruguay); PEDECIBA (UdelaR, Uruguay)	This project was financially supported by the IHU-CESTI, which received French government financial support managed by the National Research Agency, Region Pays de la Loire through Biogenouest, IBiSA program, Fondation Progreffe and TEFOR (Infrastructures d'Avenir of the French government), the integrative genomic facility of Nantes for sequencing experiments, FOCEM (MERCOSUR Structural Convergence Fund) COF 03/11 (Uruguay), and received additional support by PEDECIBA (UdelaR, Uruguay). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MC, IA and AM are fellows of Sistema Nacional de Investigadores (SNI, National Research Agency), Uruguay.	Bellec J, 2015, CURRENT GEN IN PRESS; Boch J, 2011, NAT BIOTECHNOL, V29, P135, DOI 10.1038/nbt.1767; Chan A W, 1999, Cloning, V1, P25, DOI 10.1089/15204559950020076; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crispo M, 2015, TRANSGENIC RES, V24, P31, DOI 10.1007/s11248-014-9816-x; Delacote F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053217; FAO, 2009, ETUDES TRAVAUX LASDE; Fiems Leo O, 2012, Animals (Basel), V2, P472, DOI 10.3390/ani2030472; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Han HB, 2014, FRONT AGRIC SCI ENG, V1, P2, DOI 10.15302/J-FASE-2014007; Haynes FEM, 2013, J ANIM SCI, V91, P78, DOI 10.2527/jas.2012-5482; He ZY, 2015, BIOTECHNOL BIOENG, V112, P1060, DOI 10.1002/bit.25490; Honda A, 2015, EXP ANIM TOKYO, V64, P31, DOI 10.1538/expanim.14-0034; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hyun S, 2003, BIOL REPROD, V69, P1060, DOI 10.1095/biolreprod.102.014886; Johnson PL, 2005, J ANIM SCI, V83, P2729; Kues WA, 2011, PREV VET MED, V102, P146, DOI 10.1016/j.prevetmed.2011.04.009; Larcher T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110371; LeBrasseur NK, 2009, J GERONTOL A-BIOL, V64, P940, DOI 10.1093/gerona/glp068; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Liu JH, 2008, MOL REPROD DEV, V75, P598, DOI 10.1002/mrd.20803; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Makarevich AV, 2005, ZYGOTE, V13, P125, DOI 10.1017/S0967199405003138; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Menchaca A, 2004, REPROD FERT DEVELOP, V16, P403, DOI 10.1071/RD04037; Menoret S, 2011, ADV PROTOCOLS ANIMAL, P117; Menoret S, 2013, FASEB J, V27, P703, DOI 10.1096/fj.12-219907; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106718; Niemann H, 2008, REPRODUCTION, V135, P151, DOI 10.1530/REP-07-0397; Niemann H, 2007, REPROD FERT DEVELOP, V19, P762, DOI 10.1071/RD07040; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Petersen B, 2015, TRANSGENIC RES, V24, P381, DOI 10.1007/s11248-015-9862-z; Proudfoot C, 2015, TRANSGENIC RES, V24, P147, DOI 10.1007/s11248-014-9832-x; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Remy S, 2014, GENOME RES, V24, P1371, DOI 10.1101/gr.171538.113; Remy S, 2010, TRANSGENIC RES, V19, P363, DOI 10.1007/s11248-009-9323-7; Stringfellow D. A., 2010, MANUAL INT EMBRYO TR; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Vajta G, 2007, REPROD BIOMED ONLINE, V15, P582, DOI 10.1016/S1472-6483(10)60391-4; Vilette D, 2000, IN VITRO CELL DEV-AN, V36, P45, DOI 10.1290/1071-2690(2000)036<0045:EOACLF>2.0.CO;2; Wagner E, 2002, J CELL SCI, V115, P3033; Whitelaw CBA, 2008, REPROD DOMEST ANIM, V43, P355, DOI 10.1111/j.1439-0531.2008.01184.x; Whitworth KM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121723; Wiener P, 2009, MEAT SCI, V83, P127, DOI 10.1016/j.meatsci.2009.04.010; Zhang CY, 2012, MOL BIOL REP, V39, P3081, DOI 10.1007/s11033-011-1071-0; Zhang CF, 2014, MOL BIOL REP, V41, P209, DOI 10.1007/s11033-013-2853-3; Zhou XQ, 2015, CELL MOL LIFE SCI, V72, P1175, DOI 10.1007/s00018-014-1744-7	54	166	189	11	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136690	10.1371/journal.pone.0136690	http://dx.doi.org/10.1371/journal.pone.0136690			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305800	gold, Green Published, Green Submitted			2022-12-27	WOS:000359995500107
J	Davis, J; Christie, S; Fairley, D; Coyle, P; Tubman, R; Shields, MD				Davis, Jonathan; Christie, Sharon; Fairley, Derek; Coyle, Peter; Tubman, Richard; Shields, Michael D.			Performance of a Novel Molecular Method in the Diagnosis of Late-Onset Sepsis in Very Low Birth Weight Infants	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; NEONATAL RESEARCH NETWORK; BLOOD-STREAM INFECTIONS; INTENSIVE-CARE-UNIT; C-REACTIVE PROTEIN; NOSOCOMIAL INFECTIONS; SURVEILLANCE; PCR; IDENTIFICATION; DEFINITION	Objective To compare the use of a generic molecular assay to ` standard' investigations used to assist the diagnosis of late onset bacterial sepsis in very low birth weight infants (VLBW, < 1500g). Methods VLBW infants, greater than 48 hours of age, who were clinically suspected to have sepsis were investigated using standard tests (full blood count, C-reactive protein (at presentation) and blood culture), in addition, blood was taken for a universal molecular assay (16S rRNA reverse transcriptase PCR) for comparison. Clinical data were recorded during the suspected infection episode. A validated sepsis score (NEO-KISS) was used to retrospectively determine the presence of sepsis (independent of blood culture). The performance of each of the tests were compared by sensitivity, specificity, positive/negative likihood ratios (+/-LR) and postive/negative predictive values (PPV/NPV). Results Sixty-five babies with suspected clinical sepsis were prospectively included. The performance indicators are presented with 95% confidence limits. For the detection of bacteria, blood culture had sensitivity of 0.57 (0.34-0.78), specificity of 0.45 (0.30-0.61); +LR of 1.05 (0.66-1.66) and-LR of 0.94 (0.52-1.7); PPV of 33.3 (18.56-50.97) and NPV of 68.97 (49.17-87.72). Serum CRP had sensitivity of 0.92 (0.64-1) and specificity of 0.36 (0.17-0.59); +LR of 1.45 (1-2.1) and-LR of 0.21 (0.03-1.5); PPV of 44.46 (26.6-66.6) and NPV of 88.9 (51.8-99.7). The universal molecular assay had sensitivity of 0.76 (0.53-0.92), specificity of 0.95 (0.85-0.99); +LR of 16.8 (4.2-66.3) and-LR of 0.25 (0.1-0.5); PPV of 88.9 (65.3-98.6) and NPV of 89.4 (76.9-96.5). Conclusions In VLBW infants this universal molecular assay performed better in the diagnosis of late onset sepsis (LOS) than blood culture and CRP. Further development is required to explore and improve the performance of the assay in real-time diagnosis.	[Davis, Jonathan] Fdn Trust, Univ Hosp Bristol, St Michaels Hosp, Bristol, Avon, England; [Christie, Sharon; Fairley, Derek; Coyle, Peter; Tubman, Richard; Shields, Michael D.] Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland; [Shields, Michael D.] Queens Univ Belfast, Belfast, Antrim, North Ireland	University of Bristol; Queens University Belfast	Shields, MD (corresponding author), Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland.	m.shields@qub.ac.uk			Royal Belfast Hospital for Sick Children; Belfast Health & Social Care Trust; Perinatal Trust Fund (NI); Children's Haematology fund	Royal Belfast Hospital for Sick Children; Belfast Health & Social Care Trust; Perinatal Trust Fund (NI); Children's Haematology fund	Jonathan Davis was funded by the Royal Belfast Hospital for Sick Children Research Fellowship, Belfast Health & Social Care Trust, The Perinatal Trust Fund (NI) and The Children's Haematology fund. The other authors received no external funding for this work.	Bartels DB, 2007, ARCH DIS CHILD-FETAL, V92, P449; Barton L, 1999, PEDIATRICS, V103, P446, DOI 10.1542/peds.103.2.446; Benitz WE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.4.e41; Buttery JP, 2002, ARCH DIS CHILD-FETAL, V87, pF25, DOI 10.1136/fn.87.1.F25; Chan KYY, 2009, CRIT CARE MED, V37, P2441, DOI 10.1097/CCM.0b013e3181a554de; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; Davis J, 2011, J PAEDIAT CHILD H S1, V47, P71; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Jordan JA, 2010, CLIN PERINATOL, V37, P411, DOI 10.1016/j.clp.2010.02.001; Laforgia N, 1997, ACTA PAEDIATR, V86, P1097, DOI 10.1111/j.1651-2227.1997.tb14815.x; Lam HS, 2008, PATHOLOGY, V40, P141, DOI 10.1080/00313020701813735; Leone CR, 2001, BRAZILIAN NEONATAL R, V2327; Mahalanabis M, 2009, LAB CHIP, V9, P2811, DOI 10.1039/b905065p; Makhoul IR, 2006, ACTA PAEDIATR, V95, P1218, DOI 10.1080/08035250600554250; Makhoul IR, 2002, PEDIATRICS, V109, P34, DOI 10.1542/peds.109.1.34; Modi N, 2009, ARCH DIS CHILD-FETAL, V94, pF8, DOI 10.1136/adc.2007.126458; NEAL PR, 1986, J CLIN MICROBIOL, V24, P353, DOI 10.1128/JCM.24.3.353-356.1986; NEO, 2010, NEO KISS COMPONENT R; November P, 2010, VERMONT OXFORD NETWO; Pammi M, 2011, PEDIATRICS, V128, pE973, DOI 10.1542/peds.2011-1208; Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8; Reier-Nilsen T, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-5; Reiser B, 2000, STAT MED, V19, P2115, DOI 10.1002/1097-0258(20000830)19:16<2115::AID-SIM529>3.0.CO;2-M; Schelonka RL, 1996, J PEDIATR-US, V129, P275, DOI 10.1016/S0022-3476(96)70254-8; Sohn AH, 2001, J PEDIATR-US, V139, P821, DOI 10.1067/mpd.2001.119442; Stoll BJ, 2003, SEMIN PERINATOL, V27, P293, DOI 10.1016/S0146-0005(03)00046-6; Stoll BJ, 1996, J PEDIATR-US, V129, P63, DOI 10.1016/S0022-3476(96)70191-9; Stover BH, 2001, AM J INFECT CONTROL, V29, P152, DOI 10.1067/mic.2001.115407; TSAI YL, 1992, APPL ENVIRON MICROB, V58, P2292, DOI 10.1128/AEM.58.7.2292-2295.1992; van der Zwet WC, 2005, J HOSP INFECT, V61, P300, DOI 10.1016/j.jhin.2005.03.014; Vergnano S, 2011, ARCH DIS CHILD-FETAL, V96, pF9, DOI 10.1136/adc.2009.178798; Yang S, 2002, J CLIN MICROBIOL, V40, P3449, DOI 10.1128/JCM.40.9.3449-3454.2002	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136472	10.1371/journal.pone.0136472	http://dx.doi.org/10.1371/journal.pone.0136472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305781	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500080
J	Guo, WW; Zhang, JX; Zhang, N; Xin, MM; Peng, HR; Hu, ZR; Ni, ZF; Du, JK				Guo, Weiwei; Zhang, Jinxia; Zhang, Ning; Xin, Mingming; Peng, Huiru; Hu, Zhaorong; Ni, Zhongfu; Du, Jinkun			The Wheat NAC Transcription Factor TaNAC2L Is Regulated at the Transcriptional and Post-Translational Levels and Promotes Heat Stress Tolerance in Transgenic Arabidopsis	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; LATERAL ROOT DEVELOPMENT; HIGH-TEMPERATURE STRESS; BREAD WHEAT; DOMAIN; GENE; SENESCENCE; PROTEINS; FAMILY; DOWNSTREAM	Heat stress poses a serious threat to global crop production. In efforts that aim to mitigate the adverse effects of heat stress on crops, a variety of genetic tools are being used to develop plants with improved thermotolerance. The characterization of important regulators of heat stress tolerance provides essential information for this aim. In this study, we examine the wheat (Triticum aestivum) NAC transcription factor gene TaNAC2L. High temperature induced TaNAC2L expression in wheat and overexpression of TaNAC2L in Arabidopsis thaliana enhanced acquired heat tolerance without causing obvious alterations in phenotype compared with wild type under normal conditions. TaNAC2L overexpression also activated the expression of heat-related genes in the transgenic Arabidopsis plants, suggesting that TaNAC2L may improve heat tolerance by regulating the expression of stress- responsive genes. Notably, TaNAC2L is also regulated at the post-translational level and might be degraded via a proteasome-mediated pathway. Thus, this wheat transcription factor may have potential uses in enhancing thermotolerance in crops.	[Guo, Weiwei; Zhang, Jinxia; Zhang, Ning; Xin, Mingming; Peng, Huiru; Hu, Zhaorong; Ni, Zhongfu; Du, Jinkun] China Agr Univ, Beijing Key Lab Crop Genet Improvement, Key Lab Crop Heterosis & Utilizat MOE, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Guo, Weiwei; Zhang, Jinxia; Zhang, Ning; Xin, Mingming; Peng, Huiru; Hu, Zhaorong; Ni, Zhongfu; Du, Jinkun] Natl Plant Gene Res Ctr Beijing, Beijing 100193, Peoples R China	China Agricultural University	Du, JK (corresponding author), China Agr Univ, Beijing Key Lab Crop Genet Improvement, Key Lab Crop Heterosis & Utilizat MOE, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	jkdu@cau.edu.cn			863 Project of China [2012AA10A309]; National Key Project for Research on Transgenics [2014ZX08002002-002]	863 Project of China; National Key Project for Research on Transgenics	This work was financially supported by the 863 Project of China (2012AA10A309) and the National Key Project for Research on Transgenics (2014ZX08002002-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; BREIMAN A, 1995, ISR J PLANT SCI, V43, P85, DOI 10.1080/07929978.1995.10676595; Chauhan H, 2011, PLANT MOL BIOL, V75, P35, DOI 10.1007/s11103-010-9702-8; Duval M, 2002, PLANT MOL BIOL, V50, P237, DOI 10.1023/A:1016028530943; Ernst HA, 2004, EMBO REP, V5, P297, DOI 10.1038/sj.embor.7400093; Gao F, 2010, PLANT CELL TISS ORG, V100, P255, DOI 10.1007/s11240-009-9640-9; Gill BS, 2004, GENETICS, V168, P1087, DOI 10.1534/genetics.104.034769; Greve K, 2003, BIOCHEM J, V371, P97, DOI 10.1042/BJ20021123; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hong SW, 2000, P NATL ACAD SCI USA, V97, P4392, DOI 10.1073/pnas.97.8.4392; Jeong JS, 2010, PLANT PHYSIOL, V153, P185, DOI 10.1104/pp.110.154773; Kjaersgaard T, 2011, J BIOL CHEM, V286, P35418, DOI 10.1074/jbc.M111.247221; Mao XG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084359; Mao XG, 2012, J EXP BOT, V63, P2933, DOI 10.1093/jxb/err462; Mitsuda N, 2008, PLANT J, V56, P768, DOI 10.1111/j.1365-313X.2008.03633.x; Muoki RC, 2012, MOL BIOTECHNOL, V52, P82, DOI 10.1007/s12033-011-9476-5; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Qin DD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-432; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; Shahnejat-Bushehri S, 2012, PLANT SIGNAL BEHAV, V7, P1518, DOI 10.4161/psb.22092; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Xie Q, 1999, PLANT MOL BIOL, V39, P647, DOI 10.1023/A:1006138221874; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Xue GP, 2011, MOL PLANT, V4, P697, DOI 10.1093/mp/ssr013; Yokotani N, 2009, PLANTA, V229, P1065, DOI 10.1007/s00425-009-0895-5; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399	31	37	43	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135667	10.1371/journal.pone.0135667	http://dx.doi.org/10.1371/journal.pone.0135667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305210	Green Submitted, gold, Green Published			2022-12-27	WOS:000359995500029
J	Gupta, A; Chaudhary, N; Kakularam, KR; Pallu, R; Polamarasetty, A				Gupta, Ashish; Chaudhary, Neha; Kakularam, Kumar Reddy; Pallu, Reddanna; Polamarasetty, Aparoy			The Augmenting Effects of Desolvation and Conformational Energy Terms on the Predictions of Docking Programs against mPGES-1	PLOS ONE			English	Article							PROTEIN-LIGAND INTERACTIONS; PROSTAGLANDIN-E SYNTHASE; EMPIRICAL SCORING FUNCTION; E-2 SYNTHASE-1; INHIBITOR BINDING; ENZYME; OPTIMIZATION; COMPLEXES; DISCOVERY; MODEL	In this study we introduce a rescoring method to improve the accuracy of docking programs against mPGES-1. The rescoring method developed is a result of extensive computational study in which different scoring functions and molecular descriptors were combined to develop consensus and rescoring methods. 127 mPGES-1 inhibitors were collected from literature and were segregated into training and external test sets. Docking of the 27 training set compounds was carried out using default settings in AutoDock Vina, AutoDock, DOCK6 and GOLD programs. The programs showed low to moderate correlation with the experimental activities. In order to introduce the contributions of desolvation penalty and conformation energy of the inhibitors various molecular descriptors were calculated. Later, rescoring method was developed as empirical sum of normalised values of docking scores, LogP and Nrotb. The results clearly indicated that LogP and Nrotb recuperate the predictions of these docking programs. Further the efficiency of the rescoring method was validated using 100 test set compounds. The accurate prediction of binding affinities for analogues of the same compounds is a major challenge for many of the existing docking programs; in the present study the high correlation obtained for experimental and predicted pIC(50) values for the test set compounds validates the efficiency of the scoring method.	[Gupta, Ashish; Chaudhary, Neha; Polamarasetty, Aparoy] Cent Univ Himachal Pradesh, Sch Life Sci, Ctr Computat Biol & Bioinformat, Dharamshala 176215, Himachal Prades, India; [Kakularam, Kumar Reddy; Pallu, Reddanna] Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Hyderabad 500046, Telangana, India	Central University of Himachal Pradesh; University of Hyderabad	Polamarasetty, A (corresponding author), Cent Univ Himachal Pradesh, Sch Life Sci, Ctr Computat Biol & Bioinformat, Dharamshala 176215, Himachal Prades, India.	aparoy@cuhimachal.ac.in	Gupta, Ashish/AAF-1768-2021	Gupta, Ashish/0000-0002-0496-4718; Pallu, Reddanna/0000-0001-6343-6758				Akitake Y, 2013, J NEUROSCI RES, V91, P909, DOI 10.1002/jnr.23217; Arhancet GB, 2013, BIOORG MED CHEM LETT, V23, P1114, DOI 10.1016/j.bmcl.2012.11.109; Barelier S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069153; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; BENGTSSON M, 1987, BIOORG CHEM, V15, P409, DOI 10.1016/0045-2068(87)90036-8; Bostrom J, 1998, J COMPUT AID MOL DES, V12, P383, DOI 10.1023/A:1008007507641; Chaires JB, 2008, ANNU REV BIOPHYS, V37, P135, DOI 10.1146/annurev.biophys.36.040306.132812; Charifson PS, 1999, J MED CHEM, V42, P5100, DOI 10.1021/jm990352k; Cipollone F, 2004, CIRCULATION, V109, P1482, DOI 10.1161/01.CIR.0000121735.52471.AC; Coleman RG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075992; Du JF, 2014, CHEM BIOL DRUG DES, V83, P37, DOI 10.1111/cbdd.12202; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Freire E, 2008, DRUG DISCOV TODAY, V13, P869, DOI 10.1016/j.drudis.2008.07.005; Friesen RW, 2008, J MED CHEM, V51, P4059, DOI 10.1021/jm800197b; Frisch M. J., 2010, GAUSSIAN 09; Hamza A, 2011, BIOORGAN MED CHEM, V19, P6077, DOI 10.1016/j.bmc.2011.08.040; Houston DR, 2013, J CHEM INF MODEL, V53, P384, DOI 10.1021/ci300399w; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Koeberle A, 2008, J MED CHEM, V51, P8068, DOI 10.1021/jm801085s; Kojima Fumiaki, 2011, Inflamm Regen, V31, P157; Kudo I, 2005, J BIOCHEM MOL BIOL, V38, P633; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Lauro G, 2014, EUR J MED CHEM, V80, P407, DOI 10.1016/j.ejmech.2014.04.061; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li GB, 2013, J CHEM INF MODEL, V53, P592, DOI 10.1021/ci300493w; Liljefors TaP I, 1996, TXB DRUG DESIGN DEV, P60; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; MENG EC, 1994, J COMPUT AID MOL DES, V8, P299, DOI 10.1007/BF00126747; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Mikulskis P, 2014, J CHEM INF MODEL, V54, P2794, DOI 10.1021/ci5004027; Mooij WTM, 2005, PROTEINS, V61, P272, DOI 10.1002/prot.20588; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; O'Boyle NM, 2009, J CHEM INF MODEL, V49, P1871, DOI 10.1021/ci900164f; Park H, 2014, J CHEM INF MODEL, V54, P2139, DOI 10.1021/ci500214e; Pawelzik SC, 2010, J BIOL CHEM, V285, P29254, DOI 10.1074/jbc.M110.114454; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Pettersson I, 1987, J Comput Aided Mol Des, V1, P143, DOI 10.1007/BF01676958; Polyansky AA, 2012, METHODS MOL BIOL, V819, P327, DOI 10.1007/978-1-61779-465-0_21; Prage EB, 2011, BIOCHEMISTRY-US, V50, P7684, DOI 10.1021/bi2010448; Rajamani R, 2007, CURR OPIN DRUG DISC, V10, P308; Ruan D, 2014, LIFE SCI, V116, P43, DOI 10.1016/j.lfs.2014.07.042; Schomburg I, 2004, NUCLEIC ACIDS RES, V32, pD431, DOI 10.1093/nar/gkh081; Siebel GLaK P.A, 1990, COMPREHENSIVE MED CH, V4, P125; Stichtenoth DO, 2001, J IMMUNOL, V167, P469, DOI 10.4049/jimmunol.167.1.469; Subbaramaiah K, 2004, J BIOL CHEM, V279, P12647, DOI 10.1074/jbc.M312972200; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vanquelef E, 2011, NUCLEIC ACIDS RES, V39, pW511, DOI 10.1093/nar/gkr288; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Wang F., 2013, PYTHON OBJECT ORIENT; Wang RX, 1998, J MOL MODEL, V4, P379, DOI 10.1007/s008940050096; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Wright JS, 2013, J COMPUT AID MOL DES, V27, P707, DOI 10.1007/s10822-013-9670-6; Zhang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072096	57	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0134472	10.1371/journal.pone.0134472	http://dx.doi.org/10.1371/journal.pone.0134472			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305898	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500009
J	Henry, BM; Zwinczewska, H; Roy, J; Vikse, J; Ramakrishnan, PK; Walocha, JA; Tomaszewski, KA				Henry, Brandon Michael; Zwinczewska, Helena; Roy, Joyeeta; Vikse, Jens; Ramakrishnan, Piravin Kumar; Walocha, Jerzy A.; Tomaszewski, Krzysztof A.			The Prevalence of Anatomical Variations of the Median Nerve in the Carpal Tunnel: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							THENAR MOTOR BRANCH; PATTERN; WRIST	Background and Objective The course and branches of the median nerve (MN) in the wrist vary widely among the population. Due to significant differences in the reported prevalence of such variations, extensive knowledge on the anatomy of the MN is essential to avoid iatrogenic nerve injury. Our aim was to determine the prevalence rates of anatomical variations of the MN in the carpal tunnel and the most common course patterns and variations in its thenar motor branch (TMB). Study Design A systematic search of all major databases was performed to identify articles that studied the prevalence of MN variations in the carpal tunnel and the TMB. No date or language restrictions were set. Extracted data was classified according to Lanz's classification system: variations in the course of the single TMB-extraligamentous, subligamentous, and transligamentous (type 1); accessory branches of the MN at the distal carpal tunnel (type 2); high division of the MN (type 3); and the MN and its accessory branches proximal to the carpal tunnel (type 4). Pooled prevalence rates were calculated using MetaXL 2.0. Results Thirty-one studies (n = 3918 hands) were included in the meta-analysis. The pooled prevalence rates of the extraligamentous, subligamentous, and transligamentous courses were 75.2% (95% CI: 55.4%-84.7%), 13.5% (95% CI: 3.6%-25.7%), and 11.3%(95% CI: 2.4%-23.0%), respectively. The prevalence of Lanz group 2, 3, and 4 were 4.6% (95% CI: 1.6%-9.1%), 2.6% (95% CI: 0.1%-2.8%), and 2.3% (95% CI: 0.3%-5.6%), respectively. Ulnar side of branching of the TMB was found in 2.1% (95% CI: 0.9%-3.6%) of hands. The prevalence of hypertrophic thenar muscles over the transverse carpal ligament was 18.2% (95% CI: 6.8%-33.0%). A transligamentous course of the TMB was more commonly found in hands with hypertrophic thenar muscles (23.4%, 95% CI: 5.0%-43.4%) compared to those without hypertrophic musculature (1.7%, 95% CI: 0%-100%). In four studies (n = 423 hands), identical bilateral course of the TMB was found in 72.3% (95% CI: 58.4%-84.4%) of patients. Conclusions Anatomical variations in the course of the TMB and the MN in the carpal tunnel are common in the population. Thus, we recommend an ulnar side approach to carpal tunnel release, with a careful layer by layer dissection, to avoid iatrogenic damage to the TMB.	[Henry, Brandon Michael; Zwinczewska, Helena; Roy, Joyeeta; Vikse, Jens; Ramakrishnan, Piravin Kumar; Walocha, Jerzy A.; Tomaszewski, Krzysztof A.] Jagiellonian Univ, Coll Med, Dept Anat, PL-31034 Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University	Tomaszewski, KA (corresponding author), Jagiellonian Univ, Coll Med, Dept Anat, 12 Kopernika St, PL-31034 Krakow, Poland.	krtomaszewski@gmail.com	Vikse, Jens/J-6485-2019; Walocha, Jerzy/ABB-9607-2021; Walocha, Jerzy/AAS-9174-2020	Tomaszewski, Krzysztof/0000-0001-5077-6948; Ramakrishnan, Piravin Kumar/0000-0002-1068-8481	Foundation for Polish Science (FNP) START scholarship	Foundation for Polish Science (FNP) START scholarship	Krzysztof A. Tomaszewski has received the Foundation for Polish Science (FNP) START 2015 scholarship.	Agarwal Pawan, 2014, Indian J Plast Surg, V47, P95, DOI 10.4103/0970-0358.129632; Ahn DS, 2000, ANN PLAS SURG, V44, P282, DOI 10.1097/00000637-200044030-00006; Al-Qattan MM, 2009, J HAND SURG-EUR VOL, V34E, P212, DOI 10.1177/1753193408089572; Al-Qattan MM, 2010, J HAND SURG-AM, V35A, P1820, DOI 10.1016/j.jhsa.2010.08.011; Alizadeh Khalil, 2006, Acta Orthop Belg, V72, P415; Alp M, 2005, CLIN ANAT, V18, P195, DOI 10.1002/ca.20067; Bagatur AE, 2013, ORTHOPEDICS, V36, pE451, DOI 10.3928/01477447-20130327-21; Bagatur AE, 2001, J BONE JOINT SURG BR, V83B, P655, DOI 10.1302/0301-620X.83B5.11350; Barbe M, 2005, CLIN ANAT, V18, P251, DOI 10.1002/ca.20086; Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104; Bayrak IK, 2008, J ULTRAS MED, V27, P1129, DOI 10.7863/jum.2008.27.8.1129; Caetano EB, 2006, REV BRAS ORTOP, V40, P608; Demircay E, 2011, TURK NEUROSURG, V21, P388, DOI 10.5137/1019-5149.JTN.3073-10.1; Demircay E, 2009, NEUROL INDIA, V57, P337, DOI 10.4103/0028-3886.53281; Elsaftawy Ahmed, 2013, Pol Przegl Chir, V85, P419, DOI 10.2478/pjs-2013-0064; Eskandari MM, 2005, J HAND SURG-AM, V30A, P803, DOI 10.1016/j.jhsa.2005.03.010; FALCONER D, 1985, CLIN ORTHOP RELAT R, P83; Granata G, 2011, NEUROL SCI, V32, P615, DOI 10.1007/s10072-011-0582-8; Green DP, 2008, J HAND SURG-AM, V33A, P1505, DOI 10.1016/j.jhsa.2008.05.025; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hurwitz PJ, 1996, J HAND SURG-BRIT EUR, V21B, P344, DOI 10.1016/S0266-7681(05)80198-6; JOHNSON RK, 1970, J BONE JOINT SURG AM, VA 52, P269, DOI 10.2106/00004623-197052020-00007; KESSLER I, 1969, CLIN ORTHOP RELAT R, P124; Klauser AS, 2011, RADIOLOGY, V259, P808, DOI 10.1148/radiol.11101644; Kozin SH, 1998, J HAND SURG-AM, V23A, P852, DOI 10.1016/S0363-5023(98)80162-7; Krishnan P, 2013, NEUROL INDIA, V61, P311, DOI 10.4103/0028-3886.115078; Lanz U, 1977, J Hand Surg Am, V2, P44; MACKINNON SE, 1988, ANN PLAS SURG, V21, P32, DOI 10.1097/00000637-198807000-00006; Mannerfelt L, 1972, Bull Hosp Joint Dis, V33, P15; Mizia E, 2012, FOLIA MORPHOL, V71, P183; MUMFORD J, 1987, J HAND SURG-AM, V12A, P361, DOI 10.1016/S0363-5023(87)80004-7; Olave E, 1996, J ANAT, V189, P445; Ozcanli H, 2010, SURG RADIOL ANAT, V32, P203, DOI 10.1007/s00276-009-0498-7; Padua L, 1998, J HAND SURG-BRIT EUR, V23B, P603, DOI 10.1016/S0266-7681(98)80010-7; Pereira A. K. F. T. C., 2013, Journal of Morphological Sciences, V30, P228; PERNECZKY G, 1980, NEUROCHIRURGIE, V26, P77; Planitzer U, 2014, ANN ANAT, V196, P144, DOI 10.1016/j.aanat.2013.11.002; Poisel S., 1974, CHIR PRAX, V18, P471; Raviprasanna KH, 2014, IJBR, V05; Rodriguez R, 2013, J HAND SURG-AM, V38A, P1547, DOI 10.1016/j.jhsa.2013.05.006; Sacks JM, 2007, PLAST RECONSTR SURG, V120, P713, DOI 10.1097/01.prs.0000270305.37677.e7; Samarakoon LB, 2014, PATIENT SAF SURG, V8, DOI 10.1186/1754-9493-8-8; Senanayake KJ, 2009, INTERNATIONAL JOURNA; Siverhus S W, 1989, Orthop Rev, V18, P315; STANCIC MF, 1995, INT ORTHOP, V19, P30, DOI 10.1007/BF00184911; Steinberg EL, 1998, CLIN ORTHOP RELAT R, P128; TOUNTAS CP, 1987, J HAND SURG-AM, V12A, P708, DOI 10.1016/S0363-5023(87)80053-9; Vashishtha K, 2011, J ANAT SOC INDIA, V60, P193	48	55	59	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136477	10.1371/journal.pone.0136477	http://dx.doi.org/10.1371/journal.pone.0136477			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305098	Green Submitted, Green Published, gold			2022-12-27	WOS:000359995500082
J	Contzen, N; De Pasquale, S; Mosler, HJ				Contzen, Nadja; De Pasquale, Sandra; Mosler, Hans-Joachim			Over-Reporting in Handwashing Self-Reports: Potential Explanatory Factors and Alternative Measurements	PLOS ONE			English	Article							SOCIAL DESIRABILITY SCALE; HAND-HYGIENE; STRUCTURED OBSERVATIONS; INDIVIDUAL-DIFFERENCES; COGNITIVE-DISSONANCE; SENSITIVE QUESTIONS; BURKINA-FASO; BEHAVIOR; VALIDITY; MEMORY	Handwashing interventions are a priority in development and emergency aid programs. Evaluation of these interventions is essential to assess the effectiveness of programs; however, measuring handwashing is quite difficult. Although observations are considered valid, they are time-consuming and cost-ineffective; self-reports are highly efficient but considered invalid because desirable behaviour tends to be over-reported. Socially desirable responding has been claimed to be the main cause of inflated self-reports, but its underlying factors and mechanisms are understudied. The present study investigated socially desirable responding and additional potential explanatory factors for over-reported handwashing to identify indications for measures which mitigate over-reporting. Additionally, a script-based covert recall, an alternative interview question intended to mitigate recall errors and socially desirable responding, was developed and tested. Cross-sectional data collection was conducted in the Borena Zone, Ethiopia, through 2.5-hour observations and 1-hour interviews with the primary caregivers in households. A total sample of N = 554 was surveyed. Data were analysed with correlation and multiple regression analyses and dependent t-tests. Over-reporting of handwashing was associated with factors assumed to be involved in (1) socially desirable responding, (2) encoding and recall of information, and (3) dissonance processes. The latter two factor groups explained over-reported handwashing beyond socially desirable responding. The alternative interview question-script-based covert recall-reduced over-reporting compared to conventional self-reports. Although the difficulties involved in measuring handwashing by self-reports and observations are widely known, the present study is the first to investigate the factors which explain over-reporting of handwashing. This research contributes to the limited evidence base on a highly important subject: how to evaluate handwashing interventions efficiently and accurately.	[Contzen, Nadja; Mosler, Hans-Joachim] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Environm Social Sci, Environm & Hlth Psychol, Dubendorf, Switzerland; [De Pasquale, Sandra] Univ Zurich, Dept Psychol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Zurich	Contzen, N (corresponding author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Environm Social Sci, Environm & Hlth Psychol, Dubendorf, Switzerland.	nadja.contzen@eawag.ch		Contzen, Nadja/0000-0001-5875-5578				Aiello AE, 2008, AM J PUBLIC HEALTH, V98, P1372, DOI 10.2105/AJPH.2007.124610; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Aquilino WS, 2000, SUBST USE MISUSE, V35, P845, DOI 10.3109/10826080009148424; Biran A, 2008, TROP MED INT HEALTH, V13, P278, DOI 10.1111/j.1365-3156.2007.02001.x; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Boyce JM, 2011, INFECT CONT HOSP EP, V32, P1016, DOI 10.1086/662015; Bradburn NM, 2000, SCIENCE OF SELF-REPORT, P49; Brener ND, 2003, J ADOLESCENT HEALTH, V33, P436, DOI 10.1016/S1054-139X(03)00052-1; BURTON S, 1991, PUBLIC OPIN QUART, V55, P50, DOI 10.1086/269241; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Cialdini R.B., 2006, SOC INFLUENCE, V1, p3, DOI [10.1080/15534510500181459, DOI 10.1080/15534510500181459]; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2003, APPL MULTIPLE REGRES; Contzen N, 2015, AM J INFECT CONTROL, V43, P826, DOI 10.1016/j.ajic.2015.04.186; Contzen N, 2013, J PUBLIC HEALTH-HEID, V21, P559, DOI 10.1007/s10389-013-0577-4; Cousens S, 1996, SOC SCI MED, V43, P1299, DOI 10.1016/0277-9536(95)00380-0; Crisp RJ, 2006, PERS SOC PSYCHOL B, V32, P1204, DOI 10.1177/0146167206289409; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; CURTIS V, 1993, B WORLD HEALTH ORGAN, V71, P23; Davidson KW, 2003, ANN BEHAV MED, V26, P161, DOI 10.1207/S15324796ABM2603_01; DeMaio T., 1984, SURVEYING SUBJECTIVE, P257, DOI 10.2458/v7i2.20321; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Festinger L., 1962, THEORY COGNITIVE DIS; Fishbein M., 2010, PREDICTING AND CHANG; Fotuhi O, 2013, TOB CONTROL, V22, P52, DOI 10.1136/tobaccocontrol-2011-050139; Gittelsohn J, 1997, HUM ORGAN, V56, P182, DOI 10.17730/humo.56.2.c7x0532q2u86m207; Global WASH Cluster, 2009, HYG PROM EM WASH CLU; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Gould DJ, 2007, J HOSP INFECT, V66, P109, DOI 10.1016/j.jhin.2007.02.009; Halder AK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-545; Heeb JL, 2005, ADDICT BEHAV, V30, P403, DOI 10.1016/j.addbeh.2004.04.022; Hershfield AF, 1993, SOCIAL RES DEV COUNT, P241; Hoffmeyer-Zlotnik J.H.P, 2003, DEV APPL STAT; Iyer P., 2005, HANDWASHING HDB GUID; King MF, 2000, PSYCHOL MARKET, V17, P79, DOI 10.1002/(SICI)1520-6793(200002)17:2<79::AID-MAR2>3.0.CO;2-0; KRISTIANSEN CM, 1984, PUBLIC HEALTH REP, V99, P384; LOFTUS EF, 1992, APPL COGNITIVE PSYCH, V6, P93, DOI 10.1002/acp.2350060202; Luby SP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001052; ManunEbo M, 1997, TROP MED INT HEALTH, V2, P1015, DOI 10.1046/j.1365-3156.1997.d01-180.x; McAteer J, 2008, J HOSP INFECT, V68, P222, DOI 10.1016/j.jhin.2007.12.009; Mcdowell I., 2006, MEASURING HLTH GUIDE, V3, P37, DOI [DOI 10.1093/ACPROF:OSO/9780195165678.001.0001, 10.1093/acprof:oso/9780195165678.001.0001]; MENON G, 1993, J CONSUM RES, V20, P431, DOI 10.1086/209359; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Naher AF, 2012, QUAL QUANT, V46, P1601, DOI 10.1007/s11135-011-9469-2; Pessoa-Silva CL, 2007, PEDIATRICS, V120, pE382, DOI 10.1542/peds.2006-3712; Ram P., 2010, PRACTICAL GUIDANCE M; Ram P, 2013, PRACTICAL GUIDANCE M; REYNOLDS WM, 1982, J CLIN PSYCHOL, V38, P119, DOI 10.1002/1097-4679(198201)38:1<119::AID-JCLP2270380118>3.0.CO;2-I; Schwarz N, 2001, AM J EVAL, V22, P127, DOI 10.1177/109821400102200202; STANTON BF, 1987, B WORLD HEALTH ORGAN, V65, P217; Stevenson RJ, 2009, AM J INFECT CONTROL, V37, P557, DOI 10.1016/j.ajic.2009.01.003; TAGLIACOZZO R, 1979, ADDICT BEHAV, V4, P393, DOI 10.1016/0306-4603(79)90010-8; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Turner J.C., 1987, REDISCOVERING SOCIAL; United Nations Children's Fund, 2008, WAT SAN HYG HYG PROM; Unsworth N, 2007, PSYCHOL REV, V114, P104, DOI 10.1037/0033-295X.114.1.104; Verardi S, 2010, J CROSS CULT PSYCHOL, V41, P19, DOI 10.1177/0022022109348918; Vu A, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-162; Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779; Weisberg HF, 2005, TOTAL SURVEY ERROER; Wisner B., 2002, ENV HLTH EMERGENCIES; World Health Organization, 2009, WHO GUID HAND HYG HL	62	64	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136445	10.1371/journal.pone.0136445	http://dx.doi.org/10.1371/journal.pone.0136445			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5VA	26301781	Green Submitted, Green Published, gold			2022-12-27	WOS:000359951900070
J	Kleynen, M; Braun, SM; Rasquin, SMC; Bleijlevens, MHC; Lexis, MAS; Halfens, J; Wilson, MR; Masters, RSW; Beurskens, AJ				Kleynen, Melanie; Braun, Susy M.; Rasquin, Sascha M. C.; Bleijlevens, Michel H. C.; Lexis, Monique A. S.; Halfens, Jos; Wilson, Mark R.; Masters, Rich S. W.; Beurskens, Anna J.			Multidisciplinary Views on Applying Explicit and Implicit Motor Learning in Practice: An International Survey	PLOS ONE			English	Article							ATTENTIONAL FOCUS; EXTERNAL FOCUS; PERFORMANCE; FEEDBACK; SKILL; REHABILITATION; INSTRUCTIONS; INDIVIDUALS; KNOWLEDGE; STROKE	Background A variety of options and techniques for causing implicit and explicit motor learning have been described in the literature. The aim of the current paper was to provide clearer guidance for practitioners on how to apply motor learning in practice by exploring experts' opinions and experiences, using the distinction between implicit and explicit motor learning as a conceptual departure point. Methods A survey was designed to collect and aggregate informed opinions and experiences from 40 international respondents who had demonstrable expertise related to motor learning in practice and/or research. The survey was administered through an online survey tool and addressed potential options and learning strategies for applying implicit and explicit motor learning. Responses were analysed in terms of consensus (>= 70%) and trends (>= 50%). A summary figure was developed to illustrate a taxonomy of the different learning strategies and options indicated by the experts in the survey. Results Answers of experts were widely distributed. No consensus was found regarding the application of implicit and explicit motor learning. Some trends were identified: Explicit motor learning can be promoted by using instructions and various types of feedback, but when promoting implicit motor learning, instructions and feedback should be restricted. Further, for implicit motor learning, an external focus of attention should be considered, as well as practicing the entire skill. Experts agreed on three factors that influence motor learning choices: the learner's abilities, the type of task, and the stage of motor learning (94.5%; n = 34/36). Most experts agreed with the summary figure (64.7%; n = 22/34). Conclusion The results provide an overview of possible ways to cause implicit or explicit motor learning, signposting examples from practice and factors that influence day-to-day motor learning decisions.	[Kleynen, Melanie; Braun, Susy M.; Beurskens, Anna J.] Zuyd Univ Appl Sci, Fac Hlth, Res Ctr Auton & Participat Persons Chron Illness, Heerlen, Netherlands; [Kleynen, Melanie; Halfens, Jos] Adelante Rehabil Ctr, Dept Brain Injury, Hoensbroek, Netherlands; [Kleynen, Melanie; Beurskens, Anna J.] Maastricht Univ, Sch Publ Hlth & Primary Care, Fac Hlth Med & Life Sci, Dept Family Med,CAPHRI, Maastricht, Netherlands; [Kleynen, Melanie; Rasquin, Sascha M. C.] Maastricht Univ, Sch Publ Hlth & Primary Care, Fac Hlth Med & Life Sci, Dept Rehabil Med,CAPHRI, Maastricht, Netherlands; [Braun, Susy M.; Bleijlevens, Michel H. C.] Maastricht Univ, Sch Publ Hlth & Primary Care, Fac Hlth Med & Life Sci, Dept Hlth Serv Res,CAPHRI, Maastricht, Netherlands; [Rasquin, Sascha M. C.] Adelante Ctr Expertise Rehabil & Audiol, Hoensbroek, Netherlands; [Bleijlevens, Michel H. C.] Sevagram Zorgcentra, Innovat Platform Sevagram, Heerlen, Netherlands; [Lexis, Monique A. S.] Zuyd Univ Appl Sci, Res Ctr Technol Care, Heerlen, Netherlands; [Wilson, Mark R.] Univ Exeter, Dept Sport & Hlth Sci, Exeter, Devon, England; [Masters, Rich S. W.] Univ Hong Kong, Inst Human Performance, Hong Kong, Hong Kong, Peoples R China; [Masters, Rich S. W.] Univ Waikato, Te Oranga Sch Human Dev & Movement Studies, Hamilton, New Zealand	Maastricht University; Maastricht University; Maastricht University; University of Exeter; University of Hong Kong; University of Waikato	Kleynen, M (corresponding author), Zuyd Univ Appl Sci, Fac Hlth, Res Ctr Auton & Participat Persons Chron Illness, Heerlen, Netherlands.	melanie.kleynen@zuyd.nl		Wilson, Mark/0000-0001-8145-6971	Stichting Innovatie Alliantie (Innovation Alliance Foundation), RAAK-international [2011-3-33int]	Stichting Innovatie Alliantie (Innovation Alliance Foundation), RAAK-international	This study was financially supported by Stichting Innovatie Alliantie (Innovation Alliance Foundation), RAAK-international (Registration number: 2011-3-33int).	Akizuki K, 2013, J PHYS THER SCI, V25, P827, DOI 10.1589/jpts.25.827; Capio CM, 2013, J INTELL DISABIL RES, V57, P295, DOI 10.1111/j.1365-2788.2012.01535.x; Carr J. H., 1987, MOTOR RELEARNING PRO; Fisher BE, 2014, J NEUROL PHYS THER, V38, P149, DOI 10.1097/NPT.0000000000000043; Fitts PM, 1967, BASIC CONCEPTS PSYCH; Green TD, 2003, PERCEPT MOTOR SKILL, V97, P299, DOI 10.2466/PMS.97.4.299-314; Guadagnoli MA, 2004, J MOTOR BEHAV, V36, P212, DOI 10.3200/JMBR.36.2.212-224; Halsband U, 2006, J PHYSIOL-PARIS, V99, P414, DOI 10.1016/j.jphysparis.2006.03.007; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Ille A, 2013, J SPORT SCI, V31, P1705, DOI 10.1080/02640414.2013.797097; Johnson L, 2013, PHYS THER, V93, P957, DOI 10.2522/ptj.20120300; Kleynen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100227; Kleynen M, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2604; Lauber B, 2014, EUR J SPORT SCI, V14, P36, DOI 10.1080/17461391.2012.725104; Liao CM, 2001, J SPORT SCI, V19, P307, DOI 10.1080/02640410152006081; MASTERS RSW, 1992, BRIT J PSYCHOL, V83, P343, DOI 10.1111/j.2044-8295.1992.tb02446.x; Masters RSW, 2012, SKILL ACQUISITION SP, P59; Mokkink L B, 2006, BMC Med Res Methodol, V6, P2, DOI 10.1186/1471-2288-6-2; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Orrell AJ, 2006, PHYS THER, V86, P369, DOI 10.1093/ptj/86.3.369; Ross S, 2014, RES Q EXERCISE SPORT, V85, P316, DOI 10.1080/02701367.2014.930087; Sawers A, 2012, J REHABIL RES DEV, V49, P1431, DOI 10.1682/JRRD.2011.12.0235; Schmidt RA., 1991, CONT MANAGEMENT MOTO, P49; SINGER RN, 1994, RES Q EXERCISE SPORT, V65, P143, DOI 10.1080/02701367.1994.10607609; Steenbergen B, 2010, DISABIL REHABIL, V32, P1509, DOI 10.3109/09638288.2010.497035; Sturmberg C, 2013, MANUAL THER, V18, P458, DOI 10.1016/j.math.2013.07.002; Subramanian SK, 2010, NEUROREHAB NEURAL RE, V24, P113, DOI 10.1177/1545968309349941; Tse ACY, 2014, J VOICE, V28, P196, DOI 10.1016/j.jvoice.2013.03.014; Van Tilborg IADA, 2011, EXP BRAIN RES, V214, P427, DOI 10.1007/s00221-011-2841-6; van Tilborg IADA, 2011, CLIN REHABIL, V25, P638, DOI 10.1177/0269215510396738; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Verneau M, 2014, EXP AGING RES, V40, P477, DOI 10.1080/0361073X.2014.926778; Vidoni Eric D, 2007, J Neurol Phys Ther, V31, P145; Waller SM, 2012, GAIT POSTURE, V36, P419, DOI 10.1016/j.gaitpost.2012.03.025; Winstein C, 2014, J NEUROL PHYS THER, V38, P190, DOI 10.1097/NPT.0000000000000046; Wulf G, 1998, J MOTOR BEHAV, V30, P169, DOI 10.1080/00222899809601334; Zafar SY, 2012, LANCET ONCOL, V13, pE77, DOI 10.1016/S1470-2045(11)70215-7; Zubiaur M, 1999, PERCEPT MOTOR SKILL, V89, P223	38	30	31	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135522	10.1371/journal.pone.0135522	http://dx.doi.org/10.1371/journal.pone.0135522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26296203	gold, Green Submitted, Green Published			2022-12-27	WOS:000359926900033
J	Ogutu, JO; Owen-Smith, N; Piepho, HP; Dublin, HT				Ogutu, Joseph O.; Owen-Smith, Norman; Piepho, Hans-Peter; Dublin, Holly T.			How Rainfall Variation Influences Reproductive Patterns of African Savanna Ungulates in an Equatorial Region Where Photoperiod Variation Is Absent	PLOS ONE			English	Article							PHENOLOGY; SEASONALITY; VEGETATION; DYNAMICS; POPULATION; SYNCHRONY; RUMINANTS	In high temperate latitudes, ungulates generally give birth within a narrow time window when conditions are optimal for offspring survival in spring or early summer, and use changing photoperiod to time conceptions so as to anticipate these conditions. However, in low tropical latitudes day length variation is minimal, and rainfall variation makes the seasonal cycle less predictable. Nevertheless, several ungulate species retain narrow birth peaks under such conditions, while others show births spread quite widely through the year. We investigated how within-year and between-year variation in rainfall influenced the reproductive timing of four ungulate species showing these contrasting patterns in the Masai Mara region of Kenya. All four species exhibited birth peaks during the putative optimal period in the early wet season. For hartebeest and impala, the birth peak was diffuse and offspring were born throughout the year. In contrast, topi and warthog showed a narrow seasonal concentration of births, with conceptions suppressed once monthly rainfall fell below a threshold level. High rainfall in the previous season and high early rains in the current year enhanced survival into the juvenile stage for all the species except impala. Our findings reveal how rainfall variation affecting grass growth and hence herbivore nutrition can govern the reproductive phenology of ungulates in tropical latitudes where day length variation is minimal. The underlying mechanism seems to be the suppression of conceptions once nutritional gains become insufficient. Through responding proximally to within-year variation in rainfall, tropical savanna ungulates are less likely to be affected adversely by the consequences of global warming for vegetation phenology than northern ungulates showing more rigid photoperiodic control over reproductive timing.	[Ogutu, Joseph O.] Int Livestock Res Inst, Nairobi 00100, Kenya; [Ogutu, Joseph O.; Piepho, Hans-Peter] Univ Hohenheim, Inst Crop Sci, D-70599 Stuttgart, Germany; [Owen-Smith, Norman] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Ctr African Ecol, ZA-2050 Johannesburg, South Africa; [Dublin, Holly T.] Wasaa Conservat Ctr, IUCN ESARO, Nairobi 00200, Kenya	CGIAR; International Livestock Research Institute (ILRI); University Hohenheim; University of Witwatersrand	Ogutu, JO (corresponding author), Int Livestock Res Inst, POB 30709, Nairobi 00100, Kenya.	jogutu2007@gmail.com	Owen-Smith, Norman/ABI-5113-2020	Piepho, Hans-Peter/0000-0001-7813-2992; Owen-Smith, Norman/0000-0001-8429-1201; Ogutu, Joseph O/0000-0002-7379-0387	World Wide Fund for Nature-East Africa Program (WWF-EARPO); Friends of Conservation (FOC); WWF-US; WWF-Sweden; Darwin Initiative (DICE); University of British Columbia; United States Fish and Wildlife Service; Kenya Wildlife Service; Cottar's Camp; Kichwa Tembo; Keekorok Lodge/Balloon Safaris; Kerr and Downey Safaris; National Science Foundation (NSF) [BCS 0709671, DEB-0342820]; Belgian government [DGIC BEL011]; International Livestock Research Institute (ILRI); University of Hohenheim, Biostatistics Unit; German Research Found (DFG) [OG 83/1-1]	World Wide Fund for Nature-East Africa Program (WWF-EARPO); Friends of Conservation (FOC); WWF-US; WWF-Sweden; Darwin Initiative (DICE); University of British Columbia; United States Fish and Wildlife Service(US Fish & Wildlife Service); Kenya Wildlife Service; Cottar's Camp; Kichwa Tembo; Keekorok Lodge/Balloon Safaris; Kerr and Downey Safaris; National Science Foundation (NSF)(National Science Foundation (NSF)); Belgian government; International Livestock Research Institute (ILRI)(CGIAR); University of Hohenheim, Biostatistics Unit; German Research Found (DFG)	The monitoring was funded by the World Wide Fund for Nature-East Africa Program (WWF-EARPO) and Friends of Conservation (FOC). The program also received financial, material or logistical support from WWF-US, WWF-Sweden, the Darwin Initiative (DICE), the University of British Columbia, United States Fish and Wildlife Service, Kenya Wildlife Service, Cottar's Camp, Kichwa Tembo, Keekorok Lodge/Balloon Safaris and Kerr and Downey Safaris. Data analysis and writing were partially supported by the National Science Foundation (NSF) through Grant Nos: BCS 0709671 and DEB-0342820 and a grant from the Belgian government (DGIC BEL011) to the International Livestock Research Institute. JO was supported by the International Livestock Research Institute (ILRI), the University of Hohenheim, Biostatistics Unit and a grant from the German Research Found (DFG, Research Grant # OG 83/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrestani FS, 2012, OIKOS, V121, P1300, DOI 10.1111/j.1600-0706.2011.20244.x; Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; ANDERSON JL, 1979, MAMMAL REV, V9, P33, DOI 10.1111/j.1365-2907.1979.tb00230.x; ANSELL W. F. H., 1960, PROC ZOOL SOC LONDON, V134, P251; Ansell W. F. H., 1963, Puku Occasional Papers of the Department of Game and Fisheries Northern Rhodesia, V1, P9; BOUTTON TW, 1988, AFR J ECOL, V26, P103, DOI 10.1111/j.1365-2028.1988.tb00961.x; BOUTTON TW, 1988, AFR J ECOL, V26, P89, DOI 10.1111/j.1365-2028.1988.tb00960.x; Brown O. E., 1936, Journal of Mammalogy, V17, P10, DOI 10.2307/1374541; Child G., 1964, Arnoldia, V1, P1; Child G, 1968, 2563 FAO PA; Clough G., 1969, Journal of Reproduction and Fertility Suppl, VNo.6, P323; ESTES R D, 1974, Proceedings of the Academy of Natural Sciences of Philadelphia, V126, P73; ESTES R D, 1976, East African Wildlife Journal, V14, P135; ESTES RD, BEHAV GUIDE AFRICAN; Fairall N., 1968, AFR ZOOL, V3, P180; Gosling L. M., 1969, Journal of Reproduction and Fertility Suppl, VNo. 6, P265; HALL-MARTIN A J, 1975, East African Wildlife Journal, V13, P237; Knoop MC, 2006, AFR J ECOL, V44, P228, DOI 10.1111/j.1365-2028.2006.00637.x; Laws R.M., 1975, ELEPHANTS THEIR HABI; Moe SR, 2007, J ZOOL, V273, P237, DOI 10.1111/j.1469-7998.2007.00319.x; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; MURRAY MG, 1982, Z TIERPSYCHOL, V59, P319; Oftedal O.T., 1985, P215; Ogutu JO, 2008, J ANIM ECOL, V77, P814, DOI 10.1111/j.1365-2656.2008.01392.x; Ogutu JO, 2008, AFR J ECOL, V46, P132, DOI 10.1111/j.1365-2028.2007.00821.x; Ogutu JO, 2009, J ZOOL, V278, P1, DOI 10.1111/j.1469-7998.2008.00536.x; Ogutu JO, 2014, WILDLIFE RES, V41, P323, DOI 10.1071/WR13211; Ogutu JO, 2013, WILDLIFE RES, V40, P698, DOI 10.1071/WR13117; Ogutu JO, 2011, POPUL ECOL, V53, P195, DOI 10.1007/s10144-010-0223-8; Ogutu JO, 2010, POPUL ECOL, V52, P89, DOI 10.1007/s10144-009-0163-3; Owen-Smith N, 2013, ECOGRAPHY, V36, P256, DOI 10.1111/j.1600-0587.2012.00156.x; Owen-Smith R.N., 1988, MEGAHERBIVORES INFLU, DOI [10.1017/CBO9780511565441, DOI 10.1017/CBO9780511565441]; Owen-Smith RN., 2002, ADAPTIVE HERBIVORE E, VStudent; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; RUTBERG AT, 1987, AM NAT, V130, P692, DOI 10.1086/284739; SEKULIC R, 1978, E AFR WILDL J, V16, P177; Sinclair ARE, 2000, ECOLOGY, V81, P2100, DOI 10.1890/0012-9658(2000)081[2100:WDPASO]2.0.CO;2; SKINNER J D, 1974, Journal of the Southern African Wildlife Management Association, V4, P15; Skinner J.D., 1973, Journal Reprod Fert, V19, P101; Skinner J. D., 2002, Transactions of the Royal Society of South Africa, V57, P25; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; SPINAGE CA, 1969, J REPROD FERTIL, V18, P445, DOI 10.1530/jrf.0.0180445; Wilson D. E., 1977, WILDL MONOGR, V54; Wilson V. J., 1969, Arnoldia Bulawayo, V4, P1; Wittemyer G, 2007, ECOGRAPHY, V30, P42, DOI 10.1111/j.2006.0906-7590.04900.x; Zerbe P, 2012, BIOL REV, V87, P965, DOI 10.1111/j.1469-185X.2012.00238.x	46	15	15	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0133744	10.1371/journal.pone.0133744	http://dx.doi.org/10.1371/journal.pone.0133744			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295154	Green Submitted, Green Published, gold			2022-12-27	WOS:000359926900007
J	Sun, Y; Sun, L				Sun, Yun; Sun, Li			CsBAFF, a Teleost B Cell Activating Factor, Promotes Pathogen-Induced Innate Immunity and Vaccine-Induced Adaptive Immunity	PLOS ONE			English	Article							TURBOT SCOPHTHALMUS-MAXIMUS; NECROSIS-FACTOR FAMILY; TNF13B BAFF GENE; T-CELL; LYMPHOCYTE STIMULATOR; MOLECULAR-CLONING; BIOACTIVITY CHARACTERIZATION; BIOINFORMATICS ANALYSIS; CYNOGLOSSUS-SEMILAEVIS; FUNCTIONAL-ANALYSIS	B cell activating factor (BAFF) is a member of the tumor necrosis factor family that is known to play an important role in B cell activation, proliferation, and differentiation in mammals. However, studies of BAFF in teleosts are very limited and its function, in particular that under in vivo conditions, is essentially unknown. In this study, we conducted in vivo as well as in vitro functional analyses of a BAFF homologue (CsBAFF) from the teleost fish tongue sole (Cynoglossus semilaevis). CsBAFF is composed of 261 residues and shares moderate sequence identities with known BAFFs of other teleosts. CsBAFF expression was most abundant in immune organs and was upregulated during bacterial infection. Purified recombinant CsBAFF (rCsBAFF) bound to tongue sole lymphocytes and promoted cellular proliferation and survival. The results of an in vivo study showed that CsBAFF overexpression in tongue sole significantly enhanced macrophage activation and reduced bacterial infection in fish tissues, whereas knockdown of CsBAFF expression resulted in increased bacterial dissemination and colonization in fish tissues. Furthermore, vaccination studies showed that CsBAFF enhanced the immunoprotection of a DNA vaccine and augmented the production of specific serum antibodies. Taken together, these results provide the first in vivo evidence to indicate that teleost BAFF is an immunostimulator that significantly contributes to the innate antibacterial immune response and vaccine-induced adaptive immune response.	[Sun, Yun; Sun, Li] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao 266071, Peoples R China; [Sun, Yun] Hainan Univ, Coll Marine Sci, State Key Lab Breeding Base Sustainable Exploitat, Haikou 570228, Peoples R China; [Sun, Li] Qingdao Natl Oceanog Lab, Funct Lab Marine Biol & Biotechnol, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Hainan University	Sun, L (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao 266071, Peoples R China.	lsun@qdio.ac.cn			China Postdoctoral Science Foundation [2014M550377]; Science and Technology Development Plan of Shandong Province [2014GHY115001]; Taishan Scholar Program of Shandong Province	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science and Technology Development Plan of Shandong Province; Taishan Scholar Program of Shandong Province	This work was supported by the grants from China Postdoctoral Science Foundation (2014M550377), Science and Technology Development Plan of Shandong Province (2014GHY115001), and Taishan Scholar Program of Shandong Province.	Ai HX, 2011, FISH SHELLFISH IMMUN, V30, P1265, DOI 10.1016/j.fsi.2011.03.020; Bertram EM, 2002, J IMMUNOL, V168, P3777, DOI 10.4049/jimmunol.168.8.3777; Bossen C, 2006, SEMIN IMMUNOL, V18, P263, DOI 10.1016/j.smim.2006.04.006; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Chang SK, 2006, BLOOD, V108, P2687, DOI 10.1182/blood-2005-12-017319; Chang SK, 2008, J IMMUNOL, V180, P7394, DOI 10.4049/jimmunol.180.11.7394; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Chen C, 2013, FISH SHELLFISH IMMUN, V35, P1677, DOI 10.1016/j.fsi.2013.08.020; Cui XW, 2012, INT IMMUNOPHARMACOL, V12, P34, DOI 10.1016/j.intimp.2011.10.009; Diaz-de-Durana Y, 2006, BLOOD, V107, P594, DOI 10.1182/blood-2004-12-4708; Dickinson GS, 2014, INFECT IMMUN, V82, P453, DOI 10.1128/IAI.01147-13; Elgueta R, 2010, IMMUNOL REV, V236, P139, DOI 10.1111/j.1600-065X.2010.00924.x; Groom J, 2002, J CLIN INVEST, V109, P59, DOI 10.1172/JCI200214121; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Guan ZB, 2007, DEV COMP IMMUNOL, V31, P1211, DOI 10.1016/j.dci.2007.03.006; Guan ZB, 2007, CYTOKINE, V39, P192, DOI 10.1016/j.cyto.2007.07.190; Jeon ST, 2010, IMMUNOL CELL BIOL, V88, P148, DOI 10.1038/icb.2009.75; Jiao XD, 2009, VACCINE, V27, P5195, DOI 10.1016/j.vaccine.2009.06.071; Kanagavelu SK, 2012, VACCINE, V30, P691, DOI 10.1016/j.vaccine.2011.11.088; Karpusas M, 2002, J MOL BIOL, V315, P1145, DOI 10.1006/jmbi.2001.5296; Katsenelson N, 2007, EUR J IMMUNOL, V37, P1785, DOI 10.1002/eji.200636800; Kim MY, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.4; Li MF, 2013, FISH SHELLFISH IMMUN, V35, P2026, DOI 10.1016/j.fsi.2013.10.013; Li MF, 2013, DEV COMP IMMUNOL, V41, P514, DOI 10.1016/j.dci.2013.07.022; Liang ZN, 2010, FISH SHELLFISH IMMUN, V29, P233, DOI 10.1016/j.fsi.2010.03.006; Liu CS, 2010, VACCINE, V28, P4153, DOI 10.1016/j.vaccine.2010.04.016; Long H, 2014, FISH SHELLFISH IMMUN, V37, P66, DOI 10.1016/j.fsi.2014.01.013; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Mackay F, 2007, CURR OPIN IMMUNOL, V19, P327, DOI 10.1016/j.coi.2007.04.008; Mackay F, 2006, SEMIN IMMUNOL, V18, P284, DOI 10.1016/j.smim.2006.04.005; Mackay F, 2006, SEMIN IMMUNOL, V18, P261, DOI 10.1016/j.smim.2006.07.003; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; MILLER DJ, 1992, EUR J IMMUNOL, V22, P373, DOI 10.1002/eji.1830220213; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Ng LG, 2005, MOL IMMUNOL, V42, P763, DOI 10.1016/j.molimm.2004.06.041; Ng LG, 2004, J IMMUNOL, V173, P807, DOI 10.4049/jimmunol.173.2.807; Qiu R, 2013, FISH SHELLFISH IMMUN, V34, P810, DOI 10.1016/j.fsi.2012.12.016; Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5; Salinas I, 2011, DEV COMP IMMUNOL, V35, P1346, DOI 10.1016/j.dci.2011.11.009; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shen YF, 2011, VET IMMUNOL IMMUNOP, V142, P133, DOI 10.1016/j.vetimm.2011.04.014; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Sun Y, 2011, FISH SHELLFISH IMMUN, V30, P273, DOI 10.1016/j.fsi.2010.10.020; Tertilt C, 2009, INFECT IMMUN, V77, P3044, DOI 10.1128/IAI.00927-08; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Treml LS, 2007, J IMMUNOL, V178, P7531, DOI 10.4049/jimmunol.178.12.7531; Tribouley C, 1999, BIOL CHEM, V380, P1443, DOI 10.1515/BC.1999.186; Wiens GD, 2010, FISH SHELLFISH IMMUN, V29, P639, DOI 10.1016/j.fsi.2010.06.010; Xiao W, 2014, MOL IMMUNOL, V59, P64, DOI 10.1016/j.molimm.2014.01.005; You FT, 2012, INT IMMUNOPHARMACOL, V12, P433, DOI 10.1016/j.intimp.2011.12.018; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6; Zhang M, 2008, MICROBIOL-SGM, V154, P2060, DOI 10.1099/mic.0.2008/017343-0; Zheng WJ, 2010, FISH SHELLFISH IMMUN, V29, P305, DOI 10.1016/j.fsi.2010.04.008; Zhou ZX, 2015, DEV COMP IMMUNOL, V49, P113, DOI 10.1016/j.dci.2014.11.018	62	30	30	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136015	10.1371/journal.pone.0136015	http://dx.doi.org/10.1371/journal.pone.0136015			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295165	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900061
J	De Schacht, C; Lucas, C; Sitoe, N; Machekano, R; Chongo, P; Temmerman, M; Tobaiwa, O; Guay, L; Kassaye, S; Jani, IV				De Schacht, Caroline; Lucas, Carlota; Sitoe, Nadia; Machekano, Rhoderick; Chongo, Patrina; Temmerman, Marleen; Tobaiwa, Ocean; Guay, Laura; Kassaye, Seble; Jani, Ilesh V.			Implementation of Point-of-Care Diagnostics Leads to Variable Uptake of Syphilis, Anemia and CD4+T-Cell Count Testing in Rural Maternal and Child Health Clinics	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV; INITIATION; TRANSMISSION; PREGNANCY	Introduction Anemia, syphilis and HIV are high burden diseases among pregnant women in sub-Saharan Africa. A quasi-experimental study was conducted in four health facilities in Southern Mozambique to evaluate the effect of point-of-care technologies for hemoglobin quantification, syphilis testing and CD4+ T-cell enumeration performed within maternal and child health services on testing and treatment coverage, and assessing acceptability by health workers. Methods Demographic and testing data on women attending first antenatal care services were extracted from existing records, before (2011; n = 865) and after (2012; n = 808) introduction of point-of-care testing. Study outcomes per health facility were compared using z-tests (categorical variables) and Wilcoxon rank-sum test (continuous variables), while inverse variance weights were used to adjust for possible cluster effects in the pooled analysis. A structured acceptability-assessment interview was conducted with health workers before (n = 22) and after (n = 19). Results After implementation of point-of-care testing, there was no significant change in uptake of overall hemoglobin screening (67.9% to 83.0%; p = 0.229), syphilis screening (80.8% to 87.0%; p = 0.282) and CD4+ T-cell testing (84.9% to 83.5%; p = 0.930). Initiation of antiretroviral therapy for treatment eligible women was similar in the weighted analysis before and after, with variability among the sites. Time from HIV diagnosis to treatment initiation decreased (median of 44 days to 17 days; p<0.0001). A generally good acceptability for point-of-care testing was seen among health workers. Conclusions Point-of-care CD4+ T-cell enumeration resulted in a decreased time to initiation of antiretroviral therapy among treatment eligible women, without significant increase in testing coverage. Overall hemoglobin and syphilis screening increased. Despite the perception that point-of-care technologies increase access to health services, the variability in results indicate the potential for detrimental effects in some settings. Local context needs to be considered and services restructured to accommodate innovative technologies in order to improve service delivery to expectant mothers.	[De Schacht, Caroline; Lucas, Carlota] Elizabeth Glaser Pediat AIDS Fdn, Maputo, Mozambique; [Sitoe, Nadia; Chongo, Patrina; Jani, Ilesh V.] Inst Nacl Saude, Maputo, Mozambique; [Machekano, Rhoderick; Guay, Laura; Kassaye, Seble] Elizabeth Glaser Pediat AIDS Fdn, Washington, DC USA; [Temmerman, Marleen] Univ Ghent, Int Ctr Reprod Hlth, Dept Obstet & Gynecol, B-9000 Ghent, Belgium; [Tobaiwa, Ocean] Clinton Hlth Access Initiat, Maputo, Mozambique; [Guay, Laura] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Epidemiol & Biostat, Washington, DC USA	Ghent University; George Washington University	De Schacht, C (corresponding author), Hlth Alliance Int, Maputo, Mozambique.	carolineds11@gmail.com		Sitoe, Nadia/0000-0001-7310-8221; Jani, Ilesh/0000-0002-6880-6655	President's Emergency Program for AIDS Relief (PEPFAR) through the Center for Disease Control and Prevention (CDC) [U2GGH000422-02]	President's Emergency Program for AIDS Relief (PEPFAR) through the Center for Disease Control and Prevention (CDC)	The study was funded by the President's Emergency Program for AIDS Relief (PEPFAR) through the Center for Disease Control and Prevention (CDC) Cooperative Agreement U2GGH000422-02. The funder had no role in the design, data collection or analysis. Its contents are solely the responsibility of the authors and do not represent the official views of CDC.	Aledort Julia E, 2006, Nature, V444 Suppl 1, P59, DOI 10.1038/nature05447; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Drain PK, 2014, LANCET INFECT DIS, V14, P239, DOI 10.1016/S1473-3099(13)70250-0; Gous N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085265; Hawkes S, 2011, LANCET INFECT DIS, V11, P684, DOI 10.1016/S1473-3099(11)70104-9; Hyle EP, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001725; INS INE (GTM) GTMdCaHS, 2013, ROND VIG EP HIV SIF; Ishikawa N, 2014, PLOS ONE, V9; Jafari Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054695; Jani IV, 2013, NEW ENGL J MED, V368, P2319, DOI 10.1056/NEJMsb1214197; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Kahn JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087510; Kruger C, 2010, WORLD J PEDIATR, V6, P125, DOI 10.1007/s12519-010-0028-z; Lahuerta M, 2014, CLIN INFECT DIS, V58, P432, DOI 10.1093/cid/cit724; Larson BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113868; Larson BA, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/941493; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Mnyani CN, 2012, JAIDS-J ACQ IMM DEF, V60, P260, DOI 10.1097/QAI.0b013e318256b651; MOH I ICFI, 2011, MOZ DEM HLTH SURV 20; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Mwapasa V, 2006, AIDS, V20, P1869, DOI 10.1097/01.aids.0000244206.41500.27; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Patten GEM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18518; Schmid GP, 2007, SEX TRANSM DIS, V34, pS5, DOI 10.1097/01.olq.0000261456.09797.1b; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Strasser S, 2012, JAIDS-J ACQ IMM DEF, V61, pE40, DOI 10.1097/QAI.0b013e318267bc94; *WHO, 2008, WHO GLOB DAT AN; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809	30	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135744	10.1371/journal.pone.0135744	http://dx.doi.org/10.1371/journal.pone.0135744			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308345	Green Published, gold			2022-12-27	WOS:000360069400074
J	Gruson, D; Ferracin, B; Ahn, SA; Zierold, C; Blocki, F; Hawkins, DM; Bonelli, F; Rousseau, MF				Gruson, Damien; Ferracin, Benjamin; Ahn, Sylvie A.; Zierold, Claudia; Blocki, Frank; Hawkins, Douglas M.; Bonelli, Fabrizio; Rousseau, Michel F.			1,25-Dihydroxyvitamin D to PTH(1-84) Ratios Strongly Predict Cardiovascular Death in Heart Failure	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; GROWTH-FACTOR 23; PARATHYROID-HORMONE; SECONDARY HYPERPARATHYROIDISM; CALCIUM PARADOX; CHROMOGRANIN-A; CALCITRIOL; EXPRESSION; PHOSPHATE; RISK	Objectives Vitamin D deficiency and hyperparathyroidism are common in patients with heart failure (HF). There is a growing body of evidence supporting the role of vitamin D and parathyroid hormone (PTH) in cardiac remodeling and worsening of HF. Lack of reliable automated testing of 1,25-dihydroxyvitamin D (1,25(OH)(2)D), the biologically active metabolite of vitamin D, has limited its contribution to the prognostic assessment of HF. Here, the association of 1,25(OH) 2D and PTH(1-84) levels was evaluated for prediction of cardiovascular death in chronic HF patients. Methods We conducted a single center prospective cohort including 170 chronic HF patients (females n = 36; males n = 134; NYHA II-IV; mean age: 67 years; etiology: ischemic n = 119, dilated cardiomyopathy n = 51; mean LVEF: 23%). The primary outcome was cardiovascular death. Results Serum levels of 1,25(OH)(2)D decreased markedly with increased HF severity. Medians were 33.3 pg/mL for NYHA-II patients, 23.4 pg/mL for NYHA-III, and 14.0 pg/mL for NYHA- IV patients (p<0.001). Most patients had levels of 25(OH) D below 30ng/mL, and stratification by NYHA functional class did not show significant differences (p = 0.249). The 1,25(OH)(2)D to PTH(1-84) ratio and the (1,25(OH)(2)D)(2) to PTH(1-84) ratio were found to be the most significantly related to HF severity. After a median follow-up of 4.1 years, 106 out of 170 patients reached the primary endpoint. Cox proportional hazard modeling revealed 1,25 (OH)(2)D and the 1,25(OH)(2)D to PTH(1-84) ratios to be strongly predictive of outcomes. Conclusions 1,25(OH)(2)D and its ratios to PTH(1-84) strongly and independently predict cardiovascular mortality in chronic HF.	[Gruson, Damien; Ferracin, Benjamin] Clin Univ St Luc, Pole Rech Endocrinol Diabete & Nutr, Inst Rech Expt & Clin, B-1200 Brussels, Belgium; [Gruson, Damien; Ferracin, Benjamin] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Gruson, Damien] Clin Univ St Luc, Dept Lab Med, B-1200 Brussels, Belgium; [Ahn, Sylvie A.; Rousseau, Michel F.] Clin Univ St Luc, Div Cardiol, B-1200 Brussels, Belgium; [Ahn, Sylvie A.] Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Rech Cardiovasc, B-1200 Brussels, Belgium; [Zierold, Claudia; Blocki, Frank; Bonelli, Fabrizio] DiaSorin Inc, Stillwater, MN 55082 USA; [Hawkins, Douglas M.] Univ Minnesota, Sch Stat, Minneapolis, MN 55455 USA	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; University of Minnesota System; University of Minnesota Twin Cities	Gruson, D (corresponding author), Clin Univ St Luc, Pole Rech Endocrinol Diabete & Nutr, Inst Rech Expt & Clin, B-1200 Brussels, Belgium.	damien.gruson@uclouvain.be			DiaSorin Inc.	DiaSorin Inc.	DiaSorin Inc., funder, provided support in the form of salaries for authors Claudia Zierold, Frank Blocki, and Fabrizio Bonelli, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Allay H, 2012, AM J CARDIOL, V109, P252, DOI 10.1016/j.amjcard.2011.08.039; Angelone T, 2012, CURR MED CHEM, V19, P4042, DOI 10.2174/092986712802430009; Bernheim J, 2011, NEPHROL DIAL TRANSPL; Braunwald E, 2000, CIRCULATION, V102, P14; Carbone LD, 2008, J AM COLL CARDIOL, V52, P135, DOI 10.1016/j.jacc.2008.03.039; Chhokar VS, 2005, CIRCULATION, V111, P871, DOI 10.1161/01.CIR.0000155621.10213.06; D'amico MA, 2014, ENDOCR CONNECT, V3, pR45, DOI 10.1530/EC-14-0027; de Boer RA, 2011, ANN MED, V43, P60, DOI 10.3109/07853890.2010.538080; di Giuseppe R, 2014, J CLIN ENDOCR METAB, V99, P947, DOI 10.1210/jc.2013-2963; Dong JH, 2012, EUR HEART J, V33, P2980, DOI 10.1093/eurheartj/ehr459; Eknoyan G, 2008, NEPHROL DIAL TRANSPL, V23, P47, DOI 10.1093/ndt/gfm517; Emdin M, 2009, EUR J HEART FAIL, V11, P331, DOI 10.1093/eurjhf/hfp035; Gotsman I, 2012, EUR J HEART FAIL, V14, P357, DOI 10.1093/eurjhf/hfr175; Gruson D, 2014, CLIN CHIM ACTA, V433, P290, DOI 10.1016/j.cca.2014.03.029; Gruson D, 2013, CLIN BIOCHEM, V46, P391, DOI 10.1016/j.clinbiochem.2012.12.002; Gruson D, 2012, J ENDOCRINOL INVEST, V35, P987, DOI 10.3275/8286; Gruson D, 2012, PEPTIDES, V37, P258, DOI 10.1016/j.peptides.2012.08.003; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Januzzi JL, 2008, AM J CARDIOL, V101, p29A, DOI 10.1016/j.amjcard.2007.11.017; Keyzer CA, 2014, J CLIN ENDOCR METAB; Khouzam RN, 2006, AM J MED SCI, V331, P30, DOI 10.1097/00000441-200601000-00009; Lemmila S, 1998, AM J NEPHROL, V18, P404, DOI 10.1159/000013384; Li GH, 2002, CIRCULATION, V106, P854, DOI 10.1161/01.CIR.0000024113.26985.CC; Liu LCY, 2014, EUR J HEART FAIL, V16, P122, DOI 10.1002/ejhf.43; Liu SG, 2003, J BIOL CHEM, V278, P37419, DOI 10.1074/jbc.M304544200; Lysaght AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107681; Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014; Mueller Christian, 2008, Congest Heart Fail, V14, P35; Nichols M, 2014, EUR HEART J; Nichols M, 2014, EUR HEART J, V35, P2950, DOI 10.1093/eurheartj/ehu299; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196; Renkema KY, 2008, ANN MED, V40, P82, DOI 10.1080/07853890701689645; Roubille F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075174; Rutledge MR, 2013, CARDIOVASC DRUG THER, V27, P161, DOI 10.1007/s10557-012-6378-0; Saleh FN, 2003, EUR HEART J, V24, P2054, DOI 10.1016/j.ehj.2003.09.010; Savarese G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058287; Schierbeck LL, 2011, EUR J HEART FAIL, V13, P626, DOI 10.1093/eurjhf/hfr016; Scialla JJ, 2014, NAT REV NEPHROL, V10, P268, DOI 10.1038/nrneph.2014.49; Selektor Y, 2008, AM J MED SCI, V335, P105, DOI 10.1097/MAJ.0b013e318134f013; Silver J, 2012, NEPHROL DIAL TRANSPL, V27, P1715, DOI 10.1093/ndt/gfs050; Tomaschitz A, 2012, CARDIOVASC RES, V94, P10, DOI 10.1093/cvr/cvs092; Tunon J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095402; Udell JA, 2014, J AM COLL CARDIOL, V63, P2421, DOI 10.1016/j.jacc.2014.03.026; van HJ, 2014, CLIN CHEM LAB MED; Vidal A, 2006, AM J PHYSIOL-HEART C, V290, pH286, DOI 10.1152/ajpheart.00535.2005; Volpe M, 2013, EUR HEART J; Wang LL, 2014, DIABETES RES CLIN PR, V104, P226, DOI 10.1016/j.diabres.2014.01.031; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wannamethee SG, 2014, CIRC-HEART FAIL, V7, P732, DOI 10.1161/CIRCHEARTFAILURE.114.001272; Wu C, 2012, EUR J HEART FAIL; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yoo SH, 2010, CELL MOL NEUROBIOL, V30, P1155, DOI 10.1007/s10571-010-9564-2; Zittermann A, 2008, EUR J HEART FAIL, V10, P321, DOI 10.1016/j.ejheart.2008.01.013; Zittermann A, 2009, CLIN CHEM, V55, P1163, DOI 10.1373/clinchem.2008.120006	56	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135427	10.1371/journal.pone.0135427	http://dx.doi.org/10.1371/journal.pone.0135427			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308451	Green Submitted, gold, Green Published			2022-12-27	WOS:000360069400062
J	Guo, QQ; Wang, DT; Liu, Z; Li, CY				Guo, Qianqian; Wang, Datao; Liu, Zhen; Li, Chunyi			Effects of p21 Gene Down-Regulation through RNAi on Antler Stem Cells In Vitro	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; DEER ANTLER; GENOMIC INSTABILITY; CYCLE REGULATION; REGENERATION; REPAIR; APOPTOSIS; MODEL; PROLIFERATION; SENESCENCE	Cell cycle is an integral part of cell proliferation, and consists mainly of four phases, G1, S, G2 and M. The p21 protein, a cyclin dependent kinase inhibitor, plays a key role in regulating cell cyclevia G1 phase control. Cells capable of epimorphic regeneration have G2/M accumulation as their distinctive feature, whilst the majority of somatic cells rest at G1 phase. To investigate the role played byp21 in antler regeneration, we studied the cell cycle distribution of antler stem cells (ASCs), via down-regulation of p21 in vitro using RNAi. The results showed that ASCs had high levels of p21 mRNA expression and rested at G1 phase, which was comparable to the control somatic cells. Down-regulation of p21 did not result in ASC cell cycle re-distribution toward G2/M accumulation, but DNA damage and apoptosis of the ASCs significantly increased and the process of cell aging was slowed. These findings suggest that the ASCs may have evolved to use an alternative, p21-independent cell cycle regulation mechanism. Also a unique p21-dependent inhibitory effect may control DNA damage as a protective mechanism to ensure the fast proliferating ASCs do not become dysplastic/cancerous. Understanding of the mechanism underlying the role played by p21 in the ASCs could give insight into a mammalian system where epimorphic regeneration is initiated whilst the genome stability is effectively maintained.	[Guo, Qianqian; Wang, Datao; Liu, Zhen; Li, Chunyi] Chinese Acad Agr Sci, Inst Special Wild Econ Anim & Plants, Changchun, Jilin, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Special Animal & Plant Sciences, CAAS	Li, CY (corresponding author), Chinese Acad Agr Sci, Inst Special Wild Econ Anim & Plants, Changchun, Jilin, Peoples R China.	lichunyi1959@163.com		Guo, Qianqian/0000-0001-7983-3731; , Wang/0000-0002-8372-9133	Chinese National 863 Program [2011AA100603]; Chinese National Science Foundation [31170950]	Chinese National 863 Program(National High Technology Research and Development Program of China); Chinese National Science Foundation(National Natural Science Foundation of China (NSFC))	This work was partially funded by the Chinese National 863 Program (2011AA100603, http://www.863.gov.cn/) and partially funded by the Chinese National Science Foundation (31170950, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Andrighetti-Frohner CR, 2006, MUTAT RES-GEN TOX EN, V603, P97, DOI 10.1016/j.mrgentox.2005.11.001; Arima Y, 2004, GENES CELLS, V9, P131, DOI 10.1111/j.1356-9597.2004.00710.x; Arthur LM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt71; Barnum KJ, 2014, METHODS MOL BIOL, V1170, P29, DOI 10.1007/978-1-4939-0888-2_2; Basu N, 2014, J BIOL CHEM, V289, P581, DOI 10.1074/jbc.M113.511311; Bedelbaeva K, 2010, P NATL ACAD SCI USA, V107, P5845, DOI 10.1073/pnas.1000830107; Bohbot J, 2005, INSECT BIOCHEM MOLEC, V35, P961, DOI 10.1016/j.ibmb.2005.03.010; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123; Chaffey GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083477; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; [褚文辉 CHU Wen-hui], 2009, [中国农业大学学报, Journal of China Agricultural University], V14, P29; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gotz C, 1996, REV PHYSIOL BIOCH P, V127, P65, DOI 10.1007/BFb0048265; Gulappa T, 2013, CANCER LETT, V337, P177, DOI 10.1016/j.canlet.2013.05.014; Haferkamp S, 2009, AGING-US, V1, P542, DOI 10.18632/aging.100051; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Heber-Katz E, 2013, CURR TOP MICROBIOL, V367, P253, DOI 10.1007/82_2012_294; Kaina B, 2003, BIOCHEM PHARMACOL, V66, P1547, DOI 10.1016/S0006-2952(03)00510-0; Kierdorf U, 2007, J MORPHOL, V268, P726, DOI 10.1002/jmor.10546; Li CF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034642, 10.1371/journal.pone.0030026, 10.1371/journal.pone.0047442]; Li CY, 2007, J EXP ZOOL PART A, V307A, P95, DOI 10.1002/jez.a.352; Li CY, 2014, INT J BIOCHEM CELL B, V56, P111, DOI 10.1016/j.biocel.2014.07.007; Li Chunyi, 2013, Front Biosci (Elite Ed), V5, P479; Li CY, 2012, BIRTH DEFECTS RES C, V96, P51, DOI 10.1002/bdrc.21000; Li CY, 2009, CURR STEM CELL RES T, V4, P237, DOI 10.2174/157488809789057446; Liu J, 2015, CANCER LETT, V356, P197, DOI 10.1016/j.canlet.2013.12.025; Martinez LA, 2002, CARCINOGENESIS, V23, P1289, DOI 10.1093/carcin/23.8.1289; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; MICHIELI P, 1994, CANCER RES, V54, P3391; Moseley FL, 2011, J PHARM PHARMACOL, V63, P648, DOI 10.1111/j.2042-7158.2011.01261.x; MURPHY ED, 1979, ARTHRITIS RHEUM, V22, P1188, DOI 10.1002/art.1780221105; Nye HLD, 2003, DEV DYNAM, V226, P280, DOI 10.1002/dvdy.10236; Perucca P, 2009, CELL CYCLE, V8, P105, DOI 10.4161/cc.8.1.7507; SCHMIDT T, 1986, J CELL SCI, V85, P197; Stocum D. L., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P270; Stocum DL, 2011, DEV DYNAM, V240, P943, DOI 10.1002/dvdy.22553; Sun HH, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-649; TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Zhang L, 2012, P NATL ACAD SCI USA, V109, P20937, DOI 10.1073/pnas.1214156110; Zhou ZH, 2013, INT J MED SCI, V10, P1485, DOI 10.7150/ijms.6308	45	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134268	10.1371/journal.pone.0134268	http://dx.doi.org/10.1371/journal.pone.0134268			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308075	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400020
J	Bernstein, AM; Song, MY; Zhang, XH; Pan, A; Wang, ML; Fuchs, CS; Le, N; Chan, AT; Willett, WC; Ogino, S; Giovannucci, EL; Wu, KN				Bernstein, Adam M.; Song, Mingyang; Zhang, Xuehong; Pan, An; Wang, Molin; Fuchs, Charles S.; Le, Ngoan; Chan, Andrew T.; Willett, Walter C.; Ogino, Shuji; Giovannucci, Edward L.; Wu, Kana			Processed and Unprocessed Red Meat and Risk of Colorectal Cancer: Analysis by Tumor Location and Modification by Time	PLOS ONE			English	Article							LIFE-STYLE; COLON-CANCER; PROXIMAL COLON; DISTAL COLON; CONSUMPTION; DIETARY; ASSOCIATIONS; METAANALYSIS; MUTATIONS; WOMEN	Although the association between red meat consumption and colorectal cancer (CRC) is well established, the association across subsites of the colon and rectum remains uncertain, as does time of consumption in relation to cancer development. As these relationships are key for understanding the pathogenesis of CRC, they were examined in two large cohorts with repeated dietary measures over time, the Nurses' Health Study (n = 87,108 women, 1980-2010) and Health Professionals Follow-up Study (n = 47,389 men, 1986-2010). Cox proportional hazards regression models generated hazard ratios (HRs) and 95% confidence intervals (CIs), which were pooled by random-effects meta-analysis. In combined cohorts, there were 2,731 CRC cases (1,151 proximal colon, 816 distal colon, and 589 rectum). In pooled analyses, processed red meat was positively associated with CRC risk (per 1 serving/day increase: HR = 1.15, 95% CI: 1.01-1.32; P for trend 0.03) and particularly with distal colon cancer (per 1 serving/day increase; HR = 1.36; 95% CI: 1.09-1.69; P for trend 0.006). Recent consumption of processed meat (within the past 4 years) was not associated with distal cancer. Unprocessed red meat was inversely associated with risk of distal colon cancer and a weak non-significant positive association between unprocessed red meat and proximal cancer was observed (per 1 serving/day increase: distal HR = 0.75; 95% CI: 0.68-0.82; P for trend <0.001; proximal HR = 1.14, 95% CI: 0.92-1.40; P for trend 0.22). Thus, in these two large cohorts of US health professionals, processed meat intake was positively associated with risk of CRC, particularly distal cancer, with little evidence that higher intake of unprocessed red meat substantially increased risk of CRC. Future studies, particularly those with sufficient sample size to assess associations by subsites across the colon are needed to confirm these findings and elucidate potentially distinct mechanisms underlying the relationship between processed meat and subtypes of unprocessed red meat with CRC.	[Bernstein, Adam M.] Rally Hlth, San Francisco, CA USA; [Song, Mingyang; Zhang, Xuehong; Le, Ngoan; Willett, Walter C.; Giovannucci, Edward L.; Wu, Kana] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Song, Mingyang; Willett, Walter C.; Ogino, Shuji; Giovannucci, Edward L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Pan, An] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan, Hubei, Peoples R China; [Wang, Molin] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Fuchs, Charles S.; Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Fuchs, Charles S.; Chan, Andrew T.; Willett, Walter C.; Ogino, Shuji; Giovannucci, Edward L.] Harvard Univ, Sch Med, Boston, MA USA; [Le, Ngoan] Hanoi Med Univ, Hanoi, Vietnam; [Chan, Andrew T.; Willett, Walter C.; Giovannucci, Edward L.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Huazhong University of Science & Technology; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Hanoi Medical University; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Wu, KN (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	kana.wu@channing.harvard.edu	Pan, An/C-5572-2011; Song, Mingyang/M-6701-2013	Pan, An/0000-0002-1089-7945; Song, Mingyang/0000-0002-1324-0316; Le, Ngoan Tran/0000-0001-7862-492X; Ogino, Shuji/0000-0002-3909-2323	Entertainment Industry Foundation's National Colorectal Cancer Research Alliance (NCCRA); UICC American Cancer Society Beginning Investigator Fellowship - American Cancer Society;  [UM1 CA167552];  [P01 CA 55075];  [P01 CA055075];  [UM1 CA186107];  [P01 CA87969]; NATIONAL CANCER INSTITUTE [P01CA087969, UM1CA167552, P01CA055075, UM1CA186107] Funding Source: NIH RePORTER	Entertainment Industry Foundation's National Colorectal Cancer Research Alliance (NCCRA); UICC American Cancer Society Beginning Investigator Fellowship - American Cancer Society; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the following federal grants: P01 CA87969, UM1 CA167552, P01 CA 55075, P01 CA055075, UM1 CA167552, UM1 CA186107, and P01 CA87969. In addition, funding came from the Entertainment Industry Foundation's National Colorectal Cancer Research Alliance (NCCRA). This work was also supported by a UICC American Cancer Society Beginning Investigator Fellowship (Dr. Ngoan Le), funded by the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TW, 1984, INTRO MULTIVARIATE S; Bastide NM, 2011, CANCER PREV RES, V4, P177, DOI 10.1158/1940-6207.CAPR-10-0113; Bingham SA, 1999, P NUTR SOC, V58, P243, DOI 10.1017/S0029665199000336; Carr PR, 2016, INT J CANCER, V138, P293, DOI 10.1002/ijc.29423; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; Chao A, 2005, JAMA-J AM MED ASSOC, V293, P172, DOI 10.1001/jama.293.2.172; Cross AJ, 2004, ENVIRON MOL MUTAGEN, V44, P44, DOI 10.1002/em.20030; Cross AJ, 2003, CANCER RES, V63, P2358; Cross AJ, 2010, CANCER RES, V70, P2406, DOI 10.1158/0008-5472.CAN-09-3929; DellaValle CT, 2014, INT J CANCER, V134, P2917, DOI 10.1002/ijc.28612; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Gay LJ, 2012, J PATHOL, V228, P405, DOI 10.1002/path.4085; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; Hughes LAE, 2010, INT J EPIDEMIOL, V39, P1333, DOI 10.1093/ije/dyq062; Hughes LAE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007951; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Knekt P, 1999, INT J CANCER, V80, P852, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;852::AID-IJC9&gt;3.0.CO;2-S; Larsson SC, 2005, INT J CANCER, V113, P829, DOI 10.1002/ijc.20658; Larsson SC, 2006, INT J CANCER, V119, P2657, DOI 10.1002/ijc.22170; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Miller PE, 2013, NUTR CANCER, V65, P202, DOI 10.1080/01635581.2013.756534; Norat T, 2005, J NATL CANCER I, V97, P906, DOI 10.1093/jnci/dji164; Norat T, 2002, INT J CANCER, V98, P241, DOI 10.1002/ijc.10126; Norat T, 2001, NUTR REV, V59, P37, DOI 10.1111/j.1753-4887.2001.tb06974.x; Ollberding NJ, 2012, INT J CANCER, V131, pE1125, DOI 10.1002/ijc.27546; Park JY, 2010, MUTAGENESIS, V25, P351, DOI 10.1093/mutage/geq012; Parr CL, 2013, INT J CANCER, V133, P1153, DOI 10.1002/ijc.28101; PUCKETT CD, 1986, ED ANNOTATION ICD 9; Ruder EH, 2011, AM J CLIN NUTR, V94, P1607, DOI 10.3945/ajcn.111.020701; Sandhu MS, 2001, CANCER EPIDEM BIOMAR, V10, P439; Santarelli RL, 2008, NUTR CANCER, V60, P131, DOI 10.1080/01635580701684872; Sato Y, 2006, EUR J CANCER PREV, V15, P211, DOI 10.1097/01.cej.0000197455.87356.05; Slattery ML, 2009, DIS COLON RECTUM, V52, P1304, DOI 10.1007/DCR.0b013e3181a0e5df; Slattery ML, 2002, CANCER EPIDEM BIOMAR, V11, P541; Slattery ML, 2000, CANCER RES, V60, P6935; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Svensson E, 2005, CANCER CAUSE CONTROL, V16, P215, DOI 10.1007/s10552-004-3073-x; U. S. Department of Agriculture, 1992, COMP FOODS RAW PROC; Wei EK, 2004, INT J CANCER, V108, P433, DOI 10.1002/ijc.11540; Wei EK, 2009, AM J EPIDEMIOL, V170, P863, DOI 10.1093/aje/kwp210; Willett W., 2012, NUTR EPIDEMIOLOGY; WILLETT WC, 1990, NEW ENGL J MED, V323, P1664, DOI 10.1056/NEJM199012133232404; WILLETT WC, 1988, AM J EPIDEMIOL, V127, P188, DOI 10.1093/oxfordjournals.aje.a114780; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Williams CD, 2010, NUTR CANCER, V62, P701, DOI 10.1080/01635581003605938; World Cancer Research Fund/ American Institute for Cancer Research, 2011, CONTINUOUS UPDATE PR; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Zhang XH, 2015, CANCER EPIDEM BIOMAR, V24, P690, DOI 10.1158/1055-9965.EPI-14-0909-T	54	86	89	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135959	10.1371/journal.pone.0135959	http://dx.doi.org/10.1371/journal.pone.0135959			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305323	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500039
J	Lord, JD; Shows, DM; Chen, J; Thirlby, RC				Lord, James D.; Shows, Donna M.; Chen, Janice; Thirlby, Richard C.			Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease	PLOS ONE			English	Article							HUMAN TH17 CELLS; FUNCTIONAL-CHARACTERIZATION; INTESTINAL INFLAMMATION; MEDIATED SUPPRESSION; ULCERATIVE-COLITIS; FOXP3; EFFECTOR; ENTEROPATHY; RESISTANCE; INDUCTION	Background FOXP3(+) regulatory T cells (Tregs) are critical for preventing intestinal inflammation. However, FOXP3(+) T cells are paradoxically increased in the intestines of patients with the inflammatory bowel disease (IBD) ulcerative colitis (UC) or Crohn's disease (CD). We determined whether these FOXP3(+) cells in IBD patients share or lack the phenotype of such cells from patients without IBD. Methods We quantified and characterized FOXP3(+) Treg populations, as well as FOXP3(-) CD4(+) T cells, in the lamina propria lymphocytes (LPL) of intestine surgically resected from patients with and without IBD, and in the blood of controls or Crohn's patients with or without disease activity. Results In all samples, a similar fraction of FOXP3(+) cells expressed the "natural" Treg (nTreg) marker Helios, suggesting that, in IBD, these cells are not entirely "induced" Tregs (iTregs) derived from activated effector T cells. Helios(+) and Helios(-) FOXP3(+) T cells demonstrated similar expression of maturation markers, activation markers, and inhibitory molecules between IBD patients and controls, while FOXP3-cells paradoxically expressed more of the inhibitory receptors CD39, CTLA4, and PD-1 in inflamed mucosa. Greater expression of activation markers was also seen in both Helios(+) and Helios(-) Tregs, relative to FOXP3cells, in both IBD patients and controls, indicating that Tregs are effectively activated by antigen in IBD. Conclusions Extensive immunophenotyping revealed that Helios(+) and Helios(-) mucosal Tregs exist at a similar frequency, and have a similar expression of inhibitory molecules and activation markers in patients with IBD as in healthy controls.	[Lord, James D.; Shows, Donna M.; Chen, Janice] Virginia Mason, Benaroya Res Inst, Translat Res Program, Seattle, WA 98101 USA; [Thirlby, Richard C.] Virginia Mason Med Ctr, Dept Surg, Seattle, WA 98101 USA	Benaroya Research Institute; Virginia Mason Medical Center; Virginia Mason Medical Center	Lord, JD (corresponding author), Virginia Mason, Benaroya Res Inst, Translat Res Program, Seattle, WA 98101 USA.	jlord@benaroyaresearch.org			National Institutes of Health/ The National Institute of Diabetes and Digestive and Kidney Disease [K08 DK081659]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK081659] Funding Source: NIH RePORTER	National Institutes of Health/ The National Institute of Diabetes and Digestive and Kidney Disease; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health/ The National Institute of Diabetes and Digestive and Kidney Disease: [K08 DK081659].	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Beavis PA, 2011, P NATL ACAD SCI USA, V108, P16717, DOI 10.1073/pnas.1112722108; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; BULL DM, 1977, J CLIN INVEST, V59, P966, DOI 10.1172/JCI108719; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Fantini MC, 2009, GASTROENTEROLOGY, V136, P1308, DOI 10.1053/j.gastro.2008.12.053; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Kitazawa Y, 2007, TRANSPLANTATION, V83, P774, DOI 10.1097/01.tp.0000256293.90270.e8; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Levin SD, 2011, EUR J IMMUNOL, V41, P902, DOI 10.1002/eji.201041136; Lord J, 2015, INFLAMM BOWEL DIS, V21, P19, DOI 10.1097/MIB.0000000000000242; Lord JD, 2013, J GASTROINTEST LIVER, V22, P87; Lord JD, 2012, DIGEST DIS SCI, V57, P2846, DOI 10.1007/s10620-012-2292-3; Makita S, 2004, J IMMUNOL, V173, P3119, DOI 10.4049/jimmunol.173.5.3119; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Ramsdell F, 2003, IMMUNITY, V19, P165, DOI 10.1016/S1074-7613(03)00207-3; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Saruta M, 2007, CLIN IMMUNOL, V125, P281, DOI 10.1016/j.clim.2007.08.003; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yadav M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00232; Yu QT, 2007, INFLAMM BOWEL DIS, V13, P191, DOI 10.1002/ibd.20053	30	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136485	10.1371/journal.pone.0136485	http://dx.doi.org/10.1371/journal.pone.0136485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305224	Green Submitted, Green Published, gold			2022-12-27	WOS:000359995500083
J	Ruan, D; Yu, XB; Shrestha, S; Wang, L; Chen, G				Ruan, Di; Yu, Xiao-Bo; Shrestha, Sudeep; Wang, Lin; Chen, Gao			The Role of Hemosiderin Excision in Seizure Outcome in Cerebral Cavernous Malformation Surgery: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CENTRAL-NERVOUS-SYSTEM; VASCULAR MALFORMATIONS; EPILEPTIC SEIZURES; RESECTION; PREDICTORS; HEMANGIOMAS; MANAGEMENT; NEURONS; RESPECT; FREEDOM	Background and Purpose Whether the excision of hemosiderin surrounding cerebral cavernous malformations (CCMs) is necessary to achieve a seizure-free result has been the subject of debate. Here, we report a systematic review of related literature up to Jan 1, 2015 including 594 patients to assess the effect of hemosiderin excision on seizure outcome in patients with CCMs by meta-analysis. Methods Ten studies comparing extended hemosiderin excision with only lesion resection were identified by searching the English-language literature. Meta-analyses, subgroup analyses and sensitivity analysis were conducted to determine the association between hemosiderin excision and seizure outcome after surgery. Results Seizure outcome was significantly improved in the patients who underwent an extended excision of the surrounding hemosiderin (OR, 0.62; 95% CI: 0.42-0.91; P = 0.01). In subgroup analysis, studies from Asia (OR, 0.42; 95% CI: 0.25-0.71; P = 0.001), male-majority (female ratio < 50%) studies (OR, 0.56; 95% CI: 0.33-0.96; P = 0.04), low occurrence rate of multiple CCMs (OR, 0.37; 95% CI: 0.20-0.71; P = 0.003), cohort studies (OR, 0.44; 95% CI: 0.28-0.68; P = 0.78), longer duration of seizure symptoms (> 1 year) before surgery (OR, 0.43; 95% CI: 0.22-0.84; P = 0.01), lesion diameter > 2 cm (OR, 0.41; 95% CI: 0.19-0.87; P = 0.02) and short-term (< 3 years) follow-up (OR, 0.48; 95% CI: 0.29-0.80; P = 0.005) tended to correlate with a significantly favorable outcome. Conclusion Patients who underwent extended surrounding hemosiderin excision could exhibit significantly improved seizure outcomes compared to patients without hemosiderin excision. However, further well-designed prospective multiple-center RCT studies are still needed.	[Ruan, Di; Yu, Xiao-Bo; Shrestha, Sudeep; Wang, Lin; Chen, Gao] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Chen, G (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China.	d.chengao@163.com	wang, lili/HDL-7210-2022; wang, lin/HHM-2225-2022; wang, lin/GSE-3040-2022					AWAD IA, 1993, NEUROSURGERY, V33, P179, DOI 10.1227/00006123-199308000-00001; Baumann CR, 2007, EPILEPSIA, V48, P559, DOI 10.1111/j.1528-1167.2006.00941.x; Baumann CR, 2006, EPILEPSIA, V47, P563, DOI 10.1111/j.1528-1167.2006.00468.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bertalanffy H, 2002, NEUROSURG REV, V25, P1, DOI 10.1007/s101430100179; Cappabianca P, 1997, CLIN NEUROL NEUROSUR, V99, P179, DOI 10.1016/S0303-8467(97)00023-1; Cascino GD, 2008, EPILEPSIA, V49, P79, DOI 10.1111/j.1528-1167.2008.01930.x; Chang EF, 2009, NEUROSURGERY, V65, P31, DOI 10.1227/01.NEU.0000346648.03272.07; Cramer JA, 2010, EXPERT REV NEUROTHER, V10, P885, DOI 10.1586/ERN.10.71; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Englot DJ, 2014, NEUROSURG REV, V37, P389, DOI 10.1007/s10143-014-0527-9; Englot DJ, 2011, J NEUROSURG, V115, P1169, DOI 10.3171/2011.7.JNS11536; Hammen T, 2007, SEIZURE-EUR J EPILEP, V16, P248, DOI 10.1016/j.seizure.2007.01.001; Huang C, 2013, PAK J MED SCI, V29, P1116; Jin YC, 2014, CLIN NEUROL NEUROSUR, V119, P59, DOI 10.1016/j.clineuro.2014.01.013; Kim W, 2011, J CLIN NEUROSCI, V18, P877, DOI 10.1016/j.jocn.2010.12.008; Kondziolka Douglas, 1995, Journal of Neurosurgery, V83, P822; KRAEMER DL, 1994, EPILEPSIA, V35, pS30, DOI 10.1111/j.1528-1157.1994.tb05987.x; Kwon CS, 2013, CLIN NEUROL NEUROSUR, V115, P2377, DOI 10.1016/j.clineuro.2013.08.024; Mehdorn HM, 1998, NEUROL MED-CHIR, V38, P245, DOI 10.2176/nmc.38.suppl_245; Moran NF, 1999, J NEUROL NEUROSUR PS, V66, P561, DOI 10.1136/jnnp.66.5.561; Noto S, 2005, SURG NEUROL, V64, P495, DOI 10.1016/j.surneu.2005.03.045; Stavrou I, 2008, NEUROSURGERY, V63, P888, DOI 10.1227/01.NEU.0000327881.72964.6E; Stefan H, 2004, NERVENARZT, V75, P755, DOI 10.1007/s00115-004-1697-4; Tymianski M, 1996, NEUROSURGERY, V38, P1176; Van Gompel JJ, 2010, NEUROSURG FOCUS, V29; VOLTERRA A, 1994, J NEUROSCI, V14, P2924; von der Brelie C, 2013, EPILEPSIA, V54, P1699, DOI 10.1111/epi.12327; vonEssen C, 1996, J NEUROCHEM, V67, P260; Wang XY, 2013, NEUROL INDIA, V61, P288, DOI 10.4103/0028-3886.115070; Washington CW, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.5.FOCUS10149; Wells G.A., NEWCASTLE OTTAWA SCA; Wieser HG, 2001, EPILEPSIA, V42, P282, DOI 10.1046/j.1528-1157.2001.4220282.x; Williamson A, 2003, EPILEPSIA, V44, P1413, DOI 10.1046/j.1528-1157.2003.23603.x; Yeon JY, 2009, SEIZURE-EUR J EPILEP, V18, P14, DOI 10.1016/j.seizure.2008.05.010; Zevgaridis D, 1996, ACTA NEUROCHIR, V138, P672, DOI 10.1007/BF01411470	36	25	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136619	10.1371/journal.pone.0136619	http://dx.doi.org/10.1371/journal.pone.0136619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305879	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500099
J	Caro-Vega, Y; del Rio, C; Lima, VD; Lopez-Cervantes, M; Crabtree-Ramirez, B; Bautista-Arredondo, S; Colchero, MA; Sierra-Madero, J				Caro-Vega, Yanink; del Rio, Carlos; Lima, Viviane Dias; Lopez-Cervantes, Malaquias; Crabtree-Ramirez, Brenda; Bautista-Arredondo, Sergio; Colchero, M. Arantxa; Sierra-Madero, Juan			Estimating the Impact of Earlier ART Initiation and Increased Testing Coverage on HIV Transmission among Men Who Have Sex with Men in Mexico using a Mathematical Model	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; PREVENTION; ACCESS; HAART; PREVALENCE; VIRUS	Objective To estimate the impact of late ART initiation on HIV transmission among men who have sex with men (MSM) in Mexico. Methods An HIV transmission model was built to estimate the number of infections transmitted by HIV-infected men who have sex with men (MSM-HIV+) MSM-HIV+ in the short and long term. Sexual risk behavior data were estimated from a nationwide study of MSM. CD4(+) counts at ART initiation from a representative national cohort were used to estimate time since infection. Number of MSM-HIV+ on treatment and suppressed were estimated from surveillance and government reports. Status quo scenario (SQ), and scenarios of early ART initiation and increased HIV testing were modeled. Results We estimated 14239 new HIV infections per year from MSM-HIV+ in Mexico. In SQ, MSM take an average 7.4 years since infection to initiate treatment with a median CD4(+) count of 148 cells/mm(3)(25th-75th percentiles 52-266). In SQ, 68% of MSM-HIV+ are not aware of their HIV status and transmit 78% of new infections. Increasing the CD4(+) count at ART initiation to 350 cells/mm(3) shortened the time since infection to 2.8 years. Increasing HIV testing to cover 80% of undiagnosed MSM resulted in a reduction of 70% in new infections in 20 years. Initiating ART at 500 cells/mm(3) and increasing HIV testing the reduction would be of 75% in 20 years. Conclusion A substantial number of new HIV infections in Mexico are transmitted by undiagnosed and untreated MSM-HIV+. An aggressive increase in HIV testing coverage and initiating ART at a CD4 count of 500 scells/mm(3) in this population would significantly benefit individuals and decrease the number of new HIV infections in Mexico.	[Caro-Vega, Yanink; Lopez-Cervantes, Malaquias] Univ Nacl Autonoma Mexico, Fac Med, Mexico City 04510, DF, Mexico; [Caro-Vega, Yanink; Crabtree-Ramirez, Brenda; Sierra-Madero, Juan] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Mexico City, DF, Mexico; [del Rio, Carlos] Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA USA; [del Rio, Carlos] Emory Ctr AIDS Res, Atlanta, GA USA; [Lima, Viviane Dias] Univ British Columbia, Div Aids, Dept Med, Fac Med, Vancouver, BC, Canada; [Bautista-Arredondo, Sergio; Colchero, M. Arantxa] Natl Inst Publ Hlth, Div Hlth Econ & Hlth Syst Innovat, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Emory University; Rollins School Public Health; Emory University; University of British Columbia; Instituto Nacional de Salud Publica	Sierra-Madero, J (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Mexico City, DF, Mexico.	jsmadero@yahoo.com	Sierra Madero, Juan/AAW-8825-2021; Bautista-Arredondo, Sergio/N-7305-2016; del Rio, Carlos/B-3763-2012	Bautista-Arredondo, Sergio/0000-0001-8910-3011; del Rio, Carlos/0000-0002-0153-3517; Crabtree-Ramirez, Brenda/0000-0002-2587-1123	National Council on Science and Technology (CONACyT) of Mexico; NIH/FIC (AIDS International Training and Research Program of Emory University) [D43 TW01042]; Emory Center for AIDS Research [NIH/NIAID P30 AI050409]; US National Institute on Drug Abuse [R03DA033851]; Canadian Institutes of Health Research [MOP-125948]; Michael Institute for Health Research; Canadian Institutes of Health Research; Glaxosmithkline; GSK/ViiV; Stendhal; Janssen; MSD; Pfizer; BMS; GSK; Gilead; FOGARTY INTERNATIONAL CENTER [D43TW001042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, U01AI069923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA033851] Funding Source: NIH RePORTER	National Council on Science and Technology (CONACyT) of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NIH/FIC (AIDS International Training and Research Program of Emory University); Emory Center for AIDS Research; US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Institute for Health Research; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Glaxosmithkline(GlaxoSmithKline); GSK/ViiV; Stendhal; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); MSD; Pfizer(Pfizer); BMS(Bristol-Myers Squibb); GSK(GlaxoSmithKline); Gilead(Gilead Sciences); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	YCV has been funded by a scholarship from the National Council on Science and Technology (CONACyT) of Mexico and the NIH/FIC (AIDS International Training and Research Program of Emory University; Grant No. D43 TW01042). CDR has received support from the Emory Center for AIDS Research (NIH/NIAID P30 AI050409). VDL is funded by a grant from the US National Institute on Drug Abuse (R03DA033851), by a grant from the Canadian Institutes of Health Research (MOP-125948) and by a Scholar Award from the Michael Institute for Health Research and a New Investigator award from the Canadian Institutes of Health Research. VDL has received limited unrestricted funding, paid to her institution, from Glaxosmithkline. JSM has received speaker and consulting fees from GSK/ViiV, Stendhal, Janssen, and MSD. Research support from Pfizer, BMS, MSD, GSK, Gilead. BCR is speaker for BMS and Stendhal. All others have no funding or other conflicts of interest to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andronis L, 2009, SENSITIVITY ANAL EC, V13; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bautista-Arredondo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072616; Carrizosa CM, 2010, AIDS PATIENT CARE ST, V24, P333, DOI 10.1089/apc.2009.0138; CENSIDA, 2011, B GRUP INF SECT VIH; CENSIDA, 2012, SEC SAL EI VIH SIDA; CENSIDA, 2012, INF NAC AV LUCH CONT; CENSIDA, 2011, B SALVAR; CENSIDA, 2013, VIG EP CAS VIH SIDA; Centers for Disease Control and Prevention, 1994, ZID PREV HIV TRANSM; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cori A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084511; Crabtree-Ramirez B, 2012, SALUD PUBLICA MEXICO, V54, P506, DOI 10.1590/S0036-36342012000500007; Crabtree-Ramirez B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020272; Crabtree-Ramirez B, 2010, AIDS RES HUM RETROV, V26, P373, DOI 10.1089/aid.2009.0077; Cuadra-Hernandez SM, 2012, SALUD COLECT, V8, P191, DOI 10.1590/S1851-82652012000200007; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Eyawo O, 2013, CAN J PUBLIC HEALTH, V104, pE418, DOI 10.17269/c; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Granich R, 2010, CURR OPIN HIV AIDS, V5, P298, DOI 10.1097/COH.0b013e32833a6c32; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Huang X, 1999, J ACQ IMMUN DEF SYND, V62, P441; Infante C, 2006, SALUD PUBLICA MEXICO, V48, P141, DOI 10.1590/S0036-36342006000200007; Infante C, 2009, CULT HEALTH SEX, V11, P125, DOI 10.1080/13691050802431314; Jia ZW, 2013, LANCET, V382, P1195, DOI 10.1016/S0140-6736(12)61898-4; Johnson LF, 2012, J R SOC INTERFACE, V9, P1544, DOI 10.1098/rsif.2011.0826; Johnston KM, 2010, AIDS, V24, P1929, DOI 10.1097/QAD.0b013e32833af85d; Kahn JG, 2011, CURR HIV RES, V9, P405, DOI 10.2174/157016211798038542; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Ma ZM, 2009, J VIROL, V83, P3288, DOI 10.1128/JVI.02423-08; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Gutierrez JP, 2012, TROP MED INT HEALTH, V17, P353, DOI 10.1111/j.1365-3156.2011.02934.x; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Sanchez R, 2013, REALIZARAN PRIMER DI; UNAIDS, 2011, EP FACT SHEET HIV AI; UNAIDS, 2000, WOM HIV AIDS	38	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136534	10.1371/journal.pone.0136534	http://dx.doi.org/10.1371/journal.pone.0136534			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5VA	26302044	Green Submitted, Green Published, gold			2022-12-27	WOS:000359951900073
J	Guillou, C; Derambure, C; Freret, M; Verdet, M; Avenel, G; Golinski, ML; Sabourin, JC; Le Loarer, F; Adriouch, S; Boyer, O; Lequerre, T; Vittecoq, O				Guillou, Clement; Derambure, Celine; Freret, Manuel; Verdet, Mathieu; Avenel, Gilles; Golinski, Marie-Laure; Sabourin, Jean-Christophe; Le Loarer, Francois; Adriouch, Sahil; Boyer, Olivier; Lequerre, Thierry; Vittecoq, Olivier			Prophylactic Injection of Recombinant Alpha-Enolase Reduces Arthritis Severity in the Collagen-Induced Arthritis Mice Model	PLOS ONE			English	Article							STRESS-PROTEIN BIP; RHEUMATOID-ARTHRITIS; II COLLAGEN; PEPTIDE P140; DOUBLE-BLIND; ANTIBODIES; CELL; AUTOANTIBODIES; IMMUNOTHERAPY; AUTOIMMUNITY	Objective To evaluate the ability of the glycolytic enzyme alpha-enolase (ENO1) or its immunodominant peptide (pEP1) to reduce the severity of CIA in DBA/1 mice when injected in a prophylactic way. Methods Mice were treated with mouse ENO1 or pEP1 one day prior to collagen II immunization. Clinical assessment was evaluated using 4 parameters (global and articular scores, ankle thickness and weight). Titers of serum anti-ENO1, anti-cyclic citrullinated peptides (anti-CCP) and anti-CII (total IgG and IgG1/IgG2a isotypes) antibodies were measured by ELISA at different time-points. Disease activity was assessed by histological analysis of both anterior and hind paws at the end of experimentation. Results Prophylactic injection of 100 mu g of ENO1 reduced severity of CIA. Serum levels of anti-CII antibodies were reduced in ENO1-treated mice. Concordantly, ENO1-treated mice joints presented less severe histological signs of arthritis. ENO1 did not induce a shift toward a Th2 response since IgG1/IgG2a ratio of anti-CII antibodies remained unchanged and IL-4 serum levels were similar to those measured in the control group. Conclusions Pre-immunization with ENO1 or its immunodominant peptide pEP1 reduces CIA severity at the clinical, immunological and histological levels. Effects of pEP1 were less pronounced. This immunomodulatory effect is associated a reduction in anti-CII antibodies production but is not due to a Th1/Th2 shift.	[Guillou, Clement; Derambure, Celine; Freret, Manuel; Golinski, Marie-Laure; Adriouch, Sahil; Boyer, Olivier; Lequerre, Thierry; Vittecoq, Olivier] INSERM, U905, Rouen, France; [Guillou, Clement; Derambure, Celine; Freret, Manuel; Golinski, Marie-Laure; Sabourin, Jean-Christophe; Adriouch, Sahil; Boyer, Olivier; Lequerre, Thierry; Vittecoq, Olivier] Normandy Univ, IRIB, Rouen, France; [Verdet, Mathieu; Avenel, Gilles; Lequerre, Thierry; Vittecoq, Olivier] Rouen Univ Hosp, Dept Rheumatol, Rouen, France; [Sabourin, Jean-Christophe; Le Loarer, Francois] Rouen Univ Hosp, Dept Pathol, Rouen, France; [Boyer, Olivier] Rouen Univ Hosp, Dept Immunol, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; CHU de Rouen; CHU de Rouen	Vittecoq, O (corresponding author), INSERM, U905, Rouen, France.	olivier.vittecoq@chu-rouen.fr	Boyer, Olivier/N-6552-2013; ADRIOUCH, Sahil/G-8999-2012	Boyer, Olivier/0000-0002-7591-307X; ADRIOUCH, Sahil/0000-0002-0265-7773; Derambure, celine/0000-0002-6722-5955	Region Haute-Normandie; Inserm; French Society of Rheumatology	Region Haute-Normandie(Region Normandie); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Society of Rheumatology	Clement GUILLOU is recipient of a doctoral fellowship from Region Haute-Normandie. This study has been funded by Inserm and a grant from the French Society of Rheumatology.	Arend WP, 2012, NAT REV RHEUMATOL, V8, P573, DOI 10.1038/nrrheum.2012.134; Berthelot JM, 2010, JOINT BONE SPINE, V77, P537, DOI 10.1016/j.jbspin.2010.04.015; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Blass S, 2001, ARTHRITIS RHEUM, V44, P761; Bowes J, 2008, RHEUMATOLOGY, V47, P399, DOI 10.1093/rheumatology/ken005; Brink M, 2013, ARTHRITIS RHEUM-US, V65, P899, DOI 10.1002/art.37835; Brownlie RJ, 2006, ARTHRITIS RHEUM-US, V54, P854, DOI 10.1002/art.21654; Cantaert T, 2013, ARTHRITIS RHEUM-US, V65, P939, DOI 10.1002/art.37839; Chen LJ, 2012, PHARMACEUTICALS, V5, P339, DOI 10.3390/ph5040339; Cho YG, 2007, AUTOIMMUN REV, V7, P65, DOI 10.1016/j.autrev.2007.08.001; Corrigall VM, 2001, J IMMUNOL, V166, P1492, DOI 10.4049/jimmunol.166.3.1492; Diaz-Ramos A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/156795; Farooq SM, 2014, J CELL MOL MED, V18, P2512, DOI 10.1111/jcmm.12376; Farooq SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048635; Fischer JAA, 2015, ARTHRITIS RHEUMATOL, V67, P51, DOI 10.1002/art.38896; Goeb V, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2644; Haag S, 2012, ARTHRITIS RHEUM-US, V64, P1689, DOI 10.1002/art.34379; Hill JA, 2008, J EXP MED, V205, P967, DOI 10.1084/jem.20072051; Hoovestol RA, 2011, CURR RHEUMATOL REP, V13, P431, DOI 10.1007/s11926-011-0203-9; Kim SJ, 2014, J IMMUNOL, V193, P3902, DOI 10.4049/jimmunol.1302998; Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845; Kinloch AJ, 2011, ARTHRITIS RHEUM-US, V63, P3818, DOI 10.1002/art.30639; Koffeman EC, 2009, ARTHRITIS RHEUM-US, V60, P3207, DOI 10.1002/art.24916; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Larsson E, 2004, RHEUMATOLOGY, V43, P428, DOI 10.1093/rheumatology/keh073; Li Qing-cui, 2014, Yaoxue Xuebao, V49, P322; Liblau R, 1997, IMMUNOL TODAY, V18, P599, DOI 10.1016/S0167-5699(97)01171-7; Lundberg K, 2008, ARTHRITIS RHEUM-US, V58, P3009, DOI 10.1002/art.23936; Maccioni M, 2002, J EXP MED, V195, P1071, DOI 10.1084/jem.20011941; Monneaux F, 2003, EUR J IMMUNOL, V33, P287, DOI 10.1002/immu.200310002; Muller S, 2008, ARTHRITIS RHEUM-US, V58, P3873, DOI 10.1002/art.24027; Nandakumar KS, 2003, EUR J IMMUNOL, V33, P2269, DOI 10.1002/eji.200323810; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Page N, 2011, ANN RHEUM DIS, V70, P837, DOI 10.1136/ard.2010.139832; Page N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005273; Saulot V, 2002, ARTHRITIS RHEUM, V46, P1196, DOI 10.1002/art.10252; Schubert D, 2004, J IMMUNOL, V172, P4503, DOI 10.4049/jimmunol.172.7.4503; Shoda H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3520; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Thiruppathi M, 2014, J AUTOIMMUN, V52, P64, DOI 10.1016/j.jaut.2013.12.014; van de Stadt LA, 2011, ARTHRITIS RHEUM-US, V63, P3226, DOI 10.1002/art.30537; Wegner N, 2009, INT J BIOCHEM CELL B, V41, P390, DOI 10.1016/j.biocel.2008.09.012; Wherrett DK, 2011, LANCET, V378, P319, DOI 10.1016/S0140-6736(11)60895-7; Willemze A, 2012, ANN RHEUM DIS, V71, P268, DOI 10.1136/annrheumdis-2011-200421; Yoshinari O, 2013, J MED FOOD, V16, P1039, DOI 10.1089/jmf.2013.2911	45	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136359	10.1371/journal.pone.0136359	http://dx.doi.org/10.1371/journal.pone.0136359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302382	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900064
J	Han, SK; Kim, I; Hwang, J; Kim, S				Han, Seong Kyu; Kim, Inhae; Hwang, Jihye; Kim, Sanguk			Network Modules of the Cross-Species Genotype-Phenotype Map Reflect the Clinical Severity of Human Diseases	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORK; MOLECULAR INTERACTION DATABASE; GENETIC-DISEASES; MODEL ORGANISMS; REVEALS; MICE; COMORBIDITY; DISCOVERY; RESOURCE; BIOLOGY	Recent advances in genome sequencing techniques have improved our understanding of the genotype-phenotype relationship between genetic variants and human diseases. However, genetic variations uncovered from patient populations do not provide enough information to understand the mechanisms underlying the progression and clinical severity of human diseases. Moreover, building a high-resolution genotype-phenotype map is difficult due to the diverse genetic backgrounds of the human population. We built a cross-species genotype-phenotype map to explain the clinical severity of human genetic diseases. We developed a data-integrative framework to investigate network modules composed of human diseases mapped with gene essentiality measured from a model organism. Essential and nonessential genes connect diseases of different types which form clusters in the human disease network. In a large patient population study, we found that disease classes enriched with essential genes tended to show a higher mortality rate than disease classes enriched with nonessential genes. Moreover, high disease mortality rates are explained by the multiple comorbid relationships and the high pleiotropy of disease genes found in the essential gene-enriched diseases. Our results reveal that the genotype-phenotype map of a model organism can facilitate the identification of human disease-gene associations and predict human disease progression.	[Han, Seong Kyu; Kim, Inhae; Kim, Sanguk] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; [Hwang, Jihye] Pohang Univ Sci & Technol, Dept IT Convergence & Engn, Pohang 790784, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Kim, S (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea.	sukim@postech.ac.kr		Kim, Sanguk/0000-0002-3449-3814	Korean National Research Foundation [2015004921]; Korea Institute of Oriental Medicine [K15809]; Korea Institute of Marine Science Technology [D11510215H480000140]	Korean National Research Foundation(National Research Foundation of Korea); Korea Institute of Oriental Medicine; Korea Institute of Marine Science Technology	This work was supported in part by Korean National Research Foundation grant (2015004921), Korea Institute of Oriental Medicine grant (K15809) and Korea Institute of Marine Science & Technology grant (D11510215H480000140).	Aitman TJ, 2011, NAT REV GENET, V12, P575, DOI 10.1038/nrg3047; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Beckers J, 2009, NAT REV GENET, V10, P371, DOI 10.1038/nrg2578; Bromberg KD, 2008, SCIENCE, V320, P903, DOI 10.1126/science.1152662; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chavali S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-78; Checchi F, 2008, PLOS MED, V5, pe89, DOI [10.1371/journal.pmed.0050089, DOI 10.1371/JOURNAL.PMED.0050089]; DeSalvo KB, 2005, HEALTH SERV RES, V40, P1234, DOI 10.1111/j.1475-6773.2005.00404.x; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fuchs H, 2012, MAMM GENOME, V23, P611, DOI 10.1007/s00335-012-9415-1; Goel R, 2012, MOL BIOSYST, V8, P453, DOI 10.1039/c1mb05340j; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353; Hwang S, 2014, NUCLEIC ACIDS RES, V42, pW147, DOI 10.1093/nar/gku434; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kim J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00900; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; Laughlin MR, 2012, MAMM GENOME, V23, P623, DOI 10.1007/s00335-012-9425-z; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Lehner B, 2013, NAT REV GENET, V14, P168, DOI 10.1038/nrg3404; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; McDermott J, 2003, NUCLEIC ACIDS RES, V31, P3736, DOI 10.1093/nar/gkg550; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; Mewes HW, 1999, NUCLEIC ACIDS RES, V27, P44, DOI 10.1093/nar/27.1.44; NCHS CDC, 1998, COMPRESSED MORTALITY; Nuzhdin SV, 2012, TRENDS GENET, V28, P421, DOI 10.1016/j.tig.2012.06.003; Park J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.16; Park S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00757; Park S, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.29; Queitsch C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003041; Rachel Rivka A, 2012, Cilia, V1, P22, DOI 10.1186/2046-2530-1-22; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Wang Z, 2010, P NATL ACAD SCI USA, V107, P18034, DOI 10.1073/pnas.1004666107; Wendland JR, 2007, NEUROPSYCHOPHARMACOL, V32, P2543, DOI 10.1038/sj.npp.1301394; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Xenarios I, 2001, NUCLEIC ACIDS RES, V29, P239, DOI 10.1093/nar/29.1.239; Xia K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-508; Zhang SH, 2006, COMPUT BIOL CHEM, V30, P445, DOI 10.1016/j.compbiolchem.2006.10.001	55	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136300	10.1371/journal.pone.0136300	http://dx.doi.org/10.1371/journal.pone.0136300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301634	gold, Green Published, Green Submitted			2022-12-27	WOS:000359951900056
J	Harris, JK; Wong, R; Thompson, K; Haire-Joshu, D; Hipp, JA				Harris, Jenine K.; Wong, Roger; Thompson, Kellie; Haire-Joshu, Debra; Hipp, J. Aaron			Networks of Collaboration among Scientists in a Center for Diabetes Translation Research	PLOS ONE			English	Article							ACCURACY; SCIENCE	Background Transdisciplinary collaboration is essential in addressing the translation gap between scientific discovery and delivery of evidence-based interventions to prevent and treat diabetes. We examined patterns of collaboration among scientists at the Washington University Center for Diabetes Translation Research. Methods Members (n = 56) of the Washington University Center for Diabetes Translation Research were surveyed about collaboration overall and on publications, presentations, and grants; 87.5% responded (n = 49). We used traditional and network descriptive statistics and visualization to examine the networks and exponential random graph modeling to identify predictors of collaboration. Results The 56 network members represented nine disciplines. On average, network members had been affiliated with the center for 3.86 years (s.d. = 1.41). The director was by far the most central in all networks. The overall and publication networks were the densest, while the overall and grant networks were the most centralized. The grant network was the most transdisciplinary. The presentation network was the least dense, least centralized, and least transdisciplinary. For every year of center affiliation, network members were 10% more likely to collaborate (OR: 1.10; 95% CI: 1.00-1.21) and 13% more likely to write a paper together (OR: 1.13; 95% CI: 1.02-1.25). Network members in the same discipline were over twice as likely to collaborate in the overall network (OR: 2.10; 95% CI: 1.40-3.15); however, discipline was not associated with collaboration in the other networks. Rank was not associated with collaboration in any network. Conclusions As transdisciplinary centers become more common, it is important to identify structural features, such as a central leader and ongoing collaboration over time, associated with scholarly productivity and, ultimately, with advancing science and practice.	[Harris, Jenine K.; Wong, Roger; Thompson, Kellie; Haire-Joshu, Debra] Washington Univ, Brown Sch, St Louis, MO 63130 USA; [Harris, Jenine K.; Wong, Roger] Washington Univ, Ctr Publ Hlth Syst Sci, St Louis, MO USA; [Harris, Jenine K.; Thompson, Kellie; Haire-Joshu, Debra] Washington Univ, Ctr Diabet Translat Res, St Louis, MO USA; [Hipp, J. Aaron] N Carolina State Univ, Coll Nat Resources, Dept Pk Recreat & Tourism Management, Raleigh, NC 27695 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of North Carolina; North Carolina State University	Harris, JK (corresponding author), Washington Univ, Brown Sch, One Brookings Dr, St Louis, MO 63130 USA.	harrisj@wustl.edu	Hipp, J. Aaron/AAF-9869-2021; Wong, Roger/AAB-6504-2020	Hipp, J. Aaron/0000-0002-2394-7112; Wong, Roger/0000-0002-2243-1990	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [P30DK092950]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092950] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This article was made possible by grant no. P30DK092950 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIDDK.	Balkundi P, 2006, ACAD MANAGE J, V49, P49, DOI [10.2307/20159745, 10.5465/AMJ.2006.20785500]; Borner K, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001399; Casciaro T, 1998, SOC NETWORKS, V20, P331, DOI 10.1016/S0378-8733(98)00008-2; Casciaro T, 1999, MOTIV EMOTION, V23, P285, DOI 10.1023/A:1021390826308; Costenbader E, 2003, SOC NETWORKS, V25, P283, DOI 10.1016/S0378-8733(03)00012-1; Croyle RT, 2008, AM J PREV MED, V35, pS90, DOI 10.1016/j.amepre.2008.05.012; Goodreau SM, 2007, SOC NETWORKS, V29, P231, DOI 10.1016/j.socnet.2006.08.001; Harris JK, 2014, AN INTRODUCTION TO E; Huisman M., 2009, J SOC STRUCT, V10, P1, DOI DOI 10.21307/joss-2019-051; Luke DA, 2014, CLIN TRANSL SCI; Luke DA, 2007, ANNU REV PUBL HEALTH, V28, P69, DOI 10.1146/annurev.publhealth.28.021406.144132; Luke DA, 2010, AM J PUBLIC HEALTH, V100, P1290, DOI 10.2105/AJPH.2009.184358; NRO, 2011, HEXAGON AM EYES SPAC; Okamoto J, TRANSL BEHAV MED, P1; Provan KG, 2008, AM J PREV MED, V35, pS173, DOI 10.1016/j.amepre.2008.05.015; Stokols D, 2008, AM J PREV MED, V35, pS96, DOI 10.1016/j.amepre.2008.05.003; Wasserman S., 1994, SOCIAL NETWORK ANALY	17	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136457	10.1371/journal.pone.0136457	http://dx.doi.org/10.1371/journal.pone.0136457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5VA	26301873	Green Submitted, Green Published, gold			2022-12-27	WOS:000359951900071
J	Guo, YW; Wu, YQ; Anderson, JA; Moss, JQ; Zhu, L				Guo, Yuanwen; Wu, Yanqi; Anderson, Jeff A.; Moss, Justin Q.; Zhu, Lan			Disomic Inheritance and Segregation Distortion of SSR Markers in Two Populations of Cynodon dactylon (L.) Pers. var. dactylon	PLOS ONE			English	Article							LINKAGE MAP; DIVERSITY; AFLP	Common bermudagrass [C. dactylon (L.) Pers. var. dactylon] is economically and environmentally the most important member among Cynodon species because of its extensive use for turf, forage and soil erosion control in the world. However, information regarding the inheritance within the taxon is limited. Accordingly, the objective of this study was to determine qualitative inheritance mode in common bermudagrass. Two tetraploid (2n = 4x = 36), first-generation selfed (S1) populations, 228 progenies of 'Zebra' and 273 from A12359, were analyzed for segregation with 21 and 12 simple sequence repeat (SSR) markers, respectively. It is concluded that the inheritance mode of tetraploid bermudagrass was complete or near complete disomic. It is evident that the two bermudagrass parents had an allotetraploid genome with two distinct subgenomes since 33 SSR primer pairs amplified 34 loci, each having two alleles. Severe transmission ratio distortions occurred in the Zebra population while less so in the A12359 population. The findings of disomic inheritance and segregation ratio distortion in common bermudagrass is significant in subsequent linkage map construction, quantitative trait locus mapping and marker-assisted selection in the species.	[Guo, Yuanwen; Wu, Yanqi] Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA; [Anderson, Jeff A.; Moss, Justin Q.] Oklahoma State Univ, Dept Hort & Landscape Architecture, Stillwater, OK 74078 USA; [Zhu, Lan] Oklahoma State Univ, Dept Stat, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Wu, YQ (corresponding author), Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA.	yanqi.wu@okstate.edu	Wu, Yanqi/N-8180-2016; Moss, Justin Quetone/ABF-7404-2020	Moss, Justin Quetone/0000-0002-6758-3488; Wu, Yanqi/0000-0003-0802-6881	United States Golf Association; United States Department of Agriculture Specialty Crops Research Initiative (SCRI) award [2010-51181-21064]; China Scholarship Council	United States Golf Association; United States Department of Agriculture Specialty Crops Research Initiative (SCRI) award; China Scholarship Council(China Scholarship Council)	This research was sponsored by the United States Golf Association, United States Department of Agriculture Specialty Crops Research Initiative (SCRI) award 2010-51181-21064, and China Scholarship Council.	Andru S, 2011, THEOR APPL GENET, V123, P77, DOI 10.1007/s00122-011-1568-x; Bethel CM, 2006, THEOR APPL GENET, V112, P727, DOI 10.1007/s00122-005-0177-y; Burnham CR, 1962, DISCUSSIONS CYTOGENE, P215; BURTON GW, 1947, J AM SOC AGRON, V39, P551; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Clayton WD, 1986, GENERA GRAMINUM GRAS, P411; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; FORBES IAN, 1963, CROP SCI, V3, P75, DOI 10.2135/cropsci1963.0011183X000300010023x; Gulsen O, 2009, THEOR APPL GENET, V118, P1309, DOI 10.1007/s00122-009-0982-9; HANNA WW, 1977, CROP SCI, V17, P243, DOI 10.2135/cropsci1977.0011183X001700020003x; HARLAN J. R., 1970, Herbage Abstracts, V40, P233; HARLAN JR, 1969, CROP SCI, V9, P774, DOI 10.2135/cropsci1969.0011183X000900060031x; HARLAN JR, 1970, CROP SCI, V10, P288, DOI 10.2135/cropsci1970.0011183X001000030023x; HARLAN JR, 1969, AM J BOT, V56, P944, DOI 10.2307/2440636; Harris-Shultz KR, 2010, J AM SOC HORTIC SCI, V135, P511, DOI 10.21273/JASHS.135.6.511; Hurcombe R., 1947, JOUR S AFRICAN BOT, V13, P107; Jewell MC, 2012, CROP SCI, V52, P879, DOI 10.2135/cropsci2011.09.0497; JOHNSTON RA, 1975, CROP SCI, V15, P445, DOI 10.2135/cropsci1975.0011183X001500030050x; Kang SY, 2008, MOL CELLS, V25, P163; Liu LL, 2013, MOL BREEDING, V32, P923, DOI 10.1007/s11032-013-9921-1; Liu LL, 2012, BIOENERG RES, V5, P662, DOI 10.1007/s12155-011-9173-z; Liu LL, 2012, G3-GENES GENOM GENET, V2, P357, DOI 10.1534/g3.111.001503; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Preacher K.J., 2001, CALCULATION CHI SQUA; Taliaferro C.M., 1997, PERS INT TURFGRASS S, V8, P393; TALIAFERRO CM, 1995, CROP SCI, V35, P327, DOI 10.2135/cropsci1995.0011183X003500020006x; Taliaferro CM, 2004, WARM SEASON C4 GRASS; Tan CC, 2012, MOL BREEDING, V29, P23, DOI 10.1007/s11032-010-9521-2; Wu YQ, 2006, CROP SCI, V46, P917, DOI 10.2135/cropsci2005.08.0256	30	14	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136332	10.1371/journal.pone.0136332	http://dx.doi.org/10.1371/journal.pone.0136332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295707	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900101
J	Huang, LB; Li, XF; Nguyen, TAH				Huang, Longbin; Li, Xiaofang; Nguyen, Tuan A. H.			Extremely High Phosphate Sorption Capacity in Cu-Pb-Zn Mine Tailings	PLOS ONE			English	Article							PHOSPHORUS SORPTION; EXTRACTABLE FE; SOILS; DITHIONITE; AL; ADSORPTION; MAGHEMITE	Elevated inorganic phosphate (Pi) concentrations in pore water of amended tailings under direct revegetation may cause toxicity in some native woody species but not native forbs or herb species, all of which are key constituents in target native plant communities for phytostabilizing base metal mine tailings. As a result, Pi sorption capacity has been quantified by a conventional batch procedure in three types of base metal mine tailings sampled from two copper (Cu)-lead (Pb)-zinc (Zn) mines, as the basis for Pi-fertiliser addition. It was found that the Pi-sorption capacity in the tailings and local soil was extremely high, far higher than highly weathered agricultural soils in literature, but similar to those of volcanic ash soils. The Langmuir P-sorption maximum was up to 7.72, 4.12, 4.02 and 3.62 mg P g(-1) tailings, in the fresh tailings of mixed Cu-Pb-Zn streams (MIMTD7), the weathered tailings of mixed Cu-Pb-Zn streams (MIMTD5), EHM-TD (fresh Cu-stream, high magnetite content) and local soil (weathered shale and schist), respectively. Physicochemical factors highly correlated with the high Pi-sorption in the tailings were fine particle distribution, oxalate and dithionite-citrate-bicarbonate extractable Fe (Fe-O and Fe-d), oxalate-extractable Al and Mn, and the levels of soluble Cd and Zn, and total S and Fe. Large amounts of amorphous Fe oxides and oxyhydroxides may have been formed from the oxidation of pyritic materials and redox cycles of Fe-minerals (such as pyrite (FeS2), ankerite (Ca(Fe Mg)(CO3)(2) and siderite (FeCO3), as indicated by the extractable Fe-O values. The likely formation of sparingly soluble Zn-phosphate in the Pb-Zn tailings containing high levels of Zn (from sphalerite ((Zn, Fe) S, ZnS, (Zn, Cd) S)) may substantially lower soluble Zn levels in the tailings through high rates of Pi-fertiliser addition. As a result, the possibility of P-toxicity in native plant species caused by the addition of soluble phosphate fertilizers would be minimal.	[Huang, Longbin; Li, Xiaofang; Nguyen, Tuan A. H.] Univ Queensland, Sustainable Minerals Inst, Ctr Mined Land Rehabil, Brisbane, Qld 4072, Australia	University of Queensland	Huang, LB (corresponding author), Univ Queensland, Sustainable Minerals Inst, Ctr Mined Land Rehabil, Brisbane, Qld 4072, Australia.	l.huang@uq.edu.au	Nguyen, Tuan/I-8179-2012	Nguyen, Tuan/0000-0002-3024-2081; , Longbin Huang/0000-0001-5024-0107	Xstrata Copper Ltd	Xstrata Copper Ltd	The present study was funded by Mount Isa Mines, Glencore Ltd (formerly Xstrata Copper Ltd) within a tailings phytostabilization program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auxtero E, 2008, GEODERMA, V144, P535, DOI 10.1016/j.geoderma.2008.01.008; BARBER TM, 2002, PHOSPHATE ADSORPTION; BARROW NJ, 1978, J SOIL SCI, V29, P447, DOI 10.1111/j.1365-2389.1978.tb00794.x; COLE CV, 1953, SOIL SCI SOC AM PRO, V17, P352, DOI 10.2136/sssaj1953.03615995001700040013x; Davey KJ, 2008, FULL VALUE RECOVERY; Dobbie KE, 2005, SOIL USE MANAGE, V21, P231, DOI 10.1079/SUM2005314; Dold B, 2002, CHEM GEOL, V189, P135, DOI 10.1016/S0009-2541(02)00044-X; Dzombak D.A., 1990, SURFACE COMPLEXATION, P416; Forsyth B, 2011, 7 AUSTR WORKSH AC ME, P105; Forsyth BJT., 2011, UNDERSTANDING LONG T, V1, P301; FREEMAN JS, 1981, J SOIL SCI, V32, P75, DOI 10.1111/j.1365-2389.1981.tb01687.x; Hartikainen SH, 2008, APPL GEOCHEM, V23, P2716, DOI 10.1016/j.apgeochem.2008.06.004; Hassan NM, 2007, WATER AIR SOIL POLL, V178, P323, DOI 10.1007/s11270-006-9201-3; Holford ICR, 1997, AUST J SOIL RES, V35, P227, DOI 10.1071/S96047; HOLFORD ICR, 1982, AUST J SOIL RES, V20, P233, DOI 10.1071/SR9820233; HOLMGREN GG, 1967, SOIL SCI SOC AM PRO, V31, P210, DOI 10.2136/sssaj1967.03615995003100020020x; Huang L., 2011, 2 INT SEM ENV ISS MI, P31; Huang LB, 2012, ANN BOT-LONDON, V110, P223, DOI 10.1093/aob/mcs115; Lambers H, 2010, PLANT SOIL, V334, P11, DOI 10.1007/s11104-010-0444-9; Lottermoser BG, 2010, MINE WASTES: CHARACTERIZATION, TREATMENT AND ENVIRONMENTAL IMPACTS, P1, DOI 10.1007/978-3-642-12419-8_1; MAHANEY WC, 1994, CATENA, V21, P27, DOI 10.1016/0341-8162(94)90029-9; Marschner H., 2006, MINERAL NUTR HIGHER; McGowen SL, 2001, J ENVIRON QUAL, V30, P493, DOI 10.2134/jeq2001.302493x; MCKEAGUE JA, 1966, CAN J SOIL SCI, V46, P13, DOI 10.4141/cjss66-003; Mendez Monica O., 2008, Reviews in Environmental Science and Bio/Technology, V7, P47, DOI 10.1007/s11157-007-9125-4; Merry RH, 1999, SITE DATA SOIL PROFI; O'Loughlin EJ, 2013, ENVIRON SCI TECHNOL, V47, P9157, DOI 10.1021/es400627j; PARFITT RL, 1988, AUST J SOIL RES, V26, P121, DOI 10.1071/SR9880121; PING CL, 1986, COMMUN SOIL SCI PLAN, V17, P299, DOI 10.1080/00103628609367714; Prietzel J, 2007, EUR J SOIL SCI, V58, P1027, DOI 10.1111/j.1365-2389.2006.00882.x; Rayment G.E., 2011, SOIL CHEM METHODS AU; Redwan M, 2012, SCI TOTAL ENVIRON, V414, P480, DOI 10.1016/j.scitotenv.2011.10.038; Ryan MH, 2009, ANN BOT-LONDON, V103, P901, DOI 10.1093/aob/mcp021; Services E., 1984, SOIL CLASS HILT MOUN; SINGER MJ, 1995, CLAY CLAY MINER, V43, P1, DOI 10.1346/CCMN.1995.0430101; SINGH B, 1991, AUST J SOIL RES, V29, P603, DOI 10.1071/SR9910603; Sjarif S, 1990, SOME CHARACTERISTICS; TORRENT J, 1987, SOIL SCI SOC AM J, V51, P78, DOI 10.2136/sssaj1987.03615995005100010016x; Wisawapipat W, 2009, GEODERMA, V153, P408, DOI 10.1016/j.geoderma.2009.09.005; Zachara JM, 2002, GEOMICROBIOL J, V19, P179, DOI 10.1080/01490450252864271	40	12	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135364	10.1371/journal.pone.0135364	http://dx.doi.org/10.1371/journal.pone.0135364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295582	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900028
J	Wu, M; Sun, L; Pessetto, ZY; Zang, ZH; Xie, XL; Zhong, L; Su, Q; Zan, W; Gao, XR; Zhao, Y; Sun, YY				Wu, Min; Sun, Lin; Pessetto, Ziyan Yuan; Zang, Zhihe; Xie, Xingliang; Zhong, Ling; Su, Qing; Zan, Wang; Gao, Xiurong; Zhao, Yan; Sun, Yiyi			Casitas B-Lineage Lymphoma RING Domain Inhibitors Protect Mice against High-Fat Diet-Induced Obesity and Insulin Resistance	PLOS ONE			English	Article							ENERGY-EXPENDITURE; DEFICIENT MICE; PEPTIDES; DESIGN; KINASE; BRCT	The casitas b-lineage lymphoma (c-Cbl) is an important adaptor protein with an intrinsic E3 ubiquitin ligase activity that interacts with E2 proteins such as UbCH7. c-Cbl plays a vital role in regulating receptor tyrosine kinase signaling. c-Cbl involves in whole-body energy homeostasis, which makes it a potential target for the treatment of type 2 diabetes and obesity. In the present study, we have designed two parental peptides and 55 modified peptides based on the structure of UbCH7 loop L1 and L2. Thirteen of the modified peptides showed increased inhibitory activity in a fluorescence polarization-based assay. In the in vivo proof of study principle, mice treated with peptides 10, 34, 49 and 51 were protected against high-fat diet-induced obesity and insulin resistant. These inhibitors may potentially lead to new therapeutic alternatives for obesity and type 2 diabetes.	[Wu, Min; Zang, Zhihe; Xie, Xingliang; Zhong, Ling; Su, Qing; Zan, Wang; Gao, Xiurong; Zhao, Yan; Sun, Yiyi] Chengdu Med Coll, Dept Pharm, Chengdu, Sichuan Provinc, Peoples R China; [Sun, Lin] Sichuan Univ, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China; [Pessetto, Ziyan Yuan] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	Chengdu Medical College; Sichuan University; University of Kansas; University of Kansas Medical Center	Sun, YY (corresponding author), Chengdu Med Coll, Dept Pharm, Chengdu, Sichuan Provinc, Peoples R China.	yiyisun0363@gmail.com			National Science Foundation for Distinguished Young Scholars of China [81102326]; Chengdu Medical College for Major Pharmacy Research Development Program [CYXK2012006]; program for provincial universities innovative research team in Sichuan province [13TD0028]; Heartland Institute for Clinical and Translational Research [KL2TR000119]; CTSA grant from NCATS awarded to the University of Kansas Medical Center for Frontiers	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Chengdu Medical College for Major Pharmacy Research Development Program; program for provincial universities innovative research team in Sichuan province; Heartland Institute for Clinical and Translational Research; CTSA grant from NCATS awarded to the University of Kansas Medical Center for Frontiers	This project was supported by the National Science Foundation for Distinguished Young Scholars of China (Grant No. 81102326), Chengdu Medical College for Major Pharmacy Research Development Program (Grant No. CYXK2012006) and by program for provincial universities innovative research team in Sichuan province (NO. 13TD0028). The authors thank the members of the Sun lab for their helpful discussions. This work was also supported by a CTSA grant from NCATS awarded to the University of Kansas Medical Center for Frontiers: The Heartland Institute for Clinical and Translational Research # KL2TR000119. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or NCATS.	Anisimov VM, 2011, J COMPUT AID MOL DES, V25, P1071, DOI 10.1007/s10822-011-9484-3; Aristoteli LP, 2007, J PROTEOME RES, V6, P571, DOI 10.1021/pr0602996; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Costanzo-Garvey DL, 2009, CELL METAB, V10, P366, DOI 10.1016/j.cmet.2009.09.010; Huang A, 2009, J MOL BIOL, V385, P507, DOI 10.1016/j.jmb.2008.10.044; John H, 2004, ANAL BIOANAL CHEM, V378, P883, DOI 10.1007/s00216-003-2298-y; Joseph PRB, 2010, BIOCHEM BIOPH RES CO, V393, P207, DOI 10.1016/j.bbrc.2010.01.098; Kumar EA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01639; Kumar EA, 2012, J MED CHEM, V55, P3583, DOI 10.1021/jm300078z; Lokesh GL, 2007, J AM CHEM SOC, V129, P10658, DOI 10.1021/ja0739178; Molero JC, 2006, DIABETES, V55, P708, DOI 10.2337/diabetes.55.03.06.db05-0312; Molero JC, 2004, J CLIN INVEST, V114, P1326, DOI [10.1172/JCI200421480, 10.1172/JCI21480]; Molero JC, 2006, DIABETES, V55, P3411, DOI 10.2337/db06-0955; Pessetto ZY, 2012, BREAST CANCER RES TR, V134, P511, DOI 10.1007/s10549-012-2079-4; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Reitman ML, 2002, ANNU REV NUTR, V22, P459, DOI 10.1146/annurev.nutr.22.010402.102849; Tesmer JJG, 2006, SCIENCE, V312, P377, DOI 10.1126/science.1126903; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wing SS, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S6; Xie XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078042; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	22	1	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135916	10.1371/journal.pone.0135916	http://dx.doi.org/10.1371/journal.pone.0135916			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296084	Green Submitted, gold, Green Published			2022-12-27	WOS:000359926900050
J	Zhao, Q; Li, Y; Tan, BB; Fan, LQ; Yang, PG; Tian, Y				Zhao, Qun; Li, Yong; Tan, Bi-bo; Fan, Li-qiao; Yang, Pei-gang; Tian, Yuan			HIF-1 alpha Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27a	PLOS ONE			English	Article							DRUG-RESISTANCE; DOWN-REGULATION; EXPRESSION; SURGERY; CHEMORESISTANCE; PROLIFERATION; CHEMOTHERAPY; METASTASIS; INHIBITION; HIF1-ALPHA	This study aimed to determine the correlation between HIF-1 alpha and miR-27a expression and to evaluate the effect of inhibition of HIF-1 alpha expression on miR-27a expression and drug resistance in gastric cancer (GC). In the present study, real time-PCR and Western blot were performed to detect the expression of HIF-1 alpha in GC tissues and cell lines. Then, OCUM-2MD3/L-OHP cells were transfected with HIF-1 alpha-siRNA, a miR-27a mimic or pcDNA-HIF-1 alpha, and cell survival was determined via the MTT assay. The expression of HIF-1 alpha, miR-27a, and MDR-related genes was measured via real time-PCR and Western blot. ChIP and dual luciferase activity assays were performed to assess the transcriptional regulation of HIF-1 alpha and miR-27a. The results revealed that transfection with HIF-1 alpha-siRNA markedly decreased the levels of miR-27a, resulting in dramatically enhanced inhibition of the proliferation rate of OCUM-2MD3/L-OHP cells. Compared to non-transfected cells, the survival rate was significantly reduced in the cells transfected with HIF-1 alpha-siRNA after treatment with L-OHP. The cell survival rate was significantly increased in OCUM-2MD3/L-OHP cells transfected with the miR-27a mimic, whereas HIF-1 alpha overexpression did not result in any clear change in cell survival. The results of the dual luciferase activity assay demonstrated that HIF-1 alpha enhances the transcriptional activity of the miR27a promoter in cells transfected with a reporter plasmid containing the upstream promoter region of miR27a together with pcDNA-HIF-1 alpha. ChIP analysis suggested that HIF-1 alpha directly binds to the promoter region of miR27a. Inhibition of HIF-1 alpha or miR27a expression decreased MDR1/P-gp, LRP, and Bcl-2 expression in OCUM-2MD3/L-OHP cells. Thus, we found that HIF-1 alpha is closely associated with MDR in GC and that HIF-1 alpha may suppress MDR1/P-gp, LRP and Bcl-2 expression by inhibiting miR-27a expression.	[Zhao, Qun; Li, Yong; Tan, Bi-bo; Fan, Li-qiao; Yang, Pei-gang; Tian, Yuan] Hebei Med Univ, Affiliated Hosp 4, Dept Gen Surg, Shijiazhuang, Peoples R China	Hebei Medical University	Li, Y (corresponding author), Hebei Med Univ, Affiliated Hosp 4, Dept Gen Surg, Shijiazhuang, Peoples R China.	li_yong_hbth@126.com			Provincial Natural Science Foundation of Hebei Province [H2013206311]	Provincial Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province)	This work was supported by the following grant: The Provincial Natural Science Foundation of Hebei Province (No. H2013206311 to Qun Zhao).	Pereira KMA, 2013, ONCOL LETT, V6, P311, DOI 10.3892/ol.2013.1371; Carbajo-Pescador S, 2013, BRIT J CANCER, V109, P83, DOI 10.1038/bjc.2013.285; Chen CT, 2012, MOL CANCER THER, V11, P660, DOI 10.1158/1535-7163.MCT-11-0754; Cheng JC, 2013, CANCER LETT, V329, P197, DOI 10.1016/j.canlet.2012.10.029; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; D'Ugo D, 2009, LANCET ONCOL, V10, P191, DOI 10.1016/S1470-2045(09)70021-X; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Katanoda K, 2013, JPN J CLIN ONCOL, V43, P492, DOI 10.1093/jjco/hyt038; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Li DW, 2013, ASIAN PAC J CANCER P, V14, P4853, DOI 10.7314/APJCP.2013.14.8.4853; Li Y, 2012, TUMORI J, V98, P516, DOI 10.1700/1146.12648; Li Zhi-min, 2010, Zhonghua Fu Chan Ke Za Zhi, V45, P372; Liu Wei, 2012, Int J Biochem Mol Biol, V3, P165; Liu YB, 2012, CARCINOGENESIS, V33, P1187, DOI 10.1093/carcin/bgs142; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Min LF, 2012, MOL MED REP, V5, P228, DOI 10.3892/mmr.2011.604; Miyake S, 2013, INT J ONCOL, V43, P1431, DOI 10.3892/ijo.2013.2068; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Naito Y, 2012, DIGESTION, V86, P94, DOI 10.1159/000339342; Nakamura J, 2009, ONCOL REP, V22, P693, DOI 10.3892/or_00000489; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Roukos D, 2009, ANN SURG ONCOL, V16, P795, DOI 10.1245/s10434-009-0317-8; Sandhu S, 2011, SEMIN ONCOL, V38, P781, DOI 10.1053/j.seminoncol.2011.08.007; Sermeus A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047519; Sun FQ, 2012, ONCOL LETT, V4, P156, DOI 10.3892/ol.2012.681; Tong Y, 2013, FEBS LETT, V587, P2530, DOI 10.1016/j.febslet.2013.06.017; Wang C, 2008, J BIOCHEM, V144, P313, DOI 10.1093/jb/mvn068; Wei H, 2013, EUR REV MED PHARMACO, V17, P436; Xia LM, 2012, CARCINOGENESIS, V33, P2250, DOI 10.1093/carcin/bgs249; Xu K, 2013, MOL CARCINOGEN, V52, P70, DOI 10.1002/mc.21832; Yashiro M, 1996, CLIN EXP METASTAS, V14, P43, DOI 10.1007/BF00157685; Zhao XH, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-55; Zhu H, 2012, CHINESE MED J-PEKING, V125, P1095, DOI 10.3760/cma.j.issn.0366-6999.2012.06.024	36	44	49	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0132746	10.1371/journal.pone.0132746	http://dx.doi.org/10.1371/journal.pone.0132746			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292288	Green Published, Green Submitted, gold			2022-12-27	WOS:000359919900002
J	Kim, SH; Kim, S; Nam, BH; Lee, SE; Kim, CS; Seo, IY; Kim, TN; Hong, SH; Kwon, TG; Seo, SI; Joo, KJ; Song, K; Kwak, C; Chung, J				Kim, Sung Han; Kim, Sohee; Nam, Byung-Ho; Lee, Sang Eun; Kim, Choung Soo; Seo, Ill Young; Kim, Tae Nam; Hong, Sung-Hoo; Kwon, Tae Gyun; Seo, Seong Il; Joo, Kwan Joong; Song, Kanghyon; Kwak, Cheol; Chung, Jinsoo			Efficacy and Safety of Sorafenib Therapy on Metastatic Renal Cell Carcinoma in Korean Patients: Results from a Retrospective Multicenter Study	PLOS ONE			English	Article							JAPANESE PATIENTS; PHASE-II; 2ND-LINE THERAPY; 1ST-LINE TREATMENT; EXPANDED-ACCESS; ASIAN PATIENTS; OPEN-LABEL; SUNITINIB; AXITINIB; TRIAL	Objective To evaluate the efficacy and safety of sorafenib for Korean patients with metastatic renal cell carcinoma (mRCC). Methods A total of 177 mRCC patients using sorafenib as first- (N = 116), second- (N = 43), and thirdline (N = 18) therapies were enrolled from 11 Korean centers between 2006 and 2012. The patient characteristics, therapy duration, tumor response, disease control rate, and tolerability were assessed at baseline and at routine follow-ups, and the progression-free survival (PFS) and overall survival (OS) times and rates were analyzed. Results Among all patients, 18 (10.2%) stopped sorafenib treatment for a median of 1.7 weeks, including 15 (8.5%) who discontinued the drug, while 40 (22.6%) and 12 (6.8%) patients required dose reductions and drug interruptions, respectively. Severe adverse events (AEs) or poor compliance was observed in 64 (36.2%) patients, with 118 (7.4%) >= grade 3 AEs. During the treatment, one myocardial infarction was observed. The number of >= grade 3 AEs in the first-line sorafenib group was 71 (6.8% of the total 1048 AEs). During a median follow-up of 17.2 months, the radiologically confirmed best objective response rate, disease control rate, median PFS, and median OS were 22.0%, 53.0%, 6.4 months (95% confidence interval [CI], 5.2-8.9), and 32.6 months (95% CI, 27.3-63.8) for the total 177 sorafenib-treated patients, respectively, and 23.2%, 56.0%, 7.4 months (95% CI, 5.5-10.5), and not reached yet (95% CI, 1.0-31.1) for the first-line sorafenib group, respectively. Conclusions Sorafenib produced tolerable safety, with a > grade 3 AE rate of 7.4% and an acceptable disease control rate (53.0%) in Korean mRCC patients.	[Kim, Sung Han; Chung, Jinsoo] Natl Canc Ctr, Dept Urol, Ctr Prostate Canc, Goyang, South Korea; [Kim, Sohee; Nam, Byung-Ho] Natl Canc Ctr, Biometr Res Branch, Ctr Prostate Canc, Goyang, South Korea; [Lee, Sang Eun] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea; [Kim, Choung Soo] Asan Med Ctr, Seoul, South Korea; [Seo, Ill Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; [Kim, Tae Nam] Pusan Natl Univ Hosp, Busan, South Korea; [Hong, Sung-Hoo] Seoul St Marys Hosp, Seoul, South Korea; [Kwon, Tae Gyun] Kyungpook Natl Univ, Sch Med, Daegu, South Korea; [Seo, Seong Il] Wonkwang Univ, Sch Med & Hosp, Iksan, South Korea; [Joo, Kwan Joong] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Seoul, South Korea; [Song, Kanghyon] Korea Canc Ctr Hosp, Seoul, South Korea; [Kwak, Cheol] Seoul Natl Univ Hosp, Seoul 110744, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; Pusan National University; Pusan National University Hospital; Seoul St. Mary's Hospital; Kyungpook National University; Wonkwang University; Sungkyunkwan University (SKKU); Samsung Medical Center; National Cancer Center - Korea (NCC); Seoul National University (SNU); Seoul National University Hospital	Chung, J (corresponding author), Natl Canc Ctr, Dept Urol, Ctr Prostate Canc, Goyang, South Korea.	cjs5225@ncc.re.kr	Lee, Jung Weon/AAC-1146-2020	Lee, Jung Weon/0000-0003-2722-8200; KIM, Sung Han/0000-0002-1689-5203; Kim, Sohee/0000-0003-4660-6043	Bayer Healthcare Pharmaceuticals, Korea [Asan 2012-09]; Samsung Medical Center; Kangbuk Samsung Hospital	Bayer Healthcare Pharmaceuticals, Korea; Samsung Medical Center(Samsung); Kangbuk Samsung Hospital(Samsung)	This investigator-initiated research was supported with funding by a grant from Bayer Healthcare Pharmaceuticals, Korea (Grant No. Asan 2012-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Ill Young Seo is employed by Samsung Medical Center. Coauthor Kwan Joong Joo is employed by Kangbuk Samsung Hospital. Samsung Medical Center and Kangbuk Samsung Hospital provided support in the form of salaries for authors IYS and KJJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akaza H, 2007, JPN J CLIN ONCOL, V37, P755, DOI 10.1093/jjco/hym095; Beck J, 2011, ANN ONCOL, V22, P1812, DOI 10.1093/annonc/mdq651; Chen PC, 2001, CANCER RES, V61, P3949; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Cho IC, 2012, KOREAN J UROL, V53, P217, DOI 10.4111/kju.2012.53.4.217; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Escudier B, 2014, BRIT J CANCER, V110, P2821, DOI 10.1038/bjc.2014.244; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Escudier B, 2009, J CLIN ONCOL, V27, P1280, DOI 10.1200/JCO.2008.19.3342; Heng DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114264; Hutson TE, 2014, J CLIN ONCOL, V32, P760, DOI 10.1200/JCO.2013.50.3961; Jager D, 2014, CLINICAL GENITOURINA; Kane RC, 2006, CLIN CANCER RES, V12, P7271, DOI 10.1158/1078-0432.CCR-06-1249; Kim HS, 2011, ONCOLOGY-BASEL, V80, P395, DOI 10.1159/000330361; LAW TM, 1995, CANCER-AM CANCER SOC, V76, P824, DOI 10.1002/1097-0142(19950901)76:5<824::AID-CNCR2820760517>3.0.CO;2-N; Lee JL, 2012, J CANCER RES CLIN, V138, P687, DOI 10.1007/s00432-012-1148-8; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Motzer RJ, 2014, LANCET ONCOL, V15, P286, DOI 10.1016/S1470-2045(14)70030-0; Motzer RJ, 2013, J CLIN ONCOL, V31, P3791, DOI 10.1200/JCO.2012.47.4940; Motzer RJ, 2013, LANCET ONCOL, V14, P552, DOI 10.1016/S1470-2045(13)70093-7; Naito S, 2010, EUR UROL, V57, P317, DOI 10.1016/j.eururo.2008.12.026; Naito S, 2010, JPN J CLIN ONCOL, V40, pi51, DOI 10.1093/jjco/hyq127; Park K, 2012, MED ONCOL, V29, P3291, DOI 10.1007/s12032-012-0227-7; Park SJ, 2012, CHEMOTHERAPY, V58, P468, DOI 10.1159/000346484; Procopio G, 2014, FUTURE ONCOL, V10, P1741, DOI [10.2217/fon.14.48, 10.2217/FON.14.48]; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Saijo N, 2013, YONSEI MED J, V54, P1, DOI 10.3349/ymj.2013.54.1.1; Stadler WM, 2010, CANCER-AM CANCER SOC, V116, P1272, DOI 10.1002/cncr.24864; Tanigawa G, 2011, JPN J CLIN ONCOL, V41, P1265, DOI 10.1093/jjco/hyr137; Tomita Y, 2010, JPN J CLIN ONCOL, V40, P1166, DOI 10.1093/jjco/hyq146; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Ueda T, 2013, JPN J CLIN ONCOL, V43, P616, DOI 10.1093/jjco/hyt054; Ueda T, 2010, INT J UROL, V17, P811, DOI 10.1111/j.1442-2042.2010.02604.x; Uemura H, 2010, JPN J CLIN ONCOL, V40, P194, DOI 10.1093/jjco/hyp146; van der Veldt AAM, 2008, BRIT J CANCER, V99, P259, DOI 10.1038/sj.bjc.6604456; Ward E, 2004, CA-CANCER J CLIN, V54, P78, DOI 10.3322/canjclin.54.2.78; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Ye DW, 2014, ONCOTARGETS THER, V7, P925, DOI 10.2147/OTT.S41828; Ye DW, 2014, CLIN GENITOURIN CANC, V12, P225, DOI 10.1016/j.clgc.2014.01.007; Zhang HL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-249	41	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135165	10.1371/journal.pone.0135165	http://dx.doi.org/10.1371/journal.pone.0135165			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308612	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400051
J	Liu, B; Li, ZH; Zhang, YZ; Luo, WH; Zhang, JL; Li, H; Zhou, YB				Liu, Bin; Li, Zhenhua; Zhang, Yingzhan; Luo, Wenhong; Zhang, Jiling; Li, Hui; Zhou, Yingbi			Vasomotor Reaction to Cyclooxygenase-1-Mediated Prostacyclin Synthesis in Carotid Arteries from Two-Kidney-One-Clip Hypertensive Mice	PLOS ONE			English	Article							ENDOTHELIUM-DEPENDENT CONTRACTION; UP-REGULATION; VASOCONSTRICTOR ACTIVITY; ARACHIDONIC-ACID; DYSFUNCTION; INHIBITION; COX-2; AORTA; CELLS; INVOLVEMENT	This study tested the hypothesis that in hypertensive arteries cyclooxygenase-1 (COX-1) remains as a major form, mediating prostacyclin (prostaglandin I-2; PGI(2)) synthesis that may evoke a vasoconstrictor response in the presence of functional vasodilator PGI(2) (IP) receptors. Two-kidney-one-clip (2K1C) hypertension was induced in wild-type (WT) mice and/or those with COX-1 deficiency (COX-1(-/-)). Carotid arteries were isolated for analyses 4 weeks after. Results showed that as in normotensive mice, the muscarinic receptor agonist ACh evoked a production of the PGI(2) metabolite 6-keto-PGF(1 alpha) and an endothelium-dependent vasoconstrictor response; both of them were abolished by COX-1 inhibition. At the same time, PGI(2), which evokes contraction of hypertensive vessels, caused relaxation after thromboxane-prostanoid (TP) receptor antagonism that abolished the contraction evoked by ACh. Antagonizing IP receptors enhanced the contraction to the COX substrate arachidonic acid (AA). Also, COX-1(-/-) mice was noted to develop hypertension; however, their increase of blood pressure and/or heart mass was not to a level achieved with WT mice. In addition, we found that either the contraction in response to ACh or that evoked by AA was abolished in COX-1(-/-) hypertensive mice. These results demonstrate that as in normotensive conditions, COX-1 is a major contributor of PGI(2) synthesis in 2K1C hypertensive carotid arteries, which leads to a vasoconstrictor response resulting from opposing dilator and vasoconstrictor activities of IP and TP receptors, respectively. Also, our data suggest that COX-1(-/-) attenuates the development of 2K1C hypertension in mice, reflecting a net adverse role yielded from all COX-1-mediated activities under the pathological condition.	[Liu, Bin; Zhang, Yingzhan; Zhang, Jiling; Zhou, Yingbi] Shantou Univ, Coll Med, Cardiovasc Res Ctr, Shantou, Guangdong, Peoples R China; [Li, Zhenhua] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Pathol, Shantou, Guangdong, Peoples R China; [Luo, Wenhong; Li, Hui] Shantou Univ, Coll Med, Cent Lab, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University	Zhou, YB (corresponding author), Shantou Univ, Coll Med, Cardiovasc Res Ctr, Shantou, Guangdong, Peoples R China.	yz_sumc@163.com			National Natural Science Foundation [81270345, 81470572, 81370384]; National Basic Science Research Program from Ministry of Science and Technology [2010CB912503]; Natural Science Foundation of Guangdong province, China [S2013010014519]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Science Research Program from Ministry of Science and Technology; Natural Science Foundation of Guangdong province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation (81270345 and 81470572 to YZ and 81370384 to BL, http://www.nsfc.gov.cn/), by the National Basic Science Research Program (2010CB912503 to YZ, http://www.973.gov.cn/AreaAppl.aspx) from Ministry of Science and Technology, and by the Natural Science Foundation (S2013010014519 to BL, http://pro.gdstc.gov.cn/) of Guangdong province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari HR, 2007, AM J PHYSIOL-HEART C, V293, pH3448, DOI 10.1152/ajpheart.00764.2007; Asirvatham-Jeyaraj N, 2013, AM J PHYSIOL-HEART C, V305, pH1462, DOI 10.1152/ajpheart.00245.2013; Bolego C, 2009, FASEB J, V23, P605, DOI 10.1096/fj.08-106591; Brenneis C, 2006, FASEB J, V20, P1352, DOI 10.1096/fj.05-5346com; BUNTING S, 1976, PROSTAG OTH LIPID M, V12, P897, DOI 10.1016/0090-6980(76)90125-8; Cervenka L, 2002, HYPERTENSION, V40, P735, DOI 10.1161/01.HYP.0000036452.28493.74; Chenevard R, 2003, CIRCULATION, V107, P405, DOI 10.1161/01.CIR.0000051361.69808.3A; Cosentino F, 2003, CIRCULATION, V107, P1017, DOI 10.1161/01.CIR.0000051367.92927.07; Davidge ST, 2001, CIRC RES, V89, P650, DOI 10.1161/hh2001.098351; Feletou M, 2009, BRIT J PHARMACOL, V156, P563, DOI 10.1111/j.1476-5381.2008.00060.x; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; Grosser T, 2010, ANNU REV MED, V61, P17, DOI 10.1146/annurev-med-011209-153129; Hellsten Y, 2012, J PHYSIOL-LONDON, V590, P6297, DOI 10.1113/jphysiol.2012.240762; Hernanz R, 2014, CLIN SCI, V126, P111, DOI 10.1042/CS20120651; Ihara E, 2000, BRIT J PHARMACOL, V129, P943, DOI 10.1038/sj.bjp.0703141; IIZUKA K, 1981, J MED CHEM, V24, P1139, DOI 10.1021/jm00142a005; Kirkby NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069524; Kirkby NS, 2012, P NATL ACAD SCI USA, V109, P17597, DOI 10.1073/pnas.1209192109; LEVY JV, 1978, PROSTAG OTH LIPID M, V16, P93, DOI 10.1016/0090-6980(78)90205-8; Li M, 2008, AM J PHYSIOL-HEART C, V294, pH2444, DOI 10.1152/ajpheart.01121.2007; Liu B, 2014, EXP PHYSIOL, V99, P1, DOI 10.1113/expphysiol.2013.076653; Liu B, 2013, AM J PHYSIOL-RENAL, V305, pF1315, DOI 10.1152/ajprenal.00332.2013; Liu B, 2013, EUR J PHARMACOL, V698, P354, DOI 10.1016/j.ejphar.2012.10.040; Liu B, 2012, EXP PHYSIOL, V97, P895, DOI 10.1113/expphysiol.2011.063784; Liu B, 2012, AM J PHYSIOL-RENAL, V302, pF1133, DOI 10.1152/ajprenal.00604.2011; Liu B, 2012, EXP PHYSIOL, V97, P277, DOI 10.1113/expphysiol.2011.062034; Lu T, 2005, DIABETES, V54, P2155, DOI 10.2337/diabetes.54.7.2155; Martinez-Revelles S, 2013, ANTIOXID REDOX SIGN, V18, P51, DOI 10.1089/ars.2011.4335; Mitchell JA, 2008, EXP PHYSIOL, V93, P141, DOI 10.1113/expphysiol.2007.038588; Mitchell JA, 2006, FASEB J, V20, P2468, DOI 10.1096/fj.06-6615com; Niwa K, 2001, CIRC RES, V88, P600, DOI 10.1161/01.RES.88.6.600; Ochi T, 2000, EUR J PHARMACOL, V391, P49, DOI 10.1016/S0014-2999(00)00051-0; Qi ZH, 2002, J CLIN INVEST, V110, P61, DOI 10.1172/JCI200214752; Ramos-Alves FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050593; Rapoport RM, 1996, HYPERTENSION, V28, P64, DOI 10.1161/01.HYP.28.1.64; Ricciotti E, 2013, P NATL ACAD SCI USA, V110, pE183, DOI 10.1073/pnas.1219073110; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sun D, 2006, AM J PHYSIOL-HEART C, V291, pH1429, DOI 10.1152/ajpheart.01130.2005; Tang EHC, 2005, J CARDIOVASC PHARM, V46, P761, DOI 10.1097/01.fjc.0000187174.67661.67; Tian XY, 2012, ANTIOXID REDOX SIGN, V16, P363, DOI 10.1089/ars.2010.3874; Vanhoutte PM, 2011, HYPERTENSION, V57, P526, DOI 10.1161/HYPERTENSIONAHA.110.165100; Virdis A, 2013, HYPERTENSION, V62, P337, DOI 10.1161/HYPERTENSIONAHA.111.00995; Virdis A, 2012, EUR HEART J, V33, P2225, DOI 10.1093/eurheartj/ehr138; Widlansky ME, 2003, HYPERTENSION, V42, P310, DOI 10.1161/01.HYP.0000084603.93510.28; WILLIAMS SP, 1994, AM J PHYSIOL, V267, pH796, DOI 10.1152/ajpheart.1994.267.2.H796; Wong WT, 2013, J CARDIOVASC PHARM, V61, P204, DOI 10.1097/FJC.0b013e31827fe46e; Wong WT, 2010, CIRC RES, V107, P984, DOI 10.1161/CIRCRESAHA.110.222794; Xavier FE, 2008, BRIT J PHARMACOL, V154, P1225, DOI 10.1038/bjp.2008.200; Yu Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003787; Zhao YJ, 1996, J APPL PHYSIOL, V81, P2595, DOI 10.1152/jappl.1996.81.6.2595; Zhou YB, 2005, AM J PHYSIOL-HEART C, V289, pH1027, DOI 10.1152/ajpheart.00226.2005; Zhou YB, 2013, EXP PHYSIOL, V98, P1225, DOI 10.1113/expphysiol.2013.072017; Zhu NX, 2014, AM J PHYSIOL-HEART C, V307, pH319, DOI 10.1152/ajpheart.00022.2014	53	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136738	10.1371/journal.pone.0136738	http://dx.doi.org/10.1371/journal.pone.0136738			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308616	gold, Green Submitted, Green Published			2022-12-27	WOS:000360069400155
J	Penttinen, K; Siirtola, H; Avalos-Salguero, J; Vainio, T; Juhola, M; Aalto-Setala, K				Penttinen, Kirsi; Siirtola, Harri; Avalos-Salguero, Jorge; Vainio, Tiina; Juhola, Martti; Aalto-Setala, Katriina			Novel Analysis Software for Detecting and Classifying Ca2+ Transient Abnormalities in Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							POLYMORPHIC VENTRICULAR-TACHYCARDIA	Comprehensive functioning of Ca2+ cycling is crucial for excitation-contraction coupling of cardiomyocytes (CMs). Abnormal Ca2+ cycling is linked to arrhythmogenesis, which is associated with cardiac disorders and heart failure. Accordingly, we have generated spontaneously beating CMs from induced pluripotent stem cells (iPSC) derived from patients with catecholaminergic polymorphic ventricular tachycardia (CPVT), which is an inherited and severe cardiac disease. Ca2+ cycling studies have revealed substantial abnormalities in these CMs. Ca2+ transient analysis performed manually lacks accepted analysis criteria, and has both low throughput and high variability. To overcome these issues, we have developed a software tool, AnomalyExplorer based on interactive visualization, to assist in the classification of Ca2+ transient patterns detected in CMs. Here, we demonstrate the usability and capability of the software, and we also compare the analysis efficiency to manual analysis. We show that AnomalyExplorer is suitable for detecting normal and abnormal Ca2+ transients; furthermore, this method provides more defined and consistent information regarding the Ca2+ abnormality patterns and cell line specific differences when compared to manual analysis. This tool will facilitate and speed up the analysis of CM Ca2+ transients, making it both more accurate and user-independent. AnomalyExplorer can be exploited in Ca2+ cycling analysis to study basic disease pathology and the effects of different drugs.	[Penttinen, Kirsi; Aalto-Setala, Katriina] Univ Tampere, BioMediTech, FIN-33101 Tampere, Finland; [Penttinen, Kirsi; Aalto-Setala, Katriina] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Siirtola, Harri; Avalos-Salguero, Jorge; Vainio, Tiina] Univ Tampere, Tampere Unit Comp Human Interact, FIN-33101 Tampere, Finland; [Juhola, Martti] Univ Tampere, Res Ctr Informat & Syst, FIN-33101 Tampere, Finland; [Aalto-Setala, Katriina] Tampere Univ Hosp, Ctr Heart, Tampere, Finland	Tampere University; Tampere University; Tampere University; Tampere University; Tampere University; Tampere University Hospital	Penttinen, K (corresponding author), Univ Tampere, BioMediTech, FIN-33101 Tampere, Finland.	kirsi.penttinen@uta.fi		Siirtola, Harri/0000-0002-4720-1702	TEKES; Biocenter Finland; Finnish Cultural Foundation; Finnish Cardiovascular Foundation; Pirkanmaa Hospital District (EVO) funding; Council of Tampere Region; European Regional Development Fund; Ida Montin Foundation; Aarne Koskelo Foundation; Orion-Farmos Research Foundation	TEKES(Finnish Funding Agency for Technology & Innovation (TEKES)); Biocenter Finland; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Cardiovascular Foundation; Pirkanmaa Hospital District (EVO) funding; Council of Tampere Region; European Regional Development Fund(European Commission); Ida Montin Foundation; Aarne Koskelo Foundation; Orion-Farmos Research Foundation	This work was supported by TEKES (http://www.tekes.fi/), Biocenter Finland (http://www.biocenter.fi/), the Finnish Cultural Foundation (https://www.skr.fi/en), the Finnish Cardiovascular Foundation (http://www.sydantutkimussaatio.fi/welcome-to-the-finnish-foundation-for-cardiovascularresearch/?lang=en), Pirkanmaa Hospital District (EVO) funding (http://www.tays.fi/default.aspx?contentid=2488), the Council of Tampere Region (http://www.pirkanmaa.fi/en/home/council-tampere-region), the European Regional Development Fund (http://europa.eu/legislation_summaries/agriculture/general_framework/g24234_en.htm), Ida Montin Foundation (http://www.idamontininsaatio.fi/pages/suomi/etusivu.php), the Aarne Koskelo Foundation (http://www.aarnekoskelonsaatio.fi/) and the Orion-Farmos Research Foundation (http://www.orion.fi/tutkimus/orionin-tutkimussaatio/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Card SK., 1999, READINGS INFORM VISU; CERRONE M, 2009, CATECHOLAMINERGIC PO, V6, P1652, DOI DOI 10.1016/J.HRTHM.2009.06.033; Cockburn A, 2008, ACM COMPUT SURV, V41, DOI 10.1145/1456650.1456652; Di Pasquale E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.369; Fatima A, 2011, CELL PHYSIOL BIOCHEM, V28, P579, DOI 10.1159/000335753; Han L, 2014, CARDIOVASC RES; Itzhaki I, 2012, J AM COLL CARDIOL, V60, P990, DOI 10.1016/j.jacc.2012.02.066; JANUARY CT, 1992, ANN NY ACAD SCI, V644, P23, DOI 10.1111/j.1749-6632.1992.tb30999.x; Jung CB, 2012, EMBO MOL MED, V4, P180, DOI 10.1002/emmm.201100194; Kujala K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044660; Lan F, 2013, CELL STEM CELL, V12, P101, DOI 10.1016/j.stem.2012.10.010; Lehnart SE, 2006, P NATL ACAD SCI USA, V103, P7906, DOI 10.1073/pnas.0602133103; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Novak A, 2012, J CELL MOL MED, V16, P468, DOI 10.1111/j.1582-4934.2011.01476.x; Penttinen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125366; Schlotthauer K, 2000, CIRC RES, V87, P774, DOI 10.1161/01.RES.87.9.774; Shneiderman B, 1996, IEEE SYMPOSIUM ON VISUAL LANGUAGES, PROCEEDINGS, P336, DOI 10.1109/VL.1996.545307; Siirtola H, 2014, IEEE INT CONF INF VI, P327, DOI 10.1109/IV.2014.27; Spence R., 2014, INFORMATION VISUALIZ; Spencer CI, 2014, STEM CELL REP, V3, P269, DOI 10.1016/j.stemcr.2014.06.003; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Volders PGA, 2000, CARDIOVASC RES, V46, P376, DOI 10.1016/S0008-6363(00)00022-5; Ware C., 2004, INFORM VISUALIZATION, V2nd ed; Xie LH, 2009, AM J PHYSIOL-HEART C, V297, pH997, DOI 10.1152/ajpheart.00390.2009; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yi JS, 2007, IEEE T VIS COMPUT GR, V13, P1224, DOI 10.1109/TVCG.2007.70515; Zhang XH, 2013, CELL CALCIUM, V54, P57, DOI 10.1016/j.ceca.2013.04.004	29	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135806	10.1371/journal.pone.0135806	http://dx.doi.org/10.1371/journal.pone.0135806			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308621	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400077
J	Salvo, F; Dufour, SC; Hamoutene, D; Parrish, CC				Salvo, Flora; Dufour, Suzanne C.; Hamoutene, Dounia; Parrish, Christopher C.			Lipid Classes and Fatty Acids in Ophryotrocha cyclops, a Dorvilleid from Newfoundland Aquaculture Sites	PLOS ONE			English	Article							MARINE BIOTIC INDEX; ORGANIC ENRICHMENT; FOOD-WEB; SEDIMENTS; BIOMARKERS; ANNELIDA; WASTE; PHYTOPLANKTON; BIOSYNTHESIS; POLYCHAETE	A new opportunistic annelid (Ophryotrocha cyclops) discovered on benthic substrates underneath finfish aquaculture sites in Newfoundland (NL) may be involved in the remediation of organic wastes. At those aquaculture sites, bacterial mats and O. cyclops often coexist and are used as indicators of organic enrichment. Little is known on the trophic strategies used by these annelids, including whether they might consume bacteria or other aquaculture-derived wastes. We studied the lipid and fatty acid composition of the annelids and their potential food sources (degraded flocculent organic matter, fresh fish pellets and bacterial mats) to investigate feeding relationships in these habitats and compared the lipid and fatty acid composition of annelids before and after starvation. Fish pellets were rich in lipids, mainly terrestrially derived C-18 fatty acids (18:1 omega 9, 18:2 omega 6, 18:3 omega 3), while bacterial samples were mainly composed of omega 7 fatty acids, and flocculent matter appeared to be a mixture of fresh and degrading fish pellets, feces and bacteria. Ophryotrocha cyclops did not appear to store excessive amounts of lipids (13%) but showed a high concentration of omega 3 and omega 6 fatty acids, as well as a high proportion of the main fatty acids contained in fresh fish pellets and bacterial mats. The dorvilleids and all potential food sources differed significantly in their lipid and fatty acid composition. Interestingly, while all food sources contained low proportions of 20:5 omega 3 and 20:2 omega 6, the annelids showed high concentrations of these two fatty acids, along with 20:4 omega 6. A starvation period of 13 days did not result in a major decrease in total lipid content; however, microscopic observations revealed that very few visible lipid droplets remained in the gut epithelium after three months of starvation. Ophryotrocha cyclops appears well adapted to extreme environments and may rely on lipid-rich organic matter for survival and dispersal in cold environments.	[Salvo, Flora; Dufour, Suzanne C.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Salvo, Flora; Hamoutene, Dounia] Fisheries & Oceans Canada, Northwest Atlantic Fisheries Ctr, St John, NF, Canada; [Parrish, Christopher C.] Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada	Memorial University Newfoundland; Fisheries & Oceans Canada; Memorial University Newfoundland	Salvo, F (corresponding author), Mem Univ Newfoundland, Dept Biol, St John, NF, Canada.	Flora.Salvo@dfo-mpo.gc.ca		Salvo, Flora/0000-0002-5275-2170	Natural Sciences and Engineering Research Council of Canada [462464-14, 105379- 2012]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The project was funded by the Natural Sciences and Engineering Research Council of Canada http://www.nserc-crsng.gc.ca/index_eng.asp ENGAGE grant (462464-14) (SCD) and Discovery grant (105379- 2012) (CCP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRO PW, 1992, LIPIDS, V27, P136, DOI 10.1007/BF02535813; Anderson MJ, 2008, PEMANOVA PRIMER GUID; Black KD, 2012, AQUACULTURE, V356, P317, DOI 10.1016/j.aquaculture.2012.04.049; Borja A, 2004, MAR POLLUT BULL, V48, P405, DOI 10.1016/j.marpolbul.2003.10.024; Borja A, 2000, MAR POLLUT BULL, V40, P1100, DOI 10.1016/S0025-326X(00)00061-8; Budge SM, 2001, MAR CHEM, V76, P285, DOI 10.1016/S0304-4203(01)00068-8; Carroll ML, 2003, AQUACULTURE, V226, P165, DOI 10.1016/S0044-8486(03)00475-7; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Crawford CM, 2001, ICES J MAR SCI, V58, P445, DOI 10.1006/jmsc.2000.1042; Cripps GC, 2000, CAN J FISH AQUAT SCI, V57, P31, DOI 10.1139/cjfas-57-S3-31; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; DFO, 2014, DFO CAN SCI ADV P SE; Drazen JC, 2008, MAR ECOL PROG SER, V372, P157, DOI 10.3354/meps07707; Emmett B, 2008, EVALUATION HARD SUBS; FAO,, AQ FEED FERT RES INF; George EM, 2013, AQUACULT INT, V21, P157, DOI 10.1007/s10499-012-9542-4; George EM, 2013, AQUAC RES, P1; Gorley RN, 2006, PRIMER V6; Graeve M, 1997, POLAR BIOL, V18, P53, DOI 10.1007/s003000050158; GRAEVE M, 1994, J EXP MAR BIOL ECOL, V182, P97, DOI 10.1016/0022-0981(94)90213-5; Hamoutene D., 2014, 2014063 DFO CAN SCI, V17; Hamoutene D, 2013, CAN TECH REP FISH AQ, V3028; Hamoutene D, 2015, N AM J AQUACULT, V77, P117, DOI 10.1080/15222055.2014.976681; Hamoutene D, 2014, ICES J MAR SCI, V71, P1153, DOI 10.1093/icesjms/fst223; Hansen PK, 2001, AQUACULTURE, V194, P75, DOI 10.1016/S0044-8486(00)00520-2; Hargrave BT, 1997, WATER AIR SOIL POLL, V99, P641, DOI 10.1007/BF02406903; Henderson RJ, 1997, AQUACULTURE, V158, P69, DOI 10.1016/S0044-8486(97)00207-X; Holmer G., 1989, P139; Holmer G, 2005, ENV EFFECTS MARINE A, P181; JOHNSEN RI, 1993, AQUACULTURE, V118, P229, DOI 10.1016/0044-8486(93)90459-C; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; KHARLAMENKO VI, 1995, MAR ECOL PROG SER, V120, P231, DOI 10.3354/meps120231; Levin LA, 2013, DEEP-SEA RES PT II, V92, P214, DOI 10.1016/j.dsr2.2013.02.006; Levin LA, 2009, DEEP-SEA RES PT II, V56, P1632, DOI 10.1016/j.dsr2.2009.05.010; LIE O, 1987, COMP BIOCHEM PHYS B, V88, P697, DOI 10.1016/0305-0491(87)90366-X; LUIS OJ, 1995, COMP BIOCHEM PHYS B, V111, P579, DOI 10.1016/0305-0491(95)00029-8; MARSH AG, 1989, MAR BIOL, V102, P519, DOI 10.1007/BF00438354; McGhie TK, 2000, AQUACULTURE, V187, P351, DOI 10.1016/S0044-8486(00)00317-3; McLeod RJ, 2010, LIMNOL OCEANOGR, V55, P2097, DOI 10.4319/lo.2010.55.5.2097; Mersereau J, 2015, THESIS MEMORIAL U NE; Monroig O, 2013, MAR DRUGS, V11, P3998, DOI 10.3390/md11103998; MORRIS RJ, 1985, J EXP MAR BIOL ECOL, V86, P151, DOI 10.1016/0022-0981(85)90028-0; Muxika I, 2005, ECOL INDIC, V5, P19, DOI 10.1016/j.ecolind.2004.08.004; Naesje TF, 2006, ECOL FRESHW FISH, V15, P572, DOI 10.1111/j.1600-0633.2006.00173.x; NICHOLS PD, 1991, PHYTOCHEMISTRY, V30, P3209, DOI 10.1016/0031-9422(91)83177-M; Nutter M, 1943, OIL SOAP, V20, P231; PARRISH CC, 1987, CAN J FISH AQUAT SCI, V44, P722, DOI 10.1139/f87-087; Parrish CC, 1998, LIPIDS IN FRESHWATER ECOSYSTEMS, P4; Parrish CC, 2000, HANDB ENVIRON CHEM, V5, P193; Parrish CC, 1996, COMP BIOCHEM PHYS B, V114, P59, DOI 10.1016/0305-0491(95)02117-5; Paxton H, 2010, ZOOTAXA, P53; Paxton H, 2009, P BIOL SOC WASH, V122, P26, DOI 10.2988/08-33.1; Phleger CF, 2005, DEEP-SEA RES PT I, V52, P2333, DOI 10.1016/j.dsr.2005.08.001; POCOCK DME, 1971, COMP BIOCHEM PHYSIOL, V39, P683, DOI 10.1016/0300-9629(71)90192-7; Pond DW, 2002, MAR ECOL PROG SER, V225, P219, DOI 10.3354/meps225219; Preisler A, 2007, ISME J, V1, P341, DOI 10.1038/ismej.2007.50; Sahling H, 2002, MAR ECOL PROG SER, V231, P121, DOI 10.3354/meps231121; Salvo F, 2015, J MAR BIOL ASSOC UK, V95, P713, DOI 10.1017/S0025315414002070; Salvo F, 2014, ZOOTAXA, V3887, P555, DOI 10.11646/Zootaxa.3887.5.3; SIGURGISLADOTTIR S, 1992, LIPIDS, V27, P418, DOI 10.1007/BF02536382; Stabili L, 2011, J MAR BIOL ASSOC UK, V91, P199, DOI 10.1017/S0025315410001013; Teske A, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P784, DOI 10.1007/0-387-30746-x_27; Thurber AR, 2012, ISME J, V6, P1602, DOI 10.1038/ismej.2012.16; Thurber AR, 2014, MAR ECOL, P1; Van Biesen G, 2005, MAR ENVIRON RES, V60, P375, DOI 10.1016/j.marenvres.2004.12.003; WESTON DP, 1990, MAR ECOL PROG SER, V61, P233, DOI 10.3354/meps061233; Wiklund H, 2012, SYST BIODIVERS, V10, P243, DOI 10.1080/14772000.2012.693970; Wiklund H, 2009, ZOOTAXA, P43, DOI 10.11646/zootaxa.2228.1.3; WILDISH DJ, 2005, BENTHIC MONITORING M; Wilson A, 2009, REV ENV IMPACTS AQUA; Wurzberg L, 2011, DEEP-SEA RES PT II, V58, P153, DOI 10.1016/j.dsr2.2010.10.014; Zhang CL, 2005, APPL ENVIRON MICROB, V71, P2106, DOI 10.1128/AEM.71.4.2106-2112.2005	73	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136772	10.1371/journal.pone.0136772	http://dx.doi.org/10.1371/journal.pone.0136772			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308719	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400156
J	Tanaka, H; Zaima, N; Sasaki, T; Sano, M; Yamamoto, N; Saito, T; Inuzuka, K; Hayasaka, T; Goto-Inoue, N; Sugiura, Y; Sato, K; Kugo, H; Moriyama, T; Konno, H; Setou, M; Unno, N				Tanaka, Hiroki; Zaima, Nobuhiro; Sasaki, Takeshi; Sano, Masaki; Yamamoto, Naoto; Saito, Takaaki; Inuzuka, Kazunori; Hayasaka, Takahiro; Goto-Inoue, Naoko; Sugiura, Yuki; Sato, Kohji; Kugo, Hirona; Moriyama, Tatsuya; Konno, Hiroyuki; Setou, Mitsutoshi; Unno, Naoki			Hypoperfusion of the Adventitial Vasa Vasorum Develops an Abdominal Aortic Aneurysm	PLOS ONE			English	Article							MASS-SPECTROMETRY; DISTURBED FLOW; HYPOXIA; MATRIX; CELLS; WALL; PROGRESSION; MANAGEMENT; MICE	The aortic wall is perfused by the adventitial vasa vasorum (VV). Tissue hypoxia has previously been observed as a manifestation of enlarged abdominal aortic aneurysms (AAAs). We sought to determine whether hypoperfusion of the adventitial VV could develop AAAs. We created a novel animal model of adventitial VV hypoperfusion with a combination of a polyurethane catheter insertion and a suture ligation of the infrarenal abdominal aorta in rats. VV hypoperfusion caused tissue hypoxia and developed infrarenal AAA, which had similar morphological and pathological characteristics to human AAA. In human AAA tissue, the adventitial VV were stenotic in both small AAAs (30-49 mm in diameter) and in large AAAs (>50 mm in diameter), with the sac tissue in these AAAs being ischemic and hypoxic. These results indicate that hypoperfusion of adventitial VV has critical effects on the development of infrarenal AAA.	[Tanaka, Hiroki; Sano, Masaki; Yamamoto, Naoto; Saito, Takaaki; Inuzuka, Kazunori; Unno, Naoki] Hamamatsu Univ Sch Med, Div Vasc Surg, Hamamatsu, Shizuoka 4313192, Japan; [Tanaka, Hiroki; Zaima, Nobuhiro; Hayasaka, Takahiro; Goto-Inoue, Naoko; Sugiura, Yuki; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4313192, Japan; [Tanaka, Hiroki; Sano, Masaki; Yamamoto, Naoto; Saito, Takaaki; Inuzuka, Kazunori; Konno, Hiroyuki; Unno, Naoki] Hamamatsu Univ Sch Med, Dept Surg 2, Hamamatsu, Shizuoka 4313192, Japan; [Sasaki, Takeshi; Sato, Kohji] Hamamatsu Univ Sch Med, Dept Anat & Neurosci, Hamamatsu, Shizuoka 4313192, Japan; [Kugo, Hirona; Moriyama, Tatsuya] Kinki Univ, Grad Sch Agr, Dept Appl Biol Chem, Nara, Japan; [Hayasaka, Takahiro] Hokkaido Univ, Hlth Innovat & Technol Ctr, Sapporo, Hokkaido, Japan; [Goto-Inoue, Naoko] Tokyo Metropolitan Univ, Dept Hlth Promot Sci, Tokyo 158, Japan; [Sugiura, Yuki] Keio Univ, Sch Med, Dept Biochem, Tokyo, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Kindai University (Kinki University); Hokkaido University; Tokyo Metropolitan University; Keio University	Setou, M (corresponding author), Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4313192, Japan.	setou@hama-med.ac.jp; unno@hama-med.ac.jp		Sugiura, Yuki/0000-0002-6983-8958; Moriyama, Tatsuya/0000-0002-6861-926X	Japan Science and Technology Agency (JST) [20291958, 26462103, 25713024]; Tokutei Lipid Machinery; Young Scientists [2067004]; Japan Research Foundation for Clinical Pharmacology	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Tokutei Lipid Machinery; Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Research Foundation for Clinical Pharmacology	This work was supported by Grants-in-Aid for Scientific Research (B) (20291958) to NU, (C) (26462103) to KI; Grants-in-Aid for Young Scientists (A) (25713024) to NZ; a Grant-in-Aid for SENTAN from the Japan Science and Technology Agency (JST); Tokutei Lipid Machinery; and Young Scientists S (2067004) to M. Setou. Financial support for overseas study was provided by the Japan Research Foundation for Clinical Pharmacology to HT.	ANIDJAR S, 1990, CIRCULATION, V82, P973, DOI 10.1161/01.CIR.82.3.973; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; BENJAMIN HB, 1967, SURG GYNECOL OBSTETR, V125, P1307; Biasetti J, 2010, ANN BIOMED ENG, V38, P380, DOI 10.1007/s10439-009-9843-6; Brady AR, 2004, CIRCULATION, V110, P16, DOI 10.1161/01.CIR.0000133279.07468.9F; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Choke E, 2006, ANN NY ACAD SCI, V1085, P306, DOI 10.1196/annals.1383.005; Emeto TI, 2014, CURR DRUG TARGETS, V15, P860; Erdozain OJ, 2011, J VASC RES, V48, P163, DOI 10.1159/000318806; Fan LJ, 2010, BIORHEOLOGY, V47, P31, DOI 10.3233/BIR-2010-0561; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; GANDHI RH, 1994, SURGERY, V115, P617; Hamblin M, 2010, J VASC SURG, V52, P984, DOI 10.1016/j.jvs.2010.05.089; HEISTAD DD, 1981, AM J PHYSIOL, V240, pH781, DOI 10.1152/ajpheart.1981.240.5.H781; HELIN P, 1975, ATHEROSCLEROSIS, V21, P325, DOI 10.1016/0021-9150(75)90046-5; Herrick SE, 1996, J INVEST DERMATOL, V106, P187, DOI 10.1111/1523-1747.ep12329920; Iida Y, 2013, ARTERIOSCL THROM VAS, V33, P718, DOI 10.1161/ATVBAHA.112.300329; Kubo A, 2011, ANAL BIOANAL CHEM, V400, P1895, DOI 10.1007/s00216-011-4895-5; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; OLSEN PS, 1991, J CARDIOVASC SURG, V32, P636; Ponka P, 1997, BLOOD, V89, P1; Powell JT, 2004, ARTERIOSCL THROM VAS, V24, P241, DOI 10.1161/01.ATV.0000106016.13624.4a; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; Sano M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089830; Saratzis A, 2014, HEART, V100, P916, DOI 10.1136/heartjnl-2013-305130; Sasaki T, 2013, ATHEROSCLEROSIS, V227, P43, DOI 10.1016/j.atherosclerosis.2012.12.008; Sasaki T, 2010, ATHEROSCLEROSIS, V210, P430, DOI 10.1016/j.atherosclerosis.2009.12.031; Shimma S, 2008, ANAL CHEM, V80, P878, DOI 10.1021/ac071301v; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Tanaka H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057398; Tanaka H, 2012, J VASC SURG, V55, P1440, DOI 10.1016/j.jvs.2011.09.064; Thompson RW, 2006, ANN NY ACAD SCI, V1085, P59, DOI 10.1196/annals.1383.029; Vorp DA, 2001, J VASC SURG, V34, P291, DOI 10.1067/mva.2001.114813; WOLINSKY H, 1969, CIRC RES, V25, P677, DOI 10.1161/01.RES.25.6.677; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Zaima Nobuhiro, 2014, J Vasc Res, V51, P144, DOI 10.1159/000362123	37	48	48	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134386	10.1371/journal.pone.0134386	http://dx.doi.org/10.1371/journal.pone.0134386			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308526	Green Published, gold			2022-12-27	WOS:000360069400024
J	Hyacinth, HI; Adams, RJ; Greenberg, CS; Voeks, JH; Hill, A; Hibbert, JM; Gee, BE				Hyacinth, Hyacinth I.; Adams, Robert J.; Greenberg, Charles S.; Voeks, Jenifer H.; Hill, Allyson; Hibbert, Jacqueline M.; Gee, Beatrice E.			Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; DISEASE; CHILDREN; ANEMIA; HYPERCOAGULABILITY; HEMOGLOBIN; PREVENTION; VELOCITY	Hypercoagulability in sickle cell disease (SCD) is associated with multiple SCD phenotypes, association with stroke risk has not been well described. We hypothesized that serum levels of biomarkers of coagulation activation correlate with high transcranial Doppler ultrasound velocity and decreases with blood transfusion therapy in SCD patients. Stored serum samples from subjects in the Stroke Prevention in Sickle Cell Anemia (STOP) trial were analyzed using ELISA and protein multiplexing techniques. 40 subjects from each treatment arm (Standard Care [SC] and Transfusion [Tx]) at three time points-baseline, study exit and one year post-trial and 10 each of age matched children with SCD but normal TCD (SNTCD) and with normal hemoglobin (HbAA) were analyzed. At baseline, median vWF, TAT and D-dimer levels were significantly higher among STOP subjects than either HbAA or SNTCD. At study exit, median hemoglobin level was significantly higher while median TCD velocity was significantly lower in Tx compared to SC subjects. Median vWF (409.6 vs. 542.9 mu g/ml), TAT (24.8 vs. 40.0 ng/ml) and D-dimer (9.2 vs. 19.1 mu g/ml) levels were also significantly lower in the Tx compared to the SC group at study exit. Blood levels of biomarkers coagulation activation/thrombin generation correlated positively with TCD velocity and negatively with number of blood transfusions. Biomarkers of coagulation activation/thrombin generation were significantly elevated in children with SCD, at high risk for stroke. Reduction in levels of these biomarkers correlated with reduction in stroke risk (lower TCD velocity), indicating a possible role for hypercoagulation in SCD associated stroke.	[Hyacinth, Hyacinth I.] Emory Univ, Sch Med, Dept Pediat Hematol Oncol, Atlanta, GA 30322 USA; [Hyacinth, Hyacinth I.; Adams, Robert J.; Voeks, Jenifer H.] Med Univ S Carolina, Dept Neurol, Stroke Ctr, Charleston, SC 29425 USA; [Greenberg, Charles S.] Med Univ S Carolina, Dept Hematol, Charleston, SC 29425 USA; [Hill, Allyson] Coll Charleston, Dept Biol, Charleston, SC 29424 USA; [Hibbert, Jacqueline M.] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA; [Gee, Beatrice E.] Morehouse Sch Med, Dept Pediat, Atlanta, GA 30310 USA; [Gee, Beatrice E.] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Gee, Beatrice E.] Childrens Healthcare Atlanta, Atlanta, GA USA	Emory University; Medical University of South Carolina; Medical University of South Carolina; College of Charleston; Morehouse School of Medicine; Morehouse School of Medicine; Morehouse School of Medicine; Children's Healthcare of Atlanta (CHOA)	Hyacinth, HI (corresponding author), Emory Univ, Sch Med, Dept Pediat Hematol Oncol, Atlanta, GA 30322 USA.	hhyacinth@emory.edu	Adams, Robert/GPW-8528-2022; Hyacinth, Hyacinth/U-5722-2017; Hibbert, Jacqueline/W-2282-2019	Hyacinth, Hyacinth/0000-0002-1991-7463; 	National Centre for Advancing Translational Sciences (NCATS) of National Institutes of Health [UL1TR000454]; National Institute on Minority Health and Health Disparities (NIMHD) from National Centre for Research Resources (NCRR) [8 U54 MD007588-04]; NIMHD [S21 MD000101-05]; Children's Healthcare of Atlanta Friends Pilot Project Award [00051285]; MUSC/Department of Defense Cooperative Agreement (SE VIEW) [W81XWH-10-2-0057]; National Heart, Lung, and Blood Institute [U10 HL 52193, U10 HL 52016]; NIH/NHLBI [R21HL092358]; NIH/NCRR [5P20RR0111044]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008, U54RR026137] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092358, U10HL052193, U01HL052193, U10HL052016] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007588, S21MD000101] Funding Source: NIH RePORTER	National Centre for Advancing Translational Sciences (NCATS) of National Institutes of Health; National Institute on Minority Health and Health Disparities (NIMHD) from National Centre for Research Resources (NCRR); NIMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Children's Healthcare of Atlanta Friends Pilot Project Award; MUSC/Department of Defense Cooperative Agreement (SE VIEW); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The authors are grateful to Ellen Debenham, RN, Judy Luden, Corinne Hilbert and the staff of Dr. Kindy's lab (all at MUSC) and Jane Chu from the Protein Profiling Core at MSM, for their logistical support in retrieving the samples and equipment setup. This project was supported in part by grants from The National Centre for Advancing Translational Sciences (NCATS) of the National Institutes of Health, under Award Number UL1TR000454, the National Institute on Minority Health and Health Disparities (NIMHD) Grant Number 8 U54 MD007588-04 (Formerly Grant Number U54 RR026137) from the National Centre for Research Resources (NCRR), NIMHD Grant Number S21 MD000101-05, Children's Healthcare of Atlanta Friends Pilot Project Award, Emory/Pediatrics Pilot project, grant number 00051285, the MUSC/Department of Defense Cooperative Agreement (SE VIEW) number: W81XWH-10-2-0057, the Cooperative Agreements with the National Heart, Lung, and Blood Institute (U10 HL 52193 and U10 HL 52016), and also in part by NIH/NHLBI grant number R21HL092358 and NIH/NCRR grant number 5P20RR0111044, pilot. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the Department of Defense or other sources of funding. The funding agencies have no responsibility in the preparation of this manuscript or interpretation of the results.	ADAMS R, 1992, NEW ENGL J MED, V326, P605, DOI 10.1056/NEJM199202273260905; Adams RJ, 2005, NEW ENGL J MED, V353, P2769; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Asare K, 2010, CYTOKINE, V49, P39, DOI 10.1016/j.cyto.2009.10.002; Ataga KI, 2007, HAEMATOLOGICA, V93, P20, DOI 10.3324/haematol.11763; Ataga KI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029786; Ataga KI, 2009, HAEMATOL-HEMATOL J, V94, P1481, DOI 10.3324/haematol.2009.013672; Ataga KI, 2003, AM J MED, V115, P721, DOI 10.1016/j.amjmed.2003.07.011; Blann A, 1999, BLOOD COAGUL FIBRIN, V10, P277, DOI 10.1097/00001721-199907000-00009; Centers for Disease Control and Prevention, 2012, CHILDR SICKL CELL DI, V2012; Colombatti R, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078801, DOI 10.1371/J0URNAL.P0NE.0078801]; Danesh J, 2001, CIRCULATION, V103, P2323; Deane CR, 2010, HAEMATOL-HEMATOL J, V95, P1287, DOI 10.3324/haematol.2010.022624; Dobson SR, 2002, BLOOD, V99, P3144, DOI 10.1182/blood.V99.9.3144; Gebreyohanns M, 2004, CNS SPECTRUMS, V9, P445; Hassell KL, 2010, AM J PREV MED, V38, pS512, DOI 10.1016/j.amepre.2009.12.022; Hulbert ML, 2006, J PEDIATR-US, V149, P710, DOI 10.1016/j.jpeds.2006.06.037; Hulbert ML, 2011, BLOOD, V117, P772, DOI 10.1182/blood-2010-01-261123; Hyacinth HI, 2014, AM J HEMATOL, V89, P47, DOI 10.1002/ajh.23586; Hyacinth HI, 2012, CYTOKINE, V60, P302, DOI 10.1016/j.cyto.2012.05.017; Jordan LC, 2012, BRIT J HAEMATOL, V157, P14, DOI 10.1111/j.1365-2141.2011.09005.x; Kato Gregory J, 2009, Am J Hematol, V84, P618, DOI 10.1002/ajh.21475; Lezcano NE, 2006, STROKE, V37, P1424, DOI 10.1161/01.STR.0000221173.97108.01; MERKEL KHH, 1978, STROKE, V9, P45, DOI 10.1161/01.STR.9.1.45; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; PROHOVNIK I, 1989, NEUROLOGY, V39, P344, DOI 10.1212/WNL.39.3.344; Prohovnik I, 2009, J CEREBR BLOOD F MET, V29, P803, DOI 10.1038/jcbfm.2009.6; Setty BNY, 2001, BLOOD, V98, P3228, DOI 10.1182/blood.V98.12.3228; Smith LA, 2006, PEDIATRICS, V117, P1763, DOI 10.1542/peds.2005-1611; Thorlacius-Ussing O, THROMBO RES, V81, P253; van Beers EJ, 2009, HAEMATOL-HEMATOL J, V94, P1513, DOI 10.3324/haematol.2009.008938; Ware RE, 2012, BLOOD, V119, P3925, DOI 10.1182/blood-2011-11-392340; Weatherall DJ, 2008, CURR MOL MED, V8, P592, DOI 10.2174/156652408786241375; Whelihan MF, 2013, J THROMB HAEMOST, V11, P2187, DOI 10.1111/jth.12423; Whelihan MF, 2012, BLOOD, V120, P3837, DOI 10.1182/blood-2012-05-427856; Woodhams B, 2001, BLOOD COAGUL FIBRIN, V12, P229, DOI 10.1097/00001721-200106000-00002; Zhou Z, 2009, THROMB HAEMOSTASIS, V101, P1070, DOI 10.1160/TH08-10-0677; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	38	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0134193	10.1371/journal.pone.0134193	http://dx.doi.org/10.1371/journal.pone.0134193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305570	Green Submitted, gold, Green Published			2022-12-27	WOS:000359995500006
J	Min, JW; Kim, WJ; Han, JA; Jung, YJ; Kim, KT; Park, WY; Lee, HO; Choi, SS				Min, Jae-Woong; Kim, Woo Jin; Han, Jeong A.; Jung, Yu-Jin; Kim, Kyu-Tae; Park, Woong-Yang; Lee, Hae-Ock; Choi, Sun Shim			Identification of Distinct Tumor Subpopulations in Lung Adenocarcinoma via Single-Cell RNA-seq	PLOS ONE			English	Article							INTRATUMOR HETEROGENEITY; GENETIC-HETEROGENEITY; SUPPRESSOR GENE; CANCER; CYCLE; EXPRESSION; EVOLUTION; MOUSE; MODEL; REGRESSION	Single-cell sequencing, which is used to detect clinically important tumor subpopulations, is necessary for understanding tumor heterogeneity. Here, we analyzed transcriptomic data obtained from 34 single cells from human lung adenocarcinoma (LADC) patient-derived xenografts (PDXs). To focus on the intrinsic transcriptomic signatures of these tumors, we filtered out genes that displayed extensive expression changes following xenografting and cell culture. Then, we performed clustering analysis using co-regulated gene modules rather than individual genes to minimize read drop-out errors associated with single-cell sequencing. This combined approach revealed two distinct intra-tumoral subgroups that were primarily distinguished by the gene module G64. The G64 module was predominantly composed of cell-cycle genes. E2F1 was found to be the transcription factor that most likely mediates the expression of the G64 module in single LADC cells. Interestingly, the G64 module also indicated inter-tumoral heterogeneity based on its association with patient survival and other clinical variables such as smoking status and tumor stage. Taken together, these results demonstrate the feasibility of single-cell RNA sequencing and the strength of our analytical pipeline for the identification of tumor subpopulations.	[Min, Jae-Woong; Choi, Sun Shim] Kangwon Natl Univ, Coll Biomed Sci, Dept Med Biotechnol, Chunchon 200701, South Korea; [Min, Jae-Woong; Choi, Sun Shim] Kangwon Natl Univ, Inst Biosci & Biotechnol, Chunchon 200701, South Korea; [Kim, Woo Jin; Han, Jeong A.] Kangwon Natl Univ, Sch Med, Chunchon 200701, South Korea; [Jung, Yu-Jin] Kangwon Natl Univ, Dept Biol Sci, Chunchon 200701, South Korea; [Kim, Kyu-Tae; Park, Woong-Yang; Lee, Hae-Ock] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea; [Park, Woong-Yang; Lee, Hae-Ock] Sungkyunkwan Univ, Dept Mol Cell Biol, Seoul, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)	Lee, HO (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea.	haeock.lee@samsung.com; schoi@kangwon.ac.kr	Kim, Woo Jin/A-8216-2019; Jung, Yu-Jin/GNH-4544-2022	Kim, Woo Jin/0000-0003-2927-370X; Park, Woong-Yang/0000-0003-4234-0380	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2014R1A1A4A01003793]; Kangwon National University [120131854]; national R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1020420]; Bio & Medical Technology Development Program of the National Research Foundation - Ministry of Science and Technology [2012M3A9B2029132]; Korea health technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [1020420, HI13C2096]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Kangwon National University; national R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea; Bio & Medical Technology Development Program of the National Research Foundation - Ministry of Science and Technology; Korea health technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2014R1A1A4A01003793), 2013 Research grant from Kangwon National University (No. 120131854) to SSC, the national R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (1020420), Bio & Medical Technology Development Program of the National Research Foundation funded by Ministry of Science and Technology (2012M3A9B2029132), and Korea health technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (1020420) (HI13C2096) to W-YP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0463-6; Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; COX DR, 1972, J R STAT SOC B, V34, P187; Cusnir M, 2012, HUM VACC IMMUNOTHER, V8, P1143, DOI 10.4161/hv.21203; de Bruin EC, 2013, GENOME MED, V5, DOI 10.1186/gm505; Denisov EV, 2014, SCI REPORTS, P4; EFRON B, 1988, J AM STAT ASSOC, V83, P414, DOI 10.2307/2288857; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goodwin G, 1986, BIOL CHEM, V261, P2274; Hajirasouliha I, 2014, BIOINFORMATICS, V30, P78, DOI 10.1093/bioinformatics/btu284; Heller ER, 2013, INT J ONCOL, V42, P583, DOI 10.3892/ijo.2012.1725; HEPPNER GH, 1978, CANCER RES, V38, P3758; Hiley C, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0453-8; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kelland LR, 2004, EUR J CANCER, V40, P827, DOI 10.1016/j.ejca.2003.11.028; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim KT, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0692-3; Lee HY, 2015, MOL MED REP, V11, P2034, DOI 10.3892/mmr.2014.2890; Leedham SJ, 2008, GUT, V57, P1041, DOI 10.1136/gut.2007.143339; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Lyng H, 2001, INT J CANCER, V96, P182; Michor F, 2010, CANCER PREV RES, V3, P1361, DOI 10.1158/1940-6207.CAPR-10-0234; Miyagi A, 2010, METABOLOMICS, V6, P146, DOI 10.1007/s11306-009-0186-y; MIYASHITA T, 1995, CELL, V80, P293; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; OCONNOR PM, 1993, CANCER RES, V53, P4776; Owonikoko T, 2002, AM J CLIN PATHOL, V117, P558; PAN HC, 1994, GENE DEV, V8, P1285, DOI 10.1101/gad.8.11.1285; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pinto N, 2011, CURR DRUG METAB, V12, P487, DOI 10.2174/138920011795495321; Prat A, 2013, SCI REPORTS, V3; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Roukos D, 2012, EXPERT REV ANTICANC, V12, P1245, DOI [10.1586/era.12.105, 10.1586/ERA.12.105]; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-33; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Timmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015661; Tu Y, 2002, P NATL ACAD SCI USA, V99, P14031, DOI 10.1073/pnas.222164199; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; West RB, 2006, P NATL ACAD SCI USA, V103, P690, DOI 10.1073/pnas.0507321103; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Yang JH, 2013, NUCLEIC ACIDS RES, V41, pD177, DOI 10.1093/nar/gks1060; Yasuda SU, 2008, CLIN PHARMACOL THER, V84, P417, DOI 10.1038/clpt.2008.141; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930	56	39	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135817	10.1371/journal.pone.0135817	http://dx.doi.org/10.1371/journal.pone.0135817			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305796	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500035
J	Belotte, J; Fletcher, NM; Saed, MG; Abusamaan, MS; Dyson, G; Diamond, MP; Saed, GM				Belotte, Jimmy; Fletcher, Nicole M.; Saed, Mohammed G.; Abusamaan, Mohammed S.; Dyson, Gregory; Diamond, Michael P.; Saed, Ghassan M.			A Single Nucleotide Polymorphism in Catalase Is Strongly Associated with Ovarian Cancer Survival	PLOS ONE			English	Article							PROGRESSION-FREE SURVIVAL; INDUCED DOWN-REGULATION; E-CADHERIN EXPRESSION; OXIDATIVE STRESS; BREAST-CANCER; NITRIC-OXIDE; GENETIC POLYMORPHISMS; CELL INVASION; RISK; THERAPY	Ovarian cancer is the deadliest of all gynecologic cancers. Recent evidence demonstrates an association between enzymatic activity altering single nucleotide polymorphisms (SNP) with human cancer susceptibility. We sought to evaluate the association of SNPs in key oxidant and antioxidant enzymes with increased risk and survival in epithelial ovarian cancer. Individuals (n = 143) recruited were divided into controls, (n = 94): healthy volunteers, (n = 18), high-risk BRCA1/2 negative (n = 53), high-risk BRCA1/2 positive (n = 23) and ovarian cancer cases (n = 49). DNA was subjected to TaqMan SNP genotype analysis for selected oxidant and antioxidant enzymes. Of the seven selected SNP studied, no association with ovarian cancer risk (Pearson Chi-square) was found. However, a catalase SNP was identified as a predictor of ovarian cancer survival by the Cox regression model. The presence of this SNP was associated with a higher likelihood of death (hazard ratio (HR) of 3.68 (95% confidence interval (CI): 1.149-11.836)) for ovarian cancer patients. Kaplan-Meier survival analysis demonstrated a significant median overall survival difference (108 versus 60 months, p<0.05) for those without the catalase SNP as compared to those with the SNP. Additionally, age at diagnosis greater than the median was found to be a significant predictor of death (HR of 2.78 (95% CI: 1.022-7.578)). This study indicates a strong association with the catalase SNP and survival of ovarian cancer patients, and thus may serve as a prognosticator.	[Belotte, Jimmy; Fletcher, Nicole M.; Saed, Mohammed G.; Abusamaan, Mohammed S.; Saed, Ghassan M.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, CS Mott Ctr Human Growth & Dev, Detroit, MI 48201 USA; [Dyson, Gregory] Karmanos Canc Inst, Detroit, MI USA; [Diamond, Michael P.] Georgia Regents Univ, Dept Obstet & Gynecol, Augusta, GA USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; University System of Georgia; Augusta University	Saed, GM (corresponding author), Wayne State Univ, Sch Med, Dept Obstet & Gynecol, CS Mott Ctr Human Growth & Dev, Detroit, MI 48201 USA.	gsaed@med.wayne.edu	Abusamaan, Mohammed S/AAD-8370-2021	Abusamaan, Mohammed S/0000-0001-9307-1315; Diamond, Michael/0000-0001-6353-4489	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001254] Funding Source: NIH RePORTER; NICHD NIH HHS [K12 HD001254] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Abu-Soud HM, 2000, J BIOL CHEM, V275, P5425, DOI 10.1074/jbc.275.8.5425; Ahn J, 2006, CLIN CANCER RES, V12, P7063, DOI 10.1158/1078-0432.CCR-06-0039; Ambrosone CB, 2005, CANCER RES, V65, P1105; Becquemont L, 2009, PHARMACOGENOMICS, V10, P961, DOI [10.2217/pgs.09.37, 10.2217/PGS.09.37]; Behrman HR, 2001, J SOC GYNECOL INVEST, V8, pS40, DOI 10.1016/S1071-5576(00)00106-4; Booth CM, 2012, J CLIN ONCOL, V30, P1030, DOI 10.1200/JCO.2011.38.7571; Broglio KR, 2009, JNCI-J NATL CANCER I, V101, P1642, DOI 10.1093/jnci/djp369; Castillo-Tong DC, 2013, TUMOUR BIOL; CELLA DF, 1993, J CLIN ONCOL, V11, P570, DOI 10.1200/JCO.1993.11.3.570; Cheng JC, 2013, CANCER LETT, V329, P197, DOI 10.1016/j.canlet.2012.10.029; Cheng JC, 2010, MOL ENDOCRINOL, V24, P1569, DOI 10.1210/me.2010-0034; Ciccolini J, 2010, CLIN COLORECTAL CANC, V9, P224, DOI 10.3816/CCC.2010.n.033; Crawford A, 2012, GENE, V501, P89, DOI 10.1016/j.gene.2012.04.011; Dally H, 2002, INT J CANCER, V102, P530, DOI 10.1002/ijc.10756; Didziapetriene J, 2014, MEDICINA-LITHUANIA, V50, P204, DOI 10.1016/j.medici.2014.09.001; Erichsen HC, 2004, BRIT J CANCER, V90, P747, DOI 10.1038/sj.bjc.6601574; Erickson BK, 2013, AM J OBSTET GYNECOL, V209, P409, DOI 10.1016/j.ajog.2013.04.019; Fasching PA, 2009, MOL ONCOL, V3, P171, DOI 10.1016/j.molonc.2009.01.008; Fletcher NM, 2011, CANCER BIOMARK, V10, P267, DOI 10.3233/CBM-2012-0255; Forsberg L, 2001, FREE RADICAL BIO MED, V30, P500, DOI 10.1016/S0891-5849(00)00487-1; Gill S, 2006, ONCOLOGIST, V11, P624, DOI 10.1634/theoncologist.11-6-624; Goldstein JA, 2001, BRIT J CLIN PHARMACO, V52, P349, DOI 10.1046/j.0306-5251.2001.01499.x; Gomes AM, 2009, PHARMACOGENOMICS, V10, P579, DOI [10.2217/pgs.09.7, 10.2217/PGS.09.7]; Goode EL, 2009, CANCER EPIDEM BIOMAR, V18, P935, DOI 10.1158/1055-9965.EPI-08-0860; HAMOSH A, 1992, AM J HUM GENET, V51, P245; Hart SN, 2008, PHARMACOGENET GENOM, V18, P11, DOI 10.1097/FPC.0b013e3282f2f121; He CY, 2009, BREAST CANCER RES TR, V113, P585, DOI 10.1007/s10549-008-9962-z; Hileman EO, 2004, CANCER CHEMOTH PHARM, V53, P209, DOI 10.1007/s00280-003-0726-5; Holla LI, 2009, INT ARCH ALLERGY IMM, V148, P73, DOI 10.1159/000151508; Huntsman DG, 1998, CYTOGENET CELL GENET, V83, P82, DOI 10.1159/000015134; Huser Vojtech, 2013, AMIA Jt Summits Transl Sci Proc, V2013, P81; Janicka Anna, 2013, Ann Acad Med Stetin, V59, P18; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Jiang ZL, 2011, GYNECOL ONCOL, V122, P418, DOI 10.1016/j.ygyno.2011.04.051; Kaplun L, 2012, BIOMARK INSIGHTS, V7, P151, DOI 10.4137/BMI.S10815; Klaunig JE, 2011, TOXICOL APPL PHARM, V254, P86, DOI 10.1016/j.taap.2009.11.028; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Lee CR, 2004, METHOD FIND EXP CLIN, V26, P463; Lee SY, 2011, J PATHOL, V223, P15, DOI 10.1002/path.2766; Li YL, 2009, CARCINOGENESIS, V30, P777, DOI 10.1093/carcin/bgp053; Malone JM, 2006, AM J OBSTET GYNECOL, V194, P1110, DOI 10.1016/j.ajog.2005.12.019; Marcus CS, 2014, J CANCER, V5, P25, DOI 10.7150/jca.7810; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; NCI, 2012, NAT CANC I PDQ GEN B; Notaridou M, 2011, INT J CANCER, V128, P2063, DOI 10.1002/ijc.25554; Petrucelli N, 2010, GENET MED, V12, P245, DOI 10.1097/GIM.0b013e3181d38f2f; Prat J, 2005, HUM PATHOL, V36, P861, DOI 10.1016/j.humpath.2005.06.006; Quick SK, 2008, CANCER EPIDEM BIOMAR, V17, P1082, DOI 10.1158/1055-9965.EPI-07-2755; Ramus SJ, 2008, INT J CANCER, V123, P380, DOI 10.1002/ijc.23448; Robella M, 2014, MINERVA CHIR, V69, P27; Rotimi CN, 2010, NEW ENGL J MED, V363, P1551, DOI 10.1056/NEJMra0911564; Saadat M, 2014, PATHOL ONCOL RES; Saed GM, 2011, REPROD SCI, V18, P1253, DOI 10.1177/1933719111411731; Saed GM, 2010, GYNECOL ONCOL, V116, P276, DOI 10.1016/j.ygyno.2009.11.004; Savas Sevtap, 2006, Human Genomics, V2, P287; Seibold P, 2013, BREAST, V22, P817, DOI 10.1016/j.breast.2013.02.008; Semb H, 1998, AM J HUM GENET, V63, P1588, DOI 10.1086/302173; Senthil K, 2004, CLIN CHIM ACTA, V339, P27, DOI 10.1016/j.cccn.2003.08.017; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh M, 2011, RHEUMATOL INT, V31, P421, DOI 10.1007/s00296-010-1449-7; Squassina A, 2010, PHARMACOGENOMICS, V11, P1149, DOI [10.2217/pgs.10.97, 10.2217/PGS.10.97]; Stewart DJ, 2012, J CLIN ONCOL, V30, P3426, DOI 10.1200/JCO.2012.44.1220; Tsai SM, 2012, ANN CLIN BIOCHEM, V49, P152, DOI 10.1258/acb.2011.011098; Wikoff WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057639; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033; Yanase K, 2006, CANCER LETT, V234, P73, DOI 10.1016/j.canlet.2005.04.039	67	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135739	10.1371/journal.pone.0135739	http://dx.doi.org/10.1371/journal.pone.0135739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301412	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900027
J	Burch, TC; Morris, MA; Campbell-Thompson, M; Pugliese, A; Nadler, JL; Nyalwidhe, JO				Burch, Tanya C.; Morris, Margaret A.; Campbell-Thompson, Martha; Pugliese, Alberto; Nadler, Jerry L.; Nyalwidhe, Julius O.			Proteomic Analysis of Disease Stratified Human Pancreas Tissue Indicates Unique Signature of Type 1 Diabetes	PLOS ONE			English	Article							INSULIN-RESISTANCE; MASS-SPECTROMETRY; STATISTICAL-MODEL; ISLETS; PROTEINS; MS/MS; PATHOGENESIS; DYSFUNCTION; DISCOVERY; NETWORK	Type 1 diabetes (T1D) and type 2 diabetes (T2D) are associated with functional beta cell loss due to ongoing inflammation. Despite shared similarities, T1D is an autoimmune disease with evidence of autoantibody production, as well as a role for exocrine pancreas involvement. Our hypothesis is that differential protein expression occurs in disease stratified pancreas tissues and regulated proteins from endocrine and exocrine tissues are potential markers of disease and potential therapeutic targets. The study objective was to identify novel proteins that distinguish the pancreas from donors with T1D from the pancreas from patients with T2D, or autoantibody positive non-diabetic donors. Detailed quantitative comprehensive proteomic analysis was applied to snap frozen human pancreatic tissue lysates from organ donors without diabetes, with T1D-associated autoantibodies in the absence of diabetes, with T1D, or with T2D. These disease-stratified human pancreas tissues contain exocrine and endocrine tissues (with dysfunctional islets) in the same microenvironment. The expression profiles of several of the proteins were further verified by western blot. We identified protein panels that are significantly and uniquely upregulated in the three disease-stratified pancreas tissues compared to non-disease control tissues. These proteins are involved in inflammation, metabolic regulation, and autoimmunity, all of which are pathways linked to, and likely involved in, T1 and T2 diabetes pathogenesis. Several new proteins were differentially upregulated in prediabetic, T1D, and T2D pancreas. The results identify proteins that could serve as novel prognostic, diagnostic, and therapeutic tools to preserve functional islet mass in Type 1 Diabetes.	[Burch, Tanya C.; Morris, Margaret A.; Nyalwidhe, Julius O.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Burch, Tanya C.; Nyalwidhe, Julius O.] Eastern Virginia Med Sch, Leroy T Canoles Jr Canc Res Ctr, Norfolk, VA 23501 USA; [Morris, Margaret A.; Nadler, Jerry L.] Eastern Virginia Med Sch, Dept Internal Med, Norfolk, VA 23501 USA; [Morris, Margaret A.; Nadler, Jerry L.] Eastern Virginia Med Sch, Strelitz Diabet Res Ctr, Norfolk, VA 23501 USA; [Campbell-Thompson, Martha] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Pugliese, Alberto] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA	Eastern Virginia Medical School; Eastern Virginia Medical School; Eastern Virginia Medical School; Eastern Virginia Medical School; State University System of Florida; University of Florida; University of Miami	Nadler, JL (corresponding author), Eastern Virginia Med Sch, Dept Internal Med, Norfolk, VA 23501 USA.	nadlerjl@evms.edu; nyalwijo@evms.edu	Campbell-Thompson, Martha/A-7584-2010	Campbell-Thompson, Martha/0000-0001-6878-1235	Juvenile Diabetes Research Foundation (JDRF) [25-2012-770, 25-2012-516]; JDRF Innovative Grant [1-PNF-2014-37-A-N]; Human Islet Research Network (HIRN) [1UC4DK104166-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK104166] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); JDRF Innovative Grant; Human Islet Research Network (HIRN); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was performed with the support of the Juvenile Diabetes Research Foundation (JDRF) through collaboration with the nPOD-Viral Working Group (JDRF grants #25-2012-770 and #25-2012-516), a JDRF Innovative Grant (1-PNF-2014-37-A-N) as well as a consortium grant through the Human Islet Research Network (HIRN grant #1UC4DK104166-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asara JM, 2008, PROTEOMICS, V8, P994, DOI 10.1002/pmic.200700426; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atkinson MA, 2012, COLD SPRING HARB PER, V2; Atkinson MA, 2014, DIABETES, V63, P3572, DOI 10.2337/db14-1069; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Barbagallo D, 2014, MOL BIOL CELL, V25, P2333, DOI 10.1091/mbc.E14-02-0703; Butcher MJ, 2014, DIABETOLOGIA, V57, P491, DOI 10.1007/s00125-013-3116-5; Campbell-Thompson M, 2012, DIABETES-METAB RES, V28, P608, DOI 10.1002/dmrr.2316; Canani LH, 2002, DIABETES, V51, P1188, DOI 10.2337/diabetes.51.4.1188; Choi JH, 2010, BIOL CHEM, V391, P1019, DOI 10.1515/BC.2010.101; Coffey R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086019; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Di Paola R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019462; Goldfine ID, 2008, ENDOCR REV, V29, P62, DOI 10.1210/er.2007-0004; Green-Mitchell SM, 2011, PROTEOM CLIN APPL, V5, P448, DOI 10.1002/prca.201000152; Grzesik WJ, 2015, J CLIN ENDOCR METAB, V100, pE387, DOI 10.1210/jc.2014-3630; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kall L, 2008, J PROTEOME RES, V7, P40, DOI 10.1021/pr700739d; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; Knip M, 2008, AUTOIMMUN REV, V7, P550, DOI 10.1016/j.autrev.2008.04.008; Liu WL, 2010, P NATL ACAD SCI USA, V107, P11056, DOI 10.1073/pnas.1001269107; Lockwood CR, 2003, MOL GENET METAB, V78, P145, DOI 10.1016/S1096-7192(02)00225-1; Luo XR, 2010, IMMUNITY, V32, P488, DOI 10.1016/j.immuni.2010.04.002; Maddux BA, 2006, AM J PHYSIOL-ENDOC M, V290, pE746, DOI 10.1152/ajpendo.00298.2005; Metz TO, 2006, J PROTEOME RES, V5, P3345, DOI 10.1021/pr060322n; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nishida Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107664; Pugliese A, 2014, PEDIATR DIABETES, V15, P1, DOI 10.1111/pedi.12097; Qiu LH, 2005, MOL CELL PROTEOMICS, V4, P1311, DOI 10.1074/mcp.M500016-MCP200; Rodriguez-Calvo T, 2014, DIABETES, V63, P3880, DOI 10.2337/db14-0549; Schrimpe-Rutledge AC, 2012, J PROTEOME RES, V11, P3520, DOI 10.1021/pr3002996; Spijker HS, 2015, DIABETES; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tooley JE, 2014, CURR OPIN ENDOCRINOL, V21, P287, DOI 10.1097/MED.0000000000000076; Waanders LF, 2009, P NATL ACAD SCI USA, V106, P18902, DOI 10.1073/pnas.0908351106; Wang HY, 2000, EMBO J, V19, P4257, DOI 10.1093/emboj/19.16.4257; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Xie XL, 2008, BBA-PROTEINS PROTEOM, V1784, P276, DOI 10.1016/j.bbapap.2007.11.008; Zhou JY, 2011, EXPERT REV PROTEOMIC, V8, P495, DOI 10.1586/EPR.11.39	40	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135663	10.1371/journal.pone.0135663	http://dx.doi.org/10.1371/journal.pone.0135663			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302420	gold, Green Published, Green Submitted			2022-12-27	WOS:000359951900025
J	Hay, O; Dar, G; Abbas, J; Stein, D; May, H; Masharawi, Y; Peled, N; Hershkovitz, I				Hay, Ori; Dar, Gali; Abbas, Janan; Stein, Dan; May, Hila; Masharawi, Youssef; Peled, Nathan; Hershkovitz, Israel			The Lumbar Lordosis in Males and Females, Revisited	PLOS ONE			English	Article							FACET ORIENTATION; SPINE; POSTURE; PREGNANCY; CURVATURE; STABILITY; ALIGNMENT; EVOLUTION; LOADS; PAIN	Background Whether differences exist in male and female lumbar lordosis has been debated by researchers who are divided as to the nature of variations in the spinal curve, their origin, reasoning, and implications from a morphological, functional and evolutionary perspective. Evaluation of the spinal curvature is constructive in understanding the evolution of the spine, as well as its pathology, planning of surgical procedures, monitoring its progression and treatment of spinal deformities. The aim of the current study was to revisit the nature of lumbar curve in males and females. Methods Our new automated method uses CT imaging of the spine to measure lumbar curvature in males and females. The curves extracted from 158 individuals were based on the spinal canal, thus avoiding traditional pitfalls of using bone features for curve estimation. The model analysis was carried out on the entire curve, whereby both local and global descriptors were examined in a single framework. Six parameters were calculated: segment length, curve length, curvedness, lordosis peak location, lordosis cranial peak height, and lordosis caudal peak height. Principal Findings Compared to males, the female spine manifested a statistically significant greater curvature, a caudally located lordotic peak, and greater cranial peak height. As caudal peak height is similar for males and females, the illusion of deeper lordosis among females is due partially to the fact that the upper part of the female lumbar curve is positioned more dorsally (more backwardly inclined). Conclusions Males and females manifest different lumbar curve shape, yet similar amount of inward curving (lordosis). The morphological characteristics of the female spine were probably developed to reduce stress on the vertebral elements during pregnancy and nursing.	[Hay, Ori; Stein, Dan; May, Hila; Hershkovitz, Israel] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Dar, Gali] Univ Haifa, Fac Social Welf & Hlth Sci, Dept Phys Therapy, IL-31999 Haifa, Israel; [Abbas, Janan] Zefat Acad Coll, Safed, Israel; [Masharawi, Youssef] Tel Aviv Univ, Sch Hlth Profess, Dept Physiotherapy, IL-69978 Tel Aviv, Israel; [Peled, Nathan] Carmel Hosp, Dept Radiol, Haifa, Israel	Tel Aviv University; Sackler Faculty of Medicine; University of Haifa; Tel Aviv University; Clalit Health Services; Carmel Medical Center	Hay, O (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel.	orihay@post.tau.ac.il	Hershkovitz, Israel/ABH-4511-2020; Hay, Ori/AAI-6350-2020; Stein, Dan/A-1752-2008; Dar, Gali/P-8503-2014	Hershkovitz, Israel/0000-0001-5841-6090; Stein, Dan/0000-0001-7218-7810; Dar, Gali/0000-0002-0572-5495; Peled, Nir/0000-0003-3714-4377	Israel Science Foundation [1397/08]; Dan David Foundation; Tassia and Dr. Joseph Meychan Chair for the History and Philosophy of Medicine (Tel Aviv University)	Israel Science Foundation(Israel Science Foundation); Dan David Foundation; Tassia and Dr. Joseph Meychan Chair for the History and Philosophy of Medicine (Tel Aviv University)	This project was financed by the Israel Science Foundation (Grant # 1397/08), the Dan David Foundation, and the Tassia and Dr. Joseph Meychan Chair for the History and Philosophy of Medicine (Tel Aviv University).	Andrews J, 2007, P NATL ACAD SCI USA, V104, P1118, DOI 10.1073/pnas.0609910104; Arjmand N, 2005, SPINE, V30, P2637, DOI 10.1097/01.brs.0000187907.02910.4f; Been E, 2014, SPINE J, V14, P87, DOI 10.1016/j.spinee.2013.07.464; Cobb J., 1948, AM ACADEMY ORTHOPAED, V5, P261; Franklin ME, 1998, J ORTHOP SPORT PHYS, V28, P133, DOI 10.2519/jospt.1998.28.3.133; Harrison DE, 2001, SPINE, V26, P235, DOI DOI 10.1097/00007632-200106010-00003; Hicks GE, 2006, J SPINAL DISORD TECH, V19, P501, DOI 10.1097/01.bsd.0000210116.94273.ad; Janssen MMA, 2009, SPINE, V34, pE826, DOI 10.1097/BRS.0b013e3181a9fd85; Kim H, 2010, RADIOGRAPHICS, V30, P1823, DOI 10.1148/rg.307105061; Klinder T, 2009, MED IMAGE ANAL, V13, P471, DOI 10.1016/j.media.2009.02.004; Korovessis PG, 1998, SPINE, V23, P700, DOI 10.1097/00007632-199803150-00010; Kouwenhoven JWM, 2007, SPINE, V32, P2545, DOI 10.1097/BRS.0b013e318158cd86; Letafatkar K, 2010, J RES REHAB SCI N AM, V4; Andreasen ML, 2007, J MANIP PHYSIOL THER, V30, P26, DOI 10.1016/j.jmpt.2006.11.009; Love TW, 1999, J BONE JOINT SURG BR, V81B, P670, DOI 10.1302/0301-620X.81B4.9682; Madsen R, 2008, SPINE, V33, P61, DOI 10.1097/BRS.0b013e31815e395f; Masharawi Y, 2004, SPINE, V29, P1755, DOI 10.1097/01.BRS.0000134575.04084.EF; Masharawi Y, 2010, EUR SPINE J, V19, P768, DOI 10.1007/s00586-009-1256-6; Masharawi YM, 2007, SPINE, V32, pE176, DOI 10.1097/01.brs.0000257565.41856.0f; McInerney T, 1996, Med Image Anal, V1, P91, DOI 10.1016/S1361-8415(96)80007-7; Norton BJ, 2004, J ORTHOP SPORT PHYS, V34, P524, DOI 10.2519/jospt.2004.34.9.524; Opala-Berdzik A, 2010, J HUM KINET, V26, P5, DOI 10.2478/v10078-010-0042-1; Park WM, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005541; Pawlowski B, 2003, AM J HUM BIOL, V15, P144, DOI 10.1002/ajhb.10136; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Polly DW, 1996, SPINE, V21, P1530, DOI 10.1097/00007632-199607010-00008; Rangayyan RM, 2006, J ELECTRON IMAGING, V15, DOI 10.1117/1.2234770; Sanderson PL, 1996, J BONE JOINT SURG BR, V78B, P951, DOI 10.1302/0301-620X78B6.1291; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; Shirazi-Adl A, 2005, EUR SPINE J, V14, P381, DOI 10.1007/s00586-004-0779-0; Vialle R, 2005, J BONE JOINT SURG AM, V87A, P260, DOI 10.2106/JBJS.D.02043; VOUTSINAS SA, 1986, CLIN ORTHOP RELAT R, P235; Vrtovec T, 2008, PHYS MED BIOL, V53, P1895, DOI 10.1088/0031-9155/53/7/006; Whitcome KK, 2007, NATURE, V450, P1075, DOI 10.1038/nature06342; Widhe T, 2001, EUR SPINE J, V10, P118, DOI 10.1007/s005860000230	35	40	40	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0133685	10.1371/journal.pone.0133685	http://dx.doi.org/10.1371/journal.pone.0133685			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301782	Green Published, gold, Green Submitted			2022-12-27	WOS:000359951900005
J	Lin, L; Jin, H; Huang, JP; Long, Y				Lin Li; Jin Hua; Huang Jian-Ping; Long Yan			Association between the Lipid Levels and Single Nucleotide Polymorphisms of ABCA1, APOE and HMGCR Genes in Subjects with Spontaneous Preterm Delivery	PLOS ONE			English	Article							MATERNAL LIPIDS; BIRTH; CHOLESTEROL; PREGNANCY; RISK; METABOLISM; TERM	Spontaneous preterm delivery (SPTD) with gestational age between 28 and 37 complete weeks was reported to have a genetic predisposition in lipids metabolism. This study aimed to investigate the association between the lipid levels and gene polymorphisms of ABCA1 (rs2422493), APOE (rs7412) and HMGCR (rs12916) in Chinese pregnant women with SPTD. A case-control study was conducted at the baseline randomization in 200 SPTD and 178 healthy full term delivery (FTD) women. Maternal blood lipids were detected close to delivery of fetus in SPTD group and in FTD group with gestational age-matched. Cord blood lipids were detected after delivery in two groups. Three genotypes both in maternal and cord blood were determined by real time PCR. The results showed that the levels of total cholesterol (TCHO), triglyceride (TG), high density lipoprotein (HDL), and low-density lipoprotein cholesterol (LDL) in the maternal blood in the SPTD group were significantly lower than those in the FTD group, while the levels of TCHO, HDL, and LDL in the cord blood in the SPTD group were significantly higher than those in the FTD group. In the SPTD subjects, the levels of TG and LDL in the maternal blood were associated with different genotypes of HMGCR gene rs12916 loci. These results indicate that abnormal lipid metabolism may exist in SPTD women and the premature fetus and the HMGCR gene may be a susceptible gene for SPTD.	[Lin Li; Jin Hua; Huang Jian-Ping; Long Yan] Capital Med Univ, Beijing Friendship Hosp, Dept Gynecol & Obstet, Beijing 100050, Peoples R China	Capital Medical University	Long, Y (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Gynecol & Obstet, 95 Yongan Rd, Beijing 100050, Peoples R China.	longyan_doc@sina.com			National Natural Science Foundation in China [81050013]; Scientific Research Project of Beijing Educational Committee [KM201110025015]	National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); Scientific Research Project of Beijing Educational Committee	Funding provided by fund Project of the National Natural Science Foundation in China (Grant No. 81050013) and the Scientific Research Project of Beijing Educational Committee (Grant No. KM201110025015).	Alleman BW, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.03.005; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Burkhardt R, 2008, ARTERIOSCL THROM VAS, V28, P2078, DOI 10.1161/ATVBAHA.108.172288; Catov JM, 2014, AM J EPIDEMIOL, V179, P1208, DOI 10.1093/aje/kwu037; Catov JM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.024; Chien KL, 2010, PHARMACOGENOMICS, V11, P309, DOI 10.2217/PGS.09.160; Dalziel SR, 2007, INT J EPIDEMIOL, V36, P907, DOI 10.1093/ije/dym067; Edison RJ, 2007, PEDIATRICS, V120, P723, DOI 10.1542/peds.2006-1939; Emet T, 2013, ARCH GYNECOL OBSTET, V288, P49, DOI 10.1007/s00404-013-2750-y; Ghio A, 2011, ADV CLIN CHEM, V55, P133, DOI 10.1016/B978-0-12-387042-1.00007-1; Goldenberg RL, 2002, OBSTET GYNECOL, V100, P1020, DOI 10.1016/S0029-7844(02)02212-3; [苟文丽 GOU Wenli], 2007, [中国实用妇科与产科杂志, Chineses Journal of Practical Gynecology and Obstetrics], V23, P8; Heng YJJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096901; Kramer MS, 2013, J PEDIATR-US, V163, P983, DOI 10.1016/j.jpeds.2013.05.014; Liu Sheng-lin, 2004, Di Yi Jun Yi Da Xue Xue Bao, V24, P650; Mudd LM, 2012, ACTA OBSTET GYN SCAN, V91, P726, DOI 10.1111/j.1600-0412.2012.01391.x; Pecks U, 2014, BBA-MOL CELL BIOL L, V1841, P251, DOI 10.1016/j.bbalip.2013.11.008; Plunkett J, 2008, ANN MED, V40, P167, DOI 10.1080/07853890701806181; Radaelli T, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.019; Steffen KM, 2007, J PERINATOL, V27, P672, DOI 10.1038/sj.jp.7211806; Svensson AC, 2009, AM J EPIDEMIOL, V170, P1365, DOI 10.1093/aje/kwp328; von Dadelszen P, 2002, ACTA OBSTET GYN SCAN, V81, P642, DOI 10.1034/j.1600-0412.2002.810710.x; [于连 Yu Lian], 2005, [中国老年学杂志, Chinese Journal of Gerontology], V25, P624; Zuo Lingjun, 2006, Behav Brain Funct, V2, P13, DOI 10.1186/1744-9081-2-13	24	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135785	10.1371/journal.pone.0135785	http://dx.doi.org/10.1371/journal.pone.0135785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301579	Green Published, gold, Green Submitted			2022-12-27	WOS:000359951900029
J	Buckwalter, W; Turri, J				Buckwalter, Wesley; Turri, John			Inability and Obligation in Moral Judgment	PLOS ONE			English	Article							OWNERSHIP RIGHTS; CULPABLE CONTROL; SELF-EFFICACY; OUGHT; PSYCHOLOGY; PUNISHMENT; DILEMMAS; OUTCOMES; IMPLIES; ETHICS	It is often thought that judgments about what we ought to do are limited by judgments about what we can do, or that "ought implies can." We conducted eight experiments to test the link between a range of moral requirements and abilities in ordinary moral evaluations. Moral obligations were repeatedly attributed in tandem with inability, regardless of the type (Experiments 1-3), temporal duration (Experiment 5), or scope (Experiment 6) of inability. This pattern was consistently observed using a variety of moral vocabulary to probe moral judgments and was insensitive to different levels of seriousness for the consequences of inaction (Experiment 4). Judgments about moral obligation were no different for individuals who can or cannot perform physical actions, and these judgments differed from evaluations of a non-moral obligation (Experiment 7). Together these results demonstrate that commonsense morality rejects the "ought implies can" principle for moral requirements, and that judgments about moral obligation are made independently of considerations about ability. By contrast, judgments of blame were highly sensitive to considerations about ability (Experiment 8), which suggests that commonsense morality might accept a "blame implies can" principle.	[Buckwalter, Wesley] Univ Waterloo, Dept Philosophy, Waterloo, ON N2L 3G1, Canada; [Turri, John] Univ Waterloo, Cognit Sci Program, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo	Buckwalter, W (corresponding author), Univ Waterloo, Dept Philosophy, Waterloo, ON N2L 3G1, Canada.	wesleybuckwalter@gmail.com	, Wesley/T-7853-2019	, Wesley/0000-0002-6222-5083	Social Sciences and Humanities Research Council of Canada; Ontario Ministry of Economic Development and Innovation	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Ontario Ministry of Economic Development and Innovation	This research was supported by the Social Sciences and Humanities Research Council of Canada (http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx), an Early Researcher Award from the Ontario Ministry of Economic Development and Innovation (https://www.ontario.ca/business-and-economy/early-researcher-awards) (JT), and by a Banting Postdoctoral Fellowship awarded through the Social Sciences and Humanities Research Council of Canada (http://banting.fellowships-bourses.gc.ca/home-accueil-eng.html) (WB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Alicke MD, 2008, PERS SOC PSYCHOL B, V34, P1371, DOI 10.1177/0146167208321594; Alicke MD, 2000, PSYCHOL BULL, V126, P556, DOI 10.1037//0033-2909.126.4.556; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; BANDURA A, 1980, COGNITIVE THER RES, V4, P39, DOI 10.1007/BF01173354; Bloom P., 2004, DESCARTES BABY HOW T; Blum A, 2000, ANALYSIS, V60, P287, DOI 10.1111/1467-8284.00242; Brandts J, 2001, GAME ECON BEHAV, V36, P138, DOI 10.1006/game.2000.0818; Byrne P., 2000, ADV PSYCHIAT TREATME, V6, P65, DOI [10.1192/apt.6.1.65, DOI 10.1192/APT.6.1.65]; Choi I, 1998, PERS SOC PSYCHOL B, V24, P949, DOI 10.1177/0146167298249003; Cicero M. T., 1856, COMMUNICATION; CONEE E, 1982, PHILOS REV, V91, P87, DOI 10.2307/2184670; Cushman F, 2008, COGNITION, V108, P353, DOI 10.1016/j.cognition.2008.03.006; Cushman F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006699; Dahl NO., 1974, PHILOSOPHIA, V4, P485, DOI DOI 10.1007/BF02379302; Darley JM, 2000, LAW HUMAN BEHAV, V24, P659, DOI 10.1023/A:1005552203727; DRIVER J, 1983, PHILOS STUD, V44, P221, DOI 10.1007/BF00354102; Falk A, 2003, ECON INQ, V41, P20, DOI 10.1093/ei/41.1.20; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Feldman F, 1986, DOING BEST WE CAN ES, P264; Fischer JM, 2003, ANALYSIS, V63, P244, DOI 10.1111/1467-8284.00430; Flanagan O., 1991, VARIETIES OF MORAL P; FRANKFURT HG, 1969, J PHILOS, V66, P829, DOI 10.2307/2023833; Frankfurt HG, 1988, THE IMPORTANCE OF WH, P95; Garson G, 2012, TESTING STATISTICAL; Goodwin GP, 2008, COGNITION, V106, P1339, DOI 10.1016/j.cognition.2007.06.007; Greene JD, 2007, MORAL PSYCHOLOGY VOL, V3; Greene JD, 2009, COGNITION, V111, P364, DOI 10.1016/j.cognition.2009.02.001; Guglielmo S, 2010, PERS SOC PSYCHOL B, V36, P1635, DOI 10.1177/0146167210386733; HANS VP, 1986, CRIMINOLOGY, V24, P393, DOI 10.1111/j.1745-9125.1986.tb01502.x; Hare R, 1963, FREEDOM REASON; Hinshaw SP, 2008, ANNU REV CLIN PSYCHO, V4, P367, DOI 10.1146/annurev.clinpsy.4.022007.141245; Howard-Snyder F, 2006, PHILOS STUD, V130, P233, DOI 10.1007/s11098-004-4511-z; JACQUETTE D, 1991, SYNTHESE, V88, P43, DOI 10.1007/BF00540092; Jones EE, 1971, THE ACTOR AND THE OB; KAGAN S, 1984, PHILOS PUBLIC AFF, V13, P239; Kant I., 1998, RELIGION WITHIN THE; Knobe J, 2010, BEHAV BRAIN SCI, V33, P315, DOI 10.1017/S0140525X10000907; Littlejohn C, 2012, PHILOSOPHIA, V40, P821, DOI 10.1007/s11406-012-9366-5; MARCUS RB, 1980, J PHILOS, V77, P121, DOI 10.2307/2025665; Mikhail J, 2007, TRENDS COGN SCI, V11, P143, DOI 10.1016/j.tics.2006.12.007; Mill John Stuart., 1979, UTILITARIANISM; Millar JC, 2014, COGNITION, V133, P79, DOI 10.1016/j.cognition.2014.05.018; Miresco MJ, 2006, AM J PSYCHIAT, V163, P913, DOI 10.1176/appi.ajp.163.5.913; Moore G.E., 1922, PHILOS PAPERS; Mulgan T., 2001, THE DEMANDS OF CONSE, P289; Nelson WR, 2002, J ECON BEHAV ORGAN, V48, P423, DOI 10.1016/S0167-2681(01)00245-1; Responsibility David, 2008, J PHILOS, V68, P67, DOI DOI 10.1093/ANALYS/68.1.67; Robinson P, 1996, LIABILITY AND BLAME; Ryan S, 2003, PHILOS STUD, V114, P47, DOI 10.1023/A:1024409201289; SCHEFFLER S, 1986, J PHILOS, V83, P531, DOI 10.2307/2026426; SINGER P, 1972, PHILOS PUBLIC AFF, V1, P229; Sinnott-Armstrong W., 1988, MORAL DILEMMAS; Sinnott-Armstrong W, 2011, THE OXFORD HANDBOOK, P299; SINNOTTARMSTRONG W, 1984, PHILOS REV, V93, P249, DOI 10.2307/2184585; Spencer J, 2013, PHILOS STUD, V166, P149, DOI 10.1007/s11098-012-0029-y; Stern N., 2004, UTILITAS, V16, P42, DOI [https://doi.org/10.1017/S0953820803001055, DOI 10.1017/S0953820803001055]; Stocker Michael., 1971, AUSTRALAS J PHILOS, V49, P303, DOI DOI 10.1080/00048407112341311; Streumer B, 2003, EUR J PHILOS, V11, P219, DOI 10.1111/1468-0378.00184; Sutter M, 2007, J ECON PSYCHOL, V28, P69, DOI 10.1016/j.joep.2006.09.001; Thomson J.J., 1986, MORAL THEORY; Tobia K, 2013, PHILOS PSYCHOL, V26, P629, DOI 10.1080/09515089.2012.696327; Tomasello M, 2013, ANNU REV PSYCHOL, V64, P231, DOI 10.1146/annurev-psych-113011-143812; Turri J, 2015, PHILOS STUD, V172, P615, DOI 10.1007/s11098-014-0322-z; Turri J, 2013, COGNITION, V129, P279, DOI 10.1016/j.cognition.2013.06.012; Van de Vondervoort JW, 2015, COGNITIVE SCI, V39, P184, DOI 10.1111/cogs.12154; Van Fraassen B.C., 1973, J PHILOS, V70, P5, DOI DOI 10.2307/2024762; van Inwagen P, 1983, AN ESSAY ON FREE WIL, P401; Vranas PBM, 2007, PHILOS STUD, V136, P167, DOI 10.1007/s11098-007-9071-6; WEINER B, 1988, J PERS SOC PSYCHOL, V55, P738, DOI 10.1037/0022-3514.55.5.738; Williams B., 1981, MORAL LUCK; Woolfolk RL, 2006, COGNITION, V100, P283, DOI 10.1016/j.cognition.2005.05.002	73	32	32	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136589	10.1371/journal.pone.0136589	http://dx.doi.org/10.1371/journal.pone.0136589			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CP5MR	26296206	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900123
J	Gentsch, K; Grandjean, D; Scherer, KR				Gentsch, Kornelia; Grandjean, Didier; Scherer, Klaus R.			Appraisals Generate Specific Configurations of Facial Muscle Movements in a Gambling Task: Evidence for the Component Process Model of Emotion	PLOS ONE			English	Article							CONGENITALLY BLIND; GOAL CONDUCIVENESS; ILLUSORY CONTROL; EXPRESSION; PLEASANTNESS; SURPRISE; CHANCE; DRIVEN; ARCHITECTURE; MECHANISMS	Scherer's Component Process Model provides a theoretical framework for research on the production mechanism of emotion and facial emotional expression. The model predicts that appraisal results drive facial expressions, which unfold sequentially and cumulatively over time. In two experiments, we examined facial muscle activity changes (via facial electromyography recordings over the corrugator, cheek, and frontalis regions) in response to events in a gambling task. These events were experimentally manipulated feedback stimuli which presented simultaneous information directly affecting goal conduciveness (gambling outcome: win, loss, or break-even) and power appraisals (Experiment 1 and 2), as well as control appraisal (Experiment 2). We repeatedly found main effects of goal conduciveness (starting similar to 600 ms), and power appraisals (starting similar to 800 ms after feedback onset). Control appraisal main effects were inconclusive. Interaction effects of goal conduciveness and power appraisals were obtained in both experiments (Experiment 1: over the corrugator and cheek regions; Experiment 2: over the frontalis region) suggesting amplified goal conduciveness effects when power was high in contrast to invariant goal conduciveness effects when power was low. Also an interaction of goal conduciveness and control appraisals was found over the cheek region, showing differential goal conduciveness effects when control was high and invariant effects when control was low. These interaction effects suggest that the appraisal of having sufficient control or power affects facial responses towards gambling outcomes. The result pattern suggests that corrugator and frontalis regions are primarily related to cognitive operations that process motivational pertinence, whereas the cheek region would be more influenced by coping implications. Our results provide first evidence demonstrating that cognitive-evaluative mechanisms related to goal conduciveness, control, and power appraisals affect facial expressions dynamically over time, immediately after an event is perceived. In addition, our results provide further indications for the chronography of appraisal-driven facial movements and the underlying cognitive processes.	[Gentsch, Kornelia; Grandjean, Didier; Scherer, Klaus R.] Univ Geneva, Swiss Ctr Affect Sci CISA, Geneva, Switzerland; [Gentsch, Kornelia; Grandjean, Didier] Univ Geneva, Dept Psychol, Neurosci Emot & Affect Dynam Lab NEAD, Geneva, Switzerland	University of Geneva; University of Geneva	Gentsch, K (corresponding author), Univ Geneva, Swiss Ctr Affect Sci CISA, Geneva, Switzerland.	kornelia.gentsch@yahoo.de	Gentsch, Kornelia/HHZ-4638-2022	Grandjean, Didier/0000-0001-6125-4520	ERC Advanced Grant in the European Community's 7th Framework Programme [230331]; National Center of Competence in Research (NCCR) Affective Sciences - Swiss National Science Foundation [51NF40-104897]	ERC Advanced Grant in the European Community's 7th Framework Programme; National Center of Competence in Research (NCCR) Affective Sciences - Swiss National Science Foundation	This article is part of the PhD project of Kornelia Gentsch. The research was funded by an ERC Advanced Grant in the European Community's 7th Framework Programme under grant agreement 230331-PROPEREMO (Production and perception of emotion: an affective sciences approach) to Klaus Scherer and by the National Center of Competence in Research (NCCR) Affective Sciences financed by the Swiss National Science Foundation (51NF40-104897) and hosted by the University of Geneva.	Aue T, 2008, BIOL PSYCHOL, V79, P158, DOI 10.1016/j.biopsycho.2008.04.004; Aue T, 2007, BIOL PSYCHOL, V74, P347, DOI 10.1016/j.biopsycho.2006.09.001; Baker TE, 2011, BIOL PSYCHOL, V87, P25, DOI 10.1016/j.biopsycho.2011.01.010; Biner PM, 1998, MOTIV EMOTION, V22, P277, DOI 10.1023/A:1021300306318; Darwin C., 1998, EXPRESS EMOT MAN, V3rd; Delplanque S, 2009, EMOTION, V9, P316, DOI 10.1037/a0015369; DIMBERG U, 1990, BIOL PSYCHOL, V31, P137, DOI 10.1016/0301-0511(90)90013-M; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Ekman P., 2002, MANUAL INVESTIGATORS; Ellsworth P.C., 1991, INT REV STUDIES EMOT, P143; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; Fernandez-Dols JM, 2013, EMOT REV, V5, P3, DOI 10.1177/1754073912457209; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Galati D, 2001, INT J BEHAV DEV, V25, P268, DOI 10.1080/01650250042000393; Galati D, 1997, J PERS SOC PSYCHOL, V73, P1363, DOI 10.1037/0022-3514.73.6.1363; Gentsch K, 2013, PSYCHOPHYSIOLOGY, V50, P1010, DOI 10.1111/psyp.12079; GRAMMER K, 1988, ETHOLOGY, V77, P279; Grandjean D, 2008, EMOTION, V8, P341, DOI 10.1037/1528-3542.8.3.341; Grandjean D, 2008, CONSCIOUS COGN, V17, P484, DOI 10.1016/j.concog.2008.03.019; IZARD CE, 1994, PSYCHOL BULL, V115, P288, DOI 10.1037/0033-2909.115.2.288; James W., 1894, PSYCHOL REV, V1, P516, DOI DOI 10.1037/H0065078; Johnson DDP, 2011, NATURE, V477, P317, DOI 10.1038/nature10384; Kappas A, 1999, COGNITION EMOTION, V13, P119, DOI 10.1080/026999399379401; Lanctot N, 2007, EMOTION, V7, P207, DOI 10.1037/1528-3542.7.1.207; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; LANGER EJ, 1975, J PERS SOC PSYCHOL, V32, P311, DOI 10.1037/0022-3514.32.2.311; LANGER EJ, 1975, J PERS SOC PSYCHOL, V32, P951, DOI 10.1037/0022-3514.32.6.951; LAZARUS RS, 1991, AM PSYCHOL, V46, P819, DOI 10.1037/0003-066X.46.8.819; Moors A, 2013, EMOT REV, V5, P132, DOI 10.1177/1754073912463601; Nelson NL, 2013, EMOT REV, V5, P8, DOI 10.1177/1754073912457227; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; Peleg G, 2009, ISR J ECOL EVOL, V55, P11, DOI 10.1560/IJEE.55.1.11; POPE LK, 1994, COGNITION EMOTION, V8, P65, DOI 10.1080/02699939408408929; Reisenzein R, 2006, J PERS SOC PSYCHOL, V91, P295, DOI 10.1037/0022-3514.91.2.295; RINN WE, 1984, PSYCHOL BULL, V95, P52, DOI 10.1037/0033-2909.95.1.52; Roseman I.J., 2001, APPRAISAL PROCESSES, P3, DOI DOI 10.1080/02699939108411034; Roseman I.J., 1984, REV PERSONAL SOC PSY, V5, P11; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; Scherer K.R., 2001, APPRAISAL PROCESSES, DOI DOI 10.1016/S0166-4115(08)62387-0; Scherer K.R., 1984, APPROACHES EMOTION, P293; Scherer KR, 2007, EMOTION, V7, P113, DOI 10.1037/1528-3542.7.1.113; Scherer KR, 2013, EMOT REV, V5, P47, DOI 10.1177/1754073912451504; Scherer KR, 2009, COGNITION EMOTION, V23, P1307, DOI 10.1080/02699930902928969; Scherer KR, 2004, EMOTION, V4, P389, DOI 10.1037/1528-3542.4.4.389; Scherer KR., 1987, GENEVA STUDIES EMOTI, V1, P1, DOI DOI 10.1080/02699930902928969; Schutzwohl A, 2012, EVOL HUM BEHAV, V33, P657, DOI 10.1016/j.evolhumbehav.2012.04.003; SCHWARTZ GE, 1980, PSYCHOPHYSIOLOGY, V17, P75, DOI 10.1111/j.1469-8986.1980.tb02463.x; SMITH CA, 1989, J PERS SOC PSYCHOL, V56, P339, DOI 10.1037/0022-3514.56.3.339; SMITH CA, 1985, J PERS SOC PSYCHOL, V48, P813, DOI 10.1037/0022-3514.48.4.813; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; van Peer JM, 2014, EMOTION, V14, P51, DOI 10.1037/a0034566; van Reekum CM, 2000, THESIS U GENEVA; Wohl MJA, 2002, PERS SOC PSYCHOL B, V28, P1388, DOI 10.1177/014616702236870	53	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135837	10.1371/journal.pone.0135837	http://dx.doi.org/10.1371/journal.pone.0135837			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26295338	gold, Green Submitted, Green Published			2022-12-27	WOS:000359926900044
J	Wu, XF; Lin, QZ; Chen, G; Lu, JP; Zeng, Y; Chen, X; Yan, J				Wu, Xiufeng; Lin, Qingzhong; Chen, Gang; Lu, Jianping; Zeng, Yi; Chen, Xia; Yan, Jun			Sentinel Lymph Node Detection Using Carbon Nanoparticles in Patients with Early Breast Cancer	PLOS ONE			English	Article							STAGE CERVICAL-CANCER; AXILLARY DISSECTION; METHYLENE-BLUE; BIOPSY; IDENTIFICATION; MULTICENTER; LOCALIZATION; TRIAL	Purpose Carbon nanoparticles have a strong affinity for the lymphatic system. The purpose of this study was to evaluate the feasibility of sentinel lymph node biopsy using carbon nanoparticles in early breast cancer and to optimize the application procedure. Methods Firstly, we performed a pilot study to demonstrate the optimized condition using carbon nanoparticles for sentinel lymph nodes (SLNs) detection by investigating 36 clinically node negative breast cancer patients. In subsequent prospective study, 83 patients with clinically node negative breast cancer were included to evaluate SLNs using carbon nanoparticles. Another 83 SLNs were detected by using blue dye. SLNs detection parameters were compared between the methods. All patients irrespective of the SLNs status underwent axillary lymph node dissection for verification of axillary node status after the SLN biopsy. Results In pilot study, a 1 ml carbon nanoparticles suspension used 10-15min before surgery was associated with the best detection rate. In subsequent prospective study, with carbon nanoparticles, the identification rate, accuracy, false negative rate was 100%, 96.4%, 11.1%, respectively. The identification rate and accuracy were 88% and 95.5% with 15.8% of false negative rate using blue dye technique. The use of carbon nanoparticles suspension showed significantly superior results in identification rate (p = 0.001) and reduced false-negative results compared with blue dye technique. Conclusion Our study demonstrated feasibility and accuracy of using carbon nanoparticles for SLNs mapping in breast cancer patients. Carbon nanoparticles are useful in SLNs detection in institutions without access to radioisotope.	[Wu, Xiufeng; Lin, Qingzhong; Zeng, Yi; Chen, Xia] Fujian Med Univ, Teaching Hosp, Fujian Prov Tumor Hosp, Dept Surg, Fuzhou 350014, Fujian, Peoples R China; [Yan, Jun] Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou 510515, Guangdong, Peoples R China; [Chen, Gang; Lu, Jianping] Fujian Med Univ, Teaching Hosp, Fujian Prov Tumor Hosp, Dept Pathol, Fuzhou 350014, Fujian, Peoples R China	Fujian Medical University; Southern Medical University - China; Fujian Medical University	Wu, XF (corresponding author), Fujian Med Univ, Teaching Hosp, Fujian Prov Tumor Hosp, Dept Surg, Fuzhou 350014, Fujian, Peoples R China.	wxf200104@hotmail.com; ynjun@yahoo.com			National Natural Science Foundation of China [81272574]; Natural Science Foundation of Fujian Province [2014J01300, 2014J05086]; Medical Innovation Program of Fujian Province [2012-CXB-7]; Program from Education Bureau of Fujian Province [JB13127]; Scientific Research Foundation for High Level Talents in Nanfang Hospital of Southern Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Medical Innovation Program of Fujian Province; Program from Education Bureau of Fujian Province; Scientific Research Foundation for High Level Talents in Nanfang Hospital of Southern Medical University	This work was supported by the National Natural Science Foundation of China (81272574), the Natural Science Foundation of Fujian Province (2014J01300, 2014J05086), the Medical Innovation Program of Fujian Province (2012-CXB-7), the Program from Education Bureau of Fujian Province (JB13127), and the Scientific Research Foundation for High Level Talents in Nanfang Hospital of Southern Medical University.	Ashikaga T, 2010, J SURG ONCOL, V102, P111, DOI 10.1002/jso.21535; Challa VR, 2010, INDIA J SURG ONCOL, V1, P52, DOI 10.1007/s13193-010-0012-z; Cong LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013167; Cousins A, 2014, BIOTECHNOL ADV, V32, P269, DOI 10.1016/j.biotechadv.2013.10.011; Feldman SM, 1999, J AM COLL SURGEONS, V188, P248, DOI 10.1016/S1072-7515(98)00306-8; Goyal A, 2006, BREAST CANCER RES TR, V99, P203, DOI 10.1007/s10549-006-9192-1; Hao RT, 2012, EJSO-EUR J SURG ONC, V38, P718, DOI 10.1016/j.ejso.2012.02.001; Hutteman M, 2011, BREAST CANCER RES TR, V127, P163, DOI 10.1007/s10549-011-1419-0; Johnson Laura, 2010, Cancers (Basel), V2, P1884, DOI 10.3390/cancers2041884; Johnson N, 2000, AM J SURG, V179, P386, DOI 10.1016/S0002-9610(00)00365-2; Kang T, 2010, ANN SURG ONCOL, V17, pS280, DOI 10.1245/s10434-010-1235-5; Kim T, 2006, CANCER-AM CANCER SOC, V106, P4, DOI 10.1002/cncr.21568; Kitai Toshiyuki, 2005, Breast Cancer, V12, P211, DOI 10.2325/jbcs.12.211; Krag DN, 2007, LANCET ONCOL, V8, P881, DOI 10.1016/S1470-2045(07)70278-4; Krag DN, 2010, LANCET ONCOL, V11, P927, DOI 10.1016/S1470-2045(10)70207-2; Mansel RE, 2006, J NATL CANCER I, V98, P599, DOI 10.1093/jnci/djj158; Martin RCG, 2000, SURGERY, V128, P139, DOI 10.1067/msy.2000.108064; Modugno G, 2014, BR J PHARM; Rob L, 2005, GYNECOL ONCOL, V98, P281, DOI 10.1016/j.ygyno.2005.04.016; Sohrabnezhad S, 2007, MATER LETT, V61, P2311, DOI 10.1016/j.matlet.2006.09.006; Stratmann SL, 1999, AM J SURG, V178, P454, DOI 10.1016/S0002-9610(99)00230-5; Tagaya N, 2008, AM J SURG, V195, P850, DOI 10.1016/j.amjsurg.2007.02.032; Tuttle TM, 2002, J AM COLL SURGEONS, V195, P261, DOI 10.1016/S1072-7515(02)01225-5; Verbeek FPR, 2014, BREAST CANCER RES TR, V143, P333, DOI 10.1007/s10549-013-2802-9; Veronesi U, 1999, JNCI-J NATL CANCER I, V91, P368, DOI 10.1093/jnci/91.4.368; Veronesi U, 1997, LANCET, V349, P1864, DOI 10.1016/S0140-6736(97)01004-0; Wang L, 2007, ANN SURG ONCOL, V14, P2215, DOI 10.1245/s10434-007-9418-4; Yan J, 2014, SURG ENDOSC, V28, P3315, DOI 10.1007/s00464-014-3608-5; Zhang HZ, 2007, GYNECOL ONCOL, V106, P147, DOI 10.1016/j.ygyno.2007.03.037	29	25	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135714	10.1371/journal.pone.0135714	http://dx.doi.org/10.1371/journal.pone.0135714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296136	gold, Green Published, Green Submitted			2022-12-27	WOS:000359926900041
J	Zhang, R; Cao, PJ; Yang, ZZ; Wang, ZZ; Wu, JL; Chen, Y; Pan, Y				Zhang, Rui; Cao, Peijuan; Yang, Zhongzhou; Wang, Zhenzhen; Wu, Jiu-Lin; Chen, Yan; Pan, Yi			Heparan Sulfate Biosynthesis Enzyme, Ext1, Contributes to Outflow Tract Development of Mouse Heart via Modulation of FGF Signaling	PLOS ONE			English	Article							CARDIAC NEURAL CREST; ARTERIAL POLE; EXTRACELLULAR-MATRIX; VALVE DEVELOPMENT; PHARYNGEAL ARCH; 2ND HEART; CELLS; MUTANT; FIELD; MICE	Glycosaminoglycans are important regulators of multiple signaling pathways. As a major constituent of the heart extracellular matrix, glycosaminoglycans are implicated in cardiac morphogenesis through interactions with different signaling morphogens. Ext1 is a glycosyltransferase responsible for heparan sulfate synthesis. Here, we evaluate the function of Ext1 in heart development by analyzing Ext1 hypomorphic mutant and conditional knockout mice. Outflow tract alignment is sensitive to the dosage of Ext1. Deletion of Ext1 in the mesoderm induces a cardiac phenotype similar to that of a mutant with conditional deletion of UDP-glucose dehydrogenase, a key enzyme responsible for synthesis of all glycosaminoglycans. The outflow tract defect in conditional Ext1 knockout(Ext1(f/f):Mesp1Cre) mice is attributable to the reduced contribution of second heart field and neural crest cells. Ext1 deletion leads to downregulation of FGF signaling in the pharyngeal mesoderm. Exogenous FGF8 ameliorates the defects in the outflow tract and pharyngeal explants. In addition, Ext1 expression in second heart field and neural crest cells is required for outflow tract remodeling. Our results collectively indicate that Ext1 is crucial for outflow tract formation in distinct progenitor cells, and heparan sulfate modulates FGF signaling during early heart development.	[Zhang, Rui; Cao, Peijuan; Wang, Zhenzhen; Chen, Yan; Pan, Yi] Univ Chinese Acad Sci, Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Yang, Zhongzhou] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210008, Jiangsu, Peoples R China; [Wu, Jiu-Lin] Fuzhou Univ, Inst Biomed & Pharmaceut Technol, Fuzhou 350002, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Nanjing University; Fuzhou University	Chen, Y (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Shanghai Inst Biol Sci, Shanghai, Peoples R China.	ychen3@sibs.ac.cn; ypan@sibs.ac.cn			Ministry of Science and Technology of China [2012CB524900, 2010CB529506]; National Natural Science Foundation of China [81130077, 81390350, 81321062]; Natural Science Foundation of Shanghai [14ZR1446500]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This work was supported by research grants from the Ministry of Science and Technology of China (2012CB524900 to Y.C. and 2010CB529506 to Y.P. and Z.W.), the National Natural Science Foundation of China (81130077, 81390350 and 81321062 to Y.C.), and the Natural Science Foundation of Shanghai 14ZR1446500 to Y.P.).	Abu-Issa R, 2002, DEVELOPMENT, V129, P4613; Brade T, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a013847; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Campione M, 2001, DEV BIOL, V231, P252, DOI 10.1006/dbio.2000.0133; Costell M, 2002, CIRC RES, V91, P158, DOI 10.1161/01.RES.0000026056.81424.DA; Dyer LA, 2009, DEV BIOL, V336, P137, DOI 10.1016/j.ydbio.2009.10.009; Franco D, 1999, ANAT RECORD, V254, P135; Frank DU, 2002, DEVELOPMENT, V129, P4591; Garcia-Garcia MJ, 2003, CELL, V114, P727, DOI 10.1016/S0092-8674(03)00715-3; Guo CS, 2011, J CLIN INVEST, V121, P1585, DOI 10.1172/JCI44630; Hatano S, 2012, GLYCOBIOLOGY, V22, P1268, DOI 10.1093/glycob/cws095; Hutson MR, 2007, SEMIN CELL DEV BIOL, V18, P101, DOI 10.1016/j.semcdb.2006.12.004; Hutson MR, 2006, DEV BIOL, V295, P486, DOI 10.1016/j.ydbio.2006.02.052; Hyde AS, 2012, J BIOL CHEM, V287, P32708, DOI 10.1074/jbc.M112.395202; Iwamoto R, 2010, DEVELOPMENT, V137, P2205, DOI 10.1242/dev.048926; Kitajima S, 2006, DEV DYNAM, V235, P395, DOI 10.1002/dvdy.20640; Liao J, 2008, DEV BIOL, V316, P524, DOI 10.1016/j.ydbio.2008.01.037; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lincoln J, 2007, DEV BIOL, V305, P120, DOI 10.1016/j.ydbio.2007.02.002; LITTLE CD, 1995, EXPERIENTIA, V51, P873, DOI 10.1007/BF01921738; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Mesbah K, 2008, CIRC RES, V103, P743, DOI 10.1161/CIRCRESAHA.108.172858; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ng A, 2009, DEV BIOL, V335, P208, DOI 10.1016/j.ydbio.2009.08.029; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Pan Y, 2006, DEVELOPMENT, V133, P4933, DOI 10.1242/dev.02679; Pan Y, 2014, MATRIX BIOL, V35, P253, DOI 10.1016/j.matbio.2013.10.013; Park EJ, 2008, DEVELOPMENT, V135, P3599, DOI 10.1242/dev.025437; Pellegrini L, 2001, CURR OPIN STRUC BIOL, V11, P629, DOI 10.1016/S0959-440X(00)00258-X; Princivalle M, 2002, INT J DEV BIOL, V46, P267; Qu XX, 2012, DEVELOPMENT, V139, P2730, DOI 10.1242/dev.079236; Saga Y, 1999, DEVELOPMENT, V126, P3437; Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Tirosh-Finkel L, 2006, DEVELOPMENT, V133, P1943, DOI 10.1242/dev.02365; Vincentz JW, 2008, DEV DYNAM, V237, P3809, DOI 10.1002/dvdy.21803; Waldo KL, 2005, DEV BIOL, V281, P66, DOI 10.1016/j.ydbio.2005.02.011; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; WASHINGTON SI, 2005, DEV BIOL, V283, P357, DOI DOI 10.1016/J.YDBI0.2005.04.029; Watanabe Y, 2010, CIRC RES, V106, P495, DOI 10.1161/CIRCRESAHA.109.201665; Wurdak H, 2006, BIOESSAYS, V28, P1078, DOI 10.1002/bies.20484; Yamamura H, 1997, DEV BIOL, V186, P58, DOI 10.1006/dbio.1997.8559; Yue XP, 2004, GLYCOBIOLOGY, V14, P745, DOI 10.1093/glycob/cwh083	47	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136518	10.1371/journal.pone.0136518	http://dx.doi.org/10.1371/journal.pone.0136518			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295701	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900119
J	Ellefsen, KL; Dynes, JL; Parker, I				Ellefsen, Kyle L.; Dynes, Joseph L.; Parker, Ian			Spinning-Spot Shadowless TIRF Microscopy	PLOS ONE			English	Article							INTERNAL-REFLECTION FLUORESCENCE; CELLS; ILLUMINATION; LIGHT; ANGLE	Total internal reflection fluorescence (TIRF) microscopy is a powerful tool for visualizing near-membrane cellular structures and processes, including imaging of local Ca2+ transients with single-channel resolution. TIRF is most commonly implemented in epi-fluorescence mode, whereby laser excitation light is introduced at a spot near the periphery of the back focal plane of a high numerical aperture objective lens. However, this approach results in an irregular illumination field, owing to interference fringes and scattering and shadowing by cellular structures. We describe a simple system to circumvent these limitations, utilizing a pair of galvanometer-driven mirrors to rapidly spin the laser spot in a circle at the back focal plane of the objective lens, so that irregularities average out during each camera exposure to produce an effectively uniform field. Computer control of the mirrors enables precise scanning at 200 Hz (5ms camera exposure times) or faster, and the scan radius can be altered on a frame-by-frame basis to achieve near-simultaneous imaging in TIRF, widefield and 'skimming plane' imaging modes. We demonstrate the utility of the system for dynamic recording of local inositol trisphosphate-mediated Ca2+ signals and for imaging the redistribution of STIM and Orai proteins during store-operated Ca2+ entry. We further anticipate that it will be readily applicable for numerous other near-membrane studies, especially those involving fast dynamic processes.	[Ellefsen, Kyle L.; Parker, Ian] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Dynes, Joseph L.; Parker, Ian] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Ellefsen, KL (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.	kellefse@uci.edu		Ellefsen, Kyle L./0000-0002-4019-3797	National Institutes of Health [GM048071, NS14609]; Department of Education [P200A120165]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048071, R01GM048071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014609, R37NS014609] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Education(US Department of Education); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants GM048071 and NS14609 and the Department of Education grant P200A120165. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amcheslavsky A, 2015, BIOPHYS J, V108, P237, DOI 10.1016/j.bpj.2014.11.3473; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Demuro A, 2006, CELL CALCIUM, V40, P413, DOI 10.1016/j.ceca.2006.08.006; Fiolka R, 2008, MICROSC RES TECHNIQ, V71, P45, DOI 10.1002/jemt.20527; Lei M, 2010, OPT LETT, V35, P4057, DOI 10.1364/OL.35.004057; Lin J, 2013, MICROSC MICROANAL, P350; Lin J, 2013, MICROSC MICROANAL, V19, P350, DOI 10.1017/S1431927612014420; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Martin-Fernandez ML, 2013, J MICROSC-OXFORD, V252, P16, DOI 10.1111/jmi.12070; Mattheyses AL, 2006, MICROSC RES TECHNIQ, V69, P642, DOI 10.1002/jemt.20334; Mattheyses AL, 2010, J CELL SCI, V123, P3621, DOI 10.1242/jcs.056218; Millis BA, 2012, METHODS MOL BIOL, V823, P295, DOI 10.1007/978-1-60327-216-2_19; Nystoriak MA, 2013, BBA-MOL CELL RES, V1833, P1657, DOI 10.1016/j.bbamcr.2012.10.027; Parker I, 2010, J GEN PHYSIOL, V136, P119, DOI 10.1085/jgp.200910390; Smith IF, 2009, CELL CALCIUM, V45, P65, DOI 10.1016/j.ceca.2008.06.001; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; van't Hoff M, 2008, OPT EXPRESS, V16, P18495, DOI 10.1364/OE.16.018495; Zong WJ, 2014, BIOMED OPT EXPRESS, V5, P1530, DOI 10.1364/BOE.5.001530	18	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136055	10.1371/journal.pone.0136055	http://dx.doi.org/10.1371/journal.pone.0136055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308212	Green Published, gold			2022-12-27	WOS:000360069400086
J	Fitzpatrick, MJ; Mathewson, PD; Porter, WP				Fitzpatrick, Megan J.; Mathewson, Paul D.; Porter, Warren P.			Validation of a Mechanistic Model for Non-Invasive Study of Ecological Energetics in an Endangered Wading Bird with Counter-Current Heat Exchange in its Legs	PLOS ONE			English	Article							DAILY ENERGY-EXPENDITURE; BODY-TEMPERATURE; IMPACTS; CONSERVATION; ASSOCIATION; ENDOTHERM; BEHAVIOR; CRANES	Mechanistic models provide a powerful, minimally invasive tool for gaining a deeper understanding of the ecology of animals across geographic space and time. In this paper, we modified and validated the accuracy of the mechanistic model Niche Mapper for simulating heat exchanges of animals with counter-current heat exchange mechanisms in their legs and animals that wade in water. We then used Niche Mapper to explore the effects of wading and counter-current heat exchange on the energy expenditures of Whooping Cranes, a long-legged wading bird. We validated model accuracy against the energy expenditure of two captive Whooping Cranes measured using the doubly-labeled water method and time energy budgets. Energy expenditure values modeled by Niche Mapper were similar to values measured by the doubly-labeled water method and values estimated from time-energy budgets. Future studies will be able to use Niche Mapper as a non-invasive tool to explore energy-based limits to the fundamental niche of Whooping Cranes and apply this knowledge to management decisions. Basic questions about the importance of counter-current exchange and wading to animal physiological tolerances can also now be explored with the model.	[Fitzpatrick, Megan J.; Mathewson, Paul D.; Porter, Warren P.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fitzpatrick, MJ (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	mjfitzpatric@wisc.edu			University of Wisconsin-Madison Zoology Department	University of Wisconsin-Madison Zoology Department	Three summers of graduate student support money was provided by the University of Wisconsin-Madison Zoology Department (www.zoology.wisc.edu) through Graduate Research Grant awards. Funding for doubly-labeled water supplies was provided by the University of Wisconsin-Madison Zoology Department through a First-Year Graduate Student Supplies Support Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCHOFF J, 1981, COMP BIOCHEM PHYS A, V69, P611, DOI 10.1016/0300-9629(81)90145-6; BAMFORD OS, 1980, J APPL PHYSIOL, V49, P491, DOI 10.1152/jappl.1980.49.3.491; BECH C, 1980, J COMP PHYSIOL, V136, P61, DOI 10.1007/BF00688623; BECKMAN WA, 1973, J HEAT TRANS-T ASME, V95, P257, DOI 10.1115/1.3450037; Byron Bird R, 2007, TRANSPORT PHENOMENA, V2nd, DOI DOI 10.1002/AIC.690070245; Calder W.A., 1974, AVIAN BIOL, V4, P259; Campbell Gaylon S., 1998; Cengel YA, 2008, APPENDIX 1 TABLES A, p[790, 798]; Chavez-Ramirez F., 1996, THESIS TEXAS A M U; Cheng HLM, 2002, J MAGN RESON IMAGING, V16, P598, DOI 10.1002/jmri.10199; Cooke Steven J., 2008, Endangered Species Research, V4, P165, DOI 10.3354/esr00063; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; Deville AS, 2014, J EXP BIOL, V217, P3700, DOI 10.1242/jeb.106344; Dudley PN, 2014, MAR ECOL PROG SER, V501, P265, DOI 10.3354/meps10665; Fort J, 2011, COMP BIOCHEM PHYS A, V158, P358, DOI 10.1016/j.cbpa.2010.05.004; Fuentes MMPB, 2013, ECOL MODEL, V251, P150, DOI 10.1016/j.ecolmodel.2012.12.020; GOLDSTEIN DL, 1988, AM ZOOL, V28, P829; Hainsworth F.R., 1981, ANIMAL PHYSL ADAPTAT; HORN AG, 1995, ANIM BEHAV, V50, P1171, DOI 10.1016/0003-3472(95)80033-6; Ilyashenko VY, 2008, BIOL BULL+, V35, P22, DOI 10.1134/S1062359008010044; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; KRAPU GL, 1985, AUK, V102, P362, DOI 10.2307/4086780; Long RA, 2014, ECOL MONOGR, V84, P513, DOI 10.1890/13-1273.1; Mathewson PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072863; Mathewson PD, 2013, THESIS U WISCONSIN M; MCCULLOUGH EC, 1971, ECOLOGY, V52, P1008, DOI 10.2307/1933806; Mcnab BK, 2009, COMP BIOCHEM PHYS A, V152, P22, DOI 10.1016/j.cbpa.2008.08.021; MIDTGARD U, 1981, ACTA ZOOL-STOCKHOLM, V62, P67, DOI 10.1111/j.1463-6395.1981.tb00617.x; MITCHELL JW, 1968, BIOPHYS J, V8, P897, DOI 10.1016/S0006-3495(68)86527-0; Mitchell Nicola, 2013, Biology - Basel, V2, P1, DOI 10.3390/biology2010001; Mitchell NJ, 2008, P ROY SOC B-BIOL SCI, V275, P2185, DOI 10.1098/rspb.2008.0438; Nagy KA, 1983, DOUBLY LABELED WATER; Natori Y, 2007, ECOL APPL, V17, P1441, DOI 10.1890/06-1785.1; Nelson JT, 1995, THESIS TEXAS A M U; Olsen Glenn H., 1996, P137; Porter WP, 2006, INTEGR COMP BIOL, V46, P1143, DOI 10.1093/icb/icl051; Porter W.P., 2006, METHOD SYSTEM CALCUL; PORTER WP, 1994, AUST J ZOOL, V42, P125, DOI 10.1071/ZO9940125; PORTER WP, 1973, OECOLOGIA, V13, P1, DOI 10.1007/BF00379617; PORTER WP, 1969, ECOL MONOGR, V39, P227, DOI 10.2307/1948545; PRINZINGER R, 1991, COMP BIOCHEM PHYS A, V99, P499, DOI 10.1016/0300-9629(91)90122-S; SchmidtNielson K., 1997, ANIMAL PHYSL ADAPTAT; SCHOLANDER PF, 1955, EVOLUTION, V9, P15, DOI 10.1111/j.1558-5646.1955.tb01510.x; SCHOLANDER PF, 1950, BIOL BULL, V99, P237, DOI 10.2307/1538741; SCHOLANDER PF, 1957, SCI AM, V196, P96, DOI 10.1038/scientificamerican0457-96; Speakman J.R., 1997, DOUBLY LABELLED WATE; STEEN I, 1965, ACTA PHYSIOL SCAND, V63, P285, DOI 10.1111/j.1748-1716.1965.tb04067.x; SWENGEL S, 1992, PROCEEDINGS OF THE SIXTH NORTH AMERICAN CRANE WORKSHOP, P151; Tieleman BI, 1999, PHYSIOL BIOCHEM ZOOL, V72, P87, DOI 10.1086/316640; Tomlinson S, 2014, TRENDS ECOL EVOL, V29, P280, DOI 10.1016/j.tree.2014.03.003; TUCKER VA, 1975, AM SCI, V63, P413; U.S. Fish and Wildlife Service, 2012, WHOOP CRAN GRUS AM 5; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; WOOLEY JB, 1978, J WILDLIFE MANAGE, V42, P739, DOI 10.2307/3800764	56	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136677	10.1371/journal.pone.0136677	http://dx.doi.org/10.1371/journal.pone.0136677			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308207	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400151
J	Geng, PL; Li, JJ; Wang, N; Ou, JJ; Xie, GF; Liu, C; Zhao, XX; Xiang, LS; Liao, YM; Liang, HJ				Geng, Peiliang; Li, Jianjun; Wang, Ning; Ou, Juanjuan; Xie, Ganfeng; Liu, Chen; Zhao, Xiaoxin; Xiang, Lisha; Liao, Yunmei; Liang, Houjie			PSCA rs2294008 Polymorphism with Increased Risk of Cancer	PLOS ONE			English	Article							STEM-CELL ANTIGEN; GENOME-WIDE ASSOCIATION; SINGLE NUCLEOTIDE POLYMORPHISMS; HELICOBACTER-PYLORI INFECTION; COMMON GENETIC-VARIANTS; GASTRIC-CANCER; BLADDER-CANCER; CHINESE POPULATION; SUSCEPTIBILITY LOCI; PANCREATIC-CANCER	Background Published data on the association between PSCA rs2294008 polymorphism and cancer risk have implicated inconclusive results. To determine the relationship and to precisely assess the effect size estimate of the association, we performed a meta-analysis. Methods We searched published literature in Embase and PubMed databases using the search terms "PSCA", "prostate stem cell antigen", "variants", "polymorphism", "polymorphisms", and "cancer". A total of 21 eligible articles were retrieved, with 27, 197 cancer cases and 48, 237 controls. Results On the whole, we found the association between PSCA rs2294008 polymorphism and cancer risk was statistically significant: TT vs CC: OR = 1.18, 95% CI, 1.10 to 1.27; TT + CT vs CC: OR = 1.08, 95% CI, 1.05 to 1.10; TT vs CT + CC: OR = 1.14, 95% CI, 1.07 to 1.21; T vs C: OR = 1.10, 95% CI, 1.06 to 1.14; CT vs CC: OR = 1.10, 95% CI, 1.06 to 1.13. Stratified analyses in cancer type and ethnicity showed similar results. Conclusions Based on the statistical evidence, we can draw a conclusion that the rs2294008 polymorphism of PSCA gene is likely to play a role in cancer carcinogenesis, especially in gastric cancer and bladder cancer.	[Liang, Houjie] Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing 400038, Peoples R China; Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University	Liang, HJ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing 400038, Peoples R China.	lianghoujie@sina.com	li, jian/GSE-0245-2022; LI, JIAN/GRY-2197-2022		National Natural Science Foundation of China [81272364]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant number 81272364 from the National Natural Science Foundation of China (to HJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Bahrenberg G, 2000, BIOCHEM BIOPH RES CO, V275, P783, DOI 10.1006/bbrc.2000.3393; Chan M, 2012, BREAST CANCER RES TR, V136, P209, DOI 10.1007/s10549-012-2234-y; Chung CC, 2011, HUM GENET, V130, P59, DOI 10.1007/s00439-011-1030-9; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eshel R, 2002, INT J CANCER, V98, P803, DOI 10.1002/ijc.10301; Fu YP, 2012, P NATL ACAD SCI USA, V109, P4974, DOI 10.1073/pnas.1202189109; Golka K, 2011, ARCH TOXICOL, V85, P539, DOI 10.1007/s00204-011-0676-3; Grubbs EG, 2006, ANN SURG ONCOL, V13, P1645, DOI 10.1245/s10434-006-9029-5; Han KR, 2004, J UROLOGY, V171, P1117, DOI 10.1097/01.ju.0000109982.60619.93; Hwang JY, 2013, J HUM GENET, V58, P233, DOI 10.1038/jhg.2012.158; Kim SY, 2012, ASIAN PAC J CANCER P, V13, P41, DOI 10.7314/APJCP.2012.13.1.041; Kohaar I, 2013, J NATL CANCER I, V105, P69, DOI 10.1093/jnci/djs458; Levi Edi, 2014, World J Gastrointest Pathophysiol, V5, P366, DOI 10.4291/wjgp.v5.i3.366; Li F, 2012, ASIAN PAC J CANCER P, V13, P2593, DOI 10.7314/APJCP.2012.13.6.2593; Lochhead P, 2011, GASTROENTEROLOGY, V140, P435, DOI 10.1053/j.gastro.2010.11.001; Lu Y, 2010, INT J CANCER, V127, P2183, DOI 10.1002/ijc.25228; Lunet N, 2003, INT J CANCER, V106, P953, DOI 10.1002/ijc.11306; Ma Zhicheng, 2013, Mol Carcinog, V52, P916, DOI 10.1002/mc.21932; MANTEL N, 1959, J NATL CANCER I, V22, P719; Matsuo K, 2009, INT J CANCER, V125, P1961, DOI 10.1002/ijc.24519; Oliveira-Cunha M, 2011, BRIT J CANCER, V104, P514, DOI 10.1038/sj.bjc.6606047; Ono H, 2012, GENE CHROMOSOME CANC, V51, P30, DOI 10.1002/gcc.20928; Ou JF, 2010, DNA CELL BIOL, V29, P319, DOI 10.1089/dna.2009.0960; Rai R, 2013, GENE, V530, P172, DOI 10.1016/j.gene.2013.08.058; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Rizzato C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073100; Saeki N, 2013, CANCER SCI, V104, P1, DOI 10.1111/cas.12042; Saeki N, 2011, GASTROENTEROLOGY, V140, P892, DOI 10.1053/j.gastro.2010.10.058; Saeki N, 2010, CLIN CANCER RES, V16, P3533, DOI 10.1158/1078-0432.CCR-09-3169; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Sala N, 2012, INT J CANCER, V130, P2417, DOI 10.1002/ijc.26243; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Smith Christopher, 2012, BMC Res Notes, V5, P371, DOI 10.1186/1756-0500-5-371; Song HR, 2011, MOL CARCINOGEN, V50, P871, DOI 10.1002/mc.20796; Tanikawa C, 2012, NAT GENET, V44, P430, DOI 10.1038/ng.1109; Wang ML, 2011, INT J CANCER, V129, P1207, DOI 10.1002/ijc.25740; Wang P, 2014, GENE CHROMOSOME CANC, V53, P98, DOI 10.1002/gcc.22121; Wang SZ, 2010, CARCINOGENESIS, V31, P621, DOI 10.1093/carcin/bgp323; Wang T, 2012, CANCER EPIDEM BIOMAR, V21, P843, DOI 10.1158/1055-9965.EPI-11-1176; Wang YS, 2014, MICROBES INFECT, V16, P840, DOI 10.1016/j.micinf.2014.06.009; Wu C, 2009, MOL CARCINOGEN, V48, P1131, DOI 10.1002/mc.20565; Wu RL, 1999, BIOMETRICS, V55, P355; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; Zeng ZR, 2011, MOL CARCINOGEN, V50, P353, DOI 10.1002/mc.20718; Zhang QH, 2012, ASIAN PAC J CANCER P, V13, P2867, DOI 10.7314/APJCP.2012.13.6.2867; Zhang T, 2012, EXP THER MED, V4, P158, DOI 10.3892/etm.2012.563; Zhao JD, 2012, WORLD CHIN J DIGESTO, V20, P418	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136269	10.1371/journal.pone.0136269	http://dx.doi.org/10.1371/journal.pone.0136269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308216	gold, Green Submitted, Green Published			2022-12-27	WOS:000360069400099
J	Kiferle, C; Fantini, E; Bassolino, L; Povero, G; Spelt, C; Buti, S; Giuliano, G; Quattrocchio, F; Koes, R; Perata, P; Gonzali, S				Kiferle, Claudia; Fantini, Elio; Bassolino, Laura; Povero, Giovanni; Spelt, Cornelis; Buti, Sara; Giuliano, Giovanni; Quattrocchio, Francesca; Koes, Ronald; Perata, Pierdomenico; Gonzali, Silvia			Tomato R2R3-MYB Proteins SlANT1 and SlAN2: Same Protein Activity, Different Roles	PLOS ONE			English	Article							ANTHOCYANIN-FRUIT TOMATO; GENE-EXPRESSION; PETUNIA ENCODES; POTENTIAL ROLE; FLAVONOIDS; TRANSCRIPTION; CAROTENOIDS; BIOSYNTHESIS; LYCOPERSICON; EVOLUTION	Anthocyanins are water-soluble polyphenolic compounds with a high nutraceutical value. Despite the fact that cultivated tomato varieties do not accumulate anthocyanins in the fruit, the biosynthetic pathway can be activated in the vegetative organs by several environmental stimuli. Little is known about the molecular mechanisms regulating anthocyanin synthesis in tomato. Here, we carried out a molecular and functional characterization of two genes, SlAN2 and SlANT1, encoding two R2R3-MYB transcription factors. We show that both can induce ectopic anthocyanin synthesis in transgenic tomato lines, including the fruit. However, only SlAN2 acts as a positive regulator of anthocyanin synthesis in vegetative tissues under high light or low temperature conditions.	[Kiferle, Claudia; Bassolino, Laura; Povero, Giovanni; Buti, Sara; Perata, Pierdomenico; Gonzali, Silvia] Scuola Super Sant Anna, PlantLab, Inst Life Sci, Pisa, Italy; [Fantini, Elio] Italian Natl Agcy New Technol, Energy & Sustainable Econ Dev, Trisaia Res Ctr, Rotondella, MT, Italy; [Povero, Giovanni; Spelt, Cornelis; Quattrocchio, Francesca; Koes, Ronald] Univ Amsterdam, Grad Sch Expt Plant Sci, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Giuliano, Giovanni] Italian Natl Agcy New Technol, Energy & Sustainable Econ Dev, Casaccia Res Ctr, Rome, Italy	Scuola Superiore Sant'Anna; Italian National Agency New Technical Energy & Sustainable Economics Development; University of Amsterdam; Italian National Agency New Technical Energy & Sustainable Economics Development	Perata, P (corresponding author), Scuola Super Sant Anna, PlantLab, Inst Life Sci, Pisa, Italy.	p.perata@sssup.it; s.gonzali@sssup.it	Quattrocchio, Francesca M./N-6658-2019; Fantini, Elio/AAX-7859-2020; Koes, Ronald/AAB-1716-2021; Bassolino, Laura/AHA-4771-2022; Bassolino, Laura/AGM-7099-2022; Bassolino, Laura/AAJ-3155-2020; Bassolino, Laura/AGM-7097-2022; Kiferle, Claudia/AAI-7391-2020; Giuliano, Giovanni/A-2701-2012	Quattrocchio, Francesca M./0000-0001-8040-4061; Fantini, Elio/0000-0001-6481-7560; Koes, Ronald/0000-0003-3793-5072; Bassolino, Laura/0000-0002-7242-0499; Kiferle, Claudia/0000-0002-4881-7066; Giuliano, Giovanni/0000-0002-2486-0510	Italian Ministry of Agriculture (Alisal project); Italian Ministry of Agriculture (Nutrisol project); European Commission (Traditom project) [634561]	Italian Ministry of Agriculture (Alisal project); Italian Ministry of Agriculture (Nutrisol project); European Commission (Traditom project)(European Commission)	Work supported by the Italian Ministry of Agriculture (Alisal and Nutrisol projects) and by the European Commission (Traditom project, contract n. 634561). The work benefited from the networking activities of COST action FA1106 (Quality Fruit).	Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Boches P, 2007, HORTSCIENCE, V42, P856; Boches PS, 2009, THESIS OREGON STATE; Bolger A, 2014, NAT GENET, V46, P1034, DOI 10.1038/ng.3046; Borghesi E, 2011, J AGR FOOD CHEM, V59, P11676, DOI 10.1021/jf2021623; Bovy A, 2007, METABOLOMICS, V3, P399, DOI 10.1007/s11306-007-0074-2; Brunetti C, 2013, INT J MOL SCI, V14, P3540, DOI 10.3390/ijms14023540; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Burton-Freeman BM, 2014, ADV NUTR, V5, P457, DOI 10.3945/an.114.005231; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; De Jong WS, 2004, THEOR APPL GENET, V108, P423, DOI 10.1007/s00122-003-1455-1; deVetten N, 1997, GENE DEV, V11, P1422, DOI 10.1101/gad.11.11.1422; Ekengren SK, 2003, PLANT J, V36, P905, DOI 10.1046/j.1365-313X.2003.01944.x; Fantini E, 2013, PLANT PHYSIOL, V163, P986, DOI 10.1104/pp.113.224733; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez-Pozo N, 2015, NUCLEIC ACIDS RES, V43, pD1036, DOI 10.1093/nar/gku1195; Fiedor J, 2014, NUTRIENTS, V6, P466, DOI 10.3390/nu6020466; Giovannoni JJ, PLANT CELL, V34, pS170; Gonzali S, 2009, TRENDS PLANT SCI, V14, P237, DOI 10.1016/j.tplants.2009.02.001; Gould KS, 2004, J BIOMED BIOTECHNOL, P314, DOI 10.1155/S1110724304406147; Holzapfel NP, 2013, INT J MOL SCI, V14, P14620, DOI 10.3390/ijms140714620; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Jia XY, 2015, PLANTA, V242, P283, DOI 10.1007/s00425-015-2305-5; Jones CM, 2003, J HERED, V94, P449, DOI 10.1093/jhered/esg093; Jung CS, 2009, THEOR APPL GENET, V120, P45, DOI 10.1007/s00122-009-1158-3; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Khachik F, 2002, EXP BIOL MED, V227, P845, DOI 10.1177/153537020222701002; Knight H, 2004, PLANT PHYSIOL, V135, P1710, DOI 10.1104/pp.104.043562; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Loreti E, 2008, NEW PHYTOL, V179, P1004, DOI 10.1111/j.1469-8137.2008.02511.x; Lovdal T, 2010, PHYTOCHEMISTRY, V71, P605, DOI 10.1016/j.phytochem.2009.12.014; MANGELS AR, 1993, J AM DIET ASSOC, V93, P284, DOI 10.1016/0002-8223(93)91553-3; Mathews H, 2003, PLANT CELL, V15, P1689, DOI 10.1105/tpc.012963; Meng X, 2015, PLANT PHYSIOL BIOCH, V89, P24, DOI 10.1016/j.plaphy.2015.02.005; Meng X, 2015, J PLANT PHYSIOL, V175, P1, DOI 10.1016/j.jplph.2014.09.018; Mes PJ, 2008, J AM SOC HORTIC SCI, V133, P262, DOI 10.21273/JASHS.133.2.262; Nei M., 2000, MOL EVOLUTION PHYLOG; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; Ohguro L, 2007, HIROSAKI MED J, V59, P23, DOI DOI 10.1159/0003; Orzaez D, 2006, PLANT PHYSIOL, V140, P3, DOI 10.1104/pp.105.068221; Pattanaik S, 2010, PLANTA, V231, P1061, DOI 10.1007/s00425-010-1108-y; Peralta IE, 2005, SYST BOT, V30, P424, DOI 10.1600/0363644054223657; Petro-Turza M., 1987, FOOD REV INT, V2, P309, DOI DOI 10.1080/87559128609540802; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Povero G, 2011, THESIS VRIJE U AMSTE; Povero G, 2011, J PLANT PHYSIOL, V168, P270, DOI 10.1016/j.jplph.2010.07.022; Quattrocchio F, 1998, PLANT J, V13, P475, DOI 10.1046/j.1365-313X.1998.00046.x; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sapir M, 2008, J HERED, V99, P292, DOI 10.1093/jhered/esm128; Rie S, 2007, BIOCHEM PHARMACOL, V74, P1619, DOI 10.1016/j.bcp.2007.08.008; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schreiber G, 2012, THEOR APPL GENET, V124, P295, DOI 10.1007/s00122-011-1705-6; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Spelt C, 2000, PLANT CELL, V12, P1619, DOI 10.1105/tpc.12.9.1619; Spencer JPE, 2010, BRIT J NUTR, V104, pS40, DOI 10.1017/S0007114510003934; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor IB., 1986, TOMATO CROP SCI BASI, P1, DOI DOI 10.1007/978-94-009-3137-4_1; Torres CA, 2005, J AGR FOOD CHEM, V53, P9536, DOI 10.1021/jf051176t; Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125; Tsuda T, 2012, MOL NUTR FOOD RES, V56, P159, DOI 10.1002/mnfr.201100526; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weits DA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4425; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zuluaga DL, 2008, FUNCT PLANT BIOL, V35, P606, DOI 10.1071/FP08021	69	91	101	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136365	10.1371/journal.pone.0136365	http://dx.doi.org/10.1371/journal.pone.0136365			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308527	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400115
J	Kumar, D; Sukapaka, M; Babu, GDK; Padwad, Y				Kumar, Dharmesh; Sukapaka, Mahesh; Babu, G. D. Kiran; Padwad, Yogendra			Chemical Composition and In Vitro Cytotoxicity of Essential Oils from Leaves and Flowers of Callistemon citrinus from Western Himalayas	PLOS ONE			English	Article							ANTIINFLAMMATORY ACTIVITY; CELL-CYCLE; STEM-BARK; RIGIDUS; LANCEOLATUS; EXPRESSION; ANTIOXIDANT; PROFILE; INDIA; LINE	Background Plant-based traditional system of medicine continues to play an important role in healthcare. In order to find new potent source of bioactive molecules, we studied the cytotoxic activity of the essential oils from the flowers and leaves of Callistemon citrinus. This is the first report on anticancer potential of essential oils of C. citrinus. Methods Cytotoxicity of essential oil was evaluated using sulfo-rhodamine B (SRB) assay against human lung carcinoma (A549), rat glioma (C-6), human colon cancer (Colo-205) and human cervical cancer (SiHa) cells. Apoptosis induction was evaluated by caspase-3/7 activity which was further confirmed by western blotting. Percentage cell apoptosis was determined by Annexin V based dead cell assay followed by DNA content as cell cycle analysis against A549 and C-6 cells. While 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay was used to check the toxicity against normal human peripheral blood mononuclear cells (PBMCs), the immunomodulatory activity on mouse splenocytes was evaluated using SRB assay. Results The GC and GC-MS analysis of these essential oils revealed high content of a-pinene (32.3%), limonene (13.1%) and a-terpineol (14.6%) in leaf sample, whereas the flower oil was dominated by 1,8-cineole (36.6%) followed by a-pinene (29.7%). The leaf oil contained higher amount of monoterpene hydrocarbons (52.1%) and sesquiterpenoids (14%) as compared to flower oil (44.6% and 1.2%, respectively). However, the flower oil was predominant in oxygenated monoterpenes (43.5%). Although both leaf and flower oils showed highest cytotoxicity on A549 cells (61.4%.+/- 5.0 and 66.7%+/- 2.2, respectively), only 100 mu g/mL flower oil was significantly active against C-6 cells (69.1%+/- 3.1). Interestingly, no toxicity was recorded on normal cells. Conclusion Higher concentration of 1,8-cineole and/or synergistic effect of the overall composition were probably responsible for the efficacy of flower and leaf oils against the tested cells. These oils may form potential source of natural anti-cancer compounds and play important role in human health.	[Kumar, Dharmesh; Sukapaka, Mahesh; Padwad, Yogendra] CSIR IHBT, Div Biotechnol, Regulatory Res Ctr, Palampur 176061, Himachal Prades, India; [Babu, G. D. Kiran] CSIR IHBT, Nat Plant Prod Div, Palampur 176061, Himachal Prades, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Padwad, Y (corresponding author), CSIR IHBT, Div Biotechnol, Regulatory Res Ctr, POB 6, Palampur 176061, Himachal Prades, India.	yogendra@ihbt.res.in		Padwad, Yogendra/0000-0003-1793-9340	CSIR-Institute of Himalayan Bioresource Technology [MLP-0039]	CSIR-Institute of Himalayan Bioresource Technology	This work was supoprted by CSIR-Institute of Himalayan Bioresource Technology, Institutional Project MLP-0039.	Adams R.P., 1995, IDENTIFICATION ESSEN; Aisien M. S. O., 2004, International Journal of Tropical Insect Science, V24, P196, DOI 10.1079/IJT200418; Babu GDK, 2009, BIOCHEM ENG J, V44, P226, DOI 10.1016/j.bej.2008.12.012; Babu KGD, 2005, FLAVOUR FRAG J, V20, P222, DOI 10.1002/ffj.1414; Babu KGD, 2007, IND CROP PROD, V26, P241, DOI 10.1016/j.indcrop.2007.03.013; Chane-Ming J., 1998, Journal of Essential Oil Research, V10, P429; Chistokhodova N, 2002, J ETHNOPHARMACOL, V81, P277, DOI 10.1016/S0378-8741(02)00097-1; De Vincenzi M, 2002, FITOTERAPIA, V73, P269, DOI 10.1016/S0367-326X(02)00062-X; Ding CY, 2013, J MED CHEM, V56, P5048, DOI 10.1021/jm400367n; Dongmo B. N., 2010, ASIAN J EXPT BIOL SC, V1, P907; Firoz M, 2011, BANGL J PHARMACOL, V6, P38, DOI 10.3329/bjp.v6i1.8154; Garriga J, 2003, MOL CELL BIOL, V23, P5165, DOI 10.1128/MCB.23.15.5165-5173.2003; Gomber C, 2007, CENT EUR J MED, V2, P79, DOI 10.2478/s11536-007-0004-8; Grassmann J, 2000, ARZNEIMITTELFORSCH, V50, P135; GUNDIDZA M, 1993, J SCI FOOD AGR, V63, P361, DOI 10.1002/jsfa.2740630315; Hu B, 2001, MOL CELL BIOL, V21, P2755, DOI 10.1128/MCB.21.8.2755-2766.2001; Hule A. K., 2009, International Journal of PharmTech Research, V1, P1032; Janson V, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.54; Jazet PM, 2009, J MED PLANTS RES, V3, P9; Jennings J, 1970, IND AGR ALIM, V5, P537; Jennings W., 1980, QUALITATIVE ANAL FLA; Ji T, 2009, Traditional Chinese medicine pills for treating hemorrhoid, Patent No. [CN 101352524 A, 101352524]; John PCL, 2001, PROTOPLASMA, V216, P119, DOI 10.1007/BF02673865; Joshi R, 2013, MED CHEM RES, V22, P4030, DOI 10.1007/s00044-012-0404-4; Juergens UR, 2003, RESP MED, V97, P250, DOI 10.1053/rmed.2003.1432; Kakkar P, 2007, MOL CELL BIOCHEM, V305, P235, DOI 10.1007/s11010-007-9520-8; Kim JH, 2009, J MED PLANTS RES, V3, P914; Kobayashi K, 2006, BIOL PHARM BULL, V29, P1275, DOI 10.1248/bpb.29.1275; Kohrt DM, 2009, CELL CYCLE, V8, P2837, DOI 10.4161/cc.8.17.9521; Kumar S., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P177, DOI 10.1016/S2221-1691(11)60022-1; Lee SJ, 2009, INT J ONCOL, V34, P1637, DOI 10.3892/ijo_00000294; LEVISON KK, 1994, J PHARM SCI, V83, P1367, DOI 10.1002/jps.2600830932; Mahapatra A, 2013, BIOCHEM PHARMACOL, V2, P4; Misra L. N., 1997, Journal of Essential Oil Research, V9, P625; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Naidu VGM, 2014, PHYTOMEDICINE, V21, P497, DOI 10.1016/j.phymed.2013.09.025; Oyedeji OO, 2009, MOLECULES, V14, P1990, DOI 10.3390/molecules14061990; Parashar G, 2012, MOL CELL BIOCHEM, V365, P29, DOI 10.1007/s11010-012-1240-z; Petronilho S, 2013, IND CROP PROD, V46, P369, DOI 10.1016/j.indcrop.2013.02.012; Philippi ME, 2010, ACTA POL PHARM, V67, P69; SANGWAN NK, 1990, PESTIC SCI, V28, P331, DOI 10.1002/ps.2780280311; Santos FA, 2000, PHYTOTHER RES, V14, P240, DOI 10.1002/1099-1573(200006)14:4&lt;240::AID-PTR573&gt;3.0.CO;2-X; Saxena S, 2006, PHARM BIOL, V44, P194, DOI 10.1080/13880200600685899; Seyydnejad S. M., 2010, American Journal of Applied Sciences, V7, P13; Sharma RK, 2006, FLAVOUR FRAG J, V21, P239, DOI 10.1002/ffj.1564; Sheridan C, 2008, MOL CELL, V31, P570, DOI 10.1016/j.molcel.2008.08.002; Shind PR., 2012, INT J PHARM PHARM SC, V4, P406; Silva CJ, 2010, QUIM NOVA, V33, P104, DOI 10.1590/S0100-40422010000100019; Small B. E. J., 1981, Australian Forestry, V44, P170; Spencer RD, 1991, FLORA NEW S WALES, P168; Srivastava SK, 2001, J ESSENT OIL RES, V13, P359, DOI 10.1080/10412905.2001.9712233; Stein SE., 1990, NATL I STANDARDS TEC; Sudhakar M., 2004, East and Central African Journal of Pharmaceutical Sciences, V7, P10; Sun SY, 2004, JNCI-J NATL CANCER I, V96, P662, DOI 10.1093/jnci/djh123; Walia M, 2012, ECAM	55	28	29	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0133823	10.1371/journal.pone.0133823	http://dx.doi.org/10.1371/journal.pone.0133823			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308916	Green Submitted, Green Published, gold			2022-12-27	WOS:000360069400015
J	Liao, YC; Hsiao, CT; Fuh, JL; Chern, CM; Lee, WJ; Guo, YC; Wang, SJ; Lee, IH; Liu, YT; Wang, YF; Chang, FC; Chang, MH; Soong, BW; Lee, YC				Liao, Yi-Chu; Hsiao, Cheng-Tsung; Fuh, Jong-Ling; Chern, Chang-Ming; Lee, Wei-Ju; Guo, Yuh-Cherng; Wang, Shuu-Jiun; Lee, I-Hui; Liu, Yo-Tsen; Wang, Yen-Feng; Chang, Feng-Chi; Chang, Ming-Hung; Soong, Bing-Wen; Lee, Yi-Chung			Characterization of CADASIL among the Han Chinese in Taiwan: Distinct Genotypic and Phenotypic Profiles	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT ARTERIOPATHY; SUBCORTICAL INFARCTS; NOTCH3 MUTATION; LEUKOENCEPHALOPATHY; PREVALENCE; HYPERINTENSITIES; HEADACHE; FEATURES; PATIENT; BINDING	Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is originally featured with a strong clustering of mutations in NOTCH3 exons 3-6 and leukoencephalopathy with frequent anterior temporal pole involvement. The present study aims at characterizing the genotypic and phenotypic profiles of CADASIL in Taiwan. One hundred and twelve patients with CADASIL from 95 families of Chinese descents in Taiwan were identified by Sanger sequencing of exons 2 to 24 of NOTCH3. Twenty different mutations in NOTCH3 were uncovered, including 3 novel ones, and R544C in exon 11 was the most common mutation, accounting for 70.5% of the pedigrees. Haplotype analyses were conducted in 14 families harboring NOTCH3 R544C mutation and demonstrated a common haplotype linked to NOTCH3 R544C at loci D19S929 and D19S411. Comparing with CADASIL in most Caucasian populations, CADASIL in Taiwan has several distinct features, including less frequent anterior temporal involvement, older age at symptom onset, higher incidence of intracerebral hemorrhage, and rarer occurrence of migraine. Subgroup analyses revealed that the R544C mutation is associated with lower frequency of anterior temporal involvement, later age at onset and higher frequency of cognitive dysfunction. In conclusion, the present study broadens the spectrum of NOTCH3 mutations and provides additional insights for the clinical and molecular characteristics of CADASIL patients of Han-Chinese descents.	[Liao, Yi-Chu; Hsiao, Cheng-Tsung; Fuh, Jong-Ling; Chern, Chang-Ming; Wang, Shuu-Jiun; Lee, I-Hui; Liu, Yo-Tsen; Wang, Yen-Feng; Soong, Bing-Wen; Lee, Yi-Chung] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Chang, Feng-Chi] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Liao, Yi-Chu; Hsiao, Cheng-Tsung; Fuh, Jong-Ling; Chern, Chang-Ming; Lee, Wei-Ju; Wang, Shuu-Jiun; Lee, I-Hui; Liu, Yo-Tsen; Wang, Yen-Feng; Chang, Ming-Hung; Soong, Bing-Wen; Lee, Yi-Chung] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan; [Chern, Chang-Ming; Wang, Shuu-Jiun; Lee, I-Hui] Natl Yang Ming Univ, Sch Med, Inst Brain Sci, Taipei 112, Taiwan; [Lee, Wei-Ju; Guo, Yuh-Cherng] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Fuh, Jong-Ling; Wang, Shuu-Jiun; Lee, I-Hui; Soong, Bing-Wen; Lee, Yi-Chung] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Lee, Wei-Ju; Chang, Ming-Hung] Taichung Vet Gen Hosp, Dept Neurol, Taichung, Taiwan; [Guo, Yuh-Cherng] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Guo, Yuh-Cherng] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Lee, YC (corresponding author), Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan.	ycli@vghtpe.gov.tw	Lee, Yi-Chung/GZK-7162-2022; Lee, Yi-Chung/H-8813-2019	Lee, Yi-Chung/0000-0003-0102-164X; Lee, Wei-Ju/0000-0002-3720-4539; Liao, Yi-Chu/0000-0002-9644-2086	Ministry of Science and Technology, Taiwan [102-2628-B-075-006-MY3, 103-2314-B-075-076-MY3]; Taipei Veterans General Hospital [V104C-041, V104C-061]; National Core Facility Program for Biotechnology, Taiwan [NSC-101-2319-B-010-001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Core Facility Program for Biotechnology, Taiwan	This work was supported by the grants from Ministry of Science and Technology, Taiwan (102-2628-B-075-006-MY3; 103-2314-B-075-076-MY3), Taipei Veterans General Hospital (V104C-041; V104C-061), and the High-throughput Genome Analysis Core Facility of National Core Facility Program for Biotechnology, Taiwan (NSC-101-2319-B-010-001). The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Adib-Samii P, 2010, STROKE, V41, P630, DOI 10.1161/STROKEAHA.109.568402; Bianchi S, 2015, J NEUROL, V262, P134, DOI 10.1007/s00415-014-7533-2; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Choi JC, 2014, CEPHALALGIA, V34, P22, DOI 10.1177/0333102413497598; Choi JC, 2013, J STROKE CEREBROVASC, V22, P126, DOI 10.1016/j.jstrokecerebrovasdis.2011.07.002; Choi JC, 2006, NEUROLOGY, V67, P2042, DOI 10.1212/01.wnl.0000246601.70918.06; Joutel A, 2004, AM J HUM GENET, V74, P338, DOI 10.1086/381506; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; Kim YE, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.004; Kotorii S, 2001, DEMENT GERIATR COGN, V12, P185, DOI 10.1159/000051256; Lee JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118163; Lee YC, 2006, J NEUROL SCI, V246, P111, DOI 10.1016/j.jns.2006.02.011; Lee YC, 2009, J NEUROL, V256, P249, DOI 10.1007/s00415-009-0091-3; Lian LF, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-98; Liem MK, 2008, J NEUROL, V255, P1978, DOI 10.1007/s00415-009-0036-x; Markus HS, 2002, NEUROLOGY, V59, P1134, DOI 10.1212/WNL.59.8.1134; Monet-Lepretre M, 2009, BRAIN, V132, P1601, DOI 10.1093/brain/awp049; Moreton FC, 2014, ACTA NEUROL SCAND, V130, P197, DOI 10.1111/ane.12266; Mykkanen K, 2004, EUR J HUM GENET, V12, P813, DOI 10.1038/sj.ejhg.5201221; O'Sullivan M, 2001, NEUROLOGY, V56, P628, DOI 10.1212/WNL.56.5.628; Oberstein SAJL, 2003, NEUROLOGY, V60, P2020; Opherk C, 2004, BRAIN, V127, P2533, DOI 10.1093/brain/awh282; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; Singhal S, 2005, AM J NEURORADIOL, V26, P2481; Singhal S, 2004, BRAIN, V127, P2031, DOI 10.1093/brain/awh223; Soong BW, 2013, J CHIN MED ASSOC, V76, P319, DOI 10.1016/j.jcma.2013.03.002; Stewart WF, 1996, NEUROLOGY, V47, P52, DOI 10.1212/WNL.47.1.52; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Tan QC, 2014, NEUROL INDIA, V62, P257, DOI 10.4103/0028-3886.136900; Testi S, 2012, J NEUROL SCI, V319, P37, DOI 10.1016/j.jns.2012.05.025; Tuominen S, 2001, STROKE, V32, P1767, DOI 10.1161/01.STR.32.8.1767; Wang ZX, 2011, J NEUROL NEUROSUR PS, V82, P534, DOI 10.1136/jnnp.2010.209247	32	51	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136501	10.1371/journal.pone.0136501	http://dx.doi.org/10.1371/journal.pone.0136501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308724	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400130
J	Zhou, W; Sun, Y; Zhu, LW; Zhou, B; Liu, J; Ji, X; Wang, XF; Wang, N; Gu, G; Feng, SZ; Qian, J; Guo, XJ				Zhou, Wei; Sun, Yang; Zhu, Lingwei; Zhou, Bo; Liu, Jun; Ji, Xue; Wang, Xiaofeng; Wang, Nan; Gu, Guibo; Feng, Shuzhang; Qian, Jun; Guo, Xuejun			Investigation of Anthrax Cases in North-East China, 2010-2014	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; MOLECULAR EVOLUTION; GENETIC DIVERSITY; REPEAT ANALYSIS; OUTBREAK; BEEF; POLYMORPHISM	We determined the genotypes of seven Bacillus anthracis strains that were recovered from nine anthrax outbreaks in North-East China from 2010 to 2014, and two approved vaccine strains that are currently in use in China. The causes of these cases were partly due to local farmers being unaware of the presence of anthrax, and butchers with open wounds having direct contact with anthrax-contaminated meat products. The genotype of five of the seven recovered strains was A.Br.001/002 sub-lineage, which was concordant with previously published research. The remaining two cases belongs to the A.Br.Ames sub-lineage. Both of these strains displayed an identical SNR pattern, which was the first time that this genotype was identified in North-East China. Strengthening education in remote villages of rural China is an important activity aimed at fostering attempts to prevent and control anthrax. The genotype of the vaccine strain Anthrax Spore Vaccine No. II was A.Br.008/009 and A.Br.001/002 for the vaccine strain Anthrax Spore Vaccine Non-capsulated. Further studies of their characteristics are clearly warranted.	[Zhou, Wei; Sun, Yang; Zhu, Lingwei; Zhou, Bo; Liu, Jun; Ji, Xue; Feng, Shuzhang; Qian, Jun; Guo, Xuejun] Inst Mil Vet, AMMS, Key Lab Jilin Prov Zoonosis Prevent & Control, Changchun, Jilin, Peoples R China; [Wang, Xiaofeng; Wang, Nan] Anim Dis Control & Prevent Ctr Jilin Prov, Xian, Jilin, Peoples R China; [Gu, Guibo] Anim Dis Control & Prevent Ctr Liaoning Prov, Liaoning, Peoples R China		Qian, J (corresponding author), Inst Mil Vet, AMMS, Key Lab Jilin Prov Zoonosis Prevent & Control, Changchun, Jilin, Peoples R China.	qianj1970@126.com; xuejung@yahoo.com			National High Technology Research and Development Program ("863" Program) of China [2012AA022006]; Military Medical Health Project [13CXZ024]	National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China); Military Medical Health Project	The authors are thankful for research funding from The National High Technology Research and Development Program ("863" Program) of China (No. 2012AA022006) (http://www.863.gov.cn/) and The Military Medical Health Project (No. 13CXZ024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEYER W, 1995, MICROBIOL RES, V150, P179, DOI 10.1016/S0944-5013(11)80054-6; Beyer W, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001534; Blackburn JK, 2014, VECTOR-BORNE ZOONOT, V14, P615, DOI 10.1089/vbz.2013.1519; Cameron J, 1984, Vaccine, V2, P237, DOI 10.1016/0264-410X(84)90036-7; DECANDOLE CA, 1962, CAN MED ASSOC J, V87, P1187; Derzelle S, 2011, J CLIN MICROBIOL, V49, P4286, DOI 10.1128/JCM.05439-11; Dong S, 1989, UK SALISBURY MED B; Freidlander AM, 1997, USE BIOL WEAPONS, P437; Hawkes R, 2008, CAN VET J, V49, P889; Hoffmaster AR, 2002, EMERG INFECT DIS, V8, P1111, DOI 10.3201/eid0810.020394; HUTSON RA, 1993, J APPL BACTERIOL, V75, P463, DOI 10.1111/j.1365-2672.1993.tb02803.x; Keim P, 1997, J BACTERIOL, V179, P818, DOI 10.1128/jb.179.3.818-824.1997; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Kenefic LJ, 2008, LETT APPL MICROBIOL, V46, P600, DOI 10.1111/j.1472-765X.2008.02353.x; KNISELY RF, 1966, J BACTERIOL, V92, P784, DOI 10.1128/JB.92.3.784-786.1966; Le Fleche P, 2001, BMC Microbiol, V1, P2; Lewerin SS, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-7; Liang X, 1995, SALISBURY MED B; Lista F, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-33; Muscillo M, 2005, J CLIN MICROBIOL, V43, P4758, DOI 10.1128/JCM.43.9.4758-4765.2005; Popescu R, 2011, EUROSURVEILLANCE B E, V16; Price EP, 2012, EMERG INFECT DIS, V18, P1307, DOI 10.3201/eid1808.111343; Simonson TS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-71; Stefos A, 2012, EUROSURVEILLANCE B E, V17; Stratilo CW, 2012, APPL ENVIRON MICROB, V78, P6433, DOI 10.1128/AEM.01036-12; Stratilo CW, 2006, J CLIN MICROBIOL, V44, P777, DOI 10.1128/JCM.44.3.777-782.2006; Sylvestre P, 2003, J BACTERIOL, V185, P1555, DOI 10.1128/JB.185.5.1555-1563.2003; Tan ZM, 2014, AM J TROP MED HYG, V91, P574, DOI 10.4269/ajtmh.13-0633; Thierry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095131; TURNBULL PCB, 1991, VACCINE, V9, P533, DOI 10.1016/0264-410X(91)90237-Z; Turnbull PCB, 2002, CURR TOP MICROBIOL, V271, P1; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Wang BX, 2002, PROG MICROBIOL IMMUN, V30, P14; World Organisation for Animal Health (OIE), 2012, MANUAL DIAGNOSTIC TE, V6th	35	7	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135777	10.1371/journal.pone.0135777	http://dx.doi.org/10.1371/journal.pone.0135777			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308449	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400075
J	Chen, B; Xie, FY; Tang, CC; Ma, GS; Wei, L; Chen, Z				Chen, Bin; Xie, Fangyi; Tang, Chengchun; Ma, Genshan; Wei, Li; Chen, Zhong			Study of Five Pubertal Transition-Related Gene Polymorphisms as Risk Factors for Premature Coronary Artery Disease in a Chinese Han Population	PLOS ONE			English	Article							ASSOCIATION; MENARCHE; HYPERLIPIDEMIA; OBESITY; WOMEN; MEN; AGE	Background Recently, single nucleotide polymorphisms (SNPs) (DLK-rs10144321, SIX6-rs1254337, MKRN3-rs12148769, LIN28B-rs7759938, and KCNK9-rs1469039) were found to be strongly associated with age at menarche. Recent studies also suggested that age at menarche is a heritable trait and is associated with risks for obesity, type 2 diabetes mellitus (T2DM), cardiovascular disease, and all-cause mortality. Since an association between these five SNPs and premature coronary artery disease (CAD) has never been reported, we investigated whether these SNPs are associated with premature CAD and its severity in a Chinese Han population. Methods We enrolled 432 consecutive patients including 198 with premature CAD (<55 years in men and <65 years in women) and 234 controls. All subjects were genotyped for the five SNPs by the PCR-ligase detection reaction method. The associations between these SNPs and premature CAD and its severity were analyzed. Results The following genotypes were identified: GG, AG, and AA at rs10144321 and rs12148769; TT, AT, and AA at rs1254337; CC, CT, and TT at rs1469039; and TT and CT at rs7759938. Significant differences in genotype distribution frequencies at rs1254337 were found between controls and patients with premature CAD (P < 0.05). No associations were found between the five SNPs and the severity of coronary lesions (all P > 0.05). Compared with controls, patients with premature CAD had a higher prevalence of T2DM and dyslipidemia, and the proportion of patients with T2DM rose significantly with an increase in the number of stenosed coronary vessels (all P < 0.05). After adjustment for the clinical parameters in multi-variable analysis, three factors were identified that significantly increased the risk of premature CAD: the AA genotype at rs1254337 (OR: 2.388, 95% CI: 1.190-4.792, P = 0.014), male gender (OR: 1.565, 95% CI: 1.012-2.420, P = 0.044), and T2DM (OR 2.252, 95% CI: 1.233-4.348, P = 0.015). Conclusions Among the five pubertal transition-related gene polymorphisms, we identified an association between rs1254337 and premature CAD in a Chinese Han population.	[Chen, Bin; Chen, Zhong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Cardiol, Shanghai 200233, Peoples R China; [Xie, Fangyi] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Cent Lab, Shanghai 200233, Peoples R China; [Tang, Chengchun; Ma, Genshan] Southeast Univ, Affiliated Zhongda Hosp, Dept Cardiol, Nanjing 210009, Jiangsu, Peoples R China; [Wei, Li] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol, Shanghai 200233, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Southeast University - China; Shanghai Jiao Tong University	Chen, Z (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Cardiol, 600 Yishan Rd, Shanghai 200233, Peoples R China.	zhongchen7498@sina.com.cn			Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai; Pudong New Area Science and Technology Development Fund [PKJ2014-Y09]; Shanghai Municipal Commission of Health and Family Planning Research Project [201440309]	Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai; Pudong New Area Science and Technology Development Fund; Shanghai Municipal Commission of Health and Family Planning Research Project	The study was funded by Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai (Dr. Li Wei), Pudong New Area Science and Technology Development Fund (PKJ2014-Y09), and Shanghai Municipal Commission of Health and Family Planning Research Project (201440309) (Dr. Zhong Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boekholdt SM, 2012, JAMA-J AM MED ASSOC, V307, P1302, DOI 10.1001/jama.2012.366; Chen Z, 2010, MOL BIOL REP, V37, P207, DOI 10.1007/s11033-009-9597-0; Chen Z, 2009, MOL BIOL REP, V36, P889, DOI 10.1007/s11033-008-9259-7; Davis CR, 2014, METABOLISM, V63, P199, DOI 10.1016/j.metabol.2013.08.013; Day FR, 2015, SCI REP-UK, V5, DOI 10.1038/srep11208; Demerath EW, 2013, HUM MOL GENET, V22, P3329, DOI 10.1093/hmg/ddt181; Favis R, 2000, NAT BIOTECHNOL, V18, P561, DOI 10.1038/75452; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Henrichs KL, 2014, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2014-14; Hopkins PN, 2005, J AM COLL CARDIOL, V45, P1003, DOI 10.1016/j.jacc.2004.11.062; Hopkins PN, 2003, CIRCULATION, V108, P519, DOI 10.1161/01.CIR.0000081777.17879.85; Klein LW, 2003, J AM COLL CARDIOL, V41, P529, DOI 10.1016/S0735-1097(02)02861-9; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Pencina MJ, 2015, EUR J PREV CARD 0129; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Prentice P, 2013, INT J OBESITY, V37, P1036, DOI 10.1038/ijo.2012.177; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Smith SC, 2010, ARCH INTERN MED, V170, P40, DOI 10.1001/archinternmed.2009.457; Tu WZ, 2015, J ADOLESCENT HEALTH, V56, P66, DOI 10.1016/j.jadohealth.2014.07.020; Wang W, 2014, BIOMED ENVIRON SCI, V27, P552, DOI 10.3967/bes2014.085; Xiao ZX, 2006, HEPATOL RES, V34, P150, DOI 10.1016/j.hepres.2005.12.007; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205; 陈伟伟, 2014, [中国循环杂志, Chinese Circulation Journal], V29, P487	23	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136496	10.1371/journal.pone.0136496	http://dx.doi.org/10.1371/journal.pone.0136496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305337	Green Submitted, Green Published, gold			2022-12-27	WOS:000359995500084
J	Crabb, JW; Hu, B; Crabb, JS; Triozzi, P; Saunthararajah, Y; Tubbs, R; Singh, AD				Crabb, John W.; Hu, Bo; Crabb, John S.; Triozzi, Pierre; Saunthararajah, Yogen; Tubbs, Raymond; Singh, Arun D.			iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors	PLOS ONE			English	Article							PREDICTING METASTASIS; GENE-EXPRESSION; IDENTIFICATION; OVEREXPRESSION; MONOSOMY-3; MUTATIONS; ESOPHAGUS; PROTEINS; CANCERS; MARKERS	Background Uveal melanoma is the most common malignancy of the adult eye. The overall mortality rate is high because this aggressive cancer often metastasizes before ophthalmic diagnosis. Quantitative proteomic analysis of primary metastasizing and non-metastasizing tumors was pursued for insights into mechanisms and biomarkers of uveal melanoma metastasis. Methods Eight metastatic and 7 non-metastatic human primary uveal melanoma tumors were analyzed by LC MS/MS iTRAQ technology with Bruch's membrane/choroid complex from normal postmortem eyes as control tissue. Tryptic peptides from tumor and control proteins were labeled with iTRAQ tags, fractionated by cation exchange chromatography, and analyzed by LC MS/MS. Protein identification utilized the Mascot search engine and the human Uni-Prot/Swiss-Protein database with false discovery <= 1%; protein quantitation utilized the Mascot weighted average method. Proteins designated differentially expressed exhibited quantitative differences (p <= 0.05, t-test) in a training set of five metastatic and five non-metastatic tumors. Logistic regression models developed from the training set were used to classify the metastatic status of five independent tumors. Results Of 1644 proteins identified and quantified in 5 metastatic and 5 non-metastatic tumors, 12 proteins were found uniquely in >= 3 metastatic tumors, 28 were found significantly elevated and 30 significantly decreased only in metastatic tumors, and 31 were designated differentially expressed between metastatic and non-metastatic tumors. Logistic regression modeling of differentially expressed collagen alpha-3(VI) and heat shock protein beta-1 allowed correct prediction of metastasis status for each of five independent tumor specimens. Conclusions The present data provide new clues to molecular differences in metastatic and non-metastatic uveal melanoma tumors. While sample size is limited and validation required, the results support collagen alpha-3(VI) and heat shock protein beta-1 as candidate biomarkers of uveal melanoma metastasis and establish a quantitative proteomic database for uveal melanoma primary tumors.	[Crabb, John W.; Crabb, John S.; Singh, Arun D.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Crabb, John W.; Hu, Bo] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA; [Crabb, John W.; Singh, Arun D.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Ophthalmol, Cleveland, OH 44106 USA; [Crabb, John W.; Saunthararajah, Yogen] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA; [Hu, Bo] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Triozzi, Pierre; Saunthararajah, Yogen] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA; [Tubbs, Raymond] Cleveland Clin, Dept Mol Pathol, Pathol & Lab Med Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Crabb, JW (corresponding author), Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA.	crabbj@ccf.org		Singh, Arun/0000-0001-9411-0320	National Institutes of Health [EY018147, EY14239, EY15638, EY21840, EY022134]; Ohio Biomedical Research and Technology Transfer (BRTT) [05-29]; Challenge Grant from Research to Prevent Blindness (RPB); RPB Senior Investigator Award; Cleveland Clinic Foundation; NATIONAL EYE INSTITUTE [R01EY014239, R21EY025388, R21EY021840, R21EY022134, R21EY018147, R24EY015638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Biomedical Research and Technology Transfer (BRTT); Challenge Grant from Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); RPB Senior Investigator Award; Cleveland Clinic Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported in part by National Institutes of Health grants EY018147 (JWC), EY14239 (JWC), EY15638 (Cole Eye Institute), EY21840(JWC), EY022134(JWC), Ohio Biomedical Research and Technology Transfer (BRTT) grant 05-29 (Cole Eye Institute), a Challenge Grant (Cole Eye Institute) from Research to Prevent Blindness (RPB), an RPB Senior Investigator Award to JWC, and The Cleveland Clinic Foundation (JWC).	Abildgaard SKO, 2013, J ONCOL, V2013, DOI 10.1155/2013/820953; Albert DM, 1998, AM J OPHTHALMOL, V125, P767; Arafat H, 2011, SURGERY, V150, P306, DOI 10.1016/j.surg.2011.05.011; Arrigo AP, 2014, CANCERS, V6, P333, DOI 10.3390/cancers6010333; Asch HL, 1996, CANCER RES, V56, P4841; Bagger M, 2015, INVEST OPHTH VIS SCI, V56, P438, DOI 10.1167/iovs.14-15571; Bollinger KE, 2012, MOL VIS, V18, P2001; Bollinger KE, 2011, INVEST OPHTH VIS SCI, V52, P8287, DOI 10.1167/iovs.11-8218; Booij JC, 2010, PROG RETIN EYE RES, V29, P1, DOI 10.1016/j.preteyeres.2009.08.003; Cheng P, 2005, WORLD J GASTROENTERO, V11, P5117; Choi SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092325; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Collaborative Ocular Melanoma Grp, 2006, ARCH OPHTHALMOL-CHIC, V124, P1684; Coupland SE, 2010, INVEST OPHTH VIS SCI, V51, P12, DOI 10.1167/iovs.09-3913; Crabb JW, 2010, EXP EYE RES, V91, P107, DOI 10.1016/j.exer.2010.04.004; Damato B, 2009, INVEST OPHTH VIS SCI, V50, P3048, DOI 10.1167/iovs.08-3165; DIXON WJ, 1953, BIOMETRICS, V9, P74, DOI 10.2307/3001634; Dopierala J, 2010, INVEST OPHTH VIS SCI, V51, P4898, DOI 10.1167/iovs.09-5004; Harbour JW, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00979.x; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Harbour JW, 2009, AM J OPHTHALMOL, V148, P823, DOI 10.1016/j.ajo.2009.07.004; Herlihy N, 2015, INVEST OPHTH VIS SCI, V56, P1447, DOI 10.1167/iovs.14-15250; Huck L, 2010, P NATL ACAD SCI USA, V107, P15559, DOI 10.1073/pnas.1003034107; Iyengar P, 2005, J CLIN INVEST, V115, P1163, DOI 10.1172/JCI200523424; Jmor F, 2012, ACTA OPHTHALMOL, V90, P534, DOI 10.1111/j.1755-3768.2010.02038.x; Kang CY, 2014, J GASTROINTEST SURG, V18, P7, DOI 10.1007/s11605-013-2326-y; KATH R, 1993, CANCER, V72, P2219, DOI 10.1002/1097-0142(19931001)72:7<2219::AID-CNCR2820720725>3.0.CO;2-J; Lee IN, 2005, J PROTEOME RES, V4, P2062, DOI 10.1021/pr0502018; Lee YJ, 2012, ANGIOGENESIS, V15, P229, DOI 10.1007/s10456-012-9255-3; Li Z, 2012, J PROTEOME RES, V11, P1582, DOI 10.1021/pr200748h; Lichtenfels R, 2009, MOL CELL PROTEOMICS, V8, P2827, DOI 10.1074/mcp.M900168-MCP200; Linge A, 2012, INVEST OPHTH VIS SCI, V53, P4634, DOI 10.1167/iovs.11-9019; Maat W, 2007, ARCH PATHOL LAB MED, V131, P91; Missotten GS, 2003, MELANOMA RES, V13, P627, DOI 10.1097/00008390-200312000-00013; Miyagi M, 2002, MOL CELL PROTEOMICS, V1, P293, DOI 10.1074/mcp.M100034-MCP200; Onken MD, 2007, CLIN CANCER RES, V13, P2923, DOI 10.1158/1078-0432.CCR-06-2383; Onken MD, 2012, OPHTHALMOLOGY, V119, P1596, DOI 10.1016/j.ophtha.2012.02.017; Onken MD, 2010, J MOL DIAGN, V12, P461, DOI 10.2353/jmoldx.2010.090220; Pardo M, 2005, PROTEOMICS, V5, P4980, DOI 10.1002/pmic.200500030; Pardo M, 2007, J PROTEOME RES, V6, P2802, DOI 10.1021/pr070021t; Pardo M, 2007, EXPERT REV PROTEOMIC, V4, P273, DOI 10.1586/14789450.4.2.273; Pardo M, 2006, INT J CANCER, V119, P1014, DOI 10.1002/ijc.21942; Ramasamy P, 2014, EXP EYE RES, V118, P1, DOI 10.1016/j.exer.2013.09.005; Renganathan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076325; ROSNER B, 1983, TECHNOMETRICS, V25, P165, DOI 10.2307/1268549; Sherman-Baust CA, 2003, CANCER CELL, V3, P377, DOI 10.1016/S1535-6108(03)00058-8; Singh AD, 2012, INVEST OPHTH VIS SCI, V53, P3331, DOI 10.1167/iovs.11-9027; Singh AD, 2011, OPHTHALMOLOGY, V118, P1881, DOI 10.1016/j.ophtha.2011.01.040; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Straume O, 2012, P NATL ACAD SCI USA, V109, P8699, DOI 10.1073/pnas.1017909109; Thelin MA, 2012, CANCER RES, V72, P1943, DOI 10.1158/0008-5472.CAN-11-1351; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; van den Bosch T, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/360136; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Wang AG, 2006, BIOCHEM BIOPH RES CO, V345, P1022, DOI 10.1016/j.bbrc.2006.04.175; Wang FL, 2013, J RADIAT RES, V54, P649, DOI 10.1093/jrr/rrt010; Xie XJ, 2014, ONCOL LETT, V7, P1537, DOI 10.3892/ol.2014.1910; Yamada S, 2004, ONCOGENE, V23, P5901, DOI 10.1038/sj.onc.1207782; Yan LB, 2013, INT J OPHTHALMOL-CHI, V6, P286, DOI 10.3980/j.issn.2222-3959.2013.03.06; YANG YM, 1994, J CELL BIOL, V127, P1097, DOI 10.1083/jcb.127.4.1097; Yuan XL, 2010, MOL CELL PROTEOMICS, V9, P1031, DOI 10.1074/mcp.M900523-MCP200; Zuidervaart W, 2006, INVEST OPHTH VIS SCI, V47, P786, DOI 10.1167/iovs.05-0314	63	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135543	10.1371/journal.pone.0135543	http://dx.doi.org/10.1371/journal.pone.0135543			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305875	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500027
J	Verkuil, B; Atasayi, S; Molendijk, ML				Verkuil, Bart; Atasayi, Serpil; Molendijk, Marc L.			Workplace Bullying and Mental Health: A Meta-Analysis on Cross-Sectional and Longitudinal Data	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; DEPRESSIVE SYMPTOMS; GRADUATE NURSES; MEDIATING ROLE; NEGATIVE ACTS; WORK; EXPOSURE; HARASSMENT; JOB; CHILDHOOD	Background A growing body of research has confirmed that workplace bullying is a source of distress and poor mental health. Here we summarize the cross-sectional and longitudinal literature on these associations. Methods Systematic review and meta-analyses on the relation between workplace bullying and mental health. Results The cross-sectional data (65 effect sizes, N = 115.783) showed positive associations between workplace bullying and symptoms of depression (r = .28, 95% CI = .23-.34), anxiety (r = .34, 95% CI = .29-.40) and stress-related psychological complaints (r = .37, 95% CI = .30-.44). Pooling the literature that investigated longitudinal relationships (26 effect sizes, N = 54.450) showed that workplace bullying was related to mental health complaints over time (r = 0.21, 95% CI = 0.13-0.21). Interestingly, baseline mental health problems were associated with subsequent exposure to workplace bullying (r = 0.18, 95% CI = 0.10-0.27; 11 effect sizes, N = 27.028). Limitations All data were self-reported, raising the possibility of reporting-and response set bias. Conclusions Workplace bullying is consistently, and in a bi-directional manner, associated with reduced mental health. This may call for intervention strategies against bullying at work.	[Verkuil, Bart; Atasayi, Serpil; Molendijk, Marc L.] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Verkuil, Bart; Molendijk, Marc L.] Leiden Univ, Med Ctr, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Verkuil, Bart] Skils, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Verkuil, B (corresponding author), Leiden Univ, Inst Psychol, Leiden, Netherlands.	bverkuil@fsw.leidenuniv.nl		Verkuil, Bart/0000-0002-9991-0690				Agervold M, 2004, WORK STRESS, V18, P336, DOI 10.1080/02678370412331319794; Agervold M, 2009, SCAND J PSYCHOL, V50, P267, DOI 10.1111/j.1467-9450.2009.00710.x; Balducci C, 2011, ANXIETY STRESS COPIN, V24, P499, DOI 10.1080/10615806.2011.555533; Bardakci E, 2016, J TRANSCULT NURS, V27, P166, DOI 10.1177/1043659614549073; Bhui KS, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/515874; Bilgel N, 2006, OCCUP MED-OXFORD, V56, P226, DOI 10.1093/occmed/kqj041; Bjorkqvist K, 2001, PHYSIOL BEHAV, V73, P435, DOI 10.1016/S0031-9384(01)00490-5; Bond SA, 2010, ORGANIZATION DEVELOP; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Carter M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002628; Cassidy T, 2014, WORK STRESS, V28, P255, DOI 10.1080/02678373.2014.927020; Copeland WE, 2014, P NATL ACAD SCI USA, V111, P7570, DOI 10.1073/pnas.1323641111; Dehue F, 2012, INT J STRESS MANAGE, V19, P175, DOI 10.1037/a0028969; Demir D, 2013, ASIA PAC J HUM RESOU, V51, P392, DOI 10.1111/1744-7941.12002; Duncan R. D., 1999, CHILD MALTREATMENT, V4, P45, DOI DOI 10.1177/1077559599004001005; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Einarsen S, 2009, WORK STRESS, V23, P24, DOI 10.1080/02678370902815673; Einarsen S, 2015, INT ARCH OCC ENV HEA, V88, P131, DOI 10.1007/s00420-014-0944-7; Eriksen W, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-290; Figueiredo-Ferraz H, 2015, J INTELL DISABIL RES, V59, P39, DOI 10.1111/jir.12084; Finne LB, 2011, SCAND J WORK ENV HEA, V37, P276, DOI 10.5271/sjweh.3156; Gardner D, 2013, ETHNICITY WORKPLACE; Glaso L, 2012, VIOLENCE VICTIMS, V27, P360, DOI 10.1891/0886-6708.27.3.360; Glaso L, 2011, SCAND J PSYCHOL, V52, P484, DOI 10.1111/j.1467-9450.2011.00895.x; Gullander M, 2014, J OCCUP ENVIRON MED, V56, P1258, DOI 10.1097/JOM.0000000000000339; Hansen AM, 2006, J PSYCHOSOM RES, V60, P63, DOI 10.1016/j.jpsychores.2005.06.078; Hansen AM, 2011, J PSYCHOSOM RES, V70, P19, DOI 10.1016/j.jpsychores.2010.05.010; Hansson M, 2010, J AFFECT DISORDERS, V124, P54, DOI 10.1016/j.jad.2009.10.032; Hauge LJ, 2010, SCAND J PSYCHOL, V51, P426, DOI 10.1111/j.1467-9450.2010.00813.x; Hershcovis MS, 2010, J ORGAN BEHAV, V31, P24, DOI 10.1002/job.621; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hogh A, 2005, INT J BEHAV MED, V12, P256, DOI 10.1207/s15327558ijbm1204_6; Hogh A, 2012, J PSYCHOSOM RES, V73, P47, DOI 10.1016/j.jpsychores.2012.04.004; Hogh A, 2011, J NURS MANAGE, V19, P742, DOI 10.1111/j.1365-2834.2011.01264.x; Hoobler JM, 2010, J OCCUP HEALTH PSYCH, V15, P434, DOI 10.1037/a0021000; Johannessen HA, 2013, J OCCUP ENVIRON MED, V55, P605, DOI 10.1097/JOM.0b013e3182917899; Karsten J, 2011, BRIT J PSYCHIAT, V198, P206, DOI 10.1192/bjp.bp.110.080572; Khubchandani J, 2015, J COMMUN HEALTH, V40, P555, DOI 10.1007/s10900-014-9971-2; Kingdom S E, 2011, Int Marit Health, V62, P200; Kivimaki M, 2003, OCCUP ENVIRON MED, V60, P779, DOI 10.1136/oem.60.10.779; Kivimaki M, 2000, OCCUP ENVIRON MED, V57, P656, DOI 10.1136/oem.57.10.656; Kostev K, 2014, GER MED SCI, V12; Lahelma E, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.115212; Laine H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-588; Laschinger HKS, 2015, J NURS MANAGE, V23, P252, DOI 10.1111/jonm.12122; Laschinger HKS, 2014, EUR J WORK ORGAN PSY, V23, P739, DOI 10.1080/1359432X.2013.804646; Laschinger HKS, 2012, INT J NURS STUD, V49, P282, DOI 10.1016/j.ijnurstu.2011.09.004; Laschinger HKS, 2010, J ADV NURS, V66, P2732, DOI 10.1111/j.1365-2648.2010.05420.x; Law R, 2011, ACCIDENT ANAL PREV, V43, P1782, DOI 10.1016/j.aap.2011.04.010; Lee RT, 2006, EUR J WORK ORGAN PSY, V15, P352, DOI 10.1080/13594320600636531; Lereya ST, 2015, LANCET PSYCHIAT, V2, P524, DOI 10.1016/S2215-0366(15)00165-0; Lopresti AL, 2013, J AFFECT DISORDERS, V148, P12, DOI 10.1016/j.jad.2013.01.014; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Malinauskiene V, 2014, INT J OCCUP MED ENV, V27, P919, DOI 10.2478/s13382-014-0328-y; Mathisen GE, 2008, SCAND J PSYCHOL, V49, P59, DOI 10.1111/j.1467-9450.2007.00602.x; Matthiesen SB, 2004, BRIT J GUID COUNS, V32, P335, DOI 10.1080/03069880410001723558; McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X; McTernan WP, 2013, WORK STRESS, V27, P321, DOI 10.1080/02678373.2013.846948; Mikkelsen E., 2001, EUR J WORK ORGAN PSY, V10, P393, DOI DOI 10.1080/13594320143000816; Mikkelsen EG, 2002, SCAND J PSYCHOL, V43, P397, DOI 10.1111/1467-9450.00307; Moreneo-Jimenez B, 2007, PSYCHOL SPAIN, V11, P85; Moreno-Jimenez B, 2009, PERS INDIV DIFFER, V46, P359, DOI 10.1016/j.paid.2008.10.031; Niedhammer I, 2014, OCC MED; Niedhammer I, 2006, J PSYCHOSOM RES, V61, P251, DOI 10.1016/j.jpsychores.2006.03.051; Nielsen MB, 2008, J OCCUP HEALTH PSYCH, V13, P128, DOI 10.1037/1076-8998.13.2.128; Nielsen Morten Birkeland, 2014, Tidsskr Nor Laegeforen, V134, P1233, DOI 10.4045/tidsskr.13.0880; Nielsen MB, 2015, AGGRESS VIOLENT BEH, V21, P17, DOI 10.1016/j.avb.2015.01.001; Nielsen MB, 2013, INT ARCH OCC ENV HEA, V86, P875, DOI 10.1007/s00420-012-0825-x; Nielsen MB, 2012, WORK STRESS, V26, P309, DOI 10.1080/02678373.2012.734709; Nielsen MB, 2012, SCAND J WORK ENV HEA, V38, P38, DOI 10.5271/sjweh.3178; Nurius PS, 2015, CHILD ABUSE NEGLECT, V45, P143, DOI 10.1016/j.chiabu.2015.03.008; Ortega A, 2011, J NURS MANAGE, V19, P752, DOI 10.1111/j.1365-2834.2010.01179.x; Ortega A, 2009, INT ARCH OCC ENV HEA, V82, P417, DOI 10.1007/s00420-008-0339-8; Quine L, 2003, CAMB Q HEALTHC ETHIC, V12, P91, DOI 10.1017/S0963180103121111; Quine L, 1999, BRIT MED J, V318, P228, DOI 10.1136/bmj.318.7178.228; Reijntjes A, 2010, CHILD ABUSE NEGLECT, V34, P244, DOI 10.1016/j.chiabu.2009.07.009; Reknes I, 2014, INT J NURS STUD, V51, P479, DOI 10.1016/j.ijnurstu.2013.06.017; Rodriguez-Garcia A., 2015, ALTERNATIVE MED, P1, DOI [10.1155/2015/175497, DOI 10.1155/2015/175497]; Rodriguez-Munoz A, 2011, BEHAV PSYCHOL, V19, P453; Rodwell J, 2012, INT NURS REV, V59, P539, DOI 10.1111/j.1466-7657.2012.01018.x; Rodwell J, 2012, HEALTH CARE MANAGE R, V37, P329, DOI 10.1097/HMR.0b013e31823dc2ec; Rugulies R, 2012, SCAND J WORK ENV HEA, V38, P218, DOI 10.5271/sjweh.3278; RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x; Sa Luis, 2008, Issues Ment Health Nurs, V29, P411, DOI 10.1080/01612840801904480; Sadia Malik, 2014, World Journal of Medical Sciences, V10, P43; Seedat S, 2009, ARCH GEN PSYCHIAT, V66, P785, DOI 10.1001/archgenpsychiatry.2009.36; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; Tepper BJ, 2000, ACAD MANAGE J, V43, P178, DOI 10.2307/1556375; Thayer JF, 2005, PSYCHONEUROENDOCRINO, V30, P1050, DOI 10.1016/j.psyneuen.2005.04.014; Theorell T., 1990, HEALTHY WORK STRESS; Trepanier SG, 2013, WORK STRESS, V27, P123, DOI 10.1080/02678373.2013.782158; Tuckey MR, 2014, J OCCUP HEALTH PSYCH, V19, P413, DOI 10.1037/a0037728; van Veen T, 2013, J AFFECT DISORDERS, V146, P238, DOI 10.1016/j.jad.2012.09.011; Vartia M., 2010, EUR J WORK ORGAN PSY, V11, P113, DOI DOI 10.1080/13594320143000870; Verkuil B., 2010, J EXP PSYCHOPATHOL, V1, DOI DOI 10.5127/JEP.009110; Vie TL, 2011, J PSYCHOSOM RES, V70, P37, DOI 10.1016/j.jpsychores.2010.06.007; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wells G, 2014, THE NEWCASTLE OTTAWA; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Wolke D, 2013, PSYCHOL SCI, V24, P1958, DOI 10.1177/0956797613481608	103	152	157	3	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135225	10.1371/journal.pone.0135225	http://dx.doi.org/10.1371/journal.pone.0135225			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6KK	26305785	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500017
J	Carr, SM; Duggan, AT; Stenson, GB; Marshall, HD				Carr, Steven M.; Duggan, Ana T.; Stenson, Garry B.; Marshall, H. Dawn			Quantitative Phylogenomics of Within-Species Mitogenome Variation: Monte Carlo and Non-Parametric Analysis of Phylogeographic Structure among Discrete Transatlantic Breeding Areas of Harp Seals (Pagophilus groenlandicus)	PLOS ONE			English	Article							COMPLETE MTDNA GENOMES; MITOCHONDRIAL-DNA; POPULATION-STRUCTURE; ICE CONDITIONS; NORTHWEST; ORIGIN; HYPOTHESIS; PARAMETERS; ERXLEBEN; HOMININ	Phylogenomic analysis of highly-resolved intraspecific phylogenies obtained from complete mitochondrial DNA genomes has had great success in clarifying relationships within and among human populations, but has found limited application in other wild species. Analytical challenges include assessment of random versus non-random phylogeographic distributions, and quantification of differences in tree topologies among populations. Harp Seals (Pagophilus groenlandicus Erxleben, 1777) have a biogeographic distribution based on four discrete trans-Atlantic breeding and whelping populations located on "fast ice" attached to land in the White Sea, Greenland Sea, the Labrador ice Front, and Southern Gulf of St Lawrence. This East to West distribution provides a set of a priori phylogeographic hypotheses. Outstanding biogeographic questions include the degree of genetic distinctiveness among these populations, in particular between the Greenland Sea and White Sea grounds. We obtained complete coding-region DNA sequences (15,825 bp) for 53 seals. Each seal has a unique mtDNA genome sequence, which differ by 6 similar to 107 substitutions. Six major clades / groups are detectable by parsimony, neighbor-joining, and Bayesian methods, all of which are found in breeding populations on either side of the Atlantic. The species coalescent is at 180 KYA; the most recent clade, which accounts for 66% of the diversity, reflects an expansion during the mid-Wisconsinan glaciation 40 similar to 60 KYA. FST is significant only between the White Sea and Greenland Sea or Ice Front populations. Hierarchal AMOVA of 2-, 3-, or 4-island models identifies small but significant Phi(SC) among populations within groups, but not among groups. A novel Monte-Carlo simulation indicates that the observed distribution of individuals within breeding populations over the phylogenetic tree requires significantly fewer dispersal events than random expectation, consistent with island or a priori East to West 2- or 3-stepping-stone biogeographic models, but not a simple 1-step trans-Atlantic model. Plots of the cumulative pairwise sequence difference curves among seals in each of the four populations provide continuous proxies for phylogenetic diversification within each. Non-parametric Kolmogorov-Smirnov (K-S) tests of maximum pairwise differences between these curves indicates that the Greenland Sea population has a markedly younger phylogenetic structure than either the White Sea population or the two Northwest Atlantic populations, which are of intermediate age and homogeneous structure. The Monte Carlo and K-S assessments provide sensitive quantitative tests of within-species mitogenomic phylogeography. This is the first study to indicate that the White Sea and Greenland Sea populations have different population genetic histories. The analysis supports the hypothesis that Harp Seals comprises three genetically distinguishable breeding populations, in the White Sea, Greenland Sea, and Northwest Atlantic. Implications for an ice-dependent species during ongoing climate change are discussed.	[Carr, Steven M.; Duggan, Ana T.] Mem Univ Newfoundland, Dept Biol, Genet Evolut & Mol Systemat Lab, St John, NF A1B 3X9, Canada; [Stenson, Garry B.] Mem Univ Newfoundland, Dept Biol, Wildlife Genet & Genom Lab, St John, NF A1B 3X9, Canada; [Marshall, H. Dawn] Fisheries & Oceans Canada, Marine Mammals Sect, Sci Branch, St John, NF A1C 5X1, Canada	Memorial University Newfoundland; Memorial University Newfoundland; Fisheries & Oceans Canada	Carr, SM (corresponding author), Mem Univ Newfoundland, Dept Biol, Genet Evolut & Mol Systemat Lab, St John, NF A1B 3X9, Canada.	scarr@mun.ca	Duggan, Ana T./G-8839-2016	Duggan, Ana/0000-0002-2582-2954	NSERC [RGPIN-2010-05265]; Northern Cod Research Program; Department of Fisheries and Oceans (Canada); Institute of Marine Resources (Norway); Polar Research of Marine Fisheries and Oceanography (Russia); DFO University Partnership grants	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Northern Cod Research Program; Department of Fisheries and Oceans (Canada); Institute of Marine Resources (Norway); Polar Research of Marine Fisheries and Oceanography (Russia); DFO University Partnership grants	Lab work was supported by an NSERC Discovery Grant [RGPIN-2010-05265][ http://www.nserc-crsng.gc.ca] and DFO University Partnership grants (including funding from the Northern Cod Research Program) to SMC and GBS. Funding for field collection was provided by the Department of Fisheries and Oceans (Canada), the Institute of Marine Resources (Norway), and the Polar Research of Marine Fisheries and Oceanography (Russia).	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; [Anonymous], 2012, BIOMETRY PRINCIPLES; Archer FI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063396; Arnason U, 2006, MOL PHYLOGENET EVOL, V41, P345, DOI 10.1016/j.ympev.2006.05.022; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bajzak CE, 2011, CAN J ZOOL, V89, P1050, DOI 10.1139/Z11-081; Blunden J, 2013, B AM METEOROL SOC, V94, pS1, DOI 10.1175/2013BAMSStateoftheClimate.1; BOWEN WD, 1983, CAN J FISH AQUAT SCI, V40, P728, DOI 10.1139/f83-095; Bowen WD, 1985, 8511 NAFO SCR; Carr SM, 2008, GENETICS, V180, P381, DOI 10.1534/genetics.108.089730; Carr SM, 2008, COMP BIOCHEM PHYS D, V3, P1, DOI 10.1016/j.cbd.2006.12.005; Carr SM, 2008, MITOCHONDR DNA, V19, P490, DOI 10.1080/19401730802570942; Coltman DW, 2007, MOL ECOL, V16, P1639, DOI 10.1111/j.1365-294X.2007.03229.x; Coulson MW, 2006, GENOME, V49, P1115, DOI 10.1139/G06-083; Davis CS, 2008, MOL ECOL, V17, P3078, DOI 10.1111/j.1365-294X.2008.03819.x; DFO, 2007, REV IC COND POT IMP; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flynn SMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-339; FU YX, 1993, GENETICS, V133, P693; Fulton TL, 2010, J BIOGEOGR, V37, P814, DOI 10.1111/j.1365-2699.2010.02271.x; Hammill MO, 2012, 2012148 CAN SCI ADV; Hammill MO, 2011, 2011100 CAN SCI ADV; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; International Council for the Exploration of the Sea (ICES), 2011, 2011ACOM22 ICES; International Panel on Climate Change, 2007, 4 IPCC SECR WORLD ME; Jacobsen MW, 2012, MOL ECOL, V21, P2727, DOI 10.1111/j.1365-294X.2012.05561.x; Johnston DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029158; Kapel Finn O., 1996, Northwest Atlantic Fisheries Organization Scientific Council Studies, V26, P87; KJELLQWIST SA, 1995, ICES J MAR SCI, V52, P197, DOI 10.1016/1054-3139(95)80035-2; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Nilssen KT, 1998, SARSIA, V83, P337, DOI 10.1080/00364827.1998.10413693; Oien N, 1995, DEV MAR BIO, V4, P35; Oigard TA, 2013, MAR ECOL PROG SER, V484, P287, DOI 10.3354/meps10272; Olivieri A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070492; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Perry EA, 2000, MAR BIOL, V137, P53, DOI 10.1007/s002279900248; Pope AM, 2011, GENOME, V54, P110, DOI 10.1139/G10-102; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rosing-Asvid A, 2008, MAR MAMMAL SCI, V24, P730, DOI 10.1111/j.1748-7692.2008.00216.x; Rozas J, 1995, COMPUT APPL BIOSCI, V11, P621; SERGEANT D E, 1976, Biological Conservation, V10, P95, DOI 10.1016/0006-3207(76)90055-0; Sergeant D.E., 1991, CAN SPEC PUBL FISH A, V114, P153; SERGEANT DE, 1965, J FISH RES BOARD CAN, V22, P433, DOI 10.1139/f65-043; SERGEANT DE, 1973, J FISH RES BOARD CAN, V30, P124, DOI 10.1139/f73-020; Stenson GB, 2012, 201108 CAN SCI ADV S; Stenson GB, 1997, INT COUNC EXPL SEA C, P10; Stenson GB, 2009, 2009112 CAN SCI ADV; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; VERMEIJ GJ, 1991, PALEOBIOLOGY, V17, P281, DOI 10.1017/S0094837300010617; Vinnikov KY, 1999, SCIENCE, V286, P1934, DOI 10.1126/science.286.5446.1934; Walsh JE, 2008, ECOL APPL, V18, pS3, DOI 10.1890/06-0503.1; Watson RT, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, pIX; Wilkinson JP, 2005, J CLIMATE, V18, P1216, DOI 10.1175/JCLI3325.1	60	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0134207	10.1371/journal.pone.0134207	http://dx.doi.org/10.1371/journal.pone.0134207			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301872	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000359951900006
J	Reuschel, EL; Wang, JF; Shivers, DK; Muthumani, K; Weiner, DB; Ma, ZY; Finkel, TH				Reuschel, Emma L.; Wang, JiangFang; Shivers, Debra K.; Muthumani, Karuppiah; Weiner, David B.; Ma, Zhengyu; Finkel, Terri H.			REDD1 Is Essential for Optimal T Cell Proliferation and Survival	PLOS ONE			English	Article							MAMMALIAN TARGET; MTORC1 REPRESSOR; FEEDBACK-CONTROL; DNA-DAMAGE; STRESS; EXPRESSION; AUTOPHAGY; RAPAMYCIN; HYPOXIA; GENE	REDD1 is a highly conserved stress response protein that is upregulated following many types of cellular stress, including hypoxia, DNA damage, energy stress, ER stress, and nutrient deprivation. Recently, REDD1 was shown to be involved in dexamethasone induced autophagy in murine thymocytes. However, we know little of REDD1's function in mature T cells. Here we show for the first time that REDD1 is upregulated following T cell stimulation with PHA or CD3/CD28 beads. REDD1 knockout T cells exhibit a defect in proliferation and cell survival, although markers of activation appear normal. These findings demonstrate a previously unappreciated role for REDD1 in T cell function.	[Reuschel, Emma L.; Wang, JiangFang; Shivers, Debra K.; Ma, Zhengyu; Finkel, Terri H.] Childrens Hosp Philadelphia, Div Rheumatol, Philadelphia, PA 19104 USA; [Reuschel, Emma L.; Wang, JiangFang; Ma, Zhengyu; Finkel, Terri H.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Muthumani, Karuppiah; Weiner, David B.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Finkel, TH (corresponding author), Nemours Childrens Hosp, Dept Pediat, Orlando, FL 32827 USA.	tfinkel@nemours.org	Muthumani, Kar/C-8252-2017; Muthumani, Kar/AAQ-4939-2020; Muthumani, Karuppiah/D-1092-2009	Muthumani, Kar/0000-0002-6807-2065; Muthumani, Kar/0000-0002-6807-2065; 	Children's Hospital of Philadelphia Research Institute; Joseph L. Hollander Chair; NIH [T32 AI07632, 1R41 AI071927]; Penn Center for AIDS Research; National Cancer Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007632, R41AI071927] Funding Source: NIH RePORTER	Children's Hospital of Philadelphia Research Institute; Joseph L. Hollander Chair; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn Center for AIDS Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by The Children's Hospital of Philadelphia Research Institute, the Joseph L. Hollander Chair, NIH T32 AI07632, and NIH 1R41 AI071927. The University of Pennsylvania Human Immunology Core facility receives funding from the Penn Center for AIDS Research and the National Cancer Institute.	Brafman A, 2004, INVEST OPHTH VIS SCI, V45, P3796, DOI 10.1167/iovs.04-0052; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Ch'en IL, 2011, J EXP MED, V208, P633, DOI 10.1084/jem.20110251; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Dennis MD, 2013, CELL SIGNAL, V25, P2709, DOI 10.1016/j.cellsig.2013.08.038; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Henry CM, 2013, METHODS, V61, P90, DOI 10.1016/j.ymeth.2013.01.008; Horak P, 2010, P NATL ACAD SCI USA, V107, P4675, DOI 10.1073/pnas.0907705107; Hung CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008771; Jin HO, 2009, FREE RADICAL BIO MED, V46, P1158, DOI 10.1016/j.freeradbiomed.2009.01.015; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; Li XH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039690, 10.1371/journal.pone.0036604]; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Liu GW, 2013, J LEUKOCYTE BIOL, V93, P511, DOI 10.1189/jlb.0812389; Lu JV, 2012, IMMUNOL REV, V249, P205, DOI 10.1111/j.1600-065X.2012.01147.x; McGhee NK, 2009, J NUTR, V139, P828, DOI 10.3945/jn.108.099846; Molitoris JK, 2011, J BIOL CHEM, V286, P30181, DOI 10.1074/jbc.M111.245423; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Schwarzer R, 2005, ONCOGENE, V24, P1138, DOI 10.1038/sj.onc.1208236; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Vadysirisack DD, 2011, MOL CELL BIOL, V31, P4356, DOI 10.1128/MCB.05541-11; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walsh CM, 2010, IMMUNOL REV, V236, P95, DOI 10.1111/j.1600-065X.2010.00919.x; Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200; Wang ZQ, 2003, J BIOL CHEM, V278, P27053, DOI 10.1074/jbc.M303723200; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079; Wolff NC, 2014, MOL CANCER RES, V12, P867, DOI 10.1158/1541-7786.MCR-13-0625; Yanagawa Y, 2014, IMMUNOL LETT, V158, P109, DOI 10.1016/j.imlet.2013.12.015; Yin JY, 2004, AIDS, V18, P587, DOI 10.1097/00002030-200403050-00002; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163	39	20	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136323	10.1371/journal.pone.0136323	http://dx.doi.org/10.1371/journal.pone.0136323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301899	gold, Green Published, Green Submitted			2022-12-27	WOS:000359951900059
J	Brandt, EC; Petersen, JE; Grossman, JJ; Allen, GA; Benzing, DH				Brandt, Erika C.; Petersen, John E.; Grossman, Jake J.; Allen, George A.; Benzing, David H.			Relationships between Spatial Metrics and Plant Diversity in Constructed Freshwater Wetlands	PLOS ONE			English	Article							FLORISTIC QUALITY ASSESSMENT; SPECIES RICHNESS; SEINE RIVER; BIODIVERSITY; HETEROGENEITY; COMMUNITIES; VEGETATION; INDEX	The diversity of plant species and their distribution in space are both thought to have important effects on the function of wetland ecosystems. However, knowledge of the relationships between plant species and spatial diversity remains incomplete. In this study, we investigated relationships between spatial pattern and plant species diversity over a five year period following the initial restoration of experimental wetland ecosystems. In 2003, six identical and hydrologically-isolated 0.18 ha wetland "cells" were constructed in former farmland in northeast Ohio. The systems were subjected to planting treatments that resulted in different levels of vascular plant species diversity among cells. Plant species diversity was assessed through annual inventories. Plant spatial pattern was assessed by digitizing low-altitude aerial photographs taken at the same time as the inventories. Diversity metrics derived from the inventories were significantly related to certain spatial metrics derived from the photographs, including cover type diversity and contagion. We found that wetlands with high cover type diversity harbor higher plant species diversity than wetlands with fewer types of patches. We also found significant relationships between plant species diversity and spatial patterning of patch types, but the direction of the effect differed depending on the diversity metric used. Links between diversity and spatial pattern observed in this study suggest that high-resolution aerial imagery may provide wetland scientists with a useful tool for assessing plant diversity.	[Brandt, Erika C.; Petersen, John E.; Allen, George A.; Benzing, David H.] Oberlin Coll, Adam Joseph Lewis Ctr, Dept Biol, Environm Studies Program, Oberlin, OH 44074 USA; [Grossman, Jake J.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	Oberlin College; University of Minnesota System; University of Minnesota Twin Cities	Petersen, JE (corresponding author), Oberlin Coll, Adam Joseph Lewis Ctr, Dept Biol, Environm Studies Program, 122 Elm St, Oberlin, OH 44074 USA.	john.petersen@oberlin.edu		Grossman, Jake/0000-0001-6468-8551	Oberlin College; Ohio Environmental Education Fund of Ohio Environmental Protection Agency; Sustainable Agriculture Research Education Program of the U.S. Department of Agriculture	Oberlin College; Ohio Environmental Education Fund of Ohio Environmental Protection Agency; Sustainable Agriculture Research Education Program of the U.S. Department of Agriculture	The Ohio Environmental Education Fund (http://epa.ohio.gov/oee/EnvironmentalEducation.aspx) of Ohio Environmental Protection Agency and the Sustainable Agriculture Research Education Program of the U.S. Department of Agriculture (http://www.sare.org/) provided support for initial construction of the experimental wetland system. None of the current authors were PIs on the initial grants and the authors do not have a record of the grant numbers. Funding to support student research collaborators was received from Oberlin College.	Abtew Wand Melesse A, 2013, EVAPORATION EVAPOTRA, P177; ANDREAS BK, 2004, FLORISTIC QUALITY AS; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; BERGELSON J, 1990, J ECOL, V78, P937, DOI 10.2307/2260944; Bourdaghs M, 2006, WETLANDS, V26, P718, DOI 10.1672/0277-5212(2006)26[718:PAPOTF]2.0.CO;2; Braun, 1967, DECIDUOUS FORESTS E; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Chabrerie O, 2001, ESTUARIES, V24, P1088, DOI 10.2307/1353020; Chamberlain SJ, 2012, J TORREY BOT SOC, V139, P416, DOI 10.3159/TORREY-D-12-00007.1; Cui BS, 2009, ECOL ENG, V35, P1090, DOI 10.1016/j.ecoleng.2009.03.022; Curie F, 2011, PHYS CHEM EARTH, V36, P530, DOI 10.1016/j.pce.2009.02.004; DeBerry DA, 2006, FLORISTIC QUALITY IN; Engelhardt KAM, 2001, NATURE, V411, P687, DOI 10.1038/35079573; Fairbairn SE, 2001, WETLANDS, V21, P41, DOI 10.1672/0277-5212(2001)021[0041:LALLIO]2.0.CO;2; Gilliam JW, 1993, J ENVIRON QUAL, V23, P896; Gleason H.A., 1991, MANUAL VASCULAR PLAN, V2nd ed.; Priego-Santander AG, 2013, APPL GEOGR, V40, P171, DOI 10.1016/j.apgeog.2013.02.013; Hargis CD, 1998, LANDSCAPE ECOL, V13, P167, DOI 10.1023/A:1007965018633; Jennings MD, 2008, BIODIVERS CONSERV, V17, P833, DOI 10.1007/s10531-008-9322-7; Johnston CA, 2009, ECOL APPL, V19, P1739, DOI 10.1890/08-1290.1; Kovach W., 1999, MVSP A MULTIVARIATE; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Maestre FT, 2012, J ECOL, V100, P317, DOI 10.1111/j.1365-2745.2011.01918.x; Magurran A.E., 1998, J APPL ECOL, DOI DOI 10.2307/2403731; Magurran AE, 2005, CURR BIOL, V15, pR116, DOI 10.1016/j.cub.2005.02.006; Matthews JW, 2003, NAT AREA J, V23, P53, DOI 10.1038/nature01736; McGarigal K., 2012, TECH REP; McGarigal K, 2009, LANDSCAPE ECOL, V24, P433, DOI 10.1007/s10980-009-9327-y; Miyamoto M, 2004, WETLANDS, V24, P701, DOI 10.1672/0277-5212(2004)024[0701:UOBAPF]2.0.CO;2; Mushet DM, 2002, WETLANDS, V22, P126, DOI 10.1672/0277-5212(2002)022[0126:FQAOON]2.0.CO;2; *NAT CLIM DAT CTR, 2004, MONTHL STAT CLIM SUM; Peet Robert K., 1998, Castanea, V63, P262; Petersen JE, 2015, ECOL ENG, V82, P531, DOI 10.1016/j.ecoleng.2015.05.002; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Smith JL, 2006, 1 2 YEARS MACROPHYTE; Wassen MJ, 2003, PLANT ECOL, V165, P27, DOI 10.1023/A:1021493327180; West B. T., 2014, LINEAR MIXED MODELS; Wiens JA, 1989, LANDSCAPE ECOL, V3, P87, DOI 10.1007/BF00131172; Zedler JB, 2003, FRONT ECOL ENVIRON, V1, P65, DOI 10.1890/1540-9295(2003)001[0065:WAYSRI]2.0.CO;2	39	6	7	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135917	10.1371/journal.pone.0135917	http://dx.doi.org/10.1371/journal.pone.0135917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296205	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900051
J	Jiang, L; Chen, J; Wang, P; Ren, QQ; Yuan, J; Qian, CJ; Hua, XH; Guo, ZC; Zhang, L; Yang, JK; Wang, Y; Zhang, Q; Ding, HW; Bi, D; Zhang, ZM; Wang, QQ; Chen, DS; Kan, XZ				Jiang, Lan; Chen, Juan; Wang, Ping; Ren, Qiongqiong; Yuan, Jian; Qian, Chaoju; Hua, Xinghong; Guo, Zhichun; Zhang, Lei; Yang, Jianke; Wang, Ying; Zhang, Qin; Ding, Hengwu; Bi, De; Zhang, Zongmeng; Wang, Qingqing; Chen, Dongsheng; Kan, Xianzhao			The Mitochondrial Genomes of Aquila fasciata and Buteo lagopus (Aves, Accipitriformes): Sequence, Structure and Phylogenetic Analyses	PLOS ONE			English	Article							PSEUDO-CONTROL REGIONS; OLD-WORLD VULTURES; EVOLUTIONARY HISTORY; NUCLEOTIDE-SEQUENCES; GENUS; BIRDS; EAGLES; PASSERIFORMES; EMBERIZIDAE; DIVERSITY	The family Accipitridae is one of the largest groups of non-passerine birds, including 68 genera and 243 species globally distributed. In the present study, we determined the complete mitochondrial sequences of two species of accipitrid, namely Aquila fasciata and Buteo lagopus, and conducted a comparative mitogenome analysis across the family. The mitogenome length of A. fasciata and B. lagopus are 18,513 and 18,559 bp with an A + T content of 54.2% and 55.0%, respectively. For both the two accipitrid birds mtDNAs, obvious positive AT-skew and negative GC-skew biases were detected for all 12 PCGs encoded by the H strand, whereas the reverse was found in MT-ND6 encoded by the L strand. One extra nucleotide'C'is present at the position 174 of MT-ND3 gene of A. fasciata, which is not observed at that of B. lagopus. Six conserved sequence boxes in the Domain II, named boxes F, E, D, C, CSBa, and CSBb, respectively, were recognized in the CRs of A. fasciata and B. lagopus. Rates and patterns of mitochondrial gene evolution within Accipitridae were also estimated. The highest dN/dS was detected for the MT-ATP8 gene (0.32493) among Accipitridae, while the lowest for the MT-CO1 gene (0.01415). Mitophylogenetic analysis supported the robust monophyly of Accipitriformes, and Cathartidae was basal to the balance of the order. Moreover, we performed phylogenetic analyses using two other data sets (two mitochondrial loci, and combined nuclear and mitochondrial loci). Our results indicate that the subfamily Aquilinae and all currently polytypic genera of this subfamily are monophyletic. These two novel mtDNA data will be useful in refining the phylogenetic relationships and evolutionary processes of Accipitriformes.	[Jiang, Lan; Chen, Juan; Wang, Ping; Ren, Qiongqiong; Guo, Zhichun; Zhang, Lei; Wang, Ying; Zhang, Qin; Ding, Hengwu; Bi, De; Zhang, Zongmeng; Wang, Qingqing; Chen, Dongsheng; Kan, Xianzhao] Anhui Normal Univ, Coll Life Sci, Inst Bioinformat, Wuhu, Anhui, Peoples R China; [Jiang, Lan; Kan, Xianzhao] Prov Key Lab Conservat & Exploitat Res Biol Resou, Wuhu, Anhui, Peoples R China; [Yuan, Jian] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Qian, Chaoju] Chinese Acad Sci, Key Lab Stress Physiol & Ecol Cold & Arid Reg, Dept Ecol & Agr Res, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Gansu, Peoples R China; [Hua, Xinghong] Ningguo Museum Nat Hist, Ningguo, Anhui, Peoples R China; [Yang, Jianke] Wannan Med Coll, Dept Med Biol, Wuhu, Anhui, Peoples R China	Anhui Normal University; Peking University; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Wannan Medical College	Kan, XZ (corresponding author), Anhui Normal Univ, Coll Life Sci, Inst Bioinformat, Wuhu, Anhui, Peoples R China.	xianzhao@ahnu.edu.cn	Kan, Xianzhao/AAA-5050-2021	Kan, Xianzhao/0000-0002-9225-407X; Zhang, Zongmeng/0000-0002-4144-6901; Yuan, Jian/0000-0002-1896-2561	Key Programme of Natural Science Foundation of the Anhui Higher Education Institutions [KJ2013A127]; Anhui Provincial Natural Science Foundation [1308085MC38]	Key Programme of Natural Science Foundation of the Anhui Higher Education Institutions; Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province)	This work was funded by (1) the Key Programme of Natural Science Foundation of the Anhui Higher Education Institutions (no. KJ2013A127), Special to Prof. XK (website: http://202.38.95.119/Srmis/login.aspx), and (2) the Anhui Provincial Natural Science Foundation (no. 1308085MC38), Special to Prof. XK (website: http://www.ahinfo.gov.cn/zrkxjj/index.htm).	AMADON D, 1988, Proceedings of the Western Foundation of Vertebrate Zoology, V3, P295; Asai S, 2006, BIRD CONSERV INT, V16, P113, DOI 10.1017/S0959270906000050; Asai Shigeki, 2008, Ornithological Science, V7, P143, DOI 10.2326/1347-0558-7.2.143; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Beckenbach AT, 2005, J MOL EVOL, V60, P141, DOI 10.1007/s00239-004-0178-5; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Burleigh JG, 2015, MOL PHYLOGENET EVOL, V84, P53, DOI 10.1016/j.ympev.2014.12.003; Cadahia L, 2009, J EXP ZOOL PART B, V312B, P171, DOI 10.1002/jez.b.21282; Chesser RT, 2010, AUK, V127, P726, DOI 10.1525/auk.2010.127.3.726; Clements JF, 2014, EBIRD CLEMENTS CHECK; CRACRAFT J, 1981, AUK, V98, P681; del Hoyo J, 1994, HDB BIRDS WORLD, V2, P434; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Doyle JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095599; Gibb GC, 2007, MOL BIOL EVOL, V24, P269, DOI 10.1093/molbev/msl158; Gill F., 2015, IOC WORLD BIRD LIST; Grant JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-202; Gray KA, 2015, NUCLEIC ACIDS RES, V43, pD1079, DOI 10.1093/nar/gku1071; Gregory Steven M.S., 2012, Bulletin of the British Ornithologists' Club, V132, P135; Griffiths CS, 2007, J AVIAN BIOL, V38, P587, DOI 10.1111/j.2007.0908-8857.03971.x; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Haring E, 2007, J ZOOL SYST EVOL RES, V45, P353, DOI 10.1111/j.1439-0469.2007.00410.x; Haring E, 2001, MOL BIOL EVOL, V18, P1892, DOI 10.1093/oxfordjournals.molbev.a003730; Helbig AJ, 2005, MOL PHYLOGENET EVOL, V35, P147, DOI 10.1016/j.ympev.2004.10.003; Higdon JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-216; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; JOLLIE M, 1977, Evolutionary Theory, V2, P115; Kan XZ, 2010, GENET MOL RES, V9, P1625, DOI 10.4238/vol9-3gmr898; Kan XZ, 2010, GENET MOL RES, V9, P1234, DOI 10.4238/vol9-2gmr853; Kan XZ, 2010, GENET MOL RES, V9, P1204, DOI 10.4238/vol9-2gmr820; Kan XZ, 2013, MITOCHONDR DNA, V24, P648, DOI 10.3109/19401736.2013.772165; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; KONIG C, 1982, J ORNITHOL, V123, P259, DOI 10.1007/BF01644360; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lepage D., 2014, PETERS CHECK LIST BI; Lerner HRL, 2005, MOL PHYLOGENET EVOL, V37, P327, DOI 10.1016/j.ympev.2005.04.010; Li XJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1234-9; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Livezey BC, 2001, NETH J ZOOL, V51, P179, DOI 10.1163/156854201750385145; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Mahmood MT, 2014, GENOME BIOL EVOL, V6, P326, DOI 10.1093/gbe/evu016; Marshall HD, 2013, GENE, V517, P37, DOI 10.1016/j.gene.2012.12.093; Mayr G, 2003, CLADISTICS, V19, P527, DOI [10.1016/j.cladistics.2003.10.003, 10.1111/j.1096-0031.2003.tb00387.x]; Mindell DP, 1998, MOL BIOL EVOL, V15, P1568, DOI 10.1093/oxfordjournals.molbev.a025884; Nagy Jeno, 2014, Ornis Hungarica, V22, P15; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Ong PS, 2011, MOL ECOL RESOUR, V11, P245, DOI 10.1111/j.1755-0998.2010.02928.x; Peng QK, 2014, MITOCHONDRIAL DNA; Ren QQ, 2016, MITOCHONDRIAL DNA A, V27, P375, DOI 10.3109/19401736.2014.895993; Ren QQ, 2014, J GENET, V93, P699, DOI 10.1007/s12041-014-0428-2; Riesing MJ, 2003, MOL PHYLOGENET EVOL, V27, P328, DOI 10.1016/S1055-7903(02)00450-5; Russell RD, 2008, J MOL EVOL, V67, P682, DOI 10.1007/s00239-008-9179-0; Sambrook J., 2001, MOL CLONING LAB MANU; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Seibold I, 1995, PHILOS T ROY SOC B, V350, P163, DOI 10.1098/rstb.1995.0150; Sibley CG, 1990, DISTRIBUTION TAXONOM; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Slack KE, 2007, MOL PHYLOGENET EVOL, V42, P1, DOI 10.1016/j.ympev.2006.06.002; Song XH, 2015, BIOCHEM SYST ECOL, V58, P75, DOI 10.1016/j.bse.2014.10.013; STAMATAKIS A., 2006, P 20 IEEE INT PAR DI, DOI DOI 10.1109/IPDPS.2006.1639535; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vali U, 2002, MOL ECOL, V11, P2189, DOI 10.1046/j.1365-294X.2002.01578.x; Wells D. R., 2012, Bulletin of the British Ornithologists' Club, V132, P70; Wink M, 1995, Z NATURFORSCH C, V50, P868; Wink Michael, 2004, P483; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Zhang H, 2014, MITOCHONDRIAL DNA; Zhang LQ, 2012, MOL BIOL REP, V39, P8315, DOI 10.1007/s11033-012-1681-1	73	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136297	10.1371/journal.pone.0136297	http://dx.doi.org/10.1371/journal.pone.0136297			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295156	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900097
J	Cho, GJ; Kim, LY; Sung, YN; Kim, JA; Hwang, SY; Hong, HR; Hong, SC; Oh, MJ; Kim, HJ				Cho, Geum Joon; Kim, Log Young; Sung, Ye Na; Kim, Jee Ae; Hwang, Soon Young; Hong, Hye-Ri; Hong, Soon-Cheol; Oh, Min-Jeong; Kim, Hai-Joong			Secular Trends of Gestational Diabetes Mellitus and Changes in Its Risk Factors	PLOS ONE			English	Article							INCREASING PREVALENCE; GLUCOSE-TOLERANCE; OBESITY; WOMEN; PREGNANCY; COHORT; ASSOCIATION; POPULATION; CARPENTER; DIAGNOSIS	Objective The aim of this study was to evaluate the secular trends of incidence of gestational diabetes mellitus (GDM) and insulin treatment for GDM in a Korean population and to determine the factors that contribute to the trends in the incidence of GDM. Study Design We used data collected by the Health Insurance Review & Assessment Service of Korea and analyzed data from women who had given birth from 2006 to 2010. We evaluated the trends in the incidence of GDM and GDM requiring insulin treatment and the changes in risk factors. Results There were 1,824,913 births during the study period, which included 129,666 cases of GDM, an incidence of 7.11% over this period. The incidence of GDM increased from 3.86% in 2007 to 11.83% in 2010, with a continuous increase after adjustment for age. However, the number of GDM cases that required insulin treatment decreased significantly from 13.87% in 2007 to 5.94% in 2010. The proportion of patients who were at an older age and multiparity, 2 GDM risk factors, increased during the study period. Conclusions In Korea, the incidence of GDM, especially mild GDM, increased dramatically during the period from 2006 to 2010. Further efforts are needed to monitor this trend and to identify associated factors.	[Cho, Geum Joon; Hong, Soon-Cheol; Oh, Min-Jeong; Kim, Hai-Joong] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul 136705, South Korea; [Kim, Log Young; Sung, Ye Na; Kim, Jee Ae] Hlth Insurance Review & Assessment Serv Korea, Seoul, South Korea; [Hwang, Soon Young] Korea Univ, Coll Med, Dept Biostat, Seoul 136705, South Korea; [Hong, Hye-Ri] Kyung Hee Univ, Dept Obstet & Gynecol, Sch Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Kyung Hee University	Oh, MJ (corresponding author), Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul 136705, South Korea.	mjohmd@korea.ac.kr	Rhim, Sonny H./W-9532-2019; Hong, Soon Cheol/F-6614-2013	Hong, Soon Cheol/0000-0003-2102-7555	Korea Academy of Medical Sciences	Korea Academy of Medical Sciences	This study was supported by a 2013-Grant from Korea Academy of Medical Sciences.	Albrecht SS, 2010, DIABETES CARE, V33, P768, DOI 10.2337/dc09-1801; American College of Obstetricians and Gynecologists Committee on Practice Bulletins--Obstetrics, 2001, Obstet Gynecol, V98, P525; American Diabetes Association, 2002, AM DIABETES ASS DIAB, V25, ps94, DOI DOI 10.2337/DIACARE.25.2007.S94); Anna V, 2008, DIABETES CARE, V31, P2288, DOI 10.2337/dc08-1038; Ben-Haroush A, 2004, DIABETIC MED, V21, P103, DOI 10.1046/j.1464-5491.2003.00985.x; Chen YZ, 2009, POPUL HEALTH MANAG, V12, P165, DOI 10.1089/pop.2009.12303; Cheng YW, 2009, OBSTET GYNECOL, V114, P326, DOI 10.1097/AOG.0b013e3181ae8d85; Choi NK, 2010, PHARMACOEPIDEM DR S, V19, P238, DOI 10.1002/pds.1902; Choi SK, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-6; Chon SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114972; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Chu SY, 2009, PREV MED, V49, P265, DOI 10.1016/j.ypmed.2009.07.001; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Dabelea D, 2005, DIABETES CARE, V28, P579, DOI 10.2337/diacare.28.3.579; Davenport MH, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-85; Dempsey JC, 2004, AM J EPIDEMIOL, V159, P663, DOI 10.1093/aje/kwh091; England LJ, 2004, AM J EPIDEMIOL, V160, P1205, DOI 10.1093/aje/kwh340; Ferrara A, 2004, OBSTET GYNECOL, V103, P526, DOI 10.1097/01.AOG.0000113623.18286.20; Ferrara A, 2002, DIABETES CARE, V25, P1625, DOI 10.2337/diacare.25.9.1625; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Genuth S, 2003, DIABETES CARE, V26, P3160; JANG HC, 1995, INT J GYNECOL OBSTET, V51, P115, DOI 10.1016/0020-7292(95)02524-G; Kim JY, 2006, CONSTRUCTION NATL SU; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816; Lee SY, 2007, DIABETES RES CLIN PR, V75, P72, DOI 10.1016/j.diabres.2006.04.013; Metzger BE, 1998, DIABETES CARE, V21, pB161; Murgia C, 2006, DIABETES CARE, V29, P1713, DOI 10.2337/dc06-0635; Oh SW, 2004, OBES RES, V12, P2031, DOI 10.1038/oby.2004.254; Park S, 2013, EUR J CLIN NUTR, V67, P196, DOI 10.1038/ejcn.2012.207; Radesky JS, 2008, PAEDIATR PERINAT EP, V22, P47, DOI 10.1111/j.1365-3016.2007.00899.x; Rhee SY, 2013, KOREAN J INTERN MED, V28, P29, DOI 10.3904/kjim.2013.28.1.29; Ricart W, 2005, DIABETOLOGIA, V48, P1135, DOI 10.1007/s00125-005-1756-9; Savitz DA, 2008, BJOG-INT J OBSTET GY, V115, P969, DOI 10.1111/j.1471-0528.2008.01763.x; Schmidt MI, 2001, DIABETES CARE, V24, P1151, DOI 10.2337/diacare.24.7.1151; Sella T, 2013, J MATERN-FETAL NEO M, V26, P412, DOI 10.3109/14767058.2012.733761; Sendag F, 2001, J REPROD MED, V46, P1057; WHITE P, 1949, AM J MED, V7, P609, DOI 10.1016/0002-9343(49)90382-4; Wong VW, 2012, DIABETIC MED, V29, P366, DOI 10.1111/j.1464-5491.2011.03439.x; Wong VW, 2011, AUST NZ J OBSTET GYN, V51, P432, DOI 10.1111/j.1479-828X.2011.01329.x; Zhang F, 2011, DIABETIC MED, V28, P652, DOI 10.1111/j.1464-5491.2010.03205.x	42	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136017	10.1371/journal.pone.0136017	http://dx.doi.org/10.1371/journal.pone.0136017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292282	Green Submitted, Green Published, gold			2022-12-27	WOS:000359919900046
J	Aldhous, MC; Reynolds, RM; Campbell, A; Linksted, P; Lindsay, RS; Smith, BH; Seckl, JR; Porteous, DJ; Norman, JE				Aldhous, Marian C.; Reynolds, Rebecca M.; Campbell, Archie; Linksted, Pamela; Lindsay, Robert S.; Smith, Blair H.; Seckl, Jonathan R.; Porteous, David J.; Norman, Jane E.		Generation Scotland	Sex-Differences in the Metabolic Health of Offspring of Parents with Diabetes: A Record-Linkage Study	PLOS ONE			English	Article							BODY-MASS INDEX; BRITISH BIRTH COHORT; HIGH-FAT DIET; IMPRINTED GENES; WEIGHT; ASSOCIATIONS; ADIPOSITY; PREGNANCY; AGE; GLYCOSURIA	Maternal diabetes in pregnancy affects offspring health. The impact of parental diabetes on offspring health is unclear. We investigated the impact of parental diabetes on the metabolic-health of adult-offspring who did not themselves have diabetes. Data from the Generation Scotland: Scottish Family Health Study, a population-based family cohort, were record-linked to subjects' own diabetes medical records. From F-0-parents, we identified F-1-offspring of: mothers with diabetes (OMD, n = 409), fathers with diabetes (OFD, n = 468), no parent with diabetes (ONoPD, n = 2489). Metabolic syndrome, body, biochemical measurements and blood-pressures were compared between F-1-offspring groups by sex. A higher proportion of female OMD had metabolic syndrome than female OFD or ONoPD (P<0.0001). In female offspring, predictors of metabolic syndrome were: having a mother with diabetes (OR = 1.78, CI 1.03-3.07, [reference ONoPD]), body mass index (BMI, OR = 1.21, CI 1.13-1.30) and age (OR = 1.03, CI 1.01-1.06). In male offspring, predictors of metabolic syndrome were: BMI (OR = 1.18, CI 1.09-1.29) and percent body-fat (OR = 1.12, CI 1.05-1.19). In both sexes, OMD had higher blood-pressures than OFD (P<0.0001). In females, OMD had higher glucose (P<0.0001) and percent body-fat (P<0.0001) compared with OFD or ONoPD. OMD and OFD both had increased waist-measurements (P<0.0001), BMI (P<0.0001) and percent body-fat (P<0.0001) compared with ONoPD. Female OMD and OFD had lower HDL-cholesterol levels (P<0.0001) than female ONoPD. Parental diabetes is associated with higher offspring-BMI and body-fat. In female offspring, maternal diabetes increased the odds of metabolic syndrome, even after adjusting for BMI. Further investigations are required to determine the mechanisms involved.	[Aldhous, Marian C.; Norman, Jane E.] Univ Edinburgh, Queens Med Res Inst, Tommys Ctr Maternal & Fetal Hlth, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Reynolds, Rebecca M.; Seckl, Jonathan R.] Univ Edinburgh, Queens Med Res Inst, Endocrinol Unit, Univ BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Campbell, Archie; Linksted, Pamela; Porteous, David J.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Generat Scotland,Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland; [Lindsay, Robert S.] Univ Glasgow, British Heart Fdn, Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Smith, Blair H.] Univ Dundee, Med Res Inst, Dundee, Scotland; [Porteous, David J.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Med Genet Sect,Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland; Generat Scotland, Dundee, Scotland; Generat Scotland, Edinburgh, Midlothian, Scotland; [Generation Scotland] Generat Scotland, Glasgow, Lanark, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Glasgow; University of Dundee; University of Edinburgh	Aldhous, MC (corresponding author), Univ Edinburgh, Queens Med Res Inst, Tommys Ctr Maternal & Fetal Hlth, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	M.Aldhous@ed.ac.uk	Porteous, David/AAA-3446-2021; Campbell, Archie/AAZ-1757-2021; Reynolds, Rebecca M/C-3044-2008; Smith, Blair/G-2834-2012	Porteous, David/0000-0003-1249-6106; Reynolds, Rebecca M/0000-0001-6226-8270; Smith, Blair/0000-0002-5362-9430; Norman, Jane/0000-0001-6031-6953; Lindsay, Robert/0000-0002-9868-5217; Schooling, Mary/0000-0001-9933-5887; Campbell, Archie/0000-0003-0198-5078	Chief Scientist's Office of the Scottish Government [CZH/4/881]; Tommy's the Baby Charity; Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6]; Scottish Funding Council [HR03006]; Wellcome Trust through the Scottish Health Informatics Programme (SHIP) [WT086113]; Chief Scientist Office [CZD/16/6/4, CZH/4/881] Funding Source: researchfish	Chief Scientist's Office of the Scottish Government; Tommy's the Baby Charity; Chief Scientist Office of the Scottish Government Health Directorates; Scottish Funding Council; Wellcome Trust through the Scottish Health Informatics Programme (SHIP); Chief Scientist Office	This work was supported by the Chief Scientist's Office of the Scottish Government, for funding both the record linkage and the analysis [grant no. CZH/4/881]. MCA was supported by funding from the Chief Scientist's Office of the Scottish Government [grant no. CZH/4/881] and Tommy's the Baby Charity. The funders made no contribution to the study design or execution. Generation Scotland has received core funding from the Chief Scientist Office of the Scottish Government Health Directorates [grant no. CZD/16/6] and the Scottish Funding Council [grant no. HR03006]. The authors are grateful to all the families who took part, the general practitioners and the Scottish School of Primary Care for their help in recruiting them, and the whole Generation Scotland team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists, healthcare assistants and nurses. Data are available for analysis by members of the Scottish Diabetes Research Network (SDRN) thanks to the hard work and dedication of NHS staff across Scotland who enter the data and people and organizations (the Scottish Care Information -Diabetes Collaboration [SCI-DC] Steering Group, the Scottish Diabetes Group, the Scottish Diabetes Survey Group, the managed clinical network managers and staff in each Health Board) involved in setting up, maintaining and overseeing SCI-DC. The SDRN receives core support from the Chief Scientist's Office at the Scottish Government Health Department. This work was supported by the Wellcome Trust through the Scottish Health Informatics Programme (SHIP) Grant [Ref WT086113]. SHIP is a collaboration between the Universities of Aberdeen, Dundee, Edinburgh, Glasgow and St Andrews and the Information Services Division of NHS Scotland.	Agyemang C, 2012, DIABETIC MED, V29, P1159, DOI 10.1111/j.1464-5491.2012.03616.x; Aiken CE, 2013, REPRODUCTION, V145, pR1, DOI 10.1530/REP-11-0489; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 1994, MORBIDITY MORTALITY, V43, P837; Cooper R, 2010, AM J CLIN NUTR, V92, P946, DOI 10.3945/ajcn.2010.29477; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Diabetes UK, 2012, DIAB UK 2012 KEY STA; Dunn GA, 2011, ENDOCRINOLOGY, V152, P2228, DOI 10.1210/en.2010-1461; Ejdesjo A, 2012, AM J PHYSIOL-ENDOC M, V302, pE1198, DOI 10.1152/ajpendo.00661.2011; Fairley L, 2005, PAEDIATR PERINAT EP, V19, P342, DOI 10.1111/j.1365-3016.2005.00665.x; Fowden AL, 2011, PROG BIOPHYS MOL BIO, V106, P281, DOI 10.1016/j.pbiomolbio.2010.11.005; Grasemann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050210; Hochner H, 2012, CIRCULATION, V125, P1381, DOI 10.1161/CIRCULATIONAHA.111.070060; Hoggart CJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004508; Hypponen E, 2003, BMJ-BRIT MED J, V326, P19, DOI 10.1136/bmj.326.7379.19; Hypponen E, 2008, DIABETES, V57, P298, DOI 10.2337/db07-1122; Ishida M, 2013, MOL ASPECTS MED, V34, P826, DOI 10.1016/j.mam.2012.06.009; Jouret B, 2007, AM J CLIN NUTR, V85, P1643, DOI 10.1093/ajcn/85.6.1643; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Krishnaveni GV, 2010, DIABETES CARE, V33, P402, DOI 10.2337/dc09-1393; Lawlor DA, 2010, DIABETOLOGIA, V53, P89, DOI 10.1007/s00125-009-1560-z; Lawlor DA, 2011, CIRCULATION, V123, P258, DOI 10.1161/CIRCULATIONAHA.110.980169; Segovia BL, 2012, EXP DIABETES RES, DOI 10.1155/2012/684562; Lindsay RS, 2010, DIABETES CARE, V33, P1080, DOI 10.2337/dc09-1766; Lindsay RS, 2000, DIABETES, V49, P445, DOI 10.2337/diabetes.49.3.445; Matheson FI, 2008, SOC SCI MED, V66, P675, DOI 10.1016/j.socscimed.2007.10.008; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Patel S, 2012, DIABETES CARE, V35, P63, DOI 10.2337/dc11-1633; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Philipps LH, 2011, DIABETOLOGIA, V54, P1957, DOI 10.1007/s00125-011-2180-y; Power C, 2011, ANN HUM BIOL, V38, P390, DOI 10.3109/03014460.2011.591827; Rutherford L, 2013, SCOTTISH HLTH SURVEY; Scottish Intercollegiate Guidelines Network (SIGN), 2010, SIGN PUBL, V116; Skinner MK, 2010, NATURE, V467, P922, DOI 10.1038/467922a; Smith BH, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-74; Smith BH, 2013, INT J EPIDEMIOL, V42, P689, DOI 10.1093/ije/dys084; Soubry A, 2015, INT J OBESITY, V39, P650, DOI 10.1038/ijo.2013.193; Wu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036727	40	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134883	10.1371/journal.pone.0134883	http://dx.doi.org/10.1371/journal.pone.0134883			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308734	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400039
J	Burte, E; Bousquet, J; Varraso, R; Gormand, F; Just, J; Matran, R; Pin, I; Siroux, V; Jacquemin, B; Nadif, R				Burte, Emilie; Bousquet, Jean; Varraso, Raphaelle; Gormand, Frederic; Just, Jocelyne; Matran, Regis; Pin, Isabelle; Siroux, Valerie; Jacquemin, Benedicte; Nadif, Rachel			Characterization of Rhinitis According to the Asthma Status in Adults Using an Unsupervised Approach in the EGEA Study	PLOS ONE			English	Article							NONALLERGIC RHINITIS; BRONCHIAL HYPERRESPONSIVENESS; ALLERGIC RHINITIS; LARGE-SAMPLE; PHENOTYPES; ENVIRONMENT; PREVALENCE; GENETICS; MEDALL; WORLD	Background The classification of rhinitis in adults is missing in epidemiological studies. Objective To identify phenotypes of adult rhinitis using an unsupervised approach (data-driven) compared with a classical hypothesis-driven approach. Methods 983 adults of the French Epidemiological Study on the Genetics and Environment of Asthma (EGEA) were studied. Self-reported symptoms related to rhinitis such as nasal symptoms, hay fever, sinusitis, conjunctivitis, and sensitivities to different triggers (dust, animals, hay/flowers, cold air...) were used. Allergic sensitization was defined by at least one positive skin prick test to 12 aeroallergens. Mixture model was used to cluster participants, independently in those without (Asthma-, n = 582) and with asthma (Asthma+, n = 401). Results Three clusters were identified in both groups: 1) Cluster A (55% in Asthma-, and 22% in Asthma+) mainly characterized by the absence of nasal symptoms, 2) Cluster B (23% in Asthma-, 36% in Asthma+) mainly characterized by nasal symptoms all over the year, sinusitis and a low prevalence of positive skin prick tests, and 3) Cluster C (22% in Asthma-, 42% in Asthma+) mainly characterized by a peak of nasal symptoms during spring, a high prevalence of positive skin prick tests and a high report of hay fever, allergic rhinitis and conjunctivitis. The highest rate of polysensitization (80%) was found in participants with comorbid asthma and allergic rhinitis. Conclusion This cluster analysis highlighted three clusters of rhinitis with similar characteristics than those known by clinicians but differing according to allergic sensitization, and this whatever the asthma status. These clusters could be easily rebuilt using a small number of variables.	[Burte, Emilie; Bousquet, Jean; Varraso, Raphaelle; Jacquemin, Benedicte; Nadif, Rachel] INSERM, VIMA Aging & Chron Dis Epidemiol & Publ Hlth Appr, U1168, F-94807 Villejuif, France; [Burte, Emilie; Bousquet, Jean; Varraso, Raphaelle; Jacquemin, Benedicte; Nadif, Rachel] Univ Versailles St Quentin En Yvelines, UMR S 1168, F-78180 Montigny Le Bretonneux, France; [Bousquet, Jean] Univ Hosp, Montpellier, France; [Gormand, Frederic] CHU Lyon, Dept Pneumol, Lyon, France; [Just, Jocelyne] Hop Armand Trousseau, AP HP, Ctr Asthme & Allergies, Dept Allergol, Paris, France; [Just, Jocelyne] Univ Paris 06, Paris, France; [Matran, Regis] Univ Lille Nord France, F-59000 Lille, France; [Pin, Isabelle; Siroux, Valerie] INSERM, Team Environm Epidemiol Appl Reprod & Resp Hlth, IAB, F-38000 Grenoble, France; [Pin, Isabelle; Siroux, Valerie] Univ Grenoble Alpes, F-38000 Grenoble, France; [Pin, Isabelle; Siroux, Valerie] CHU Grenoble, F-38000 Grenoble, France; [Pin, Isabelle] CHU Grenoble, Dept Pediat, F-38000 Grenoble, France; [Jacquemin, Benedicte] Parc Recerca Biomed Barcelona, CREAL Ctr Res Environm Epidemiol, Barcelona, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Universite de Montpellier; CHU de Montpellier; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Pompeu Fabra University	Burte, E (corresponding author), INSERM, VIMA Aging & Chron Dis Epidemiol & Publ Hlth Appr, U1168, F-94807 Villejuif, France.	emilie.burte@inserm.fr	Jacquemin, Benedicte/D-8948-2018; Nadif, Rachel/R-2876-2016; PIN, Isabelle/N-3020-2013; siroux, valerie/N-1865-2013; Varraso, Raphaelle/R-8740-2016; Bousquet, Jean/O-4221-2019; GORMAND, FREDERIC/I-1414-2017	Jacquemin, Benedicte/0000-0003-1273-9892; Nadif, Rachel/0000-0003-4938-9339; siroux, valerie/0000-0001-7329-7237; Varraso, Raphaelle/0000-0002-3338-7825; 				Anto JM, 2012, CURR ALLERGY ASTHM R, V12, P192, DOI 10.1007/s11882-012-0254-7; Bachert C, 2006, ALLERGY, V61, P693, DOI 10.1111/j.1398-9995.2006.01054.x; Bernstein JA, 2013, AM J RHINOL ALLERGY, V27, P457, DOI 10.2500/ajra.2013.27.3983; Bernstein JA, 2013, CURR OPIN ALLERGY CL, V13, P410, DOI 10.1097/ACI.0b013e3283630cd8; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2011, ALLERGY, V66, P596, DOI 10.1111/j.1398-9995.2010.02534.x; Bousquet PJ, 2008, ALLERGY, V63, P1301, DOI 10.1111/j.1398-9995.2008.01824.x; Burgel PR, 2010, EUR RESPIR J, V36, P531, DOI 10.1183/09031936.00175109; Di Lorenzo G, 2011, INT ARCH ALLERGY IMM, V155, P263, DOI 10.1159/000320050; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; Izquierdo-Dominguez A, 2013, CURR ALLERGY ASTHM R, V13, P142, DOI 10.1007/s11882-012-0331-y; Kalpaklioglu AF, 2009, J ASTHMA, V46, P481, DOI 10.1080/02770900902849897; Katelaris CH, 2012, CLIN EXP ALLERGY, V42, P186, DOI 10.1111/j.1365-2222.2011.03891.x; Kauffmann F, 1999, CLIN EXP ALLERGY, V29, P17; Kauffmann F, 1997, AM J RESP CRIT CARE, V156, pS123, DOI 10.1164/ajrccm.156.4.12tac9; Kurukulaaratchy RJ, 2015, J ALLERGY CLIN IMMUN, V135, P143, DOI 10.1016/j.jaci.2014.06.017; McLachlan G., 2000, WILEY SER PROB STAT; Molgaard E, 2007, ALLERGY, V62, P1033, DOI 10.1111/j.1398-9995.2007.01355.x; Pinart M, 2014, LANCET RESP MED, V2, P131, DOI 10.1016/S2213-2600(13)70277-7; Quillen DM, 2006, AM FAM PHYSICIAN, V73, P1583; Settipane RA, 2011, IMMUNOL ALLERGY CLIN, V31, P457, DOI 10.1016/j.iac.2011.05.011; Shaaban R, 2008, LANCET, V372, P1049, DOI 10.1016/S0140-6736(08)61446-4; Siroux V, 2011, EUR RESPIR J, V38, P310, DOI 10.1183/09031936.00120810; Siroux V, 2009, J ALLERGY CLIN IMMUN, V124, P681, DOI 10.1016/j.jaci.2009.06.010; Topal E, 2014, INT FORUM ALLERGY RH, V4, P447, DOI 10.1002/alr.21312; Tran NP, 2011, ALLERGY ASTHMA IMMUN, V3, P148, DOI 10.4168/aair.2011.3.3.148; Weatherall M, 2009, EUR RESPIR J, V34, P812, DOI 10.1183/09031936.00174408	27	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136191	10.1371/journal.pone.0136191	http://dx.doi.org/10.1371/journal.pone.0136191			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309034	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400094
J	Golbeck, J				Golbeck, Jennifer			Benford's Law Applies to Online Social Networks	PLOS ONE			English	Article							1ST DIGIT	Benford's Law states that, in naturally occurring systems, the frequency of numbers' first digits is not evenly distributed. Numbers beginning with a 1 occur roughly 30% of the time, and are six times more common than numbers beginning with a 9. We show that Benford's Law applies to social and behavioral features of users in online social networks. Using social data from five major social networks (Facebook, Twitter, Google Plus, Pinterest, and LiveJournal), we show that the distribution of first significant digits of friend and follower counts for users in these systems follow Benford's Law. The same is true for the number of posts users make. We extend this to egocentric networks, showing that friend counts among the people in an individual's social network also follows the expected distribution. We discuss how this can be used to detect suspicious or fraudulent activity online and to validate datasets.	Univ Maryland, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Golbeck, J (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	jgolbeck@umd.edu						Asur S., 2011, P INT AAAI C WEB SOC, P434, DOI [10.2139/ssrn.1755748, DOI 10.2139/SSRN.1755748]; Backstrom L, 2006, P 12 ACM SIGKDD INT, P44, DOI DOI 10.1145/1150402.1150412; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Benford F, 1938, P AM PHILOS SOC, V78, P551, DOI DOI 10.2307/984802; Bhattacharya S, 2011, DECIS SUPPORT SYST, V50, P576, DOI 10.1016/j.dss.2010.08.011; DIACONIS P, 1979, J AM STAT ASSOC, V74, P359, DOI 10.2307/2286335; Diekmann A, 2007, J APPL STAT, V34, P321, DOI 10.1080/02664760601004940; Durtschi C., 2004, J FORENSIC ACCOUNT, V5, P17; Fu Dongdong, 2007, ELECT IMAGING 2007; Giles DE, 2007, APPL ECON LETT, V14, P157, DOI 10.1080/13504850500425667; Hill TP, 1995, STAT SCI, V10, P354, DOI 10.1214/ss/1177009869; Hill TP, 1998, AM SCI, V86, P358, DOI 10.1511/1998.4.358; Hoyle DC, 2002, BIOINFORMATICS, V18, P576, DOI 10.1093/bioinformatics/18.4.576; Jolion JM, 2001, J MATH IMAGING VIS, V14, P73, DOI 10.1023/A:1008363415314; Judge G, 2009, J HUM RESOUR, V44, P1; Leskovec J., 2008, CORR; Leskovec J., 2012, ADV NEURAL INFORM PR, P539, DOI DOI 10.1109/ICDM.2012.159; Pietronero L, 2001, PHYSICA A, V293, P297, DOI 10.1016/S0378-4371(00)00633-6; Shikano S, 2011, JAHRB NATL STAT, V231, P719; Stoessiger R., 2013, AUSTR SENIOR MATH J, V27, P29; Zhong C, 2014, 23 INT WORLD WID WEB	21	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135169	10.1371/journal.pone.0135169	http://dx.doi.org/10.1371/journal.pone.0135169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LO	26308716	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400052
J	Huang, ZH; Jin, MH; Zhou, H; Dong, ZQ; Zhang, SC; Han, JK; Fu, KQ; Wu, JL; Wu, SD; Du, HR; Yang, ZR				Huang, Zhaohui; Jin, Meihua; Zhou, Huan; Dong, Zhengquan; Zhang, Sichao; Han, Jiankang; Fu, Keqin; Wu, Jianli; Wu, Shudong; Du, Huarong; Yang, Zhongrong			The Uptake of Prevention of Mother-to-Child HIV Transmission Programs in China: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							WOMEN; EPIDEMIOLOGY; INFECTION	Background No systematic review of prevention of mother to child transmission (PMTCT) in China has been performed. We aimed to estimate the uptake of PMTCT programs services in China. Methods We searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, China National Knowledge Infrastructure, Chinese Biomedical Literature Database, and Wanfang (Chinese) to identify research studies. Only descriptive epidemiological studies were eligible for this study. Results A total of 57 eligible cross-section studies were finally included. We estimated that the mean HIV-positive rate of exposed infants was 4.4% (95% CI = 3.2-5.5), and more than 33% of exposed infants had not undergone HIV diagnostic testing. The percentage of initiating antiretroviral therapy (ART) in HIV-positive women was 71.0%(95% CI = 66.3-75.8), and that for initiating antiretroviral prophylaxis (ARP) in exposed infants was 78.3% (95% CI = 74.9-81.8); also, 31.3%(95% CI = 15.5-47.0) of women with HIV and <1% of exposed infants received the combination of three antiretroviral drugs. There were bigger gap of uptake of PMTCT programs between income levels, and cities with a low income level had a higher percentage of initiating ART in HIV-positive women (80%) and ARP in exposed infants (85%) compared to cities with high-middle income (57% and 65%, respectively) (P<0.05). Conclusions This paper highlights the need to further scale up PMTCT services in China, especially in regions with the lowest coverage, so that more women can access and utilize them. However, some estimated outcome should be interpreted with caution due to the high level of heterogeneity and the small number of studies.	[Huang, Zhaohui; Fu, Keqin; Wu, Jianli; Wu, Shudong; Du, Huarong] Anhui Prov Family Planning Inst Sci & Technol, Hefei 230031, Anhui, Peoples R China; [Jin, Meihua; Dong, Zhengquan; Zhang, Sichao; Han, Jiankang; Yang, Zhongrong] Huzhou Ctr Dis Control & Prevent, Huzhou 313000, Zhejiang, Peoples R China; [Zhou, Huan] Bengbu Med Coll, Affiliated Hosp 1, Hlth Management Teaching & Res Sect, Bengbu 233000, Anhui, Peoples R China	Bengbu Medical College	Yang, ZR (corresponding author), Huzhou Ctr Dis Control & Prevent, Huzhou 313000, Zhejiang, Peoples R China.	yzhr91@126.com		Yang, Zhongrong/0000-0003-2070-9976				Ailika S, 2013, CHINESE J HLTH ED, V8, P687; Bai Y, 2012, J MED PEST CONTROL, V28, P836; Cao YZ, 2011, MODERN MED J CHINA, V13, P5; Car LT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056550; Car LT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035268; Chen L, 2013, CHINA TROPICAL MED, V13, P1074; Chen Y, 2013, XINJIANG MED, V43, P162; Chen ZY, 2010, CHIN J AIDS STD, V4, P401; Cheng W, 2009, MODERN PREV MED, V36, P1252; Cheng WM, 2006, OCCUPATION HLTH, V22, P2104; Cheng WM, 2009, MODERN PREVENTIVE ME, V36, P422; China Ministry of Health China Center for Disease Control and Prevention, WORK GUID PREV MOTH; Dai GuoHong, 2010, Maternal and Child Health Care of China, V25, P4370; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Du M, 2006, SOFT SCI HLTH, V20, P323; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fang Li-wen, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P1003; Feng L, 2013, CHIN J DIS CONTROL P, V17, P178; Ferguson L, 2012, TROP MED INT HEALTH, V17, P564, DOI 10.1111/j.1365-3156.2012.02958.x; Gong SY, 2007, CHIN J AIDS STD, V13, P320; Gong SY, 2007, CHIN J AIDS STD, V13, P314; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hong Y, 2009, MATERN CHILD HLTH J, V24, P4647; Huang S, 2013, MOD HOSP, V13, P145; Jia LQ, 2010, CHINA FOREIGN MED TR, V29, P71; Jiang W, 2013, CHINESE J NEW CLIN M, V12, P1154; Kalembo FW, 2013, CHINESE MED J-PEKING, V126, P3172, DOI 10.3760/cma.j.issn.0366-6999.20123475; Li B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-591; Li Tao, 2012, Modern Preventive Medicine, V39, P2720; Li Y, 2012, MATERN CHILD HLTH J, V27, P5450; Liang K, 2011, CHIN J PERINAT MED, V14, P550; Lin AWC, 2014, AIDS CARE, V26, P169, DOI 10.1080/09540121.2013.819402; Ling L, 2009, CHIN J DIS CONTROL P, V13, P422; Ling L, 2009, CHIN J DIS CONTROL P, V13, P426; Lu QC, 2008, CHIN J AIDS STD, V14, P508; Luo XM, 2011, CHINESE FORENGH WOME, V19, P312; Ma JZ, 2010, HENAN J PREV MED, V21, P87; Ma JZ, 2010, HENAN J PREV MED, V21, P100; Ma Q, 2012, SOFT SCI HLTH, V26, P230; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; MANTEL N, 1959, J NATL CANCER I, V22, P719; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Ministry of Civil Affairs of the People's Republic of China, ADM DIV PEOPL REP CH; Research centers of Chinese livable city, GDP PER CAP GDP CHIN; Rostom A, CELIAC DIS; Shetty AK, 2013, CURR HIV RES, V11, P81, DOI 10.2174/1570162X11311020002; Song JM, 2013, SEX TRANSM DIS, V40, P329, DOI 10.1097/OLQ.0b013e3182805186; Sun LD, 2011, CHINESE FORENGH WOME, V19, P453; Tan YM, 2013, GUANGXI MED J, V4, P491; The General Office of the State Council, 12 5 YEAR ACT PLAN C; UNAIDS, 2012, REP GLOB AIDS EP; UNAIDS, 2012, 2012 CHIN AIDS RESP; UNAIDS, 2013, PROGR REP GLOB PLAN; UNAIDS, 2012, TOG WE WILL END AIDS; UNAIDS, 2010, REP GLOB AIDS EP 201; UNICEF, 2013, GLOB UPD HIV TREATM; Wang AL, 2006, MATERN CHILD HLTH J, V21, P1765; Wang Fu-kun, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P988; Wang Q., 2008, CHIN J AIDS STD, V14, P351; Wang Q, 2006, SURV NEEDS US PREV M; Wang Q, 2013, CHINESE J HLTH ED, V29, P211; Wang Q, 2009, MATERN CHILD HLTH J, V24, P5182; Wang Q, 2012, MATERN CHILD HLTH J, V27, P4842; Wang QF, 2011, TODAY NURSE, P173; [王前 Wang Qian], 2013, [中国公共卫生, China Journal of Public Health], V29, P1417; Wang Qiong, 2011, Modern Preventive Medicine, V38, P34; Wang WM, 2008, CHIN J PUBLIC HLTH, V24, P4; Wang XY, 2013, CHIN J AIDS STD, V12, P880; Wang XY, 2010, CHINESE J WOMAN CHIL, V21, P282; Wang XY, 2010, CHINESE J WOMAN CHIL, V21, P326; Wang YX, 2011, CHINESE J COAL IND M, V14, P877; Wang ZZ, 2007, MATERN CHILD HLTH J, V22, P4858; Wen Yong, 2011, Chinese Journal of Practical Pediatrics, V26, P933; Weng YuQiu, 2010, China Tropical Medicine, V10, P957; WHO, 2013, GLOB UPD HIV TREATM; Wilcher R, 2013, CURR OPIN HIV AIDS, V8, P490, DOI 10.1097/COH.0b013e3283632bd7; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2010, PMTCT STRAT VIS 2010; Wu M, 2011, PRACTICAL PREVENTIVE, V18, P1058; Xiong YH, 2010, MATERN CHILD HLTH J, V25, P2097; Yang M, 2011, GUIZHOU MED J, V35, P162; yang M, 2014, MATERN CHILD HLTH J, V29, P10; Zhang HY, 2011, CHINESE J BIRTH HLTH, V19, P78; Zhang SP, 2012, ANHUI J PREV MED, V18, P190; Zhang XH, 2009, MATERN CHILD HLTH J, V24, P152; Zhang XH, 2014, CURRENT HIV RES; Zhou FengRong, 2010, Chinese Preventive Medicine, V11, P692; Zhu XX, 2005, MATERN CHILD HLTH J, V20, P1430	89	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135068	10.1371/journal.pone.0135068	http://dx.doi.org/10.1371/journal.pone.0135068			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308335	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400048
J	Panigada, M; Zacchetti, L; L'Acqua, C; Cressoni, M; Anzoletti, MB; Bader, R; Protti, A; Consonni, D; D'Angelo, A; Gattinoni, L				Panigada, Mauro; Zacchetti, Lucia; L'Acqua, Camilla; Cressoni, Massimo; Anzoletti, Massimo Boscolo; Bader, Rossella; Protti, Alessandro; Consonni, Dario; D'Angelo, Armando; Gattinoni, Luciano			Assessment of Fibrinolysis in Sepsis Patients with Urokinase Modified Thromboelastography	PLOS ONE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; PLASMINOGEN-ACTIVATOR INHIBITOR-1; HUMAN SOLUBLE THROMBOMODULIN; INFECTION; EFFICACY; SAFETY; HEMOSTASIS; MORTALITY; PLASMA; ADULTS	Introduction Impairment of fibrinolysis during sepsis is associated with worse outcome. Early identification of this condition could be of interest. The aim of this study was to evaluate whether a modified point-of-care viscoelastic hemostatic assay can detect sepsis-induced impairment of fibrinolysis and to correlate impaired fibrinolysis with morbidity and mortality. Methods This single center observational prospective pilot study was performed in an adult Intensive Care Unit (ICU) of a tertiary academic hospital. Forty consecutive patients admitted to the ICU with severe sepsis or septic shock were included. Forty healthy individuals served as controls. We modified conventional kaolin activated thromboelastography (TEG) adding urokinase to improve assessment of fibrinolysis in real time (UK-TEG). TEG, UK-TEG, plasminogen activator inhibitor (PAI)-1, thrombin-activatable fibrinolysis inhibitor (TAFI), d-dimer, DIC scores and morbidity (rated with the SOFA score) were measured upon ICU admission. Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs) of mortality at ICU discharge. Results UK-TEG revealed a greater impairment of fibrinolysis in sepsis patients compared to healthy individuals confirmed by PAI-1. TAFI was not different between sepsis patients and healthy individuals. 18/40 sepsis patients had fibrinolysis impaired according to UK-TEG and showed higher SOFA score (8 (6-13) vs 5 (4-7), p = 0.03), higher mortality (39% vs 5%, p = 0.01) and greater markers of cellular damage (lactate levels, LDH and bilirubin). Mortality at ICU discharge was predicted by the degree of fibrinolysis impairment measured by UK-TEG Ly30 (%) parameter (OR 0.95, 95% CI 0.93-0.98, p = 0.003). Conclusions Sepsis-induced impairment of fibrinolysis detected at UK-TEG was associated with increased markers of cellular damage, morbidity and mortality.	[Panigada, Mauro; Zacchetti, Lucia; L'Acqua, Camilla; Cressoni, Massimo; Protti, Alessandro; Gattinoni, Luciano] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Anesthesiol Intens Care & Emergency, Milan, Italy; [Anzoletti, Massimo Boscolo; Bader, Rossella] Fdn IRCCS Ca Granda Osped Maggiore Policlin, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy; [Consonni, Dario] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Epidemiol Unit, Milan, Italy; [D'Angelo, Armando] IRCCS Osped San Raffaele, Coagulat Serv, Milan, Italy; [D'Angelo, Armando] IRCCS Osped San Raffaele, Thrombosis Res Unit, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Panigada, M (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Anesthesiol Intens Care & Emergency, Milan, Italy.	mauro.panigada@outlook.com	Protti, Alessandro/AAC-3122-2020; Consonni, Dario/AAM-2947-2020; Panigada, Mauro/K-4650-2014; D'Angelo, Armando/K-2583-2018; Cressoni, Massimo/B-7315-2017	Consonni, Dario/0000-0002-8935-3843; Panigada, Mauro/0000-0003-4841-9794; D'Angelo, Armando/0000-0002-9857-4509; Protti, Alessandro/0000-0002-0172-6079; L'Acqua, Camilla/0000-0002-0533-8284; Gattinoni, Luciano/0000-0001-5380-2494				Abraham E, 2003, JAMA-J AM MED ASSOC, V290, P238, DOI 10.1001/jama.290.2.238; Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Annane D, 2013, AM J RESP CRIT CARE, V187, P1091, DOI 10.1164/rccm.201211-2020OC; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Carrieri C, 2011, J THROMB HAEMOST, V9, P154, DOI 10.1111/j.1538-7836.2010.04120.x; Collins PW, 2006, BRIT J HAEMATOL, V135, P220, DOI 10.1111/j.1365-2141.2006.06281.x; Colucci M, 2004, BLOOD, V103, P2157, DOI 10.1182/blood-2003-06-2169; Daudel F, 2009, CRIT CARE, V13, DOI 10.1186/cc7765; Degen JL, 2007, J THROMB HAEMOST, V5, P24, DOI 10.1111/j.1538-7836.2007.02519.x; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Durila M, 2010, ANAESTHESIA, V65, P864, DOI 10.1111/j.1365-2044.2010.06441.x; Emonts M, 2008, J THROMB HAEMOST, V6, P268, DOI 10.1111/j.1538-7836.2007.02841.x; Gallimore MJ, 2005, J THROMB HAEMOST, V3, P2506, DOI 10.1111/j.1538-7836.2005.01615.x; Gando S, 2013, SEMIN THROMB HEMOST, V39, P392, DOI 10.1055/s-0033-1334140; Ganter MT, 2008, ANESTH ANALG, V106, P1366, DOI 10.1213/ane.0b013e318168b367; HESSELVIK JF, 1989, CRIT CARE MED, V17, P724, DOI 10.1097/00003246-198908000-00002; Julious SA, 2005, PHARM STAT, V4, P287, DOI 10.1002/pst.185; Kang YG, 1995, SEMIN THROMB HEMOST, V21, P34; KANG YG, 1985, ANESTH ANALG, V64, P888; Kato T, 2013, THROMB J, V11, DOI 10.1186/1477-9560-11-3; Kupesiz A, 2010, BLOOD COAGUL FIBRIN, V21, P320, DOI 10.1097/MBC.0b013e32833464e9; LORENTE JA, 1993, CHEST, V103, P1536, DOI 10.1378/chest.103.5.1536; Lorente L, 2014, THROMB RES, V134, P182, DOI 10.1016/j.thromres.2014.04.013; MacLaren R, 2007, PHARMACOTHERAPY, V27, P860, DOI 10.1592/phco.27.6.860; Madoiwa S, 2006, INT J HEMATOL, V84, P398, DOI 10.1532/IJH97.05190; Mesters RM, 1996, THROMB HAEMOSTASIS, V75, P902; Moreland V, 2010, ARCH PATHOL LAB MED, V134, P1736, DOI 10.1043/2010-0253-LER.1; Muller MC, 2014, CRIT CARE, V18, DOI 10.1186/cc13721; Nadel S, 2007, LANCET, V369, P836, DOI 10.1016/S0140-6736(07)60411-5; Ostrowski SR, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.09.003; PRALONG G, 1989, THROMB HAEMOSTASIS, V61, P459; Raaphorst J, 2001, THROMB HAEMOSTASIS, V86, P543, DOI 10.1055/s-0037-1616084; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Savioli M, 2009, CRIT CARE MED, V37, P424, DOI 10.1097/CCM.0b013e31819542da; Sawamura A, 2009, THROMB RES, V124, P706, DOI 10.1016/j.thromres.2009.06.036; Schochl H, 2014, ANESTH ANALG, V119, P1064, DOI 10.1213/ANE.0b013e318270a6f7; Sebag SC, 2011, CURR PHARM BIOTECHNO, V12, P1481; Sivula M, 2009, BLOOD COAGUL FIBRIN, V20, P419, DOI 10.1097/MBC.0b013e32832a76e1; Spiess B D, 1987, J Clin Monit, V3, P25, DOI 10.1007/BF00770880; SUFFREDINI AF, 1989, NEW ENGL J MED, V320, P1165, DOI 10.1056/NEJM198905043201802; Summaria L, 1995, SEMIN THROMB HEMOST, V21, P63; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Vincent JL, 2013, CRIT CARE MED, V41, P2069, DOI 10.1097/CCM.0b013e31828e9b03; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wada H, 2013, J Thromb Haemost, DOI 10.1111/jth.12155; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Watanabe R, 2001, THROMB RES, V104, P1, DOI 10.1016/S0049-3848(01)00331-0; Yamakawa K, 2011, CRIT CARE, V15, DOI 10.1186/cc10228; ZENZ W, 1995, PEDIATRICS, V96, P144; [No title captured]; [No title captured]	51	36	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136463	10.1371/journal.pone.0136463	http://dx.doi.org/10.1371/journal.pone.0136463			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308340	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400126
J	Frati, F; Piersanti, S; Conti, E; Rebora, M; Salerno, G				Frati, Francesca; Piersanti, Silvana; Conti, Eric; Rebora, Manuela; Salerno, Gianandrea			Scent of a Dragonfly: Sex Recognition in a Polymorphic Coenagrionid	PLOS ONE			English	Article							LIBELLULA-DEPRESSA ODONATA; FEMALE COLOR MORPHS; ISCHNURA-ELEGANS; ANTENNAL SENSILLA; MATE RECOGNITION; DAMSELFLIES ODONATA; MATING-BEHAVIOR; MALES; CUES; HARASSMENT	In polymorphic damselflies discrimination of females from males is complex owing to the presence of androchrome and gynochrome females. To date there is no evidence that damselflies use sensory modalities other than vision (and tactile stimuli) in mate searching and sex recognition. The results of the present behavioural and electrophysiological investigations on Ischnura elegans, a polymorphic damselfly, support our hypothesis that chemical cues could be involved in Odonata sex recognition. The bioassays demonstrate that males in laboratory prefer female to male odour, while no significant difference was present in male behavior between stimuli from males and control. The bioassays suggest also some ability of males to distinguish between the two female morphs using chemical stimuli. The ability of male antennae to perceive odours from females has been confirmed by electrophysiological recordings. These findings are important not only to get insight into the chemical ecology of Odonata, and to shed light into the problem of olfaction in Paleoptera, but could be useful to clarify the controversial aspects of the mating behavior of polymorphic coenagrionids. Behavioural studies in the field are necessary to investigate further these aspects.	[Frati, Francesca; Conti, Eric; Salerno, Gianandrea] Univ Perugia, Dipartimento Sci Agr Alimentari & Ambientali, I-06100 Perugia, Italy; [Piersanti, Silvana; Rebora, Manuela] Univ Perugia, Dipartimento Chim Biol & Biotecnol, I-06100 Perugia, Italy	University of Perugia; University of Perugia	Rebora, M (corresponding author), Univ Perugia, Dipartimento Chim Biol & Biotecnol, I-06100 Perugia, Italy.	manuela.rebora@unipg.it	Rebora, Manuela/G-9840-2012; Salerno, Gianandrea/G-9296-2011; Piersanti, Silvana/F-9083-2014; Rebora, Manuela/AAB-7848-2019; Piersanti, Silvana/AAC-8109-2022	Rebora, Manuela/0000-0002-4271-6336; Salerno, Gianandrea/0000-0002-8357-7598; Rebora, Manuela/0000-0002-4271-6336; Frati, Francesca/0000-0002-9891-9757	Italian Ministry for Education, University and Research (MIUR-Fondo Integrativo per la Ricerca di Base - F.I.R.B.) [RBFR10Z196]	Italian Ministry for Education, University and Research (MIUR-Fondo Integrativo per la Ricerca di Base - F.I.R.B.)	Funding was provided by Italian Ministry for Education, University and Research (MIUR-Fondo Integrativo per la Ricerca di Base - F.I.R.B., 2010, RBFR10Z196). SP and FF received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JK, 2009, ECOL ENTOMOL, V34, P378, DOI 10.1111/j.1365-2311.2009.01087.x; Andres JA, 2001, ANIM BEHAV, V61, P1; BICK G H, 1981, Odonatologica, V10, P259; BICK GH, 1965, CAN ENTOMOL, V97, P32, DOI 10.4039/Ent9732-1; BLOMQUIST GJ, 1987, ARCH INSECT BIOCHEM, V6, P227, DOI 10.1002/arch.940060404; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; CORDERO A, 1989, Odonatologica, V18, P237; Cordero A, 1998, ANIM BEHAV, V55, P185, DOI 10.1006/anbe.1997.0603; CORDERO A, 1992, J ANIM ECOL, V61, P769, DOI 10.2307/5630; Cordero A., 1996, Journal of the British Dragonfly Society, V12, P50; Ephrussi B, 1936, AM NAT, V70, P218, DOI 10.1086/280658; Fincke OM, 2015, J EVOLUTION BIOL, V28, P931, DOI 10.1111/jeb.12623; Fincke Ola M., 2005, International Journal of Odonatology, V8, P183; Fincke OM, 2007, BEHAV ECOL SOCIOBIOL, V61, P1121, DOI 10.1007/s00265-006-0345-3; FINCKE OM, 1994, ANIM BEHAV, V47, P1249, DOI 10.1006/anbe.1994.1174; Fincke OM, 2004, ANIM BEHAV, V67, P833, DOI 10.1016/j.anbehav.2003.04.017; Gorb S., 1992, Odonatologica, V21, P299; Gorb S. N., 1994, Odonatologica, V23, P341; Gorb SN, 1998, J INSECT BEHAV, V11, P73, DOI 10.1023/A:1020818617066; Greenfield MD, 2002, SIGNALERS RECEIVERS; HINNEKINT BON, 1987, HYDROBIOLOGIA, V146, P3, DOI 10.1007/BF00007574; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Huang SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087972; Iserbyt A, 2011, ECOL ENTOMOL, V36, P544, DOI 10.1111/j.1365-2311.2011.01300.x; LABHART T, 1995, J COMP PHYSIOL A, V176, P437, DOI 10.1007/BF00196410; Marascuilo L. A., 1988, STAT METHODS SOCIAL; Mazzoni V, 2009, J ECON ENTOMOL, V102, P974, DOI 10.1603/029.102.0316; Miller MN, 1999, J INSECT BEHAV, V12, P801, DOI 10.1023/A:1020957110842; Pajunen V. I., 1964, Ann Zool Fenn, P357; Partan SR, 2005, AM NAT, V166, P231, DOI 10.1086/431246; Piersanti S, 2010, ODONATOLOGICA, V39, P235; Piersanti S, 2015, INT J ODONATOL, V18, P125, DOI 10.1080/13887890.2015.1015179; Piersanti S, 2014, J INSECT PHYSIOL, V70, P49, DOI 10.1016/j.jinsphys.2014.09.003; Piersanti S, 2014, J INSECT PHYSIOL, V62, P26, DOI 10.1016/j.jinsphys.2014.01.006; Rebora M, 2009, ODONATOLOGICA, V38, P329; Rebora M, 2008, ARTHROPOD STRUCT DEV, V37, P504, DOI 10.1016/j.asd.2008.03.003; Rebora M, 2013, ZOOLOGY, V116, P205, DOI 10.1016/j.zool.2013.04.001; Rebora M, 2012, J INSECT PHYSIOL, V58, P270, DOI 10.1016/j.jinsphys.2011.11.018; Rivera AC, 2007, ANIM BEHAV, V74, P247, DOI 10.1016/j.anbehav.2006.06.023; ROBERTSON HM, 1985, ANIM BEHAV, V33, P805, DOI 10.1016/S0003-3472(85)80013-0; ROBERTSON HM, 1982, EVOLUTION, V36, P243, DOI 10.1111/j.1558-5646.1982.tb05037.x; Ruppell G., 1989, Odonatologica, V18, P391; Sherratt TN, 2001, ANIM BEHAV, V62, P653, DOI 10.1006/anbe.2001.1789; Sirot LK, 2003, ANIM BEHAV, V66, P763, DOI 10.1006/anbe.2003.2279; Sokal RR, 1998, BIOMETRY; Statsoft Inc, 2001, STAT DAT AN SOFTW SY; Ting JJ, 2009, BEHAV ECOL SOCIOBIOL, V64, P225, DOI 10.1007/s00265-009-0839-x; UBUKATA H, 1983, Odonatologica, V12, P71; UTZERI C, 1988, Odonatologica, V17, P45; Van Gossum H, 2005, ODONATOLOGICA, V34, P407; Van Gossum H, 2005, BIOL LETT-UK, V1, P268, DOI 10.1098/rsbl.2005.0315; Van Gossum H, 1999, ANIM BEHAV, V57, P1229, DOI 10.1006/anbe.1999.1100; Van Gossum H, 2001, BEHAV ECOL SOCIOBIOL, V51, P69; van Gossum H, 2001, P ROY SOC B-BIOL SCI, V268, P83; Whiting MJ, 2009, P ROY SOC B-BIOL SCI, V276, P1585, DOI 10.1098/rspb.2008.1822; Xu MZ, 2014, ANIM BEHAV, V92, P9, DOI 10.1016/j.anbehav.2014.03.016; Yang EC, 1996, J COMP PHYSIOL A, V178, P543, DOI 10.1007/BF00190184	58	16	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136697	10.1371/journal.pone.0136697	http://dx.doi.org/10.1371/journal.pone.0136697			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305118	Green Submitted, gold, Green Published			2022-12-27	WOS:000359995500109
J	Kang, DH; Choi, M; Chang, S; Lee, MY; Lee, DJ; Choi, K; Park, J; Han, EC; Hwang, D; Kwon, K; Jo, H; Choi, C; Kang, SW				Kang, Dong Hoon; Choi, Mina; Chang, Soyoung; Lee, Min Young; Lee, Doo Jae; Choi, Kyungsun; Park, Junseong; Han, Eun Chun; Hwang, Daehee; Kwon, Kihwan; Jo, Hanjoong; Choi, Chulhee; Kang, Sang Won			Vascular Proteomics Reveal Novel Proteins Involved in SMC Phenotypic Change: OLR1 as a SMC Receptor Regulating Proliferation and Inflammatory Response	PLOS ONE			English	Article							GROWTH-FACTOR; CORONARY ANGIOPLASTY; NEOINTIMAL GROWTH; CAROTID STENOSIS; MICE LACKING; ATHEROSCLEROSIS; INHIBITION; EXPRESSION; PATHWAY; RESTENOSIS	Neointimal hyperplasia of vascular smooth muscle cells (VSMC) plays a critical role in atherosclerotic plaque formation and in-stent restenosis, but the underlying mechanisms are still incompletely understood. We performed a proteomics study to identify novel signaling molecules organizing the VSMC hyperplasia. The differential proteomics analysis in a balloon- induced injury model of rat carotid artery revealed that the expressions of 44 proteins are changed within 3 days post injury. The combination of cellular function assays and a protein network analysis further demonstrated that 27 out of 44 proteins constitute key signaling networks orchestrating the phenotypic change of VSMC from contractile to epithelial-like synthetic. Among the list of proteins, the in vivo validation specifically revealed that six proteins (Rab 15, ITR, OLR1, PDH beta, PTP epsilon) are positive regulators for VSMC hyperplasia. In particular, the OLR1 played dual roles in the VSMC hyperplasia by directly mediating oxidized LDL-induced monocyte adhesion via NF-kappa B activation and by assisting the PDGF-induced proliferation/migration. Importantly, OLR1 and PDGFR beta were associated in close proximity in the plasma membrane. Thus, this study elicits the protein network organizing the phenotypic change of VSMC in the vascular injury diseases such as atherosclerosis and discovers OLR1 as a novel molecular link between the proliferative and inflammatory responses of VSMCs.	[Kang, Dong Hoon; Choi, Mina; Lee, Doo Jae; Kang, Sang Won] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea; [Kang, Dong Hoon; Choi, Mina; Lee, Doo Jae; Kang, Sang Won] Ewha Womans Univ, Res Ctr Cell Homeostasis, Seoul 120750, South Korea; [Kwon, Kihwan] Ewha Womans Univ, Dept Cardiol, Seoul 120750, South Korea; [Kwon, Kihwan] Ewha Womans Univ, Coll Med, Seoul 120750, South Korea; [Kwon, Kihwan; Kang, Sang Won] Ewha Womans Univ, Global Res Program Top5, Seoul 120750, South Korea; [Chang, Soyoung; Choi, Kyungsun; Park, Junseong; Han, Eun Chun; Choi, Chulhee] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Lee, Min Young; Hwang, Daehee] POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, South Korea; [Hwang, Daehee] DGIST, Dept New Biol, Taegu 711873, South Korea; [Hwang, Daehee] DGIST, Inst Basic Sci, Ctr Plant Aging Res, Taegu 711873, South Korea; [Jo, Hanjoong] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Jo, Hanjoong] Emory Univ, Atlanta, GA 30322 USA	Ewha Womans University; Ewha Womans University; Ewha Womans University; Ewha Womans University; Ewha Womans University; Korea Advanced Institute of Science & Technology (KAIST); Pohang University of Science & Technology (POSTECH); Daegu Gyeongbuk Institute of Science & Technology (DGIST); Daegu Gyeongbuk Institute of Science & Technology (DGIST); Institute for Basic Science - Korea (IBS); University System of Georgia; Georgia Institute of Technology; Emory University	Kang, DH (corresponding author), Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea.	ref423@ewha.ac.kr; cchoi@kaist.ac.kr; kangsw@ewha.ac.kr	Jo, Hanjoong/L-6216-2019; Park, Junseong/C-1973-2012; Choi, Chulhee/C-1642-2011	Jo, Hanjoong/0000-0003-1833-372X; Choi, Chulhee/0000-0001-5542-9136	Bio & Medical Development Program [2011-0019696]; Research Center for Cellular Homeostasis [2012R1A5A1048236]; National Research Foundation grant - Korean government [2012M3A9C5048709]; GIST Systems Biology Infrastructure establishment Grant [2013]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL095070, R01HL119798] Funding Source: NIH RePORTER	Bio & Medical Development Program; Research Center for Cellular Homeostasis; National Research Foundation grant - Korean government(National Research Foundation of Korea); GIST Systems Biology Infrastructure establishment Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by Bio & Medical Development Program (2011-0019696), the Research Center for Cellular Homeostasis (2012R1A5A1048236), and the National Research Foundation grant (2012M3A9C5048709) funded by the Korean government (SWK). This work was also supported by GIST Systems Biology Infrastructure establishment Grant (2013) (SWK).	Anderson L, 2005, J PHYSIOL-LONDON, V563, P23, DOI 10.1113/jphysiol.2004.080473; Berhane BT, 2005, PROTEOMICS, V5, P3520, DOI 10.1002/pmic.200401308; Brito PM, 2009, ATHEROSCLEROSIS, V205, P126, DOI 10.1016/j.atherosclerosis.2008.11.011; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Chun JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009422; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; CLOWES AW, 1983, LAB INVEST, V49, P208; Cyrus T, 2008, ARTERIOSCL THROM VAS, V28, P820, DOI 10.1161/ATVBAHA.107.156281; de la Cuesta F, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003517; Ekins S, 2007, METH MOL B, V356, P319; Engberding N, 2009, ARTERIOSCL THROM VAS, V29, P408, DOI 10.1161/ATVBAHA.108.181727; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Escargueil-Blanc I, 2001, CIRCULATION, V104, P1814, DOI 10.1161/hc4001.097179; Eto H, 2006, BIOCHEM BIOPH RES CO, V341, P591, DOI 10.1016/j.bbrc.2005.12.211; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Forte A, 2008, J CELL MOL MED, V12, P1956, DOI 10.1111/j.1582-4934.2008.00212.x; Ganesh SK, 2004, PHARMACOGENOMICS, V5, P949, DOI 10.1517/14622416.5.7.949; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jantzen Stuart G, 2011, BMC Res Notes, V4, P267, DOI 10.1186/1756-0500-4-267; Jia GH, 2007, AM J PHYSIOL-HEART C, V292, pH1051, DOI 10.1152/ajpheart.00801.2006; Jing LH, 2011, PROTEOMICS, V11, P2763, DOI 10.1002/pmic.201000202; Kang DH, 2013, CIRCULATION, V128, P834, DOI 10.1161/CIRCULATIONAHA.113.001725; Kozaki K, 2002, AM J PATHOL, V161, P1395, DOI 10.1016/S0002-9440(10)64415-X; Leppanen O, 2000, ARTERIOSCL THROM VAS, V20, pE89, DOI 10.1161/01.ATV.20.11.e89; Leppanen O, 2004, CIRCULATION, V109, P1140, DOI 10.1161/01.CIR.0000117234.08626.7C; Lewis GD, 2008, J AM COLL CARDIOL, V52, P117, DOI 10.1016/j.jacc.2008.03.043; Li F, 2005, AM J PHYSIOL-HEART C, V289, pH2592, DOI 10.1152/ajpheart.00450.2005; Li W, 2010, J CLIN INVEST, V120, P3996, DOI 10.1172/JCI42823; Matter CM, 2006, CIRCULATION, V113, P1879, DOI 10.1161/CIRCULATIONAHA.106.611731; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; NOBUYOSHI M, 1988, J AM COLL CARDIOL, V12, P616, DOI 10.1016/S0735-1097(88)80046-9; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Serruys Patrick W, 2003, Int J Cardiovasc Intervent, V5, P214; SERRUYS PW, 1988, CIRCULATION, V77, P361, DOI 10.1161/01.CIR.77.2.361; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Takami Y, 2007, ARTERIOSCL THROM VAS, V27, P2184, DOI 10.1161/ATVBAHA.107.142505; Tsukada S, 2003, CIRCULATION, V107, P313, DOI 10.1161/01.CIR.0000043804.29963.B4; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Yamada Y, 1998, CELL MOL LIFE SCI, V54, P628, DOI 10.1007/s000180050191	43	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0133845	10.1371/journal.pone.0133845	http://dx.doi.org/10.1371/journal.pone.0133845			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305474	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500005
J	Sharma, P; Wang, NY; Chervin, AS; Quinn, CL; Stone, JD; Kranz, DM				Sharma, Preeti; Wang, Ningyan; Chervin, Adam S.; Quinn, Cheryl L.; Stone, Jennifer D.; Kranz, David M.			A Multiplex Assay for Detection of Staphylococcal and Streptococcal Exotoxins	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; FOOD POISONING OUTBREAKS; HIGH-AFFINITY; ENTEROTOXIN-A; AUREUS ENTEROTOXIN; BIOTIN BINDING; PCR ASSAY; SUPERANTIGENS; STREPTAVIDIN; ELISA	Staphylococcal and streptococcal exotoxins, also known as superantigens, mediate a range of diseases including toxic shock syndrome, and they exacerbate skin, pulmonary and systemic infections caused by these organisms. When present in food sources they can cause enteric effects commonly known as food poisoning. A rapid, sensitive assay for the toxins would enable testing of clinical samples and improve surveillance of food sources. Here we developed a bead-based, two-color flow cytometry assay using single protein domains of the beta chain of T cell receptors engineered for high-affinity for staphylococcal (SEA, SEB and TSST-1) and streptococcal (SpeA and SpeC) toxins. Site-directed biotinylated forms of these high-affinity agents were used together with commercial, polyclonal, anti-toxin reagents to enable specific and sensitive detection with SD50 values of 400 pg/ml (SEA), 3 pg/ml (SEB), 25 pg/ml (TSST-1), 6 ng/ml (SpeA), and 100 pg/ml (SpeC). These sensitivities were in the range of 4- to 80-fold higher than achieved with standard ELISAs using the same reagents. A multiplex format of the assay showed reduced sensitivity due to higher noise associated with the use of multiple polyclonal agents, but the sensitivities were still well within the range necessary for detection in food sources or for rapid detection of toxins in culture supernatants. For example, the assay specifically detected toxins in supernatants derived from cultures of Staphylococcus aureus. Thus, these reagents can be used for simultaneous detection of the toxins in food sources or culture supernatants of potential pathogenic strains of Staphylococcus aureus and Streptococcus pyogenes.	[Sharma, Preeti; Stone, Jennifer D.; Kranz, David M.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Wang, Ningyan; Chervin, Adam S.; Quinn, Cheryl L.] ImmuVen Inc, Champaign, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Kranz, DM (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	d-kranz@illinois.edu	Sharma, Preeti/P-1044-2019	Sharma, Preeti/0000-0002-8210-9004	National Institutes of Health [R43 AI102432, U54 AI57153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R43AI102432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by various National Institutes of Health grants over the past decade, including R43 AI102432 (to DMK) and a grant from the National Institutes of Health-supported Great Lakes Regional Center for Excellence in Biodefense and Emerging Diseases (U54 AI57153 to DMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2010, TOXINS, V2, P1751, DOI 10.3390/toxins2071751; Asao T, 2003, EPIDEMIOL INFECT, V130, P33, DOI 10.1017/S0950268802007951; Balaban N, 2000, INT J FOOD MICROBIOL, V61, P1, DOI 10.1016/S0168-1605(00)00377-9; Berman HF, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-294; Buchan BW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001478; Buonpane RA, 2005, J MOL BIOL, V353, P308, DOI 10.1016/j.jmb.2005.08.041; Buonpane RA, 2007, NAT MED, V13, P725, DOI 10.1038/nm1584; Chung JW, 2014, DIAGN MICR INFEC DIS, V79, P119, DOI 10.1016/j.diagmicrobio.2014.03.009; Clarisse T, 2013, FOOD CONTROL, V32, P255, DOI 10.1016/j.foodcont.2012.11.021; Commons RJ, 2014, TRENDS MOL MED, V20, P48, DOI 10.1016/j.molmed.2013.10.004; Cook E, 2007, CLIN VACCINE IMMUNOL, V14, P1094, DOI 10.1128/CVI.00183-07; Derzelle S, 2009, FOOD MICROBIOL, V26, P896, DOI 10.1016/j.fm.2009.06.007; Descloux E, 2008, EUR J CLIN MICROBIOL, V27, P37, DOI 10.1007/s10096-007-0405-2; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; EDWIN C, 1989, J CLIN MICROBIOL, V27, P1496, DOI 10.1128/JCM.27.7.1496-1501.1989; EVENSON ML, 1988, INT J FOOD MICROBIOL, V7, P311, DOI 10.1016/0168-1605(88)90057-8; Fetsch A, 2014, INT J FOOD MICROBIOL, V187, P1, DOI 10.1016/j.ijfoodmicro.2014.06.017; Fosheim GE, 2011, J CLIN MICROBIOL, V49, P3071, DOI 10.1128/JCM.00795-11; Garber EAE, 2010, J AGR FOOD CHEM, V58, P6600, DOI 10.1021/jf100789n; Hait J, 2014, J APPL MICROBIOL, V117, P866, DOI 10.1111/jam.12571; HAUSER AR, 1991, J CLIN MICROBIOL, V29, P1562, DOI 10.1128/JCM.29.8.1562-1567.1991; Ikeda T, 2005, APPL ENVIRON MICROB, V71, P2793, DOI 10.1128/AEM.71.5.2793-2795.2005; KAIN KC, 1993, CLIN INFECT DIS, V16, P100, DOI 10.1093/clinids/16.1.100; Kerouanton A, 2007, INT J FOOD MICROBIOL, V115, P369, DOI 10.1016/j.ijfoodmicro.2006.10.050; Kuang H, 2013, INT J ENV RES PUB HE, V10, P1598, DOI 10.3390/ijerph10041598; Kwon KH, 2014, J FOOD SAFETY, V34, P249, DOI 10.1111/jfs.12120; LEUNG DYM, 1995, J CLIN INVEST, V96, P2106, DOI 10.1172/JCI118263; Levine WC, 1996, J INFECT DIS, V173, P1263, DOI 10.1093/infdis/173.5.1263; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; Miwa N, 2001, INT J FOOD MICROBIOL, V64, P361, DOI 10.1016/S0168-1605(00)00446-3; Miyamoto T, 2003, J FOOD PROTECT, V66, P1222, DOI 10.4315/0362-028X-66.7.1222; Ostyn A., 2010, EURO SURVEILL, V15, P19528; PARK CE, 1994, APPL ENVIRON MICROB, V60, P677, DOI 10.1128/AEM.60.2.677-681.1994; PARK CE, 1992, APPL ENVIRON MICROB, V58, P2509, DOI 10.1128/AEM.58.8.2509-2512.1992; Peters T, 2011, ISRN PULMONOLOGY, P1; Peterson ML, 2005, INFECT IMMUN, V73, P2164, DOI 10.1128/IAI.73.4.2164-2174.2005; Reddy P, 2014, J IMMUNOL METHODS, V408, P114, DOI 10.1016/j.jim.2014.05.012; Richman Sarah A., 2009, V504, P323, DOI 10.1007/978-1-60327-569-9_19; Salgado-Pabon W, 2013, MBIO, V4, DOI 10.1128/mBio.00494-13; SANO T, 1990, J BIOL CHEM, V265, P3369; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Shalaby T, 2014, CLIN MED, V14, P316, DOI 10.7861/clinmedicine.14-3-316; Sharma P, 2013, PROTEIN ENG DES SEL, V26, P781, DOI 10.1093/protein/gzt054; Sharma P, 2014, TOXINS, V6, P556, DOI 10.3390/toxins6020556; Spaulding AR, 2013, CLIN MICROBIOL REV, V26, P422, DOI 10.1128/CMR.00104-12; STEVENS DL, 1992, CLIN INFECT DIS, V14, P2, DOI 10.1093/clinids/14.1.2; Tallent SM, 2013, APPL ENVIRON MICROB, V79, P1422, DOI 10.1128/AEM.02743-12; Veras JF, 2008, INT J INFECT DIS, V12, P410, DOI 10.1016/j.ijid.2007.09.018; Vernozy-Rozand C, 2004, LETT APPL MICROBIOL, V39, P490, DOI 10.1111/j.1472-765X.2004.01602.x; Wang NY, 2010, CLIN VACCINE IMMUNOL, V17, P1781, DOI 10.1128/CVI.00277-10; WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722; Wojewoda CM, 2013, J CLIN MICROBIOL, V51, P2072, DOI 10.1128/JCM.00831-13	52	4	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135986	10.1371/journal.pone.0135986	http://dx.doi.org/10.1371/journal.pone.0135986			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305471	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500041
J	Zhang, CX; Sheng, CL; Wang, W; Hu, HB; Peng, HS; Zhang, XH				Zhang, Chunxiao; Sheng, Chaolan; Wang, Wei; Hu, Hongbo; Peng, Huasong; Zhang, Xuehong			Identification of the Lomofungin Biosynthesis Gene Cluster and Associated Flavin-Dependent Monooxygenase Gene in Streptomyces lomondensis S015	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA PYOCYANIN; PHENAZINE BIOSYNTHESIS; PHENAZINE-1-CARBOXYLIC ACID; CHLORORAPHIS PCL1391; FUNCTIONAL-ANALYSIS; ESCHERICHIA-COLI; BIOCONTROL; HYDROXYLATION; PRENYLATION; CLONING	Streptomyces lomondensis S015 synthesizes the broad-spectrum phenazine antibiotic lomofungin. Whole genome sequencing of this strain revealed a genomic locus consisting of 23 open reading frames that includes the core phenazine biosynthesis gene cluster lphzGFEDCB. lomo10, encoding a putative flavin-dependent monooxygenase, was also identified in this locus. Inactivation of lomo10 by in-frame partial deletion resulted in the bio-synthesis of a new phenazine metabolite, 1-carbomethoxy-6-formyl-4,9-dihydroxy-phenazine, along with the absence of lomofungin. This result suggests that lomo10 is responsible for the hydroxylation of lomofungin at its C-7 position. This is the first description of a phenazine hydroxylation gene in Streptomyces, and the results of this study lay the foundation for further investigation of phenazine metabolite biosynthesis in Streptomyces.	[Zhang, Chunxiao; Sheng, Chaolan; Wang, Wei; Hu, Hongbo; Peng, Huasong; Zhang, Xuehong] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China	Shanghai Jiao Tong University	Wang, W (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	weiwang100@sjtu.edu.cn			863 Program of China [2012AA022107]; National Natural Science Foundation of China (NSFC) [20706037]; 973 Project of China [2012CB721005]	863 Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 973 Project of China(National Basic Research Program of China)	This study was supported by grants from the 863 Program of China (Grant No. 2012AA022107), the National Natural Science Foundation of China (NSFC project No. 20706037), and the 973 Project of China (Grant No. 2012CB721005).	BAUER NJ, 1988, J BIOL CHEM, V263, P15619; BERGY ME, 1969, J ANTIBIOT, V22, P126, DOI 10.7164/antibiotics.22.126; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Blankenfeldt W, 2004, P NATL ACAD SCI USA, V101, P16431, DOI 10.1073/pnas.0407371101; BUCKLAND PR, 1981, J CHEM RES-S, P362; Chin-A-Woeng TFC, 1998, MOL PLANT MICROBE IN, V11, P1069, DOI 10.1094/MPMI.1998.11.11.1069; Chin-A-Woeng TFC, 2001, MOL PLANT MICROBE IN, V14, P1006, DOI 10.1094/MPMI.2001.14.8.1006; Delaney SM, 2001, J BACTERIOL, V183, P318, DOI 10.1128/JB.183.1.318-327.2001; GOTTLIEB D, 1969, APPL MICROBIOL, V18, P35, DOI 10.1128/AEM.18.1.35-40.1969; Haagen Y, 2006, CHEMBIOCHEM, V7, P2016, DOI 10.1002/cbic.200600338; Healy FG, 2002, J BACTERIOL, V184, P2019, DOI 10.1128/JB.184.7.2019-2029.2002; Hopwood D. A., 1985, GENETIC MANIPULATION; Huang D, 2013, J IND MICROBIOL BIOT, V40, P1023, DOI 10.1007/s10295-013-1301-7; Huang L, 2011, APPL MICROBIOL BIOT, V89, P169, DOI 10.1007/s00253-010-2863-1; JOHNSON LE, 1969, APPL MICROBIOL, V17, P755, DOI 10.1128/AEM.17.5.755-759.1969; Kaneko Y, 2013, J INFECT CHEMOTHER, V19, P1141, DOI 10.1007/s10156-013-0639-0; Kerr JR, 1999, J CLIN PATHOL, V52, P385, DOI 10.1136/jcp.52.5.385; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KOPECKA M, 1978, ARCH MICROBIOL, V119, P305, DOI 10.1007/BF00405411; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Laursen JB, 2004, CHEM REV, V104, P1663, DOI 10.1021/cr020473j; Li YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019413; Liu HM, 2007, CURR MICROBIOL, V54, P302, DOI 10.1007/s00284-006-0444-4; Luo Q, 2015, CHINESE J CHEM ENG, V23, P699, DOI 10.1016/j.cjche.2015.01.001; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Manerba M, 2012, CHEMMEDCHEM, V7, P311, DOI 10.1002/cmdc.201100471; Mavrodi DV, 2006, ANNU REV PHYTOPATHOL, V44, P417, DOI 10.1146/annurev.phyto.44.013106.145710; Mavrodi DV, 2010, APPL ENVIRON MICROB, V76, P866, DOI 10.1128/AEM.02009-09; Mavrodi DV, 1998, J BACTERIOL, V180, P2541, DOI 10.1128/JB.180.9.2541-2548.1998; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; MAZODIER P, 1989, J BACTERIOL, V171, P3583, DOI 10.1128/jb.171.6.3583-3585.1989; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Mentel M, 2009, CHEMBIOCHEM, V10, P2295, DOI 10.1002/cbic.200900323; Parsons JF, 2007, BIOCHEMISTRY-US, V46, P1821, DOI 10.1021/bi6024403; Rix U, 2003, CHEMBIOCHEM, V4, P109, DOI 10.1002/cbic.200390002; Saleh O, 2012, BEILSTEIN J ORG CHEM, V8, DOI 10.3762/bjoc.8.57; Saleh O, 2009, J BIOL CHEM, V284, P14439, DOI 10.1074/jbc.M901312200; Sambrook J, 1989, MOL CLONING; Seeger K, 2011, MICROB BIOTECHNOL, V4, P252, DOI 10.1111/j.1751-7915.2010.00234.x; Shen XM, 2012, J BACTERIOL, V194, P1269, DOI 10.1128/JB.06713-11; TURNER JM, 1986, ADV MICROB PHYSIOL, V27, P211, DOI 10.1016/S0065-2911(08)60306-9; Valton J, 2006, J BIOL CHEM, V281, P27, DOI 10.1074/jbc.M506146200; Valton J, 2004, J BIOL CHEM, V279, P44362, DOI 10.1074/jbc.M407722200; Volokhan O, 2006, APPL ENVIRON MICROB, V72, P2514, DOI 10.1128/AEM.72.4.2514-2519.2006; Wang HuaSheng, 2014, Journal of Shanghai Jiaotong University - Agricultural Science, V32, P48; Wang W, 2015, J MICROBIOL BIOTECHN, V25, P672, DOI 10.4014/jmb.1409.09091; Wilkinson CJ, 2002, J MOL MICROB BIOTECH, V4, P417; Wu DQ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-438; Xu YR, 1997, J BACTERIOL, V179, P1112, DOI 10.1128/jb.179.4.1112-1116.1997; Zeyhle P, 2014, CHEMBIOCHEM, V15, P2385, DOI 10.1002/cbic.201402394; Zhang YX, 1999, MICROBIOL-SGM, V145, P2323, DOI 10.1099/00221287-145-9-2323	51	10	15	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136228	10.1371/journal.pone.0136228	http://dx.doi.org/10.1371/journal.pone.0136228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305803	gold, Green Published, Green Submitted			2022-12-27	WOS:000359995500053
J	Goetze, E; Andrews, KR; Peijnenburg, KTCA; Portner, E; Norton, EL				Goetze, Erica; Andrews, Kimberly R.; Peijnenburg, Katja T. C. A.; Portner, Elan; Norton, Emily L.			Temporal Stability of Genetic Structure in a Mesopelagic Copepod	PLOS ONE			English	Article							POPULATION-STRUCTURE; EUROPEAN EEL; MEGANYCTIPHANES-NORVEGICA; PATCHINESS; ATLANTIC; ZOOPLANKTON; DISPERSAL; DIFFERENTIATION; PHYLOGEOGRAPHY; CONNECTIVITY	Although stochasticity in oceanographic conditions is known to be an important driver of temporal genetic change in many marine species, little is known about whether genetically distinct plankton populations can persist in open ocean habitats. A prior study demonstrated significant population genetic structure among oceanic gyres in the mesopelagic copepod Haloptilus longicornis in both the Atlantic and Pacific Oceans, and we hypothesized that populations within each gyre represent distinct gene pools that persist over time. We tested this expectation through basin-scale sampling across the Atlantic Ocean in 2010 and 2012. Using both mitochondrial (mtCOII) and microsatellite markers (7 loci), we show that the genetic composition of populations was stable across two years in both the northern and southern subtropical gyres. Genetic variation in this species was partitioned among ocean gyres (F-CT = 0.285, P < 0.0001 for mtCOII, F-CT = 0.013, P < 0.0001 for microsatellites), suggesting strong spatial population structure, but no significant partitioning was found among sampling years. This temporal persistence of population structure across a large geographic scale was coupled with chaotic genetic patchiness at smaller spatial scales, but the magnitude of genetic differentiation was an order of magnitude lower at these smaller scales. Our results demonstrate that genetically distinct plankton populations persist over time in highly-dispersive open ocean habitats, and this is the first study to rigorously test for temporal stability of large scale population structure in the plankton.	[Goetze, Erica; Andrews, Kimberly R.; Portner, Elan; Norton, Emily L.] Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA; [Andrews, Kimberly R.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83844 USA; [Peijnenburg, Katja T. C. A.] Nat Biodivers Ctr, NL-2300 RA Leiden, Netherlands; [Peijnenburg, Katja T. C. A.] Univ Amsterdam, IBED, NL-1090 GE Amsterdam, Netherlands	University of Hawaii System; Idaho; University of Idaho; Naturalis Biodiversity Center; University of Amsterdam	Goetze, E (corresponding author), Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA.	egoetze@hawaii.edu	Peijnenburg, Katja TCA/F-7176-2016	Peijnenburg, Katja TCA/0000-0001-7544-1079; Portner, Elan/0000-0001-9112-863X	National Science Foundation [OCE-1029478, OCE-1338959]; NWO-VENI grant [863.08.024]; National Geographic Society/Waitt grant [W119-10]; UK Natural Environment Research Council National Capability; Directorate For Geosciences [1338959] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NWO-VENI grant; National Geographic Society/Waitt grant(National Geographic Society); UK Natural Environment Research Council National Capability(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by National Science Foundation grants OCE-1029478 and OCE-1338959 to E. Goetze, NWO-VENI grant 863.08.024 to K.T.C.A. Peijnenburg, as well as National Geographic Society/Waitt grant W119-10 to E.Goetze. Plankton collections were partially supported by the UK Natural Environment Research Council National Capability funding to Plymouth Marine Laboratory and the National Oceanography Centre, Southampton, through the Atlantic Meridional Transect (AMT) Programme.	Aglieri G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099647; Albrecht GT, 2014, J CRUSTACEAN BIOL, V34, P31, DOI 10.1163/1937240X-00002197; Ambler JW, 2002, HYDROBIOLOGIA, V480, P155, DOI 10.1023/A:1021201605329; Andrews KR, 2014, MOL ECOL, V23, P5462, DOI 10.1111/mec.12950; Barshis DJ, 2011, MAR ECOL PROG SER, V439, P139, DOI 10.3354/meps09339; Batta-Lona PG, 2011, DEEP-SEA RES PT II, V58, P1652, DOI 10.1016/j.dsr2.2010.11.017; Belkhir K, 1996, GENETIX 4 05 LOGICIE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoit-Bird KJ, 2012, BIOL LETTERS, V8, P813, DOI 10.1098/rsbl.2012.0232; Bortolotto E, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-32; Bradford-Grieve JM, 1999, NIWA BIODIVERS MEM, P39; Broquet T, 2013, EVOLUTION, V67, P1660, DOI 10.1111/j.1558-5646.2012.01826.x; Bucklin A, 1997, J PLANKTON RES, V19, P1763, DOI 10.1093/plankt/19.11.1763; Bucklin A, 2002, DEEP-SEA RES PT I, V49, P437, DOI 10.1016/S0967-0637(01)00063-2; BUCKLIN A, 1986, LIMNOL OCEANOGR, V31, P1346, DOI 10.4319/lo.1986.31.6.1346; BUCKLIN A, 1991, J GEOPHYS RES-OCEANS, V96, P14799, DOI 10.1029/91JC01209; BUCKLIN A, 1989, J GEOPHYS RES-OCEANS, V94, P8277, DOI 10.1029/JC094iC06p08277; Burton RS, 1997, EVOLUTION, V51, P993, DOI 10.1111/j.1558-5646.1997.tb03681.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chen G, 2011, MOL ECOL, V20, P2425, DOI 10.1111/j.1365-294X.2011.05079.x; Cote CL, 2013, MOL ECOL, V22, P1763, DOI 10.1111/mec.12142; Dannewitz J, 2005, P ROY SOC B-BIOL SCI, V272, P1129, DOI 10.1098/rspb.2005.3064; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fernandez-Silva I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055990; Folt CL, 1999, TRENDS ECOL EVOL, V14, P300, DOI 10.1016/S0169-5347(99)01616-X; Goetze E, 2005, EVOLUTION, V59, P2378; Goetze E, 2011, INTEGR COMP BIOL, V51, P580, DOI 10.1093/icb/icr104; Goetze E, 2010, DEEP-SEA RES PT II, V57, P2110, DOI 10.1016/j.dsr2.2010.09.014; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Haury L.R., 1978, SPATIAL PATTERN PLAN, V3, DOI DOI 10.1007/978-1-4899-2195-6_12; Hedgecock D, 2007, OCEANOGRAPHY, V20, P70, DOI 10.5670/oceanog.2007.30; Hedgecock D, 2011, B MAR SCI, V87, P971, DOI 10.5343/bms.2010.1051; Hogan JD, 2010, MAR ECOL PROG SER, V417, P263, DOI 10.3354/meps08793; Horne JB, 2013, J EVOLUTION BIOL, V26, P783, DOI 10.1111/jeb.12092; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Iacchei M, 2013, MOL ECOL, V22, P3476, DOI 10.1111/mec.12341; Jarman SN, 2002, CCAMLR SCI, V9, P107; Jarman SN, 2002, HEREDITY, V88, P280, DOI 10.1038/sj.hdy.6800041; JOHNSON MS, 1984, EVOLUTION, V38, P1371, DOI 10.1111/j.1558-5646.1984.tb05658.x; JOHNSON MS, 1982, MAR BIOL, V70, P157, DOI 10.1007/BF00397680; Lee HJE, 2009, MOL ECOL, V18, P2165, DOI 10.1111/j.1365-294X.2009.04169.x; Lee HJ, 2007, MOL ECOL, V16, P3084, DOI 10.1111/j.1365-294X.2007.03364.x; Maes GE, 2006, MOL ECOL, V15, P2095, DOI 10.1111/j.1365-294X.2006.02925.x; Mauchline J., 1998, ADV MAR BIOL, V33, P1, DOI DOI 10.1163/156854008784513492; Muths D, 2009, AQUAT BIOL, V5, P117, DOI 10.3354/ab00138; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Nelson RJ, 2009, MAR ECOL PROG SER, V381, P129, DOI 10.3354/meps07940; Norton E, 2013, EMP BIOPH MOD STUD D; Norton EL, 2013, LIMNOL OCEANOGR, V58, P1581, DOI 10.4319/lo.2013.58.5.1581; Papetti C, 2005, MAR ECOL PROG SER, V289, P225, DOI 10.3354/meps289225; Patarnello T, 2010, ADV MAR BIOL, V57, P41, DOI 10.1016/B978-0-12-381308-4.00002-9; Peijnenburg KTCA, 2006, MOL ECOL, V15, P3319, DOI 10.1111/j.1365-294X.2006.03002.x; Peijnenburg KTCA, 2013, ECOL EVOL, V3, P2765, DOI 10.1002/ece3.644; Peijnenburg KTCA, 2005, MAR BIOL, V147, P1279, DOI 10.1007/s00227-005-0041-2; Peijnenburg KTCA, 2004, EVOLUTION, V58, P1472; Pritchard JK, 2000, GENETICS, V155, P945; Provan J, 2009, P R SOC B, V276, P301, DOI 10.1098/rspb.2008.1062; Pujolar JM, 2006, MAR ECOL PROG SER, V307, P209, DOI 10.3354/meps307209; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reisser CMO, 2014, MAR BIOL, V161, P297, DOI 10.1007/s00227-013-2335-0; Selkoe KA, 2006, ECOLOGY, V87, P3082, DOI 10.1890/0012-9658(2006)87[3082:CSAKAE]2.0.CO;2; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THUESEN EV, 1993, MAR ECOL PROG SER, V101, P243, DOI 10.3354/meps101243; Toonen RJ, 2011, CRUSTACEAN ISS, V19, P75; Unal E, 2006, DEEP-SEA RES PT II, V53, P1961, DOI 10.1016/j.dsr2.2006.03.017; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Yebra L, 2011, MAR ECOL PROG SER, V428, P135, DOI 10.3354/meps09056	71	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136087	10.1371/journal.pone.0136087	http://dx.doi.org/10.1371/journal.pone.0136087			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302332	Green Submitted, gold, Green Published			2022-12-27	WOS:000359951900037
J	Wen, JH; Wen, H; Gibson-Corley, KN; Glenn, KA				Wen, John H.; Wen, Hsiang; Gibson-Corley, Katherine N.; Glenn, Kevin A.			FBG1 Is the Final Arbitrator of A1AT-Z Degradation	PLOS ONE			English	Article							MUTANT ALPHA(1)-ANTITRYPSIN Z; ENDOPLASMIC-RETICULUM; ALPHA-1-ANTITRYPSIN DEFICIENCY; UBIQUITIN LIGASE; LIVER-DISEASE; DEUBIQUITINATING ENZYME; NEUTROPHIL LIPOCALIN; REGULATES AUTOPHAGY; Z-VARIANT; PROTEIN	Alpha-1 antitrypsin deficiency is the leading cause of childhood liver failure and one of the most common lethal genetic diseases. The disease-causing mutant A1AT-Z fails to fold correctly and accumulates in the endoplasmic reticulum (ER) of the liver, resulting in hepatic fibrosis and hepatocellular carcinoma in a subset of patients. Furthermore, A1AT-Z sequestration in hepatocytes leads to a reduction in A1AT secretion into the serum, causing panacinar emphysema in adults. The purpose of this work was to elucidate the details by which A1AT-Z is degraded in hepatic cell lines. We identified the ubiquitin ligase FBG1, which has been previously shown to degrade proteins by both the ubiquitin proteasome pathway and autophagy, as being key to A1AT-Z degradation. Using chemical and genetic approaches we show that FBG1 degrades A1AT-Z through both the ubiquitin proteasome system and autophagy. Overexpression of FBG1 decreases the half-life of A1AT-Z and knocking down FBG1 in a hepatic cell line, and in mice results in an increase in ATAT. Finally, we show that FBG1 degrades A1AT-Z through a Beclin1-dependent arm of autophagy. In our model, FBG1 acts as a safety ubiquitin ligase, whose function is to re-ubiquitinate ER proteins that have previously undergone de-ubiquitination to ensure they are degraded.	[Wen, John H.] Yale Univ, New Haven, CT 06520 USA; [Wen, Hsiang; Glenn, Kevin A.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Gibson-Corley, Katherine N.] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Glenn, Kevin A.] VA Med Ctr, Iowa City, IA USA	Yale University; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Glenn, KA (corresponding author), Yale Univ, New Haven, CT 06520 USA.	kevin-glenn@uiowa.edu		Glenn, Kevin/0000-0002-6941-9649; Gibson-Corley, Katherine/0000-0002-1846-1580	Veteran Affairs Research Career Development Award	Veteran Affairs Research Career Development Award	Veteran Affairs Research Career Development Award to KAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Thoracic Soc European Respir, 2003, AM J RESP CRIT CARE, V168, P818, DOI 10.1164/rccm.168.7.818; Ballar P, 2011, INT J BIOCHEM CELL B, V43, P613, DOI 10.1016/j.biocel.2010.12.021; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Bouchecareilh M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404707; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Chang JW, 2011, J NEUROCHEM, V116, P659, DOI 10.1111/j.1471-4159.2010.07158.x; Choi CH, 2012, BIOCHEM BIOPH RES CO, V418, P759, DOI 10.1016/j.bbrc.2012.01.095; Chu AS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/459823; Claessen JHL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090204; Claessen JHL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028542; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Comunale MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012419; Cooper GR, 1997, BIOCHEM J, V325, P601, DOI 10.1042/bj3250601; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Fairbanks KD, 2008, AM J GASTROENTEROL, V103, P2136, DOI 10.1111/j.1572-0241.2008.01955.x; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Gelling CL, 2012, GENETICS, V192, P889, DOI 10.1534/genetics.112.143487; Glenn KA, 2008, J BIOL CHEM, V283, P12717, DOI 10.1074/jbc.M709508200; GOKAL PK, 1986, J BIOL CHEM, V261, P2536; Gordon KL, 2012, NEUROSCIENCE, V224, P160, DOI 10.1016/j.neuroscience.2012.08.023; Grishchuk Y, 2011, AUTOPHAGY, V7, P1115, DOI 10.4161/auto.7.10.16608; Haspel J, 2011, AUTOPHAGY, V7, P629, DOI 10.4161/auto.7.6.15100; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Hidvegi T, 2011, METHOD ENZYMOL, V499, P33, DOI [10.1016/B978-0-12-386471-0.00003-1, 10.1016/13978-0-12-386471-0.00003-1]; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Jones SA, 2013, IMMUNOL CELL BIOL, V91, P250, DOI 10.1038/icb.2012.82; Juenemann Katrin, 2012, Int J Cell Biol, V2012, P189794, DOI 10.1155/2012/189794; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kaushal S, 2010, EXP BIOL MED, V235, P700, DOI 10.1258/ebm.2010.009297; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kruse KB, 2006, MOL BIOL CELL, V17, P203, DOI 10.1091/mbc.e04-09-0779; Lawless MW, 2004, J IMMUNOL, V172, P5722, DOI 10.4049/jimmunol.172.9.5722; Le Fourn V, 2009, CELL MOL LIFE SCI, V66, P1434, DOI 10.1007/s00018-009-9038-1; Lomas DJ, 1995, LANCET, V346, pS20, DOI 10.1016/0140-6736(95)90019-5; Mallinger A, 2012, BIOCHEM BIOPH RES CO, V418, P44, DOI 10.1016/j.bbrc.2011.12.109; Motoi Y, 2014, ACS CHEM NEUROSCI, V5, P434, DOI 10.1021/cn500056q; Nelson DR, 2012, CLIN GASTROENTEROL H, V10, P575, DOI 10.1016/j.cgh.2011.12.028; Nelson RF, 2007, J NEUROSCI, V27, P5163, DOI 10.1523/JNEUROSCI.0206-07.2007; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Perlmutter DH, 2007, HEPATOLOGY, V45, P1313, DOI 10.1002/hep.21628; Perlmutter DH, 2006, AUTOPHAGY, V2, P258, DOI 10.4161/auto.2882; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Renna M, 2010, J BIOL CHEM, V285, P11061, DOI 10.1074/jbc.R109.072181; SAMANDARI T, 1993, PROTEIN SCI, V2, P1400, DOI 10.1002/pro.5560020905; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Schmidt BZ, 2005, AM J PHYSIOL-GASTR L, V289, pG444, DOI 10.1152/ajpgi.00237.2004; Shen YX, 2006, BIOCHEM BIOPH RES CO, V349, P1285, DOI 10.1016/j.bbrc.2006.08.173; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Smith SE, 2011, J BIOL CHEM, V286, P41563, DOI 10.1074/jbc.M111.280073; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Sveger T, 1998, PEDIATR RES, V44, P939, DOI 10.1203/00006450-199812000-00019; Sveger T, 2003, SCAND J CLIN LAB INV, V63, P89, DOI 10.1080/00365510310000961; SVEGER T, 1995, HEPATOLOGY, V22, P514, DOI 10.1002/hep.1840220221; SVEGER T, 1976, NEW ENGL J MED, V294, P1316, DOI 10.1056/NEJM197606102942404; SVEGER T, 1984, J PEDIATR-US, V104, P91, DOI 10.1016/S0022-3476(84)80599-5; SVEGER T, 1994, ACTA PAEDIATR, V83, P18, DOI 10.1111/j.1651-2227.1994.tb13201.x; SVEGER T, 1978, PEDIATRICS, V62, P22; Sveger T, 1997, ACTA PAEDIATR, V86, P37, DOI 10.1111/j.1651-2227.1997.tb08828.x; SVEGER T, 1988, ACTA PAEDIATR SCAND, V77, P847, DOI 10.1111/j.1651-2227.1988.tb10767.x; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Teckman JH, 2002, AM J PHYSIOL-GASTR L, V283, pG1156, DOI 10.1152/ajpgi.00041.2002; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V278, pG39, DOI 10.1152/ajpgi.2000.278.1.G39; Teckman JH, 2001, J BIOL CHEM, V276, P44865, DOI 10.1074/jbc.M103703200; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang HP, 2011, MOL CELL BIOCHEM, V346, P137, DOI 10.1007/s11010-010-0600-9; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Wen H, 2014, INT J BIOCH RES REV; Wen H, 2010, CELL CYCLE, V9, P4506, DOI 10.4161/cc.9.22.13743; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Zhou CH, 2012, ACTA BIOCH BIOPH SIN, V44, P815, DOI 10.1093/abbs/gms064	78	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135591	10.1371/journal.pone.0135591	http://dx.doi.org/10.1371/journal.pone.0135591			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295339	Green Submitted, Green Published, gold			2022-12-27	WOS:000359926900035
J	Aguilar, C; Gardiner, DM				Aguilar, Cristian; Gardiner, David M.			DNA Methylation Dynamics Regulate the Formation of a Regenerative Wound Epithelium during Axolotl Limb Regeneration	PLOS ONE			English	Article							EPIGENETIC REGULATION; STEM-CELLS; DEDIFFERENTIATION; DIFFERENTIATION; BLASTEMA; DNMT3A; NEWT	The formation of a blastema during regeneration of an axolotl limb involves important changes in the behavior and function of cells at the site of injury. One of the earliest events is the formation of the wound epithelium and subsequently the apical epidermal cap, which involves in vivo dedifferentiation that is controlled by signaling from the nerve. We have investigated the role of epigenetic modifications to the genome as a possible mechanism for regulating changes in gene expression patterns of keratinocytes of the wound and blastema epithelium that are involved in regeneration. We report a modulation of the expression DNMT3a, a de novo DNA methyltransferase, within the first 72 hours post injury that is dependent on nerve signaling. Treatment of skin wounds on the upper forelimb with decitabine, a DNA methyltransferase inhibitor, induced changes in gene expression and cellular behavior associated with a regenerative response. Furthermore, decitabine-treated wounds were able to participate in regeneration while untreated wounds inhibited a regenerative response. Elucidation of the specific epigenetic modifications that mediate cellular dedifferentiation likely will lead to insights for initiating a regenerative response in organisms that lack this ability.	[Aguilar, Cristian; Gardiner, David M.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Gardiner, DM (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	dmgardin@uci.edu			Defense Advanced Research Projects Agency (DARPA) from Tulane University [TUL 519-05/06]; US Army Multidisciplinary University Research Initiative (MURI) from Tulane University [TUL 589-09/10]; National Science Foundation (NSF) through the Ambystoma Genetic Stock Center at the University of Kentucky, Lexington	Defense Advanced Research Projects Agency (DARPA) from Tulane University; US Army Multidisciplinary University Research Initiative (MURI) from Tulane University; National Science Foundation (NSF) through the Ambystoma Genetic Stock Center at the University of Kentucky, Lexington(National Science Foundation (NSF))	The research was funded by a Defense Advanced Research Projects Agency (DARPA; http://www.darpa.mil/default.aspx) subcontract from Tulane University (TUL 519-05/06), a US Army Multidisciplinary University Research Initiative (MURI) subcontract from Tulane University (TUL 589-09/10), and the National Science Foundation (NSF; http://www.nsf.gov/) through its support of the Ambystoma Genetic Stock Center at the University of Kentucky, Lexington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang YS, 2011, TRENDS PHARMACOL SCI, V32, P394, DOI 10.1016/j.tips.2011.03.002; Artyomov MN, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000785; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bryant SV, 2002, INT J DEV BIOL, V46, P887; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Flotho C, 2009, LEUKEMIA, V23, P1019, DOI 10.1038/leu.2008.397; Forsberg M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00019; Gu Y, 2014, PROTEIN CELL, V5, P59, DOI 10.1007/s13238-013-0016-x; He SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027684; Holliday R, 2005, BIOCHEMISTRY-MOSCOW+, V70, P500, DOI 10.1007/s10541-005-0144-x; Hu B, 2010, AM J PATHOL, V177, P21, DOI 10.2353/ajpath.2010.090999; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Muller TL, 1999, SEMIN CELL DEV BIOL, V10, P405, DOI 10.1006/scdb.1999.0327; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; Neufeld DA, 1996, ANAT RECORD, V245, P122; Odelberg S, 2002, SEMIN CELL DEV BIOL, V13, P335, DOI 10.1016/S1084952102000897; Salley-Guydon JD, 2006, WOUND REPAIR REGEN, V14, P479, DOI 10.1111/j.1743-6109.2006.00154.x; Sandoval-Guzman T, 2014, CELL STEM CELL, V14, P174, DOI 10.1016/j.stem.2013.11.007; Santos EM, 1999, BIOMATERIALS, V20, P1695, DOI 10.1016/S0142-9612(99)00066-6; Satoh A, 2008, DEV BIOL, V319, P321, DOI 10.1016/j.ydbio.2008.04.030; Satoh A, 2007, DEV BIOL, V312, P231, DOI 10.1016/j.ydbio.2007.09.021; Satoh A, 2012, DEV BIOL, V366, P374, DOI 10.1016/j.ydbio.2012.03.022; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; SINGER M, 1974, ANN NY ACAD SCI, V228, P308, DOI 10.1111/j.1749-6632.1974.tb20520.x; STEPHENS N, 1985, PROC R SOC SER B-BIO, V224, P341, DOI 10.1098/rspb.1985.0036; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tomazou EM, 2010, ADV EXP MED BIOL, V695, P26, DOI 10.1007/978-1-4419-7037-4_3; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Wallace, 1981, VERTEBRATE LIMB REGE; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Zyluk Andrzej, 2011, Pol Przegl Chir, V83, P87, DOI 10.2478/v10035-011-0014-8	36	20	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134791	10.1371/journal.pone.0134791	http://dx.doi.org/10.1371/journal.pone.0134791			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308461	Green Published, gold			2022-12-27	WOS:000360069400036
J	Badri, H; Monsieurs, P; Coninx, I; Nauts, R; Wattiez, R; Leys, N				Badri, Hanene; Monsieurs, Pieter; Coninx, Ilse; Nauts, Robin; Wattiez, Ruddy; Leys, Natalie			Temporal Gene Expression of the Cyanobacterium Arthrospira in Response to Gamma Rays	PLOS ONE			English	Article							II SIGNAL-TRANSDUCTION; SPIRULINA-PLATENSIS; PCC 6803; DEINOCOCCUS-RADIODURANS; PHYCOBILISOME DEGRADATION; GLUTAMATE-DEHYDROGENASE; STRESS; PROTEINS; PHOTOSYNTHESIS; NITROGEN	The edible cyanobacterium Arthrospira is resistant to ionising radiation. The cellular mechanisms underlying this radiation resistance are, however, still largely unknown. Therefore, additional molecular analysis was performed to investigate how these cells can escape from, protect against, or repair the radiation damage. Arthrospira cells were shortly exposed to different doses of Co-60 gamma rays and the dynamic response was investigated by monitoring its gene expression and cell physiology at different time points after irradiation. The results revealed a fast switch from an active growth state to a kind of 'survival modus' during which the cells put photosynthesis, carbon and nitrogen assimilation on hold and activate pathways for cellular protection, detoxification, and repair. The higher the radiation dose, the more pronounced this global emergency response is expressed. Genes repressed during early response, suggested a reduction of photosystem II and I activity and reduced tricarboxylic acid (TCA) and Calvin-Benson-Bassham (CBB) cycles, combined with an activation of the pentose phosphate pathway (PPP). For reactive oxygen species detoxification and restoration of the redox balance in Arthrospira cells, the results suggested a powerful contribution of the antioxidant molecule glutathione. The repair mechanisms of Arthrospira cells that were immediately switched on, involve mainly proteases for damaged protein removal, single strand DNA repair and restriction modification systems, while recA was not induced. Additionally, the exposed cells showed significant increased expression of arh genes, coding for a novel group of protein of unknown function, also seen in our previous irradiation studies. This observation confirms our hypothesis that arh genes are key elements in radiation resistance of Arthrospira, requiring further investigation. This study provides new insights into phasic response and the cellular pathways involved in the radiation resistance of microbial cells, in particularly for photosynthetic organisms as the cyanobacterium Arthrospira.	[Badri, Hanene; Monsieurs, Pieter; Coninx, Ilse; Nauts, Robin; Leys, Natalie] CEN SCK, Belgian Nucl Res Ctr, Expert Grp Mol & Cellular Biol, B-2400 Mol, Belgium; [Badri, Hanene; Monsieurs, Pieter; Coninx, Ilse; Nauts, Robin; Leys, Natalie] CEN SCK, Belgian Nucl Res Ctr, Expert Grp Biosphere Impact Studies, B-2400 Mol, Belgium; [Badri, Hanene; Wattiez, Ruddy] Univ Mons, Res Inst Biosci, Prote & Microbiol Grp, B-7000 Mons, Belgium	Belgian Nuclear Research Centre (SCK-CEN); Belgian Nuclear Research Centre (SCK-CEN); University of Mons	Leys, N (corresponding author), CEN SCK, Belgian Nucl Res Ctr, Expert Grp Mol & Cellular Biol, B-2400 Mol, Belgium.	Natalie.Leys@sckcen.be	Leys, Natalie M.E.J./P-2761-2017; Monsieurs, Pieter/A-2917-2009; Monsieurs, Pieter/W-3916-2019	Monsieurs, Pieter/0000-0003-2214-6652; wattiez, ruddy/0000-0003-2071-4310	SCK.CEN; ESA/Belspo PRODEX, MELiSSA project	SCK.CEN; ESA/Belspo PRODEX, MELiSSA project	This work was supported by SCK.CEN and ESA/Belspo PRODEX, via the ArtEMISS study, which is part of the MELiSSA project.	Ahsan M., 2008, FOOD AND AGR; Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Badri H, 2015, MICROBIOLOGYOPEN, V4, P187, DOI 10.1002/mbo3.229; Baptista MS, 2006, CRIT REV MICROBIOL, V32, P127, DOI 10.1080/10408410600822934; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNETT A, 1973, J CELL BIOL, V58, P419, DOI 10.1083/jcb.58.2.419; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bouchereau A, 1999, PLANT SCI, V140, P103, DOI 10.1016/S0168-9452(98)00218-0; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; Carrieri D, 2011, APPL ENVIRON MICROB, V77, P7185, DOI 10.1128/AEM.00612-11; Chaiklahan R., 2007, Kasetsart Journal, Natural Sciences, V41, P123; Chavez S, 1999, J BACTERIOL, V181, P808; Chen CB, 2005, P NATL ACAD SCI USA, V102, P3459, DOI 10.1073/pnas.0407960102; Cogne G, 2003, BIOTECHNOL BIOENG, V81, P588, DOI 10.1002/bit.10504; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Deng RT, 2010, CARDIOVASC THER, V28, pe33, DOI 10.1111/j.1755-5922.2010.00200.x; Deschoenmaeker F, 2014, MICROBIOL-SGM, V160, P1224, DOI 10.1099/mic.0.074641-0; Domain F, 2004, MOL MICROBIOL, V53, P65, DOI 10.1111/j.1365-2958.2004.04100.x; Fatma T, 2007, J APPL PHYCOL, V19, P625, DOI 10.1007/s10811-007-9195-2; Forchhammer K, 2004, FEMS MICROBIOL REV, V28, P319, DOI 10.1016/j.femsre.2003.11.001; Fujisawa T, 2010, DNA RES, V17, P85, DOI 10.1093/dnares/dsq004; Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375; Gao KS, 2008, J PHYCOL, V44, P777, DOI 10.1111/j.1529-8817.2008.00512.x; Gao Y, 2009, J EXP BOT, V60, P1141, DOI 10.1093/jxb/ern356; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; Godia F, 2002, J BIOTECHNOL, V99, P319, DOI 10.1016/S0168-1656(02)00222-5; Graumann PL, 2009, CHROMOSOME RES, V17, P265, DOI 10.1007/s10577-008-9014-x; Graumann PL, 2001, BIOCHIMIE, V83, P53, DOI 10.1016/S0300-9084(00)01218-9; Grundel M, 2012, MICROBIOL-SGM, V158, P3032, DOI 10.1099/mic.0.062950-0; GUTTERIDGE JMC, 1992, FREE RADICAL BIO MED, V12, P93, DOI 10.1016/0891-5849(92)90062-L; Helling RB, 1998, J BACTERIOL, V180, P4571, DOI 10.1128/JB.180.17.4571-4575.1998; Helmann JD, 2011, ANTIOXID REDOX SIGN, V15, P123, DOI 10.1089/ars.2010.3562; Herrero A, 2001, J BACTERIOL, V183, P411, DOI 10.1128/JB.183.2.411-425.2001; Hongsthong A, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-33; Hossain M.A., 2012, J BOT, V2012, P37, DOI DOI 10.1155/2012/872875; Huergo LF, 2012, MICROBIOL-SGM, V158, P176, DOI 10.1099/mic.0.049783-0; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Karradt A, 2008, J BIOL CHEM, V283, P32394, DOI 10.1074/jbc.M805823200; Kurdrid P, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-39; Li S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-527; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Lopez-Garcia P, 1999, TRENDS BIOCHEM SCI, V24, P88, DOI 10.1016/S0968-0004(98)01342-5; Luan HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085649; Ludanyi M, 2014, MOL MICROBIOL, V94, P434, DOI 10.1111/mmi.12774; Maheswaran M, 2006, J BACTERIOL, V188, P2730, DOI 10.1128/JB.188.7.2730-2734.2006; MARQUES S, 1989, ANAL BIOCHEM, V180, P152, DOI 10.1016/0003-2697(89)90104-8; Masojidek J, 2010, DEVEL APPL PHYCOL, V4, P277, DOI 10.1007/978-90-481-9268-7_13; Matallana-Surget S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099076; Moon YJ, 2012, INT J MOL SCI, V13, P16303, DOI 10.3390/ijms131216303; Mullineaux PM, 2005, PHOTOSYNTH RES, V86, P459, DOI 10.1007/s11120-005-8811-8; Narumi I, 2001, J BACTERIOL, V183, P6951, DOI 10.1128/JB.183.23.6951-6956.2001; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Newton KN, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/271453; Ohmori K, 2009, MICROBES ENVIRON, V24, P52, DOI 10.1264/jsme2.ME08537; Orillard E, 2011, J BACTERIOL, V193, P6490, DOI 10.1128/JB.05646-11; Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6; Rajeev L, 2013, ISME J, V7, P2178, DOI 10.1038/ismej.2013.83; Raksajit W, 2012, INT J HYDROGEN ENERG, V37, P18791, DOI 10.1016/j.ijhydene.2012.10.011; Raksajit W, 2009, J MICROBIOL BIOTECHN, V19, P447, DOI 10.4014/jmb.0809.555; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Ramadan MF, 2008, CZECH J FOOD SCI, V26, P211, DOI 10.17221/2567-CJFS; Richaud C, 2001, J BACTERIOL, V183, P2989, DOI 10.1128/JB.183.10.2989-2994.2001; Robinson CK, 2011, J BACTERIOL, V193, P1653, DOI 10.1128/JB.01310-10; ROBINSON SA, 1991, PLANT PHYSIOL, V95, P509, DOI 10.1104/pp.95.2.509; ROHDE M, 1990, EUR J BIOCHEM, V191, P389, DOI 10.1111/j.1432-1033.1990.tb19134.x; Schulz H, 1999, P NATL ACAD SCI USA, V96, P6462, DOI 10.1073/pnas.96.11.6462; Schwammle V, 2010, BIOINFORMATICS, V26, P2841, DOI 10.1093/bioinformatics/btq534; Shcolnick S, 2006, PLANT PHYSIOL, V141, P805, DOI 10.1104/pp.106.079251; Singh SC, 2002, ACTA PROTOZOOL, V41, P297; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Takahashi T, 2010, ANN BOT-LONDON, V105, P1, DOI 10.1093/aob/mcp259; Tamagnini P, 2002, MICROBIOL MOL BIOL R, V66, P1, DOI 10.1128/MMBR.66.1.1-20.2002; Tang Y, 1999, MICROBIOL-SGM, V145, P3069, DOI 10.1099/00221287-145-11-3069; Timperio AM, 2008, J PROTEOMICS, V71, P391, DOI 10.1016/j.jprot.2008.07.005; Trovato M, 2008, REND LINCEI-SCI FIS, V19, P325, DOI 10.1007/s12210-008-0022-8; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Vass IZ, 2014, J PHOTOCH PHOTOBIO B, V130, P318, DOI 10.1016/j.jphotobiol.2013.12.006; VONSHAK A, 1990, BIOTECHNOL ADV, V8, P709, DOI 10.1016/0734-9750(90)91993-Q; VONSHAK A, 1988, ARCH MICROBIOL, V150, P417, DOI 10.1007/BF00422279; Webb KM, 2012, ARCHAEA, V2012, DOI 10.1155/2012/845756; Wu HY, 2005, APPL ENVIRON MICROB, V71, P5004, DOI 10.1128/AEM.71.9.5004-5013.2005; Zhang CC, 2005, PROTEOMICS, V5, P138, DOI 10.1002/pmic.200300875; Zhou YZ, 2008, J MOL BIOL, V381, P174, DOI 10.1016/j.jmb.2008.05.084	86	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135565	10.1371/journal.pone.0135565	http://dx.doi.org/10.1371/journal.pone.0135565			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308624	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400064
J	Chen, CH; Xiu, DM; Chen, CS; Moyzis, R; Xia, MR; He, Y; Xue, G; Li, J; He, QH; Lei, XM; Wang, YX; Liu, B; Chen, W; Zhu, B; Dong, Q				Chen, Chunhui; Xiu, Daiming; Chen, Chuansheng; Moyzis, Robert; Xia, Mingrui; He, Yong; Xue, Gui; Li, Jin; He, Qinghua; Lei, Xuemei; Wang, Yunxin; Liu, Bin; Chen, Wen; Zhu, Bi; Dong, Qi			Regional Homogeneity of Resting-State Brain Activity Suppresses the Effect of Dopamine-Related Genes on Sensory Processing Sensitivity	PLOS ONE			English	Article							DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; ALZHEIMERS-DISEASE; ARCHITECTURE; ASSOCIATION; CORTEX; IDENTIFICATION; POLYMORPHISMS; SCHIZOPHRENIA; HERITABILITY	Sensory processing sensitivity (SPS) is an intrinsic personality trait whose genetic and neural bases have recently been studied. The current study used a neural mediation model to explore whether resting-state brain functions mediated the effects of dopamine-related genes on SPS. 298 healthy Chinese college students (96 males, mean age = 20.42 years, SD = 0.89) were scanned with magnetic resonance imaging during resting state, genotyped for 98 loci within the dopamine system, and administered the Highly Sensitive Person Scale. We extracted a "gene score" that summarized the genetic variations representing the 10 loci that were significantly linked to SPS, and then used path analysis to search for brain regions whose resting-state data would help explain the gene-behavior association. Mediation analysis revealed that temporal homogeneity of regional spontaneous activity (ReHo) in the precuneus actually suppressed the effect of dopamine-related genes on SPS. The path model explained 16% of the variance of SPS. This study represents the first attempt at using a multi-gene voxel-based neural mediation model to explore the complex relations among genes, brain, and personality.	[Chen, Chunhui; Xiu, Daiming; Xia, Mingrui; He, Yong; Xue, Gui; Li, Jin; Lei, Xuemei; Wang, Yunxin; Liu, Bin; Chen, Wen; Zhu, Bi; Dong, Qi] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Chen, Chunhui; Xiu, Daiming; Moyzis, Robert; Xia, Mingrui; He, Yong; Xue, Gui; Li, Jin; Lei, Xuemei; Wang, Yunxin; Liu, Bin; Chen, Wen; Zhu, Bi; Dong, Qi] Beijing Normal Univ, IDG, McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Chen, Chunhui; Xiu, Daiming; Xia, Mingrui; He, Yong; Xue, Gui; Zhu, Bi; Dong, Qi] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China; [Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA 92697 USA; [Moyzis, Robert] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Moyzis, Robert] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA; [He, Qinghua] Southwest Univ, Fac Psychol, Chongqing 400715, Peoples R China; [Xiu, Daiming] Univ Zurich, Inst Psychol, Div Psychopathol & Clin Intervent, CH-8050 Zurich, Switzerland	Beijing Normal University; Beijing Normal University; Beijing Normal University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Southwest University - China; University of Zurich	Chen, CS (corresponding author), Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA 92697 USA.	cschen@uci.edu; cschen@uci.edu; dongqi@bnu.edu.cn	He, Yong/C-2161-2009; He, Yong/Q-5756-2018; He, Qinghua/B-2573-2008; Xia, Mingrui/J-3267-2019; Xue, Gui/A-1762-2009	He, Qinghua/0000-0001-6396-6273; Xia, Mingrui/0000-0003-4615-9132; Xue, Gui/0000-0001-7891-8151; He, Yong/0000-0002-7039-2850; Chen, Chuansheng/0000-0002-8224-1005	National Natural Science Foundation of China [31100807]; 111 Project of the Ministry of Education of China [B07008]; Fundamental Research Funds for the Central Universities [2012LYB05]; Research Fund for the Doctoral Program of Higher Education [20110003120001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project of the Ministry of Education of China(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This work was supported by the National Natural Science Foundation of China (31100807); the 111 Project of the Ministry of Education of China (B07008); the Fundamental Research Funds for the Central Universities (2012LYB05); and The Research Fund for the Doctoral Program of Higher Education (20110003120001).	Acevedo BP, 2014, BRAIN BEHAV, V4, P580, DOI 10.1002/brb3.242; Adelstein JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027633; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Aron A, 2010, SOC COGN AFFECT NEUR, V5, P219, DOI 10.1093/scan/nsq028; Aron EN, 2012, PERS SOC PSYCHOL REV, V16, P262, DOI 10.1177/1088868311434213; Aron EN, 1997, J PERS SOC PSYCHOL, V73, P345, DOI 10.1037/0022-3514.73.2.345; Aron EN, 2005, PERS SOC PSYCHOL B, V31, P181, DOI 10.1177/0146167204271419; Beck AT, 1996, PSYCHOL ASSESS; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Buckholtz JW, 2008, MOL PSYCHIATR, V13, P313, DOI 10.1038/sj.mp.4002020; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chen CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021636; Chen J, 2013, AM J MED GENET B, V162B, P191, DOI 10.1002/ajmg.b.32131; Cho Ah Rang, 2012, Clin Psychopharmacol Neurosci, V10, P88, DOI 10.9758/cpn.2012.10.2.88; Cole DM, 2013, CEREB CORTEX, V23, P1509, DOI 10.1093/cercor/bhs136; Congdon E, 2009, BIOL PSYCHOL, V81, P144, DOI 10.1016/j.biopsycho.2009.03.005; de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Diaconescu AO, 2010, BRAIN RES, V1313, P143, DOI 10.1016/j.brainres.2009.11.064; Fakra E, 2009, ARCH GEN PSYCHIAT, V66, P33, DOI 10.1001/archpsyc.66.1.33; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Fujita I, 2002, J NEUROCYTOL, V31, P359, DOI 10.1023/A:1024138413082; Furmark T, 2008, J NEUROSCI, V28, P13066, DOI 10.1523/JNEUROSCI.2534-08.2008; Goldsmith SK, 1996, NEUROSCIENCE, V74, P435, DOI 10.1016/0306-4522(96)00132-7; GOLDSMITH SK, 1994, HIPPOCAMPUS, V4, P354, DOI 10.1002/hipo.450040318; Gordon EM, 2013, CEREB CORTEX; Green AE, 2013, CEREB CORTEX, V23, P552, DOI 10.1093/cercor/bhs035; Hamer D, 2002, SCIENCE, V298, P71, DOI 10.1126/science.1077582; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Jagiellowicz J, 2011, SOC COGN AFFECT NEUR, V6, P38, DOI 10.1093/scan/nsq001; JOYCE JN, 1991, J PHARMACOL EXP THER, V257, P1253; Kelly C, 2009, J NEUROSCI, V29, P7364, DOI 10.1523/JNEUROSCI.0810-09.2009; Kunisato Y, 2011, NEUROSCI LETT, V492, P109, DOI 10.1016/j.neulet.2011.01.067; Li J, 2013, NEUROIMAGE, V75, P79, DOI 10.1016/j.neuroimage.2012.09.077; Liu Y, 2008, NEUROPSYCHOLOGIA, V46, P1648, DOI 10.1016/j.neuropsychologia.2008.01.027; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; McGuffin P, 2001, SCIENCE, V291, P1232, DOI 10.1126/science.1057264; Munafo MR, 2011, TRENDS COGN SCI, V15, P395, DOI 10.1016/j.tics.2011.07.007; Nikolova YS, 2011, NEUROPSYCHOPHARMACOL, V36, P1940, DOI 10.1038/npp.2011.82; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Pal P, 2009, CROAT MED J, V50, P361, DOI 10.3325/cmj.2009.50.361; Parasuraman R, 2005, PSYCHOL SCI, V16, P200, DOI 10.1111/j.0956-7976.2005.00804.x; PERRY RH, 1981, J NEUROL SCI, V51, P465, DOI 10.1016/0022-510X(81)90123-4; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Ramaekers JG, 2013, PSYCHOPHARMACOLOGY, P1; Ryman SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026758; Sadaghiani S, 2013, NEUROIMAGE, V80, P379, DOI 10.1016/j.neuroimage.2013.04.100; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sipila T, 2010, BIOL PSYCHIAT, V67, P1163, DOI 10.1016/j.biopsych.2009.12.011; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tomasi D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006102; Van Schuerbeek P, 2011, BRAIN RES, V1371, P32, DOI 10.1016/j.brainres.2010.11.073; Wei LQ, 2014, HUM BRAIN MAPP, V35, P331, DOI 10.1002/hbm.22176; [温忠麟 Wen Zhonglin], 2006, [心理学报, Acta Psychologica Sinica], V38, P448; Wolf M, 2008, P NATL ACAD SCI USA, V105, P15825, DOI 10.1073/pnas.0805473105; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yamada M, 2013, P NATL ACAD SCI USA, V110, P4363, DOI 10.1073/pnas.1221681110; Yamamoto M, 2001, NEUROSCIENCE, V107, P209, DOI 10.1016/S0306-4522(01)00356-6; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhu B, 2012, NEUROPSYCHOBIOLOGY, V65, P83, DOI 10.1159/000329555; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	65	6	7	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0133143	10.1371/journal.pone.0133143	http://dx.doi.org/10.1371/journal.pone.0133143			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308205	Green Published, gold			2022-12-27	WOS:000360069400008
J	Correia, T; Lockwood, N; Kumar, S; Yin, J; Ramel, MC; Andrews, N; Katan, M; Bugeon, L; Dallman, MJ; McGinty, J; Frankel, P; French, PMW; Arridge, S				Correia, Teresa; Lockwood, Nicola; Kumar, Sunil; Yin, Jun; Ramel, Marie-Christine; Andrews, Natalie; Katan, Matilda; Bugeon, Laurence; Dallman, Margaret J.; McGinty, James; Frankel, Paul; French, Paul M. W.; Arridge, Simon			Accelerated Optical Projection Tomography Applied to In Vivo Imaging of Zebrafish	PLOS ONE			English	Article							TOTAL VARIATION MINIMIZATION; ALGORITHMS; ANGIOGENESIS; RESTORATION; RECOVERY; TOOL; MRI	Optical projection tomography (OPT) provides a non-invasive 3-D imaging modality that can be applied to longitudinal studies of live disease models, including in zebrafish. Current limitations include the requirement of a minimum number of angular projections for reconstruction of reasonable OPT images using filtered back projection (FBP), which is typically several hundred, leading to acquisition times of several minutes. It is highly desirable to decrease the number of required angular projections to decrease both the total acquisition time and the light dose to the sample. This is particularly important to enable longitudinal studies, which involve measurements of the same fish at different time points. In this work, we demonstrate that the use of an iterative algorithm to reconstruct sparsely sampled OPT data sets can provide useful 3-D images with 50 or fewer projections, thereby significantly decreasing the minimum acquisition time and light dose while maintaining image quality. A transgenic zebrafish embryo with fluorescent labelling of the vasculature was imaged to acquire densely sampled (800 projections) and under-sampled data sets of transmitted and fluorescence projection images. The under-sampled OPT data sets were reconstructed using an iterative total variation-based image reconstruction algorithm and compared against FBP reconstructions of the densely sampled data sets. To illustrate the potential for quantitative analysis following rapid OPT data acquisition, a Hessian-based method was applied to automatically segment the reconstructed images to select the vasculature network. Results showed that 3-D images of the zebrafish embryo and its vasculature of sufficient visual quality for quantitative analysis can be reconstructed using the iterative algorithm from only 32 projections-achieving up to 28 times improvement in imaging speed and leading to total acquisition times of a few seconds.	[Correia, Teresa; Yin, Jun; Arridge, Simon] UCL, Dept Comp Sci, London, England; [Lockwood, Nicola; Ramel, Marie-Christine; Frankel, Paul] UCL, Div Med, London, England; [Lockwood, Nicola] UCL, CoMPLEX, London, England; [Kumar, Sunil; McGinty, James; French, Paul M. W.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, London, England; [Ramel, Marie-Christine; Andrews, Natalie; Bugeon, Laurence; Dallman, Margaret J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Div Cell & Mol Biol, London, England; [Katan, Matilda] UCL, Dept Struct & Mol Biol, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Imperial College London; Imperial College London; University of London; University College London	Correia, T (corresponding author), UCL, Dept Comp Sci, London, England.	tcorreia@cs.ucl.ac.uk	Correia, Teresa Matias/ABB-4135-2020; French, Paul/E-8649-2011; Zebrafish, UCL/A-3125-2009; Lockwood, Nicola/AAA-2833-2019	Correia, Teresa Matias/0000-0002-1606-9550; French, Paul/0000-0002-0478-6755; Bugeon, Laurence/0000-0002-6978-2878; Kumar, Sunil/0000-0001-8200-9671; Ramel, Marie-Christine/0000-0002-2865-8272; Arridge, Simon/0000-0003-1292-0210	Medical Research Council (MRC) [MR/K011561/1]; Wellcome Trust [WT 095931/Z/11/Z]; Institute of Chemical Biology EPSRC funded Doctoral Training Centre; British Heart Foundation (BHF) [SP/08/004]; UCL COMPLEX doctoral training programme; BBSRC [BB/L018039/1] Funding Source: UKRI; EPSRC [EP/M020533/1] Funding Source: UKRI; MRC [MR/K011561/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L018039/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1105099, EP/M020533/1] Funding Source: researchfish; Medical Research Council [MR/K011561/1] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Institute of Chemical Biology EPSRC funded Doctoral Training Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); British Heart Foundation (BHF)(British Heart Foundation); UCL COMPLEX doctoral training programme; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors gratefully acknowledge funding from the Medical Research Council (MRC, MR/K011561/1) and the Wellcome Trust (Institutional Strategic Support Fund Networks of Excellence Award and WT 095931/Z/11/Z). NA acknowledges a studentship from the Institute of Chemical Biology EPSRC funded Doctoral Training Centre. This work was also supported by a doctoral training grant (SP/08/004) from the British Heart Foundation (BHF) to NL, MK and PF. NL is also supported through the UCL COMPLEX doctoral training programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso MV, 2010, IEEE T IMAGE PROCESS, V19, P2345, DOI 10.1109/TIP.2010.2047910; Ariga Junko, 2010, J Vis Exp, DOI 10.3791/2093; Arranz A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07325; Bassi A, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3640808; Beck A, 2009, IEEE T IMAGE PROCESS, V18, P2419, DOI 10.1109/TIP.2009.2028250; Bioucas-Dias JM, 2007, IEEE T IMAGE PROCESS, V16, P2992, DOI 10.1109/TIP.2007.909319; Chambolle A, 1997, NUMER MATH, V76, P167, DOI 10.1007/s002110050258; Chambolle A, 2004, J MATH IMAGING VIS, V20, P89; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Fang LH, 2013, NATURE, V498, P118, DOI 10.1038/nature12166; Fei P, 2012, OPT EXPRESS, V20, P8824, DOI 10.1364/OE.20.008824; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Herman GT, 2008, INVERSE PROBL, V24, DOI 10.1088/0266-5611/24/4/045011; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Kak A, 1988, PRINCIPLES OF COMPUT; Krauss J, 2013, BIOL OPEN, V2, P703, DOI 10.1242/bio.20135132; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Limaye A, 2012, P SOC PHOTO-OPT INS, V8506; Lustig M, 2008, IEEE SIGNAL PROC MAG, V25, P72, DOI 10.1109/MSP.2007.914728; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; McGinty J, 2011, BIOMED OPT EXPRESS, V2, P1340, DOI 10.1364/BOE.2.001340; McGinty J, 2008, J BIOPHOTONICS, V1, P390, DOI 10.1002/jbio.200810044; Nord H, 2014, MOL BIOL CELL, V25, P1384, DOI 10.1091/mbc.E13-08-0486; Osher S, 2005, MULTISCALE MODEL SIM, V4, P460, DOI 10.1137/040605412; Pardo-Martin C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2475; Ramani S, 2012, IEEE T MED IMAGING, V31, P677, DOI 10.1109/TMI.2011.2175233; Ramani S, 2011, IEEE T MED IMAGING, V30, P694, DOI 10.1109/TMI.2010.2093536; Rieckher M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018963; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Tobia C, 2011, INT J DEV BIOL, V55, P505, DOI 10.1387/ijdb.103238ct; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; While R, 2008, CELL STEM CELL, V2, P183, DOI [10.1016/j.stem.2007.11.002, DOI 10.1016/J.STEM.2007.11.002]; Xie J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-76	36	34	35	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136213	10.1371/journal.pone.0136213	http://dx.doi.org/10.1371/journal.pone.0136213			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308086	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400098
J	Erickson, JC; Herrera, M; Bustamante, M; Shingiro, A; Bowen, T				Erickson, Jonathan C.; Herrera, Maria; Bustamante, Mauricio; Shingiro, Aristide; Bowen, Thomas			Effective Stimulus Parameters for Directed Locomotion in Madagascar Hissing Cockroach Biobot	PLOS ONE			English	Article							PERIPLANETA-AMERICANA; THORACIC INTERNEURONS; BEHAVIOR; STIMULATION; SYSTEM; RESPONSES; PATTERNS; MOTION; INSECT; MUSCLE	Swarms of insects instrumented with wireless electronic backpacks have previously been proposed for potential use in search and rescue operations. Before deploying such biobot swarms, an effective long-term neural-electric stimulus interface must be established, and the locomotion response to various stimuli quantified. To this end, we studied a variety of pulse types (mono-vs. bipolar; voltage-vs. current-controlled) and shapes (amplitude, frequency, duration) to parameters that are most effective for evoking locomotion along a desired path in the Madagascar hissing cockroach (G. portentosa) in response to antennal and cercal stimulation. We identified bipolar, 2 V, 50 Hz, 0.5 s voltage controlled pulses as being optimal for evoking forward motion and turns in the expected contraversive direction without habituation in approximate to 50% of test subjects, a substantial increase over approximate to 10% success rates previously reported. Larger amplitudes for voltage (1-4 V) and current (50-150 mu A) pulses generally evoked larger forward walking (15.6-25.6 cm; 3.9-5.6 cm/s) but smaller concomitant turning responses (149 to 80.0 deg; 62.8 to 41.2 deg/s). Thus, the radius of curvature of the initial turn-then-run locomotor response (approximate to 10-25 cm) could be controlled in a graded manner by varying the stimulus amplitude. These findings could be used to help optimize stimulus protocols for swarms of cockroach biobots navigating unknown terrain.	[Erickson, Jonathan C.; Herrera, Maria; Bustamante, Mauricio; Shingiro, Aristide; Bowen, Thomas] Washington & Lee Univ, Dept Engn Phys, Lexington, VA 24450 USA	Washington & Lee University	Erickson, JC (corresponding author), Washington & Lee Univ, Dept Engn Phys, Lexington, VA 24450 USA.	ericksonj@wlu.edu		Bustamante, Mauricio/0000-0001-7499-160X	Washington and Lee University, Lenfest faculty research grant	Washington and Lee University, Lenfest faculty research grant	Washington and Lee University, Lenfest faculty research grant. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozkurt A, 2008, PROC IEEE MICR ELECT, P160; Bozkurt A., 2014, SPIE DEFENSE SECURIT; CAMHI JM, 1988, EXPERIENTIA, V44, P401, DOI 10.1007/BF01940534; Cao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105389; Christoffersen GRJ, 1997, PROG NEUROBIOL, V53, P45, DOI 10.1016/S0301-0082(97)00031-2; Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518; Gazi V, 2015, MOBILE ROBOTS DYNAMI, P81; Giampalmo SL, 2011, IEEE ENG MED BIO, P1275, DOI 10.1109/IEMBS.2011.6090300; Hedrick AV, 2007, J NEUROSCI METH, V164, P86, DOI 10.1016/j.jneumeth.2007.04.004; Holzer R, 1997, INT ROB SYST 1997 IR, V3, P1514; Kreyszig E., 1991, DIFFERENTIAL GEOMETR, V12, P34; Latif T, 2014, IEEE ENG MED BIO, P1670, DOI 10.1109/EMBC.2014.6943927; Latif T, 2012, IEEE ENG MED BIO, P972, DOI 10.1109/EMBC.2012.6346095; Levi R, 1996, J EXP BIOL, V199, P563; McGorry CA, 2014, J INSECT PHYSIOL, V66, P59, DOI 10.1016/j.jinsphys.2014.05.017; Moore RJD, 2014, J NEUROSCI METH, V225, P106, DOI 10.1016/j.jneumeth.2014.01.010; Moore Thomas E., 1998, Acta Entomologica Slovenica, V6, P71; Mulder P, 2008, L 278 MADAGASCAR HIS, V17, P2008; NELSON MC, 1980, BEHAV ECOL SOCIOBIOL, V6, P305, DOI 10.1007/BF00292773; Nenadic Z, 2005, IEEE T BIO-MED ENG, V52, P74, DOI 10.1109/TBME.2004.839800; RITZMANN RE, 1994, J NEUROBIOL, V25, P1113, DOI 10.1002/neu.480250907; RITZMANN RE, 1991, BRAIN RES, V563, P175, DOI 10.1016/0006-8993(91)91531-5; Sanchez CJ, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1363; Sato H, 2015, CURR BIOL, V25, P798, DOI 10.1016/j.cub.2015.01.051; Sato H, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.024.2009; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Sokal RR, 1994, BIOMETRY THE PRINCIP; Takalo J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00324; Visvanathan K, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/12/125002; Wagenaar DA, 2004, J NEUROSCI METH, V138, P27, DOI 10.1016/j.jneumeth.2004.03.005; Whitmire E, 2014, SENSORS 2014 IEEE, P2195; Whitmire E, 2013, IEEE ENG MED BIO, P1470, DOI 10.1109/EMBC.2013.6609789; YE S, 1995, J NEUROSCI METH, V60, P199, DOI 10.1016/0165-0270(95)00013-K; Ye S, 2003, J COMP PHYSIOL A, V189, P89, DOI 10.1007/s00359-002-0383-x; Ye SP, 1996, J NEUROSCI, V16, P5844	35	24	24	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134348	10.1371/journal.pone.0134348	http://dx.doi.org/10.1371/journal.pone.0134348			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308337	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400022
J	Fulmer, EB; Neilands, TB; Dube, SR; Kuiper, NM; Arrazola, RA; Glantz, SA				Fulmer, Erika B.; Neilands, Torsten B.; Dube, Shanta R.; Kuiper, Nicole M.; Arrazola, Rene A.; Glantz, Stanton A.			Protobacco Media Exposure and Youth Susceptibility to Smoking Cigarettes, Cigarette Experimentation, and Current Tobacco Use among US Youth	PLOS ONE			English	Article							HIGH-SCHOOL-STUDENTS; ENTERTAINMENT MEDIA; ADOLESCENT SMOKING; UNITED-STATES; FIT INDEXES; MOVIES; ATTITUDES; MIDDLE; ONSET	Purpose Youth are exposed to many types of protobacco influences, including smoking in movies, which has been shown to cause initiation. This study investigates associations between different channels of protobacco media and susceptibility to smoking cigarettes, cigarette experimentation, and current tobacco use among US middle and high school students. Methods By using data from the 2012 National Youth Tobacco Survey, structural equation modeling was performed in 2013. The analyses examined exposure to tobacco use in different channels of protobacco media on smoking susceptibility, experimentation, and current tobacco use, accounting for perceived peer tobacco use. Results In 2012, 27.9% of respondents were never-smokers who reported being susceptible to trying cigarette smoking. Cigarette experimentation increased from 6.3% in 6th grade to 37.1% in 12th grade. Likewise, current tobacco use increased from 5.2% in 6th grade to 33.2% in 12th grade. Structural equation modeling supported a model in which current tobacco use is associated with exposure to static advertising through perception of peer use, and by exposure to tobacco use depicted on TV and in movies, both directly and through perception of peer use. Exposure to static advertising appears to directly increase smoking susceptibility but indirectly (through increased perceptions of peer use) to increase cigarette experimentation. Models that explicitly incorporate peer use as a mediator can better discern the direct and indirect effects of exposure to static advertising on youth tobacco use initiation. Conclusions These findings underscore the importance of reducing youth exposure to smoking in TV, movies, and static advertising.	[Fulmer, Erika B.; Kuiper, Nicole M.; Arrazola, Rene A.] Ctr Dis Control & Prevent, Off Smoking & Hlth, Atlanta, GA 30341 USA; [Neilands, Torsten B.] Univ Calif San Francisco, Ctr AIDS Prevent Studies CAPS, Dept Med, San Francisco, CA 94105 USA; [Dube, Shanta R.] Georgia State Univ, Sch Publ Hlth, Epidemiol & Biostat, Atlanta, GA 30303 USA; [Glantz, Stanton A.] Univ Calif San Francisco, Dept Med, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA	Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco; University System of Georgia; Georgia State University; University of California System; University of California San Francisco	Fulmer, EB (corresponding author), Ctr Dis Control & Prevent, Off Smoking & Hlth, 4770 Buford Highway,NE,MS F-79, Atlanta, GA 30341 USA.	efulmer@cdc.gov						Agaku IT, 2014, PREV MED, V58, P45, DOI 10.1016/j.ypmed.2013.10.012; Arrazola RA, 2013, MMWR-MORBID MORTAL W, V62, P893; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Bollen KA, 1989, STRUCTURAL EQUATIONS; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Centers for Disease Control and Prevention, 2013, FACT SHEET SMOK MOV; Centers for Disease Control and Prevention, 2015, NAT YOUTH TOB SURV N; Charlesworth A, 2005, PEDIATRICS, V116, P1516, DOI 10.1542/peds.2005-0141; Dal Cin S, 2012, J HEALTH COMMUN, V17, P76, DOI 10.1080/10810730.2011.585697; Dube SR, 2013, J ADOLESCENT HEALTH, V52, pS45, DOI 10.1016/j.jadohealth.2012.07.007; Federal Trade Commission, 2015, SMOK TOB REP 2012; Federal Trade Commission, 2015, CIG REP 2012; Flora DB, 2004, PSYCHOL METHODS, V9, P466, DOI 10.1037/1082-989X.9.4.466; Glantz SA, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120170; Henriksen L, 2010, PEDIATRICS, V126, P232, DOI 10.1542/peds.2009-3021; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kim AE, 2013, J PUBLIC HEALTH MAN, V19, pE1, DOI 10.1097/PHH.0b013e3182980c47; Ling PM, 2009, AM J PREV MED, V36, P389, DOI 10.1016/j.amepre.2009.01.028; Loehlin JC, 1998, LATENT VARIABLE MODE; Lyons A, 2014, TOB CONTROL, V23, P257, DOI 10.1136/tobaccocontrol-2012-050650; Morgenstern M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002907; National Association of Attorneys General, 2010, MAST SETTL AGR; National Cancer Institute, 2008, NAT CANC I TOB CONTR; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health, 2014, HLTH CONS SMOK 50 YE; Pierce JP, 1996, HEALTH PSYCHOL, V15, P6; Polansky JP, 2012, SMOKING TOP GROSSING; Rhemtulla M, 2012, PSYCHOL METHODS, V17, P354, DOI 10.1037/a0029315; Sargent JD, 2009, TOB CONTROL, V18, P47, DOI 10.1136/tc.2008.026153; Sargent JD, 2009, ADDICTION, V104, P815, DOI 10.1111/j.1360-0443.2009.02542.x; Sargent JD, 2008, COMMUN METHODS MEAS, V2, P134, DOI 10.1080/19312450802063404; Sargent JD, 2002, AM J PREV MED, V22, P137, DOI 10.1016/S0749-3797(01)00434-2; Song AV, 2007, AM J PREV MED, V33, P396, DOI 10.1016/j.amepre.2007.07.026; Starr G, 2005, KEY OUTCOME INDICATO; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; US Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; Wills TA, 2008, PSYCHOL ADDICT BEHAV, V22, P269, DOI 10.1037/0893-164X.22.2.269; Wills TA, 2007, HEALTH PSYCHOL, V26, P769, DOI 10.1037/0278-6133.26.6.769; Yu C.Y., 2002, EVALUATING CUTOFF CR	38	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134734	10.1371/journal.pone.0134734	http://dx.doi.org/10.1371/journal.pone.0134734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LO	26308217	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400034
J	Keppner, A; Andreasen, D; Merillat, AM; Bapst, J; Ansermet, C; Wang, Q; Maillard, M; Malsure, S; Nobile, A; Hummler, E				Keppner, Anna; Andreasen, Ditte; Merillat, Anne-Marie; Bapst, Julie; Ansermet, Camille; Wang, Qing; Maillard, Marc; Malsure, Sumedha; Nobile, Antoine; Hummler, Edith			Epithelial Sodium Channel-Mediated Sodium Transport Is Not Dependent on the Membrane-Bound Serine Protease CAP2/Tmprss4	PLOS ONE			English	Article							EPIDERMAL BARRIER FUNCTION; CELL LUNG-CANCER; ALPHA-ENAC; PROTEOLYTIC ACTIVATION; INFLUENZA-VIRUS; XENOPUS-OOCYTES; NA+ CHANNEL; TMPRSS4; EXPRESSION; ALDOSTERONE	The membrane-bound serine protease CAP2/Tmprss4 has been previously identified in vitro as a positive regulator of the epithelial sodium channel (ENaC). To study its in vivo implication in ENaC-mediated sodium absorption, we generated a knockout mouse model for CAP2/Tmprss4. Mice deficient in CAP2/Tmprss4 were viable, fertile, and did not show any obvious histological abnormalities. Unexpectedly, when challenged with sodium-deficient diet, these mice did not develop any impairment in renal sodium handling as evidenced by normal plasma and urinary sodium and potassium electrolytes, as well as normal aldosterone levels. Despite minor alterations in ENaC mRNA expression, we found no evidence for altered proteolytic cleavage of ENaC subunits. In consequence, ENaC activity, as monitored by the amiloride-sensitive rectal potential difference (Delta PD), was not altered even under dietary sodium restriction. In summary, ENaC-mediated sodium balance is not affected by lack of CAP2/Tmprss4 expression and thus, does not seem to directly control ENaC expression and activity in vivo.	[Keppner, Anna; Andreasen, Ditte; Merillat, Anne-Marie; Bapst, Julie; Ansermet, Camille; Malsure, Sumedha; Hummler, Edith] Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland; [Wang, Qing; Maillard, Marc] CHU Vaudois, Univ Lausanne Hosp, Dept Med, Div Nephrol & Hypertens, CH-1011 Lausanne, Switzerland; [Wang, Qing] Univ Fribourg, Dept Med Physiol, CH-1700 Fribourg, Switzerland; [Nobile, Antoine] CHU Vaudois, Univ Lausanne Hosp, Inst Univ Pathol, CH-1011 Lausanne, Switzerland	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Fribourg; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Hummler, E (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland.	Edith.Hummler@unil.ch	Maillard, Marc/AAY-8604-2020	Keppner, Anna/0000-0002-7880-3810	Swiss National Science Foundation [31003A_144198/1]; National Center for Competence in Research (NCCR) Kidney Control of Homeostasis (Kidney.CH); Fondation Leducq [26077648]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center for Competence in Research (NCCR) Kidney Control of Homeostasis (Kidney.CH)(Swiss National Science Foundation (SNSF)); Fondation Leducq(Leducq Foundation)	This work was supported by the Swiss National Science Foundation (http://www.snf.ch/fr/Pages/default.aspx) grant number 31003A_144198/1, to AK, DA, AMM, SM and EH, the National Center for Competence in Research (NCCR) Kidney Control of Homeostasis (Kidney.CH) (http://www.nccr-kidney.ch) to AK, AMM, JB, SM and EH, and Fondation Leducq, grant number 26077648 (https://www.fondationleducq.org) to AK, DA, AMM, SM and EH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Bahgat MM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-27; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Buchholz F, 2000, EMBO REP, V1, P133, DOI 10.1093/embo-reports/kvd027; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2014, AM J PHYSIOL-RENAL, V307, pF1080, DOI 10.1152/ajprenal.00157.2014; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Cheng DY, 2013, INT J MOL SCI, V14, P14659, DOI 10.3390/ijms140714659; Christensen BM, 2010, J AM SOC NEPHROL, V21, P1942, DOI 10.1681/ASN.2009101077; Dai W, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0749-7; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; FALCONER DS, 1952, J HERED, V43, P53, DOI 10.1093/oxfordjournals.jhered.a106262; Frateschi S, 2012, AM J PATHOL, V181, P605, DOI 10.1016/j.ajpath.2012.05.007; Garcia-Caballero A, 2011, CHANNELS, V5, P14, DOI 10.4161/chan.5.1.13759; Garcia-Caballero A, 2008, J GEN PHYSIOL, V132, P521, DOI 10.1085/jgp.200810030; Haerteis S, 2014, J BIOL CHEM, V289, P19067, DOI 10.1074/jbc.M113.538470; Harris M, 2008, J BIOL CHEM, V283, P7455, DOI 10.1074/jbc.M707399200; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Huang A, 2014, CANCER BIOL THER, V15, P297, DOI 10.4161/cbt.27308; Huang A, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0712-7; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Hummler E, 2002, GENESIS, V32, P169, DOI 10.1002/gene.10041; Hummler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055796; Kim S, 2014, IEEE SYM EMBED SYST, P12, DOI 10.1109/ESTIMedia.2014.6962341; Lahiry P, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-126; Larzabal L, 2011, BRIT J CANCER, V105, P1608, DOI 10.1038/bjc.2011.432; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; Loffing J, 2009, PFLUG ARCH EUR J PHY, V458, P111, DOI 10.1007/s00424-009-0656-0; Luo ZR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076203; Malsure S, 2014, J AM SOC NEPHROL, V25, P1453, DOI 10.1681/ASN.2013090936; May A, 1997, J AM SOC NEPHROL, V8, P1813; Merillat AM, 2009, AM J PHYSIOL-RENAL, V296, pF249, DOI 10.1152/ajprenal.00612.2007; Ohler A, 2011, BIOL CHEM, V392, P653, DOI 10.1515/BC.2011.070; Panteleyev AA, 2001, COMPARATIVE MED, V51, P49; Passero CJ, 2012, AM J PHYSIOL-RENAL, V302, pF1, DOI 10.1152/ajprenal.00330.2011; Planes C, 2005, AM J PHYSIOL-LUNG C, V288, pL1099, DOI 10.1152/ajplung.00332.2004; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Porret Andree, 2006, V337, P185; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rossier BC, 2013, FEBS LETT, V587, P1929, DOI 10.1016/j.febslet.2013.05.013; Rubera I, 2003, J CLIN INVEST, V112, P554, DOI 10.1172/JCI200316956; Sheng H, 2014, NEOPLASMA, V61, P213, DOI 10.4149/neo_2014_027; Spacek DV, 2010, EXP DERMATOL, V19, P527, DOI 10.1111/j.1600-0625.2009.01054.x; Tan CD, 2014, J PHYSIOL-LONDON, V592, P5251, DOI 10.1113/jphysiol.2013.267286; Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865; Nguyen TH, 2012, INT J ONCOL, V41, P829, DOI 10.3892/ijo.2012.1513; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Vallet V, 1998, KIDNEY INT, V54, pS109, DOI 10.1046/j.1523-1755.1998.06721.x; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vallet VR, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133588; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Wallrapp C, 2000, CANCER RES, V60, P2602; Wang Q, 2000, CLIN EXP PHARMACOL P, V27, P60, DOI 10.1046/j.1440-1681.2000.03204.x; Wu XY, 2014, TUMOR BIOL, V35, P5481, DOI 10.1007/s13277-014-1716-4; Zachar RM, 2015, J AM SOC NEPHROL, V26, P95, DOI 10.1681/ASN.2013111173	63	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135224	10.1371/journal.pone.0135224	http://dx.doi.org/10.1371/journal.pone.0135224			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309024	Green Published, gold			2022-12-27	WOS:000360069400055
J	Liu, B; Rennenberg, H; Kreuzwieser, J				Liu, Bin; Rennenberg, Heinz; Kreuzwieser, Juergen			Hypoxia Affects Nitrogen Uptake and Distribution in Young Poplar (Populus x canescens) Trees	PLOS ONE			English	Article							SPRUCE PICEA-ABIES; AMINO-ACIDS; ORGANIC NITROGEN; N-METABOLISM; GREY POPLAR; NITRATE; ROOTS; SEEDLINGS; AMMONIUM; GROWTH	The present study with young poplar trees aimed at characterizing the effect of O-2 shortage in the soil on net uptake of NO3- and NH4+ and the spatial distribution of the N taken up. Moreover, we assessed biomass increment as well as N status of the trees affected by O-2 deficiency. For this purpose, an experiment was conducted in which hydroponically grown young poplar trees were exposed to hypoxic and normoxic (control) conditions for 14 days. N-15-labelled NO3- and NH4+ were used to elucidate N uptake and distribution of currently absorbed N and N allocation rates in the plants. Whereas shoot biomass was not affected by soil O-2 deficiency, it significantly reduced root biomass and, consequently, the root-toshoot ratio. Uptake of NO3- but not of NH4+ by the roots of the trees was severely impaired by hypoxia. As a consequence of reduced N uptake, the N content of all poplar tissues was significantly diminished. Under normoxic control conditions, the spatial distribution of currently absorbed N and N allocation rates differed depending on the N source. Whereas NO3- derived N was mainly transported to the younger parts of the shoot, particularly to the developing and young mature leaves, N derived from NH4+ was preferentially allocated to older parts of the shoot, mainly to wood and bark. Soil O-2 deficiency enhanced this differential allocation pattern. From these results we assume that NO3- was assimilated in developing tissues and preferentially used to maintain growth and ensure plant survival under hypoxia, whereas NH4+ based N was used for biosynthesis of storage proteins in bark and wood of the trees. Still, further studies are needed to understand the mechanistic basis as well as the eco-physiological advantages of such differential allocation patterns.	[Liu, Bin; Rennenberg, Heinz; Kreuzwieser, Juergen] Univ Freiburg, Inst Forest Sci, Chair Tree Physiol, D-79106 Freiburg, Germany	University of Freiburg	Kreuzwieser, J (corresponding author), Univ Freiburg, Inst Forest Sci, Chair Tree Physiol, Hugstetter Str 55, D-79106 Freiburg, Germany.	juergen.kreuzwieser@ctp.uni-freiburg.de	Liu, Bin/AAJ-8004-2021	Liu, Bin/0000-0003-4738-8690	German Research Foundation (DFG); Albert Ludwigs University Freiburg; China Scholarship Council (CSC) [2010630072]; Graduiertenforderung (LGFG) Baden-Wurttemberg; University of Freiburg	German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg; China Scholarship Council (CSC)(China Scholarship Council); Graduiertenforderung (LGFG) Baden-Wurttemberg; University of Freiburg	The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. Bin Liu was supported by scholarships from China Scholarship Council (CSC, Grant# 2010630072), Graduiertenforderung (LGFG) Baden-Wurttemberg and the University of Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG W, 1994, ACTA BOT NEERL, V43, P307; Ashraf M, 1999, PLANT SCI, V144, P35, DOI 10.1016/S0168-9452(99)00055-2; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Black BL, 2002, TREE PHYSIOL, V22, P717, DOI 10.1093/treephys/22.10.717; Bloom AJ, 1997, Z PFLANZ BODENKUNDE, V160, P253, DOI 10.1002/jpln.19971600219; BRINSON MM, 1984, J APPL ECOL, V21, P1041, DOI 10.2307/2405066; Callesen I, 1999, FOREST ECOL MANAG, V114, P71, DOI 10.1016/S0378-1127(98)00382-X; Castro-Rodriguez V, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-119; Chapin FS, 1987, BIOSCIENCE, P49; Chen HJ, 2005, AQUAT BOT, V82, P250, DOI 10.1016/j.aquabot.2005.02.013; Coleman HD, 2012, PLANT BIOTECHNOL J, V10, P883, DOI 10.1111/j.1467-7652.2012.00714.x; Colmer TD, 2009, FUNCT PLANT BIOL, V36, P665, DOI 10.1071/FP09144; Colmer TD, 1998, PLANT CELL ENVIRON, V21, P240, DOI 10.1046/j.1365-3040.1998.00261.x; Colmer TD, 2010, J EXP BOT; Davanso VM, 2002, BRAZ ARCH BIOL TECHN, V45, P375, DOI 10.1590/S1516-89132002000300016; DesRochers A, 2003, CAN J FOREST RES, V33, P552, DOI [10.1139/x02-191, 10.1139/X02-191]; Drew MC, 1997, ANNU REV PLANT PHYS, V48, P223, DOI 10.1146/annurev.arplant.48.1.223; DREW MC, 1991, PLANT LIFE OXYGEN DE, P303; Elzenga JTM, 2010, WATERLOGGING SIGNALLING AND TOLERANCE IN PLANTS, P23, DOI 10.1007/978-3-642-10305-6_2; FINLAY RD, 1989, NEW PHYTOL, V113, P47, DOI 10.1111/j.1469-8137.1989.tb02394.x; Garnett TP, 2001, PLANT SOIL, V236, P55, DOI 10.1023/A:1011951413917; Gessler A, 1998, J EXP BOT, V49, P1529, DOI 10.1093/jexbot/49.326.1529; Givan CV, 1980, BIOCH PLANTS, V5, P331; Glass ADM, 2002, J EXP BOT, V53, P855, DOI 10.1093/jexbot/53.370.855; Gruffman L, 2013, TREE PHYSIOL, V33, P590, DOI 10.1093/treephys/tpt041; HAYNES RJ, 1978, BIOL REV, V53, P465, DOI 10.1111/j.1469-185X.1978.tb00862.x; Herrera A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00106; Herschbach C, 2012, PROG BOT, V73, P161, DOI 10.1007/978-3-642-22746-2_6; Hoagland DR, 1950, 347 CAL AGR EXP STAT, V347; Islam MA, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest:2008077; Jordan MO, 1998, J PLANT NUTR, V21, P2441, DOI 10.1080/01904169809365576; KAMMINGAVANWIJK C, 1993, PLANT SOIL, V151, P91, DOI 10.1007/BF00010789; Klok EJ, 2002, PLANT CELL, V14, P2481, DOI 10.1105/tpc.004747; Kreuzwieser J, 2002, PLANT CELL ENVIRON, V25, P1039, DOI 10.1046/j.1365-3040.2002.00886.x; Kreuzwieser J, 1997, J EXP BOT, V48, P1431, DOI 10.1093/jxb/48.7.1431; Kreuzwieser J, 2009, PLANT PHYSIOL, V149, P461, DOI 10.1104/pp.108.125989; Kreuzwieser J, 2014, PLANT CELL ENVIRON, V37, P2245, DOI 10.1111/pce.12310; Kronzucker HJ, 1997, NATURE, V385, P59, DOI 10.1038/385059a0; Kruse J, 2002, J EXP BOT, V53, P2351, DOI 10.1093/jxb/erf094; Liu FL, 2005, PLANT PHYSIOL, V137, P1115, DOI 10.1104/pp.104.055475; Liu ZB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107636; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; Malik AI, 2002, NEW PHYTOL, V153, P225, DOI 10.1046/j.0028-646X.2001.00318.x; MARSCHNER H, 1991, TREES-STRUCT FUNCT, V5, P14, DOI 10.1007/BF00225330; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Martinez-Alcantara B, 2012, J PLANT PHYSIOL, V169, P1150, DOI 10.1016/j.jplph.2012.03.016; MCKEVLIN MR, 1995, TREE PHYSIOL, V15, P753; Medina CL, 2009, ANN BOT; Mielke Marcelo S., 2005, Acta Bot. Bras., V19, P905, DOI 10.1590/S0102-33062005000400025; Mielke MS, 2003, ENVIRON EXP BOT, V50, P221, DOI 10.1016/S0098-8472(03)00036-4; Miller AJ, 2005, PLANT SOIL, V274, P1, DOI 10.1007/s11104-004-0965-1; MULLER B, 1992, J EXP BOT, V43, P617, DOI 10.1093/jxb/43.5.617; MUNOZ N, 1993, PLANT SOIL, V150, P263, DOI 10.1007/BF00013023; Nasholm T, 2009, NEW PHYTOL, V182, P31, DOI 10.1111/j.1469-8137.2008.02751.x; OAKS A, 1985, ANNU REV PLANT PHYS, V36, P345; PATE J S, 1973, Soil Biology and Biochemistry, V5, P109, DOI 10.1016/0038-0717(73)90097-7; Persson J, 2003, OECOLOGIA, V137, P252, DOI 10.1007/s00442-003-1334-0; Pezeshki SR, 1999, J PLANT NUTR, V22, P1481, DOI 10.1080/01904169909365729; Ponnamperuma F, 1984, FLOODING PLANT GROWT, P30; Raven P.H., 1992, BIOL PLANTS; Rennenberg H, 1996, J EXP BOT, V47, P1491, DOI 10.1093/jxb/47.10.1491; Rennenberg H, 2009, PLANT BIOLOGY, V11, P4, DOI 10.1111/j.1438-8677.2009.00241.x; Robertson G, 2007, SOIL MICROBIOLOGY BI, P355; Rubinigg M, 2002, FUNCT PLANT BIOL, V29, P1475, DOI 10.1071/FP02081; SAGLIO PH, 1984, PLANT PHYSIOL, V76, P151, DOI 10.1104/pp.76.1.151; Schaffer B, 2006, HORTSCIENCE, V41, P549, DOI 10.21273/HORTSCI.41.3.549; Schneider S, 1996, NEW PHYTOL, V134, P103, DOI 10.1111/j.1469-8137.1996.tb01150.x; Shabala S, 2014, PLANT CELL ENVIRON, V37, P2216, DOI 10.1111/pce.12339; STEPIEN V, 1994, PLANT PHYSIOL BIOCH, V32, P185; Stoelken G, 2010, TREE PHYSIOL, V30, P1118, DOI 10.1093/treephys/tpq050; STROHM M, 1995, PLANT J, V7, P141, DOI 10.1046/j.1365-313X.1995.07010141.x; Tegeder M, 2014, J EXP BOT; Tripathi G, 2007, FRONTIERS ECOLOGY RE, P231; van Dongen JT, 2009, ANN BOT-LONDON, V103, P269, DOI 10.1093/aob/mcn126; Vartapetian BB, 1997, ANN BOT-LONDON, V79, P3, DOI 10.1006/anbo.1996.0295; Wildhagen H, 2013, PLANT BIOLOGY, V15, P44, DOI 10.1111/j.1438-8677.2012.00687.x; Wildhagen H, 2010, TREE PHYSIOL, V30, P1096, DOI 10.1093/treephys/tpq018; Xu GH, 2012, ANNU REV PLANT BIOL, V63, P153, DOI 10.1146/annurev-arplant-042811-105532; Zanne AE, 2006, FUNCT PLANT BIOL, V33, P457, DOI 10.1071/FP05299; Zhang LZ, 2010, PLANT CELL, V22, P3603, DOI 10.1105/tpc.110.073833	80	19	19	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136579	10.1371/journal.pone.0136579	http://dx.doi.org/10.1371/journal.pone.0136579			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308462	gold, Green Submitted, Green Published			2022-12-27	WOS:000360069400140
J	Sanchez, JP; McInnes, CR				Sanchez, Joan-Pau; McInnes, Colin R.			Optimal Sunshade Configurations for Space-Based Geoengineering near the Sun-Earth L-1 Point	PLOS ONE			English	Review							CLIMATE-CHANGE; FEASIBILITY; BALANCE; CLOUD	Within the context of anthropogenic climate change, but also considering the Earth's natural climate variability, this paper explores the speculative possibility of large-scale active control of the Earth's radiative forcing. In particular, the paper revisits the concept of deploying a large sunshade or occulting disk at a static position near the Sun-Earth L-1 Lagrange equilibrium point. Among the solar radiation management methods that have been proposed thus far, space-based concepts are generally seen as the least timely, albeit also as one of the most efficient. Large occulting structures could potentially offset all of the global mean temperature increase due to greenhouse gas emissions. This paper investigates optimal configurations of orbiting occulting disks that not only offset a global temperature increase, but also mitigate regional differences such as latitudinal and seasonal difference of monthly mean temperature. A globally resolved energy balance model is used to provide insights into the coupling between the motion of the occulting disks and the Earth's climate. This allows us to revise previous studies, but also, for the first time, to search for families of orbits that improve the efficiency of occulting disks at offsetting climate change on both global and regional scales. Although natural orbits exist near the L-1 equilibrium point, their period does not match that required for geoengineering purposes, thus forced orbits were designed that require small changes to the disk attitude in order to control its motion. Finally, configurations of two occulting disks are presented which provide the same shading area as previously published studies, but achieve reductions of residual latitudinal and seasonal temperature changes.	[Sanchez, Joan-Pau] Cranfield Univ, Space Res Ctr, Cranfield MK43 0AL, Beds, England; [McInnes, Colin R.] Univ Glasgow, Sch Engn, Glasgow, Lanark, Scotland	Cranfield University; University of Glasgow	Sanchez, JP (corresponding author), Cranfield Univ, Space Res Ctr, Cranfield MK43 0AL, Beds, England.	jp.sanchez@cranfield.ac.uk	McInnes, Colin R/H-7794-2012; Cuartielles, Joan Pau Sanchez/AAI-1879-2019	Cuartielles, Joan Pau Sanchez/0000-0002-0626-9014; McInnes, Colin/0000-0003-0988-8854	European Research Council [227571]; Marie Curie grant [330649]	European Research Council(European Research Council (ERC)European Commission); Marie Curie grant(European Commission)	JPS was supported by European Research Council grant 227571 (VISIONSPACE) and the Marie Curie grant 330649 (AsteroidRetrieval). CRM was supported by European Research Council grant 227571 (VISIONSPACE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel R, 2006, P NATL ACAD SCI USA, V103, P17184, DOI 10.1073/pnas.0608163103; Ban-Weiss GA, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/3/034009; Bewick R, 2013, ADV SPACE RES, V51, P1132, DOI 10.1016/j.asr.2012.10.024; Bewick R, 2012, ADV SPACE RES, V49, P1212, DOI 10.1016/j.asr.2012.01.010; Cox ANE, 2000, ALL ASTR QUANT; Deb Kalyanmoy, 2001, MULTIOBJECTIVE OPTIM, V16; Dicaire I, 2013, 64 INT ASTR C 2013; Dommenget D, 2011, CLIM DYNAM, V37, P2143, DOI 10.1007/s00382-011-1026-0; Early JT., 1989, J BRIT INTER SOC, V42, P567; GLASER PE, 1968, SCIENCE, V162, P857, DOI 10.1126/science.162.3856.857; Gomez G, 2000, DYNAMICS MISSION DES; Govindasamy B, 2000, GEOPHYS RES LETT, V27, P2141, DOI 10.1029/1999GL006086; Howell KC, 2001, J ASTRONAUT SCI, V49, P107; Robert GK, 2013, ACTA ASTRONAUT, V82, P225, DOI 10.1016/j.actaastro.2012.10.022; Kosugi T, 2010, ACTA ASTRONAUT, V67, P241, DOI 10.1016/j.actaastro.2010.02.009; Lenton TM, 2009, ATMOS CHEM PHYS, V9, P5539, DOI 10.5194/acp-9-5539-2009; Lunt DJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033674; MacMartin DG, 2013, NAT CLIM CHANGE, V3, P365, DOI [10.1038/nclimate1722, 10.1038/NCLIMATE1722]; MARCHETTI C, 1977, CLIMATIC CHANGE, V1, P59, DOI 10.1007/BF00162777; McInnes CR, 2010, P I MECH ENG C-J MEC, V224, P571, DOI 10.1243/09544062JMES1439; McInnes C.R., 1999, SOLAR SAILING TECHNO, DOI DOI 10.1007/978-1-4471-3992-8; Mcinnes CR, 2002, JBIS-J BRIT INTERPLA, V55, P307; MCINNES CR, 1994, J GUID CONTROL DYNAM, V17, P399, DOI 10.2514/3.21211; McInnes CR, 2014, SPACE BASED GEOENGIN, P186; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Moreno-Cruz JB, 2012, CLIMATIC CHANGE, V110, P649, DOI 10.1007/s10584-011-0103-z; National Research Council, 2011, CLIM STAB TARG EM CO; Pearson J, 2006, ACTA ASTRONAUT, V58, P44, DOI 10.1016/j.actaastro.2005.03.071; Sanchez JP, 2011, J SPACECRAFT ROCKETS, V48, P153, DOI 10.2514/1.49851; Schmelz JT, 1992, SUN LAB ASTROPHYSICS; Schneider SH, 1996, CLIMATIC CHANGE, V33, P291, DOI 10.1007/BF00142577; SEIFRITZ W, 1989, NATURE, V340, P603, DOI 10.1038/340603a0; Shepherd J, 2009, GEOENGINEERING CLIMA; Struck C, 2007, JBIS-J BRIT INTERPLA, V60, P82; UNEP (United Nations Environment Programme), 2019, EM GAP REP 2019	36	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136648	10.1371/journal.pone.0136648	http://dx.doi.org/10.1371/journal.pone.0136648			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309047	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000360069400146
J	Young, MR; Hebert, PDN				Young, Monica R.; Hebert, Paul D. N.			Patterns of Protein Evolution in Cytochrome c Oxidase 1 (COI) from the Class Arachnida	PLOS ONE			English	Article							MITOCHONDRIAL GENES; MOLECULAR EVOLUTION; RATES; ACARI; DNA; OPILIONES; BIOLOGY; PARASITIFORMES; CYPHOPHTHALMI; ARTHROPODA	Because sequence information is now available for the 648bp barcode region of cytochrome c oxidase 1 (COI) from more than 400,000 animal species, this gene segment can be used to probe patterns of mitochondrial evolution. The present study examines levels of amino acid substitution and the frequency of indels in COI from 4177 species of arachnids, including representatives from all 16 orders and 43% of its families (267/625). It examines divergences at three taxonomic levels-among members of each order to an outgroup, among families in each order and among BINs, a species proxy, in each family. Order Distances vary fourfold (0.10-0.39), while the mean of the Family Distances for the ten orders ranges fivefold (0.07-0.35). BIN Distances show great variation, ranging from 0.01 or less in 12 families to more than 0.25 in eight families. Patterns of amino acid substitution in COI are generally congruent with previously reported variation in nucleotide substitution rates in arachnids, but provide some new insights, such as clear rate acceleration in the Opiliones. By revealing a strong association between elevated rates of nucleotide and amino acid substitution, this study builds evidence for the selective importance of the rate variation among arachnid lineages. Moreover, it establishes that groups whose COI genes have elevated levels of amino acid substitution also regularly possess indels, a dramatic form of protein reconfiguration. Overall, this study suggests that the mitochondrial genome of some arachnid groups is dynamic with high rates of amino acid substitution and frequent indels, while it is 'locked down' in others. Dynamic genomes are most prevalent in arachnids with short generation times, but the possible impact of breeding system deserves investigation since many of the rapidly evolving lineages reproduce by haplodiploidy, a mode of reproduction absent in 'locked down' taxa.	[Young, Monica R.; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	University of Guelph	Young, MR (corresponding author), Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	myoung02@uoguelph.ca	Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700	government of Canada through Genome Canada; Ontario Genomics institute [OGI-036]; Consejo Nacional de Ciencia y Tecnologia (the National Council of Science and Technology)	government of Canada through Genome Canada(Genome Canada); Ontario Genomics institute; Consejo Nacional de Ciencia y Tecnologia (the National Council of Science and Technology)	This study was funded by a grant from the government of Canada through Genome Canada and the Ontario Genomics institute in support of the International Barcode of Life Project (OGI-036), http://www.genomecanada.ca/en/. Ricardo Paredes and Griselda Montiel provided access to an Opilioacarida sequence from their project: Codigo de Barras de los Aracnidos de Mexico: Acaros (Arachnida: Acari) asociados a los vertebrados e invertebrados de Mexico, No. 122944, funded by Consejo Nacional de Ciencia y Tecnologia (the National Council of Science and Technology), http://www.conacyt.mx/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabi J, 2012, J MOL EVOL, V74, P81, DOI 10.1007/s00239-012-9490-7; Blagoev GA, 2016, MOL ECOL RESOUR, V16, P325, DOI 10.1111/1755-0998.12444; Boyer SL, 2005, MOL PHYLOGENET EVOL, V36, P554, DOI 10.1016/j.ympev.2005.04.004; Chatzaki M, 2009, J ARACHNOL, V37, P139, DOI 10.1636/T07-38.1; Clare EL, 2008, J MOL EVOL, V66, P362, DOI 10.1007/s00239-008-9088-2; COOKE JAL, 1967, J ZOOL, V151, P31, DOI 10.1111/j.1469-7998.1967.tb02864.x; CROZIER RH, 1989, MOL BIOL EVOL, V6, P399; Dabert M, 2010, MOL PHYLOGENET EVOL, V56, P222, DOI 10.1016/j.ympev.2009.12.020; Dowling APG, 2010, INT J ACAROL, V36, P299, DOI 10.1080/01647951003604569; Dowton M, 1995, J MOL EVOL, V41, P958, DOI 10.1007/BF00173176; Gantenbein B, 2004, EVOLUTION, V58, P2486, DOI 10.1111/j.0014-3820.2004.tb00878.x; Giribet G, 2012, BIOL J LINN SOC, V105, P92, DOI 10.1111/j.1095-8312.2011.01774.x; HAMILTON A, 1986, ENTOMOL EXP APPL, V41, P147, DOI 10.1007/BF00195570; Harvey MS, 2002, J ARACHNOL, V30, P357, DOI 10.1636/0161-8202(2002)030[0357:TNCWDW]2.0.CO;2; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hebert PDN, 2002, EVOLUTION, V56, P909; Kern WHJ, 2011, GIANT WHIP SCORPION; Klompen H, 2007, MOL PHYLOGENET EVOL, V43, P936, DOI 10.1016/j.ympev.2006.10.024; Krantz GW, 2009, MANUAL ACAROLOGY, P807; Mardulyn P, 1999, MOL PHYLOGENET EVOL, V12, P282, DOI 10.1006/mpev.1999.0618; Min XJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000325; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Murrell A, 2005, INVERTEBR SYST, V19, P383, DOI 10.1071/IS05027; Norton Roy A., 1993, P8; NUR U, 1972, CHROMOSOMA, V39, P381, DOI 10.1007/BF00326174; OLIVER JH, 1989, ANNU REV ECOL SYST, V20, P397, DOI 10.1146/annurev.es.20.110189.002145; Pfeiler E, 2009, MOL PHYLOGENET EVOL, V52, P133, DOI 10.1016/j.ympev.2008.12.020; Pinto-da-Rocha Ricardo, 2007, P88; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; ROWLAND J M, 1972, Entomological News, V83, P69; Shao RF, 2003, MOL BIOL EVOL, V20, P1612, DOI 10.1093/molbev/msg176; Sharma PP, 2014, MOL BIOL EVOL; Shultz JW, 2007, ZOOL J LINN SOC-LOND, V150, P221, DOI 10.1111/j.1096-3642.2007.00284.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Walter DE, 1999, MITES ECOLOGY EVOLUT; Weygoldt P., 2000, THEIR BIOL MORPHOLOG; WHARTON RA, 1986, J ARACHNOL, V14, P363	40	13	13	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135053	10.1371/journal.pone.0135053	http://dx.doi.org/10.1371/journal.pone.0135053			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308206	Green Published, gold			2022-12-27	WOS:000360069400047
J	Zuliani, A; Massolo, A; Lysyk, T; Johnson, G; Marshall, S; Berger, K; Cork, SC				Zuliani, Anna; Massolo, Alessandro; Lysyk, Timothy; Johnson, Gregory; Marshall, Shawn; Berger, Kathryn; Cork, Susan Catherine			Modelling the Northward Expansion of Culicoides sonorensis (Diptera: Ceratopogonidae) under Future Climate Scenarios	PLOS ONE			English	Article							EPIZOOTIC HEMORRHAGIC-DISEASE; VARIIPENNIS DIPTERA; SPECIES DISTRIBUTIONS; SEASONAL ABUNDANCE; SOUTHERN ALBERTA; BLUETONGUE; CATTLE; DAIRY; RISK; TRANSMISSION	Climate change is affecting the distribution of pathogens and their arthropod vectors world-wide, particularly at northern latitudes. The distribution of Culicoides sonorensis (Diptera: Ceratopogonidae) plays a key role in affecting the emergence and spread of significant vector borne diseases such as Bluetongue (BT) and Epizootic Hemorrhagic Disease (EHD) at the border between USA and Canada. We used 50 presence points for C. sonorensis collected in Montana (USA) and south-central Alberta (Canada) between 2002 and 2012, together with monthly climatic and environmental predictors to develop a series of alternative maximum entropy distribution models. The best distribution model under current climatic conditions was selected through the Akaike Information Criterion, and included four predictors: Vapour Pressure Deficit of July, standard deviation of Elevation, Land Cover and mean Precipitation of May. This model was then projected into three climate change scenarios adopted by the IPCC in its 5th assessment report and defined as Representative Concentration Pathways (RCP) 2.6, 4.5 and 8.5. Climate change data for each predictor and each RCP were calculated for two time points pooling decadal data around each one of them: 2030 (2021-2040) and 2050 (2041-2060). Our projections showed that the areas predicted to be at moderate-high probability of C. sonorensis occurrence would increase from the baseline scenario to 2030 and from 2030 to 2050 for each RCP. The projection also indicated that the current northern limit of C. sonorensis distribution is expected to move northwards to above 53 degrees N. This may indicate an increased risk of Culicoides-borne diseases occurrence over the next decades, particularly at the USA-Canada border, as a result of changes which favor C. sonorensis presence when associated to other factors (i.e. host and pathogen factors). Recent observations of EHD outbreaks in northern Montana and southern Alberta supported our projections and considerations. The results of this study can inform the development of cost effective surveillance programs, targeting areas within the predicted limits of C. sonorensis geographical occurrence under current and future climatic conditions.	[Zuliani, Anna; Massolo, Alessandro; Berger, Kathryn; Cork, Susan Catherine] Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB, Canada; [Massolo, Alessandro] Univ Calgary, OBrien Inst Publ Hlth, Cumming Sch Med, Calgary, AB, Canada; [Lysyk, Timothy] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Johnson, Gregory] Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA; [Marshall, Shawn] Univ Calgary, Dept Geog, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary; Agriculture & Agri Food Canada; Montana State University System; Montana State University Bozeman; University of Calgary	Massolo, A (corresponding author), Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB, Canada.	amassolo@ucalgary.ca	Cork, Susan/AAG-8820-2020; Massolo, Alessandro/AAO-5344-2021; Lysyk, Timothy/Q-2495-2018; Massolo, Alessandro/I-3437-2012	Cork, Susan/0000-0002-8200-3584; Lysyk, Timothy/0000-0001-7591-0648; Massolo, Alessandro/0000-0002-6333-4281	Faculty of Veterinary Medicine of the University of Calgary	Faculty of Veterinary Medicine of the University of Calgary	The study has been funded by the Faculty of Veterinary Medicine of the University of Calgary through start up funds to SC (stipend for AZ and KB), and to AM (stipend, software and equipment).	Acevedo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014236; Alberta Fish and Wildlife, 2013, HAEM DIS EHD ALB; Baylis M, 2004, VETER ITAL SER, V40, P176; Baylis M, 2001, VET REC, V149, P639, DOI 10.1136/vr.149.21.639; Boyer TC, 2010, AM J TROP MED HYG, V83, P789, DOI 10.4269/ajtmh.2010.10-0132; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chalmers HNV G.A., 1964, J WILDLIFE DIS, V15, P1; Chylek P., 2011, ATMOS CHEM PHYS DISC, V11, P22893, DOI 10.5194/acpd-11-22893-2011; Cooperation CfE, 1997, EC REG N AM COMM PER; de la Roque S, 2008, REV SCI TECH OIE, V27, P339, DOI 10.20506/rst.27.2.1807; De Liberato C, 2010, J MED ENTOMOL, V47, P313, DOI 10.1603/ME09148; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Dulac G. C., 1992, Bluetongue, African horse sickness, and related orbiviruses: Proceedings of the Second International Symposium., P120; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; FAO, 1998, MET DAT CROP EV GUID; Flory AR, 2012, J APPL ECOL, V49, P680, DOI 10.1111/j.1365-2664.2012.02129.x; Gerry AC, 2000, J MED ENTOMOL, V37, P675, DOI 10.1603/0022-2585-37.5.675; Guis H, 2012, J R SOC INTERFACE, V9, P339, DOI 10.1098/rsif.2011.0255; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hay SI, 2000, ADV PARASIT, V47, P1, DOI 10.1016/S0065-308X(00)47005-3; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Johnson CG, 1942, BIOL REV CAMB PHILOS, V17, P151; Kovats RS, 2001, PHILOS T R SOC B, V356, P1057, DOI 10.1098/rstb.2001.0894; Lysyk TJ, 2007, J MED ENTOMOL, V44, P959, DOI 10.1603/0022-2585(2007)44[959:SAPASO]2.0.CO;2; Lysyk TJ, 2007, J MED ENTOMOL, V44, P741, DOI 10.1603/0022-2585(2007)44[741:EOTOLH]2.0.CO;2; Lysyk TJ, 2006, J MED ENTOMOL, V43, P840, DOI 10.1603/0022-2585(2006)43[840:AASCOC]2.0.CO;2; Lysyk TJ, 2014, J MED ENTOMOL, V51, P560, DOI 10.1603/ME13239; MARTENS WJM, 1995, GLOBAL ENVIRON CHANG, V5, P195, DOI 10.1016/0959-3780(95)00051-O; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Miller Myrna M, 2010, J Am Vet Med Assoc, V237, P955, DOI 10.2460/javma.237.8.955; Montana Department of Livestock, 2005, MONT TAK PREC VES ST; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; MULLENS BA, 1987, J MED ENTOMOL, V24, P566, DOI 10.1093/jmedent/24.5.566; MULLENS BA, 1989, J MED ENTOMOL, V26, P559, DOI 10.1093/jmedent/26.6.559; MULLENS BA, 1985, ENVIRON ENTOMOL, V14, P749, DOI 10.1093/ee/14.6.749; Murray KA, 2010, J APPL ECOL, P1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2004, MED VET ENTOMOL, V18, P90, DOI 10.1111/j.0269-283X.2004.00492.x; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Pybus MJ, 2014, J WILDLIFE DIS, V50, P720, DOI 10.7589/2014-02-024; Reisen W. K., 1989, Bulletin of the Society for Vector Ecology, V14, P39; Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874; Rodda GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014670; Rogers DJ, 2006, ADV PARASIT, V62, P1, DOI 10.1016/S0065-308X(05)62001-5; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Ruder MG, VECTOR BORN IN PRESS; Schmidtmann ET, 2011, J MED ENTOMOL, V48, P634, DOI 10.1603/ME10231; Schmidtmann ET, 2000, J MED ENTOMOL, V37, P58, DOI 10.1603/0022-2585-37.1.58; SCHMIDTMANN ET, 1983, ENVIRON ENTOMOL, V12, P768, DOI 10.1093/ee/12.3.768; Sedda L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03361; SHAPIRO JL, 1991, CAN J VET RES, V55, P203; Tol, 1998, UNEP HDB METHODS CLI, P3; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wiken E., 2011, N AM TERRESTRIAL ECO; WILLIAMS GD, 1969, NAT CAN, V96, P621; Wittman EJ, 2001, REV SCI TECH OIE, V20, P731, DOI 10.20506/rst.20.3.1306; Wittmann EJ, 2002, MED VET ENTOMOL, V16, P147, DOI 10.1046/j.1365-2915.2002.00357.x	63	24	24	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0130294	10.1371/journal.pone.0130294	http://dx.doi.org/10.1371/journal.pone.0130294			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301509	Green Published, gold, Green Submitted			2022-12-27	WOS:000359951900002
J	Fischbeck, S; Imruck, BH; Blettner, M; Weyer, V; Binder, H; Zeissig, SR; Emrich, K; Friedrich-Mai, P; Beutel, ME				Fischbeck, Sabine; Imruck, Barbara H.; Blettner, Maria; Weyer, Veronika; Binder, Harald; Zeissig, Sylke R.; Emrich, Katharina; Friedrich-Mai, Peter; Beutel, Manfred E.			Psychosocial Care Needs of Melanoma Survivors: Are They Being Met?	PLOS ONE			English	Article							QUALITY-OF-LIFE; MALIGNANT-MELANOMA; PSYCHOLOGICAL ADJUSTMENT; COPING STRATEGIES; CANCER-PATIENTS; INSTRUMENT; SUPPORT; DEPRESSION; DISTRESS; FATIGUE	Patients who have survived malignant melanoma for more than five years may lack the opportunity to talk about their burden. As a consequence their psychosocial care needs remain undetected and available supportive interventions may not be utilised. Therefore, the psychosocial burden of this patient group needs to be assessed using specific screening instruments. The aim of this study was to investigate the psychosocial burden of long-term melanoma survivors, their psychosocial care needs and the determinants of these needs. We wanted to find out if the use of professional support corresponds to the care needs defined by experts. Using the cancer registry of Rhineland-Palatinate, melanoma patients diagnosed at least 5 years before the survey were contacted by physicians. N = 689 former patients completed the Hornheide Questionnaire (short form HQ-S) to identify psychosocial support need (scale cut off >= 16 or item-based cut-off score) and the potential psychosocial determinants of these needs. Additionally, they were asked about their utilisation of the professional support system. More than one third (36%) of them was in need for professional psychosocial support. The highest burden scores concerned worry about tumour progression. Younger age (<50), higher general fatigue, higher symptom burden, lower general health, negative social interactions and unfulfilled information needs were significant predictors of the need for psychosocial intervention. Related to the percentage of survivors identified as 'in need', the professional support system was underused. Further studies should investigate whether using the HQ-S to routinely identify burdened melanoma patients could lead to better fulfilment of their intervention needs, ultimately enhancing health-related quality of life.	[Fischbeck, Sabine] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy Med Psychol, D-55122 Mainz, Germany; [Imruck, Barbara H.; Friedrich-Mai, Peter; Beutel, Manfred E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, D-55122 Mainz, Germany; [Blettner, Maria; Weyer, Veronika; Binder, Harald] Johannes Gutenberg Univ Mainz, Univ Med Ctr, IMBEI, D-55122 Mainz, Germany; [Zeissig, Sylke R.; Emrich, Katharina] Johannes Gutenberg Univ Mainz, Univ Med Ctr, IMBEI, Canc Registry, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Fischbeck, S (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy Med Psychol, D-55122 Mainz, Germany.	fischbec@uni-mainz.de	Weyer-Elberich, Veronika/AAB-8993-2020; Binder, Harald/C-7413-2009	Binder, Harald/0000-0002-5666-8662	German Cancer Aid DKH [109225]	German Cancer Aid DKH(Deutsche Krebshilfe)	This work was funded by German Cancer Aid DKH Nr. 109225.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Avril MF, 2004, J CLIN ONCOL, V22, P1118, DOI 10.1200/JCO.2004.04.165; Berking C, 2005, HAUTARZT, V56, P687, DOI 10.1007/s00105-005-0984-8; Bermejo I, 2005, PRIMARY CARE COMMUN, V10, P125, DOI 10.1185/135525706X75285; Beutel ME, 2009, HAUTARZT, V60, P727, DOI 10.1007/s00105-009-1814-1; Blum A, 2003, PSYCHOTHER PSYCH MED, V53, P258; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Garbe C, 2008, DTSCH ARZTEBL INT, V105, P845, DOI 10.3238/arztebl.2008.0845; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Hamama-Raz Y, 2007, PSYCHO-ONCOLOGY, V16, P287, DOI 10.1002/pon.1055; Hamama-Raz Y, 2012, PSYCHO-ONCOLOGY, V21, P255, DOI 10.1002/pon.1889; Herschbach P, 2006, ONKOLOGE, V12, P41; Husson O, 2014, PSYCHO-ONCOLOGY, V23, P946, DOI 10.1002/pon.3514; Kasparian NA, 2009, ARCH DERMATOL, V145, P1415, DOI 10.1001/archdermatol.2009.308; Knoll N, 2002, THESIS U BERLIN; Krageloh CU, 2011, RELIGIONS, V2, P216, DOI 10.3390/rel2030216; Lampert T, 2009, KONZEPTE METHODEN, V2, P309; Loewe B, 2007, PSYCHOTHER PSYCH MED, V57; Loquai C, 2014, J EUR ACAD DERMATOL, V28, P1676, DOI 10.1111/jdv.12361; Loquai C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066800; Lowe B, 2004, PSYCHOTHER PSYCHOSOM, V73, P386, DOI 10.1159/000080393; McLoone J, 2012, QUAL HEALTH RES, V22, P1102, DOI 10.1177/1049732312448542; Mehnert A, 2008, J PSYCHOSOM RES, V64, P383, DOI 10.1016/j.jpsychores.2007.12.005; Molenberghs G., 2007, MISSING DATA CLIN ST; Nashan Dorothee, 2004, J Dtsch Dermatol Ges, V2, P105, DOI 10.1046/j.1439-0353.2004.04749.x; Ramm GC, 2003, Z MED PSYCHOL, V12, P29; RKI GEKID, 2012, KREBS DTSCH 2009 201; Schulz KH, 2007, PSYCHOTHER PSYCH MED, V57, P221, DOI 10.1055/s-2006-951954; Schwarz R, 2003, ONKOLOGIE, V26, P140, DOI 10.1159/000069834; Sigurdardottir V, 1996, ACTA ONCOL, V35, P149, DOI 10.3109/02841869609098495; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Sollner W, 1998, PSYCHOTHER PSYCHOSOM, V67, P94; Sollner W, 1996, HAUTARZT, V47, P200, DOI 10.1007/s001050050403; Strittmatter G, 2004, HAUTARZT, V55, P735, DOI 10.1007/s00105-004-0768-6; Strittmatter G, 1998, PSYCHOTHER PSYCH MED, V48, P349; Strittmatter G, 2003, DIAGNOSTISCHE VERFAH, P164; Strittmatter G, 1997, INDIKATION INTERVENT; Trotter Shannon C, 2013, J Clin Aesthet Dermatol, V6, P18; Vodermaier A, 2009, JNCI-J NATL CANCER I, V101, P1464, DOI 10.1093/jnci/djp336; Waldmann Annika, 2011, Cancers (Basel), V3, P2316, DOI 10.3390/cancers3022316; Winzer A, 2009, PSYCHO-ONCOLOGY, V18, P1179, DOI 10.1002/pon.1164; Zschocke I, 2001, THESIS ALBERT LUDWIG	43	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0132754	10.1371/journal.pone.0132754	http://dx.doi.org/10.1371/journal.pone.0132754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26296089	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900005
J	Gong, Z; Martin-Garcia, JM; Daskalova, SM; Craciunescu, FM; Song, LS; Dorner, K; Hansen, DT; Yang, JH; LaBaer, J; Hogue, BG; Mor, TS; Fromme, P				Gong, Zhen; Martin-Garcia, Jose M.; Daskalova, Sasha M.; Craciunescu, Felicia M.; Song, Lusheng; Doerner, Katerina; Hansen, Debra T.; Yang, Jay-How; LaBaer, Joshua; Hogue, Brenda G.; Mor, Tsafrir S.; Fromme, Petra			Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; IMMUNODEFICIENCY-VIRUS TYPE-1; BROADLY NEUTRALIZING ANTIBODIES; C-TERMINAL TAIL; ENVELOPE GLYCOPROTEIN; SECONDARY STRUCTURE; EPITHELIAL TRANSCYTOSIS; LIGHT-SCATTERING; EXTERNAL REGION; SPANNING DOMAIN	The membrane proximal region (MPR, residues 649-683) and transmembrane domain (TMD, residues 684-705) of the gp41 subunit of HIV-1's envelope protein are highly conserved and are important in viral mucosal transmission, virus attachment and membrane fusion with target cells. Several structures of the trimeric membrane proximal external region (residues 662-683) of MPR have been reported at the atomic level; however, the atomic structure of the TMD still remains unknown. To elucidate the structure of both MPR and TMD, we expressed the region spanning both domains, MPR-TM (residues 649-705), in Escherichia coli as a fusion protein with maltose binding protein (MBP). MPR-TM was initially fused to the C-terminus of MBP via a 42 aa-long linker containing a TEV protease recognition site (MBP-linker-MPR-TM). Biophysical characterization indicated that the purified MBP-linker-MPR-TM protein was a monodisperse and stable candidate for crystallization. However, crystals of the MBP-linker-MPR-TM protein could not be obtained in extensive crystallization screens. It is possible that the 42 residue-long linker between MBP and MPR-TM was interfering with crystal formation. To test this hypothesis, the 42 residue-long linker was replaced with three alanine residues. The fusion protein, MBP-AAA-MPR-TM, was similarly purified and characterized. Significantly, both the MBP-linker-MPR-TM and MBP-AAA-MPR-TM proteins strongly interacted with broadly neutralizing monoclonal antibodies 2F5 and 4E10. With epitopes accessible to the broadly neutralizing antibodies, these MBP/MPR-TM recombinant proteins may be in immunologically relevant conformations that mimic a pre-hairpin intermediate of gp41.	[Gong, Zhen; Martin-Garcia, Jose M.; Daskalova, Sasha M.; Doerner, Katerina; Hansen, Debra T.; Yang, Jay-How; LaBaer, Joshua; Fromme, Petra] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Gong, Zhen; Martin-Garcia, Jose M.; Craciunescu, Felicia M.; Doerner, Katerina; Hansen, Debra T.; Yang, Jay-How; Hogue, Brenda G.; Fromme, Petra] Arizona State Univ, Biodesign Inst, Ctr Appl Struct Discovery, Tempe, AZ 85287 USA; [Daskalova, Sasha M.; Hogue, Brenda G.; Mor, Tsafrir S.] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA; [Craciunescu, Felicia M.; Hansen, Debra T.] Arizona State Univ, Biodesign Inst, Ctr Innovat Med, Tempe, AZ 85287 USA; [Song, Lusheng; LaBaer, Joshua] Arizona State Univ, Biodesign Inst, Virginia G Piper Ctr Personalized Diagnost, Tempe, AZ 85287 USA; [Hogue, Brenda G.; Mor, Tsafrir S.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Mor, TS (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA.	tsafrir.mor@asu.edu; pfromme@asu.edu	MARTIN GARCIA, JOSE MANUEL/AAB-6838-2020; Garcia, Jose Manuel Martin/V-2043-2018; MARTIN GARCIA, JOSE MANUEL/GQA-3160-2022; Gong, Zhen/A-6932-2016	MARTIN GARCIA, JOSE MANUEL/0000-0002-4558-3858; Garcia, Jose Manuel Martin/0000-0002-4558-3858; MARTIN GARCIA, JOSE MANUEL/0000-0002-4558-3858; Hogue, Brenda/0000-0002-4545-9208; Hansen, Debra T./0000-0003-4395-8297	PSI: Biology program within the National Institute of General Medical Sciences' Protein Structure Initiative (National Institutes of Health) [U54GM094599]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094599] Funding Source: NIH RePORTER	PSI: Biology program within the National Institute of General Medical Sciences' Protein Structure Initiative (National Institutes of Health); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by PSI: Biology program within the National Institute of General Medical Sciences' Protein Structure Initiative (National Institutes of Health grant number U54GM094599) to PF, TSM, BGH, JL.	Alfsen A, 2002, J BIOL CHEM, V277, P25649, DOI 10.1074/jbc.M200554200; Alfsen A, 2001, J IMMUNOL, V166, P6257, DOI 10.4049/jimmunol.166.10.6257; Andrew P, 2006, ESTIMATION OF MOLECU, P1; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Center RJ, 1998, PROTEIN SCI, V7, P1612, DOI 10.1002/pro.5560070715; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; CHU B, 1970, ANNU REV PHYS CHEM, V21, P145, DOI 10.1146/annurev.pc.21.100170.001045; Cohen T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001085; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Devito C, 2000, J IMMUNOL, V165, P5170, DOI 10.4049/jimmunol.165.9.5170; Do BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089906; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; GABUZDA D, 1991, J ACQ IMMUN DEF SYND, V4, P34; Gong Z, 2014, PROTEIN SCI, V23, P1607, DOI 10.1002/pro.2540; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hamilton MD, 2007, NUCLEIC ACIDS RES, V35, P143, DOI 10.1093/nar/gkl1015; Hollier MJ, 2005, VIROLOGY, V337, P284, DOI 10.1016/j.virol.2005.04.015; Hoo CM, 2008, J NANOPART RES, V10, P89, DOI 10.1007/s11051-008-9435-7; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Ke W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039168; KENNEDY RC, 1986, SCIENCE, V231, P1556, DOI 10.1126/science.3006246; Kobe B, 1999, P NATL ACAD SCI USA, V96, P4319, DOI 10.1073/pnas.96.8.4319; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; Nguyen MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089038; Miyauchi K, 2005, J VIROL, V79, P4720, DOI 10.1128/JVI.79.8.4720-4729.2005; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Newstead S, 2008, PROTEIN SCI, V17, P466, DOI 10.1110/ps.073263108; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Proteau Ariane, 2010, Curr Protoc Protein Sci, VChapter 17, DOI 10.1002/0471140864.ps1710s61; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Puryear WB, 2013, ADV EXP MED BIOL, V762, P131, DOI 10.1007/978-1-4614-4433-6_5; Raran-Kurussi S, 2014, BIOTECHNOL BIOENG, V111, P2407, DOI 10.1002/bit.25317; Reardon PN, 2014, P NATL ACAD SCI USA, V111, P1391, DOI 10.1073/pnas.1309842111; Reuven EM, 2012, BIOCHEMISTRY-US, V51, P2867, DOI 10.1021/bi201721r; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott J.E., 2004, ASSAY GUIDANCE MANUA; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; Shen RZ, 2011, AM J REPROD IMMUNOL, V65, P261, DOI 10.1111/j.1600-0897.2010.00939.x; Shi WX, 2010, J BIOL CHEM, V285, P24290, DOI 10.1074/jbc.M110.111351; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Steckbeck JD, 2013, J GEN VIROL, V94, P1, DOI 10.1099/vir.0.046508-0; Tan MHE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074359; Thao Sandy, 2004, Journal of Structural and Functional Genomics, V5, P267, DOI 10.1007/s10969-004-7148-4; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Tudor D, 2009, MUCOSAL IMMUNOL, V2, P412, DOI 10.1038/mi.2009.89; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	59	4	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136507	10.1371/journal.pone.0136507	http://dx.doi.org/10.1371/journal.pone.0136507			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295457	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900117
J	Huang, LQ				Huang, Liqiang			Statistical Properties Demand as Much Attention as Object Features	PLOS ONE			English	Article							ENSEMBLE STATISTICS; VISUAL-ATTENTION; BOOLEAN MAP; REPRESENTATION; CONSCIOUSNESS; MEMORY; SIZE	Recent studies have argued that the statistical properties of a set of visual items can be extracted with little or even no cost. In the present study, observers (N = 188) performed a color task and an orientation task, and the attention effect was measured as the advantage of pre-cueing one of the two tasks. The color and orientation tasks required participants to report either an object feature or the mean of a 4x4 array (i.e., statistical property). The pre-cueing advantages were approximately equal regardless of the nature of the tasks (object features vs. statistical properties), providing evidence that statistical properties are not perceived with zero cost, but demand as much attention as object features.	Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Huang, LQ (corresponding author), Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China.	lqhuang@psy.cuhk.edu.hk	Huang, Liqiang/A-3228-2008	Huang, Liqiang/0000-0002-0007-9375	Research Grants Council of Hong Kong [446411]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	The sole author (LH) was supported by grant 446411 from the The Research Grants Council of Hong Kong (http://www.ugc.edu.hk/eng/rgc/fund/fund.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2008, PSYCHOL SCI, V19, P392, DOI 10.1111/j.1467-9280.2008.02098.x; Alvarez GA, 2011, TRENDS COGN SCI, V15, P122, DOI 10.1016/j.tics.2011.01.003; Alvarez GA, 2009, P NATL ACAD SCI USA, V106, P7345, DOI 10.1073/pnas.0808981106; Ariely D, 2001, PSYCHOL SCI, V12, P157, DOI 10.1111/1467-9280.00327; Brady TF, 2011, PSYCHOL SCI, V22, P384, DOI 10.1177/0956797610397956; Brady TF, 2009, J EXP PSYCHOL GEN, V138, P487, DOI 10.1037/a0016797; Bronfman ZZ, 2014, PSYCHOL SCI, V25, P1394, DOI 10.1177/0956797614532656; Chong SC, 2003, VISION RES, V43, P393, DOI 10.1016/S0042-6989(02)00596-5; Chong SC, 2005, VISION RES, V45, P891, DOI 10.1016/j.visres.2004.10.004; Chong SC, 2005, PERCEPT PSYCHOPHYS, V67, P1, DOI 10.3758/BF03195009; Choo H, 2010, ATTEN PERCEPT PSYCHO, V72, P86, DOI 10.3758/APP.72.1.86; Cohen MA, 2012, TRENDS COGN SCI, V16, P411, DOI 10.1016/j.tics.2012.06.013; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Huang LQ, 2007, PSYCHOL REV, V114, P599, DOI 10.1037/0033-295X.114.3.599; Huang L, 2007, SCIENCE, V317, P823, DOI 10.1126/science.1143515; Huang LQ, 2010, J EXP PSYCHOL GEN, V139, P162, DOI 10.1037/a0018034; Joo SJ, 2009, J VISION, V9, DOI 10.1167/9.9.7; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; POSNER MI, 1994, P NATL ACAD SCI USA, V91, P7398, DOI 10.1073/pnas.91.16.7398; Sweeny TD, 2014, PSYCHOL SCI, V25, P1903, DOI 10.1177/0956797614544510; Walker D, 2014, PSYCHOL SCI, V25, P230, DOI 10.1177/0956797613497969	22	24	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0131191	10.1371/journal.pone.0131191	http://dx.doi.org/10.1371/journal.pone.0131191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295808	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900003
J	Ming, M; Schirra, C; Becherer, U; Stevens, DR; Rettig, J				Ming, Min; Schirra, Claudia; Becherer, Ute; Stevens, David R.; Rettig, Jens			Behavior and Properties of Mature Lytic Granules at the Immunological Synapse of Human Cytotoxic T Lymphocytes	PLOS ONE			English	Article							CYTOLYTIC GRANULES; SECRETORY VESICLES; CELL-ACTIVATION; FUSION; DOCKING; CAPACITANCE; EXOCYTOSIS; BIOGENESIS; LYSOSOMES; RELEASE	Killing of virally infected cells or tumor cells by cytotoxic T lymphocytes requires targeting of lytic granules to the junction between the CTL and its target. We used whole-cell patch clamp to measure the cell capacitance at fixed intracellular [Ca2+] to study fusion of lytic granules in human CTLs. Expression of a fluorescently labeled human granzyme B construct allowed identification of lytic granule fusion using total internal reflection fluorescence microscopy. In this way capacitance steps due to lytic granule fusion were identified. Our goal was to determine the size of fusing lytic granules and to describe their behavior at the plasma membrane. On average, 5.02 +/- 3.09 (mean +/- s.d.) lytic granules were released per CTL. The amplitude of lytic granule fusion events was similar to 3.3 fF consistent with a diameter of about 325 nm. Fusion latency was biphasic with time constants of 15.9 and 106 seconds. The dwell time of fusing lytic granules was exponentially distributed with a mean dwell time of 28.5 seconds. Fusion ended in spite of the continued presence of granules at the immune synapse. The mobility of fusing granules at themembrane was indistinguishable from that of lytic granules which failed to fuse. While dwelling at the plasma membrane lytic granules exhibit mobility consistent with docking interspersed with short periods of greater mobility. The failure of lytic granules to fuse when visible in TIRF at the membrane may indicate that a membrane-confined reaction is rate limiting.	[Ming, Min; Schirra, Claudia; Becherer, Ute; Stevens, David R.; Rettig, Jens] Univ Saarland, Fac Med, CIPMM, D-66421 Homburg, Germany	Saarland University	Stevens, DR (corresponding author), Univ Saarland, Fac Med, CIPMM, D-66421 Homburg, Germany.	phdste@uks.eu	Becherer, Ute/AGW-2576-2022; Becherer, Ute/F-6711-2010; Rettig, Jens/K-5103-2013	Becherer, Ute/0000-0001-6005-7517; Rettig, Jens/0000-0001-6160-3954; Stevens, David/0000-0003-4651-1706	Deutsche Forschungsgemeinschaft [Re 1092/7-1, SFB 894]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/) (Re 1092/7-1 and SFB 894 to JR).	Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; Becherer U, 2006, CELL TISSUE RES, V326, P393, DOI 10.1007/s00441-006-0243-z; Becherer U, 2012, CELL CALCIUM, V52, P303, DOI 10.1016/j.ceca.2012.04.002; Bertrand F, 2013, P NATL ACAD SCI USA, V110, P6073, DOI 10.1073/pnas.1218640110; Billadeau DD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3121pe16; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Bossi G, 2002, IMMUNOL REV, V189, P152, DOI 10.1034/j.1600-065X.2002.18913.x; BOUGHARIOS G, 1991, HISTOCHEM J, V23, P474, DOI 10.1007/BF01041378; Brown ACN, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001152; BURKHARDT JK, 1990, J CELL BIOL, V111, P2327, DOI 10.1083/jcb.111.6.2327; Choudhuri K, 2010, FEBS LETT, V584, P4823, DOI 10.1016/j.febslet.2010.10.015; Colvin RA, 2010, NAT IMMUNOL, V11, P495, DOI 10.1038/ni.1878; de Saint Basile G, 2010, NAT REV IMMUNOL, V10, P568, DOI 10.1038/nri2803; de Wit H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000126; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Dudenhoffer-Pfeifer M, 2013, TRAFFIC, V14, P798, DOI 10.1111/tra.12074; Dustin ML, 2010, IMMUNOL REV, V235, P24, DOI 10.1111/j.0105-2896.2010.00904.x; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Gillis K. D., 1995, TECHNIQUES MEMBRANE, P155; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; GRIFFITHS GM, 1993, J CELL BIOL, V120, P885, DOI 10.1083/jcb.120.4.885; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Halimani M, 2014, EUR J IMMUNOL, V44, P573, DOI 10.1002/eji.201344011; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; HARTMANN J, 1995, J PHYSIOL-LONDON, V483, P201, DOI 10.1113/jphysiol.1995.sp020578; Henkel AW, 1996, CURR OPIN NEUROBIOL, V6, P350, DOI 10.1016/S0959-4388(96)80119-X; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Krzewski K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00335; Marks MS, 2013, CURR OPIN CELL BIOL, V25, P495, DOI 10.1016/j.ceb.2013.04.008; Marshall MR, 2015, J CELL BIOL, V210, P135, DOI 10.1083/jcb.201411093; Martina JA, 2011, CELL IMMUNOL, V271, P267, DOI 10.1016/j.cellimm.2011.07.004; Matti U, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2467; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Moser T, 1997, P NATL ACAD SCI USA, V94, P6735, DOI 10.1073/pnas.94.13.6735; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Nofal S, 2007, J NEUROSCI, V27, P1386, DOI 10.1523/JNEUROSCI.4714-06.2007; Oheim M, 1998, EUR BIOPHYS J BIOPHY, V27, P83, DOI 10.1007/s002490050114; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; OLSEN I, 1990, EUR J IMMUNOL, V20, P2161, DOI 10.1002/eji.1830201003; Page LJ, 1998, BBA-MOL CELL RES, V1401, P146, DOI 10.1016/S0167-4889(97)00138-9; Pasche M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036416; Pattu V, 2011, TRAFFIC, V12, P890, DOI 10.1111/j.1600-0854.2011.01193.x; PETERS PJ, 1989, EUR J IMMUNOL, V19, P1469, DOI 10.1002/eji.1830190819; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; Pores-Fernando AT, 2009, IMMUNOL REV, V231, P160, DOI 10.1111/j.1600-065X.2009.00809.x; Pores-Fernando AT, 2005, J PHYSIOL-LONDON, V567, P891, DOI 10.1113/jphysiol.2005.089565; Qu B, 2011, J IMMUNOL, V186, P6894, DOI 10.4049/jimmunol.1003471; Sanchez-Ruiz Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027057; Schwarz EC, 2007, EUR J IMMUNOL, V37, P2723, DOI 10.1002/eji.200737039; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Soares H, 2013, J EXP MED, V210, P2415, DOI 10.1084/jem.20130150; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Stinchcombe JC, 2000, TRAFFIC, V1, P435, DOI 10.1034/j.1600-0854.2000.010508.x; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	57	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135994	10.1371/journal.pone.0135994	http://dx.doi.org/10.1371/journal.pone.0135994			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296096	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900059
J	Faillettaz, R; Blandin, A; Paris, CB; Koubbi, P; Irisson, JO				Faillettaz, Robin; Blandin, Agathe; Paris, Claire B.; Koubbi, Philippe; Irisson, Jean-Olivier			Sun-Compass Orientation in Mediterranean Fish Larvae	PLOS ONE			English	Article							CORAL-REEF FISHES; DEMERSAL FISHES; IN-SITU; PELAGIC ENVIRONMENT; SELF-RECRUITMENT; MARINE; BEHAVIOR; TEMPERATE; CONNECTIVITY; SETTLEMENT	Mortality is very high during the pelagic larval phase of fishes but the factors that determine recruitment success remain unclear and hard to predict. Because of their bipartite life history, larvae of coastal species have to head back to the shore at the end of their pelagic episode, to settle. These settlement-stage larvae are known to display strong sensory and motile abilities, but most work has been focused on tropical, insular environments and on the influence of coast-related cues on orientation. In this study we quantified the in situ orientation behavior of settlement- stage larvae in a temperate region, with a continuous coast and a dominant along-shore current, and inspected both coast-dependent and independent cues. We tested six species: one Pomacentridae, Chromis chromis, and five Sparidae, Boops boops, Diplodus annularis, Oblada melanura, Spicara smaris and Spondyliosoma cantharus. Over 85% of larvae were highly capable of keeping a bearing, which is comparable to the orientation abilities of tropical species. Sun-related cues influenced the precision of bearing-keeping at individual level. Three species, out of the four tested in sufficient numbers, oriented significantly relative to the sun position. These are the first in situ observations demonstrating the use of a sun compass for orientation by wild-caught settlement-stage larvae. This mechanism has potential for large-scale orientation of fish larvae globally.	[Faillettaz, Robin; Blandin, Agathe; Irisson, Jean-Olivier] Univ Paris 06, Sorbonne Univ, INSU, CNRS,Lab Oceanog Villefranche, Villefranche Sur Mer, France; [Paris, Claire B.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Ocean Sci, Miami, FL 33149 USA; [Koubbi, Philippe] Univ Paris 06, Sorbonne Univ, Museum Natl Hist Nat, UMR 7208,BOREA, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; University of Miami; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN)	Irisson, JO (corresponding author), Univ Paris 06, Sorbonne Univ, INSU, CNRS,Lab Oceanog Villefranche, Villefranche Sur Mer, France.	irisson@normalesup.org	Faillettaz, Robin/AAR-6709-2020	Faillettaz, Robin/0000-0002-4894-3783; Paris-Limouzy, Claire Beatrix/0000-0002-0637-1334	Partner University Fund; French Ministry for Education and Research [247/2012]; NSF-OTIC [1155698]	Partner University Fund; French Ministry for Education and Research; NSF-OTIC	This work was supported by a grant from the Partner University Fund to JOI and CBP. Institutional support to the Laboratoire d'Oceanographie de Villefranche and Observatoire Oceanologique de Villefranche (for JOI and RF) provided light traps and ship time. RF's doctoral fellowship is provided by the French Ministry for Education and Research (no. 247/2012). NSF-OTIC 1155698 to CBP supported the DISC development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; [Anonymous], 2014, R LANG ENV STAT COMP; Batschelet E, 1981, CIRCULAR STAT BIOL; Berenshtein I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088468; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; Catalan IA, 2014, MEDITERR MAR SCI, V15, P338, DOI 10.12681/mms.539; Codling EA, 2004, MAR ECOL PROG SER, V279, P215, DOI 10.3354/meps279215; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Guidetti P, 2000, ESTUAR COAST SHELF S, V50, P515, DOI 10.1006/ecss.1999.0584; Hegedus R, 2007, J OPT SOC AM A, V24, P2347, DOI 10.1364/JOSAA.24.002347; Hindell JS, 2003, OECOLOGIA, V135, P158, DOI 10.1007/s00442-003-1180-0; Irisson JO, 2009, LIMNOL OCEANOGR-METH, V7, P664, DOI 10.4319/lom.2009.7.664; Irisson JO, 2004, J THEOR BIOL, V227, P205, DOI 10.1016/j.jtbi.2003.10.016; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Leis JM, 2006, ADV MAR BIOL, V51, P57, DOI 10.1016/S0065-2881(06)51002-8; Leis JM, 2014, MAR ECOL PROG SER, V505, P193, DOI 10.3354/meps10792; Leis JM, 2011, INTEGR COMP BIOL, V51, P826, DOI 10.1093/icb/icr004; Leis JM, 2010, ICHTHYOL RES, V57, P325, DOI 10.1007/s10228-010-0177-z; Leis JM, 2006, MAR BIOL, V148, P655, DOI 10.1007/s00227-005-0108-0; Leis JM, 2003, MAR ECOL PROG SER, V252, P239, DOI 10.3354/meps252239; Lo Bianco S., 1931, FAUNA E FLORA DEL GO, V38; Mann DA, 2007, MAR ECOL PROG SER, V338, P307, DOI 10.3354/meps338307; Mouillot D, 2011, CURR BIOL, V21, P1044, DOI 10.1016/j.cub.2011.05.005; Mouritsen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066039; Mussi M, 2005, J EXP BIOL, V208, P3037, DOI 10.1242/jeb.01750; North E.W., 2009, MANUAL RECOMMENDED P, P111; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Paris CB, 2008, CARIBBEAN CONNECTIVI, P54; Paris CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072808; Putman NF, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0979; Raventos N, 2001, MAR BIOL, V138, P1115; Reda I, 2004, SOL ENERGY, V76, P577, DOI 10.1016/j.solener.2003.12.003; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Staaterman E, 2014, ICES J MAR SCI, V71, P918, DOI 10.1093/icesjms/fst103; Staaterman E, 2012, J THEOR BIOL, V304, P188, DOI 10.1016/j.jtbi.2012.03.016; Stemmann L, 2008, J MARINE SYST, V70, P1, DOI 10.1016/j.jmarsys.2007.02.014; Stobutzki IC, 1998, CORAL REEFS, V17, P103, DOI 10.1007/s003380050103; Trnski T, 2002, MAR ECOL PROG SER, V242, P205, DOI 10.3354/meps242205; Vandromme P, 2011, BIOGEOSCIENCES, V8, P3143, DOI 10.5194/bg-8-3143-2011; Vikebo F, 2007, MAR ECOL PROG SER, V347, P207, DOI 10.3354/meps06979; Waterman TH., 1988, P SOC PHOTO-OPT INS, V0925, P431; Wolanski E, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0209	42	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135213	10.1371/journal.pone.0135213	http://dx.doi.org/10.1371/journal.pone.0135213			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308915	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400054
J	Han, YX; Ye, AF; Zhang, Y; Cai, ZM; Wang, W; Sun, L; Jiang, SF; Wu, JB; Yu, K; Zhang, SH				Han, Yixiang; Ye, Aifang; Zhang, Yan; Cai, Zhimin; Wang, Wei; Sun, Lan; Jiang, Songfu; Wu, Jianbo; Yu, Kang; Zhang, Shenghui			Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to Daunorubicin	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; POOR-PROGNOSIS; CELL-FATE; ACTIVATION; APOPTOSIS; GROWTH; MSI2; INHIBITION; EXPRESSION; INDUCTION	RNA-binding protein Musashi-2 (Msi2) is known to play a critical role in leukemogenesis and contributes to poor clinical prognosis in acute myeloid leukemia (AML). However, the effect of Msi2 silencing on treatment for AML still remains poorly understood. In this study, we used lentivirus-mediated RNA interference targeting Msi2 to investigate the resulting changes in cellular processes and the underlying mechanisms in AML cell lines as well as primary AML cells isolated from AML patients. We found that Msi2 was highly expressed in AML cells, and its depletion inhibited Ki-67 expression and resulted in decreased in vitro and in vivo proliferation. Msi2 silencing induced cell cycle arrest in G0/G1 phase, with decreased Cyclin D1 and increased p21 expression. Msi2 silencing induced apoptosis through down-regulation of Bcl-2 expression and up-regulation of Bax expression. Suppression of Akt, Erk1/2 and p38 phosphorylation also contributed to apoptosis mediated by Msi2 silencing. Finally, Msi2 silencing in AML cells also enhanced their chemosensitivity to daunorubicin. Conclusively, our data suggest that Msi2 is a promising target for gene therapy to optimize conventional chemotherapeutics in AML treatment.	[Han, Yixiang; Ye, Aifang; Cai, Zhimin; Wu, Jianbo] Wenzhou Med Univ, Affiliated Hosp 1, Lab Internal Med, Wenzhou 325015, Peoples R China; [Zhang, Yan] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Mol Med, Shanghai 200032, Peoples R China; [Zhang, Yan] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Shanghai 200032, Peoples R China; [Wang, Wei; Sun, Lan; Jiang, Songfu; Yu, Kang; Zhang, Shenghui] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hematol, Wenzhou 325015, Peoples R China	Wenzhou Medical University; Fudan University; Fudan University; Wenzhou Medical University	Zhang, SH (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Hematol, Wenzhou 325015, Peoples R China.	shenghuizhang1@126.com	Zhang, Shenghui/AAI-7388-2021		National Natural Science of Foundation of China [81100355, 81172613, 81300430]; Zhejiang Provincial Natural Science Foundation of China [LQ12H08002, Y2111000]	National Natural Science of Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science of Foundation of China (No.81100355, 81172613, 81300430) and Zhejiang Provincial Natural Science Foundation of China (No. LQ12H08002, Y2111000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly RM, 2015, INT J LAB HEMATOL, V37, P272, DOI 10.1111/ijlh.12284; Burnett AK, 2012, CURR OPIN HEMATOL, V19, P76, DOI 10.1097/MOH.0b013e3283500a92; Byers RJ, 2011, BLOOD, V118, P2857, DOI 10.1182/blood-2011-04-346767; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Fernandez HF, 2009, NEW ENGL J MED, V361, P1249, DOI 10.1056/NEJMoa0904544; Ferrara F, 2013, LANCET, V381, P484, DOI 10.1016/S0140-6736(12)61727-9; Gillies LA, 2014, J CELL BIOCHEM, V115, P632, DOI 10.1002/jcb.24709; Han YX, 2014, CANCER SCI, V105, P933, DOI 10.1111/cas.12459; Han YX, 2010, LEUKEMIA LYMPHOMA, V51, P1337, DOI 10.3109/10428194.2010.488708; He L, 2014, J CELL MOL MED, V18, P49, DOI 10.1111/jcmm.12158; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Minami Y, 2014, CANCER SCI, V105, P1152, DOI 10.1111/cas.12479; Morgan MA, 2001, BLOOD, V97, P1823, DOI 10.1182/blood.V97.6.1823; Mu QT, 2013, LEUKEMIA RES, V37, P922, DOI 10.1016/j.leukres.2013.05.012; Okano H, 2002, J CELL SCI, V115, P1355; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Park S, 2010, HAEMATOL-HEMATOL J, V95, P819, DOI 10.3324/haematol.2009.013797; Park SM, 2015, J CLIN INVEST, V125, P1286, DOI 10.1172/JCI78440; Vo TT, 2012, CELL, V151, P344, DOI 10.1016/j.cell.2012.08.038; Thol F, 2013, ANN HEMATOL, V92, P315, DOI 10.1007/s00277-012-1637-5; Vo DT, 2012, AM J PATHOL, V181, P1762, DOI 10.1016/j.ajpath.2012.07.031; Wang Q, 2013, INT J BIOCHEM CELL B, V45, P2852, DOI 10.1016/j.biocel.2013.09.010; Wang XY, 2013, ONCOTARGET, V4, P739, DOI 10.18632/oncotarget.1034; Wei TYW, 2012, CANCER SCI, V103, P1640, DOI 10.1111/j.1349-7006.2012.02367.x; Wuebben EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034827; Ye CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122712; Zhang HJ, 2014, EXP CELL RES, V320, P119, DOI 10.1016/j.yexcr.2013.09.009; Zhang SH, 2013, J THROMB HAEMOST, V11, P1855, DOI 10.1111/jth.12362; Zhang SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046853	33	23	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136484	10.1371/journal.pone.0136484	http://dx.doi.org/10.1371/journal.pone.0136484			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308531	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400128
J	Hawkins, J; de Vere, N; Griffith, A; Ford, CR; Allainguillaume, J; Hegarty, MJ; Baillie, L; Adams-Groom, B				Hawkins, Jennifer; de Vere, Natasha; Griffith, Adelaide; Ford, Col R.; Allainguillaume, Joel; Hegarty, Matthew J.; Baillie, Les; Adams-Groom, Beverley			Using DNA Metabarcoding to Identify the Floral Composition of Honey: A New Tool for Investigating Honey Bee Foraging Preferences	PLOS ONE			English	Article							FUNGAL COMMUNITIES; POLLEN MORPHOLOGY; BOTANICAL ORIGIN; INSECT VISITS; COLONIES; BIODIVERSITY; EXTRACTION; PLANTS; HYMENOPTERA; EFFICIENT	Identifying the floral composition of honey provides a method for investigating the plants that honey bees visit. We compared melissopalynology, where pollen grains retrieved from honey are identified morphologically, with a DNA metabarcoding approach using the rbcL DNA barcode marker and 454-pyrosequencing. We compared nine honeys supplied by beekeepers in the UK. DNA metabarcoding and melissopalynology were able to detect the most abundant floral components of honey. There was 92% correspondence for the plant taxa that had an abundance of over 20%. However, the level of similarity when all taxa were compared was lower, ranging from 22-45%, and there was little correspondence between the relative abundance of taxa found using the two techniques. DNA metabarcoding provided much greater repeatability, with a 64% taxa match compared to 28% with melissopalynology. DNA metabarcoding has the advantage over melissopalynology in that it does not require a high level of taxonomic expertise, a greater sample size can be screened and it provides greater resolution for some plant families. However, it does not provide a quantitative approach and pollen present in low levels are less likely to be detected. We investigated the plants that were frequently used by honey bees by examining the results obtained from both techniques. Plants with a broad taxonomic range were detected, covering 46 families and 25 orders, but a relatively small number of plants were consistently seen across multiple honey samples. Frequently found herbaceous species were Rubus fruticosus, Filipendula ulmaria, Taraxacum officinale, Trifolium spp., Brassica spp. and the non-native, invasive, Impatiens glandulifera. Tree pollen was frequently seen belonging to Castanea sativa, Crataegus monogyna and species of Malus, Salix and Quercus. We conclude that although honey bees are considered to be supergeneralists in their foraging choices, there are certain key species or plant groups that are particularly important in the honey bees environment. The reasons for this require further investigation in order to better understand honey bee nutritional requirements. DNA metabarcoding can be easily and widely used to investigate floral visitation in honey bees and can be adapted for use with other insects. It provides a starting point for investigating how we can better provide for the insects that we rely upon for pollination.	[Hawkins, Jennifer; de Vere, Natasha; Griffith, Adelaide; Ford, Col R.] Natl Bot Garden Wales, Llanarthne, Carmarthenshire, Wales; [Hawkins, Jennifer; Baillie, Les] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff CF10 3AX, S Glam, Wales; [de Vere, Natasha; Hegarty, Matthew J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Allainguillaume, Joel] Univ W England, Dept Biol Biomed & Analyt Sci, Bristol BS16 1QY, Avon, England; [Adams-Groom, Beverley] Univ Worcester, Natl Pollen & Aerobiol Res Unit, Worcester, MA USA	Cardiff University; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); University of West England	de Vere, N (corresponding author), Natl Bot Garden Wales, Llanarthne, Carmarthenshire, Wales.	natasha.devere@gardenofwales.org.uk	Baillie, Les/AAG-7090-2020	Baillie, Les/0000-0002-8186-223X; de Vere, Natasha/0000-0001-9593-6925; Hegarty, Matthew/0000-0001-6547-3800	Knowledge Economy Skills Scholarship; European Social Fund [08300]; Natural Resources Wales [22694]; National Botanic Garden of Wales	Knowledge Economy Skills Scholarship; European Social Fund(European Social Fund (ESF)); Natural Resources Wales; National Botanic Garden of Wales	This work was supported by the Knowledge Economy Skills Scholarship, European Social Fund, Case ID: 08300 (http://www.higherskillswales.co.uk/kess/) (JH); the Natural Resources Wales, Grant Number: 22694 (http://naturalresourceswales.gov.uk/) (NdV); and the National Botanic Garden of Wales (http://www.gardenofwales.org.uk/) (NdV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeonipekun P, 2012, ASIAN J PLANT SCI RE, V2, P274; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; [Anonymous], IS UKS POLLINATOR BI; Aronne G, 2012, FUNCT ECOL, V26, P1186, DOI 10.1111/j.1365-2435.2012.02017.x; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Beekman M, 2004, FUNCT ECOL, V18, P829, DOI 10.1111/j.0269-8463.2004.00924.x; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Blaalid R, 2012, MOL ECOL, V21, P1897, DOI 10.1111/j.1365-294X.2011.05214.x; Bogdanov Stefan, 1999, Mitteilungen aus Lebensmitteluntersuchung und Hygiene, V90, P108; Borg M, 2011, POLLEN STRUCTURE DEV; Bruni I, 2015, FOOD CHEM, V170, P308, DOI 10.1016/j.foodchem.2014.08.060; Cheng H, 2007, FOOD BIOPROD PROCESS, V85, P141, DOI 10.1205/fbp06056; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; Comba L, 1999, ANN BOT-LONDON, V83, P73, DOI 10.1006/anbo.1998.0798; Comba L, 1999, ANN BOT-LONDON, V83, P369, DOI 10.1006/anbo.1998.0835; Cook A, 1885, FUNGUS SPORES BEE BR, V12, P455; Corbet SA, 2001, ANN BOT-LONDON, V87, P219, DOI 10.1006/anbo.2000.1322; Corbet SA, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P315; Cubey J, 2014, RHS PLANT FINDER 201; de Vere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037945; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Donkersley P, 2014, ECOL EVOL, V4, P4195, DOI 10.1002/ece3.1293; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; FREE JB, 1974, J APPL ECOL, V11, P925, DOI 10.2307/2401754; Galimberti A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109363; Galimberti A, 2013, FOOD RES INT, V50, P55, DOI 10.1016/j.foodres.2012.09.036; Garbuzov M, 2014, BIOSCIENCE, V64, P1019, DOI 10.1093/biosci/biu150; Garbuzov M, 2014, FUNCT ECOL, V28, P364, DOI 10.1111/1365-2435.12178; Gibson J, 2014, P NATL ACAD SCI USA, V111, P8007, DOI 10.1073/pnas.1406468111; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Guertler P, 2014, FOOD CHEM, V149, P302, DOI 10.1016/j.foodchem.2013.10.129; Hajibabaei M, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-28; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hanley ME, 2008, FUNCT ECOL, V22, P592, DOI 10.1111/j.1365-2435.2008.01415.x; HEBDA RJ, 1990, REV PALAEOBOT PALYNO, V64, P103, DOI 10.1016/0034-6667(90)90123-Z; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Howes F.N., 1945, PLANTS BEEKEEPING; Jain SA, 2013, FOOD SCI TECH-BRAZIL, V33, P753, DOI 10.1590/S0101-20612013000400022; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Kajtoch L, 2014, FOLIA BIOL-KRAKOW, V62, P223, DOI 10.3409/fb62_3.223; Kane N, 2012, AM J BOT, V99, P320, DOI 10.3732/ajb.1100570; Keller A, 2015, PLANT BIOLOGY, V17, P558, DOI 10.1111/plb.12251; Khansari E, 2012, FLORA, V207, P203, DOI 10.1016/j.flora.2012.01.006; Kirk W. D., 2012, PLANTS BEES GUIDE PL; Kraaijeveld K, 2015, MOL ECOL RESOUR, V15, P8, DOI 10.1111/1755-0998.12288; Laube I, 2010, FOOD CHEM, V118, P979, DOI 10.1016/j.foodchem.2008.09.063; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; LOUVEAUX J, 1978, BEE WORLD, V59, P139, DOI 10.1080/0005772X.1978.11097714; Madesis P, 2014, FOOD RES INT, V60, P163, DOI 10.1016/j.foodres.2013.10.042; Mao W, 2013, P NATL ACAD SCI USA, V110, P8842, DOI 10.1073/pnas.1303884110; Maurizio A., 1950, BEE WORLD, V31, P9, DOI 10.1080/0005772X.1950.11094617; Mayer C, 2011, POLLINATION ECOLOGY; MOAR NT, 1985, NEW ZEAL J AGR RES, V28, P39, DOI 10.1080/00288233.1985.10426997; Moore P.D., 1991, BLACKWELL SCI PUBLI; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Nelson MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094249; Oddo L., 2004, APIDOLOGIE, V35, pS38, DOI [10.1051/apido:2004049, DOI 10.1051/APIDO:2004049]; Olivieri C, 2012, J FORENSIC SCI, V57, P222, DOI 10.1111/j.1556-4029.2011.01964.x; Pahl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019669; Paudayal KN, 2012, J NATURAL HIST MUSEU, V26, P29; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Poretsky R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093827; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Preston C, 2002, NEW ATLAS BRIT IRISH; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Reille M., 1995, POLLEN SPORES EUROPE; Reille M., 1998, POLLEN SPORES EUR S2; Reille M., 1999, POLLEN SPORES EUROPE; Richardson RT, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1400066; SCHMIDT LS, 1995, J ECON ENTOMOL, V88, P1591, DOI 10.1093/jee/88.6.1591; Schnell IB, 2010, ARTHROPOD-PLANT INTE, V4, P107, DOI 10.1007/s11829-010-9089-0; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Soares S, 2015, FOOD CONTROL, V48, P130, DOI 10.1016/j.foodcont.2014.02.035; Stace C.A., 2010, STACE, V3rd Edn; STANDIFER LN, 1967, INSECT SOC, V14, P415, DOI 10.1007/BF02223687; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Synge A. D., 1947, JOUR ANIMAL ECOL, V16, P122, DOI 10.2307/1492; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Tang M, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku917; Valentini A., 2010, Diversity, V2, P610; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vetrovsky T, 2013, BIOL FERT SOILS, V49, P1027, DOI 10.1007/s00374-013-0801-y; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; von Frisch K., 1967, DANCE LANGUAGE ORIEN; WADDINGTON KD, 1994, BEHAV ECOL SOCIOBIOL, V35, P423, DOI 10.1007/BF00165845; Waiblinger HU, 2012, J VERBRAUCH LEBENSM, V7, P243, DOI 10.1007/s00003-012-0774-z; Wilson EE, 2010, MOL ECOL, V19, P4823, DOI 10.1111/j.1365-294X.2010.04849.x; Wilson MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077512; Winston M.L., 1991, BIOL HONEY BEE	92	135	146	5	165	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134735	10.1371/journal.pone.0134735	http://dx.doi.org/10.1371/journal.pone.0134735			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308362	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000360069400035
J	Larrouy-Maestri, P; Magis, D; Grabenhorst, M; Morsomme, D				Larrouy-Maestri, Pauline; Magis, David; Grabenhorst, Matthias; Morsomme, Dominique			Layman versus Professional Musician: Who Makes the Better Judge?	PLOS ONE			English	Article							TONE-DEAFNESS; SELF-ASSESSMENT; PERFORMANCE; INTERVAL; CONTOUR; PERCEPTION; REPRESENTATION; RECOGNITION; COGNITION; ACCURACY	The increasing number of casting shows and talent contests in the media over the past years suggests a public interest in rating the quality of vocal performances. In many of these formats, laymen alongside music experts act as judges. Whereas experts' judgments are considered objective and reliable when it comes to evaluating singing voice, little is known about laymen's ability to evaluate peers. On the one hand, layman listeners-who by definition did not have any formal training or regular musical practice-are known to have internalized the musical rules on which singing accuracy is based. On the other hand, layman listeners' judgment of their own vocal skills is highly inaccurate. Also, when compared with that of music experts, their level of competence in pitch perception has proven limited. The present study investigates laypersons' ability to objectively evaluate melodies performed by untrained singers. For this purpose, laymen listeners were asked to judge sung melodies. The results were compared with those of music experts who had performed the same task in a previous study. Interestingly, the findings show a high objectivity and reliability in layman listeners. Whereas both the laymen's and experts' definition of pitch accuracy overlap, differences regarding the musical criteria employed in the rating task were evident. The findings suggest that the effect of expertise is circumscribed and limited and supports the view that laypersons make trustworthy judges when evaluating the pitch accuracy of untrained singers.	[Larrouy-Maestri, Pauline; Grabenhorst, Matthias] Max Planck Inst Empir Aesthet, Neurosci Dept, Frankfurt, Germany; [Magis, David] Fonds Rech Sci FNRS, Brussels, Belgium; [Larrouy-Maestri, Pauline; Morsomme, Dominique] Univ Liege, Dept Psychol, Liege, Belgium	Fonds de la Recherche Scientifique - FNRS; University of Liege	Larrouy-Maestri, P (corresponding author), Max Planck Inst Empir Aesthet, Neurosci Dept, Frankfurt, Germany.	Pauline.Larrouy-Maestri@aesthetics.mpg.de						Ackerman PL, 2014, INTELLIGENCE, V45, P6, DOI 10.1016/j.intell.2013.04.009; BESSON M, 1995, J EXP PSYCHOL HUMAN, V21, P1278, DOI 10.1037/0096-1523.21.6.1278; Bigand E, 2006, COGNITION, V100, P100, DOI 10.1016/j.cognition.2005.11.007; Bigand E, 2010, MUSIQUE LANGAGE EMOT, P35; Bunch M, 2000, J VOICE, V14, P363, DOI 10.1016/S0892-1997(00)80081-8; Burson KA, 2006, J PERS SOC PSYCHOL, V90, P60, DOI 10.1037/0022-3514.90.1.60; Butkovic A, 2015, PERS INDIV DIFFER, V74, P133, DOI 10.1016/j.paid.2014.10.006; Cross I, 2001, ANN NY ACAD SCI, V930, P28, DOI 10.1111/j.1749-6632.2001.tb05723.x; Cuddy LL, 2005, ANN NY ACAD SCI, V1060, P311, DOI 10.1196/annals.1360.026; Davidson JW, 1996, BRIT J DEV PSYCHOL, V14, P399, DOI 10.1111/j.2044-835X.1996.tb00714.x; DOWLING WJ, 1971, J ACOUST SOC AM, V49, P524, DOI 10.1121/1.1912382; EDWORTHY J, 1985, MUSIC PERCEPT, V2, P375; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Fiske Harold E, 1978, ONTARIO ED RES COUNC; FISKE HE, 1977, J RES MUSIC EDUC, V25, P256, DOI 10.2307/3345266; FISKE HE, 1975, J RES MUSIC EDUC, V23, P186, DOI 10.2307/3344643; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Gebel B, 2013, NEUROIMAGE, V74, P37, DOI 10.1016/j.neuroimage.2013.02.021; Hambrick DZ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00751; Hambrick DZ, 2014, INTELLIGENCE, V45, P34, DOI 10.1016/j.intell.2013.04.001; Hannon E, 2007, TRENDS COGN SCI; Haueisen J, 2001, J COGNITIVE NEUROSCI, V13, P786, DOI 10.1162/08989290152541449; Hutchins S, 2012, MUSIC PERCEPT, V30, P147, DOI 10.1525/MP.2012.30.2.147; Hutchins S, 2012, J EXP PSYCHOL GEN, V141, P76, DOI 10.1037/a0025064; Jonaitis EM, 2009, COGNITIVE SCI, V33, P951, DOI 10.1111/j.1551-6709.2009.01036.x; Kajihara T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00349; Kinney DW, 2009, J RES MUSIC EDUC, V56, P322, DOI 10.1177/0022429408328934; Koelsch S, 2007, PSYCHOPHYSIOLOGY, V44, P476, DOI 10.1111/j.1469-8986.2007.00517.x; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Larrouy-Maestri P, 2015, 9 TRIENN EUR SOC COG; Larrouy-Maestri P, 2014, J VOICE, V28, DOI 10.1016/j.jvoice.2013.10.019; Larrouy-Maestri P, 2014, LOGOP PHONIATR VOCO, V39, P11, DOI 10.3109/14015439.2012.696139; Larrouy-Maestri P, 2013, J VOICE, V27, DOI 10.1016/j.jvoice.2012.11.003; Lee H, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00868; Lehmann A. C., 1997, PSYCHOMUSICOLOGY, V16, P40, DOI DOI 10.1037/H0094068; Lehmann AC, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P457; Lerdahl F., 1983, GENERATIVE THEORY TO; Loui P, 2010, MUSIC PERCEPT, V27, P377, DOI 10.1525/mp.2010.27.5.377; Marmel F, 2008, PERCEPT PSYCHOPHYS, V70, P841, DOI 10.3758/PP.70.5.841; McPherson G.E., 2002, NEW HDB RES MUSIC TE, P327; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; MOORE BCJ, 1973, J ACOUST SOC AM, V54, P610, DOI 10.1121/1.1913640; Morrison SJ, 2004, J RES MUSIC EDUC, V52, P116, DOI 10.2307/3345434; Mosing MA, 2014, PSYCHOL SCI, V25, P1795, DOI 10.1177/0956797614541990; Mullensiefan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089642; Novembre G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00603; Parker ZJ, 2015, BEHAV RES THER, V66, P1, DOI 10.1016/j.brat.2014.12.010; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Pfordresher PQ, 2007, MUSIC PERCEPT, V25, P95, DOI 10.1525/MP.2007.25.2.95; Pfordresher PQ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00271; Platz F, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00646; Plomin R, 2014, INTELLIGENCE, V45, P46, DOI 10.1016/j.intell.2013.06.008; Racette A, 2006, BRAIN, V129, P2571, DOI 10.1093/brain/awl250; Ringer AL, 2002, MELODY DEFINITION OR; Russo FA, 2005, PERCEPT PSYCHOPHYS, V67, P559, DOI 10.3758/BF03193514; Schellenberg EG, 2013, PSYCHOLOGY OF MUSIC, THIRD EDITION, P499, DOI 10.1016/B978-0-12-381460-9.00012-2; Schellenberg EG, 2010, PSYCHOL MUSIC, V38, P209, DOI 10.1177/0305735609339473; Schon D, 2004, PSYCHOPHYSIOLOGY, V41, P341, DOI 10.1111/1469-8986.00172.x; Simonton D. K., 2011, WILEY BLACKWELL HDB, P635; Sloboda JA, 2005, ANN NY ACAD SCI, V1060, P255, DOI 10.1196/annals.1360.018; Stalinski SM, 2008, J ACOUST SOC AM, V124, P1759, DOI 10.1121/1.2956470; Stalinski SM, 2012, TOP COGN SCI, V4, P485, DOI 10.1111/j.1756-8765.2012.01217.x; Strait DL, 2010, HEARING RES, V261, P22, DOI 10.1016/j.heares.2009.12.021; Tervaniemi M, 2005, EXP BRAIN RES, V161, P1, DOI 10.1007/s00221-004-2044-5; Trainor LJ, 2012, ANN NY ACAD SCI, V1252, P129, DOI 10.1111/j.1749-6632.2012.06462.x; Trainor LJ, 2005, DEV PSYCHOBIOL, V46, P262, DOI 10.1002/dev.20059; TRAINOR LJ, 1992, J EXP PSYCHOL HUMAN, V18, P394, DOI 10.1037/0096-1523.18.2.394; Tsay CJ, 2013, P NATL ACAD SCI USA, V110, P14580, DOI 10.1073/pnas.1221454110; Vurma A, 2011, PSYCHOL MUSIC, V39, P291, DOI 10.1177/0305735610373602; Walfish S, 2012, PSYCHOL REP, V110, P639, DOI 10.2466/02.07.17.PR0.110.2.639-644; WAPNICK J, 1993, J RES MUSIC EDUC, V41, P282, DOI 10.2307/3345504; Warrier CM, 2002, PERCEPT PSYCHOPHYS, V64, P198, DOI 10.3758/BF03195786; Watts C, 2003, J VOICE, V17, P298, DOI 10.1067/S0892-1997(03)00068-7; Wise KJ, 2008, MUSIC SCI, V12, P3, DOI 10.1177/102986490801200102; Wise KJ, 2007, BRIT ACAD REV, P52; Zarate JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075410	76	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135394	10.1371/journal.pone.0135394	http://dx.doi.org/10.1371/journal.pone.0135394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CP7LO	26308213	Green Published, gold			2022-12-27	WOS:000360069400060
J	Pachahara, SK; Adicherla, H; Nagaraj, R				Pachahara, Sanjai Kumar; Adicherla, Harikrishna; Nagaraj, Ramakrishnan			Self-Assembly of A beta 40, A beta 42 and A beta 43 Peptides in Aqueous Mixtures of Fluorinated Alcohols	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDE; ALZHEIMER-DISEASE BRAINS; ATOMIC-FORCE MICROSCOPY; FIBRIL FORMATION; CONFORMATIONAL TRANSITION; PROTEIN FIBRILLOGENESIS; SUBSTITUTED ALCOHOLS; TRANSGENIC MICE; IN-VITRO; AGGREGATION	Fluorinated alcohols such as hexafluoroisopropanol (HFIP) and trifluoroethanol (TFE) have the ability to promote alpha-helix and beta-hairpin structure in proteins and peptides. HFIP has been used extensively to dissolve various amyloidogenic proteins and peptides including A beta, in order to ensure their monomeric status. In this paper, we have investigated the self-assembly of A beta 40, A beta 42, and A beta 43 in aqueous mixtures of fluorinated alcohols from freshly dissolved stock solutions in HFIP. We have observed that formation of fibrillar and non-fibrillar structures are dependent on the solvent composition. Peptides form fibrils with ease when reconstituted in deionized water from freshly dissolved HFIP stocks. In aqueous mixtures of fluorinated alcohols, either predominant fibrillar structures or clustered aggregates were observed. Aqueous mixtures of 20% HFIP are more favourable for A beta fibril formation as compared to 20% TFE. When A beta 40, A beta 42, and A beta 43 stocks in HFIP are diluted in 50% aqueous mixtures in phosphate buffer or deionized water followed by slow evaporation of HFIP, A beta peptides form fibrils in phosphate buffer and deionized water. The clustered structures could be off-pathway aggregates. A beta 40, A beta 42, and A beta 43 showed significant alpha-helical content in freshly dissolved HFIP stocks. The alpha-helical conformational intermediate in A beta 40, A beta 42, and A beta 43 could favour the formation of both fibrillar and non-fibrillar aggregates depending on solvent conditions and rate of alpha-helical to beta-sheet transition.	[Pachahara, Sanjai Kumar; Adicherla, Harikrishna; Nagaraj, Ramakrishnan] CSIR Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Nagaraj, R (corresponding author), CSIR Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	nraj@ccmb.res.in			Council of Scientific & Industrial Research, India [BSC 112]; JC Bose Fellowship, Department of Science and Technology, India [SR/S2/JCB-40/2010]	Council of Scientific & Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); JC Bose Fellowship, Department of Science and Technology, India	This work was supported by BSC 112, Council of Scientific & Industrial Research, India (RN), and JC Bose Fellowship, SR/S2/JCB-40/2010 Department of Science and Technology, India (RN).	Abelein A, 2014, J BIOL INORG CHEM, V19, P623, DOI 10.1007/s00775-014-1131-8; Anderson VL, 2010, P NATL ACAD SCI USA, V107, P18850, DOI 10.1073/pnas.1012336107; Arimon M, 2005, FASEB J, V19, P1344, DOI 10.1096/fj.04-3137fje; Baine M, 2009, J PEPT SCI, V15, P499, DOI 10.1002/psc.1150; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bhowmik D, 2014, PHYS CHEM CHEM PHYS, V16, P885, DOI 10.1039/c3cp54151g; Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960; Broersen K, 2011, PROTEIN ENG DES SEL, V24, P743, DOI 10.1093/protein/gzr020; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Chalifour RJ, 2003, J BIOL CHEM, V278, P34874, DOI 10.1074/jbc.M212694200; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Cohen T, 2006, BIOCHEMISTRY-US, V45, P4727, DOI 10.1021/bi051525c; Dai XL, 2010, J MOL NEUROSCI, V41, P66, DOI 10.1007/s12031-009-9282-8; De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com; Durairajan SSK, 2008, NEUROCHEM INT, V52, P741, DOI 10.1016/j.neuint.2007.09.006; Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200; Frydman-Marom A, 2011, ACS CHEM BIOL, V6, P1265, DOI 10.1021/cb200103h; Fulop L, 2006, NANOPAGES, V1, P69, DOI DOI 10.1556/NANO.1.2006.1.3.; Funke SA, 2010, ACS CHEM NEUROSCI, V1, P639, DOI 10.1021/cn100057j; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Gordon DJ, 2001, BIOCHEMISTRY-US, V40, P8237, DOI 10.1021/bi002416v; Gordon DJ, 2003, BIOCHEMISTRY-US, V42, P475, DOI 10.1021/bi0259857; Green JD, 2004, J BIOL CHEM, V279, P12206, DOI 10.1074/jbc.M312452200; Gupta-Bansal R, 1998, J NEUROCHEM, V70, P292; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hirota N, 1997, PROTEIN SCI, V6, P416; Hong DP, 1999, J AM CHEM SOC, V121, P8427, DOI 10.1021/ja990833t; Hubin E, 2014, CELL MOL LIFE SCI, V71, P3507, DOI 10.1007/s00018-014-1634-z; Jagota S, 2012, INT J PEPT RES THER, V18, P53, DOI 10.1007/s10989-011-9278-4; Jakob-Roetne R, 2009, ANGEW CHEM INT EDIT, V48, P3030, DOI 10.1002/anie.200802808; Janek K, 2001, BIOCHEMISTRY-US, V40, P5457, DOI 10.1021/bi002005e; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kanno T, 2005, J STRUCT BIOL, V149, P213, DOI 10.1016/j.jsb.2004.11.008; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lasagna-Reeves CA, 2011, J BIOL CHEM, V286, P22122, DOI 10.1074/jbc.M111.236257; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LeVine H, 2002, ARCH BIOCHEM BIOPHYS, V404, P106; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mastrangelo IA, 2006, J MOL BIOL, V358, P106, DOI 10.1016/j.jmb.2006.01.042; McLaurin J, 2000, J STRUCT BIOL, V130, P259, DOI 10.1006/jsbi.2000.4289; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; Nichols MR, 2005, J BIOL CHEM, V280, P2471, DOI 10.1074/jbc.M410553200; Pachahara Sanjai Kumar, 2015, Biochem Biophys Rep, V2, P1, DOI 10.1016/j.bbrep.2015.04.005; Pachahara SK, 2012, J PEPT SCI, V18, P233, DOI 10.1002/psc.2391; Padrick SB, 2002, BIOCHEMISTRY-US, V41, P4694, DOI 10.1021/bi0160462; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Poduslo JF, 2012, BIOCHEMISTRY-US, V51, P3993, DOI 10.1021/bi300275g; Powers ET, 2008, BIOPHYS J, V94, P379, DOI 10.1529/biophysj.107.117168; Rasool S, 2013, MOL NEUROBIOL, V48, P931, DOI 10.1007/s12035-013-8478-7; Rasool S, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-37; Rezaei-Ghaleh N, 2014, J AM CHEM SOC, V136, P4913, DOI 10.1021/ja411707y; Robb E, 2015, J ALZHEIMERS DIS, V44, P69, DOI 10.3233/JAD-132024; Ryan TM, 2013, PEERJ, V1, DOI 10.7717/peerj.73; Ryu J, 2008, BIOCHEMISTRY-US, V47, P5328, DOI 10.1021/bi800012e; Sabate R, 2005, J PHYS CHEM B, V109, P11027, DOI 10.1021/jp050716m; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Shin TM, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-16; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; Vandersteen A, 2012, FEBS LETT, V586, P4088, DOI 10.1016/j.febslet.2012.10.022; Vandersteen A, 2012, J BIOL CHEM, V287, P36732, DOI 10.1074/jbc.M112.394635; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Ward RV, 2000, BIOCHEM J, V348, P137, DOI 10.1042/0264-6021:3480137; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Wetzel R, 2007, BIOCHEMISTRY-US, V46, P1, DOI 10.1021/bi0620959; Wood SJ, 1996, J MOL BIOL, V256, P870, DOI 10.1006/jmbi.1996.0133; Yamaguchi K, 2006, J MOL BIOL, V363, P279, DOI 10.1016/j.jmb.2006.08.030; Yu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020575, 10.1371/journal.pone.0028680]	74	14	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136567	10.1371/journal.pone.0136567	http://dx.doi.org/10.1371/journal.pone.0136567			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308214	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400138
J	Pal, SK; Lin, YI; Yuh, B; DeWalt, K; Kazarian, A; Vogelzang, N; Nelson, RA				Pal, Sumanta Kumar; Lin, Yulan Ingrid; Yuh, Bertram; DeWalt, Kara; Kazarian, Austin; Vogelzang, Nicholas; Nelson, Rebecca A.			Conditional Survival in de novo Metastatic Urothelial Carcinoma	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; PHASE-II TRIAL; 1ST-LINE TREATMENT; GEMCITABINE; THERAPY; CISPLATIN; CANCER; CHEMOTHERAPY; COMBINATION; CARBOPLATIN	Background Second-line therapy is frequently utilized for metastatic urothelial carcinoma, but there are limited data to guide this approach. While an assessment of overall survival based on registry data may not capture the impact of second-and third-line therapies on clinical outcome, this may be reflected in relative conditional survival (RCS). Methods Patients with stage IV urothelial carcinoma diagnosed from 1990-2010 were identified from the Surveillance, Epidemiology and End Results (SEER) dataset. The association of clinicopathologic variables with disease specific survival (DSS) was explored through univariate and multivariate analyses. DSS in subgroups divided by time period (1990-2000 v 2001-2010) was compared using the Kaplan-Meier method and log-rank test. One-year RCS at annual landmarks up to 5 years was compared in subgroups divided by time period. Results Of 261,987 patients diagnosed with urothelial carcinoma from 1990-2010, 3,110 patients met criteria for the current analysis. Characteristics of patients diagnosed between 1990 and 2000 (n = 810) and 2001 to 2010 (n = 2,300) were similar and there was no significant difference in DSS between the two groups. On multivariate analysis, older age (age >= 80) was associated with shorter DSS (HR 1.79, 95% CI 1.48-2.15), but no association was found between time period of diagnosis and outcome. One-year RCS improved substantially through successive annual landmarks up to 5 years, but no differences were seen in subgroups divided by time of diagnosis. Conclusions No difference in RCS was observed amongst patients with stage IV urothelial carcinoma diagnosed from 1990-2000 and 2001-2010. A lack of difference in RCS (more so than cumulative DSS) may reflect a lack of progress in salvage therapies for the disease.	[Pal, Sumanta Kumar; Lin, Yulan Ingrid; DeWalt, Kara; Kazarian, Austin] City Hope Comprehens Canc Ctr, Dept Med Oncol & Expt Therapeut, Duarte, CA USA; [Yuh, Bertram] City Hope Comprehens Canc Ctr, Dept Surg, Div Urol, Duarte, CA USA; [Vogelzang, Nicholas] US Oncol Res, Ctr Comprehens Canc, Las Vegas, NV USA; [Nelson, Rebecca A.] City Hope Comprehens Canc Ctr, Dept Informat Sci, Div Biostat, Duarte, CA USA	City of Hope; City of Hope; US Oncology Network; City of Hope	Pal, SK (corresponding author), City Hope Comprehens Canc Ctr, Dept Med Oncol & Expt Therapeut, Duarte, CA USA.	spal@coh.org			NIH [K12 2K12CA001727-16A1]; NATIONAL CANCER INSTITUTE [K12CA001727] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH K12 2K12CA001727-16A1 (to S.K.P.) (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abida W, 2015, HEMATOL ONCOL CLIN N, V29, P319, DOI 10.1016/j.hoc.2014.10.005; Bajorin DF, 1999, J CLIN ONCOL, V17, P3173, DOI 10.1200/JCO.1999.17.10.3173; Bamias A, 2006, CANCER, V106, P297, DOI 10.1002/cncr.21604; Bellmunt J, 2009, J CLIN ONCOL, V27, P4454, DOI 10.1200/JCO.2008.20.5534; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; Dreicer R, 2008, CANCER-AM CANCER SOC, V112, P2671, DOI 10.1002/cncr.23503; Fechner G, 2006, INT J CLIN PRACT, V60, P27, DOI 10.1111/j.1368-5031.2005.00663.x; Galsky MD, 2013, CANCER-AM CANCER SOC, V119, P3012, DOI 10.1002/cncr.28146; Galsky MD, 2011, LANCET ONCOL, V12, P211, DOI 10.1016/S1470-2045(10)70275-8; Galsky MD, 2013, J CLIN ONCOL, V31; Gitlitz BJ, 2003, CANCER-AM CANCER SOC, V98, P1863, DOI 10.1002/cncr.11726; Gondo T, 2011, INT J CLIN ONCOL, V16, P345, DOI 10.1007/s10147-011-0188-4; Grivas P, 2012, J CLIN ONCOL, V30; Hahn NM, 2011, J CLIN ONCOL, V29, P1525, DOI 10.1200/JCO.2010.31.6067; Harshman LC, 2012, LANCET ONCOL, V13, P927, DOI 10.1016/S1470-2045(12)70285-1; Linardou H, 2004, UROLOGY, V64, P479, DOI 10.1016/j.urology.2004.04.024; OSTROW S, 1980, CANCER, V46, P1715, DOI 10.1002/1097-0142(19801015)46:8<1715::AID-CNCR2820460802>3.0.CO;2-H; Pal SK, 2013, J NATL COMPR CANC NE, V11, P793, DOI 10.6004/jnccn.2013.0101; Ploussard G, 2014, EUR UROL, V66, P361, DOI 10.1016/j.eururo.2013.09.050; Pond GR, 2014, BJU INT, V113, pE137, DOI 10.1111/bju.12564; Rossof AH, CANC TREAT REP, V63, P1605; Rossof AH, CANC TREAT REP, V63, P557; Sonpavde G, 2010, LANCET ONCOL, V11, P861, DOI 10.1016/S1470-2045(10)70086-3; Srinivas S, 2009, CHEMOTHERAPY, V55, P321, DOI 10.1159/000230695; Sun M, 2012, EUR J CANCER, V48, P1503, DOI 10.1016/j.ejca.2011.11.024; Surveillance E, SEER STAT DAT MORT A; Sweeney CJ, 2006, J CLIN ONCOL, V24, P3451, DOI 10.1200/JCO.2005.03.6699; YAGODA A, 1976, CANCER TREAT REP, V60, P917	28	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136622	10.1371/journal.pone.0136622	http://dx.doi.org/10.1371/journal.pone.0136622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308952	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400145
J	Zhou, JM; Yang, X; Lu, QY; Liu, F				Zhou, Jianming; Yang, Xiao; Lu, Qiuyuan; Liu, Fan			A Novel Low-Ringing Monocycle Picosecond Pulse Generator Based on Step Recovery Diode	PLOS ONE			English	Article							ULTRA-WIDE-BAND; UWB APPLICATIONS; RADAR	This paper presents a high-performance low-ringing ultra-wideband monocycle picosecond pulse generator, formed using a step recovery diode (SRD), simulated in ADS software and generated through experimentation. The pulse generator comprises three parts, a step recovery diode, a field-effect transistor and a Schottky diode, used to eliminate the positive and negative ringing of pulse. Simulated results validate the design. Measured results indicate an output waveform of 1.88 peak-to-peak amplitude and 307ps pulse duration with a minimal ringing of -22.5 dB, providing good symmetry and low level of ringing. A high degree of coordination between the simulated and measured results is achieved.	[Zhou, Jianming; Yang, Xiao; Lu, Qiuyuan; Liu, Fan] Beijing Inst Technol, Sch Informat & Elect, Beijing 100081, Peoples R China	Beijing Institute of Technology	Zhou, JM (corresponding author), Beijing Inst Technol, Sch Informat & Elect, Beijing 100081, Peoples R China.	zhoujm@bit.edu.cn	Liu, Fan/U-1728-2019	Liu, Fan/0000-0002-5299-9317	Chinese Defence Advance Research Program of Science and Technology, China [40405050402, 40402040101-4, 51307020202]	Chinese Defence Advance Research Program of Science and Technology, China	Project supported by the Chinese Defence Advance Research Program of Science and Technology, China (Grant No. 40405050402, 40402040101-4 and 51307020202).	Andrews JR, 2003, IEEE TOP C WIR COMM, V15-17, P439, DOI [10.1109/WCT.2003.1321594, DOI 10.1109/WCT.2003.1321594]; Benedetto A, 2005, IEEE SENS J, V5, P471, DOI 10.1109/JSEN.2005.846176; De Angelis A, 2009, IEEE T INSTRUM MEAS, V58, P3935, DOI 10.1109/TIM.2009.2020834; Gerding M., 2004, ADV RADIO SCI, V2, P7, DOI DOI 10.5194/ARS-2-7-2004; Han J, 2006, IEEE T MICROW THEORY, V54, P285, DOI 10.1109/TMTT.2005.860299; Han J, 2005, IEEE T MICROW THEORY, V53, P1875, DOI 10.1109/TMTT.2005.848091; Han JW, 2002, IEEE MICROW WIREL CO, V12, P206, DOI 10.1109/LMWC.2002.1009996; Kamal A, 2014, MICROW OPT TECHN LET, V56, P2289, DOI 10.1002/mop.28581; Lee JS, 2001, IEEE T MICROW THEORY, V49, P1126, DOI 10.1109/22.925501; Liu BS, 2012, ADV MAT RES, V588-589, P781, DOI [10.4028/www.scientific.net/AMR.588-589.781, DOI 10.4028/WWW.SCIENTIFIC.NET/AMR.588-589.781]; Ma TG, 2007, MICROW OPT TECHN LET, V49, P459, DOI 10.1002/mop.22145; Protiva P, 2010, MICROW OPT TECHN LET, V52, P438, DOI 10.1002/mop.24945; Teshirogi T, 2005, ELECTRON LETT, V41, P535, DOI 10.1049/el:20050604; Xia T, 2012, IEEE T INSTRUM MEAS, V61, P261, DOI 10.1109/TIM.2011.2161022; YU RY, 1994, IEEE MICROW GUIDED W, V4, P220, DOI 10.1109/75.298246; Zhou JM, 2006, IEICE ELECTRON EXPR, V3, P534, DOI 10.1587/elex.3.534	16	7	7	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136287	10.1371/journal.pone.0136287	http://dx.doi.org/10.1371/journal.pone.0136287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308450	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400101
J	Hardy, L; Jespers, V; Dahchour, N; Mwambarangwe, L; Musengamana, V; Vaneechoutte, M; Crucitti, T				Hardy, Liselotte; Jespers, Vicky; Dahchour, Nassira; Mwambarangwe, Lambert; Musengamana, Viateur; Vaneechoutte, Mario; Crucitti, Tania			Unravelling the Bacterial Vaginosis-Associated Biofilm: A Multiplex Gardnerella vaginalis and Atopobium vaginae Fluorescence In Situ Hybridization Assay Using Peptide Nucleic Acid Probes	PLOS ONE			English	Article							RAPID DETECTION; METRONIDAZOLE THERAPY; QUANTIFICATION; SUSCEPTIBILITY; IDENTIFICATION; ENUMERATION; MICROFLORA; DIAGNOSIS; FIXATION; SUGGESTS	Bacterial vaginosis (BV), a condition defined by increased vaginal discharge without significant inflammation, is characterized by a change in the bacterial composition of the vagina. Lactobacillus spp., associated with a healthy vaginal microbiome, are outnumbered by BV-associated organisms. These bacteria could form a polymicrobial biofilm which allows them to persist in spite of antibiotic treatment. In this study, we examined the presence of Gardnerella vaginalis and Atopobium vaginae in vaginal biofilms using Peptide Nucleic Acid (PNA) probes targeting these bacteria. For this purpose, we developed three new PNA probes for A. vaginae. The most specific A. vaginae probe, AtoITM1, was selected and then used in an assay with two existing probes, Gard162 and BacUni-1, to evaluate multiplex FISH on clinical samples. Using quantitative polymerase chain reaction (qPCR) as the gold standard, we demonstrated a sensitivity of 66.7% (95% confidence interval: 54.5% - 77.1%) and a specificity of 89.4% (95% confidence interval: 76.1% - 96%) of the new AtoITM1 probe. FISH enabled us to show the presence of a polymicrobial biofilm in bacterial vaginosis, in which Atopobium vaginae is part of a Gardnerella vaginalis-dominated biofilm. We showed that the presence of this biofilm is associated with high bacterial loads of A. vaginae and G. vaginalis.	[Hardy, Liselotte; Jespers, Vicky] Inst Trop Med, Dept Publ Hlth, Unit Epidemiol & Control HIV STD, B-2000 Antwerp, Belgium; [Hardy, Liselotte; Vaneechoutte, Mario] Univ Ghent, Fac Med & Hlth Sci, Lab Bacteriol Res, B-9000 Ghent, Belgium; [Hardy, Liselotte; Dahchour, Nassira; Crucitti, Tania] Inst Trop Med, Dept Clin Sci, STI Reference Lab, B-2000 Antwerp, Belgium; [Dahchour, Nassira] Plantijn Hgsk, Antwerp, Belgium; [Mwambarangwe, Lambert; Musengamana, Viateur] Rinda Ubuzima, Kigali, Rwanda	Institute of Tropical Medicine (ITM); Ghent University; Institute of Tropical Medicine (ITM)	Hardy, L (corresponding author), Inst Trop Med, Dept Publ Hlth, Unit Epidemiol & Control HIV STD, B-2000 Antwerp, Belgium.	liselotte.hardy@gmail.com	Vaneechoutte, Mario/A-6189-2009; Crucitti, Tania/AAB-9967-2019; Hardy, Liselotte/AAF-3515-2019; Crucitti, Tania/AAH-1902-2021; Crucitti, Tania/AEQ-9792-2022	Vaneechoutte, Mario/0000-0002-4586-203X; Crucitti, Tania/0000-0002-2235-6038; Crucitti, Tania/0000-0002-2235-6038; Hardy, Liselotte/0000-0002-8785-5081	European and Developing Countries Clinical Trials Partnership [SP.2011.41304.043]; Combined Highly Active Anti-Retroviral Microbicides under EU [FP7: 242135]; Dormeur Investment Service Ltd.	European and Developing Countries Clinical Trials Partnership; Combined Highly Active Anti-Retroviral Microbicides under EU; Dormeur Investment Service Ltd.	Funding was received by TC from European and Developing Countries Clinical Trials Partnership: SP.2011.41304.043, http://www.edctp.org/; by VJ from Combined Highly Active Anti-Retroviral Microbicides under EU FP7: 242135, http://cordis.europa.eu/fp7/home_en.html; and by VJ from Dormeur Investment Service Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Bradshaw CS, 2006, J INFECT DIS, V194, P828, DOI 10.1086/506621; Bradshaw DJ, 1998, INFECT IMMUN, V66, P4729, DOI 10.1128/IAI.66.10.4729-4732.1998; Burton JP, 2004, J CLIN MICROBIOL, V42, P1829, DOI 10.1128/JCM.42.4.1829-1831.2004; Cools P, 2011, MOLECULAR DETECTION OF HUMAN BACTERIAL PATHOGENS, P31; Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI200320365; De Backer E, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-51; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; Elias S, 2012, FEMS MICROBIOL REV, V36, P990, DOI 10.1111/j.1574-6976.2012.00325.x; Ferris MJ, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-5; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2009, J CLIN MICROBIOL, V47, P721, DOI 10.1128/JCM.01384-08; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Harmsen HJM, 2000, APPL ENVIRON MICROB, V66, P4523, DOI 10.1128/AEM.66.10.4523-4527.2000; Jespers V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-83; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; Machado A, 2015, PEERJ, V3, DOI 10.7717/peerj.780; Machado A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-82; Marrazzo JM, 2010, SEX TRANSM DIS, V37, P732, DOI 10.1097/OLQ.0b013e3181fbbc95; Matsuo K, 1997, GUT, V40, P782, DOI 10.1136/gut.40.6.782; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Olson ME, 2002, CAN J VET RES, V66, P86; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Patterson JL, 2010, MICROBIOL-SGM, V156, P392, DOI 10.1099/mic.0.034280-0; Patterson T, 2007, AM J OBSTET GYNECOL, V197, pS175, DOI 10.1016/j.ajog.2007.10.634; Peltroche-Llacsahuanga H, 2010, J MED MICROBIOL, V59, P179, DOI 10.1099/jmm.0.013995-0; Perry-O'Keefe H, 2001, J APPL MICROBIOL, V90, P180, DOI 10.1046/j.1365-2672.2001.01230.x; Polatti F, 2012, CURR CLIN PHARMACOL, V7, P36, DOI 10.2174/157488412799218824; PUCHTLER H, 1968, HISTOCHEMISTRY, V16, P361, DOI 10.1007/BF00306359; Schurmans C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1680-y; Schwebke JR, 2014, J INFECT DIS, V210, P338, DOI 10.1093/infdis/jiu089; Shamsi M, 2008, ACTA CYTOL, V52, P187, DOI 10.1159/000325477; SPIEGEL CA, 1991, CLIN MICROBIOL REV, V4, P485, DOI 10.1128/CMR.4.4.485-502.1991; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Swidsinski A, 2010, GYNECOL OBSTET INVES, V70, P256, DOI 10.1159/000314015; Van Acker H, 2014, TRENDS MICROBIOL, V22, P326, DOI 10.1016/j.tim.2014.02.001; van de Wijgert JHHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105998; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Verstraelen H, 2004, AM J OBSTET GYNECOL, V191, P1130, DOI 10.1016/j.ajog.2004.04.013; Verstraelen H, 2013, CURR OPIN INFECT DIS, V26, P86, DOI 10.1097/QCO.0b013e32835c20cd; Williams Brett, 2002, Methods Mol Biol, V208, P181; Wolcott R, 2013, CLIN MICROBIOL INFEC, V19, P107, DOI 10.1111/j.1469-0691.2012.04001.x	45	52	55	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136658	10.1371/journal.pone.0136658	http://dx.doi.org/10.1371/journal.pone.0136658			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305575	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500105
J	Norton, EB; Branco, LM; Clements, JD				Norton, Elizabeth B.; Branco, Luis M.; Clements, John D.			Evaluating the A-Subunit of the Heat-Labile Toxin (LT) As an Immunogen and a Protective Antigen Against Enterotoxigenic Escherichia coli (ETEC)	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; CHOLERA-TOXIN; ENTERO-TOXIN; VACCINE; ADJUVANTICITY; COLONIZATION; RESPONSES; INFECTIONS; COUNTRIES; DIARRHEA	Diarrheal illness contributes to malnutrition, stunted growth, impaired cognitive development, and high morbidity rates in children worldwide. Enterotoxigenic Escherichia coli (ETEC) is a major contributor to this diarrheal disease burden. ETEC cause disease in the small intestine by means of colonization factors and by production of a heat-labile enterotoxin (LT) and/or a small non-immunogenic heat-stable enterotoxin (ST). Overall, the majority of ETEC produce both ST and LT. LT induces secretion via an enzymatically active A-subunit (LT-A) and a pentameric, cell-binding B-subunit (LT-B). The importance of anti-LT antibodies has been demonstrated in multiple clinical and epidemiological studies, and a number of potential ETEC vaccine candidates have included LT-B as an important immunogen. However, there is limited information about the potential contribution of LT-A to development of protective immunity. In the current study, we evaluate the immune response against the A-subunit of LT as well as the A-subunit's potential as a protective antigen when administered alone or in combination with the B-subunit of LT. We evaluated human sera from individuals challenged with a prototypic wild-type ETEC strain as well as sera from individuals living in an ETEC endemic area for the presence of anti-LT, anti-LT-A and anti-LT-B antibodies. In both cases, a significant number of individuals intentionally or endemically infected with ETEC developed antibodies against both LT subunits. In addition, animals immunized with the recombinant proteins developed robust antibody responses that were able to neutralize the enterotoxic and cytotoxic effects of native LT by blocking binding and entry into cells (anti-LT-B) or the intracellular enzymatic activity of the toxin (anti-LT-A). Moreover, antibodies to both LT subunits acted synergistically to neutralize the holotoxin when combined. Taken together, these data support the inclusion of both LT-A and LT-B in prospective vaccines against ETEC.	[Norton, Elizabeth B.; Branco, Luis M.; Clements, John D.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA	Tulane University	Norton, EB (corresponding author), Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA.	enorton@tulane.edu		Branco, Luis/0000-0001-8161-0182	National Institutes of Health [R56 AI099008-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI099008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a grant from the National Institutes of Health (R56 AI099008-01A1). This funder provided support in the form of salaries for author [JDC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Author Contributions" section. The current affiliation of Dr. Branco, Zalgen Labs, played no part in this study.	Allen KP, 2006, INFECT IMMUN, V74, P869, DOI 10.1128/IAI.74.2.869-875.2006; Beatty ME, 2004, EMERG INFECT DIS, V10, P518, DOI 10.3201/eid1003.030268; BELISLE BW, 1984, INFECT IMMUN, V43, P1027, DOI 10.1128/IAI.43.3.1027-1032.1984; BELISLE BW, 1984, INFECT IMMUN, V46, P759, DOI 10.1128/IAI.46.3.759-764.1984; Branco LM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-478; Carpenter CM, 2006, VACCINE, V24, P3709, DOI 10.1016/j.vaccine.2005.07.022; Chen LH, 2009, EMERG INFECT DIS, V15, P1773, DOI 10.3201/eid1511.090945; Cheng E, 1999, VACCINE, V18, P38, DOI 10.1016/S0264-410X(99)00168-1; CLEMENTS JD, 1979, INFECT IMMUN, V24, P760, DOI 10.1128/IAI.24.3.760-769.1979; CLEMENTS JD, 1988, VACCINE, V6, P269, DOI 10.1016/0264-410X(88)90223-X; CLEMENTS JD, 1984, INFECT IMMUN, V46, P564, DOI 10.1128/IAI.46.2.564-569.1984; Connell TD, 2007, EXPERT REV VACCINES, V6, P821, DOI 10.1586/14760584.6.5.821; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; CRUZ JR, 1988, ACTA PAEDIATR SCAND, V77, P658, DOI 10.1111/j.1651-2227.1988.tb10726.x; Darsley MJ, 2012, CLIN VACCINE IMMUNOL, V19, P1921, DOI 10.1128/CVI.00364-12; DICKINSON BL, 1995, INFECT IMMUN, V63, P1617, DOI 10.1128/IAI.63.5.1617-1623.1995; FINKELSTEIN RA, 1985, DEV BIOL STAND, V59, P51; FINKELSTEIN RA, 1987, REV INFECT DIS, V9, P544; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Glenn GM, 2007, INFECT IMMUN, V75, P2163, DOI 10.1128/IAI.01740-06; Guerrant RL, 2013, NAT REV GASTRO HEPAT, V10, P220, DOI 10.1038/nrgastro.2012.239; Guidry JJ, 1997, INFECT IMMUN, V65, P4943, DOI 10.1128/IAI.65.12.4943-4950.1997; Gupta SK, 2008, EPIDEMIOL INFECT, V136, P721, DOI 10.1017/S095026880700934X; HOLMES RK, 1983, INFECT IMMUN, V42, P914, DOI 10.1128/IAI.42.3.914-923.1983; Holmgren J, 2013, VACCINE, V31, P2457, DOI 10.1016/j.vaccine.2013.03.027; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Initiative for Vaccine Research (IVR), 2009, IN VACC RES IVR DIAR; Isidean SD, 2011, VACCINE, V29, P6167, DOI 10.1016/j.vaccine.2011.06.084; Johnson AM, 2009, J BACTERIOL, V191, P178, DOI 10.1128/JB.00822-08; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; LINDHOLM L, 1983, INFECT IMMUN, V40, P570, DOI 10.1128/IAI.40.2.570-576.1983; Macdonald E, 2014, EPIDEMIOL INFECT, V9, P1, DOI DOI 10.1017/S0950268814001058; Mondal D, 2012, CLIN INFECT DIS, V54, P185, DOI 10.1093/cid/cir807; Nair P, 2014, J TRAVEL MED, V21, P153, DOI 10.1111/jtm.12114; Norton EB, 2012, INFECT IMMUN, V80, P2426, DOI 10.1128/IAI.00181-12; Norton EB, 2011, CLIN VACCINE IMMUNOL, V18, P546, DOI 10.1128/CVI.00538-10; PETERSON JW, 1979, INFECT IMMUN, V24, P774, DOI 10.1128/IAI.24.3.774-779.1979; PIZZA M, 1994, J EXP MED, V180, P2147, DOI 10.1084/jem.180.6.2147; Porter CK, 2011, VACCINE, V29, P5869, DOI 10.1016/j.vaccine.2011.05.021; Qadri F, 2007, INFECT IMMUN, V75, P3961, DOI 10.1128/IAI.00459-07; REMMERS EF, 1982, INFECT IMMUN, V37, P70, DOI 10.1128/IAI.37.1.70-76.1982; Rivera FP, 2010, J CLIN MICROBIOL, V48, P3198, DOI 10.1128/JCM.00644-10; SVENNERHOLM AM, 1983, J INFECT DIS, V147, P514, DOI 10.1093/infdis/147.3.514; Svennerholm AM, 2011, INDIAN J MED RES, V133, P188; Thabane M, 2007, ALIMENT PHARM THER, V26, P535, DOI 10.1111/j.1365-2036.2007.03399.x; Uddowla S, 2007, VACCINE, V25, P7984, DOI 10.1016/j.vaccine.2007.09.030; Wenneras C, 2004, J HEALTH POPUL NUTR, V22, P370	47	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136302	10.1371/journal.pone.0136302	http://dx.doi.org/10.1371/journal.pone.0136302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305793	Green Published, Green Submitted, gold			2022-12-27	WOS:000359995500062
J	Wang, X; Zhou, C; Yang, XP; Miao, D; Zhang, YS				Wang, Xin; Zhou, Chen; Yang, Xianpeng; Miao, Di; Zhang, Yansheng			De Novo Transcriptome Analysis of Warburgia ugandensis to Identify Genes Involved in Terpenoids and Unsaturated Fatty Acids Biosynthesis	PLOS ONE			English	Article							PEPPER-BARK TREE; FUNCTIONAL ANNOTATION; STEM-BARK; SESQUITERPENES; PLANTS; IDENTIFICATION; METABOLITES; DIVERSITY; PATHWAY; CLONING	The bark of Warburgia ugandensis (Canellaceae family) has been used as a medicinal source for a long history in many African countries. The presence of diverse terpenoids and abundant polyunsaturated fatty acids (PUFAs) in this organ contributes to its broad range of pharmacological properties. Despite its medicinal and economic importance, the knowledge on the biosynthesis of terpenoid and unsaturated fatty acid in W. ugandensis bark remains largely unknown. Therefore, it is necessary to construct a genomic and/or transcriptomic database for the functional genomics study on W. ugandensis. The chemical profiles of terpenoids and fatty acids between the bark and leaves of W. ugandensis were compared by gas chromatography-mass spectrometry (GC-MS) analysis. Meanwhile, the transcriptome database derived from both tissues was created using Illumina sequencing technology. In total, about 17.1 G clean nucleotides were obtained, and de novo assembled into 72,591 unigenes, of which about 38.06% can be aligned to the NCBI non-redundant protein database. Many candidate genes in the biosynthetic pathways of terpenoids and unsaturated fatty acids were identified, including 14 unigenes for terpene synthases. Furthermore, 2,324 unigenes were discovered to be differentially expressed between both tissues; the functions of those differentially expressed genes (DEGs) were predicted by gene ontology enrichment and metabolic pathway enrichment analyses. In addition, the expression of 12 DEGs with putative roles in terpenoid and unsaturated fatty acid metabolic pathways was confirmed by qRT-PCRs, which was consistent with the data of the RNA-sequencing. In conclusion, we constructed a comprehensive transcriptome dataset derived from the bark and leaf of W. ugandensis, which forms the basis for functional genomics studies on this plant species. Particularly, the comparative analysis of the transcriptome data between the bark and leaf will provide critical clues to reveal the regulatory mechanisms underlying the biosynthesis of terpenoids and PUFAs in W. ugandensis.	[Wang, Xin; Zhou, Chen; Yang, Xianpeng; Miao, Di; Zhang, Yansheng] Chinese Acad Sci, Wuhan Bot Garden, CAS Key Lab Plant Germplasm Enhancement & Special, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Zhang, YS (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, CAS Key Lab Plant Germplasm Enhancement & Special, Wuhan, Hubei, Peoples R China.	zhangys@wbgcas.cn			Chinese Academy of Science [KSCX2-EW-J-20]; One Hundred Talent Program of the CAS [29Y129441R0104444]	Chinese Academy of Science(Chinese Academy of Sciences); One Hundred Talent Program of the CAS	This work was supported by the Innovation Project of Chinese Academy of Science to XW (Project No. KSCX2-EW-J-20, http://www.cas.cn/) and the Grant of One Hundred Talent Program of the CAS to YZ (project No. 29Y129441R0104444, http://www.cas.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubourg S, 2002, MOL GENET GENOMICS, V267, P730, DOI 10.1007/s00438-002-0709-y; Botha J, 2004, BIODIVERS CONSERV, V13, P1675, DOI 10.1023/B:BIOC.0000029333.72945.b0; BROOKS CJW, 1969, TETRAHEDRON, V25, P2865, DOI 10.1016/0040-4020(69)80030-X; Chen H, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0239-x; Cheng AX, 2007, PHYTOCHEMISTRY, V68, P1632, DOI 10.1016/j.phytochem.2007.04.008; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Drage S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00013; Drew DP, 2013, INT J MOL SCI, V14, P9080, DOI 10.3390/ijms14059080; Drewes SE, 2001, S AFR J SCI, V97, P383; Dussert S, 2013, PLANT PHYSIOL, V162, P1337, DOI 10.1104/pp.113.220525; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guzman F, 2014, PLANT SCI, V229, P238, DOI 10.1016/j.plantsci.2014.10.003; Han XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076890; KIOY D, 1990, PHYTOCHEMISTRY, V29, P3535, DOI 10.1016/0031-9422(90)85270-P; Kuglerova M, 2011, AFR J BIOTECHNOL, V10, P3628; Lange BM, 2013, PLANT BIOTECHNOL J, V11, P169, DOI 10.1111/pbi.12022; Ma YMA, 2012, J EXP BOT, V63, P2809, DOI 10.1093/jxb/err466; Maroyi A, 2014, PHARM BIOL, V52, P378, DOI 10.3109/13880209.2013.837935; Martin DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-226; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murray M, 2014, PHYTOCHEM REV, V13, P139, DOI 10.1007/s11101-013-9294-4; Ngure PK, 2009, J MED PLANTS RES, V3, P61, DOI 10.3923/rjmp.2009.61.68; Ohlrogge JB, 1997, ANNU REV PLANT PHYS, V48, P109, DOI 10.1146/annurev.arplant.48.1.109; Opiyo SA, 2011, PHYTOCHEM LETT, V4, P161, DOI 10.1016/j.phytol.2011.02.007; Rajab MS, 2000, B CHEM SOC ETHIOPIA, V14, P45; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Ruiz-Lopez N, 2012, J EXP BOT, V63, P2397, DOI 10.1093/jxb/err454; Sando T, 2008, BIOSCI BIOTECH BIOCH, V72, P2049, DOI 10.1271/bbb.80165; Tholl D, 2006, CURR OPIN PLANT BIOL, V9, P297, DOI 10.1016/j.pbi.2006.03.014; Troncoso-Ponce MA, 2011, PLANT J, V68, P1014, DOI 10.1111/j.1365-313X.2011.04751.x; Truksa M, 2009, MOL BREEDING, V23, P1, DOI 10.1007/s11032-008-9218-y; Van Wyk BE, 2011, S AFR J BOT, V77, P812, DOI 10.1016/j.sajb.2011.08.011; Wang XJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-716; Warude D, 2006, CRIT REV BIOTECHNOL, V26, P83, DOI 10.1080/07388550600697479; Wube AA, 2008, PLANTA MED, V74, P994; Wube AA, 2005, PHYTOCHEMISTRY, V66, P2309, DOI 10.1016/j.phytochem.2005.07.018; Xiao M, 2013, J BIOTECHNOL, V166, P122, DOI 10.1016/j.jbiotec.2013.04.004; Xu M, 2009, MOLECULES, V14, P3844, DOI 10.3390/molecules14103844; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080464	42	2	2	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0135724	10.1371/journal.pone.0135724	http://dx.doi.org/10.1371/journal.pone.0135724			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305373	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500031
J	Botting, GM; Rastogi, I; Chhabra, G; Nlend, M; Puri, N				Botting, Gregory M.; Rastogi, Ichwaku; Chhabra, Gagan; Nlend, Marie; Puri, Neelu			Mechanism of Resistance and Novel Targets Mediating Resistance to EGFR and c-Met Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; ACQUIRED-RESISTANCE; BETA-CATENIN; T790M MUTATIONS; GENE-EXPRESSION; DOWN-REGULATION; PATHWAY; WNT; MTOR; TUMORIGENESIS	Tyrosine kinase inhibitors (TKIs) against EGFR and c-Met are initially effective when administered individually or in combination to non-small cell lung cancer (NSCLC) patients. However, the overall efficacies of TKIs are limited due to the development of drug resistance. Therefore, it is important to elucidate mechanisms of EGFR and c-Met TKI resistance in order to develop more effective therapies. Model NSCLC cell lines H1975 and H2170 were used to study the similarities and differences in mechanisms of EGFR/c-Met TKI resistance. H1975 cells are positive for the T790M EGFR mutation, which confers resistance to current EGFR TKI therapies, while H2170 cells are EGFR wild-type. Previously, H2170 cells were made resistant to the EGFR TKI erlotinib and the c-Met TKI SU11274 by exposure to progressively increasing concentrations of TKIs. In H2170 and H1975 TKI-resistant cells, key Wnt and mTOR proteins were found to be differentially modulated. Wnt signaling transducer, active beta-catenin was upregulated in TKI-resistant H2170 cells when compared to parental cells. GATA-6, a transcriptional activator of Wnt, was also found to be upregulated in resistant H2170 cells. In H2170 erlotinib resistant cells, upregulation of inactive GSK3 beta (p-GSK3 beta) was observed, indicating activation of Wnt and mTOR pathways which are otherwise inhibited by its active form. However, in H1975 cells, Wnt modulators such as active beta-catenin, GATA-6 and p-GSK3 beta were downregulated. Additional results from MTT cell viability assays demonstrated that H1975 cell proliferation was not significantly decreased after Wnt inhibition by XAV939, but combination treatment with everolimus (mTOR inhibitor) and erlotinib resulted in synergistic cell growth inhibition. Thus, in H2170 cells and H1975 cells, simultaneous inhibition of key Wnt or mTOR pathway proteins in addition to EGFR and c-Met may be a promising strategy for overcoming EGFR and c-Met TKI resistance in NSCLC patients.	[Botting, Gregory M.; Rastogi, Ichwaku; Chhabra, Gagan; Puri, Neelu] Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA; [Nlend, Marie] Thermo Fisher Sci, Rockford, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Rockford; Thermo Fisher Scientific	Puri, N (corresponding author), Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA.	neelupur@uic.edu	Rastogi, Ichwaku/GWZ-4097-2022	Chhabra, Gagan/0000-0001-5205-7218	National Cancer Institute of the National Institutes of Health [R21CA158965-01A1]; Community Foundation of Norther Illinois; NATIONAL CANCER INSTITUTE [R21CA158965] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Community Foundation of Norther Illinois; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award number R21CA158965-01A1 (http://www.nih.gov) to Neelu Puri. This work was also funded in part by a Community Grant from the Community Foundation of Norther Illinois to Neelu Puri. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2008, ONCOGENE, V27, P4921, DOI 10.1038/onc.2008.133; Agarwal A, 2005, ONCOGENE, V24, P1021, DOI 10.1038/sj.onc.1208296; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Casas-Selves M, 2012, CANCER RES, V72, P4154, DOI 10.1158/0008-5472.CAN-11-2848; Choo AY, 2006, CELL, V126, P834, DOI 10.1016/j.cell.2006.08.025; Dienstmann R, 2012, MOL ONCOL, V6, P15, DOI 10.1016/j.molonc.2011.11.009; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Ekman S, 2012, J THORAC ONCOL, V7, P947, DOI 10.1097/JTO.0b013e31825581bd; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Etnyre D, 2014, CANCER BIOL THER, V15, P1129, DOI 10.4161/cbt.29451; Fong JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078398; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Gridelli C, 2008, ONCOLOGIST, V13, P139, DOI 10.1634/theoncologist.2007-0171; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jessen JR, 2009, ZEBRAFISH, V6, P21, DOI 10.1089/zeb.2008.0571; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Komiya Yuko, 2008, Organogenesis, V4, P68; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Lee DF, 2007, CELL CYCLE, V6, P3011, DOI 10.4161/cc.6.24.5085; Li ZG, 2008, ONCOGENE, V27, P596, DOI 10.1038/sj.onc.1210694; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; LONGATI P, 1994, ONCOGENE, V9, P49; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Nakachi I, 2010, MOL CANCER RES, V8, P1142, DOI 10.1158/1541-7786.MCR-09-0388; Pacheco-Pinedo EC, 2011, J CLIN INVEST, V121, P1935, DOI 10.1172/JCI44871; Paul Indranil, 2013, Genes Cancer, V4, P427, DOI 10.1177/1947601913503341; Puri Neelu, 2008, J Carcinog, V7, P9; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sadiq AA, 2013, J CLIN ONCOL, V31, P1089, DOI 10.1200/JCO.2012.43.9422; Schroeder JA, 2000, ONCOGENE, V19, P3193, DOI 10.1038/sj.onc.1203652; Schroeder JA, 2002, J BIOL CHEM, V277, P22692, DOI 10.1074/jbc.M201975200; Sequist LV, 2011, J CLIN ONCOL, V29, P3307, DOI 10.1200/JCO.2010.34.0570; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Sierra JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-75; Soria JC, 2009, ANN ONCOL, V20, P1674, DOI 10.1093/annonc/mdp060; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Tahir SA, 2013, CANCER RES, V73, P1900, DOI 10.1158/0008-5472.CAN-12-3040; Takayasu H, 2007, J PEDIATR SURG, V42, P426, DOI 10.1016/j.jpedsurg.2006.10.018; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Weidenfeld J, 2002, J BIOL CHEM, V277, P21061, DOI 10.1074/jbc.M111702200; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P2242, DOI 10.1167/iovs.06-0560; Xu L, 2010, ONCOGENE, V29, P2616, DOI 10.1038/onc.2010.16; Yu HA, 2013, J THORAC ONCOL, V8, P346, DOI 10.1097/JTO.0b013e31827e1f83; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157; Zhang ZF, 2010, ONCOTARGET, V1, P497; Zhong Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022129	60	33	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136155	10.1371/journal.pone.0136155	http://dx.doi.org/10.1371/journal.pone.0136155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301867	gold, Green Submitted, Green Published			2022-12-27	WOS:000359951900045
J	Buyukturkoglu, K; Roettgers, H; Sommer, J; Rana, M; Dietzsch, L; Arikan, EB; Veit, R; Malekshahi, R; Kircher, T; Birbaumer, N; Sitaram, R; Ruiz, S				Buyukturkoglu, Korhan; Roettgers, Hans; Sommer, Jens; Rana, Mohit; Dietzsch, Leonie; Arikan, Ezgi Belkis; Veit, Ralf; Malekshahi, Rahim; Kircher, Tilo; Birbaumer, Niels; Sitaram, Ranganatha; Ruiz, Sergio			Self-Regulation of Anterior Insula with Real-Time fMRI and Its Behavioral Effects in Obsessive-Compulsive Disorder: A Feasibility Study	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; CINGULATE CORTEX ACTIVITY; GLUCOSE METABOLIC-RATE; DISGUST SENSITIVITY; ANXIETY DISORDERS; FUNCTIONAL MRI; NEUROFEEDBACK; SYMPTOMS; ACTIVATION; RESPONSES	Introduction Obsessive-compulsive disorder (OCD) is a common and chronic condition that can have disabling effects throughout the patient's lifespan. Frequent symptoms among OCD patients include fear of contamination and washing compulsions. Several studies have shown a link between contamination fears, disgust over-reactivity, and insula activation in OCD. In concordance with the role of insula in disgust processing, new neural models based on neuroimaging studies suggest that abnormally high activations of insula could be implicated in OCD psychopathology, at least in the subgroup of patients with contamination fears and washing compulsions. Methods In the current study, we used a Brain Computer Interface (BCI) based on real-time functional magnetic resonance imaging (rtfMRI) to aid OCD patients to achieve down-regulation of the Blood Oxygenation Level Dependent (BOLD) signal in anterior insula. Our first aim was to investigate whether patients with contamination obsessions and washing compulsions can learn to volitionally decrease (down-regulate) activity in the insula in the presence of disgust/anxiety provoking stimuli. Our second aim was to evaluate the effect of down-regulation on clinical, behavioural and physiological changes pertaining to OCD symptoms. Hence, several pre- and post-training measures were performed, i.e., confronting the patient with a disgust/anxiety inducing real-world object (Ecological Disgust Test), and subjective rating and physiological responses (heart rate, skin conductance level) of disgust towards provoking pictures. Results Results of this pilot study, performed in 3 patients (2 females), show that OCD patients can gain self-control of the BOLD activity of insula, albeit to different degrees. In two patients positive changes in behaviour in the EDT were observed following the rtfMRI trainings. Behavioural changes were also confirmed by reductions in the negative valence and in the subjective perception of disgust towards symptom provoking images. Conclusion Although preliminary, results of this study confirmed that insula down-regulation is possible in patients suffering from OCD, and that volitional decreases of insula activation could be used for symptom alleviation in this disorder.	[Buyukturkoglu, Korhan; Rana, Mohit; Malekshahi, Rahim] Univ Tubingen, Int Max Planck Res Sch, Grad Sch Neural & Behav Sci, Tubingen, Germany; [Buyukturkoglu, Korhan; Rana, Mohit; Veit, Ralf; Malekshahi, Rahim; Birbaumer, Niels; Sitaram, Ranganatha; Ruiz, Sergio] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Roettgers, Hans; Sommer, Jens; Dietzsch, Leonie; Arikan, Ezgi Belkis; Kircher, Tilo] Univ Marburg, Dept Psychiat & Psychotherapy, Marburg, Germany; [Birbaumer, Niels] Osped San Camillo, Ist Ricovero & Cura Carattere Sci, Venice, Italy; [Rana, Mohit; Sitaram, Ranganatha] Univ Florida, Dept Biomed Engn, Gainesville, FL USA; [Ruiz, Sergio] Pontificia Univ Catolica Chile, Ctr Interdisciplinario Neurociencia, Escuela Med, Dept Psiquiatria, Santiago, Chile	Eberhard Karls University of Tubingen; Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Philipps University Marburg; State University System of Florida; University of Florida; Pontificia Universidad Catolica de Chile	Sitaram, R (corresponding author), Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany.	ranganatha.sitaram@bme.ufl.edu; smruiz@med.puc.cl	Kircher, Tilo/AAT-6480-2020; Veit, Ralf/F-8907-2012	Kircher, Tilo/0000-0002-2514-2625; Veit, Ralf/0000-0001-9860-642X; Sitaram, Ranganatha/0000-0002-8577-8035; Birbaumer, Niels/0000-0002-6786-5127	Center of Integrated Neurosciences-Tuebingen (CIN-Pool Project); Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (Conicyt) through Fondo Nacional de Desarrollo Cientifico y Tecnologico Fondecyt [11121153]; European Union and Indian collaboration grant (New INDIGO); Badenwuerttemberg-Singapore Life Sciences grant; EU Collaborative Project BRAINTRAIN; Proyectos de Investigacion Interdisciplinaria, Vicerrectoria de Investigacion (VRI), Pontificia Universidad Catolica de Chile; Deutsche Forschungsgemeinschaft (DFG)	Center of Integrated Neurosciences-Tuebingen (CIN-Pool Project); Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (Conicyt) through Fondo Nacional de Desarrollo Cientifico y Tecnologico Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); European Union and Indian collaboration grant (New INDIGO); Badenwuerttemberg-Singapore Life Sciences grant; EU Collaborative Project BRAINTRAIN; Proyectos de Investigacion Interdisciplinaria, Vicerrectoria de Investigacion (VRI), Pontificia Universidad Catolica de Chile; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the Center of Integrated Neurosciences-Tuebingen (CIN-Pool Project 2011-08) http://www.cin.uni-tuebingen.de/ RS SR NB; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (Conicyt) through Fondo Nacional de Desarrollo Cientifico y Tecnologico Fondecyt (project no 11121153) http://www.conicyt.cl SR; European Union and Indian collaboration grant (New INDIGO) http://www.newindigo.eu/ RS; Badenwuerttemberg-Singapore Life Sciences grant RS; EU Collaborative Project BRAINTRAIN http://www.braintrainproject.eu/ NB; Proyectos de Investigacion Interdisciplinaria, Vicerrectoria de Investigacion (VRI), Pontificia Universidad Catolica de Chile, http://www.uc.cl/ SR and Deutsche Forschungsgemeinschaft (DFG), Koselleck Award http://www.dfg.de/ NB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlaouiIsmaili O, 1997, PHYSIOL BEHAV, V62, P713, DOI 10.1016/S0031-9384(97)90016-0; Aouizerate B, 2004, PROG NEUROBIOL, V72, P195, DOI 10.1016/j.pneurobio.2004.02.004; APA-American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ashby FG, 2007, PERCEPT PSYCHOPHYS, V69, P865; BAXTER LR, 1992, ARCH GEN PSYCHIAT, V49, P681; BENKELFAT C, 1991, PSYCHIAT RES, V37, P321, DOI 10.1016/0165-1781(91)90067-Y; Berle D, 2006, PSYCHIATRY, V69, P228, DOI 10.1521/psyc.2006.69.3.228; Birbaumer N, 2007, J PHYSIOL-LONDON, V579, P621, DOI 10.1113/jphysiol.2006.125633; Birbaumer N, 2013, TRENDS COGN SCI, V17, P295, DOI 10.1016/j.tics.2013.04.009; Bray S, 2007, J NEUROSCI, V27, P7498, DOI 10.1523/JNEUROSCI.2118-07.2007; Broderick J, 2013, BEHAV THER, V44, P27, DOI 10.1016/j.beth.2012.05.005; Bruhl A, 2014, BRAIN TOPOGR, V27, P138, DOI 10.1007/s10548-013-0331-9; Buyukturkoglu K, 2013, I IEEE EMBS C NEUR E, P677, DOI 10.1109/NER.2013.6696025; Caria A, 2012, NEUROSCIENTIST, V18, P487, DOI 10.1177/1073858411407205; Caria A, 2010, BIOL PSYCHIAT, V68, P425, DOI 10.1016/j.biopsych.2010.04.020; Cisler JM, 2009, CLIN PSYCHOL REV, V29, P34, DOI 10.1016/j.cpr.2008.09.007; Craig B, 2011, NAT REV NEUROSCI, V10, P59; Cuthbert B. N, 2005, A6 U FLOR; Dewiputri WI, 2013, ORG HUM BRAIN MAPP O; Doron G, 2009, ISR J PSYCHIATR REL, V46, P257; Figee M, 2013, NAT NEUROSCI, V16, P386, DOI 10.1038/nn.3344; Gerich J, 2007, BEHAV RES METHODS, V39, P985, DOI 10.3758/BF03192994; Goebel R, 2001, NEUROIMAGE, V13, pS129; Goetz AR, 2013, ANXIETY STRESS COPIN, V26, P431, DOI 10.1080/10615806.2012.684241; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; GROSS JJ, 1993, J PERS SOC PSYCHOL, V64, P970, DOI 10.1037/0022-3514.64.6.970; Haller S, 2010, EUR RADIOL, V20, P696, DOI 10.1007/s00330-009-1595-z; Hamilton JP, 2011, HUM BRAIN MAPP, V32, P22, DOI 10.1002/hbm.20997; Hand I, 1991, VERHALTENSTHERAPIE, V1, P223, DOI DOI 10.1159/000257972; Hautzinger M., 2009, BDI 2 BECK DEPRESSIO; HOEHNSARIC R, 1995, ARCH GEN PSYCHIAT, V52, P688; HOLLANDER E, 1991, PSYCHIAT RES, V37, P161, DOI 10.1016/0165-1781(91)90073-X; Insel T. R., 1985, ANXIETY ANXIETY DISO, P577; JOHNSEN BH, 1995, J PSYCHOPHYSIOL, V9, P193; Johnson KA, 2012, J NEUROIMAGING, V22, P58, DOI 10.1111/j.1552-6569.2010.00529.x; Kwon JS, 2009, EXPERT REV NEUROTHER, V9, P255, DOI 10.1586/14737175.9.2.255; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; Laux L., 1981, STATE TRAIT ANGSTINV; Lawrence EJ, 2014, NEUROIMAGE, V88, P113, DOI 10.1016/j.neuroimage.2013.10.069; Lehrl S., 1995, MEHRFACHWAHL WORTSCH; LEVENSON RW, 1992, PSYCHOL SCI, V3, P23, DOI 10.1111/j.1467-9280.1992.tb00251.x; Li XB, 2013, ADDICT BIOL, V18, P739, DOI 10.1111/j.1369-1600.2012.00449.x; Linden DEJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038115; Mataix-Cols D, 2004, ARCH GEN PSYCHIAT, V61, P564, DOI 10.1001/archpsyc.61.6.564; MCCARTHY PR, 1995, INT J PSYCHOPHYSIOL, V19, P215, DOI 10.1016/0167-8760(95)00009-H; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Millet B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053241; Mindus P, 1986, Acta Radiol Suppl, V369, P444; Moretz MW, 2008, J ANXIETY DISORD, V22, P707, DOI 10.1016/j.janxdis.2007.07.004; Muris P, 2008, J BEHAV THER EXP PSY, V39, P133, DOI 10.1016/j.jbtep.2007.02.001; Nakao T, 2005, BIOL PSYCHIAT, V57, P901, DOI 10.1016/j.biopsych.2004.12.039; Ninaus M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00914; Olatunji BO, 2004, BEHAV RES THER, V42, P93, DOI 10.1016/S0005-7967(03)00102-5; Olatunji BO, 2007, J ANXIETY DISORD, V21, P918, DOI 10.1016/j.janxdis.2006.12.005; Olatunji BO, 2013, J PSYCHIATR RES, V47, P33, DOI 10.1016/j.jpsychires.2012.08.020; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ougrin D, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-200; Phillips ML, 2000, PSYCHOL MED, V30, P1037, DOI 10.1017/S0033291799002652; Posse S, 2003, NEUROIMAGE, V18, P760, DOI 10.1016/S1053-8119(03)00004-1; Rachman S, 2004, BEHAV RES THER, V42, P1227, DOI 10.1016/j.brat.2003.10.009; Rotge JY, 2008, J PSYCHIATR NEUROSCI, V33, P405; Ruiz S, 2014, BIOL PSYCHOL, V95, P4, DOI 10.1016/j.biopsycho.2013.04.010; Ruiz S, 2013, HUM BRAIN MAPP, V34, P200, DOI 10.1002/hbm.21427; Ruscio AM, 2010, MOL PSYCHIATR, V15, P53, DOI 10.1038/mp.2008.94; Saxe R, 2006, NEUROIMAGE, V30, P1088, DOI 10.1016/j.neuroimage.2005.12.062; Schacter D. L., 2011, PSYCHOLOGY; Scheinost D, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.24; Schienle A, 2003, J PSYCHOPHYSIOL, V17, P87, DOI 10.1027//0269-8803.17.2.87; Schienle A, 2001, LEARN MOTIV, V32, P65, DOI 10.1006/lmot.2000.1067; Schienle A, 2002, Z KLIN PSYCHOL PSYCH, V39, P80; Schiepek G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071863; Schwartz JM, 1996, ARCH GEN PSYCHIAT, V53, P109; SEIBELL PJ, 2014, F1000 PRIME REP, V6, P1, DOI DOI 10.12703/P6-68; Shapira NA, 2003, BIOL PSYCHIAT, V54, P751, DOI 10.1016/S0006-3223(03)00003-9; Sitaram R, 2008, 38 ANN M SOC NEUR WA; Sitaram R, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00344; Sitaram R, 2012, NEUROREHAB NEURAL RE, V26, P256, DOI 10.1177/1545968311418345; Sitaram R, 2011, NEUROIMAGE, V56, P753, DOI 10.1016/j.neuroimage.2010.08.007; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Starcevic V, 2011, AUST NZ J PSYCHIAT, V45, P449, DOI 10.3109/00048674.2011.567243; Stefanis C., 1977, TREATMENT PHOBIC OBS, P115; Stein DJ, 2006, METAB BRAIN DIS, V21, P267, DOI 10.1007/s11011-006-9021-6; Sulzer J, 2013, NEUROIMAGE, V76, P386, DOI 10.1016/j.neuroimage.2013.03.033; SWEDO SE, 1992, ARCH GEN PSYCHIAT, V49, P690; Tsao SD, 2004, BEHAV RES THER, V42, P207, DOI 10.1016/S0005-7967(03)00119-0; Veit R, 2012, SOC COGN AFFECT NEUR, V7, P623, DOI 10.1093/scan/nsr061; VRANA SR, 1994, J PSYCHOPHYSIOL, V8, P211; Weygandt M, 2012, NEUROIMAGE, V60, P1186, DOI 10.1016/j.neuroimage.2012.01.064; Wright P, 2004, NEUROREPORT, V15, P2347, DOI 10.1097/00001756-200410250-00009; Yoo SS, 2002, NEUROREPORT, V13, P1377, DOI 10.1097/00001756-200208070-00005; Zahn TP, 1996, PSYCHIAT RES, V60, P67, DOI 10.1016/0165-1781(95)02846-3	92	22	22	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0135872	10.1371/journal.pone.0135872	http://dx.doi.org/10.1371/journal.pone.0135872			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301829	Green Submitted, Green Published, gold			2022-12-27	WOS:000359951900032
J	Fall, ML; Tremblay, DM; Gobeil-Richard, M; Couillard, J; Rocheleau, H; Van der Heyden, H; Levesque, CA; Beaulieu, C; Carisse, O				Fall, Mamadou Lamine; Tremblay, David Mathieu; Gobeil-Richard, Melanie; Couillard, Julie; Rocheleau, Helene; Van der Heyden, Herve; Levesque, Camile Andre; Beaulieu, Carole; Carisse, Odile			Infection Efficiency of Four Phytophthora infestans Clonal Lineages and DNA-Based Quantification of Sporangia	PLOS ONE			English	Article							LATE BLIGHT; PCR; PATHOGEN; MANAGEMENT; FUNGICIDES; RESISTANCE; TAQMAN; HOST	The presence and abundance of pathogen inoculum is with host resistance and environmental conditions a key factor in epidemic development. Therefore, several spore-sampling devices have been proposed to monitor pathogen inoculum above fields. However, to make spore sampling more reliable as a management tool and to facilitate its adoption, information on infection efficiency and molecular tools for estimating airborne sporangia concentration are needed. Experiments were thus undertaken in a growth chamber to study the infection efficiency of four clonal lineages of P. infestans (US-8, US-11, US-23, and US-24) by measuring the airborne sporangia concentration and resulting disease intensity. The relationship between the airborne sporangia concentration and the number of lesions per leaf was exponential. For the same concentration, the sporangia of US-23 caused significantly more lesions than the sporangia of the other clonal lineages did. Under optimal conditions, an airborne sporangia concentration of 10 sporangia m(-3) for US-23 was sufficient to cause one lesion per leaf, whereas for the other clonal lineages, it took 15 to 25 sporangia m(-3) to reach the same disease intensity. However, in terms of diseased leaf area, there was no difference between clonal lineages US-8, US-23 and US-24. Also, a sensitive quantitative real-time polymerase chain reaction (qPCR) tool was developed to quantify P. infestans airborne sporangia with detection sensitivity of one sporangium. The specificity of the qPCR assay was rigorously tested for airborne inoculum and was either similar to, or an improvement on, other published PCR assays. This assay allows rapid and reliable detection and quantification of P. infestans airborne sporangia and thereby, facilitates the implementation of spores-sampling network.	[Fall, Mamadou Lamine; Beaulieu, Carole] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Fall, Mamadou Lamine; Tremblay, David Mathieu; Couillard, Julie; Carisse, Odile] Agr & Agri Food Canada, Hort Res & Dev Ctr, St Jean Sur Le Richelieu, PQ, Canada; [Gobeil-Richard, Melanie; Couillard, Julie; Van der Heyden, Herve] Compagnie Rech Phytodata Inc, Sherrington, PQ, Canada; [Rocheleau, Helene; Levesque, Camile Andre] Agr & Agri Food Canada, Cent Expt Farm, Ottawa, ON, Canada	University of Sherbrooke; Agriculture & Agri Food Canada; Agriculture & Agri Food Canada	Carisse, O (corresponding author), Agr & Agri Food Canada, Hort Res & Dev Ctr, St Jean Sur Le Richelieu, PQ, Canada.	odile.carisse@agr.gc.ca	Fall, Mamadou/GXG-1190-2022; Van der Heyden, Hervé/AAT-8247-2021; vanderheyden, Herve/GYD-6202-2022	Fall, Mamadou Lamine/0000-0002-1747-6481; Van der Heyden, Herve/0000-0003-4085-6658	Agriculture and Agri-Food Canada; Compagnie de recherche Phytodata inc.; Canadian Safety & Security Program [CRTI 04-0045RD]	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Compagnie de recherche Phytodata inc.; Canadian Safety & Security Program	This work was financially supported by Agriculture and Agri-Food Canada and Compagnie de recherche Phytodata inc. under a collaborative research agreement. The development of the primers with DNA from pure cultures was funded by the Canadian Safety & Security Program (project CRTI 04-0045RD). Compagnie de recherche Phytodata inc. provided support in the form of salaries for HVdH, MGR and JC. HVdH was involved in the decision to publish and preparation of the manuscript.	Abbott CL, 2010, CAN J PLANT PATHOL, V32, P440, DOI 10.1080/07060661.2010.510648; Adler NE, 2004, PHYTOPATHOLOGY, V94, P154, DOI 10.1094/PHYTO.2004.94.2.154; Andreu AB, 2006, CROP PROT, V25, P281, DOI 10.1016/j.cropro.2005.05.002; Aylor DE, 2011, AGR FOREST METEOROL, V151, P251, DOI 10.1016/j.agrformet.2010.10.013; Bilodeau GJ, 2007, PHYTOPATHOLOGY, V97, P632, DOI 10.1094/PHYTO-97-5-0632; Blair JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037003; Carisse O, 2009, PHYTOPATHOLOGY, V99, P1273, DOI 10.1094/PHYTO-99-11-1273; COHEN Y, 1994, PHYTOPATHOLOGY, V84, P55, DOI 10.1094/Phyto-84-55; Cooke DEL, 2004, PLANT PATHOL, V53, P692, DOI 10.1111/j.1365-3059.2004.01104.x; Danies G, 2013, PLANT DIS, V97, P873, DOI 10.1094/PDIS-07-12-0682-RE; Fall ML, 2015, PLANT DIS, V99, P1010, DOI 10.1094/PDIS-05-14-0548-RE; Fall ML, 2015, PLANT PATHOL, V64, P178, DOI 10.1111/ppa.12235; Fry WE, 2013, PLANT DIS, V97, P296, DOI 10.1094/PDIS-08-12-0791-FE; Fry WE, 2012, APS FEATURES, DOI [10.1094/APSFeature-2012-08, DOI 10.1094/APSFEATURE-2012-08]; Gisi U, 1996, ANNU REV PHYTOPATHOL, V34, P549, DOI 10.1146/annurev.phyto.34.1.549; Goss EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024543; Grunwald NJ, 2005, ANNU REV PHYTOPATHOL, V43, P171, DOI 10.1146/annurev.phyto.43.040204.135906; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Haverkort AJ, 2009, POTATO RES, V52, P249, DOI 10.1007/s11540-009-9136-3; Johnson ACS, 2014, PLANT DIS, V98, P761, DOI 10.1094/PDIS-06-13-0674-RE; Judelson HS, 2000, PHYTOPATHOLOGY, V90, P1112, DOI 10.1094/PHYTO.2000.90.10.1112; Kalischuk ML, 2012, PLANT DIS, V96, P1729, DOI 10.1094/PDIS-10-11-0859-RE; Lees AK, 2012, PLANT PATHOL, V61, P867, DOI 10.1111/j.1365-3059.2011.02574.x; Llorente B, 2010, LETT APPL MICROBIOL, V51, P603, DOI 10.1111/j.1472-765X.2010.02942.x; Logan M, 2010, BIOSTATISTICAL DESIN; Madden L.V., 2007, STUDY PLANT DIS EPID; Olanya O. M., 2012, Archives of Phytopathology and Plant Protection, V45, P1558, DOI 10.1080/03235408.2012.681502; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Refardt D, 2006, PARASITOLOGY, V133, P11, DOI 10.1017/S0031182006000060; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; Shakya SK, 2015, PHYTOPATHOLOGY, V105, P230, DOI 10.1094/PHYTO-05-14-0132-R; Skelsey P, 2009, PHYTOPATHOLOGY, V99, P887, DOI 10.1094/PHYTO-99-7-0887; Skelsey P, 2008, THESIS WAGENINGEN U; Stein JM, 2002, CROP PROT, V21, P575, DOI 10.1016/S0261-2194(01)00147-8; Stevens RB., 1960, PLANT PATHOLOGY ADV, P357; Tooley PW, 1997, APPL ENVIRON MICROB, V63, P1467, DOI 10.1128/AEM.63.4.1467-1475.1997	36	22	23	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136312	10.1371/journal.pone.0136312	http://dx.doi.org/10.1371/journal.pone.0136312			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26301826	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900058
J	Nwigwe, IJ; Kim, YJ; Wacker, DA; Kim, TH				Nwigwe, Ifeoma Jane; Kim, Yoon Jung; Wacker, David A.; Kim, Tae Hoon			Boundary Associated Long Noncoding RNA Mediates Long-Range Chromosomal Interactions	PLOS ONE			English	Article							FISSION YEAST CENTROMERE; HETEROCHROMATIN BARRIER; SACCHAROMYCES-CEREVISIAE; CHROMATIN ARCHITECTURE; GENE-EXPRESSION; POLYMERASE-III; CTCF; GENOME; CONFORMATION; PROMOTER	CCCTC binding factor (CTCF) is involved in organizing chromosomes into mega base-sized, topologically associated domains (TADs) along with other factors that define sub-TAD organization. CTCF-Cohesin interactions have been shown to be critical for transcription insulation activity as it stabilizes long-range interactions to promote proper gene expression. Previous studies suggest that heterochromatin boundary activity of CTCF may be independent of Cohesin, and there may be additional mechanisms for defining topological domains. Here, we show that a boundary site we previously identified known as CTCF binding site 5 (CBS5) from the homeotic gene cluster A (HOXA) locus exhibits robust promoter activity. This promoter activity from the CBS5 boundary element generates a long noncoding RNA that we designate as boundary associated long noncoding RNA-1 (blncRNA1). Functional characterization of this RNA suggests that the transcript stabilizes long-range interactions at the HOXA locus and promotes proper expression of HOXA genes. Additionally, our functional analysis also shows that this RNA is not needed in the stabilization of CTCF-Cohesin interactions however CTCF-Cohesin interactions are critical in the transcription of blncRNA1. Thus, the CTCF-associated boundary element, CBS5, employs both Cohesin and noncoding RNA to establish and maintain topologically associated domains at the HOXA locus.	[Nwigwe, Ifeoma Jane] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Kim, Yoon Jung; Kim, Tae Hoon] Univ Texas Dallas, Ctr Syst Biol, Richardson, TX 75080 USA; [Kim, Yoon Jung; Kim, Tae Hoon] Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75080 USA; [Wacker, David A.] Univ Maryland, Sch Med, Dept Internal Med, Baltimore, MD USA; [Wacker, David A.] Univ Maryland, Sch Med, Dept Emergency Med, Baltimore, MD USA	Yale University; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Kim, TH (corresponding author), Univ Texas Dallas, Ctr Syst Biol, Richardson, TX 75080 USA.	genome@utdallas.edu	Wacker, David/AHA-7557-2022	Wacker, David/0000-0002-1504-7819; Kim, Tae Hoon/0000-0003-3950-7557	Rita Allen Foundation; Sidney Kimmel Foundation for Cancer Research; Alexander and Margaret Stewart Trust; National Institute of Allergy and Infection Disease [R21AI107067]; National Cancer Institute [R01CA140485]; NATIONAL CANCER INSTITUTE [R01CA140485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107067] Funding Source: NIH RePORTER	Rita Allen Foundation; Sidney Kimmel Foundation for Cancer Research; Alexander and Margaret Stewart Trust; National Institute of Allergy and Infection Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Grants to T.H.K. from the Rita Allen Foundation, Sidney Kimmel Foundation for Cancer Research, Alexander and Margaret Stewart Trust, National Institute of Allergy and Infection Disease (R21AI107067), and National Cancer Institute (R01CA140485) supported this work.	Chernukhin I, 2007, MOL CELL BIOL, V27, P1631, DOI 10.1128/MCB.01993-06; Chopra VS, 2009, GENE DEV, V23, P1505, DOI 10.1101/gad.1807309; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Dostie J, 2007, NAT PROTOC, V2, P988, DOI 10.1038/nprot.2007.116; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Hacisuleyman E, 2014, NAT STRUCT MOL BIOL, V21, P198, DOI 10.1038/nsmb.2764; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim YJ, 2011, P NATL ACAD SCI USA, V108, P7391, DOI 10.1073/pnas.1018279108; Kung JT, 2015, MOL CELL, V57, P361, DOI 10.1016/j.molcel.2014.12.006; Kuzmin I, 2005, J MOL BIOL, V346, P411, DOI 10.1016/j.jmb.2004.11.066; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; NICKERSON JA, 1989, P NATL ACAD SCI USA, V86, P177, DOI 10.1073/pnas.86.1.177; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Ohlsson R, 2010, CHROMOSOMA, V119, P351, DOI 10.1007/s00412-010-0262-0; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Raab JR, 2010, NAT REV GENET, V11, P439, DOI 10.1038/nrg2765; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Saldana-Meyer R, 2014, GENE DEV, V28, P723, DOI 10.1101/gad.236869.113; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; Scott KC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001099; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Sun S, 2013, CELL, V153, P1537, DOI 10.1016/j.cell.2013.05.028; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wendt KS, 2009, CHROMOSOME RES, V17, P201, DOI 10.1007/s10577-008-9017-7; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; Yao HJ, 2010, GENE DEV, V24, P2543, DOI 10.1101/gad.1967810; Zhang H, 2014, J CELL BIOL, V204, P61, DOI 10.1083/jcb.201304152; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	42	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136104	10.1371/journal.pone.0136104	http://dx.doi.org/10.1371/journal.pone.0136104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302455	Green Submitted, Green Published, gold			2022-12-27	WOS:000359951900039
J	Zhao, GX; Li, YZ; Cui, L; Li, X; Jin, ZY; Han, XY; Fang, EN; Gao, YH; Zhou, DM; Jiang, HY; Jin, XY; Piao, GH; Li, XS; Yang, G; Jin, JY; Zhu, EB; Piao, MN; Piao, LM; Yuan, KC; Lei, YN; Ding, DZ; Jin, CZ; Nan, YS; Cheng, XW				Zhao, Guangxian; Li, Yuzi; Cui, Lan; Li, Xiang; Jin, Zhenyi; Han, Xiongyi; Fang, Ennan; Gao, Yihua; Zhou, Dongmei; Jiang, Haiying; Jin, Xueying; Piao, Guanghao; Li, Xiangshan; Yang, Guang; Jin, Jiyong; Zhu, Enbo; Piao, Meina; Piao, Limei; Yuan, Kuichang; Lei, Yanna; Ding, Dazhi; Jin, Chengzhi; Nan, Yongshan; Cheng, Xianwu			Increased Circulating Cathepsin K in Patients with Chronic Heart Failure	PLOS ONE			English	Article							ISCHEMIA-INDUCED NEOVASCULARIZATION; CYSTEINE PROTEASE CATHEPSINS; CYSTATIN-C; REDUCES ATHEROSCLEROSIS; MYOCARDIAL CONTRACTILE; DOBUTAMINE STRESS; RECEPTOR; CONTRIBUTES; DEFICIENCY; MECHANISMS	Cysteinyl cathepsin K (CatK) is one of the most potent mammalian collagenases involved in cardiovascular disease. Here, we investigated the clinical predictive value of serum CatK levels in patients with chronic heart failure (CHF). We examined 134 patients with CHF, measuring their serum CatK, troponin I, high-sensitive C-reactive protein, and pre-operative N-terminal pro-brain natriuretic peptide levels. The patients were divided into two groups: the 44 patients who showed a left ventricular (LV) ejection fraction (LVEF) < 40% (the "lowLVEF" group) and the 90 patients showing LVEF values >= 40% (the "highLVEF" group). The lowLVEF patients had significantly higher serum CatK levels compared to the highLVEF patients (58.4 +/- 12.2 vs. 44.7 +/- 16.4, P < 0.001). Overall, a linear regression analysis showed that CatK levels correlated negatively with LVEF (r = -0.4, P < 0.001) and positively with LV end-diastolic dimensions (r = 0.2, P < 0.01), LV end-systolic dimensions (r = 0.3, P < 0.001), and left atrial diameters (r = 0.3, P < 0.01). A multiple logistic regression analysis showed that CatK levels were independent predictors of CHF (odds ratio, 0.90; 95% confidence interval, 0.84-0.95; P < 0.01). These data indicate that elevated levels of CatK are closely associated with the presence of CHF and that the measurement of circulating CatK provides a noninvasive method of documenting and monitoring the extent of cardiac remodeling and dysfunction in patients with CHF.	[Zhao, Guangxian; Li, Yuzi; Cui, Lan; Li, Xiang; Jin, Zhenyi; Han, Xiongyi; Fang, Ennan; Jin, Xueying; Piao, Guanghao; Yang, Guang; Jin, Jiyong; Zhu, Enbo; Piao, Meina; Piao, Limei; Yuan, Kuichang; Lei, Yanna; Ding, Dazhi; Cheng, Xianwu] Yanbian Univ Hosp, Dept Cardiol, Yanji, Jilin, Peoples R China; [Gao, Yihua; Jin, Chengzhi] Yanbian Univ Hosp, Clin Examinat Dept, Yanji, Jilin, Peoples R China; [Zhou, Dongmei; Li, Xiangshan] Yanbian Univ Hosp, Dept Cent Lab, Yanji, Jilin, Peoples R China; [Jiang, Haiying] Yanbian Univ, Coll Med, Dept Physiol & Pathophysiol, Yanji, Jilin, Peoples R China; [Nan, Yongshan] Yanbian Univ Hosp, Dept Anesthesiol, Yanji, Jilin, Peoples R China	Yanbian University; Yanbian University; Yanbian University; Yanbian University; Yanbian University	Cui, L (corresponding author), Yanbian Univ Hosp, Dept Cardiol, Yanji, Jilin, Peoples R China.	lancui@ybu.edu.cn; chengxw0908@163.com			Scientific Research Fund of the Chinese Ministry of Education [30960128, 82160068]	Scientific Research Fund of the Chinese Ministry of Education	This work was supported by the Scientific Research Fund of the Chinese Ministry of Education (nos. 30960128, 82160068). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto T, 2005, J CARD FAIL, V11, P595, DOI 10.1016/j.cardfail.2005.06.001; Chen H, 2013, CARDIOVASC RES, V100, P84, DOI 10.1093/cvr/cvt158; Cheng XW, 2008, AM J PATHOL, V173, P358, DOI 10.2353/ajpath.2008.071126; Cheng XW, 2007, CIRC RES, V100, P904, DOI 10.1161/01.RES.0000260801.12916.b5; Cheng XW, 2006, HYPERTENSION, V48, P979, DOI 10.1161/01.HYP.0000242331.99369.2f; Cheng XW, 2013, ATHEROSCLEROSIS, V228, P211, DOI 10.1016/j.atherosclerosis.2013.01.004; Cheng XW, 2012, CIRCULATION, V125, P1551, DOI 10.1161/CIRCULATIONAHA.111.066712; Cheng XW, 2011, HYPERTENSION, V58, P978, DOI 10.1161/HYPERTENSIONAHA.111.180935; Cheng XW, 2011, HYPERTENSION, V57, P981, DOI 10.1161/HYPERTENSIONAHA.110.168385; Cheng XW, 2009, J CARDIOVASC PHARM, V54, P47, DOI 10.1097/FJC.0b013e3181ab371d; Fujita M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000503; Gonzalez A, 2010, HYPERTENSION, V55, P1418, DOI 10.1161/HYPERTENSIONAHA.109.149112; Hayashi D, 2013, J AM COLL CARDIOL, V61, P2007, DOI 10.1016/j.jacc.2013.01.074; Hua YA, 2015, AGING CELL, V14, P345, DOI 10.1111/acel.12276; Hua YA, 2013, HYPERTENSION, V61, P1184, DOI 10.1161/HYPERTENSIONAHA.111.00947; Hua YN, 2013, DIABETES, V62, P498, DOI 10.2337/db12-0350; Jiang HY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4838; Kobayashi M, 2008, JACC-CARDIOVASC IMAG, V1, P718, DOI 10.1016/j.jcmg.2008.04.012; Kozawa E, 2012, ARTHRITIS RHEUM-US, V64, P454, DOI 10.1002/art.33398; Li X, 2015, INT J CARDIOL, V183, P198, DOI 10.1016/j.ijcard.2015.01.058; Li Xiang, 2012, Chonnam Med J, V48, P77, DOI 10.4068/cmj.2012.48.2.77; Li ZQ, 2000, BIOCHEMISTRY-US, V39, P529, DOI 10.1021/bi992251u; Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012; Lutgens E, 2006, CIRCULATION, V113, P98, DOI 10.1161/CIRCULATIONAHA.105.561449; Manzano-Fernandez S, 2011, J AM COLL CARDIOL, V57, P849, DOI 10.1016/j.jacc.2010.08.644; Novinec M, 2007, J BIOL CHEM, V282, P7893, DOI 10.1074/jbc.M610107200; Patel PC, 2009, CIRC-HEART FAIL, V2, P98, DOI 10.1161/CIRCHEARTFAILURE.108.807271; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; SHI GP, 1992, J BIOL CHEM, V267, P7258; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Sun J, 2012, ARTERIOSCLER THROMB, V31, P2500; Sun JS, 2012, ARTERIOSCL THROM VAS, V32, P15, DOI 10.1161/ATVBAHA.111.235002; Sun Y, 2009, CIRC RES, V104, P455, DOI 10.1161/CIRCRESAHA.108.182568; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Westermann D, 2011, CIRC-HEART FAIL, V4, P44, DOI 10.1161/CIRCHEARTFAILURE.109.931451; Wilder CL, 2011, ARCH BIOCHEM BIOPHYS, V516, P52, DOI 10.1016/j.abb.2011.09.009; Xie LF, 2010, CARDIOVASC RES, V87, P628, DOI 10.1093/cvr/cvq138	38	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136093	10.1371/journal.pone.0136093	http://dx.doi.org/10.1371/journal.pone.0136093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	26302400	Green Published, Green Submitted, gold			2022-12-27	WOS:000359951900038
J	Shiba, N; Matsuse, H; Takano, Y; Yoshimitsu, K; Omoto, M; Hashida, R; Tagawa, Y; Inada, T; Yamada, S; Ohshima, H				Shiba, Naoto; Matsuse, Hiroo; Takano, Yoshio; Yoshimitsu, Kazuhiro; Omoto, Masayuki; Hashida, Ryuki; Tagawa, Yoshihiko; Inada, Tomohisa; Yamada, Shin; Ohshima, Hiroshi			Electrically Stimulated Antagonist Muscle Contraction Increased Muscle Mass and Bone Mineral Density of One Astronaut - Initial Verification on the International Space Station	PLOS ONE			English	Article							EXERCISE; VOLUNTARY; STRENGTH; HYPERTROPHY; SPACEFLIGHT; RESPONSES; VOLUME	Background Musculoskeletal atrophy is one of the major problems of extended periods of exposure to weightlessness such as on the International Space Station (ISS). We developed the Hybrid Training System (HTS) to maintain an astronaut's musculoskeletal system using an electrically stimulated antagonist to resist the volitional contraction of the agonist instead of gravity. The present study assessed the system's orbital operation capability and utility, as well as its preventative effect on an astronaut's musculoskeletal atrophy. Methods HTS was attached to the non-dominant arm of an astronaut staying on the ISS, and his dominant arm without HTS was established as the control (CTR). 10 sets of 10 reciprocal elbow curls were one training session, and 12 total sessions of training (3 times per week for 4 weeks) were performed. Pre and post flight ground based evaluations were performed by Biodex (muscle performance), MRI (muscle volume), and DXA (BMD, lean [muscle] mass, fat mass). Pre and post training inflight evaluations were performed by a hand held dynamometer (muscle force) and a measuring tape (upper arm circumference). Results The experiment was completed on schedule, and HTS functioned well without problems. Isokinetic elbow extension torque (Nm) changed -19.4% in HTS, and -21.7% in CTR. Isokinetic elbow flexion torque changed -23.7% in HTS, and there was no change in CTR. Total Work (Joule) of elbow extension changed -8.3% in HTS, and +0.3% in CTR. For elbow flexion it changed -23.3% in HTS and -32.6% in CTR. Average Power (Watts) of elbow extension changed +22.1% in HTS and -8.0% in CTR. For elbow flexion it changed -6.5% in HTS and -4.8% in CTR. Triceps muscle volume according to MRI changed +11.7% and that of biceps was +2.1% using HTS, however -0.1% and -0.4% respectively for CTR. BMD changed +4.6% in the HTS arm and -1.2% for CTR. Lean (muscle) mass of the arm changed only +10.6% in HTS. Fat mass changed -12.6% in HTS and -6.4% in CTR. Conclusions These results showed the orbital operation capability and utility, and the preventive effect of HTS for an astronaut's musculoskeletal atrophy. The initial flight data together with the ground data obtained so far will be utilized in the future planning of human space exploration.	[Shiba, Naoto; Yoshimitsu, Kazuhiro; Omoto, Masayuki; Hashida, Ryuki] Kurume Univ, Sch Med, Dept Orthoped, Kurume, Fukuoka 830, Japan; [Shiba, Naoto; Matsuse, Hiroo; Omoto, Masayuki; Hashida, Ryuki] Kurume Univ, Sch Med, Div Rehabil, Kurume, Fukuoka 830, Japan; [Takano, Yoshio] Fukuoka Int Univ Hlth & Welf, Div Phys Therapy, Okawa City, Fukuoka 8318501, Japan; [Tagawa, Yoshihiko; Inada, Tomohisa] Kyushu Inst Technol, Dept Mech & Control Engn, Kitakyushu, Fukuoka 804, Japan; [Yamada, Shin; Ohshima, Hiroshi] Japan Aerosp Explorat Agcy, Space Environm Utilizat Ctr, Tsukuba, Ibaraki, Japan	Kurume University; Kurume University; International University of Health & Welfare; Kyushu Institute of Technology; Japan Aerospace Exploration Agency (JAXA)	Shiba, N (corresponding author), Kurume Univ, Sch Med, Dept Orthoped, Kurume, Fukuoka 830, Japan.	nshiba@med.kurume-u.ac.jp			International Announcement of Utilization at ISS; Grant of ISS Research of Japan Space Forum	International Announcement of Utilization at ISS; Grant of ISS Research of Japan Space Forum	This study was supported by the International Announcement of Utilization at ISS 2009 and Grant of ISS Research of Japan Space Forum.	Akima H, 2000, MED SCI SPORT EXER, V32, P1743, DOI 10.1097/00005768-200010000-00013; BALOGUN JA, 1993, ARCH PHYS MED REHAB, V74, P910; Belavy DL, 2013, J APPL PHYSIOL, V115, P586, DOI 10.1152/japplphysiol.00376.2013; Bennie SD, 2002, EUR J APPL PHYSIOL, V88, P13, DOI 10.1007/s00421-002-0711-4; Cavanagh Peter R, 2005, Gravit Space Biol Bull, V18, P39; Conley MS, 1997, EUR J APPL PHYSIOL, V75, P443, DOI 10.1007/s004210050186; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Gopalakrishnan R, 2010, AVIAT SPACE ENVIR MD, V81, P91, DOI 10.3357/ASEM.2583.2010; HAINAUT K, 1992, SPORTS MED, V14, P100, DOI 10.2165/00007256-199214020-00003; Iwasaki T, 2006, TOHOKU J EXP MED, V209, P33, DOI 10.1620/tjem.209.33; Kawaguchi T, 2011, APPL PHYSIOL NUTR ME, V36, P276, DOI [10.1139/h10-108, 10.1139/H10-108]; Kawaguchi T, 2011, J GASTROENTEROL, V46, P746, DOI 10.1007/s00535-011-0378-x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LeBlanc A, 2000, J APPL PHYSIOL, V89, P2158, DOI 10.1152/jappl.2000.89.6.2158; LEBLANC A, 1995, AVIAT SPACE ENVIR MD, V66, P1151; LeBlanc A, 2013, OSTEOPOROSIS INT, V24, P2105, DOI 10.1007/s00198-012-2243-z; LeBlanc A., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P157; LeBlanc A. D., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P33; Matsugaki Toru, 2010, Kurume Medical Journal, V57, P101; Matsuse H, 2013, J REHABIL RES DEV, V50, P545, DOI 10.1682/JRRD.2012.04.0067; Orwoll ES, 2013, J BONE MINER RES, V28, P1243, DOI 10.1002/jbmr.1948; Ploutz-Snyder LL, 2015, HRP47072 HUM HLTH CO; Seger JY, 2000, ACTA PHYSIOL SCAND, V169, P63; Smith SM, 2012, J BONE MINER RES, V27, P1896, DOI 10.1002/jbmr.1647; Stein RB, 1999, J BIOMECH, V32, P347, DOI 10.1016/S0021-9290(98)00187-0; Tesch PA, 2005, EUR J APPL PHYSIOL, V93, P463, DOI 10.1007/s00421-004-1236-9; Thornton W.E., 1977, BIOMEDICAL RESULTS S, P191; Trappe S, 2009, J APPL PHYSIOL, V106, P1159, DOI 10.1152/japplphysiol.91578.2008; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Welle S, 1996, J GERONTOL A-BIOL, V51, pM270, DOI 10.1093/gerona/51A.6.M270; Yanagi T, 2003, ARCH PHYS MED REHAB, V84, P843, DOI 10.1016/S0003-9993(02)04948-1; Yoshimitsu K, 2010, TOHOKU J EXP MED, V220, P83, DOI 10.1620/tjem.220.83; Zwart SR, 2005, INT SPORTMED J, V6, P199	33	11	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0134736	10.1371/journal.pone.0134736	http://dx.doi.org/10.1371/journal.pone.0134736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26296204	Green Published, Green Submitted, gold			2022-12-27	WOS:000359926900015
J	Trianni, V; Lopez-Ibanez, M				Trianni, Vito; Lopez-Ibanez, Manuel			Advantages of Task-Specific Multi-Objective Optimisation in Evolutionary Robotics	PLOS ONE			English	Article							INCREMENTAL EVOLUTION; SELF-ORGANIZATION; CONTROLLERS; COMPLEXITY; GENERATION; MORPHOLOGY; BEHAVIORS	The application of multi-objective optimisation to evolutionary robotics is receiving increasing attention. A survey of the literature reveals the different possibilities it offers to improve the automatic design of efficient and adaptive robotic systems, and points to the successful demonstrations available for both task-specific and task-agnostic approaches (i.e., with or without reference to the specific design problem to be tackled). However, the advantages of multi-objective approaches over single-objective ones have not been clearly spelled out and experimentally demonstrated. This paper fills this gap for task-specific approaches: starting from well-known results in multi-objective optimisation, we discuss how to tackle commonly recognised problems in evolutionary robotics. In particular, we show that multi-objective optimisation (i) allows evolving a more varied set of behaviours by exploring multiple trade-offs of the objectives to optimise, (ii) supports the evolution of the desired behaviour through the introduction of objectives as proxies, (iii) avoids the premature convergence to local optima possibly introduced by multi-component fitness functions, and (iv) solves the bootstrap problem exploiting ancillary objectives to guide evolution in the early phases. We present an experimental demonstration of these benefits in three different case studies: maze navigation in a single robot domain, flocking in a swarm robotics context, and a strictly collaborative task in collective robotics.	[Trianni, Vito] CNR, ISTC, Rome, Italy; [Lopez-Ibanez, Manuel] ULB, IRIDIA, CoDE, Brussels, Belgium	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); Universite Libre de Bruxelles	Trianni, V (corresponding author), CNR, ISTC, Rome, Italy.	vito.trianni@istc.cnr.it	López-Ibáñez, Manuel/L-4517-2014; Trianni, Vito/B-8332-2015	López-Ibáñez, Manuel/0000-0001-9974-1295; Trianni, Vito/0000-0002-9114-8486				Agapitos A, 2007, IEEE C EVOL COMPUTAT, P1562, DOI 10.1109/CEC.2007.4424659; Auerbach JE, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003399; Bader J, 2011, EVOL COMPUT, V19, P45, DOI 10.1162/EVCO_a_00009; Baldassarre G, 2003, ARTIF LIFE, V9, P255, DOI 10.1162/106454603322392460; Barlow GJ, 2004, CONF CYBERN INTELL S, P689; Bernatskiy A., 2014, ARTIFICIAL LIFE 14 I, V14, P726; Beume N, 2007, EUR J OPER RES, V181, P1653, DOI 10.1016/j.ejor.2006.08.008; Bonani M, 2010, IEEE INT C INT ROBOT, P4187, DOI 10.1109/IROS.2010.5649153; Bongard J, 2010, ARTIF LIFE, V16, P201, DOI 10.1162/artl.2010.Bongard.024; Bongard JC, 2013, GECCO'13: PROCEEDINGS OF THE 2013 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P159; Bongard JC, 2011, IEEE T EVOLUT COMPUT, V15, P571, DOI 10.1109/TEVC.2010.2096540; Branke J., 2008, LNCS, V5252; Capi G, 2007, IEEE T ROBOT, V23, P1225, DOI 10.1109/TRO.2007.910773; da Fonseca V.G., 2010, EXPT METHODS ANAL OP, P103; da Fonseca VG, 2001, LECT NOTES COMPUT SC, V1993, P213; Das I, 1997, STRUCT OPTIMIZATION, V14, P63, DOI 10.1007/BF01197559; de Margerie E, 2007, BIOINSPIR BIOMIM, V2, P65, DOI 10.1088/1748-3182/2/4/002; Deb K., 2001, WIL INT S SYS OPT; Doncieux S, 2013, PROCEEDINGS OF THE 2, P1; Doncieux S, 2015, FRONT ROBOT AI, DOI 10.3389/frobt.2015.00004; Doncieux S, 2014, EVOL INTELL, V7, P71, DOI 10.1007/s12065-014-0110-x; Fehervari I, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P1209; FLOREANO D, 1994, COM ADAP SY, P421; Floreano D, 2000, NEURAL NETWORKS, V13, P431, DOI 10.1016/S0893-6080(00)00032-0; Floreano D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000292; GRUAU F, 1997, COM ADAP SY, P368; Handl J., 2008, MULTIOBJECTIVE PROBL, P131; Ortiz JAH, 2013, ENG OPTIMIZ, V45, P19, DOI 10.1080/0305215X.2012.658781; Ijspeert AJ, 2001, AUTON ROBOT, V11, P149, DOI 10.1023/A:1011227210047; Ishibuchi H, 2008, IEEE C EVOL COMPUTAT, P2419, DOI 10.1109/CEC.2008.4631121; Jaszkiewicz A, 2008, LECT NOTES COMPUT SC, V5252, P179, DOI 10.1007/978-3-540-88908-3_7; Koos S, 2013, INT J ROBOT RES, V32, P1700, DOI 10.1177/0278364913499192; Koos S, 2013, IEEE T EVOLUT COMPUT, V17, P122, DOI 10.1109/TEVC.2012.2185849; Lehman J, 2013, ADAPT BEHAV, V21, P484, DOI 10.1177/1059712313487390; Lehman J, 2013, GECCO'13: PROCEEDINGS OF THE 2013 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P215; Lehman J, 2011, GECCO-2011: PROCEEDINGS OF THE 13TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P211; Lehman J, 2011, EVOL COMPUT, V19, P189, DOI 10.1162/EVCO_a_00025; Lipson H, 2006, BIOMIMETICS: BIOLOGICALLY INSPIRED TECHNOLOGIES, P129; Lopes MA, 2010, ESTUD HUMAN, P209, DOI 10.1007/978-3-642-02538-9_9; Marler RT, 2004, STRUCT MULTIDISCIP O, V26, P369, DOI 10.1007/s00158-003-0368-6; Miglino O, 2008, ARTIF LIFE ROBOT, V13, P1, DOI 10.1007/s10015-008-0503-y; Moshaiov A, 2014, 2014 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P2809, DOI 10.1109/CEC.2014.6900433; Moshaiov A, 2009, IEEE C EVOL COMPUTAT, P1093, DOI 10.1109/CEC.2009.4983068; Mouret JB, 2012, EVOL COMPUT, V20, P91, DOI 10.1162/EVCO_a_00048; Mouret JB, 2008, LECT NOTES ARTIF INT, V5040, P210; Mouret JB, 2006, LECT NOTES COMPUT SC, V4095, P606; Mouret JB, 2011, STUD COMPUT INTELL, V341, P139; Mouret JB, 2009, IEEE C EVOL COMPUTAT, P1161, DOI 10.1109/CEC.2009.4983077; Nelson AL, 2009, ROBOT AUTON SYST, V57, P345, DOI 10.1016/j.robot.2008.09.009; Nolfi S., 2000, EVOLUTIONARY ROBOTIC; Oliveira M, 2013, IEEE-RAS INT C HUMAN, P106, DOI 10.1109/HUMANOIDS.2013.7029963; Oliveira M, 2013, IEEE INT CONF ROBOT, P3130, DOI 10.1109/ICRA.2013.6631012; Ollion C, 2012, ARTIF LIFE, V13, P407; Pfeifer R, 2007, SCIENCE, V318, P1088, DOI 10.1126/science.1145803; Pinciroli C, 2012, SWARM INTELL-US, V6, P271, DOI 10.1007/s11721-012-0072-5; Pinville T, 2011, GECCO-2011: PROCEEDINGS OF THE 13TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P259; Quinn M, 2003, PHILOS T R SOC A, V361, P2321, DOI 10.1098/rsta.2003.1258; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Takagi H, 2001, P IEEE, V89, P1275, DOI 10.1109/5.949485; Teo J, 2005, IEEE T EVOLUT COMPUT, V9, P337, DOI 10.1109/TEVC.2005.846902; Teo J, 2004, EVOL COMPUT, V12, P355, DOI 10.1162/1063656041774974; Terekhov AV, 2011, IEEE INT C INT ROBOT, P4360, DOI 10.1109/IROS.2011.6048597; Terekhov AV, 2010, IEEE INT C INT ROBOT, P4782, DOI 10.1109/IROS.2010.5651397; Trianni V, 2011, ARTIF LIFE, V17, P183, DOI 10.1162/artl_a_00031; Van Veldhuizen D. A., 2007, EVOLUTIONARY ALGORIT, V5; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Zitzler E, 1998, LECT NOTES COMPUT SC, V1498, P292, DOI 10.1007/BFb0056872	68	15	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136406	10.1371/journal.pone.0136406	http://dx.doi.org/10.1371/journal.pone.0136406			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295151	Green Submitted, gold, Green Published			2022-12-27	WOS:000359926900106
J	Bahudhanapati, H; Bhattacharya, S; Wei, S				Bahudhanapati, Harinath; Bhattacharya, Shashwati; Wei, Shuo			Evolution of Vertebrate Adam Genes; Duplication of Testicular Adams from Ancient Adam9/9-like Loci	PLOS ONE			English	Article							CRANIAL NEURAL CREST; POTENTIAL ROLE; GENOME EVOLUTION; SPERM; METALLOPROTEASE; PROTEIN; DISINTEGRIN; IDENTIFICATION; DOMAIN; FERTILIZATION	Members of the disintegrin metalloproteinase (ADAM) family have important functions in regulating cell-cell and cell-matrix interactions as well as cell signaling. There are two major types of ADAMs: the somatic ADAMs (sADAMs) that have a significant presence in somatic tissues, and the testicular ADAMs (tADAMs) that are expressed predominantly in the testis. Genes encoding tADAMs can be further divided into two groups: group I (intronless) and group II (intron-containing). To date, tAdams have only been reported in placental mammals, and their evolutionary origin and relationship to sAdams remain largely unknown. Using phylogenetic and syntenic tools, we analyzed the Adam genes in various vertebrates ranging from fishes to placental mammals. Our analyses reveal duplication and loss of some sAdams in certain vertebrate species. In particular, there exists an Adam9-like gene in non-mammalian vertebrates but not mammals. We also identified putative group I and group II tAdams in all amniote species that have been examined. These tAdam homologues are more closely related to Adams 9 and 9-like than to other sAdams. In all amniote species examined, group II tAdams lie in close vicinity to Adam9 and hence likely arose from tandem duplication, whereas group I tAdams likely originated through retroposition because of their lack of introns. Clusters of multiple group I tAdams are also common, suggesting tandem duplication after retroposition. Therefore, Adam9/9-like and some of the derived tAdam loci are likely preferred targets for tandem duplication and/or retroposition. Consistent with this hypothesis, we identified a young retroposed gene that duplicated recently from Adam9 in the opossum. As a result of gene duplication, some tAdams were pseudogenized in certain species, whereas others acquired new expression patterns and functions. The rapid duplication of Adam genes has a major contribution to the diversity of ADAMs in various vertebrate species.	[Bahudhanapati, Harinath; Bhattacharya, Shashwati; Wei, Shuo] W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA	West Virginia University	Wei, S (corresponding author), W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA.	Shuo.Wei@mail.wvu.edu		Wei, Shuo/0000-0001-8203-4922; Bhattacharya, Shashwati/0000-0003-1327-9808	U.S. National Institute of Health [GM114105, DE022813]; March of Dimes Foundation [1-FY10-399]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE022813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114105] Funding Source: NIH RePORTER	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the U.S. National Institute of Health (GM114105 and DE022813 to SW) and the March of Dimes Foundation (1-FY10-399 to SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Angerer L, 2006, DEV BIOL, V300, P267, DOI 10.1016/j.ydbio.2006.07.046; Bates EEM, 2002, IMMUNOGENETICS, V54, P96, DOI 10.1007/s00251-002-0430-3; BLOBEL CP, 1992, NATURE, V356, P248, DOI 10.1038/356248a0; Cho CH, 1998, SCIENCE, V281, P1857, DOI 10.1126/science.281.5384.1857; Cho C, 2012, NAT REV UROL, V9, P550, DOI 10.1038/nrurol.2012.167; Choi H, 2013, MOL BIOL REP, V40, P787, DOI 10.1007/s11033-012-2116-8; Christian L, 2013, CRIT REV BIOCHEM MOL, V48, P544, DOI 10.3109/10409238.2013.838203; Cousin H, 2011, DEV CELL, V20, P256, DOI 10.1016/j.devcel.2010.12.009; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Grzmil P, 2001, BIOCHEM J, V357, P551, DOI 10.1042/0264-6021:3570551; Han C, 2009, BIOL REPROD, V80, P1001, DOI 10.1095/biolreprod.108.073700; Huxley-Jones J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-63; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jury JA, 1997, BIOCHEM J, V321, P577, DOI 10.1042/bj3210577; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kurisaki T, 2003, MOL CELL BIOL, V23, P55, DOI 10.1128/MCB.23.1.55-61.2003; Louis A, 2013, NUCLEIC ACIDS RES, V41, pD700, DOI 10.1093/nar/gks1156; Lum L, 1997, DEV BIOL, V191, P131, DOI 10.1006/dbio.1997.8609; Mandal PK, 2013, HUM MOL GENET, V22, P3730, DOI 10.1093/hmg/ddt225; Maretzky T, 2009, BIOCHEM J, V420, P105, DOI 10.1042/BJ20082127; Marques AC, 2005, PLOS BIOL, V3, P1970, DOI 10.1371/journal.pbio.0030357; Meslin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044548; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Murase SI, 2008, EUR J NEUROSCI, V27, P1585, DOI 10.1111/j.1460-9568.2008.06119.x; Najy AJ, 2008, J BIOL CHEM, V283, P18393, DOI 10.1074/jbc.M801329200; Nishimura H, 2004, J BIOL CHEM, V279, P34957, DOI 10.1074/jbc.M314249200; Okamura K, 2008, MOL BIOL EVOL, V25, P1231, DOI 10.1093/molbev/msn071; Parry DA, 2009, AM J HUM GENET, V84, P683, DOI 10.1016/j.ajhg.2009.04.005; Peduto L, 2009, CURR PHARM DESIGN, V15, P2282, DOI 10.2174/138161209788682415; PRIMAKOFF P, 1987, J CELL BIOL, V104, P141, DOI 10.1083/jcb.104.1.141; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rooke J, 1996, SCIENCE, V273, P1227, DOI 10.1126/science.273.5279.1227; Sapir A, 2005, DEVELOPMENT, V132, P123, DOI 10.1242/dev.01546; Shamsadin R, 1999, BIOL REPROD, V61, P1445, DOI 10.1095/biolreprod61.6.1445; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Shilling FM, 1997, DEV BIOL, V186, P155, DOI 10.1006/dbio.1997.8586; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vinckenbosch N, 2006, P NATL ACAD SCI USA, V103, P3220, DOI 10.1073/pnas.0511307103; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Wei S, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1086, DOI 10.1016/B978-0-12-382219-2.00248-9; Wei S, 2012, DEV BIOL, V363, P147, DOI 10.1016/j.ydbio.2011.12.031; Wei S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-211; Wei S, 2010, DEV CELL, V19, P345, DOI 10.1016/j.devcel.2010.07.012; WOLFSBERG TG, 1993, P NATL ACAD SCI USA, V90, P10783, DOI 10.1073/pnas.90.22.10783; WOLFSBERG TG, 1995, DEV BIOL, V169, P378, DOI 10.1006/dbio.1995.1152; YAGAMIHIROMASA T, 1995, NATURE, V377, P652, DOI 10.1038/377652a0; Yamaguchi R, 2009, BIOL REPROD, V81, P142, DOI 10.1095/biolreprod.108.074021; Zhu GZ, 2009, MOL REPROD DEV, V76, P1106, DOI 10.1002/mrd.21076; Zhu GZ, 2001, J CELL SCI, V114, P1787; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	56	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136281	10.1371/journal.pone.0136281	http://dx.doi.org/10.1371/journal.pone.0136281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26308360	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400100
J	Belke, B; Leder, H; Carbon, CC				Belke, Benno; Leder, Helmut; Carbon, Claus Christian			When Challenging Art Gets Liked: Evidences for a Dual Preference Formation Process for Fluent and Non-Fluent Portraits	PLOS ONE			English	Article								Although fluency theory predominates psychological research on human aesthetics, its most severe limitation may be to explain why art that challenges or even violates easy processing can nevertheless be aesthetically rewarding. We discuss long-standing notions on art's potential to offer mental growth opportunities and to tap into a basic epistemic predisposition that hint at a fluency counteracting aesthetic pleasure mechanism. Based on divergent strands of literature on empirical, evolutionary, and philosophical aesthetics, as well as research on disfluency, we presumed that challenging art requires deliberate reflexive processing at the level of "aboutness" in order to be experientially pleasing. Here, we probed such a cognitive mastering mechanism, achieved by iterative cycles of elaboration, as predicted by our model of aesthetic experiences. For the study, two kinds of portraits were applied, one associable to a high fluency and one to a high stimulation potential (according to results of an extensive rating study). In Experiment 1, we provided a repeated evaluation task, which revealed a distinctive preference effect for challenging portraits that was absent in the visual exposition conditions of a familiarity and a mere exposure task (Experiment 2). In a follow-up task (Experiment 3) this preference effect was observed with a novel and more encompassing pool of portraits, which corroborated its stability and robustness. In an explorative stimulus-transfer task (Experiment 4), we investigated the presumed underlying mechanism by testing whether the observed effect would generalize onto novel portraits of the same artist-specific styles. Results discounted an alternative interpretation of a perceptual adaptation effect and hinted at meaning-driven mental activity. Conjointly, findings for inexperienced viewers were indicative of an elaboration based mastering mechanism that selectively operated for mentally challenging portraits. Moreover, findings were in line with a dual-process view of human preference formation with art. Theoretical implications and boundary conditions are discussed.	[Belke, Benno; Leder, Helmut] Univ Vienna, Fac Psychol, Dept Basic Psychol Res & Res Methods, Vienna, Austria; [Carbon, Claus Christian] Univ Bamberg, Dept Gen Psychol & Methodol, Bamberg, Germany; [Carbon, Claus Christian] Bamberg Grad Sch Affect & Cognit Sci, Bamberg, Germany	University of Vienna; Otto Friedrich University Bamberg	Belke, B (corresponding author), Univ Vienna, Fac Psychol, Dept Basic Psychol Res & Res Methods, Vienna, Austria.	benno.belke@gmail.com	Carbon, Claus-Christian/A-7494-2008; Carbon, Claus-Christian/GLQ-6274-2022	Carbon, Claus-Christian/0000-0002-3446-9347; Carbon, Claus-Christian/0000-0002-3446-9347	Austrian Science Fond (FWF) [P23538]; Austrian Science Fund (FWF) [P 23538] Funding Source: researchfish	Austrian Science Fond (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by the Austrian Science Fond (FWF); Project Number: P23538 [http://www.fwf.ac.at]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.		0	40	40	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0131796	10.1371/journal.pone.0131796	http://dx.doi.org/10.1371/journal.pone.0131796			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309095	gold, Green Published			2022-12-27	WOS:000360069400004
J	Cai, YX; Zheng, YQ; Liang, MJ; Zhao, F; Yu, GZ; Liu, Y; Chen, YB; Chen, GS				Cai, Yuexin; Zheng, Yiqing; Liang, Maojin; Zhao, Fei; Yu, Guangzheng; Liu, Yu; Chen, Yuebo; Chen, Guisheng			Auditory Spatial Discrimination and the Mismatch Negativity Response in Hearing-Impaired Individuals	PLOS ONE			English	Article							BILATERAL COCHLEAR IMPLANTS; MINIMUM AUDIBLE ANGLE; SOUND LOCALIZATION; BINAURAL HEARING; INTERAURAL DIFFERENCES; SPEECH-PERCEPTION; OLDER-ADULTS; SCALE SSQ; CORTEX; CHILDREN	The aims of the present study were to investigate the ability of hearing-impaired (HI) individuals with different binaural hearing conditions to discriminate spatial auditory-sources at the midline and lateral positions, and to explore the possible central processing mechanisms by measuring the minimal audible angle (MAA) and mismatch negativity (MMN) response. To measure MAA at the left/right 0 degrees, 45 degrees and 90 degrees positions, 12 normal-hearing (NH) participants and 36 patients with sensorineural hearing loss, which included 12 patients with symmetrical hearing loss (SHL) and 24 patients with asymmetrical hearing loss (AHL) [12 with unilateral hearing loss on the left (UHLL) and 12 with unilateral hearing loss on the right (UHLR)] were recruited. In addition, 128-electrode electroencephalography was used to record the MMN response in a separate group of 60 patients (20 UHLL, 20 UHLR and 20 SHL patients) and 20 NH participants. The results showed MAA thresholds of the NH participants to be significantly lower than the HI participants. Also, a significantly smaller MAA threshold was obtained at the midline position than at the lateral position in both NH and SHL groups. However, in the AHL group, MAA threshold for the 90 degrees position on the affected side was significantly smaller than the MMA thresholds obtained at other positions. Significantly reduced amplitudes and prolonged latencies of the MMN were found in the HI groups compared to the NH group. In addition, contralateral activation was found in the UHL group for sounds emanating from the 90 degrees position on the affected side and in the NH group. These findings suggest that the abilities of spatial discrimination at the midline and lateral positions vary significantly in different hearing conditions. A reduced MMN amplitude and prolonged latency together with bilaterally symmetrical cortical activations over the auditory hemispheres indicate possible cortical compensatory changes associated with poor behavioral spatial discrimination in individuals with HI.	[Cai, Yuexin; Zheng, Yiqing; Liang, Maojin; Chen, Yuebo; Chen, Guisheng] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Otolaryngol, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Yuexin; Zheng, Yiqing; Liang, Maojin; Chen, Yuebo; Chen, Guisheng] Sun Yat Sen Univ, Inst Hearing & Speech Language Sci, Guangzhou 510275, Guangdong, Peoples R China; [Zhao, Fei] Cardiff Metropolitan Univ, Dept Speech Language Therapy & Hearing Sci, Cardiff, S Glam, Wales; [Zhao, Fei] Sun Yat Sen Univ, Xinhua Coll, Dept Hearing & Speech Sci, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Guangzheng; Liu, Yu] S China Univ Technol, Dept Phys, Acoust Lab, Guangzhou 510641, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Cardiff Metropolitan University; Sun Yat Sen University; South China University of Technology	Zheng, YQ (corresponding author), Sun Yat Sen Univ, Inst Hearing & Speech Language Sci, Guangzhou 510275, Guangdong, Peoples R China.	yiqingzheng@hotmail.com	Yu, Guangzheng/I-6053-2018	Yu, Guangzheng/0000-0002-8521-0474; zheng, yiqing/0000-0002-3641-1640; Zhao, Fei/0000-0002-0936-4447	National Science Foundation of China [81170921]; Science Foundation of Guangdong Province [S2011010004576]; National University Student Innovation Training Scheme [201501091]; British Council PMI2	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National University Student Innovation Training Scheme; British Council PMI2	This work was partially funded by National Science Foundation of China (Grant No. 81170921), Science Foundation of Guangdong Province (Grant No. S2011010004576), National University Student Innovation Training Scheme (Grant No. 201501091), and British Council PMI2 funding.	Altman JA, 2005, NEUROSCI LETT, V384, P330, DOI 10.1016/j.neulet.2005.05.002; Bennemann J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00338; Bottari D, 2014, NEUROIMAGE, V94, P172, DOI 10.1016/j.neuroimage.2014.02.031; Campbell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090594; Campbell J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00071; Ching Teresa Y C, 2006, Audiol Neurootol, V11 Suppl 1, P6; Colin C, 2002, CLIN NEUROPHYSIOL, V113, P507, DOI 10.1016/S1388-2457(02)00028-7; Deouell LY, 2007, NEURON, V55, P985, DOI 10.1016/j.neuron.2007.08.019; Deouell LY, 2006, EUR J NEUROSCI, V24, P1488, DOI 10.1111/j.1460-9568.2006.05025.x; Doucet ME, 2006, BRAIN, V129, P3376, DOI 10.1093/brain/awl264; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Finney EM, 2003, NEUROREPORT, V14, P1425, DOI 10.1097/00001756-200308060-00004; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; Firszt JB, 2008, J REHABIL RES DEV, V45, P749, DOI 10.1682/JRRD.2007.08.0120; Freigang C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00146; Glyde H, 2013, EAR HEARING, V34, P15, DOI 10.1097/AUD.0b013e3182617f94; Godar SP, 2010, OTOL NEUROTOL, V31, P1287, DOI 10.1097/MAO.0b013e3181e75784; Gordon KA, 2013, BRAIN, V136, P1609, DOI 10.1093/brain/awt052; Grieco-Calub TM, 2012, EAR HEARING, V33, P561, DOI 10.1097/AUD.0b013e31824c7801; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Harkrider AW, 2009, EAR HEARING, V30, P31, DOI 10.1097/AUD.0b013e31818f359f; HAWKINS DB, 1980, AUDIOLOGY, V19, P495; Hawley ML, 2004, J ACOUST SOC AM, V115, P833, DOI 10.1121/1.1639908; Hine J, 2007, CLIN NEUROPHYSIOL, V118, P1274, DOI 10.1016/j.clinph.2007.03.012; Hopkins K, 2011, J ACOUST SOC AM, V130, P334, DOI 10.1121/1.3585848; Keating P, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00123; Kerber S, 2012, EAR HEARING, V33, P445, DOI 10.1097/AUD.0b013e318257607b; Kidd G, 2005, J ACOUST SOC AM, V118, P3804, DOI 10.1121/1.2109187; Kuhnle S, 2013, AUDIOL NEURO-OTOL, V18, P48, DOI 10.1159/000342904; Lee DS, 2001, NATURE, V409, P149, DOI 10.1038/35051653; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Litovsky RY, 2006, INT J AUDIOL, V45, pS78, DOI 10.1080/14992020600782956; Maslin MRD, 2013, CLIN NEUROPHYSIOL, V124, P391, DOI 10.1016/j.clinph.2012.07.016; Matthews N, 2007, CLIN NEUROPHYSIOL, V118, P833, DOI 10.1016/j.clinph.2006.11.017; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; MILLS AW, 1958, J ACOUST SOC AM, V30, P237, DOI 10.1121/1.1909553; Naatanen R., 2018, ATTENTION BRAIN FUNC; Noble W, 2006, INT J AUDIOL, V45, P172, DOI 10.1080/14992020500376933; Noble W, 2004, INT J AUDIOL, V43, P100, DOI 10.1080/14992020400050015; Noble W, 2010, J AM ACAD AUDIOL, V21, P568, DOI 10.3766/jaaa.21.9.2; Oates PA, 2002, EAR HEARING, V23, P399, DOI 10.1097/00003446-200210000-00002; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Richter N, 2009, NEUROPSYCHOLOGIA, V47, P2652, DOI 10.1016/j.neuropsychologia.2009.05.017; Ross B, 2007, J NEUROSCI, V27, P11172, DOI 10.1523/JNEUROSCI.1813-07.2007; Rothpletz AM, 2012, J SPEECH LANG HEAR R, V55, P511, DOI 10.1044/1092-4388(2011/10-0205); Sandmann P, 2012, BRAIN, V135, P555, DOI 10.1093/brain/awr329; Savel S, 2009, HEARING RES, V255, P142, DOI 10.1016/j.heares.2009.06.013; Senn P, 2005, AUDIOL NEURO-OTOL, V10, P342, DOI 10.1159/000087351; Shestopalova LB, 2012, NEUROPSYCHOLOGIA, V50, P2720, DOI 10.1016/j.neuropsychologia.2012.07.043; Spierer L, 2009, BRAIN, V132, P1953, DOI 10.1093/brain/awp127; Strelnikov K, 2013, BRAIN, V136, P3682, DOI 10.1093/brain/awt274; van Hoesel RJM, 2004, AUDIOL NEURO-OTOL, V9, P234, DOI 10.1159/000078393; van Hoesel RJM, 2003, J ACOUST SOC AM, V113, P1617, DOI 10.1121/1.1539520; Woldorff MG, 1999, HUM BRAIN MAPP, V7, P49, DOI 10.1002/(SICI)1097-0193(1999)7:1<49::AID-HBM5>3.3.CO;2-A; Xie B., 2013, HEAD RELATED TRANSFE; Xie BS, 2012, J ACOUST SOC AM, V132, P282, DOI 10.1121/1.4728168; YOST WA, 1988, J ACOUST SOC AM, V83, P1846, DOI 10.1121/1.396520; Zatorre RJ, 2001, J NEUROSCI, V21, P6321, DOI 10.1523/JNEUROSCI.21-16-06321.2001; Zhong XL, 2009, J ACOUST SOC AM, V125, P2209, DOI 10.1121/1.3087433	59	13	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136299	10.1371/journal.pone.0136299	http://dx.doi.org/10.1371/journal.pone.0136299			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305694	Green Submitted, Green Published, gold			2022-12-27	WOS:000359995500061
J	Chowdhury, S; Grimm, L; Gong, YJK; Wang, BX; Li, B; Srikant, CB; Gao, ZH; Liu, JL				Chowdhury, Subrata; Grimm, Larson; Gong, Ying Jia Kate; Wang, Beixi; Li, Bing; Srikant, Coimbatore B.; Gao, Zu-hua; Liu, Jun-Li			Decreased 11 beta-Hydroxysteroid Dehydrogenase 1 Level and Activity in Murine Pancreatic Islets Caused by Insulin-Like Growth Factor I Overexpression	PLOS ONE			English	Article							IGF-I; BETA-CELLS; GENE-EXPRESSION; SIGNIFICANT RESISTANCE; DIABETES-MELLITUS; TYPE-1; DEXAMETHASONE; SECRETION; STREPTOZOTOCIN; ACTIVATION	We have reported a high expression of IGF-I in pancreatic islet beta-cells of transgenic mice under the metallothionein promoter. cDNA microarray analysis of the islets revealed that the expression of 82 genes was significantly altered compared to wild-type mice. Of these, 11 beta-hydroxysteroid dehydrogenase 1 (11 beta-HSD1), which is responsible for the conversion of inert cortisone (11-dehydrocorticosterone, DHC in rodents) to active cortisol (corticosterone) in the liver and adipose tissues, has not been identified previously as an IGF-I target in pancreatic islets. We characterized the changes in its protein level, enzyme activity and glucose-stimulated insulin secretion. In freshly isolated islets, the level of 11 beta-HSD1 protein was significantly lower in MT-IGF mice. Using dual-labeled immunofluorescence, 11 beta-HSD1 was observed exclusively in glucagon-producing, islet a-cells but at a lower level in transgenic vs. wild-type animals. MT-IGF islets also exhibited reduced enzymatic activities. Dexamethasone (DEX) and DHC inhibited glucose-stimulated insulin secretion from freshly isolated islets of wild-type mice. In the islets of MT-IGF mice, 48-h pre-incubation of DEX caused a significant decrease in insulin release, while the effect of DHC was largely blunted consistent with diminished 11 beta-HSD1 activity. In order to establish the function of intracrine glucocorticoids, we overexpressed 11 beta-HSD1 cDNA in MIN6 insulinoma cells, which together with DHC caused apoptosis and a significant decrease in proliferation. Both effects were abolished with the treatment of an 11 beta-HSD1 inhibitor. Our results demonstrate an inhibitory effect of IGF-I on 11 beta-HSD1 expression and activity within the pancreatic islets, which may mediate part of the IGF-I effects on cell proliferation, survival and insulin secretion.	[Chowdhury, Subrata; Grimm, Larson; Gong, Ying Jia Kate; Wang, Beixi; Li, Bing; Srikant, Coimbatore B.; Liu, Jun-Li] McGill Univ, Ctr Hlth, Res Inst, Fraser Labs Diabet Res,Dept Med, Montreal, PQ, Canada; [Gao, Zu-hua] McGill Univ, Ctr Hlth, Res Inst, Dept Pathol, Montreal, PQ, Canada; [Liu, Jun-Li] Montreal Diabet Res Ctr, Montreal, PQ, Canada	McGill University; McGill University; Universite de Montreal	Gao, ZH (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Dept Pathol, Montreal, PQ, Canada.	zu-hua.gao@mcgill.ca; jun-li.liu@mcgill.ca	Liu, Jun-Li/A-1501-2008; liu, jun-li/O-2115-2019	Liu, Jun-Li/0000-0001-6251-6406; Grimm, Larson/0000-0003-3372-9618	Research Institute of McGill University Health Centre; Canadian Diabetes Association [OG-3-11-3469-JL]	Research Institute of McGill University Health Centre; Canadian Diabetes Association	This work was supported by the Research Institute of McGill University Health Centre and Canadian Diabetes Association (OG-3-11-3469-JL).	[Anonymous], 2012, J THEOR PHYS, DOI DOI 10.1103/PHYSREVA.85; Brereton PS, 2001, ENDOCRINOLOGY, V142, P1644, DOI 10.1210/en.142.4.1644; Chapman K, 2013, PHYSIOL REV, V93, P1139, DOI 10.1152/physrev.00020.2012; Chowdhury S, 2014, ENDOCRINOLOGY, V155, P1629, DOI 10.1210/en.2013-1735; Davani B, 2000, J BIOL CHEM, V275, P34841, DOI 10.1074/jbc.C000600200; Duplomb L, 2004, BIOCHEM BIOPH RES CO, V313, P594, DOI 10.1016/j.bbrc.2003.11.160; Getty-Kaushik L, 2009, OBESITY, V17, P1856, DOI 10.1038/oby.2009.234; Gremlich S, 1997, J BIOL CHEM, V272, P3216, DOI 10.1074/jbc.272.6.3216; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; HAMAMDZIC D, 1995, AM J PHYSIOL-ENDOC M, V269, pE162, DOI 10.1152/ajpendo.1995.269.1.E162; Hansson A, 1996, CELL BIOCHEM FUNCT, V14, P121; Hughes KA, 2008, EXPERT OPIN INV DRUG, V17, P481, DOI [10.1517/13543784.17.4.481, 10.1517/13543784.17.4.481 ]; Jeong IK, 2001, DIABETES RES CLIN PR, V51, P163, DOI 10.1016/S0168-8227(00)00229-1; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Ku GM, 2012, MOL ENDOCRINOL, V26, P1783, DOI 10.1210/me.2012-1176; Lambillotte C, 1997, J CLIN INVEST, V99, P414, DOI 10.1172/JCI119175; Liu JL, 2007, CELL BIOCHEM BIOPHYS, V48, P115, DOI 10.1007/s12013-007-0016-7; Liu JL, 2011, P NATL ACAD SCI USA, V108, pE1390, DOI 10.1073/pnas.1116146109; Lu YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE50, DOI 10.1152/ajpendo.00596.2005; Lu YR, 2004, DIABETES, V53, P3131, DOI 10.2337/diabetes.53.12.3131; Man TY, 2011, AM J PHYSIOL-ENDOC M, V300, pE1076, DOI 10.1152/ajpendo.00531.2010; Moore JS, 1999, J CLIN ENDOCR METAB, V84, P4172, DOI 10.1210/jc.84.11.4172; Morita J, 2009, ENDOCR J, V56, P561, DOI 10.1507/endocrj.K08E-311; Nordentoft I, 2008, DIABETES OBES METAB, V10, P939, DOI 10.1111/j.1463-1326.2007.00836.x; Ortsater H, 2005, DIABETES-METAB RES, V21, P359, DOI 10.1002/dmrr.525; Rajpathak SN, 2009, DIABETES-METAB RES, V25, P3, DOI 10.1002/dmrr.919; Ranta F, 2006, DIABETES, V55, P1380, DOI 10.2337/db05-1220; Robertson K, 2008, AM J PHYSIOL-ENDOC M, V294, pE928, DOI 10.1152/ajpendo.00606.2007; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Schmid J, 2011, P NATL ACAD SCI USA, V108, P13722, DOI 10.1073/pnas.1110965108; Schmidt S, 2004, CELL DEATH DIFFER, V11, pS45, DOI 10.1038/sj.cdd.4401456; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Swali A, 2008, DIABETOLOGIA, V51, P2003, DOI 10.1007/s00125-008-1137-2; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; TERUI Y, 1995, J CELL PHYSIOL, V164, P74, DOI 10.1002/jcp.1041640110; Tomlinson JW, 2001, ENDOCRINOLOGY, V142, P1982, DOI 10.1210/en.142.5.1982; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Turban S, 2012, DIABETES, V61, P642, DOI 10.2337/db11-1054; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Voice MW, 1996, BIOCHEM J, V317, P621, DOI 10.1042/bj3170621; Xiong XQ, 2011, AM J PHYSIOL-ENDOC M, V300, pE669, DOI 10.1152/ajpendo.00600.2010; Zhang XF, 2009, ENDOCRINOLOGY, V150, P4065, DOI 10.1210/en.2009-0343	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136656	10.1371/journal.pone.0136656	http://dx.doi.org/10.1371/journal.pone.0136656			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26305481	Green Published, gold, Green Submitted			2022-12-27	WOS:000359995500104
J	Beleznai, O; Tholt, G; Toth, Z; Horvath, V; Marczali, Z; Samu, F				Beleznai, Orsolya; Tholt, Gergely; Toth, Zoltan; Horvath, Vivien; Marczali, Zsolt; Samu, Ferenc			Cool Headed Individuals Are Better Survivors: Non-Consumptive and Consumptive Effects of a Generalist Predator on a Sap Feeding Insect	PLOS ONE			English	Article							ANTIPREDATOR RESPONSES; RISK; BEHAVIOR; VIRUS; LEAFHOPPER; SPIDERS; FEAR; CICADELLIDAE; LANDSCAPE; DEFENSE	Non-consumptive effects (NCEs) of predators are part of the complex interactions among insect natural enemies and prey. NCEs have been shown to significantly affect prey foraging and feeding. Leafhopper's (Auchenorrhyncha) lengthy phloem feeding bouts may play a role in pathogen transmission in vector species and also exposes them to predation risk. However, NCEs on leafhoppers have been scarcely studied, and we lack basic information about how anti-predator behaviour influences foraging and feeding in these species. Here we report a study on non-consumptive and consumptive predator-prey interactions in a naturally co-occurring spider-leafhopper system. In mesocosm arenas we studied movement patterns during foraging and feeding of the leafhopper Psammotettix alienus in the presence of the spider predator Tibellus oblongus. Leafhoppers delayed feeding and fed much less often when the spider was present. Foraging movement pattern changed under predation risk: movements became more frequent and brief. There was considerable individual variation in foraging movement activity. Those individuals that increased movement activity in the presence of predators exposed themselves to higher predation risk. However, surviving individuals exhibited a 'cool headed' reaction to spider presence by moving less than leafhoppers in control trials. No leafhoppers were preyed upon while feeding. We consider delayed feeding as a "paradoxical" antipredator tactic, since it is not necessarily an optimal strategy against a sit-and-wait generalist predator.	[Beleznai, Orsolya; Tholt, Gergely; Horvath, Vivien; Samu, Ferenc] Hungarian Acad Sci, Inst Plant Protect, Dept Zool, Agr Res Ctr, Budapest, Hungary; [Beleznai, Orsolya; Tholt, Gergely; Horvath, Vivien; Samu, Ferenc] Univ Pannonia, Inst Plant Protect, Georgikon Fac, Keszthely, Hungary; [Tholt, Gergely] Eotvos Lorand Univ, Fac Sci, Inst Biol, Budapest, Hungary; [Toth, Zoltan] Hungarian Acad Sci, Inst Plant Protect, Lendulet Evolutionary Ecol Res Grp, Budapest, Hungary; [Horvath, Vivien] Szent Istvan Univ, Fac Agr & Environm Sci, Inst Genet & Biotechnol, Godollo, Hungary	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; University of Pannonia; Eotvos Lorand University; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian University of Agriculture & Life Sciences	Samu, F (corresponding author), Hungarian Acad Sci, Inst Plant Protect, Dept Zool, Agr Res Ctr, Budapest, Hungary.	samu.ferenc@agrar.mta.hu	Tholt, Gergely/J-7308-2017; Tholt, Gergely/S-3748-2019; Horvath, Vivien/ABH-8684-2020; Zsolt, Marczali/AAG-3058-2020; Samu, Ferenc/B-2827-2011	Horvath, Vivien/0000-0001-6536-1710; Samu, Ferenc/0000-0002-6591-2284; Toth, Zoltan/0000-0002-2634-8393; Tholt, Gergely/0000-0003-3364-0322	British Ecological Society Research grant [4768/5806]; Orszagos Tudomanyos Kutatasi Alapprogramok [K81971]; 'Lendulet' programme of the Hungarian Academy of Sciences (MTA) [LP2012-24/2012]; Orszagos Tudomanyos Kutatasi Alapprogramok grant [PD108938]; Hungarian Academy of Sciences [SZ-029/2013]	British Ecological Society Research grant; Orszagos Tudomanyos Kutatasi Alapprogramok(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); 'Lendulet' programme of the Hungarian Academy of Sciences (MTA); Orszagos Tudomanyos Kutatasi Alapprogramok grant; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	Funding for the study was provided by British Ecological Society Research grant (http://www.britishecologicalsociety.org) 4768/5806 to FS and Orszagos Tudomanyos Kutatasi Alapprogramok (K81971; www.otka.hu/en/) to FS. During the study, ZT was supported by the 'Lendulet' programme of the Hungarian Academy of Sciences (MTA, LP2012-24/2012; www.mta.hu), Orszagos Tudomanyos Kutatasi Alapprogramok grant (PD108938; www.otka.hu/en/) and the postdoctoral research programme of the Hungarian Academy of Sciences (SZ-029/2013; www.mta.hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks PB, 2000, P ROY SOC B-BIOL SCI, V267, P1621, DOI 10.1098/rspb.2000.1187; Barcos AKS, 2014, PHILIPP AGRIC SCI, V97, P155; Barnier F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0446; Bell RD, 2006, ETHOLOGY, V112, P903, DOI 10.1111/j.1439-0310.2006.01244.x; Bowler DE, 2013, J ZOOL, V289, P52, DOI 10.1111/j.1469-7998.2012.00961.x; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; COX DR, 1972, J R STAT SOC B, V34, P187; Daane KM, 1996, ENVIRON ENTOMOL, V25, P1224, DOI 10.1093/ee/25.5.1224; Embar K, 2011, OIKOS, V120, P1657, DOI 10.1111/j.1600-0706.2011.19278.x; Englund G, 1997, ECOLOGY, V78, P2316; Fereres A, 2009, VIRUS RES, V141, P158, DOI 10.1016/j.virusres.2008.10.020; Fievet V, 2008, OIKOS, V117, P1380, DOI 10.1111/j.0030-1299.2008.16629.x; Garamszegi LZ, 2006, BEHAV ECOL, V17, P682, DOI 10.1093/beheco/ark005; Grafen A., 2002, MODERN STAT LIFE SCI; Hardie J, 1996, ENTOMOL EXP APPL, V80, P73, DOI 10.1007/BF00194727; Hawlena D, 2012, SCIENCE, V336, P1434, DOI 10.1126/science.1220097; Hawlena D, 2010, AM NAT, V176, P537, DOI 10.1086/656495; Hein AM, 2012, P NATL ACAD SCI USA, V109, P12070, DOI 10.1073/pnas.1202686109; Hogg BN, 2014, ECOL ENTOMOL, V39, P149, DOI 10.1111/een.12079; Honma A, 2006, P ROY SOC B-BIOL SCI, V273, P1631, DOI 10.1098/rspb.2006.3501; Jones EI, 2011, BEHAV ECOL SOCIOBIOL, V65, P1505, DOI 10.1007/s00265-011-1160-z; Klingauf F.A., 1987, World Crop Pests, V2A, P209; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; Li DQ, 2005, J CHEM ECOL, V31, P333, DOI 10.1007/s10886-005-1344-y; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Lone K, 2014, OIKOS, V123, P641, DOI 10.1111/j.1600-0706.2013.00938.x; Martin J, 2009, ANIM BEHAV, V78, P1011, DOI 10.1016/j.anbehav.2009.07.026; McDermott DR, 2014, BEHAV ECOL SOCIOBIOL, V68, P425, DOI 10.1007/s00265-013-1657-8; Pinheiro J, 2000, MIXED EFFECTS MODELS; Pompon J, 2010, J INSECT PHYSIOL, V56, P610, DOI 10.1016/j.jinsphys.2009.12.009; Preisser EL, 2007, ECOLOGY, V88, P2744, DOI 10.1890/07-0260.1; R Core Team, 2021, R LANGUAGE ENV STAT; Reader T, 2006, BEHAV ECOL, V17, P933, DOI 10.1093/beheco/arl027; Rothley KD, 1997, BEHAV ECOL, V8, P551, DOI 10.1093/beheco/8.5.551; Rypstra AL, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0948; Samu F, 2002, J ARACHNOL, V30, P389, DOI 10.1636/0161-8202(2002)030[0389:OTNOAS]2.0.CO;2; Samu F, 2013, BIOL CONTROL, V67, P390, DOI 10.1016/j.biocontrol.2013.08.016; SAS Institute, 2005, JMP STAT GRAPH GUID; Schmidt-Entling Martin H, 2009, Biol Lett, V5, P773, DOI 10.1098/rsbl.2009.0436; Schmitz OJ, 2008, ECOLOGY, V89, P2436, DOI 10.1890/07-1030.1; SKELLY DK, 1994, ANIM BEHAV, V47, P465, DOI 10.1006/anbe.1994.1063; Slos S, 2009, ECOL ENTOMOL, V34, P297, DOI 10.1111/j.1365-2311.2008.01077.x; STADLER B, 1994, J ANIM ECOL, V63, P419, DOI 10.2307/5559; Stafford CA, 2009, ENTOMOL EXP APPL, V130, P130, DOI 10.1111/j.1570-7458.2008.00813.x; Straub CS, 2013, J PEST SCI, V86, P235, DOI 10.1007/s10340-012-0465-7; Tholt G, 2015, ENTOMOL EXP APPL, V155, P123, DOI 10.1111/eea.12290; VACKE J, 1961, BIOL PLANTARUM, V3, P228, DOI 10.1007/BF02933566; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; Villagra CA, 2002, ANIM BEHAV, V64, P677, DOI 10.1006/anbe.2002.4015; Wajnberg E, 2003, J ANIM ECOL, V72, P618, DOI 10.1046/j.1365-2656.2003.00731.x; Wegener C, 1998, ENTOMOL GEN, V22, P295; Welton NJ, 2003, THEOR POPUL BIOL, V64, P417, DOI 10.1016/S0040-5809(03)00097-2; Wisniewska J, 1997, EUR J ENTOMOL, V94, P243; Zhang T, 2013, P NATL ACAD SCI USA, V110, P15431, DOI 10.1073/pnas.1308816110; Zhao LQ, 2010, MICRON, V41, P754, DOI 10.1016/j.micron.2010.06.001; Zrubecz Peter, 2004, Novenyvedelem, V40, P527	58	15	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135954	10.1371/journal.pone.0135954	http://dx.doi.org/10.1371/journal.pone.0135954			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295476	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000359926900054
J	Dugbartey, GJ; Bouma, HR; Strijkstra, AM; Boerema, AS; Henning, RH				Dugbartey, George J.; Bouma, Hjalmar R.; Strijkstra, Arjen M.; Boerema, Ate S.; Henning, Robert H.			Induction of a Torpor-Like State by 5 '-AMP Does Not Depend on H2S Production	PLOS ONE			English	Article							ANIMATION-LIKE STATE; HYDROGEN-SULFIDE; RENAL ISCHEMIA/REPERFUSION; COLD ISCHEMIA; LUNG-TISSUE; HIBERNATION; REPERFUSION; RESPONSES; PROTECTS; INJURY	Background Therapeutic hypothermia is used to reduce ischemia/reperfusion injury (IRI) during organ transplantation and major surgery, but does not fully prevent organ injury. Interestingly, hibernating animals undergo repetitive periods of low body temperature called 'torpor' without signs of organ injury. Recently, we identified an essential role of hydrogen sulfide (H2S) in entrance into torpor and preservation of kidney integrity during hibernation. A torpor-like state can be induced pharmacologically by injecting 5'-Adenosine monophosphate (5'-AMP). The mechanism by which 5'-AMP leads to the induction of a torpor-like state, and the role of H2S herein, remains to be unraveled. Therefore, we investigated whether induction of a torpor-like state by 5-AMP depends on H2S production. Methods To study the role of H2S on the induction of torpor, amino-oxyacetic acid (AOAA), a nonspecific inhibitor of H2S, was administered before injection with 5'-AMP to block endogenous H2S production in Syrian hamster. To assess the role of H2S on maintenance of torpor induced by 5'-AMP, additional animals were injected with AOAA during torpor. Key Results During the torpor-like state induced by 5'-AMP, the expression of H2S-synthesizing enzymes in the kidneys and plasma levels of H2S were increased. Blockade of these enzymes inhibited the rise in the plasma level of H2S, but neither precluded torpor nor induced arousal. Remarkably, blockade of endogenous H2S production was associated with increased renal injury. Conclusions Induction of a torpor-like state by 5'-AMP does not depend on H2S, although production of H2S seems to attenuate renal injury. Unraveling the mechanisms by which 5'-AMP reduces the metabolism without organ injury may allow optimization of current strategies to limit (hypothermic) IRI and improve outcome following organ transplantation, major cardiac and brain surgery.	[Dugbartey, George J.; Bouma, Hjalmar R.; Henning, Robert H.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Strijkstra, Arjen M.; Boerema, Ate S.] Univ Groningen, Groningen Inst Evolutionary Life Sci, Dept Chronobiol, NL-9700 RB Groningen, Netherlands; [Strijkstra, Arjen M.; Boerema, Ate S.] Univ Groningen, Groningen Inst Evolutionary Life Sci, Dept Mol Neurobiol, NL-9700 RB Groningen, Netherlands; [Boerema, Ate S.] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Dugbartey, GJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.	g.j.dugbartey@umcg.nl	Boerema, A.S./W-9810-2018; Henning, Robert H/AAY-5222-2020; Bouma, Hjalmar/F-9737-2015	Boerema, A.S./0000-0002-4771-5156; Henning, Robert/0000-0002-5135-4621; Bouma, Hjalmar/0000-0003-1032-321X; Dugbartey, George/0000-0001-8161-7202	Groningen Institute for Drug Exploration (GUIDE), Netherlands; University Medical Center Groningen (UMCG), Netherlands	Groningen Institute for Drug Exploration (GUIDE), Netherlands(Netherlands Government); University Medical Center Groningen (UMCG), Netherlands(Netherlands Government)	The work was funded by Groningen Institute for Drug Exploration (GUIDE), Netherlands and University Medical Center Groningen (UMCG), Netherlands.	Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; BARNES BM, 1989, SCIENCE, V244, P1593, DOI 10.1126/science.2740905; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Blackstone E, 2007, SHOCK, V27, P370, DOI 10.1097/SHK.0b013e31802e27a0; Bos EM, 2013, J AM SOC NEPHROL, V24, P759, DOI 10.1681/ASN.2012030268; Bos EM, 2009, J AM SOC NEPHROL, V20, P1901, DOI 10.1681/ASN.2008121269; Bouma HR, 2010, VET IMMUNOL IMMUNOP, V136, P319, DOI 10.1016/j.vetimm.2010.03.016; Bouma HR, 2013, J LEUKOCYTE BIOL, V94, P431, DOI 10.1189/jlb.0611298; Bouma HR, 2013, DEV COMP IMMUNOL, V39, P154, DOI 10.1016/j.dci.2012.11.004; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; de Vrij EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093218; ELNAHAS AM, 1991, KIDNEY INT, V40, P29, DOI 10.1038/ki.1991.175; Florant GL, 2010, J EXP BIOL, V213, P2031, DOI 10.1242/jeb.039131; Gross MLP, 2006, LAB INVEST, V86, P262, DOI 10.1038/labinvest.3700383; Jani A, 2011, TRANSPLANTATION, V92, P1215, DOI 10.1097/TP.0b013e3182366401; Lee CC, 2008, ANNU REV MED, V59, P177, DOI 10.1146/annurev.med.59.061506.110403; Lindsley JE, 2004, COMP BIOCHEM PHYS B, V139, P543, DOI 10.1016/j.cbpc.2004.06.014; Lobb Ian, 2014, Can Urol Assoc J, V8, pE413, DOI 10.5489/cuaj.1694; Miao ZM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/459617; Nikolic-Paterson DJ, 2001, NEPHROL DIAL TRANSPL, V16, P3, DOI 10.1093/ndt/16.suppl_5.3; Olson KR, 2009, BBA-BIOENERGETICS, V1787, P856, DOI 10.1016/j.bbabio.2009.03.019; Peralta C, 2001, HEPATOLOGY, V34, P1164, DOI 10.1053/jhep.2001.29197; Revsbech IG, 2014, FREE RADICAL BIO MED, V73, P349, DOI 10.1016/j.freeradbiomed.2014.05.025; Swoap SJ, 2007, AM J PHYSIOL-REG I, V293, pR468, DOI 10.1152/ajpregu.00888.2006; Talaei F, 2012, J EXP BIOL, V215, P2912, DOI 10.1242/jeb.067363; Talaei F, 2011, J EXP BIOL, V214, P1276, DOI 10.1242/jeb.052704; Wang YL, 2014, J GASTROEN HEPATOL, V29, P742, DOI 10.1111/jgh.12448; Zancanaro C, 1999, NEPHROL DIAL TRANSPL, V14, P1982, DOI 10.1093/ndt/14.8.1982; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368	30	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136113	10.1371/journal.pone.0136113	http://dx.doi.org/10.1371/journal.pone.0136113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295351	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900071
J	Goosen, S; Hoebe, CJPA; Waldhober, Q; Kunst, AE				Goosen, Simone; Hoebe, Christian J. P. A.; Waldhober, Quita; Kunst, Anton E.			High HIV Prevalence among Asylum Seekers Who Gave Birth in the Netherlands: A Nationwide Study Based on Antenatal HIV Tests	PLOS ONE			English	Article							RISK; REFUGEES; COUNTRIES; MIGRANTS; SURVEILLANCE; INFECTION; HIV/AIDS; PEOPLE	Objectives Asylum seekers are considered to be a particularly vulnerable group with respect to HIV. Data on the HIV prevalence among asylum seekers, however, are scarce. The aim of this study is to map the HIV prevalence among asylum seekers who gave birth in The Netherlands. Methods We used a nationwide electronic medical records database from the community health services for asylum seekers (MOA). The study population consisted of 4,854 women and girls who delivered in asylum reception between 2000 and 2008. A unique electronic health data base was used and case allocation was based on ICPC-codes. Results The number of women and girls that was HIV positive during their last pregnancy was 80, of which 79 originated fromsub-Saharan Africa. The prevalence for women from this region of origin (3.4%) was high compared to women from all other regions of origin (0.04%; OR = 90.2; 95% CI 12.5-648.8). The highest HIV prevalence rates were found for women from Rwanda (17.0%) and Cameroon (13.2%). HIV prevalence rates were higher among women who arrived in reception without partner (OR = 1.82; 95% CI 0.75-4.44) and unaccompanied minors (OR = 2.59; 95% CI 0.79-8.49), compared to women who arrived in reception with partner. Conclusions We conclude that, among asylum-seeking women from sub-Saharan Africa giving birth in The Netherlands, the HIV prevalence is high compared to the host population. For women from other regions of origin, the prevalence is at the same level as in the host population. The high HIV prevalence underlines the importance of preventive interventions and voluntary HIV testing for sub-Saharan African asylum seekers as from shortly after arrival.	[Goosen, Simone; Kunst, Anton E.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [Goosen, Simone; Waldhober, Quita] Netherlands Assoc Community Hlth Serv, Utrecht, Netherlands; [Hoebe, Christian J. P. A.] South Limburg Publ Hlth Serv, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands; [Hoebe, Christian J. P. A.] MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University	Goosen, S (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	sgoosen@ggdghor.nl		Kunst, Anton/0000-0002-3313-5273; Hoebe, Christian/0000-0003-1815-0974				Alvarez-del Arco D, 2014, EUR J PUBLIC HEALTH, V24, P139, DOI 10.1093/eurpub/ckt108; Alvarez-del Arco D, 2013, EUR J PUBLIC HEALTH, V23, P1039, DOI 10.1093/eurpub/cks130; [Anonymous], 2009, POL STAT HIV TEST CO; Birukila G, 2013, NEW ZEAL MED J, V126, P19; Boer K, 2011, EUR J PUBLIC HEALTH, V21, P632, DOI 10.1093/eurpub/ckq157; Boisson E, 1996, J ACQ IMMUN DEF SYND, V13, P434, DOI 10.1097/00042560-199612150-00006; Clark RC, 2007, J PUBLIC HEALTH-UK, V29, P420, DOI 10.1093/pubmed/fdm063; Del Amo J, 2004, AIDS, V18, P1867, DOI 10.1097/00002030-200409240-00002; Del Amo J, 2011, EUR J PUBLIC HEALTH, V21, P620, DOI 10.1093/eurpub/ckq150; Europaisches Zentrum fur die Pravention und die Kontrolle von Krankheiten, 2010, HIV TEST INCR UPT EF; European Centre for Disease Prevention and Control, 2013, MON IMPL DUBL DECL P; European Centre for Disease Prevention and Control, 2011, IMPR HIV DAT COMP MI; European Centre for Disease Prevention and Control, 2013, EV BRIEF MIGR MON IM; European Centre for Disease Prevention and Control, 2010, MIGR HLTH EP HIV AID; European Centre for Disease Prevention and Control, 2013, MIGR HLTH SEX TRANSM; EUROSTAT, 2015, STAT EXPL AS STAT; Fenton KA, 2002, SEX TRANSM INFECT, V78, P241, DOI 10.1136/sti.78.4.241; GGD Nederland STI AIDS Netherlands, 2008, HIV STI PREV AS SEEK; Goosen S, 2014, DIABETIC MED, V31, P1532, DOI 10.1111/dme.12510; Goosen S, 2009, J EPIDEMIOL COMMUN H, V63, P528, DOI 10.1136/jech.2008.079368; Goosen S, 2014, INT J EPIDEMIOL, V43, P94, DOI 10.1093/ije/dyt233; Goosen Simone, 2010, Ned Tijdschr Geneeskd, V154, pA2318; Gouws E, 2008, SEX TRANSM INFECT, V84, pI17, DOI 10.1136/sti.2008.030452; Kayirangwa E, 2006, SEX TRANSM INFECT, V82, pI27, DOI 10.1136/sti.2006.019588; Keygnaert I, 2012, CULT HEALTH SEX, V14, P505, DOI 10.1080/13691058.2012.671961; Lowther SA, 2012, INT J ENV RES PUB HE, V9, P4197, DOI 10.3390/ijerph9114197; Manfred H., 2008, SOCIAL AFFAIRS EQUAL; McMichael C, 2010, CULT HEALTH SEX, V12, P263, DOI 10.1080/13691050903359265; Norredam Marie, 2006, Eur J Public Health, V16, P286, DOI 10.1093/eurpub/cki191; Op de Coul ELM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-185; Pottie K, 2011, CAN MED ASSOC J, V183, pE824, DOI 10.1503/cmaj.090313; RESCON, 2008, STUD EFF ASERAG INT; Rollins NC, 2007, JAIDS-J ACQ IMM DEF, V44, P321, DOI 10.1097/QAI.0b013e31802ea4b0; Spiegel PB, 2007, LANCET, V369, P2187, DOI 10.1016/S0140-6736(07)61015-0; Tafuri S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-213; TEMMERMAN M, 1990, AIDS, V4, P1087, DOI 10.1097/00002030-199011000-00006; UNAIDS, 2006, 2006 REP GLOB AIDS E; United Nations High Commissioner for Refugees, 2015, UNHCR STAT ONL POP D; United Nations High Commissioner for Refugees, 2008, UNHCR GUID FORM DET; United Nations High Commissioner for Refugees, 2003, SEX GEND BAS VIOL RE; van Oostrum IEA, 2011, J EPIDEMIOL COMMUN H, V65, P376, DOI 10.1136/jech.2009.087064; WEED LL, 1968, NEW ENGL J MED, V278, P593, DOI 10.1056/NEJM196803142781105; World Health Orgzanization Regional Office for Europe, 2011, EUR ACT PLAN HIV AID	43	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0134724	10.1371/journal.pone.0134724	http://dx.doi.org/10.1371/journal.pone.0134724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26296093	Green Submitted, Green Published, gold			2022-12-27	WOS:000359926900014
J	Luo, Y; Wang, JG; Liu, B; Wang, ZL; Yuan, YH; Yue, TL				Luo, Ying; Wang, Jianguo; Liu, Bin; Wang, Zhouli; Yuan, Yahong; Yue, Tianli			Effect of Yeast Cell Morphology, Cell Wall Physical Structure and Chemical Composition on Patulin Adsorption	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MYCOTOXINS CITRININ; APPLE JUICE	The capability of yeast to adsorb patulin in fruit juice can aid in substantially reducing the patulin toxic effect on human health. This study aimed to investigate the capability of yeast cell morphology and cell wall internal structure and composition to adsorb patulin. To compare different yeast cell morphologies, cell wall internal structure and composition, scanning electron microscope, transmission electron microscope and ion chromatography were used. The results indicated that patulin adsorption capability of yeast was influenced by cell surface areas, volume, and cell wall thickness, as well as 1,3-beta-glucan content. Among these factors, cell wall thickness and 1,3-beta-glucan content serve significant functions. The investigation revealed that patulin adsorption capability was mainly affected by the three-dimensional network structure of the cell wall composed of 1,3-beta-glucan. Finally, patulin adsorption in commercial kiwi fruit juice was investigated, and the results indicated that yeast cells could adsorb patulin from commercial kiwi fruit juice efficiently. This study can potentially simulate in vitro cell walls to enhance patulin adsorption capability and successfully apply to fruit juice industry.	[Luo, Ying; Wang, Jianguo; Liu, Bin; Wang, Zhouli; Yuan, Yahong; Yue, Tianli] Northwest A&F Univ, Coll Food Sci & Engn, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Yue, TL (corresponding author), Northwest A&F Univ, Coll Food Sci & Engn, Yangling 712100, Shaanxi, Peoples R China.	yuetl305@nwsuaf.edu.cn	yue, tianli/AEY-3384-2022; Wang, JianGuo/L-6445-2018	yue, tianli/0000-0002-4768-5831; Wang, JianGuo/0000-0001-7060-8212	National Natural Science Foundation of China [31371814]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Natural Science Foundation of China under Grant No. 31371814, and TY received the funding; the funders supported data collection and analysis of the manuscript.	Aguilar-Uscanga B, 2003, LETT APPL MICROBIOL, V37, P268, DOI 10.1046/j.1472-765X.2003.01394.x; ARAFAT W, 1995, RES COMMUN MOL PATH, V87, P177; Baptista AS, 2004, WORLD J MICROB BIOT, V20, P475, DOI 10.1023/B:WIBI.0000040397.48873.3b; Burroughs LF, 1997, J AOAC, V60, P100; Celyk K, 2003, REV BRAS ZOOTECN, V32, P615, DOI 10.1590/S1516-35982003000300013; Dallies N, 1998, YEAST, V14, P1297, DOI 10.1002/(SICI)1097-0061(1998100)14:14<1297::AID-YEA310>3.0.CO;2-L; DEVEGOWDA G, 1996, P AUST POULT SCI S, V8, P103, DOI DOI 10.1080/09712119.2004.9706502; FLEET GH, 1976, J GEN MICROBIOL, V94, P180, DOI 10.1099/00221287-94-1-180; Fuchs S, 2008, FOOD CHEM TOXICOL, V46, P1398, DOI 10.1016/j.fct.2007.10.008; Gokmen V, 2001, EUR FOOD RES TECHNOL, V213, P194, DOI 10.1007/s002170100354; Hatab S, 2012, J APPL MICROBIOL, V112, P892, DOI 10.1111/j.1365-2672.2012.05279.x; Huebner HJ, 2000, J FOOD PROTECT, V63, P106, DOI 10.4315/0362-028X-63.1.106; Huwig A, 2001, TOXICOL LETT, V122, P179, DOI 10.1016/S0378-4274(01)00360-5; Joint F, 1995, WHO TECH REP SER; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; KREGER DR, 1975, J GEN MICROBIOLOGY, V0092; Lugauskas A, 2005, ANN AGR ENV MED, V12, P109; MacDonald S, 2000, J AOAC INT, V83, P1387; Magnelli P, 2002, ANAL BIOCHEM, V301, P136, DOI 10.1006/abio.2001.5473; MANNERS DJ, 1973, BIOCHEM J, V135, P19, DOI 10.1042/bj1350019; Morris GJ, 1983, J GEN MICROBIOL, V129, P2023; Nguyen TH, 1998, APPL MICROBIOL BIOT, V50, P206, DOI 10.1007/s002530051278; Pfeiffer E, 1998, CARCINOGENESIS, V19, P1313, DOI 10.1093/carcin/19.7.1313; Popolo L, 1997, J BACTERIOL, V179, P463, DOI 10.1128/jb.179.2.463-469.1997; Reddy K R N, 2010, Mycotoxin Res, V26, P257, DOI 10.1007/s12550-010-0064-5; Salomao BCM, 2008, J FOOD PROTECT, V71, P643, DOI 10.4315/0362-028X-71.3.643; Santin E., 2003, International Journal of Poultry Science, V2, P465; Schiavone M, 2014, FEMS YEAST RES, V14, P933, DOI 10.1111/1567-1364.12182; Shephard GS, 2000, J CHROMATOGR A, V882, P17, DOI 10.1016/S0021-9673(99)01341-2; Shetty PH, 2006, TRENDS FOOD SCI TECH, V17, P48, DOI 10.1016/j.tifs.2005.10.004; STINSON EE, 1978, APPL ENVIRON MICROB, V36, P620, DOI 10.1128/AEM.36.4.620-622.1978; Wang L., 2007, THESIS NW A F U; Wichmann G, 2002, ENVIRON TOXICOL, V17, P211, DOI 10.1002/tox.10050; Yiannikouris A, 2004, J AGR FOOD CHEM, V52, P3666, DOI 10.1021/jf035127x; Yiannikouris A, 2006, BIOMACROMOLECULES, V7, P1147, DOI 10.1021/bm050968t; Yiannikouris A, 2003, BIOTECHNOL LETT, V25, P783, DOI 10.1023/A:1023576520932; Yue TL, 2011, J FOOD PROTECT, V74, P149, DOI 10.4315/0362-028X.JFP-10-326	38	39	43	3	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136045	10.1371/journal.pone.0136045	http://dx.doi.org/10.1371/journal.pone.0136045			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295574	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900064
J	Vazquez, P; del Rio, JA; Cedano, KG; Martinez, M; Jensen, HJ				Vazquez, Pavel; del Rio, Jesus A.; Cedano, Karla G.; Martinez, Manuel; Jensen, Henrik J.			An Entangled Model for Sustainability Indicators	PLOS ONE			English	Article							TANGLED NATURE MODEL; COMPLEXITY; SYSTEMS	Nowadays the challenge for humanity is to find pathways towards sustainable development. Decision makers require a set of sustainability indicators to know if the sustainability strategies are following those pathways. There are more than one hundred sustainability indicators but they differ on their relative importance according to the size of the locality and change on time. The resources needed to follow these sustainability indicators are scarce and in some instances finite, especially in smaller regions. Therefore strategies to select set of these indicators are useful for decision makers responsible for monitoring sustainability. In this paper we propose a model for the identification and selection of a set of sustainability indicators that adequately represents human systems. In developing this model, we applied evolutionary dynamics in a space where sustainability indicators are fundamental entities interconnected by an interaction matrix. we used a fixed interaction that simulates the current context for the city of Cuernavaca, Mexico as an example. We were able to identify and define relevant sets indicators for the system by using the Pareto principle. In this case we identified a set of sixteen sustainability indicators with more than 80% of the total strength. This set presents resilience to perturbations. For the Tangled Nature framework we provided a manner of treating different contexts (i.e., cities, counties, states, regions, countries, continents or the whole planet), dealing with small dimensions. This model provides decision makers with a valuable tool to select sustainability indicators set for towns, cities, regions, countries, continents or the entire planet according to a coevolutionary framework. The social legitimacy can arise from the fact that each individual indicator must be selected from those that are most important for the subject community.	[Vazquez, Pavel] Univ Autonoma Estado Morelos, Inst Invest Ciencias Basicas & Aplicadas, Cuernavaca, Morelos, Mexico; [del Rio, Jesus A.; Martinez, Manuel] Univ Nacl Autonoma Mexico, Inst Energias Renovables, Temixco, Morelos, Mexico; [del Rio, Jesus A.] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Temixco, Morelos, Mexico; [Cedano, Karla G.] InnoBa, Cuernavaca, Morelos, Mexico; [Jensen, Henrik J.] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [Jensen, Henrik J.] Univ London Imperial Coll Sci Technol & Med, Ctr Complex Sci, London, England	Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Imperial College London; Imperial College London	Vazquez, P (corresponding author), Univ Autonoma Estado Morelos, Inst Invest Ciencias Basicas & Aplicadas, Cuernavaca, Morelos, Mexico.	pavelv@ier.unam.mx	Cedano Villavicencio, Karla Graciela/AAX-1973-2020; del Rio Portilla, Jesus Antonio/C-2125-2009; Fernández, Manuel Martínez/G-8921-2018	Cedano Villavicencio, Karla Graciela/0000-0002-8102-7226; del Rio Portilla, Jesus Antonio/0000-0001-6180-0608; Fernández, Manuel Martínez/0000-0002-8548-3472; Vazquez, Pavel/0000-0003-0471-9517	European project CONGAS [FP7-ICT-2011-8-317672]	European project CONGAS	This study was supported by regular budget from all institutions and HJ was partially founded by European project CONGAS (Grant FP7-ICT-2011-8-317672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beittel JS, 2015, MEXICOS DRUG TRAFFIC; Bell S., 2008, SUSTAINABILITY INDIC, Vsecond; Chatterjee A, 2005, NEW ECON WINDOWS, P1, DOI 10.1007/88-470-0389-X; Christensen K, 2002, J THEOR BIOL, V216, P73, DOI 10.1006/jtbi.2002.2530; Davies JB, 1999, DISTRIBUTION WEALTH; di Collobiano SA, 2003, J PHYS A-MATH GEN, V36, P883, DOI 10.1088/0305-4470/36/4/302; Espinosa A, 2008, EUR J OPER RES, V187, P636, DOI 10.1016/j.ejor.2007.03.023; Espinosa A, 2011, LEARN ORGAN, V18, P54, DOI 10.1108/09696471111096000; Grosskurth J, 2008, TOOLS INTEGRATED GOV; Ho MW, 2005, BIOSYSTEMS, V82, P39, DOI 10.1016/j.biosystems.2005.05.009; Kauffman S.A., 1993, ORIGINS ORDER; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Laird S, 2006, ECOL COMPLEX, V3, P253, DOI 10.1016/j.ecocom.2006.06.001; Longair M, 1997, LARGE SMALL HUMAN MI; Meadows D.H., 2008, THINKING SYSTEMS PRI; O'Neil S, FOREIGN AFFAIRS, P63; Pereyra G, 2012, REV MEX SOCIOL, V74; Pesci R, 2007, PROYECTAR SUSTENTABI; Rihani S, 2002, COMPLEX SYSTEMS THEO; Robalino JD, 2013, PHYSICA A, V392, P773, DOI 10.1016/j.physa.2012.10.037; Todorov V, 2011, MATH COMPUT SIMULAT, V81, P1397, DOI 10.1016/j.matcom.2010.05.022; UN, 2007, ALP CONV SUST RUR DE, V3rd; World Commission on Environment and Development, 1987, OUR COMMON FUTURE	23	11	11	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135250	10.1371/journal.pone.0135250	http://dx.doi.org/10.1371/journal.pone.0135250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295948	Green Submitted, gold, Green Published			2022-12-27	WOS:000359926900022
J	Yuasa, K; Yotsumoto, Y				Yuasa, Kenichi; Yotsumoto, Yuko			Opposite Distortions in Interval Timing Perception for Visual and Auditory Stimuli with Temporal Modulations	PLOS ONE			English	Article							TIME PERCEPTION; INTERNAL CLOCK; SPEEDING-UP; SUBJECTIVE TIME; CROSSMODAL INTERACTION; PERCEIVED DURATION; NEURAL BASIS; CHILDREN; FLICKER; VISION	When an object is presented visually and moves or flickers, the perception of its duration tends to be overestimated. Such an overestimation is called time dilation. Perceived time can also be distorted when a stimulus is presented aurally as an auditory flutter, but the mechanisms and their relationship to visual processing remains unclear. In the present study, we measured interval timing perception while modulating the temporal characteristics of visual and auditory stimuli, and investigated whether the interval times of visually and aurally presented objects shared a common mechanism. In these experiments, participants compared the durations of flickering or fluttering stimuli to standard stimuli, which were presented continuously. Perceived durations for auditory flutters were underestimated, while perceived durations of visual flickers were overestimated. When auditory flutters and visual flickers were presented simultaneously, these distortion effects were cancelled out. When auditory flutters were presented with a constantly presented visual stimulus, the interval timing perception of the visual stimulus was affected by the auditory flutters. These results indicate that interval timing perception is governed by independent mechanisms for visual and auditory processing, and that there are some interactions between the two processing systems.	[Yuasa, Kenichi; Yotsumoto, Yuko] Univ Tokyo, Dept Life Sci, Tokyo, Japan	University of Tokyo	Yotsumoto, Y (corresponding author), Univ Tokyo, Dept Life Sci, Tokyo, Japan.	cyuko@mail.ecc.u-tokyo.ac.jp	Yuasa, Kenichi/ABC-4428-2021	Yuasa, Kenichi/0000-0002-5697-7537	Japan Society for the Promotion of Science, Research fellowship for young scientists [02601927];  [25119003];  [24330208]	Japan Society for the Promotion of Science, Research fellowship for young scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; 	This work was supported by Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research on Innovative Areas (25119003) for YY; Grant-in-Aid for Scientific Research(B)(24330208) for YY; and Japan Society for the Promotion of Science, Research fellowship for young scientists (02601927) for KY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Allman MJ, 2014, ANNU REV PSYCHOL, V65, P743, DOI 10.1146/annurev-psych-010213-115117; Allman MJ, 2012, BRAIN, V135, P656, DOI 10.1093/brain/awr210; Arnal LH, 2015, CEREB CORTEX, V25, P3077, DOI 10.1093/cercor/bhu103; Aschersleben G, 2003, INT J PSYCHOPHYSIOL, V50, P157, DOI 10.1016/S0167-8760(03)00131-4; BERTELSON P, 1981, PERCEPT PSYCHOPHYS, V29, P578, DOI 10.3758/BF03207374; Bertelson P, 2003, INT J PSYCHOPHYSIOL, V50, P147, DOI 10.1016/S0167-8760(03)00130-2; Binetti N, 2012, J VISION, V12, DOI 10.1167/12.7.8; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buhusi CV, 2013, BEHAV PROCESS, V95, P60, DOI 10.1016/j.beproc.2013.02.015; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Burle B, 2001, J EXP PSYCHOL HUMAN, V27, P195, DOI 10.1037/0096-1523.27.1.195; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Chen KM, 2009, ACTA PSYCHOL, V130, P225, DOI 10.1016/j.actpsy.2008.12.008; Cordes S, 2014, J EXP PSYCHOL GEN, V143, P710, DOI 10.1037/a0032439; CREELMAN CD, 1962, J ACOUST SOC AM, V34, P582, DOI 10.1121/1.1918172; Droit-Volet S, 2004, Q J EXP PSYCHOL-A, V57, P797, DOI 10.1080/02724980343000495; Droit-Volet S, 2002, Q J EXP PSYCHOL-B, V55, P193, DOI 10.1080/02724990143000252; Droit-Volet S, 2007, BEHAV PROCESS, V74, P244, DOI 10.1016/j.beproc.2006.09.012; Droit-Volet S, 2010, BEHAV PROCESS, V85, P126, DOI 10.1016/j.beproc.2010.06.017; Escoffier N, 2015, NEUROIMAGE, V111, P267, DOI 10.1016/j.neuroimage.2015.02.024; Fendrich R, 2001, PERCEPT PSYCHOPHYS, V63, P719, DOI 10.3758/BF03194432; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; Gil S, 2011, ACTA PSYCHOL, V136, P354, DOI 10.1016/j.actpsy.2010.12.010; Grahn JA, 2011, NEUROIMAGE, V54, P1231, DOI 10.1016/j.neuroimage.2010.09.033; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Gu BM, 2015, NEUROSCI BIOBEHAV R, V48, P160, DOI 10.1016/j.neubiorev.2014.10.008; Harrington DL, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00032; Hashimoto Y, TIMING TIME PERCEPTI; Hayashi MJ, 2014, J COGNITIVE NEUROSCI, V26, P1685, DOI 10.1162/jocn_a_00580; Herbst SK, 2015, BRAIN TOPOGR, V28, P559, DOI 10.1007/s10548-014-0389-z; Herbst SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076074; Heron J, 2013, J VISION, V13, DOI 10.1167/13.14.4; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; Kanai R, 2011, EXP BRAIN RES, V209, P465, DOI 10.1007/s00221-011-2577-3; Kanai R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001253; Kleiner M, 2007, PERCEPTION, V36, P14; Koch G, 2009, PHILOS T R SOC B, V364, P1907, DOI 10.1098/rstb.2009.0018; Kosem A, 2014, NEUROIMAGE, V92, P274, DOI 10.1016/j.neuroimage.2014.02.010; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Lewis PA, 2006, TRENDS COGN SCI, V10, P401, DOI 10.1016/j.tics.2006.07.006; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Matthews WJ, 2014, WIRES COGN SCI, V5, P429, DOI 10.1002/wcs.1298; Matthews WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019815; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Morillon B, 2009, J NEUROSCI, V29, P14803, DOI 10.1523/JNEUROSCI.3222-09.2009; Ono F, 2010, ATTEN PERCEPT PSYCHO, V72, P492, DOI 10.3758/APP.72.2.492; Ortega L, 2008, BEHAV PROCESS, V78, P380, DOI 10.1016/j.beproc.2008.02.004; Pariyadath V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001264; Park J, 2003, EXP BRAIN RES, V149, P527, DOI 10.1007/s00221-003-1376-x; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Penney TB, 2000, J EXP PSYCHOL HUMAN, V26, P1770, DOI 10.1037//0096-1523.26.6.1770; Penney TB, 2014, ACTA PSYCHOL, V147, P97, DOI 10.1016/j.actpsy.2013.07.017; PentonVoak IS, 1996, J EXP PSYCHOL ANIM B, V22, P307, DOI 10.1037/0097-7403.22.3.307; Pouthas V, 2005, HUM BRAIN MAPP, V25, P433, DOI 10.1002/hbm.20126; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P1085, DOI 10.1037//0096-1523.28.5.1085; Repp BH, 2013, TIMING TIME PERCEPTI, V1, P65, DOI [10.1163/22134468-00002001, DOI 10.1163/22134468-00002001]; Rousseau L, 1996, PERCEPT PSYCHOPHYS, V58, P434, DOI 10.3758/BF03206819; Schwartze M, 2012, NEUROIMAGE, V60, P290, DOI 10.1016/j.neuroimage.2011.11.089; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; Shi ZH, 2013, TRENDS COGN SCI, V17, P556, DOI 10.1016/j.tics.2013.09.009; Shimojo S., 2001, Acoustical Science and Technology, V22, P61, DOI 10.1250/ast.22.61; Shimojo S, 2001, CURR OPIN NEUROBIOL, V11, P505, DOI 10.1016/S0959-4388(00)00241-5; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; TREISMAN M, 1990, PERCEPTION, V19, P705, DOI 10.1068/p190705; TREISMAN M, 1992, EUR J COGN PSYCHOL, V4, P41, DOI 10.1080/09541449208406242; Ulrich R, 2006, PSYCHOL RES-PSYCH FO, V70, P77, DOI 10.1007/S00426-004-0195-4; van Rijn H, 2014, ADV EXP MED BIOL, V829, P75, DOI 10.1007/978-1-4939-1782-2_5; van Rijn H, 2008, ACTA PSYCHOL, V129, P365, DOI 10.1016/j.actpsy.2008.09.002; van Wassenhove V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001437; Wada Y, 2003, INT J PSYCHOPHYSIOL, V50, P117, DOI 10.1016/S0167-8760(03)00128-4; Wearden JH, 2006, Q J EXP PSYCHOL, V59, P1709, DOI 10.1080/17470210500314729; Wearden JH, 1998, Q J EXP PSYCHOL-B, V51, P97; Wearden JH, 1999, BEHAV PROCESS, V46, P63, DOI 10.1016/S0376-6357(99)00004-2; Wearden JH, 2009, Q J EXP PSYCHOL, V62, P33, DOI 10.1080/17470210802229047; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Yarrow K, 2003, CURR BIOL, V13, P1134, DOI 10.1016/S0960-9822(03)00413-5	80	10	10	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135646	10.1371/journal.pone.0135646	http://dx.doi.org/10.1371/journal.pone.0135646			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5KH	26292285	Green Published, gold, Green Submitted			2022-12-27	WOS:000359919900024
J	Zhang, YQ; Wei, XL; Liang, YK; Chen, WL; Zhang, F; Bai, JW; Qiu, SQ; Du, CW; Huang, WH; Zhang, GJ				Zhang, Yong-Qu; Wei, Xiao-Long; Liang, Yuan-Ke; Chen, Wei-Ling; Zhang, Fan; Bai, Jing-Wen; Qiu, Si-Qi; Du, Cal-Wen; Huang, Wen-He; Zhang, Guo-Jun			Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; TRANSCRIPTION FACTORS; CONSERVING THERAPY; LOCAL RECURRENCE; BETA-CATENIN; PHOSPHORYLATION; METASTASIS; RESISTANCE; CARCINOMA; PROTEIN	Overexpression of Twist, a highly conserved basic helix-loop-helix transcription factor, is associated with epithelial-mesenchymal transition (EMT) and predicts poor prognosis in various kinds of cancers, including breast cancer. In order to further clarify Twist's role in breast cancer, we detected Twist expression in breast cancer tissues by immunohistochemistry. Twist expression was observed in 54% (220/408) of breast cancer patients and was positively associated with tumor size, Ki67, VEGF-C and HER2 expression. Conversely, Twist was negatively associated with estrogen receptor (ER), progesterone receptor (PgR) and E-cadherin expression. Patients with Twist expression had a poorer prognosis for 30-month disease free survival (DFS) (82.9%) than patients with negative Twist (92.3%). Overexpression of Twist led to dramatic changes in cellular morphology, proliferation, migratory/ invasive capability, and expression of EMT-related biomarkers in breast cancer cells. Moreover, we show that Twist serves as a driver of tumorigenesis, as well as an inducer of EMT, at least in part, through activation of the Akt and extracellular signal-regulated protein kinase (ERK) pathways which are critical for Twist-mediated EMT. Our results demonstrate that Twist expression is an important prognostic factor in breast cancer patients.	[Zhang, Yong-Qu; Chen, Wei-Ling; Bai, Jing-Wen; Qiu, Si-Qi; Huang, Wen-He; Zhang, Guo-Jun] Shantou Univ, Coll Med, Canc Hosp, Breast Ctr, Shantou, Guangdong, Peoples R China; [Zhang, Yong-Qu; Liang, Yuan-Ke; Bai, Jing-Wen; Zhang, Guo-Jun] Shantou Univ, Coll Med, Canc Res Ctr, Shantou, Guangdong, Peoples R China; [Wei, Xiao-Long] Shantou Univ, Coll Med, Canc Hosp, Dept Pathol, Shantou, Guangdong, Peoples R China; [Liang, Yuan-Ke; Chen, Wei-Ling; Zhang, Fan; Bai, Jing-Wen; Zhang, Guo-Jun] Shantou Univ, Coll Med, Canc Hosp, Changjiang Scholars Res Lab, Shantou, Guangdong, Peoples R China; [Du, Cal-Wen] Shantou Univ, Coll Med, Canc Hosp, Dept Breast Med Oncol, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University; Shantou University; Shantou University	Zhang, GJ (corresponding author), Shantou Univ, Coll Med, Canc Hosp, Breast Ctr, Shantou, Guangdong, Peoples R China.	huangwenhe2009@163.com; guoj_zhang@yahoo.com	Zhang, Guo-Jun/H-3890-2015; Bai, Jingwen/AAG-3794-2019; Liang, Yuanke/AAG-2045-2021	Zhang, Guo-Jun/0000-0001-5182-5887; bai, jingwen/0000-0002-2107-2746	Major State Basic Research Development Program of China [2011CB707705]; Natural Science Foundation Committee [31271068, 81302331]; Guangdong Provincial Science and Technology Planning Project [2011B031800305]; Guangdong Provincial Key Laboratory on Breast Cancer Diagnosis and Treatment Research	Major State Basic Research Development Program of China(National Basic Research Program of China); Natural Science Foundation Committee(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Science and Technology Planning Project; Guangdong Provincial Key Laboratory on Breast Cancer Diagnosis and Treatment Research	This work was partly supported by the funds from the Major State Basic Research Development Program of China (No. 2011CB707705. http://www.973.gov.cn/English/Index.aspx); Natural Science Foundation Committee (No. 31271068, 81302331/http://www.nsfc.gov.cn/publish/portal1/); Guangdong Provincial Science and Technology Planning Project (2011B031800305/http://www.gdstc.gov.cn/eng/mission.html) and Guangdong Provincial Key Laboratory on Breast Cancer Diagnosis and Treatment Research.	Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; [Anonymous], 2012, J THEOR PHYS, DOI DOI 10.1103/PHYSREVA.85; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; Dong AL, 2011, J PHARMACOL EXP THER, V339, P238, DOI 10.1124/jpet.111.181081; Elkhuizen PHM, 1999, INT J RADIAT ONCOL, V45, P73, DOI 10.1016/S0360-3016(99)00158-3; Elkhuizen PHM, 2000, J CLIN ONCOL, V18, P1075, DOI 10.1200/JCO.2000.18.5.1075; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Hong J, 2011, CANCER RES, V71, P3980, DOI 10.1158/0008-5472.CAN-10-2914; Howe LR, 2003, CANCER RES, V63, P1906; Huang J, 2014, EUR REV MED PHARMACO, V18, P2662; Hung JJ, 2009, THORAX, V64, P1082, DOI 10.1136/thx.2009.115691; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Li NY, 2013, SURGERY, V154, P404, DOI 10.1016/j.surg.2013.05.012; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Luo GQ, 2008, WORLD J GASTROENTERO, V14, P2487, DOI 10.3748/wjg.14.2487; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Mechera R, 2009, BREAST CANCER RES TR, V116, P171, DOI 10.1007/s10549-008-0187-y; Millar EKA, 2009, J CLIN ONCOL, V27, P4701, DOI 10.1200/JCO.2008.21.7075; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Mirza NQ, 2002, ANN SURG ONCOL, V9, P256, DOI 10.1245/aso.2002.9.3.256; Pai HC, 2013, J MOL MED, V91, P347, DOI 10.1007/s00109-012-0945-5; Piccinin S, 2012, CANCER CELL, V22, P404, DOI 10.1016/j.ccr.2012.08.003; Pinho AV, 2011, CELL CYCLE, V10, P1312, DOI 10.4161/cc.10.8.15363; Rausei S, 2010, BREAST J, V16, pS29, DOI 10.1111/j.1524-4741.2010.01000.x; Saadai P, 2011, BREAST CANCER-TOKYO, V18, P221, DOI 10.1007/s12282-011-0262-9; Seng TJ, 2007, ONCOGENE, V26, P934, DOI 10.1038/sj.onc.1209839; Shibata K, 2008, ANN ONCOL, V19, P81, DOI 10.1093/annonc/mdm344; Shiota M, 2011, BJU INT, V108, pE142, DOI 10.1111/j.1464-410X.2010.09810.x; Soini Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-73; Sun SR, 2012, AM J NEPHROL, V35, P141, DOI 10.1159/000335191; Teng Y, 2014, CLIN EXP METASTAS, V31, P367, DOI 10.1007/s10585-013-9621-6; van Nes JGH, 2012, BREAST CANCER RES TR, V133, P49, DOI 10.1007/s10549-011-1684-y; Vesuna F, 2012, ONCOGENE, V31, P3223, DOI 10.1038/onc.2011.483; Vichalkovski A, 2010, ONCOGENE, V29, P3554, DOI 10.1038/onc.2010.115; Wallerand H, 2010, UROL ONCOL-SEMIN ORI, V28, P473, DOI 10.1016/j.urolonc.2008.12.018; Wang XH, 2004, ONCOGENE, V23, P474, DOI 10.1038/sj.onc.1207128; Watanabe O, 2004, ANTICANCER RES, V24, P3851; Way TD, 2014, EUR J CANCER, V50, P366, DOI 10.1016/j.ejca.2013.09.025; Wei XM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-248; Wei XL, 2015, ONCOTARGET; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang P, 2014, CURR MOL MED, V14, P174, DOI 10.2174/1566524013666131121115656; Yuen HF, 2007, HISTOPATHOLOGY, V50, P648, DOI 10.1111/j.1365-2559.2007.02665.x; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhuo WL, 2008, BIOCHEM BIOPH RES CO, V369, P1098, DOI 10.1016/j.bbrc.2008.02.143	51	59	63	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135851	10.1371/journal.pone.0135851	http://dx.doi.org/10.1371/journal.pone.0135851			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26251878	Green Published, gold, Green Submitted			2022-12-27	WOS:000359926900045
